{"query_id": "topic_001_turn_1", "conversation_id": "topic_001", "turn_id": 1, "query": "Key tribological properties and advantages of MoS₂ as a solid lubricant", "history": [], "ground_truth": ["permed-74387", "permed-74388", "permed-85910", "permed-76277", "permed-74392", "permed-74390", "permed-73328", "permed-85911", "permed-91516", "permed-54902"]}
{"query_id": "topic_001_turn_2", "conversation_id": "topic_001", "turn_id": 2, "query": "Influence of oxygen incorporation on these MoS₂ tribological properties and its effect on lubricant performance and durability", "history": ["Key tribological properties and advantages of MoS₂ as a solid lubricant"], "ground_truth": ["permed-74387", "permed-85910", "permed-74392", "permed-76277", "permed-73328", "permed-86677", "permed-74388", "permed-74390", "permed-78865", "permed-81161"]}
{"query_id": "topic_001_turn_3", "conversation_id": "topic_001", "turn_id": 3, "query": "Long-term performance and degradation mechanisms of oxygen-incorporated MoS₂ solid lubricant films under variable industrial environmental stressors (e.g., temperature, humidity, reactive atmospheres)", "history": ["Key tribological properties and advantages of MoS₂ as a solid lubricant", "Influence of oxygen incorporation on these MoS₂ tribological properties and its effect on lubricant performance and durability"], "ground_truth": ["permed-74387", "permed-76277", "permed-85910", "permed-74388", "permed-73328", "permed-87332", "permed-74392", "permed-79308", "permed-51035", "permed-86500"]}
{"query_id": "topic_002_turn_1", "conversation_id": "topic_002", "turn_id": 1, "query": "What treatments are available for older adults with EGFR-mutated non-small cell lung cancer?", "history": [], "ground_truth": ["permed-81444", "permed-56787", "permed-55075", "permed-55070", "permed-20906", "permed-20911", "permed-56447", "permed-56784", "permed-81445", "permed-20908"]}
{"query_id": "topic_002_turn_2", "conversation_id": "topic_002", "turn_id": 2, "query": "How effective is osimertinib, specifically, in improving outcomes for this group of patients?", "history": ["What treatments are available for older adults with EGFR-mutated non-small cell lung cancer?"], "ground_truth": ["permed-80688", "permed-71202", "permed-81444", "permed-80145", "permed-55073", "permed-80689", "permed-70489", "permed-55080", "permed-72636", "permed-21417"]}
{"query_id": "topic_002_turn_3", "conversation_id": "topic_002", "turn_id": 3, "query": "Since osimertinib has shown good efficacy in improving progression-free survival for older adults with advanced EGFR-mutated NSCLC, what do we know about its long-term effects on their quality of life and cognitive function? And how do these outcomes compare with those seen in younger patients receiving the same treatment?", "history": ["What treatments are available for older adults with EGFR-mutated non-small cell lung cancer?", "How effective is osimertinib, specifically, in improving outcomes for this group of patients?"], "ground_truth": ["permed-81444", "permed-80688", "permed-21417", "permed-55075", "permed-75855", "permed-20911", "permed-50981", "permed-80145", "permed-55073", "permed-55080"]}
{"query_id": "topic_003_turn_1", "conversation_id": "topic_003", "turn_id": 1, "query": "What role does environmental exposure play in the development of neurodevelopmental disorders in children?", "history": [], "ground_truth": ["permed-78415", "permed-79037", "permed-87954", "permed-69943", "permed-81924", "permed-81646", "permed-78152", "permed-58098", "permed-53539", "permed-35660"]}
{"query_id": "topic_003_turn_2", "conversation_id": "topic_003", "turn_id": 2, "query": "How specifically does prenatal exposure to certain toxins, like pesticides, impact this risk?", "history": ["What role does environmental exposure play in the development of neurodevelopmental disorders in children?"], "ground_truth": ["permed-65859", "permed-65858", "permed-65857", "permed-81922", "permed-78415", "permed-39670", "permed-69853", "permed-58111", "permed-77822", "permed-77881"]}
{"query_id": "topic_003_turn_3", "conversation_id": "topic_003", "turn_id": 3, "query": "Given that prenatal pesticide exposure increases the risk of neurodevelopmental disorders, how do genetic predispositions and epigenetic modifications interact with this exposure to further modulate the risk for conditions like ASD and ADHD? What are the potential biological mechanisms behind these interactions?", "history": ["What role does environmental exposure play in the development of neurodevelopmental disorders in children?", "How specifically does prenatal exposure to certain toxins, like pesticides, impact this risk?"], "ground_truth": ["permed-81922", "permed-81923", "permed-81924", "permed-79037", "permed-81926", "permed-65859", "permed-53539", "permed-81786", "permed-78415", "permed-55749"]}
{"query_id": "topic_004_turn_1", "conversation_id": "topic_004", "turn_id": 1, "query": "Identify primary vectors of African tick bite fever and their role in disease transmission.", "history": [], "ground_truth": ["permed-75074", "permed-62086", "permed-85211", "permed-75075", "permed-66969", "permed-89144", "permed-85213", "permed-61296", "permed-79179", "permed-64243"]}
{"query_id": "topic_004_turn_2", "conversation_id": "topic_004", "turn_id": 2, "query": "Ecology of African tick bite fever vectors like *Amblyomma hebraeum* and its impact on disease transmission regionally.", "history": ["Identify primary vectors of African tick bite fever and their role in disease transmission."], "ground_truth": ["permed-75074", "permed-61296", "permed-62086", "permed-75075", "permed-72252", "permed-66969", "permed-64243", "permed-62082", "permed-79179", "permed-85206"]}
{"query_id": "topic_004_turn_3", "conversation_id": "topic_004", "turn_id": 3, "query": "Eastern Cape climate and cattle farming effects on *Amblyomma hebraeum* seasonality, *Rickettsia africae* vector competence, and ATBF risk.", "history": ["Identify primary vectors of African tick bite fever and their role in disease transmission.", "Ecology of African tick bite fever vectors like *Amblyomma hebraeum* and its impact on disease transmission regionally."], "ground_truth": ["permed-75074", "permed-72252", "permed-75076", "permed-75075", "permed-61294", "permed-89145", "permed-62086", "permed-62082", "permed-79176", "permed-89144"]}
{"query_id": "topic_005_turn_1", "conversation_id": "topic_005", "turn_id": 1, "query": "Comprehensive review of Solute Carrier (SLC) gene family roles in colorectal cancer development and progression", "history": [], "ground_truth": ["permed-85505", "permed-73587", "permed-82373", "permed-68070", "permed-68563", "permed-84468", "permed-78221", "permed-74304", "permed-53496", "permed-56488"]}
{"query_id": "topic_005_turn_2", "conversation_id": "topic_005", "turn_id": 2, "query": "Impact of downregulating specific SLC genes, such as SLC4A4, on colorectal tumor biology and patient outcomes, given their established oncogenic or tumor-suppressive functions", "history": ["Comprehensive review of Solute Carrier (SLC) gene family roles in colorectal cancer development and progression"], "ground_truth": ["permed-73587", "permed-82373", "permed-68070", "permed-53496", "permed-51224", "permed-87972", "permed-74304", "permed-70941", "permed-51109", "permed-56617"]}
{"query_id": "topic_005_turn_3", "conversation_id": "topic_005", "turn_id": 3, "query": "Investigating SLC4A4 downregulation in colorectal cancer: its regulation by miRNAs like hsa-miR-106a-5p and hsa-miR-223-3p, effects on tumor microenvironment (immune infiltration, EMT), and potential therapeutic targeting of these pathways", "history": ["Comprehensive review of Solute Carrier (SLC) gene family roles in colorectal cancer development and progression", "Impact of downregulating specific SLC genes, such as SLC4A4, on colorectal tumor biology and patient outcomes, given their established oncogenic or tumor-suppressive functions"], "ground_truth": ["permed-73587", "permed-75079", "permed-68070", "permed-67155", "permed-73566", "permed-73503", "permed-56251", "permed-73583", "permed-49093", "permed-55315"]}
{"query_id": "topic_006_turn_1", "conversation_id": "topic_006", "turn_id": 1, "query": "What advancements have been made in using neural networks for improving MRI reconstruction quality?", "history": [], "ground_truth": ["permed-75784", "permed-51670", "permed-51672", "permed-60554", "permed-75785", "permed-87560", "permed-87558", "permed-83773", "permed-28724", "permed-61607"]}
{"query_id": "topic_006_turn_2", "conversation_id": "topic_006", "turn_id": 2, "query": "How does spatial-temporal dictionary learning fit into this area of research, particularly for 4D-MRI applications?", "history": ["What advancements have been made in using neural networks for improving MRI reconstruction quality?"], "ground_truth": ["permed-51670", "permed-81022", "permed-75784", "permed-28724", "permed-81188", "permed-68809", "permed-75787", "permed-75785", "permed-73815", "permed-59315"]}
{"query_id": "topic_006_turn_3", "conversation_id": "topic_006", "turn_id": 3, "query": "Building on these approaches, how might integrating adaptive learning rates into the coefficient estimation modules of stDLNNs further enhance reconstruction quality and computational efficiency for high-acceleration 4D-MRI? What clinical benefits and patient outcome improvements could we expect from such optimizations?", "history": ["What advancements have been made in using neural networks for improving MRI reconstruction quality?", "How does spatial-temporal dictionary learning fit into this area of research, particularly for 4D-MRI applications?"], "ground_truth": ["permed-51670", "permed-75784", "permed-51672", "permed-29527", "permed-51665", "permed-29129", "permed-83773", "permed-29606", "permed-51668", "permed-60522"]}
{"query_id": "topic_007_turn_1", "conversation_id": "topic_007", "turn_id": 1, "query": "What role do GLP-1 receptors play in the body beyond glucose regulation?", "history": [], "ground_truth": ["permed-23404", "permed-58577", "permed-25238", "permed-29741", "permed-31397", "permed-58576", "permed-82201", "permed-23407", "permed-66289", "permed-58404"]}
{"query_id": "topic_007_turn_2", "conversation_id": "topic_007", "turn_id": 2, "query": "Given their broad expression, how might targeting these receptors systemically impact neurological health and function?", "history": ["What role do GLP-1 receptors play in the body beyond glucose regulation?"], "ground_truth": ["permed-78886", "permed-79929", "permed-70722", "permed-56473", "permed-69134", "permed-56586", "permed-89314", "permed-72010", "permed-69268", "permed-63186"]}
{"query_id": "topic_007_turn_3", "conversation_id": "topic_007", "turn_id": 3, "query": "Since GLP-1 receptors are widely expressed in the brain and their systemic targeting could affect neurological health, how might administering GLP-1 receptor agonists impact the neurovascular unit's integrity and cerebral blood flow dynamics in neurodegenerative disease models? What would these changes mean for cognitive function and disease progression?", "history": ["What role do GLP-1 receptors play in the body beyond glucose regulation?", "Given their broad expression, how might targeting these receptors systemically impact neurological health and function?"], "ground_truth": ["permed-54216", "permed-58891", "permed-58577", "permed-10973", "permed-82200", "permed-78886", "permed-23404", "permed-82557", "permed-62647", "permed-89006"]}
{"query_id": "topic_008_turn_1", "conversation_id": "topic_008", "turn_id": 1, "query": "What role do uncorrelated inputs play in neural network learning processes?", "history": [], "ground_truth": ["permed-79055", "permed-59379", "permed-61674", "permed-61677", "permed-68807", "permed-67923", "permed-69427", "permed-61740", "permed-84311", "permed-79063"]}
{"query_id": "topic_008_turn_2", "conversation_id": "topic_008", "turn_id": 2, "query": "How might introducing temporal patterns into these uncorrelated inputs affect their impact on network performance?", "history": ["What role do uncorrelated inputs play in neural network learning processes?"], "ground_truth": ["permed-79055", "permed-69427", "permed-61675", "permed-61728", "permed-79063", "permed-61674", "permed-61724", "permed-61727", "permed-62886", "permed-79057"]}
{"query_id": "topic_008_turn_3", "conversation_id": "topic_008", "turn_id": 3, "query": "Given that uncorrelated inputs help learning in balanced firing-rate networks, how would adding specific temporal patterns to them affect the network's information encoding and processing capabilities? And what could this mean for designing artificial neural networks that better mimic biological learning?", "history": ["What role do uncorrelated inputs play in neural network learning processes?", "How might introducing temporal patterns into these uncorrelated inputs affect their impact on network performance?"], "ground_truth": ["permed-79055", "permed-61674", "permed-69427", "permed-61675", "permed-61740", "permed-59379", "permed-59593", "permed-61677", "permed-61728", "permed-84311"]}
{"query_id": "topic_009_turn_1", "conversation_id": "topic_009", "turn_id": 1, "query": "What are the current treatment options for aneurysmal subarachnoid hemorrhage (aSAH) and how effective are they?", "history": [], "ground_truth": ["permed-59717", "permed-69317", "permed-63332", "permed-63330", "permed-66039", "permed-84172", "permed-79349", "permed-76166", "permed-46942", "permed-79347"]}
{"query_id": "topic_009_turn_2", "conversation_id": "topic_009", "turn_id": 2, "query": "Specifically, in cases involving very small aneurysms, such as those found in the anterior communicating artery, what considerations come into play when choosing a treatment approach for this area?", "history": ["What are the current treatment options for aneurysmal subarachnoid hemorrhage (aSAH) and how effective are they?"], "ground_truth": ["permed-69317", "permed-81322", "permed-68798", "permed-72191", "permed-79563", "permed-66039", "permed-59717", "permed-56265", "permed-81324", "permed-71333"]}
{"query_id": "topic_009_turn_3", "conversation_id": "topic_009", "turn_id": 3, "query": "For these very small anterior communicating artery aneurysms (vsACoA), how do the different management strategies—like surgical clipping versus endovascular coiling—impact patients' long-term neurological outcomes and quality of life after aSAH? And given the unique challenges posed by their size and location, what specific factors should guide the choice between these treatment options?", "history": ["What are the current treatment options for aneurysmal subarachnoid hemorrhage (aSAH) and how effective are they?", "Specifically, in cases involving very small aneurysms, such as those found in the anterior communicating artery, what considerations come into play when choosing a treatment approach for this area?"], "ground_truth": ["permed-69317", "permed-59717", "permed-81322", "permed-54129", "permed-79564", "permed-59718", "permed-59719", "permed-61404", "permed-79563", "permed-63330"]}
{"query_id": "topic_010_turn_1", "conversation_id": "topic_010", "turn_id": 1, "query": "Who are some key figures that have influenced the development of pathological practices?", "history": [], "ground_truth": ["permed-81605", "permed-1453", "permed-5251", "permed-72010", "permed-45068", "permed-81602", "permed-5249", "permed-86778", "permed-61297", "permed-60971"]}
{"query_id": "topic_010_turn_2", "conversation_id": "topic_010", "turn_id": 2, "query": "What impact has Georgiy Vladimirovich Shor's work had on this area of medical research?", "history": ["Who are some key figures that have influenced the development of pathological practices?"], "ground_truth": ["permed-79747", "permed-79748", "permed-53292", "permed-0861", "permed-4433", "permed-41031", "permed-70237", "permed-5799", "permed-91516", "permed-50971"]}
{"query_id": "topic_010_turn_3", "conversation_id": "topic_010", "turn_id": 3, "query": "How have Shor's methodologies and findings shaped modern pathological practices, and which specific areas of medical research still draw on his foundational work today?", "history": ["Who are some key figures that have influenced the development of pathological practices?", "What impact has Georgiy Vladimirovich Shor's work had on this area of medical research?"], "ground_truth": ["permed-79747", "permed-70237", "permed-53292", "permed-45068", "permed-81620", "permed-23267", "permed-8735", "permed-52075", "permed-1453", "permed-6395"]}
{"query_id": "topic_011_turn_1", "conversation_id": "topic_011", "turn_id": 1, "query": "How do passive exoskeletons enhance human mobility across complex or uneven terrains?", "history": [], "ground_truth": ["permed-88212", "permed-61752", "permed-61748", "permed-54865", "permed-61749", "permed-75503", "permed-61755", "permed-61745", "permed-81570", "permed-83189"]}
{"query_id": "topic_011_turn_2", "conversation_id": "topic_011", "turn_id": 2, "query": "How can optimizing key components (e.g., materials, joint mechanisms) in these passive exoskeletons reduce user energy expenditure?", "history": ["How do passive exoskeletons enhance human mobility across complex or uneven terrains?"], "ground_truth": ["permed-61748", "permed-71490", "permed-61745", "permed-75503", "permed-88212", "permed-61752", "permed-54865", "permed-54643", "permed-86859", "permed-61749"]}
{"query_id": "topic_011_turn_3", "conversation_id": "topic_011", "turn_id": 3, "query": "Impact of inverted cam mechanisms and spring steel selection in passive exoskeletons on metabolic cost and user adaptation across varying terrains and body weights", "history": ["How do passive exoskeletons enhance human mobility across complex or uneven terrains?", "How can optimizing key components (e.g., materials, joint mechanisms) in these passive exoskeletons reduce user energy expenditure?"], "ground_truth": ["permed-61748", "permed-61749", "permed-88212", "permed-61752", "permed-86859", "permed-61745", "permed-54865", "permed-65029", "permed-64586", "permed-81570"]}
{"query_id": "topic_012_turn_1", "conversation_id": "topic_012", "turn_id": 1, "query": "Major subtypes of primary cutaneous T-cell lymphoma: classification and key characteristics", "history": [], "ground_truth": ["permed-59442", "permed-56804", "permed-59448", "permed-12909", "permed-13270", "permed-59445", "permed-68136", "permed-67388", "permed-9364", "permed-77066"]}
{"query_id": "topic_012_turn_2", "conversation_id": "topic_012", "turn_id": 2, "query": "Comparative clinical profiles and treatment response variations among these primary cutaneous T-cell lymphoma subtypes", "history": ["Major subtypes of primary cutaneous T-cell lymphoma: classification and key characteristics"], "ground_truth": ["permed-59442", "permed-56804", "permed-67382", "permed-59448", "permed-12909", "permed-67388", "permed-12464", "permed-13270", "permed-52008", "permed-12461"]}
{"query_id": "topic_012_turn_3", "conversation_id": "topic_012", "turn_id": 3, "query": "Molecular mechanisms underlying distinct clinical behaviors and therapeutic vulnerabilities in syringotropic vs folliculotropic mycosis fungoides", "history": ["Major subtypes of primary cutaneous T-cell lymphoma: classification and key characteristics", "Comparative clinical profiles and treatment response variations among these primary cutaneous T-cell lymphoma subtypes"], "ground_truth": ["permed-67387", "permed-77065", "permed-68140", "permed-77067", "permed-67384", "permed-82373", "permed-59568", "permed-59569", "permed-13645", "permed-68414"]}
{"query_id": "topic_013_turn_1", "conversation_id": "topic_013", "turn_id": 1, "query": "What are the primary contaminants found in urban rivers in China that pose a risk to aquatic ecosystems?", "history": [], "ground_truth": ["permed-88881", "permed-81904", "permed-81006", "permed-77780", "permed-80985", "permed-90437", "permed-81019", "permed-81010", "permed-77155", "permed-13664"]}
{"query_id": "topic_013_turn_2", "conversation_id": "topic_013", "turn_id": 2, "query": "How do chlorinated paraffins, like those often identified in this area, affect the health and biodiversity of aquatic organisms?", "history": ["What are the primary contaminants found in urban rivers in China that pose a risk to aquatic ecosystems?"], "ground_truth": ["permed-81904", "permed-82046", "permed-88909", "permed-87814", "permed-81905", "permed-85539", "permed-76126", "permed-78358", "permed-77148", "permed-76123"]}
{"query_id": "topic_013_turn_3", "conversation_id": "topic_013", "turn_id": 3, "query": "Given the prevalence of SCCPs and MCCPs in these black-odorous urban river sediments, along with their co-occurrence with other persistent pollutants, how do these complex mixtures interact within aquatic ecosystems—specifically, what are their combined effects (whether synergistic or antagonistic) on aquatic organism health and overall biodiversity? Furthermore, what long-term human health risks might arise from consuming contaminated fish or water, and how could improved wastewater treatment technologies and environmental policies help mitigate these risks?", "history": ["What are the primary contaminants found in urban rivers in China that pose a risk to aquatic ecosystems?", "How do chlorinated paraffins, like those often identified in this area, affect the health and biodiversity of aquatic organisms?"], "ground_truth": ["permed-81904", "permed-90437", "permed-82250", "permed-87815", "permed-63450", "permed-87814", "permed-81006", "permed-80543", "permed-85539", "permed-80985"]}
{"query_id": "topic_014_turn_1", "conversation_id": "topic_014", "turn_id": 1, "query": "Applications of additive manufacturing for enhancing automotive component safety", "history": [], "ground_truth": ["permed-74194", "permed-74196", "permed-51457", "permed-83121", "permed-60645", "permed-51449", "permed-69706", "permed-82651", "permed-83549", "permed-74078"]}
{"query_id": "topic_014_turn_2", "conversation_id": "topic_014", "turn_id": 2, "query": "Building on these applications, how can polymeric additive manufacturing specifically enhance vehicle interior safety during secondary impacts?", "history": ["Applications of additive manufacturing for enhancing automotive component safety"], "ground_truth": ["permed-74194", "permed-74196", "permed-51457", "permed-51449", "permed-73037", "permed-87249", "permed-57403", "permed-90239", "permed-75260", "permed-51450"]}
{"query_id": "topic_014_turn_3", "conversation_id": "topic_014", "turn_id": 3, "query": "Considering these polymeric AM enhancements for interior safety, what are optimal strategies for combining advanced material properties with design optimization to control component dynamic response and energy absorption in secondary impacts?", "history": ["Applications of additive manufacturing for enhancing automotive component safety", "Building on these applications, how can polymeric additive manufacturing specifically enhance vehicle interior safety during secondary impacts?"], "ground_truth": ["permed-74194", "permed-51450", "permed-90239", "permed-74196", "permed-87249", "permed-73037", "permed-74035", "permed-74195", "permed-51459", "permed-51449"]}
{"query_id": "topic_015_turn_1", "conversation_id": "topic_015", "turn_id": 1, "query": "Primary challenges impacting infant and young child nutrition (IYCN) across diverse cultural settings", "history": [], "ground_truth": ["permed-74807", "permed-74808", "permed-92337", "permed-87509", "permed-45012", "permed-83524", "permed-91759", "permed-55115", "permed-74977", "permed-74809"]}
{"query_id": "topic_015_turn_2", "conversation_id": "topic_015", "turn_id": 2, "query": "Leveraging local agricultural practices and traditional food preparation to overcome those IYCN challenges in such settings", "history": ["Primary challenges impacting infant and young child nutrition (IYCN) across diverse cultural settings"], "ground_truth": ["permed-55107", "permed-69940", "permed-74807", "permed-65029", "permed-70847", "permed-69934", "permed-91759", "permed-66148", "permed-71272", "permed-75160"]}
{"query_id": "topic_015_turn_3", "conversation_id": "topic_015", "turn_id": 3, "query": "Designing culturally-tailored IYCN interventions in Kenya: strategies for integrating local food systems to improve dietary diversity, meal frequency, food safety, and accessibility, while navigating socioeconomic barriers.", "history": ["Primary challenges impacting infant and young child nutrition (IYCN) across diverse cultural settings", "Leveraging local agricultural practices and traditional food preparation to overcome those IYCN challenges in such settings"], "ground_truth": ["permed-74807", "permed-74977", "permed-62789", "permed-74808", "permed-74357", "permed-62791", "permed-74809", "permed-83517", "permed-55115", "permed-74318"]}
{"query_id": "topic_016_turn_1", "conversation_id": "topic_016", "turn_id": 1, "query": "Is there a link between diet and the risk of developing Parkinson's disease in older adults?", "history": [], "ground_truth": ["permed-66149", "permed-81477", "permed-81518", "permed-54210", "permed-65135", "permed-54212", "permed-64878", "permed-92287", "permed-54211", "permed-61990"]}
{"query_id": "topic_016_turn_2", "conversation_id": "topic_016", "turn_id": 2, "query": "How might specific dietary patterns, such as the Mediterranean or Western diets, influence this risk?", "history": ["Is there a link between diet and the risk of developing Parkinson's disease in older adults?"], "ground_truth": ["permed-81477", "permed-81478", "permed-65209", "permed-66149", "permed-65120", "permed-72426", "permed-64992", "permed-34574", "permed-73391", "permed-62923"]}
{"query_id": "topic_016_turn_3", "conversation_id": "topic_016", "turn_id": 3, "query": "Building on these findings about how Mediterranean and Western diets affect Parkinson's risk in older adults, what biological mechanisms might explain why components of the Mediterranean diet appear protective while elements like high sugar intake in Western diets seem harmful? How do these dietary factors interact with genetic predispositions to PD, and what could this mean for developing personalized nutrition strategies to prevent or manage the disease?", "history": ["Is there a link between diet and the risk of developing Parkinson's disease in older adults?", "How might specific dietary patterns, such as the Mediterranean or Western diets, influence this risk?"], "ground_truth": ["permed-81477", "permed-66149", "permed-54212", "permed-54210", "permed-54211", "permed-65135", "permed-92287", "permed-73520", "permed-14120", "permed-81478"]}
{"query_id": "topic_017_turn_1", "conversation_id": "topic_017", "turn_id": 1, "query": "Fingolimod anti-inflammatory properties and mechanisms in respiratory diseases overview", "history": [], "ground_truth": ["permed-76495", "permed-64689", "permed-89603", "permed-68415", "permed-58626", "permed-68512", "permed-86124", "permed-70791", "permed-81296", "permed-66783"]}
{"query_id": "topic_017_turn_2", "conversation_id": "topic_017", "turn_id": 2, "query": "Building on its known respiratory anti-inflammatory effects, what are fingolimod's specific therapeutic mechanisms and benefits for chronic asthma?", "history": ["Fingolimod anti-inflammatory properties and mechanisms in respiratory diseases overview"], "ground_truth": ["permed-76495", "permed-89603", "permed-64689", "permed-79851", "permed-63128", "permed-70791", "permed-53865", "permed-66288", "permed-75922", "permed-21166"]}
{"query_id": "topic_017_turn_3", "conversation_id": "topic_017", "turn_id": 3, "query": "Impact of fingolimod's MAPK/ERK modulation in allergic airway inflammation on chronic asthma: long-term lung function, airway remodeling, and disease course alteration", "history": ["Fingolimod anti-inflammatory properties and mechanisms in respiratory diseases overview", "Building on its known respiratory anti-inflammatory effects, what are fingolimod's specific therapeutic mechanisms and benefits for chronic asthma?"], "ground_truth": ["permed-76495", "permed-89603", "permed-63128", "permed-79851", "permed-76497", "permed-86337", "permed-67281", "permed-66286", "permed-84913", "permed-76496"]}
{"query_id": "topic_018_turn_1", "conversation_id": "topic_018", "turn_id": 1, "query": "What impact is global warming having on ocean currents and atmospheric patterns?", "history": [], "ground_truth": ["permed-59349", "permed-79953", "permed-79952", "permed-79957", "permed-79955", "permed-77921", "permed-82727", "permed-82726", "permed-79960", "permed-81998"]}
{"query_id": "topic_018_turn_2", "conversation_id": "topic_018", "turn_id": 2, "query": "How might changes in this area affect weather systems, particularly in the Southern Hemisphere?", "history": ["What impact is global warming having on ocean currents and atmospheric patterns?"], "ground_truth": ["permed-79952", "permed-79957", "permed-73392", "permed-83709", "permed-59349", "permed-59352", "permed-74166", "permed-84990", "permed-79953", "permed-73999"]}
{"query_id": "topic_018_turn_3", "conversation_id": "topic_018", "turn_id": 3, "query": "Given these impacts on Southern Hemisphere weather systems, how might projected changes in Southern Ocean currents and atmospheric circulation patterns affect the distribution and intensity of storms across different latitudes? What implications could these shifts have for regional climate variability and extreme weather events?", "history": ["What impact is global warming having on ocean currents and atmospheric patterns?", "How might changes in this area affect weather systems, particularly in the Southern Hemisphere?"], "ground_truth": ["permed-79952", "permed-59349", "permed-83709", "permed-79957", "permed-82726", "permed-79953", "permed-59356", "permed-74166", "permed-59351", "permed-73999"]}
{"query_id": "topic_019_turn_1", "conversation_id": "topic_019", "turn_id": 1, "query": "Comprehensive overview of PAH contamination sources, levels, and distribution in Southeast Asian agricultural products", "history": [], "ground_truth": ["permed-78235", "permed-83765", "permed-79820", "permed-78239", "permed-78237", "permed-78238", "permed-79822", "permed-78242", "permed-78241", "permed-78240"]}
{"query_id": "topic_019_turn_2", "conversation_id": "topic_019", "turn_id": 2, "query": "Specific effects of this PAH contamination on paddy rice varieties in Southeast Asia and efficacy of current mitigation techniques", "history": ["Comprehensive overview of PAH contamination sources, levels, and distribution in Southeast Asian agricultural products"], "ground_truth": ["permed-78235", "permed-79820", "permed-73003", "permed-74125", "permed-68563", "permed-89618", "permed-64170", "permed-87697", "permed-74143", "permed-74122"]}
{"query_id": "topic_019_turn_3", "conversation_id": "topic_019", "turn_id": 3, "query": "Developing advanced mitigation strategies for PAH in Thai and Lao paddy rice: optimizing alternative farming and urban planning based on contamination patterns to reduce human exposure and ecological risks", "history": ["Comprehensive overview of PAH contamination sources, levels, and distribution in Southeast Asian agricultural products", "Specific effects of this PAH contamination on paddy rice varieties in Southeast Asia and efficacy of current mitigation techniques"], "ground_truth": ["permed-78235", "permed-79820", "permed-74143", "permed-77822", "permed-74125", "permed-78237", "permed-68563", "permed-73003", "permed-78240", "permed-83765"]}
{"query_id": "topic_020_turn_1", "conversation_id": "topic_020", "turn_id": 1, "query": "Ecological consequences of habitat fragmentation for local species diversity and ecosystem functions", "history": [], "ground_truth": ["permed-74410", "permed-74411", "permed-62986", "permed-62991", "permed-62963", "permed-74417", "permed-74412", "permed-74592", "permed-62954", "permed-62960"]}
{"query_id": "topic_020_turn_2", "conversation_id": "topic_020", "turn_id": 2, "query": "How does the spatial arrangement of these fragmented habitats influence their ecological resilience to climate change and other environmental disturbances?", "history": ["Ecological consequences of habitat fragmentation for local species diversity and ecosystem functions"], "ground_truth": ["permed-62986", "permed-74411", "permed-74410", "permed-88353", "permed-62962", "permed-62954", "permed-64044", "permed-71975", "permed-77374", "permed-74417"]}
{"query_id": "topic_020_turn_3", "conversation_id": "topic_020", "turn_id": 3, "query": "Impact of habitat patch configuration (connectivity, shape, size) on species community resilience to environmental stressors and evidence-based design of conservation corridors and reserve networks", "history": ["Ecological consequences of habitat fragmentation for local species diversity and ecosystem functions", "How does the spatial arrangement of these fragmented habitats influence their ecological resilience to climate change and other environmental disturbances?"], "ground_truth": ["permed-62986", "permed-74410", "permed-74411", "permed-75160", "permed-62958", "permed-77374", "permed-62963", "permed-74417", "permed-62886", "permed-62960"]}
{"query_id": "topic_021_turn_1", "conversation_id": "topic_021", "turn_id": 1, "query": "Survey of current methods for converting plastic waste into valuable chemicals", "history": [], "ground_truth": ["permed-74753", "permed-82856", "permed-60645", "permed-74755", "permed-74757", "permed-74754", "permed-80629", "permed-87929", "permed-86233", "permed-74759"]}
{"query_id": "topic_021_turn_2", "conversation_id": "topic_021", "turn_id": 2, "query": "Effectiveness of photocatalysis and biocatalysis for such plastic chemical conversion", "history": ["Survey of current methods for converting plastic waste into valuable chemicals"], "ground_truth": ["permed-74753", "permed-58015", "permed-60900", "permed-74922", "permed-80329", "permed-87955", "permed-64285", "permed-58016", "permed-87957", "permed-83507"]}
{"query_id": "topic_021_turn_3", "conversation_id": "topic_021", "turn_id": 3, "query": "Strategies for enhancing integrated photocatalysis-biocatalysis in plastic upcycling: advanced materials, catalyst design, mild conditions, and scale-up challenges", "history": ["Survey of current methods for converting plastic waste into valuable chemicals", "Effectiveness of photocatalysis and biocatalysis for such plastic chemical conversion"], "ground_truth": ["permed-78257", "permed-74753", "permed-60900", "permed-87961", "permed-58268", "permed-87957", "permed-74756", "permed-83507", "permed-80329", "permed-78329"]}
{"query_id": "topic_022_turn_1", "conversation_id": "topic_022", "turn_id": 1, "query": "What role does iron oxide play in photoelectrochemical systems, particularly in enhancing light absorption and charge transport?", "history": [], "ground_truth": ["permed-55229", "permed-83406", "permed-55227", "permed-55272", "permed-83405", "permed-74971", "permed-59170", "permed-60469", "permed-76729", "permed-76721"]}
{"query_id": "topic_022_turn_2", "conversation_id": "topic_022", "turn_id": 2, "query": "How can the properties of iron oxide be tailored during synthesis to improve its performance in these systems?", "history": ["What role does iron oxide play in photoelectrochemical systems, particularly in enhancing light absorption and charge transport?"], "ground_truth": ["permed-77035", "permed-90287", "permed-90103", "permed-76729", "permed-76108", "permed-59165", "permed-60470", "permed-85163", "permed-90195", "permed-75438"]}
{"query_id": "topic_022_turn_3", "conversation_id": "topic_022", "turn_id": 3, "query": "Given the role of iron oxide in these systems and the ways its properties can be tailored during synthesis, how can we systematically control the morphology of its precursors to optimize the balance between light absorption and charge transport? What specific mechanisms drive the observed improvements in photocurrent density and reduction in onset potential? Furthermore, how do different post-synthesis treatments and cocatalyst combinations affect the long-term stability and operational efficiency of iron oxide photoanodes in practical photoelectrochemical applications?", "history": ["What role does iron oxide play in photoelectrochemical systems, particularly in enhancing light absorption and charge transport?", "How can the properties of iron oxide be tailored during synthesis to improve its performance in these systems?"], "ground_truth": ["permed-55229", "permed-83406", "permed-90103", "permed-62930", "permed-75938", "permed-55231", "permed-81148", "permed-85163", "permed-75592", "permed-55227"]}
{"query_id": "topic_023_turn_1", "conversation_id": "topic_023", "turn_id": 1, "query": "Current challenges and evolving strategies in diagnosing and treating ACTH-independent Cushing syndrome.", "history": [], "ground_truth": ["permed-86033", "permed-77486", "permed-29934", "permed-58897", "permed-82658", "permed-86034", "permed-5301", "permed-77487", "permed-58901", "permed-82657"]}
{"query_id": "topic_023_turn_2", "conversation_id": "topic_023", "turn_id": 2, "query": "Regarding such diagnostic challenges, what is the comparative efficacy of advanced imaging techniques for localizing ectopic adrenocortical adenomas in ACTH-independent Cushing syndrome?", "history": ["Current challenges and evolving strategies in diagnosing and treating ACTH-independent Cushing syndrome."], "ground_truth": ["permed-77456", "permed-86033", "permed-56728", "permed-77486", "permed-23385", "permed-48650", "permed-25214", "permed-29931", "permed-5301", "permed-23445"]}
{"query_id": "topic_023_turn_3", "conversation_id": "topic_023", "turn_id": 3, "query": "Building on these imaging insights for ectopic adrenocortical adenomas, how does integrating 68Ga-DOTATATE PET/CT with multimodal approaches and biochemical markers refine diagnosis and guide intervention for persistent ACTH-independent Cushing syndrome after failed surgery?", "history": ["Current challenges and evolving strategies in diagnosing and treating ACTH-independent Cushing syndrome.", "Regarding such diagnostic challenges, what is the comparative efficacy of advanced imaging techniques for localizing ectopic adrenocortical adenomas in ACTH-independent Cushing syndrome?"], "ground_truth": ["permed-77456", "permed-23385", "permed-56706", "permed-48379", "permed-30064", "permed-77486", "permed-58896", "permed-56728", "permed-48650", "permed-48496"]}
{"query_id": "topic_024_turn_1", "conversation_id": "topic_024", "turn_id": 1, "query": "What role do milk-based bionutrients play in the development and health of preterm infants?", "history": [], "ground_truth": ["permed-57668", "permed-90231", "permed-67070", "permed-87509", "permed-24565", "permed-45090", "permed-81641", "permed-90229", "permed-91900", "permed-81642"]}
{"query_id": "topic_024_turn_2", "conversation_id": "topic_024", "turn_id": 2, "query": "How do different sources of these bionutrients impact their effectiveness in this area?", "history": ["What role do milk-based bionutrients play in the development and health of preterm infants?"], "ground_truth": ["permed-57668", "permed-65029", "permed-65321", "permed-65194", "permed-82651", "permed-83886", "permed-91759", "permed-45034", "permed-38842", "permed-89314"]}
{"query_id": "topic_024_turn_3", "conversation_id": "topic_024", "turn_id": 3, "query": "Given these differences in composition and bioavailability between human milk, bovine milk, and artificial supplements, how exactly do these variations affect their efficacy in supporting preterm infant development and health? And what approaches could be used to enhance their therapeutic benefits while reducing potential risks?", "history": ["What role do milk-based bionutrients play in the development and health of preterm infants?", "How do different sources of these bionutrients impact their effectiveness in this area?"], "ground_truth": ["permed-90231", "permed-57668", "permed-90229", "permed-81641", "permed-87509", "permed-67070", "permed-45090", "permed-45122", "permed-45123", "permed-65178"]}
{"query_id": "topic_025_turn_1", "conversation_id": "topic_025", "turn_id": 1, "query": "Factors contributing to recent cervical cancer incidence trends in Japan", "history": [], "ground_truth": ["permed-71367", "permed-71354", "permed-85505", "permed-68598", "permed-71353", "permed-7421", "permed-31992", "permed-35859", "permed-68563", "permed-61992"]}
{"query_id": "topic_025_turn_2", "conversation_id": "topic_025", "turn_id": 2, "query": "Impact of these Japanese cervical cancer trends on younger women AND emerging alternative prevention strategies", "history": ["Factors contributing to recent cervical cancer incidence trends in Japan"], "ground_truth": ["permed-71367", "permed-7689", "permed-21506", "permed-59568", "permed-74394", "permed-73409", "permed-85505", "permed-7421", "permed-7685", "permed-68598"]}
{"query_id": "topic_025_turn_3", "conversation_id": "topic_025", "turn_id": 3, "query": "Efficacy of non-HPV vaccine cervical cancer prevention strategies for young women in Japan AND projected long-term public health and healthcare system impacts", "history": ["Factors contributing to recent cervical cancer incidence trends in Japan", "Impact of these Japanese cervical cancer trends on younger women AND emerging alternative prevention strategies"], "ground_truth": ["permed-71367", "permed-21506", "permed-7689", "permed-59568", "permed-7684", "permed-21507", "permed-79409", "permed-73409", "permed-83206", "permed-21511"]}
{"query_id": "topic_026_turn_1", "conversation_id": "topic_026", "turn_id": 1, "query": "Autophagy mechanisms in mitigating Parkinson's disease progression and neuronal loss.", "history": [], "ground_truth": ["permed-67686", "permed-77829", "permed-79637", "permed-67923", "permed-62648", "permed-54215", "permed-50617", "permed-77830", "permed-67792", "permed-9033"]}
{"query_id": "topic_026_turn_2", "conversation_id": "topic_026", "turn_id": 2, "query": "Flavonoid compounds enhancing *these autophagy mechanisms* for dopaminergic neuron protection in Parkinson's.", "history": ["Autophagy mechanisms in mitigating Parkinson's disease progression and neuronal loss."], "ground_truth": ["permed-67686", "permed-62648", "permed-77830", "permed-52953", "permed-91269", "permed-82051", "permed-66417", "permed-62652", "permed-62653", "permed-79613"]}
{"query_id": "topic_026_turn_3", "conversation_id": "topic_026", "turn_id": 3, "query": "Kaempferol's specific molecular interactions with mTOR pathway components to enhance autophagy, preserve mitochondrial function, and reduce α-synuclein aggregates in Parkinson's dopaminergic neurons.", "history": ["Autophagy mechanisms in mitigating Parkinson's disease progression and neuronal loss.", "Flavonoid compounds enhancing *these autophagy mechanisms* for dopaminergic neuron protection in Parkinson's."], "ground_truth": ["permed-67686", "permed-62648", "permed-66417", "permed-77829", "permed-63158", "permed-71411", "permed-71414", "permed-63159", "permed-82442", "permed-86344"]}
{"query_id": "topic_027_turn_1", "conversation_id": "topic_027", "turn_id": 1, "query": "Synthesis and application advancements of novel cycloparaphenylene derivatives for high-performance organic photovoltaics", "history": [], "ground_truth": ["permed-77736", "permed-77739", "permed-77737", "permed-53786", "permed-64164", "permed-60645", "permed-53780", "permed-75689", "permed-53784", "permed-86531"]}
{"query_id": "topic_027_turn_2", "conversation_id": "topic_027", "turn_id": 2, "query": "Influence of heteroatom incorporation, such as in N,N-dimethyl-diaza{6}cycloparaphenylene, on excitonic and charge carrier dynamics within these novel cycloparaphenylene-based photovoltaic materials", "history": ["Synthesis and application advancements of novel cycloparaphenylene derivatives for high-performance organic photovoltaics"], "ground_truth": ["permed-77736", "permed-77737", "permed-77739", "permed-75698", "permed-53786", "permed-86531", "permed-53776", "permed-75447", "permed-76878", "permed-76856"]}
{"query_id": "topic_027_turn_3", "conversation_id": "topic_027", "turn_id": 3, "query": "Computational and experimental design strategies for tuning N,N-dimethyl-diaza{6}cycloparaphenylene's frontier molecular orbitals and intramolecular charge transfer to enhance light absorption spectrum and charge mobility in next-generation organic solar cells and nonlinear optical devices", "history": ["Synthesis and application advancements of novel cycloparaphenylene derivatives for high-performance organic photovoltaics", "Influence of heteroatom incorporation, such as in N,N-dimethyl-diaza{6}cycloparaphenylene, on excitonic and charge carrier dynamics within these novel cycloparaphenylene-based photovoltaic materials"], "ground_truth": ["permed-77736", "permed-75693", "permed-77738", "permed-77737", "permed-77739", "permed-90370", "permed-53787", "permed-75447", "permed-75414", "permed-75687"]}
{"query_id": "topic_028_turn_1", "conversation_id": "topic_028", "turn_id": 1, "query": "What are the key challenges in designing internal lengthening devices like Fitbone TAA for limb lengthening procedures?", "history": [], "ground_truth": ["permed-81946", "permed-19136", "permed-13949", "permed-81948", "permed-19137", "permed-54532", "permed-14967", "permed-90029", "permed-66338", "permed-14651"]}
{"query_id": "topic_028_turn_2", "conversation_id": "topic_028", "turn_id": 2, "query": "How do the design features of devices like it impact the occurrence of complications such as osteolysis and periosteal reactions?", "history": ["What are the key challenges in designing internal lengthening devices like Fitbone TAA for limb lengthening procedures?"], "ground_truth": ["permed-81946", "permed-51469", "permed-75177", "permed-92182", "permed-75140", "permed-83189", "permed-31461", "permed-60181", "permed-75234", "permed-53157"]}
{"query_id": "topic_028_turn_3", "conversation_id": "topic_028", "turn_id": 3, "query": "Given these challenges and design impacts we've discussed, how exactly do the biomechanical properties and specific features of Fitbone TAA's femoral or tibial nails prevent osteolysis and periosteal reactions at the telescopic junction? And what does this tell us about designing and applying future motorized lengthening devices?", "history": ["What are the key challenges in designing internal lengthening devices like Fitbone TAA for limb lengthening procedures?", "How do the design features of devices like it impact the occurrence of complications such as osteolysis and periosteal reactions?"], "ground_truth": ["permed-81946", "permed-19136", "permed-57593", "permed-81948", "permed-83189", "permed-64452", "permed-90029", "permed-91160", "permed-53157", "permed-63064"]}
{"query_id": "topic_029_turn_1", "conversation_id": "topic_029", "turn_id": 1, "query": "What role does PINK1 play in mitochondrial function and neurodegenerative diseases like Parkinson's?", "history": [], "ground_truth": ["permed-79637", "permed-79636", "permed-67792", "permed-54214", "permed-67790", "permed-67793", "permed-54215", "permed-77828", "permed-62479", "permed-90247"]}
{"query_id": "topic_029_turn_2", "conversation_id": "topic_029", "turn_id": 2, "query": "How might variations in the PINK1 gene, such as specific substitutions, impact its function and potential as a therapeutic target in this area?", "history": ["What role does PINK1 play in mitochondrial function and neurodegenerative diseases like Parkinson's?"], "ground_truth": ["permed-79636", "permed-79637", "permed-82373", "permed-67158", "permed-87437", "permed-67792", "permed-50790", "permed-67793", "permed-76216", "permed-40456"]}
{"query_id": "topic_029_turn_3", "conversation_id": "topic_029", "turn_id": 3, "query": "Given that the PINK1 Gly411Ala substitution enhances mitophagy and neuronal survival under stress, how could this variant be used to develop targeted Parkinson's therapies? Specifically, what molecular mechanisms should be explored to maximize its therapeutic benefits while reducing side effects? Also, what might be the long-term consequences of sustained high mitophagy rates in neurons, and how could this inform clinical trial designs for PINK1-based treatments?", "history": ["What role does PINK1 play in mitochondrial function and neurodegenerative diseases like Parkinson's?", "How might variations in the PINK1 gene, such as specific substitutions, impact its function and potential as a therapeutic target in this area?"], "ground_truth": ["permed-79636", "permed-79637", "permed-67792", "permed-67793", "permed-77828", "permed-77829", "permed-54214", "permed-89762", "permed-73746", "permed-88516"]}
{"query_id": "topic_030_turn_1", "conversation_id": "topic_030", "turn_id": 1, "query": "Impact of international rankings and cultural achievements on public perception of national identity", "history": [], "ground_truth": ["permed-66153", "permed-86237", "permed-85818", "permed-82767", "permed-55645", "permed-91814", "permed-62837", "permed-82768", "permed-75909", "permed-70216"]}
{"query_id": "topic_030_turn_2", "conversation_id": "topic_030", "turn_id": 2, "query": "Influence of these international rankings, particularly happiness indexes like Finland's, on national collective self-esteem and identity narratives", "history": ["Impact of international rankings and cultural achievements on public perception of national identity"], "ground_truth": ["permed-71350", "permed-75909", "permed-62837", "permed-82767", "permed-90791", "permed-61461", "permed-66153", "permed-71649", "permed-69454", "permed-61463"]}
{"query_id": "topic_030_turn_3", "conversation_id": "topic_030", "turn_id": 3, "query": "Finnish digital media framing of national happiness index scores: impact on public discourse, social cohesion, and citizens' differential psychological assimilation", "history": ["Impact of international rankings and cultural achievements on public perception of national identity", "Influence of these international rankings, particularly happiness indexes like Finland's, on national collective self-esteem and identity narratives"], "ground_truth": ["permed-75909", "permed-66153", "permed-61461", "permed-61463", "permed-71649", "permed-90791", "permed-85699", "permed-71350", "permed-69454", "permed-61465"]}
{"query_id": "topic_031_turn_1", "conversation_id": "topic_031", "turn_id": 1, "query": "What is known about the neurological basis of aggressive behaviors in schizophrenia?", "history": [], "ground_truth": ["permed-52245", "permed-55778", "permed-80460", "permed-79630", "permed-77571", "permed-55542", "permed-70669", "permed-88373", "permed-78088", "permed-60971"]}
{"query_id": "topic_031_turn_2", "conversation_id": "topic_031", "turn_id": 2, "query": "Does this involve disruptions in specific brain regions or neural pathways that could be targeted therapeutically?", "history": ["What is known about the neurological basis of aggressive behaviors in schizophrenia?"], "ground_truth": ["permed-64694", "permed-66783", "permed-66488", "permed-63134", "permed-68386", "permed-83050", "permed-72002", "permed-73751", "permed-55035", "permed-72010"]}
{"query_id": "topic_031_turn_3", "conversation_id": "topic_031", "turn_id": 3, "query": "Given the disruptions in specific brain regions and pathways we've discussed, how might the dysconnectivity between the anterior insula and other key areas—like the amygdala and dorsolateral prefrontal cortex—during emotional response inhibition tasks contribute to aggressive behaviors in male schizophrenia patients? And what therapeutic interventions could potentially target these neural pathways to reduce such behaviors?", "history": ["What is known about the neurological basis of aggressive behaviors in schizophrenia?", "Does this involve disruptions in specific brain regions or neural pathways that could be targeted therapeutically?"], "ground_truth": ["permed-52245", "permed-55778", "permed-55542", "permed-55745", "permed-52247", "permed-86987", "permed-89728", "permed-55742", "permed-81314", "permed-80830"]}
{"query_id": "topic_032_turn_1", "conversation_id": "topic_032", "turn_id": 1, "query": "What role do cell wall polysaccharides and phenolic compounds play in red wine production?", "history": [], "ground_truth": ["permed-52770", "permed-80907", "permed-80906", "permed-78740", "permed-78736", "permed-78737", "permed-52763", "permed-78733", "permed-80910", "permed-86191"]}
{"query_id": "topic_032_turn_2", "conversation_id": "topic_032", "turn_id": 2, "query": "How can manipulating the interactions between these compounds affect the quality and characteristics of the final product?", "history": ["What role do cell wall polysaccharides and phenolic compounds play in red wine production?"], "ground_truth": ["permed-60645", "permed-64159", "permed-80610", "permed-64164", "permed-82651", "permed-89208", "permed-72468", "permed-75160", "permed-56264", "permed-89070"]}
{"query_id": "topic_032_turn_3", "conversation_id": "topic_032", "turn_id": 3, "query": "Given these interactions between cell wall polysaccharides and phenolic compounds, how can we specifically manipulate different types—like anthocyanins and tannins—to optimize extraction yield and quality in red wine production? And what would this mean for the wine's sensory properties and stability?", "history": ["What role do cell wall polysaccharides and phenolic compounds play in red wine production?", "How can manipulating the interactions between these compounds affect the quality and characteristics of the final product?"], "ground_truth": ["permed-80906", "permed-52770", "permed-80907", "permed-52763", "permed-78737", "permed-78740", "permed-78736", "permed-80912", "permed-80910", "permed-65010"]}
{"query_id": "topic_033_turn_1", "conversation_id": "topic_033", "turn_id": 1, "query": "What is known about the effects of chrysin on blood pressure and its potential as a therapeutic agent for hypertension?", "history": [], "ground_truth": ["permed-64793", "permed-32907", "permed-71057", "permed-57307", "permed-64791", "permed-71601", "permed-64796", "permed-80419", "permed-72167", "permed-51132"]}
{"query_id": "topic_033_turn_2", "conversation_id": "topic_033", "turn_id": 2, "query": "How does it exert its vasorelaxant effects, and are there any specific mechanisms that have been identified as key to its potential antihypertensive properties?", "history": ["What is known about the effects of chrysin on blood pressure and its potential as a therapeutic agent for hypertension?"], "ground_truth": ["permed-80419", "permed-64791", "permed-64793", "permed-57307", "permed-71601", "permed-57306", "permed-64796", "permed-16309", "permed-89863", "permed-58362"]}
{"query_id": "topic_033_turn_3", "conversation_id": "topic_033", "turn_id": 3, "query": "Given that chrysin's vasorelaxant effects involve multiple mechanisms like the NO/sGC/cGMP pathway, muscarinic and β-adrenergic receptors, and ion channel modulation, what specific molecular or cellular adaptations in spontaneously hypertensive rats (SHRs) might limit its ability to effectively lower blood pressure in vivo compared to its in vitro effects? How do these adaptations differ from normotensive rats, and what strategies could overcome these limitations to enhance chrysin's antihypertensive efficacy in SHRs?", "history": ["What is known about the effects of chrysin on blood pressure and its potential as a therapeutic agent for hypertension?", "How does it exert its vasorelaxant effects, and are there any specific mechanisms that have been identified as key to its potential antihypertensive properties?"], "ground_truth": ["permed-64793", "permed-71601", "permed-80419", "permed-64791", "permed-72167", "permed-59775", "permed-57310", "permed-85188", "permed-88807", "permed-69249"]}
{"query_id": "topic_034_turn_1", "conversation_id": "topic_034", "turn_id": 1, "query": "What role does blood pressure management play in reducing major cardiovascular events?", "history": [], "ground_truth": ["permed-80253", "permed-74881", "permed-74876", "permed-74877", "permed-57352", "permed-66041", "permed-10881", "permed-25297", "permed-84179", "permed-32907"]}
{"query_id": "topic_034_turn_2", "conversation_id": "topic_034", "turn_id": 2, "query": "Are the benefits of this approach consistent across different patient populations, such as those with and without type 2 diabetes?", "history": ["What role does blood pressure management play in reducing major cardiovascular events?"], "ground_truth": ["permed-63461", "permed-65670", "permed-20860", "permed-58825", "permed-82584", "permed-80192", "permed-80239", "permed-69124", "permed-89894", "permed-58878"]}
{"query_id": "topic_034_turn_3", "conversation_id": "topic_034", "turn_id": 3, "query": "Since blood pressure lowering shows similar cardiovascular benefits in patients with and without type 2 diabetes, what underlying mechanisms might explain these comparable outcomes, and how could understanding these pathways help refine treatment approaches for both groups?", "history": ["What role does blood pressure management play in reducing major cardiovascular events?", "Are the benefits of this approach consistent across different patient populations, such as those with and without type 2 diabetes?"], "ground_truth": ["permed-80253", "permed-23578", "permed-74877", "permed-65670", "permed-23576", "permed-58398", "permed-23947", "permed-68958", "permed-23409", "permed-23575"]}
{"query_id": "topic_035_turn_1", "conversation_id": "topic_035", "turn_id": 1, "query": "What are the challenges in identifying anatomical structures during laparoscopic cholecystectomy?", "history": [], "ground_truth": ["permed-54768", "permed-51372", "permed-66064", "permed-50694", "permed-2674", "permed-1263", "permed-56985", "permed-64802", "permed-54767", "permed-50688"]}
{"query_id": "topic_035_turn_2", "conversation_id": "topic_035", "turn_id": 2, "query": "How can techniques for dissecting tissues in this area be improved to reduce complications?", "history": ["What are the challenges in identifying anatomical structures during laparoscopic cholecystectomy?"], "ground_truth": ["permed-56525", "permed-1500", "permed-42806", "permed-87737", "permed-4339", "permed-92093", "permed-14201", "permed-54768", "permed-70524", "permed-57302"]}
{"query_id": "topic_035_turn_3", "conversation_id": "topic_035", "turn_id": 3, "query": "Given these challenges and potential improvements, how can we specifically optimize the mobilization and dissection of fatty and fibrous tissues in the hepatocystic triangle to better visualize and identify critical structures during the procedure? What long-term benefits might achieving a more precise \"critical view of safety\" have in reducing postoperative complications?", "history": ["What are the challenges in identifying anatomical structures during laparoscopic cholecystectomy?", "How can techniques for dissecting tissues in this area be improved to reduce complications?"], "ground_truth": ["permed-54768", "permed-2674", "permed-66064", "permed-17288", "permed-2914", "permed-24345", "permed-2164", "permed-2683", "permed-2482", "permed-2675"]}
{"query_id": "topic_036_turn_1", "conversation_id": "topic_036", "turn_id": 1, "query": "What role does the immune system play in treating malignant pleural mesothelioma?", "history": [], "ground_truth": ["permed-79246", "permed-50754", "permed-52314", "permed-68240", "permed-73376", "permed-31728", "permed-56041", "permed-33265", "permed-12469", "permed-31619"]}
{"query_id": "topic_036_turn_2", "conversation_id": "topic_036", "turn_id": 2, "query": "How does modifying it, particularly through immune checkpoint blockade, impact patient outcomes in this area?", "history": ["What role does the immune system play in treating malignant pleural mesothelioma?"], "ground_truth": ["permed-56699", "permed-79276", "permed-60152", "permed-73919", "permed-71206", "permed-79248", "permed-51771", "permed-62397", "permed-70754", "permed-55080"]}
{"query_id": "topic_036_turn_3", "conversation_id": "topic_036", "turn_id": 3, "query": "How do shifts in immune cell composition and function within the tumor microenvironment—specifically the mobilization of CD57+ effector memory T cells and formation of tertiary lymphoid structures—affect long-term outcomes and quality of life for resectable malignant pleural mesothelioma patients undergoing this neoadjuvant combination immune checkpoint blockade therapy?", "history": ["What role does the immune system play in treating malignant pleural mesothelioma?", "How does modifying it, particularly through immune checkpoint blockade, impact patient outcomes in this area?"], "ground_truth": ["permed-79246", "permed-50754", "permed-68240", "permed-52314", "permed-80139", "permed-31728", "permed-73376", "permed-73636", "permed-33265", "permed-51429"]}
{"query_id": "topic_037_turn_1", "conversation_id": "topic_037", "turn_id": 1, "query": "Clinical significance and oncogenic pathways of SPP1-CD44 interaction in intrahepatic cholangiocarcinoma development and patient prognosis", "history": [], "ground_truth": ["permed-77801", "permed-68936", "permed-70397", "permed-2749", "permed-82373", "permed-55414", "permed-54983", "permed-55340", "permed-85505", "permed-55343"]}
{"query_id": "topic_037_turn_2", "conversation_id": "topic_037", "turn_id": 2, "query": "Impact of targeting this interaction on the tumor microenvironment of such cancers, focusing on changes in cytokine release and key immune cell populations", "history": ["Clinical significance and oncogenic pathways of SPP1-CD44 interaction in intrahepatic cholangiocarcinoma development and patient prognosis"], "ground_truth": ["permed-56649", "permed-50744", "permed-67709", "permed-67788", "permed-53177", "permed-56500", "permed-68242", "permed-82373", "permed-53182", "permed-68296"]}
{"query_id": "topic_037_turn_3", "conversation_id": "topic_037", "turn_id": 3, "query": "Preclinical strategies for SPP1-CD44 blockade in intrahepatic cholangiocarcinoma to enhance T-cell mediated cytotoxicity and overcome adaptive immune resistance", "history": ["Clinical significance and oncogenic pathways of SPP1-CD44 interaction in intrahepatic cholangiocarcinoma development and patient prognosis", "Impact of targeting this interaction on the tumor microenvironment of such cancers, focusing on changes in cytokine release and key immune cell populations"], "ground_truth": ["permed-77801", "permed-56372", "permed-72572", "permed-2749", "permed-70397", "permed-88691", "permed-68326", "permed-68329", "permed-91423", "permed-10279"]}
{"query_id": "topic_038_turn_1", "conversation_id": "topic_038", "turn_id": 1, "query": "What role do TLR8 agonists play in immune response, particularly in fighting viral infections and cancer?", "history": [], "ground_truth": ["permed-79543", "permed-51434", "permed-54980", "permed-71167", "permed-67035", "permed-68067", "permed-87652", "permed-91292", "permed-68256", "permed-66758"]}
{"query_id": "topic_038_turn_2", "conversation_id": "topic_038", "turn_id": 2, "query": "How are advancements in computational techniques helping us better understand the properties of these agonists and their potential as therapeutic agents?", "history": ["What role do TLR8 agonists play in immune response, particularly in fighting viral infections and cancer?"], "ground_truth": ["permed-78128", "permed-53314", "permed-79927", "permed-51259", "permed-84970", "permed-79543", "permed-53316", "permed-76967", "permed-53326", "permed-77127"]}
{"query_id": "topic_038_turn_3", "conversation_id": "topic_038", "turn_id": 3, "query": "Given these computational insights into TLR8 agonists, how do their newly identified structural features and binding mechanisms affect their efficacy and selectivity in activating the TLR8 pathway? And what could this mean for developing new therapeutic approaches against cancer and viral infections?", "history": ["What role do TLR8 agonists play in immune response, particularly in fighting viral infections and cancer?", "How are advancements in computational techniques helping us better understand the properties of these agonists and their potential as therapeutic agents?"], "ground_truth": ["permed-79543", "permed-67929", "permed-79927", "permed-87710", "permed-92518", "permed-85302", "permed-10867", "permed-77323", "permed-5215", "permed-56693"]}
{"query_id": "topic_039_turn_1", "conversation_id": "topic_039", "turn_id": 1, "query": "What role does PAP therapy play in treating sleep disorders, and how is its effectiveness currently evaluated?", "history": [], "ground_truth": ["permed-55141", "permed-88482", "permed-73829", "permed-54627", "permed-83851", "permed-71437", "permed-71292", "permed-73828", "permed-64781", "permed-83070"]}
{"query_id": "topic_039_turn_2", "conversation_id": "topic_039", "turn_id": 2, "query": "Are there limitations to the current metrics used to evaluate this treatment's effectiveness, particularly in terms of accounting for variability in patient responses?", "history": ["What role does PAP therapy play in treating sleep disorders, and how is its effectiveness currently evaluated?"], "ground_truth": ["permed-13306", "permed-61841", "permed-72540", "permed-51752", "permed-81581", "permed-61615", "permed-53342", "permed-91787", "permed-64337", "permed-82587"]}
{"query_id": "topic_039_turn_3", "conversation_id": "topic_039", "turn_id": 3, "query": "Given these limitations in current evaluation metrics and the variability in patient responses, could advanced machine learning techniques help develop more dynamic and comprehensive measures for assessing PAP therapy effectiveness—particularly by accounting for fluctuations in rAHI, standardizing data across different devices, and better capturing how intermittent treatment affects long-term outcomes?", "history": ["What role does PAP therapy play in treating sleep disorders, and how is its effectiveness currently evaluated?", "Are there limitations to the current metrics used to evaluate this treatment's effectiveness, particularly in terms of accounting for variability in patient responses?"], "ground_truth": ["permed-55141", "permed-57110", "permed-57108", "permed-77816", "permed-52533", "permed-60561", "permed-61788", "permed-57109", "permed-69127", "permed-57343"]}
{"query_id": "topic_040_turn_1", "conversation_id": "topic_040", "turn_id": 1, "query": "What role do regulatory T cells play in immune homeostasis and autoimmune disorders?", "history": [], "ground_truth": ["permed-67927", "permed-68248", "permed-55185", "permed-23042", "permed-81813", "permed-11691", "permed-53184", "permed-13405", "permed-53175", "permed-54302"]}
{"query_id": "topic_040_turn_2", "conversation_id": "topic_040", "turn_id": 2, "query": "How might manipulating the function of these cells impact the effectiveness of treatments like biologics in this area?", "history": ["What role do regulatory T cells play in immune homeostasis and autoimmune disorders?"], "ground_truth": ["permed-82865", "permed-67927", "permed-58149", "permed-60149", "permed-53184", "permed-91322", "permed-53180", "permed-68130", "permed-68116", "permed-76180"]}
{"query_id": "topic_040_turn_3", "conversation_id": "topic_040", "turn_id": 3, "query": "Given how crucial Tregs are for immune balance, how could we fine-tune the specific cytokine networks and signaling pathways that control their stability and function to improve biologic treatments for autoimmune disorders and transplant patients? What strategies might help ensure these biologics not only suppress inflammation effectively but also maintain or even boost Treg-mediated regulation, achieving immune balance without weakening overall immune defenses?", "history": ["What role do regulatory T cells play in immune homeostasis and autoimmune disorders?", "How might manipulating the function of these cells impact the effectiveness of treatments like biologics in this area?"], "ground_truth": ["permed-67927", "permed-53184", "permed-68248", "permed-53177", "permed-51348", "permed-68249", "permed-67928", "permed-56653", "permed-55185", "permed-53175"]}
{"query_id": "topic_041_turn_1", "conversation_id": "topic_041", "turn_id": 1, "query": "Ureteral stricture impact on patient health-related quality of life (HRQoL) and mental health", "history": [], "ground_truth": ["permed-77647", "permed-54749", "permed-89378", "permed-52161", "permed-70564", "permed-82914", "permed-89597", "permed-52036", "permed-65275", "permed-3834"]}
{"query_id": "topic_041_turn_2", "conversation_id": "topic_041", "turn_id": 2, "query": "Developing personalized ureteral stricture treatment strategies based on these documented HRQoL and mental health impacts", "history": ["Ureteral stricture impact on patient health-related quality of life (HRQoL) and mental health"], "ground_truth": ["permed-77647", "permed-54749", "permed-82914", "permed-55032", "permed-70564", "permed-89598", "permed-89378", "permed-86432", "permed-87877", "permed-88040"]}
{"query_id": "topic_041_turn_3", "conversation_id": "topic_041", "turn_id": 3, "query": "Clinical implementation models for personalized ureteral stricture care: integrating medical-psychological interventions tailored by patient profiles (e.g., age, gender, stricture type, symptoms)", "history": ["Ureteral stricture impact on patient health-related quality of life (HRQoL) and mental health", "Developing personalized ureteral stricture treatment strategies based on these documented HRQoL and mental health impacts"], "ground_truth": ["permed-77647", "permed-89598", "permed-54749", "permed-55032", "permed-86432", "permed-82914", "permed-91814", "permed-87877", "permed-89352", "permed-92093"]}
{"query_id": "topic_042_turn_1", "conversation_id": "topic_042", "turn_id": 1, "query": "Key factors and principles guiding pediatric organ allocation policies within diverse international healthcare systems", "history": [], "ground_truth": ["permed-74646", "permed-74645", "permed-52843", "permed-74647", "permed-91926", "permed-87344", "permed-67226", "permed-74690", "permed-46063", "permed-72540"]}
{"query_id": "topic_042_turn_2", "conversation_id": "topic_042", "turn_id": 2, "query": "Comparative analysis of how these varying pediatric organ allocation principles affect waitlist mortality, graft success, and early post-transplant outcomes for child recipients across countries", "history": ["Key factors and principles guiding pediatric organ allocation policies within diverse international healthcare systems"], "ground_truth": ["permed-74646", "permed-74647", "permed-74645", "permed-52843", "permed-74650", "permed-87344", "permed-83155", "permed-90454", "permed-67226", "permed-72540"]}
{"query_id": "topic_042_turn_3", "conversation_id": "topic_042", "turn_id": 3, "query": "In-depth analysis of ethical frameworks and socio-medical justifications underpinning specific highly divergent pediatric organ allocation policies identified, and their correlation with long-term patient survival and quality of life metrics", "history": ["Key factors and principles guiding pediatric organ allocation policies within diverse international healthcare systems", "Comparative analysis of how these varying pediatric organ allocation principles affect waitlist mortality, graft success, and early post-transplant outcomes for child recipients across countries"], "ground_truth": ["permed-74646", "permed-52843", "permed-74647", "permed-74645", "permed-90537", "permed-87344", "permed-74690", "permed-74711", "permed-87347", "permed-67226"]}
{"query_id": "topic_043_turn_1", "conversation_id": "topic_043", "turn_id": 1, "query": "What role do activin and inhibin proteins play in animal reproduction and development?", "history": [], "ground_truth": ["permed-73498", "permed-86488", "permed-85182", "permed-50849", "permed-76391", "permed-58606", "permed-85183", "permed-74694", "permed-89441", "permed-71939"]}
{"query_id": "topic_043_turn_2", "conversation_id": "topic_043", "turn_id": 2, "query": "How does this pathway's function vary between males and females, particularly in model organisms like zebrafish?", "history": ["What role do activin and inhibin proteins play in animal reproduction and development?"], "ground_truth": ["permed-53810", "permed-73496", "permed-52697", "permed-73498", "permed-72181", "permed-71707", "permed-62979", "permed-81225", "permed-72052", "permed-53801"]}
{"query_id": "topic_043_turn_3", "conversation_id": "topic_043", "turn_id": 3, "query": "Given these sex-specific differences in zebrafish, particularly how βAa/b mutant males show normal spermatogenesis while females exhibit severe ovarian dysfunction, what does this tell us about the activin-inhibin pathway's sex-specific regulatory mechanisms? And considering the pathway's evolutionary conservation, how might these findings translate into potential therapeutic strategies for human reproductive disorders?", "history": ["What role do activin and inhibin proteins play in animal reproduction and development?", "How does this pathway's function vary between males and females, particularly in model organisms like zebrafish?"], "ground_truth": ["permed-73498", "permed-72181", "permed-80748", "permed-82509", "permed-72176", "permed-76122", "permed-62979", "permed-73496", "permed-72174", "permed-81225"]}
{"query_id": "topic_044_turn_1", "conversation_id": "topic_044", "turn_id": 1, "query": "Lipoprotein apheresis for hyperlipidemia: indications, mechanism, and patient applications", "history": [], "ground_truth": ["permed-74705", "permed-74736", "permed-68272", "permed-56265", "permed-58883", "permed-74606", "permed-4862", "permed-71333", "permed-4871", "permed-4863"]}
{"query_id": "topic_044_turn_2", "conversation_id": "topic_044", "turn_id": 2, "query": "Effectiveness of this lipoprotein apheresis technique for patients with refractory hyperlipidemia or intolerance to standard therapies", "history": ["Lipoprotein apheresis for hyperlipidemia: indications, mechanism, and patient applications"], "ground_truth": ["permed-74736", "permed-74705", "permed-74606", "permed-68272", "permed-58883", "permed-4871", "permed-56265", "permed-4864", "permed-71333", "permed-74605"]}
{"query_id": "topic_044_turn_3", "conversation_id": "topic_044", "turn_id": 3, "query": "Optimizing lipoprotein apheresis for refractory hyperlipidemia: treatment schedules, long-term cardiovascular outcomes, and predictive biomarkers for patient selection", "history": ["Lipoprotein apheresis for hyperlipidemia: indications, mechanism, and patient applications", "Effectiveness of this lipoprotein apheresis technique for patients with refractory hyperlipidemia or intolerance to standard therapies"], "ground_truth": ["permed-74736", "permed-68272", "permed-58883", "permed-74705", "permed-4863", "permed-74605", "permed-74606", "permed-4862", "permed-58858", "permed-4871"]}
{"query_id": "topic_045_turn_1", "conversation_id": "topic_045", "turn_id": 1, "query": "Automated guidewire segmentation methods in X-ray fluoroscopy: recent breakthroughs and challenges", "history": [], "ground_truth": ["permed-78052", "permed-53470", "permed-71333", "permed-56265", "permed-91746", "permed-80812", "permed-92049", "permed-28483", "permed-55061", "permed-29193"]}
{"query_id": "topic_045_turn_2", "conversation_id": "topic_045", "turn_id": 2, "query": "Comparative effectiveness of CNN-based approaches versus traditional methods for *that* automated X-ray guidewire segmentation, focusing on accuracy metrics under specific complex conditions like low contrast or overlapping structures.", "history": ["Automated guidewire segmentation methods in X-ray fluoroscopy: recent breakthroughs and challenges"], "ground_truth": ["permed-78052", "permed-53145", "permed-83771", "permed-55061", "permed-91746", "permed-85761", "permed-73810", "permed-90518", "permed-80758", "permed-62528"]}
{"query_id": "topic_045_turn_3", "conversation_id": "topic_045", "turn_id": 3, "query": "Optimizing Deep CNNs with jigsaw self-supervision and BRA module for guidewire segmentation: achieving robustness across diverse X-ray fluoroscopy datasets (varied anatomies, dynamic noise) and BRA module adaptations for enhanced dual-guidewire detection and tracking.", "history": ["Automated guidewire segmentation methods in X-ray fluoroscopy: recent breakthroughs and challenges", "Comparative effectiveness of CNN-based approaches versus traditional methods for *that* automated X-ray guidewire segmentation, focusing on accuracy metrics under specific complex conditions like low contrast or overlapping structures."], "ground_truth": ["permed-78052", "permed-73810", "permed-90519", "permed-59315", "permed-91749", "permed-59613", "permed-62521", "permed-53463", "permed-53471", "permed-91747"]}
{"query_id": "topic_046_turn_1", "conversation_id": "topic_046", "turn_id": 1, "query": "Key differences and challenges in acne treatment based on body site", "history": [], "ground_truth": ["permed-77076", "permed-77062", "permed-68414", "permed-77102", "permed-52002", "permed-68412", "permed-77061", "permed-77073", "permed-77068", "permed-77078"]}
{"query_id": "topic_046_turn_2", "conversation_id": "topic_046", "turn_id": 2, "query": "How do these treatment challenges for acne compare between facial and truncal areas, especially regarding therapeutic management strategies?", "history": ["Key differences and challenges in acne treatment based on body site"], "ground_truth": ["permed-77062", "permed-77076", "permed-76521", "permed-77061", "permed-77068", "permed-77074", "permed-76560", "permed-52624", "permed-13030", "permed-76565"]}
{"query_id": "topic_046_turn_3", "conversation_id": "topic_046", "turn_id": 3, "query": "Given these distinct therapeutic management strategies, what specific pharmaceutical formulation hurdles exist for topical truncal acne products, and how do these affect patient adherence and clinical efficacy compared to facial acne formulations?", "history": ["Key differences and challenges in acne treatment based on body site", "How do these treatment challenges for acne compare between facial and truncal areas, especially regarding therapeutic management strategies?"], "ground_truth": ["permed-77062", "permed-77076", "permed-77068", "permed-77075", "permed-76565", "permed-77063", "permed-72468", "permed-76560", "permed-72470", "permed-85685"]}
{"query_id": "topic_047_turn_1", "conversation_id": "topic_047", "turn_id": 1, "query": "Are there any natural compounds that have shown potential in interacting with SARS-CoV-2 proteins?", "history": [], "ground_truth": ["permed-58468", "permed-58134", "permed-58126", "permed-69960", "permed-58133", "permed-91215", "permed-55364", "permed-79540", "permed-60337", "permed-79542"]}
{"query_id": "topic_047_turn_2", "conversation_id": "topic_047", "turn_id": 2, "query": "How might understanding these interactions impact the development of new antiviral therapies using phytocompounds?", "history": ["Are there any natural compounds that have shown potential in interacting with SARS-CoV-2 proteins?"], "ground_truth": ["permed-58468", "permed-53438", "permed-60337", "permed-79542", "permed-81716", "permed-71728", "permed-89192", "permed-52206", "permed-55358", "permed-69960"]}
{"query_id": "topic_047_turn_3", "conversation_id": "topic_047", "turn_id": 3, "query": "Building on these findings about phytocompound interactions with SARS-CoV-2 proteins, how could we apply pharmacodynamic and pharmacokinetic principles to optimize their formulation and delivery—especially when combined with existing antiviral drugs? What are the key challenges in moving from these theoretical insights to clinically effective treatments?", "history": ["Are there any natural compounds that have shown potential in interacting with SARS-CoV-2 proteins?", "How might understanding these interactions impact the development of new antiviral therapies using phytocompounds?"], "ground_truth": ["permed-58468", "permed-60337", "permed-69960", "permed-55358", "permed-71728", "permed-69961", "permed-58128", "permed-90186", "permed-58134", "permed-69045"]}
{"query_id": "topic_048_turn_1", "conversation_id": "topic_048", "turn_id": 1, "query": "What role does alternative splicing play in uterine carcinosarcoma development and progression?", "history": [], "ground_truth": ["permed-81185", "permed-67122", "permed-53588", "permed-85942", "permed-82373", "permed-50768", "permed-47959", "permed-76378", "permed-90670", "permed-73425"]}
{"query_id": "topic_048_turn_2", "conversation_id": "topic_048", "turn_id": 2, "query": "Can understanding this process reveal new targets for therapy, particularly through manipulating specific splicing factors?", "history": ["What role does alternative splicing play in uterine carcinosarcoma development and progression?"], "ground_truth": ["permed-50768", "permed-82373", "permed-55344", "permed-70692", "permed-56724", "permed-70695", "permed-72106", "permed-89303", "permed-67125", "permed-82374"]}
{"query_id": "topic_048_turn_3", "conversation_id": "topic_048", "turn_id": 3, "query": "Given these insights into alternative splicing's role and its potential therapeutic targets, how might the relationship between specific splicing events and key splicing factor expression levels affect treatment response and survival in uterine carcinosarcoma patients? And what new therapeutic approaches could emerge from understanding this interplay?", "history": ["What role does alternative splicing play in uterine carcinosarcoma development and progression?", "Can understanding this process reveal new targets for therapy, particularly through manipulating specific splicing factors?"], "ground_truth": ["permed-81185", "permed-50768", "permed-67122", "permed-55344", "permed-53588", "permed-85942", "permed-56021", "permed-73425", "permed-80395", "permed-90670"]}
{"query_id": "topic_049_turn_1", "conversation_id": "topic_049", "turn_id": 1, "query": "What factors contribute to the severity of crashes on freeways?", "history": [], "ground_truth": ["permed-74223", "permed-81254", "permed-74221", "permed-81255", "permed-81252", "permed-83203", "permed-81257", "permed-75657", "permed-81253", "permed-74066"]}
{"query_id": "topic_049_turn_2", "conversation_id": "topic_049", "turn_id": 2, "query": "Can analyzing these factors help in assessing the effectiveness of intelligent transportation systems in enhancing freeway safety?", "history": ["What factors contribute to the severity of crashes on freeways?"], "ground_truth": ["permed-81252", "permed-81263", "permed-74219", "permed-81256", "permed-74065", "permed-74223", "permed-74221", "permed-81254", "permed-81255", "permed-74066"]}
{"query_id": "topic_049_turn_3", "conversation_id": "topic_049", "turn_id": 3, "query": "Given these findings about crash severity factors from the copula-based model, how could they be used to assess which types of ITS are most effective at reducing severity—and what specific system features might be prioritized for optimization to improve freeway safety?", "history": ["What factors contribute to the severity of crashes on freeways?", "Can analyzing these factors help in assessing the effectiveness of intelligent transportation systems in enhancing freeway safety?"], "ground_truth": ["permed-74223", "permed-81254", "permed-81255", "permed-74221", "permed-81257", "permed-81252", "permed-74066", "permed-81256", "permed-74219", "permed-74065"]}
{"query_id": "topic_050_turn_1", "conversation_id": "topic_050", "turn_id": 1, "query": "Validated clinical prediction tools and risk scores for post-stroke pneumonia in acute care settings", "history": [], "ground_truth": ["permed-73475", "permed-60547", "permed-55184", "permed-90330", "permed-59919", "permed-68512", "permed-66153", "permed-33118", "permed-75525", "permed-70446"]}
{"query_id": "topic_050_turn_2", "conversation_id": "topic_050", "turn_id": 2, "query": "Among these validated tools, what is the comparative effectiveness and identified limitations of PNEUMOINDEX for stratifying post-stroke pneumonia risk in high-risk acute stroke patients?", "history": ["Validated clinical prediction tools and risk scores for post-stroke pneumonia in acute care settings"], "ground_truth": ["permed-73475", "permed-60547", "permed-59919", "permed-55184", "permed-59917", "permed-90330", "permed-27073", "permed-87138", "permed-60491", "permed-83970"]}
{"query_id": "topic_050_turn_3", "conversation_id": "topic_050", "turn_id": 3, "query": "Strategies for optimizing PNEUMOINDEX: enhancing sensitivity and specificity for post-stroke pneumonia prediction through adaptation for distinct patient cohorts (e.g., hemorrhagic stroke, varying demographics) and integration of novel inflammatory or immunological biomarkers.", "history": ["Validated clinical prediction tools and risk scores for post-stroke pneumonia in acute care settings", "Among these validated tools, what is the comparative effectiveness and identified limitations of PNEUMOINDEX for stratifying post-stroke pneumonia risk in high-risk acute stroke patients?"], "ground_truth": ["permed-73475", "permed-33118", "permed-87558", "permed-60547", "permed-64314", "permed-90330", "permed-55184", "permed-63134", "permed-33218", "permed-70415"]}
{"query_id": "topic_051_turn_1", "conversation_id": "topic_051", "turn_id": 1, "query": "Role of selenium and vitamin C as antioxidants in modulating immune function in critically ill patients", "history": [], "ground_truth": ["permed-58917", "permed-51312", "permed-68512", "permed-74537", "permed-68415", "permed-58626", "permed-74716", "permed-27804", "permed-68513", "permed-89318"]}
{"query_id": "topic_051_turn_2", "conversation_id": "topic_051", "turn_id": 2, "query": "Impact of varying dosages of these antioxidants on oxidative stress biomarkers in critically ill patients", "history": ["Role of selenium and vitamin C as antioxidants in modulating immune function in critically ill patients"], "ground_truth": ["permed-51312", "permed-58626", "permed-58917", "permed-54997", "permed-74244", "permed-51314", "permed-72540", "permed-63995", "permed-68512", "permed-72012"]}
{"query_id": "topic_051_turn_3", "conversation_id": "topic_051", "turn_id": 3, "query": "Supraphysiologic selenium and vitamin C: differential mechanisms for immune modulation and oxidative stress in critically ill patients, and implications for nutritional interventions", "history": ["Role of selenium and vitamin C as antioxidants in modulating immune function in critically ill patients", "Impact of varying dosages of these antioxidants on oxidative stress biomarkers in critically ill patients"], "ground_truth": ["permed-58917", "permed-74537", "permed-51312", "permed-58626", "permed-23261", "permed-89318", "permed-27804", "permed-68512", "permed-74539", "permed-74538"]}
{"query_id": "topic_052_turn_1", "conversation_id": "topic_052", "turn_id": 1, "query": "What role does visual information play in human decision-making processes?", "history": [], "ground_truth": ["permed-61743", "permed-69670", "permed-80018", "permed-88619", "permed-69675", "permed-88658", "permed-73438", "permed-62742", "permed-61716", "permed-61677"]}
{"query_id": "topic_052_turn_2", "conversation_id": "topic_052", "turn_id": 2, "query": "How does the way we process different types of visual information impact our ability to make effective decisions in complex situations?", "history": ["What role does visual information play in human decision-making processes?"], "ground_truth": ["permed-80018", "permed-88619", "permed-61743", "permed-90768", "permed-69675", "permed-71475", "permed-69670", "permed-73438", "permed-61677", "permed-84311"]}
{"query_id": "topic_052_turn_3", "conversation_id": "topic_052", "turn_id": 3, "query": "Given that we process different types of visual information differently, how might this distinction between quantitative and qualitative visual data affect decision-making strategies in complex environments? And what would that mean for designing visual interfaces that aim to optimize decisions, particularly in high-stakes fields like medical diagnosis or financial trading?", "history": ["What role does visual information play in human decision-making processes?", "How does the way we process different types of visual information impact our ability to make effective decisions in complex situations?"], "ground_truth": ["permed-69670", "permed-69440", "permed-80018", "permed-59257", "permed-71475", "permed-77419", "permed-88619", "permed-83703", "permed-86046", "permed-78478"]}
{"query_id": "topic_053_turn_1", "conversation_id": "topic_053", "turn_id": 1, "query": "What's known about the impact of bioencapsulation on animal microbiomes?", "history": [], "ground_truth": ["permed-90392", "permed-66770", "permed-65029", "permed-70675", "permed-73874", "permed-66901", "permed-51677", "permed-52468", "permed-76735", "permed-89803"]}
{"query_id": "topic_053_turn_2", "conversation_id": "topic_053", "turn_id": 2, "query": "Does this technique have any specific effects when applied to reptiles, such as turtles?", "history": ["What's known about the impact of bioencapsulation on animal microbiomes?"], "ground_truth": ["permed-92093", "permed-79268", "permed-78830", "permed-91516", "permed-78872", "permed-68412", "permed-56264", "permed-67575", "permed-55126", "permed-65286"]}
{"query_id": "topic_053_turn_3", "conversation_id": "topic_053", "turn_id": 3, "query": "Given these effects of bioencapsulation on reptile microbiomes, what would be the long-term consequences of repeatedly administering terbinafine via this method to earthworms—specifically on the gastrointestinal microbiome of western pond turtles? And how might these microbiome changes affect the drug's pharmacodynamics and the turtles' overall health?", "history": ["What's known about the impact of bioencapsulation on animal microbiomes?", "Does this technique have any specific effects when applied to reptiles, such as turtles?"], "ground_truth": ["permed-78830", "permed-82045", "permed-71560", "permed-85539", "permed-82038", "permed-50837", "permed-78831", "permed-63986", "permed-66588", "permed-68222"]}
{"query_id": "topic_054_turn_1", "conversation_id": "topic_054", "turn_id": 1, "query": "Current pharmacological treatments for NAFLD-associated liver fibrosis", "history": [], "ground_truth": ["permed-62693", "permed-75520", "permed-60273", "permed-62691", "permed-75553", "permed-62695", "permed-62692", "permed-2512", "permed-62712", "permed-85533"]}
{"query_id": "topic_054_turn_2", "conversation_id": "topic_054", "turn_id": 2, "query": "Efficacy of these pharmacological treatments for NAFLD-associated liver fibrosis regression and their associated adverse event profiles", "history": ["Current pharmacological treatments for NAFLD-associated liver fibrosis"], "ground_truth": ["permed-75520", "permed-62693", "permed-75553", "permed-60273", "permed-2512", "permed-62692", "permed-62691", "permed-85533", "permed-62695", "permed-60269"]}
{"query_id": "topic_054_turn_3", "conversation_id": "topic_054", "turn_id": 3, "query": "Personalized medicine for NAFLD-associated liver fibrosis: tailoring treatment based on drug efficacy/safety profiles and patient stratification biomarkers", "history": ["Current pharmacological treatments for NAFLD-associated liver fibrosis", "Efficacy of these pharmacological treatments for NAFLD-associated liver fibrosis regression and their associated adverse event profiles"], "ground_truth": ["permed-62693", "permed-52636", "permed-75520", "permed-52637", "permed-60269", "permed-52641", "permed-62718", "permed-75553", "permed-60273", "permed-84831"]}
{"query_id": "topic_055_turn_1", "conversation_id": "topic_055", "turn_id": 1, "query": "What role does supercritical water gasification play in managing oily sludge waste?", "history": [], "ground_truth": ["permed-81353", "permed-78439", "permed-78436", "permed-81354", "permed-79502", "permed-79492", "permed-79501", "permed-78440", "permed-81893", "permed-66167"]}
{"query_id": "topic_055_turn_2", "conversation_id": "topic_055", "turn_id": 2, "query": "How do variations in catalysts affect the efficiency and byproducts of this technique?", "history": ["What role does supercritical water gasification play in managing oily sludge waste?"], "ground_truth": ["permed-64912", "permed-57980", "permed-88221", "permed-53473", "permed-76110", "permed-88472", "permed-79490", "permed-57955", "permed-88471", "permed-73183"]}
{"query_id": "topic_055_turn_3", "conversation_id": "topic_055", "turn_id": 3, "query": "Building on the catalyst effects we just discussed, could you elaborate on how different concentrations and types of alkali catalysts like K2CO3 and Na2CO3 specifically influence molecular-level interactions during this process? How do these interactions affect the degradation pathways of nitrogenous compounds and solid residue formation? Also, what would be the long-term environmental implications of these altered residue characteristics for soil and water systems, and how could this understanding help optimize industrial-scale SCWG setups for more sustainable waste management?", "history": ["What role does supercritical water gasification play in managing oily sludge waste?", "How do variations in catalysts affect the efficiency and byproducts of this technique?"], "ground_truth": ["permed-81353", "permed-53101", "permed-79776", "permed-80797", "permed-57933", "permed-76110", "permed-87040", "permed-58057", "permed-57930", "permed-53100"]}
{"query_id": "topic_056_turn_1", "conversation_id": "topic_056", "turn_id": 1, "query": "Common challenges in percutaneous retrieval of migrated central venous catheter fragments", "history": [], "ground_truth": ["permed-70542", "permed-70541", "permed-71333", "permed-56265", "permed-52259", "permed-70549", "permed-70543", "permed-55152", "permed-75270", "permed-52036"]}
{"query_id": "topic_056_turn_2", "conversation_id": "topic_056", "turn_id": 2, "query": "Specialized techniques and tools for improving safety and efficacy in retrieving these catheter fragments, especially in complex cases", "history": ["Common challenges in percutaneous retrieval of migrated central venous catheter fragments"], "ground_truth": ["permed-70542", "permed-70541", "permed-71333", "permed-52259", "permed-75270", "permed-56265", "permed-70549", "permed-70544", "permed-56525", "permed-75430"]}
{"query_id": "topic_056_turn_3", "conversation_id": "topic_056", "turn_id": 3, "query": "Optimizing the modified two-step technique (using pigtail catheters, hydrophilic wires, snares) for retrieving catheter fragments in complex cases with comorbidities: safety, efficacy, long-term outcomes, and comparison to surgical intervention", "history": ["Common challenges in percutaneous retrieval of migrated central venous catheter fragments", "Specialized techniques and tools for improving safety and efficacy in retrieving these catheter fragments, especially in complex cases"], "ground_truth": ["permed-70542", "permed-70541", "permed-70544", "permed-71333", "permed-75270", "permed-56265", "permed-70549", "permed-82911", "permed-57296", "permed-52259"]}
{"query_id": "topic_057_turn_1", "conversation_id": "topic_057", "turn_id": 1, "query": "What role does postmortem computed tomography (PMCT) play in forensic pathology, particularly in estimating time since death?", "history": [], "ground_truth": ["permed-80822", "permed-80823", "permed-84056", "permed-86771", "permed-86773", "permed-84054", "permed-59797", "permed-84055", "permed-90504", "permed-56145"]}
{"query_id": "topic_057_turn_2", "conversation_id": "topic_057", "turn_id": 2, "query": "How do changes in cerebrospinal fluid composition over time affect the accuracy of PMCT scans in this context?", "history": ["What role does postmortem computed tomography (PMCT) play in forensic pathology, particularly in estimating time since death?"], "ground_truth": ["permed-72903", "permed-80822", "permed-11625", "permed-55725", "permed-23988", "permed-58783", "permed-58775", "permed-23985", "permed-9179", "permed-48667"]}
{"query_id": "topic_057_turn_3", "conversation_id": "topic_057", "turn_id": 3, "query": "Given that CSF composition changes over time, how do specific variations like protein content and cellular components influence the Hounsfield Units measured by PMCT across different postmortem intervals? What do these changes mean for forensic pathology's ability to estimate time since death?", "history": ["What role does postmortem computed tomography (PMCT) play in forensic pathology, particularly in estimating time since death?", "How do changes in cerebrospinal fluid composition over time affect the accuracy of PMCT scans in this context?"], "ground_truth": ["permed-80822", "permed-84056", "permed-86771", "permed-86773", "permed-80823", "permed-86765", "permed-72903", "permed-84054", "permed-84570", "permed-74590"]}
{"query_id": "topic_058_turn_1", "conversation_id": "topic_058", "turn_id": 1, "query": "Clinical practice guidelines for managing moderate to severe periodontitis: treatment options and recommendations", "history": [], "ground_truth": ["permed-40227", "permed-40230", "permed-40333", "permed-76005", "permed-75235", "permed-92165", "permed-61086", "permed-75121", "permed-75186", "permed-64756"]}
{"query_id": "topic_058_turn_2", "conversation_id": "topic_058", "turn_id": 2, "query": "Within these guidelines, what is the evidence for adjunctive laser therapy improving clinical outcomes like pocket depth and attachment levels in moderate to severe periodontitis?", "history": ["Clinical practice guidelines for managing moderate to severe periodontitis: treatment options and recommendations"], "ground_truth": ["permed-75235", "permed-64756", "permed-61086", "permed-75216", "permed-61088", "permed-40033", "permed-40036", "permed-38722", "permed-75123", "permed-62377"]}
{"query_id": "topic_058_turn_3", "conversation_id": "topic_058", "turn_id": 3, "query": "Cellular and molecular mechanisms of 1064-nm Nd:YAG laser (e.g., LANAP protocol) in promoting periodontal regeneration vs. conventional flap surgery: effects on probing depth, attachment level, and bone regeneration.", "history": ["Clinical practice guidelines for managing moderate to severe periodontitis: treatment options and recommendations", "Within these guidelines, what is the evidence for adjunctive laser therapy improving clinical outcomes like pocket depth and attachment levels in moderate to severe periodontitis?"], "ground_truth": ["permed-75235", "permed-75215", "permed-75123", "permed-75199", "permed-75207", "permed-61086", "permed-64756", "permed-45613", "permed-52414", "permed-75198"]}
{"query_id": "topic_059_turn_1", "conversation_id": "topic_059", "turn_id": 1, "query": "What role can wearable sensors like IMUs play in tracking and aiding rehabilitation for upper limb injuries?", "history": [], "ground_truth": ["permed-71310", "permed-74120", "permed-71487", "permed-54870", "permed-63175", "permed-80402", "permed-58414", "permed-66436", "permed-54643", "permed-54923"]}
{"query_id": "topic_059_turn_2", "conversation_id": "topic_059", "turn_id": 2, "query": "How accurately can this technology capture detailed movement patterns, such as arm cycles, over extended periods?", "history": ["What role can wearable sensors like IMUs play in tracking and aiding rehabilitation for upper limb injuries?"], "ground_truth": ["permed-80402", "permed-58426", "permed-54923", "permed-74120", "permed-58423", "permed-83189", "permed-85419", "permed-78729", "permed-71310", "permed-63174"]}
{"query_id": "topic_059_turn_3", "conversation_id": "topic_059", "turn_id": 3, "query": "Given that IMU sensors can accurately track and count arm cycles over time, how could these capabilities be leveraged to create personalized rehabilitation protocols for upper limb injuries, accounting for individual movement variations and potential differences in sensor accuracy across patients? Furthermore, how might machine learning enhance this system by improving cycle detection precision and dynamically adjusting exercises based on real-time patient performance and progress?", "history": ["What role can wearable sensors like IMUs play in tracking and aiding rehabilitation for upper limb injuries?", "How accurately can this technology capture detailed movement patterns, such as arm cycles, over extended periods?"], "ground_truth": ["permed-80402", "permed-74120", "permed-71310", "permed-71487", "permed-54643", "permed-66436", "permed-54855", "permed-58414", "permed-74121", "permed-54870"]}
{"query_id": "topic_060_turn_1", "conversation_id": "topic_060", "turn_id": 1, "query": "MTSF4 role in plant mitochondrial transcript regulation", "history": [], "ground_truth": ["permed-76400", "permed-89562", "permed-64170", "permed-63779", "permed-63780", "permed-82373", "permed-53719", "permed-63698", "permed-76401", "permed-63695"]}
{"query_id": "topic_060_turn_2", "conversation_id": "topic_060", "turn_id": 2, "query": "Consequences of MTSF4's target RNA interactions for plant mitochondrial bioenergetics", "history": ["MTSF4 role in plant mitochondrial transcript regulation"], "ground_truth": ["permed-76400", "permed-89562", "permed-63779", "permed-64170", "permed-82351", "permed-82373", "permed-63780", "permed-53809", "permed-89441", "permed-84822"]}
{"query_id": "topic_060_turn_3", "conversation_id": "topic_060", "turn_id": 3, "query": "MTSF4 mutant Arabidopsis: rpl5-cob mRNA stability, mitochondrial metabolism, and stress compensatory mechanisms", "history": ["MTSF4 role in plant mitochondrial transcript regulation", "Consequences of MTSF4's target RNA interactions for plant mitochondrial bioenergetics"], "ground_truth": ["permed-76400", "permed-89562", "permed-67158", "permed-64170", "permed-50790", "permed-76404", "permed-82373", "permed-86606", "permed-53719", "permed-70740"]}
{"query_id": "topic_061_turn_1", "conversation_id": "topic_061", "turn_id": 1, "query": "What factors influence vaccine confidence among different communities in the US?", "history": [], "ground_truth": ["permed-52284", "permed-83452", "permed-71668", "permed-52277", "permed-64302", "permed-66299", "permed-52286", "permed-52292", "permed-65792", "permed-68152"]}
{"query_id": "topic_061_turn_2", "conversation_id": "topic_061", "turn_id": 2, "query": "How can understanding these factors help improve vaccination rates in underserved areas like urban Black American communities?", "history": ["What factors influence vaccine confidence among different communities in the US?"], "ground_truth": ["permed-64303", "permed-90576", "permed-52283", "permed-52278", "permed-52286", "permed-52279", "permed-64302", "permed-92263", "permed-65390", "permed-52287"]}
{"query_id": "topic_061_turn_3", "conversation_id": "topic_061", "turn_id": 3, "query": "Given these factors and their potential impact on vaccination rates in underserved Black communities, how can we best combine historical context with tailored communication strategies to boost both vaccine confidence and accessibility in these areas?", "history": ["What factors influence vaccine confidence among different communities in the US?", "How can understanding these factors help improve vaccination rates in underserved areas like urban Black American communities?"], "ground_truth": ["permed-64303", "permed-65792", "permed-90576", "permed-64302", "permed-52286", "permed-78392", "permed-52278", "permed-54554", "permed-52282", "permed-52284"]}
{"query_id": "topic_062_turn_1", "conversation_id": "topic_062", "turn_id": 1, "query": "What role do memory processes play in the development of delusions in schizophrenia?", "history": [], "ground_truth": ["permed-80458", "permed-80459", "permed-55782", "permed-80462", "permed-70280", "permed-88373", "permed-71706", "permed-61824", "permed-55503", "permed-55748"]}
{"query_id": "topic_062_turn_2", "conversation_id": "topic_062", "turn_id": 2, "query": "How does this relationship between memory and delusion formation change during episodes of acute psychosis?", "history": ["What role do memory processes play in the development of delusions in schizophrenia?"], "ground_truth": ["permed-80458", "permed-70668", "permed-71478", "permed-69591", "permed-63181", "permed-80459", "permed-63302", "permed-55782", "permed-71706", "permed-81284"]}
{"query_id": "topic_062_turn_3", "conversation_id": "topic_062", "turn_id": 3, "query": "Building on this relationship between memory and delusion formation during acute psychosis, how can we better understand the transition from delusion-like beliefs in the general population to full-blown delusions by examining the interaction between abnormal associative memory and metamemory impairments? What specific neurobiological mechanisms or markers might drive this transition, and how could they help develop more targeted treatments?", "history": ["What role do memory processes play in the development of delusions in schizophrenia?", "How does this relationship between memory and delusion formation change during episodes of acute psychosis?"], "ground_truth": ["permed-80458", "permed-70668", "permed-63181", "permed-71478", "permed-81284", "permed-55782", "permed-80459", "permed-69591", "permed-77571", "permed-80462"]}
{"query_id": "topic_063_turn_1", "conversation_id": "topic_063", "turn_id": 1, "query": "SARS-CoV-2 main protease: role in viral replication and rationale as an antiviral drug target", "history": [], "ground_truth": ["permed-68513", "permed-58469", "permed-58128", "permed-69042", "permed-69047", "permed-58134", "permed-58471", "permed-79540", "permed-68421", "permed-68512"]}
{"query_id": "topic_063_turn_2", "conversation_id": "topic_063", "turn_id": 2, "query": "Structural insights into this main protease, focusing on subpocket analysis for designing effective non-covalent inhibitors", "history": ["SARS-CoV-2 main protease: role in viral replication and rationale as an antiviral drug target"], "ground_truth": ["permed-75911", "permed-58471", "permed-71552", "permed-89404", "permed-82189", "permed-79814", "permed-71557", "permed-58137", "permed-58469", "permed-75976"]}
{"query_id": "topic_063_turn_3", "conversation_id": "topic_063", "turn_id": 3, "query": "Leveraging AI/ML to enhance non-covalent inhibitor binding affinity for the SARS-CoV-2 main protease S4 subpocket: predictive modeling and clinical advantages over existing antivirals", "history": ["SARS-CoV-2 main protease: role in viral replication and rationale as an antiviral drug target", "Structural insights into this main protease, focusing on subpocket analysis for designing effective non-covalent inhibitors"], "ground_truth": ["permed-75911", "permed-53318", "permed-58470", "permed-58471", "permed-79540", "permed-58128", "permed-69042", "permed-58137", "permed-58134", "permed-60335"]}
{"query_id": "topic_064_turn_1", "conversation_id": "topic_064", "turn_id": 1, "query": "What factors contribute to cognitive decline in late adulthood, and how can it be mitigated?", "history": [], "ground_truth": ["permed-52390", "permed-65600", "permed-66410", "permed-54249", "permed-35465", "permed-13077", "permed-25942", "permed-8419", "permed-9009", "permed-21483"]}
{"query_id": "topic_064_turn_2", "conversation_id": "topic_064", "turn_id": 2, "query": "Does this area of research suggest that lifestyle interventions during midlife could have a significant impact on brain health later in life?", "history": ["What factors contribute to cognitive decline in late adulthood, and how can it be mitigated?"], "ground_truth": ["permed-65680", "permed-52363", "permed-70973", "permed-8419", "permed-66460", "permed-81591", "permed-66355", "permed-66458", "permed-10833", "permed-74642"]}
{"query_id": "topic_064_turn_3", "conversation_id": "topic_064", "turn_id": 3, "query": "Given that midlife lifestyle interventions seem important for later brain health, how do individual differences in cognitive performance and habits like physical activity and diet during midlife affect the connection between long-term cognitive changes and brain health markers in late adulthood? Specifically, could improving these midlife factors help offset the cognitive impact of later β-amyloid buildup and white matter hyperintensities?", "history": ["What factors contribute to cognitive decline in late adulthood, and how can it be mitigated?", "Does this area of research suggest that lifestyle interventions during midlife could have a significant impact on brain health later in life?"], "ground_truth": ["permed-70973", "permed-66458", "permed-33259", "permed-8419", "permed-66411", "permed-66355", "permed-66460", "permed-61980", "permed-52390", "permed-51518"]}
{"query_id": "topic_065_turn_1", "conversation_id": "topic_065", "turn_id": 1, "query": "What are the current advancements in treating high cholesterol, particularly with PCSK9 inhibitors?", "history": [], "ground_truth": ["permed-60085", "permed-43032", "permed-60086", "permed-58890", "permed-66101", "permed-60088", "permed-74675", "permed-60084", "permed-4864", "permed-60087"]}
{"query_id": "topic_065_turn_2", "conversation_id": "topic_065", "turn_id": 2, "query": "How might combining this treatment approach with existing therapies impact patient outcomes, especially for those at higher risk?", "history": ["What are the current advancements in treating high cholesterol, particularly with PCSK9 inhibitors?"], "ground_truth": ["permed-59586", "permed-72565", "permed-72519", "permed-56699", "permed-81424", "permed-7221", "permed-56024", "permed-51822", "permed-60143", "permed-56784"]}
{"query_id": "topic_065_turn_3", "conversation_id": "topic_065", "turn_id": 3, "query": "Given these developments in PCSK9 inhibitors and their potential combination with existing therapies, how do you see this treatment landscape evolving over the next decade—especially for high-risk patients? What innovative approaches could improve both the accessibility and affordability of these treatments globally, and how might health policies need to adapt across different economic contexts to support broader adoption?", "history": ["What are the current advancements in treating high cholesterol, particularly with PCSK9 inhibitors?", "How might combining this treatment approach with existing therapies impact patient outcomes, especially for those at higher risk?"], "ground_truth": ["permed-58890", "permed-60085", "permed-66101", "permed-60086", "permed-43032", "permed-74675", "permed-60087", "permed-60084", "permed-60090", "permed-4864"]}
{"query_id": "topic_066_turn_1", "conversation_id": "topic_066", "turn_id": 1, "query": "What role does imaging play in detecting bleeding complications in COVID-19 patients?", "history": [], "ground_truth": ["permed-77785", "permed-78897", "permed-60574", "permed-72703", "permed-80823", "permed-80819", "permed-84935", "permed-78667", "permed-5136", "permed-66141"]}
{"query_id": "topic_066_turn_2", "conversation_id": "topic_066", "turn_id": 2, "query": "Can advanced techniques like DCE-CT enhance this detection process and improve patient care in this area?", "history": ["What role does imaging play in detecting bleeding complications in COVID-19 patients?"], "ground_truth": ["permed-77721", "permed-76544", "permed-70308", "permed-56321", "permed-23985", "permed-60507", "permed-58776", "permed-83773", "permed-5108", "permed-56143"]}
{"query_id": "topic_066_turn_3", "conversation_id": "topic_066", "turn_id": 3, "query": "How might integrating advanced techniques like DCE-CT improve early detection and characterization of spontaneous bleeding in these patients, and what could this mean for optimizing endovascular interventions and ultimately improving their outcomes?", "history": ["What role does imaging play in detecting bleeding complications in COVID-19 patients?", "Can advanced techniques like DCE-CT enhance this detection process and improve patient care in this area?"], "ground_truth": ["permed-78897", "permed-68351", "permed-63327", "permed-71333", "permed-50278", "permed-4028", "permed-46746", "permed-1482", "permed-71720", "permed-82625"]}
{"query_id": "topic_067_turn_1", "conversation_id": "topic_067", "turn_id": 1, "query": "How does historical trauma impact business decision-making, particularly among top managers?", "history": [], "ground_truth": ["permed-60998", "permed-69614", "permed-60004", "permed-69615", "permed-54612", "permed-66559", "permed-50944", "permed-60327", "permed-66242", "permed-50954"]}
{"query_id": "topic_067_turn_2", "conversation_id": "topic_067", "turn_id": 2, "query": "Does this impact vary based on individual psychological traits, and if so, how might it influence strategic risk-taking behaviors in different organizational settings?", "history": ["How does historical trauma impact business decision-making, particularly among top managers?"], "ground_truth": ["permed-59510", "permed-53927", "permed-69615", "permed-69718", "permed-51549", "permed-55566", "permed-87904", "permed-79605", "permed-86568", "permed-79913"]}
{"query_id": "topic_067_turn_3", "conversation_id": "topic_067", "turn_id": 3, "query": "Building on this, how might specific historical traumas like the Vietnam War interact with individual traits—particularly trait affectivity and cognitive ability—to influence top managers' strategic risk-taking and long-term planning across different organizational contexts? And what could this mean for firm performance and sustainability in the long run?", "history": ["How does historical trauma impact business decision-making, particularly among top managers?", "Does this impact vary based on individual psychological traits, and if so, how might it influence strategic risk-taking behaviors in different organizational settings?"], "ground_truth": ["permed-69615", "permed-65482", "permed-53927", "permed-66566", "permed-69614", "permed-69718", "permed-50550", "permed-55784", "permed-69923", "permed-60662"]}
{"query_id": "topic_068_turn_1", "conversation_id": "topic_068", "turn_id": 1, "query": "Current therapeutic challenges and unmet needs in managing severe traumatic osteonecrosis of the femoral head (TONFH) in young adults", "history": [], "ground_truth": ["permed-77506", "permed-52739", "permed-57589", "permed-77508", "permed-91707", "permed-52190", "permed-91152", "permed-59455", "permed-77507", "permed-90150"]}
{"query_id": "topic_068_turn_2", "conversation_id": "topic_068", "turn_id": 2, "query": "To address *these TONFH challenges*, how can advanced imaging (e.g., MRI, CT) improve diagnostic accuracy and outcome prediction for young adults, specifically concerning free vascularized iliac bone flap (FVIBF) procedures?", "history": ["Current therapeutic challenges and unmet needs in managing severe traumatic osteonecrosis of the femoral head (TONFH) in young adults"], "ground_truth": ["permed-77506", "permed-77511", "permed-57218", "permed-61512", "permed-91502", "permed-48653", "permed-3572", "permed-48918", "permed-31831", "permed-19963"]}
{"query_id": "topic_068_turn_3", "conversation_id": "topic_068", "turn_id": 3, "query": "Given *this potential of advanced imaging* for FVIBF, what specific MRI-CT integrated protocols enhance preoperative assessment in *these young TONFH patients* for predicting femoral head collapse and improving functional recovery, and what are the critical quantitative imaging biomarkers?", "history": ["Current therapeutic challenges and unmet needs in managing severe traumatic osteonecrosis of the femoral head (TONFH) in young adults", "To address *these TONFH challenges*, how can advanced imaging (e.g., MRI, CT) improve diagnostic accuracy and outcome prediction for young adults, specifically concerning free vascularized iliac bone flap (FVIBF) procedures?"], "ground_truth": ["permed-77506", "permed-77507", "permed-29261", "permed-83988", "permed-63294", "permed-60523", "permed-80812", "permed-57218", "permed-23989", "permed-23985"]}
{"query_id": "topic_069_turn_1", "conversation_id": "topic_069", "turn_id": 1, "query": "What role does personalized medicine play in current oncology practice?", "history": [], "ground_truth": ["permed-53997", "permed-78129", "permed-68621", "permed-87478", "permed-80135", "permed-60430", "permed-51873", "permed-87093", "permed-51785", "permed-73669"]}
{"query_id": "topic_069_turn_2", "conversation_id": "topic_069", "turn_id": 2, "query": "How is this approach affected by variations in interpreting genomic data across different institutions?", "history": ["What role does personalized medicine play in current oncology practice?"], "ground_truth": ["permed-78521", "permed-56400", "permed-53718", "permed-53719", "permed-64138", "permed-54310", "permed-54308", "permed-53717", "permed-78518", "permed-70012"]}
{"query_id": "topic_069_turn_3", "conversation_id": "topic_069", "turn_id": 3, "query": "How do differences in clinical guidelines and genomic data interpretation among multidisciplinary tumor boards affect how personalized medicine is implemented in routine oncology care, particularly for cases with limited evidence like TP53 mutations?", "history": ["What role does personalized medicine play in current oncology practice?", "How is this approach affected by variations in interpreting genomic data across different institutions?"], "ground_truth": ["permed-78469", "permed-73669", "permed-92532", "permed-71143", "permed-56448", "permed-56785", "permed-20240", "permed-64384", "permed-53997", "permed-56401"]}
{"query_id": "topic_070_turn_1", "conversation_id": "topic_070", "turn_id": 1, "query": "What are the current challenges in assessing the health impacts of air pollution on children near major roadways?", "history": [], "ground_truth": ["permed-65349", "permed-77880", "permed-54842", "permed-74140", "permed-54845", "permed-84498", "permed-33867", "permed-69943", "permed-78244", "permed-54841"]}
{"query_id": "topic_070_turn_2", "conversation_id": "topic_070", "turn_id": 2, "query": "Can integrating real-time data and new techniques like machine learning improve the accuracy of these assessments in this area?", "history": ["What are the current challenges in assessing the health impacts of air pollution on children near major roadways?"], "ground_truth": ["permed-69550", "permed-66153", "permed-86740", "permed-58495", "permed-77309", "permed-74121", "permed-84665", "permed-65765", "permed-83694", "permed-59407"]}
{"query_id": "topic_070_turn_3", "conversation_id": "topic_070", "turn_id": 3, "query": "Given these challenges and potential improvements through real-time data and machine learning, how specifically could combining these techniques with meteorological data enhance predictive models—both short-term and long-term—for assessing air pollution's health effects on children near roadways? And how might changing environmental policies or public health interventions influence this approach, particularly for school settings?", "history": ["What are the current challenges in assessing the health impacts of air pollution on children near major roadways?", "Can integrating real-time data and new techniques like machine learning improve the accuracy of these assessments in this area?"], "ground_truth": ["permed-54845", "permed-81982", "permed-54847", "permed-65349", "permed-33868", "permed-81358", "permed-51750", "permed-65712", "permed-77880", "permed-65713"]}
{"query_id": "topic_071_turn_1", "conversation_id": "topic_071", "turn_id": 1, "query": "What role does the KRAS protein play in colorectal cancer development and progression?", "history": [], "ground_truth": ["permed-73656", "permed-74302", "permed-55371", "permed-53500", "permed-79026", "permed-89033", "permed-55315", "permed-74304", "permed-85505", "permed-70393"]}
{"query_id": "topic_071_turn_2", "conversation_id": "topic_071", "turn_id": 2, "query": "How do variations or modifications in this protein affect its interaction with other signaling pathways, such as MAPK?", "history": ["What role does the KRAS protein play in colorectal cancer development and progression?"], "ground_truth": ["permed-64165", "permed-71707", "permed-72047", "permed-71538", "permed-76613", "permed-73656", "permed-89298", "permed-83858", "permed-64093", "permed-87202"]}
{"query_id": "topic_071_turn_3", "conversation_id": "topic_071", "turn_id": 3, "query": "Given these effects of KRAS variations on MAPK pathway interactions, how do specific proteoforms—particularly those with unique post-translational modifications or truncations—influence the localization and activity of other key signaling proteins in this pathway? And what would this mean for developing targeted therapies in colorectal cancer?", "history": ["What role does the KRAS protein play in colorectal cancer development and progression?", "How do variations or modifications in this protein affect its interaction with other signaling pathways, such as MAPK?"], "ground_truth": ["permed-73656", "permed-83858", "permed-89033", "permed-55371", "permed-71084", "permed-70804", "permed-53530", "permed-67638", "permed-66190", "permed-53501"]}
{"query_id": "topic_072_turn_1", "conversation_id": "topic_072", "turn_id": 1, "query": "What is currently known about the inflammatory pathways involved in diabetic kidney disease?", "history": [], "ground_truth": ["permed-53065", "permed-57230", "permed-65118", "permed-58614", "permed-58651", "permed-10654", "permed-27497", "permed-58954", "permed-58607", "permed-51198"]}
{"query_id": "topic_072_turn_2", "conversation_id": "topic_072", "turn_id": 2, "query": "How might a better understanding of these pathways lead to new therapeutic approaches for DKD?", "history": ["What is currently known about the inflammatory pathways involved in diabetic kidney disease?"], "ground_truth": ["permed-53065", "permed-57309", "permed-51143", "permed-23552", "permed-62484", "permed-51198", "permed-58399", "permed-6597", "permed-10654", "permed-5177"]}
{"query_id": "topic_072_turn_3", "conversation_id": "topic_072", "turn_id": 3, "query": "Given what we know about these inflammatory pathways and their therapeutic potential, how can integrating advanced molecular insights help develop synergistic treatments that combine standard DKD care with novel anti-inflammatory agents? And what are the main challenges and opportunities in translating these approaches into clinical practice by 2030?", "history": ["What is currently known about the inflammatory pathways involved in diabetic kidney disease?", "How might a better understanding of these pathways lead to new therapeutic approaches for DKD?"], "ground_truth": ["permed-53065", "permed-23552", "permed-57309", "permed-62484", "permed-57230", "permed-51143", "permed-58954", "permed-58399", "permed-68054", "permed-58651"]}
{"query_id": "topic_073_turn_1", "conversation_id": "topic_073", "turn_id": 1, "query": "What role do quaternary ammonium compounds play in photoswitchable ligands and their application in neural circuits?", "history": [], "ground_truth": ["permed-60850", "permed-53576", "permed-51020", "permed-53553", "permed-74523", "permed-60859", "permed-90113", "permed-82199", "permed-75409", "permed-51007"]}
{"query_id": "topic_073_turn_2", "conversation_id": "topic_073", "turn_id": 2, "query": "How do structural modifications affect the photoresponsive properties of these compounds, and can this be leveraged to improve their performance?", "history": ["What role do quaternary ammonium compounds play in photoswitchable ligands and their application in neural circuits?"], "ground_truth": ["permed-74520", "permed-75409", "permed-53576", "permed-75407", "permed-80452", "permed-73350", "permed-78037", "permed-60850", "permed-74523", "permed-75448"]}
{"query_id": "topic_073_turn_3", "conversation_id": "topic_073", "turn_id": 3, "query": "Given that structural modifications influence their photoresponsive properties, what exactly happens at the molecular level to cause these differential effects in quaternary ammonium compounds? And how can we use this mechanistic understanding to better design next-gen photoswitchable ligands for precisely controlling synaptic transmission in neural circuits?", "history": ["What role do quaternary ammonium compounds play in photoswitchable ligands and their application in neural circuits?", "How do structural modifications affect the photoresponsive properties of these compounds, and can this be leveraged to improve their performance?"], "ground_truth": ["permed-60850", "permed-53576", "permed-75409", "permed-74520", "permed-74523", "permed-51020", "permed-75407", "permed-51007", "permed-53553", "permed-86730"]}
{"query_id": "topic_074_turn_1", "conversation_id": "topic_074", "turn_id": 1, "query": "Recent advancements in automated insulin delivery (AID) systems for type 1 and type 2 diabetes management", "history": [], "ground_truth": ["permed-53507", "permed-70666", "permed-76381", "permed-87570", "permed-89894", "permed-87568", "permed-53509", "permed-47395", "permed-47396", "permed-87527"]}
{"query_id": "topic_074_turn_2", "conversation_id": "topic_074", "turn_id": 2, "query": "Adapting these automated insulin delivery systems for older adults: addressing challenges like dexterity, vision impairment, and cognitive load", "history": ["Recent advancements in automated insulin delivery (AID) systems for type 1 and type 2 diabetes management"], "ground_truth": ["permed-76380", "permed-53507", "permed-60787", "permed-76382", "permed-87570", "permed-70666", "permed-87571", "permed-53509", "permed-30229", "permed-78729"]}
{"query_id": "topic_074_turn_3", "conversation_id": "topic_074", "turn_id": 3, "query": "Design strategies for next-generation closed-loop insulin systems for elderly patients: focusing on minimizing user burden, enhancing CGM accuracy, and improving affordability for sustained adoption", "history": ["Recent advancements in automated insulin delivery (AID) systems for type 1 and type 2 diabetes management", "Adapting these automated insulin delivery systems for older adults: addressing challenges like dexterity, vision impairment, and cognitive load"], "ground_truth": ["permed-76380", "permed-53507", "permed-60787", "permed-87569", "permed-87568", "permed-70650", "permed-76381", "permed-87570", "permed-70661", "permed-53509"]}
{"query_id": "topic_075_turn_1", "conversation_id": "topic_075", "turn_id": 1, "query": "What role does molecular dynamics play in understanding organic chromophores' optical properties?", "history": [], "ground_truth": ["permed-52463", "permed-75409", "permed-72911", "permed-77738", "permed-75410", "permed-77736", "permed-75414", "permed-74520", "permed-75406", "permed-60321"]}
{"query_id": "topic_075_turn_2", "conversation_id": "topic_075", "turn_id": 2, "query": "Can combining this technique with other computational methods like machine learning offer new insights into optimizing chromophore design?", "history": ["What role does molecular dynamics play in understanding organic chromophores' optical properties?"], "ground_truth": ["permed-75406", "permed-72911", "permed-77738", "permed-60323", "permed-52463", "permed-52683", "permed-86533", "permed-75411", "permed-60928", "permed-83334"]}
{"query_id": "topic_075_turn_3", "conversation_id": "topic_075", "turn_id": 3, "query": "Building on these approaches, how might integrating machine learning with classical molecular dynamics and DFT improve our understanding of dynamic structural fluctuations in organic chromophores and their effect on second-order nonlinear optical properties? Specifically, could such combined methods offer new strategies for optimizing chromophore design to enhance NLO performance across different environments—like biological systems and nanostructured materials?", "history": ["What role does molecular dynamics play in understanding organic chromophores' optical properties?", "Can combining this technique with other computational methods like machine learning offer new insights into optimizing chromophore design?"], "ground_truth": ["permed-52463", "permed-77738", "permed-72911", "permed-77740", "permed-77736", "permed-90370", "permed-77737", "permed-75453", "permed-60323", "permed-77282"]}
{"query_id": "topic_076_turn_1", "conversation_id": "topic_076", "turn_id": 1, "query": "What effects do parabens have on aquatic life, particularly concerning reproductive health?", "history": [], "ground_truth": ["permed-80789", "permed-81776", "permed-82046", "permed-76122", "permed-62980", "permed-82041", "permed-80792", "permed-80543", "permed-87661", "permed-72052"]}
{"query_id": "topic_076_turn_2", "conversation_id": "topic_076", "turn_id": 2, "query": "Are there any specific parabens, like methylparaben, that have been studied more extensively in this area to understand their potential long-term impacts?", "history": ["What effects do parabens have on aquatic life, particularly concerning reproductive health?"], "ground_truth": ["permed-80789", "permed-78353", "permed-87814", "permed-89744", "permed-78242", "permed-82046", "permed-79821", "permed-82047", "permed-80792", "permed-76118"]}
{"query_id": "topic_076_turn_3", "conversation_id": "topic_076", "turn_id": 3, "query": "Given what we know about methylparaben's effects on zebrafish reproduction and endocrine systems, how might chronic exposure to lower, environmentally realistic levels of this paraben impact the long-term fertility and genetic diversity of wild fish populations? And what broader ecological consequences could such disruptions have on aquatic ecosystems?", "history": ["What effects do parabens have on aquatic life, particularly concerning reproductive health?", "Are there any specific parabens, like methylparaben, that have been studied more extensively in this area to understand their potential long-term impacts?"], "ground_truth": ["permed-80789", "permed-82046", "permed-76122", "permed-81776", "permed-80792", "permed-53540", "permed-83311", "permed-72052", "permed-81777", "permed-67391"]}
{"query_id": "topic_077_turn_1", "conversation_id": "topic_077", "turn_id": 1, "query": "What advancements have been made in treating Crohn's disease and ulcerative colitis with biologic therapies and small molecule inhibitors?", "history": [], "ground_truth": ["permed-53285", "permed-71644", "permed-71631", "permed-71630", "permed-90574", "permed-6263", "permed-6259", "permed-55931", "permed-6262", "permed-1097"]}
{"query_id": "topic_077_turn_2", "conversation_id": "topic_077", "turn_id": 2, "query": "How do patient-specific factors impact the effectiveness of these treatments in managing inflammatory bowel diseases like this?", "history": ["What advancements have been made in treating Crohn's disease and ulcerative colitis with biologic therapies and small molecule inhibitors?"], "ground_truth": ["permed-55929", "permed-53285", "permed-1337", "permed-55930", "permed-55926", "permed-54908", "permed-6261", "permed-6259", "permed-22844", "permed-55928"]}
{"query_id": "topic_077_turn_3", "conversation_id": "topic_077", "turn_id": 3, "query": "Given these patient-specific factors, how do genetic predisposition and baseline disease activity specifically affect the long-term efficacy and safety of these treatments for Crohn's and ulcerative colitis? And what does this mean for developing personalized treatment approaches?", "history": ["What advancements have been made in treating Crohn's disease and ulcerative colitis with biologic therapies and small molecule inhibitors?", "How do patient-specific factors impact the effectiveness of these treatments in managing inflammatory bowel diseases like this?"], "ground_truth": ["permed-73548", "permed-67921", "permed-50782", "permed-52026", "permed-1097", "permed-75533", "permed-71631", "permed-35302", "permed-21053", "permed-70946"]}
{"query_id": "topic_078_turn_1", "conversation_id": "topic_078", "turn_id": 1, "query": "Diagnostic imaging techniques for non-FDG-avid pancreatic lesions", "history": [], "ground_truth": ["permed-77462", "permed-48420", "permed-82599", "permed-48427", "permed-3633", "permed-56705", "permed-48568", "permed-21492", "permed-23985", "permed-48461"]}
{"query_id": "topic_078_turn_2", "conversation_id": "topic_078", "turn_id": 2, "query": "Comparative efficacy of 68Ga-FAPI-04 PET for these non-FDG-avid pancreatic lesions versus conventional FDG-PET", "history": ["Diagnostic imaging techniques for non-FDG-avid pancreatic lesions"], "ground_truth": ["permed-29841", "permed-77462", "permed-48494", "permed-61159", "permed-77454", "permed-48495", "permed-48498", "permed-61160", "permed-77460", "permed-48592"]}
{"query_id": "topic_078_turn_3", "conversation_id": "topic_078", "turn_id": 3, "query": "Mechanisms of differential 68Ga-FAPI-04 uptake in non-FDG-avid solid pseudopapillary neoplasms: implications for diagnostic precision and targeted therapy", "history": ["Diagnostic imaging techniques for non-FDG-avid pancreatic lesions", "Comparative efficacy of 68Ga-FAPI-04 PET for these non-FDG-avid pancreatic lesions versus conventional FDG-PET"], "ground_truth": ["permed-77462", "permed-29841", "permed-77454", "permed-77459", "permed-48391", "permed-48397", "permed-48592", "permed-42276", "permed-48392", "permed-75850"]}
{"query_id": "topic_079_turn_1", "conversation_id": "topic_079", "turn_id": 1, "query": "What effects can chemical contaminants have on aquatic species like Japanese medaka?", "history": [], "ground_truth": ["permed-82046", "permed-80663", "permed-73502", "permed-80543", "permed-80789", "permed-59153", "permed-84089", "permed-82036", "permed-82037", "permed-82041"]}
{"query_id": "topic_079_turn_2", "conversation_id": "topic_079", "turn_id": 2, "query": "How specifically does exposure to certain contaminants, like endocrine disruptors, impact this species over time?", "history": ["What effects can chemical contaminants have on aquatic species like Japanese medaka?"], "ground_truth": ["permed-80792", "permed-80789", "permed-73502", "permed-31421", "permed-78353", "permed-81777", "permed-80786", "permed-74152", "permed-31423", "permed-80790"]}
{"query_id": "topic_079_turn_3", "conversation_id": "topic_079", "turn_id": 3, "query": "Given that DEHS has been shown to disrupt thyroid hormone-related gene expression and metabolism in Japanese medaka, what long-term physiological and behavioral adaptations might we expect from chronic exposure to this contaminant? And how could these changes potentially affect the species' populations in contaminated aquatic ecosystems?", "history": ["What effects can chemical contaminants have on aquatic species like Japanese medaka?", "How specifically does exposure to certain contaminants, like endocrine disruptors, impact this species over time?"], "ground_truth": ["permed-73502", "permed-80792", "permed-80663", "permed-81777", "permed-50839", "permed-82046", "permed-76122", "permed-80789", "permed-53540", "permed-71936"]}
{"query_id": "topic_080_turn_1", "conversation_id": "topic_080", "turn_id": 1, "query": "What impact do SGLT2 inhibitors and GLP1 receptor agonists have on kidney function in type 2 diabetes patients?", "history": [], "ground_truth": ["permed-78412", "permed-58403", "permed-57246", "permed-58395", "permed-58398", "permed-69051", "permed-58399", "permed-11996", "permed-58322", "permed-58405"]}
{"query_id": "topic_080_turn_2", "conversation_id": "topic_080", "turn_id": 2, "query": "Are there any notable patterns or trends in how these treatments affect eGFR over time, particularly in patients who experience early declines?", "history": ["What impact do SGLT2 inhibitors and GLP1 receptor agonists have on kidney function in type 2 diabetes patients?"], "ground_truth": ["permed-78412", "permed-73826", "permed-58744", "permed-27720", "permed-8765", "permed-64799", "permed-27425", "permed-85333", "permed-61145", "permed-85801"]}
{"query_id": "topic_080_turn_3", "conversation_id": "topic_080", "turn_id": 3, "query": "Given these observed eGFR trends in patients treated with these medications, what specific mechanisms or biomarkers could help predict individual responses—particularly for those showing early declines—and how might this understanding be used to personalize treatment strategies and improve long-term kidney outcomes?", "history": ["What impact do SGLT2 inhibitors and GLP1 receptor agonists have on kidney function in type 2 diabetes patients?", "Are there any notable patterns or trends in how these treatments affect eGFR over time, particularly in patients who experience early declines?"], "ground_truth": ["permed-78412", "permed-73826", "permed-58744", "permed-85801", "permed-27425", "permed-61149", "permed-85333", "permed-27720", "permed-61145", "permed-8765"]}
{"query_id": "topic_081_turn_1", "conversation_id": "topic_081", "turn_id": 1, "query": "What are the key applications and proven benefits of therapeutic drug monitoring in chronic disease patient care?", "history": [], "ground_truth": ["permed-54908", "permed-84409", "permed-52745", "permed-75814", "permed-4610", "permed-77619", "permed-50787", "permed-72540", "permed-58384", "permed-8724"]}
{"query_id": "topic_081_turn_2", "conversation_id": "topic_081", "turn_id": 2, "query": "How can dried blood spot sampling specifically improve the practicality and patient accessibility for this therapeutic drug monitoring in managing these chronic conditions?", "history": ["What are the key applications and proven benefits of therapeutic drug monitoring in chronic disease patient care?"], "ground_truth": ["permed-75814", "permed-75818", "permed-75811", "permed-75812", "permed-75817", "permed-77618", "permed-4610", "permed-72540", "permed-54908", "permed-75813"]}
{"query_id": "topic_081_turn_3", "conversation_id": "topic_081", "turn_id": 3, "query": "What is the specific impact of patient hematocrit variability on the quantitative accuracy of home-based dried blood spot TDM, and how can this be addressed to advance personalized medicine in chronic disease?", "history": ["What are the key applications and proven benefits of therapeutic drug monitoring in chronic disease patient care?", "How can dried blood spot sampling specifically improve the practicality and patient accessibility for this therapeutic drug monitoring in managing these chronic conditions?"], "ground_truth": ["permed-75814", "permed-75818", "permed-75811", "permed-84060", "permed-4610", "permed-77618", "permed-37954", "permed-78986", "permed-60786", "permed-37957"]}
{"query_id": "topic_082_turn_1", "conversation_id": "topic_082", "turn_id": 1, "query": "Primary synovial sarcoma of the prostate: epidemiology, clinical features, and patient outcomes", "history": [], "ground_truth": ["permed-85504", "permed-60204", "permed-50938", "permed-77489", "permed-59570", "permed-90670", "permed-74286", "permed-36513", "permed-77470", "permed-56150"]}
{"query_id": "topic_082_turn_2", "conversation_id": "topic_082", "turn_id": 2, "query": "Molecular and genetic characteristics of this rare prostatic cancer relevant to its diagnosis and treatment", "history": ["Primary synovial sarcoma of the prostate: epidemiology, clinical features, and patient outcomes"], "ground_truth": ["permed-85504", "permed-56151", "permed-36550", "permed-6983", "permed-59568", "permed-82373", "permed-50938", "permed-73669", "permed-56044", "permed-86439"]}
{"query_id": "topic_082_turn_3", "conversation_id": "topic_082", "turn_id": 3, "query": "Targetable molecular pathways and specific biomarkers (e.g., SS18-SSX fusion) in prostatic synovial sarcoma for developing early detection methods and precision therapies", "history": ["Primary synovial sarcoma of the prostate: epidemiology, clinical features, and patient outcomes", "Molecular and genetic characteristics of this rare prostatic cancer relevant to its diagnosis and treatment"], "ground_truth": ["permed-85504", "permed-50938", "permed-36267", "permed-36426", "permed-60204", "permed-56356", "permed-56146", "permed-5017", "permed-48579", "permed-56511"]}
{"query_id": "topic_083_turn_1", "conversation_id": "topic_083", "turn_id": 1, "query": "Exploring current challenges in status epilepticus: diagnosing, initial management, and differentiating focal vs generalized forms.", "history": [], "ground_truth": ["permed-71949", "permed-75014", "permed-49643", "permed-71948", "permed-67661", "permed-70955", "permed-9300", "permed-71950", "permed-67658", "permed-71033"]}
{"query_id": "topic_083_turn_2", "conversation_id": "topic_083", "turn_id": 2, "query": "Evolving therapeutic approaches for refractory status epilepticus, considering these challenges in differentiating focal and generalized forms.", "history": ["Exploring current challenges in status epilepticus: diagnosing, initial management, and differentiating focal vs generalized forms."], "ground_truth": ["permed-71949", "permed-75014", "permed-49643", "permed-71032", "permed-67661", "permed-24660", "permed-75015", "permed-70959", "permed-8591", "permed-91081"]}
{"query_id": "topic_083_turn_3", "conversation_id": "topic_083", "turn_id": 3, "query": "Novel biomarkers and clinical outcomes for optimizing anesthetic drug therapy in refractory focal status epilepticus, addressing prior diagnostic and treatment complexities.", "history": ["Exploring current challenges in status epilepticus: diagnosing, initial management, and differentiating focal vs generalized forms.", "Evolving therapeutic approaches for refractory status epilepticus, considering these challenges in differentiating focal and generalized forms."], "ground_truth": ["permed-71949", "permed-71032", "permed-67661", "permed-71948", "permed-75014", "permed-70959", "permed-90475", "permed-90881", "permed-70957", "permed-71162"]}
{"query_id": "topic_084_turn_1", "conversation_id": "topic_084", "turn_id": 1, "query": "Exploring the role of bioethics in navigating societal challenges stemming from human-nonhuman interactions", "history": [], "ground_truth": ["permed-53038", "permed-53039", "permed-74865", "permed-54375", "permed-72675", "permed-72676", "permed-87900", "permed-74855", "permed-53040", "permed-67610"]}
{"query_id": "topic_084_turn_2", "conversation_id": "topic_084", "turn_id": 2, "query": "Methods for enhancing this bioethical role to better incorporate diverse perspectives and community values in human-nonhuman contexts", "history": ["Exploring the role of bioethics in navigating societal challenges stemming from human-nonhuman interactions"], "ground_truth": ["permed-53038", "permed-54375", "permed-87900", "permed-53040", "permed-53039", "permed-72676", "permed-74856", "permed-54377", "permed-69886", "permed-53042"]}
{"query_id": "topic_084_turn_3", "conversation_id": "topic_084", "turn_id": 3, "query": "Technical approaches for adapting existing bioethical frameworks to systematically integrate underrepresented stakeholder perspectives, aiming for inclusive and practical guidelines in complex human-nonhuman interaction scenarios.", "history": ["Exploring the role of bioethics in navigating societal challenges stemming from human-nonhuman interactions", "Methods for enhancing this bioethical role to better incorporate diverse perspectives and community values in human-nonhuman contexts"], "ground_truth": ["permed-53038", "permed-72676", "permed-87900", "permed-55968", "permed-53042", "permed-53039", "permed-54375", "permed-74865", "permed-72675", "permed-74856"]}
{"query_id": "topic_085_turn_1", "conversation_id": "topic_085", "turn_id": 1, "query": "Effects of peer influence on adolescent decision-making", "history": [], "ground_truth": ["permed-69598", "permed-69602", "permed-75160", "permed-55645", "permed-53117", "permed-66295", "permed-74343", "permed-60974", "permed-65427", "permed-69596"]}
{"query_id": "topic_085_turn_2", "conversation_id": "topic_085", "turn_id": 2, "query": "How do cognitive and social development stages modulate these peer influence effects on adolescent decision-making, especially concerning moral dilemmas?", "history": ["Effects of peer influence on adolescent decision-making"], "ground_truth": ["permed-69598", "permed-69602", "permed-60974", "permed-55602", "permed-83489", "permed-55695", "permed-53117", "permed-69599", "permed-77768", "permed-55802"]}
{"query_id": "topic_085_turn_3", "conversation_id": "topic_085", "turn_id": 3, "query": "Psychological mechanisms explaining these developmental modulations of peer influence on moral decision-making in adolescents and young adults", "history": ["Effects of peer influence on adolescent decision-making", "How do cognitive and social development stages modulate these peer influence effects on adolescent decision-making, especially concerning moral dilemmas?"], "ground_truth": ["permed-69598", "permed-75160", "permed-69602", "permed-73845", "permed-55602", "permed-55802", "permed-66297", "permed-69663", "permed-69527", "permed-89165"]}
{"query_id": "topic_086_turn_1", "conversation_id": "topic_086", "turn_id": 1, "query": "Recent advancements in CAR-T cell therapy for B-cell malignancies", "history": [], "ground_truth": ["permed-22564", "permed-68129", "permed-67310", "permed-60150", "permed-22572", "permed-56395", "permed-5445", "permed-22425", "permed-72519", "permed-63502"]}
{"query_id": "topic_086_turn_2", "conversation_id": "topic_086", "turn_id": 2, "query": "Comparative efficacy of bispecific vs single-antigen CAR-T cell therapies for these B-cell malignancies", "history": ["Recent advancements in CAR-T cell therapy for B-cell malignancies"], "ground_truth": ["permed-22564", "permed-72519", "permed-60150", "permed-77342", "permed-68134", "permed-22429", "permed-67310", "permed-22572", "permed-77345", "permed-68133"]}
{"query_id": "topic_086_turn_3", "conversation_id": "topic_086", "turn_id": 3, "query": "Molecular modifications to bispecific CAR-T receptors to enhance signaling and binding for B-cell tumors with single antigen expression (e.g., CD19 or CD79a/b loss)", "history": ["Recent advancements in CAR-T cell therapy for B-cell malignancies", "Comparative efficacy of bispecific vs single-antigen CAR-T cell therapies for these B-cell malignancies"], "ground_truth": ["permed-77342", "permed-68130", "permed-22564", "permed-77345", "permed-58146", "permed-68134", "permed-22336", "permed-77344", "permed-56395", "permed-22429"]}
{"query_id": "topic_087_turn_1", "conversation_id": "topic_087", "turn_id": 1, "query": "Mechanisms of EGFR in promoting cancer cell proliferation and metastasis", "history": [], "ground_truth": ["permed-82373", "permed-55309", "permed-56627", "permed-68563", "permed-55371", "permed-75914", "permed-51216", "permed-77321", "permed-82128", "permed-57519"]}
{"query_id": "topic_087_turn_2", "conversation_id": "topic_087", "turn_id": 2, "query": "Advanced imaging techniques for visualizing EGFR interactions with its signaling partners during these cancer processes", "history": ["Mechanisms of EGFR in promoting cancer cell proliferation and metastasis"], "ground_truth": ["permed-77321", "permed-82373", "permed-53718", "permed-71707", "permed-48398", "permed-77325", "permed-56627", "permed-85301", "permed-20916", "permed-68941"]}
{"query_id": "topic_087_turn_3", "conversation_id": "topic_087", "turn_id": 3, "query": "Combining circular bivalent aptamer-functionalized optical probes with advanced imaging for tracking EGFR dynamic interactions with nuclear proteins during cancer cell proliferation and metastasis", "history": ["Mechanisms of EGFR in promoting cancer cell proliferation and metastasis", "Advanced imaging techniques for visualizing EGFR interactions with its signaling partners during these cancer processes"], "ground_truth": ["permed-77321", "permed-77322", "permed-48391", "permed-52692", "permed-53718", "permed-60888", "permed-77323", "permed-48398", "permed-80633", "permed-73142"]}
{"query_id": "topic_088_turn_1", "conversation_id": "topic_088", "turn_id": 1, "query": "Current technologies for pre-analytical analyte stability in blood samples during transport and storage", "history": [], "ground_truth": ["permed-81833", "permed-81835", "permed-52759", "permed-86311", "permed-53311", "permed-81837", "permed-72540", "permed-91235", "permed-66153", "permed-75811"]}
{"query_id": "topic_088_turn_2", "conversation_id": "topic_088", "turn_id": 2, "query": "Comparing hemaPEN to such blood stabilization technologies: sample volume consistency and overall performance analysis", "history": ["Current technologies for pre-analytical analyte stability in blood samples during transport and storage"], "ground_truth": ["permed-75811", "permed-91349", "permed-56265", "permed-71333", "permed-66093", "permed-84059", "permed-72012", "permed-72540", "permed-84061", "permed-76328"]}
{"query_id": "topic_088_turn_3", "conversation_id": "topic_088", "turn_id": 3, "query": "Impact of hemaPEN's confirmed analyte stability and sample volume consistency on suitability for epidemiological studies, remote sample collection, and long-term drug trend analysis reliability", "history": ["Current technologies for pre-analytical analyte stability in blood samples during transport and storage", "Comparing hemaPEN to such blood stabilization technologies: sample volume consistency and overall performance analysis"], "ground_truth": ["permed-75811", "permed-72641", "permed-75813", "permed-88327", "permed-68511", "permed-75814", "permed-66153", "permed-66093", "permed-75818", "permed-52759"]}
{"query_id": "topic_089_turn_1", "conversation_id": "topic_089", "turn_id": 1, "query": "Systematic reviews of resveratrol's neuroprotective effects in animal models of kidney dysfunction", "history": [], "ground_truth": ["permed-78039", "permed-82440", "permed-78568", "permed-81083", "permed-68143", "permed-81086", "permed-78700", "permed-69155", "permed-80224", "permed-91280"]}
{"query_id": "topic_089_turn_2", "conversation_id": "topic_089", "turn_id": 2, "query": "Influence of uninephrectomy on resveratrol's neuroprotective efficacy in these animal models and implications for human kidney disease therapy", "history": ["Systematic reviews of resveratrol's neuroprotective effects in animal models of kidney dysfunction"], "ground_truth": ["permed-78039", "permed-82440", "permed-78568", "permed-68143", "permed-62480", "permed-81086", "permed-91281", "permed-69155", "permed-72852", "permed-69156"]}
{"query_id": "topic_089_turn_3", "conversation_id": "topic_089", "turn_id": 3, "query": "Optimizing resveratrol dosage and timing in uninephrectomized rats for cognitive/molecular neuroprotection: translational insights for early CKD and novel mechanisms beyond SIRT1/BDNF/AChE", "history": ["Systematic reviews of resveratrol's neuroprotective effects in animal models of kidney dysfunction", "Influence of uninephrectomy on resveratrol's neuroprotective efficacy in these animal models and implications for human kidney disease therapy"], "ground_truth": ["permed-78039", "permed-82440", "permed-78568", "permed-91281", "permed-91280", "permed-69155", "permed-81083", "permed-81086", "permed-60751", "permed-51231"]}
{"query_id": "topic_090_turn_1", "conversation_id": "topic_090", "turn_id": 1, "query": "What advancements have been made in detecting pineal region tumors using imaging techniques?", "history": [], "ground_truth": ["permed-78468", "permed-73779", "permed-73783", "permed-54110", "permed-72720", "permed-75849", "permed-23988", "permed-85256", "permed-5108", "permed-56706"]}
{"query_id": "topic_090_turn_2", "conversation_id": "topic_090", "turn_id": 2, "query": "Can integrating machine learning with these imaging techniques, like MRI, further improve diagnosis accuracy in this area?", "history": ["What advancements have been made in detecting pineal region tumors using imaging techniques?"], "ground_truth": ["permed-84419", "permed-53332", "permed-74985", "permed-63378", "permed-56321", "permed-61138", "permed-72904", "permed-87560", "permed-70308", "permed-56231"]}
{"query_id": "topic_090_turn_3", "conversation_id": "topic_090", "turn_id": 3, "query": "Given these developments in MRI and machine learning for pineal tumor detection, how could combining advanced ML techniques with multi-parametric MRI improve early-stage detection and subtyping accuracy? Specifically, what would be the optimal imaging protocols, and how might demographic factors influence the model's performance?", "history": ["What advancements have been made in detecting pineal region tumors using imaging techniques?", "Can integrating machine learning with these imaging techniques, like MRI, further improve diagnosis accuracy in this area?"], "ground_truth": ["permed-78468", "permed-28200", "permed-56144", "permed-5365", "permed-68010", "permed-56143", "permed-56445", "permed-53339", "permed-17428", "permed-2698"]}
{"query_id": "topic_091_turn_1", "conversation_id": "topic_091", "turn_id": 1, "query": "What are the current challenges in predicting outcomes for patients with pituitary neuroendocrine tumors?", "history": [], "ground_truth": ["permed-78963", "permed-56333", "permed-56708", "permed-58905", "permed-2531", "permed-1543", "permed-2524", "permed-78887", "permed-56677", "permed-1358"]}
{"query_id": "topic_091_turn_2", "conversation_id": "topic_091", "turn_id": 2, "query": "Can advances in molecular markers and genetic analysis improve predictions in this area?", "history": ["What are the current challenges in predicting outcomes for patients with pituitary neuroendocrine tumors?"], "ground_truth": ["permed-71547", "permed-56046", "permed-58667", "permed-74050", "permed-54615", "permed-56694", "permed-72062", "permed-52485", "permed-73575", "permed-53717"]}
{"query_id": "topic_091_turn_3", "conversation_id": "topic_091", "turn_id": 3, "query": "Given these advances in molecular markers and genetic analysis, how specifically could integrating markers like TERT promoter methylation and other genetic alterations enhance our ability to predict clinical outcomes and recurrence patterns in patients with highly aggressive pituitary neuroendocrine tumors?", "history": ["What are the current challenges in predicting outcomes for patients with pituitary neuroendocrine tumors?", "Can advances in molecular markers and genetic analysis improve predictions in this area?"], "ground_truth": ["permed-56708", "permed-78963", "permed-87042", "permed-1357", "permed-2524", "permed-29312", "permed-56694", "permed-58762", "permed-78887", "permed-32044"]}
{"query_id": "topic_092_turn_1", "conversation_id": "topic_092", "turn_id": 1, "query": "What is known about the role of PoC1qDC in immune responses, particularly in aquatic organisms?", "history": [], "ground_truth": ["permed-82058", "permed-50844", "permed-73959", "permed-50848", "permed-82064", "permed-35074", "permed-90437", "permed-11437", "permed-22787", "permed-57471"]}
{"query_id": "topic_092_turn_2", "conversation_id": "topic_092", "turn_id": 2, "query": "How does its interaction with IgM and leukocytes impact this process, and are there any environmental factors that influence its activity?", "history": ["What is known about the role of PoC1qDC in immune responses, particularly in aquatic organisms?"], "ground_truth": ["permed-92455", "permed-67940", "permed-68415", "permed-66966", "permed-91322", "permed-82058", "permed-53182", "permed-56649", "permed-72202", "permed-55186"]}
{"query_id": "topic_092_turn_3", "conversation_id": "topic_092", "turn_id": 3, "query": "Considering PoC1qDC's involvement in complement activation and its interactions with IgM and leukocytes, how might structural variations or expression level changes in this protein influence immune response efficiency under different environmental conditions—like shifts in water temperature or salinity? And based on these potential effects, what therapeutic approaches could be developed to modulate PoC1qDC activity for improving disease resistance in aquaculture?", "history": ["What is known about the role of PoC1qDC in immune responses, particularly in aquatic organisms?", "How does its interaction with IgM and leukocytes impact this process, and are there any environmental factors that influence its activity?"], "ground_truth": ["permed-82058", "permed-9058", "permed-73959", "permed-23264", "permed-11430", "permed-46153", "permed-11437", "permed-57471", "permed-68209", "permed-84923"]}
{"query_id": "topic_093_turn_1", "conversation_id": "topic_093", "turn_id": 1, "query": "Impact of YouTube on patient education for serious diseases", "history": [], "ground_truth": ["permed-76822", "permed-89001", "permed-65311", "permed-66069", "permed-66153", "permed-66148", "permed-78003", "permed-78001", "permed-91926", "permed-76818"]}
{"query_id": "topic_093_turn_2", "conversation_id": "topic_093", "turn_id": 2, "query": "How effective are these YouTube videos for educating patients about rare conditions such as pancreatic cancer?", "history": ["Impact of YouTube on patient education for serious diseases"], "ground_truth": ["permed-76822", "permed-66069", "permed-76823", "permed-76818", "permed-77094", "permed-20929", "permed-89358", "permed-78001", "permed-77092", "permed-76824"]}
{"query_id": "topic_093_turn_3", "conversation_id": "topic_093", "turn_id": 3, "query": "Healthcare provider strategies for enhancing YouTube patient education on pancreatic cancer: focusing on content quality, engagement, and comprehensiveness", "history": ["Impact of YouTube on patient education for serious diseases", "How effective are these YouTube videos for educating patients about rare conditions such as pancreatic cancer?"], "ground_truth": ["permed-76822", "permed-66069", "permed-20929", "permed-76823", "permed-89780", "permed-77094", "permed-76818", "permed-83804", "permed-65311", "permed-89358"]}
{"query_id": "topic_094_turn_1", "conversation_id": "topic_094", "turn_id": 1, "query": "Fundamental roles and molecular mechanisms of microRNAs in rheumatoid arthritis and ankylosing spondylitis", "history": [], "ground_truth": ["permed-73559", "permed-91630", "permed-57271", "permed-61772", "permed-78072", "permed-73541", "permed-60986", "permed-74842", "permed-70505", "permed-68933"]}
{"query_id": "topic_094_turn_2", "conversation_id": "topic_094", "turn_id": 2, "query": "Diagnostic and therapeutic potential of targeting microRNA dysregulation observed in these rheumatic diseases", "history": ["Fundamental roles and molecular mechanisms of microRNAs in rheumatoid arthritis and ankylosing spondylitis"], "ground_truth": ["permed-73559", "permed-91630", "permed-57271", "permed-61772", "permed-78072", "permed-74842", "permed-73684", "permed-53268", "permed-82373", "permed-68055"]}
{"query_id": "topic_094_turn_3", "conversation_id": "topic_094", "turn_id": 3, "query": "Utilizing specific microRNA signatures associated with bone homeostasis and joint remodeling in RA and AS for early diagnosis, prognosis, and tailored therapeutic interventions", "history": ["Fundamental roles and molecular mechanisms of microRNAs in rheumatoid arthritis and ankylosing spondylitis", "Diagnostic and therapeutic potential of targeting microRNA dysregulation observed in these rheumatic diseases"], "ground_truth": ["permed-73559", "permed-91630", "permed-57271", "permed-61772", "permed-53718", "permed-91744", "permed-61769", "permed-70505", "permed-74842", "permed-4852"]}
{"query_id": "topic_095_turn_1", "conversation_id": "topic_095", "turn_id": 1, "query": "Are there any known complications of SARS-CoV-2 infection that affect bone health?", "history": [], "ground_truth": ["permed-55991", "permed-68513", "permed-91998", "permed-56805", "permed-68512", "permed-55998", "permed-62491", "permed-51264", "permed-58304", "permed-54238"]}
{"query_id": "topic_095_turn_2", "conversation_id": "topic_095", "turn_id": 2, "query": "How might this impact on bone health be related to the virus's effects on the body's inflammatory response?", "history": ["Are there any known complications of SARS-CoV-2 infection that affect bone health?"], "ground_truth": ["permed-82274", "permed-72512", "permed-55991", "permed-56815", "permed-53858", "permed-74285", "permed-67573", "permed-77364", "permed-26324", "permed-68512"]}
{"query_id": "topic_095_turn_3", "conversation_id": "topic_095", "turn_id": 3, "query": "Given these connections between SARS-CoV-2, inflammation, and bone health, how might the virus's inflammatory and hypercoagulable effects specifically compromise bone microcirculation in cases like osteonecrosis and osteomyelitis? And what therapeutic approaches could help protect high-risk patients from such complications?", "history": ["Are there any known complications of SARS-CoV-2 infection that affect bone health?", "How might this impact on bone health be related to the virus's effects on the body's inflammatory response?"], "ground_truth": ["permed-55991", "permed-54799", "permed-56806", "permed-55993", "permed-55996", "permed-55998", "permed-59812", "permed-57154", "permed-52540", "permed-58318"]}
{"query_id": "topic_096_turn_1", "conversation_id": "topic_096", "turn_id": 1, "query": "What initiatives support the professional development of newly graduated nurses in challenging healthcare environments?", "history": [], "ground_truth": ["permed-78647", "permed-53033", "permed-78660", "permed-78648", "permed-54910", "permed-51092", "permed-78661", "permed-80233", "permed-65756", "permed-78659"]}
{"query_id": "topic_096_turn_2", "conversation_id": "topic_096", "turn_id": 2, "query": "How can programs like this be tailored for settings with limited resources, focusing on both development and mental well-being?", "history": ["What initiatives support the professional development of newly graduated nurses in challenging healthcare environments?"], "ground_truth": ["permed-56855", "permed-69975", "permed-87457", "permed-78642", "permed-84438", "permed-51976", "permed-84730", "permed-62307", "permed-52800", "permed-62313"]}
{"query_id": "topic_096_turn_3", "conversation_id": "topic_096", "turn_id": 3, "query": "Given these considerations about supporting new nurses in challenging environments, how could the Nursing The Future 2.0 initiative's principles be adapted for resource-limited settings to better address both their professional development and mental well-being amid current global health challenges?", "history": ["What initiatives support the professional development of newly graduated nurses in challenging healthcare environments?", "How can programs like this be tailored for settings with limited resources, focusing on both development and mental well-being?"], "ground_truth": ["permed-78647", "permed-53014", "permed-53033", "permed-78648", "permed-77262", "permed-61611", "permed-78660", "permed-51092", "permed-78661", "permed-67608"]}
{"query_id": "topic_097_turn_1", "conversation_id": "topic_097", "turn_id": 1, "query": "Impact of patient engagement on healthcare outcomes in diverse patient populations", "history": [], "ground_truth": ["permed-69059", "permed-52213", "permed-66153", "permed-91926", "permed-80051", "permed-51911", "permed-66148", "permed-88327", "permed-60770", "permed-55875"]}
{"query_id": "topic_097_turn_2", "conversation_id": "topic_097", "turn_id": 2, "query": "Leveraging social determinants of health to improve *such* patient engagement strategies: approaches and implementation barriers", "history": ["Impact of patient engagement on healthcare outcomes in diverse patient populations"], "ground_truth": ["permed-52213", "permed-91926", "permed-66148", "permed-51911", "permed-60767", "permed-66153", "permed-69418", "permed-78589", "permed-50966", "permed-69059"]}
{"query_id": "topic_097_turn_3", "conversation_id": "topic_097", "turn_id": 3, "query": "Models for integrating SDoH-informed patient engagement in diverse settings to promote health equity: specific tools and impact measurement methodologies", "history": ["Impact of patient engagement on healthcare outcomes in diverse patient populations", "Leveraging social determinants of health to improve *such* patient engagement strategies: approaches and implementation barriers"], "ground_truth": ["permed-52213", "permed-66153", "permed-91926", "permed-60767", "permed-78589", "permed-66148", "permed-53994", "permed-65625", "permed-65404", "permed-68445"]}
{"query_id": "topic_098_turn_1", "conversation_id": "topic_098", "turn_id": 1, "query": "Overview of retinal anatomical changes in acute macular neuroretinopathy (AMN)", "history": [], "ground_truth": ["permed-62471", "permed-16373", "permed-87208", "permed-51074", "permed-70266", "permed-62465", "permed-41059", "permed-62409", "permed-90562", "permed-48228"]}
{"query_id": "topic_098_turn_2", "conversation_id": "topic_098", "turn_id": 2, "query": "Regarding these retinal anatomical changes in AMN, how do specific alterations within the Henle fiber layer influence disease progression?", "history": ["Overview of retinal anatomical changes in acute macular neuroretinopathy (AMN)"], "ground_truth": ["permed-62471", "permed-16373", "permed-51074", "permed-71016", "permed-66398", "permed-8176", "permed-66391", "permed-48203", "permed-62814", "permed-41059"]}
{"query_id": "topic_098_turn_3", "conversation_id": "topic_098", "turn_id": 3, "query": "Based on these Henle fiber layer alterations in AMN, how do Henle fiber layer anatomical variations affect the spatial interaction between deep capillary plexus (DCP) vascular changes and outer nuclear layer (ONL) thinning, and what are the resulting pathophysiological insights and implications for personalized treatment?", "history": ["Overview of retinal anatomical changes in acute macular neuroretinopathy (AMN)", "Regarding these retinal anatomical changes in AMN, how do specific alterations within the Henle fiber layer influence disease progression?"], "ground_truth": ["permed-62471", "permed-16373", "permed-82074", "permed-48352", "permed-66398", "permed-16167", "permed-16635", "permed-92170", "permed-15925", "permed-57462"]}
{"query_id": "topic_099_turn_1", "conversation_id": "topic_099", "turn_id": 1, "query": "What role did Robert Koch's early medical experiences play in shaping his contributions to public health?", "history": [], "ground_truth": ["permed-81601", "permed-53011", "permed-53008", "permed-70257", "permed-53009", "permed-53006", "permed-53023", "permed-26932", "permed-81608", "permed-81603"]}
{"query_id": "topic_099_turn_2", "conversation_id": "topic_099", "turn_id": 2, "query": "How might the methodologies developed from this background influence modern healthcare practices, especially in underserved areas?", "history": ["What role did Robert Koch's early medical experiences play in shaping his contributions to public health?"], "ground_truth": ["permed-61888", "permed-61614", "permed-91926", "permed-66148", "permed-61613", "permed-82791", "permed-88283", "permed-26206", "permed-66153", "permed-54924"]}
{"query_id": "topic_099_turn_3", "conversation_id": "topic_099", "turn_id": 3, "query": "Given Koch's early rural medical practice and its influence on his methodologies, how do those formative experiences specifically inform current ethical and practical approaches in public health initiatives for resource-limited regions?", "history": ["What role did Robert Koch's early medical experiences play in shaping his contributions to public health?", "How might the methodologies developed from this background influence modern healthcare practices, especially in underserved areas?"], "ground_truth": ["permed-81601", "permed-52056", "permed-53039", "permed-70257", "permed-70905", "permed-66219", "permed-69886", "permed-70240", "permed-53046", "permed-21611"]}
{"query_id": "topic_100_turn_1", "conversation_id": "topic_100", "turn_id": 1, "query": "What are the current challenges in treating toxic epidermal necrolysis (TEN), and how effective are traditional treatments?", "history": [], "ground_truth": ["permed-67386", "permed-78993", "permed-61453", "permed-61448", "permed-61454", "permed-38740", "permed-67337", "permed-57125", "permed-89951", "permed-31629"]}
{"query_id": "topic_100_turn_2", "conversation_id": "topic_100", "turn_id": 2, "query": "Are there any newer therapies being explored to improve upon the efficacy and safety of these traditional treatments, especially in terms of managing severe skin reactions?", "history": ["What are the current challenges in treating toxic epidermal necrolysis (TEN), and how effective are traditional treatments?"], "ground_truth": ["permed-12315", "permed-56023", "permed-12539", "permed-12432", "permed-53275", "permed-77068", "permed-60140", "permed-50854", "permed-31629", "permed-38799"]}
{"query_id": "topic_100_turn_3", "conversation_id": "topic_100", "turn_id": 3, "query": "Given these newer immunomodulatory approaches being explored, how do targeted biologics and novel cytokine inhibitors compare to traditional treatments like cyclosporine and corticosteroids in terms of efficacy and safety for TEN? Also, what do we know about long-term outcomes with these advanced therapies, and are there any biomarkers that could help predict patient response?", "history": ["What are the current challenges in treating toxic epidermal necrolysis (TEN), and how effective are traditional treatments?", "Are there any newer therapies being explored to improve upon the efficacy and safety of these traditional treatments, especially in terms of managing severe skin reactions?"], "ground_truth": ["permed-67386", "permed-53282", "permed-53285", "permed-67337", "permed-67927", "permed-75528", "permed-53289", "permed-68055", "permed-68820", "permed-53286"]}
{"query_id": "topic_101_turn_1", "conversation_id": "topic_101", "turn_id": 1, "query": "What factors influence the screening and diagnosis of pheochromocytoma/paraganglioma (PPGL) in patients with hypertension?", "history": [], "ground_truth": ["permed-80034", "permed-56328", "permed-29935", "permed-56112", "permed-62004", "permed-76795", "permed-80035", "permed-74602", "permed-62003", "permed-79353"]}
{"query_id": "topic_101_turn_2", "conversation_id": "topic_101", "turn_id": 2, "query": "How do healthcare provider specialties and patient characteristics, such as education level, impact the decision-making process in this area?", "history": ["What factors influence the screening and diagnosis of pheochromocytoma/paraganglioma (PPGL) in patients with hypertension?"], "ground_truth": ["permed-51534", "permed-88523", "permed-51601", "permed-78059", "permed-77999", "permed-25420", "permed-80051", "permed-52218", "permed-83090", "permed-51532"]}
{"query_id": "topic_101_turn_3", "conversation_id": "topic_101", "turn_id": 3, "query": "How do these provider specialties and practice settings affect both the decision-making process and how often PPGL screening actually occurs in hypertensive patients, particularly those with complex cases like multiple comorbidities or genetic risks? And given what we know about patient education and health literacy's role in this, how might these factors influence screening rates—and how could we use that understanding to enhance early detection and management approaches?", "history": ["What factors influence the screening and diagnosis of pheochromocytoma/paraganglioma (PPGL) in patients with hypertension?", "How do healthcare provider specialties and patient characteristics, such as education level, impact the decision-making process in this area?"], "ground_truth": ["permed-80034", "permed-63365", "permed-74777", "permed-26130", "permed-60005", "permed-74779", "permed-65903", "permed-26132", "permed-87860", "permed-88350"]}
{"query_id": "topic_102_turn_1", "conversation_id": "topic_102", "turn_id": 1, "query": "Mass spectrometry techniques for structural elucidation of complex glycoconjugates", "history": [], "ground_truth": ["permed-66185", "permed-74587", "permed-66184", "permed-64604", "permed-76029", "permed-65169", "permed-82590", "permed-60645", "permed-86109", "permed-53718"]}
{"query_id": "topic_102_turn_2", "conversation_id": "topic_102", "turn_id": 2, "query": "How does ion mobility hyphenated with mass spectrometry improve such structural elucidation of glycoconjugates?", "history": ["Mass spectrometry techniques for structural elucidation of complex glycoconjugates"], "ground_truth": ["permed-66185", "permed-77755", "permed-77048", "permed-66191", "permed-72986", "permed-74587", "permed-66184", "permed-82821", "permed-78978", "permed-76774"]}
{"query_id": "topic_102_turn_3", "conversation_id": "topic_102", "turn_id": 3, "query": "MALDI-ion mobility-mass spectrometry for quantitative glycomics: innovations in structural isomer differentiation and applications in biomarker discovery", "history": ["Mass spectrometry techniques for structural elucidation of complex glycoconjugates", "How does ion mobility hyphenated with mass spectrometry improve such structural elucidation of glycoconjugates?"], "ground_truth": ["permed-66185", "permed-66184", "permed-53718", "permed-4669", "permed-66182", "permed-53719", "permed-66180", "permed-77755", "permed-78978", "permed-86109"]}
{"query_id": "topic_103_turn_1", "conversation_id": "topic_103", "turn_id": 1, "query": "Key environmental and sensor-related factors affecting in-situ soil moisture measurement accuracy", "history": [], "ground_truth": ["permed-76194", "permed-76195", "permed-63990", "permed-76198", "permed-62247", "permed-89708", "permed-53718", "permed-87549", "permed-73973", "permed-86071"]}
{"query_id": "topic_103_turn_2", "conversation_id": "topic_103", "turn_id": 2, "query": "Influence of specific soil physical properties (e.g., texture, porosity, organic matter content) on the accuracy of these in-situ soil moisture measurements", "history": ["Key environmental and sensor-related factors affecting in-situ soil moisture measurement accuracy"], "ground_truth": ["permed-76194", "permed-76198", "permed-76195", "permed-63990", "permed-62247", "permed-85869", "permed-76196", "permed-67032", "permed-89708", "permed-85775"]}
{"query_id": "topic_103_turn_3", "conversation_id": "topic_103", "turn_id": 3, "query": "Advanced soil-specific calibration strategies for in-situ moisture sensors to correct errors induced by texture, porosity, and organic matter, ensuring data consistency across monitoring networks", "history": ["Key environmental and sensor-related factors affecting in-situ soil moisture measurement accuracy", "Influence of specific soil physical properties (e.g., texture, porosity, organic matter content) on the accuracy of these in-situ soil moisture measurements"], "ground_truth": ["permed-76194", "permed-76195", "permed-76198", "permed-62247", "permed-63990", "permed-76197", "permed-86071", "permed-83764", "permed-88904", "permed-52710"]}
{"query_id": "topic_104_turn_1", "conversation_id": "topic_104", "turn_id": 1, "query": "What role do crystalline phase transitions play in the stability of perovskite solar cells?", "history": [], "ground_truth": ["permed-77386", "permed-77387", "permed-78702", "permed-77384", "permed-78704", "permed-76107", "permed-88550", "permed-75757", "permed-77392", "permed-73239"]}
{"query_id": "topic_104_turn_2", "conversation_id": "topic_104", "turn_id": 2, "query": "How does understanding this aspect of perovskite material properties impact the development of more efficient solar cells?", "history": ["What role do crystalline phase transitions play in the stability of perovskite solar cells?"], "ground_truth": ["permed-53784", "permed-73239", "permed-73231", "permed-53785", "permed-77390", "permed-76878", "permed-78707", "permed-53817", "permed-53818", "permed-79573"]}
{"query_id": "topic_104_turn_3", "conversation_id": "topic_104", "turn_id": 3, "query": "Given this connection between A-site cations and crystalline phase transitions in lead halide perovskites, how can we use that understanding to design targeted defect passivation strategies that specifically mitigate deep-level trap formation, ultimately improving the stability and efficiency of these solar cells under real operating conditions?", "history": ["What role do crystalline phase transitions play in the stability of perovskite solar cells?", "How does understanding this aspect of perovskite material properties impact the development of more efficient solar cells?"], "ground_truth": ["permed-75757", "permed-53789", "permed-76107", "permed-73242", "permed-78702", "permed-78707", "permed-82839", "permed-73240", "permed-78704", "permed-77385"]}
{"query_id": "topic_105_turn_1", "conversation_id": "topic_105", "turn_id": 1, "query": "What natural compounds have shown promise in enhancing burn wound healing?", "history": [], "ground_truth": ["permed-91808", "permed-77095", "permed-39000", "permed-38999", "permed-77075", "permed-72802", "permed-60642", "permed-39122", "permed-86989", "permed-38884"]}
{"query_id": "topic_105_turn_2", "conversation_id": "topic_105", "turn_id": 2, "query": "How effective are nanofibers in delivering these compounds, particularly in terms of biocompatibility and therapeutic efficacy?", "history": ["What natural compounds have shown promise in enhancing burn wound healing?"], "ground_truth": ["permed-91395", "permed-51331", "permed-89461", "permed-51332", "permed-92311", "permed-51343", "permed-67181", "permed-63010", "permed-64448", "permed-79428"]}
{"query_id": "topic_105_turn_3", "conversation_id": "topic_105", "turn_id": 3, "query": "Given that Lawsonia inermis (LI) incorporated into PLDLLA nanofibers shows promise for burn wound healing, how can we optimize their long-term biocompatibility and degradation behavior to ensure sustained therapeutic effects with minimal adverse reactions in vivo? Specifically, what molecular interactions between LI and PLDLLA influence cellular responses like inflammation and fibroblast activation, and how can these be leveraged to improve the system's performance?", "history": ["What natural compounds have shown promise in enhancing burn wound healing?", "How effective are nanofibers in delivering these compounds, particularly in terms of biocompatibility and therapeutic efficacy?"], "ground_truth": ["permed-79894", "permed-76864", "permed-75702", "permed-84109", "permed-79896", "permed-60918", "permed-73031", "permed-57619", "permed-60883", "permed-73039"]}
{"query_id": "topic_106_turn_1", "conversation_id": "topic_106", "turn_id": 1, "query": "What are the significant diagnostic challenges encountered in identifying and staging hypopharyngeal cancers?", "history": [], "ground_truth": ["permed-77467", "permed-51776", "permed-59570", "permed-51816", "permed-56127", "permed-75290", "permed-56200", "permed-83861", "permed-48083", "permed-80391"]}
{"query_id": "topic_106_turn_2", "conversation_id": "topic_106", "turn_id": 2, "query": "Addressing these diagnostic challenges, how do specific imaging modalities and serum/tissue biomarkers assist in differentiating primary hypopharyngeal tumors from metastatic lesions in the same anatomical region?", "history": ["What are the significant diagnostic challenges encountered in identifying and staging hypopharyngeal cancers?"], "ground_truth": ["permed-77467", "permed-56200", "permed-68203", "permed-59570", "permed-51776", "permed-56107", "permed-56108", "permed-56127", "permed-51816", "permed-77465"]}
{"query_id": "topic_106_turn_3", "conversation_id": "topic_106", "turn_id": 3, "query": "Focusing on these discussed imaging modalities and biomarkers, what is their comparative efficacy in distinguishing de novo or recurrent primary hypopharyngeal squamous cell carcinoma (HPSCC) from hypopharyngeal metastasis of papillary thyroid cancer (PTC), particularly when evaluating patients with a history of thyroidectomy?", "history": ["What are the significant diagnostic challenges encountered in identifying and staging hypopharyngeal cancers?", "Addressing these diagnostic challenges, how do specific imaging modalities and serum/tissue biomarkers assist in differentiating primary hypopharyngeal tumors from metastatic lesions in the same anatomical region?"], "ground_truth": ["permed-77467", "permed-51816", "permed-91829", "permed-59564", "permed-56744", "permed-37426", "permed-56127", "permed-56200", "permed-47981", "permed-51776"]}
{"query_id": "topic_107_turn_1", "conversation_id": "topic_107", "turn_id": 1, "query": "Overview of established treatment approaches for pediatric lymphatic malformations", "history": [], "ground_truth": ["permed-54567", "permed-77639", "permed-77637", "permed-77635", "permed-41086", "permed-77638", "permed-77636", "permed-24637", "permed-92120", "permed-64805"]}
{"query_id": "topic_107_turn_2", "conversation_id": "topic_107", "turn_id": 2, "query": "Comparative effectiveness of surgery versus sclerotherapy for these pediatric lymphatic malformations", "history": ["Overview of established treatment approaches for pediatric lymphatic malformations"], "ground_truth": ["permed-54567", "permed-77635", "permed-77639", "permed-77638", "permed-77637", "permed-56265", "permed-77636", "permed-80401", "permed-71333", "permed-56525"]}
{"query_id": "topic_107_turn_3", "conversation_id": "topic_107", "turn_id": 3, "query": "Influence of malformation characteristics (size, location), patient co-morbidities, and specific procedural techniques on long-term functional outcomes and quality of life following surgery versus sclerotherapy for pediatric lymphatic malformations", "history": ["Overview of established treatment approaches for pediatric lymphatic malformations", "Comparative effectiveness of surgery versus sclerotherapy for these pediatric lymphatic malformations"], "ground_truth": ["permed-54567", "permed-77635", "permed-77638", "permed-77639", "permed-77637", "permed-80401", "permed-56265", "permed-24629", "permed-56269", "permed-41086"]}
{"query_id": "topic_108_turn_1", "conversation_id": "topic_108", "turn_id": 1, "query": "What are the common treatments for conditions associated with a unicornuate uterus, such as non-communicating rudimentary uterine horns?", "history": [], "ground_truth": ["permed-81457", "permed-70612", "permed-55299", "permed-70615", "permed-70616", "permed-6519", "permed-52158", "permed-92093", "permed-91782", "permed-6520"]}
{"query_id": "topic_108_turn_2", "conversation_id": "topic_108", "turn_id": 2, "query": "How does laparoscopic surgery fit into this area of treatment, particularly in terms of its effectiveness and potential complications?", "history": ["What are the common treatments for conditions associated with a unicornuate uterus, such as non-communicating rudimentary uterine horns?"], "ground_truth": ["permed-70521", "permed-50694", "permed-78077", "permed-92093", "permed-56524", "permed-91715", "permed-78959", "permed-0884", "permed-51374", "permed-60202"]}
{"query_id": "topic_108_turn_3", "conversation_id": "topic_108", "turn_id": 3, "query": "How does preoperative assessment with imaging techniques like MRI and ultrasound impact the success and long-term outcomes of laparoscopic surgery for these cases, especially regarding symptom resolution and recurrence of issues like pelvic pain and hematometra?", "history": ["What are the common treatments for conditions associated with a unicornuate uterus, such as non-communicating rudimentary uterine horns?", "How does laparoscopic surgery fit into this area of treatment, particularly in terms of its effectiveness and potential complications?"], "ground_truth": ["permed-78369", "permed-91856", "permed-60202", "permed-81459", "permed-60211", "permed-75310", "permed-51390", "permed-70612", "permed-81457", "permed-78077"]}
{"query_id": "topic_109_turn_1", "conversation_id": "topic_109", "turn_id": 1, "query": "Mechanisms and significance of tRNA modifications in bacterial environmental stress adaptation", "history": [], "ground_truth": ["permed-64537", "permed-71588", "permed-70688", "permed-76696", "permed-71584", "permed-90079", "permed-76694", "permed-83758", "permed-71585", "permed-88016"]}
{"query_id": "topic_109_turn_2", "conversation_id": "topic_109", "turn_id": 2, "query": "Influence of these tRNA modifications on secondary metabolite biosynthesis and regulation in Streptomyces", "history": ["Mechanisms and significance of tRNA modifications in bacterial environmental stress adaptation"], "ground_truth": ["permed-64537", "permed-71588", "permed-76696", "permed-89441", "permed-76697", "permed-70688", "permed-67158", "permed-52997", "permed-64159", "permed-82373"]}
{"query_id": "topic_109_turn_3", "conversation_id": "topic_109", "turn_id": 3, "query": "Specific tRNA modification profiles in *Streptomyces albidoflavus J1074* and their role in mediating stress response and antibiotic production", "history": ["Mechanisms and significance of tRNA modifications in bacterial environmental stress adaptation", "Influence of these tRNA modifications on secondary metabolite biosynthesis and regulation in Streptomyces"], "ground_truth": ["permed-64537", "permed-71588", "permed-76696", "permed-70688", "permed-76693", "permed-53719", "permed-50790", "permed-82373", "permed-89441", "permed-71584"]}
{"query_id": "topic_110_turn_1", "conversation_id": "topic_110", "turn_id": 1, "query": "Plasmonic enhancement mechanisms for energy transfer efficiency in quantum-cutting structures", "history": [], "ground_truth": ["permed-75671", "permed-76035", "permed-79794", "permed-64274", "permed-71744", "permed-72954", "permed-64276", "permed-76768", "permed-64285", "permed-64286"]}
{"query_id": "topic_110_turn_2", "conversation_id": "topic_110", "turn_id": 2, "query": "Optimizing spacer layer thickness for improved plasmon-enhanced energy transfer in these quantum-cutting multilayer structures", "history": ["Plasmonic enhancement mechanisms for energy transfer efficiency in quantum-cutting structures"], "ground_truth": ["permed-75671", "permed-64274", "permed-77743", "permed-76035", "permed-71744", "permed-64279", "permed-76768", "permed-69389", "permed-75674", "permed-76085"]}
{"query_id": "topic_110_turn_3", "conversation_id": "topic_110", "turn_id": 3, "query": "Advanced optimization of layer thickness variation in CsPbCl3/Yb3+ plasmonic quantum-cutting multilayers for maximum energy transfer efficiency and nanophotonic device applications", "history": ["Plasmonic enhancement mechanisms for energy transfer efficiency in quantum-cutting structures", "Optimizing spacer layer thickness for improved plasmon-enhanced energy transfer in these quantum-cutting multilayer structures"], "ground_truth": ["permed-75671", "permed-64274", "permed-74972", "permed-75672", "permed-75779", "permed-75675", "permed-73230", "permed-76085", "permed-75677", "permed-77741"]}
{"query_id": "topic_111_turn_1", "conversation_id": "topic_111", "turn_id": 1, "query": "Current obstacles and gaps in HDFN detection and management for resource-limited regions", "history": [], "ground_truth": ["permed-55107", "permed-66153", "permed-91926", "permed-66148", "permed-74114", "permed-58851", "permed-53716", "permed-73930", "permed-67575", "permed-63109"]}
{"query_id": "topic_111_turn_2", "conversation_id": "topic_111", "turn_id": 2, "query": "Impact of novel diagnostic technologies on overcoming these HDFN management obstacles in resource-limited settings versus traditional prevention", "history": ["Current obstacles and gaps in HDFN detection and management for resource-limited regions"], "ground_truth": ["permed-61024", "permed-66688", "permed-66153", "permed-91926", "permed-71226", "permed-84590", "permed-66148", "permed-55182", "permed-68512", "permed-59138"]}
{"query_id": "topic_111_turn_3", "conversation_id": "topic_111", "turn_id": 3, "query": "Integrating NIPT and molecular diagnostics for HDFN in resource-limited settings: strategies for improving early detection, managing RhIG inaccessibility, ensuring equitable access, and assessing long-term health equity impact", "history": ["Current obstacles and gaps in HDFN detection and management for resource-limited regions", "Impact of novel diagnostic technologies on overcoming these HDFN management obstacles in resource-limited settings versus traditional prevention"], "ground_truth": ["permed-51953", "permed-61024", "permed-81638", "permed-51956", "permed-5947", "permed-71113", "permed-84590", "permed-81696", "permed-45148", "permed-86035"]}
{"query_id": "topic_112_turn_1", "conversation_id": "topic_112", "turn_id": 1, "query": "What methods are currently used to detect microplastics in aquatic environments?", "history": [], "ground_truth": ["permed-74153", "permed-72730", "permed-79387", "permed-74154", "permed-72736", "permed-80535", "permed-88908", "permed-72735", "permed-72738", "permed-88876"]}
{"query_id": "topic_112_turn_2", "conversation_id": "topic_112", "turn_id": 2, "query": "How effective is this technique in water with varying conditions, such as different salinity and temperature levels?", "history": ["What methods are currently used to detect microplastics in aquatic environments?"], "ground_truth": ["permed-82001", "permed-56264", "permed-55655", "permed-65114", "permed-88943", "permed-90848", "permed-59303", "permed-84354", "permed-78318", "permed-90220"]}
{"query_id": "topic_112_turn_3", "conversation_id": "topic_112", "turn_id": 3, "query": "Given these detection methods and their effectiveness under varying conditions, how could magnetism-assisted density gradient separation be adapted to improve microplastic detection and quantification in aquatic environments? What adjustments to the current setup would be needed to optimize its performance across different salinity and temperature levels?", "history": ["What methods are currently used to detect microplastics in aquatic environments?", "How effective is this technique in water with varying conditions, such as different salinity and temperature levels?"], "ground_truth": ["permed-79386", "permed-72730", "permed-74153", "permed-74154", "permed-79387", "permed-87791", "permed-72736", "permed-80544", "permed-72735", "permed-88883"]}
{"query_id": "topic_113_turn_1", "conversation_id": "topic_113", "turn_id": 1, "query": "Role of NeuroD in neural and endocrine system development across diverse species", "history": [], "ground_truth": ["permed-74327", "permed-67923", "permed-89594", "permed-53717", "permed-66783", "permed-70716", "permed-84047", "permed-82373", "permed-66780", "permed-72010"]}
{"query_id": "topic_113_turn_2", "conversation_id": "topic_113", "turn_id": 2, "query": "Investigating these NeuroD functions and evolutionary origins by studying simpler organisms like sea urchin larvae", "history": ["Role of NeuroD in neural and endocrine system development across diverse species"], "ground_truth": ["permed-74327", "permed-77335", "permed-67923", "permed-74332", "permed-53709", "permed-89283", "permed-66490", "permed-92485", "permed-63201", "permed-89594"]}
{"query_id": "topic_113_turn_3", "conversation_id": "topic_113", "turn_id": 3, "query": "NeuroD1 expression and function in sea urchin larvae presumptive ganglia and gut: implications for ancestral bilaterian neural and gut patterning", "history": ["Role of NeuroD in neural and endocrine system development across diverse species", "Investigating these NeuroD functions and evolutionary origins by studying simpler organisms like sea urchin larvae"], "ground_truth": ["permed-74327", "permed-67923", "permed-74332", "permed-74334", "permed-89594", "permed-66780", "permed-64697", "permed-63201", "permed-85181", "permed-74329"]}
{"query_id": "topic_114_turn_1", "conversation_id": "topic_114", "turn_id": 1, "query": "Applications and mechanisms of LED irradiation in periodontitis treatment and tissue regeneration", "history": [], "ground_truth": ["permed-64756", "permed-75188", "permed-75194", "permed-89799", "permed-64755", "permed-89800", "permed-52632", "permed-75235", "permed-51831", "permed-72082"]}
{"query_id": "topic_114_turn_2", "conversation_id": "topic_114", "turn_id": 2, "query": "Impact of different LED wavelengths on these periodontal therapies, focusing on inflammatory response modulation", "history": ["Applications and mechanisms of LED irradiation in periodontitis treatment and tissue regeneration"], "ground_truth": ["permed-64756", "permed-75188", "permed-89799", "permed-52410", "permed-83475", "permed-72082", "permed-76005", "permed-75194", "permed-75235", "permed-52630"]}
{"query_id": "topic_114_turn_3", "conversation_id": "topic_114", "turn_id": 3, "query": "Cellular and molecular effects of 470nm vs 525nm LED irradiation parameters (duration, frequency) on periodontitis: experimental models of inflammation, tissue regeneration, and long-term oral microbiome/systemic immune system changes", "history": ["Applications and mechanisms of LED irradiation in periodontitis treatment and tissue regeneration", "Impact of different LED wavelengths on these periodontal therapies, focusing on inflammatory response modulation"], "ground_truth": ["permed-64756", "permed-75188", "permed-89799", "permed-52632", "permed-64755", "permed-75194", "permed-89800", "permed-52630", "permed-83475", "permed-69166"]}
{"query_id": "topic_115_turn_1", "conversation_id": "topic_115", "turn_id": 1, "query": "What is known about the bacteria Helicobacter pylori and its role in human stomach infections?", "history": [], "ground_truth": ["permed-66798", "permed-76580", "permed-67908", "permed-76579", "permed-20416", "permed-23886", "permed-79302", "permed-76800", "permed-80859", "permed-65418"]}
{"query_id": "topic_115_turn_2", "conversation_id": "topic_115", "turn_id": 2, "query": "How does it adapt to different areas of the stomach, and what implications might this have for disease progression?", "history": ["What is known about the bacteria Helicobacter pylori and its role in human stomach infections?"], "ground_truth": ["permed-85506", "permed-24474", "permed-79302", "permed-64801", "permed-3722", "permed-58707", "permed-66798", "permed-81435", "permed-56747", "permed-85505"]}
{"query_id": "topic_115_turn_3", "conversation_id": "topic_115", "turn_id": 3, "query": "Given its ability to adapt to different stomach regions, what specific molecular mechanisms and selective pressures drive H. pylori's diversification in areas like the antrum and corpus? And how do these adaptations affect its pathogenicity and the host's immune response?", "history": ["What is known about the bacteria Helicobacter pylori and its role in human stomach infections?", "How does it adapt to different areas of the stomach, and what implications might this have for disease progression?"], "ground_truth": ["permed-79302", "permed-76580", "permed-76579", "permed-31751", "permed-23888", "permed-66798", "permed-76582", "permed-34775", "permed-23886", "permed-20418"]}
{"query_id": "topic_116_turn_1", "conversation_id": "topic_116", "turn_id": 1, "query": "Impact of extended school closures on anxiety and depression in K-12 students", "history": [], "ground_truth": ["permed-77913", "permed-55591", "permed-65432", "permed-89992", "permed-72380", "permed-61920", "permed-74336", "permed-74351", "permed-75160", "permed-60970"]}
{"query_id": "topic_116_turn_2", "conversation_id": "topic_116", "turn_id": 2, "query": "Effectiveness of peer social support in mitigating anxiety and depression in K-12 students resulting from such educational disruptions, comparing online versus hybrid learning environments.", "history": ["Impact of extended school closures on anxiety and depression in K-12 students"], "ground_truth": ["permed-55591", "permed-55585", "permed-74336", "permed-72380", "permed-65664", "permed-74518", "permed-77913", "permed-55590", "permed-62852", "permed-71735"]}
{"query_id": "topic_116_turn_3", "conversation_id": "topic_116", "turn_id": 3, "query": "Evidence-based school intervention models for fostering K-12 peer support networks within virtual learning environments to reduce student anxiety and depression linked to these prolonged educational disruptions.", "history": ["Impact of extended school closures on anxiety and depression in K-12 students", "Effectiveness of peer social support in mitigating anxiety and depression in K-12 students resulting from such educational disruptions, comparing online versus hybrid learning environments."], "ground_truth": ["permed-55591", "permed-55585", "permed-74336", "permed-56836", "permed-55519", "permed-55590", "permed-55589", "permed-74518", "permed-71735", "permed-58554"]}
{"query_id": "topic_117_turn_1", "conversation_id": "topic_117", "turn_id": 1, "query": "What advancements have been made in treating infantile osteopetrosis with Hematopoietic Stem Cell Transplantation (HSCT)?", "history": [], "ground_truth": ["permed-55937", "permed-87037", "permed-72602", "permed-55936", "permed-59705", "permed-23329", "permed-49260", "permed-55046", "permed-10458", "permed-42154"]}
{"query_id": "topic_117_turn_2", "conversation_id": "topic_117", "turn_id": 2, "query": "How effective is it in reducing complications when donors are not HLA-compatible, and what challenges does this pose?", "history": ["What advancements have been made in treating infantile osteopetrosis with Hematopoietic Stem Cell Transplantation (HSCT)?"], "ground_truth": ["permed-82635", "permed-61460", "permed-75546", "permed-47578", "permed-54623", "permed-55936", "permed-81962", "permed-82636", "permed-82637", "permed-61456"]}
{"query_id": "topic_117_turn_3", "conversation_id": "topic_117", "turn_id": 3, "query": "Given these advancements and challenges with non-HLA compatible donors, what specific strategies could help minimize serious side effects like transplant failure and hypercalcemic crises in infantile osteopetrosis patients? How might these approaches impact long-term outcomes and quality of life, particularly regarding sensory and neurological functions?", "history": ["What advancements have been made in treating infantile osteopetrosis with Hematopoietic Stem Cell Transplantation (HSCT)?", "How effective is it in reducing complications when donors are not HLA-compatible, and what challenges does this pose?"], "ground_truth": ["permed-55937", "permed-59705", "permed-23311", "permed-55046", "permed-55936", "permed-87037", "permed-72602", "permed-49271", "permed-56389", "permed-82275"]}
{"query_id": "topic_118_turn_1", "conversation_id": "topic_118", "turn_id": 1, "query": "Principal challenges in the overall management of lower extremity bypass surgery for chronic limb-threatening ischemia.", "history": [], "ground_truth": ["permed-75575", "permed-52600", "permed-82519", "permed-90860", "permed-80297", "permed-71333", "permed-92177", "permed-56265", "permed-90009", "permed-85771"]}
{"query_id": "topic_118_turn_2", "conversation_id": "topic_118", "turn_id": 2, "query": "Considering these overall management challenges, how does optimizing preoperative risk factors specifically reduce postoperative complications in patients undergoing lower extremity bypass for CLTI?", "history": ["Principal challenges in the overall management of lower extremity bypass surgery for chronic limb-threatening ischemia."], "ground_truth": ["permed-75575", "permed-82519", "permed-85771", "permed-90860", "permed-80297", "permed-57080", "permed-54815", "permed-75580", "permed-88677", "permed-11360"]}
{"query_id": "topic_118_turn_3", "conversation_id": "topic_118", "turn_id": 3, "query": "What is the specific impact of early preoperative identification and aggressive management of severe tissue loss (e.g., Rutherford V/VI) on reducing wound complications and 30-day readmission rates following these bypass procedures for CLTI?", "history": ["Principal challenges in the overall management of lower extremity bypass surgery for chronic limb-threatening ischemia.", "Considering these overall management challenges, how does optimizing preoperative risk factors specifically reduce postoperative complications in patients undergoing lower extremity bypass for CLTI?"], "ground_truth": ["permed-75575", "permed-90860", "permed-85771", "permed-82519", "permed-52600", "permed-75577", "permed-88677", "permed-89794", "permed-57080", "permed-82520"]}
{"query_id": "topic_119_turn_1", "conversation_id": "topic_119", "turn_id": 1, "query": "What methods are being researched to improve the biodegradation of waste-activated sludge?", "history": [], "ground_truth": ["permed-79492", "permed-73002", "permed-79501", "permed-79496", "permed-82401", "permed-66164", "permed-66634", "permed-78438", "permed-79493", "permed-78436"]}
{"query_id": "topic_119_turn_2", "conversation_id": "topic_119", "turn_id": 2, "query": "How effective is pretreatment in enhancing this process, particularly when it involves advanced techniques like ultrasonication?", "history": ["What methods are being researched to improve the biodegradation of waste-activated sludge?"], "ground_truth": ["permed-79492", "permed-65145", "permed-79497", "permed-73175", "permed-89171", "permed-52713", "permed-65125", "permed-92077", "permed-79491", "permed-67543"]}
{"query_id": "topic_119_turn_3", "conversation_id": "topic_119", "turn_id": 3, "query": "Given the effectiveness of ultrasonication pretreatment, how can we quantify the synergistic effects when combining it with Free Nitrous Acid (FNA) pretreatment—specifically in terms of how these methods alter the microbial community structure and metabolic activity in thickened waste-activated sludge (TWAS)? What do these changes mean for the overall efficiency of sludge biodegradation and resource recovery?", "history": ["What methods are being researched to improve the biodegradation of waste-activated sludge?", "How effective is pretreatment in enhancing this process, particularly when it involves advanced techniques like ultrasonication?"], "ground_truth": ["permed-79492", "permed-79493", "permed-66568", "permed-79497", "permed-79494", "permed-80531", "permed-89755", "permed-66634", "permed-66640", "permed-82401"]}
{"query_id": "topic_120_turn_1", "conversation_id": "topic_120", "turn_id": 1, "query": "What's the current understanding on the use of antibiotic prophylaxis for preventing infections after invasive dental procedures in patients with prosthetic joints?", "history": [], "ground_truth": ["permed-59424", "permed-80298", "permed-91440", "permed-82917", "permed-50728", "permed-82967", "permed-80299", "permed-54890", "permed-59414", "permed-59415"]}
{"query_id": "topic_120_turn_2", "conversation_id": "topic_120", "turn_id": 2, "query": "How has the effectiveness of this practice been questioned or reevaluated in recent studies, particularly concerning late periprosthetic joint infections?", "history": ["What's the current understanding on the use of antibiotic prophylaxis for preventing infections after invasive dental procedures in patients with prosthetic joints?"], "ground_truth": ["permed-59415", "permed-59414", "permed-59423", "permed-59419", "permed-59418", "permed-18893", "permed-18892", "permed-59424", "permed-30892", "permed-82917"]}
{"query_id": "topic_120_turn_3", "conversation_id": "topic_120", "turn_id": 3, "query": "Given that recent evidence questions the effectiveness of antibiotic prophylaxis in preventing late periprosthetic joint infections after invasive dental procedures, what might be the long-term implications of stopping this practice—both for patient outcomes and healthcare costs? How should these findings inform updates to clinical guidelines and patient discussions about the risks versus benefits of prophylaxis across different patient groups?", "history": ["What's the current understanding on the use of antibiotic prophylaxis for preventing infections after invasive dental procedures in patients with prosthetic joints?", "How has the effectiveness of this practice been questioned or reevaluated in recent studies, particularly concerning late periprosthetic joint infections?"], "ground_truth": ["permed-59424", "permed-91440", "permed-80298", "permed-59415", "permed-50728", "permed-80300", "permed-80299", "permed-59414", "permed-80304", "permed-84634"]}
{"query_id": "topic_121_turn_1", "conversation_id": "topic_121", "turn_id": 1, "query": "What role does oxidative stress play in radiation-induced injury to endothelial cells?", "history": [], "ground_truth": ["permed-80221", "permed-13223", "permed-33064", "permed-81514", "permed-42030", "permed-13750", "permed-85945", "permed-54997", "permed-42116", "permed-22853"]}
{"query_id": "topic_121_turn_2", "conversation_id": "topic_121", "turn_id": 2, "query": "Are there specific pathways or mechanisms, like those involving microRNAs, that have been identified as key factors in mitigating this type of injury?", "history": ["What role does oxidative stress play in radiation-induced injury to endothelial cells?"], "ground_truth": ["permed-54117", "permed-11899", "permed-92177", "permed-53766", "permed-70400", "permed-74482", "permed-68112", "permed-55181", "permed-79570", "permed-36885"]}
{"query_id": "topic_121_turn_3", "conversation_id": "topic_121", "turn_id": 3, "query": "Given that AP2a and miR-125a-5p mitigate radiation-induced oxidative stress through the BRD4/Nrf2/HO-1 pathway in HUVECs, what would be the long-term consequences of AP2a overexpression on vascular function and endothelial integrity if these cells are subjected to repeated radiation exposure? And how might these effects impact therapeutic outcomes for patients undergoing radiation therapy?", "history": ["What role does oxidative stress play in radiation-induced injury to endothelial cells?", "Are there specific pathways or mechanisms, like those involving microRNAs, that have been identified as key factors in mitigating this type of injury?"], "ground_truth": ["permed-80221", "permed-33064", "permed-90397", "permed-13223", "permed-57385", "permed-74482", "permed-90416", "permed-53527", "permed-69112", "permed-42266"]}
{"query_id": "topic_122_turn_1", "conversation_id": "topic_122", "turn_id": 1, "query": "What role does Dicke cooperativity play in the development of terahertz metasurfaces for quantum applications?", "history": [], "ground_truth": ["permed-79790", "permed-74263", "permed-74448", "permed-69379", "permed-69380", "permed-72954", "permed-83498", "permed-79798", "permed-76395", "permed-79792"]}
{"query_id": "topic_122_turn_2", "conversation_id": "topic_122", "turn_id": 2, "query": "How can this phenomenon be leveraged to enhance ultrastrong coupling and manipulate quantum states in these metasurfaces?", "history": ["What role does Dicke cooperativity play in the development of terahertz metasurfaces for quantum applications?"], "ground_truth": ["permed-79790", "permed-74263", "permed-60833", "permed-69380", "permed-79798", "permed-64273", "permed-72954", "permed-69377", "permed-79791", "permed-69372"]}
{"query_id": "topic_122_turn_3", "conversation_id": "topic_122", "turn_id": 3, "query": "Building on these principles of Dicke cooperativity and ultrastrong coupling enhancement, how could we design novel terahertz metasurfaces that not only improve quantum state manipulation but also advance applications like quantum computing and communication? Specifically, what key design parameters and material choices would optimize the meta-atom-photonic field interaction, and how might these affect the scalability and performance of quantum technologies?", "history": ["What role does Dicke cooperativity play in the development of terahertz metasurfaces for quantum applications?", "How can this phenomenon be leveraged to enhance ultrastrong coupling and manipulate quantum states in these metasurfaces?"], "ground_truth": ["permed-79790", "permed-74263", "permed-69379", "permed-69380", "permed-72954", "permed-83498", "permed-74448", "permed-79798", "permed-79792", "permed-76395"]}
{"query_id": "topic_123_turn_1", "conversation_id": "topic_123", "turn_id": 1, "query": "What role do lignin and cellulose nanocrystals play in enhancing the performance of waterborne coatings?", "history": [], "ground_truth": ["permed-79242", "permed-82194", "permed-91976", "permed-50914", "permed-74109", "permed-73369", "permed-73112", "permed-89478", "permed-80905", "permed-85970"]}
{"query_id": "topic_123_turn_2", "conversation_id": "topic_123", "turn_id": 2, "query": "How can the properties of these nanocrystals be optimized to improve the durability and functionality of such coatings?", "history": ["What role do lignin and cellulose nanocrystals play in enhancing the performance of waterborne coatings?"], "ground_truth": ["permed-67550", "permed-91974", "permed-74389", "permed-74072", "permed-91973", "permed-75453", "permed-83732", "permed-85911", "permed-79031", "permed-73988"]}
{"query_id": "topic_123_turn_3", "conversation_id": "topic_123", "turn_id": 3, "query": "Given their potential for enhancing waterborne coatings, how can we optimize the chemical and physical properties of lignin and cellulose nanocrystals when derived from different lignocellulosic sources to further improve their multifunctional performance—particularly in thermal stability, barrier properties, and environmental durability? Also, what specific molecular interactions and structural configurations in these lignin@CNCs composites are most critical for driving these enhancements?", "history": ["What role do lignin and cellulose nanocrystals play in enhancing the performance of waterborne coatings?", "How can the properties of these nanocrystals be optimized to improve the durability and functionality of such coatings?"], "ground_truth": ["permed-79242", "permed-79403", "permed-50914", "permed-50907", "permed-73112", "permed-63732", "permed-79402", "permed-64643", "permed-80905", "permed-73369"]}
{"query_id": "topic_124_turn_1", "conversation_id": "topic_124", "turn_id": 1, "query": "What advancements have been made in genome editing for crops using CRISPR/Cas systems?", "history": [], "ground_truth": ["permed-63738", "permed-63736", "permed-79381", "permed-63490", "permed-58185", "permed-63822", "permed-79380", "permed-83928", "permed-79382", "permed-63741"]}
{"query_id": "topic_124_turn_2", "conversation_id": "topic_124", "turn_id": 2, "query": "How effective is this technique when applied outside of lab settings, particularly in field-grown crops?", "history": ["What advancements have been made in genome editing for crops using CRISPR/Cas systems?"], "ground_truth": ["permed-81752", "permed-89277", "permed-63976", "permed-64170", "permed-79380", "permed-77746", "permed-63990", "permed-81743", "permed-63748", "permed-65999"]}
{"query_id": "topic_124_turn_3", "conversation_id": "topic_124", "turn_id": 3, "query": "Given these CRISPR/Cas advancements and their field applications, how could combining them with a simplified heat-shock method be optimized to boost editing efficiency in crops grown under real agricultural conditions? What are the key challenges and considerations when adapting this lab-based approach to actual farming environments?", "history": ["What advancements have been made in genome editing for crops using CRISPR/Cas systems?", "How effective is this technique when applied outside of lab settings, particularly in field-grown crops?"], "ground_truth": ["permed-79380", "permed-63736", "permed-63822", "permed-79381", "permed-58185", "permed-63738", "permed-63490", "permed-83723", "permed-63741", "permed-83932"]}
{"query_id": "topic_125_turn_1", "conversation_id": "topic_125", "turn_id": 1, "query": "Novel therapeutic approaches for dermatological infections beyond conventional antibiotics", "history": [], "ground_truth": ["permed-60825", "permed-50863", "permed-60681", "permed-77102", "permed-68058", "permed-77068", "permed-53289", "permed-89681", "permed-12683", "permed-68414"]}
{"query_id": "topic_125_turn_2", "conversation_id": "topic_125", "turn_id": 2, "query": "Considering these novel approaches for skin infections, what are the specific mechanisms of action and unique advantages of bacteriophage therapy?", "history": ["Novel therapeutic approaches for dermatological infections beyond conventional antibiotics"], "ground_truth": ["permed-60825", "permed-12683", "permed-72264", "permed-60681", "permed-66902", "permed-60695", "permed-77049", "permed-70406", "permed-66899", "permed-72238"]}
{"query_id": "topic_125_turn_3", "conversation_id": "topic_125", "turn_id": 3, "query": "Critical challenges and methodological considerations in designing clinical trials for topical bacteriophage therapy in dermatology, focusing on safety, efficacy, skin microbiome impact, and host immune response.", "history": ["Novel therapeutic approaches for dermatological infections beyond conventional antibiotics", "Considering these novel approaches for skin infections, what are the specific mechanisms of action and unique advantages of bacteriophage therapy?"], "ground_truth": ["permed-60825", "permed-82438", "permed-54447", "permed-12683", "permed-50863", "permed-66899", "permed-77068", "permed-89680", "permed-68063", "permed-76208"]}
{"query_id": "topic_126_turn_1", "conversation_id": "topic_126", "turn_id": 1, "query": "What factors affect the quality of cryopreserved semen in bulls?", "history": [], "ground_truth": ["permed-76038", "permed-80484", "permed-80483", "permed-80488", "permed-80482", "permed-80480", "permed-80485", "permed-80486", "permed-80490", "permed-80481"]}
{"query_id": "topic_126_turn_2", "conversation_id": "topic_126", "turn_id": 2, "query": "Does lipid composition play a significant role in this process, particularly in bulls known to be poor responders to cryopreservation?", "history": ["What factors affect the quality of cryopreserved semen in bulls?"], "ground_truth": ["permed-76038", "permed-80480", "permed-80484", "permed-80702", "permed-80493", "permed-80753", "permed-80481", "permed-72107", "permed-80490", "permed-57797"]}
{"query_id": "topic_126_turn_3", "conversation_id": "topic_126", "turn_id": 3, "query": "Building on the importance of lipid composition and oxidative stress in cryopreservation outcomes for Holstein bulls, especially those classified as 'bad freezers,' what specific molecular mechanisms explain why some bulls respond better to cryopreservation than others? And how could understanding these differences help develop targeted strategies to improve sperm resilience and fertility in genetically valuable bulls?", "history": ["What factors affect the quality of cryopreserved semen in bulls?", "Does lipid composition play a significant role in this process, particularly in bulls known to be poor responders to cryopreservation?"], "ground_truth": ["permed-76038", "permed-80481", "permed-80482", "permed-80480", "permed-80490", "permed-80488", "permed-80753", "permed-80483", "permed-76042", "permed-80484"]}
{"query_id": "topic_127_turn_1", "conversation_id": "topic_127", "turn_id": 1, "query": "Overview of rodent models for peri-implantitis and their translational relevance to human dental implant complications", "history": [], "ground_truth": ["permed-75119", "permed-72274", "permed-75120", "permed-64756", "permed-75141", "permed-75113", "permed-75208", "permed-83477", "permed-61052", "permed-75213"]}
{"query_id": "topic_127_turn_2", "conversation_id": "topic_127", "turn_id": 2, "query": "Impact of different induction methodologies on outcomes in these peri-implantitis rodent models", "history": ["Overview of rodent models for peri-implantitis and their translational relevance to human dental implant complications"], "ground_truth": ["permed-75119", "permed-64756", "permed-75120", "permed-75215", "permed-75203", "permed-75199", "permed-52405", "permed-75249", "permed-75144", "permed-75140"]}
{"query_id": "topic_127_turn_3", "conversation_id": "topic_127", "turn_id": 3, "query": "Marginal bone loss comparison in rodent peri-implantitis models: ligature vs LPS vs microbial infection vs titanium particles, and human translation implications", "history": ["Overview of rodent models for peri-implantitis and their translational relevance to human dental implant complications", "Impact of different induction methodologies on outcomes in these peri-implantitis rodent models"], "ground_truth": ["permed-75119", "permed-75120", "permed-61052", "permed-75215", "permed-64756", "permed-75208", "permed-75207", "permed-75113", "permed-87819", "permed-75199"]}
{"query_id": "topic_128_turn_1", "conversation_id": "topic_128", "turn_id": 1, "query": "What role does the Type III secretion system play in Pseudomonas aeruginosa infections?", "history": [], "ground_truth": ["permed-76694", "permed-63912", "permed-66793", "permed-60463", "permed-70581", "permed-63609", "permed-63619", "permed-63616", "permed-66847", "permed-22025"]}
{"query_id": "topic_128_turn_2", "conversation_id": "topic_128", "turn_id": 2, "query": "How does it contribute to the development of catheter-associated urinary tract infections, specifically?", "history": ["What role does the Type III secretion system play in Pseudomonas aeruginosa infections?"], "ground_truth": ["permed-70580", "permed-59984", "permed-70581", "permed-86447", "permed-79991", "permed-70582", "permed-79990", "permed-70579", "permed-79988", "permed-90715"]}
{"query_id": "topic_128_turn_3", "conversation_id": "topic_128", "turn_id": 3, "query": "Since we know T3SS plays different roles in acute versus chronic phases of these infections, how do its specific effectors modulate host immune responses to drive the transition from acute infection to chronic colonization? And based on that mechanism, what therapeutic targets could we focus on to block this transition in clinical settings?", "history": ["What role does the Type III secretion system play in Pseudomonas aeruginosa infections?", "How does it contribute to the development of catheter-associated urinary tract infections, specifically?"], "ground_truth": ["permed-30784", "permed-76424", "permed-89761", "permed-76694", "permed-63912", "permed-60453", "permed-27279", "permed-67868", "permed-67993", "permed-83295"]}
{"query_id": "topic_129_turn_1", "conversation_id": "topic_129", "turn_id": 1, "query": "Overview of intrinsic and extrinsic factors affecting avian hematological and plasma biochemical parameters", "history": [], "ground_truth": ["permed-50836", "permed-72010", "permed-58227", "permed-58234", "permed-50841", "permed-76485", "permed-79666", "permed-76478", "permed-82651", "permed-58349"]}
{"query_id": "topic_129_turn_2", "conversation_id": "topic_129", "turn_id": 2, "query": "Investigating the impact of extrinsic environmental factors, such as diet and seasonal variation, on these avian blood values", "history": ["Overview of intrinsic and extrinsic factors affecting avian hematological and plasma biochemical parameters"], "ground_truth": ["permed-50836", "permed-82247", "permed-58234", "permed-71938", "permed-58227", "permed-65029", "permed-80749", "permed-72010", "permed-76478", "permed-89172"]}
{"query_id": "topic_129_turn_3", "conversation_id": "topic_129", "turn_id": 3, "query": "Detailed analysis of dietary and seasonal effects on hematological and plasma biochemical reference intervals in captive Amazona albifrons, addressing causes of high analyte variability", "history": ["Overview of intrinsic and extrinsic factors affecting avian hematological and plasma biochemical parameters", "Investigating the impact of extrinsic environmental factors, such as diet and seasonal variation, on these avian blood values"], "ground_truth": ["permed-50836", "permed-81825", "permed-53718", "permed-50834", "permed-86076", "permed-76478", "permed-75980", "permed-66153", "permed-53717", "permed-81823"]}
{"query_id": "topic_130_turn_1", "conversation_id": "topic_130", "turn_id": 1, "query": "What role do retentive surgical guides play in implant surgery?", "history": [], "ground_truth": ["permed-73880", "permed-82309", "permed-83123", "permed-83126", "permed-75142", "permed-51474", "permed-51468", "permed-75230", "permed-83125", "permed-51498"]}
{"query_id": "topic_130_turn_2", "conversation_id": "topic_130", "turn_id": 2, "query": "How does the stability of this type of guide impact the surrounding tissues during procedures like it?", "history": ["What role do retentive surgical guides play in implant surgery?"], "ground_truth": ["permed-73880", "permed-57296", "permed-71333", "permed-56265", "permed-92093", "permed-81324", "permed-50691", "permed-78918", "permed-52036", "permed-84557"]}
{"query_id": "topic_130_turn_3", "conversation_id": "topic_130", "turn_id": 3, "query": "How might improving the design of these guides to enhance their stability affect the biomechanical forces on surrounding bone and soft tissues during implant surgery? And what could that mean for long-term patient outcomes in terms of implant integration and tissue health?", "history": ["What role do retentive surgical guides play in implant surgery?", "How does the stability of this type of guide impact the surrounding tissues during procedures like it?"], "ground_truth": ["permed-73880", "permed-83123", "permed-75129", "permed-51468", "permed-75145", "permed-75142", "permed-83124", "permed-87818", "permed-75127", "permed-82309"]}
{"query_id": "topic_131_turn_1", "conversation_id": "topic_131", "turn_id": 1, "query": "Systematic review of factors contributing to regional COVID-19 mortality rate variations", "history": [], "ground_truth": ["permed-68512", "permed-83970", "permed-68513", "permed-88327", "permed-65992", "permed-80764", "permed-85788", "permed-65991", "permed-54096", "permed-87701"]}
{"query_id": "topic_131_turn_2", "conversation_id": "topic_131", "turn_id": 2, "query": "Focusing on those factors, how have demographic and socioeconomic variables specifically affected COVID-19 mortality patterns in Navarra, Spain?", "history": ["Systematic review of factors contributing to regional COVID-19 mortality rate variations"], "ground_truth": ["permed-65987", "permed-65602", "permed-66192", "permed-65992", "permed-90896", "permed-65885", "permed-64815", "permed-63358", "permed-61382", "permed-65884"]}
{"query_id": "topic_131_turn_3", "conversation_id": "topic_131", "turn_id": 3, "query": "Quantitative analysis of demographic and socioeconomic drivers of age-specific COVID-19 mortality disparities in Navarra, and modelling their long-term consequences on regional life expectancy and healthcare resource allocation.", "history": ["Systematic review of factors contributing to regional COVID-19 mortality rate variations", "Focusing on those factors, how have demographic and socioeconomic variables specifically affected COVID-19 mortality patterns in Navarra, Spain?"], "ground_truth": ["permed-65987", "permed-65992", "permed-66192", "permed-59483", "permed-88169", "permed-61934", "permed-80764", "permed-85788", "permed-63358", "permed-65884"]}
{"query_id": "topic_132_turn_1", "conversation_id": "topic_132", "turn_id": 1, "query": "What role does the silanolate-mediated desilylation process play in organic synthesis reactions?", "history": [], "ground_truth": ["permed-79317", "permed-53752", "permed-79316", "permed-58034", "permed-86548", "permed-79318", "permed-67591", "permed-83860", "permed-51646", "permed-87237"]}
{"query_id": "topic_132_turn_2", "conversation_id": "topic_132", "turn_id": 2, "query": "How sensitive is this technique to the properties of the nucleophile used, particularly in arylation reactions?", "history": ["What role does the silanolate-mediated desilylation process play in organic synthesis reactions?"], "ground_truth": ["permed-79316", "permed-76873", "permed-57989", "permed-79156", "permed-74687", "permed-52676", "permed-52685", "permed-51049", "permed-76837", "permed-57985"]}
{"query_id": "topic_132_turn_3", "conversation_id": "topic_132", "turn_id": 3, "query": "Given the sensitivity of this process to nucleophile properties, how can we systematically vary the electronic effects of different aryl substituents to optimize both yield and selectivity in these arylation reactions—especially when dealing with complex, multifunctional substrates?", "history": ["What role does the silanolate-mediated desilylation process play in organic synthesis reactions?", "How sensitive is this technique to the properties of the nucleophile used, particularly in arylation reactions?"], "ground_truth": ["permed-79316", "permed-76873", "permed-51049", "permed-74687", "permed-52685", "permed-76670", "permed-57988", "permed-57985", "permed-79156", "permed-57989"]}
{"query_id": "topic_133_turn_1", "conversation_id": "topic_133", "turn_id": 1, "query": "What role does cholesterol play in the development of type 2 diabetes?", "history": [], "ground_truth": ["permed-78591", "permed-78592", "permed-54808", "permed-21443", "permed-2121", "permed-58916", "permed-58854", "permed-29712", "permed-58740", "permed-59531"]}
{"query_id": "topic_133_turn_2", "conversation_id": "topic_133", "turn_id": 2, "query": "Are there specific types of cholesterol, like remnant cholesterol, that have a more significant impact on this process?", "history": ["What role does cholesterol play in the development of type 2 diabetes?"], "ground_truth": ["permed-78591", "permed-57014", "permed-5433", "permed-75029", "permed-64993", "permed-78592", "permed-4736", "permed-64805", "permed-57178", "permed-52036"]}
{"query_id": "topic_133_turn_3", "conversation_id": "topic_133", "turn_id": 3, "query": "Given that remnant cholesterol appears to have a significant impact on type 2 diabetes development, how does this effect differ across demographic groups? Also, what are the potential mechanisms by which it influences glucose metabolism and insulin sensitivity in these populations?", "history": ["What role does cholesterol play in the development of type 2 diabetes?", "Are there specific types of cholesterol, like remnant cholesterol, that have a more significant impact on this process?"], "ground_truth": ["permed-78591", "permed-78592", "permed-29712", "permed-58740", "permed-2121", "permed-58950", "permed-21443", "permed-88268", "permed-58877", "permed-23144"]}
{"query_id": "topic_134_turn_1", "conversation_id": "topic_134", "turn_id": 1, "query": "What factors contribute to the growth and accumulation of Ulva species in coastal areas?", "history": [], "ground_truth": ["permed-67499", "permed-80997", "permed-77921", "permed-64764", "permed-88381", "permed-81998", "permed-81001", "permed-77924", "permed-64766", "permed-72328"]}
{"query_id": "topic_134_turn_2", "conversation_id": "topic_134", "turn_id": 2, "query": "How do environmental conditions in these areas, such as water temperature and light intensity, affect this growth?", "history": ["What factors contribute to the growth and accumulation of Ulva species in coastal areas?"], "ground_truth": ["permed-82420", "permed-72328", "permed-63751", "permed-88403", "permed-64044", "permed-63992", "permed-63752", "permed-84226", "permed-62538", "permed-73487"]}
{"query_id": "topic_134_turn_3", "conversation_id": "topic_134", "turn_id": 3, "query": "Given these environmental influences on Ulva growth, how do factors like water temperature, nutrient levels, and light intensity specifically shape its seasonal growth patterns and biomass accumulation in intertidal zones? And what do these patterns tell us about predicting and managing future green tide outbreaks in coastal areas?", "history": ["What factors contribute to the growth and accumulation of Ulva species in coastal areas?", "How do environmental conditions in these areas, such as water temperature and light intensity, affect this growth?"], "ground_truth": ["permed-80997", "permed-72328", "permed-66873", "permed-64759", "permed-64761", "permed-86503", "permed-82019", "permed-67499", "permed-81998", "permed-63751"]}
{"query_id": "topic_135_turn_1", "conversation_id": "topic_135", "turn_id": 1, "query": "What role does dietary β-1,3-glucan play in mitigating infections in poultry?", "history": [], "ground_truth": ["permed-80716", "permed-68174", "permed-68223", "permed-88719", "permed-57794", "permed-58168", "permed-84880", "permed-66654", "permed-67816", "permed-80694"]}
{"query_id": "topic_135_turn_2", "conversation_id": "topic_135", "turn_id": 2, "query": "How effective is this supplement in enhancing intestinal health, particularly against Clostridium perfringens infection?", "history": ["What role does dietary β-1,3-glucan play in mitigating infections in poultry?"], "ground_truth": ["permed-80716", "permed-62620", "permed-65163", "permed-64998", "permed-24563", "permed-72391", "permed-68221", "permed-71817", "permed-64094", "permed-66655"]}
{"query_id": "topic_135_turn_3", "conversation_id": "topic_135", "turn_id": 3, "query": "Given these effects of β-1,3-glucan on Clostridium perfringens infection in broilers, how does the timing and duration of supplementation affect its ability to enhance intestinal barrier function and modulate the cecal microbiome? Specifically, how might this relate to changes in gene expression of key transporters and tight junction proteins during different growth stages?", "history": ["What role does dietary β-1,3-glucan play in mitigating infections in poultry?", "How effective is this supplement in enhancing intestinal health, particularly against Clostridium perfringens infection?"], "ground_truth": ["permed-80716", "permed-62620", "permed-68174", "permed-58168", "permed-88719", "permed-70492", "permed-62068", "permed-57794", "permed-66655", "permed-24754"]}
{"query_id": "topic_136_turn_1", "conversation_id": "topic_136", "turn_id": 1, "query": "What potential uses are being explored for agricultural by-products like asparagus waste in the food industry?", "history": [], "ground_truth": ["permed-80913", "permed-52777", "permed-59650", "permed-83560", "permed-80914", "permed-63671", "permed-59652", "permed-59656", "permed-74230", "permed-59655"]}
{"query_id": "topic_136_turn_2", "conversation_id": "topic_136", "turn_id": 2, "query": "How can the sensory properties of ingredients derived from this type of waste be improved to make them more viable for use in food products?", "history": ["What potential uses are being explored for agricultural by-products like asparagus waste in the food industry?"], "ground_truth": ["permed-80913", "permed-59652", "permed-80923", "permed-59650", "permed-80918", "permed-73010", "permed-59654", "permed-74230", "permed-74234", "permed-63671"]}
{"query_id": "topic_136_turn_3", "conversation_id": "topic_136", "turn_id": 3, "query": "Given the focus on improving sensory properties of asparagus waste-derived ingredients, how can we better identify and quantify their volatile compounds to enhance food appeal? Also, what advanced processing techniques could help minimize negative sensory impacts while maximizing the use of these by-products?", "history": ["What potential uses are being explored for agricultural by-products like asparagus waste in the food industry?", "How can the sensory properties of ingredients derived from this type of waste be improved to make them more viable for use in food products?"], "ground_truth": ["permed-80913", "permed-80914", "permed-52777", "permed-80918", "permed-59654", "permed-59652", "permed-86191", "permed-80919", "permed-88945", "permed-75718"]}
{"query_id": "topic_137_turn_1", "conversation_id": "topic_137", "turn_id": 1, "query": "What treatments are commonly used for lymphatic malformations in infants, especially those with airway involvement?", "history": [], "ground_truth": ["permed-77639", "permed-77637", "permed-54567", "permed-77638", "permed-24638", "permed-24629", "permed-77635", "permed-24639", "permed-80401", "permed-87143"]}
{"query_id": "topic_137_turn_2", "conversation_id": "topic_137", "turn_id": 2, "query": "How effective is sirolimus in managing this condition, and what are its potential risks?", "history": ["What treatments are commonly used for lymphatic malformations in infants, especially those with airway involvement?"], "ground_truth": ["permed-67385", "permed-70789", "permed-91197", "permed-77639", "permed-25129", "permed-82455", "permed-25127", "permed-72638", "permed-62455", "permed-57241"]}
{"query_id": "topic_137_turn_3", "conversation_id": "topic_137", "turn_id": 3, "query": "For infants with significant airway involvement from lymphatic malformations, how does sirolimus therapy affect their risk of pulmonary complications, and what strategies can help minimize these risks while still achieving good treatment outcomes?", "history": ["What treatments are commonly used for lymphatic malformations in infants, especially those with airway involvement?", "How effective is sirolimus in managing this condition, and what are its potential risks?"], "ground_truth": ["permed-77639", "permed-77638", "permed-77637", "permed-1638", "permed-54567", "permed-24637", "permed-24638", "permed-25129", "permed-25127", "permed-24629"]}
{"query_id": "topic_138_turn_1", "conversation_id": "topic_138", "turn_id": 1, "query": "What are the fundamental roles of phospholipids in the membrane fusion mechanisms of enveloped viruses?", "history": [], "ground_truth": ["permed-75739", "permed-83379", "permed-53443", "permed-53574", "permed-75026", "permed-75741", "permed-75743", "permed-83413", "permed-53577", "permed-75742"]}
{"query_id": "topic_138_turn_2", "conversation_id": "topic_138", "turn_id": 2, "query": "Focusing on specific phospholipids like BMP, how does their molecular structure influence these viral fusion mechanisms?", "history": ["What are the fundamental roles of phospholipids in the membrane fusion mechanisms of enveloped viruses?"], "ground_truth": ["permed-75739", "permed-83379", "permed-75743", "permed-53443", "permed-53437", "permed-78009", "permed-75741", "permed-53574", "permed-75742", "permed-75746"]}
{"query_id": "topic_138_turn_3", "conversation_id": "topic_138", "turn_id": 3, "query": "BMP's role in viral fusion: How do its headgroup physical properties (specifically size and shape) impact membrane curvature and lipid packing, and how does this compare to other anionic phospholipids in promoting fusion?", "history": ["What are the fundamental roles of phospholipids in the membrane fusion mechanisms of enveloped viruses?", "Focusing on specific phospholipids like BMP, how does their molecular structure influence these viral fusion mechanisms?"], "ground_truth": ["permed-75739", "permed-83379", "permed-53574", "permed-53577", "permed-77118", "permed-75741", "permed-53443", "permed-53568", "permed-75026", "permed-53309"]}
{"query_id": "topic_139_turn_1", "conversation_id": "topic_139", "turn_id": 1, "query": "Overview of Japanese laws and official guidelines governing Assisted Reproductive Technology (ART)", "history": [], "ground_truth": ["permed-68438", "permed-7642", "permed-31339", "permed-7243", "permed-31079", "permed-76434", "permed-92093", "permed-61236", "permed-7404", "permed-74729"]}
{"query_id": "topic_139_turn_2", "conversation_id": "topic_139", "turn_id": 2, "query": "Influence of Japanese cultural norms and ethical principles on the development and enforcement of these ART regulations", "history": ["Overview of Japanese laws and official guidelines governing Assisted Reproductive Technology (ART)"], "ground_truth": ["permed-68438", "permed-74725", "permed-55645", "permed-63479", "permed-66153", "permed-31339", "permed-7642", "permed-66309", "permed-82373", "permed-91814"]}
{"query_id": "topic_139_turn_3", "conversation_id": "topic_139", "turn_id": 3, "query": "Impact of Japan's culturally-influenced ART regulations on the specific mechanisms defining government oversight versus medical professional autonomy, and implications for patient consent protocols and access to advanced ART procedures.", "history": ["Overview of Japanese laws and official guidelines governing Assisted Reproductive Technology (ART)", "Influence of Japanese cultural norms and ethical principles on the development and enforcement of these ART regulations"], "ground_truth": ["permed-68438", "permed-31339", "permed-80119", "permed-46259", "permed-7642", "permed-90989", "permed-84520", "permed-64818", "permed-67373", "permed-52842"]}
{"query_id": "topic_140_turn_1", "conversation_id": "topic_140", "turn_id": 1, "query": "What is the role and impact of collaborative networks on the performance of agricultural production cooperatives in developing countries?", "history": [], "ground_truth": ["permed-74111", "permed-70323", "permed-89277", "permed-63680", "permed-91944", "permed-53394", "permed-84094", "permed-54004", "permed-61615", "permed-69626"]}
{"query_id": "topic_140_turn_2", "conversation_id": "topic_140", "turn_id": 2, "query": "How do national policies and legal frameworks in Iran influence the operational effectiveness of these agricultural cooperative networks?", "history": ["What is the role and impact of collaborative networks on the performance of agricultural production cooperatives in developing countries?"], "ground_truth": ["permed-74111", "permed-70323", "permed-53394", "permed-73931", "permed-72682", "permed-89277", "permed-63491", "permed-91944", "permed-69939", "permed-77746"]}
{"query_id": "topic_140_turn_3", "conversation_id": "topic_140", "turn_id": 3, "query": "Based on insights from Iran's experience, what specific digital technologies can enhance information sharing and collaborative decision-making within agricultural cooperative networks in other developing countries facing similar challenges?", "history": ["What is the role and impact of collaborative networks on the performance of agricultural production cooperatives in developing countries?", "How do national policies and legal frameworks in Iran influence the operational effectiveness of these agricultural cooperative networks?"], "ground_truth": ["permed-74111", "permed-53393", "permed-77747", "permed-54001", "permed-89277", "permed-70323", "permed-61880", "permed-56855", "permed-73931", "permed-74380"]}
{"query_id": "topic_141_turn_1", "conversation_id": "topic_141", "turn_id": 1, "query": "What role does socioeconomic status play in mental health outcomes?", "history": [], "ground_truth": ["permed-71649", "permed-61461", "permed-77916", "permed-84711", "permed-92627", "permed-87617", "permed-65949", "permed-54386", "permed-55766", "permed-66373"]}
{"query_id": "topic_141_turn_2", "conversation_id": "topic_141", "turn_id": 2, "query": "How does this relationship vary across different demographic groups, particularly in countries like China?", "history": ["What role does socioeconomic status play in mental health outcomes?"], "ground_truth": ["permed-53165", "permed-69902", "permed-65658", "permed-58481", "permed-54390", "permed-65951", "permed-69904", "permed-53167", "permed-65455", "permed-84683"]}
{"query_id": "topic_141_turn_3", "conversation_id": "topic_141", "turn_id": 3, "query": "How might the combination of socioeconomic status and relative deprivation specifically impact the development and progression of mental health disorders like depression across different demographic groups in China? And what are the key mechanisms through which these factors interact to influence health outcomes?", "history": ["What role does socioeconomic status play in mental health outcomes?", "How does this relationship vary across different demographic groups, particularly in countries like China?"], "ground_truth": ["permed-54390", "permed-69486", "permed-84711", "permed-69489", "permed-55685", "permed-35845", "permed-53167", "permed-89553", "permed-65657", "permed-81593"]}
{"query_id": "topic_142_turn_1", "conversation_id": "topic_142", "turn_id": 1, "query": "What role does machine learning play in predicting dementia?", "history": [], "ground_truth": ["permed-53330", "permed-69746", "permed-53331", "permed-53332", "permed-59412", "permed-33351", "permed-71706", "permed-77538", "permed-81767", "permed-53346"]}
{"query_id": "topic_142_turn_2", "conversation_id": "topic_142", "turn_id": 2, "query": "How effective is it when applied to different types of study designs, like cross-sectional versus longitudinal studies?", "history": ["What role does machine learning play in predicting dementia?"], "ground_truth": ["permed-6827", "permed-52647", "permed-82631", "permed-84949", "permed-55479", "permed-34463", "permed-66153", "permed-52652", "permed-23679", "permed-82588"]}
{"query_id": "topic_142_turn_3", "conversation_id": "topic_142", "turn_id": 3, "query": "Given that machine learning shows varying effectiveness across different study designs for dementia prediction, how can its techniques be integrated to improve accuracy when moving from cross-sectional to longitudinal studies? What specific challenges arise in maintaining consistent performance metrics like sensitivity and specificity across these different designs?", "history": ["What role does machine learning play in predicting dementia?", "How effective is it when applied to different types of study designs, like cross-sectional versus longitudinal studies?"], "ground_truth": ["permed-81767", "permed-53330", "permed-59412", "permed-33351", "permed-53332", "permed-72904", "permed-69746", "permed-77538", "permed-53331", "permed-53346"]}
{"query_id": "topic_143_turn_1", "conversation_id": "topic_143", "turn_id": 1, "query": "What impact has allogeneic stem cell transplantation had on treating hematological malignancies?", "history": [], "ground_truth": ["permed-55936", "permed-56387", "permed-72651", "permed-56384", "permed-21781", "permed-49251", "permed-80123", "permed-21782", "permed-80126", "permed-56388"]}
{"query_id": "topic_143_turn_2", "conversation_id": "topic_143", "turn_id": 2, "query": "How have recent advancements in this area improved patient outcomes over time?", "history": ["What impact has allogeneic stem cell transplantation had on treating hematological malignancies?"], "ground_truth": ["permed-50971", "permed-27127", "permed-58626", "permed-72540", "permed-87093", "permed-61615", "permed-56265", "permed-66153", "permed-26726", "permed-62341"]}
{"query_id": "topic_143_turn_3", "conversation_id": "topic_143", "turn_id": 3, "query": "Given these advancements in allogeneic stem cell transplantation, how have improvements in supportive care and GVHD management specifically affected long-term survival and quality of life for patients? And what do these developments mean for how allo-SCT is integrated into standard treatment protocols for hematological malignancies?", "history": ["What impact has allogeneic stem cell transplantation had on treating hematological malignancies?", "How have recent advancements in this area improved patient outcomes over time?"], "ground_truth": ["permed-80123", "permed-55936", "permed-54296", "permed-49260", "permed-80129", "permed-56388", "permed-56384", "permed-80127", "permed-74579", "permed-47578"]}
{"query_id": "topic_144_turn_1", "conversation_id": "topic_144", "turn_id": 1, "query": "What role does the mitochondrial genome play in the genetic diversity of Cannabis sativa L.?", "history": [], "ground_truth": ["permed-63927", "permed-63695", "permed-63701", "permed-63694", "permed-63698", "permed-89610", "permed-85023", "permed-76685", "permed-81747", "permed-50790"]}
{"query_id": "topic_144_turn_2", "conversation_id": "topic_144", "turn_id": 2, "query": "How do variations within this genome, such as repeat sequences, impact its stability and potential for genetic engineering?", "history": ["What role does the mitochondrial genome play in the genetic diversity of Cannabis sativa L.?"], "ground_truth": ["permed-52490", "permed-83855", "permed-73730", "permed-83853", "permed-77579", "permed-50790", "permed-52499", "permed-52493", "permed-83885", "permed-91625"]}
{"query_id": "topic_144_turn_3", "conversation_id": "topic_144", "turn_id": 3, "query": "Given these variations in repeat sequences and their impact on stability, how do their specific distributions within the mitochondrial genome affect genetic recombination dynamics and overall genome stability in Cannabis sativa L.? What implications could this have for engineering Cannabis varieties with improved traits?", "history": ["What role does the mitochondrial genome play in the genetic diversity of Cannabis sativa L.?", "How do variations within this genome, such as repeat sequences, impact its stability and potential for genetic engineering?"], "ground_truth": ["permed-63927", "permed-63695", "permed-83855", "permed-76685", "permed-73730", "permed-76842", "permed-63701", "permed-64015", "permed-64116", "permed-82352"]}
{"query_id": "topic_145_turn_1", "conversation_id": "topic_145", "turn_id": 1, "query": "What is known about the neurological effects of type 1 diabetes on brain connectivity and function?", "history": [], "ground_truth": ["permed-79780", "permed-55535", "permed-79782", "permed-70651", "permed-29163", "permed-63219", "permed-64848", "permed-54734", "permed-52237", "permed-26470"]}
{"query_id": "topic_145_turn_2", "conversation_id": "topic_145", "turn_id": 2, "query": "How does this area of research relate to the development of diabetic peripheral neuropathy, particularly in terms of early detection or prevention?", "history": ["What is known about the neurological effects of type 1 diabetes on brain connectivity and function?"], "ground_truth": ["permed-87761", "permed-79780", "permed-59751", "permed-9272", "permed-71676", "permed-15742", "permed-43205", "permed-58823", "permed-91262", "permed-41224"]}
{"query_id": "topic_145_turn_3", "conversation_id": "topic_145", "turn_id": 3, "query": "Given these observed differences in thalamic and postcentral gyrus connectivity between type 1 diabetes patients and healthy controls, how might these neural patterns change as patients progress from asymptomatic diabetes to developing painful or painless DPN? What potential biomarkers could longitudinal fMRI studies reveal to predict the onset or progression of neuropathic complications, and how might such biomarkers guide personalized treatment approaches?", "history": ["What is known about the neurological effects of type 1 diabetes on brain connectivity and function?", "How does this area of research relate to the development of diabetic peripheral neuropathy, particularly in terms of early detection or prevention?"], "ground_truth": ["permed-79780", "permed-82665", "permed-79781", "permed-17705", "permed-58823", "permed-72453", "permed-91262", "permed-79782", "permed-26281", "permed-52237"]}
{"query_id": "topic_146_turn_1", "conversation_id": "topic_146", "turn_id": 1, "query": "Mechanisms of environmental filtering and its impact on species evolution in temperate grassland ecosystems", "history": [], "ground_truth": ["permed-77373", "permed-62986", "permed-86233", "permed-82651", "permed-75160", "permed-74592", "permed-79987", "permed-91516", "permed-53717", "permed-53718"]}
{"query_id": "topic_146_turn_2", "conversation_id": "topic_146", "turn_id": 2, "query": "Influence of this environmental filtering sensitivity on adaptive strategies of large-genome species in temperate grasslands", "history": ["Mechanisms of environmental filtering and its impact on species evolution in temperate grassland ecosystems"], "ground_truth": ["permed-77373", "permed-75160", "permed-60604", "permed-86233", "permed-53718", "permed-64253", "permed-62951", "permed-53717", "permed-84357", "permed-59343"]}
{"query_id": "topic_146_turn_3", "conversation_id": "topic_146", "turn_id": 3, "query": "Role of evolutionary history and genetic architecture in shaping adaptive strategies of large-genome species to environmental filtering in temperate grasslands, and projected long-term ecological consequences under global environmental change", "history": ["Mechanisms of environmental filtering and its impact on species evolution in temperate grassland ecosystems", "Influence of this environmental filtering sensitivity on adaptive strategies of large-genome species in temperate grasslands"], "ground_truth": ["permed-77373", "permed-64253", "permed-59343", "permed-62951", "permed-74477", "permed-53712", "permed-58192", "permed-62986", "permed-59320", "permed-62954"]}
{"query_id": "topic_147_turn_1", "conversation_id": "topic_147", "turn_id": 1, "query": "What role do nanocatalysts play in industrial ammonia production?", "history": [], "ground_truth": ["permed-80182", "permed-87505", "permed-53778", "permed-67582", "permed-88191", "permed-51010", "permed-80524", "permed-57933", "permed-57928"]}
{"query_id": "topic_147_turn_2", "conversation_id": "topic_147", "turn_id": 2, "query": "How does the structure of these nanocatalysts, like Cu2O and Co3O4, impact their performance in such reactions?", "history": ["What role do nanocatalysts play in industrial ammonia production?"], "ground_truth": ["permed-80182", "permed-78338", "permed-74573", "permed-57875", "permed-78337"]}
{"query_id": "topic_147_turn_3", "conversation_id": "topic_147", "turn_id": 3, "query": "Given what we know about how Cu2O and Co3O4 nanocubes transform during nitrate reduction, how can these insights be used to improve both the operational conditions and long-term stability of such tandem catalysts for industrial ammonia production?", "history": ["What role do nanocatalysts play in industrial ammonia production?", "How does the structure of these nanocatalysts, like Cu2O and Co3O4, impact their performance in such reactions?"], "ground_truth": ["permed-80182", "permed-75435", "permed-88191", "permed-80524"]}
{"query_id": "topic_148_turn_1", "conversation_id": "topic_148", "turn_id": 1, "query": "Deep-sea gas hydrate formation mechanisms and overall significance", "history": [], "ground_truth": ["permed-73149", "permed-91516", "permed-86233", "permed-89441", "permed-60645", "permed-73153", "permed-58349", "permed-76740", "permed-82651", "permed-72010"]}
{"query_id": "topic_148_turn_2", "conversation_id": "topic_148", "turn_id": 2, "query": "Impact of high-pressure discovery of novel hydrate structures on understanding these deep-sea gas hydrate formation mechanisms", "history": ["Deep-sea gas hydrate formation mechanisms and overall significance"], "ground_truth": ["permed-73149", "permed-73153", "permed-73148", "permed-75490", "permed-86233", "permed-73021", "permed-50883", "permed-75488", "permed-66975", "permed-76280"]}
{"query_id": "topic_148_turn_3", "conversation_id": "topic_148", "turn_id": 3, "query": "Influence of newly discovered high-pressure potassium chloride hydrate on deep-sea gas hydrate formation/stability and marine geochemical cycles", "history": ["Deep-sea gas hydrate formation mechanisms and overall significance", "Impact of high-pressure discovery of novel hydrate structures on understanding these deep-sea gas hydrate formation mechanisms"], "ground_truth": ["permed-75487", "permed-75490", "permed-91516", "permed-86233", "permed-50883", "permed-73153", "permed-75488", "permed-73149", "permed-75492", "permed-58349"]}
{"query_id": "topic_149_turn_1", "conversation_id": "topic_149", "turn_id": 1, "query": "What impact does lithium have on soil ecosystems?", "history": [], "ground_truth": ["permed-81886", "permed-82038", "permed-64170", "permed-78127", "permed-81207", "permed-74128", "permed-66775", "permed-74123", "permed-81890", "permed-67682"]}
{"query_id": "topic_149_turn_2", "conversation_id": "topic_149", "turn_id": 2, "query": "How might this effect on soil translate into changes in microbial communities and overall soil health?", "history": ["What impact does lithium have on soil ecosystems?"], "ground_truth": ["permed-66775", "permed-66574", "permed-66914", "permed-62254", "permed-66912", "permed-66913", "permed-66224", "permed-81894", "permed-76627", "permed-66774"]}
{"query_id": "topic_149_turn_3", "conversation_id": "topic_149", "turn_id": 3, "query": "Given these effects on soil nutrient dynamics and enzymatic activities, how do different lithium concentrations specifically shape microbial community structure and function in agricultural soils, and what could this mean for long-term soil fertility and crop yields?", "history": ["What impact does lithium have on soil ecosystems?", "How might this effect on soil translate into changes in microbial communities and overall soil health?"], "ground_truth": ["permed-81886", "permed-66775", "permed-81890", "permed-66574", "permed-66915", "permed-63946", "permed-67300", "permed-84080", "permed-88397", "permed-66914"]}
{"query_id": "topic_150_turn_1", "conversation_id": "topic_150", "turn_id": 1, "query": "Key determinants of adolescent depressive symptoms in South Korea", "history": [], "ground_truth": ["permed-77912", "permed-61920", "permed-77917", "permed-77771", "permed-69628", "permed-55630", "permed-55629", "permed-77913", "permed-55604", "permed-89693"]}
{"query_id": "topic_150_turn_2", "conversation_id": "topic_150", "turn_id": 2, "query": "Role of socio-economic status and academic pressure in these South Korean adolescent depressive symptoms, considering cultural context", "history": ["Key determinants of adolescent depressive symptoms in South Korea"], "ground_truth": ["permed-77912", "permed-77771", "permed-65662", "permed-61920", "permed-77913", "permed-89693", "permed-55630", "permed-55629", "permed-77917", "permed-55604"]}
{"query_id": "topic_150_turn_3", "conversation_id": "topic_150", "turn_id": 3, "query": "Longitudinal impact of SES and academic stress on South Korean adolescent depression trajectories and evidence-based interventions", "history": ["Key determinants of adolescent depressive symptoms in South Korea", "Role of socio-economic status and academic pressure in these South Korean adolescent depressive symptoms, considering cultural context"], "ground_truth": ["permed-77912", "permed-77917", "permed-65662", "permed-61920", "permed-77913", "permed-55591", "permed-89693", "permed-69628", "permed-92096", "permed-85277"]}
{"query_id": "topic_151_turn_1", "conversation_id": "topic_151", "turn_id": 1, "query": "What role does P2RY2 play in cancer cell proliferation and metastasis?", "history": [], "ground_truth": ["permed-79024", "permed-55371", "permed-79025", "permed-53530", "permed-79026", "permed-55342", "permed-16669", "permed-82373", "permed-73653", "permed-67158"]}
{"query_id": "topic_151_turn_2", "conversation_id": "topic_151", "turn_id": 2, "query": "How does its involvement in signaling pathways, like AKT/GSK-3beta/VEGF, impact this process, and are there other receptors that interact with it in the tumor microenvironment?", "history": ["What role does P2RY2 play in cancer cell proliferation and metastasis?"], "ground_truth": ["permed-51215", "permed-68287", "permed-71707", "permed-79024", "permed-51125", "permed-56316", "permed-68073", "permed-79025", "permed-75866", "permed-67775"]}
{"query_id": "topic_151_turn_3", "conversation_id": "topic_151", "turn_id": 3, "query": "Given P2RY2's role in the AKT/GSK-3beta/VEGF pathway and its effects on gastric cancer progression, how might its interactions with other GPCRs in the tumor microenvironment affect targeted therapy outcomes? What approaches could be taken to improve treatment efficacy by modulating this network of receptors?", "history": ["What role does P2RY2 play in cancer cell proliferation and metastasis?", "How does its involvement in signaling pathways, like AKT/GSK-3beta/VEGF, impact this process, and are there other receptors that interact with it in the tumor microenvironment?"], "ground_truth": ["permed-79024", "permed-79025", "permed-53530", "permed-71453", "permed-20552", "permed-89850", "permed-55371", "permed-82128", "permed-75919", "permed-31850"]}
{"query_id": "topic_152_turn_1", "conversation_id": "topic_152", "turn_id": 1, "query": "How has the COVID-19 pandemic affected the presentation and treatment of acute coronary syndrome (ACS) patients?", "history": [], "ground_truth": ["permed-81651", "permed-56806", "permed-26235", "permed-65731", "permed-4899", "permed-6039", "permed-81653", "permed-42986", "permed-59859", "permed-65736"]}
{"query_id": "topic_152_turn_2", "conversation_id": "topic_152", "turn_id": 2, "query": "What specific changes in ACS patient profiles during this time have had the most significant impact on their care, particularly regarding revascularization strategies?", "history": ["How has the COVID-19 pandemic affected the presentation and treatment of acute coronary syndrome (ACS) patients?"], "ground_truth": ["permed-80621", "permed-4899", "permed-81651", "permed-70418", "permed-22938", "permed-43072", "permed-42986", "permed-26235", "permed-43004", "permed-43002"]}
{"query_id": "topic_152_turn_3", "conversation_id": "topic_152", "turn_id": 3, "query": "Given these shifts in clinical presentation and disease complexity among ACS patients during the pandemic, how have they specifically influenced revascularization strategy selection and effectiveness? What does this mean for long-term outcomes and how healthcare resources should be allocated moving forward?", "history": ["How has the COVID-19 pandemic affected the presentation and treatment of acute coronary syndrome (ACS) patients?", "What specific changes in ACS patient profiles during this time have had the most significant impact on their care, particularly regarding revascularization strategies?"], "ground_truth": ["permed-81651", "permed-65731", "permed-56806", "permed-81655", "permed-85142", "permed-57113", "permed-65736", "permed-81653", "permed-84074", "permed-22938"]}
{"query_id": "topic_153_turn_1", "conversation_id": "topic_153", "turn_id": 1, "query": "Comparative overview of seminoma metastasis characteristics (e.g., common sites, progression speed, presentation patterns) in avian species versus mammals.", "history": [], "ground_truth": ["permed-76489", "permed-82373", "permed-89594", "permed-68563", "permed-59570", "permed-85504", "permed-85505", "permed-59569", "permed-76485", "permed-50790"]}
{"query_id": "topic_153_turn_2", "conversation_id": "topic_153", "turn_id": 2, "query": "Following these comparative metastatic characteristics, what are the resultant diagnostic and therapeutic implications for managing seminoma in avian species?", "history": ["Comparative overview of seminoma metastasis characteristics (e.g., common sites, progression speed, presentation patterns) in avian species versus mammals."], "ground_truth": ["permed-76489", "permed-76485", "permed-77665", "permed-82373", "permed-63463", "permed-59570", "permed-68575", "permed-76577", "permed-79666", "permed-71939"]}
{"query_id": "topic_153_turn_3", "conversation_id": "topic_153", "turn_id": 3, "query": "Investigating avian-specific molecular mechanisms underlying seminoma metastasis (particularly to distant organs like the brain and kidneys) versus mammalian pathways, and how these mechanistic divergences can be leveraged for developing novel early-detection imaging techniques and targeted therapies in avian oncology.", "history": ["Comparative overview of seminoma metastasis characteristics (e.g., common sites, progression speed, presentation patterns) in avian species versus mammals.", "Following these comparative metastatic characteristics, what are the resultant diagnostic and therapeutic implications for managing seminoma in avian species?"], "ground_truth": ["permed-76489", "permed-79666", "permed-82373", "permed-76485", "permed-53696", "permed-80576", "permed-76576", "permed-63463", "permed-77454", "permed-82507"]}
{"query_id": "topic_154_turn_1", "conversation_id": "topic_154", "turn_id": 1, "query": "What role does longitudinal patient interaction play in medical students' education?", "history": [], "ground_truth": ["permed-83306", "permed-90987", "permed-51507", "permed-80046", "permed-51502", "permed-51505", "permed-51506", "permed-90682", "permed-51503", "permed-85261"]}
{"query_id": "topic_154_turn_2", "conversation_id": "topic_154", "turn_id": 2, "query": "Can this type of interactive learning enhance students' understanding of patients' emotional experiences with surgery?", "history": ["What role does longitudinal patient interaction play in medical students' education?"], "ground_truth": ["permed-51506", "permed-69809", "permed-83020", "permed-80775", "permed-80767", "permed-83018", "permed-78817", "permed-87266", "permed-84505", "permed-91842"]}
{"query_id": "topic_154_turn_3", "conversation_id": "topic_154", "turn_id": 3, "query": "Given the potential benefits of longitudinal patient interaction for understanding patients' emotional experiences with surgery, how could the Longitudinal Patient Project (LPP) be adapted or enhanced to further improve students' grasp of these psychological impacts—both for patients and their families? What specific strategies within the LPP framework would best foster this deeper appreciation?", "history": ["What role does longitudinal patient interaction play in medical students' education?", "Can this type of interactive learning enhance students' understanding of patients' emotional experiences with surgery?"], "ground_truth": ["permed-80775", "permed-51506", "permed-83306", "permed-66307", "permed-49530", "permed-60167", "permed-78817", "permed-67162", "permed-65743", "permed-80046"]}
{"query_id": "topic_155_turn_1", "conversation_id": "topic_155", "turn_id": 1, "query": "Role of metabolic activity in lymphoma prognosis and progression mechanisms", "history": [], "ground_truth": ["permed-82373", "permed-68563", "permed-56468", "permed-84708", "permed-56277", "permed-20443", "permed-66028", "permed-79836", "permed-88665", "permed-72010"]}
{"query_id": "topic_155_turn_2", "conversation_id": "topic_155", "turn_id": 2, "query": "PET/CT characterization of these prognostic metabolic patterns in specific lymphomas like nasal NK/T-cell lymphoma", "history": ["Role of metabolic activity in lymphoma prognosis and progression mechanisms"], "ground_truth": ["permed-31799", "permed-32079", "permed-3633", "permed-48777", "permed-21492", "permed-68203", "permed-60573", "permed-28412", "permed-48609", "permed-31557"]}
{"query_id": "topic_155_turn_3", "conversation_id": "topic_155", "turn_id": 3, "query": "Using temporal changes in 18F-FDG PET/CT metabolic signatures of nasal NK/T-cell lymphoma to predict osteonecrosis development and inform early intervention strategies", "history": ["Role of metabolic activity in lymphoma prognosis and progression mechanisms", "PET/CT characterization of these prognostic metabolic patterns in specific lymphomas like nasal NK/T-cell lymphoma"], "ground_truth": ["permed-31799", "permed-77500", "permed-32079", "permed-21492", "permed-32083", "permed-32084", "permed-23985", "permed-3633", "permed-31557", "permed-56107"]}
{"query_id": "topic_156_turn_1", "conversation_id": "topic_156", "turn_id": 1, "query": "latest trends and key advancements in pediatric palliative care", "history": [], "ground_truth": ["permed-61610", "permed-80808", "permed-53028", "permed-76010", "permed-80809", "permed-32468", "permed-79845", "permed-66153", "permed-58626", "permed-61782"]}
{"query_id": "topic_156_turn_2", "conversation_id": "topic_156", "turn_id": 2, "query": "evolving ethical considerations for these pediatric palliative care advancements regarding end-of-life decisions for young children", "history": ["latest trends and key advancements in pediatric palliative care"], "ground_truth": ["permed-80808", "permed-74711", "permed-90537", "permed-52843", "permed-74651", "permed-67369", "permed-76010", "permed-80197", "permed-71137", "permed-74819"]}
{"query_id": "topic_156_turn_3", "conversation_id": "topic_156", "turn_id": 3, "query": "Legal and medical protocols for implementing pediatric euthanasia considering recent palliative care advancements and ethical frameworks", "history": ["latest trends and key advancements in pediatric palliative care", "evolving ethical considerations for these pediatric palliative care advancements regarding end-of-life decisions for young children"], "ground_truth": ["permed-74819", "permed-80808", "permed-74711", "permed-76010", "permed-90537", "permed-52843", "permed-80197", "permed-82956", "permed-74821", "permed-74823"]}
{"query_id": "topic_157_turn_1", "conversation_id": "topic_157", "turn_id": 1, "query": "Overview of recent policy reforms affecting scientific research landscape in Mexico", "history": [], "ground_truth": ["permed-75747", "permed-66309", "permed-86237", "permed-69929", "permed-91926", "permed-66153", "permed-86233", "permed-86235", "permed-86232", "permed-91814"]}
{"query_id": "topic_157_turn_2", "conversation_id": "topic_157", "turn_id": 2, "query": "Specific effects of these Mexican policy reforms on the autonomy and decision-making processes of national research institutions", "history": ["Overview of recent policy reforms affecting scientific research landscape in Mexico"], "ground_truth": ["permed-75747", "permed-91926", "permed-61615", "permed-74117", "permed-66153", "permed-91814", "permed-82651", "permed-66309", "permed-67243", "permed-69929"]}
{"query_id": "topic_157_turn_3", "conversation_id": "topic_157", "turn_id": 3, "query": "Mechanisms of political influence impacting academic freedom in daily operations of Mexican research institutions experiencing reduced autonomy post-reform", "history": ["Overview of recent policy reforms affecting scientific research landscape in Mexico", "Specific effects of these Mexican policy reforms on the autonomy and decision-making processes of national research institutions"], "ground_truth": ["permed-75747", "permed-66309", "permed-61466", "permed-91926", "permed-86237", "permed-82651", "permed-55645", "permed-61615", "permed-75160", "permed-53716"]}
{"query_id": "topic_158_turn_1", "conversation_id": "topic_158", "turn_id": 1, "query": "Primary threats to fish biodiversity in the Tanguar Haor wetland ecosystem", "history": [], "ground_truth": ["permed-71240", "permed-74415", "permed-64760", "permed-85784", "permed-74411", "permed-64765", "permed-64766", "permed-62964", "permed-91516", "permed-66955"]}
{"query_id": "topic_158_turn_2", "conversation_id": "topic_158", "turn_id": 2, "query": "How does climate change exacerbate these identified primary threats to fish biodiversity within Tanguar Haor?", "history": ["Primary threats to fish biodiversity in the Tanguar Haor wetland ecosystem"], "ground_truth": ["permed-71240", "permed-64760", "permed-85784", "permed-74147", "permed-76126", "permed-59351", "permed-64768", "permed-80039", "permed-86505", "permed-52707"]}
{"query_id": "topic_158_turn_3", "conversation_id": "topic_158", "turn_id": 3, "query": "Developing integrated socio-ecological models and adaptive management practices for fish biodiversity resilience and livelihood sustainability in Tanguar Haor Ramsar site under climate change-amplified threats", "history": ["Primary threats to fish biodiversity in the Tanguar Haor wetland ecosystem", "How does climate change exacerbate these identified primary threats to fish biodiversity within Tanguar Haor?"], "ground_truth": ["permed-71240", "permed-62986", "permed-82001", "permed-62963", "permed-75160", "permed-67089", "permed-69938", "permed-80996", "permed-64765", "permed-74415"]}
{"query_id": "topic_159_turn_1", "conversation_id": "topic_159", "turn_id": 1, "query": "How has the COVID-19 pandemic impacted physical activity levels across different populations?", "history": [], "ground_truth": ["permed-65599", "permed-72101", "permed-64876", "permed-84285", "permed-90994", "permed-54038", "permed-81303", "permed-54401", "permed-84527", "permed-54035"]}
{"query_id": "topic_159_turn_2", "conversation_id": "topic_159", "turn_id": 2, "query": "What role might psychological factors play in sustaining physical activity over time, especially considering this disruption?", "history": ["How has the COVID-19 pandemic impacted physical activity levels across different populations?"], "ground_truth": ["permed-81306", "permed-58343", "permed-54042", "permed-81302", "permed-54043", "permed-69758", "permed-65394", "permed-68395", "permed-81944", "permed-58441"]}
{"query_id": "topic_159_turn_3", "conversation_id": "topic_159", "turn_id": 3, "query": "Considering these pandemic-related disruptions and psychological factors we've discussed, how does the interaction between autonomous motivation, implicit attitudes, and habitual behaviors affect long-term physical activity adherence across different demographic groups? And what practical strategies could help sustain engagement in physical activity as we move beyond the pandemic?", "history": ["How has the COVID-19 pandemic impacted physical activity levels across different populations?", "What role might psychological factors play in sustaining physical activity over time, especially considering this disruption?"], "ground_truth": ["permed-54043", "permed-54038", "permed-54042", "permed-53420", "permed-69758", "permed-58441", "permed-58346", "permed-54761", "permed-84285", "permed-58343"]}
{"query_id": "topic_160_turn_1", "conversation_id": "topic_160", "turn_id": 1, "query": "What materials are commonly used for oral soft tissue augmentation and how effective are they?", "history": [], "ground_truth": ["permed-75201", "permed-40535", "permed-92165", "permed-40131", "permed-20096", "permed-87085", "permed-75141", "permed-40272", "permed-60047", "permed-77848"]}
{"query_id": "topic_160_turn_2", "conversation_id": "topic_160", "turn_id": 2, "query": "Are there any specific types of dermal matrices that have shown promising results in terms of graft integration and functionality over time?", "history": ["What materials are commonly used for oral soft tissue augmentation and how effective are they?"], "ground_truth": ["permed-79371", "permed-75200", "permed-75201", "permed-75249", "permed-38846", "permed-12447", "permed-75242", "permed-85993", "permed-76177", "permed-12444"]}
{"query_id": "topic_160_turn_3", "conversation_id": "topic_160", "turn_id": 3, "query": "How do human gingival fibroblasts behave at the cellular and molecular level when cultured on modified P-ADM versus SCTG and B-ADM over the long term, and how do these differences impact graft integration and functionality in oral soft tissue augmentation?", "history": ["What materials are commonly used for oral soft tissue augmentation and how effective are they?", "Are there any specific types of dermal matrices that have shown promising results in terms of graft integration and functionality over time?"], "ground_truth": ["permed-75201", "permed-88031", "permed-75207", "permed-75199", "permed-51829", "permed-75198", "permed-60048", "permed-75152", "permed-76867", "permed-52669"]}
{"query_id": "topic_161_turn_1", "conversation_id": "topic_161", "turn_id": 1, "query": "What role do metal complexes play in forming complex organic molecules?", "history": [], "ground_truth": ["permed-67588", "permed-86657", "permed-79777", "permed-67594", "permed-58073", "permed-72908", "permed-76537", "permed-80312", "permed-78881", "permed-76607"]}
{"query_id": "topic_161_turn_2", "conversation_id": "topic_161", "turn_id": 2, "query": "Can modifying the ligand environment in these complexes enhance their reactivity with certain compounds?", "history": ["What role do metal complexes play in forming complex organic molecules?"], "ground_truth": ["permed-52518", "permed-78859", "permed-78860", "permed-57981", "permed-72935", "permed-84013", "permed-86659", "permed-72933", "permed-78876", "permed-86657"]}
{"query_id": "topic_161_turn_3", "conversation_id": "topic_161", "turn_id": 3, "query": "How can we modulate the reactivity and selectivity of Al-Sc bonded complexes by adjusting their ligand environments, and what impact would these modifications have on their ability to form complex organic molecules when reacting with aromatic compounds and alkyl halides?", "history": ["What role do metal complexes play in forming complex organic molecules?", "Can modifying the ligand environment in these complexes enhance their reactivity with certain compounds?"], "ground_truth": ["permed-80312", "permed-78859", "permed-52616", "permed-72908", "permed-79085", "permed-53111", "permed-76828", "permed-52676", "permed-79786", "permed-74685"]}
{"query_id": "topic_162_turn_1", "conversation_id": "topic_162", "turn_id": 1, "query": "Role of orbital hybridization in CsV3Sb5 kagome metals: impact on phase transitions and electronic properties", "history": [], "ground_truth": ["permed-75749", "permed-75754", "permed-75752", "permed-75750", "permed-75753", "permed-76083", "permed-75755", "permed-78824", "permed-75836", "permed-75450"]}
{"query_id": "topic_162_turn_2", "conversation_id": "topic_162", "turn_id": 2, "query": "Manipulating this orbital hybridization in CsV3Sb5: effects on superconducting phase stability and emergence", "history": ["Role of orbital hybridization in CsV3Sb5 kagome metals: impact on phase transitions and electronic properties"], "ground_truth": ["permed-75749", "permed-75750", "permed-75752", "permed-76083", "permed-78824", "permed-75753", "permed-82839", "permed-75754", "permed-60645", "permed-60600"]}
{"query_id": "topic_162_turn_3", "conversation_id": "topic_162", "turn_id": 3, "query": "Advanced V3d-Sb5p orbital interaction tuning in CsV3Sb5: influence on CDW, unconventional superconductivity, correlated electron phases, and microscopic experimental verification for designing new quantum materials", "history": ["Role of orbital hybridization in CsV3Sb5 kagome metals: impact on phase transitions and electronic properties", "Manipulating this orbital hybridization in CsV3Sb5: effects on superconducting phase stability and emergence"], "ground_truth": ["permed-75749", "permed-75750", "permed-75752", "permed-75753", "permed-75754", "permed-60600", "permed-76083", "permed-78824", "permed-74972", "permed-60959"]}
{"query_id": "topic_163_turn_1", "conversation_id": "topic_163", "turn_id": 1, "query": "What are the current trends and techniques in wound closure after mastectomy for breast cancer patients?", "history": [], "ground_truth": ["permed-78675", "permed-77443", "permed-64326", "permed-69330", "permed-75334", "permed-78681", "permed-91827", "permed-30975", "permed-84561", "permed-60282"]}
{"query_id": "topic_163_turn_2", "conversation_id": "topic_163", "turn_id": 2, "query": "Are there any newer methods, like drain-free flap fixation, that have been showing promise in improving outcomes in this area?", "history": ["What are the current trends and techniques in wound closure after mastectomy for breast cancer patients?"], "ground_truth": ["permed-78675", "permed-75198", "permed-75151", "permed-91046", "permed-76412", "permed-52600", "permed-75150", "permed-91048", "permed-76414", "permed-75153"]}
{"query_id": "topic_163_turn_3", "conversation_id": "topic_163", "turn_id": 3, "query": "How do the long-term outcomes of these drain-free flap fixation techniques compare to traditional methods with drains, especially regarding patient quality of life, seroma recurrence, and late-onset infection rates in post-mastectomy breast cancer patients?", "history": ["What are the current trends and techniques in wound closure after mastectomy for breast cancer patients?", "Are there any newer methods, like drain-free flap fixation, that have been showing promise in improving outcomes in this area?"], "ground_truth": ["permed-78675", "permed-78677", "permed-90462", "permed-82924", "permed-88110", "permed-90463", "permed-64326", "permed-56552", "permed-91048", "permed-68540"]}
{"query_id": "topic_164_turn_1", "conversation_id": "topic_164", "turn_id": 1, "query": "Factors influencing myofibrillar protein quality and structural integrity in meat during postmortem aging", "history": [], "ground_truth": ["permed-80701", "permed-89170", "permed-52717", "permed-80702", "permed-89169", "permed-82366", "permed-65023", "permed-65026", "permed-82114", "permed-52712"]}
{"query_id": "topic_164_turn_2", "conversation_id": "topic_164", "turn_id": 2, "query": "How does oxidative stress impact these myofibrillar protein dynamics and structural integrity in specific muscles like longissimus dorsi?", "history": ["Factors influencing myofibrillar protein quality and structural integrity in meat during postmortem aging"], "ground_truth": ["permed-54997", "permed-65069", "permed-60762", "permed-65077", "permed-58435", "permed-72014", "permed-74440", "permed-51214", "permed-53699", "permed-91265"]}
{"query_id": "topic_164_turn_3", "conversation_id": "topic_164", "turn_id": 3, "query": "Interaction of CaMKKβ/AMPK pathway and calcium ions with oxidative stress affecting myofibrillar protein integrity and functionality in yak longissimus dorsi during early postmortem: implications for meat texture and color stability.", "history": ["Factors influencing myofibrillar protein quality and structural integrity in meat during postmortem aging", "How does oxidative stress impact these myofibrillar protein dynamics and structural integrity in specific muscles like longissimus dorsi?"], "ground_truth": ["permed-65077", "permed-75391", "permed-65078", "permed-80701", "permed-44955", "permed-89562", "permed-60762", "permed-74283", "permed-72103", "permed-74441"]}
{"query_id": "topic_165_turn_1", "conversation_id": "topic_165", "turn_id": 1, "query": "What advancements have been made in personalized treatment approaches for uterine sarcoma?", "history": [], "ground_truth": ["permed-56021", "permed-90670", "permed-80450", "permed-73421", "permed-73422", "permed-56322", "permed-56038", "permed-90671", "permed-85942", "permed-73425"]}
{"query_id": "topic_165_turn_2", "conversation_id": "topic_165", "turn_id": 2, "query": "Can this kind of personalized approach, like stratification systems, improve outcomes for specific subgroups of patients with uterine sarcoma?", "history": ["What advancements have been made in personalized treatment approaches for uterine sarcoma?"], "ground_truth": ["permed-80450", "permed-90670", "permed-56021", "permed-56028", "permed-73421", "permed-85942", "permed-81185", "permed-56038", "permed-56512", "permed-56322"]}
{"query_id": "topic_165_turn_3", "conversation_id": "topic_165", "turn_id": 3, "query": "Given this nomogram-based stratification system that identifies which uterine sarcoma patients might benefit most from adjuvant radiotherapy, how could it be incorporated into clinical guidelines to improve treatment decisions and resource use? What might be the long-term effects on both healthcare costs and patients' quality of life?", "history": ["What advancements have been made in personalized treatment approaches for uterine sarcoma?", "Can this kind of personalized approach, like stratification systems, improve outcomes for specific subgroups of patients with uterine sarcoma?"], "ground_truth": ["permed-80450", "permed-73421", "permed-56322", "permed-56774", "permed-90670", "permed-56432", "permed-68645", "permed-56340", "permed-90205", "permed-56775"]}
{"query_id": "topic_166_turn_1", "conversation_id": "topic_166", "turn_id": 1, "query": "Fundamental role of conformer sampling in protein structure determination and protein interaction analysis", "history": [], "ground_truth": ["permed-75071", "permed-75068", "permed-75066", "permed-53327", "permed-71538", "permed-63048", "permed-63044", "permed-89298", "permed-53316", "permed-53319"]}
{"query_id": "topic_166_turn_2", "conversation_id": "topic_166", "turn_id": 2, "query": "Impact of advancements in these conformer sampling techniques, such as improved force fields, on studying intrinsically disordered proteins (IDPs) and their complexes", "history": ["Fundamental role of conformer sampling in protein structure determination and protein interaction analysis"], "ground_truth": ["permed-75066", "permed-75071", "permed-75068", "permed-75067", "permed-53319", "permed-53316", "permed-71541", "permed-71539", "permed-80237", "permed-65168"]}
{"query_id": "topic_166_turn_3", "conversation_id": "topic_166", "turn_id": 3, "query": "Applications of enhanced conformer sampling by ff03CMAP force field (improving accuracy, diversity) for IDPs and ordered proteins in advancing protein-protein interaction understanding and therapeutic design, considering IDP dynamic pathway roles", "history": ["Fundamental role of conformer sampling in protein structure determination and protein interaction analysis", "Impact of advancements in these conformer sampling techniques, such as improved force fields, on studying intrinsically disordered proteins (IDPs) and their complexes"], "ground_truth": ["permed-75066", "permed-75071", "permed-75068", "permed-53327", "permed-71539", "permed-53319", "permed-71538", "permed-75067", "permed-75069", "permed-89298"]}
{"query_id": "topic_167_turn_1", "conversation_id": "topic_167", "turn_id": 1, "query": "What challenges do older adults in China face after losing their only child?", "history": [], "ground_truth": ["permed-79591", "permed-77535", "permed-53166", "permed-67229", "permed-53167", "permed-80079", "permed-79333", "permed-60178", "permed-53165", "permed-88426"]}
{"query_id": "topic_167_turn_2", "conversation_id": "topic_167", "turn_id": 2, "query": "How can community support systems address some of these challenges, particularly in terms of social isolation?", "history": ["What challenges do older adults in China face after losing their only child?"], "ground_truth": ["permed-67357", "permed-58472", "permed-80187", "permed-80079", "permed-82779", "permed-55107", "permed-79385", "permed-53138", "permed-67356", "permed-63357"]}
{"query_id": "topic_167_turn_3", "conversation_id": "topic_167", "turn_id": 3, "query": "Given these challenges and the role of community support in addressing social isolation, what specific enhancements could be made to such systems to better meet the broader needs of these older adults, particularly in reducing isolation and improving their overall well-being?", "history": ["What challenges do older adults in China face after losing their only child?", "How can community support systems address some of these challenges, particularly in terms of social isolation?"], "ground_truth": ["permed-63357", "permed-82779", "permed-80079", "permed-53163", "permed-50574", "permed-67166", "permed-80187", "permed-53168", "permed-80080", "permed-51710"]}
{"query_id": "topic_168_turn_1", "conversation_id": "topic_168", "turn_id": 1, "query": "What is known about the regulation of peptidoglycan hydrolysis and cell separation in bacteria like Mycobacterium tuberculosis?", "history": [], "ground_truth": ["permed-71597", "permed-79992", "permed-60453", "permed-79994", "permed-71592", "permed-79999", "permed-77834", "permed-88576", "permed-21751", "permed-60457"]}
{"query_id": "topic_168_turn_2", "conversation_id": "topic_168", "turn_id": 2, "query": "How do specific proteins involved in this process, such as RipA, influence bacterial pathogenicity and resistance to antibiotics in these organisms?", "history": ["What is known about the regulation of peptidoglycan hydrolysis and cell separation in bacteria like Mycobacterium tuberculosis?"], "ground_truth": ["permed-67931", "permed-79993", "permed-72287", "permed-71597", "permed-89819", "permed-79645", "permed-77019", "permed-63915", "permed-89275", "permed-87391"]}
{"query_id": "topic_168_turn_3", "conversation_id": "topic_168", "turn_id": 3, "query": "Given the roles of RipA and Cg1604 in peptidoglycan hydrolysis and cell separation within Corynebacteriales, how might their interactions with other cell wall remodeling enzymes affect both pathogenicity and antibiotic resistance in Mycobacterium tuberculosis and Corynebacterium diphtheriae? Could understanding these interactions reveal potential therapeutic targets?", "history": ["What is known about the regulation of peptidoglycan hydrolysis and cell separation in bacteria like Mycobacterium tuberculosis?", "How do specific proteins involved in this process, such as RipA, influence bacterial pathogenicity and resistance to antibiotics in these organisms?"], "ground_truth": ["permed-71597", "permed-79993", "permed-79992", "permed-60457", "permed-79994", "permed-60444", "permed-63916", "permed-67931", "permed-88641", "permed-66627"]}
{"query_id": "topic_169_turn_1", "conversation_id": "topic_169", "turn_id": 1, "query": "What impact does environmental change have on plant genetic diversity?", "history": [], "ground_truth": ["permed-59343", "permed-59320", "permed-63992", "permed-64170", "permed-58193", "permed-59341", "permed-50790", "permed-53712", "permed-64115", "permed-53717"]}
{"query_id": "topic_169_turn_2", "conversation_id": "topic_169", "turn_id": 2, "query": "How specifically might factors like climate change and habitat fragmentation affect this genetic diversity in certain species?", "history": ["What impact does environmental change have on plant genetic diversity?"], "ground_truth": ["permed-71972", "permed-62963", "permed-91380", "permed-62954", "permed-90389", "permed-87536", "permed-74591", "permed-74411", "permed-83668", "permed-87539"]}
{"query_id": "topic_169_turn_3", "conversation_id": "topic_169", "turn_id": 3, "query": "Given these effects of climate change and habitat fragmentation on genetic diversity, how do they specifically influence the genetic diversity and expression of selfing-related traits in Daphne kiusiana across different elevations within its range? And what does this mean for the species' long-term adaptability and survival?", "history": ["What impact does environmental change have on plant genetic diversity?", "How specifically might factors like climate change and habitat fragmentation affect this genetic diversity in certain species?"], "ground_truth": ["permed-78788", "permed-91380", "permed-86092", "permed-78789", "permed-87225", "permed-71972", "permed-63674", "permed-87536", "permed-59343", "permed-84848"]}
{"query_id": "topic_170_turn_1", "conversation_id": "topic_170", "turn_id": 1, "query": "Metal oxide catalysts: principles and applications in formaldehyde oxidation and ozone decomposition", "history": [], "ground_truth": ["permed-73186", "permed-55248", "permed-88471", "permed-78335", "permed-88470", "permed-74578", "permed-78757", "permed-88472", "permed-79307", "permed-74636"]}
{"query_id": "topic_170_turn_2", "conversation_id": "topic_170", "turn_id": 2, "query": "Impact of compositional modification (e.g., doping, mixed oxides) on these metal oxide catalysts' efficiency and stability for formaldehyde and ozone abatement", "history": ["Metal oxide catalysts: principles and applications in formaldehyde oxidation and ozone decomposition"], "ground_truth": ["permed-73186", "permed-88471", "permed-78335", "permed-55248", "permed-79490", "permed-78757", "permed-55250", "permed-88470", "permed-88472", "permed-74578"]}
{"query_id": "topic_170_turn_3", "conversation_id": "topic_170", "turn_id": 3, "query": "FeO<sub>x</sub> modified Mn-Ce-Ni oxide catalysts: mechanistic insights into enhanced formaldehyde oxidation and ozone decomposition, focusing on electronic structure, redox properties, and hydrothermal stability", "history": ["Metal oxide catalysts: principles and applications in formaldehyde oxidation and ozone decomposition", "Impact of compositional modification (e.g., doping, mixed oxides) on these metal oxide catalysts' efficiency and stability for formaldehyde and ozone abatement"], "ground_truth": ["permed-73186", "permed-78335", "permed-88471", "permed-88470", "permed-55248", "permed-78340", "permed-74578", "permed-79777", "permed-87150", "permed-78766"]}
{"query_id": "topic_171_turn_1", "conversation_id": "topic_171", "turn_id": 1, "query": "Key determinants and current policies in deceased donor organ allocation for pediatric patients", "history": [], "ground_truth": ["permed-74646", "permed-52843", "permed-74645", "permed-74647", "permed-87344", "permed-74690", "permed-61456", "permed-74691", "permed-67226", "permed-72540"]}
{"query_id": "topic_171_turn_2", "conversation_id": "topic_171", "turn_id": 2, "query": "Ethical dilemmas arising from these pediatric organ allocation determinants and policies: balancing medical utility against principles of fairness and justice", "history": ["Key determinants and current policies in deceased donor organ allocation for pediatric patients"], "ground_truth": ["permed-52843", "permed-74646", "permed-74647", "permed-74645", "permed-67226", "permed-74711", "permed-87344", "permed-90537", "permed-55645", "permed-91926"]}
{"query_id": "topic_171_turn_3", "conversation_id": "topic_171", "turn_id": 3, "query": "Evaluation of specific pediatric priority organ allocation models (e.g., age-weighting, urgency criteria adjustments) in addressing the utility-justice tension, and their impact on international transplant guidelines", "history": ["Key determinants and current policies in deceased donor organ allocation for pediatric patients", "Ethical dilemmas arising from these pediatric organ allocation determinants and policies: balancing medical utility against principles of fairness and justice"], "ground_truth": ["permed-52843", "permed-74647", "permed-74646", "permed-74645", "permed-74650", "permed-72540", "permed-67226", "permed-82275", "permed-74649", "permed-87344"]}
{"query_id": "topic_172_turn_1", "conversation_id": "topic_172", "turn_id": 1, "query": "What role does endoscopic ultrasound play in diagnosing gastric subepithelial lesions?", "history": [], "ground_truth": ["permed-81436", "permed-0074", "permed-50706", "permed-56991", "permed-1258", "permed-1173", "permed-75548", "permed-50712", "permed-50704", "permed-50705"]}
{"query_id": "topic_172_turn_2", "conversation_id": "topic_172", "turn_id": 2, "query": "How effective is this technique in identifying potential malignancies in small lesions?", "history": ["What role does endoscopic ultrasound play in diagnosing gastric subepithelial lesions?"], "ground_truth": ["permed-82600", "permed-56433", "permed-85060", "permed-56435", "permed-29106", "permed-56461", "permed-56459", "permed-56436", "permed-77625", "permed-61512"]}
{"query_id": "topic_172_turn_3", "conversation_id": "topic_172", "turn_id": 3, "query": "Given what we know about EUS's diagnostic role and its effectiveness in identifying malignancies in small gastric SELs, how do specific imaging features seen on EUS correlate with long-term growth and malignant potential for lesions under 20 mm? And what would this mean for tailoring follow-up approaches in clinical practice?", "history": ["What role does endoscopic ultrasound play in diagnosing gastric subepithelial lesions?", "How effective is this technique in identifying potential malignancies in small lesions?"], "ground_truth": ["permed-50706", "permed-56337", "permed-50700", "permed-60541", "permed-1173", "permed-75548", "permed-35181", "permed-81436", "permed-0074", "permed-0266"]}
{"query_id": "topic_173_turn_1", "conversation_id": "topic_173", "turn_id": 1, "query": "Radiographic assessment of avian cardiac health and diagnosis of associated respiratory conditions", "history": [], "ground_truth": ["permed-76454", "permed-76456", "permed-66153", "permed-78024", "permed-60565", "permed-58626", "permed-72010", "permed-90909", "permed-64801", "permed-74630"]}
{"query_id": "topic_173_turn_2", "conversation_id": "topic_173", "turn_id": 2, "query": "Using this radiographic assessment technique, how are avian reference intervals established for cardiac and respiratory parameters to differentiate normal variations from disease?", "history": ["Radiographic assessment of avian cardiac health and diagnosis of associated respiratory conditions"], "ground_truth": ["permed-76454", "permed-76456", "permed-78024", "permed-60565", "permed-50841", "permed-57427", "permed-76457", "permed-90909", "permed-11535", "permed-61790"]}
{"query_id": "topic_173_turn_3", "conversation_id": "topic_173", "turn_id": 3, "query": "Interpreting these cardiac size radiographic reference intervals in Common Mynahs: distinguishing normal physiology from pathology when chronic respiratory disease impacts thoracic conformation and heart morphology", "history": ["Radiographic assessment of avian cardiac health and diagnosis of associated respiratory conditions", "Using this radiographic assessment technique, how are avian reference intervals established for cardiac and respiratory parameters to differentiate normal variations from disease?"], "ground_truth": ["permed-76454", "permed-64801", "permed-78024", "permed-89811", "permed-56269", "permed-60565", "permed-72010", "permed-58626", "permed-57343", "permed-74718"]}
{"query_id": "topic_174_turn_1", "conversation_id": "topic_174", "turn_id": 1, "query": "Mechanisms of action and applications for key radioactive isotopes (e.g., <sup>123</sup>I, <sup>131</sup>I, <sup>99m</sup>Tc) in thyroid imaging and therapy", "history": [], "ground_truth": ["permed-43349", "permed-29182", "permed-77212", "permed-43346", "permed-42037", "permed-17842", "permed-48520", "permed-5108", "permed-51700", "permed-29950"]}
{"query_id": "topic_174_turn_2", "conversation_id": "topic_174", "turn_id": 2, "query": "Impact of advancements in these thyroid diagnostic and therapeutic radiopharmaceutical techniques on patient dosimetry and clinical outcomes", "history": ["Mechanisms of action and applications for key radioactive isotopes (e.g., <sup>123</sup>I, <sup>131</sup>I, <sup>99m</sup>Tc) in thyroid imaging and therapy"], "ground_truth": ["permed-29182", "permed-43349", "permed-48520", "permed-51692", "permed-42456", "permed-5108", "permed-20559", "permed-43346", "permed-11024", "permed-56033"]}
{"query_id": "topic_174_turn_3", "conversation_id": "topic_174", "turn_id": 3, "query": "Role of medical physics and endocrinology collaboration in developing and implementing optimized <sup>131</sup>Iodine ablation protocols for differentiated thyroid cancer, focusing on recent EANM/SNMMI guideline updates", "history": ["Mechanisms of action and applications for key radioactive isotopes (e.g., <sup>123</sup>I, <sup>131</sup>I, <sup>99m</sup>Tc) in thyroid imaging and therapy", "Impact of advancements in these thyroid diagnostic and therapeutic radiopharmaceutical techniques on patient dosimetry and clinical outcomes"], "ground_truth": ["permed-43348", "permed-43349", "permed-43346", "permed-29182", "permed-29950", "permed-74029", "permed-11024", "permed-42038", "permed-3692"]}
{"query_id": "topic_175_turn_1", "conversation_id": "topic_175", "turn_id": 1, "query": "Role and benefits of patient-reported outcomes (PROs) in chronic disease management", "history": [], "ground_truth": ["permed-66153", "permed-13640", "permed-91926", "permed-38980", "permed-74570", "permed-44386", "permed-66148", "permed-49287", "permed-72540", "permed-91638"]}
{"query_id": "topic_175_turn_2", "conversation_id": "topic_175", "turn_id": 2, "query": "How can capturing detailed pain and discomfort within these PROs improve their utility in chronic disease care?", "history": ["Role and benefits of patient-reported outcomes (PROs) in chronic disease management"], "ground_truth": ["permed-73763", "permed-44386", "permed-60167", "permed-13684", "permed-74570", "permed-13640", "permed-68398", "permed-84645", "permed-44387", "permed-51870"]}
{"query_id": "topic_175_turn_3", "conversation_id": "topic_175", "turn_id": 3, "query": "Impact of incorporating temporal pain dynamics (variability, episodic intensity) into the EQ-5D-5L pain/discomfort dimension on its patient discrimination and clinical utility for chronic disease management", "history": ["Role and benefits of patient-reported outcomes (PROs) in chronic disease management", "How can capturing detailed pain and discomfort within these PROs improve their utility in chronic disease care?"], "ground_truth": ["permed-55903", "permed-78046", "permed-63560", "permed-84645", "permed-55548", "permed-84654", "permed-86480", "permed-78049", "permed-60167", "permed-58550"]}
{"query_id": "topic_176_turn_1", "conversation_id": "topic_176", "turn_id": 1, "query": "What is known about the relationship between inflammation and muscle function in older adults?", "history": [], "ground_truth": ["permed-81339", "permed-75624", "permed-60127", "permed-27278", "permed-23365", "permed-54252", "permed-91675", "permed-91438", "permed-91674", "permed-87232"]}
{"query_id": "topic_176_turn_2", "conversation_id": "topic_176", "turn_id": 2, "query": "Does this relationship involve specific biomarkers like C-reactive protein, and if so, how are they correlated with measures of physical capability?", "history": ["What is known about the relationship between inflammation and muscle function in older adults?"], "ground_truth": ["permed-84654", "permed-81339", "permed-91524", "permed-69402", "permed-54758", "permed-91311", "permed-32936", "permed-72010", "permed-72012", "permed-81705"]}
{"query_id": "topic_176_turn_3", "conversation_id": "topic_176", "turn_id": 3, "query": "Given these findings about hsCRP's association with poorer handgrip strength and gait speed in older adults, why might higher baseline levels not predict more rapid decline in these measures over time? What mechanisms could explain this pattern, and how might such insights guide interventions to maintain muscle function in elderly populations with chronic low-grade inflammation?", "history": ["What is known about the relationship between inflammation and muscle function in older adults?", "Does this relationship involve specific biomarkers like C-reactive protein, and if so, how are they correlated with measures of physical capability?"], "ground_truth": ["permed-81339", "permed-34846", "permed-52355", "permed-52361", "permed-52357", "permed-52356", "permed-54238", "permed-52362", "permed-91314", "permed-52359"]}
{"query_id": "topic_177_turn_1", "conversation_id": "topic_177", "turn_id": 1, "query": "Role of microbial community structure in Cr(VI) bioreduction from wastewater", "history": [], "ground_truth": ["permed-78326", "permed-78327", "permed-82010", "permed-76726", "permed-82396", "permed-76725", "permed-66640", "permed-76728", "permed-83483", "permed-78330"]}
{"query_id": "topic_177_turn_2", "conversation_id": "topic_177", "turn_id": 2, "query": "Impact of microbial community shifts on Cr(VI) bioreduction efficiency and long-term stability in such systems", "history": ["Role of microbial community structure in Cr(VI) bioreduction from wastewater"], "ground_truth": ["permed-78326", "permed-76725", "permed-78330", "permed-76728", "permed-76726", "permed-80532", "permed-51800", "permed-78327", "permed-53627", "permed-90392"]}
{"query_id": "topic_177_turn_3", "conversation_id": "topic_177", "turn_id": 3, "query": "Influence of evolving microbial consortia and EPS production on Cr(VI) removal stability and operational parameter optimization in propane-fed membrane biofilm reactors", "history": ["Role of microbial community structure in Cr(VI) bioreduction from wastewater", "Impact of microbial community shifts on Cr(VI) bioreduction efficiency and long-term stability in such systems"], "ground_truth": ["permed-78326", "permed-89590", "permed-81874", "permed-66770", "permed-76726", "permed-90410", "permed-66984", "permed-76728", "permed-78332", "permed-80075"]}
{"query_id": "topic_178_turn_1", "conversation_id": "topic_178", "turn_id": 1, "query": "What role does metabolomics play in understanding and predicting outcomes for ischemic stroke patients?", "history": [], "ground_truth": ["permed-65138", "permed-69048", "permed-78781", "permed-83776", "permed-83809", "permed-57206", "permed-70446", "permed-64873", "permed-61490", "permed-62660"]}
{"query_id": "topic_178_turn_2", "conversation_id": "topic_178", "turn_id": 2, "query": "Can this technique, specifically through nuclear magnetic resonance, offer insights into individualized risk stratification for stroke patients undergoing certain treatments?", "history": ["What role does metabolomics play in understanding and predicting outcomes for ischemic stroke patients?"], "ground_truth": ["permed-87558", "permed-63266", "permed-44021", "permed-77104", "permed-65138", "permed-54855", "permed-75947", "permed-63134", "permed-63141", "permed-63136"]}
{"query_id": "topic_178_turn_3", "conversation_id": "topic_178", "turn_id": 3, "query": "Given these NMR-based metabolomics insights, how could we use the dynamic changes in specific lipoprotein subfractions and inflammatory markers to build predictive models for individualized risk stratification—both for early and late adverse outcomes—in ischemic stroke patients receiving intravenous thrombolysis?", "history": ["What role does metabolomics play in understanding and predicting outcomes for ischemic stroke patients?", "Can this technique, specifically through nuclear magnetic resonance, offer insights into individualized risk stratification for stroke patients undergoing certain treatments?"], "ground_truth": ["permed-65138", "permed-78781", "permed-61325", "permed-62660", "permed-23882", "permed-57206", "permed-84569", "permed-73475", "permed-57152", "permed-90544"]}
{"query_id": "topic_179_turn_1", "conversation_id": "topic_179", "turn_id": 1, "query": "Comprehensive overview of chemokine involvement in peritoneal fibrosis pathogenesis", "history": [], "ground_truth": ["permed-76388", "permed-64092", "permed-72084", "permed-90381", "permed-69181", "permed-68328", "permed-89645", "permed-10592", "permed-72164", "permed-66783"]}
{"query_id": "topic_179_turn_2", "conversation_id": "topic_179", "turn_id": 2, "query": "Therapeutic strategies targeting these chemokine pathways for peritoneal fibrosis treatment", "history": ["Comprehensive overview of chemokine involvement in peritoneal fibrosis pathogenesis"], "ground_truth": ["permed-76388", "permed-72084", "permed-90381", "permed-64092", "permed-74831", "permed-89645", "permed-69181", "permed-74832", "permed-70707", "permed-68328"]}
{"query_id": "topic_179_turn_3", "conversation_id": "topic_179", "turn_id": 3, "query": "Targeting the CCL8/CCR8 axis in peritoneal fibrosis: implications for peritoneal dialysis outcomes (survival, QoL), considering TGF-β modulation, and potential adverse events", "history": ["Comprehensive overview of chemokine involvement in peritoneal fibrosis pathogenesis", "Therapeutic strategies targeting these chemokine pathways for peritoneal fibrosis treatment"], "ground_truth": ["permed-76388", "permed-72084", "permed-90381", "permed-52251", "permed-52252", "permed-64092", "permed-52253", "permed-52250", "permed-58385", "permed-92662"]}
{"query_id": "topic_180_turn_1", "conversation_id": "topic_180", "turn_id": 1, "query": "What is known about the impact of diet on sleep patterns across different age groups?", "history": [], "ground_truth": ["permed-62917", "permed-81076", "permed-64971", "permed-91759", "permed-34741", "permed-64881", "permed-65085", "permed-66430", "permed-50432", "permed-35786"]}
{"query_id": "topic_180_turn_2", "conversation_id": "topic_180", "turn_id": 2, "query": "Does research in this area suggest that specific types of food, like ultra-processed foods, have a notable effect on sleep quality?", "history": ["What is known about the impact of diet on sleep patterns across different age groups?"], "ground_truth": ["permed-64881", "permed-86540", "permed-78539", "permed-81067", "permed-62916", "permed-81025", "permed-81287", "permed-76910", "permed-78540", "permed-81280"]}
{"query_id": "topic_180_turn_3", "conversation_id": "topic_180", "turn_id": 3, "query": "Given these findings about ultra-processed foods and sleep quality, how do such dietary patterns affect sleep architecture and circadian rhythms at different developmental stages? And what biological mechanisms might explain these effects?", "history": ["What is known about the impact of diet on sleep patterns across different age groups?", "Does research in this area suggest that specific types of food, like ultra-processed foods, have a notable effect on sleep quality?"], "ground_truth": ["permed-64881", "permed-78539", "permed-86540", "permed-85236", "permed-78540", "permed-72142", "permed-52553", "permed-64880", "permed-34740", "permed-34741"]}
{"query_id": "topic_181_turn_1", "conversation_id": "topic_181", "turn_id": 1, "query": "What are the common pathogens responsible for leaf and stem spot diseases in Astragalus sinicus?", "history": [], "ground_truth": ["permed-80024", "permed-77774", "permed-82680", "permed-66826", "permed-89497", "permed-84997", "permed-85019", "permed-64029", "permed-64106", "permed-66223"]}
{"query_id": "topic_181_turn_2", "conversation_id": "topic_181", "turn_id": 2, "query": "How does understanding the genetic diversity of these pathogens impact the development of resistant varieties of A. sinicus?", "history": ["What are the common pathogens responsible for leaf and stem spot diseases in Astragalus sinicus?"], "ground_truth": ["permed-85023", "permed-88390", "permed-78965", "permed-86092", "permed-70022", "permed-64032", "permed-84400", "permed-80024", "permed-85046", "permed-66662"]}
{"query_id": "topic_181_turn_3", "conversation_id": "topic_181", "turn_id": 3, "query": "Now that we've identified *Stemphylium astragali* and the novel *St. henanense* as key pathogens in *A. sinicus*, how might their genetic diversity and evolutionary relationships within the *Stemphylium* genus inform the development of resistant varieties? What specific breeding strategies could leverage this understanding to enhance genetic resistance against these pathogens?", "history": ["What are the common pathogens responsible for leaf and stem spot diseases in Astragalus sinicus?", "How does understanding the genetic diversity of these pathogens impact the development of resistant varieties of A. sinicus?"], "ground_truth": ["permed-80024", "permed-85023", "permed-73508", "permed-84400", "permed-78965", "permed-70022", "permed-69982", "permed-86092", "permed-85046", "permed-84349"]}
{"query_id": "topic_182_turn_1", "conversation_id": "topic_182", "turn_id": 1, "query": "Role and indications of radiotherapy in atypical meningioma management", "history": [], "ground_truth": ["permed-77953", "permed-83997", "permed-77954", "permed-56734", "permed-52309", "permed-56525", "permed-77964", "permed-89594", "permed-51786", "permed-78169"]}
{"query_id": "topic_182_turn_2", "conversation_id": "topic_182", "turn_id": 2, "query": "Efficacy variations among different radiotherapy techniques for treating these atypical meningiomas and impact on patient outcomes", "history": ["Role and indications of radiotherapy in atypical meningioma management"], "ground_truth": ["permed-77953", "permed-77954", "permed-52309", "permed-83997", "permed-78169", "permed-56734", "permed-58784", "permed-56525", "permed-89594", "permed-51786"]}
{"query_id": "topic_182_turn_3", "conversation_id": "topic_182", "turn_id": 3, "query": "Influence of EQD2, fractionation schedules, Ki-67, and specific genetic alterations on local control, PFS, and OS after such adjuvant radiotherapy for atypical meningioma", "history": ["Role and indications of radiotherapy in atypical meningioma management", "Efficacy variations among different radiotherapy techniques for treating these atypical meningiomas and impact on patient outcomes"], "ground_truth": ["permed-77953", "permed-77954", "permed-78169", "permed-83997", "permed-36178", "permed-52309", "permed-52306", "permed-36513", "permed-20367", "permed-84455"]}
{"query_id": "topic_183_turn_1", "conversation_id": "topic_183", "turn_id": 1, "query": "Observed association between COVID-19 infection and development of new-onset irritable bowel syndrome (IBS)", "history": [], "ground_truth": ["permed-75536", "permed-68512", "permed-51261", "permed-71637", "permed-77184", "permed-68513", "permed-85373", "permed-71658", "permed-51262", "permed-85809"]}
{"query_id": "topic_183_turn_2", "conversation_id": "topic_183", "turn_id": 2, "query": "Patient characteristics (e.g., age, sex, comorbidities, COVID-19 severity) predisposing to irritable bowel syndrome (IBS) development following *such* COVID-19 infection", "history": ["Observed association between COVID-19 infection and development of new-onset irritable bowel syndrome (IBS)"], "ground_truth": ["permed-75536", "permed-51261", "permed-85373", "permed-71637", "permed-51262", "permed-71658", "permed-61228", "permed-71634", "permed-77184", "permed-33023"]}
{"query_id": "topic_183_turn_3", "conversation_id": "topic_183", "turn_id": 3, "query": "Biological mechanisms (e.g., gut dysbiosis, immune dysregulation, hormonal changes) explaining increased post-COVID IBS susceptibility in *these* patient cohorts (e.g., females, individuals with high baseline inflammation), and therapeutic implications.", "history": ["Observed association between COVID-19 infection and development of new-onset irritable bowel syndrome (IBS)", "Patient characteristics (e.g., age, sex, comorbidities, COVID-19 severity) predisposing to irritable bowel syndrome (IBS) development following *such* COVID-19 infection"], "ground_truth": ["permed-75536", "permed-51261", "permed-60108", "permed-71634", "permed-55928", "permed-84269", "permed-71637", "permed-85373", "permed-33023", "permed-51269"]}
{"query_id": "topic_184_turn_1", "conversation_id": "topic_184", "turn_id": 1, "query": "What role does Regnase-1 play in regulating inflammation within the skin?", "history": [], "ground_truth": ["permed-82313", "permed-11691", "permed-51003", "permed-53486", "permed-38651", "permed-67926", "permed-80514", "permed-82316", "permed-61110", "permed-34151"]}
{"query_id": "topic_184_turn_2", "conversation_id": "topic_184", "turn_id": 2, "query": "How might its interaction with other pathways in keratinocytes impact conditions like psoriasis or atopic dermatitis?", "history": ["What role does Regnase-1 play in regulating inflammation within the skin?"], "ground_truth": ["permed-77102", "permed-67893", "permed-68414", "permed-68251", "permed-68063", "permed-68252", "permed-82314", "permed-13238", "permed-68948", "permed-68178"]}
{"query_id": "topic_184_turn_3", "conversation_id": "topic_184", "turn_id": 3, "query": "Given that Regnase-1 in keratinocytes downregulates COX-2 and affects both inflammation and carcinogenesis, how might its interplay with other regulatory pathways in these cells shape the broader immune response and tumor microenvironment in chronic skin disorders like psoriasis or atopic dermatitis? Could targeting these interactions potentially offer a therapeutic approach to reduce skin cancer risk in such patients?", "history": ["What role does Regnase-1 play in regulating inflammation within the skin?", "How might its interaction with other pathways in keratinocytes impact conditions like psoriasis or atopic dermatitis?"], "ground_truth": ["permed-82313", "permed-11691", "permed-88116", "permed-67893", "permed-68251", "permed-53179", "permed-12523", "permed-67803", "permed-85294", "permed-68178"]}
{"query_id": "topic_185_turn_1", "conversation_id": "topic_185", "turn_id": 1, "query": "What role does land use play in affecting groundwater quality, especially in tropical regions?", "history": [], "ground_truth": ["permed-81857", "permed-81017", "permed-81861", "permed-81859", "permed-81858", "permed-72920", "permed-81012", "permed-67032", "permed-81014", "permed-67499"]}
{"query_id": "topic_185_turn_2", "conversation_id": "topic_185", "turn_id": 2, "query": "Can advanced technologies like geospatial mapping help us better understand this relationship and its implications for agriculture and public health?", "history": ["What role does land use play in affecting groundwater quality, especially in tropical regions?"], "ground_truth": ["permed-66158", "permed-73394", "permed-84094", "permed-80763", "permed-70250", "permed-66148", "permed-75652", "permed-90617", "permed-58483", "permed-66153"]}
{"query_id": "topic_185_turn_3", "conversation_id": "topic_185", "turn_id": 3, "query": "How can combining these advanced geospatial technologies with hydrological modeling improve our understanding of how land use changes dynamically affect groundwater quality in tropical regions, especially in terms of guiding sustainable agriculture and public health strategies?", "history": ["What role does land use play in affecting groundwater quality, especially in tropical regions?", "Can advanced technologies like geospatial mapping help us better understand this relationship and its implications for agriculture and public health?"], "ground_truth": ["permed-81857", "permed-81861", "permed-67499", "permed-81012", "permed-81017", "permed-72920", "permed-82008", "permed-90405", "permed-81859", "permed-81858"]}
{"query_id": "topic_186_turn_1", "conversation_id": "topic_186", "turn_id": 1, "query": "Brolucizumab comprehensive overview of known adverse events and safety risks", "history": [], "ground_truth": ["permed-78042", "permed-68894", "permed-62413", "permed-56265", "permed-17230", "permed-71994", "permed-15870", "permed-71333", "permed-62414", "permed-89594"]}
{"query_id": "topic_186_turn_2", "conversation_id": "topic_186", "turn_id": 2, "query": "Among these reported brolucizumab adverse events, which are identified as particularly severe or represent significant safety signals?", "history": ["Brolucizumab comprehensive overview of known adverse events and safety risks"], "ground_truth": ["permed-78042", "permed-69202", "permed-69203", "permed-55392", "permed-62413", "permed-71994", "permed-68894", "permed-29717", "permed-69197", "permed-36341"]}
{"query_id": "topic_186_turn_3", "conversation_id": "topic_186", "turn_id": 3, "query": "Brolucizumab retinal vasculitis & vascular occlusion: patient risk factors, predictive markers, and mitigation strategies through patient selection and monitoring", "history": ["Brolucizumab comprehensive overview of known adverse events and safety risks", "Among these reported brolucizumab adverse events, which are identified as particularly severe or represent significant safety signals?"], "ground_truth": ["permed-78042", "permed-62413", "permed-62414", "permed-15870", "permed-78043", "permed-84518", "permed-62415", "permed-87208", "permed-16460", "permed-62467"]}
{"query_id": "topic_187_turn_1", "conversation_id": "topic_187", "turn_id": 1, "query": "What is known about the relationship between foot function and Achilles tendinopathy?", "history": [], "ground_truth": ["permed-80967", "permed-57596", "permed-80970", "permed-80971", "permed-88747", "permed-75258", "permed-80969", "permed-71945", "permed-80377", "permed-77598"]}
{"query_id": "topic_187_turn_2", "conversation_id": "topic_187", "turn_id": 2, "query": "Does this area of research consider how variations in foot alignment might affect the development of Achilles tendinopathy?", "history": ["What is known about the relationship between foot function and Achilles tendinopathy?"], "ground_truth": ["permed-80967", "permed-57596", "permed-80970", "permed-80969", "permed-71945", "permed-80973", "permed-80974", "permed-75258", "permed-37130", "permed-64585"]}
{"query_id": "topic_187_turn_3", "conversation_id": "topic_187", "turn_id": 3, "query": "Given what we know about foot alignment's role in Achilles tendinopathy, how do dynamic factors like gait patterns and muscle activation during movement contribute to its development and progression across different alignment variations? Could these movement-related factors help explain the underlying mechanisms behind symptom severity?", "history": ["What is known about the relationship between foot function and Achilles tendinopathy?", "Does this area of research consider how variations in foot alignment might affect the development of Achilles tendinopathy?"], "ground_truth": ["permed-80967", "permed-57596", "permed-80970", "permed-80969", "permed-80973", "permed-71945", "permed-80971", "permed-64585", "permed-88747", "permed-80975"]}
{"query_id": "topic_188_turn_1", "conversation_id": "topic_188", "turn_id": 1, "query": "Efficacy of lactobacilli-based throat sprays for upper respiratory health and infection prevention", "history": [], "ground_truth": ["permed-66707", "permed-86998", "permed-92165", "permed-86997", "permed-66699", "permed-68512", "permed-68513", "permed-88345", "permed-65029", "permed-81832"]}
{"query_id": "topic_188_turn_2", "conversation_id": "topic_188", "turn_id": 2, "query": "Impact of repeated use of these lactobacilli throat sprays on upper respiratory tract microbiota composition and stability", "history": ["Efficacy of lactobacilli-based throat sprays for upper respiratory health and infection prevention"], "ground_truth": ["permed-66707", "permed-66699", "permed-65029", "permed-86998", "permed-66978", "permed-81832", "permed-66585", "permed-68512", "permed-49834", "permed-81196"]}
{"query_id": "topic_188_turn_3", "conversation_id": "topic_188", "turn_id": 3, "query": "Long-term ecological impact of lactobacilli throat spray-induced upper respiratory microbiota alterations: risk of dysbiosis and viral infection susceptibility", "history": ["Efficacy of lactobacilli-based throat sprays for upper respiratory health and infection prevention", "Impact of repeated use of these lactobacilli throat sprays on upper respiratory tract microbiota composition and stability"], "ground_truth": ["permed-66707", "permed-66699", "permed-68512", "permed-68513", "permed-86998", "permed-65029", "permed-57757", "permed-66704", "permed-66978", "permed-86999"]}
{"query_id": "topic_189_turn_1", "conversation_id": "topic_189", "turn_id": 1, "query": "What role do vinyl cyclopropanes play in the synthesis of nitrogen-containing heterocycles?", "history": [], "ground_truth": ["permed-76825", "permed-92598", "permed-57986", "permed-52672", "permed-64164", "permed-76672", "permed-76831", "permed-64159", "permed-76836", "permed-57985"]}
{"query_id": "topic_189_turn_2", "conversation_id": "topic_189", "turn_id": 2, "query": "How does the choice of catalytic system impact the reactivity of vinyl cyclopropanes in this process?", "history": ["What role do vinyl cyclopropanes play in the synthesis of nitrogen-containing heterocycles?"], "ground_truth": ["permed-52672", "permed-52677", "permed-57986", "permed-76835", "permed-76831", "permed-87239", "permed-85307", "permed-52675", "permed-51018", "permed-88231"]}
{"query_id": "topic_189_turn_3", "conversation_id": "topic_189", "turn_id": 3, "query": "Given these insights about catalytic systems and their impact on vinyl cyclopropane reactivity, how could we further explore their chemodivergent behavior to expand the synthetic toolbox for nitrogen heterocycles—specifically by examining how catalyst valency and ligand design influence product selectivity and diversity?", "history": ["What role do vinyl cyclopropanes play in the synthesis of nitrogen-containing heterocycles?", "How does the choice of catalytic system impact the reactivity of vinyl cyclopropanes in this process?"], "ground_truth": ["permed-52672", "permed-57986", "permed-76825", "permed-57985", "permed-52675", "permed-52682", "permed-73223", "permed-52677", "permed-52676", "permed-76672"]}
{"query_id": "topic_190_turn_1", "conversation_id": "topic_190", "turn_id": 1, "query": "What non-invasive methods are currently used to assess liver disease complexity?", "history": [], "ground_truth": ["permed-62718", "permed-52639", "permed-61496", "permed-62703", "permed-4826", "permed-4808", "permed-60528", "permed-60270", "permed-62696", "permed-9646"]}
{"query_id": "topic_190_turn_2", "conversation_id": "topic_190", "turn_id": 2, "query": "How effective is MRI, specifically, in evaluating liver conditions like steatosis and fibrosis, given its potential in this area?", "history": ["What non-invasive methods are currently used to assess liver disease complexity?"], "ground_truth": ["permed-9762", "permed-58781", "permed-10048", "permed-10003", "permed-52640", "permed-60528", "permed-28173", "permed-62703", "permed-28073", "permed-79139"]}
{"query_id": "topic_190_turn_3", "conversation_id": "topic_190", "turn_id": 3, "query": "Given that T2 relaxation time is known to correlate with liver iron content in cases of steatosis and fibrosis, how could combining it with other MRI techniques like DWI or MRE improve our ability to non-invasively assess liver disease complexity—especially for distinguishing early from advanced fibrosis in patients with iron overload?", "history": ["What non-invasive methods are currently used to assess liver disease complexity?", "How effective is MRI, specifically, in evaluating liver conditions like steatosis and fibrosis, given its potential in this area?"], "ground_truth": ["permed-79139", "permed-9762", "permed-28172", "permed-28073", "permed-60528", "permed-10003", "permed-48499", "permed-10046", "permed-28072", "permed-10115"]}
{"query_id": "topic_191_turn_1", "conversation_id": "topic_191", "turn_id": 1, "query": "What is known about the molecular pathways involved in cardiac fibrosis and their potential as therapeutic targets?", "history": [], "ground_truth": ["permed-72130", "permed-57167", "permed-53075", "permed-68932", "permed-57399", "permed-71693", "permed-80183", "permed-51209", "permed-72128", "permed-90395"]}
{"query_id": "topic_191_turn_2", "conversation_id": "topic_191", "turn_id": 2, "query": "How does the EZH2 pathway, in particular, contribute to this process, and are there any promising inhibitors or modulators of it being studied?", "history": ["What is known about the molecular pathways involved in cardiac fibrosis and their potential as therapeutic targets?"], "ground_truth": ["permed-53827", "permed-71693", "permed-6234", "permed-80184", "permed-56167", "permed-77022", "permed-77025", "permed-82374", "permed-24182", "permed-52950"]}
{"query_id": "topic_191_turn_3", "conversation_id": "topic_191", "turn_id": 3, "query": "Given that GSK126 affects the EZH2-PAX6-CXCL10 pathway in cardiac fibrosis, how might this pathway interact with other key signaling pathways like TGF-β or Wnt/β-catenin, which are also involved in myocardial fibrosis? Could these interactions create synergistic or antagonistic effects that influence GSK126's therapeutic potential for treating cardiac fibrosis and associated hypertrophy?", "history": ["What is known about the molecular pathways involved in cardiac fibrosis and their potential as therapeutic targets?", "How does the EZH2 pathway, in particular, contribute to this process, and are there any promising inhibitors or modulators of it being studied?"], "ground_truth": ["permed-71693", "permed-72128", "permed-51209", "permed-57167", "permed-72130", "permed-90395", "permed-72164", "permed-39573", "permed-70493", "permed-80183"]}
{"query_id": "topic_192_turn_1", "conversation_id": "topic_192", "turn_id": 1, "query": "Role of PET/CT imaging in rectal cancer treatment response assessment", "history": [], "ground_truth": ["permed-56100", "permed-56323", "permed-3633", "permed-51385", "permed-48431", "permed-56318", "permed-4209", "permed-85505", "permed-29620", "permed-51380"]}
{"query_id": "topic_192_turn_2", "conversation_id": "topic_192", "turn_id": 2, "query": "For this PET/CT assessment in rectal cancer, how can its SUV values predict disease-free survival in patients undergoing neoadjuvant therapy?", "history": ["Role of PET/CT imaging in rectal cancer treatment response assessment"], "ground_truth": ["permed-56100", "permed-48431", "permed-68208", "permed-56323", "permed-3633", "permed-51385", "permed-56318", "permed-56099", "permed-56336", "permed-68573"]}
{"query_id": "topic_192_turn_3", "conversation_id": "topic_192", "turn_id": 3, "query": "Advanced PET/CT metrics (MTV, lymph node SUV) combined with SUV for improving treatment response and DFS prediction in locally advanced rectal cancer alongside complementary biomarkers.", "history": ["Role of PET/CT imaging in rectal cancer treatment response assessment", "For this PET/CT assessment in rectal cancer, how can its SUV values predict disease-free survival in patients undergoing neoadjuvant therapy?"], "ground_truth": ["permed-56100", "permed-56318", "permed-48431", "permed-56105", "permed-68573", "permed-60573", "permed-91050", "permed-3633", "permed-56323", "permed-83862"]}
{"query_id": "topic_193_turn_1", "conversation_id": "topic_193", "turn_id": 1, "query": "What are the common pain management strategies used by professional athletes, particularly cyclists?", "history": [], "ground_truth": ["permed-81574", "permed-86925", "permed-81556", "permed-65396", "permed-81558", "permed-80135", "permed-81559", "permed-81557", "permed-63569", "permed-81555"]}
{"query_id": "topic_193_turn_2", "conversation_id": "topic_193", "turn_id": 2, "query": "Are opioids like tramadol frequently prescribed in this area, and what are the concerns surrounding their use?", "history": ["What are the common pain management strategies used by professional athletes, particularly cyclists?"], "ground_truth": ["permed-81574", "permed-69144", "permed-69154", "permed-55826", "permed-55828", "permed-69148", "permed-55823", "permed-69153", "permed-55824", "permed-80558"]}
{"query_id": "topic_193_turn_3", "conversation_id": "topic_193", "turn_id": 3, "query": "Given the concerns about tramadol use among cyclists, what are its potential long-term health effects on professional athletes, and how do these risks influence current usage trends despite regulations and ongoing debates about its performance-enhancing effects?", "history": ["What are the common pain management strategies used by professional athletes, particularly cyclists?", "Are opioids like tramadol frequently prescribed in this area, and what are the concerns surrounding their use?"], "ground_truth": ["permed-81574", "permed-69151", "permed-55674", "permed-81560", "permed-90477", "permed-55710", "permed-55713", "permed-68384", "permed-86925", "permed-72094"]}
{"query_id": "topic_194_turn_1", "conversation_id": "topic_194", "turn_id": 1, "query": "Evidence-based treatments for adult parasomnias and associated sleep disorders.", "history": [], "ground_truth": ["permed-71292", "permed-71439", "permed-71438", "permed-59823", "permed-86621", "permed-75907", "permed-60971", "permed-71437", "permed-81289", "permed-81284"]}
{"query_id": "topic_194_turn_2", "conversation_id": "topic_194", "turn_id": 2, "query": "Comparative effectiveness and mechanisms of Cognitive Behavioral Therapy for these adult parasomnias.", "history": ["Evidence-based treatments for adult parasomnias and associated sleep disorders."], "ground_truth": ["permed-71292", "permed-75905", "permed-71439", "permed-75160", "permed-71291", "permed-75907", "permed-75906", "permed-64786", "permed-81311", "permed-68381"]}
{"query_id": "topic_194_turn_3", "conversation_id": "topic_194", "turn_id": 3, "query": "Specific mechanisms of action in transdiagnostic CBT (CBTp) for reducing parasomnia symptoms in adults.", "history": ["Evidence-based treatments for adult parasomnias and associated sleep disorders.", "Comparative effectiveness and mechanisms of Cognitive Behavioral Therapy for these adult parasomnias."], "ground_truth": ["permed-71292", "permed-75906", "permed-75160", "permed-75905", "permed-71291", "permed-90646", "permed-64786", "permed-75907", "permed-83851", "permed-72475"]}
{"query_id": "topic_195_turn_1", "conversation_id": "topic_195", "turn_id": 1, "query": "What methods are being used to estimate the prevalence of opioid use disorder across different regions?", "history": [], "ground_truth": ["permed-80560", "permed-84200", "permed-79126", "permed-84201", "permed-55684", "permed-69149", "permed-80561", "permed-80137", "permed-74421", "permed-55828"]}
{"query_id": "topic_195_turn_2", "conversation_id": "topic_195", "turn_id": 2, "query": "How effective is the capture-recapture analysis technique in particular for estimating OUD prevalence, and can it be improved with additional data?", "history": ["What methods are being used to estimate the prevalence of opioid use disorder across different regions?"], "ground_truth": ["permed-80560", "permed-55684", "permed-55817", "permed-91684", "permed-89688", "permed-60478", "permed-55818", "permed-84200", "permed-80561", "permed-79126"]}
{"query_id": "topic_195_turn_3", "conversation_id": "topic_195", "turn_id": 3, "query": "Building on these findings from Kentucky's multi-sample capture-recapture analysis, how could incorporating additional data sources—like social media activity or community health outreach programs—help refine OUD prevalence estimates and better target interventions in high-risk areas? And what ethical considerations would arise when combining such diverse datasets to balance public health benefits with individual privacy protections?", "history": ["What methods are being used to estimate the prevalence of opioid use disorder across different regions?", "How effective is the capture-recapture analysis technique in particular for estimating OUD prevalence, and can it be improved with additional data?"], "ground_truth": ["permed-80560", "permed-80498", "permed-55817", "permed-55684", "permed-84200", "permed-66193", "permed-79471", "permed-80561", "permed-79126", "permed-80267"]}
{"query_id": "topic_196_turn_1", "conversation_id": "topic_196", "turn_id": 1, "query": "What factors influence HPV vaccine acceptance among young adults, particularly in China?", "history": [], "ground_truth": ["permed-65788", "permed-79406", "permed-79407", "permed-79408", "permed-79409", "permed-79696", "permed-83206", "permed-61182", "permed-52277", "permed-65781"]}
{"query_id": "topic_196_turn_2", "conversation_id": "topic_196", "turn_id": 2, "query": "Can educational interventions effectively address these factors and improve vaccination rates in this demographic?", "history": ["What factors influence HPV vaccine acceptance among young adults, particularly in China?"], "ground_truth": ["permed-82908", "permed-92263", "permed-74106", "permed-79701", "permed-79696", "permed-37387", "permed-79408", "permed-54553", "permed-52277", "permed-90576"]}
{"query_id": "topic_196_turn_3", "conversation_id": "topic_196", "turn_id": 3, "query": "Given these findings about educational interventions addressing HPV vaccine acceptance factors, how could we specifically tailor such programs to enhance motivational factors and behavioral skills for Chinese female college students? Furthermore, what might be the long-term effects of these optimized interventions on reducing cervical cancer rates in this population?", "history": ["What factors influence HPV vaccine acceptance among young adults, particularly in China?", "Can educational interventions effectively address these factors and improve vaccination rates in this demographic?"], "ground_truth": ["permed-79406", "permed-79407", "permed-79408", "permed-65788", "permed-83206", "permed-61182", "permed-79410", "permed-21935", "permed-78573", "permed-34388"]}
{"query_id": "topic_197_turn_1", "conversation_id": "topic_197", "turn_id": 1, "query": "What are the current advancements in treating moderate to severe chronic plaque psoriasis?", "history": [], "ground_truth": ["permed-67330", "permed-79192", "permed-67334", "permed-67328", "permed-67338", "permed-67333", "permed-88026", "permed-12539", "permed-68414", "permed-12490"]}
{"query_id": "topic_197_turn_2", "conversation_id": "topic_197", "turn_id": 2, "query": "How do newer therapies like deucravacitinib fit into this area of treatment, particularly in terms of their mechanism of action?", "history": ["What are the current advancements in treating moderate to severe chronic plaque psoriasis?"], "ground_truth": ["permed-67330", "permed-67333", "permed-53286", "permed-53191", "permed-67388", "permed-69184", "permed-53275", "permed-60152", "permed-53288", "permed-72519"]}
{"query_id": "topic_197_turn_3", "conversation_id": "topic_197", "turn_id": 3, "query": "Given its promising efficacy and safety profile, how might deucravacitinib's selective TYK2 inhibition influence long-term management of moderate to severe chronic plaque psoriasis, particularly regarding patient quality of life? Additionally, could this mechanism have broader implications for treating other inflammatory conditions involving similar cytokine pathways?", "history": ["What are the current advancements in treating moderate to severe chronic plaque psoriasis?", "How do newer therapies like deucravacitinib fit into this area of treatment, particularly in terms of their mechanism of action?"], "ground_truth": ["permed-67330", "permed-67333", "permed-88026", "permed-68776", "permed-89034", "permed-12812", "permed-53287", "permed-53275", "permed-23056", "permed-67335"]}
{"query_id": "topic_198_turn_1", "conversation_id": "topic_198", "turn_id": 1, "query": "What role does understanding facial anatomy play in the precision of soft tissue filler injections?", "history": [], "ground_truth": ["permed-76228", "permed-76229", "permed-45705", "permed-76225", "permed-76223", "permed-38672", "permed-45706", "permed-76222", "permed-45542", "permed-52849"]}
{"query_id": "topic_198_turn_2", "conversation_id": "topic_198", "turn_id": 2, "query": "Does this understanding of facial anatomy also impact the safety of these injections, particularly in relation to avoiding vascular complications?", "history": ["What role does understanding facial anatomy play in the precision of soft tissue filler injections?"], "ground_truth": ["permed-76228", "permed-76229", "permed-45705", "permed-45706", "permed-38672", "permed-45641", "permed-13801", "permed-45508", "permed-76223", "permed-12702"]}
{"query_id": "topic_198_turn_3", "conversation_id": "topic_198", "turn_id": 3, "query": "Given that understanding facial anatomy improves both precision and safety in filler injections, how could deeper knowledge of the facial arterial network—especially variations across ethnic groups—further enhance these outcomes? Additionally, what innovative imaging techniques might help visualize these vascular structures more clearly before procedures?", "history": ["What role does understanding facial anatomy play in the precision of soft tissue filler injections?", "Does this understanding of facial anatomy also impact the safety of these injections, particularly in relation to avoiding vascular complications?"], "ground_truth": ["permed-76229", "permed-76228", "permed-45705", "permed-79320", "permed-13801", "permed-41201", "permed-45508", "permed-38672", "permed-76225", "permed-76223"]}
{"query_id": "topic_199_turn_1", "conversation_id": "topic_199", "turn_id": 1, "query": "Electron cryo-tomography (cryo-ET): principles and applications for studying biological assemblies", "history": [], "ground_truth": ["permed-76075", "permed-76072", "permed-89299", "permed-76078", "permed-71699", "permed-76073", "permed-86233", "permed-91732", "permed-74888", "permed-76074"]}
{"query_id": "topic_199_turn_2", "conversation_id": "topic_199", "turn_id": 2, "query": "Advancements in Bayesian statistical methods: enhancing data processing and 3D reconstruction for *this cryo-ET technique*", "history": ["Electron cryo-tomography (cryo-ET): principles and applications for studying biological assemblies"], "ground_truth": ["permed-76072", "permed-76073", "permed-76078", "permed-76075", "permed-71699", "permed-91732", "permed-89299", "permed-53719", "permed-86233", "permed-53718"]}
{"query_id": "topic_199_turn_3", "conversation_id": "topic_199", "turn_id": 3, "query": "RELION-4.0 Bayesian approaches in cryo-ET workflows: achieving near-atomic resolution of dynamic conformational states in complex biological assemblies", "history": ["Electron cryo-tomography (cryo-ET): principles and applications for studying biological assemblies", "Advancements in Bayesian statistical methods: enhancing data processing and 3D reconstruction for *this cryo-ET technique*"], "ground_truth": ["permed-76072", "permed-76078", "permed-89299", "permed-71699", "permed-76073", "permed-76075", "permed-53719", "permed-53718", "permed-86233", "permed-75071"]}
{"query_id": "topic_200_turn_1", "conversation_id": "topic_200", "turn_id": 1, "query": "Healthcare access barriers for women who inject drugs in urban environments", "history": [], "ground_truth": ["permed-70149", "permed-70154", "permed-63473", "permed-83064", "permed-91926", "permed-71368", "permed-65938", "permed-68484", "permed-74470", "permed-65780"]}
{"query_id": "topic_200_turn_2", "conversation_id": "topic_200", "turn_id": 2, "query": "Effects of solitary drug use on their access to and engagement with healthcare, specifically harm reduction programs", "history": ["Healthcare access barriers for women who inject drugs in urban environments"], "ground_truth": ["permed-59903", "permed-83064", "permed-55714", "permed-55828", "permed-55825", "permed-80498", "permed-70148", "permed-91926", "permed-75287", "permed-84437"]}
{"query_id": "topic_200_turn_3", "conversation_id": "topic_200", "turn_id": 3, "query": "Community-based harm reduction strategies for urban women injecting drugs alone: addressing social-environmental drivers and overdose risk", "history": ["Healthcare access barriers for women who inject drugs in urban environments", "Effects of solitary drug use on their access to and engagement with healthcare, specifically harm reduction programs"], "ground_truth": ["permed-59903", "permed-55828", "permed-70149", "permed-70151", "permed-66193", "permed-74422", "permed-83064", "permed-63473", "permed-87234", "permed-70154"]}
{"query_id": "topic_201_turn_1", "conversation_id": "topic_201", "turn_id": 1, "query": "What innovations are being explored to improve the sustainability of water resource recovery facilities?", "history": [], "ground_truth": ["permed-85961", "permed-73277", "permed-78349", "permed-50971", "permed-80800", "permed-82651", "permed-79287", "permed-63998", "permed-75660", "permed-78350"]}
{"query_id": "topic_201_turn_2", "conversation_id": "topic_201", "turn_id": 2, "query": "How might integrating technologies like biochar production impact the environmental footprint and cost-effectiveness of these facilities compared to traditional methods?", "history": ["What innovations are being explored to improve the sustainability of water resource recovery facilities?"], "ground_truth": ["permed-78437", "permed-78436", "permed-82399", "permed-82411", "permed-82426", "permed-79363", "permed-80530", "permed-72992", "permed-72997", "permed-72995"]}
{"query_id": "topic_201_turn_3", "conversation_id": "topic_201", "turn_id": 3, "query": "Building on these discussions about biochar production and its potential benefits, how might integrating such advanced technologies specifically influence the long-term sustainability and operational efficiency of WRRFs—particularly in reducing their environmental footprint and improving economic viability compared to traditional sludge management like agricultural use or incineration? Additionally, what strategies could optimize pharmaceutical micropollutant removal using sludge-based activated carbon, and how would varying CO2 externality pricing affect the cost-effectiveness and environmental performance of these approaches?", "history": ["What innovations are being explored to improve the sustainability of water resource recovery facilities?", "How might integrating technologies like biochar production impact the environmental footprint and cost-effectiveness of these facilities compared to traditional methods?"], "ground_truth": ["permed-78436", "permed-81872", "permed-73002", "permed-66167", "permed-78437", "permed-66164", "permed-82401", "permed-78440", "permed-79498", "permed-73276"]}
{"query_id": "topic_201_turn_4", "conversation_id": "topic_201", "turn_id": 4, "query": "Given these proposed strategies for optimizing pharmaceutical micropollutant removal, what specific analytical methodologies would you recommend for validating the adsorption efficiency of sludge-based activated carbon? Particularly, how should experimental protocols be designed to simultaneously assess regeneration cycles of the carbon material while maintaining analytical sensitivity for trace contaminants? Additionally, what statistical approaches would best quantify the performance variability across different sludge feedstocks under varying CO2 pricing scenarios?", "history": ["What innovations are being explored to improve the sustainability of water resource recovery facilities?", "How might integrating technologies like biochar production impact the environmental footprint and cost-effectiveness of these facilities compared to traditional methods?", "Building on these discussions about biochar production and its potential benefits, how might integrating such advanced technologies specifically influence the long-term sustainability and operational efficiency of WRRFs—particularly in reducing their environmental footprint and improving economic viability compared to traditional sludge management like agricultural use or incineration? Additionally, what strategies could optimize pharmaceutical micropollutant removal using sludge-based activated carbon, and how would varying CO2 externality pricing affect the cost-effectiveness and environmental performance of these approaches?"], "ground_truth": ["permed-64917", "permed-73169", "permed-64911", "permed-73002", "permed-73001", "permed-64910", "permed-79499", "permed-88332", "permed-73180", "permed-64502"]}
{"query_id": "topic_202_turn_1", "conversation_id": "topic_202", "turn_id": 1, "query": "Is there a link between sexual orientation and mental health outcomes like self-harm and suicide?", "history": [], "ground_truth": ["permed-81393", "permed-69297", "permed-55634", "permed-77771", "permed-90012", "permed-69293", "permed-90351", "permed-65260", "permed-89976", "permed-52803"]}
{"query_id": "topic_202_turn_2", "conversation_id": "topic_202", "turn_id": 2, "query": "How does this relationship vary among different sexual minority groups, and what factors contribute to increased risk in this area?", "history": ["Is there a link between sexual orientation and mental health outcomes like self-harm and suicide?"], "ground_truth": ["permed-52803", "permed-81393", "permed-65609", "permed-69463", "permed-80249", "permed-70088", "permed-62284", "permed-65618", "permed-69292", "permed-69297"]}
{"query_id": "topic_202_turn_3", "conversation_id": "topic_202", "turn_id": 3, "query": "Given these patterns across different sexual minority groups, what psychological processes specifically connect sexual orientation to NSSI severity and suicide risk? And how could understanding these mechanisms help create more effective mental health interventions tailored to their needs?", "history": ["Is there a link between sexual orientation and mental health outcomes like self-harm and suicide?", "How does this relationship vary among different sexual minority groups, and what factors contribute to increased risk in this area?"], "ground_truth": ["permed-81393", "permed-81394", "permed-37245", "permed-69665", "permed-40806", "permed-40804", "permed-69630", "permed-69292", "permed-69662", "permed-40805"]}
{"query_id": "topic_202_turn_4", "conversation_id": "topic_202", "turn_id": 4, "query": "Given these psychological mechanisms, what specific methodological approaches are most effective for quantifying their impact on NSSI severity? I'm particularly interested in whether structural equation modeling or longitudinal mediation analysis provides better causal inference, and what validated instruments should be used to measure mechanisms like internalized stigma or emotion dysregulation. How should study designs control for confounding variables while maintaining ecological validity in this sensitive research area?", "history": ["Is there a link between sexual orientation and mental health outcomes like self-harm and suicide?", "How does this relationship vary among different sexual minority groups, and what factors contribute to increased risk in this area?", "Given these patterns across different sexual minority groups, what psychological processes specifically connect sexual orientation to NSSI severity and suicide risk? And how could understanding these mechanisms help create more effective mental health interventions tailored to their needs?"], "ground_truth": ["permed-40806", "permed-40804", "permed-40805", "permed-53938", "permed-81393", "permed-37245", "permed-69662", "permed-40948", "permed-37246", "permed-40943"]}
{"query_id": "topic_203_turn_1", "conversation_id": "topic_203", "turn_id": 1, "query": "Barriers and facilitators influencing healthcare system access for geriatric patients in Italy during the COVID-19 pandemic.", "history": [], "ground_truth": ["permed-91926", "permed-68512", "permed-81759", "permed-76526", "permed-88327", "permed-64816", "permed-61961", "permed-80267", "permed-54754", "permed-80079"]}
{"query_id": "topic_203_turn_2", "conversation_id": "topic_203", "turn_id": 2, "query": "Consequences of these healthcare access limitations on chronic disease management for Italy's geriatric patients during COVID-19.", "history": ["Barriers and facilitators influencing healthcare system access for geriatric patients in Italy during the COVID-19 pandemic."], "ground_truth": ["permed-68512", "permed-64816", "permed-76526", "permed-91926", "permed-78200", "permed-65901", "permed-81759", "permed-68513", "permed-85788", "permed-71233"]}
{"query_id": "topic_203_turn_3", "conversation_id": "topic_203", "turn_id": 3, "query": "Impact of altered medication access protocols on pharmaceutical adherence and clinical outcomes in Italian geriatric patients with chronic conditions during COVID-19, and efficacy of telehealth interventions for mitigating care gaps from delayed screenings.", "history": ["Barriers and facilitators influencing healthcare system access for geriatric patients in Italy during the COVID-19 pandemic.", "Consequences of these healthcare access limitations on chronic disease management for Italy's geriatric patients during COVID-19."], "ground_truth": ["permed-78200", "permed-61168", "permed-69086", "permed-68429", "permed-53990", "permed-57550", "permed-75381", "permed-78202", "permed-65902", "permed-78205"]}
{"query_id": "topic_203_turn_4", "conversation_id": "topic_203", "turn_id": 4, "query": "Regarding the altered medication access protocols and telehealth interventions you mentioned, what specific methodological approaches were used to quantify adherence changes - were digital pill monitoring systems, prescription refill data, or patient self-reporting scales utilized? Additionally, for evaluating telehealth efficacy in replacing delayed screenings, what statistical models controlled for confounding variables like baseline health status or digital literacy, and how was outcome validation performed against standard in-person assessments?", "history": ["Barriers and facilitators influencing healthcare system access for geriatric patients in Italy during the COVID-19 pandemic.", "Consequences of these healthcare access limitations on chronic disease management for Italy's geriatric patients during COVID-19.", "Impact of altered medication access protocols on pharmaceutical adherence and clinical outcomes in Italian geriatric patients with chronic conditions during COVID-19, and efficacy of telehealth interventions for mitigating care gaps from delayed screenings."], "ground_truth": ["permed-61168", "permed-82103", "permed-52112", "permed-85590", "permed-77305", "permed-59686", "permed-80191", "permed-61891", "permed-61613", "permed-85586"]}
{"query_id": "topic_204_turn_1", "conversation_id": "topic_204", "turn_id": 1, "query": "What are effective strategies for preventing diabetes, especially in populations with sedentary lifestyles?", "history": [], "ground_truth": ["permed-55114", "permed-30188", "permed-23282", "permed-58826", "permed-78587", "permed-6496", "permed-54670", "permed-66316", "permed-23144", "permed-23910"]}
{"query_id": "topic_204_turn_2", "conversation_id": "topic_204", "turn_id": 2, "query": "Can digital health technologies enhance the impact of these strategies, particularly when combined with behavioral economic principles?", "history": ["What are effective strategies for preventing diabetes, especially in populations with sedentary lifestyles?"], "ground_truth": ["permed-61165", "permed-61613", "permed-52220", "permed-61880", "permed-55101", "permed-61614", "permed-59469", "permed-65661", "permed-55560", "permed-74380"]}
{"query_id": "topic_204_turn_3", "conversation_id": "topic_204", "turn_id": 3, "query": "How can we design a scalable, person-centered diabetes prevention program that builds on these digital health technologies and behavioral economic principles to boost engagement and long-term adherence, especially for populations disproportionately impacted by sedentary lifestyles during the pandemic?", "history": ["What are effective strategies for preventing diabetes, especially in populations with sedentary lifestyles?", "Can digital health technologies enhance the impact of these strategies, particularly when combined with behavioral economic principles?"], "ground_truth": ["permed-55114", "permed-78587", "permed-66316", "permed-61168", "permed-71065", "permed-78730", "permed-78588", "permed-84001", "permed-78402", "permed-84285"]}
{"query_id": "topic_204_turn_4", "conversation_id": "topic_204", "turn_id": 4, "query": "To implement this person-centered design, what specific methodological framework would you recommend for developing the adaptive intervention components? I'm particularly interested in how we might employ a sequential multiple assignment randomized trial (SMART) design to dynamically tailor digital health features based on individual engagement patterns. Should we also incorporate mixed-methods approaches to capture both quantitative adherence metrics and qualitative user experience data during the iterative refinement process?", "history": ["What are effective strategies for preventing diabetes, especially in populations with sedentary lifestyles?", "Can digital health technologies enhance the impact of these strategies, particularly when combined with behavioral economic principles?", "How can we design a scalable, person-centered diabetes prevention program that builds on these digital health technologies and behavioral economic principles to boost engagement and long-term adherence, especially for populations disproportionately impacted by sedentary lifestyles during the pandemic?"], "ground_truth": ["permed-58499", "permed-74318", "permed-62578", "permed-61880", "permed-61614", "permed-74902", "permed-54911", "permed-61165", "permed-61613", "permed-65624"]}
{"query_id": "topic_205_turn_1", "conversation_id": "topic_205", "turn_id": 1, "query": "What role do endophytic fungi play in producing compounds with antibacterial properties?", "history": [], "ground_truth": ["permed-52203", "permed-66923", "permed-63978", "permed-77678", "permed-86080", "permed-89492", "permed-89491", "permed-78971", "permed-79586", "permed-79584"]}
{"query_id": "topic_205_turn_2", "conversation_id": "topic_205", "turn_id": 2, "query": "How might variations in the structures of these compounds, such as those found in newly discovered fungi, impact their efficacy against bacteria?", "history": ["What role do endophytic fungi play in producing compounds with antibacterial properties?"], "ground_truth": ["permed-55445", "permed-89492", "permed-89489", "permed-78968", "permed-89491", "permed-66644", "permed-91775", "permed-67452", "permed-79584", "permed-71555"]}
{"query_id": "topic_205_turn_3", "conversation_id": "topic_205", "turn_id": 3, "query": "Given these findings about structural variations in antibacterial compounds from endophytic fungi, how might the differences between newly discovered xylarchalasins and their known analogues affect their biological activity—especially their antibacterial properties—and what could this mean for developing new antibiotics from such fungi associated with medicinal plants?", "history": ["What role do endophytic fungi play in producing compounds with antibacterial properties?", "How might variations in the structures of these compounds, such as those found in newly discovered fungi, impact their efficacy against bacteria?"], "ground_truth": ["permed-79584", "permed-89492", "permed-89491", "permed-78974", "permed-79586", "permed-63978", "permed-66644", "permed-78968", "permed-67450", "permed-79588"]}
{"query_id": "topic_205_turn_4", "conversation_id": "topic_205", "turn_id": 4, "query": "When characterizing these xylarchalasins' antibacterial mechanisms, what specific experimental approaches would you recommend for determining whether their enhanced activity stems from improved membrane penetration versus targeted protein inhibition? Would surface plasmon resonance or microscale thermophoresis be more appropriate for quantifying binding affinities to bacterial enzymes, and what validation controls would ensure these assays distinguish between specific and non-specific interactions?", "history": ["What role do endophytic fungi play in producing compounds with antibacterial properties?", "How might variations in the structures of these compounds, such as those found in newly discovered fungi, impact their efficacy against bacteria?", "Given these findings about structural variations in antibacterial compounds from endophytic fungi, how might the differences between newly discovered xylarchalasins and their known analogues affect their biological activity—especially their antibacterial properties—and what could this mean for developing new antibiotics from such fungi associated with medicinal plants?"], "ground_truth": ["permed-79584", "permed-67451", "permed-91775", "permed-57505", "permed-78974", "permed-67458", "permed-60688", "permed-67462", "permed-92367", "permed-92517"]}
{"query_id": "topic_206_turn_1", "conversation_id": "topic_206", "turn_id": 1, "query": "What role does CCN2/CTGF play in liver fibrosis?", "history": [], "ground_truth": ["permed-50796", "permed-68929", "permed-53826", "permed-68930", "permed-78787", "permed-68927", "permed-86129", "permed-86122", "permed-24648", "permed-50802"]}
{"query_id": "topic_206_turn_2", "conversation_id": "topic_206", "turn_id": 2, "query": "How does its interaction with other signaling pathways, like Slit2/Robo, impact this process?", "history": ["What role does CCN2/CTGF play in liver fibrosis?"], "ground_truth": ["permed-71707", "permed-64170", "permed-76613", "permed-64165", "permed-63024", "permed-82211", "permed-66780", "permed-82373", "permed-64421", "permed-76558"]}
{"query_id": "topic_206_turn_3", "conversation_id": "topic_206", "turn_id": 3, "query": "Given this interaction between CCN2/CTGF and the Slit2/Robo pathway in liver fibrosis, what are the specific molecular mechanisms through which they synergistically enhance PI3K and AKT activation in hepatic stellate cells? And how could targeting these mechanisms offer new therapeutic approaches to prevent or reverse fibrosis in chronic liver disease?", "history": ["What role does CCN2/CTGF play in liver fibrosis?", "How does its interaction with other signaling pathways, like Slit2/Robo, impact this process?"], "ground_truth": ["permed-50796", "permed-68930", "permed-53826", "permed-68299", "permed-78787", "permed-57754", "permed-86129", "permed-68927", "permed-53253", "permed-53853"]}
{"query_id": "topic_206_turn_4", "conversation_id": "topic_206", "turn_id": 4, "query": "When investigating these synergistic activation mechanisms in hepatic stellate cells, what specific experimental approaches would best quantify the temporal dynamics of PI3K/AKT pathway activation? I'm particularly interested in methodological considerations for co-stimulation experiments - should we use sequential versus simultaneous CCN2/CTGF and Slit2 treatments, and what statistical models would appropriately capture potential synergistic effects versus merely additive interactions in the resulting phosphorylation data?", "history": ["What role does CCN2/CTGF play in liver fibrosis?", "How does its interaction with other signaling pathways, like Slit2/Robo, impact this process?", "Given this interaction between CCN2/CTGF and the Slit2/Robo pathway in liver fibrosis, what are the specific molecular mechanisms through which they synergistically enhance PI3K and AKT activation in hepatic stellate cells? And how could targeting these mechanisms offer new therapeutic approaches to prevent or reverse fibrosis in chronic liver disease?"], "ground_truth": ["permed-50796", "permed-10328", "permed-82124", "permed-68930", "permed-11732", "permed-77883", "permed-76374", "permed-86129", "permed-86209", "permed-63278"]}
{"query_id": "topic_207_turn_1", "conversation_id": "topic_207", "turn_id": 1, "query": "What is the role of hydrogen peroxide in pancreatic β-cell dysfunction?", "history": [], "ground_truth": ["permed-59040", "permed-59035", "permed-59034", "permed-59038", "permed-76600", "permed-59041", "permed-53567", "permed-53811", "permed-59036", "permed-84341"]}
{"query_id": "topic_207_turn_2", "conversation_id": "topic_207", "turn_id": 2, "query": "Given its role in dysfunction, how does modulating hydrogen peroxide levels within the β-cell endoplasmic reticulum specifically affect their insulin secretion and overall cellular health?", "history": ["What is the role of hydrogen peroxide in pancreatic β-cell dysfunction?"], "ground_truth": ["permed-76600", "permed-59036", "permed-59040", "permed-53811", "permed-59035", "permed-53567", "permed-59034", "permed-81066", "permed-59041", "permed-21071"]}
{"query_id": "topic_207_turn_3", "conversation_id": "topic_207", "turn_id": 3, "query": "For β-cells exposed to chronic palmitate, what targeted strategies (e.g., upregulating ER GPx8) can modulate luminal H₂O₂ to mitigate associated ER calcium dysregulation and mitochondrial dysfunction, thereby restoring insulin secretion and cellular bioenergetics?", "history": ["What is the role of hydrogen peroxide in pancreatic β-cell dysfunction?", "Given its role in dysfunction, how does modulating hydrogen peroxide levels within the β-cell endoplasmic reticulum specifically affect their insulin secretion and overall cellular health?"], "ground_truth": ["permed-76600", "permed-59036", "permed-53811", "permed-59040", "permed-59035", "permed-59034", "permed-81066", "permed-29824", "permed-53513", "permed-59038"]}
{"query_id": "topic_207_turn_4", "conversation_id": "topic_207", "turn_id": 4, "query": "When implementing these GPx8-upregulation strategies in palmitate-treated β-cells, what specific experimental protocols would you recommend for quantifying luminal H₂O₂ fluctuations in real-time? I'm particularly interested in the technical considerations for ER-targeted fluorescent probes like HyPer-ER—including calibration methods, normalization approaches, and how you'd simultaneously monitor ER calcium dynamics to establish temporal relationships between redox and calcium signaling during the rescue of insulin secretion.", "history": ["What is the role of hydrogen peroxide in pancreatic β-cell dysfunction?", "Given its role in dysfunction, how does modulating hydrogen peroxide levels within the β-cell endoplasmic reticulum specifically affect their insulin secretion and overall cellular health?", "For β-cells exposed to chronic palmitate, what targeted strategies (e.g., upregulating ER GPx8) can modulate luminal H₂O₂ to mitigate associated ER calcium dysregulation and mitochondrial dysfunction, thereby restoring insulin secretion and cellular bioenergetics?"], "ground_truth": ["permed-76600", "permed-59040", "permed-59036", "permed-92561", "permed-59038", "permed-22385", "permed-11503", "permed-53513", "permed-50010", "permed-13110"]}
{"query_id": "topic_208_turn_1", "conversation_id": "topic_208", "turn_id": 1, "query": "What are the current challenges in managing haemothorax in pediatric polytrauma patients?", "history": [], "ground_truth": ["permed-81674", "permed-59784", "permed-62340", "permed-54457", "permed-81423", "permed-78898", "permed-90009", "permed-55160", "permed-83143", "permed-91901"]}
{"query_id": "topic_208_turn_2", "conversation_id": "topic_208", "turn_id": 2, "query": "How can interdisciplinary guidelines be applied to address some of these challenges, particularly in reducing long-term complications?", "history": ["What are the current challenges in managing haemothorax in pediatric polytrauma patients?"], "ground_truth": ["permed-80879", "permed-52111", "permed-71289", "permed-52567", "permed-83267", "permed-66109", "permed-51084", "permed-55182", "permed-51542", "permed-61615"]}
{"query_id": "topic_208_turn_3", "conversation_id": "topic_208", "turn_id": 3, "query": "Given these interdisciplinary approaches from the DGT and DGU, how could they be specifically adapted to manage occult and retained haemothorax in pediatric polytrauma cases, with a focus on reducing long-term respiratory complications and promoting optimal lung recovery?", "history": ["What are the current challenges in managing haemothorax in pediatric polytrauma patients?", "How can interdisciplinary guidelines be applied to address some of these challenges, particularly in reducing long-term complications?"], "ground_truth": ["permed-81674", "permed-59784", "permed-11559", "permed-57111", "permed-62340", "permed-51943", "permed-12205", "permed-90536", "permed-17875", "permed-55160"]}
{"query_id": "topic_208_turn_4", "conversation_id": "topic_208", "turn_id": 4, "query": "When adapting these interdisciplinary guidelines for occult and retained haemothorax, what specific diagnostic protocols and imaging modalities should be prioritized in pediatric patients? I'm particularly interested in how to optimize the timing and sequencing between ultrasound, CT angiography, and potential MRI assessments while minimizing radiation exposure. Additionally, what validated criteria should guide the transition between conservative management and interventional procedures like thoracoscopy in this population, considering both clinical stability metrics and quantitative imaging findings?", "history": ["What are the current challenges in managing haemothorax in pediatric polytrauma patients?", "How can interdisciplinary guidelines be applied to address some of these challenges, particularly in reducing long-term complications?", "Given these interdisciplinary approaches from the DGT and DGU, how could they be specifically adapted to manage occult and retained haemothorax in pediatric polytrauma cases, with a focus on reducing long-term respiratory complications and promoting optimal lung recovery?"], "ground_truth": ["permed-81674", "permed-57111", "permed-19376", "permed-77784", "permed-59784", "permed-83143", "permed-51786", "permed-61790", "permed-59782", "permed-17879"]}
{"query_id": "topic_209_turn_1", "conversation_id": "topic_209", "turn_id": 1, "query": "Role of force fields in solvation free energy calculations for biological systems", "history": [], "ground_truth": ["permed-78128", "permed-75069", "permed-53327", "permed-80444", "permed-53602", "permed-53319", "permed-79259", "permed-74948", "permed-80441", "permed-53316"]}
{"query_id": "topic_209_turn_2", "conversation_id": "topic_209", "turn_id": 2, "query": "Effectiveness of ARROW force field for modeling charged species in these biological systems", "history": ["Role of force fields in solvation free energy calculations for biological systems"], "ground_truth": ["permed-75069", "permed-86233", "permed-82651", "permed-53718", "permed-75160", "permed-71707", "permed-60645", "permed-53717", "permed-56264", "permed-72010"]}
{"query_id": "topic_209_turn_3", "conversation_id": "topic_209", "turn_id": 3, "query": "Adapting ARROW force field principles and methodologies for improved solvation free energy calculations in biological systems and associated challenges", "history": ["Role of force fields in solvation free energy calculations for biological systems", "Effectiveness of ARROW force field for modeling charged species in these biological systems"], "ground_truth": ["permed-75069", "permed-78128", "permed-53327", "permed-53319", "permed-75160", "permed-60645", "permed-53325", "permed-82651", "permed-86233", "permed-79259"]}
{"query_id": "topic_209_turn_4", "conversation_id": "topic_209", "turn_id": 4, "query": "When implementing these adapted ARROW methodologies for solvation free energy calculations, what specific statistical validation protocols do you employ to assess force field accuracy across diverse biological molecules? Given the challenges mentioned, how do you technically implement quality control for partial charge assignments and handle conformational sampling biases when calculating free energy differences between solution states?", "history": ["Role of force fields in solvation free energy calculations for biological systems", "Effectiveness of ARROW force field for modeling charged species in these biological systems", "Adapting ARROW force field principles and methodologies for improved solvation free energy calculations in biological systems and associated challenges"], "ground_truth": ["permed-75069", "permed-53319", "permed-53327", "permed-80444", "permed-78128", "permed-75071", "permed-71540", "permed-80445", "permed-53325", "permed-79259"]}
{"query_id": "topic_210_turn_1", "conversation_id": "topic_210", "turn_id": 1, "query": "What role do P2X receptors play in human physiology and disease?", "history": [], "ground_truth": ["permed-69132", "permed-69131", "permed-12186", "permed-11607", "permed-69231", "permed-72010", "permed-53592", "permed-79026", "permed-71677", "permed-81500"]}
{"query_id": "topic_210_turn_2", "conversation_id": "topic_210", "turn_id": 2, "query": "Are there any species where the function of these receptors has been particularly well-studied, which could provide insights into their potential as therapeutic targets?", "history": ["What role do P2X receptors play in human physiology and disease?"], "ground_truth": ["permed-69132", "permed-59005", "permed-84366", "permed-50678", "permed-33677", "permed-82207", "permed-59003", "permed-59002", "permed-66389", "permed-79929"]}
{"query_id": "topic_210_turn_3", "conversation_id": "topic_210", "turn_id": 3, "query": "Given what we know about P2X receptors' roles and the insights from studying them in species like dogs, how might comparing the evolutionary conservation or divergence of P2X3 and P2X7 functions between canines and humans help us understand their involvement in inflammatory diseases like asthma? And what would this mean for developing species-specific therapies targeting these receptors?", "history": ["What role do P2X receptors play in human physiology and disease?", "Are there any species where the function of these receptors has been particularly well-studied, which could provide insights into their potential as therapeutic targets?"], "ground_truth": ["permed-69132", "permed-12186", "permed-69131", "permed-53592", "permed-78198", "permed-79026", "permed-11607", "permed-81500", "permed-69139", "permed-66288"]}
{"query_id": "topic_210_turn_4", "conversation_id": "topic_210", "turn_id": 4, "query": "When implementing this comparative evolutionary analysis between canine and human P2X3/P2X7 receptors, what specific methodology would you recommend for quantifying functional divergence? Would you prioritize in vitro characterization using heterologous expression systems with standardized ATP dose-response curves, or employ proteomic approaches to map differential post-translational modifications? How should we statistically validate conserved functional domains versus species-specific epitopes, particularly regarding their inflammatory signaling pathways? Also, what controls would ensure that observed differences reflect genuine evolutionary divergence rather than experimental artifacts?", "history": ["What role do P2X receptors play in human physiology and disease?", "Are there any species where the function of these receptors has been particularly well-studied, which could provide insights into their potential as therapeutic targets?", "Given what we know about P2X receptors' roles and the insights from studying them in species like dogs, how might comparing the evolutionary conservation or divergence of P2X3 and P2X7 functions between canines and humans help us understand their involvement in inflammatory diseases like asthma? And what would this mean for developing species-specific therapies targeting these receptors?"], "ground_truth": ["permed-69132", "permed-69131", "permed-12186", "permed-79026", "permed-11607", "permed-71591", "permed-81500", "permed-78198", "permed-67740", "permed-53592"]}
{"query_id": "topic_211_turn_1", "conversation_id": "topic_211", "turn_id": 1, "query": "Role of magnetoelastic materials in enhancing neuronal induction and maturation", "history": [], "ground_truth": ["permed-61682", "permed-66780", "permed-75736", "permed-66783", "permed-67923", "permed-77406", "permed-67657", "permed-72977", "permed-63384", "permed-61681"]}
{"query_id": "topic_211_turn_2", "conversation_id": "topic_211", "turn_id": 2, "query": "Scalability of these magnetoelastic materials for promoting neuronal induction and maturation in 3D brain organoid models", "history": ["Role of magnetoelastic materials in enhancing neuronal induction and maturation"], "ground_truth": ["permed-75736", "permed-64505", "permed-63384", "permed-66780", "permed-61682", "permed-75367", "permed-67923", "permed-77302", "permed-61681", "permed-72977"]}
{"query_id": "topic_211_turn_3", "conversation_id": "topic_211", "turn_id": 3, "query": "Optimizing magnetoelastic stimulation parameters and biomaterial design for long-term neuronal viability and functional integration within brain organoid models", "history": ["Role of magnetoelastic materials in enhancing neuronal induction and maturation", "Scalability of these magnetoelastic materials for promoting neuronal induction and maturation in 3D brain organoid models"], "ground_truth": ["permed-75736", "permed-64505", "permed-82298", "permed-63384", "permed-66780", "permed-61682", "permed-60791", "permed-67923", "permed-77302", "permed-63248"]}
{"query_id": "topic_211_turn_4", "conversation_id": "topic_211", "turn_id": 4, "query": "Given these optimization strategies for magnetoelastic stimulation, what specific statistical designs and validation metrics are being implemented to quantitatively assess the functional integration of induced neurons within organoid networks? I'm particularly interested in how researchers are establishing reproducibility across different organoid batches while controlling for variability in stimulation parameters and biomaterial properties during long-term culture. What quality control protocols are being standardized for these multi-parametric analyses?", "history": ["Role of magnetoelastic materials in enhancing neuronal induction and maturation", "Scalability of these magnetoelastic materials for promoting neuronal induction and maturation in 3D brain organoid models", "Optimizing magnetoelastic stimulation parameters and biomaterial design for long-term neuronal viability and functional integration within brain organoid models"], "ground_truth": ["permed-64505", "permed-63248", "permed-75736", "permed-75368", "permed-59113", "permed-75367", "permed-64503", "permed-77303", "permed-63205", "permed-91223"]}
{"query_id": "topic_212_turn_1", "conversation_id": "topic_212", "turn_id": 1, "query": "What factors contribute to exhaustion and recovery in daily activities, and how do they impact well-being?", "history": [], "ground_truth": ["permed-80149", "permed-69908", "permed-78794", "permed-77997", "permed-86542", "permed-65029", "permed-77990", "permed-77994", "permed-17748", "permed-33536"]}
{"query_id": "topic_212_turn_2", "conversation_id": "topic_212", "turn_id": 2, "query": "How does the balance between expectations and actual experiences influence it, particularly in terms of work and leisure time?", "history": ["What factors contribute to exhaustion and recovery in daily activities, and how do they impact well-being?"], "ground_truth": ["permed-80149", "permed-69908", "permed-61004", "permed-69785", "permed-78794", "permed-65740", "permed-69761", "permed-78387", "permed-92514", "permed-57479"]}
{"query_id": "topic_212_turn_3", "conversation_id": "topic_212", "turn_id": 3, "query": "Given these factors and their interplay between expectations and experiences, how could we use this understanding of subjective exhaustion and recovery patterns during work and leisure to develop personalized interventions that boost well-being and productivity? Specifically, how do cognitive biases influence these expectations, and what psychological approaches might effectively modify them to improve outcomes in both professional and personal life?", "history": ["What factors contribute to exhaustion and recovery in daily activities, and how do they impact well-being?", "How does the balance between expectations and actual experiences influence it, particularly in terms of work and leisure time?"], "ground_truth": ["permed-80149", "permed-55784", "permed-59082", "permed-86542", "permed-69785", "permed-63321", "permed-78794", "permed-55689", "permed-69687", "permed-79480"]}
{"query_id": "topic_212_turn_4", "conversation_id": "topic_212", "turn_id": 4, "query": "Building on this intervention framework, what specific methodological approaches would be most effective for implementing and testing these psychological modifications? I'm particularly interested in how we might design a controlled trial to measure the efficacy of cognitive bias modification techniques - should we use ecological momentary assessment for real-time data collection, and what statistical models (like multilevel modeling) would best capture the dynamic interactions between modified expectations, daily exhaustion patterns, and long-term well-being outcomes across work and leisure contexts?", "history": ["What factors contribute to exhaustion and recovery in daily activities, and how do they impact well-being?", "How does the balance between expectations and actual experiences influence it, particularly in terms of work and leisure time?", "Given these factors and their interplay between expectations and experiences, how could we use this understanding of subjective exhaustion and recovery patterns during work and leisure to develop personalized interventions that boost well-being and productivity? Specifically, how do cognitive biases influence these expectations, and what psychological approaches might effectively modify them to improve outcomes in both professional and personal life?"], "ground_truth": ["permed-82430", "permed-73911", "permed-69900", "permed-74900", "permed-64779", "permed-74902", "permed-71425", "permed-72757", "permed-55812", "permed-60044"]}
{"query_id": "topic_213_turn_1", "conversation_id": "topic_213", "turn_id": 1, "query": "Pathogenic role and mechanisms of autoantibodies in lupus nephritis", "history": [], "ground_truth": ["permed-58364", "permed-58363", "permed-53257", "permed-92133", "permed-89486", "permed-61519", "permed-27667", "permed-78022", "permed-61153", "permed-53199"]}
{"query_id": "topic_213_turn_2", "conversation_id": "topic_213", "turn_id": 2, "query": "Longitudinal changes in these lupus nephritis-associated autoantibody profiles and their correlation with specific histological classes (e.g., proliferative vs. membranous)", "history": ["Pathogenic role and mechanisms of autoantibodies in lupus nephritis"], "ground_truth": ["permed-58364", "permed-92133", "permed-89486", "permed-58363", "permed-53200", "permed-53199", "permed-61153", "permed-71104", "permed-61519", "permed-53257"]}
{"query_id": "topic_213_turn_3", "conversation_id": "topic_213", "turn_id": 3, "query": "Prognostic value of dynamic autoantibody signatures in differentiating proliferative vs. membranous lupus nephritis for predicting disease activity, treatment response, and informing personalized therapy", "history": ["Pathogenic role and mechanisms of autoantibodies in lupus nephritis", "Longitudinal changes in these lupus nephritis-associated autoantibody profiles and their correlation with specific histological classes (e.g., proliferative vs. membranous)"], "ground_truth": ["permed-58364", "permed-92133", "permed-89486", "permed-61102", "permed-53196", "permed-61519", "permed-89216", "permed-71104", "permed-58363", "permed-53199"]}
{"query_id": "topic_213_turn_4", "conversation_id": "topic_213", "turn_id": 4, "query": "When analyzing these dynamic autoantibody signatures for their prognostic value, what specific statistical methodologies did you employ to handle the longitudinal nature of the data? Were mixed-effects models or survival analysis techniques preferred for tracking antibody trajectory changes against clinical outcomes, and how did you validate the predictive accuracy of these models? Additionally, what quality control measures were implemented to ensure reproducibility across different assay batches when quantifying these autoantibody profiles over time?", "history": ["Pathogenic role and mechanisms of autoantibodies in lupus nephritis", "Longitudinal changes in these lupus nephritis-associated autoantibody profiles and their correlation with specific histological classes (e.g., proliferative vs. membranous)", "Prognostic value of dynamic autoantibody signatures in differentiating proliferative vs. membranous lupus nephritis for predicting disease activity, treatment response, and informing personalized therapy"], "ground_truth": ["permed-1608", "permed-6022", "permed-4842", "permed-4850", "permed-37716", "permed-77046", "permed-64941", "permed-89487", "permed-41650", "permed-4959"]}
{"query_id": "topic_214_turn_1", "conversation_id": "topic_214", "turn_id": 1, "query": "Role and mechanisms of genomic selection in enhancing crop resilience to climate change", "history": [], "ground_truth": ["permed-63821", "permed-85929", "permed-63681", "permed-53712", "permed-52064", "permed-63684", "permed-64123", "permed-74049", "permed-70014", "permed-64016"]}
{"query_id": "topic_214_turn_2", "conversation_id": "topic_214", "turn_id": 2, "query": "How can machine learning improve these genomic selection mechanisms for climate resilience in soybean cultivation?", "history": ["Role and mechanisms of genomic selection in enhancing crop resilience to climate change"], "ground_truth": ["permed-63821", "permed-53712", "permed-70015", "permed-64123", "permed-69984", "permed-69983", "permed-74049", "permed-52486", "permed-85929", "permed-63820"]}
{"query_id": "topic_214_turn_3", "conversation_id": "topic_214", "turn_id": 3, "query": "Integrating specific haplotype block analysis (e.g., soybean chromosome 19) with machine learning to optimize soybean resilience and productivity under varying climate conditions: implications for advancing genomic selection in crops.", "history": ["Role and mechanisms of genomic selection in enhancing crop resilience to climate change", "How can machine learning improve these genomic selection mechanisms for climate resilience in soybean cultivation?"], "ground_truth": ["permed-63821", "permed-69983", "permed-53712", "permed-76842", "permed-70015", "permed-69984", "permed-87874", "permed-85022", "permed-64123", "permed-63676"]}
{"query_id": "topic_214_turn_4", "conversation_id": "topic_214", "turn_id": 4, "query": "When implementing this haplotype block analysis with machine learning, what specific statistical validation framework would you recommend for assessing model performance across different environmental conditions? I'm particularly interested in how to structure cross-validation protocols to account for genotype-by-environment interactions, and whether you've found recurrent neural networks more effective than random forests for capturing temporal climate patterns in these integrated models.", "history": ["Role and mechanisms of genomic selection in enhancing crop resilience to climate change", "How can machine learning improve these genomic selection mechanisms for climate resilience in soybean cultivation?", "Integrating specific haplotype block analysis (e.g., soybean chromosome 19) with machine learning to optimize soybean resilience and productivity under varying climate conditions: implications for advancing genomic selection in crops."], "ground_truth": ["permed-87874", "permed-71547", "permed-63821", "permed-74049", "permed-85022", "permed-67212", "permed-74050", "permed-73576", "permed-52483", "permed-85565"]}
{"query_id": "topic_215_turn_1", "conversation_id": "topic_215", "turn_id": 1, "query": "Gut microbiome role in modulating immune system response to cancer", "history": [], "ground_truth": ["permed-56500", "permed-60105", "permed-56485", "permed-56501", "permed-56499", "permed-56498", "permed-56490", "permed-65029", "permed-56488", "permed-82373"]}
{"query_id": "topic_215_turn_2", "conversation_id": "topic_215", "turn_id": 2, "query": "Leveraging this gut microbiome-immune interplay: Can its modulation enhance cancer immunotherapy efficacy for patients with distinct tumor microenvironment features?", "history": ["Gut microbiome role in modulating immune system response to cancer"], "ground_truth": ["permed-56500", "permed-56487", "permed-56499", "permed-56485", "permed-56501", "permed-60105", "permed-56498", "permed-56490", "permed-70412", "permed-56488"]}
{"query_id": "topic_215_turn_3", "conversation_id": "topic_215", "turn_id": 3, "query": "Investigating these gut microbiome-immunotherapy effects: Specific molecular mechanisms of particular microbial metabolites influencing tumor immune cell recruitment and activation, and their potential to improve immunotherapy in cancers with low tertiary lymphoid structures (TLS).", "history": ["Gut microbiome role in modulating immune system response to cancer", "Leveraging this gut microbiome-immune interplay: Can its modulation enhance cancer immunotherapy efficacy for patients with distinct tumor microenvironment features?"], "ground_truth": ["permed-56500", "permed-56501", "permed-56649", "permed-56499", "permed-56485", "permed-69187", "permed-56486", "permed-56490", "permed-60105", "permed-56498"]}
{"query_id": "topic_215_turn_4", "conversation_id": "topic_215", "turn_id": 4, "query": "When investigating these microbial metabolite mechanisms in low-TLS cancers, what specific experimental approaches would you recommend for validating whether metabolite supplementation directly enhances cytotoxic T-cell infiltration? I'm particularly interested in methodological details about how to track spatial distribution of immune cells post-treatment, quantify activation markers, and determine optimal dosing protocols while controlling for potential microbiome-mediated indirect effects.", "history": ["Gut microbiome role in modulating immune system response to cancer", "Leveraging this gut microbiome-immune interplay: Can its modulation enhance cancer immunotherapy efficacy for patients with distinct tumor microenvironment features?", "Investigating these gut microbiome-immunotherapy effects: Specific molecular mechanisms of particular microbial metabolites influencing tumor immune cell recruitment and activation, and their potential to improve immunotherapy in cancers with low tertiary lymphoid structures (TLS)."], "ground_truth": ["permed-56649", "permed-75765", "permed-56500", "permed-51433", "permed-56653", "permed-12378", "permed-67974", "permed-68242", "permed-67970", "permed-56651"]}
{"query_id": "topic_216_turn_1", "conversation_id": "topic_216", "turn_id": 1, "query": "Current approaches for identifying and predicting eating disorder progression", "history": [], "ground_truth": ["permed-74361", "permed-74360", "permed-78095", "permed-74463", "permed-75360", "permed-78098", "permed-81277", "permed-75356", "permed-58443", "permed-79301"]}
{"query_id": "topic_216_turn_2", "conversation_id": "topic_216", "turn_id": 2, "query": "Enhancing *these* eating disorder progression predictions: role of advanced computational techniques in identifying critical transition points", "history": ["Current approaches for identifying and predicting eating disorder progression"], "ground_truth": ["permed-74361", "permed-66153", "permed-78095", "permed-61668", "permed-65029", "permed-74463", "permed-74360", "permed-58851", "permed-85506", "permed-82373"]}
{"query_id": "topic_216_turn_3", "conversation_id": "topic_216", "turn_id": 3, "query": "Combining Dynamic Time Warp and machine learning to predict *those* critical transition points in eating disorder progression: investigating bridge symptom mediation", "history": ["Current approaches for identifying and predicting eating disorder progression", "Enhancing *these* eating disorder progression predictions: role of advanced computational techniques in identifying critical transition points"], "ground_truth": ["permed-78095", "permed-75160", "permed-58851", "permed-74361", "permed-81277", "permed-66153", "permed-65029", "permed-60971", "permed-60645", "permed-53717"]}
{"query_id": "topic_216_turn_4", "conversation_id": "topic_216", "turn_id": 4, "query": "In your Dynamic Time Warp and machine learning pipeline for identifying bridge symptom-mediated transitions, what specific validation procedures did you implement to ensure temporal alignment accuracy? I'm particularly interested in how you addressed potential overfitting given the high-dimensional longitudinal data, and whether you employed cross-validation strategies that account for within-subject dependency across timepoints rather than traditional random splitting approaches.", "history": ["Current approaches for identifying and predicting eating disorder progression", "Enhancing *these* eating disorder progression predictions: role of advanced computational techniques in identifying critical transition points", "Combining Dynamic Time Warp and machine learning to predict *those* critical transition points in eating disorder progression: investigating bridge symptom mediation"], "ground_truth": ["permed-61725", "permed-34458", "permed-53345", "permed-65668", "permed-78095", "permed-61540", "permed-70000", "permed-69746", "permed-44413", "permed-85716"]}
{"query_id": "topic_217_turn_1", "conversation_id": "topic_217", "turn_id": 1, "query": "What are the latest breakthroughs in water purification technologies leveraging nanomaterials?", "history": [], "ground_truth": ["permed-75659", "permed-75660", "permed-75661", "permed-79364", "permed-79287", "permed-66249", "permed-60905", "permed-79366", "permed-62929", "permed-75666"]}
{"query_id": "topic_217_turn_2", "conversation_id": "topic_217", "turn_id": 2, "query": "Following these nanomaterial breakthroughs, how is graphene specifically being applied to enhance membrane efficiency in such water purification systems?", "history": ["What are the latest breakthroughs in water purification technologies leveraging nanomaterials?"], "ground_truth": ["permed-75659", "permed-75665", "permed-75261", "permed-75662", "permed-78763", "permed-73990", "permed-75661", "permed-64620", "permed-73015", "permed-75666"]}
{"query_id": "topic_217_turn_3", "conversation_id": "topic_217", "turn_id": 3, "query": "Building on graphene's established role in membrane efficiency, what synergistic strategies combine graphene-based nanomaterials with other advanced materials to significantly improve both performance and durability, particularly for overcoming current challenges in nanofiltration and solar desalination technologies?", "history": ["What are the latest breakthroughs in water purification technologies leveraging nanomaterials?", "Following these nanomaterial breakthroughs, how is graphene specifically being applied to enhance membrane efficiency in such water purification systems?"], "ground_truth": ["permed-75659", "permed-75261", "permed-75665", "permed-75663", "permed-73990", "permed-64620", "permed-73015", "permed-75662", "permed-78298", "permed-75664"]}
{"query_id": "topic_217_turn_4", "conversation_id": "topic_217", "turn_id": 4, "query": "Given these synergistic material combinations, what specific fabrication protocols and characterization techniques are most critical for validating interfacial stability between graphene oxides and polymer matrices? Particularly, how do researchers quantitatively assess covalent versus non-covalent bonding efficacy through spectroscopic methods, and what standardized mechanical testing regimens reliably predict long-term durability under operational stressors like cyclic pressure variations or UV exposure in solar desalination contexts?", "history": ["What are the latest breakthroughs in water purification technologies leveraging nanomaterials?", "Following these nanomaterial breakthroughs, how is graphene specifically being applied to enhance membrane efficiency in such water purification systems?", "Building on graphene's established role in membrane efficiency, what synergistic strategies combine graphene-based nanomaterials with other advanced materials to significantly improve both performance and durability, particularly for overcoming current challenges in nanofiltration and solar desalination technologies?"], "ground_truth": ["permed-75698", "permed-74391", "permed-76287", "permed-78262", "permed-75659", "permed-73150", "permed-78725", "permed-75018", "permed-76283", "permed-84106"]}
{"query_id": "topic_218_turn_1", "conversation_id": "topic_218", "turn_id": 1, "query": "Challenges in diagnosing primary liver cancers stemming from their rarity or symptom overlap with other conditions", "history": [], "ground_truth": ["permed-87035", "permed-79735", "permed-85505", "permed-67353", "permed-3178", "permed-10486", "permed-74663", "permed-8812", "permed-10481", "permed-77452"]}
{"query_id": "topic_218_turn_2", "conversation_id": "topic_218", "turn_id": 2, "query": "How can advanced imaging techniques help overcome these diagnostic challenges, particularly in improving accuracy for distinguishing between different types of primary hepatic malignancies?", "history": ["Challenges in diagnosing primary liver cancers stemming from their rarity or symptom overlap with other conditions"], "ground_truth": ["permed-3293", "permed-29386", "permed-74663", "permed-87840", "permed-87035", "permed-87841", "permed-17185", "permed-79487", "permed-3700", "permed-3031"]}
{"query_id": "topic_218_turn_3", "conversation_id": "topic_218", "turn_id": 3, "query": "Considering these diagnostic difficulties and the potential of such advanced imaging, how might integrating 18F-FDG PET/CT with CT and MRI enhance preoperative diagnostic accuracy for primary liver mesothelioma, especially in differentiating it from other hepatic malignancies, and what specific metabolic insights from 18F-FDG PET/CT could inform personalized treatment and prognosis?", "history": ["Challenges in diagnosing primary liver cancers stemming from their rarity or symptom overlap with other conditions", "How can advanced imaging techniques help overcome these diagnostic challenges, particularly in improving accuracy for distinguishing between different types of primary hepatic malignancies?"], "ground_truth": ["permed-77452", "permed-75289", "permed-16905", "permed-16910", "permed-48663", "permed-61159", "permed-48411", "permed-28409", "permed-87035", "permed-48461"]}
{"query_id": "topic_218_turn_4", "conversation_id": "topic_218", "turn_id": 4, "query": "Given this multi-modal imaging approach, what specific acquisition protocols and quantification methods would you recommend for 18F-FDG PET/CT when integrated with contrast-enhanced CT and MRI? I'm particularly interested in how to standardize the SUV measurements across different scanners and the optimal timing between contrast administration and PET acquisition to maximize diagnostic accuracy while minimizing artifacts. Additionally, what statistical validation approaches would be most appropriate for assessing the reproducibility of these metabolic parameters in clinical practice?", "history": ["Challenges in diagnosing primary liver cancers stemming from their rarity or symptom overlap with other conditions", "How can advanced imaging techniques help overcome these diagnostic challenges, particularly in improving accuracy for distinguishing between different types of primary hepatic malignancies?", "Considering these diagnostic difficulties and the potential of such advanced imaging, how might integrating 18F-FDG PET/CT with CT and MRI enhance preoperative diagnostic accuracy for primary liver mesothelioma, especially in differentiating it from other hepatic malignancies, and what specific metabolic insights from 18F-FDG PET/CT could inform personalized treatment and prognosis?"], "ground_truth": ["permed-48764", "permed-23989", "permed-48461", "permed-61845", "permed-29407", "permed-77495", "permed-32084", "permed-21490", "permed-48490", "permed-90504"]}
{"query_id": "topic_219_turn_1", "conversation_id": "topic_219", "turn_id": 1, "query": "What is known about the role of ADAR1 in regulating immune responses and its connection to human diseases?", "history": [], "ground_truth": ["permed-79007", "permed-79006", "permed-68844", "permed-67708", "permed-33021", "permed-70721", "permed-10616", "permed-70984", "permed-66449", "permed-23044"]}
{"query_id": "topic_219_turn_2", "conversation_id": "topic_219", "turn_id": 2, "query": "How does the specific isoform ADAR1 p150 contribute to this regulation, and what implications might it have for developing targeted therapies in this area?", "history": ["What is known about the role of ADAR1 in regulating immune responses and its connection to human diseases?"], "ground_truth": ["permed-79006", "permed-68844", "permed-79007", "permed-67708", "permed-72947", "permed-59008", "permed-60886", "permed-82373", "permed-51824", "permed-71584"]}
{"query_id": "topic_219_turn_3", "conversation_id": "topic_219", "turn_id": 3, "query": "Given ADAR1 p150's key role in dsRNA-sensing pathways and its link to conditions like Aicardi-Goutières syndrome, how could therapies be designed to enhance or correct its function—not just for AGS but also other disorders with dysregulated interferon responses? What challenges might arise in specifically targeting p150 over p110, and how could these approaches avoid disrupting ADAR1's broader cellular functions?", "history": ["What is known about the role of ADAR1 in regulating immune responses and its connection to human diseases?", "How does the specific isoform ADAR1 p150 contribute to this regulation, and what implications might it have for developing targeted therapies in this area?"], "ground_truth": ["permed-79006", "permed-79007", "permed-66449", "permed-68844", "permed-68726", "permed-68054", "permed-87710", "permed-78072", "permed-53236", "permed-20991"]}
{"query_id": "topic_219_turn_4", "conversation_id": "topic_219", "turn_id": 4, "query": "Building on these therapeutic targeting strategies, what specific experimental approaches would best validate ADAR1 p150 functional enhancement in vivo? I'm particularly interested in methodology for assessing dsRNA editing efficiency while preserving p110 functions - would you recommend AAV-mediated delivery systems with tissue-specific promoters, and what quantitative measures (e.g., RNA-seq validation protocols, interferon signature scoring) would most reliably demonstrate functional correction without triggering compensatory mechanisms in disease models like AGS mice?", "history": ["What is known about the role of ADAR1 in regulating immune responses and its connection to human diseases?", "How does the specific isoform ADAR1 p150 contribute to this regulation, and what implications might it have for developing targeted therapies in this area?", "Given ADAR1 p150's key role in dsRNA-sensing pathways and its link to conditions like Aicardi-Goutières syndrome, how could therapies be designed to enhance or correct its function—not just for AGS but also other disorders with dysregulated interferon responses? What challenges might arise in specifically targeting p150 over p110, and how could these approaches avoid disrupting ADAR1's broader cellular functions?"], "ground_truth": ["permed-79006", "permed-79007", "permed-68844", "permed-53583", "permed-66449", "permed-79008", "permed-62111", "permed-82304", "permed-86493", "permed-63744"]}
{"query_id": "topic_220_turn_1", "conversation_id": "topic_220", "turn_id": 1, "query": "What role does self-distancing play in emotional regulation after traumatic events?", "history": [], "ground_truth": ["permed-55521", "permed-75160", "permed-69529", "permed-60971", "permed-58438", "permed-65435", "permed-84646", "permed-65346", "permed-83741", "permed-51877"]}
{"query_id": "topic_220_turn_2", "conversation_id": "topic_220", "turn_id": 2, "query": "Can interventions based on this technique really enhance posttraumatic growth, and if so, what factors influence their effectiveness?", "history": ["What role does self-distancing play in emotional regulation after traumatic events?"], "ground_truth": ["permed-55521", "permed-73912", "permed-55688", "permed-69994", "permed-79830", "permed-32322", "permed-58543", "permed-60328", "permed-84857", "permed-73911"]}
{"query_id": "topic_220_turn_3", "conversation_id": "topic_220", "turn_id": 3, "query": "Given these mixed findings about self-distancing interventions, what specific individual differences—like personality traits, cognitive styles, or prior trauma exposure—might explain why they work better for some people than others? And how could we use these moderators to tailor interventions for diverse populations affected by COVID-19, improving both emotional regulation and posttraumatic growth?", "history": ["What role does self-distancing play in emotional regulation after traumatic events?", "Can interventions based on this technique really enhance posttraumatic growth, and if so, what factors influence their effectiveness?"], "ground_truth": ["permed-55521", "permed-62860", "permed-65435", "permed-65503", "permed-72376", "permed-58447", "permed-62853", "permed-54761", "permed-55520", "permed-69560"]}
{"query_id": "topic_220_turn_4", "conversation_id": "topic_220", "turn_id": 4, "query": "Building on your interest in moderator variables, what specific methodological approaches would best capture these individual differences in intervention studies? For instance, should we employ mixed-methods designs combining standardized trait assessments with qualitative interviews about participants' cognitive processing styles? What statistical techniques—like moderated mediation analysis or growth mixture modeling—would most effectively reveal how these moderators influence both emotional regulation mechanisms and posttraumatic growth outcomes in COVID-19 affected populations?", "history": ["What role does self-distancing play in emotional regulation after traumatic events?", "Can interventions based on this technique really enhance posttraumatic growth, and if so, what factors influence their effectiveness?", "Given these mixed findings about self-distancing interventions, what specific individual differences—like personality traits, cognitive styles, or prior trauma exposure—might explain why they work better for some people than others? And how could we use these moderators to tailor interventions for diverse populations affected by COVID-19, improving both emotional regulation and posttraumatic growth?"], "ground_truth": ["permed-55521", "permed-62860", "permed-72376", "permed-55519", "permed-55767", "permed-79830", "permed-62017", "permed-59545", "permed-82787", "permed-66221"]}
{"query_id": "topic_221_turn_1", "conversation_id": "topic_221", "turn_id": 1, "query": "What role does lysosomal labile iron play in neurodegenerative diseases and cellular processes?", "history": [], "ground_truth": ["permed-64811", "permed-58179", "permed-79514", "permed-54306", "permed-87913", "permed-79528", "permed-60884", "permed-63164", "permed-66783", "permed-79622"]}
{"query_id": "topic_221_turn_2", "conversation_id": "topic_221", "turn_id": 2, "query": "How can fluorescent probes, like those based on naphthalimide, be utilized to detect or study it in biological systems?", "history": ["What role does lysosomal labile iron play in neurodegenerative diseases and cellular processes?"], "ground_truth": ["permed-58179", "permed-75805", "permed-76067", "permed-75806", "permed-88008", "permed-73349", "permed-73142", "permed-75801", "permed-86684", "permed-75804"]}
{"query_id": "topic_221_turn_3", "conversation_id": "topic_221", "turn_id": 3, "query": "Given the importance of lysosomal labile iron in these contexts, how could we adapt the design of naphthalimide-based fluorescent probes to improve their performance in more complex in vivo environments—where factors like tissue autofluorescence and physiological variability might compromise sensitivity and specificity? Also, what approaches might help integrate such probes into high-throughput platforms for early detection or monitoring of iron-related pathologies?", "history": ["What role does lysosomal labile iron play in neurodegenerative diseases and cellular processes?", "How can fluorescent probes, like those based on naphthalimide, be utilized to detect or study it in biological systems?"], "ground_truth": ["permed-58179", "permed-76067", "permed-75825", "permed-73140", "permed-73142", "permed-88008", "permed-83330", "permed-75806", "permed-75801", "permed-73145"]}
{"query_id": "topic_221_turn_4", "conversation_id": "topic_221", "turn_id": 4, "query": "Regarding these proposed design adaptations for complex in vivo use, what specific normalization or ratiometric strategies would you implement to counteract tissue autofluorescence? Additionally, for high-throughput integration, what statistical validation framework—such as Z'-factor calculations or coefficient of variation thresholds—would be most appropriate to confirm that these modified probes maintain robust performance across different biological replicates while minimizing false positives in automated screening platforms?", "history": ["What role does lysosomal labile iron play in neurodegenerative diseases and cellular processes?", "How can fluorescent probes, like those based on naphthalimide, be utilized to detect or study it in biological systems?", "Given the importance of lysosomal labile iron in these contexts, how could we adapt the design of naphthalimide-based fluorescent probes to improve their performance in more complex in vivo environments—where factors like tissue autofluorescence and physiological variability might compromise sensitivity and specificity? Also, what approaches might help integrate such probes into high-throughput platforms for early detection or monitoring of iron-related pathologies?"], "ground_truth": ["permed-58175", "permed-75810", "permed-73142", "permed-88984", "permed-76067", "permed-82292", "permed-75806", "permed-52551", "permed-78032", "permed-58181"]}
{"query_id": "topic_222_turn_1", "conversation_id": "topic_222", "turn_id": 1, "query": "What laws protect the rights of disabled individuals during public health emergencies?", "history": [], "ground_truth": ["permed-81656", "permed-78837", "permed-84565", "permed-51719", "permed-65926", "permed-69759", "permed-90024", "permed-53019", "permed-91926", "permed-81415"]}
{"query_id": "topic_222_turn_2", "conversation_id": "topic_222", "turn_id": 2, "query": "How have countries implemented it to ensure equitable access to healthcare in crisis situations?", "history": ["What laws protect the rights of disabled individuals during public health emergencies?"], "ground_truth": ["permed-91926", "permed-66148", "permed-63442", "permed-72628", "permed-59940", "permed-65380", "permed-84756", "permed-67357", "permed-60174", "permed-55968"]}
{"query_id": "topic_222_turn_3", "conversation_id": "topic_222", "turn_id": 3, "query": "Given these legal protections and implementation approaches, how could the principles from Germany's Infection Protection Act be adapted to help other countries ensure equitable healthcare access for disabled individuals during public health emergencies, particularly when facing similar ethical and legal challenges?", "history": ["What laws protect the rights of disabled individuals during public health emergencies?", "How have countries implemented it to ensure equitable access to healthcare in crisis situations?"], "ground_truth": ["permed-81656", "permed-59645", "permed-81661", "permed-55968", "permed-81657", "permed-78837", "permed-79475", "permed-69895", "permed-53039", "permed-51090"]}
{"query_id": "topic_222_turn_4", "conversation_id": "topic_222", "turn_id": 4, "query": "When adapting the Infection Protection Act's principles to different national contexts, what methodological approaches would you recommend for quantitatively measuring equity in healthcare access for disabled populations during emergencies? Specifically, how should researchers design longitudinal studies to track accessibility metrics, validate cross-cultural applicability of assessment tools, and establish statistical power for detecting disparities across different disability types and emergency phases while maintaining methodological rigor?", "history": ["What laws protect the rights of disabled individuals during public health emergencies?", "How have countries implemented it to ensure equitable access to healthcare in crisis situations?", "Given these legal protections and implementation approaches, how could the principles from Germany's Infection Protection Act be adapted to help other countries ensure equitable healthcare access for disabled individuals during public health emergencies, particularly when facing similar ethical and legal challenges?"], "ground_truth": ["permed-55979", "permed-65404", "permed-69887", "permed-55094", "permed-61961", "permed-63107", "permed-65382", "permed-58480", "permed-81305", "permed-88712"]}
{"query_id": "topic_223_turn_1", "conversation_id": "topic_223", "turn_id": 1, "query": "What role does trichoscopy play in diagnosing hair and scalp disorders?", "history": [], "ground_truth": ["permed-81469", "permed-81473", "permed-81470", "permed-92220", "permed-81472", "permed-81476", "permed-77101", "permed-12699", "permed-81471", "permed-81474"]}
{"query_id": "topic_223_turn_2", "conversation_id": "topic_223", "turn_id": 2, "query": "Can advancements in technology, like AI, significantly improve the effectiveness of this technique?", "history": ["What role does trichoscopy play in diagnosing hair and scalp disorders?"], "ground_truth": ["permed-0121", "permed-5249", "permed-69330", "permed-55065", "permed-15058", "permed-54947", "permed-16283", "permed-70775", "permed-82651", "permed-52824"]}
{"query_id": "topic_223_turn_3", "conversation_id": "topic_223", "turn_id": 3, "query": "How exactly could AI and machine learning integration improve trichoscopy's ability to detect subtle hair shaft abnormalities, and what might this mean for earlier diagnosis and more personalized treatment approaches in dermatology?", "history": ["What role does trichoscopy play in diagnosing hair and scalp disorders?", "Can advancements in technology, like AI, significantly improve the effectiveness of this technique?"], "ground_truth": ["permed-81469", "permed-52828", "permed-81473", "permed-41290", "permed-40983", "permed-63053", "permed-81472", "permed-18716", "permed-19888", "permed-51382"]}
{"query_id": "topic_223_turn_4", "conversation_id": "topic_223", "turn_id": 4, "query": "Given this proposed AI integration, what specific preprocessing protocols would be required for trichoscopic images before algorithmic analysis? I'm particularly interested in how you'd standardize image acquisition parameters—such as magnification, lighting conditions, and focus depth—across different clinical settings to ensure data uniformity. Additionally, what validation strategies, like cross-validation with histopathology or inter-rater reliability studies, would be necessary to confirm these computational methods maintain diagnostic accuracy when detecting subtle shaft abnormalities?", "history": ["What role does trichoscopy play in diagnosing hair and scalp disorders?", "Can advancements in technology, like AI, significantly improve the effectiveness of this technique?", "How exactly could AI and machine learning integration improve trichoscopy's ability to detect subtle hair shaft abnormalities, and what might this mean for earlier diagnosis and more personalized treatment approaches in dermatology?"], "ground_truth": ["permed-81469", "permed-18716", "permed-63378", "permed-29515", "permed-63053", "permed-81473", "permed-53882", "permed-18692", "permed-52828", "permed-4941"]}
{"query_id": "topic_224_turn_1", "conversation_id": "topic_224", "turn_id": 1, "query": "What role does Rheo-NMR spectroscopy play in studying protein structures and dynamics?", "history": [], "ground_truth": ["permed-79509", "permed-71540", "permed-71538", "permed-77688", "permed-79511", "permed-75409", "permed-86711", "permed-88992", "permed-53323", "permed-91052"]}
{"query_id": "topic_224_turn_2", "conversation_id": "topic_224", "turn_id": 2, "query": "Can this technique be enhanced with machine learning to improve detection of early-stage changes in proteins associated with neurodegenerative diseases?", "history": ["What role does Rheo-NMR spectroscopy play in studying protein structures and dynamics?"], "ground_truth": ["permed-53332", "permed-55584", "permed-71275", "permed-11741", "permed-79509", "permed-84892", "permed-84360", "permed-63045", "permed-51623", "permed-66779"]}
{"query_id": "topic_224_turn_3", "conversation_id": "topic_224", "turn_id": 3, "query": "Building on this combination of Rheo-NMR and machine learning for detecting early protein changes, how could integrating machine learning algorithms with cryogenic-probe-based Rheo-NMR improve the precision and efficiency of identifying early structural alterations in amyloidogenic proteins? What potential diagnostic applications might this have for neurodegenerative diseases? Also, how feasible would it be to use this integrated approach to study how environmental factors like pH and temperature affect protein aggregation dynamics?", "history": ["What role does Rheo-NMR spectroscopy play in studying protein structures and dynamics?", "Can this technique be enhanced with machine learning to improve detection of early-stage changes in proteins associated with neurodegenerative diseases?"], "ground_truth": ["permed-79509", "permed-54225", "permed-80235", "permed-73139", "permed-88307", "permed-85259", "permed-28317", "permed-79513", "permed-79512", "permed-77688"]}
{"query_id": "topic_224_turn_4", "conversation_id": "topic_224", "turn_id": 4, "query": "Given this integrated machine learning and cryogenic-probe Rheo-NMR approach, what specific experimental protocols would optimize data acquisition for transient protein states? I'm particularly interested in how you'd design the rheological shear parameters and sampling intervals to capture early oligomerization events. What statistical validation methods would be most appropriate for ensuring the machine learning models reliably distinguish between benign fluctuations and pathogenic structural alterations? Also, how would you implement quality control for reproducibility across different protein systems and experimental conditions?", "history": ["What role does Rheo-NMR spectroscopy play in studying protein structures and dynamics?", "Can this technique be enhanced with machine learning to improve detection of early-stage changes in proteins associated with neurodegenerative diseases?", "Building on this combination of Rheo-NMR and machine learning for detecting early protein changes, how could integrating machine learning algorithms with cryogenic-probe-based Rheo-NMR improve the precision and efficiency of identifying early structural alterations in amyloidogenic proteins? What potential diagnostic applications might this have for neurodegenerative diseases? Also, how feasible would it be to use this integrated approach to study how environmental factors like pH and temperature affect protein aggregation dynamics?"], "ground_truth": ["permed-79509", "permed-79513", "permed-65172", "permed-76078", "permed-84330", "permed-91052", "permed-71540", "permed-83858", "permed-77688", "permed-81331"]}
{"query_id": "topic_225_turn_1", "conversation_id": "topic_225", "turn_id": 1, "query": "Overview of zoonotic rotavirus transmission: animal reservoirs, human infection pathways, and public health impact", "history": [], "ground_truth": ["permed-74040", "permed-68513", "permed-74039", "permed-68512", "permed-65335", "permed-67008", "permed-74045", "permed-67050", "permed-74041", "permed-59148"]}
{"query_id": "topic_225_turn_2", "conversation_id": "topic_225", "turn_id": 2, "query": "Assessing risks of this rotavirus transmission from Tanzanian piglets to humans: local prevalence, severity, and vulnerable populations", "history": ["Overview of zoonotic rotavirus transmission: animal reservoirs, human infection pathways, and public health impact"], "ground_truth": ["permed-74039", "permed-74045", "permed-62170", "permed-74040", "permed-59148", "permed-68513", "permed-68512", "permed-71897", "permed-71859", "permed-68153"]}
{"query_id": "topic_225_turn_3", "conversation_id": "topic_225", "turn_id": 3, "query": "Mechanisms of Rotavirus A genomic reassortment and environmental drivers enhancing pig-to-human transmission in Tanzania: implications for targeted surveillance and intervention strategies", "history": ["Overview of zoonotic rotavirus transmission: animal reservoirs, human infection pathways, and public health impact", "Assessing risks of this rotavirus transmission from Tanzanian piglets to humans: local prevalence, severity, and vulnerable populations"], "ground_truth": ["permed-74039", "permed-74040", "permed-71897", "permed-74041", "permed-68513", "permed-59148", "permed-68512", "permed-59569", "permed-85754", "permed-74042"]}
{"query_id": "topic_225_turn_4", "conversation_id": "topic_225", "turn_id": 4, "query": "Considering these genomic reassortment mechanisms and environmental drivers, what specific laboratory protocols would you recommend for detecting interspecies transmission events in Tanzanian field samples? I'm particularly interested in the methodological details of how to distinguish pure zoonotic strains from reassorted variants - would this require full genome sequencing with phylogenetic analysis, or could targeted PCR assays focusing on key genomic segments provide sufficient resolution? What quality control measures should be implemented to ensure reproducibility across different sampling sites?", "history": ["Overview of zoonotic rotavirus transmission: animal reservoirs, human infection pathways, and public health impact", "Assessing risks of this rotavirus transmission from Tanzanian piglets to humans: local prevalence, severity, and vulnerable populations", "Mechanisms of Rotavirus A genomic reassortment and environmental drivers enhancing pig-to-human transmission in Tanzania: implications for targeted surveillance and intervention strategies"], "ground_truth": ["permed-72654", "permed-62165", "permed-62189", "permed-59205", "permed-67050", "permed-74039", "permed-74040", "permed-62190", "permed-66687", "permed-71968"]}
{"query_id": "topic_226_turn_1", "conversation_id": "topic_226", "turn_id": 1, "query": "What role does biological phenotyping play in understanding and treating sepsis and ARDS?", "history": [], "ground_truth": ["permed-74679", "permed-57130", "permed-67916", "permed-74680", "permed-59916", "permed-4533", "permed-74678", "permed-23048", "permed-57236", "permed-21403"]}
{"query_id": "topic_226_turn_2", "conversation_id": "topic_226", "turn_id": 2, "query": "Can advancements in this area be leveraged to improve patient outcomes through more personalized approaches?", "history": ["What role does biological phenotyping play in understanding and treating sepsis and ARDS?"], "ground_truth": ["permed-53997", "permed-62341", "permed-53342", "permed-53348", "permed-50971", "permed-87478", "permed-56692", "permed-55037", "permed-61615", "permed-78129"]}
{"query_id": "topic_226_turn_3", "conversation_id": "topic_226", "turn_id": 3, "query": "Building on these advancements in biological phenotyping and omics integration for sepsis and ARDS, how could machine learning be specifically adapted to better identify subphenotypes in these conditions? And what ethical challenges might arise when implementing such approaches in clinical practice?", "history": ["What role does biological phenotyping play in understanding and treating sepsis and ARDS?", "Can advancements in this area be leveraged to improve patient outcomes through more personalized approaches?"], "ground_truth": ["permed-74679", "permed-74680", "permed-26794", "permed-52655", "permed-57130", "permed-83088", "permed-65761", "permed-57236", "permed-5605", "permed-57638"]}
{"query_id": "topic_226_turn_4", "conversation_id": "topic_226", "turn_id": 4, "query": "Given the proposed machine learning adaptation for identifying subphenotypes, what specific validation frameworks would you recommend for ensuring these computational models maintain clinical reliability? I'm particularly interested in how we might implement temporal validation across different ICU cohorts and what statistical approaches would be most appropriate for assessing model calibration and discrimination in real-world settings, especially when dealing with the inherent heterogeneity of sepsis and ARDS patient populations.", "history": ["What role does biological phenotyping play in understanding and treating sepsis and ARDS?", "Can advancements in this area be leveraged to improve patient outcomes through more personalized approaches?", "Building on these advancements in biological phenotyping and omics integration for sepsis and ARDS, how could machine learning be specifically adapted to better identify subphenotypes in these conditions? And what ethical challenges might arise when implementing such approaches in clinical practice?"], "ground_truth": ["permed-74680", "permed-74679", "permed-33399", "permed-61537", "permed-25882", "permed-58919", "permed-83088", "permed-56976", "permed-44907", "permed-82934"]}
{"query_id": "topic_227_turn_1", "conversation_id": "topic_227", "turn_id": 1, "query": "Genetic variation across Fasciola species: impact on their transmission dynamics and pathogenicity mechanisms", "history": [], "ground_truth": ["permed-62073", "permed-50790", "permed-53717", "permed-58160", "permed-72203", "permed-68513", "permed-72205", "permed-66965", "permed-87533", "permed-89605"]}
{"query_id": "topic_227_turn_2", "conversation_id": "topic_227", "turn_id": 2, "query": "Geographical influence on Fasciola species' genetic adaptability and how this affects their resulting transmission dynamics and pathogenicity mechanisms", "history": ["Genetic variation across Fasciola species: impact on their transmission dynamics and pathogenicity mechanisms"], "ground_truth": ["permed-62073", "permed-62954", "permed-75078", "permed-58160", "permed-72205", "permed-90219", "permed-62962", "permed-84398", "permed-53717", "permed-61294"]}
{"query_id": "topic_227_turn_3", "conversation_id": "topic_227", "turn_id": 3, "query": "Designing geographically-tailored control strategies for Fasciola hepatica vs Fasciola gigantica based on their distinct genetic adaptability, regional transmission dynamics, and pathogenicity profiles", "history": ["Genetic variation across Fasciola species: impact on their transmission dynamics and pathogenicity mechanisms", "Geographical influence on Fasciola species' genetic adaptability and how this affects their resulting transmission dynamics and pathogenicity mechanisms"], "ground_truth": ["permed-62073", "permed-72205", "permed-62954", "permed-54928", "permed-64243", "permed-62086", "permed-82478", "permed-71810", "permed-79181", "permed-81823"]}
{"query_id": "topic_227_turn_4", "conversation_id": "topic_227", "turn_id": 4, "query": "When designing these geographically-tailored control strategies, what specific molecular markers and sequencing approaches would provide the most robust differentiation between F. hepatica and F. gigantica populations across diverse regions? I'm particularly interested in how to validate these genetic markers against phenotypic manifestations of pathogenicity, and what statistical thresholds you'd recommend for establishing population structure versus local adaptation in field-collected samples.", "history": ["Genetic variation across Fasciola species: impact on their transmission dynamics and pathogenicity mechanisms", "Geographical influence on Fasciola species' genetic adaptability and how this affects their resulting transmission dynamics and pathogenicity mechanisms", "Designing geographically-tailored control strategies for Fasciola hepatica vs Fasciola gigantica based on their distinct genetic adaptability, regional transmission dynamics, and pathogenicity profiles"], "ground_truth": ["permed-62954", "permed-81742", "permed-52484", "permed-88388", "permed-71805", "permed-79302", "permed-53756", "permed-52480", "permed-79068", "permed-89416"]}
{"query_id": "topic_228_turn_1", "conversation_id": "topic_228", "turn_id": 1, "query": "Current postoperative management strategies for Crohn's disease", "history": [], "ground_truth": ["permed-52025", "permed-52026", "permed-52027", "permed-4216", "permed-3117", "permed-71646", "permed-51379", "permed-82930", "permed-0115", "permed-1101"]}
{"query_id": "topic_228_turn_2", "conversation_id": "topic_228", "turn_id": 2, "query": "Regarding these postoperative Crohn's management strategies, how effective is immunomodulator combination therapy versus monotherapy in preventing recurrence?", "history": ["Current postoperative management strategies for Crohn's disease"], "ground_truth": ["permed-52025", "permed-71646", "permed-52026", "permed-52027", "permed-3117", "permed-1273", "permed-4378", "permed-0115", "permed-67339", "permed-71644"]}
{"query_id": "topic_228_turn_3", "conversation_id": "topic_228", "turn_id": 3, "query": "To leverage its benefits in extending treatment duration and reducing post-resection failure risk, what patient biomarkers or clinical characteristics predict superior outcomes with that immunomodulator combination therapy versus monotherapy in Crohn's for personalized treatment?", "history": ["Current postoperative management strategies for Crohn's disease", "Regarding these postoperative Crohn's management strategies, how effective is immunomodulator combination therapy versus monotherapy in preventing recurrence?"], "ground_truth": ["permed-71646", "permed-75528", "permed-52027", "permed-67339", "permed-82930", "permed-52025", "permed-67769", "permed-50782", "permed-61771", "permed-71644"]}
{"query_id": "topic_228_turn_4", "conversation_id": "topic_228", "turn_id": 4, "query": "Regarding these predictive biomarkers and clinical characteristics, what specific statistical modeling approaches—such as multivariate regression, machine learning algorithms, or time-to-event analyses—were employed to validate their association with combination therapy outcomes? Additionally, how were potential confounders like preoperative disease behavior or concomitant medications controlled for in these analytical frameworks to ensure robust predictive performance for personalizing postoperative Crohn's management?", "history": ["Current postoperative management strategies for Crohn's disease", "Regarding these postoperative Crohn's management strategies, how effective is immunomodulator combination therapy versus monotherapy in preventing recurrence?", "To leverage its benefits in extending treatment duration and reducing post-resection failure risk, what patient biomarkers or clinical characteristics predict superior outcomes with that immunomodulator combination therapy versus monotherapy in Crohn's for personalized treatment?"], "ground_truth": ["permed-82930", "permed-52025", "permed-67769", "permed-28216", "permed-71646", "permed-75292", "permed-16995", "permed-58876", "permed-61771", "permed-32651"]}
{"query_id": "topic_229_turn_1", "conversation_id": "topic_229", "turn_id": 1, "query": "Asylum-seeker mental health care access in Israel: primary challenges and systemic barriers", "history": [], "ground_truth": ["permed-77914", "permed-75160", "permed-66153", "permed-77915", "permed-55107", "permed-69895", "permed-91926", "permed-88738", "permed-66148", "permed-57845"]}
{"query_id": "topic_229_turn_2", "conversation_id": "topic_229", "turn_id": 2, "query": "Given these overall challenges, what distinct barriers hinder consistent mental health care access for male asylum-seeker fathers in Israel?", "history": ["Asylum-seeker mental health care access in Israel: primary challenges and systemic barriers"], "ground_truth": ["permed-77914", "permed-62307", "permed-69895", "permed-60059", "permed-86526", "permed-77915", "permed-69991", "permed-87461", "permed-57845", "permed-92141"]}
{"query_id": "topic_229_turn_3", "conversation_id": "topic_229", "turn_id": 3, "query": "In light of the distinct barriers for male asylum-seeker fathers, what specific intervention strategies or culturally-sensitive service delivery models could improve mental health support inclusivity in Israel?", "history": ["Asylum-seeker mental health care access in Israel: primary challenges and systemic barriers", "Given these overall challenges, what distinct barriers hinder consistent mental health care access for male asylum-seeker fathers in Israel?"], "ground_truth": ["permed-77914", "permed-62307", "permed-77915", "permed-60059", "permed-69991", "permed-57845", "permed-52796", "permed-52798", "permed-92141", "permed-92142"]}
{"query_id": "topic_229_turn_4", "conversation_id": "topic_229", "turn_id": 4, "query": "Regarding these proposed culturally-sensitive interventions, what specific methodological frameworks would be most appropriate for evaluating their implementation fidelity and effectiveness? I'm particularly interested in how one might design mixed-methods approaches that combine quantitative outcome measures with qualitative process evaluation, while accounting for the complex contextual factors affecting this population. What statistical methods would be suitable for analyzing both the intervention's direct impacts and potential mediating variables in such a dynamic service delivery environment?", "history": ["Asylum-seeker mental health care access in Israel: primary challenges and systemic barriers", "Given these overall challenges, what distinct barriers hinder consistent mental health care access for male asylum-seeker fathers in Israel?", "In light of the distinct barriers for male asylum-seeker fathers, what specific intervention strategies or culturally-sensitive service delivery models could improve mental health support inclusivity in Israel?"], "ground_truth": ["permed-66109", "permed-69900", "permed-61614", "permed-64788", "permed-69898", "permed-52380", "permed-64779", "permed-61613", "permed-84050", "permed-91393"]}
{"query_id": "topic_230_turn_1", "conversation_id": "topic_230", "turn_id": 1, "query": "How will climate change affect marine ecosystems like the Yellow Sea Cold Water Ecosystem?", "history": [], "ground_truth": ["permed-59351", "permed-81905", "permed-77921", "permed-64759", "permed-59352", "permed-82019", "permed-88346", "permed-82004", "permed-59349", "permed-83708"]}
{"query_id": "topic_230_turn_2", "conversation_id": "topic_230", "turn_id": 2, "query": "What specific challenges will this pose for local aquaculture industries, such as deep-sea salmon farming, in this area?", "history": ["How will climate change affect marine ecosystems like the Yellow Sea Cold Water Ecosystem?"], "ground_truth": ["permed-59351", "permed-77923", "permed-64762", "permed-82702", "permed-82706", "permed-71835", "permed-58279", "permed-82732", "permed-67808", "permed-59330"]}
{"query_id": "topic_230_turn_3", "conversation_id": "topic_230", "turn_id": 3, "query": "Given these projected impacts on the YSCW ecosystem and the challenges for deep-sea salmon farming, what adaptive strategies could help mitigate the negative effects on both biodiversity and aquaculture in the region? Specifically, how could such strategies be combined with advanced environmental monitoring technologies to enhance ecosystem resilience and ensure sustainable development under changing climatic conditions?", "history": ["How will climate change affect marine ecosystems like the Yellow Sea Cold Water Ecosystem?", "What specific challenges will this pose for local aquaculture industries, such as deep-sea salmon farming, in this area?"], "ground_truth": ["permed-59351", "permed-64253", "permed-67808", "permed-68687", "permed-68688", "permed-92470", "permed-77923", "permed-71779", "permed-67502", "permed-88347"]}
{"query_id": "topic_230_turn_4", "conversation_id": "topic_230", "turn_id": 4, "query": "When implementing these adaptive strategies with environmental monitoring technologies, what specific experimental designs would best evaluate their effectiveness for ecosystem resilience? For instance, should we use before-after-control-impact designs with paired monitoring stations, and what statistical approaches—like generalized additive mixed models accounting for temporal autocorrelation—would properly quantify intervention effects? How should we validate sensor network data against traditional sampling methods to ensure reliability when assessing biodiversity metrics and aquaculture performance indicators under climate stress scenarios?", "history": ["How will climate change affect marine ecosystems like the Yellow Sea Cold Water Ecosystem?", "What specific challenges will this pose for local aquaculture industries, such as deep-sea salmon farming, in this area?", "Given these projected impacts on the YSCW ecosystem and the challenges for deep-sea salmon farming, what adaptive strategies could help mitigate the negative effects on both biodiversity and aquaculture in the region? Specifically, how could such strategies be combined with advanced environmental monitoring technologies to enhance ecosystem resilience and ensure sustainable development under changing climatic conditions?"], "ground_truth": ["permed-71764", "permed-82004", "permed-69938", "permed-74417", "permed-64262", "permed-74497", "permed-54344", "permed-89691", "permed-87227", "permed-53389"]}
{"query_id": "topic_231_turn_1", "conversation_id": "topic_231", "turn_id": 1, "query": "Current challenges and limitations in conservative orthotic management of cervical spine fractures.", "history": [], "ground_truth": ["permed-77573", "permed-77574", "permed-53901", "permed-77575", "permed-53912", "permed-61909", "permed-57589", "permed-77695", "permed-77705", "permed-92659"]}
{"query_id": "topic_231_turn_2", "conversation_id": "topic_231", "turn_id": 2, "query": "Given *these* limitations with orthotic management, what are the key research gaps concerning long-term effectiveness and patient selection criteria for *this* approach to cervical spine fractures?", "history": ["Current challenges and limitations in conservative orthotic management of cervical spine fractures."], "ground_truth": ["permed-77573", "permed-77575", "permed-53901", "permed-53912", "permed-77574", "permed-19097", "permed-70209", "permed-77705", "permed-77690", "permed-36854"]}
{"query_id": "topic_231_turn_3", "conversation_id": "topic_231", "turn_id": 3, "query": "Advanced RCT design for *such* conservative cervical spine fracture management to address *identified* research gaps: integrating novel imaging, biomarkers, and patient-specific factors for predicting outcomes and healing across diverse fracture patterns.", "history": ["Current challenges and limitations in conservative orthotic management of cervical spine fractures.", "Given *these* limitations with orthotic management, what are the key research gaps concerning long-term effectiveness and patient selection criteria for *this* approach to cervical spine fractures?"], "ground_truth": ["permed-77573", "permed-53156", "permed-87277", "permed-53901", "permed-77574", "permed-58775", "permed-61909", "permed-77695", "permed-77576", "permed-77704"]}
{"query_id": "topic_231_turn_4", "conversation_id": "topic_231", "turn_id": 4, "query": "For this adaptive trial design incorporating imaging and biomarkers, what specific statistical approaches would you recommend for handling the multiple interim analyses while maintaining power? I'm particularly interested in how to pre-specify the biomarker adaptation rules and validate the imaging outcome measures. Could Bayesian methods with predictive probability monitoring be appropriate here, and what sample size considerations would be necessary given the planned subgroup analyses across different fracture patterns?", "history": ["Current challenges and limitations in conservative orthotic management of cervical spine fractures.", "Given *these* limitations with orthotic management, what are the key research gaps concerning long-term effectiveness and patient selection criteria for *this* approach to cervical spine fractures?", "Advanced RCT design for *such* conservative cervical spine fracture management to address *identified* research gaps: integrating novel imaging, biomarkers, and patient-specific factors for predicting outcomes and healing across diverse fracture patterns."], "ground_truth": ["permed-84948", "permed-51748", "permed-66294", "permed-79010", "permed-52656", "permed-84949", "permed-67437", "permed-71006", "permed-61842", "permed-51751"]}
{"query_id": "topic_232_turn_1", "conversation_id": "topic_232", "turn_id": 1, "query": "Key determinants and drivers of spatial clustering in mother-to-child HIV transmission", "history": [], "ground_truth": ["permed-75641", "permed-59204", "permed-75607", "permed-75640", "permed-88327", "permed-75644", "permed-73764", "permed-22757", "permed-59205", "permed-57908"]}
{"query_id": "topic_232_turn_2", "conversation_id": "topic_232", "turn_id": 2, "query": "Role of geospatial analysis in identifying socioeconomic patterns influencing these mother-to-child HIV transmission clusters, with a focus on Pará, Brazil", "history": ["Key determinants and drivers of spatial clustering in mother-to-child HIV transmission"], "ground_truth": ["permed-75641", "permed-75640", "permed-75644", "permed-73764", "permed-75607", "permed-88327", "permed-70255", "permed-75643", "permed-75645", "permed-71221"]}
{"query_id": "topic_232_turn_3", "conversation_id": "topic_232", "turn_id": 3, "query": "Advanced geospatial techniques for integrating socioeconomic indicators (e.g., employment, education, healthcare access) to model and elucidate drivers of mother-to-child HIV transmission spatial clustering in Pará, Brazil", "history": ["Key determinants and drivers of spatial clustering in mother-to-child HIV transmission", "Role of geospatial analysis in identifying socioeconomic patterns influencing these mother-to-child HIV transmission clusters, with a focus on Pará, Brazil"], "ground_truth": ["permed-75641", "permed-75640", "permed-75607", "permed-75644", "permed-59204", "permed-73764", "permed-70255", "permed-75642", "permed-65884", "permed-88327"]}
{"query_id": "topic_232_turn_4", "conversation_id": "topic_232", "turn_id": 4, "query": "Regarding these advanced geospatial techniques for integrating socioeconomic indicators, what specific spatial regression models – such as geographically weighted regression or spatial lag models – were most appropriate for quantifying the relative contributions of each socioeconomic driver to MTCT clustering in Pará? Furthermore, how were the modifiable areal unit problem and spatial autocorrelation addressed during the statistical validation of these model outputs to ensure robust inference?", "history": ["Key determinants and drivers of spatial clustering in mother-to-child HIV transmission", "Role of geospatial analysis in identifying socioeconomic patterns influencing these mother-to-child HIV transmission clusters, with a focus on Pará, Brazil", "Advanced geospatial techniques for integrating socioeconomic indicators (e.g., employment, education, healthcare access) to model and elucidate drivers of mother-to-child HIV transmission spatial clustering in Pará, Brazil"], "ground_truth": ["permed-65884", "permed-75641", "permed-70255", "permed-61201", "permed-79471", "permed-57850", "permed-79173", "permed-65229", "permed-75651", "permed-80763"]}
{"query_id": "topic_233_turn_1", "conversation_id": "topic_233", "turn_id": 1, "query": "What role do ion pair reagents play in chromatography techniques?", "history": [], "ground_truth": ["permed-73196", "permed-88991", "permed-72986", "permed-88146", "permed-79870", "permed-77757", "permed-89023", "permed-87726", "permed-89026", "permed-80439"]}
{"query_id": "topic_233_turn_2", "conversation_id": "topic_233", "turn_id": 2, "query": "How does understanding their interaction with the stationary phase impact the separation of complex mixtures using this technique?", "history": ["What role do ion pair reagents play in chromatography techniques?"], "ground_truth": ["permed-79870", "permed-85983", "permed-88146", "permed-53578", "permed-77047", "permed-88991", "permed-80587", "permed-73116", "permed-81232", "permed-89026"]}
{"query_id": "topic_233_turn_3", "conversation_id": "topic_233", "turn_id": 3, "query": "Building on these interactions between ion pair reagents and the stationary phase, how can adsorption isotherm data for tributylammonium acetate and triethylammonium acetate help optimize separation efficiency and resolution for complex oligonucleotide mixtures? What innovative approaches could be developed to improve the specificity and selectivity of these separations based on these findings?", "history": ["What role do ion pair reagents play in chromatography techniques?", "How does understanding their interaction with the stationary phase impact the separation of complex mixtures using this technique?"], "ground_truth": ["permed-73196", "permed-85983", "permed-79873", "permed-86643", "permed-89026", "permed-79870", "permed-88146", "permed-66552", "permed-58057", "permed-79872"]}
{"query_id": "topic_233_turn_4", "conversation_id": "topic_233", "turn_id": 4, "query": "Given the adsorption isotherm data for these ion-pairing reagents, what specific chromatographic parameters should be systematically adjusted during method optimization? I'm particularly interested in how we might implement a gradient elution strategy that accounts for the differential adsorption behaviors of tributylammonium versus triethylammonium acetate. Should we prioritize column temperature, flow rate, or gradient slope as primary variables when translating these isotherm findings into practical separation protocols? What statistical design of experiments approach would best capture the interaction effects between these parameters?", "history": ["What role do ion pair reagents play in chromatography techniques?", "How does understanding their interaction with the stationary phase impact the separation of complex mixtures using this technique?", "Building on these interactions between ion pair reagents and the stationary phase, how can adsorption isotherm data for tributylammonium acetate and triethylammonium acetate help optimize separation efficiency and resolution for complex oligonucleotide mixtures? What innovative approaches could be developed to improve the specificity and selectivity of these separations based on these findings?"], "ground_truth": ["permed-73196", "permed-85983", "permed-88991", "permed-84219", "permed-77161", "permed-89023", "permed-88146", "permed-79873", "permed-79870", "permed-52783"]}
{"query_id": "topic_234_turn_1", "conversation_id": "topic_234", "turn_id": 1, "query": "What role does surface morphology play in the properties of biomaterials like PCL-CA scaffolds?", "history": [], "ground_truth": ["permed-82176", "permed-87323", "permed-79898", "permed-82179", "permed-64485", "permed-57769", "permed-76053", "permed-76867", "permed-64575", "permed-67603"]}
{"query_id": "topic_234_turn_2", "conversation_id": "topic_234", "turn_id": 2, "query": "How can modifying it at the microscale or nanoscale impact their performance in biomedical applications?", "history": ["What role does surface morphology play in the properties of biomaterials like PCL-CA scaffolds?"], "ground_truth": ["permed-64579", "permed-51339", "permed-75267", "permed-77893", "permed-58043", "permed-82300", "permed-60899", "permed-91200", "permed-64486", "permed-60836"]}
{"query_id": "topic_234_turn_3", "conversation_id": "topic_234", "turn_id": 3, "query": "Given how surface morphology affects these PCL-CA scaffolds' properties, and considering the potential of microscale or nanoscale modifications to improve their performance, how could we optimize those surface features specifically to enhance both hemocompatibility and mechanical strength? What fabrication techniques would be most promising for achieving this optimization in biomedical applications?", "history": ["What role does surface morphology play in the properties of biomaterials like PCL-CA scaffolds?", "How can modifying it at the microscale or nanoscale impact their performance in biomedical applications?"], "ground_truth": ["permed-82176", "permed-87323", "permed-76867", "permed-64395", "permed-79898", "permed-64400", "permed-64575", "permed-64491", "permed-67414", "permed-64485"]}
{"query_id": "topic_234_turn_4", "conversation_id": "topic_234", "turn_id": 4, "query": "Given these proposed fabrication techniques for optimizing PCL-CA scaffolds, what specific characterization protocols would you recommend for systematically evaluating both hemocompatibility and mechanical properties? I'm particularly interested in the standardized testing methods for blood-material interactions, the specific mechanical testing parameters (e.g., compression/stress-strain protocols), and how to correlate these datasets to establish structure-property relationships. Additionally, what statistical validation approaches would ensure reproducibility across different fabrication batches?", "history": ["What role does surface morphology play in the properties of biomaterials like PCL-CA scaffolds?", "How can modifying it at the microscale or nanoscale impact their performance in biomedical applications?", "Given how surface morphology affects these PCL-CA scaffolds' properties, and considering the potential of microscale or nanoscale modifications to improve their performance, how could we optimize those surface features specifically to enhance both hemocompatibility and mechanical strength? What fabrication techniques would be most promising for achieving this optimization in biomedical applications?"], "ground_truth": ["permed-87323", "permed-82176", "permed-64456", "permed-64395", "permed-57625", "permed-57376", "permed-76267", "permed-75701", "permed-67603", "permed-64636"]}
{"query_id": "topic_235_turn_1", "conversation_id": "topic_235", "turn_id": 1, "query": "What role do organophotocatalysts play in organic transformations?", "history": [], "ground_truth": ["permed-58008", "permed-51008", "permed-51009", "permed-51006", "permed-55271", "permed-58016", "permed-74925", "permed-79274", "permed-76835", "permed-88472"]}
{"query_id": "topic_235_turn_2", "conversation_id": "topic_235", "turn_id": 2, "query": "How can the properties of these photocatalysts, like carbazole-based ones, be optimized for better performance in such reactions?", "history": ["What role do organophotocatalysts play in organic transformations?"], "ground_truth": ["permed-51009", "permed-79083", "permed-51014", "permed-78259", "permed-55232", "permed-51012", "permed-87961", "permed-78258", "permed-53776", "permed-60907"]}
{"query_id": "topic_235_turn_3", "conversation_id": "topic_235", "turn_id": 3, "query": "Given their importance in organic transformations and the need to optimize their properties, how can we systematically modify the electronic characteristics of these carbazole-based photocatalysts—particularly their excited state oxidation potentials and lifetimes—to improve their efficiency and selectivity in visible light-driven reactions beyond just producing vicinal diols and diamines?", "history": ["What role do organophotocatalysts play in organic transformations?", "How can the properties of these photocatalysts, like carbazole-based ones, be optimized for better performance in such reactions?"], "ground_truth": ["permed-51009", "permed-79083", "permed-51014", "permed-78259", "permed-60907", "permed-78029", "permed-53776", "permed-51011", "permed-51006", "permed-75407"]}
{"query_id": "topic_235_turn_4", "conversation_id": "topic_235", "turn_id": 4, "query": "Considering these systematic modifications to carbazole-based photocatalysts' electronic characteristics, what specific electrochemical and spectroscopic techniques would you recommend for quantitatively tracking changes in excited state oxidation potentials and lifetimes? I'm particularly interested in the methodological details for correlating time-resolved absorption measurements with electrochemical data, and how to validate that observed changes in these parameters directly correspond to improved photocatalytic efficiency in our reaction systems.", "history": ["What role do organophotocatalysts play in organic transformations?", "How can the properties of these photocatalysts, like carbazole-based ones, be optimized for better performance in such reactions?", "Given their importance in organic transformations and the need to optimize their properties, how can we systematically modify the electronic characteristics of these carbazole-based photocatalysts—particularly their excited state oxidation potentials and lifetimes—to improve their efficiency and selectivity in visible light-driven reactions beyond just producing vicinal diols and diamines?"], "ground_truth": ["permed-51009", "permed-60907", "permed-78259", "permed-74576", "permed-74688", "permed-74516", "permed-79083", "permed-51014", "permed-78773", "permed-78029"]}
{"query_id": "topic_236_turn_1", "conversation_id": "topic_236", "turn_id": 1, "query": "Core contributions of feminist theory to contemporary healthcare and bioethics", "history": [], "ground_truth": ["permed-54375", "permed-91926", "permed-66153", "permed-53042", "permed-54379", "permed-66148", "permed-7131", "permed-74581", "permed-74729", "permed-71648"]}
{"query_id": "topic_236_turn_2", "conversation_id": "topic_236", "turn_id": 2, "query": "Applying these feminist bioethical insights: implications for health policy development and patient-centered care practices", "history": ["Core contributions of feminist theory to contemporary healthcare and bioethics"], "ground_truth": ["permed-54375", "permed-53038", "permed-66153", "permed-74859", "permed-91926", "permed-53039", "permed-53040", "permed-74855", "permed-66148", "permed-68405"]}
{"query_id": "topic_236_turn_3", "conversation_id": "topic_236", "turn_id": 3, "query": "Feminist epistemology in health research: methodologies for analyzing emotional labor in caregiving and designing responsive psychosocial interventions", "history": ["Core contributions of feminist theory to contemporary healthcare and bioethics", "Applying these feminist bioethical insights: implications for health policy development and patient-centered care practices"], "ground_truth": ["permed-66153", "permed-70065", "permed-80767", "permed-91926", "permed-54375", "permed-60971", "permed-69887", "permed-75160", "permed-67553", "permed-69535"]}
{"query_id": "topic_236_turn_4", "conversation_id": "topic_236", "turn_id": 4, "query": "Given this epistemological framework, could you detail the specific qualitative coding procedures used to categorize emotional labor in caregiving transcripts? I'm particularly interested in how researcher positionality was systematically documented during data analysis, and what inter-coder reliability measures were implemented to ensure consistent interpretation of emotionally nuanced narratives while maintaining feminist methodological integrity.", "history": ["Core contributions of feminist theory to contemporary healthcare and bioethics", "Applying these feminist bioethical insights: implications for health policy development and patient-centered care practices", "Feminist epistemology in health research: methodologies for analyzing emotional labor in caregiving and designing responsive psychosocial interventions"], "ground_truth": ["permed-80767", "permed-69470", "permed-69535", "permed-85715", "permed-34416", "permed-57558", "permed-78394", "permed-50866", "permed-51858", "permed-69955"]}
{"query_id": "topic_237_turn_1", "conversation_id": "topic_237", "turn_id": 1, "query": "What impact does socioeconomic status have on the effectiveness of social welfare policies for families in crisis?", "history": [], "ground_truth": ["permed-61461", "permed-71649", "permed-77916", "permed-86027", "permed-54389", "permed-65183", "permed-39462", "permed-75380", "permed-56010", "permed-53062"]}
{"query_id": "topic_237_turn_2", "conversation_id": "topic_237", "turn_id": 2, "query": "How does this relationship change when factors like racial identity and intimate partner violence are also considered?", "history": ["What impact does socioeconomic status have on the effectiveness of social welfare policies for families in crisis?"], "ground_truth": ["permed-91062", "permed-80342", "permed-69816", "permed-50521", "permed-69678", "permed-70186", "permed-91030", "permed-84489", "permed-80095", "permed-84487"]}
{"query_id": "topic_237_turn_3", "conversation_id": "topic_237", "turn_id": 3, "query": "Given these intersecting factors—socioeconomic status, racial identity, and intimate partner violence—how might they specifically shape the effectiveness of programs like TANF in supporting affected families? And what targeted policy changes could better address their unique challenges?", "history": ["What impact does socioeconomic status have on the effectiveness of social welfare policies for families in crisis?", "How does this relationship change when factors like racial identity and intimate partner violence are also considered?"], "ground_truth": ["permed-80082", "permed-80081", "permed-52796", "permed-69991", "permed-54389", "permed-70632", "permed-80083", "permed-78380", "permed-63578", "permed-69646"]}
{"query_id": "topic_237_turn_4", "conversation_id": "topic_237", "turn_id": 4, "query": "When designing a study to investigate these intersecting factors in TANF program effectiveness, what specific methodological approaches would you recommend for quantifying their combined impact? I'm particularly interested in the statistical modeling—would a multilevel model accounting for individual, household, and community-level variables be most appropriate, or are there alternative analytical frameworks better suited for capturing such complex interactions? How should researchers establish causal pathways while maintaining methodological rigor given the observational nature of most policy data?", "history": ["What impact does socioeconomic status have on the effectiveness of social welfare policies for families in crisis?", "How does this relationship change when factors like racial identity and intimate partner violence are also considered?", "Given these intersecting factors—socioeconomic status, racial identity, and intimate partner violence—how might they specifically shape the effectiveness of programs like TANF in supporting affected families? And what targeted policy changes could better address their unique challenges?"], "ground_truth": ["permed-80081", "permed-80082", "permed-35839", "permed-55479", "permed-34892", "permed-79201", "permed-35363", "permed-33668", "permed-73929", "permed-53878"]}
{"query_id": "topic_238_turn_1", "conversation_id": "topic_238", "turn_id": 1, "query": "What is known about the aggregation states of amyloid-beta peptides and their role in disease?", "history": [], "ground_truth": ["permed-53306", "permed-54225", "permed-58070", "permed-80235", "permed-85259", "permed-58074", "permed-58072", "permed-72606", "permed-63310", "permed-74982"]}
{"query_id": "topic_238_turn_2", "conversation_id": "topic_238", "turn_id": 2, "query": "Can computational models effectively simulate this process, particularly under conditions similar to those in the human body?", "history": ["What is known about the aggregation states of amyloid-beta peptides and their role in disease?"], "ground_truth": ["permed-64452", "permed-72010", "permed-56815", "permed-60181", "permed-83052", "permed-84060", "permed-86920", "permed-57514", "permed-64564", "permed-77302"]}
{"query_id": "topic_238_turn_3", "conversation_id": "topic_238", "turn_id": 3, "query": "Given these computational approaches, how could they be specifically adapted to model the dynamic shifts between amyloid-beta aggregation states under near-physiological conditions? And what might such simulations reveal about potential therapeutic targets that could disrupt toxic oligomer formation?", "history": ["What is known about the aggregation states of amyloid-beta peptides and their role in disease?", "Can computational models effectively simulate this process, particularly under conditions similar to those in the human body?"], "ground_truth": ["permed-53306", "permed-58070", "permed-80235", "permed-54225", "permed-54229", "permed-58072", "permed-58074", "permed-51174", "permed-85259", "permed-63310"]}
{"query_id": "topic_238_turn_4", "conversation_id": "topic_238", "turn_id": 4, "query": "Building on these computational approaches for modeling dynamic aggregation shifts, what specific molecular dynamics protocols would you implement to capture transient oligomer states? I'm particularly interested in force field parameterization strategies for amyloid-beta under near-physiological ion concentrations, and how you'd validate these simulations against experimental biophysical data like single-molecule FRET or cryo-EM to ensure the observed transitions aren't simulation artifacts. What sampling enhancement techniques would be most appropriate for capturing these rare conformational changes?", "history": ["What is known about the aggregation states of amyloid-beta peptides and their role in disease?", "Can computational models effectively simulate this process, particularly under conditions similar to those in the human body?", "Given these computational approaches, how could they be specifically adapted to model the dynamic shifts between amyloid-beta aggregation states under near-physiological conditions? And what might such simulations reveal about potential therapeutic targets that could disrupt toxic oligomer formation?"], "ground_truth": ["permed-53306", "permed-80236", "permed-80235", "permed-79509", "permed-85259", "permed-71539", "permed-75068", "permed-75071", "permed-54225", "permed-71540"]}
{"query_id": "topic_239_turn_1", "conversation_id": "topic_239", "turn_id": 1, "query": "What role do probiotics play in treating gastrointestinal disorders?", "history": [], "ground_truth": ["permed-79278", "permed-79279", "permed-71831", "permed-74534", "permed-56491", "permed-63200", "permed-81519", "permed-73873", "permed-65029", "permed-66699"]}
{"query_id": "topic_239_turn_2", "conversation_id": "topic_239", "turn_id": 2, "query": "Can manipulating the adhesion properties of probiotics enhance their therapeutic effects in this area?", "history": ["What role do probiotics play in treating gastrointestinal disorders?"], "ground_truth": ["permed-79278", "permed-79279", "permed-62066", "permed-66699", "permed-76192", "permed-73873", "permed-68064", "permed-72297", "permed-66745", "permed-74534"]}
{"query_id": "topic_239_turn_3", "conversation_id": "topic_239", "turn_id": 3, "query": "Given that probiotic adhesion properties can enhance their therapeutic effects, how exactly could we manipulate the molecular interactions between their adhesion factors and host cells to further improve treatment outcomes for gastrointestinal disorders? What are the key technical hurdles and ethical implications of genetically engineering probiotics for this purpose?", "history": ["What role do probiotics play in treating gastrointestinal disorders?", "Can manipulating the adhesion properties of probiotics enhance their therapeutic effects in this area?"], "ground_truth": ["permed-79278", "permed-79279", "permed-74534", "permed-73873", "permed-58977", "permed-66699", "permed-76192", "permed-55474", "permed-71831", "permed-66745"]}
{"query_id": "topic_239_turn_4", "conversation_id": "topic_239", "turn_id": 4, "query": "Following this genetic engineering approach, what specific molecular techniques would be most effective for modifying probiotic adhesion factors? I'm particularly interested in comparing CRISPR-Cas9 systems versus traditional plasmid-based methods for introducing targeted mutations in adhesion genes. What validation protocols would you recommend to confirm both the genetic modifications and functional adhesion improvements while ensuring strain stability? Additionally, how should we design in vitro assays to quantitatively measure changes in adhesion kinetics and specificity before proceeding to animal models?", "history": ["What role do probiotics play in treating gastrointestinal disorders?", "Can manipulating the adhesion properties of probiotics enhance their therapeutic effects in this area?", "Given that probiotic adhesion properties can enhance their therapeutic effects, how exactly could we manipulate the molecular interactions between their adhesion factors and host cells to further improve treatment outcomes for gastrointestinal disorders? What are the key technical hurdles and ethical implications of genetically engineering probiotics for this purpose?"], "ground_truth": ["permed-79278", "permed-82089", "permed-55474", "permed-82091", "permed-88245", "permed-72297", "permed-77018", "permed-92559", "permed-63746", "permed-92543"]}
{"query_id": "topic_240_turn_1", "conversation_id": "topic_240", "turn_id": 1, "query": "Mechanisms linking liver steatosis, intestinal barrier dysfunction, and metabolic syndrome: an overview", "history": [], "ground_truth": ["permed-75552", "permed-62733", "permed-64874", "permed-62717", "permed-58590", "permed-62731", "permed-57747", "permed-65176", "permed-62667", "permed-68865"]}
{"query_id": "topic_240_turn_2", "conversation_id": "topic_240", "turn_id": 2, "query": "Based on these mechanisms, what is the evidence for improving intestinal barrier function to mitigate liver steatosis and metabolic syndrome progression?", "history": ["Mechanisms linking liver steatosis, intestinal barrier dysfunction, and metabolic syndrome: an overview"], "ground_truth": ["permed-64874", "permed-58590", "permed-68053", "permed-75552", "permed-68865", "permed-53742", "permed-58977", "permed-9838", "permed-59095", "permed-57665"]}
{"query_id": "topic_240_turn_3", "conversation_id": "topic_240", "turn_id": 3, "query": "Targeted probiotics and dietary strategies for MAFLD: effects on intestinal permeability (diamine oxidase, D-lactate), disease progression, and long-term metabolic outcomes.", "history": ["Mechanisms linking liver steatosis, intestinal barrier dysfunction, and metabolic syndrome: an overview", "Based on these mechanisms, what is the evidence for improving intestinal barrier function to mitigate liver steatosis and metabolic syndrome progression?"], "ground_truth": ["permed-75552", "permed-82561", "permed-67842", "permed-62667", "permed-58594", "permed-58590", "permed-58977", "permed-82562", "permed-51265", "permed-59032"]}
{"query_id": "topic_240_turn_4", "conversation_id": "topic_240", "turn_id": 4, "query": "When implementing these probiotic and dietary interventions in clinical studies, what specific methodologies are used to quantify changes in intestinal permeability markers like diamine oxidase and D-lactate? I'm particularly interested in the analytical techniques for serum biomarker measurement, sampling frequency protocols to capture temporal changes, and how researchers control for dietary variations that might independently affect these markers. Additionally, what statistical approaches are typically employed to correlate permeability improvements with histological liver outcomes?", "history": ["Mechanisms linking liver steatosis, intestinal barrier dysfunction, and metabolic syndrome: an overview", "Based on these mechanisms, what is the evidence for improving intestinal barrier function to mitigate liver steatosis and metabolic syndrome progression?", "Targeted probiotics and dietary strategies for MAFLD: effects on intestinal permeability (diamine oxidase, D-lactate), disease progression, and long-term metabolic outcomes."], "ground_truth": ["permed-76186", "permed-66659", "permed-58977", "permed-75552", "permed-58594", "permed-77187", "permed-76192", "permed-64874", "permed-71817", "permed-84661"]}
{"query_id": "topic_241_turn_1", "conversation_id": "topic_241", "turn_id": 1, "query": "Scope of psychological, physical, social, and financial challenges for family caregivers of older adults with dementia", "history": [], "ground_truth": ["permed-77535", "permed-75012", "permed-77536", "permed-77539", "permed-79334", "permed-77530", "permed-50970", "permed-51743", "permed-78106", "permed-78107"]}
{"query_id": "topic_241_turn_2", "conversation_id": "topic_241", "turn_id": 2, "query": "How do these psychological, physical, social, and financial caregiving challenges influence family decisions for nursing home placement of dementia patients, and what are the critical precipitating factors?", "history": ["Scope of psychological, physical, social, and financial challenges for family caregivers of older adults with dementia"], "ground_truth": ["permed-77535", "permed-77528", "permed-90893", "permed-77536", "permed-77530", "permed-50871", "permed-63325", "permed-75012", "permed-72708", "permed-52113"]}
{"query_id": "topic_241_turn_3", "conversation_id": "topic_241", "turn_id": 3, "query": "Evidence-based interventions to alleviate specific caregiver burdens (psychological, physical, financial, social) and delay institutionalization for dementia patients: comparing efficacy for spousal versus adult-child caregivers based on unique stressors and institutionalization pathways.", "history": ["Scope of psychological, physical, social, and financial challenges for family caregivers of older adults with dementia", "How do these psychological, physical, social, and financial caregiving challenges influence family decisions for nursing home placement of dementia patients, and what are the critical precipitating factors?"], "ground_truth": ["permed-77535", "permed-56935", "permed-75682", "permed-75012", "permed-78107", "permed-67553", "permed-77536", "permed-50962", "permed-78104", "permed-75010"]}
{"query_id": "topic_241_turn_4", "conversation_id": "topic_241", "turn_id": 4, "query": "In the comparative analysis of caregiver interventions, what specific methodological approaches were employed to statistically differentiate efficacy between spousal and adult-child caregiver groups? Were propensity score matching or multivariate regression techniques used to control for confounders like baseline burden severity or patient dementia stage? Additionally, how did researchers validate intervention fidelity across different delivery modalities, and what quality control measures ensured reproducible outcomes across diverse caregiver populations?", "history": ["Scope of psychological, physical, social, and financial challenges for family caregivers of older adults with dementia", "How do these psychological, physical, social, and financial caregiving challenges influence family decisions for nursing home placement of dementia patients, and what are the critical precipitating factors?", "Evidence-based interventions to alleviate specific caregiver burdens (psychological, physical, financial, social) and delay institutionalization for dementia patients: comparing efficacy for spousal versus adult-child caregivers based on unique stressors and institutionalization pathways."], "ground_truth": ["permed-21153", "permed-40917", "permed-56935", "permed-88305", "permed-67553", "permed-77535", "permed-82573", "permed-86911", "permed-75682", "permed-86676"]}
{"query_id": "topic_242_turn_1", "conversation_id": "topic_242", "turn_id": 1, "query": "**Factors influencing photostability of mixed-halide perovskite nanocrystals**", "history": [], "ground_truth": ["permed-76877", "permed-86731", "permed-77387", "permed-60960", "permed-90126", "permed-77385", "permed-78704", "permed-78702", "permed-73234", "permed-83323"]}
{"query_id": "topic_242_turn_2", "conversation_id": "topic_242", "turn_id": 2, "query": "**Impact of size and surface chemistry of these nanocrystals on their photostability and photosegregation under photoirradiation**", "history": ["**Factors influencing photostability of mixed-halide perovskite nanocrystals**"], "ground_truth": ["permed-76877", "permed-60321", "permed-90126", "permed-75451", "permed-91723", "permed-74688", "permed-73155", "permed-60900", "permed-55263", "permed-53782"]}
{"query_id": "topic_242_turn_3", "conversation_id": "topic_242", "turn_id": 3, "query": "**Influence of surface-to-volume ratio and surface defects on anion segregation dynamics and photostability in CsPb(I<sub>0.5</sub>Br<sub>0.5</sub>)<sub>3</sub> nanocrystals under prolonged irradiation, and surface modification strategies for enhanced device stability**", "history": ["**Factors influencing photostability of mixed-halide perovskite nanocrystals**", "**Impact of size and surface chemistry of these nanocrystals on their photostability and photosegregation under photoirradiation**"], "ground_truth": ["permed-90126", "permed-76877", "permed-77387", "permed-73242", "permed-77392", "permed-73234", "permed-78702", "permed-76088", "permed-77384", "permed-74972"]}
{"query_id": "topic_242_turn_4", "conversation_id": "topic_242", "turn_id": 4, "query": "Given your focus on surface modification strategies for CsPb(I<sub>0.5</sub>Br<sub>0.5</sub>)<sub>3</sub> nanocrystals, could you elaborate on the specific characterization protocols used to quantify surface defect passivation? I'm particularly interested in how you distinguished between different defect types through spectroscopic techniques, the quantification methods for assessing ligand coverage density, and whether you employed any in-situ monitoring approaches to track surface chemistry changes during prolonged irradiation stability testing.", "history": ["**Factors influencing photostability of mixed-halide perovskite nanocrystals**", "**Impact of size and surface chemistry of these nanocrystals on their photostability and photosegregation under photoirradiation**", "**Influence of surface-to-volume ratio and surface defects on anion segregation dynamics and photostability in CsPb(I<sub>0.5</sub>Br<sub>0.5</sub>)<sub>3</sub> nanocrystals under prolonged irradiation, and surface modification strategies for enhanced device stability**"], "ground_truth": ["permed-90126", "permed-73242", "permed-75675", "permed-75757", "permed-53789", "permed-77387", "permed-77384", "permed-75671", "permed-77392", "permed-78702"]}
{"query_id": "topic_243_turn_1", "conversation_id": "topic_243", "turn_id": 1, "query": "Determinants of diagnostic success in thyroid fine-needle aspiration (FNA) biopsy", "history": [], "ground_truth": ["permed-77622", "permed-71797", "permed-65280", "permed-77623", "permed-60283", "permed-77625", "permed-65278", "permed-91145", "permed-91144", "permed-77472"]}
{"query_id": "topic_243_turn_2", "conversation_id": "topic_243", "turn_id": 2, "query": "Influence of needle gauge on sample quality and diagnostic accuracy in these thyroid FNA biopsies", "history": ["Determinants of diagnostic success in thyroid fine-needle aspiration (FNA) biopsy"], "ground_truth": ["permed-77622", "permed-71797", "permed-77623", "permed-65284", "permed-65280", "permed-60283", "permed-91145", "permed-43619", "permed-77625", "permed-91144"]}
{"query_id": "topic_243_turn_3", "conversation_id": "topic_243", "turn_id": 3, "query": "Cellular and molecular basis for needle gauge-induced variations in thyroid FNA diagnostic yield and implications for technique refinement", "history": ["Determinants of diagnostic success in thyroid fine-needle aspiration (FNA) biopsy", "Influence of needle gauge on sample quality and diagnostic accuracy in these thyroid FNA biopsies"], "ground_truth": ["permed-77622", "permed-71797", "permed-77623", "permed-65284", "permed-65280", "permed-60283", "permed-77625", "permed-42804", "permed-65282", "permed-91145"]}
{"query_id": "topic_243_turn_4", "conversation_id": "topic_243", "turn_id": 4, "query": "Given these molecular variations tied to needle gauge, what specific protocols were used to standardize sample processing and RNA extraction across different gauge specimens? I'm particularly interested in how researchers controlled for potential biases during cytological preparation and whether any normalization strategies were implemented for downstream molecular analyses like RNA sequencing to ensure comparable results between gauge groups despite differing cellularity and potential hemodilution effects.", "history": ["Determinants of diagnostic success in thyroid fine-needle aspiration (FNA) biopsy", "Influence of needle gauge on sample quality and diagnostic accuracy in these thyroid FNA biopsies", "Cellular and molecular basis for needle gauge-induced variations in thyroid FNA diagnostic yield and implications for technique refinement"], "ground_truth": ["permed-5709", "permed-4647", "permed-70841", "permed-81684", "permed-67049", "permed-77622", "permed-91599", "permed-76854", "permed-72860", "permed-82607"]}
{"query_id": "topic_244_turn_1", "conversation_id": "topic_244", "turn_id": 1, "query": "Are there any notable effects of COVID-19 or its vaccination on the ocular surface?", "history": [], "ground_truth": ["permed-82068", "permed-82066", "permed-62491", "permed-82071", "permed-82065", "permed-82067", "permed-69355", "permed-82072", "permed-16076", "permed-92124"]}
{"query_id": "topic_244_turn_2", "conversation_id": "topic_244", "turn_id": 2, "query": "How might these effects impact tear film stability in different populations, particularly when comparing those who have recovered from COVID-19 to healthy individuals?", "history": ["Are there any notable effects of COVID-19 or its vaccination on the ocular surface?"], "ground_truth": ["permed-82065", "permed-82071", "permed-82066", "permed-82075", "permed-82067", "permed-72877", "permed-51263", "permed-69355", "permed-62387", "permed-92124"]}
{"query_id": "topic_244_turn_3", "conversation_id": "topic_244", "turn_id": 3, "query": "What's actually causing these tear film stability differences we're seeing between post-COVID recovery, post-vaccination, and healthy groups—and how could understanding those mechanisms help us better manage and treat ocular surface conditions in these populations long-term?", "history": ["Are there any notable effects of COVID-19 or its vaccination on the ocular surface?", "How might these effects impact tear film stability in different populations, particularly when comparing those who have recovered from COVID-19 to healthy individuals?"], "ground_truth": ["permed-82065", "permed-82066", "permed-82067", "permed-82068", "permed-82075", "permed-82071", "permed-69355", "permed-59001", "permed-89236", "permed-75594"]}
{"query_id": "topic_244_turn_4", "conversation_id": "topic_244", "turn_id": 4, "query": "Given the mechanistic pathways you've outlined, what specific experimental protocols would you recommend for validating these proposed mechanisms? I'm particularly interested in the technical implementation - would you use multiplex cytokine profiling of tear samples, proteomic analysis of specific inflammatory markers, or perhaps confocal microscopy to examine conjunctival immune cell infiltration? Also, what statistical approaches would be most appropriate for establishing causal relationships between these molecular changes and the observed clinical tear film instability across the different patient groups?", "history": ["Are there any notable effects of COVID-19 or its vaccination on the ocular surface?", "How might these effects impact tear film stability in different populations, particularly when comparing those who have recovered from COVID-19 to healthy individuals?", "What's actually causing these tear film stability differences we're seeing between post-COVID recovery, post-vaccination, and healthy groups—and how could understanding those mechanisms help us better manage and treat ocular surface conditions in these populations long-term?"], "ground_truth": ["permed-41522", "permed-41872", "permed-67107", "permed-41673", "permed-16572", "permed-82065", "permed-16579", "permed-16585", "permed-41874", "permed-16580"]}
{"query_id": "topic_245_turn_1", "conversation_id": "topic_245", "turn_id": 1, "query": "What role does wastewater treatment play in the spread of antibiotic resistance genes?", "history": [], "ground_truth": ["permed-82010", "permed-66820", "permed-68507", "permed-63444", "permed-68509", "permed-77903", "permed-51279", "permed-66818", "permed-90146", "permed-82233"]}
{"query_id": "topic_245_turn_2", "conversation_id": "topic_245", "turn_id": 2, "query": "Can high-throughput sequencing techniques be effectively applied in this area to monitor and understand the movement of these genes?", "history": ["What role does wastewater treatment play in the spread of antibiotic resistance genes?"], "ground_truth": ["permed-53719", "permed-76846", "permed-52491", "permed-53717", "permed-52496", "permed-5261", "permed-52492", "permed-63928", "permed-53718", "permed-87628"]}
{"query_id": "topic_245_turn_3", "conversation_id": "topic_245", "turn_id": 3, "query": "Given these high-throughput sequencing techniques for monitoring antibiotic resistance genes in wastewater, how could we extend their application to evaluate the long-term public health and environmental impacts of these genes? And what mitigation strategies could be developed based on such findings?", "history": ["What role does wastewater treatment play in the spread of antibiotic resistance genes?", "Can high-throughput sequencing techniques be effectively applied in this area to monitor and understand the movement of these genes?"], "ground_truth": ["permed-68507", "permed-82010", "permed-63444", "permed-66820", "permed-62045", "permed-90146", "permed-63445", "permed-63448", "permed-67116", "permed-66818"]}
{"query_id": "topic_245_turn_4", "conversation_id": "topic_245", "turn_id": 4, "query": "Regarding this longitudinal monitoring approach for assessing public health impacts, what specific statistical methods would be most appropriate for establishing causal relationships between antibiotic resistance gene abundance in wastewater and clinical resistance rates over time? Particularly, how should we handle temporal autocorrelation and confounding variables like seasonal variations in antibiotic usage or population mobility when analyzing these extended time series datasets?", "history": ["What role does wastewater treatment play in the spread of antibiotic resistance genes?", "Can high-throughput sequencing techniques be effectively applied in this area to monitor and understand the movement of these genes?", "Given these high-throughput sequencing techniques for monitoring antibiotic resistance genes in wastewater, how could we extend their application to evaluate the long-term public health and environmental impacts of these genes? And what mitigation strategies could be developed based on such findings?"], "ground_truth": ["permed-68507", "permed-62945", "permed-63448", "permed-90146", "permed-63451", "permed-82010", "permed-82230", "permed-63444", "permed-68914", "permed-63445"]}
{"query_id": "topic_246_turn_1", "conversation_id": "topic_246", "turn_id": 1, "query": "Definition and prevalence of incidentalomas detected during breast cancer screening", "history": [], "ground_truth": ["permed-75848", "permed-68647", "permed-75849", "permed-90436", "permed-85505", "permed-89594", "permed-74620", "permed-86442", "permed-56436", "permed-85504"]}
{"query_id": "topic_246_turn_2", "conversation_id": "topic_246", "turn_id": 2, "query": "Impact of discovery method (e.g., PET-CT scans) on management and follow-up strategies for these incidental breast findings", "history": ["Definition and prevalence of incidentalomas detected during breast cancer screening"], "ground_truth": ["permed-75848", "permed-75849", "permed-68647", "permed-28412", "permed-90434", "permed-30634", "permed-28277", "permed-18626", "permed-90436", "permed-56436"]}
{"query_id": "topic_246_turn_3", "conversation_id": "topic_246", "turn_id": 3, "query": "Variations in clinical management of breast incidentalomas detected by 18-FDG PET-CT: role of multimodal imaging, impact on patient outcomes and psychological well-being", "history": ["Definition and prevalence of incidentalomas detected during breast cancer screening", "Impact of discovery method (e.g., PET-CT scans) on management and follow-up strategies for these incidental breast findings"], "ground_truth": ["permed-75848", "permed-18626", "permed-3227", "permed-3633", "permed-21492", "permed-23985", "permed-3234", "permed-5108", "permed-32089", "permed-75849"]}
{"query_id": "topic_246_turn_4", "conversation_id": "topic_246", "turn_id": 4, "query": "Given the documented variations in clinical management of PET-CT-detected breast incidentalomas, what specific imaging protocols and diagnostic algorithms were implemented across different institutions to standardize characterization? I'm particularly interested in how facilities validated their multimodal imaging integration approaches - did they employ quantitative parameters like SUVmax thresholds combined with BI-RADS criteria, and what statistical methods were used to assess inter-observer reliability in interpreting these combined modality findings?", "history": ["Definition and prevalence of incidentalomas detected during breast cancer screening", "Impact of discovery method (e.g., PET-CT scans) on management and follow-up strategies for these incidental breast findings", "Variations in clinical management of breast incidentalomas detected by 18-FDG PET-CT: role of multimodal imaging, impact on patient outcomes and psychological well-being"], "ground_truth": ["permed-75848", "permed-28624", "permed-19376", "permed-18513", "permed-90434", "permed-5365", "permed-48542", "permed-56436", "permed-85061", "permed-75849"]}
{"query_id": "topic_247_turn_1", "conversation_id": "topic_247", "turn_id": 1, "query": "Pharmacogenomic testing applications in pediatric mental health treatment", "history": [], "ground_truth": ["permed-74814", "permed-61661", "permed-74816", "permed-74815", "permed-86355", "permed-52935", "permed-50786", "permed-53717", "permed-85591", "permed-77549"]}
{"query_id": "topic_247_turn_2", "conversation_id": "topic_247", "turn_id": 2, "query": "How does integrating such pharmacogenomic testing influence clinical decisions and treatment efficacy for pediatric anxiety and ADHD?", "history": ["Pharmacogenomic testing applications in pediatric mental health treatment"], "ground_truth": ["permed-74814", "permed-61661", "permed-69172", "permed-74815", "permed-86355", "permed-74816", "permed-50786", "permed-53128", "permed-86808", "permed-81290"]}
{"query_id": "topic_247_turn_3", "conversation_id": "topic_247", "turn_id": 3, "query": "For pediatric patients with comorbid anxiety, MDD, and ADHD, how does pharmacogenomic-informed treatment (considering markers beyond CYP450 and SLC6A4) specifically affect long-term medication adherence and quality of life?", "history": ["Pharmacogenomic testing applications in pediatric mental health treatment", "How does integrating such pharmacogenomic testing influence clinical decisions and treatment efficacy for pediatric anxiety and ADHD?"], "ground_truth": ["permed-74814", "permed-61661", "permed-74815", "permed-69172", "permed-86355", "permed-78193", "permed-81290", "permed-53118", "permed-70518", "permed-89394"]}
{"query_id": "topic_247_turn_4", "conversation_id": "topic_247", "turn_id": 4, "query": "In implementing this pharmacogenomic-informed approach for pediatric comorbidities, what specific statistical methodologies were employed to establish causality between genetic markers and long-term adherence outcomes? Were propensity score matching or instrumental variable analyses used to address confounding by indication, and what quality control measures ensured reproducibility across multiple testing platforms when incorporating non-CYP450/SLC6A4 markers?", "history": ["Pharmacogenomic testing applications in pediatric mental health treatment", "How does integrating such pharmacogenomic testing influence clinical decisions and treatment efficacy for pediatric anxiety and ADHD?", "For pediatric patients with comorbid anxiety, MDD, and ADHD, how does pharmacogenomic-informed treatment (considering markers beyond CYP450 and SLC6A4) specifically affect long-term medication adherence and quality of life?"], "ground_truth": ["permed-74814", "permed-61661", "permed-71083", "permed-77549", "permed-58880", "permed-50782", "permed-52935", "permed-74815", "permed-50786", "permed-86355"]}
{"query_id": "topic_248_turn_1", "conversation_id": "topic_248", "turn_id": 1, "query": "What role do magnetic nanoparticles play in targeted drug delivery systems?", "history": [], "ground_truth": ["permed-68903", "permed-91064", "permed-91065", "permed-89162", "permed-60841", "permed-51332", "permed-68480", "permed-72909", "permed-75820", "permed-72499"]}
{"query_id": "topic_248_turn_2", "conversation_id": "topic_248", "turn_id": 2, "query": "How can the configuration of these nanoparticles be optimized to improve the efficiency of this technique?", "history": ["What role do magnetic nanoparticles play in targeted drug delivery systems?"], "ground_truth": ["permed-74446", "permed-71745", "permed-71744", "permed-53578", "permed-77394", "permed-79258", "permed-73086", "permed-83597", "permed-76881", "permed-58041"]}
{"query_id": "topic_248_turn_3", "conversation_id": "topic_248", "turn_id": 3, "query": "Given the potential of optimizing these nanoparticles' configuration, how could further refinement of magnetic field gradients and their geometric arrangement within hydrogels improve the precision and efficiency of such targeted drug delivery systems? Additionally, what challenges might arise when scaling these optimized systems for clinical use, and how could they be addressed?", "history": ["What role do magnetic nanoparticles play in targeted drug delivery systems?", "How can the configuration of these nanoparticles be optimized to improve the efficiency of this technique?"], "ground_truth": ["permed-80130", "permed-91064", "permed-72972", "permed-75389", "permed-72909", "permed-91065", "permed-76767", "permed-64489", "permed-75001", "permed-58083"]}
{"query_id": "topic_248_turn_4", "conversation_id": "topic_248", "turn_id": 4, "query": "Building on these geometric arrangements within hydrogels, could you detail the specific protocols for quantifying magnetic field gradients in 3D space during experimental validation? What instrumentation and calibration standards would ensure accurate measurement of nanoparticle displacement vectors? Additionally, regarding statistical analysis, what multivariate models would best account for both spatial distribution and temporal release kinetics when assessing targeting precision? Finally, how should quality control protocols be implemented to maintain reproducibility across hydrogel batches with embedded nanoparticle arrays?", "history": ["What role do magnetic nanoparticles play in targeted drug delivery systems?", "How can the configuration of these nanoparticles be optimized to improve the efficiency of this technique?", "Given the potential of optimizing these nanoparticles' configuration, how could further refinement of magnetic field gradients and their geometric arrangement within hydrogels improve the precision and efficiency of such targeted drug delivery systems? Additionally, what challenges might arise when scaling these optimized systems for clinical use, and how could they be addressed?"], "ground_truth": ["permed-80130", "permed-76767", "permed-72972", "permed-75386", "permed-76158", "permed-72909", "permed-76285", "permed-75001", "permed-64489", "permed-18628"]}
{"query_id": "topic_249_turn_1", "conversation_id": "topic_249", "turn_id": 1, "query": "What are the current treatment approaches for acute cholecystitis in elderly patients?", "history": [], "ground_truth": ["permed-76784", "permed-76786", "permed-33840", "permed-0148", "permed-55008", "permed-54587", "permed-1102", "permed-85630", "permed-17309", "permed-81344"]}
{"query_id": "topic_249_turn_2", "conversation_id": "topic_249", "turn_id": 2, "query": "How does the timing of surgical intervention, such as cholecystectomy, impact outcomes in this patient population?", "history": ["What are the current treatment approaches for acute cholecystitis in elderly patients?"], "ground_truth": ["permed-76784", "permed-50694", "permed-33840", "permed-32718", "permed-76783", "permed-33835", "permed-76786", "permed-55011", "permed-81343", "permed-52033"]}
{"query_id": "topic_249_turn_3", "conversation_id": "topic_249", "turn_id": 3, "query": "Given these considerations about treatment timing and outcomes, how do patient-specific factors like comorbidities and physiological reserve affect the decision between early versus delayed cholecystectomy in elderly patients with acute cholecystitis, especially for those who've had percutaneous transhepatic gallbladder drainage?", "history": ["What are the current treatment approaches for acute cholecystitis in elderly patients?", "How does the timing of surgical intervention, such as cholecystectomy, impact outcomes in this patient population?"], "ground_truth": ["permed-76784", "permed-0148", "permed-76786", "permed-17021", "permed-60024", "permed-78917", "permed-2803", "permed-17023", "permed-55012", "permed-76783"]}
{"query_id": "topic_249_turn_4", "conversation_id": "topic_249", "turn_id": 4, "query": "Given this patient-specific decision framework, what specific methods were used to stratify physiological reserve and quantify cumulative comorbidity burden in these elderly patients? How were these parameters statistically weighted in the surgical timing algorithm, and what validation approaches ensured the reliability of this risk assessment tool across different healthcare settings?", "history": ["What are the current treatment approaches for acute cholecystitis in elderly patients?", "How does the timing of surgical intervention, such as cholecystectomy, impact outcomes in this patient population?", "Given these considerations about treatment timing and outcomes, how do patient-specific factors like comorbidities and physiological reserve affect the decision between early versus delayed cholecystectomy in elderly patients with acute cholecystitis, especially for those who've had percutaneous transhepatic gallbladder drainage?"], "ground_truth": ["permed-10832", "permed-0159", "permed-59965", "permed-58630", "permed-84037", "permed-91331", "permed-54948", "permed-80279", "permed-61421", "permed-25696"]}
{"query_id": "topic_250_turn_1", "conversation_id": "topic_250", "turn_id": 1, "query": "What role do peptide amphiphiles play in biomedical research, especially regarding drug delivery systems?", "history": [], "ground_truth": ["permed-60894", "permed-57953", "permed-76103", "permed-72499", "permed-67987", "permed-53309", "permed-86044", "permed-58081", "permed-89509", "permed-72971"]}
{"query_id": "topic_250_turn_2", "conversation_id": "topic_250", "turn_id": 2, "query": "How can modifications to their structure, such as incorporating intrinsically disordered regions, enhance this capability?", "history": ["What role do peptide amphiphiles play in biomedical research, especially regarding drug delivery systems?"], "ground_truth": ["permed-71541", "permed-80237", "permed-71086", "permed-73085", "permed-53316", "permed-61290", "permed-75071", "permed-71539", "permed-75067", "permed-77127"]}
{"query_id": "topic_250_turn_3", "conversation_id": "topic_250", "turn_id": 3, "query": "Given that incorporating intrinsically disordered regions can enhance their drug delivery capabilities, how could we specifically tailor the enzymatic sensitivity of these peptide amphiphiles through amino acid modifications? And how might such tailored IDPAs improve targeted therapeutic delivery in complex biological environments?", "history": ["What role do peptide amphiphiles play in biomedical research, especially regarding drug delivery systems?", "How can modifications to their structure, such as incorporating intrinsically disordered regions, enhance this capability?"], "ground_truth": ["permed-73085", "permed-60684", "permed-62604", "permed-77291", "permed-60682", "permed-60820", "permed-85303", "permed-85305", "permed-60690", "permed-58078"]}
{"query_id": "topic_250_turn_4", "conversation_id": "topic_250", "turn_id": 4, "query": "Regarding the enzymatic sensitivity optimization you mentioned, what specific experimental protocols would you recommend for systematically testing the degradation kinetics of these tailored IDPAs? I'm particularly interested in methodological details - which enzyme assays would provide the most reliable data, what statistical approaches should be used to compare degradation rates across modifications, and how should we validate that the observed cleavage patterns actually correlate with enhanced drug release in physiologically relevant conditions?", "history": ["What role do peptide amphiphiles play in biomedical research, especially regarding drug delivery systems?", "How can modifications to their structure, such as incorporating intrinsically disordered regions, enhance this capability?", "Given that incorporating intrinsically disordered regions can enhance their drug delivery capabilities, how could we specifically tailor the enzymatic sensitivity of these peptide amphiphiles through amino acid modifications? And how might such tailored IDPAs improve targeted therapeutic delivery in complex biological environments?"], "ground_truth": ["permed-73085", "permed-84848", "permed-72464", "permed-73040", "permed-52782", "permed-58154", "permed-79294", "permed-85984", "permed-80564", "permed-88695"]}
{"query_id": "topic_251_turn_1", "conversation_id": "topic_251", "turn_id": 1, "query": "Latest non-invasive colorectal cancer screening methods overview", "history": [], "ground_truth": ["permed-85505", "permed-75339", "permed-85506", "permed-51385", "permed-0351", "permed-4221", "permed-1045", "permed-78479", "permed-34753", "permed-4219"]}
{"query_id": "topic_251_turn_2", "conversation_id": "topic_251", "turn_id": 2, "query": "Impact of combining these novel screening approaches, particularly stool DNA tests, on colorectal cancer detection accuracy in at-risk groups", "history": ["Latest non-invasive colorectal cancer screening methods overview"], "ground_truth": ["permed-75339", "permed-34755", "permed-34756", "permed-75342", "permed-37291", "permed-37292", "permed-1047", "permed-34935", "permed-34749", "permed-85505"]}
{"query_id": "topic_251_turn_3", "conversation_id": "topic_251", "turn_id": 3, "query": "Clinical utility of stool DNA testing plus serum biomarkers versus stool DNA plus imaging for early colorectal cancer detection in high-risk Chinese cohorts: comparative accuracy and cost-effectiveness analysis", "history": ["Latest non-invasive colorectal cancer screening methods overview", "Impact of combining these novel screening approaches, particularly stool DNA tests, on colorectal cancer detection accuracy in at-risk groups"], "ground_truth": ["permed-75339", "permed-37292", "permed-34755", "permed-34756", "permed-34749", "permed-1047", "permed-34935", "permed-37291", "permed-85505", "permed-75342"]}
{"query_id": "topic_251_turn_4", "conversation_id": "topic_251", "turn_id": 4, "query": "Given this comparative design, could you elaborate on the specific statistical methods used to validate the diagnostic accuracy metrics between these two combination approaches? I'm particularly interested in how you calculated and compared sensitivity/specificity with confidence intervals, whether you used McNemar's test for paired proportions, and what sample size justification was employed to ensure adequate power for detecting clinically meaningful differences in detection rates between the stool DNA plus biomarkers versus stool DNA plus imaging arms.", "history": ["Latest non-invasive colorectal cancer screening methods overview", "Impact of combining these novel screening approaches, particularly stool DNA tests, on colorectal cancer detection accuracy in at-risk groups", "Clinical utility of stool DNA testing plus serum biomarkers versus stool DNA plus imaging for early colorectal cancer detection in high-risk Chinese cohorts: comparative accuracy and cost-effectiveness analysis"], "ground_truth": ["permed-75339", "permed-34755", "permed-34756", "permed-56147", "permed-37291", "permed-56142", "permed-28946", "permed-56361", "permed-87842", "permed-23680"]}
{"query_id": "topic_252_turn_1", "conversation_id": "topic_252", "turn_id": 1, "query": "Key determinants of mental health among immigrant caregivers", "history": [], "ground_truth": ["permed-65949", "permed-75010", "permed-57845", "permed-75160", "permed-84839", "permed-75012", "permed-66153", "permed-60135", "permed-75011", "permed-65261"]}
{"query_id": "topic_252_turn_2", "conversation_id": "topic_252", "turn_id": 2, "query": "How does acculturation modify *these mental health determinants* for immigrant caregivers, comparing experiences of first-generation and subsequent generations?", "history": ["Key determinants of mental health among immigrant caregivers"], "ground_truth": ["permed-75010", "permed-57845", "permed-60135", "permed-65949", "permed-75012", "permed-63578", "permed-52798", "permed-69470", "permed-69900", "permed-69898"]}
{"query_id": "topic_252_turn_3", "conversation_id": "topic_252", "turn_id": 3, "query": "Moderating effects of community support and healthcare access on mental health outcomes: acculturation strategies and caregiving burden in first-generation vs. later-generation immigrant caregivers.", "history": ["Key determinants of mental health among immigrant caregivers", "How does acculturation modify *these mental health determinants* for immigrant caregivers, comparing experiences of first-generation and subsequent generations?"], "ground_truth": ["permed-75010", "permed-60135", "permed-65949", "permed-57845", "permed-75012", "permed-65796", "permed-63578", "permed-77536", "permed-78107", "permed-53167"]}
{"query_id": "topic_252_turn_4", "conversation_id": "topic_252", "turn_id": 4, "query": "When implementing this moderated moderation analysis examining community support and healthcare access, what specific statistical approaches did you employ to validate the three-way interaction models? I'm particularly interested in how you addressed potential multicollinearity between acculturation strategies and caregiving burden measures, and what bootstrapping or robustness checks were implemented to ensure the reliability of these complex interaction effects across different generational strata.", "history": ["Key determinants of mental health among immigrant caregivers", "How does acculturation modify *these mental health determinants* for immigrant caregivers, comparing experiences of first-generation and subsequent generations?", "Moderating effects of community support and healthcare access on mental health outcomes: acculturation strategies and caregiving burden in first-generation vs. later-generation immigrant caregivers."], "ground_truth": ["permed-75010", "permed-26082", "permed-61864", "permed-63578", "permed-60168", "permed-77536", "permed-60135", "permed-25774", "permed-88629", "permed-50514"]}
{"query_id": "topic_253_turn_1", "conversation_id": "topic_253", "turn_id": 1, "query": "What role does the lateral occipitotemporal cortex play in object recognition and tool use?", "history": [], "ground_truth": ["permed-79325", "permed-66509", "permed-79326", "permed-66513", "permed-59259", "permed-79329", "permed-66532", "permed-81792", "permed-88619", "permed-88618"]}
{"query_id": "topic_253_turn_2", "conversation_id": "topic_253", "turn_id": 2, "query": "How might expertise in using specific tools impact the development or function of this area?", "history": ["What role does the lateral occipitotemporal cortex play in object recognition and tool use?"], "ground_truth": ["permed-79326", "permed-82651", "permed-83189", "permed-52810", "permed-55107", "permed-86233", "permed-70065", "permed-52082", "permed-91516", "permed-79325"]}
{"query_id": "topic_253_turn_3", "conversation_id": "topic_253", "turn_id": 3, "query": "How does integrating causal event schemas with tool use influence the development and plasticity of the LOTC, particularly in individuals with different expertise levels, and what does this reveal about the neural mechanisms behind tool-related object recognition and action planning?", "history": ["What role does the lateral occipitotemporal cortex play in object recognition and tool use?", "How might expertise in using specific tools impact the development or function of this area?"], "ground_truth": ["permed-79325", "permed-79326", "permed-59327", "permed-66438", "permed-88611", "permed-81107", "permed-61595", "permed-66530", "permed-69410", "permed-69411"]}
{"query_id": "topic_253_turn_4", "conversation_id": "topic_253", "turn_id": 4, "query": "Given this investigation into causal event schemas, what specific experimental paradigms are most appropriate for directly manipulating the integration of these schemas during tool-use tasks? I'm particularly interested in the methodological details for an fMRI study—how would we design task blocks and control conditions to isolate LOTC plasticity in novices versus experts, and what statistical modeling approaches (e.g., multivariate pattern analysis, psychophysiological interaction) would best quantify the resulting neural changes in connectivity and representational geometry?", "history": ["What role does the lateral occipitotemporal cortex play in object recognition and tool use?", "How might expertise in using specific tools impact the development or function of this area?", "How does integrating causal event schemas with tool use influence the development and plasticity of the LOTC, particularly in individuals with different expertise levels, and what does this reveal about the neural mechanisms behind tool-related object recognition and action planning?"], "ground_truth": ["permed-79325", "permed-92400", "permed-69441", "permed-82748", "permed-66438", "permed-77859", "permed-66534", "permed-52247", "permed-52241", "permed-66452"]}
{"query_id": "topic_254_turn_1", "conversation_id": "topic_254", "turn_id": 1, "query": "Guided implant surgery: impact on osseointegration and dental implant primary stability", "history": [], "ground_truth": ["permed-75144", "permed-73880", "permed-75129", "permed-83123", "permed-75145", "permed-83125", "permed-83124", "permed-75180", "permed-75234", "permed-75176"]}
{"query_id": "topic_254_turn_2", "conversation_id": "topic_254", "turn_id": 2, "query": "Considering *its impact*, how do simplified drilling protocols in guided implant surgery affect clinical efficiency and osseointegration outcomes?", "history": ["Guided implant surgery: impact on osseointegration and dental implant primary stability"], "ground_truth": ["permed-75143", "permed-75129", "permed-75144", "permed-83123", "permed-73880", "permed-75234", "permed-75145", "permed-83125", "permed-75233", "permed-75182"]}
{"query_id": "topic_254_turn_3", "conversation_id": "topic_254", "turn_id": 3, "query": "Biomechanical and histological effects of modified drilling protocols (e.g., varied drill sequence, step omission) in guided implant surgery on peri-implant bone and long-term implant success.", "history": ["Guided implant surgery: impact on osseointegration and dental implant primary stability", "Considering *its impact*, how do simplified drilling protocols in guided implant surgery affect clinical efficiency and osseointegration outcomes?"], "ground_truth": ["permed-75129", "permed-75143", "permed-75145", "permed-83123", "permed-75123", "permed-68120", "permed-75182", "permed-75180", "permed-75144", "permed-75119"]}
{"query_id": "topic_254_turn_4", "conversation_id": "topic_254", "turn_id": 4, "query": "When implementing these modified drilling protocols, what specific instrumentation and validation methods are used to ensure precise osteotomy preparation? I'm particularly interested in the torque measurement protocols during implant placement and whether any finite element analysis was employed to model bone stress distribution following protocol modifications. How were drilling forces quantitatively monitored, and what statistical approaches were used to correlate these mechanical parameters with histological bone quality assessments?", "history": ["Guided implant surgery: impact on osseointegration and dental implant primary stability", "Considering *its impact*, how do simplified drilling protocols in guided implant surgery affect clinical efficiency and osseointegration outcomes?", "Biomechanical and histological effects of modified drilling protocols (e.g., varied drill sequence, step omission) in guided implant surgery on peri-implant bone and long-term implant success."], "ground_truth": ["permed-75144", "permed-75129", "permed-75143", "permed-75145", "permed-53157", "permed-75127", "permed-75204", "permed-83125", "permed-20199", "permed-63251"]}
{"query_id": "topic_255_turn_1", "conversation_id": "topic_255", "turn_id": 1, "query": "What alternative therapies are being explored to improve the quality of life for children undergoing chemotherapy?", "history": [], "ground_truth": ["permed-78672", "permed-67789", "permed-32557", "permed-24437", "permed-79191", "permed-78671", "permed-67388", "permed-76010", "permed-51819", "permed-78674"]}
{"query_id": "topic_255_turn_2", "conversation_id": "topic_255", "turn_id": 2, "query": "How effective is acupressure, in particular, in reducing stress and anxiety in this patient population?", "history": ["What alternative therapies are being explored to improve the quality of life for children undergoing chemotherapy?"], "ground_truth": ["permed-14751", "permed-40911", "permed-50519", "permed-64592", "permed-78671", "permed-69767", "permed-92401", "permed-11081", "permed-60970", "permed-92196"]}
{"query_id": "topic_255_turn_3", "conversation_id": "topic_255", "turn_id": 3, "query": "How does incorporating acupressure into pediatric oncology nursing routines impact children's long-term quality of life and emotional well-being during chemotherapy, and what effect does this have on parental satisfaction and their perceptions of care?", "history": ["What alternative therapies are being explored to improve the quality of life for children undergoing chemotherapy?", "How effective is acupressure, in particular, in reducing stress and anxiety in this patient population?"], "ground_truth": ["permed-78671", "permed-82958", "permed-51979", "permed-78672", "permed-69066", "permed-76010", "permed-32319", "permed-11091", "permed-74746", "permed-83999"]}
{"query_id": "topic_255_turn_4", "conversation_id": "topic_255", "turn_id": 4, "query": "Given this nursing-integrated acupressure approach, what specific methodological considerations were implemented to ensure treatment fidelity across different nursing shifts? I'm particularly interested in the standardization protocols for acupressure point localization and pressure application, the training methodology for nursing staff competency assessment, and how you quantitatively monitored adherence to the intervention protocol while accounting for individual patient tolerance variations in the pediatric oncology setting.", "history": ["What alternative therapies are being explored to improve the quality of life for children undergoing chemotherapy?", "How effective is acupressure, in particular, in reducing stress and anxiety in this patient population?", "How does incorporating acupressure into pediatric oncology nursing routines impact children's long-term quality of life and emotional well-being during chemotherapy, and what effect does this have on parental satisfaction and their perceptions of care?"], "ground_truth": ["permed-78671", "permed-51783", "permed-89865", "permed-89414", "permed-54339", "permed-54476", "permed-66048", "permed-55151", "permed-60198", "permed-55157"]}
{"query_id": "topic_256_turn_1", "conversation_id": "topic_256", "turn_id": 1, "query": "What advancements have been made in the topical treatment of cutaneous leishmaniasis using nanoparticles?", "history": [], "ground_truth": ["permed-62050", "permed-62108", "permed-75192", "permed-62105", "permed-89629", "permed-54697", "permed-72220", "permed-62103", "permed-62107", "permed-60821"]}
{"query_id": "topic_256_turn_2", "conversation_id": "topic_256", "turn_id": 2, "query": "How do the properties of these nanoparticles, such as silver-based formulations, affect their interaction with the skin and overall therapeutic efficacy?", "history": ["What advancements have been made in the topical treatment of cutaneous leishmaniasis using nanoparticles?"], "ground_truth": ["permed-78955", "permed-92530", "permed-62058", "permed-67532", "permed-80640", "permed-80641", "permed-62997", "permed-62050", "permed-79258", "permed-87638"]}
{"query_id": "topic_256_turn_3", "conversation_id": "topic_256", "turn_id": 3, "query": "Given these promising findings with MTCAg nanoparticles for topical leishmaniasis treatment, how might their physicochemical properties—like zeta potential and particle size—affect their interaction with the skin barrier and cellular uptake? And what would these interactions mean for the long-term safety and efficacy of MTCAg-loaded emulgels?", "history": ["What advancements have been made in the topical treatment of cutaneous leishmaniasis using nanoparticles?", "How do the properties of these nanoparticles, such as silver-based formulations, affect their interaction with the skin and overall therapeutic efficacy?"], "ground_truth": ["permed-62050", "permed-89636", "permed-60669", "permed-62108", "permed-51332", "permed-78120", "permed-79166", "permed-62047", "permed-60275", "permed-68480"]}
{"query_id": "topic_256_turn_4", "conversation_id": "topic_256", "turn_id": 4, "query": "For the MTCAg nanoparticle characterization mentioned, what specific analytical techniques were employed to determine zeta potential and particle size distributions? Were dynamic light scattering measurements validated using electron microscopy, and what quality control thresholds ensured batch-to-batch reproducibility in particle morphology? Additionally, could you detail the experimental protocol for assessing cellular uptake kinetics—particularly whether flow cytometry with specific fluorescent markers or confocal microscopy with z-stacking was utilized to quantify internalization rates in different skin cell layers?", "history": ["What advancements have been made in the topical treatment of cutaneous leishmaniasis using nanoparticles?", "How do the properties of these nanoparticles, such as silver-based formulations, affect their interaction with the skin and overall therapeutic efficacy?", "Given these promising findings with MTCAg nanoparticles for topical leishmaniasis treatment, how might their physicochemical properties—like zeta potential and particle size—affect their interaction with the skin barrier and cellular uptake? And what would these interactions mean for the long-term safety and efficacy of MTCAg-loaded emulgels?"], "ground_truth": ["permed-76193", "permed-53305", "permed-62050", "permed-62047", "permed-90819", "permed-57866", "permed-88570", "permed-51159", "permed-57868", "permed-53569"]}
{"query_id": "topic_257_turn_1", "conversation_id": "topic_257", "turn_id": 1, "query": "What role does predictive analytics play in managing pulmonary arterial hypertension (PAH)?", "history": [], "ground_truth": ["permed-77816", "permed-61788", "permed-52533", "permed-69127", "permed-57113", "permed-57108", "permed-57110", "permed-57114", "permed-70473", "permed-69126"]}
{"query_id": "topic_257_turn_2", "conversation_id": "topic_257", "turn_id": 2, "query": "Can integrating it with patient-specific biomarkers improve treatment outcomes for PAH patients?", "history": ["What role does predictive analytics play in managing pulmonary arterial hypertension (PAH)?"], "ground_truth": ["permed-57108", "permed-82105", "permed-57113", "permed-57109", "permed-70473", "permed-52533", "permed-57110", "permed-52532", "permed-69112", "permed-57118"]}
{"query_id": "topic_257_turn_3", "conversation_id": "topic_257", "turn_id": 3, "query": "Given this integration of predictive analytics and patient-specific biomarkers for PAH, how might it improve the timing and appropriateness of palliative care referrals? What long-term effects could this approach have on patients' quality of life and healthcare resource utilization?", "history": ["What role does predictive analytics play in managing pulmonary arterial hypertension (PAH)?", "Can integrating it with patient-specific biomarkers improve treatment outcomes for PAH patients?"], "ground_truth": ["permed-80805", "permed-77816", "permed-68648", "permed-74825", "permed-90539", "permed-87590", "permed-86676", "permed-82105", "permed-69127", "permed-57113"]}
{"query_id": "topic_257_turn_4", "conversation_id": "topic_257", "turn_id": 4, "query": "Given this integrated approach for optimizing palliative care timing, what specific statistical validation methods would be most appropriate for determining the predictive accuracy of biomarker thresholds in PAH? I'm particularly interested in how one would establish confidence intervals for time-to-referral predictions and what sample size calculations would be necessary to ensure adequate power for detecting significant improvements in both quality of life metrics and healthcare utilization outcomes.", "history": ["What role does predictive analytics play in managing pulmonary arterial hypertension (PAH)?", "Can integrating it with patient-specific biomarkers improve treatment outcomes for PAH patients?", "Given this integration of predictive analytics and patient-specific biomarkers for PAH, how might it improve the timing and appropriateness of palliative care referrals? What long-term effects could this approach have on patients' quality of life and healthcare resource utilization?"], "ground_truth": ["permed-80805", "permed-87590", "permed-51747", "permed-77816", "permed-74804", "permed-86676", "permed-60196", "permed-90539", "permed-56678", "permed-83222"]}
{"query_id": "topic_258_turn_1", "conversation_id": "topic_258", "turn_id": 1, "query": "What effects do static magnetic fields have on cellular development and tissue growth, particularly in bone formation?", "history": [], "ground_truth": ["permed-58220", "permed-79547", "permed-54878", "permed-75175", "permed-58213", "permed-65023", "permed-54888", "permed-51469", "permed-15091", "permed-70794"]}
{"query_id": "topic_258_turn_2", "conversation_id": "topic_258", "turn_id": 2, "query": "How might this technique specifically influence the development of the mandibular condyle, considering its complex structure and function?", "history": ["What effects do static magnetic fields have on cellular development and tissue growth, particularly in bone formation?"], "ground_truth": ["permed-52721", "permed-86938", "permed-69246", "permed-79547", "permed-64745", "permed-86936", "permed-82946", "permed-87737", "permed-64635", "permed-91849"]}
{"query_id": "topic_258_turn_3", "conversation_id": "topic_258", "turn_id": 3, "query": "Given that a 280 mT static magnetic field affects condylar chondrocytes through FLRT3, FGF2, and BMP2 signaling—influencing their proliferation, differentiation, and endochondral ossification—how might varying the timing and duration of exposure alter the balance between these pathways and the condyle's structural integrity during different postnatal stages? Furthermore, could these changes impact the mandible's long-term biomechanical properties and its responsiveness to orthopedic interventions later in life?", "history": ["What effects do static magnetic fields have on cellular development and tissue growth, particularly in bone formation?", "How might this technique specifically influence the development of the mandibular condyle, considering its complex structure and function?"], "ground_truth": ["permed-79547", "permed-79548", "permed-52721", "permed-54161", "permed-64452", "permed-58220", "permed-91596", "permed-86921", "permed-48573", "permed-92298"]}
{"query_id": "topic_258_turn_4", "conversation_id": "topic_258", "turn_id": 4, "query": "Given these signaling pathway interactions, what specific experimental protocols would you recommend for determining optimal exposure timing? Would pulsed versus continuous magnetic field application yield different outcomes in regulating FLRT3-FGF2-BMP2 crosstalk? Also, what statistical approaches would best capture the temporal dynamics of proliferation versus differentiation markers across different postnatal stages, particularly given the need to correlate molecular changes with structural integrity measurements?", "history": ["What effects do static magnetic fields have on cellular development and tissue growth, particularly in bone formation?", "How might this technique specifically influence the development of the mandibular condyle, considering its complex structure and function?", "Given that a 280 mT static magnetic field affects condylar chondrocytes through FLRT3, FGF2, and BMP2 signaling—influencing their proliferation, differentiation, and endochondral ossification—how might varying the timing and duration of exposure alter the balance between these pathways and the condyle's structural integrity during different postnatal stages? Furthermore, could these changes impact the mandible's long-term biomechanical properties and its responsiveness to orthopedic interventions later in life?"], "ground_truth": ["permed-79547", "permed-22402", "permed-89334", "permed-37899", "permed-48787", "permed-15830", "permed-22403", "permed-48573", "permed-85204", "permed-39793"]}
{"query_id": "topic_259_turn_1", "conversation_id": "topic_259", "turn_id": 1, "query": "Key psychological determinants of job satisfaction and burnout in teachers", "history": [], "ground_truth": ["permed-69784", "permed-69618", "permed-69619", "permed-69620", "permed-69786", "permed-69783", "permed-51855", "permed-69683", "permed-51853", "permed-69924"]}
{"query_id": "topic_259_turn_2", "conversation_id": "topic_259", "turn_id": 2, "query": "Exploring how these psychological determinants, particularly cognitive flexibility and psychological hardiness, interact to impact overall teacher well-being across different school environments.", "history": ["Key psychological determinants of job satisfaction and burnout in teachers"], "ground_truth": ["permed-74348", "permed-69683", "permed-69620", "permed-69619", "permed-69784", "permed-51856", "permed-74349", "permed-51855", "permed-69783", "permed-69786"]}
{"query_id": "topic_259_turn_3", "conversation_id": "topic_259", "turn_id": 3, "query": "Investigating the synergistic effects of cognitive flexibility, psychological hardiness, and adaptive humor styles on teacher job satisfaction versus burnout, considering contextual differences in urban and rural secondary schools and potential cultural moderators.", "history": ["Key psychological determinants of job satisfaction and burnout in teachers", "Exploring how these psychological determinants, particularly cognitive flexibility and psychological hardiness, interact to impact overall teacher well-being across different school environments."], "ground_truth": ["permed-74348", "permed-69784", "permed-69619", "permed-69618", "permed-69783", "permed-51855", "permed-91230", "permed-51556", "permed-65871", "permed-56910"]}
{"query_id": "topic_259_turn_4", "conversation_id": "topic_259", "turn_id": 4, "query": "Given this multi-dimensional investigation of teacher well-being factors, what specific methodological approaches would you recommend for capturing the synergistic effects between cognitive flexibility, psychological hardiness, and adaptive humor styles? I'm particularly interested in whether structural equation modeling would be appropriate for testing these complex interactions, and what validated instruments you would employ to measure these psychological constructs while maintaining cross-cultural validity across diverse urban and rural educational contexts.", "history": ["Key psychological determinants of job satisfaction and burnout in teachers", "Exploring how these psychological determinants, particularly cognitive flexibility and psychological hardiness, interact to impact overall teacher well-being across different school environments.", "Investigating the synergistic effects of cognitive flexibility, psychological hardiness, and adaptive humor styles on teacher job satisfaction versus burnout, considering contextual differences in urban and rural secondary schools and potential cultural moderators."], "ground_truth": ["permed-74348", "permed-84852", "permed-69683", "permed-89364", "permed-69620", "permed-51966", "permed-69618", "permed-58550", "permed-69619", "permed-69783"]}
{"query_id": "topic_260_turn_1", "conversation_id": "topic_260", "turn_id": 1, "query": "What role do amyloid fibers play in the formation of biocrystals?", "history": [], "ground_truth": ["permed-54225", "permed-80054", "permed-53306", "permed-72606", "permed-80235", "permed-82162", "permed-85259", "permed-79514", "permed-58068", "permed-58070"]}
{"query_id": "topic_260_turn_2", "conversation_id": "topic_260", "turn_id": 2, "query": "How do the structures formed by these amyloid fibers influence the optical properties of the resulting biocrystals?", "history": ["What role do amyloid fibers play in the formation of biocrystals?"], "ground_truth": ["permed-80054", "permed-54225", "permed-83288", "permed-53306", "permed-72606", "permed-80235", "permed-75274", "permed-73139", "permed-88992", "permed-75409"]}
{"query_id": "topic_260_turn_3", "conversation_id": "topic_260", "turn_id": 3, "query": "Given that these amyloid fibers form 20-nm-thick scaffolds for guanine crystal nucleation, what specific molecular mechanisms and signaling pathways drive their assembly? And how do these assembly processes ultimately affect the biocrystals' optical properties?", "history": ["What role do amyloid fibers play in the formation of biocrystals?", "How do the structures formed by these amyloid fibers influence the optical properties of the resulting biocrystals?"], "ground_truth": ["permed-80054", "permed-54225", "permed-53306", "permed-58068", "permed-72606", "permed-85259", "permed-77315", "permed-80235", "permed-76766", "permed-79509"]}
{"query_id": "topic_260_turn_4", "conversation_id": "topic_260", "turn_id": 4, "query": "Given these assembly mechanisms, what specific experimental approaches would best validate the proposed signaling pathways? I'm particularly interested in how one would technically distinguish between nucleation occurring directly on amyloid scaffolds versus through intermediate protein complexes. Would cryo-electron tomography with targeted labeling be sufficient to resolve these spatial relationships, or would we need complementary techniques like fluorescence resonance energy transfer to confirm molecular proximity during crystal formation?", "history": ["What role do amyloid fibers play in the formation of biocrystals?", "How do the structures formed by these amyloid fibers influence the optical properties of the resulting biocrystals?", "Given that these amyloid fibers form 20-nm-thick scaffolds for guanine crystal nucleation, what specific molecular mechanisms and signaling pathways drive their assembly? And how do these assembly processes ultimately affect the biocrystals' optical properties?"], "ground_truth": ["permed-85259", "permed-80235", "permed-53306", "permed-54225", "permed-58074", "permed-58072", "permed-79509", "permed-80054", "permed-72606", "permed-58070"]}
{"query_id": "topic_261_turn_1", "conversation_id": "topic_261", "turn_id": 1, "query": "Rhythmic skeletal muscle tension effects on heart rate variability: a comprehensive review", "history": [], "ground_truth": ["permed-77852", "permed-72012", "permed-69971", "permed-88747", "permed-75505", "permed-72010", "permed-57323", "permed-2070", "permed-18453", "permed-77857"]}
{"query_id": "topic_261_turn_2", "conversation_id": "topic_261", "turn_id": 2, "query": "Do the HRV effects of this rhythmic skeletal muscle tension significantly improve when combined with ancillary core muscle contractions (e.g., abdominal bracing)?", "history": ["Rhythmic skeletal muscle tension effects on heart rate variability: a comprehensive review"], "ground_truth": ["permed-77852", "permed-44442", "permed-88741", "permed-77856", "permed-70199", "permed-63055", "permed-70898", "permed-65649", "permed-69971", "permed-44352"]}
{"query_id": "topic_261_turn_3", "conversation_id": "topic_261", "turn_id": 3, "query": "Optimizing combined wrist-ankle RSMT and core contraction protocols for long-term HRV biofeedback in cardiovascular patients: dose-response (intensity/duration), neural pathways, and influence of baseline HRV.", "history": ["Rhythmic skeletal muscle tension effects on heart rate variability: a comprehensive review", "Do the HRV effects of this rhythmic skeletal muscle tension significantly improve when combined with ancillary core muscle contractions (e.g., abdominal bracing)?"], "ground_truth": ["permed-77852", "permed-69971", "permed-90297", "permed-91876", "permed-88351", "permed-68837", "permed-70199", "permed-84190", "permed-55179", "permed-88741"]}
{"query_id": "topic_261_turn_4", "conversation_id": "topic_261", "turn_id": 4, "query": "Given this combined protocol optimization, what specific statistical approaches would be most appropriate for analyzing the dose-response relationships between contraction intensity/duration and HRV changes? Should we employ mixed-effects models to account for repeated measurements and baseline HRV variability, and what power analysis considerations would ensure adequate detection of clinically meaningful effect sizes across different patient subgroups? Additionally, what quality control measures would you implement for the biofeedback equipment calibration and data collection consistency throughout the long-term intervention period?", "history": ["Rhythmic skeletal muscle tension effects on heart rate variability: a comprehensive review", "Do the HRV effects of this rhythmic skeletal muscle tension significantly improve when combined with ancillary core muscle contractions (e.g., abdominal bracing)?", "Optimizing combined wrist-ankle RSMT and core contraction protocols for long-term HRV biofeedback in cardiovascular patients: dose-response (intensity/duration), neural pathways, and influence of baseline HRV."], "ground_truth": ["permed-75506", "permed-91876", "permed-75505", "permed-69835", "permed-88741", "permed-77852", "permed-17555", "permed-70628", "permed-57394", "permed-70199"]}
{"query_id": "topic_262_turn_1", "conversation_id": "topic_262", "turn_id": 1, "query": "What role do denitrifying bioreactors play in treating agricultural runoff?", "history": [], "ground_truth": ["permed-80591", "permed-89585", "permed-66991", "permed-82396", "permed-80532", "permed-90411", "permed-53630", "permed-78333", "permed-66984", "permed-66983"]}
{"query_id": "topic_262_turn_2", "conversation_id": "topic_262", "turn_id": 2, "query": "How can the efficiency of these bioreactors be optimized to improve nitrate removal while minimizing potential drawbacks?", "history": ["What role do denitrifying bioreactors play in treating agricultural runoff?"], "ground_truth": ["permed-80591", "permed-53630", "permed-89585", "permed-90411", "permed-87935", "permed-66983", "permed-66987", "permed-82391", "permed-90410", "permed-66985"]}
{"query_id": "topic_262_turn_3", "conversation_id": "topic_262", "turn_id": 3, "query": "Given our discussion on optimizing these bioreactors for nitrate removal, how can we improve their long-term sustainability through better carbon dosing strategies—balancing enhanced nitrate removal with maintaining good hydraulic performance? Specifically, how do factors like dosing rate, frequency, and carbon source type influence this balance, and how could these insights help design more resilient systems for agricultural runoff treatment?", "history": ["What role do denitrifying bioreactors play in treating agricultural runoff?", "How can the efficiency of these bioreactors be optimized to improve nitrate removal while minimizing potential drawbacks?"], "ground_truth": ["permed-80591", "permed-53630", "permed-66964", "permed-89585", "permed-66983", "permed-66987", "permed-66985", "permed-66573", "permed-66991", "permed-73250"]}
{"query_id": "topic_262_turn_4", "conversation_id": "topic_262", "turn_id": 4, "query": "Considering this carbon dosing strategy framework, what specific experimental protocols would you recommend for systematically testing different carbon source types and dosing regimes in pilot-scale bioreactors? I'm particularly interested in methodological details about how to monitor hydraulic performance metrics alongside nitrate removal efficiency - what sampling frequencies, sensor placements, and statistical analyses would best capture the trade-offs between treatment efficacy and system clogging risks over extended operational periods?", "history": ["What role do denitrifying bioreactors play in treating agricultural runoff?", "How can the efficiency of these bioreactors be optimized to improve nitrate removal while minimizing potential drawbacks?", "Given our discussion on optimizing these bioreactors for nitrate removal, how can we improve their long-term sustainability through better carbon dosing strategies—balancing enhanced nitrate removal with maintaining good hydraulic performance? Specifically, how do factors like dosing rate, frequency, and carbon source type influence this balance, and how could these insights help design more resilient systems for agricultural runoff treatment?"], "ground_truth": ["permed-80591", "permed-53630", "permed-66983", "permed-66991", "permed-66985", "permed-90411", "permed-89585", "permed-80592", "permed-73250", "permed-66964"]}
{"query_id": "topic_263_turn_1", "conversation_id": "topic_263", "turn_id": 1, "query": "Mechanisms of human gut microbiome involvement in metabolic disorders.", "history": [], "ground_truth": ["permed-58592", "permed-65029", "permed-56496", "permed-58594", "permed-76633", "permed-84072", "permed-71560", "permed-51268", "permed-68062", "permed-71399"]}
{"query_id": "topic_263_turn_2", "conversation_id": "topic_263", "turn_id": 2, "query": "How does spatial organization of this gut microbiome influence its involvement in these metabolic disorders and potential for therapeutic intervention?", "history": ["Mechanisms of human gut microbiome involvement in metabolic disorders."], "ground_truth": ["permed-58592", "permed-56496", "permed-58594", "permed-76633", "permed-65029", "permed-71560", "permed-84072", "permed-51267", "permed-51268", "permed-62612"]}
{"query_id": "topic_263_turn_3", "conversation_id": "topic_263", "turn_id": 3, "query": "Leveraging gut microbiome spatial enzymology: strategies for developing targeted therapies for metabolic disorders based on secreted enzyme distribution and overcoming clinical translation barriers.", "history": ["Mechanisms of human gut microbiome involvement in metabolic disorders.", "How does spatial organization of this gut microbiome influence its involvement in these metabolic disorders and potential for therapeutic intervention?"], "ground_truth": ["permed-58161", "permed-71560", "permed-90392", "permed-56496", "permed-65029", "permed-58594", "permed-71399", "permed-62612", "permed-62614", "permed-76699"]}
{"query_id": "topic_263_turn_4", "conversation_id": "topic_263", "turn_id": 4, "query": "When implementing these spatial enzymology strategies, what specific analytical techniques would you recommend for quantifying secreted enzyme distributions along different gut regions? I'm particularly interested in how to validate spatial resolution claims - do researchers typically use multiplexed fluorescence in situ hybridization combined with activity-based probes, or are there more robust mass spectrometry imaging approaches? Also, what statistical methods best account for inter-individual variability when mapping enzyme gradients to therapeutic outcomes in preclinical models?", "history": ["Mechanisms of human gut microbiome involvement in metabolic disorders.", "How does spatial organization of this gut microbiome influence its involvement in these metabolic disorders and potential for therapeutic intervention?", "Leveraging gut microbiome spatial enzymology: strategies for developing targeted therapies for metabolic disorders based on secreted enzyme distribution and overcoming clinical translation barriers."], "ground_truth": ["permed-87163", "permed-58161", "permed-58250", "permed-58770", "permed-87520", "permed-53734", "permed-70767", "permed-52752", "permed-79175", "permed-79173"]}
{"query_id": "topic_264_turn_1", "conversation_id": "topic_264", "turn_id": 1, "query": "Is there a link between sleep patterns and cognitive processes like unguided thoughts?", "history": [], "ground_truth": ["permed-80364", "permed-73433", "permed-80365", "permed-70969", "permed-86873", "permed-71500", "permed-66431", "permed-70970", "permed-66428", "permed-72142"]}
{"query_id": "topic_264_turn_2", "conversation_id": "topic_264", "turn_id": 2, "query": "How might disturbances in this area impact overall mental health and well-being?", "history": ["Is there a link between sleep patterns and cognitive processes like unguided thoughts?"], "ground_truth": ["permed-66148", "permed-75160", "permed-51076", "permed-61782", "permed-60970", "permed-69628", "permed-60971", "permed-81995", "permed-55107", "permed-55751"]}
{"query_id": "topic_264_turn_3", "conversation_id": "topic_264", "turn_id": 3, "query": "Given these connections between sleep patterns, unguided thoughts, and mental health, how exactly does sleep quality and timing affect the cognitive mechanisms behind unguided thoughts? And what interventions might help improve both sleep and reduce these thoughts in people with poor sleep?", "history": ["Is there a link between sleep patterns and cognitive processes like unguided thoughts?", "How might disturbances in this area impact overall mental health and well-being?"], "ground_truth": ["permed-80364", "permed-69553", "permed-80365", "permed-59823", "permed-66428", "permed-86872", "permed-33540", "permed-73433", "permed-86873", "permed-80367"]}
{"query_id": "topic_264_turn_4", "conversation_id": "topic_264", "turn_id": 4, "query": "To investigate these cognitive mechanisms, what specific neuroimaging protocols would you recommend for tracking real-time unguided thought patterns during different sleep stages? I'm particularly interested in how fMRI preprocessing pipelines handle sleep-related motion artifacts, and whether there are validated methods for correlating spontaneous thought content with polysomnography data. What statistical approaches best capture the dynamic relationships between sleep architecture metrics and thought pattern variability across multiple recording sessions?", "history": ["Is there a link between sleep patterns and cognitive processes like unguided thoughts?", "How might disturbances in this area impact overall mental health and well-being?", "Given these connections between sleep patterns, unguided thoughts, and mental health, how exactly does sleep quality and timing affect the cognitive mechanisms behind unguided thoughts? And what interventions might help improve both sleep and reduce these thoughts in people with poor sleep?"], "ground_truth": ["permed-80364", "permed-40849", "permed-20421", "permed-73433", "permed-61688", "permed-29208", "permed-73439", "permed-29503", "permed-29435", "permed-48475"]}
{"query_id": "topic_265_turn_1", "conversation_id": "topic_265", "turn_id": 1, "query": "Applications of laccase enzymes in organic chemical synthesis reactions", "history": [], "ground_truth": ["permed-60645", "permed-64159", "permed-79813", "permed-89441", "permed-80926", "permed-82818", "permed-64164", "permed-64534", "permed-87583", "permed-82408"]}
{"query_id": "topic_265_turn_2", "conversation_id": "topic_265", "turn_id": 2, "query": "Efficiency of these laccase-mediated syntheses for complex nitrogen-containing molecules compared to traditional chemical methods", "history": ["Applications of laccase enzymes in organic chemical synthesis reactions"], "ground_truth": ["permed-60645", "permed-64159", "permed-64164", "permed-83754", "permed-72441", "permed-89441", "permed-76869", "permed-52998", "permed-87633", "permed-87158"]}
{"query_id": "topic_265_turn_3", "conversation_id": "topic_265", "turn_id": 3, "query": "Designing improved biocatalytic processes for complex nitrogen-containing molecules via laccase/oxidase/peroxidase catalyzed nitroso-ene reactions: mechanistic insights and sustainable manufacturing implications", "history": ["Applications of laccase enzymes in organic chemical synthesis reactions", "Efficiency of these laccase-mediated syntheses for complex nitrogen-containing molecules compared to traditional chemical methods"], "ground_truth": ["permed-57987", "permed-82408", "permed-64159", "permed-60472", "permed-88472", "permed-51650", "permed-60645", "permed-76836", "permed-86692", "permed-76963"]}
{"query_id": "topic_265_turn_4", "conversation_id": "topic_265", "turn_id": 4, "query": "Given these proposed biocatalytic processes for nitroso-ene reactions, what specific experimental protocols would you recommend for optimizing reaction conditions—particularly regarding enzyme immobilization techniques, solvent system selection for nitrogen-containing substrates, and methods for maintaining oxidase/peroxidase stability during scale-up? Also, what analytical validation strategies would be most appropriate for confirming reaction intermediates and monitoring enantioselectivity in these complex transformations?", "history": ["Applications of laccase enzymes in organic chemical synthesis reactions", "Efficiency of these laccase-mediated syntheses for complex nitrogen-containing molecules compared to traditional chemical methods", "Designing improved biocatalytic processes for complex nitrogen-containing molecules via laccase/oxidase/peroxidase catalyzed nitroso-ene reactions: mechanistic insights and sustainable manufacturing implications"], "ground_truth": ["permed-57987", "permed-80182", "permed-60472", "permed-51650", "permed-82647", "permed-58027", "permed-58022", "permed-75876", "permed-75875", "permed-76869"]}
{"query_id": "topic_266_turn_1", "conversation_id": "topic_266", "turn_id": 1, "query": "What role does digital marketing play in the business strategies of solopreneurs online?", "history": [], "ground_truth": ["permed-80398", "permed-62578", "permed-72184", "permed-80399", "permed-58418", "permed-66242", "permed-90042", "permed-61613", "permed-54001", "permed-81577"]}
{"query_id": "topic_266_turn_2", "conversation_id": "topic_266", "turn_id": 2, "query": "How do the principles from this area apply to understanding customer engagement, particularly in sensitive or stigmatized industries?", "history": ["What role does digital marketing play in the business strategies of solopreneurs online?"], "ground_truth": ["permed-69808", "permed-70067", "permed-85694", "permed-69912", "permed-52061", "permed-69827", "permed-52213", "permed-55109", "permed-78405", "permed-68372"]}
{"query_id": "topic_266_turn_3", "conversation_id": "topic_266", "turn_id": 3, "query": "Given these digital marketing principles and their application to sensitive industries, how can they specifically help us understand the engagement strategies employed by online sex workers? And how do these strategies differ from those used by non-sexual solopreneurs in building and maintaining customer relationships digitally?", "history": ["What role does digital marketing play in the business strategies of solopreneurs online?", "How do the principles from this area apply to understanding customer engagement, particularly in sensitive or stigmatized industries?"], "ground_truth": ["permed-80398", "permed-62282", "permed-80399", "permed-67097", "permed-62286", "permed-58308", "permed-62578", "permed-52192", "permed-85968", "permed-26265"]}
{"query_id": "topic_266_turn_4", "conversation_id": "topic_266", "turn_id": 4, "query": "Given this comparative framework for examining engagement strategies, what specific methodological approaches would you recommend for systematically analyzing the digital communication patterns between these two solopreneur groups? I'm particularly interested in the technical implementation - would you employ automated content analysis of platform interactions, structured coding of relationship-building tactics, or network analysis of customer engagement metrics? How might we validate these analytical methods to ensure reliable comparison while addressing the unique ethical considerations inherent in studying sensitive digital spaces?", "history": ["What role does digital marketing play in the business strategies of solopreneurs online?", "How do the principles from this area apply to understanding customer engagement, particularly in sensitive or stigmatized industries?", "Given these digital marketing principles and their application to sensitive industries, how can they specifically help us understand the engagement strategies employed by online sex workers? And how do these strategies differ from those used by non-sexual solopreneurs in building and maintaining customer relationships digitally?"], "ground_truth": ["permed-62578", "permed-80399", "permed-74380", "permed-80398", "permed-52192", "permed-52384", "permed-58481", "permed-56871", "permed-62575", "permed-71996"]}
{"query_id": "topic_267_turn_1", "conversation_id": "topic_267", "turn_id": 1, "query": "What is known about the relationship between climate factors and meningitis outbreaks?", "history": [], "ground_truth": ["permed-74167", "permed-68153", "permed-74172", "permed-74164", "permed-61304", "permed-74171", "permed-74173", "permed-70139", "permed-75618", "permed-35735"]}
{"query_id": "topic_267_turn_2", "conversation_id": "topic_267", "turn_id": 2, "query": "How might temperature variability, in particular, influence the incidence of meningitis in this context?", "history": ["What is known about the relationship between climate factors and meningitis outbreaks?"], "ground_truth": ["permed-74167", "permed-74172", "permed-74171", "permed-80045", "permed-74164", "permed-74162", "permed-33865", "permed-82228", "permed-74173", "permed-74165"]}
{"query_id": "topic_267_turn_3", "conversation_id": "topic_267", "turn_id": 3, "query": "Building on this connection between temperature variability and meningitis incidence, how do other climatic factors like humidity and precipitation interact with temperature to shape the geographical distribution and seasonal patterns of outbreaks in vulnerable regions? Furthermore, how might socioeconomic factors—such as healthcare access and vaccination rates—influence the impact of these climate variables, and what would integrated climate-health models need to account for to better predict and mitigate risks under different climate scenarios?", "history": ["What is known about the relationship between climate factors and meningitis outbreaks?", "How might temperature variability, in particular, influence the incidence of meningitis in this context?"], "ground_truth": ["permed-74167", "permed-74171", "permed-74173", "permed-74164", "permed-61304", "permed-80045", "permed-74162", "permed-74172", "permed-80069", "permed-74165"]}
{"query_id": "topic_267_turn_4", "conversation_id": "topic_267", "turn_id": 4, "query": "Given the complex interactions between temperature, humidity, precipitation, and socioeconomic factors discussed, what specific statistical modeling approaches—such as generalized additive models or machine learning algorithms—are most appropriate for quantifying these multivariate relationships while controlling for confounding variables? Additionally, how should researchers validate these integrated climate-health models to ensure their predictive accuracy across different geographical scales and climate scenarios, particularly regarding cross-validation strategies and handling of spatial autocorrelation in outbreak data?", "history": ["What is known about the relationship between climate factors and meningitis outbreaks?", "How might temperature variability, in particular, influence the incidence of meningitis in this context?", "Building on this connection between temperature variability and meningitis incidence, how do other climatic factors like humidity and precipitation interact with temperature to shape the geographical distribution and seasonal patterns of outbreaks in vulnerable regions? Furthermore, how might socioeconomic factors—such as healthcare access and vaccination rates—influence the impact of these climate variables, and what would integrated climate-health models need to account for to better predict and mitigate risks under different climate scenarios?"], "ground_truth": ["permed-83561", "permed-44584", "permed-61935", "permed-74166", "permed-75642", "permed-74173", "permed-75605", "permed-53886", "permed-87495", "permed-36056"]}
{"query_id": "topic_268_turn_1", "conversation_id": "topic_268", "turn_id": 1, "query": "What role do heat shock proteins play in helping insects adapt to environmental stressors?", "history": [], "ground_truth": ["permed-78632", "permed-71934", "permed-76052", "permed-78636", "permed-67127", "permed-73489", "permed-87786", "permed-91617", "permed-78633", "permed-68093"]}
{"query_id": "topic_268_turn_2", "conversation_id": "topic_268", "turn_id": 2, "query": "Are small heat shock proteins particularly significant in this area, especially regarding pests like Ostrinia furnacalis?", "history": ["What role do heat shock proteins play in helping insects adapt to environmental stressors?"], "ground_truth": ["permed-78632", "permed-71934", "permed-68090", "permed-78636", "permed-67127", "permed-78634", "permed-72146", "permed-58234", "permed-78633", "permed-72177"]}
{"query_id": "topic_268_turn_3", "conversation_id": "topic_268", "turn_id": 3, "query": "Given how important these small heat shock proteins seem to be for Ostrinia furnacalis's stress adaptation, could differences in their gene expression affect the pest's survival and reproduction under changing climate conditions? And based on this, what pest control strategies might target this adaptive mechanism?", "history": ["What role do heat shock proteins play in helping insects adapt to environmental stressors?", "Are small heat shock proteins particularly significant in this area, especially regarding pests like Ostrinia furnacalis?"], "ground_truth": ["permed-78632", "permed-71934", "permed-72146", "permed-72177", "permed-91617", "permed-76052", "permed-67127", "permed-73489", "permed-68090", "permed-78636"]}
{"query_id": "topic_268_turn_4", "conversation_id": "topic_268", "turn_id": 4, "query": "When studying these proposed gene expression differences in Ostrinia furnacalis small heat shock proteins, what specific methodological approaches would you recommend for quantifying expression changes under simulated climate scenarios? I'm particularly interested in experimental designs that control for developmental stages, the statistical methods for validating differential expression (beyond basic qPCR normalization), and whether RNA-seq with longitudinal sampling would provide sufficient resolution to correlate expression patterns with survival and reproductive metrics across multiple generations.", "history": ["What role do heat shock proteins play in helping insects adapt to environmental stressors?", "Are small heat shock proteins particularly significant in this area, especially regarding pests like Ostrinia furnacalis?", "Given how important these small heat shock proteins seem to be for Ostrinia furnacalis's stress adaptation, could differences in their gene expression affect the pest's survival and reproduction under changing climate conditions? And based on this, what pest control strategies might target this adaptive mechanism?"], "ground_truth": ["permed-78632", "permed-71934", "permed-92384", "permed-63782", "permed-63880", "permed-63959", "permed-72146", "permed-63875", "permed-85566", "permed-80748"]}
{"query_id": "topic_269_turn_1", "conversation_id": "topic_269", "turn_id": 1, "query": "Exploring technological solutions for reducing dental patient anxiety", "history": [], "ground_truth": ["permed-88200", "permed-92165", "permed-92196", "permed-75252", "permed-92197", "permed-92047", "permed-60970", "permed-90905", "permed-51476", "permed-75160"]}
{"query_id": "topic_269_turn_2", "conversation_id": "topic_269", "turn_id": 2, "query": "Effectiveness of active noise-canceling (ANC) technology as one such solution for dental anxiety", "history": ["Exploring technological solutions for reducing dental patient anxiety"], "ground_truth": ["permed-75252", "permed-92165", "permed-92197", "permed-92196", "permed-63478", "permed-60970", "permed-84903", "permed-84355", "permed-88200", "permed-75160"]}
{"query_id": "topic_269_turn_3", "conversation_id": "topic_269", "turn_id": 3, "query": "Impact of patient variables (age, gender, anxiety history) on ANC headphone efficacy in mitigating dental procedure distress, and long-term effects of this technology's integration into dental practice", "history": ["Exploring technological solutions for reducing dental patient anxiety", "Effectiveness of active noise-canceling (ANC) technology as one such solution for dental anxiety"], "ground_truth": ["permed-75252", "permed-92165", "permed-92197", "permed-92182", "permed-88200", "permed-87491", "permed-84355", "permed-90905", "permed-92196", "permed-54627"]}
{"query_id": "topic_269_turn_4", "conversation_id": "topic_269", "turn_id": 4, "query": "Building on this examination of patient variables and long-term integration, could you detail the specific statistical models used to control for demographic covariates when assessing ANC efficacy? I'm particularly interested in whether researchers employed mixed-effects models to account for repeated measures across multiple dental visits, and what validation strategies were implemented to ensure the reliability of self-reported anxiety scales across different age groups in these clinical settings.", "history": ["Exploring technological solutions for reducing dental patient anxiety", "Effectiveness of active noise-canceling (ANC) technology as one such solution for dental anxiety", "Impact of patient variables (age, gender, anxiety history) on ANC headphone efficacy in mitigating dental procedure distress, and long-term effects of this technology's integration into dental practice"], "ground_truth": ["permed-88200", "permed-65747", "permed-92197", "permed-65725", "permed-65664", "permed-75187", "permed-73400", "permed-65645", "permed-25146", "permed-74352"]}
{"query_id": "topic_270_turn_1", "conversation_id": "topic_270", "turn_id": 1, "query": "COVID-19 pandemic's effects on adolescent mental health and correlation with social media usage", "history": [], "ground_truth": ["permed-62836", "permed-55764", "permed-74347", "permed-65432", "permed-52192", "permed-55768", "permed-88777", "permed-52194", "permed-55773", "permed-54034"]}
{"query_id": "topic_270_turn_2", "conversation_id": "topic_270", "turn_id": 2, "query": "Community healthcare provider interventions for addressing these adolescent mental health and social media effects", "history": ["COVID-19 pandemic's effects on adolescent mental health and correlation with social media usage"], "ground_truth": ["permed-55764", "permed-74343", "permed-77917", "permed-62836", "permed-55793", "permed-69768", "permed-74362", "permed-85769", "permed-65260", "permed-52191"]}
{"query_id": "topic_270_turn_3", "conversation_id": "topic_270", "turn_id": 3, "query": "Evidence-based digital literacy program components for integration into community healthcare to mitigate social media's negative mental health impact on adolescents", "history": ["COVID-19 pandemic's effects on adolescent mental health and correlation with social media usage", "Community healthcare provider interventions for addressing these adolescent mental health and social media effects"], "ground_truth": ["permed-55793", "permed-85769", "permed-84730", "permed-55764", "permed-62836", "permed-56011", "permed-55522", "permed-90023", "permed-69768", "permed-55519"]}
{"query_id": "topic_270_turn_4", "conversation_id": "topic_270", "turn_id": 4, "query": "What specific methodological approaches were used to validate the effectiveness of these digital literacy program components in community healthcare settings? I'm particularly interested in the experimental design – was this tested through randomized controlled trials or quasi-experimental studies? How did researchers measure fidelity of implementation across different healthcare providers, and what statistical methods were employed to account for potential confounding variables like socioeconomic status or pre-existing mental health conditions when analyzing program outcomes?", "history": ["COVID-19 pandemic's effects on adolescent mental health and correlation with social media usage", "Community healthcare provider interventions for addressing these adolescent mental health and social media effects", "Evidence-based digital literacy program components for integration into community healthcare to mitigate social media's negative mental health impact on adolescents"], "ground_truth": ["permed-78731", "permed-61613", "permed-88300", "permed-88302", "permed-61614", "permed-56011", "permed-61184", "permed-61888", "permed-61882", "permed-82632"]}
{"query_id": "topic_271_turn_1", "conversation_id": "topic_271", "turn_id": 1, "query": "Association between systemic cardiovascular conditions and primary open-angle glaucoma (POAG) risk.", "history": [], "ground_truth": ["permed-77352", "permed-77354", "permed-77353", "permed-87208", "permed-89321", "permed-66392", "permed-77358", "permed-41253", "permed-51068", "permed-16480"]}
{"query_id": "topic_271_turn_2", "conversation_id": "topic_271", "turn_id": 2, "query": "Investigating this association: impact of specific cardiovascular factors such as blood pressure dysregulation and endothelial dysfunction on POAG pathophysiology and clinical severity.", "history": ["Association between systemic cardiovascular conditions and primary open-angle glaucoma (POAG) risk."], "ground_truth": ["permed-77355", "permed-68197", "permed-70496", "permed-57268", "permed-57051", "permed-77352", "permed-57183", "permed-70096", "permed-65136", "permed-87922"]}
{"query_id": "topic_271_turn_3", "conversation_id": "topic_271", "turn_id": 3, "query": "Mechanisms of synergy between confirmed cardiovascular risk factors (e.g., systemic hypertension, impaired ocular perfusion) and metabolic comorbidities like diabetes or chronic kidney disease in accelerating POAG progression, and novel therapeutic approaches targeting these interactions in high-risk populations.", "history": ["Association between systemic cardiovascular conditions and primary open-angle glaucoma (POAG) risk.", "Investigating this association: impact of specific cardiovascular factors such as blood pressure dysregulation and endothelial dysfunction on POAG pathophysiology and clinical severity."], "ground_truth": ["permed-63364", "permed-55182", "permed-34875", "permed-57269", "permed-23574", "permed-57183", "permed-58398", "permed-58832", "permed-33126", "permed-68958"]}
{"query_id": "topic_271_turn_4", "conversation_id": "topic_271", "turn_id": 4, "query": "When implementing this multi-system approach to POAG progression, what specific methodologies would you recommend for quantifying the synergistic effects between systemic hypertension and metabolic comorbidities? I'm particularly interested in the statistical modeling techniques for handling longitudinal ophthalmic data alongside time-varying cardiovascular parameters, and how to validate whether observed interactions are truly additive or multiplicative in their impact on retinal ganglion cell loss.", "history": ["Association between systemic cardiovascular conditions and primary open-angle glaucoma (POAG) risk.", "Investigating this association: impact of specific cardiovascular factors such as blood pressure dysregulation and endothelial dysfunction on POAG pathophysiology and clinical severity.", "Mechanisms of synergy between confirmed cardiovascular risk factors (e.g., systemic hypertension, impaired ocular perfusion) and metabolic comorbidities like diabetes or chronic kidney disease in accelerating POAG progression, and novel therapeutic approaches targeting these interactions in high-risk populations."], "ground_truth": ["permed-48331", "permed-5344", "permed-77352", "permed-77353", "permed-55478", "permed-77354", "permed-15630", "permed-51068", "permed-51904", "permed-33126"]}
{"query_id": "topic_272_turn_1", "conversation_id": "topic_272", "turn_id": 1, "query": "Ecological mechanisms underpinning western U.S. forest resilience to compounded drought and heat stress", "history": [], "ground_truth": ["permed-51639", "permed-83638", "permed-83923", "permed-83926", "permed-75160", "permed-74497", "permed-74500", "permed-51630", "permed-63889", "permed-62968"]}
{"query_id": "topic_272_turn_2", "conversation_id": "topic_272", "turn_id": 2, "query": "Investigating how plant functional traits, such as drought tolerance strategies and phenological timing, influence this resilience in western U.S. forests facing climate variability", "history": ["Ecological mechanisms underpinning western U.S. forest resilience to compounded drought and heat stress"], "ground_truth": ["permed-51639", "permed-59343", "permed-51630", "permed-83638", "permed-83923", "permed-83926", "permed-58193", "permed-64044", "permed-83924", "permed-80750"]}
{"query_id": "topic_272_turn_3", "conversation_id": "topic_272", "turn_id": 3, "query": "Advanced remote sensing approaches for assessing interactive impacts of drought tolerance and phenological shifts on western U.S. forest mortality and ecosystem recovery trajectories", "history": ["Ecological mechanisms underpinning western U.S. forest resilience to compounded drought and heat stress", "Investigating how plant functional traits, such as drought tolerance strategies and phenological timing, influence this resilience in western U.S. forests facing climate variability"], "ground_truth": ["permed-51639", "permed-83638", "permed-63889", "permed-86233", "permed-62970", "permed-53657", "permed-83926", "permed-63893", "permed-74500", "permed-74496"]}
{"query_id": "topic_272_turn_4", "conversation_id": "topic_272", "turn_id": 4, "query": "Given these remote sensing approaches, what specific spectral indices and temporal resolution parameters were most effective for quantifying phenological shifts? Additionally, how were drought-induced mortality signals statistically separated from background vegetation dynamics in the time-series analysis, and what validation methods were used to confirm these mortality classifications against ground-truth data?", "history": ["Ecological mechanisms underpinning western U.S. forest resilience to compounded drought and heat stress", "Investigating how plant functional traits, such as drought tolerance strategies and phenological timing, influence this resilience in western U.S. forests facing climate variability", "Advanced remote sensing approaches for assessing interactive impacts of drought tolerance and phenological shifts on western U.S. forest mortality and ecosystem recovery trajectories"], "ground_truth": ["permed-51639", "permed-63953", "permed-84092", "permed-63733", "permed-61627", "permed-86070", "permed-88354", "permed-63947", "permed-61630", "permed-84091"]}
{"query_id": "topic_273_turn_1", "conversation_id": "topic_273", "turn_id": 1, "query": "Endoscopy suite vs operating room: distinguishing features for endoscopic procedures", "history": [], "ground_truth": ["permed-50711", "permed-92093", "permed-71344", "permed-70467", "permed-56265", "permed-64801", "permed-0819", "permed-62278", "permed-71333", "permed-56525"]}
{"query_id": "topic_273_turn_2", "conversation_id": "topic_273", "turn_id": 2, "query": "Influence of these distinct procedural settings on patient preparation and outcomes for endoscopic submucosal dissection (ESD)", "history": ["Endoscopy suite vs operating room: distinguishing features for endoscopic procedures"], "ground_truth": ["permed-50711", "permed-50719", "permed-50718", "permed-70816", "permed-83036", "permed-50716", "permed-50717", "permed-62278", "permed-89904", "permed-50703"]}
{"query_id": "topic_273_turn_3", "conversation_id": "topic_273", "turn_id": 3, "query": "Comparative analysis of ESD patient selection, pre-procedural protocols, outcomes, and cost-effectiveness: endoscopy suite vs operating room", "history": ["Endoscopy suite vs operating room: distinguishing features for endoscopic procedures", "Influence of these distinct procedural settings on patient preparation and outcomes for endoscopic submucosal dissection (ESD)"], "ground_truth": ["permed-50711", "permed-70816", "permed-50719", "permed-50716", "permed-0211", "permed-82592", "permed-50720", "permed-83036", "permed-78076", "permed-72194"]}
{"query_id": "topic_273_turn_4", "conversation_id": "topic_273", "turn_id": 4, "query": "Regarding this comparative analysis of ESD settings, what specific statistical methodologies were employed to control for confounding variables like lesion characteristics and operator experience? Were propensity score matching or multivariate regression models utilized to ensure valid outcome comparisons? Additionally, what quality control protocols were implemented for standardized data collection across both environments, particularly regarding procedure duration measurements and complication grading systems?", "history": ["Endoscopy suite vs operating room: distinguishing features for endoscopic procedures", "Influence of these distinct procedural settings on patient preparation and outcomes for endoscopic submucosal dissection (ESD)", "Comparative analysis of ESD patient selection, pre-procedural protocols, outcomes, and cost-effectiveness: endoscopy suite vs operating room"], "ground_truth": ["permed-50711", "permed-70816", "permed-0211", "permed-50719", "permed-4058", "permed-89086", "permed-50716", "permed-47951", "permed-91555", "permed-63458"]}
{"query_id": "topic_274_turn_1", "conversation_id": "topic_274", "turn_id": 1, "query": "Key challenges and decision-making criteria in managing prosthetic valve endocarditis affecting aortic or mitral valves", "history": [], "ground_truth": ["permed-57004", "permed-57008", "permed-57012", "permed-68792", "permed-62896", "permed-57002", "permed-76321", "permed-63242", "permed-64521", "permed-57006"]}
{"query_id": "topic_274_turn_2", "conversation_id": "topic_274", "turn_id": 2, "query": "Impact of advanced surgical repair versus replacement techniques on outcomes for these cases of aortic/mitral prosthetic valve endocarditis, particularly with destructive complications like intervalvular pseudoaneurysms.", "history": ["Key challenges and decision-making criteria in managing prosthetic valve endocarditis affecting aortic or mitral valves"], "ground_truth": ["permed-68792", "permed-57004", "permed-57008", "permed-75430", "permed-75431", "permed-57222", "permed-78547", "permed-64521", "permed-70040", "permed-62899"]}
{"query_id": "topic_274_turn_3", "conversation_id": "topic_274", "turn_id": 3, "query": "Comparative long-term survival and reoperation rates of Commando procedure versus alternative aortic root reconstruction techniques for these extensive aortic/mitral prosthetic valve endocarditis cases with mitral-aortic intervalvular fibrosa (MAIF) pseudoaneurysm and left atrial fistula, considering concomitant persistent left superior vena cava.", "history": ["Key challenges and decision-making criteria in managing prosthetic valve endocarditis affecting aortic or mitral valves", "Impact of advanced surgical repair versus replacement techniques on outcomes for these cases of aortic/mitral prosthetic valve endocarditis, particularly with destructive complications like intervalvular pseudoaneurysms."], "ground_truth": ["permed-68792", "permed-57004", "permed-78547", "permed-73901", "permed-78896", "permed-51764", "permed-57327", "permed-68505", "permed-62899", "permed-57222"]}
{"query_id": "topic_274_turn_4", "conversation_id": "topic_274", "turn_id": 4, "query": "For the Commando procedure versus alternative reconstructions in these complex cases, what specific intraoperative quality control measures were implemented to verify prosthesis seating and intervalvular reconstruction integrity? I'm particularly interested in the protocol for intraoperative echocardiography assessment - were there standardized views or doppler criteria used to evaluate the mitral-aortic continuity, and how was surgical success quantitatively defined before chest closure in these patients with complex anatomical variations?", "history": ["Key challenges and decision-making criteria in managing prosthetic valve endocarditis affecting aortic or mitral valves", "Impact of advanced surgical repair versus replacement techniques on outcomes for these cases of aortic/mitral prosthetic valve endocarditis, particularly with destructive complications like intervalvular pseudoaneurysms.", "Comparative long-term survival and reoperation rates of Commando procedure versus alternative aortic root reconstruction techniques for these extensive aortic/mitral prosthetic valve endocarditis cases with mitral-aortic intervalvular fibrosa (MAIF) pseudoaneurysm and left atrial fistula, considering concomitant persistent left superior vena cava."], "ground_truth": ["permed-68792", "permed-51764", "permed-18400", "permed-57004", "permed-75960", "permed-62899", "permed-18492", "permed-75430", "permed-78547", "permed-62896"]}
{"query_id": "topic_275_turn_1", "conversation_id": "topic_275", "turn_id": 1, "query": "What's known about the relationship between SARS-CoV-2 infection and endothelial dysfunction?", "history": [], "ground_truth": ["permed-56806", "permed-89064", "permed-58352", "permed-65652", "permed-56805", "permed-52043", "permed-51264", "permed-59858", "permed-52535", "permed-55993"]}
{"query_id": "topic_275_turn_2", "conversation_id": "topic_275", "turn_id": 2, "query": "Does this area of research suggest any specific biomarkers that could predict the severity of COVID-19 outcomes?", "history": ["What's known about the relationship between SARS-CoV-2 infection and endothelial dysfunction?"], "ground_truth": ["permed-55394", "permed-59633", "permed-59622", "permed-65921", "permed-70297", "permed-59621", "permed-52339", "permed-59632", "permed-59628", "permed-59623"]}
{"query_id": "topic_275_turn_3", "conversation_id": "topic_275", "turn_id": 3, "query": "Given that high FVIIa-AT plasma levels have been linked to SARS-CoV-2-induced endotheliopathy, how do the fluctuations in these levels throughout infection correlate with the progression of endothelial dysfunction and coagulopathy? And what might these dynamic changes suggest about potential early interventions to prevent severe COVID-19 outcomes?", "history": ["What's known about the relationship between SARS-CoV-2 infection and endothelial dysfunction?", "Does this area of research suggest any specific biomarkers that could predict the severity of COVID-19 outcomes?"], "ground_truth": ["permed-61549", "permed-56806", "permed-89064", "permed-6323", "permed-55993", "permed-59858", "permed-59625", "permed-91348", "permed-78667", "permed-5136"]}
{"query_id": "topic_275_turn_4", "conversation_id": "topic_275", "turn_id": 4, "query": "Given these dynamic FVIIa-AT measurements throughout infection progression, what specific analytical approaches were used to model the temporal relationship between biomarker fluctuations and clinical outcomes? Were longitudinal mixed-effects models applied to account for repeated measures, and how was the time-dependent covariation between endothelial dysfunction markers and coagulopathy parameters statistically validated? Additionally, what quality control measures ensured assay reproducibility across different sampling timepoints in critically ill patients?", "history": ["What's known about the relationship between SARS-CoV-2 infection and endothelial dysfunction?", "Does this area of research suggest any specific biomarkers that could predict the severity of COVID-19 outcomes?", "Given that high FVIIa-AT plasma levels have been linked to SARS-CoV-2-induced endotheliopathy, how do the fluctuations in these levels throughout infection correlate with the progression of endothelial dysfunction and coagulopathy? And what might these dynamic changes suggest about potential early interventions to prevent severe COVID-19 outcomes?"], "ground_truth": ["permed-61549", "permed-91348", "permed-54796", "permed-78798", "permed-60067", "permed-37134", "permed-78804", "permed-37138", "permed-59917", "permed-83622"]}
{"query_id": "topic_276_turn_1", "conversation_id": "topic_276", "turn_id": 1, "query": "Determinants of medication adherence in atrial fibrillation patients", "history": [], "ground_truth": ["permed-77208", "permed-65673", "permed-86722", "permed-80276", "permed-57037", "permed-86687", "permed-82800", "permed-92057", "permed-80810", "permed-82760"]}
{"query_id": "topic_276_turn_2", "conversation_id": "topic_276", "turn_id": 2, "query": "Exploring the impact of specific socioeconomic and psychological factors, such as financial strain or diagnosed anxiety, on medication adherence among these atrial fibrillation patients.", "history": ["Determinants of medication adherence in atrial fibrillation patients"], "ground_truth": ["permed-77208", "permed-57037", "permed-92057", "permed-86722", "permed-82800", "permed-82760", "permed-65672", "permed-65673", "permed-65669", "permed-86687"]}
{"query_id": "topic_276_turn_3", "conversation_id": "topic_276", "turn_id": 3, "query": "Design and efficacy of personalized, multi-component intervention strategies for atrial fibrillation patients addressing the interplay of socioeconomic status, cognitive function, and comorbid depression/anxiety to improve medication adherence.", "history": ["Determinants of medication adherence in atrial fibrillation patients", "Exploring the impact of specific socioeconomic and psychological factors, such as financial strain or diagnosed anxiety, on medication adherence among these atrial fibrillation patients."], "ground_truth": ["permed-77208", "permed-57037", "permed-80276", "permed-86722", "permed-57022", "permed-57023", "permed-57025", "permed-57262", "permed-82573", "permed-57027"]}
{"query_id": "topic_276_turn_4", "conversation_id": "topic_276", "turn_id": 4, "query": "Regarding this multi-component intervention approach, what specific randomization procedures and allocation concealment methods were used in the trial design? Additionally, how did you validate the fidelity of intervention delivery across different healthcare settings, and what statistical methods were employed to account for potential clustering effects when analyzing adherence outcomes across multiple clinical sites?", "history": ["Determinants of medication adherence in atrial fibrillation patients", "Exploring the impact of specific socioeconomic and psychological factors, such as financial strain or diagnosed anxiety, on medication adherence among these atrial fibrillation patients.", "Design and efficacy of personalized, multi-component intervention strategies for atrial fibrillation patients addressing the interplay of socioeconomic status, cognitive function, and comorbid depression/anxiety to improve medication adherence."], "ground_truth": ["permed-70629", "permed-74318", "permed-70151", "permed-75287", "permed-75283", "permed-63473", "permed-70501", "permed-83317", "permed-54484", "permed-89012"]}
{"query_id": "topic_277_turn_1", "conversation_id": "topic_277", "turn_id": 1, "query": "Global prevalence and impact of micronutrient deficiencies and heavy metal contamination in rice cultivation", "history": [], "ground_truth": ["permed-74141", "permed-64071", "permed-74122", "permed-74124", "permed-63926", "permed-64078", "permed-62790", "permed-74143", "permed-92337", "permed-74131"]}
{"query_id": "topic_277_turn_2", "conversation_id": "topic_277", "turn_id": 2, "query": "Assessing the significance of these nutritional deficiencies and heavy metal problems in rice from Ahvaz and Bawie Counties, Iran, alongside current local agricultural practices", "history": ["Global prevalence and impact of micronutrient deficiencies and heavy metal contamination in rice cultivation"], "ground_truth": ["permed-74141", "permed-64071", "permed-63926", "permed-63924", "permed-74122", "permed-77778", "permed-63723", "permed-74138", "permed-74131", "permed-85822"]}
{"query_id": "topic_277_turn_3", "conversation_id": "topic_277", "turn_id": 3, "query": "Technical solutions: specific agricultural practices and soil amendments for rice in Ahvaz and Bawie Counties to improve micronutrient bioavailability and reduce heavy metal uptake, considering effects of such interventions on long-term regional rice sustainability and food safety.", "history": ["Global prevalence and impact of micronutrient deficiencies and heavy metal contamination in rice cultivation", "Assessing the significance of these nutritional deficiencies and heavy metal problems in rice from Ahvaz and Bawie Counties, Iran, alongside current local agricultural practices"], "ground_truth": ["permed-74141", "permed-74125", "permed-74122", "permed-64071", "permed-89112", "permed-63647", "permed-63924", "permed-63926", "permed-74126", "permed-65148"]}
{"query_id": "topic_277_turn_4", "conversation_id": "topic_277", "turn_id": 4, "query": "Regarding these technical solutions involving soil amendments and agricultural practices, what specific experimental designs would be most appropriate for field validation in Ahvaz and Bawie Counties? I'm particularly interested in the statistical power calculations needed for detecting significant changes in heavy metal uptake, the randomization protocols for different treatment groups, and the sampling frequency required to monitor both immediate bioavailability changes and long-term soil health impacts. How should we structure the control groups to account for seasonal variations in these specific regions?", "history": ["Global prevalence and impact of micronutrient deficiencies and heavy metal contamination in rice cultivation", "Assessing the significance of these nutritional deficiencies and heavy metal problems in rice from Ahvaz and Bawie Counties, Iran, alongside current local agricultural practices", "Technical solutions: specific agricultural practices and soil amendments for rice in Ahvaz and Bawie Counties to improve micronutrient bioavailability and reduce heavy metal uptake, considering effects of such interventions on long-term regional rice sustainability and food safety."], "ground_truth": ["permed-74141", "permed-86368", "permed-74126", "permed-77781", "permed-81350", "permed-75365", "permed-80041", "permed-67032", "permed-77777", "permed-66962"]}
{"query_id": "topic_278_turn_1", "conversation_id": "topic_278", "turn_id": 1, "query": "What tools and methodologies are used to assess the feasibility of conservation translocations for endangered species?", "history": [], "ground_truth": ["permed-82001", "permed-74928", "permed-76481", "permed-78520", "permed-87628", "permed-59350", "permed-89546", "permed-85866", "permed-76846", "permed-62956"]}
{"query_id": "topic_278_turn_2", "conversation_id": "topic_278", "turn_id": 2, "query": "How effective is the REVIVE tool, in particular, in evaluating translocation feasibility, and can it be applied across different environmental contexts?", "history": ["What tools and methodologies are used to assess the feasibility of conservation translocations for endangered species?"], "ground_truth": ["permed-82001", "permed-52492", "permed-87628", "permed-52493", "permed-78520", "permed-52499", "permed-76846", "permed-68814", "permed-58529", "permed-52496"]}
{"query_id": "topic_278_turn_3", "conversation_id": "topic_278", "turn_id": 3, "query": "Given what we know about REVIVE's approach to assessing translocation feasibility, how could its principles and methodologies be adapted specifically for freshwater fish species in seasonally drying river systems, like those in semi-arid regions? What unique challenges and considerations would this present compared to more stable environments like Mediterranean climates?", "history": ["What tools and methodologies are used to assess the feasibility of conservation translocations for endangered species?", "How effective is the REVIVE tool, in particular, in evaluating translocation feasibility, and can it be applied across different environmental contexts?"], "ground_truth": ["permed-82001", "permed-82229", "permed-92504", "permed-85784", "permed-92472", "permed-62964", "permed-64251", "permed-81855", "permed-64253", "permed-71980"]}
{"query_id": "topic_278_turn_4", "conversation_id": "topic_278", "turn_id": 4, "query": "When adapting REVIVE's framework for freshwater fish in seasonally drying rivers, what specific modifications to the habitat suitability modeling component would be methodologically necessary? Would you implement temporally dynamic hydrological variables within the modeling protocol, and how would you statistically validate this modified approach given the non-stationary climate conditions in semi-arid regions compared to using static environmental predictors in more stable Mediterranean systems?", "history": ["What tools and methodologies are used to assess the feasibility of conservation translocations for endangered species?", "How effective is the REVIVE tool, in particular, in evaluating translocation feasibility, and can it be applied across different environmental contexts?", "Given what we know about REVIVE's approach to assessing translocation feasibility, how could its principles and methodologies be adapted specifically for freshwater fish species in seasonally drying river systems, like those in semi-arid regions? What unique challenges and considerations would this present compared to more stable environments like Mediterranean climates?"], "ground_truth": ["permed-82001", "permed-79981", "permed-82229", "permed-82002", "permed-83646", "permed-83440", "permed-79982", "permed-89397", "permed-69938", "permed-83562"]}
{"query_id": "topic_279_turn_1", "conversation_id": "topic_279", "turn_id": 1, "query": "What is known about the Baby-Friendly Hospital Initiative's impact on maternal and neonatal care?", "history": [], "ground_truth": ["permed-45012", "permed-34631", "permed-90617", "permed-74103", "permed-80212", "permed-45258", "permed-61204", "permed-55083", "permed-74102", "permed-45170"]}
{"query_id": "topic_279_turn_2", "conversation_id": "topic_279", "turn_id": 2, "query": "How do healthcare providers' perceptions of it influence the implementation of policies like 24-hour rooming-in?", "history": ["What is known about the Baby-Friendly Hospital Initiative's impact on maternal and neonatal care?"], "ground_truth": ["permed-80212", "permed-70264", "permed-80214", "permed-61877", "permed-89414", "permed-52275", "permed-77531", "permed-51911", "permed-60657", "permed-67376"]}
{"query_id": "topic_279_turn_3", "conversation_id": "topic_279", "turn_id": 3, "query": "How can healthcare providers' perceptions and practices around the Baby-Friendly Hospital Initiative be better aligned with new mothers' needs and preferences to improve acceptance and effectiveness of policies like 24-hour rooming-in, particularly given how varying rates of labor induction and cesarean births might affect maternal and neonatal care?", "history": ["What is known about the Baby-Friendly Hospital Initiative's impact on maternal and neonatal care?", "How do healthcare providers' perceptions of it influence the implementation of policies like 24-hour rooming-in?"], "ground_truth": ["permed-80212", "permed-74104", "permed-74552", "permed-52554", "permed-74102", "permed-52555", "permed-65430", "permed-54476", "permed-61204", "permed-45170"]}
{"query_id": "topic_279_turn_4", "conversation_id": "topic_279", "turn_id": 4, "query": "Given this proposed alignment between healthcare providers' practices and maternal preferences, what specific mixed-methods approach would you recommend to quantitatively measure implementation fidelity of 24-hour rooming-in protocols while qualitatively capturing mothers' lived experiences? How should researchers statistically account for confounding variables like delivery method when analyzing the relationship between provider adherence to BFHI guidelines and neonatal outcomes, and what validation strategies would ensure the reliability of provider practice assessments across different hospital settings?", "history": ["What is known about the Baby-Friendly Hospital Initiative's impact on maternal and neonatal care?", "How do healthcare providers' perceptions of it influence the implementation of policies like 24-hour rooming-in?", "How can healthcare providers' perceptions and practices around the Baby-Friendly Hospital Initiative be better aligned with new mothers' needs and preferences to improve acceptance and effectiveness of policies like 24-hour rooming-in, particularly given how varying rates of labor induction and cesarean births might affect maternal and neonatal care?"], "ground_truth": ["permed-80212", "permed-57450", "permed-55083", "permed-74552", "permed-74103", "permed-74102", "permed-90617", "permed-74554", "permed-54476", "permed-74555"]}
{"query_id": "topic_280_turn_1", "conversation_id": "topic_280", "turn_id": 1, "query": "Impact of family history of psychiatric disorders on functional outcomes in bipolar disorder patients", "history": [], "ground_truth": ["permed-77944", "permed-77946", "permed-77042", "permed-55624", "permed-70274", "permed-55570", "permed-77945", "permed-51315", "permed-60971", "permed-73819"]}
{"query_id": "topic_280_turn_2", "conversation_id": "topic_280", "turn_id": 2, "query": "Does this link between family psychiatric history and functioning extend to newly diagnosed bipolar patients and their unaffected relatives, or are other factors more prominent?", "history": ["Impact of family history of psychiatric disorders on functional outcomes in bipolar disorder patients"], "ground_truth": ["permed-77944", "permed-77946", "permed-77042", "permed-63226", "permed-83941", "permed-55570", "permed-81770", "permed-51315", "permed-77945", "permed-55743"]}
{"query_id": "topic_280_turn_3", "conversation_id": "topic_280", "turn_id": 3, "query": "Investigating alternative mechanisms (e.g., neurobiological, psychosocial, environmental resilience factors) impacting functioning in newly diagnosed bipolar patients and unaffected relatives, independent of direct family psychiatric history, for developing targeted interventions.", "history": ["Impact of family history of psychiatric disorders on functional outcomes in bipolar disorder patients", "Does this link between family psychiatric history and functioning extend to newly diagnosed bipolar patients and their unaffected relatives, or are other factors more prominent?"], "ground_truth": ["permed-77944", "permed-77042", "permed-51315", "permed-77946", "permed-63226", "permed-81770", "permed-55623", "permed-83941", "permed-84534", "permed-55624"]}
{"query_id": "topic_280_turn_4", "conversation_id": "topic_280", "turn_id": 4, "query": "When exploring these neurobiological and psychosocial mechanisms in newly diagnosed patients and unaffected relatives, what specific methodological approaches would you recommend for distinguishing their relative contributions? I'm particularly interested in whether hierarchical regression models would be appropriate for parsing variance among these alternative factors, and what validation strategies might ensure the robustness of such multivariate analyses while controlling for potential confounding variables like medication adherence or socioeconomic status.", "history": ["Impact of family history of psychiatric disorders on functional outcomes in bipolar disorder patients", "Does this link between family psychiatric history and functioning extend to newly diagnosed bipolar patients and their unaffected relatives, or are other factors more prominent?", "Investigating alternative mechanisms (e.g., neurobiological, psychosocial, environmental resilience factors) impacting functioning in newly diagnosed bipolar patients and unaffected relatives, independent of direct family psychiatric history, for developing targeted interventions."], "ground_truth": ["permed-77944", "permed-77946", "permed-63226", "permed-55579", "permed-63237", "permed-55612", "permed-81970", "permed-58104", "permed-63239", "permed-54488"]}
{"query_id": "topic_281_turn_1", "conversation_id": "topic_281", "turn_id": 1, "query": "What role does modeling play in understanding tumor microenvironment dynamics?", "history": [], "ground_truth": ["permed-72762", "permed-56500", "permed-75563", "permed-82293", "permed-92433", "permed-82373", "permed-67857", "permed-48714", "permed-71752", "permed-70783"]}
{"query_id": "topic_281_turn_2", "conversation_id": "topic_281", "turn_id": 2, "query": "Can combining different modeling approaches, like the ones used in this area, provide more accurate predictions of therapeutic outcomes?", "history": ["What role does modeling play in understanding tumor microenvironment dynamics?"], "ground_truth": ["permed-59408", "permed-53886", "permed-12213", "permed-21347", "permed-70669", "permed-70671", "permed-34458", "permed-55478", "permed-53344", "permed-55334"]}
{"query_id": "topic_281_turn_3", "conversation_id": "topic_281", "turn_id": 3, "query": "Given these different modeling approaches, how might integrating multi-scale methods—like combining the Lotka-Volterra model with agent-based or spatially-resolved cellular automaton models—improve our understanding of tumor microenvironment dynamics and help predict therapeutic outcomes, particularly when targeting specific cell-cell interactions in heterogeneous tumors?", "history": ["What role does modeling play in understanding tumor microenvironment dynamics?", "Can combining different modeling approaches, like the ones used in this area, provide more accurate predictions of therapeutic outcomes?"], "ground_truth": ["permed-82293", "permed-64258", "permed-72762", "permed-68230", "permed-59213", "permed-75563", "permed-56690", "permed-67857", "permed-17208", "permed-77657"]}
{"query_id": "topic_281_turn_4", "conversation_id": "topic_281", "turn_id": 4, "query": "Regarding this multi-scale integration approach, what specific coupling strategies and numerical implementation schemes would be most effective for linking the differential equations in the Lotka-Volterra framework with the discrete rules of agent-based models? I'm particularly interested in how temporal synchronization and parameter transfer between these different modeling paradigms are handled, and what validation metrics you'd recommend to ensure the integrated model maintains biological fidelity while remaining computationally tractable across these scales.", "history": ["What role does modeling play in understanding tumor microenvironment dynamics?", "Can combining different modeling approaches, like the ones used in this area, provide more accurate predictions of therapeutic outcomes?", "Given these different modeling approaches, how might integrating multi-scale methods—like combining the Lotka-Volterra model with agent-based or spatially-resolved cellular automaton models—improve our understanding of tumor microenvironment dynamics and help predict therapeutic outcomes, particularly when targeting specific cell-cell interactions in heterogeneous tumors?"], "ground_truth": ["permed-64258", "permed-77657", "permed-64364", "permed-84322", "permed-60481", "permed-62958", "permed-71885", "permed-76985", "permed-61725", "permed-67985"]}
{"query_id": "topic_282_turn_1", "conversation_id": "topic_282", "turn_id": 1, "query": "What is known about the role of genetic factors in arterial thrombosis and atherosclerotic disease?", "history": [], "ground_truth": ["permed-78995", "permed-3472", "permed-57050", "permed-3473", "permed-57057", "permed-78669", "permed-45973", "permed-83435", "permed-78224", "permed-78668"]}
{"query_id": "topic_282_turn_2", "conversation_id": "topic_282", "turn_id": 2, "query": "Specifically, how does the JCAD gene contribute to this process, and what are the implications for therapeutic intervention in this area?", "history": ["What is known about the role of genetic factors in arterial thrombosis and atherosclerotic disease?"], "ground_truth": ["permed-78995", "permed-82373", "permed-55497", "permed-86565", "permed-88892", "permed-76417", "permed-73591", "permed-56165", "permed-68843", "permed-68954"]}
{"query_id": "topic_282_turn_3", "conversation_id": "topic_282", "turn_id": 3, "query": "Given JCAD's role in modulating the PI3K/Akt pathway and its impact on arterial thrombosis, how might genetic variations within this locus affect the efficacy and safety of therapies targeting this pathway—especially across patients with different stages of atherosclerotic disease? What potential off-target effects could arise from these interventions, and how might they be mitigated to improve treatment outcomes?", "history": ["What is known about the role of genetic factors in arterial thrombosis and atherosclerotic disease?", "Specifically, how does the JCAD gene contribute to this process, and what are the implications for therapeutic intervention in this area?"], "ground_truth": ["permed-78995", "permed-58880", "permed-55497", "permed-57050", "permed-79155", "permed-35202", "permed-73675", "permed-61345", "permed-67739", "permed-89316"]}
{"query_id": "topic_282_turn_4", "conversation_id": "topic_282", "turn_id": 4, "query": "Given these pathway-specific interactions, what experimental designs would best characterize how JCAD variants modulate PI3K/Akt inhibitor responses across atherosclerotic disease stages? Specifically, should we prioritize longitudinal cohort studies with stratified genetic sampling or develop patient-derived endothelial cell models that recapitulate different disease severities? What statistical approaches—such as time-varying covariate models or machine learning methods—would most effectively account for both genetic heterogeneity and disease progression when evaluating therapeutic efficacy and adverse event profiles?", "history": ["What is known about the role of genetic factors in arterial thrombosis and atherosclerotic disease?", "Specifically, how does the JCAD gene contribute to this process, and what are the implications for therapeutic intervention in this area?", "Given JCAD's role in modulating the PI3K/Akt pathway and its impact on arterial thrombosis, how might genetic variations within this locus affect the efficacy and safety of therapies targeting this pathway—especially across patients with different stages of atherosclerotic disease? What potential off-target effects could arise from these interventions, and how might they be mitigated to improve treatment outcomes?"], "ground_truth": ["permed-78995", "permed-55497", "permed-73675", "permed-70439", "permed-58880", "permed-67739", "permed-73517", "permed-89316", "permed-80217", "permed-60087"]}
{"query_id": "topic_283_turn_1", "conversation_id": "topic_283", "turn_id": 1, "query": "`Effectiveness of music interventions for reducing patient anxiety during medical procedures`", "history": [], "ground_truth": ["permed-69770", "permed-69767", "permed-66153", "permed-82954", "permed-75160", "permed-75255", "permed-69766", "permed-89864", "permed-60970", "permed-55519"]}
{"query_id": "topic_283_turn_2", "conversation_id": "topic_283", "turn_id": 2, "query": "`Efficacy of these music interventions for anxiety across a broader range of medical procedures beyond cardiac catheterization`", "history": ["`Effectiveness of music interventions for reducing patient anxiety during medical procedures`"], "ground_truth": ["permed-69770", "permed-69767", "permed-66153", "permed-82954", "permed-55519", "permed-69766", "permed-75160", "permed-88921", "permed-60970", "permed-89864"]}
{"query_id": "topic_283_turn_3", "conversation_id": "topic_283", "turn_id": 3, "query": "`Optimizing music interventions via personalization (patient preference, psychological profile) for enhanced anxiety reduction and long-term patient recovery across diverse medical procedures`", "history": ["`Effectiveness of music interventions for reducing patient anxiety during medical procedures`", "`Efficacy of these music interventions for anxiety across a broader range of medical procedures beyond cardiac catheterization`"], "ground_truth": ["permed-69770", "permed-75160", "permed-69767", "permed-66153", "permed-82954", "permed-60645", "permed-70065", "permed-75256", "permed-60970", "permed-89864"]}
{"query_id": "topic_283_turn_4", "conversation_id": "topic_283", "turn_id": 4, "query": "Given this personalized approach, what specific statistical methodologies would be most appropriate for analyzing differential treatment effects when dealing with nested data structures—for instance, accounting for procedure type variations while controlling for individual patient characteristics like musical familiarity or baseline anxiety levels? Additionally, how should we determine adequate sample sizes across these stratified subgroups to ensure sufficient power for detecting clinically meaningful interaction effects between personalization factors and anxiety reduction outcomes?", "history": ["`Effectiveness of music interventions for reducing patient anxiety during medical procedures`", "`Efficacy of these music interventions for anxiety across a broader range of medical procedures beyond cardiac catheterization`", "`Optimizing music interventions via personalization (patient preference, psychological profile) for enhanced anxiety reduction and long-term patient recovery across diverse medical procedures`"], "ground_truth": ["permed-51753", "permed-65493", "permed-69770", "permed-51752", "permed-53360", "permed-81310", "permed-51749", "permed-55571", "permed-92401", "permed-55519"]}
{"query_id": "topic_284_turn_1", "conversation_id": "topic_284", "turn_id": 1, "query": "Key determinants of carbon and greenhouse gas emissions in OECD countries", "history": [], "ground_truth": ["permed-67250", "permed-78252", "permed-74058", "permed-60580", "permed-78263", "permed-78268", "permed-60581", "permed-78253", "permed-74769", "permed-65639"]}
{"query_id": "topic_284_turn_2", "conversation_id": "topic_284", "turn_id": 2, "query": "How does the influence of these determinants on emissions vary across OECD countries by economic development level?", "history": ["Key determinants of carbon and greenhouse gas emissions in OECD countries"], "ground_truth": ["permed-67250", "permed-78252", "permed-78253", "permed-78254", "permed-60580", "permed-67253", "permed-78263", "permed-74058", "permed-79077", "permed-60581"]}
{"query_id": "topic_284_turn_3", "conversation_id": "topic_284", "turn_id": 3, "query": "Comparative impact of export diversification, institutional quality, and urbanization on emissions in high vs. low-income OECD countries and tailored policy interventions", "history": ["Key determinants of carbon and greenhouse gas emissions in OECD countries", "How does the influence of these determinants on emissions vary across OECD countries by economic development level?"], "ground_truth": ["permed-67250", "permed-78252", "permed-78253", "permed-74058", "permed-78314", "permed-60576", "permed-65637", "permed-68734", "permed-60581", "permed-67253"]}
{"query_id": "topic_284_turn_4", "conversation_id": "topic_284", "turn_id": 4, "query": "Given this comparative framework, what specific econometric methodologies would best address potential endogeneity between institutional quality and emissions? Should we employ system GMM to control for dynamic panel bias, or would instrumental variable approaches with governance indices as instruments be more appropriate? How were confounding factors like technological adoption and energy mix accounted for in the model specification, particularly when comparing high versus low-income OECD subsamples?", "history": ["Key determinants of carbon and greenhouse gas emissions in OECD countries", "How does the influence of these determinants on emissions vary across OECD countries by economic development level?", "Comparative impact of export diversification, institutional quality, and urbanization on emissions in high vs. low-income OECD countries and tailored policy interventions"], "ground_truth": ["permed-67250", "permed-60576", "permed-60581", "permed-65633", "permed-74057", "permed-60580", "permed-78252", "permed-65637", "permed-81368", "permed-66117"]}
{"query_id": "topic_285_turn_1", "conversation_id": "topic_285", "turn_id": 1, "query": "Recent advancements in natural rubber latex modification for enhanced performance in medical applications.", "history": [], "ground_truth": ["permed-75259", "permed-87251", "permed-74390", "permed-75262", "permed-16321", "permed-73992", "permed-54902", "permed-83423", "permed-56265", "permed-58626"]}
{"query_id": "topic_285_turn_2", "conversation_id": "topic_285", "turn_id": 2, "query": "Following these modifications, how does incorporating inorganic materials into natural rubber latex influence its key functional properties relevant to medical devices?", "history": ["Recent advancements in natural rubber latex modification for enhanced performance in medical applications."], "ground_truth": ["permed-75259", "permed-74390", "permed-87251", "permed-75262", "permed-87518", "permed-73111", "permed-83423", "permed-60899", "permed-73992", "permed-53545"]}
{"query_id": "topic_285_turn_3", "conversation_id": "topic_285", "turn_id": 3, "query": "Specifically for these inorganic material-latex composites, what are the comparative effects of different types of inorganic additives (e.g., nanofillers like silica or TiO2, clays, bioactive glasses) on the precise mechanical strength, elasticity, barrier integrity, and biocompatibility (allergenicity, cytotoxicity) of NRL films intended for condoms and surgical gloves, considering long-term in vivo stability and patient safety?", "history": ["Recent advancements in natural rubber latex modification for enhanced performance in medical applications.", "Following these modifications, how does incorporating inorganic materials into natural rubber latex influence its key functional properties relevant to medical devices?"], "ground_truth": ["permed-75259", "permed-57766", "permed-57619", "permed-73368", "permed-51043", "permed-76284", "permed-73039", "permed-75262", "permed-79403", "permed-51458"]}
{"query_id": "topic_285_turn_4", "conversation_id": "topic_285", "turn_id": 4, "query": "Given these comparative assessments of inorganic additives, could you elaborate on the specific testing protocols used to quantify mechanical strength and barrier integrity? I'm particularly interested in whether researchers employed standardized ASTM/ISO methods for tensile testing and water vapor transmission rates, what strain rates were used during deformation studies, how sample conditioning was standardized, and whether any specialized techniques like cyclic fatigue testing or micro-CT imaging were utilized to evaluate long-term structural integrity under simulated use conditions.", "history": ["Recent advancements in natural rubber latex modification for enhanced performance in medical applications.", "Following these modifications, how does incorporating inorganic materials into natural rubber latex influence its key functional properties relevant to medical devices?", "Specifically for these inorganic material-latex composites, what are the comparative effects of different types of inorganic additives (e.g., nanofillers like silica or TiO2, clays, bioactive glasses) on the precise mechanical strength, elasticity, barrier integrity, and biocompatibility (allergenicity, cytotoxicity) of NRL films intended for condoms and surgical gloves, considering long-term in vivo stability and patient safety?"], "ground_truth": ["permed-74391", "permed-83121", "permed-91655", "permed-91507", "permed-89548", "permed-76186", "permed-64570", "permed-87448", "permed-90192", "permed-87215"]}
{"query_id": "topic_286_turn_1", "conversation_id": "topic_286", "turn_id": 1, "query": "Golgi apparatus functions in human cell protein sorting and glycosylation", "history": [], "ground_truth": ["permed-89441", "permed-64170", "permed-66780", "permed-71707", "permed-89562", "permed-82373", "permed-71583", "permed-78004", "permed-71574", "permed-53717"]}
{"query_id": "topic_286_turn_2", "conversation_id": "topic_286", "turn_id": 2, "query": "How COG inactivation affects these Golgi functions (protein sorting, glycosylation) and contributes to cellular dysfunction and disease states", "history": ["Golgi apparatus functions in human cell protein sorting and glycosylation"], "ground_truth": ["permed-71583", "permed-82373", "permed-89562", "permed-67939", "permed-50779", "permed-74375", "permed-66780", "permed-71707", "permed-78004", "permed-72010"]}
{"query_id": "topic_286_turn_3", "conversation_id": "topic_286", "turn_id": 3, "query": "Acute COG inactivation: effects on Golgi vesicle dynamics (composition, distribution, specific CCD vesicle segregation of residents), disruption to protein glycosylation/sorting, and long-term implications for cellular homeostasis and congenital disorders of glycosylation.", "history": ["Golgi apparatus functions in human cell protein sorting and glycosylation", "How COG inactivation affects these Golgi functions (protein sorting, glycosylation) and contributes to cellular dysfunction and disease states"], "ground_truth": ["permed-71583", "permed-74375", "permed-50779", "permed-77401", "permed-63017", "permed-78004", "permed-66780", "permed-67939", "permed-61705", "permed-89562"]}
{"query_id": "topic_286_turn_4", "conversation_id": "topic_286", "turn_id": 4, "query": "For the acute COG inactivation experiments you described, what specific live-cell imaging protocols were used to track Golgi vesicle dynamics? I'm particularly interested in how you distinguished between different CCD vesicle populations - did you employ multiplexed fluorescent markers or sequential labeling strategies? Also, what statistical validation methods ensured that observed vesicle segregation changes weren't artifacts of photobleaching or movement within the imaging plane?", "history": ["Golgi apparatus functions in human cell protein sorting and glycosylation", "How COG inactivation affects these Golgi functions (protein sorting, glycosylation) and contributes to cellular dysfunction and disease states", "Acute COG inactivation: effects on Golgi vesicle dynamics (composition, distribution, specific CCD vesicle segregation of residents), disruption to protein glycosylation/sorting, and long-term implications for cellular homeostasis and congenital disorders of glycosylation."], "ground_truth": ["permed-71583", "permed-61705", "permed-74375", "permed-92562", "permed-64468", "permed-63376", "permed-31484", "permed-28917", "permed-16419", "permed-88984"]}
{"query_id": "topic_287_turn_1", "conversation_id": "topic_287", "turn_id": 1, "query": "Overview of current therapeutic strategies for managing fibrosis progression in non-alcoholic fatty liver disease (NAFLD)", "history": [], "ground_truth": ["permed-62693", "permed-62691", "permed-75520", "permed-51265", "permed-52641", "permed-62695", "permed-60269", "permed-52636", "permed-52637", "permed-60273"]}
{"query_id": "topic_287_turn_2", "conversation_id": "topic_287", "turn_id": 2, "query": "Among these therapeutic strategies for NAFLD fibrosis, what is the comparative effectiveness of pharmacological treatments (e.g., semaglutide) versus non-pharmacological approaches?", "history": ["Overview of current therapeutic strategies for managing fibrosis progression in non-alcoholic fatty liver disease (NAFLD)"], "ground_truth": ["permed-62693", "permed-75520", "permed-62691", "permed-62692", "permed-62712", "permed-75553", "permed-60273", "permed-62713", "permed-58208", "permed-62706"]}
{"query_id": "topic_287_turn_3", "conversation_id": "topic_287", "turn_id": 3, "query": "Deep dive into semaglutide and obeticholic acid for NAFLD fibrosis: comparative long-term safety, impact on quality of life, and their mechanisms affecting noninvasive fibrosis markers.", "history": ["Overview of current therapeutic strategies for managing fibrosis progression in non-alcoholic fatty liver disease (NAFLD)", "Among these therapeutic strategies for NAFLD fibrosis, what is the comparative effectiveness of pharmacological treatments (e.g., semaglutide) versus non-pharmacological approaches?"], "ground_truth": ["permed-62693", "permed-75520", "permed-60273", "permed-90703", "permed-60745", "permed-75553", "permed-84474", "permed-67833", "permed-62695", "permed-68960"]}
{"query_id": "topic_287_turn_4", "conversation_id": "topic_287", "turn_id": 4, "query": "Regarding these pharmacological mechanisms affecting noninvasive fibrosis markers, what specific validation protocols were employed for transient elastography measurements in long-term trials? I'm particularly interested in how inter-observer variability was controlled, whether standardized quality criteria (like IQR/median thresholds) were consistently applied across study sites, and what statistical methods were used to account for repeated measurements when analyzing fibrosis marker trajectories over time.", "history": ["Overview of current therapeutic strategies for managing fibrosis progression in non-alcoholic fatty liver disease (NAFLD)", "Among these therapeutic strategies for NAFLD fibrosis, what is the comparative effectiveness of pharmacological treatments (e.g., semaglutide) versus non-pharmacological approaches?", "Deep dive into semaglutide and obeticholic acid for NAFLD fibrosis: comparative long-term safety, impact on quality of life, and their mechanisms affecting noninvasive fibrosis markers."], "ground_truth": ["permed-62698", "permed-62703", "permed-62700", "permed-91679", "permed-62693", "permed-60524", "permed-60269", "permed-60528", "permed-10002", "permed-10414"]}
{"query_id": "topic_288_turn_1", "conversation_id": "topic_288", "turn_id": 1, "query": "Key impacts of climate change and urbanization on global flood management strategies", "history": [], "ground_truth": ["permed-67091", "permed-67100", "permed-82015", "permed-85524", "permed-82013", "permed-75160", "permed-73998", "permed-55107", "permed-90131", "permed-74497"]}
{"query_id": "topic_288_turn_2", "conversation_id": "topic_288", "turn_id": 2, "query": "Integrating resilience and sustainability principles into *these* flood management strategies to address *such* climate and urbanization impacts", "history": ["Key impacts of climate change and urbanization on global flood management strategies"], "ground_truth": ["permed-73998", "permed-67091", "permed-67100", "permed-69928", "permed-62737", "permed-55217", "permed-69938", "permed-75160", "permed-90131", "permed-74497"]}
{"query_id": "topic_288_turn_3", "conversation_id": "topic_288", "turn_id": 3, "query": "Advanced tools and adaptive methodologies for implementing *such* resilient flood management in high-risk urbanized catchments, including efficacy evaluation against conventional controls", "history": ["Key impacts of climate change and urbanization on global flood management strategies", "Integrating resilience and sustainability principles into *these* flood management strategies to address *such* climate and urbanization impacts"], "ground_truth": ["permed-73998", "permed-85524", "permed-67100", "permed-67091", "permed-75160", "permed-85545", "permed-66153", "permed-72384", "permed-69938", "permed-82015"]}
{"query_id": "topic_288_turn_4", "conversation_id": "topic_288", "turn_id": 4, "query": "Given these advanced tools' implementation, what specific validation protocols were used to assess their hydrological performance against conventional controls? I'm particularly interested in the statistical methods employed for comparing flood peak reduction and runoff volume between adaptive and traditional systems, and how you ensured measurement consistency across different urban catchment scales during these efficacy evaluations.", "history": ["Key impacts of climate change and urbanization on global flood management strategies", "Integrating resilience and sustainability principles into *these* flood management strategies to address *such* climate and urbanization impacts", "Advanced tools and adaptive methodologies for implementing *such* resilient flood management in high-risk urbanized catchments, including efficacy evaluation against conventional controls"], "ground_truth": ["permed-82013", "permed-85524", "permed-82002", "permed-79984", "permed-82015", "permed-67091", "permed-89746", "permed-67100", "permed-89748", "permed-69938"]}
{"query_id": "topic_289_turn_1", "conversation_id": "topic_289", "turn_id": 1, "query": "What factors can affect the accuracy of fecal immunochemical test (FIT) results in colorectal cancer screening?", "history": [], "ground_truth": ["permed-75819", "permed-1534", "permed-1047", "permed-34749", "permed-75340", "permed-83891", "permed-34748", "permed-75339", "permed-34750", "permed-34752"]}
{"query_id": "topic_289_turn_2", "conversation_id": "topic_289", "turn_id": 2, "query": "How sensitive is this testing method to environmental conditions during specimen handling and storage?", "history": ["What factors can affect the accuracy of fecal immunochemical test (FIT) results in colorectal cancer screening?"], "ground_truth": ["permed-75819", "permed-43890", "permed-43889", "permed-81832", "permed-91235", "permed-66608", "permed-75811", "permed-65803", "permed-53311", "permed-55183"]}
{"query_id": "topic_289_turn_3", "conversation_id": "topic_289", "turn_id": 3, "query": "Given the sensitivity of FIT to environmental conditions mentioned earlier, how exactly do temperature fluctuations and humidity during specimen transportation and storage affect hemoglobin integrity and the test's reliability for early colorectal cancer detection, especially in settings where maintaining controlled conditions might be challenging?", "history": ["What factors can affect the accuracy of fecal immunochemical test (FIT) results in colorectal cancer screening?", "How sensitive is this testing method to environmental conditions during specimen handling and storage?"], "ground_truth": ["permed-75819", "permed-34752", "permed-1047", "permed-83891", "permed-34754", "permed-34750", "permed-34748", "permed-75339", "permed-4474", "permed-84220"]}
{"query_id": "topic_289_turn_4", "conversation_id": "topic_289", "turn_id": 4, "query": "Building on these environmental challenges, what specific quality control protocols and validation methods should be implemented when designing specimen transport studies to accurately quantify hemoglobin degradation under variable temperature and humidity conditions? I'm particularly interested in how researchers establish standardized testing intervals, select appropriate control samples, and determine the statistical thresholds for clinically significant hemoglobin decay that would impact FIT sensitivity in real-world screening scenarios.", "history": ["What factors can affect the accuracy of fecal immunochemical test (FIT) results in colorectal cancer screening?", "How sensitive is this testing method to environmental conditions during specimen handling and storage?", "Given the sensitivity of FIT to environmental conditions mentioned earlier, how exactly do temperature fluctuations and humidity during specimen transportation and storage affect hemoglobin integrity and the test's reliability for early colorectal cancer detection, especially in settings where maintaining controlled conditions might be challenging?"], "ground_truth": ["permed-75819", "permed-84220", "permed-65224", "permed-60786", "permed-37954", "permed-21447", "permed-75650", "permed-6348", "permed-81423", "permed-37962"]}
{"query_id": "topic_290_turn_1", "conversation_id": "topic_290", "turn_id": 1, "query": "What role can web-based educational programs play in enhancing professional capabilities of government officials in low-resource settings?", "history": [], "ground_truth": ["permed-56855", "permed-63528", "permed-57442", "permed-80774", "permed-57445", "permed-62335", "permed-75373", "permed-56885", "permed-69975", "permed-81456"]}
{"query_id": "topic_290_turn_2", "conversation_id": "topic_290", "turn_id": 2, "query": "How might technologies like adaptive learning be particularly beneficial in this area, especially for complex health issues?", "history": ["What role can web-based educational programs play in enhancing professional capabilities of government officials in low-resource settings?"], "ground_truth": ["permed-66148", "permed-51543", "permed-52082", "permed-91926", "permed-66063", "permed-61880", "permed-78687", "permed-54383", "permed-54524", "permed-68370"]}
{"query_id": "topic_290_turn_3", "conversation_id": "topic_290", "turn_id": 3, "query": "Given these potential benefits of adaptive learning in web-based programs for government officials, how could integrating personalized feedback mechanisms—like those in OneLearns—further enhance their professional capabilities in low-resource settings, particularly for tackling complex health issues such as malnutrition and improving digital health literacy? What long-term effects might such programs have on policy development and implementation, especially in relation to sustainable development goals?", "history": ["What role can web-based educational programs play in enhancing professional capabilities of government officials in low-resource settings?", "How might technologies like adaptive learning be particularly beneficial in this area, especially for complex health issues?"], "ground_truth": ["permed-56855", "permed-51543", "permed-57576", "permed-57445", "permed-52082", "permed-69975", "permed-82747", "permed-63528", "permed-84730", "permed-90445"]}
{"query_id": "topic_290_turn_4", "conversation_id": "topic_290", "turn_id": 4, "query": "Building on this adaptive learning approach with personalized feedback, what specific experimental designs would best evaluate its efficacy for health officials? I'm particularly interested in how we might structure control groups—perhaps comparing standard e-learning against the adaptive system—and what validated instruments could measure digital health literacy gains. What statistical methods would be appropriate for analyzing skill retention across different implementation contexts, and how might we establish reproducibility benchmarks given the variability in low-resource settings?", "history": ["What role can web-based educational programs play in enhancing professional capabilities of government officials in low-resource settings?", "How might technologies like adaptive learning be particularly beneficial in this area, especially for complex health issues?", "Given these potential benefits of adaptive learning in web-based programs for government officials, how could integrating personalized feedback mechanisms—like those in OneLearns—further enhance their professional capabilities in low-resource settings, particularly for tackling complex health issues such as malnutrition and improving digital health literacy? What long-term effects might such programs have on policy development and implementation, especially in relation to sustainable development goals?"], "ground_truth": ["permed-78731", "permed-56855", "permed-88216", "permed-88302", "permed-90788", "permed-61614", "permed-61613", "permed-52384", "permed-91628", "permed-88300"]}
{"query_id": "topic_291_turn_1", "conversation_id": "topic_291", "turn_id": 1, "query": "What role do mutational signatures play in understanding tumor development and progression in cancer research?", "history": [], "ground_truth": ["permed-78604", "permed-77274", "permed-78605", "permed-82373", "permed-77277", "permed-74456", "permed-56750", "permed-56532", "permed-54311", "permed-51353"]}
{"query_id": "topic_291_turn_2", "conversation_id": "topic_291", "turn_id": 2, "query": "How can analyzing changes in these mutational signature activities help in developing more targeted and effective therapies?", "history": ["What role do mutational signatures play in understanding tumor development and progression in cancer research?"], "ground_truth": ["permed-77274", "permed-78604", "permed-50790", "permed-82373", "permed-51227", "permed-71707", "permed-54311", "permed-78605", "permed-87435", "permed-73592"]}
{"query_id": "topic_291_turn_3", "conversation_id": "topic_291", "turn_id": 3, "query": "Given these insights into how mutational signature activities can guide therapy development, how might identifying recurrent changepoints in these signatures across tumor types—particularly those independent of gene density, mutation density, and chromatin state—inform more precise therapeutic targeting? What would this mean for personalizing oncology treatments, especially in predicting patient responses across different tumor stages?", "history": ["What role do mutational signatures play in understanding tumor development and progression in cancer research?", "How can analyzing changes in these mutational signature activities help in developing more targeted and effective therapies?"], "ground_truth": ["permed-77274", "permed-78604", "permed-56689", "permed-51228", "permed-78605", "permed-77277", "permed-58767", "permed-50751", "permed-51227", "permed-83730"]}
{"query_id": "topic_291_turn_4", "conversation_id": "topic_291", "turn_id": 4, "query": "Given these recurrent changepoints you've identified across tumor types, what specific computational methodology would you use to establish their statistical significance while controlling for confounding genomic variables? Would you implement a multivariate changepoint detection algorithm with covariate adjustment, and what validation framework - perhaps bootstrap resampling or cross-validation across independent cohorts - would ensure these changepoints represent biologically meaningful transitions rather than technical artifacts?", "history": ["What role do mutational signatures play in understanding tumor development and progression in cancer research?", "How can analyzing changes in these mutational signature activities help in developing more targeted and effective therapies?", "Given these insights into how mutational signature activities can guide therapy development, how might identifying recurrent changepoints in these signatures across tumor types—particularly those independent of gene density, mutation density, and chromatin state—inform more precise therapeutic targeting? What would this mean for personalizing oncology treatments, especially in predicting patient responses across different tumor stages?"], "ground_truth": ["permed-77274", "permed-78605", "permed-56250", "permed-52691", "permed-87620", "permed-58767", "permed-77277", "permed-37829", "permed-51228", "permed-58770"]}
{"query_id": "topic_292_turn_1", "conversation_id": "topic_292", "turn_id": 1, "query": "Impact of planetary health on public health policy development and implementation.", "history": [], "ground_truth": ["permed-91926", "permed-55180", "permed-88327", "permed-66153", "permed-74858", "permed-66148", "permed-54928", "permed-65029", "permed-53023", "permed-91759"]}
{"query_id": "topic_292_turn_2", "conversation_id": "topic_292", "turn_id": 2, "query": "Given these impacts, how can integrating a planetary health approach into bioethics improve equity in public health outcomes for diverse communities?", "history": ["Impact of planetary health on public health policy development and implementation."], "ground_truth": ["permed-72675", "permed-67610", "permed-53039", "permed-54375", "permed-59645", "permed-53037", "permed-52056", "permed-74860", "permed-53038", "permed-65625"]}
{"query_id": "topic_292_turn_3", "conversation_id": "topic_292", "turn_id": 3, "query": "What specific bioethical frameworks and policy mechanisms, informed by planetary health, ensure fair environmental risk/benefit distribution across populations and generations, and build resilient public health governance for ecological crises?", "history": ["Impact of planetary health on public health policy development and implementation.", "Given these impacts, how can integrating a planetary health approach into bioethics improve equity in public health outcomes for diverse communities?"], "ground_truth": ["permed-72675", "permed-59645", "permed-74860", "permed-68405", "permed-53039", "permed-52056", "permed-74856", "permed-74858", "permed-52052", "permed-69392"]}
{"query_id": "topic_292_turn_4", "conversation_id": "topic_292", "turn_id": 4, "query": "Given these frameworks emphasizing equitable risk distribution, what specific methodological approaches—such as multi-criteria decision analysis or health impact assessment protocols—would best operationalize intergenerational equity in environmental policymaking? How do we technically quantify and weight cross-temporal tradeoffs between immediate public health needs and long-term planetary health preservation, particularly when validating these models against real-world ecological crisis scenarios? What statistical methods ensure robust uncertainty quantification when projecting health outcomes across different demographic groups over extended time horizons?", "history": ["Impact of planetary health on public health policy development and implementation.", "Given these impacts, how can integrating a planetary health approach into bioethics improve equity in public health outcomes for diverse communities?", "What specific bioethical frameworks and policy mechanisms, informed by planetary health, ensure fair environmental risk/benefit distribution across populations and generations, and build resilient public health governance for ecological crises?"], "ground_truth": ["permed-52052", "permed-53060", "permed-51750", "permed-53013", "permed-25814", "permed-80053", "permed-53878", "permed-59645", "permed-69887", "permed-52219"]}
{"query_id": "topic_293_turn_1", "conversation_id": "topic_293", "turn_id": 1, "query": "Influence of historical medical ethics on current public health policy development", "history": [], "ground_truth": ["permed-91926", "permed-66153", "permed-74855", "permed-53039", "permed-88327", "permed-53036", "permed-56876", "permed-61420", "permed-53038", "permed-70240"]}
{"query_id": "topic_293_turn_2", "conversation_id": "topic_293", "turn_id": 2, "query": "Impact of these historical medical ethics failures on developing equitable public health strategies", "history": ["Influence of historical medical ethics on current public health policy development"], "ground_truth": ["permed-74855", "permed-91926", "permed-53039", "permed-66153", "permed-74781", "permed-81608", "permed-59645", "permed-56876", "permed-53051", "permed-69638"]}
{"query_id": "topic_293_turn_3", "conversation_id": "topic_293", "turn_id": 3, "query": "Technical methods for incorporating lessons from historical injustices like Tuskegee into bioethics frameworks to ensure equitable public health policies during global crises and social justice movements", "history": ["Influence of historical medical ethics on current public health policy development", "Impact of these historical medical ethics failures on developing equitable public health strategies"], "ground_truth": ["permed-74855", "permed-53039", "permed-53037", "permed-53051", "permed-53042", "permed-74783", "permed-54375", "permed-67610", "permed-74859", "permed-72675"]}
{"query_id": "topic_293_turn_4", "conversation_id": "topic_293", "turn_id": 4, "query": "When implementing these historical bioethics frameworks, what specific methodological approaches are used to validate their effectiveness in real-time policy development? I'm particularly interested in how researchers establish metrics for measuring equity outcomes, what statistical models help quantify the impact of these ethical safeguards, and whether there are standardized protocols for monitoring unintended consequences during rapid public health implementations. How do you ensure methodological rigor while maintaining flexibility during evolving crises?", "history": ["Influence of historical medical ethics on current public health policy development", "Impact of these historical medical ethics failures on developing equitable public health strategies", "Technical methods for incorporating lessons from historical injustices like Tuskegee into bioethics frameworks to ensure equitable public health policies during global crises and social justice movements"], "ground_truth": ["permed-53039", "permed-74651", "permed-53035", "permed-70241", "permed-74783", "permed-87900", "permed-74855", "permed-72676", "permed-88216", "permed-53038"]}
{"query_id": "topic_294_turn_1", "conversation_id": "topic_294", "turn_id": 1, "query": "What's known about the relationship between OCD and depression in clinical settings?", "history": [], "ground_truth": ["permed-81387", "permed-81389", "permed-52232", "permed-67194", "permed-69628", "permed-59825", "permed-75907", "permed-67195", "permed-92216", "permed-79626"]}
{"query_id": "topic_294_turn_2", "conversation_id": "topic_294", "turn_id": 2, "query": "How does treating one condition over the other impact patient outcomes in this area?", "history": ["What's known about the relationship between OCD and depression in clinical settings?"], "ground_truth": ["permed-77068", "permed-66148", "permed-61615", "permed-57447", "permed-91926", "permed-83267", "permed-53187", "permed-72010", "permed-59136", "permed-71333"]}
{"query_id": "topic_294_turn_3", "conversation_id": "topic_294", "turn_id": 3, "query": "If we prioritize treating OCD over depression in clinical practice, how might that affect patients' long-term outcomes? And given what we know about how OCD influences depression severity, what specific therapeutic approaches could be developed to target these underlying mechanisms?", "history": ["What's known about the relationship between OCD and depression in clinical settings?", "How does treating one condition over the other impact patient outcomes in this area?"], "ground_truth": ["permed-81387", "permed-67194", "permed-69772", "permed-81389", "permed-67195", "permed-52232", "permed-52241", "permed-92216", "permed-59823", "permed-40764"]}
{"query_id": "topic_294_turn_4", "conversation_id": "topic_294", "turn_id": 4, "query": "For these proposed therapeutic approaches targeting OCD-depression mechanisms, what specific experimental designs would best test their efficacy? I'm particularly interested in how we might structure randomized controlled trials - should we use crossover designs comparing treatment sequences, or parallel groups with different intervention priorities? What statistical methods would be most appropriate for analyzing the longitudinal outcomes, and how should we handle potential confounding factors like medication adherence or comorbid anxiety symptoms in the analysis?", "history": ["What's known about the relationship between OCD and depression in clinical settings?", "How does treating one condition over the other impact patient outcomes in this area?", "If we prioritize treating OCD over depression in clinical practice, how might that affect patients' long-term outcomes? And given what we know about how OCD influences depression severity, what specific therapeutic approaches could be developed to target these underlying mechanisms?"], "ground_truth": ["permed-81387", "permed-67194", "permed-69772", "permed-55684", "permed-67195", "permed-52232", "permed-52241", "permed-50505", "permed-40764", "permed-75907"]}
{"query_id": "topic_295_turn_1", "conversation_id": "topic_295", "turn_id": 1, "query": "Nav1.5 channel function in cardiomyocytes and contribution to cardiac electrophysiology and mechanics", "history": [], "ground_truth": ["permed-77237", "permed-77238", "permed-76598", "permed-43162", "permed-90209", "permed-76593", "permed-57418", "permed-90337", "permed-76594", "permed-76596"]}
{"query_id": "topic_295_turn_2", "conversation_id": "topic_295", "turn_id": 2, "query": "Impact of subcellular localization on these Nav1.5 channels' activity, particularly concerning their role in cardiac electrophysiology", "history": ["Nav1.5 channel function in cardiomyocytes and contribution to cardiac electrophysiology and mechanics"], "ground_truth": ["permed-77237", "permed-77238", "permed-43162", "permed-76598", "permed-90209", "permed-76594", "permed-76593", "permed-76596", "permed-77241", "permed-53609"]}
{"query_id": "topic_295_turn_3", "conversation_id": "topic_295", "turn_id": 3, "query": "Differential regulation of Nav1.5 in distinct cardiomyocyte microenvironments (e.g., lateral membrane vs. intercalated disc): effects on channel biophysics, implications for arrhythmogenesis and cardiac manifestations of muscular dystrophies, and therapeutic targeting of localized dysfunction.", "history": ["Nav1.5 channel function in cardiomyocytes and contribution to cardiac electrophysiology and mechanics", "Impact of subcellular localization on these Nav1.5 channels' activity, particularly concerning their role in cardiac electrophysiology"], "ground_truth": ["permed-77237", "permed-77238", "permed-43162", "permed-76596", "permed-72134", "permed-76598", "permed-76593", "permed-82113", "permed-57418", "permed-71390"]}
{"query_id": "topic_295_turn_4", "conversation_id": "topic_295", "turn_id": 4, "query": "Given this focus on differential regulation across microenvironments, what specific experimental approaches were employed to isolate and characterize Nav1.5 subpopulations from the lateral membrane versus the intercalated disc? I'm particularly interested in the technical details of the biochemical fractionation or proximity-based labeling protocols used, and how the subsequent patch-clamp configurations were optimized to reliably record from these specific, spatially restricted membrane domains while preserving their native regulatory context.", "history": ["Nav1.5 channel function in cardiomyocytes and contribution to cardiac electrophysiology and mechanics", "Impact of subcellular localization on these Nav1.5 channels' activity, particularly concerning their role in cardiac electrophysiology", "Differential regulation of Nav1.5 in distinct cardiomyocyte microenvironments (e.g., lateral membrane vs. intercalated disc): effects on channel biophysics, implications for arrhythmogenesis and cardiac manifestations of muscular dystrophies, and therapeutic targeting of localized dysfunction."], "ground_truth": ["permed-77237", "permed-43162", "permed-77238", "permed-67660", "permed-11738", "permed-37905", "permed-53610", "permed-64497", "permed-76598", "permed-58081"]}
{"query_id": "topic_296_turn_1", "conversation_id": "topic_296", "turn_id": 1, "query": "What is known about the therapeutic potential of argenteolides, particularly their cytotoxic and antibacterial properties?", "history": [], "ground_truth": ["permed-78966", "permed-59491", "permed-69205", "permed-62997", "permed-90289", "permed-86222", "permed-68982", "permed-64190", "permed-79588", "permed-59503"]}
{"query_id": "topic_296_turn_2", "conversation_id": "topic_296", "turn_id": 2, "query": "How do the unique structural features of these compounds influence their biological activities, making them potentially useful in this area?", "history": ["What is known about the therapeutic potential of argenteolides, particularly their cytotoxic and antibacterial properties?"], "ground_truth": ["permed-86697", "permed-60336", "permed-79218", "permed-73072", "permed-85690", "permed-72935", "permed-58120", "permed-52763", "permed-66642", "permed-59492"]}
{"query_id": "topic_296_turn_3", "conversation_id": "topic_296", "turn_id": 3, "query": "Given these structural features and their biological activities, how exactly does the 5/5/5 tricyclic system within the 20-membered macrocycle influence argenteolides' binding affinity and mechanism of action at the molecular level—particularly for their cytotoxic and antibacterial effects? Furthermore, what strategies could potentially enhance these activities for therapeutic use, and how might such modifications impact the compounds' overall stability and pharmacokinetic properties?", "history": ["What is known about the therapeutic potential of argenteolides, particularly their cytotoxic and antibacterial properties?", "How do the unique structural features of these compounds influence their biological activities, making them potentially useful in this area?"], "ground_truth": ["permed-78966", "permed-87599", "permed-55445", "permed-67452", "permed-86545", "permed-58114", "permed-79588", "permed-60824", "permed-75042", "permed-89340"]}
{"query_id": "topic_296_turn_4", "conversation_id": "topic_296", "turn_id": 4, "query": "Following this molecular-level analysis, what specific experimental techniques would best characterize the binding interactions between the 5/5/5 tricyclic system and its biological targets? I'm particularly interested in the methodology for distinguishing cytotoxic versus antibacterial mechanisms—would you recommend using isothermal titration calorimetry to quantify affinity, complemented by X-ray crystallography for structural resolution? Furthermore, what statistical validation approaches are most appropriate for ensuring the reproducibility of these binding assays across different cellular models?", "history": ["What is known about the therapeutic potential of argenteolides, particularly their cytotoxic and antibacterial properties?", "How do the unique structural features of these compounds influence their biological activities, making them potentially useful in this area?", "Given these structural features and their biological activities, how exactly does the 5/5/5 tricyclic system within the 20-membered macrocycle influence argenteolides' binding affinity and mechanism of action at the molecular level—particularly for their cytotoxic and antibacterial effects? Furthermore, what strategies could potentially enhance these activities for therapeutic use, and how might such modifications impact the compounds' overall stability and pharmacokinetic properties?"], "ground_truth": ["permed-73351", "permed-84217", "permed-72930", "permed-90376", "permed-86312", "permed-60341", "permed-89340", "permed-73652", "permed-60342", "permed-85692"]}
{"query_id": "topic_297_turn_1", "conversation_id": "topic_297", "turn_id": 1, "query": "What are the main factors contributing to the rise of antibiotic-resistant bacterial infections?", "history": [], "ground_truth": ["permed-6199", "permed-51275", "permed-88652", "permed-66820", "permed-51278", "permed-60427", "permed-58453", "permed-51277", "permed-89788", "permed-67889"]}
{"query_id": "topic_297_turn_2", "conversation_id": "topic_297", "turn_id": 2, "query": "Can optimizing vaccination programs and diagnostic technologies help mitigate this issue, especially in high-risk populations?", "history": ["What are the main factors contributing to the rise of antibiotic-resistant bacterial infections?"], "ground_truth": ["permed-13679", "permed-21612", "permed-91022", "permed-67295", "permed-59940", "permed-67197", "permed-61174", "permed-63518", "permed-64307", "permed-37387"]}
{"query_id": "topic_297_turn_3", "conversation_id": "topic_297", "turn_id": 3, "query": "Given these factors and potential solutions, how can we best integrate vaccination programs with improved diagnostic tools and antibiotic stewardship to effectively lower antibiotic-resistant infection rates in high-risk groups?", "history": ["What are the main factors contributing to the rise of antibiotic-resistant bacterial infections?", "Can optimizing vaccination programs and diagnostic technologies help mitigate this issue, especially in high-risk populations?"], "ground_truth": ["permed-63520", "permed-54446", "permed-63447", "permed-68912", "permed-79394", "permed-80202", "permed-60688", "permed-72359", "permed-5954", "permed-67889"]}
{"query_id": "topic_297_turn_4", "conversation_id": "topic_297", "turn_id": 4, "query": "When implementing this integrated approach, what specific experimental designs would best evaluate the synergistic effects between rapid diagnostic technologies and targeted vaccination protocols? I'm particularly interested in methodological considerations for real-world deployment—should we use stepped-wedge cluster randomization or interrupted time series analysis to measure outcomes like antibiotic prescription patterns and resistance incidence? How should we standardize data collection across different healthcare settings while maintaining statistical power to detect meaningful changes in resistant infection rates?", "history": ["What are the main factors contributing to the rise of antibiotic-resistant bacterial infections?", "Can optimizing vaccination programs and diagnostic technologies help mitigate this issue, especially in high-risk populations?", "Given these factors and potential solutions, how can we best integrate vaccination programs with improved diagnostic tools and antibiotic stewardship to effectively lower antibiotic-resistant infection rates in high-risk groups?"], "ground_truth": ["permed-1923", "permed-54446", "permed-63520", "permed-65408", "permed-63447", "permed-90944", "permed-66694", "permed-5954", "permed-65913", "permed-61932"]}
{"query_id": "topic_298_turn_1", "conversation_id": "topic_298", "turn_id": 1, "query": "Comprehensive overview of medical imaging modalities in thyroid cancer diagnosis, staging, and treatment management.", "history": [], "ground_truth": ["permed-29182", "permed-43349", "permed-20559", "permed-2854", "permed-48520", "permed-65279", "permed-56740", "permed-76924", "permed-77465", "permed-3450"]}
{"query_id": "topic_298_turn_2", "conversation_id": "topic_298", "turn_id": 2, "query": "Given their established applications in thyroid cancer, what advantages do advanced imaging techniques offer over traditional methods such as SPECT/CT for improving diagnostic accuracy and treatment stratification?", "history": ["Comprehensive overview of medical imaging modalities in thyroid cancer diagnosis, staging, and treatment management."], "ground_truth": ["permed-77465", "permed-3450", "permed-77450", "permed-29094", "permed-5108", "permed-28091", "permed-68647", "permed-56062", "permed-29954", "permed-17812"]}
{"query_id": "topic_298_turn_3", "conversation_id": "topic_298", "turn_id": 3, "query": "Clinical utility of hybrid advanced molecular imaging and SPECT/CT for differentiating benign subcutaneous lesions from metastases in post-RAI thyroid cancer patients: implications for personalized treatment strategies.", "history": ["Comprehensive overview of medical imaging modalities in thyroid cancer diagnosis, staging, and treatment management.", "Given their established applications in thyroid cancer, what advantages do advanced imaging techniques offer over traditional methods such as SPECT/CT for improving diagnostic accuracy and treatment stratification?"], "ground_truth": ["permed-77465", "permed-48520", "permed-5108", "permed-17485", "permed-77464", "permed-65279", "permed-17972", "permed-3633", "permed-29182", "permed-80552"]}
{"query_id": "topic_298_turn_4", "conversation_id": "topic_298", "turn_id": 4, "query": "Regarding the hybrid imaging protocol for differentiating post-RAI lesions, could you elaborate on the specific co-registration methodology used to align the advanced molecular imaging data with the SPECT/CT anatomical datasets? I'm particularly interested in the validation strategy employed for this fusion process—were mutual information or normalized mutual information metrics used to quantitatively assess registration accuracy, and what was the established threshold for clinical acceptability of the co-registered images in this diagnostic context?", "history": ["Comprehensive overview of medical imaging modalities in thyroid cancer diagnosis, staging, and treatment management.", "Given their established applications in thyroid cancer, what advantages do advanced imaging techniques offer over traditional methods such as SPECT/CT for improving diagnostic accuracy and treatment stratification?", "Clinical utility of hybrid advanced molecular imaging and SPECT/CT for differentiating benign subcutaneous lesions from metastases in post-RAI thyroid cancer patients: implications for personalized treatment strategies."], "ground_truth": ["permed-63378", "permed-61809", "permed-60523", "permed-60556", "permed-60552", "permed-61544", "permed-80552", "permed-87841", "permed-56460", "permed-56767"]}
{"query_id": "topic_299_turn_1", "conversation_id": "topic_299", "turn_id": 1, "query": "Impact of gut microbiota alterations on COVID-19 patient recovery, focusing on antibiotic use and associated dysbiosis", "history": [], "ground_truth": ["permed-51262", "permed-51263", "permed-72653", "permed-51261", "permed-68512", "permed-66978", "permed-77184", "permed-78425", "permed-68513", "permed-58588"]}
{"query_id": "topic_299_turn_2", "conversation_id": "topic_299", "turn_id": 2, "query": "Mechanisms and clinical efficacy of Saccharomyces boulardii in modulating these antibiotic-induced gut microbiota changes and improving COVID-19 recovery", "history": ["Impact of gut microbiota alterations on COVID-19 patient recovery, focusing on antibiotic use and associated dysbiosis"], "ground_truth": ["permed-77184", "permed-51262", "permed-51263", "permed-68512", "permed-68513", "permed-72653", "permed-64094", "permed-58168", "permed-89657", "permed-65029"]}
{"query_id": "topic_299_turn_3", "conversation_id": "topic_299", "turn_id": 3, "query": "Preventive administration of Saccharomyces boulardii CNCM I-745: effects on gut microbiome composition, metabolomic profiles, and clinical outcomes in hospitalized COVID-19 patients receiving antibiotics - clinical trial data", "history": ["Impact of gut microbiota alterations on COVID-19 patient recovery, focusing on antibiotic use and associated dysbiosis", "Mechanisms and clinical efficacy of Saccharomyces boulardii in modulating these antibiotic-induced gut microbiota changes and improving COVID-19 recovery"], "ground_truth": ["permed-77184", "permed-72653", "permed-51262", "permed-68512", "permed-68513", "permed-90470", "permed-64094", "permed-81071", "permed-77189", "permed-66978"]}
{"query_id": "topic_299_turn_4", "conversation_id": "topic_299", "turn_id": 4, "query": "For this clinical trial design, what specific statistical methods were employed to analyze the longitudinal microbiome sequencing data? Were differential abundance analyses conducted using tools like DESeq2 or LEfSe, and how was multiple testing correction handled? Regarding metabolomic profiles, what normalization and dimensionality reduction techniques were applied to the mass spectrometry data prior to associating microbial features with clinical outcomes? Additionally, how was the randomization protocol implemented to ensure comparable baseline characteristics between intervention and control groups receiving antibiotics?", "history": ["Impact of gut microbiota alterations on COVID-19 patient recovery, focusing on antibiotic use and associated dysbiosis", "Mechanisms and clinical efficacy of Saccharomyces boulardii in modulating these antibiotic-induced gut microbiota changes and improving COVID-19 recovery", "Preventive administration of Saccharomyces boulardii CNCM I-745: effects on gut microbiome composition, metabolomic profiles, and clinical outcomes in hospitalized COVID-19 patients receiving antibiotics - clinical trial data"], "ground_truth": ["permed-78425", "permed-57643", "permed-57640", "permed-58588", "permed-67119", "permed-69753", "permed-82012", "permed-67964", "permed-40734", "permed-66976"]}
{"query_id": "topic_300_turn_1", "conversation_id": "topic_300", "turn_id": 1, "query": "What role does oxidative stress play in neuroinflammatory diseases like multiple sclerosis?", "history": [], "ground_truth": ["permed-67796", "permed-66783", "permed-19548", "permed-53766", "permed-63190", "permed-53078", "permed-68158", "permed-73685", "permed-54306", "permed-67791"]}
{"query_id": "topic_300_turn_2", "conversation_id": "topic_300", "turn_id": 2, "query": "How do findings from mouse models, such as those with mitochondrial dysfunction, inform our understanding of this process?", "history": ["What role does oxidative stress play in neuroinflammatory diseases like multiple sclerosis?"], "ground_truth": ["permed-89562", "permed-65111", "permed-82351", "permed-53810", "permed-53811", "permed-77272", "permed-54254", "permed-54214", "permed-74333", "permed-81126"]}
{"query_id": "topic_300_turn_3", "conversation_id": "topic_300", "turn_id": 3, "query": "Given what we know about oxidative stress in neuroinflammation and the insights from MnSOD-deficient mouse models showing its role in demyelination, how might targeting mitochondrial function or reducing oxidative damage specifically in neurons affect disease progression in conditions like multiple sclerosis? What therapeutic strategies could emerge from these findings?", "history": ["What role does oxidative stress play in neuroinflammatory diseases like multiple sclerosis?", "How do findings from mouse models, such as those with mitochondrial dysfunction, inform our understanding of this process?"], "ground_truth": ["permed-67796", "permed-68158", "permed-53766", "permed-81126", "permed-67791", "permed-63190", "permed-19548", "permed-54227", "permed-71415", "permed-73691"]}
{"query_id": "topic_300_turn_4", "conversation_id": "topic_300", "turn_id": 4, "query": "Given this therapeutic direction, what specific experimental protocols would you recommend for testing mitochondrial-targeted antioxidants in these MnSOD-deficient models? I'm particularly interested in the technical implementation—should we use localized CNS delivery systems or systemic administration, and what would be the optimal dosing schedules? Additionally, what functional and molecular readouts (beyond standard demyelination scoring) would best capture neuron-specific effects while controlling for systemic inflammatory responses in this experimental setup?", "history": ["What role does oxidative stress play in neuroinflammatory diseases like multiple sclerosis?", "How do findings from mouse models, such as those with mitochondrial dysfunction, inform our understanding of this process?", "Given what we know about oxidative stress in neuroinflammation and the insights from MnSOD-deficient mouse models showing its role in demyelination, how might targeting mitochondrial function or reducing oxidative damage specifically in neurons affect disease progression in conditions like multiple sclerosis? What therapeutic strategies could emerge from these findings?"], "ground_truth": ["permed-67796", "permed-68158", "permed-81126", "permed-4773", "permed-83721", "permed-61112", "permed-67791", "permed-81298", "permed-71415", "permed-62653"]}
{"query_id": "topic_301_turn_1", "conversation_id": "topic_301", "turn_id": 1, "query": "What role does autophagy play in the development and progression of pancreatic cancer?", "history": [], "ground_truth": ["permed-75109", "permed-76581", "permed-57855", "permed-57107", "permed-55401", "permed-10104", "permed-56504", "permed-16696", "permed-55322", "permed-72846"]}
{"query_id": "topic_301_turn_2", "conversation_id": "topic_301", "turn_id": 2, "query": "Can manipulating this process, particularly through inhibition, offer new avenues for targeted therapies in this area?", "history": ["What role does autophagy play in the development and progression of pancreatic cancer?"], "ground_truth": ["permed-56693", "permed-60152", "permed-79639", "permed-82373", "permed-83871", "permed-69179", "permed-57855", "permed-62495", "permed-75109", "permed-73065"]}
{"query_id": "topic_301_turn_3", "conversation_id": "topic_301", "turn_id": 3, "query": "Given that autophagy inhibition shows promise for targeted pancreatic cancer therapies, how could a newly discovered interaction between this process and cell cycle regulation be exploited to develop more effective treatments that specifically suppress tumors while reducing systemic side effects?", "history": ["What role does autophagy play in the development and progression of pancreatic cancer?", "Can manipulating this process, particularly through inhibition, offer new avenues for targeted therapies in this area?"], "ground_truth": ["permed-75109", "permed-57855", "permed-77883", "permed-57861", "permed-56504", "permed-72846", "permed-56508", "permed-57853", "permed-55322", "permed-67978"]}
{"query_id": "topic_301_turn_4", "conversation_id": "topic_301", "turn_id": 4, "query": "Given this potential therapeutic strategy targeting autophagy-cell cycle interactions, what specific experimental approaches would best validate whether combined pharmacological inhibition of both processes produces synergistic anti-tumor effects? I'm particularly interested in the methodology for determining optimal dosing sequences, appropriate combination indices for synergy quantification, and which in vivo models would most accurately capture the therapeutic window while monitoring systemic toxicity through what specific biomarkers and histological assessments.", "history": ["What role does autophagy play in the development and progression of pancreatic cancer?", "Can manipulating this process, particularly through inhibition, offer new avenues for targeted therapies in this area?", "Given that autophagy inhibition shows promise for targeted pancreatic cancer therapies, how could a newly discovered interaction between this process and cell cycle regulation be exploited to develop more effective treatments that specifically suppress tumors while reducing systemic side effects?"], "ground_truth": ["permed-75109", "permed-57855", "permed-57853", "permed-57861", "permed-69209", "permed-10266", "permed-89655", "permed-69265", "permed-87472", "permed-73129"]}
{"query_id": "topic_302_turn_1", "conversation_id": "topic_302", "turn_id": 1, "query": "Role of spectrin isoforms in regulating cell membrane structure and dynamics across different cell types", "history": [], "ground_truth": ["permed-77117", "permed-53699", "permed-70800", "permed-90263", "permed-76159", "permed-79922", "permed-83363", "permed-90266", "permed-72012", "permed-79919"]}
{"query_id": "topic_302_turn_2", "conversation_id": "topic_302", "turn_id": 2, "query": "Investigating how structural variations in these spectrin isoforms, particularly between erythroid and nonerythroid types, influence specific membrane mechanical properties and cytoskeletal organization", "history": ["Role of spectrin isoforms in regulating cell membrane structure and dynamics across different cell types"], "ground_truth": ["permed-77117", "permed-90266", "permed-53699", "permed-83363", "permed-90263", "permed-76159", "permed-79717", "permed-79922", "permed-87044", "permed-92426"]}
{"query_id": "topic_302_turn_3", "conversation_id": "topic_302", "turn_id": 3, "query": "Molecular mechanisms: How do differences in tertiary structure and flexibility between erythroid and nonerythroid spectrin isoforms dictate their interactions with PC/PE lipid bilayers, altering membrane phase behavior and fluidity, and what are the downstream consequences for associated membrane protein function?", "history": ["Role of spectrin isoforms in regulating cell membrane structure and dynamics across different cell types", "Investigating how structural variations in these spectrin isoforms, particularly between erythroid and nonerythroid types, influence specific membrane mechanical properties and cytoskeletal organization"], "ground_truth": ["permed-77117", "permed-76159", "permed-77118", "permed-76162", "permed-90266", "permed-76278", "permed-75027", "permed-79182", "permed-53579", "permed-58081"]}
{"query_id": "topic_302_turn_4", "conversation_id": "topic_302", "turn_id": 4, "query": "Given these structural comparisons, what specific biophysical techniques would be most appropriate for quantifying the differential interactions between erythroid versus nonerythroid spectrin isoforms with PC/PE bilayers? I'm particularly interested in methodological considerations for measuring binding kinetics, membrane deformation dynamics, and phase separation behavior - would surface plasmon resonance, atomic force microscopy, or fluorescence recovery after photobleaching provide the most reliable data? Also, what controls should be implemented to validate specificity in these complex lipid-protein systems?", "history": ["Role of spectrin isoforms in regulating cell membrane structure and dynamics across different cell types", "Investigating how structural variations in these spectrin isoforms, particularly between erythroid and nonerythroid types, influence specific membrane mechanical properties and cytoskeletal organization", "Molecular mechanisms: How do differences in tertiary structure and flexibility between erythroid and nonerythroid spectrin isoforms dictate their interactions with PC/PE lipid bilayers, altering membrane phase behavior and fluidity, and what are the downstream consequences for associated membrane protein function?"], "ground_truth": ["permed-77117", "permed-73077", "permed-76278", "permed-77118", "permed-82290", "permed-71570", "permed-82199", "permed-83500", "permed-76162", "permed-83291"]}
{"query_id": "topic_303_turn_1", "conversation_id": "topic_303", "turn_id": 1, "query": "What are some of the challenges in diagnosing and managing inflammatory myopathies?", "history": [], "ground_truth": ["permed-68829", "permed-54740", "permed-4581", "permed-84833", "permed-68827", "permed-4589", "permed-4585", "permed-23060", "permed-68828", "permed-68832"]}
{"query_id": "topic_303_turn_2", "conversation_id": "topic_303", "turn_id": 2, "query": "How do rare forms of this condition complicate the development of effective diagnostic tools and treatments?", "history": ["What are some of the challenges in diagnosing and managing inflammatory myopathies?"], "ground_truth": ["permed-71114", "permed-85359", "permed-84417", "permed-59136", "permed-85344", "permed-32391", "permed-83250", "permed-8038", "permed-23846", "permed-59880"]}
{"query_id": "topic_303_turn_3", "conversation_id": "topic_303", "turn_id": 3, "query": "Given these challenges with rare forms, how do the unique clinical presentations and diagnostic pitfalls of localized inflammatory myopathies specifically affect efforts to develop targeted diagnostic tools and treatments? What interdisciplinary approaches would help improve early detection and management of these cases?", "history": ["What are some of the challenges in diagnosing and managing inflammatory myopathies?", "How do rare forms of this condition complicate the development of effective diagnostic tools and treatments?"], "ground_truth": ["permed-68829", "permed-54740", "permed-84833", "permed-4581", "permed-4585", "permed-23060", "permed-4589", "permed-68827", "permed-55906", "permed-4586"]}
{"query_id": "topic_303_turn_4", "conversation_id": "topic_303", "turn_id": 4, "query": "Given these diagnostic challenges with localized presentations, what specific methodological adaptations would be required for imaging protocols like MRI or muscle ultrasound to reliably detect small-scale, asymmetrical inflammation? How should biopsy sampling strategies be statistically validated to account for patchy involvement, and what quality control measures would ensure reproducibility across different centers when implementing this multidisciplinary diagnostic approach?", "history": ["What are some of the challenges in diagnosing and managing inflammatory myopathies?", "How do rare forms of this condition complicate the development of effective diagnostic tools and treatments?", "Given these challenges with rare forms, how do the unique clinical presentations and diagnostic pitfalls of localized inflammatory myopathies specifically affect efforts to develop targeted diagnostic tools and treatments? What interdisciplinary approaches would help improve early detection and management of these cases?"], "ground_truth": ["permed-55906", "permed-68829", "permed-8159", "permed-42806", "permed-29266", "permed-79138", "permed-61483", "permed-71793", "permed-1500", "permed-23710"]}
{"query_id": "topic_304_turn_1", "conversation_id": "topic_304", "turn_id": 1, "query": "What role does environmental factors play in the spread of multidrug-resistant bacteria?", "history": [], "ground_truth": ["permed-66820", "permed-5959", "permed-88652", "permed-60413", "permed-60604", "permed-5954", "permed-51275", "permed-63617", "permed-51274", "permed-51278"]}
{"query_id": "topic_304_turn_2", "conversation_id": "topic_304", "turn_id": 2, "query": "How might specific regional conditions, such as those influenced by monsoon patterns, impact this spread?", "history": ["What role does environmental factors play in the spread of multidrug-resistant bacteria?"], "ground_truth": ["permed-67575", "permed-68153", "permed-74173", "permed-62251", "permed-74166", "permed-74171", "permed-59266", "permed-79957", "permed-74172", "permed-74162"]}
{"query_id": "topic_304_turn_3", "conversation_id": "topic_304", "turn_id": 3, "query": "Given how monsoon patterns and antibiotic usage in places like the Indian subcontinent can influence multidrug-resistant bacteria, how might their interaction with atmospheric circulation affect the spread and evolution of these bacteria in Tibetan glacier ecosystems? And what would this mean for microbial communities in downstream environments?", "history": ["What role does environmental factors play in the spread of multidrug-resistant bacteria?", "How might specific regional conditions, such as those influenced by monsoon patterns, impact this spread?"], "ground_truth": ["permed-82226", "permed-66910", "permed-66911", "permed-5954", "permed-82227", "permed-81933", "permed-66714", "permed-82233", "permed-76628", "permed-76743"]}
{"query_id": "topic_304_turn_4", "conversation_id": "topic_304", "turn_id": 4, "query": "Given the complex atmospheric transport mechanisms you've described, what specific sampling and metagenomic approaches would be most effective for tracking multidrug-resistant bacteria across this environmental continuum? I'm particularly interested in the technical implementation - would you recommend longitudinal sampling at multiple altitudes, and what bioinformatics pipelines would best distinguish recently transported bacterial populations from established glacier microbiota while accounting for potential horizontal gene transfer events during transit?", "history": ["What role does environmental factors play in the spread of multidrug-resistant bacteria?", "How might specific regional conditions, such as those influenced by monsoon patterns, impact this spread?", "Given how monsoon patterns and antibiotic usage in places like the Indian subcontinent can influence multidrug-resistant bacteria, how might their interaction with atmospheric circulation affect the spread and evolution of these bacteria in Tibetan glacier ecosystems? And what would this mean for microbial communities in downstream environments?"], "ground_truth": ["permed-82226", "permed-66714", "permed-81933", "permed-68507", "permed-63444", "permed-83427", "permed-66819", "permed-67045", "permed-60406", "permed-37740"]}
{"query_id": "topic_305_turn_1", "conversation_id": "topic_305", "turn_id": 1, "query": "What is known about the relationship between exercise and PTSD symptoms in women?", "history": [], "ground_truth": ["permed-88165", "permed-51879", "permed-51875", "permed-80409", "permed-51880", "permed-51878", "permed-7373", "permed-51877", "permed-87648", "permed-66409"]}
{"query_id": "topic_305_turn_2", "conversation_id": "topic_305", "turn_id": 2, "query": "Does this area of research suggest that certain types of exercise have a more significant impact on psychological resilience than others?", "history": ["What is known about the relationship between exercise and PTSD symptoms in women?"], "ground_truth": ["permed-65029", "permed-81705", "permed-69557", "permed-55666", "permed-70203", "permed-57049", "permed-58346", "permed-55669", "permed-55520", "permed-55685"]}
{"query_id": "topic_305_turn_3", "conversation_id": "topic_305", "turn_id": 3, "query": "Given that circulating AEA levels have been linked to improved mood in women with PTSD, how might regular moderate-intensity aerobic exercise affect their endocannabinoid system and psychological resilience over time? And what implications could these changes have for PTSD treatment and progression?", "history": ["What is known about the relationship between exercise and PTSD symptoms in women?", "Does this area of research suggest that certain types of exercise have a more significant impact on psychological resilience than others?"], "ground_truth": ["permed-51879", "permed-88165", "permed-66539", "permed-72487", "permed-51886", "permed-51875", "permed-51877", "permed-53357", "permed-53359", "permed-51876"]}
{"query_id": "topic_305_turn_4", "conversation_id": "topic_305", "turn_id": 4, "query": "In studying how moderate-intensity aerobic exercise affects the endocannabinoid system and psychological resilience in women with PTSD, what specific experimental design would you recommend for tracking these relationships longitudinally? I'm particularly interested in the optimal frequency of AEA level measurements, the most valid psychological resilience assessment tools for this population, and how to control for potential confounders like medication changes or trauma history variability across participants. What statistical modeling approaches would best capture these temporal dynamics?", "history": ["What is known about the relationship between exercise and PTSD symptoms in women?", "Does this area of research suggest that certain types of exercise have a more significant impact on psychological resilience than others?", "Given that circulating AEA levels have been linked to improved mood in women with PTSD, how might regular moderate-intensity aerobic exercise affect their endocannabinoid system and psychological resilience over time? And what implications could these changes have for PTSD treatment and progression?"], "ground_truth": ["permed-51879", "permed-88165", "permed-66539", "permed-51886", "permed-53359", "permed-53357", "permed-53363", "permed-51875", "permed-53130", "permed-51884"]}
{"query_id": "topic_306_turn_1", "conversation_id": "topic_306", "turn_id": 1, "query": "What is known about the effectiveness of far-UVC light in disinfecting airborne microorganisms?", "history": [], "ground_truth": ["permed-73106", "permed-62010", "permed-73101", "permed-73103", "permed-73105", "permed-78693", "permed-73109", "permed-73102", "permed-75189", "permed-77887"]}
{"query_id": "topic_306_turn_2", "conversation_id": "topic_306", "turn_id": 2, "query": "How does air velocity impact the efficacy of this technique in real-world settings?", "history": ["What is known about the effectiveness of far-UVC light in disinfecting airborne microorganisms?"], "ground_truth": ["permed-58626", "permed-84352", "permed-78848", "permed-71333", "permed-56265", "permed-92008", "permed-72893", "permed-51499", "permed-73106", "permed-51438"]}
{"query_id": "topic_306_turn_3", "conversation_id": "topic_306", "turn_id": 3, "query": "Building on these findings about air velocity's impact, how might environmental factors like humidity and temperature influence the single-pass disinfection performance of far-UVC light in real ventilation systems? And what would these combined effects mean for optimizing far-UVC unit designs across different indoor environments?", "history": ["What is known about the effectiveness of far-UVC light in disinfecting airborne microorganisms?", "How does air velocity impact the efficacy of this technique in real-world settings?"], "ground_truth": ["permed-73106", "permed-73103", "permed-73102", "permed-78693", "permed-62010", "permed-73101", "permed-91931", "permed-91957", "permed-77887", "permed-78695"]}
{"query_id": "topic_306_turn_4", "conversation_id": "topic_306", "turn_id": 4, "query": "Given these environmental interactions, what specific experimental protocols would you recommend for systematically testing multi-factor effects on far-UVC disinfection? I'm particularly interested in how one might design a controlled chamber study that simultaneously varies humidity, temperature, and air velocity while monitoring microbial inactivation rates. What statistical approaches would be most appropriate for analyzing such multi-factorial data, and how should we validate these experimental setups against real HVAC system conditions to ensure translational relevance?", "history": ["What is known about the effectiveness of far-UVC light in disinfecting airborne microorganisms?", "How does air velocity impact the efficacy of this technique in real-world settings?", "Building on these findings about air velocity's impact, how might environmental factors like humidity and temperature influence the single-pass disinfection performance of far-UVC light in real ventilation systems? And what would these combined effects mean for optimizing far-UVC unit designs across different indoor environments?"], "ground_truth": ["permed-73106", "permed-73102", "permed-73103", "permed-62010", "permed-77887", "permed-73101", "permed-73105", "permed-78693", "permed-72893", "permed-43716"]}
{"query_id": "topic_307_turn_1", "conversation_id": "topic_307", "turn_id": 1, "query": "What non-invasive brain stimulation techniques are being researched for improving cognitive functions in older adults?", "history": [], "ground_truth": ["permed-29139", "permed-44237", "permed-68376", "permed-20461", "permed-63184", "permed-68378", "permed-66365", "permed-8614", "permed-68380", "permed-29141"]}
{"query_id": "topic_307_turn_2", "conversation_id": "topic_307", "turn_id": 2, "query": "How effective is this technique, specifically targeting neural networks like the fronto-parietal network, in enhancing dual-task performance?", "history": ["What non-invasive brain stimulation techniques are being researched for improving cognitive functions in older adults?"], "ground_truth": ["permed-66352", "permed-84237", "permed-79969", "permed-54872", "permed-58410", "permed-71497", "permed-66534", "permed-84753", "permed-8522", "permed-69980"]}
{"query_id": "topic_307_turn_3", "conversation_id": "topic_307", "turn_id": 3, "query": "How do different frequency and intensity settings of tACS and tDCS, when applied to specific nodes in the fronto-parietal network, affect long-term neural plasticity and adaptability for dual-task performance in older adults? What mechanisms might explain these effects on cognitive function?", "history": ["What non-invasive brain stimulation techniques are being researched for improving cognitive functions in older adults?", "How effective is this technique, specifically targeting neural networks like the fronto-parietal network, in enhancing dual-task performance?"], "ground_truth": ["permed-66352", "permed-66362", "permed-71497", "permed-8607", "permed-72002", "permed-29039", "permed-72095", "permed-66365", "permed-36906", "permed-8605"]}
{"query_id": "topic_307_turn_4", "conversation_id": "topic_307", "turn_id": 4, "query": "Given these neuromodulation protocols targeting fronto-parietal network nodes, what specific experimental designs are being used to validate their effects on long-term neural plasticity? I'm particularly interested in the technical implementation of pre/post neuroimaging protocols, how researchers are controlling for sham stimulation effects, and what statistical approaches are employed to correlate stimulation parameters with both neuroplastic changes and dual-task performance metrics across extended follow-up periods.", "history": ["What non-invasive brain stimulation techniques are being researched for improving cognitive functions in older adults?", "How effective is this technique, specifically targeting neural networks like the fronto-parietal network, in enhancing dual-task performance?", "How do different frequency and intensity settings of tACS and tDCS, when applied to specific nodes in the fronto-parietal network, affect long-term neural plasticity and adaptability for dual-task performance in older adults? What mechanisms might explain these effects on cognitive function?"], "ground_truth": ["permed-58410", "permed-68386", "permed-71497", "permed-63137", "permed-71496", "permed-78087", "permed-72002", "permed-55577", "permed-63138", "permed-78085"]}
{"query_id": "topic_308_turn_1", "conversation_id": "topic_308", "turn_id": 1, "query": "What's known about the impact of diet on cognitive decline in middle-aged adults?", "history": [], "ground_truth": ["permed-52390", "permed-66458", "permed-65600", "permed-65677", "permed-74642", "permed-37308", "permed-70973", "permed-26389", "permed-78539", "permed-66459"]}
{"query_id": "topic_308_turn_2", "conversation_id": "topic_308", "turn_id": 2, "query": "Does this relationship change when considering specific dietary factors, like ultraprocessed foods?", "history": ["What's known about the impact of diet on cognitive decline in middle-aged adults?"], "ground_truth": ["permed-64881", "permed-85236", "permed-78540", "permed-64949", "permed-78539", "permed-82515", "permed-57817", "permed-70074", "permed-91759", "permed-65029"]}
{"query_id": "topic_308_turn_3", "conversation_id": "topic_308", "turn_id": 3, "query": "Given these findings about ultraprocessed foods and cognitive decline, how does genetic predisposition interact with high consumption of such foods to affect the rate of decline in executive functions among middle-aged adults across different ethnic groups?", "history": ["What's known about the impact of diet on cognitive decline in middle-aged adults?", "Does this relationship change when considering specific dietary factors, like ultraprocessed foods?"], "ground_truth": ["permed-78539", "permed-69918", "permed-66458", "permed-65600", "permed-78541", "permed-65595", "permed-52390", "permed-70969", "permed-66459", "permed-64881"]}
{"query_id": "topic_308_turn_4", "conversation_id": "topic_308", "turn_id": 4, "query": "When investigating this gene-diet interaction across ethnic groups, what statistical models were employed to account for population stratification while maintaining power to detect interaction effects? Specifically, how were covariates like socioeconomic status and dietary measurement errors handled in these models, and what validation approaches ensured the robustness of these gene-environment interaction findings against multiple testing?", "history": ["What's known about the impact of diet on cognitive decline in middle-aged adults?", "Does this relationship change when considering specific dietary factors, like ultraprocessed foods?", "Given these findings about ultraprocessed foods and cognitive decline, how does genetic predisposition interact with high consumption of such foods to affect the rate of decline in executive functions among middle-aged adults across different ethnic groups?"], "ground_truth": ["permed-20388", "permed-63903", "permed-34813", "permed-35349", "permed-66022", "permed-52649", "permed-82346", "permed-67506", "permed-73577", "permed-65374"]}
{"query_id": "topic_309_turn_1", "conversation_id": "topic_309", "turn_id": 1, "query": "What challenges are health systems facing with nurse retention in the post-pandemic era?", "history": [], "ground_truth": ["permed-78649", "permed-91926", "permed-65750", "permed-52374", "permed-54910", "permed-84653", "permed-78647", "permed-76861", "permed-91964", "permed-61068"]}
{"query_id": "topic_309_turn_2", "conversation_id": "topic_309", "turn_id": 2, "query": "How can addressing this issue through workforce management strategies impact overall healthcare delivery and job satisfaction?", "history": ["What challenges are health systems facing with nurse retention in the post-pandemic era?"], "ground_truth": ["permed-90720", "permed-52374", "permed-88299", "permed-34919", "permed-84589", "permed-88296", "permed-37513", "permed-55855", "permed-65872", "permed-62780"]}
{"query_id": "topic_309_turn_3", "conversation_id": "topic_309", "turn_id": 3, "query": "Given these challenges and workforce management strategies, how can health systems best incorporate a multigenerational workforce framework into their strategic planning to improve nurse retention and job satisfaction, especially with the ongoing shifts in post-pandemic healthcare needs?", "history": ["What challenges are health systems facing with nurse retention in the post-pandemic era?", "How can addressing this issue through workforce management strategies impact overall healthcare delivery and job satisfaction?"], "ground_truth": ["permed-52374", "permed-70246", "permed-78647", "permed-78649", "permed-55855", "permed-60975", "permed-61068", "permed-91964", "permed-65750", "permed-78646"]}
{"query_id": "topic_309_turn_4", "conversation_id": "topic_309", "turn_id": 4, "query": "Given this multigenerational framework approach, what specific methodological designs would be most effective for evaluating its implementation? I'm particularly interested in the comparative analytics—should health systems employ longitudinal cohort studies tracking retention metrics across generations, or would a mixed-methods approach combining survey data with qualitative interviews provide more actionable insights? Also, what statistical models would best control for confounding variables like clinical specialty and geographic location when measuring the framework's impact on job satisfaction outcomes?", "history": ["What challenges are health systems facing with nurse retention in the post-pandemic era?", "How can addressing this issue through workforce management strategies impact overall healthcare delivery and job satisfaction?", "Given these challenges and workforce management strategies, how can health systems best incorporate a multigenerational workforce framework into their strategic planning to improve nurse retention and job satisfaction, especially with the ongoing shifts in post-pandemic healthcare needs?"], "ground_truth": ["permed-88216", "permed-52374", "permed-69924", "permed-88296", "permed-52840", "permed-57446", "permed-37263", "permed-26512", "permed-80225", "permed-87616"]}
{"query_id": "topic_310_turn_1", "conversation_id": "topic_310", "turn_id": 1, "query": "What's the current status of HPV testing in primary healthcare settings?", "history": [], "ground_truth": ["permed-61169", "permed-61175", "permed-73406", "permed-70171", "permed-59568", "permed-73402", "permed-73411", "permed-6509", "permed-70166", "permed-6175"]}
{"query_id": "topic_310_turn_2", "conversation_id": "topic_310", "turn_id": 2, "query": "How are healthcare providers adapting to changes in guidelines related to it, particularly in systems that haven't fully adopted new screening protocols?", "history": ["What's the current status of HPV testing in primary healthcare settings?"], "ground_truth": ["permed-85936", "permed-80052", "permed-87860", "permed-71143", "permed-81696", "permed-87768", "permed-78477", "permed-90713", "permed-61615", "permed-91926"]}
{"query_id": "topic_310_turn_3", "conversation_id": "topic_310", "turn_id": 3, "query": "What practical strategies could help healthcare providers better understand and adopt primary HPV testing guidelines in systems still transitioning to these protocols, and how should these approaches be tailored to address the distinct challenges faced by different age groups and healthcare settings?", "history": ["What's the current status of HPV testing in primary healthcare settings?", "How are healthcare providers adapting to changes in guidelines related to it, particularly in systems that haven't fully adopted new screening protocols?"], "ground_truth": ["permed-73406", "permed-61175", "permed-61169", "permed-63468", "permed-61888", "permed-70171", "permed-61070", "permed-65422", "permed-52108", "permed-61995"]}
{"query_id": "topic_310_turn_4", "conversation_id": "topic_310", "turn_id": 4, "query": "Given these proposed strategies for guideline implementation, what specific methodological frameworks would be most appropriate for systematically evaluating their effectiveness across different healthcare settings? I'm particularly interested in how researchers should design the measurement protocols for assessing provider comprehension and adoption rates, what statistical approaches would best account for the nested structure of providers within clinics, and how implementation fidelity should be quantitatively monitored throughout the transition period to ensure reproducible outcomes.", "history": ["What's the current status of HPV testing in primary healthcare settings?", "How are healthcare providers adapting to changes in guidelines related to it, particularly in systems that haven't fully adopted new screening protocols?", "What practical strategies could help healthcare providers better understand and adopt primary HPV testing guidelines in systems still transitioning to these protocols, and how should these approaches be tailored to address the distinct challenges faced by different age groups and healthcare settings?"], "ground_truth": ["permed-13306", "permed-57443", "permed-65577", "permed-84895", "permed-69063", "permed-41403", "permed-74374", "permed-88216", "permed-52112", "permed-84732"]}
{"query_id": "topic_311_turn_1", "conversation_id": "topic_311", "turn_id": 1, "query": "Tumor microenvironment regulation of NK cell effector functions and viability in cancer", "history": [], "ground_truth": ["permed-56650", "permed-56651", "permed-68116", "permed-82373", "permed-68115", "permed-67967", "permed-67978", "permed-70395", "permed-87663", "permed-68307"]}
{"query_id": "topic_311_turn_2", "conversation_id": "topic_311", "turn_id": 2, "query": "Consequences of these TME-driven alterations in NK cell effector functions for their metabolic programming and anti-cancer therapeutic efficacy", "history": ["Tumor microenvironment regulation of NK cell effector functions and viability in cancer"], "ground_truth": ["permed-56650", "permed-56651", "permed-60153", "permed-68116", "permed-68307", "permed-68115", "permed-67978", "permed-82373", "permed-70395", "permed-67775"]}
{"query_id": "topic_311_turn_3", "conversation_id": "topic_311", "turn_id": 3, "query": "Mechanisms of TME-induced mitochondrial dysfunction affecting NK cell metabolic fitness and novel therapies (beyond IL-15) to restore their anti-tumor activity in pediatric and adult cancers", "history": ["Tumor microenvironment regulation of NK cell effector functions and viability in cancer", "Consequences of these TME-driven alterations in NK cell effector functions for their metabolic programming and anti-cancer therapeutic efficacy"], "ground_truth": ["permed-56650", "permed-56651", "permed-59051", "permed-68307", "permed-87663", "permed-68115", "permed-31671", "permed-76181", "permed-67966", "permed-84708"]}
{"query_id": "topic_311_turn_4", "conversation_id": "topic_311", "turn_id": 4, "query": "When evaluating these novel therapies to restore NK cell metabolic fitness, what specific mitochondrial respiration assays (e.g., Seahorse XF, Oroboros O2k) and immunometabolic markers are most appropriate for quantifying functional recovery in both pediatric and adult primary NK cell models? Additionally, what standardized protocols should be implemented for co-culture systems with patient-derived tumor spheroids to ensure reproducibility when assessing restored cytotoxic activity across different cancer types?", "history": ["Tumor microenvironment regulation of NK cell effector functions and viability in cancer", "Consequences of these TME-driven alterations in NK cell effector functions for their metabolic programming and anti-cancer therapeutic efficacy", "Mechanisms of TME-induced mitochondrial dysfunction affecting NK cell metabolic fitness and novel therapies (beyond IL-15) to restore their anti-tumor activity in pediatric and adult cancers"], "ground_truth": ["permed-56651", "permed-56650", "permed-71713", "permed-73146", "permed-60153", "permed-68307", "permed-60151", "permed-68308", "permed-68116", "permed-83022"]}
{"query_id": "topic_312_turn_1", "conversation_id": "topic_312", "turn_id": 1, "query": "What are the main concerns regarding PFAS contamination from incineration plants?", "history": [], "ground_truth": ["permed-74962", "permed-74968", "permed-74966", "permed-74964", "permed-81909", "permed-78237", "permed-81871", "permed-74960", "permed-78358", "permed-77148"]}
{"query_id": "topic_312_turn_2", "conversation_id": "topic_312", "turn_id": 2, "query": "How effective is current wastewater treatment in addressing this issue, particularly for short-chain PFAS?", "history": ["What are the main concerns regarding PFAS contamination from incineration plants?"], "ground_truth": ["permed-74968", "permed-74963", "permed-74966", "permed-81871", "permed-74962", "permed-81872", "permed-73277", "permed-82401", "permed-79823", "permed-89755"]}
{"query_id": "topic_312_turn_3", "conversation_id": "topic_312", "turn_id": 3, "query": "Given these concerns about PFAS from incineration and the limitations of current wastewater treatment for short-chain compounds, what are the long-term environmental and health impacts of residual short-chain PFAS in treated leachates? And how could advanced treatment technologies be better optimized to reduce these contaminants to negligible levels?", "history": ["What are the main concerns regarding PFAS contamination from incineration plants?", "How effective is current wastewater treatment in addressing this issue, particularly for short-chain PFAS?"], "ground_truth": ["permed-74962", "permed-74966", "permed-74968", "permed-74963", "permed-81871", "permed-74960", "permed-81909", "permed-79823", "permed-78358", "permed-81872"]}
{"query_id": "topic_312_turn_4", "conversation_id": "topic_312", "turn_id": 4, "query": "Given your discussion of optimizing advanced treatment technologies for residual short-chain PFAS in leachates, could you elaborate on the specific analytical methodologies used to validate removal efficiency? I'm particularly interested in the separation techniques for distinguishing various short-chain homologues, the mass spectrometry parameters for quantification at trace levels, and how quality control measures like matrix spikes and isotopically-labeled standards address potential matrix effects during these complex environmental analyses.", "history": ["What are the main concerns regarding PFAS contamination from incineration plants?", "How effective is current wastewater treatment in addressing this issue, particularly for short-chain PFAS?", "Given these concerns about PFAS from incineration and the limitations of current wastewater treatment for short-chain compounds, what are the long-term environmental and health impacts of residual short-chain PFAS in treated leachates? And how could advanced treatment technologies be better optimized to reduce these contaminants to negligible levels?"], "ground_truth": ["permed-77151", "permed-74966", "permed-74962", "permed-77148", "permed-81871", "permed-77152", "permed-74963", "permed-74968", "permed-79823", "permed-77149"]}
{"query_id": "topic_313_turn_1", "conversation_id": "topic_313", "turn_id": 1, "query": "Role of social cognition impairments in traumatic brain injury recovery trajectories", "history": [], "ground_truth": ["permed-55785", "permed-86850", "permed-69519", "permed-73437", "permed-75017", "permed-66783", "permed-67671", "permed-53772", "permed-69979", "permed-90712"]}
{"query_id": "topic_313_turn_2", "conversation_id": "topic_313", "turn_id": 2, "query": "Effectiveness of rehabilitation interventions for these social cognition impairments post-TBI and influence of recovery stage on treatment outcomes", "history": ["Role of social cognition impairments in traumatic brain injury recovery trajectories"], "ground_truth": ["permed-55785", "permed-75017", "permed-85588", "permed-86850", "permed-69995", "permed-92156", "permed-86675", "permed-91930", "permed-83165", "permed-69519"]}
{"query_id": "topic_313_turn_3", "conversation_id": "topic_313", "turn_id": 3, "query": "Comparative efficacy of such social cognition rehabilitation programs for TBI across acute, subacute, and chronic recovery stages, including identification of specific neurobiological or psychosocial factors modulating treatment response in each stage.", "history": ["Role of social cognition impairments in traumatic brain injury recovery trajectories", "Effectiveness of rehabilitation interventions for these social cognition impairments post-TBI and influence of recovery stage on treatment outcomes"], "ground_truth": ["permed-55785", "permed-86850", "permed-75017", "permed-69519", "permed-69995", "permed-60040", "permed-60035", "permed-63141", "permed-86675", "permed-63134"]}
{"query_id": "topic_313_turn_4", "conversation_id": "topic_313", "turn_id": 4, "query": "Regarding your comparative efficacy framework across recovery stages, what specific methodological approaches were used to ensure consistent outcome measurement across these temporally distinct populations? I'm particularly interested in how researchers addressed potential confounding variables like baseline injury severity when implementing this staged comparison, and whether any specialized statistical modeling was employed to account for the non-linear recovery trajectories while still maintaining adequate power for stage-specific treatment effect detection.", "history": ["Role of social cognition impairments in traumatic brain injury recovery trajectories", "Effectiveness of rehabilitation interventions for these social cognition impairments post-TBI and influence of recovery stage on treatment outcomes", "Comparative efficacy of such social cognition rehabilitation programs for TBI across acute, subacute, and chronic recovery stages, including identification of specific neurobiological or psychosocial factors modulating treatment response in each stage."], "ground_truth": ["permed-63134", "permed-69749", "permed-19149", "permed-14293", "permed-52439", "permed-60479", "permed-52647", "permed-38902", "permed-79200", "permed-40650"]}
{"query_id": "topic_314_turn_1", "conversation_id": "topic_314", "turn_id": 1, "query": "Diagnostic pitfalls and classification difficulties in shoulder joint pathologies, including bursitis subtypes.", "history": [], "ground_truth": ["permed-78090", "permed-78089", "permed-53161", "permed-78092", "permed-58212", "permed-60116", "permed-92301", "permed-52973", "permed-44240", "permed-81958"]}
{"query_id": "topic_314_turn_2", "conversation_id": "topic_314", "turn_id": 2, "query": "How does the specific symptomatology of Subacromial Subdeltoid (SASD) bursitis exacerbate these previously identified diagnostic pitfalls in shoulder conditions?", "history": ["Diagnostic pitfalls and classification difficulties in shoulder joint pathologies, including bursitis subtypes."], "ground_truth": ["permed-78089", "permed-78090", "permed-52973", "permed-83583", "permed-60251", "permed-78092", "permed-66341", "permed-19557", "permed-81958", "permed-33977"]}
{"query_id": "topic_314_turn_3", "conversation_id": "topic_314", "turn_id": 3, "query": "Overcoming diagnostic dilemmas of atypical (e.g., painless) Subacromial Subdeltoid bursitis: advanced imaging techniques (MRI, ultrasound) and interventional radiology for refining diagnostic accuracy and guiding treatment strategies.", "history": ["Diagnostic pitfalls and classification difficulties in shoulder joint pathologies, including bursitis subtypes.", "How does the specific symptomatology of Subacromial Subdeltoid (SASD) bursitis exacerbate these previously identified diagnostic pitfalls in shoulder conditions?"], "ground_truth": ["permed-78090", "permed-78089", "permed-55906", "permed-91499", "permed-54588", "permed-52807", "permed-71147", "permed-78565", "permed-91242", "permed-50817"]}
{"query_id": "topic_314_turn_4", "conversation_id": "topic_314", "turn_id": 4, "query": "Regarding these advanced imaging approaches for atypical SASD bursitis, what specific MRI and ultrasound protocols provide optimal diagnostic yield? I'm particularly interested in the technical parameters - such as field strength, pulse sequences for MRI, and transducer frequencies with dynamic maneuvers for ultrasound. Additionally, how do you validate these imaging findings against interventional procedures like diagnostic injections, and what statistical methods are most appropriate for assessing inter-rater reliability in interpreting these subtle imaging features?", "history": ["Diagnostic pitfalls and classification difficulties in shoulder joint pathologies, including bursitis subtypes.", "How does the specific symptomatology of Subacromial Subdeltoid (SASD) bursitis exacerbate these previously identified diagnostic pitfalls in shoulder conditions?", "Overcoming diagnostic dilemmas of atypical (e.g., painless) Subacromial Subdeltoid bursitis: advanced imaging techniques (MRI, ultrasound) and interventional radiology for refining diagnostic accuracy and guiding treatment strategies."], "ground_truth": ["permed-17843", "permed-56433", "permed-29305", "permed-55906", "permed-17845", "permed-17528", "permed-37972", "permed-92160", "permed-78089", "permed-50817"]}
{"query_id": "topic_315_turn_1", "conversation_id": "topic_315", "turn_id": 1, "query": "What role does morphological inhomogeneity play in the optical properties of semiconductor nanocrystals?", "history": [], "ground_truth": ["permed-78522", "permed-74688", "permed-75453", "permed-75779", "permed-75776", "permed-75447", "permed-88202", "permed-75516", "permed-92679", "permed-60321"]}
{"query_id": "topic_315_turn_2", "conversation_id": "topic_315", "turn_id": 2, "query": "How can engineering this structural feature in materials like ZnSeTe nanocrystals impact their performance in optoelectronic devices?", "history": ["What role does morphological inhomogeneity play in the optical properties of semiconductor nanocrystals?"], "ground_truth": ["permed-78522", "permed-55242", "permed-55240", "permed-64266", "permed-92680", "permed-55238", "permed-73155", "permed-74515", "permed-78523", "permed-76085"]}
{"query_id": "topic_315_turn_3", "conversation_id": "topic_315", "turn_id": 3, "query": "Given these effects of morphological inhomogeneity on excitonic states and photophysical properties in ZnSe<sub>1-X</sub>Te<sub>X</sub> nanocrystals, how could we strategically engineer these structural features to precisely control and optimize both the emission spectra and exciton temporal dynamics—particularly for advanced applications like single-photon sources or high-efficiency solar cells?", "history": ["What role does morphological inhomogeneity play in the optical properties of semiconductor nanocrystals?", "How can engineering this structural feature in materials like ZnSeTe nanocrystals impact their performance in optoelectronic devices?"], "ground_truth": ["permed-78522", "permed-78523", "permed-73155", "permed-74515", "permed-89133", "permed-55238", "permed-91723", "permed-83407", "permed-55242", "permed-79151"]}
{"query_id": "topic_315_turn_4", "conversation_id": "topic_315", "turn_id": 4, "query": "Given this approach to strategically engineering structural features in ZnSe<sub>1-X</sub>Te<sub>X</sub> nanocrystals, what specific synthesis protocols—such as precursor injection rates, temperature gradients, or ligand chemistry combinations—would enable precise control over composition gradients while maintaining crystallinity? Additionally, what characterization techniques beyond standard TEM and XRD would you recommend to quantitatively map these heterostructures and correlate morphological parameters with measured exciton lifetimes and quantum yields?", "history": ["What role does morphological inhomogeneity play in the optical properties of semiconductor nanocrystals?", "How can engineering this structural feature in materials like ZnSeTe nanocrystals impact their performance in optoelectronic devices?", "Given these effects of morphological inhomogeneity on excitonic states and photophysical properties in ZnSe<sub>1-X</sub>Te<sub>X</sub> nanocrystals, how could we strategically engineer these structural features to precisely control and optimize both the emission spectra and exciton temporal dynamics—particularly for advanced applications like single-photon sources or high-efficiency solar cells?"], "ground_truth": ["permed-78522", "permed-78523", "permed-55242", "permed-89133", "permed-88202", "permed-83407", "permed-76881", "permed-55237", "permed-58261", "permed-55238"]}
{"query_id": "topic_316_turn_1", "conversation_id": "topic_316", "turn_id": 1, "query": "What's known about the relationship between ICA stenosis and blood flow dynamics in stroke patients?", "history": [], "ground_truth": ["permed-79320", "permed-57187", "permed-80031", "permed-3613", "permed-79321", "permed-57191", "permed-57375", "permed-59712", "permed-33440", "permed-92441"]}
{"query_id": "topic_316_turn_2", "conversation_id": "topic_316", "turn_id": 2, "query": "How might alterations in this blood flow affect treatment outcomes for acute ischemic stroke, particularly with interventions like thrombolytic therapy?", "history": ["What's known about the relationship between ICA stenosis and blood flow dynamics in stroke patients?"], "ground_truth": ["permed-66041", "permed-69310", "permed-60515", "permed-74632", "permed-54175", "permed-84177", "permed-9370", "permed-65138", "permed-89219", "permed-63241"]}
{"query_id": "topic_316_turn_3", "conversation_id": "topic_316", "turn_id": 3, "query": "Given that we've seen ECA to OA anterograde flow is more common in ICA stenosis patients, how might this vascular adaptation impact the effectiveness and risks of thrombolytic therapy for acute ischemic stroke? What specific factors should clinicians consider when planning this treatment for patients with significant ICA stenosis?", "history": ["What's known about the relationship between ICA stenosis and blood flow dynamics in stroke patients?", "How might alterations in this blood flow affect treatment outcomes for acute ischemic stroke, particularly with interventions like thrombolytic therapy?"], "ground_truth": ["permed-79320", "permed-63244", "permed-69309", "permed-63241", "permed-69311", "permed-69310", "permed-84178", "permed-77107", "permed-73795", "permed-21540"]}
{"query_id": "topic_316_turn_4", "conversation_id": "topic_316", "turn_id": 4, "query": "Given this collateral flow pattern, what specific imaging protocols and quantification methods would you recommend for pre-therapeutic assessment of ECA to OA flow in acute stroke settings? I'm particularly interested in how to standardize flow velocity measurements across different Doppler parameters and validate these against perfusion imaging data. What statistical approaches would best correlate the degree of anterograde flow with both thrombolytic efficacy metrics and hemorrhagic transformation risk?", "history": ["What's known about the relationship between ICA stenosis and blood flow dynamics in stroke patients?", "How might alterations in this blood flow affect treatment outcomes for acute ischemic stroke, particularly with interventions like thrombolytic therapy?", "Given that we've seen ECA to OA anterograde flow is more common in ICA stenosis patients, how might this vascular adaptation impact the effectiveness and risks of thrombolytic therapy for acute ischemic stroke? What specific factors should clinicians consider when planning this treatment for patients with significant ICA stenosis?"], "ground_truth": ["permed-75947", "permed-89221", "permed-23006", "permed-29261", "permed-79320", "permed-8999", "permed-63327", "permed-25435", "permed-46810", "permed-48655"]}
{"query_id": "topic_317_turn_1", "conversation_id": "topic_317", "turn_id": 1, "query": "What is known about the effectiveness of accountable care programs in improving healthcare quality and reducing costs?", "history": [], "ground_truth": ["permed-80103", "permed-78657", "permed-56935", "permed-52110", "permed-54489", "permed-78480", "permed-61615", "permed-54487", "permed-85949", "permed-70260"]}
{"query_id": "topic_317_turn_2", "conversation_id": "topic_317", "turn_id": 2, "query": "How do variations in the design and implementation of these programs impact their overall success in different healthcare settings?", "history": ["What is known about the effectiveness of accountable care programs in improving healthcare quality and reducing costs?"], "ground_truth": ["permed-82791", "permed-91926", "permed-61609", "permed-61615", "permed-64338", "permed-74114", "permed-80105", "permed-55875", "permed-65576", "permed-61613"]}
{"query_id": "topic_317_turn_3", "conversation_id": "topic_317", "turn_id": 3, "query": "Given what we know about how design and implementation variations affect these programs' success, how do differences in commercial accountable care programs across regions and payer types influence their long-term sustainability and scalability—especially in maintaining consistent cost reductions and quality improvements? And what specific strategies or policy changes could make these programs more effective across diverse healthcare markets?", "history": ["What is known about the effectiveness of accountable care programs in improving healthcare quality and reducing costs?", "How do variations in the design and implementation of these programs impact their overall success in different healthcare settings?"], "ground_truth": ["permed-80103", "permed-80105", "permed-64338", "permed-52110", "permed-54489", "permed-62794", "permed-74570", "permed-78657", "permed-56935", "permed-65385"]}
{"query_id": "topic_317_turn_4", "conversation_id": "topic_317", "turn_id": 4, "query": "Given these regional and payer-specific implementation challenges for commercial accountable care programs, what specific methodological approaches – such as quasi-experimental designs or interrupted time series analyses – would best isolate the causal effects of different program structures on cost and quality outcomes? How should researchers address selection bias when comparing programs across diverse markets, and what statistical techniques would be most appropriate for modeling the longitudinal sustainability of these effects while accounting for varying baseline characteristics?", "history": ["What is known about the effectiveness of accountable care programs in improving healthcare quality and reducing costs?", "How do variations in the design and implementation of these programs impact their overall success in different healthcare settings?", "Given what we know about how design and implementation variations affect these programs' success, how do differences in commercial accountable care programs across regions and payer types influence their long-term sustainability and scalability—especially in maintaining consistent cost reductions and quality improvements? And what specific strategies or policy changes could make these programs more effective across diverse healthcare markets?"], "ground_truth": ["permed-80103", "permed-56935", "permed-46568", "permed-78657", "permed-51749", "permed-35363", "permed-64338", "permed-80107", "permed-53878", "permed-46275"]}
{"query_id": "topic_318_turn_1", "conversation_id": "topic_318", "turn_id": 1, "query": "Current analytical strategies for detecting low-abundance protein therapeutics in complex biological samples", "history": [], "ground_truth": ["permed-53718", "permed-53719", "permed-86233", "permed-86235", "permed-71707", "permed-65912", "permed-77045", "permed-66153", "permed-69257", "permed-53717"]}
{"query_id": "topic_318_turn_2", "conversation_id": "topic_318", "turn_id": 2, "query": "Assessing the utility and limitations of mass spectrometry for detecting these low-abundance protein therapeutics in such complex samples", "history": ["Current analytical strategies for detecting low-abundance protein therapeutics in complex biological samples"], "ground_truth": ["permed-77044", "permed-66188", "permed-77045", "permed-66191", "permed-66182", "permed-4669", "permed-79011", "permed-71701", "permed-66189", "permed-76028"]}
{"query_id": "topic_318_turn_3", "conversation_id": "topic_318", "turn_id": 3, "query": "Optimization of combined AEMS and HR-QTOF mass spectrometry methodologies for enhanced sensitivity and accuracy in detecting low-abundance protein therapeutics in complex matrices, and its impact on accelerating early-stage drug discovery", "history": ["Current analytical strategies for detecting low-abundance protein therapeutics in complex biological samples", "Assessing the utility and limitations of mass spectrometry for detecting these low-abundance protein therapeutics in such complex samples"], "ground_truth": ["permed-77044", "permed-66178", "permed-66188", "permed-66182", "permed-77149", "permed-77045", "permed-66191", "permed-53718", "permed-52746", "permed-77048"]}
{"query_id": "topic_318_turn_4", "conversation_id": "topic_318", "turn_id": 4, "query": "Regarding this optimized AEMS/HR-QTOF methodology, could you elaborate on the specific chromatographic separation parameters and gradient conditions employed to enhance sensitivity for low-abundance proteins? Additionally, what statistical validation approaches were implemented to ensure reproducibility across multiple sample matrices, particularly concerning limit of detection calculations and interference testing with endogenous compounds?", "history": ["Current analytical strategies for detecting low-abundance protein therapeutics in complex biological samples", "Assessing the utility and limitations of mass spectrometry for detecting these low-abundance protein therapeutics in such complex samples", "Optimization of combined AEMS and HR-QTOF mass spectrometry methodologies for enhanced sensitivity and accuracy in detecting low-abundance protein therapeutics in complex matrices, and its impact on accelerating early-stage drug discovery"], "ground_truth": ["permed-77044", "permed-77149", "permed-86113", "permed-77045", "permed-52752", "permed-88988", "permed-52783", "permed-4699", "permed-77687", "permed-58991"]}
{"query_id": "topic_319_turn_1", "conversation_id": "topic_319", "turn_id": 1, "query": "Community-engaged research contributions and strategies during the COVID-19 pandemic", "history": [], "ground_truth": ["permed-55978", "permed-55979", "permed-68512", "permed-51707", "permed-53019", "permed-84697", "permed-70137", "permed-65735", "permed-59521", "permed-88327"]}
{"query_id": "topic_319_turn_2", "conversation_id": "topic_319", "turn_id": 2, "query": "Applying insights from this COVID-19 community-engaged research to broader public health crisis preparedness", "history": ["Community-engaged research contributions and strategies during the COVID-19 pandemic"], "ground_truth": ["permed-68512", "permed-55979", "permed-52295", "permed-53019", "permed-66153", "permed-70137", "permed-84697", "permed-70257", "permed-88327", "permed-84929"]}
{"query_id": "topic_319_turn_3", "conversation_id": "topic_319", "turn_id": 3, "query": "Adapting COVID-19 community-engaged research methodologies and findings for sustainable, effective interventions targeting environmental disasters or emerging infectious diseases in under-resourced communities", "history": ["Community-engaged research contributions and strategies during the COVID-19 pandemic", "Applying insights from this COVID-19 community-engaged research to broader public health crisis preparedness"], "ground_truth": ["permed-55979", "permed-55978", "permed-52052", "permed-70257", "permed-53019", "permed-53061", "permed-84697", "permed-54928", "permed-71227", "permed-53020"]}
{"query_id": "topic_319_turn_4", "conversation_id": "topic_319", "turn_id": 4, "query": "When adapting these community-engaged methodologies to environmental disasters, what specific participatory framework—such as community-based participatory research (CBPR) or participatory action research (PAR)—proved most effective for co-designing interventions? Furthermore, what were the concrete operational protocols for establishing and maintaining community advisory boards, including their meeting frequency, compensation structures, and decision-making authority, to ensure methodological rigor and equitable partnership throughout the research lifecycle in under-resourced settings?", "history": ["Community-engaged research contributions and strategies during the COVID-19 pandemic", "Applying insights from this COVID-19 community-engaged research to broader public health crisis preparedness", "Adapting COVID-19 community-engaged research methodologies and findings for sustainable, effective interventions targeting environmental disasters or emerging infectious diseases in under-resourced communities"], "ground_truth": ["permed-90782", "permed-71611", "permed-52380", "permed-65837", "permed-53389", "permed-62268", "permed-89361", "permed-55979", "permed-88838", "permed-84562"]}
{"query_id": "topic_320_turn_1", "conversation_id": "topic_320", "turn_id": 1, "query": "What role does tartaric acid play in the hydrothermal deposition process of semiconductor materials?", "history": [], "ground_truth": ["permed-78456", "permed-81150", "permed-64918", "permed-88281", "permed-78295", "permed-92684", "permed-59179", "permed-92703", "permed-73184", "permed-60935"]}
{"query_id": "topic_320_turn_2", "conversation_id": "topic_320", "turn_id": 2, "query": "How does its concentration affect the properties of the resulting thin films, particularly in this area of absorber layer development?", "history": ["What role does tartaric acid play in the hydrothermal deposition process of semiconductor materials?"], "ground_truth": ["permed-83660", "permed-74672", "permed-55236", "permed-88995", "permed-77743", "permed-80905", "permed-64274", "permed-69381", "permed-81243", "permed-87333"]}
{"query_id": "topic_320_turn_3", "conversation_id": "topic_320", "turn_id": 3, "query": "How does changing its concentration affect the morphology, crystallinity, and defect density of Sb<sub>2</sub>S<sub>3</sub> absorber layers in this process, and what impact does that have on the photovoltaic performance and stability of the resulting solar cells?", "history": ["What role does tartaric acid play in the hydrothermal deposition process of semiconductor materials?", "How does its concentration affect the properties of the resulting thin films, particularly in this area of absorber layer development?"], "ground_truth": ["permed-78456", "permed-60959", "permed-73236", "permed-78704", "permed-73230", "permed-53793", "permed-77385", "permed-55236", "permed-73231", "permed-77392"]}
{"query_id": "topic_320_turn_4", "conversation_id": "topic_320", "turn_id": 4, "query": "Given your insights into how tartaric acid concentration modulates Sb<sub>2</sub>S<sub>3</sub> film properties, could you elaborate on the specific characterization protocols used to quantify these morphological and crystallographic changes? I'm particularly interested in the experimental parameters for techniques like SEM and XRD—such as acceleration voltages, scan rates, and diffraction angles—and how you ensured measurement reproducibility across different sample batches when correlating these structural properties with photovoltaic performance metrics.", "history": ["What role does tartaric acid play in the hydrothermal deposition process of semiconductor materials?", "How does its concentration affect the properties of the resulting thin films, particularly in this area of absorber layer development?", "How does changing its concentration affect the morphology, crystallinity, and defect density of Sb<sub>2</sub>S<sub>3</sub> absorber layers in this process, and what impact does that have on the photovoltaic performance and stability of the resulting solar cells?"], "ground_truth": ["permed-78456", "permed-60959", "permed-92680", "permed-73231", "permed-53818", "permed-55238", "permed-76105", "permed-92602", "permed-87215", "permed-77026"]}
{"query_id": "topic_321_turn_1", "conversation_id": "topic_321", "turn_id": 1, "query": "What role does CRLF2 rearrangement play in pediatric B-ALL, particularly in complex cases?", "history": [], "ground_truth": ["permed-80345", "permed-46112", "permed-68603", "permed-49338", "permed-32340", "permed-49323", "permed-50783", "permed-72567", "permed-49292", "permed-46111"]}
{"query_id": "topic_321_turn_2", "conversation_id": "topic_321", "turn_id": 2, "query": "Can integrating multiple types of omics data help us better understand the molecular mechanisms behind it?", "history": ["What role does CRLF2 rearrangement play in pediatric B-ALL, particularly in complex cases?"], "ground_truth": ["permed-55581", "permed-55579", "permed-63675", "permed-63825", "permed-53428", "permed-58107", "permed-58105", "permed-79160", "permed-58217", "permed-57647"]}
{"query_id": "topic_321_turn_3", "conversation_id": "topic_321", "turn_id": 3, "query": "Given what we know about CRLF2 rearrangements in pediatric B-ALL and the potential of multi-omics integration, how might combining genomics, transcriptomics, and epigenomics data help us better map the molecular pathways disrupted by these rearrangements—particularly in complex karyotype cases—and what promising therapeutic targets could such an approach reveal?", "history": ["What role does CRLF2 rearrangement play in pediatric B-ALL, particularly in complex cases?", "Can integrating multiple types of omics data help us better understand the molecular mechanisms behind it?"], "ground_truth": ["permed-80345", "permed-46112", "permed-68603", "permed-77583", "permed-72649", "permed-72567", "permed-50760", "permed-88029", "permed-50783", "permed-48139"]}
{"query_id": "topic_321_turn_4", "conversation_id": "topic_321", "turn_id": 4, "query": "Given this multi-omics integration approach for mapping disrupted molecular pathways, what specific computational pipelines would you recommend for aligning genomic rearrangement data with transcriptomic expression patterns and epigenetic modifications? I'm particularly interested in how to statistically validate the integration method itself—whether you'd use mutual information metrics, network correlation analyses, or other approaches to ensure these disparate data layers are meaningfully integrated rather than simply co-analyzed. What quality control benchmarks would establish reproducibility across different pediatric B-ALL cohorts?", "history": ["What role does CRLF2 rearrangement play in pediatric B-ALL, particularly in complex cases?", "Can integrating multiple types of omics data help us better understand the molecular mechanisms behind it?", "Given what we know about CRLF2 rearrangements in pediatric B-ALL and the potential of multi-omics integration, how might combining genomics, transcriptomics, and epigenomics data help us better map the molecular pathways disrupted by these rearrangements—particularly in complex karyotype cases—and what promising therapeutic targets could such an approach reveal?"], "ground_truth": ["permed-70478", "permed-80345", "permed-72764", "permed-50760", "permed-91625", "permed-53587", "permed-55579", "permed-63464", "permed-79170", "permed-58107"]}
{"query_id": "topic_322_turn_1", "conversation_id": "topic_322", "turn_id": 1, "query": "What methods are currently used to assess dehydration risk in adult patients with acute infectious diarrhea?", "history": [], "ground_truth": ["permed-80425", "permed-13562", "permed-85779", "permed-88899", "permed-65765", "permed-65274", "permed-57885", "permed-11307", "permed-58294", "permed-92416"]}
{"query_id": "topic_322_turn_2", "conversation_id": "topic_322", "turn_id": 2, "query": "How effective is the Clinical Dehydration Scale in this area, and are there any limitations to its use?", "history": ["What methods are currently used to assess dehydration risk in adult patients with acute infectious diarrhea?"], "ground_truth": ["permed-80425", "permed-13562", "permed-85779", "permed-88899", "permed-55184", "permed-91086", "permed-80731", "permed-89568", "permed-87094", "permed-56269"]}
{"query_id": "topic_322_turn_3", "conversation_id": "topic_322", "turn_id": 3, "query": "Given the CDS's limitations we just discussed, how could it be adapted or combined with other clinical indicators to better predict both IV rehydration needs and hospitalization risk in these adult diarrhea patients? And what implementation challenges might arise if we tried to use such a modified tool in emergency departments?", "history": ["What methods are currently used to assess dehydration risk in adult patients with acute infectious diarrhea?", "How effective is the Clinical Dehydration Scale in this area, and are there any limitations to its use?"], "ground_truth": ["permed-80425", "permed-83032", "permed-35053", "permed-84037", "permed-83273", "permed-73869", "permed-32359", "permed-87137", "permed-59138", "permed-78686"]}
{"query_id": "topic_322_turn_4", "conversation_id": "topic_322", "turn_id": 4, "query": "For this modified assessment tool integrating CDS with additional clinical indicators, what specific statistical approaches would you recommend for validating its predictive accuracy for both IV rehydration and hospitalization outcomes? Would a time-to-event analysis using Cox proportional hazards models be appropriate here, and how should we determine optimal cutoff points while accounting for potential confounding variables like comorbidities or baseline vital signs in our emergency department population?", "history": ["What methods are currently used to assess dehydration risk in adult patients with acute infectious diarrhea?", "How effective is the Clinical Dehydration Scale in this area, and are there any limitations to its use?", "Given the CDS's limitations we just discussed, how could it be adapted or combined with other clinical indicators to better predict both IV rehydration needs and hospitalization risk in these adult diarrhea patients? And what implementation challenges might arise if we tried to use such a modified tool in emergency departments?"], "ground_truth": ["permed-80425", "permed-36873", "permed-44876", "permed-84037", "permed-33160", "permed-10768", "permed-44646", "permed-78686", "permed-89539", "permed-49901"]}
{"query_id": "topic_323_turn_1", "conversation_id": "topic_323", "turn_id": 1, "query": "What is known about the biological activities of triterpenoids from fungi, particularly those found in marine environments?", "history": [], "ground_truth": ["permed-79549", "permed-78967", "permed-89489", "permed-79551", "permed-79587", "permed-63665", "permed-66928", "permed-79609", "permed-79632", "permed-59491"]}
{"query_id": "topic_323_turn_2", "conversation_id": "topic_323", "turn_id": 2, "query": "How do the unique structures of these compounds, like lanostane-type triterpenoids, influence their antimicrobial and antifouling properties?", "history": ["What is known about the biological activities of triterpenoids from fungi, particularly those found in marine environments?"], "ground_truth": ["permed-79549", "permed-79594", "permed-89489", "permed-79595", "permed-67452", "permed-59491", "permed-78974", "permed-63665", "permed-59494", "permed-67451"]}
{"query_id": "topic_323_turn_3", "conversation_id": "topic_323", "turn_id": 3, "query": "Given the unique structures and properties of these lanostane-type triterpenoids, how do the specific structural modifications in the novel compound from *Ceriporia lacerata* CD7-5 affect its antimicrobial and antifouling activities compared to other natural triterpenoids? Furthermore, what ecological implications might these findings have for marine ecosystems, particularly in terms of fungal-host interactions?", "history": ["What is known about the biological activities of triterpenoids from fungi, particularly those found in marine environments?", "How do the unique structures of these compounds, like lanostane-type triterpenoids, influence their antimicrobial and antifouling properties?"], "ground_truth": ["permed-79549", "permed-89489", "permed-86226", "permed-79609", "permed-79587", "permed-55445", "permed-59494", "permed-67452", "permed-78974", "permed-63984"]}
{"query_id": "topic_323_turn_4", "conversation_id": "topic_323", "turn_id": 4, "query": "Building on the structural modifications you mentioned in *Ceriporia lacerata* CD7-5, what specific *in vitro* assays and minimum inhibitory concentration protocols were used to quantify its antimicrobial potency? Were standardized biofilm formation assays employed for the antifouling assessment, and how did you statistically validate the dose-response relationships for these activities against your comparator compounds to ensure reproducibility?", "history": ["What is known about the biological activities of triterpenoids from fungi, particularly those found in marine environments?", "How do the unique structures of these compounds, like lanostane-type triterpenoids, influence their antimicrobial and antifouling properties?", "Given the unique structures and properties of these lanostane-type triterpenoids, how do the specific structural modifications in the novel compound from *Ceriporia lacerata* CD7-5 affect its antimicrobial and antifouling activities compared to other natural triterpenoids? Furthermore, what ecological implications might these findings have for marine ecosystems, particularly in terms of fungal-host interactions?"], "ground_truth": ["permed-89783", "permed-63620", "permed-62051", "permed-51280", "permed-63610", "permed-12691", "permed-89801", "permed-81114", "permed-70432", "permed-89819"]}
{"query_id": "topic_324_turn_1", "conversation_id": "topic_324", "turn_id": 1, "query": "What is known about the role of autoantibodies in idiopathic inflammatory myopathy (IIM)?", "history": [], "ground_truth": ["permed-68828", "permed-68827", "permed-4580", "permed-4589", "permed-4581", "permed-67348", "permed-4586", "permed-68830", "permed-54740", "permed-4582"]}
{"query_id": "topic_324_turn_2", "conversation_id": "topic_324", "turn_id": 2, "query": "How might the discovery of new autoantibody profiles impact our understanding of IIM subtypes and their clinical presentations?", "history": ["What is known about the role of autoantibodies in idiopathic inflammatory myopathy (IIM)?"], "ground_truth": ["permed-68827", "permed-68828", "permed-4580", "permed-4584", "permed-61125", "permed-1608", "permed-4581", "permed-4842", "permed-77280", "permed-89488"]}
{"query_id": "topic_324_turn_3", "conversation_id": "topic_324", "turn_id": 3, "query": "Given these findings about novel autoantibodies against aminoacyl tRNA synthetases in both seropositive and seronegative IIM patients, how might they help us better understand the clinical and prognostic heterogeneity among IIM subtypes? And what approaches could be taken to incorporate these biomarkers into more personalized diagnostic and treatment strategies?", "history": ["What is known about the role of autoantibodies in idiopathic inflammatory myopathy (IIM)?", "How might the discovery of new autoantibody profiles impact our understanding of IIM subtypes and their clinical presentations?"], "ground_truth": ["permed-68828", "permed-68827", "permed-67348", "permed-89488", "permed-4580", "permed-4584", "permed-4581", "permed-68049", "permed-26895", "permed-4589"]}
{"query_id": "topic_324_turn_4", "conversation_id": "topic_324", "turn_id": 4, "query": "When implementing these autoantibody biomarkers into diagnostic workflows, what specific validation protocols would you recommend for mass spectrometry-based detection methods? I'm particularly interested in how to establish appropriate sensitivity thresholds across different IIM subtypes, whether internal standardization approaches using stable isotope-labeled peptides would improve quantification accuracy, and what statistical methods would best handle the high-dimensional proteomic data while accounting for clinical covariates like disease duration and treatment history.", "history": ["What is known about the role of autoantibodies in idiopathic inflammatory myopathy (IIM)?", "How might the discovery of new autoantibody profiles impact our understanding of IIM subtypes and their clinical presentations?", "Given these findings about novel autoantibodies against aminoacyl tRNA synthetases in both seropositive and seronegative IIM patients, how might they help us better understand the clinical and prognostic heterogeneity among IIM subtypes? And what approaches could be taken to incorporate these biomarkers into more personalized diagnostic and treatment strategies?"], "ground_truth": ["permed-68827", "permed-1608", "permed-4842", "permed-79011", "permed-4675", "permed-70449", "permed-89487", "permed-4609", "permed-4850", "permed-79012"]}
{"query_id": "topic_325_turn_1", "conversation_id": "topic_325", "turn_id": 1, "query": "What is known about how multimorbidity affects the quality of life in older adults?", "history": [], "ground_truth": ["permed-65571", "permed-52388", "permed-81588", "permed-65470", "permed-60129", "permed-81336", "permed-65566", "permed-52386", "permed-59965", "permed-65564"]}
{"query_id": "topic_325_turn_2", "conversation_id": "topic_325", "turn_id": 2, "query": "Are there any identified patterns or differences in how it impacts men versus women that could inform healthcare strategies?", "history": ["What is known about how multimorbidity affects the quality of life in older adults?"], "ground_truth": ["permed-61977", "permed-79334", "permed-65542", "permed-56937", "permed-66322", "permed-80249", "permed-65541", "permed-86891", "permed-66148", "permed-62284"]}
{"query_id": "topic_325_turn_3", "conversation_id": "topic_325", "turn_id": 3, "query": "Given these gender-specific patterns in multimorbidity and their differing impacts on HRQoL, how could we develop targeted interventions or personalized healthcare approaches that account for these distinct profiles in men and women? Specifically, how might preventive measures, early diagnosis, and integrated care models be tailored to manage common conditions like arthritis, diabetes, and cardiovascular diseases—and what potential long-term benefits could such strategies have on overall health and well-being?", "history": ["What is known about how multimorbidity affects the quality of life in older adults?", "Are there any identified patterns or differences in how it impacts men versus women that could inform healthcare strategies?"], "ground_truth": ["permed-65571", "permed-68394", "permed-61488", "permed-52388", "permed-65566", "permed-65564", "permed-81589", "permed-81588", "permed-61977", "permed-65470"]}
{"query_id": "topic_325_turn_4", "conversation_id": "topic_325", "turn_id": 4, "query": "Building on this proposed framework for gender-tailored interventions, what specific methodological approaches would best validate these personalized healthcare models? For instance, what statistical techniques could quantify treatment effect heterogeneity between genders, and what trial designs—perhaps adaptive platform trials or stratified randomization schemes—would effectively test differential outcomes for conditions like arthritis and cardiovascular diseases? Additionally, how should we operationalize and measure fidelity when implementing these integrated care models across diverse clinical settings to ensure reproducibility?", "history": ["What is known about how multimorbidity affects the quality of life in older adults?", "Are there any identified patterns or differences in how it impacts men versus women that could inform healthcare strategies?", "Given these gender-specific patterns in multimorbidity and their differing impacts on HRQoL, how could we develop targeted interventions or personalized healthcare approaches that account for these distinct profiles in men and women? Specifically, how might preventive measures, early diagnosis, and integrated care models be tailored to manage common conditions like arthritis, diabetes, and cardiovascular diseases—and what potential long-term benefits could such strategies have on overall health and well-being?"], "ground_truth": ["permed-59135", "permed-61977", "permed-53342", "permed-74572", "permed-52211", "permed-56937", "permed-56935", "permed-51749", "permed-55106", "permed-53997"]}
{"query_id": "topic_326_turn_1", "conversation_id": "topic_326", "turn_id": 1, "query": "What impact does deception have on negotiators' long-term psychological outcomes?", "history": [], "ground_truth": ["permed-78819", "permed-78820", "permed-79332", "permed-75160", "permed-85441", "permed-69689", "permed-69671", "permed-55636", "permed-55645", "permed-60971"]}
{"query_id": "topic_326_turn_2", "conversation_id": "topic_326", "turn_id": 2, "query": "Does this impact vary when the deception involves moral character and financial incentives?", "history": ["What impact does deception have on negotiators' long-term psychological outcomes?"], "ground_truth": ["permed-78819", "permed-79332", "permed-62741", "permed-69689", "permed-69671", "permed-69686", "permed-62740", "permed-74818", "permed-82790", "permed-68674"]}
{"query_id": "topic_326_turn_3", "conversation_id": "topic_326", "turn_id": 3, "query": "How do these effects on negotiators' long-term psychological outcomes differ based on their individual moral character and the size of the incentives involved, especially regarding how it shapes their future trust levels and ability to form new collaborations when their deception goes undetected?", "history": ["What impact does deception have on negotiators' long-term psychological outcomes?", "Does this impact vary when the deception involves moral character and financial incentives?"], "ground_truth": ["permed-78819", "permed-78820", "permed-79332", "permed-69689", "permed-69805", "permed-85441", "permed-62742", "permed-76736", "permed-82774", "permed-69686"]}
{"query_id": "topic_326_turn_4", "conversation_id": "topic_326", "turn_id": 4, "query": "Given these complex interaction effects, what specific experimental designs and statistical models would best capture how moral character moderates the relationship between incentive size and long-term trust erosion? I'm particularly interested in methodological approaches for measuring latent psychological constructs like post-negotiation trust formation, and whether structural equation modeling or hierarchical linear modeling would be more appropriate for analyzing these mediation pathways while controlling for detected versus undetected deception conditions.", "history": ["What impact does deception have on negotiators' long-term psychological outcomes?", "Does this impact vary when the deception involves moral character and financial incentives?", "How do these effects on negotiators' long-term psychological outcomes differ based on their individual moral character and the size of the incentives involved, especially regarding how it shapes their future trust levels and ability to form new collaborations when their deception goes undetected?"], "ground_truth": ["permed-78819", "permed-79332", "permed-68674", "permed-55541", "permed-69686", "permed-69689", "permed-82773", "permed-62741", "permed-78820", "permed-64817"]}
{"query_id": "topic_327_turn_1", "conversation_id": "topic_327", "turn_id": 1, "query": "What role does evolutionary biology play in understanding and managing infectious diseases?", "history": [], "ground_truth": ["permed-54928", "permed-53063", "permed-67815", "permed-81625", "permed-53301", "permed-21923", "permed-71863", "permed-70160", "permed-54935", "permed-72205"]}
{"query_id": "topic_327_turn_2", "conversation_id": "topic_327", "turn_id": 2, "query": "How can principles from this area be applied to develop more effective public health strategies?", "history": ["What role does evolutionary biology play in understanding and managing infectious diseases?"], "ground_truth": ["permed-54928", "permed-55180", "permed-54521", "permed-53013", "permed-54930", "permed-53010", "permed-56876", "permed-35509", "permed-84597", "permed-91926"]}
{"query_id": "topic_327_turn_3", "conversation_id": "topic_327", "turn_id": 3, "query": "Given these evolutionary biology principles and their application to public health strategies, how could the concepts of natura naturans and natura naturata be incorporated into designing adaptive interventions that dynamically account for pathogen evolution, host immune responses, and environmental factors—especially when managing emerging infectious diseases across different ecological settings?", "history": ["What role does evolutionary biology play in understanding and managing infectious diseases?", "How can principles from this area be applied to develop more effective public health strategies?"], "ground_truth": ["permed-81625", "permed-54928", "permed-54930", "permed-61297", "permed-67815", "permed-16791", "permed-64259", "permed-67997", "permed-67999", "permed-53234"]}
{"query_id": "topic_327_turn_4", "conversation_id": "topic_327", "turn_id": 4, "query": "Given this theoretical framework integrating active and passive nature concepts, what specific computational modeling approaches would best implement these adaptive interventions? I'm particularly interested in how to structure the feedback loops between surveillance data and intervention parameters - should we use stochastic optimization methods or reinforcement learning algorithms? Also, what statistical validation strategies would ensure these dynamic models remain robust across different ecological settings while accounting for uncertainties in pathogen mutation rates and host immunological landscapes?", "history": ["What role does evolutionary biology play in understanding and managing infectious diseases?", "How can principles from this area be applied to develop more effective public health strategies?", "Given these evolutionary biology principles and their application to public health strategies, how could the concepts of natura naturans and natura naturata be incorporated into designing adaptive interventions that dynamically account for pathogen evolution, host immune responses, and environmental factors—especially when managing emerging infectious diseases across different ecological settings?"], "ground_truth": ["permed-67815", "permed-62369", "permed-54099", "permed-36118", "permed-53886", "permed-54928", "permed-59205", "permed-64259", "permed-64246", "permed-52657"]}
{"query_id": "topic_328_turn_1", "conversation_id": "topic_328", "turn_id": 1, "query": "What role do wild migratory birds play in the spread of avian influenza viruses?", "history": [], "ground_truth": ["permed-67012", "permed-81847", "permed-67009", "permed-81848", "permed-80752", "permed-79412", "permed-67010", "permed-22821", "permed-67006", "permed-80697"]}
{"query_id": "topic_328_turn_2", "conversation_id": "topic_328", "turn_id": 2, "query": "How can understanding their migration patterns help in predicting the emergence of new, highly pathogenic strains like HPAI?", "history": ["What role do wild migratory birds play in the spread of avian influenza viruses?"], "ground_truth": ["permed-81847", "permed-67012", "permed-67006", "permed-67009", "permed-81848", "permed-67007", "permed-67010", "permed-54928", "permed-68153", "permed-85024"]}
{"query_id": "topic_328_turn_3", "conversation_id": "topic_328", "turn_id": 3, "query": "Given this understanding of wild birds' role in spreading HPAI and how their migration patterns help predict new strains, how could combining migration data with genetic surveillance improve our models for tracking emerging viruses like A/H5N5 in key ecological corridors? Also, what specific genetic markers in these viruses might signal adaptations for increased transmission between species—including potential human-to-human spread—and how could this guide public health strategies and vaccine development?", "history": ["What role do wild migratory birds play in the spread of avian influenza viruses?", "How can understanding their migration patterns help in predicting the emergence of new, highly pathogenic strains like HPAI?"], "ground_truth": ["permed-67012", "permed-81847", "permed-22239", "permed-67006", "permed-67009", "permed-81848", "permed-67007", "permed-22795", "permed-79412", "permed-22823"]}
{"query_id": "topic_328_turn_4", "conversation_id": "topic_328", "turn_id": 4, "query": "When implementing this combined migration-genetic surveillance approach, what specific statistical methods would best quantify the correlation between migratory connectivity and viral genetic distance? Particularly, how should we handle temporal autocorrelation in longitudinal sequence data, and what spatial analysis frameworks (e.g., Mantel tests, phylogenetic diffusion models) could validate that observed genetic similarities truly reflect transmission routes rather than convergent evolution? Additionally, what sampling frequency and geographic resolution would be methodologically necessary to achieve sufficient statistical power in these analyses?", "history": ["What role do wild migratory birds play in the spread of avian influenza viruses?", "How can understanding their migration patterns help in predicting the emergence of new, highly pathogenic strains like HPAI?", "Given this understanding of wild birds' role in spreading HPAI and how their migration patterns help predict new strains, how could combining migration data with genetic surveillance improve our models for tracking emerging viruses like A/H5N5 in key ecological corridors? Also, what specific genetic markers in these viruses might signal adaptations for increased transmission between species—including potential human-to-human spread—and how could this guide public health strategies and vaccine development?"], "ground_truth": ["permed-79068", "permed-83668", "permed-62963", "permed-71715", "permed-59354", "permed-59204", "permed-63530", "permed-68814", "permed-85578", "permed-59205"]}
{"query_id": "topic_329_turn_1", "conversation_id": "topic_329", "turn_id": 1, "query": "Key contributing factors to stress in food insecure rural populations.", "history": [], "ground_truth": ["permed-56000", "permed-62350", "permed-65029", "permed-91759", "permed-74977", "permed-74358", "permed-67084", "permed-83519", "permed-89581", "permed-88327"]}
{"query_id": "topic_329_turn_2", "conversation_id": "topic_329", "turn_id": 2, "query": "Influence of neighborhood social dynamics and food access on such stress among these rural individuals.", "history": ["Key contributing factors to stress in food insecure rural populations."], "ground_truth": ["permed-56000", "permed-74466", "permed-84683", "permed-65949", "permed-53165", "permed-59274", "permed-56002", "permed-53168", "permed-65029", "permed-66197"]}
{"query_id": "topic_329_turn_3", "conversation_id": "topic_329", "turn_id": 3, "query": "Technical design of effective community interventions for mental health in food insecure rural areas post-pandemic: strategies for strengthening social support, improving food systems, and ensuring sustainable NGO-government partnerships.", "history": ["Key contributing factors to stress in food insecure rural populations.", "Influence of neighborhood social dynamics and food access on such stress among these rural individuals."], "ground_truth": ["permed-56000", "permed-74977", "permed-58472", "permed-55589", "permed-62350", "permed-61952", "permed-77845", "permed-74357", "permed-81534", "permed-91844"]}
{"query_id": "topic_329_turn_4", "conversation_id": "topic_329", "turn_id": 4, "query": "Regarding the technical design of these multi-pronged interventions, what specific implementation protocols were developed for coordinating NGO-government partnerships? I'm particularly interested in the operational frameworks used for data sharing between sectors, joint monitoring mechanisms for community mental health outcomes, and the quality control measures established to maintain intervention fidelity across different rural contexts while adapting to local food system particularities.", "history": ["Key contributing factors to stress in food insecure rural populations.", "Influence of neighborhood social dynamics and food access on such stress among these rural individuals.", "Technical design of effective community interventions for mental health in food insecure rural areas post-pandemic: strategies for strengthening social support, improving food systems, and ensuring sustainable NGO-government partnerships."], "ground_truth": ["permed-65626", "permed-63533", "permed-90617", "permed-91392", "permed-90782", "permed-70630", "permed-52380", "permed-53020", "permed-53138", "permed-58473"]}
{"query_id": "topic_330_turn_1", "conversation_id": "topic_330", "turn_id": 1, "query": "Impact of economic development programs on dietary diversity and food security in low-income communities", "history": [], "ground_truth": ["permed-75099", "permed-74977", "permed-91759", "permed-62350", "permed-62788", "permed-65029", "permed-82583", "permed-83517", "permed-62790", "permed-62789"]}
{"query_id": "topic_330_turn_2", "conversation_id": "topic_330", "turn_id": 2, "query": "Effectiveness of combining these economic development programs with Positive Deviant health initiatives for improved community health and economic outcomes", "history": ["Impact of economic development programs on dietary diversity and food security in low-income communities"], "ground_truth": ["permed-91926", "permed-75099", "permed-66153", "permed-62788", "permed-90617", "permed-74977", "permed-84590", "permed-85068", "permed-84747", "permed-66148"]}
{"query_id": "topic_330_turn_3", "conversation_id": "topic_330", "turn_id": 3, "query": "Optimizing combined economic and Positive Deviant/Hearth interventions: adjusting timing, intensity, components, or adding health education and financial support to improve child nutrition and household income", "history": ["Impact of economic development programs on dietary diversity and food security in low-income communities", "Effectiveness of combining these economic development programs with Positive Deviant health initiatives for improved community health and economic outcomes"], "ground_truth": ["permed-75099", "permed-74977", "permed-91844", "permed-62790", "permed-62788", "permed-91926", "permed-72332", "permed-45883", "permed-86027", "permed-85593"]}
{"query_id": "topic_330_turn_4", "conversation_id": "topic_330", "turn_id": 4, "query": "For optimizing these combined interventions, what specific statistical approaches would you recommend for analyzing the interaction effects between economic support components and Positive Deviant/Hearth elements? I'm particularly interested in whether structural equation modeling or multilevel mixed-effects models would better account for the temporal sequencing of interventions while controlling for household-level covariates. How should we validate these models to ensure robustness in measuring the complex pathways from program components to nutritional and income outcomes?", "history": ["Impact of economic development programs on dietary diversity and food security in low-income communities", "Effectiveness of combining these economic development programs with Positive Deviant health initiatives for improved community health and economic outcomes", "Optimizing combined economic and Positive Deviant/Hearth interventions: adjusting timing, intensity, components, or adding health education and financial support to improve child nutrition and household income"], "ground_truth": ["permed-75099", "permed-62788", "permed-62790", "permed-53878", "permed-75101", "permed-84050", "permed-79201", "permed-72338", "permed-55479", "permed-54350"]}
{"query_id": "topic_331_turn_1", "conversation_id": "topic_331", "turn_id": 1, "query": "Function of sensory integration in motor responses and decision-making processes", "history": [], "ground_truth": ["permed-61677", "permed-69435", "permed-66532", "permed-77297", "permed-89293", "permed-59249", "permed-79063", "permed-64693", "permed-66495", "permed-77417"]}
{"query_id": "topic_331_turn_2", "conversation_id": "topic_331", "turn_id": 2, "query": "Influence of this sensory integration on performance during complex multi-step motor tasks and decision-making", "history": ["Function of sensory integration in motor responses and decision-making processes"], "ground_truth": ["permed-71501", "permed-77417", "permed-69435", "permed-61677", "permed-59249", "permed-77859", "permed-66495", "permed-66532", "permed-58501", "permed-59827"]}
{"query_id": "topic_331_turn_3", "conversation_id": "topic_331", "turn_id": 3, "query": "Neural basis for enhanced motor precision and timing via visuo-tactile integration in such complex multi-action decision tasks", "history": ["Function of sensory integration in motor responses and decision-making processes", "Influence of this sensory integration on performance during complex multi-step motor tasks and decision-making"], "ground_truth": ["permed-59247", "permed-59249", "permed-66495", "permed-59245", "permed-59256", "permed-66475", "permed-58413", "permed-68953", "permed-61677", "permed-79965"]}
{"query_id": "topic_331_turn_4", "conversation_id": "topic_331", "turn_id": 4, "query": "Given this neural framework for visuo-tactile integration, what specific experimental protocols were used to quantify the temporal precision of motor outputs? I'm particularly interested in the methodology for synchronizing the visual and tactile stimulus delivery, the kinematic metrics employed to assess movement timing, and the statistical approaches used to validate that the observed precision enhancements were specifically attributable to cross-modal integration rather than unimodal practice effects.", "history": ["Function of sensory integration in motor responses and decision-making processes", "Influence of this sensory integration on performance during complex multi-step motor tasks and decision-making", "Neural basis for enhanced motor precision and timing via visuo-tactile integration in such complex multi-action decision tasks"], "ground_truth": ["permed-59247", "permed-59249", "permed-66519", "permed-58413", "permed-77859", "permed-66436", "permed-59245", "permed-61741", "permed-66477", "permed-59250"]}
{"query_id": "topic_332_turn_1", "conversation_id": "topic_332", "turn_id": 1, "query": "What is known about the environmental impacts of common plastic blends like polyethylene terephthalate and linear low-density polyethylene?", "history": [], "ground_truth": ["permed-57623", "permed-58264", "permed-72740", "permed-72739", "permed-80629", "permed-80333", "permed-80632", "permed-82704", "permed-66169", "permed-90172"]}
{"query_id": "topic_332_turn_2", "conversation_id": "topic_332", "turn_id": 2, "query": "How can additives like dihydroxy polyethylene improve the recyclability and mechanical properties of these blends?", "history": ["What is known about the environmental impacts of common plastic blends like polyethylene terephthalate and linear low-density polyethylene?"], "ground_truth": ["permed-80333", "permed-75796", "permed-75793", "permed-57619", "permed-84109", "permed-73037", "permed-57626", "permed-51461", "permed-80335", "permed-75792"]}
{"query_id": "topic_332_turn_3", "conversation_id": "topic_332", "turn_id": 3, "query": "Given these plastic blends and the use of dihydroxy polyethylene additives to improve their properties, what are the long-term environmental impacts and degradation behaviors of these compatibilized blends? Also, how do they maintain their mechanical properties and recyclability after undergoing multiple mechanical recycling cycles?", "history": ["What is known about the environmental impacts of common plastic blends like polyethylene terephthalate and linear low-density polyethylene?", "How can additives like dihydroxy polyethylene improve the recyclability and mechanical properties of these blends?"], "ground_truth": ["permed-80333", "permed-75796", "permed-57619", "permed-73037", "permed-57622", "permed-84109", "permed-75793", "permed-57621", "permed-80629", "permed-57626"]}
{"query_id": "topic_332_turn_4", "conversation_id": "topic_332", "turn_id": 4, "query": "Given these degradation and recyclability assessments, could you detail the specific experimental protocols used to simulate long-term environmental aging? I'm particularly interested in the accelerated weathering parameters—UV exposure cycles, temperature/humidity regimes, and soil burial conditions—employed to mimic natural degradation. Additionally, what statistical models were used to extrapolate accelerated data to real-time environmental persistence, and how was method validation performed against field-collected samples to ensure predictive accuracy?", "history": ["What is known about the environmental impacts of common plastic blends like polyethylene terephthalate and linear low-density polyethylene?", "How can additives like dihydroxy polyethylene improve the recyclability and mechanical properties of these blends?", "Given these plastic blends and the use of dihydroxy polyethylene additives to improve their properties, what are the long-term environmental impacts and degradation behaviors of these compatibilized blends? Also, how do they maintain their mechanical properties and recyclability after undergoing multiple mechanical recycling cycles?"], "ground_truth": ["permed-60922", "permed-57623", "permed-87963", "permed-73108", "permed-58066", "permed-78702", "permed-72734", "permed-89170", "permed-87962", "permed-31584"]}
{"query_id": "topic_333_turn_1", "conversation_id": "topic_333", "turn_id": 1, "query": "What role does phototherapy play in treating neonatal conditions related to allergic disorders?", "history": [], "ground_truth": ["permed-81489", "permed-73715", "permed-12280", "permed-12330", "permed-45997", "permed-77102", "permed-62443", "permed-68030", "permed-82497", "permed-12339"]}
{"query_id": "topic_333_turn_2", "conversation_id": "topic_333", "turn_id": 2, "query": "Does the effectiveness of this treatment method depend on specific factors, such as intensity or timing of intervention?", "history": ["What role does phototherapy play in treating neonatal conditions related to allergic disorders?"], "ground_truth": ["permed-82587", "permed-55479", "permed-13306", "permed-50971", "permed-82588", "permed-58626", "permed-82651", "permed-65029", "permed-61615", "permed-63134"]}
{"query_id": "topic_333_turn_3", "conversation_id": "topic_333", "turn_id": 3, "query": "Given that the effectiveness of phototherapy depends on factors like intensity and timing, how do these variations specifically affect the development of immune responses—particularly IgE sensitization—related to allergic disorders in early childhood?", "history": ["What role does phototherapy play in treating neonatal conditions related to allergic disorders?", "Does the effectiveness of this treatment method depend on specific factors, such as intensity or timing of intervention?"], "ground_truth": ["permed-81489", "permed-59075", "permed-68030", "permed-67784", "permed-68032", "permed-12930", "permed-74547", "permed-71027", "permed-83642", "permed-82497"]}
{"query_id": "topic_333_turn_4", "conversation_id": "topic_333", "turn_id": 4, "query": "Considering these variations in phototherapy parameters affect IgE sensitization, what specific experimental protocols would you recommend for isolating the immunological mechanisms? I'm particularly interested in methodological details regarding dose-response study designs, the timing of immune cell sampling from peripheral blood, and which flow cytometry panels would be most appropriate for tracking Th1/Th2 balance and regulatory T cell populations in neonatal subjects undergoing different phototherapy regimens.", "history": ["What role does phototherapy play in treating neonatal conditions related to allergic disorders?", "Does the effectiveness of this treatment method depend on specific factors, such as intensity or timing of intervention?", "Given that the effectiveness of phototherapy depends on factors like intensity and timing, how do these variations specifically affect the development of immune responses—particularly IgE sensitization—related to allergic disorders in early childhood?"], "ground_truth": ["permed-81489", "permed-13674", "permed-43355", "permed-24666", "permed-57792", "permed-68049", "permed-67784", "permed-48337", "permed-67977", "permed-68003"]}
{"query_id": "topic_334_turn_1", "conversation_id": "topic_334", "turn_id": 1, "query": "What are the current approaches to managing cancer-related pain, especially in patients with complex medical histories?", "history": [], "ground_truth": ["permed-36049", "permed-13687", "permed-60188", "permed-69146", "permed-13684", "permed-52329", "permed-83078", "permed-69145", "permed-63215", "permed-54960"]}
{"query_id": "topic_334_turn_2", "conversation_id": "topic_334", "turn_id": 2, "query": "How effective is combining opioid therapy with non-pharmacological interventions in this area, and what considerations come into play?", "history": ["What are the current approaches to managing cancer-related pain, especially in patients with complex medical histories?"], "ground_truth": ["permed-80135", "permed-55684", "permed-55824", "permed-74419", "permed-80137", "permed-80557", "permed-55088", "permed-84200", "permed-88263", "permed-55828"]}
{"query_id": "topic_334_turn_3", "conversation_id": "topic_334", "turn_id": 3, "query": "Given these approaches combining opioids with non-pharmacological methods for cancer pain, how can multidisciplinary teams best integrate these therapies for patients who also have conditions like chronic kidney disease or liver dysfunction? What do we know about the long-term outcomes and quality of life impacts of such integrated care?", "history": ["What are the current approaches to managing cancer-related pain, especially in patients with complex medical histories?", "How effective is combining opioid therapy with non-pharmacological interventions in this area, and what considerations come into play?"], "ground_truth": ["permed-69146", "permed-69145", "permed-80135", "permed-72483", "permed-60430", "permed-74825", "permed-84379", "permed-13131", "permed-63215", "permed-36049"]}
{"query_id": "topic_334_turn_4", "conversation_id": "topic_334", "turn_id": 4, "query": "When implementing these integrated care models for patients with complex comorbidities, what specific methodological approaches are used to standardize treatment protocols across different specialties? How do researchers typically operationalize and measure care coordination – for instance, through specific documentation systems, regular interdisciplinary meeting structures, or standardized communication protocols? Additionally, what statistical methods are most appropriate for analyzing the longitudinal outcomes data, particularly when dealing with missing data points from patients with progressive organ dysfunction?", "history": ["What are the current approaches to managing cancer-related pain, especially in patients with complex medical histories?", "How effective is combining opioid therapy with non-pharmacological interventions in this area, and what considerations come into play?", "Given these approaches combining opioids with non-pharmacological methods for cancer pain, how can multidisciplinary teams best integrate these therapies for patients who also have conditions like chronic kidney disease or liver dysfunction? What do we know about the long-term outcomes and quality of life impacts of such integrated care?"], "ground_truth": ["permed-57447", "permed-80879", "permed-57583", "permed-74572", "permed-52110", "permed-88305", "permed-25210", "permed-74570", "permed-52111", "permed-63533"]}
{"query_id": "topic_335_turn_1", "conversation_id": "topic_335", "turn_id": 1, "query": "What is known about the therapeutic potential of essential oils from Eugenia stipitata against parasitic diseases like leishmaniasis?", "history": [], "ground_truth": ["permed-64186", "permed-64196", "permed-79602", "permed-92327", "permed-79600", "permed-72803", "permed-92328", "permed-79601", "permed-60821", "permed-86674"]}
{"query_id": "topic_335_turn_2", "conversation_id": "topic_335", "turn_id": 2, "query": "How do specific compounds within this oil contribute to its efficacy, particularly in terms of selective cytotoxicity?", "history": ["What is known about the therapeutic potential of essential oils from Eugenia stipitata against parasitic diseases like leishmaniasis?"], "ground_truth": ["permed-59495", "permed-59491", "permed-86385", "permed-52460", "permed-64186", "permed-75042", "permed-86230", "permed-79609", "permed-59501", "permed-62048"]}
{"query_id": "topic_335_turn_3", "conversation_id": "topic_335", "turn_id": 3, "query": "Given the role of β-eudesmol, γ-eudesmol, elemol, and caryophyllene oxide in this oil's selective cytotoxicity against Leishmania, how do their specific ratios influence this effect, and what molecular mechanisms might explain the selectivity? Furthermore, could these compounds be structurally modified or synthesized to enhance their anti-leishmanial activity while reducing toxicity to mammalian cells?", "history": ["What is known about the therapeutic potential of essential oils from Eugenia stipitata against parasitic diseases like leishmaniasis?", "How do specific compounds within this oil contribute to its efficacy, particularly in terms of selective cytotoxicity?"], "ground_truth": ["permed-60647", "permed-64196", "permed-86221", "permed-92327", "permed-60821", "permed-79602", "permed-68740", "permed-62108", "permed-64186", "permed-90355"]}
{"query_id": "topic_335_turn_4", "conversation_id": "topic_335", "turn_id": 4, "query": "When investigating the synergistic effects of these sesquiterpene ratios, what specific experimental design would you recommend for determining optimal combinations? Should researchers employ factorial design or response surface methodology to model the interactions? Also, what validation strategies—such as checkerboard assays or isobologram analysis—would best quantify synergism versus additive effects, and how should cytotoxicity thresholds be statistically defined to maintain selectivity between promastigote and mammalian cell lines in these combination studies?", "history": ["What is known about the therapeutic potential of essential oils from Eugenia stipitata against parasitic diseases like leishmaniasis?", "How do specific compounds within this oil contribute to its efficacy, particularly in terms of selective cytotoxicity?", "Given the role of β-eudesmol, γ-eudesmol, elemol, and caryophyllene oxide in this oil's selective cytotoxicity against Leishmania, how do their specific ratios influence this effect, and what molecular mechanisms might explain the selectivity? Furthermore, could these compounds be structurally modified or synthesized to enhance their anti-leishmanial activity while reducing toxicity to mammalian cells?"], "ground_truth": ["permed-87695", "permed-76183", "permed-64258", "permed-81082", "permed-66884", "permed-75039", "permed-86017", "permed-59491", "permed-90192", "permed-82209"]}
{"query_id": "topic_336_turn_1", "conversation_id": "topic_336", "turn_id": 1, "query": "Primary challenges and adverse effects for chronic intestinal failure patients on home parenteral nutrition", "history": [], "ground_truth": ["permed-55150", "permed-74721", "permed-89936", "permed-89255", "permed-55161", "permed-50104", "permed-55046", "permed-55041", "permed-24509", "permed-30672"]}
{"query_id": "topic_336_turn_2", "conversation_id": "topic_336", "turn_id": 2, "query": "Innovations in HPN patient education programs for managing these adverse effects and preventing at-home complications", "history": ["Primary challenges and adverse effects for chronic intestinal failure patients on home parenteral nutrition"], "ground_truth": ["permed-66153", "permed-58626", "permed-91926", "permed-55150", "permed-66148", "permed-66063", "permed-75160", "permed-55182", "permed-84730", "permed-51590"]}
{"query_id": "topic_336_turn_3", "conversation_id": "topic_336", "turn_id": 3, "query": "Efficacy of these innovative HPN education strategies in improving long-term patient outcomes, quality of life, and reducing catheter-related bloodstream infections and metabolic derangements in CIF patients", "history": ["Primary challenges and adverse effects for chronic intestinal failure patients on home parenteral nutrition", "Innovations in HPN patient education programs for managing these adverse effects and preventing at-home complications"], "ground_truth": ["permed-55150", "permed-61352", "permed-61351", "permed-78981", "permed-77813", "permed-85935", "permed-61360", "permed-66066", "permed-59966", "permed-10535"]}
{"query_id": "topic_336_turn_4", "conversation_id": "topic_336", "turn_id": 4, "query": "How were these innovative education strategies specifically implemented in terms of delivery frequency, duration, and instructional modalities? Could you detail the statistical methods used to compare CRBSI rates and metabolic parameter changes between intervention and control groups, including how covariates were adjusted for in the regression models and what power calculations determined the sample size?", "history": ["Primary challenges and adverse effects for chronic intestinal failure patients on home parenteral nutrition", "Innovations in HPN patient education programs for managing these adverse effects and preventing at-home complications", "Efficacy of these innovative HPN education strategies in improving long-term patient outcomes, quality of life, and reducing catheter-related bloodstream infections and metabolic derangements in CIF patients"], "ground_truth": ["permed-84374", "permed-49558", "permed-55154", "permed-87682", "permed-12095", "permed-78698", "permed-54790", "permed-84375", "permed-51586", "permed-84188"]}
{"query_id": "topic_337_turn_1", "conversation_id": "topic_337", "turn_id": 1, "query": "What are chlorinated paraffins, and how do they affect indoor air quality?", "history": [], "ground_truth": ["permed-78355", "permed-78247", "permed-81904", "permed-74965", "permed-78358", "permed-82683", "permed-74964", "permed-88909", "permed-37420", "permed-87001"]}
{"query_id": "topic_337_turn_2", "conversation_id": "topic_337", "turn_id": 2, "query": "How does the variation in these compounds' levels impact human health in different settings, such as homes versus commercial spaces?", "history": ["What are chlorinated paraffins, and how do they affect indoor air quality?"], "ground_truth": ["permed-78355", "permed-66148", "permed-65029", "permed-81999", "permed-91926", "permed-72010", "permed-72870", "permed-72871", "permed-82000", "permed-86636"]}
{"query_id": "topic_337_turn_3", "conversation_id": "topic_337", "turn_id": 3, "query": "Given what we know about chlorinated paraffins and their varying health impacts across different settings, how do differences in the chemical composition and concentration levels of SCCPs and MCCPs—particularly in environments like newly renovated apartments, older buildings, and commercial spaces—affect their bioaccumulation and toxicity in humans, especially for sensitive groups like children and pregnant women? Also, how do factors like ventilation rates and specific indoor materials influence these exposure risks?", "history": ["What are chlorinated paraffins, and how do they affect indoor air quality?", "How does the variation in these compounds' levels impact human health in different settings, such as homes versus commercial spaces?"], "ground_truth": ["permed-78355", "permed-81904", "permed-78247", "permed-90437", "permed-78358", "permed-81907", "permed-88749", "permed-87814", "permed-65858", "permed-79821"]}
{"query_id": "topic_337_turn_4", "conversation_id": "topic_337", "turn_id": 4, "query": "Given this complex exposure scenario across different building types, what specific analytical methods are most suitable for quantifying SCCP and MCCP concentrations in indoor air and dust samples? How do these methods address the challenge of congener-specific analysis while maintaining sensitivity for low-level detection? Furthermore, what quality control measures—such as internal standards and recovery experiments—should be implemented to ensure reproducibility when comparing contamination levels across diverse indoor environments with varying ventilation rates and material compositions?", "history": ["What are chlorinated paraffins, and how do they affect indoor air quality?", "How does the variation in these compounds' levels impact human health in different settings, such as homes versus commercial spaces?", "Given what we know about chlorinated paraffins and their varying health impacts across different settings, how do differences in the chemical composition and concentration levels of SCCPs and MCCPs—particularly in environments like newly renovated apartments, older buildings, and commercial spaces—affect their bioaccumulation and toxicity in humans, especially for sensitive groups like children and pregnant women? Also, how do factors like ventilation rates and specific indoor materials influence these exposure risks?"], "ground_truth": ["permed-78355", "permed-78247", "permed-37344", "permed-81904", "permed-39392", "permed-39613", "permed-39311", "permed-86372", "permed-39518", "permed-39160"]}
{"query_id": "topic_338_turn_1", "conversation_id": "topic_338", "turn_id": 1, "query": "What role do smartphone applications play in promoting exercise among elderly populations?", "history": [], "ground_truth": ["permed-81455", "permed-34942", "permed-81454", "permed-65681", "permed-58342", "permed-34943", "permed-71734", "permed-87657", "permed-65029", "permed-90600"]}
{"query_id": "topic_338_turn_2", "conversation_id": "topic_338", "turn_id": 2, "query": "Can personalized feedback within these apps improve adherence to home-based exercise programs, particularly for fall prevention?", "history": ["What role do smartphone applications play in promoting exercise among elderly populations?"], "ground_truth": ["permed-81454", "permed-61342", "permed-61044", "permed-61045", "permed-77526", "permed-61338", "permed-77304", "permed-34942", "permed-81455", "permed-88212"]}
{"query_id": "topic_338_turn_3", "conversation_id": "topic_338", "turn_id": 3, "query": "How can personalized feedback mechanisms in apps like 'Motivate Me' and 'My Activity Programme' be optimized to better address individual differences in motivation and engagement, thereby improving long-term adherence and effectiveness of these home-based exercise programs for fall prevention in older adults?", "history": ["What role do smartphone applications play in promoting exercise among elderly populations?", "Can personalized feedback within these apps improve adherence to home-based exercise programs, particularly for fall prevention?"], "ground_truth": ["permed-81454", "permed-61045", "permed-61342", "permed-77526", "permed-69758", "permed-34942", "permed-61044", "permed-82522", "permed-80189", "permed-65681"]}
{"query_id": "topic_338_turn_4", "conversation_id": "topic_338", "turn_id": 4, "query": "When implementing these personalized feedback mechanisms, what specific statistical approaches are most appropriate for analyzing the relationship between user engagement patterns and adherence outcomes? I'm particularly interested in whether survival analysis techniques could effectively model long-term program retention, or if mixed-effects models would better account for repeated measures of motivation fluctuations while controlling for covariates like baseline mobility and prior fall history.", "history": ["What role do smartphone applications play in promoting exercise among elderly populations?", "Can personalized feedback within these apps improve adherence to home-based exercise programs, particularly for fall prevention?", "How can personalized feedback mechanisms in apps like 'Motivate Me' and 'My Activity Programme' be optimized to better address individual differences in motivation and engagement, thereby improving long-term adherence and effectiveness of these home-based exercise programs for fall prevention in older adults?"], "ground_truth": ["permed-65673", "permed-61045", "permed-53346", "permed-81454", "permed-81306", "permed-80810", "permed-74902", "permed-65672", "permed-73828", "permed-68672"]}
{"query_id": "topic_339_turn_1", "conversation_id": "topic_339", "turn_id": 1, "query": "Current diagnostic challenges for hematological disorders specifically in cockatiels", "history": [], "ground_truth": ["permed-50841", "permed-76485", "permed-50836", "permed-76489", "permed-85505", "permed-82373", "permed-76442", "permed-68563", "permed-68512", "permed-76478"]}
{"query_id": "topic_339_turn_2", "conversation_id": "topic_339", "turn_id": 2, "query": "Given these diagnostic challenges, how can advanced leukocyte estimation techniques enhance understanding of cockatiel immune function and health?", "history": ["Current diagnostic challenges for hematological disorders specifically in cockatiels"], "ground_truth": ["permed-50841", "permed-67816", "permed-84672", "permed-89187", "permed-71982", "permed-67812", "permed-66651", "permed-50837", "permed-66695", "permed-57227"]}
{"query_id": "topic_339_turn_3", "conversation_id": "topic_339", "turn_id": 3, "query": "Using Natt-Herrick versus smear-based leukocyte estimates and established cockatiel hematologic reference intervals to refine diagnostic criteria for disorders linked to environmental stressors and diet", "history": ["Current diagnostic challenges for hematological disorders specifically in cockatiels", "Given these diagnostic challenges, how can advanced leukocyte estimation techniques enhance understanding of cockatiel immune function and health?"], "ground_truth": ["permed-50841", "permed-50836", "permed-66153", "permed-91516", "permed-86233", "permed-89187", "permed-50834", "permed-86235", "permed-82651", "permed-75160"]}
{"query_id": "topic_339_turn_4", "conversation_id": "topic_339", "turn_id": 4, "query": "When implementing the Natt-Herrick versus smear-based comparison you described, what specific statistical validation approaches were employed to ensure these differential counting methods reliably detect clinically significant variations within cockatiel reference intervals? I'm particularly interested in how you established minimum sample sizes, handled inter-observer variability in smear analysis, and determined the statistical power needed to distinguish stress-related lymphocytopenia from dietary deficiency patterns in your experimental design.", "history": ["Current diagnostic challenges for hematological disorders specifically in cockatiels", "Given these diagnostic challenges, how can advanced leukocyte estimation techniques enhance understanding of cockatiel immune function and health?", "Using Natt-Herrick versus smear-based leukocyte estimates and established cockatiel hematologic reference intervals to refine diagnostic criteria for disorders linked to environmental stressors and diet"], "ground_truth": ["permed-50841", "permed-50834", "permed-57833", "permed-23679", "permed-5708", "permed-52650", "permed-22017", "permed-89860", "permed-72863", "permed-74658"]}
{"query_id": "topic_340_turn_1", "conversation_id": "topic_340", "turn_id": 1, "query": "What is known about how plants respond to different forms of iron in soil, especially under conditions where iron is scarce?", "history": [], "ground_truth": ["permed-85222", "permed-64077", "permed-63926", "permed-64104", "permed-64126", "permed-64075", "permed-64071", "permed-82081", "permed-52205", "permed-82082"]}
{"query_id": "topic_340_turn_2", "conversation_id": "topic_340", "turn_id": 2, "query": "How might the use of nanomaterials, like nanoparticles, impact this process and potentially enhance iron acquisition in plants?", "history": ["What is known about how plants respond to different forms of iron in soil, especially under conditions where iron is scarce?"], "ground_truth": ["permed-82081", "permed-81209", "permed-78310", "permed-74110", "permed-64071", "permed-82712", "permed-74109", "permed-85222", "permed-64077", "permed-74122"]}
{"query_id": "topic_340_turn_3", "conversation_id": "topic_340", "turn_id": 3, "query": "Given these findings about nanohaematite particles interacting with cucumber roots and affecting Fe-regulated genes and mobilization, how might this reshape our understanding of plant iron responses in iron-deficient soils? Furthermore, what practical strategies could leverage nanomaterials to improve iron acquisition in agriculture, considering their ability to influence gene expression and iron homeostasis pathways?", "history": ["What is known about how plants respond to different forms of iron in soil, especially under conditions where iron is scarce?", "How might the use of nanomaterials, like nanoparticles, impact this process and potentially enhance iron acquisition in plants?"], "ground_truth": ["permed-82081", "permed-64126", "permed-63926", "permed-81209", "permed-64077", "permed-64086", "permed-63627", "permed-64071", "permed-85222", "permed-80525"]}
{"query_id": "topic_340_turn_4", "conversation_id": "topic_340", "turn_id": 4, "query": "Given these nanomaterial-mediated gene expression changes, could you elaborate on the experimental protocols used to quantify FRO2 and IRT1 transcript levels in cucumber roots? Specifically, what RNA extraction methods, reverse transcription conditions, and qPCR validation strategies were employed to ensure reproducibility across biological replicates? Additionally, how were the nanohaematite concentrations standardized for root exposure experiments, and what statistical approaches were used to correlate particle uptake with gene expression kinetics under iron-deficient conditions?", "history": ["What is known about how plants respond to different forms of iron in soil, especially under conditions where iron is scarce?", "How might the use of nanomaterials, like nanoparticles, impact this process and potentially enhance iron acquisition in plants?", "Given these findings about nanohaematite particles interacting with cucumber roots and affecting Fe-regulated genes and mobilization, how might this reshape our understanding of plant iron responses in iron-deficient soils? Furthermore, what practical strategies could leverage nanomaterials to improve iron acquisition in agriculture, considering their ability to influence gene expression and iron homeostasis pathways?"], "ground_truth": ["permed-82081", "permed-63926", "permed-72860", "permed-82083", "permed-64126", "permed-22270", "permed-74122", "permed-63636", "permed-64077", "permed-63626"]}
{"query_id": "topic_341_turn_1", "conversation_id": "topic_341", "turn_id": 1, "query": "RNF43 gene function and pathways in colon cancer initiation and progression", "history": [], "ground_truth": ["permed-53530", "permed-82373", "permed-85505", "permed-68563", "permed-89851", "permed-74304", "permed-70531", "permed-56633", "permed-55371", "permed-73606"]}
{"query_id": "topic_341_turn_2", "conversation_id": "topic_341", "turn_id": 2, "query": "Investigating RNF43's E3 ligase role: how does its specific regulation of PAR2 turnover influence colon cancer tumor proliferation and the anti-tumor immune response?", "history": ["RNF43 gene function and pathways in colon cancer initiation and progression"], "ground_truth": ["permed-53530", "permed-70531", "permed-55371", "permed-56633", "permed-89851", "permed-82373", "permed-72043", "permed-91830", "permed-71199", "permed-69025"]}
{"query_id": "topic_341_turn_3", "conversation_id": "topic_341", "turn_id": 3, "query": "Strategies for modulating RNF43 expression in colon cancer: effects on integrated PAR2 and β-catenin signaling, cancer stem cell populations, and overcoming therapeutic resistance within the tumor microenvironment", "history": ["RNF43 gene function and pathways in colon cancer initiation and progression", "Investigating RNF43's E3 ligase role: how does its specific regulation of PAR2 turnover influence colon cancer tumor proliferation and the anti-tumor immune response?"], "ground_truth": ["permed-53530", "permed-82373", "permed-70531", "permed-55371", "permed-64384", "permed-49129", "permed-82057", "permed-56633", "permed-91835", "permed-67157"]}
{"query_id": "topic_341_turn_4", "conversation_id": "topic_341", "turn_id": 4, "query": "Given these genetic and pharmacological modulation strategies, what specific experimental designs would best distinguish between RNF43's direct effects on PAR2/β-catenin signaling versus secondary effects through tumor microenvironment remodeling? I'm particularly interested in the technical implementation - would co-culture systems with immune cells combined with targeted pathway inhibitors provide sufficient mechanistic resolution, or would spatial transcriptomics approaches be necessary to map signaling dynamics while preserving tissue architecture? What validation strategies would confirm the specificity of observed effects?", "history": ["RNF43 gene function and pathways in colon cancer initiation and progression", "Investigating RNF43's E3 ligase role: how does its specific regulation of PAR2 turnover influence colon cancer tumor proliferation and the anti-tumor immune response?", "Strategies for modulating RNF43 expression in colon cancer: effects on integrated PAR2 and β-catenin signaling, cancer stem cell populations, and overcoming therapeutic resistance within the tumor microenvironment"], "ground_truth": ["permed-53530", "permed-12850", "permed-70531", "permed-59009", "permed-68727", "permed-79290", "permed-55371", "permed-84483", "permed-87713", "permed-81053"]}
{"query_id": "topic_342_turn_1", "conversation_id": "topic_342", "turn_id": 1, "query": "Key advancements and applications of Vision Transformers (ViTs) in medical image analysis", "history": [], "ground_truth": ["permed-62534", "permed-55427", "permed-76890", "permed-55064", "permed-61715", "permed-55055", "permed-76892", "permed-53961", "permed-55583", "permed-55054"]}
{"query_id": "topic_342_turn_2", "conversation_id": "topic_342", "turn_id": 2, "query": "Assessing the generalization capabilities of these Vision Transformers across diverse medical imaging modalities and anatomical regions", "history": ["Key advancements and applications of Vision Transformers (ViTs) in medical image analysis"], "ground_truth": ["permed-62534", "permed-76890", "permed-57433", "permed-55064", "permed-55054", "permed-76892", "permed-55055", "permed-55427", "permed-61715", "permed-55583"]}
{"query_id": "topic_342_turn_3", "conversation_id": "topic_342", "turn_id": 3, "query": "Strategies for optimizing self-distillation and masked image modeling in SMIT Vision Transformer pre-training to improve representation transferability, efficiency, and robustness for medical image segmentation with significant pre-train/target data disparities", "history": ["Key advancements and applications of Vision Transformers (ViTs) in medical image analysis", "Assessing the generalization capabilities of these Vision Transformers across diverse medical imaging modalities and anatomical regions"], "ground_truth": ["permed-62534", "permed-62521", "permed-55064", "permed-57433", "permed-62518", "permed-61623", "permed-76892", "permed-59613", "permed-78172", "permed-76893"]}
{"query_id": "topic_342_turn_4", "conversation_id": "topic_342", "turn_id": 4, "query": "Regarding these self-distillation and masked image modeling optimization strategies, what specific architectural modifications to the SMIT ViT encoder-decoder framework were most impactful for handling domain shifts? I'm particularly interested in how you implemented cross-attention mechanisms between teacher-student pathways and whether you employed progressive masking ratios during pre-training. Additionally, what validation metrics beyond segmentation Dice scores did you use to quantitatively assess representation quality before downstream fine-tuning?", "history": ["Key advancements and applications of Vision Transformers (ViTs) in medical image analysis", "Assessing the generalization capabilities of these Vision Transformers across diverse medical imaging modalities and anatomical regions", "Strategies for optimizing self-distillation and masked image modeling in SMIT Vision Transformer pre-training to improve representation transferability, efficiency, and robustness for medical image segmentation with significant pre-train/target data disparities"], "ground_truth": ["permed-62534", "permed-57433", "permed-62521", "permed-67491", "permed-59613", "permed-67488", "permed-61623", "permed-62518", "permed-90519", "permed-76894"]}
{"query_id": "topic_343_turn_1", "conversation_id": "topic_343", "turn_id": 1, "query": "What challenges do pregnant women with asthma face in managing their condition?", "history": [], "ground_truth": ["permed-79854", "permed-66281", "permed-66279", "permed-26883", "permed-34434", "permed-89963", "permed-79853", "permed-87828", "permed-25638", "permed-34435"]}
{"query_id": "topic_343_turn_2", "conversation_id": "topic_343", "turn_id": 2, "query": "How does adherence to prescribed medications like inhaled corticosteroids factor into this challenge?", "history": ["What challenges do pregnant women with asthma face in managing their condition?"], "ground_truth": ["permed-79857", "permed-79855", "permed-75925", "permed-79856", "permed-82497", "permed-79853", "permed-21167", "permed-58626", "permed-81199", "permed-88028"]}
{"query_id": "topic_343_turn_3", "conversation_id": "topic_343", "turn_id": 3, "query": "Given these challenges with medication adherence, what specific strategies could help bridge the gap between pregnant women's perceptions of ICS necessity and their actual usage, particularly for those with mild asthma? How might educational interventions be designed to better align their beliefs about medication safety and efficacy with clinical guidelines?", "history": ["What challenges do pregnant women with asthma face in managing their condition?", "How does adherence to prescribed medications like inhaled corticosteroids factor into this challenge?"], "ground_truth": ["permed-79853", "permed-75925", "permed-79857", "permed-79858", "permed-79854", "permed-66279", "permed-79856", "permed-79855", "permed-65829", "permed-66281"]}
{"query_id": "topic_343_turn_4", "conversation_id": "topic_343", "turn_id": 4, "query": "For these educational interventions targeting necessity beliefs, what specific behavioral change techniques would be most appropriate to incorporate into the intervention design? I'm particularly interested in how we might operationally define and measure shifts in medication necessity beliefs versus concerns - would a validated scale like the Beliefs about Medicines Questionnaire be suitable? What methodological considerations should guide the frequency and delivery mode (e.g., in-person vs digital) of these interventions to maximize engagement while maintaining scientific rigor in measuring adherence outcomes?", "history": ["What challenges do pregnant women with asthma face in managing their condition?", "How does adherence to prescribed medications like inhaled corticosteroids factor into this challenge?", "Given these challenges with medication adherence, what specific strategies could help bridge the gap between pregnant women's perceptions of ICS necessity and their actual usage, particularly for those with mild asthma? How might educational interventions be designed to better align their beliefs about medication safety and efficacy with clinical guidelines?"], "ground_truth": ["permed-89012", "permed-79853", "permed-65672", "permed-65577", "permed-74704", "permed-65673", "permed-75381", "permed-79858", "permed-85586", "permed-90754"]}
{"query_id": "topic_344_turn_1", "conversation_id": "topic_344", "turn_id": 1, "query": "What role does adiponectin play in metabolic processes within the body?", "history": [], "ground_truth": ["permed-51235", "permed-52578", "permed-68260", "permed-82344", "permed-79708", "permed-59030", "permed-53565", "permed-78491", "permed-53563", "permed-92490"]}
{"query_id": "topic_344_turn_2", "conversation_id": "topic_344", "turn_id": 2, "query": "How might variations in this protein impact conditions like metabolic syndrome and atherosclerosis?", "history": ["What role does adiponectin play in metabolic processes within the body?"], "ground_truth": ["permed-72074", "permed-51285", "permed-61982", "permed-79708", "permed-70506", "permed-58881", "permed-74706", "permed-86162", "permed-58973", "permed-22673"]}
{"query_id": "topic_344_turn_3", "conversation_id": "topic_344", "turn_id": 3, "query": "Considering adiponectin's involvement in lipid metabolism, insulin sensitivity, and endothelial function, how could differences in its levels and transport dynamics lead to varying outcomes in metabolic syndrome and atherosclerosis patients? And what therapeutic approaches might target these pathways to prevent or treat these conditions?", "history": ["What role does adiponectin play in metabolic processes within the body?", "How might variations in this protein impact conditions like metabolic syndrome and atherosclerosis?"], "ground_truth": ["permed-79708", "permed-51235", "permed-61982", "permed-53563", "permed-59033", "permed-74706", "permed-70769", "permed-52578", "permed-65189", "permed-58973"]}
{"query_id": "topic_344_turn_4", "conversation_id": "topic_344", "turn_id": 4, "query": "Given these therapeutic approaches targeting adiponectin pathways, what specific experimental designs would best validate their efficacy in clinical models? I'm particularly interested in the statistical power calculations for patient stratification based on adiponectin isoforms, the validation protocols for endothelial function assessments, and the technical considerations for maintaining adiponectin stability during longitudinal studies. How are researchers addressing potential confounding variables when measuring insulin sensitivity improvements in these complex metabolic disease models?", "history": ["What role does adiponectin play in metabolic processes within the body?", "How might variations in this protein impact conditions like metabolic syndrome and atherosclerosis?", "Considering adiponectin's involvement in lipid metabolism, insulin sensitivity, and endothelial function, how could differences in its levels and transport dynamics lead to varying outcomes in metabolic syndrome and atherosclerosis patients? And what therapeutic approaches might target these pathways to prevent or treat these conditions?"], "ground_truth": ["permed-54413", "permed-53559", "permed-79804", "permed-79708", "permed-70685", "permed-82344", "permed-65032", "permed-77203", "permed-61066", "permed-65370"]}
{"query_id": "topic_345_turn_1", "conversation_id": "topic_345", "turn_id": 1, "query": "What is known about the metastatic progression of non-small cell lung cancer (NSCLC) and its treatment options?", "history": [], "ground_truth": ["permed-51770", "permed-56446", "permed-56788", "permed-77505", "permed-47608", "permed-52520", "permed-52521", "permed-21128", "permed-51768", "permed-31595"]}
{"query_id": "topic_345_turn_2", "conversation_id": "topic_345", "turn_id": 2, "query": "How does the nature of metastases, such as being oligometastatic, impact the choice of therapy in this area?", "history": ["What is known about the metastatic progression of non-small cell lung cancer (NSCLC) and its treatment options?"], "ground_truth": ["permed-92532", "permed-51770", "permed-52522", "permed-52525", "permed-52139", "permed-56307", "permed-51768", "permed-73780", "permed-85438", "permed-56534"]}
{"query_id": "topic_345_turn_3", "conversation_id": "topic_345", "turn_id": 3, "query": "How do the biological and molecular features of oligometastatic NSCLC lesions differ from those with widespread metastases, and what does this mean for choosing local ablative therapies alongside systemic treatments?", "history": ["What is known about the metastatic progression of non-small cell lung cancer (NSCLC) and its treatment options?", "How does the nature of metastases, such as being oligometastatic, impact the choice of therapy in this area?"], "ground_truth": ["permed-51770", "permed-92532", "permed-51768", "permed-56788", "permed-52521", "permed-56731", "permed-52522", "permed-77505", "permed-55081", "permed-27170"]}
{"query_id": "topic_345_turn_4", "conversation_id": "topic_345", "turn_id": 4, "query": "When implementing local ablative therapies based on these molecular distinctions, what specific technical protocols are used for tumor sampling and sequencing to ensure accurate oligometastatic classification? I'm particularly interested in how researchers standardize biopsy procedures across multiple lesions and validate sequencing depth requirements to reliably detect the genomic features differentiating oligometastatic from widespread disease, especially when working with limited tissue samples. What quality control metrics are typically implemented throughout this process?", "history": ["What is known about the metastatic progression of non-small cell lung cancer (NSCLC) and its treatment options?", "How does the nature of metastases, such as being oligometastatic, impact the choice of therapy in this area?", "How do the biological and molecular features of oligometastatic NSCLC lesions differ from those with widespread metastases, and what does this mean for choosing local ablative therapies alongside systemic treatments?"], "ground_truth": ["permed-51770", "permed-92532", "permed-54620", "permed-70767", "permed-56046", "permed-56194", "permed-56189", "permed-71798", "permed-82607", "permed-56401"]}
{"query_id": "topic_346_turn_1", "conversation_id": "topic_346", "turn_id": 1, "query": "What impact do environmental factors have on the prevalence of CIAV in poultry populations?", "history": [], "ground_truth": ["permed-79411", "permed-67816", "permed-80752", "permed-78693", "permed-66728", "permed-90558", "permed-80745", "permed-89190", "permed-81847", "permed-84881"]}
{"query_id": "topic_346_turn_2", "conversation_id": "topic_346", "turn_id": 2, "query": "Are farming practices in regions with high CIAV incidence contributing to the emergence of new genotypes, or is it primarily driven by other factors related to this area of study?", "history": ["What impact do environmental factors have on the prevalence of CIAV in poultry populations?"], "ground_truth": ["permed-79411", "permed-52483", "permed-90219", "permed-74041", "permed-85024", "permed-66815", "permed-67007", "permed-87373", "permed-52064", "permed-75078"]}
{"query_id": "topic_346_turn_3", "conversation_id": "topic_346", "turn_id": 3, "query": "Given these environmental factors and farming practices we've discussed, how do they specifically affect both the distribution and mutation rates of the predominant CIAV genotype found in Chinese poultry populations in recent years?", "history": ["What impact do environmental factors have on the prevalence of CIAV in poultry populations?", "Are farming practices in regions with high CIAV incidence contributing to the emergence of new genotypes, or is it primarily driven by other factors related to this area of study?"], "ground_truth": ["permed-79411", "permed-67007", "permed-79412", "permed-22238", "permed-71932", "permed-37825", "permed-80742", "permed-81848", "permed-66728", "permed-67006"]}
{"query_id": "topic_346_turn_4", "conversation_id": "topic_346", "turn_id": 4, "query": "Considering this investigation into how environmental factors and farming practices affect CIAV genotype distribution and mutation rates in Chinese poultry populations, what specific sequencing and phylogenetic analysis methods were employed to track these evolutionary changes? I'm particularly interested in the technical implementation - how did researchers handle viral RNA extraction from field samples, account for potential sequencing artifacts, and validate their genotyping approach? Were there specific quality control measures implemented to ensure the mutation rate calculations accurately reflected true evolutionary changes rather than technical variability?", "history": ["What impact do environmental factors have on the prevalence of CIAV in poultry populations?", "Are farming practices in regions with high CIAV incidence contributing to the emergence of new genotypes, or is it primarily driven by other factors related to this area of study?", "Given these environmental factors and farming practices we've discussed, how do they specifically affect both the distribution and mutation rates of the predominant CIAV genotype found in Chinese poultry populations in recent years?"], "ground_truth": ["permed-79411", "permed-43943", "permed-22826", "permed-22606", "permed-79415", "permed-79417", "permed-22795", "permed-79412", "permed-22828", "permed-22825"]}
{"query_id": "topic_347_turn_1", "conversation_id": "topic_347", "turn_id": 1, "query": "Overview of recent technological innovations transforming ambulance services and emergency medical response systems", "history": [], "ground_truth": ["permed-91926", "permed-66153", "permed-76368", "permed-60490", "permed-9482", "permed-56265", "permed-58626", "permed-38994", "permed-44846", "permed-61615"]}
{"query_id": "topic_347_turn_2", "conversation_id": "topic_347", "turn_id": 2, "query": "Building on these innovations, which specific digital technologies have proven most effective for enhancing ambulance service efficiency and patient care quality in urban settings?", "history": ["Overview of recent technological innovations transforming ambulance services and emergency medical response systems"], "ground_truth": ["permed-55101", "permed-80242", "permed-76368", "permed-88215", "permed-85662", "permed-54365", "permed-52220", "permed-60490", "permed-74380", "permed-25974"]}
{"query_id": "topic_347_turn_3", "conversation_id": "topic_347", "turn_id": 3, "query": "Investigating such effective urban technologies, what is the specific impact of integrated GPS and telemedicine solutions on ambulance efficiency and care quality during health crises in developing cities like Kathmandu, and what are the implications for improving prehospital care in other resource-limited contexts?", "history": ["Overview of recent technological innovations transforming ambulance services and emergency medical response systems", "Building on these innovations, which specific digital technologies have proven most effective for enhancing ambulance service efficiency and patient care quality in urban settings?"], "ground_truth": ["permed-76367", "permed-76368", "permed-44846", "permed-79065", "permed-53985", "permed-44818", "permed-44821", "permed-44765", "permed-61872", "permed-53990"]}
{"query_id": "topic_347_turn_4", "conversation_id": "topic_347", "turn_id": 4, "query": "When studying GPS and telemedicine integration in Kathmandu's ambulances, what specific methodological approaches were used to quantify their impact on response times and care quality? Did researchers employ time-series analysis of dispatch records, structured observational protocols during patient handoffs, or validated instruments like the Prehospital Quality Index? How were confounding variables - such as traffic patterns and provider training levels - controlled for statistically, and what validation methods ensured the reliability of telemedicine diagnoses in these prehospital settings?", "history": ["Overview of recent technological innovations transforming ambulance services and emergency medical response systems", "Building on these innovations, which specific digital technologies have proven most effective for enhancing ambulance service efficiency and patient care quality in urban settings?", "Investigating such effective urban technologies, what is the specific impact of integrated GPS and telemedicine solutions on ambulance efficiency and care quality during health crises in developing cities like Kathmandu, and what are the implications for improving prehospital care in other resource-limited contexts?"], "ground_truth": ["permed-76367", "permed-44818", "permed-44765", "permed-61883", "permed-83091", "permed-53989", "permed-44821", "permed-53990", "permed-91166", "permed-61872"]}
{"query_id": "topic_348_turn_1", "conversation_id": "topic_348", "turn_id": 1, "query": "Glycine's fundamental role in early peptide bond formation under prebiotic conditions", "history": [], "ground_truth": ["permed-77313", "permed-64159", "permed-89441", "permed-64164", "permed-60645", "permed-92667", "permed-53717", "permed-91516", "permed-86708", "permed-90079"]}
{"query_id": "topic_348_turn_2", "conversation_id": "topic_348", "turn_id": 2, "query": "How do environmental factors, specifically humidity, affect this glycine-mediated peptide formation process and the stability of the resulting structures?", "history": ["Glycine's fundamental role in early peptide bond formation under prebiotic conditions"], "ground_truth": ["permed-77314", "permed-77313", "permed-74947", "permed-74945", "permed-74946", "permed-73153", "permed-82821", "permed-82822", "permed-88714", "permed-53308"]}
{"query_id": "topic_348_turn_3", "conversation_id": "topic_348", "turn_id": 3, "query": "Investigating glycine's interaction with amorphous silica surfaces: impact of variable humidity on the aforementioned peptide synthesis pathways and oligomer stability, relevant to prebiotic chemical evolution", "history": ["Glycine's fundamental role in early peptide bond formation under prebiotic conditions", "How do environmental factors, specifically humidity, affect this glycine-mediated peptide formation process and the stability of the resulting structures?"], "ground_truth": ["permed-77313", "permed-60645", "permed-89441", "permed-92667", "permed-77314", "permed-10998", "permed-53306", "permed-80057", "permed-74946", "permed-73153"]}
{"query_id": "topic_348_turn_4", "conversation_id": "topic_348", "turn_id": 4, "query": "Regarding these humidity-controlled experiments with amorphous silica surfaces, what specific analytical techniques were employed to quantify glycine oligomer formation and degradation rates? I'm particularly interested in the temporal resolution of your HPLC-MS methods and how you validated the stability measurements against potential sampling artifacts during extended humidity exposure cycles. Could you also detail the statistical approaches used to distinguish between surface-catalyzed versus solution-phase reaction pathways under these conditions?", "history": ["Glycine's fundamental role in early peptide bond formation under prebiotic conditions", "How do environmental factors, specifically humidity, affect this glycine-mediated peptide formation process and the stability of the resulting structures?", "Investigating glycine's interaction with amorphous silica surfaces: impact of variable humidity on the aforementioned peptide synthesis pathways and oligomer stability, relevant to prebiotic chemical evolution"], "ground_truth": ["permed-77313", "permed-73153", "permed-86678", "permed-74666", "permed-81055", "permed-74652", "permed-53752", "permed-73163", "permed-80898", "permed-66182"]}
{"query_id": "topic_349_turn_1", "conversation_id": "topic_349", "turn_id": 1, "query": "Diagnostic utility of FDG PET/CT in conditions with pleural involvement", "history": [], "ground_truth": ["permed-77478", "permed-21492", "permed-23985", "permed-21133", "permed-5108", "permed-16911", "permed-48461", "permed-48768", "permed-48681", "permed-48442"]}
{"query_id": "topic_349_turn_2", "conversation_id": "topic_349", "turn_id": 2, "query": "Regarding its use in pleural involvement, how does FDG PET/CT help differentiate inflammatory processes (e.g., Langerhans cell histiocytosis) from malignant neoplasms?", "history": ["Diagnostic utility of FDG PET/CT in conditions with pleural involvement"], "ground_truth": ["permed-77478", "permed-48490", "permed-21492", "permed-48461", "permed-23985", "permed-28750", "permed-48565", "permed-48637", "permed-48465", "permed-48492"]}
{"query_id": "topic_349_turn_3", "conversation_id": "topic_349", "turn_id": 3, "query": "Given FDG PET/CT's established differentiation capabilities for these pleural conditions, how can specific metabolic characteristics (e.g., SUV values, heterogeneity indices) be leveraged to refine diagnostic algorithms for distinguishing pleural Langerhans cell histiocytosis from malignant neoplasms?", "history": ["Diagnostic utility of FDG PET/CT in conditions with pleural involvement", "Regarding its use in pleural involvement, how does FDG PET/CT help differentiate inflammatory processes (e.g., Langerhans cell histiocytosis) from malignant neoplasms?"], "ground_truth": ["permed-77478", "permed-60573", "permed-48461", "permed-48718", "permed-21133", "permed-77495", "permed-48490", "permed-48411", "permed-48442", "permed-23985"]}
{"query_id": "topic_349_turn_4", "conversation_id": "topic_349", "turn_id": 4, "query": "Building on this metabolic characterization approach, what specific statistical validation strategies were employed to establish optimal SUV threshold ranges and heterogeneity cutoffs for distinguishing these entities? I'm particularly interested in the methodological details of how ROC curve analysis was implemented, whether machine learning classifiers were validated through cross-validation techniques, and what quality control measures ensured reproducibility across different PET/CT scanner platforms when applying these diagnostic algorithms to pleural lesions.", "history": ["Diagnostic utility of FDG PET/CT in conditions with pleural involvement", "Regarding its use in pleural involvement, how does FDG PET/CT help differentiate inflammatory processes (e.g., Langerhans cell histiocytosis) from malignant neoplasms?", "Given FDG PET/CT's established differentiation capabilities for these pleural conditions, how can specific metabolic characteristics (e.g., SUV values, heterogeneity indices) be leveraged to refine diagnostic algorithms for distinguishing pleural Langerhans cell histiocytosis from malignant neoplasms?"], "ground_truth": ["permed-77495", "permed-61544", "permed-48367", "permed-77629", "permed-48683", "permed-60573", "permed-31559", "permed-48718", "permed-29620", "permed-36426"]}
{"query_id": "topic_350_turn_1", "conversation_id": "topic_350", "turn_id": 1, "query": "What is known about mantle cell lymphoma and its various presentation forms?", "history": [], "ground_truth": ["permed-59448", "permed-71189", "permed-49212", "permed-31590", "permed-18081", "permed-30963", "permed-26641", "permed-68141", "permed-72560", "permed-49417"]}
{"query_id": "topic_350_turn_2", "conversation_id": "topic_350", "turn_id": 2, "query": "Are there any unique challenges associated with diagnosing it when the disease presents outside of typical areas, such as the lymph nodes?", "history": ["What is known about mantle cell lymphoma and its various presentation forms?"], "ground_truth": ["permed-0764", "permed-52643", "permed-62161", "permed-3680", "permed-91407", "permed-2400", "permed-67575", "permed-13804", "permed-68153", "permed-88237"]}
{"query_id": "topic_350_turn_3", "conversation_id": "topic_350", "turn_id": 3, "query": "When MCL first presents with cutaneous lesions instead of typical lymph node involvement, how do its initial clinical manifestations and diagnostic challenges differ from more common presentations? And what specific biomarkers or imaging techniques could help overcome these challenges for earlier and more accurate diagnosis in such cases?", "history": ["What is known about mantle cell lymphoma and its various presentation forms?", "Are there any unique challenges associated with diagnosing it when the disease presents outside of typical areas, such as the lymph nodes?"], "ground_truth": ["permed-59448", "permed-68141", "permed-5438", "permed-15968", "permed-26641", "permed-59444", "permed-59442", "permed-72623", "permed-54739", "permed-13269"]}
{"query_id": "topic_350_turn_4", "conversation_id": "topic_350", "turn_id": 4, "query": "For cutaneous MCL cases where traditional lymph node biopsies aren't indicative, what specific immunohistochemical staining protocols and sequencing approaches would you recommend for validating diagnostic biomarkers? Given the potential for false negatives in skin-limited disease, how should we optimize the technical workflow - from sample processing to molecular analysis - to ensure both sensitivity and specificity? What quality control measures are most critical when implementing these methods in clinical practice?", "history": ["What is known about mantle cell lymphoma and its various presentation forms?", "Are there any unique challenges associated with diagnosing it when the disease presents outside of typical areas, such as the lymph nodes?", "When MCL first presents with cutaneous lesions instead of typical lymph node involvement, how do its initial clinical manifestations and diagnostic challenges differ from more common presentations? And what specific biomarkers or imaging techniques could help overcome these challenges for earlier and more accurate diagnosis in such cases?"], "ground_truth": ["permed-48125", "permed-59448", "permed-59442", "permed-72623", "permed-5438", "permed-77629", "permed-13277", "permed-71180", "permed-72548", "permed-68141"]}
{"query_id": "topic_351_turn_1", "conversation_id": "topic_351", "turn_id": 1, "query": "What role can proteins play in removing uranium from contaminated environments?", "history": [], "ground_truth": ["permed-88015", "permed-78855", "permed-78853", "permed-77285", "permed-66712", "permed-77284", "permed-65325", "permed-90071", "permed-74110", "permed-60955"]}
{"query_id": "topic_351_turn_2", "conversation_id": "topic_351", "turn_id": 2, "query": "How might modifying these proteins, like calmodulin, enhance their ability to bind with uranium?", "history": ["What role can proteins play in removing uranium from contaminated environments?"], "ground_truth": ["permed-78853", "permed-78854", "permed-88015", "permed-51243", "permed-78856", "permed-78855", "permed-71086", "permed-87553", "permed-78128", "permed-86889"]}
{"query_id": "topic_351_turn_3", "conversation_id": "topic_351", "turn_id": 3, "query": "Given these modified calmodulin proteins with enhanced uranyl binding and selectivity, how could they be practically implemented in bioremediation strategies for uranium contamination? What real-world challenges might arise when applying such engineered proteins in environmental cleanup efforts?", "history": ["What role can proteins play in removing uranium from contaminated environments?", "How might modifying these proteins, like calmodulin, enhance their ability to bind with uranium?"], "ground_truth": ["permed-78853", "permed-78854", "permed-88015", "permed-78855", "permed-77284", "permed-51243", "permed-78297", "permed-78856", "permed-76137", "permed-86889"]}
{"query_id": "topic_351_turn_4", "conversation_id": "topic_351", "turn_id": 4, "query": "When implementing these engineered calmodulin proteins in bioremediation systems, what specific experimental protocols would you recommend for validating their uranyl binding efficiency under varying environmental conditions? I'm particularly interested in the analytical techniques for quantifying binding kinetics and the statistical methods for comparing performance across different pH levels, competing ions, and temperature ranges. How would you design quality control measures to ensure reproducible protein functionality in field applications?", "history": ["What role can proteins play in removing uranium from contaminated environments?", "How might modifying these proteins, like calmodulin, enhance their ability to bind with uranium?", "Given these modified calmodulin proteins with enhanced uranyl binding and selectivity, how could they be practically implemented in bioremediation strategies for uranium contamination? What real-world challenges might arise when applying such engineered proteins in environmental cleanup efforts?"], "ground_truth": ["permed-78853", "permed-78854", "permed-51243", "permed-88015", "permed-78856", "permed-87553", "permed-52790", "permed-76137", "permed-58177", "permed-84217"]}
{"query_id": "topic_352_turn_1", "conversation_id": "topic_352", "turn_id": 1, "query": "Efficacy of complementary and alternative medicine in neurorehabilitation for cognitive and motor recovery post-neurologic injury and in dementia patients", "history": [], "ground_truth": ["permed-59836", "permed-66783", "permed-71442", "permed-54856", "permed-52399", "permed-71706", "permed-67923", "permed-63175", "permed-61820", "permed-74214"]}
{"query_id": "topic_352_turn_2", "conversation_id": "topic_352", "turn_id": 2, "query": "Evidence for cognitive enhancement via specific CAM techniques like music therapy and acupuncture for these individuals with neurologic injury or dementia", "history": ["Efficacy of complementary and alternative medicine in neurorehabilitation for cognitive and motor recovery post-neurologic injury and in dementia patients"], "ground_truth": ["permed-59836", "permed-74214", "permed-68380", "permed-66783", "permed-55501", "permed-69748", "permed-52399", "permed-81311", "permed-69571", "permed-71706"]}
{"query_id": "topic_352_turn_3", "conversation_id": "topic_352", "turn_id": 3, "query": "Neurobiological mechanisms of how music therapy and acupuncture promote neural plasticity and cognitive recovery in neurologic injury and dementia, and strategies for integrating these into personalized rehabilitation programs", "history": ["Efficacy of complementary and alternative medicine in neurorehabilitation for cognitive and motor recovery post-neurologic injury and in dementia patients", "Evidence for cognitive enhancement via specific CAM techniques like music therapy and acupuncture for these individuals with neurologic injury or dementia"], "ground_truth": ["permed-59836", "permed-74214", "permed-66427", "permed-44358", "permed-58410", "permed-66783", "permed-69766", "permed-61105", "permed-71442", "permed-43663"]}
{"query_id": "topic_352_turn_4", "conversation_id": "topic_352", "turn_id": 4, "query": "When implementing these neuroplasticity-focused interventions, what specific experimental designs are most appropriate for measuring their efficacy? I'm particularly interested in how researchers control for placebo effects in music therapy trials, what sham acupuncture protocols are validated for neurological populations, and which neuroimaging parameters (like fMRI resting-state connectivity or DTI metrics) serve as optimal secondary endpoints in such rehabilitation studies. Additionally, what statistical approaches best account for the multimodal nature of these interventions when analyzing cognitive outcomes?", "history": ["Efficacy of complementary and alternative medicine in neurorehabilitation for cognitive and motor recovery post-neurologic injury and in dementia patients", "Evidence for cognitive enhancement via specific CAM techniques like music therapy and acupuncture for these individuals with neurologic injury or dementia", "Neurobiological mechanisms of how music therapy and acupuncture promote neural plasticity and cognitive recovery in neurologic injury and dementia, and strategies for integrating these into personalized rehabilitation programs"], "ground_truth": ["permed-59836", "permed-58410", "permed-66427", "permed-73858", "permed-25224", "permed-44358", "permed-54855", "permed-59828", "permed-25569", "permed-7338"]}
{"query_id": "topic_353_turn_1", "conversation_id": "topic_353", "turn_id": 1, "query": "Applications of multi-omics data in elucidating liver disease pathophysiology", "history": [], "ground_truth": ["permed-56676", "permed-53718", "permed-75562", "permed-82373", "permed-57746", "permed-52955", "permed-55581", "permed-55191", "permed-79753", "permed-9873"]}
{"query_id": "topic_353_turn_2", "conversation_id": "topic_353", "turn_id": 2, "query": "Impact of integrating these multi-omics datasets with liver organoid models on deciphering liver disease mechanisms", "history": ["Applications of multi-omics data in elucidating liver disease pathophysiology"], "ground_truth": ["permed-56676", "permed-75562", "permed-57746", "permed-79753", "permed-9782", "permed-83817", "permed-9779", "permed-70055", "permed-53718", "permed-55581"]}
{"query_id": "topic_353_turn_3", "conversation_id": "topic_353", "turn_id": 3, "query": "Computational strategies for integrating multi-omics from liver organoids to resolve molecular disease signatures and identify personalized therapeutic targets", "history": ["Applications of multi-omics data in elucidating liver disease pathophysiology", "Impact of integrating these multi-omics datasets with liver organoid models on deciphering liver disease mechanisms"], "ground_truth": ["permed-53718", "permed-56676", "permed-75562", "permed-82373", "permed-55581", "permed-57746", "permed-56825", "permed-53719", "permed-57638", "permed-56692"]}
{"query_id": "topic_353_turn_4", "conversation_id": "topic_353", "turn_id": 4, "query": "When implementing these computational integration strategies for liver organoid multi-omics data, what specific statistical frameworks and validation protocols are most appropriate for distinguishing true biological signatures from technical artifacts? I'm particularly interested in how batch effect correction methods should be adapted for organoid culture variations, and what statistical power calculations are needed to ensure robust biomarker discovery given the typical sample sizes in these personalized medicine approaches.", "history": ["Applications of multi-omics data in elucidating liver disease pathophysiology", "Impact of integrating these multi-omics datasets with liver organoid models on deciphering liver disease mechanisms", "Computational strategies for integrating multi-omics from liver organoids to resolve molecular disease signatures and identify personalized therapeutic targets"], "ground_truth": ["permed-56676", "permed-67918", "permed-59118", "permed-55581", "permed-53428", "permed-75562", "permed-66762", "permed-64503", "permed-55579", "permed-57638"]}
{"query_id": "topic_354_turn_1", "conversation_id": "topic_354", "turn_id": 1, "query": "What impact does cardiovascular screening have on older adults' health outcomes?", "history": [], "ground_truth": ["permed-80272", "permed-52171", "permed-88759", "permed-2727", "permed-32195", "permed-78477", "permed-57148", "permed-54810", "permed-77305", "permed-78471"]}
{"query_id": "topic_354_turn_2", "conversation_id": "topic_354", "turn_id": 2, "query": "Are there specific factors that make this type of screening more or less effective in improving long-term quality of life?", "history": ["What impact does cardiovascular screening have on older adults' health outcomes?"], "ground_truth": ["permed-78477", "permed-86796", "permed-61343", "permed-81597", "permed-78472", "permed-80272", "permed-71990", "permed-52386", "permed-80274", "permed-65593"]}
{"query_id": "topic_354_turn_3", "conversation_id": "topic_354", "turn_id": 3, "query": "Given these factors affecting screening effectiveness, how do long-term health outcomes and quality of life compare between older men who receive comprehensive cardiovascular screening versus those who don't—particularly when accounting for differences in age, pre-existing conditions, and lifestyle?", "history": ["What impact does cardiovascular screening have on older adults' health outcomes?", "Are there specific factors that make this type of screening more or less effective in improving long-term quality of life?"], "ground_truth": ["permed-80272", "permed-32999", "permed-78477", "permed-65593", "permed-61343", "permed-86796", "permed-71641", "permed-52171", "permed-80274", "permed-85118"]}
{"query_id": "topic_354_turn_4", "conversation_id": "topic_354", "turn_id": 4, "query": "When comparing these two cohorts longitudinally, what specific statistical methods would you recommend for handling the confounding variables mentioned—particularly age stratification, pre-existing condition severity scoring, and lifestyle covariate adjustment? I'm interested in whether propensity score matching or multivariable regression would better address selection bias, and what validation approaches ensure the robustness of these comparative effectiveness results over extended follow-up periods.", "history": ["What impact does cardiovascular screening have on older adults' health outcomes?", "Are there specific factors that make this type of screening more or less effective in improving long-term quality of life?", "Given these factors affecting screening effectiveness, how do long-term health outcomes and quality of life compare between older men who receive comprehensive cardiovascular screening versus those who don't—particularly when accounting for differences in age, pre-existing conditions, and lifestyle?"], "ground_truth": ["permed-51746", "permed-79199", "permed-35363", "permed-79200", "permed-51749", "permed-80275", "permed-35841", "permed-37829", "permed-52647", "permed-75649"]}
{"query_id": "topic_355_turn_1", "conversation_id": "topic_355", "turn_id": 1, "query": "What's currently known about how COVID-19 affects different populations over time?", "history": [], "ground_truth": ["permed-68512", "permed-52338", "permed-71998", "permed-58448", "permed-51264", "permed-65400", "permed-84526", "permed-65719", "permed-85695", "permed-73385"]}
{"query_id": "topic_355_turn_2", "conversation_id": "topic_355", "turn_id": 2, "query": "How are advancements in treatments and vaccinations impacting the trends we see in this area?", "history": ["What's currently known about how COVID-19 affects different populations over time?"], "ground_truth": ["permed-13679", "permed-68153", "permed-79697", "permed-69927", "permed-51926", "permed-13680", "permed-65719", "permed-21612", "permed-50971", "permed-68512"]}
{"query_id": "topic_355_turn_3", "conversation_id": "topic_355", "turn_id": 3, "query": "How do viral mutations, combined with these evolving treatments and vaccines, affect COVID-19's changing patterns—like who gets sick, how severe cases are, and long-term outcomes—especially for high-risk groups nationally?", "history": ["What's currently known about how COVID-19 affects different populations over time?", "How are advancements in treatments and vaccinations impacting the trends we see in this area?"], "ground_truth": ["permed-52338", "permed-22838", "permed-63550", "permed-22629", "permed-51928", "permed-54091", "permed-67019", "permed-61929", "permed-69927", "permed-27151"]}
{"query_id": "topic_355_turn_4", "conversation_id": "topic_355", "turn_id": 4, "query": "Considering this complex interaction between mutations and interventions, what specific statistical modeling approaches are researchers using to disentangle their relative contributions to epidemiological outcomes? I'm particularly interested in how they're handling time-varying covariates like vaccination rates and variant prevalence in longitudinal analyses, and what validation strategies ensure these models remain robust when projecting future scenarios for vulnerable populations. Are there established frameworks for quantifying uncertainty in these dynamic systems?", "history": ["What's currently known about how COVID-19 affects different populations over time?", "How are advancements in treatments and vaccinations impacting the trends we see in this area?", "How do viral mutations, combined with these evolving treatments and vaccines, affect COVID-19's changing patterns—like who gets sick, how severe cases are, and long-term outcomes—especially for high-risk groups nationally?"], "ground_truth": ["permed-54099", "permed-54087", "permed-54090", "permed-61929", "permed-57909", "permed-71715", "permed-63550", "permed-54928", "permed-61936", "permed-64259"]}
{"query_id": "topic_356_turn_1", "conversation_id": "topic_356", "turn_id": 1, "query": "Overview of common surgical approaches for tumors invading the jugular foramen", "history": [], "ground_truth": ["permed-77726", "permed-56525", "permed-92093", "permed-54465", "permed-77728", "permed-87737", "permed-59570", "permed-56092", "permed-43473", "permed-79311"]}
{"query_id": "topic_356_turn_2", "conversation_id": "topic_356", "turn_id": 2, "query": "Considering these common surgical approaches, how does tumor invasion extent into surrounding structures influence the selection criteria for jugular foramen tumors?", "history": ["Overview of common surgical approaches for tumors invading the jugular foramen"], "ground_truth": ["permed-77726", "permed-54465", "permed-87318", "permed-77728", "permed-72721", "permed-58906", "permed-2583", "permed-74295", "permed-87737", "permed-15001"]}
{"query_id": "topic_356_turn_3", "conversation_id": "topic_356", "turn_id": 3, "query": "Given tumor invasion extent considerations for jugular foramen cases, what specific anatomical and clinical factors determine the choice between a modified retrosigmoid infra-jugular approach and other surgical options?", "history": ["Overview of common surgical approaches for tumors invading the jugular foramen", "Considering these common surgical approaches, how does tumor invasion extent into surrounding structures influence the selection criteria for jugular foramen tumors?"], "ground_truth": ["permed-77726", "permed-54465", "permed-77728", "permed-87737", "permed-54457", "permed-87318", "permed-72721", "permed-85597", "permed-74295", "permed-50713"]}
{"query_id": "topic_356_turn_4", "conversation_id": "topic_356", "turn_id": 4, "query": "When implementing the modified retrosigmoid infra-jugular approach based on these anatomical factors, what specific intraoperative monitoring protocols and technical modifications do surgeons employ to preserve lower cranial nerve function? I'm particularly interested in how they adapt the surgical technique when dealing with varying degrees of venous plexus invasion and whether there are standardized neurophysiological monitoring setups used to guide the extent of jugular bulb resection while maintaining functional outcomes.", "history": ["Overview of common surgical approaches for tumors invading the jugular foramen", "Considering these common surgical approaches, how does tumor invasion extent into surrounding structures influence the selection criteria for jugular foramen tumors?", "Given tumor invasion extent considerations for jugular foramen cases, what specific anatomical and clinical factors determine the choice between a modified retrosigmoid infra-jugular approach and other surgical options?"], "ground_truth": ["permed-77726", "permed-76790", "permed-71871", "permed-76788", "permed-18526", "permed-47041", "permed-11623", "permed-10700", "permed-11385", "permed-32414"]}
{"query_id": "topic_357_turn_1", "conversation_id": "topic_357", "turn_id": 1, "query": "What role can graphene oxide nanoparticles play in developing more environmentally friendly pesticides?", "history": [], "ground_truth": ["permed-79252", "permed-84113", "permed-74108", "permed-51163", "permed-89262", "permed-51154", "permed-77681", "permed-81121", "permed-79819", "permed-72999"]}
{"query_id": "topic_357_turn_2", "conversation_id": "topic_357", "turn_id": 2, "query": "How can analyzing the binding mechanisms of pesticides to these nanoparticle hybrids, using techniques like DLS, help optimize their design?", "history": ["What role can graphene oxide nanoparticles play in developing more environmentally friendly pesticides?"], "ground_truth": ["permed-79252", "permed-89262", "permed-77681", "permed-77378", "permed-74108", "permed-66257", "permed-79260", "permed-51320", "permed-84803", "permed-88784"]}
{"query_id": "topic_357_turn_3", "conversation_id": "topic_357", "turn_id": 3, "query": "Given these insights from DLS and zeta-potential analysis on pesticide binding to GO-nanoparticle hybrids, how can we apply them to optimize the design of more environmentally friendly pesticides—specifically to reduce non-target adsorption and improve biodegradability? Additionally, what new methods or modifications to existing techniques could help us better predict how these pesticide-nanomaterial complexes will behave and move through aquatic environments?", "history": ["What role can graphene oxide nanoparticles play in developing more environmentally friendly pesticides?", "How can analyzing the binding mechanisms of pesticides to these nanoparticle hybrids, using techniques like DLS, help optimize their design?"], "ground_truth": ["permed-79252", "permed-74108", "permed-77681", "permed-66257", "permed-84113", "permed-77375", "permed-89262", "permed-77378", "permed-90362", "permed-80536"]}
{"query_id": "topic_357_turn_4", "conversation_id": "topic_357", "turn_id": 4, "query": "Following this approach to optimize pesticide-nanomaterial complexes, what specific statistical modeling techniques would you employ to correlate the DLS and zeta-potential parameters with environmental fate parameters? Would multiple regression analysis or principal component analysis better predict the relationships between nanoparticle surface characteristics and observed biodegradation rates? Additionally, what experimental controls and validation protocols should we implement to ensure the statistical models accurately reflect real-world aquatic system behavior?", "history": ["What role can graphene oxide nanoparticles play in developing more environmentally friendly pesticides?", "How can analyzing the binding mechanisms of pesticides to these nanoparticle hybrids, using techniques like DLS, help optimize their design?", "Given these insights from DLS and zeta-potential analysis on pesticide binding to GO-nanoparticle hybrids, how can we apply them to optimize the design of more environmentally friendly pesticides—specifically to reduce non-target adsorption and improve biodegradability? Additionally, what new methods or modifications to existing techniques could help us better predict how these pesticide-nanomaterial complexes will behave and move through aquatic environments?"], "ground_truth": ["permed-80536", "permed-79252", "permed-66257", "permed-60909", "permed-51159", "permed-78319", "permed-59155", "permed-79363", "permed-65820", "permed-92406"]}
{"query_id": "topic_358_turn_1", "conversation_id": "topic_358", "turn_id": 1, "query": "Recent advancements in materials for implant-retained mandibular overdentures", "history": [], "ground_truth": ["permed-75132", "permed-87816", "permed-75133", "permed-75232", "permed-75130", "permed-75208", "permed-85086", "permed-75126", "permed-89925", "permed-75134"]}
{"query_id": "topic_358_turn_2", "conversation_id": "topic_358", "turn_id": 2, "query": "Impact of these newer materials on durability and maintenance requirements of implant overdenture attachment systems, specifically Novaloc versus older designs", "history": ["Recent advancements in materials for implant-retained mandibular overdentures"], "ground_truth": ["permed-75132", "permed-75130", "permed-89925", "permed-87816", "permed-75126", "permed-75140", "permed-75134", "permed-75148", "permed-83111", "permed-83117"]}
{"query_id": "topic_358_turn_3", "conversation_id": "topic_358", "turn_id": 3, "query": "Long-term biomechanical performance, wear resistance, and maintenance of Novaloc vs Locator with newer overdenture materials: implications for longevity and clinical decision-making", "history": ["Recent advancements in materials for implant-retained mandibular overdentures", "Impact of these newer materials on durability and maintenance requirements of implant overdenture attachment systems, specifically Novaloc versus older designs"], "ground_truth": ["permed-75132", "permed-75130", "permed-83111", "permed-89925", "permed-52410", "permed-51487", "permed-91508", "permed-87816", "permed-75136", "permed-75126"]}
{"query_id": "topic_358_turn_4", "conversation_id": "topic_358", "turn_id": 4, "query": "When comparing the long-term biomechanical performance of Novaloc versus Locator systems, what specific wear testing protocols and quantitative metrics were used to evaluate material degradation? How did the study design account for variables like cyclic loading conditions and oral environment simulation? Were there standardized statistical methods for comparing wear rates between attachment systems, and what quality control measures ensured reproducibility across testing batches?", "history": ["Recent advancements in materials for implant-retained mandibular overdentures", "Impact of these newer materials on durability and maintenance requirements of implant overdenture attachment systems, specifically Novaloc versus older designs", "Long-term biomechanical performance, wear resistance, and maintenance of Novaloc vs Locator with newer overdenture materials: implications for longevity and clinical decision-making"], "ground_truth": ["permed-75132", "permed-75130", "permed-51487", "permed-89925", "permed-51481", "permed-64628", "permed-75148", "permed-19593", "permed-83475", "permed-40485"]}
{"query_id": "topic_359_turn_1", "conversation_id": "topic_359", "turn_id": 1, "query": "What role does social interaction play in the development and maintenance of Obsessive-Compulsive Personality Disorder (OCPD)?", "history": [], "ground_truth": ["permed-79626", "permed-81387", "permed-81389", "permed-79628", "permed-74464", "permed-69518", "permed-52241", "permed-52232", "permed-81388", "permed-69465"]}
{"query_id": "topic_359_turn_2", "conversation_id": "topic_359", "turn_id": 2, "query": "How do maladaptive coping strategies impact this condition, particularly in relation to social anxiety aspects of it?", "history": ["What role does social interaction play in the development and maintenance of Obsessive-Compulsive Personality Disorder (OCPD)?"], "ground_truth": ["permed-75160", "permed-60980", "permed-62866", "permed-65492", "permed-79626", "permed-69518", "permed-79608", "permed-91229", "permed-86363", "permed-62859"]}
{"query_id": "topic_359_turn_3", "conversation_id": "topic_359", "turn_id": 3, "query": "Given how social interaction anxiety and maladaptive coping strategies shape OCPD traits, how do these factors affect treatment outcomes, and what tailored interventions could address them to enhance therapy effectiveness?", "history": ["What role does social interaction play in the development and maintenance of Obsessive-Compulsive Personality Disorder (OCPD)?", "How do maladaptive coping strategies impact this condition, particularly in relation to social anxiety aspects of it?"], "ground_truth": ["permed-79626", "permed-84720", "permed-88164", "permed-69772", "permed-67194", "permed-75932", "permed-84721", "permed-79608", "permed-74464", "permed-77919"]}
{"query_id": "topic_359_turn_4", "conversation_id": "topic_359", "turn_id": 4, "query": "When implementing these tailored interventions for OCPD treatment, what specific methodological approaches are used to measure their differential effectiveness? I'm particularly interested in the experimental design—are researchers using randomized controlled trials with active comparators, and what specific instruments or protocols are employed to quantify changes in both social interaction anxiety and maladaptive coping strategies throughout the intervention period? Additionally, how do you statistically control for comorbidities while ensuring measurement validity across different assessment timepoints?", "history": ["What role does social interaction play in the development and maintenance of Obsessive-Compulsive Personality Disorder (OCPD)?", "How do maladaptive coping strategies impact this condition, particularly in relation to social anxiety aspects of it?", "Given how social interaction anxiety and maladaptive coping strategies shape OCPD traits, how do these factors affect treatment outcomes, and what tailored interventions could address them to enhance therapy effectiveness?"], "ground_truth": ["permed-79626", "permed-50505", "permed-81387", "permed-69772", "permed-88164", "permed-50956", "permed-82573", "permed-60044", "permed-52241", "permed-75932"]}
{"query_id": "topic_360_turn_1", "conversation_id": "topic_360", "turn_id": 1, "query": "Surgical management options for critical anterior glenoid bone loss (>25%) in recurrent shoulder instability", "history": [], "ground_truth": ["permed-76643", "permed-82487", "permed-76638", "permed-76641", "permed-71120", "permed-76640", "permed-76639", "permed-60116", "permed-76642", "permed-59480"]}
{"query_id": "topic_360_turn_2", "conversation_id": "topic_360", "turn_id": 2, "query": "Evaluating these management options for critical anterior glenoid bone loss: comparative effectiveness of arthroscopic (e.g., free bone block) vs. open surgical techniques.", "history": ["Surgical management options for critical anterior glenoid bone loss (>25%) in recurrent shoulder instability"], "ground_truth": ["permed-76638", "permed-76643", "permed-76639", "permed-59480", "permed-76642", "permed-59673", "permed-60258", "permed-76640", "permed-82487", "permed-76641"]}
{"query_id": "topic_360_turn_3", "conversation_id": "topic_360", "turn_id": 3, "query": "Latarjet vs. arthroscopic free bone block with dynamic anterior stabilization for >25% anterior glenoid bone loss: long-term biomechanical stability, patient-reported outcomes, and surgical decision factors.", "history": ["Surgical management options for critical anterior glenoid bone loss (>25%) in recurrent shoulder instability", "Evaluating these management options for critical anterior glenoid bone loss: comparative effectiveness of arthroscopic (e.g., free bone block) vs. open surgical techniques."], "ground_truth": ["permed-76638", "permed-76639", "permed-76640", "permed-76643", "permed-82487", "permed-59480", "permed-76641", "permed-76642", "permed-76645", "permed-74280"]}
{"query_id": "topic_360_turn_4", "conversation_id": "topic_360", "turn_id": 4, "query": "Regarding this comparison between Latarjet and arthroscopic free bone block with dynamic anterior stabilization, what specific intraoperative measurement protocols and validation techniques were used to quantify postoperative glenoid bone restoration and track graft integration over time? I'm particularly interested in how researchers standardized CT or 3D imaging analyses across multiple centers to ensure consistent assessment of graft position, union rates, and any subsequent resorption in these long-term biomechanical studies.", "history": ["Surgical management options for critical anterior glenoid bone loss (>25%) in recurrent shoulder instability", "Evaluating these management options for critical anterior glenoid bone loss: comparative effectiveness of arthroscopic (e.g., free bone block) vs. open surgical techniques.", "Latarjet vs. arthroscopic free bone block with dynamic anterior stabilization for >25% anterior glenoid bone loss: long-term biomechanical stability, patient-reported outcomes, and surgical decision factors."], "ground_truth": ["permed-76638", "permed-76639", "permed-76640", "permed-82487", "permed-76642", "permed-64559", "permed-59480", "permed-64553", "permed-76643", "permed-85563"]}
{"query_id": "topic_361_turn_1", "conversation_id": "topic_361", "turn_id": 1, "query": "What role do miRNAs play in the interaction between SARS-CoV-2 and host cellular processes?", "history": [], "ground_truth": ["permed-59684", "permed-71615", "permed-82371", "permed-69959", "permed-67801", "permed-54185", "permed-64683", "permed-83416", "permed-67020", "permed-70103"]}
{"query_id": "topic_361_turn_2", "conversation_id": "topic_361", "turn_id": 2, "query": "How might variations in miRNA coding potential across different COVID-19 variants impact this interaction, particularly in terms of immune response?", "history": ["What role do miRNAs play in the interaction between SARS-CoV-2 and host cellular processes?"], "ground_truth": ["permed-82371", "permed-82372", "permed-59684", "permed-86579", "permed-87053", "permed-64690", "permed-55488", "permed-53378", "permed-64685", "permed-67799"]}
{"query_id": "topic_361_turn_3", "conversation_id": "topic_361", "turn_id": 3, "query": "Given these differences in miRNA coding potential between Delta and Omicron variants, how might they specifically affect the virus-host interaction, particularly in immune response modulation and potential cross-talk with other infections or chronic conditions like diabetes and cardiovascular diseases? Building on this, what therapeutic approaches could target these miRNAs or their pathways to reduce COVID-19 severity, especially in vulnerable populations with such comorbidities?", "history": ["What role do miRNAs play in the interaction between SARS-CoV-2 and host cellular processes?", "How might variations in miRNA coding potential across different COVID-19 variants impact this interaction, particularly in terms of immune response?"], "ground_truth": ["permed-82371", "permed-65773", "permed-82372", "permed-59684", "permed-53460", "permed-55489", "permed-51928", "permed-70147", "permed-53450", "permed-59811"]}
{"query_id": "topic_361_turn_4", "conversation_id": "topic_361", "turn_id": 4, "query": "Following these therapeutic approaches targeting miRNA pathways, what specific in vitro experimental protocols would best validate miRNA-virus interactions across variants? I'm particularly interested in methodological details for dual-luciferase reporter assays to confirm miRNA binding specificity, optimal transfection strategies for primary human cells from diabetic patients, and appropriate statistical power calculations for detecting differential expression patterns in comorbid versus healthy controls. How should we standardize RNA extraction protocols across different sample types to ensure reproducible qPCR quantification of these subtle miRNA changes?", "history": ["What role do miRNAs play in the interaction between SARS-CoV-2 and host cellular processes?", "How might variations in miRNA coding potential across different COVID-19 variants impact this interaction, particularly in terms of immune response?", "Given these differences in miRNA coding potential between Delta and Omicron variants, how might they specifically affect the virus-host interaction, particularly in immune response modulation and potential cross-talk with other infections or chronic conditions like diabetes and cardiovascular diseases? Building on this, what therapeutic approaches could target these miRNAs or their pathways to reduce COVID-19 severity, especially in vulnerable populations with such comorbidities?"], "ground_truth": ["permed-71613", "permed-56366", "permed-53732", "permed-72244", "permed-30392", "permed-91565", "permed-71767", "permed-71615", "permed-50621", "permed-30220"]}
{"query_id": "topic_362_turn_1", "conversation_id": "topic_362", "turn_id": 1, "query": "Impact of psychological resilience on disaster response effectiveness among healthcare professionals", "history": [], "ground_truth": ["permed-75160", "permed-55520", "permed-84562", "permed-69684", "permed-65343", "permed-55969", "permed-65869", "permed-55526", "permed-88661", "permed-54761"]}
{"query_id": "topic_362_turn_2", "conversation_id": "topic_362", "turn_id": 2, "query": "Effectiveness of targeted training in these psychological resilience principles for improving nurse performance in high-stress disaster environments", "history": ["Impact of psychological resilience on disaster response effectiveness among healthcare professionals"], "ground_truth": ["permed-75160", "permed-51559", "permed-62859", "permed-55526", "permed-51973", "permed-67553", "permed-55520", "permed-65708", "permed-88661", "permed-84374"]}
{"query_id": "topic_362_turn_3", "conversation_id": "topic_362", "turn_id": 3, "query": "Long-term impact of combined resilience and advanced disaster-specific education for nurses on mental health, leadership, and community resilience to emerging biological and chemical threats", "history": ["Impact of psychological resilience on disaster response effectiveness among healthcare professionals", "Effectiveness of targeted training in these psychological resilience principles for improving nurse performance in high-stress disaster environments"], "ground_truth": ["permed-65708", "permed-55526", "permed-51973", "permed-62859", "permed-77259", "permed-75160", "permed-84562", "permed-44842", "permed-69894", "permed-55520"]}
{"query_id": "topic_362_turn_4", "conversation_id": "topic_362", "turn_id": 4, "query": "For the combined resilience and disaster education intervention, what specific longitudinal assessment methods were employed to track changes in mental health outcomes and leadership competencies over time? Were standardized psychometric scales used consistently across measurement points, and how did the methodology account for potential attrition bias in long-term follow-up while maintaining data comparability between intervention and control groups?", "history": ["Impact of psychological resilience on disaster response effectiveness among healthcare professionals", "Effectiveness of targeted training in these psychological resilience principles for improving nurse performance in high-stress disaster environments", "Long-term impact of combined resilience and advanced disaster-specific education for nurses on mental health, leadership, and community resilience to emerging biological and chemical threats"], "ground_truth": ["permed-58487", "permed-51076", "permed-57576", "permed-81306", "permed-54761", "permed-65575", "permed-69975", "permed-84504", "permed-62316", "permed-65708"]}
{"query_id": "topic_363_turn_1", "conversation_id": "topic_363", "turn_id": 1, "query": "How can design principles improve healthcare system resilience?", "history": [], "ground_truth": ["permed-91926", "permed-53018", "permed-62737", "permed-66153", "permed-53888", "permed-55180", "permed-53887", "permed-67357", "permed-70065", "permed-72896"]}
{"query_id": "topic_363_turn_2", "conversation_id": "topic_363", "turn_id": 2, "query": "Does incorporating human-centered design into nursing teams enhance this resilience, especially with rapid technological changes?", "history": ["How can design principles improve healthcare system resilience?"], "ground_truth": ["permed-78653", "permed-70245", "permed-54001", "permed-51973", "permed-74380", "permed-69565", "permed-80198", "permed-78648", "permed-65750", "permed-78647"]}
{"query_id": "topic_363_turn_3", "conversation_id": "topic_363", "turn_id": 3, "query": "Given these discussions, how exactly does combining human-centered design with the existing trust dynamics in nursing teams boost healthcare systems' adaptability and resilience amid rapid tech changes and shifting patient needs? And what practical strategies could help embed these principles effectively into healthcare professionals' training and ongoing development?", "history": ["How can design principles improve healthcare system resilience?", "Does incorporating human-centered design into nursing teams enhance this resilience, especially with rapid technological changes?"], "ground_truth": ["permed-78653", "permed-70245", "permed-69565", "permed-52116", "permed-69805", "permed-53975", "permed-78654", "permed-74380", "permed-69907", "permed-78647"]}
{"query_id": "topic_363_turn_4", "conversation_id": "topic_363", "turn_id": 4, "query": "Given these proposed training strategies, could you elaborate on the specific evaluation metrics and longitudinal study designs that would best measure the effectiveness of human-centered design integration? I'm particularly interested in how researchers might quantitatively assess changes in team adaptability metrics and resilience indicators while controlling for confounding variables like workplace environment differences. What statistical approaches would be appropriate for analyzing the relationship between design training interventions and observed resilience outcomes in complex healthcare settings?", "history": ["How can design principles improve healthcare system resilience?", "Does incorporating human-centered design into nursing teams enhance this resilience, especially with rapid technological changes?", "Given these discussions, how exactly does combining human-centered design with the existing trust dynamics in nursing teams boost healthcare systems' adaptability and resilience amid rapid tech changes and shifting patient needs? And what practical strategies could help embed these principles effectively into healthcare professionals' training and ongoing development?"], "ground_truth": ["permed-55526", "permed-69975", "permed-58486", "permed-75050", "permed-55589", "permed-88661", "permed-85767", "permed-85811", "permed-53977", "permed-61960"]}
{"query_id": "topic_364_turn_1", "conversation_id": "topic_364", "turn_id": 1, "query": "What methods are commonly used for trace gas detection in environmental monitoring?", "history": [], "ground_truth": ["permed-88799", "permed-77141", "permed-77926", "permed-77140", "permed-87793", "permed-88798", "permed-84158", "permed-87550", "permed-73272", "permed-88796"]}
{"query_id": "topic_364_turn_2", "conversation_id": "topic_364", "turn_id": 2, "query": "How effective is the Hilbert transform-based demodulation method compared to other techniques in this area?", "history": ["What methods are commonly used for trace gas detection in environmental monitoring?"], "ground_truth": ["permed-79093", "permed-83625", "permed-56264", "permed-72752", "permed-74272", "permed-72754", "permed-74274", "permed-83433", "permed-55123", "permed-73117"]}
{"query_id": "topic_364_turn_3", "conversation_id": "topic_364", "turn_id": 3, "query": "Given the effectiveness of Hilbert transform-based demodulation in TDLAS for trace gas detection, how could integrating advanced signal processing techniques like machine learning further optimize its performance to achieve more accurate and robust measurements under highly variable environmental conditions?", "history": ["What methods are commonly used for trace gas detection in environmental monitoring?", "How effective is the Hilbert transform-based demodulation method compared to other techniques in this area?"], "ground_truth": ["permed-79093", "permed-77142", "permed-83625", "permed-63949", "permed-77141", "permed-73314", "permed-55123", "permed-89031", "permed-74274", "permed-74272"]}
{"query_id": "topic_364_turn_4", "conversation_id": "topic_364", "turn_id": 4, "query": "When integrating machine learning with Hilbert transform-based demodulation for TDLAS signal processing, what specific neural network architectures or ensemble methods would you recommend for handling the non-stationary noise characteristics typical of field environments? How should the training datasets be structured to account for environmental variability while maintaining model generalizability, and what validation protocols would ensure these hybrid methods outperform traditional signal processing approaches in real-world deployment?", "history": ["What methods are commonly used for trace gas detection in environmental monitoring?", "How effective is the Hilbert transform-based demodulation method compared to other techniques in this area?", "Given the effectiveness of Hilbert transform-based demodulation in TDLAS for trace gas detection, how could integrating advanced signal processing techniques like machine learning further optimize its performance to achieve more accurate and robust measurements under highly variable environmental conditions?"], "ground_truth": ["permed-79093", "permed-83625", "permed-73950", "permed-77142", "permed-83433", "permed-75254", "permed-72752", "permed-55578", "permed-91954", "permed-73340"]}
{"query_id": "topic_365_turn_1", "conversation_id": "topic_365", "turn_id": 1, "query": "Defining the role and potential of nature-inspired analogies in shaping community-based healthcare interventions", "history": [], "ground_truth": ["permed-66153", "permed-91926", "permed-75160", "permed-69418", "permed-70065", "permed-69635", "permed-91814", "permed-61615", "permed-66148", "permed-67553"]}
{"query_id": "topic_365_turn_2", "conversation_id": "topic_365", "turn_id": 2, "query": "Building on these nature-inspired analogies, how can the plant growth analogy specifically provide insights for post-pandemic bioethics and community well-being?", "history": ["Defining the role and potential of nature-inspired analogies in shaping community-based healthcare interventions"], "ground_truth": ["permed-67610", "permed-53040", "permed-72675", "permed-74860", "permed-74783", "permed-53035", "permed-54375", "permed-53039", "permed-53034", "permed-53038"]}
{"query_id": "topic_365_turn_3", "conversation_id": "topic_365", "turn_id": 3, "query": "Operationalizing the plant growth analogy: Frameworks and strategies for equitable post-pandemic community bioethics interventions and fostering collective well-being.", "history": ["Defining the role and potential of nature-inspired analogies in shaping community-based healthcare interventions", "Building on these nature-inspired analogies, how can the plant growth analogy specifically provide insights for post-pandemic bioethics and community well-being?"], "ground_truth": ["permed-67610", "permed-74783", "permed-74860", "permed-53034", "permed-54375", "permed-53039", "permed-53040", "permed-53035", "permed-72675", "permed-74859"]}
{"query_id": "topic_365_turn_4", "conversation_id": "topic_365", "turn_id": 4, "query": "When implementing these frameworks for community bioethics interventions, what specific methodological approaches were used to evaluate their equitable distribution? I'm particularly interested in how you operationalized metrics for collective well-being - did you employ longitudinal mixed-methods designs, and what statistical validation strategies ensured the reliability of your equity measurements across different community strata? Also, how were participatory action research components systematically integrated into the intervention protocols to maintain methodological rigor while honoring community voices?", "history": ["Defining the role and potential of nature-inspired analogies in shaping community-based healthcare interventions", "Building on these nature-inspired analogies, how can the plant growth analogy specifically provide insights for post-pandemic bioethics and community well-being?", "Operationalizing the plant growth analogy: Frameworks and strategies for equitable post-pandemic community bioethics interventions and fostering collective well-being."], "ground_truth": ["permed-65625", "permed-69887", "permed-55979", "permed-90782", "permed-65795", "permed-52380", "permed-67610", "permed-91392", "permed-65837", "permed-53060"]}
{"query_id": "topic_366_turn_1", "conversation_id": "topic_366", "turn_id": 1, "query": "What role does presynaptic active zone plasticity play in aging and brain function?", "history": [], "ground_truth": ["permed-72143", "permed-82337", "permed-53613", "permed-53611", "permed-78085", "permed-54289", "permed-82338", "permed-88517", "permed-79915", "permed-53614"]}
{"query_id": "topic_366_turn_2", "conversation_id": "topic_366", "turn_id": 2, "query": "How might changes in this process impact an organism's ability to adapt to environmental stressors over time?", "history": ["What role does presynaptic active zone plasticity play in aging and brain function?"], "ground_truth": ["permed-60604", "permed-59341", "permed-53709", "permed-59318", "permed-75160", "permed-76052", "permed-90134", "permed-60608", "permed-52055", "permed-82651"]}
{"query_id": "topic_366_turn_3", "conversation_id": "topic_366", "turn_id": 3, "query": "Given that presynaptic active zone plasticity (PreScale) modulates sleep, longevity, and memory in early aging Drosophila, how might its temporal dynamics interact with circadian rhythms and neuroendocrine signaling to shape the brain's adaptive responses to environmental and metabolic stressors across the lifespan? Additionally, what molecular mechanisms could explain how spermidine supplementation and pharmacologically induced sleep affect PreScale, and how do these interventions influence the balance between neuronal excitability and synaptic stability in aging?", "history": ["What role does presynaptic active zone plasticity play in aging and brain function?", "How might changes in this process impact an organism's ability to adapt to environmental stressors over time?"], "ground_truth": ["permed-72143", "permed-82338", "permed-78085", "permed-64847", "permed-72055", "permed-53082", "permed-54293", "permed-53613", "permed-63279", "permed-72145"]}
{"query_id": "topic_366_turn_4", "conversation_id": "topic_366", "turn_id": 4, "query": "Given these proposed molecular interactions, what specific experimental protocols would you recommend for tracking PreScale dynamics in real-time during circadian cycle perturbations? Should we combine live imaging of active zone proteins with simultaneous calcium monitoring in specific neuronal populations, and what statistical approaches would best capture the temporal relationship between PreScale modifications and subsequent changes in synaptic efficacy under different neuroendocrine conditions?", "history": ["What role does presynaptic active zone plasticity play in aging and brain function?", "How might changes in this process impact an organism's ability to adapt to environmental stressors over time?", "Given that presynaptic active zone plasticity (PreScale) modulates sleep, longevity, and memory in early aging Drosophila, how might its temporal dynamics interact with circadian rhythms and neuroendocrine signaling to shape the brain's adaptive responses to environmental and metabolic stressors across the lifespan? Additionally, what molecular mechanisms could explain how spermidine supplementation and pharmacologically induced sleep affect PreScale, and how do these interventions influence the balance between neuronal excitability and synaptic stability in aging?"], "ground_truth": ["permed-72143", "permed-61673", "permed-82338", "permed-61136", "permed-79915", "permed-80830", "permed-63310", "permed-71685", "permed-53553", "permed-82341"]}
{"query_id": "topic_367_turn_1", "conversation_id": "topic_367", "turn_id": 1, "query": "What is known about the relationship between neuropsychiatric symptoms and functional decline in Huntington's disease?", "history": [], "ground_truth": ["permed-73704", "permed-68783", "permed-81316", "permed-81315", "permed-59838", "permed-59396", "permed-81317", "permed-71498", "permed-85658", "permed-55746"]}
{"query_id": "topic_367_turn_2", "conversation_id": "topic_367", "turn_id": 2, "query": "Are apathy and perseverative behavior specifically identified as significant factors in this decline, and if so, how are they currently understood to impact disease progression?", "history": ["What is known about the relationship between neuropsychiatric symptoms and functional decline in Huntington's disease?"], "ground_truth": ["permed-81317", "permed-81315", "permed-55723", "permed-53935", "permed-51622", "permed-69517", "permed-70668", "permed-77208", "permed-34422", "permed-25885"]}
{"query_id": "topic_367_turn_3", "conversation_id": "topic_367", "turn_id": 3, "query": "Given that apathy and perseverative behavior appear to play significant roles in functional decline, what are the specific mechanisms through which these symptoms contribute to reduced total functional capacity during early-moderate stages of Huntington's disease? How do they interact with each other and with other clinical features as the disease progresses?", "history": ["What is known about the relationship between neuropsychiatric symptoms and functional decline in Huntington's disease?", "Are apathy and perseverative behavior specifically identified as significant factors in this decline, and if so, how are they currently understood to impact disease progression?"], "ground_truth": ["permed-73704", "permed-81315", "permed-81317", "permed-81316", "permed-71498", "permed-68783", "permed-59838", "permed-51622", "permed-55723", "permed-55746"]}
{"query_id": "topic_367_turn_4", "conversation_id": "topic_367", "turn_id": 4, "query": "When investigating these proposed mechanisms through longitudinal studies, what specific methodological approaches are most effective for tracking apathy and perseverative behavior's temporal relationship with functional capacity? I'm particularly interested in how researchers operationally define these behavioral constructs across different assessment tools, what statistical models account for their interaction effects over time, and how study designs address potential confounding by motor symptoms and cognitive changes during early-moderate disease stages.", "history": ["What is known about the relationship between neuropsychiatric symptoms and functional decline in Huntington's disease?", "Are apathy and perseverative behavior specifically identified as significant factors in this decline, and if so, how are they currently understood to impact disease progression?", "Given that apathy and perseverative behavior appear to play significant roles in functional decline, what are the specific mechanisms through which these symptoms contribute to reduced total functional capacity during early-moderate stages of Huntington's disease? How do they interact with each other and with other clinical features as the disease progresses?"], "ground_truth": ["permed-81317", "permed-73704", "permed-55723", "permed-81315", "permed-53935", "permed-81318", "permed-81593", "permed-71498", "permed-51518", "permed-78541"]}
{"query_id": "topic_368_turn_1", "conversation_id": "topic_368", "turn_id": 1, "query": "Role of excipients in generic drug formulations and their impact on patient therapeutic response", "history": [], "ground_truth": ["permed-64714", "permed-86295", "permed-76208", "permed-67543", "permed-51253", "permed-65129", "permed-86234", "permed-75857", "permed-60711", "permed-69280"]}
{"query_id": "topic_368_turn_2", "conversation_id": "topic_368", "turn_id": 2, "query": "Documented cases of adverse drug reactions, including hypersensitivity, linked to these excipient differences in generic medications", "history": ["Role of excipients in generic drug formulations and their impact on patient therapeutic response"], "ground_truth": ["permed-76203", "permed-67368", "permed-76206", "permed-78189", "permed-72485", "permed-84446", "permed-71322", "permed-12273", "permed-54989", "permed-69152"]}
{"query_id": "topic_368_turn_3", "conversation_id": "topic_368", "turn_id": 3, "query": "Mechanisms by which specific excipient compositional variations in generics influence hypersensitivity reaction frequency and severity, and clinical strategies for predicting and mitigating these risks", "history": ["Role of excipients in generic drug formulations and their impact on patient therapeutic response", "Documented cases of adverse drug reactions, including hypersensitivity, linked to these excipient differences in generic medications"], "ground_truth": ["permed-76203", "permed-71322", "permed-67368", "permed-76208", "permed-84970", "permed-81498", "permed-55330", "permed-67543", "permed-81844", "permed-77102"]}
{"query_id": "topic_368_turn_4", "conversation_id": "topic_368", "turn_id": 4, "query": "Given these mechanistic insights about excipient-driven hypersensitivity, what specific analytical techniques and validation protocols are most suitable for quantifying trace-level variations in allergenic excipients between generic formulations? I'm particularly interested in how techniques like mass spectrometry or chromatography are being optimized for detecting compositional differences at clinically relevant thresholds, and what statistical approaches ensure these measurements reliably predict actual immunogenic potential in patient populations.", "history": ["Role of excipients in generic drug formulations and their impact on patient therapeutic response", "Documented cases of adverse drug reactions, including hypersensitivity, linked to these excipient differences in generic medications", "Mechanisms by which specific excipient compositional variations in generics influence hypersensitivity reaction frequency and severity, and clinical strategies for predicting and mitigating these risks"], "ground_truth": ["permed-76203", "permed-83610", "permed-80669", "permed-88468", "permed-71321", "permed-81844", "permed-52791", "permed-71322", "permed-80854", "permed-84970"]}
{"query_id": "topic_369_turn_1", "conversation_id": "topic_369", "turn_id": 1, "query": "What is known about the crystal bridge growth model and its applications in materials science?", "history": [], "ground_truth": ["permed-80054", "permed-64452", "permed-80898", "permed-72981", "permed-75022", "permed-73207", "permed-86764", "permed-73937", "permed-90101", "permed-60321"]}
{"query_id": "topic_369_turn_2", "conversation_id": "topic_369", "turn_id": 2, "query": "Can this technique be used to study the stability of compounds like sugar alcohols under varying conditions?", "history": ["What is known about the crystal bridge growth model and its applications in materials science?"], "ground_truth": ["permed-80898", "permed-53311", "permed-60645", "permed-83853", "permed-80899", "permed-52779", "permed-53308", "permed-52787", "permed-79015", "permed-67543"]}
{"query_id": "topic_369_turn_3", "conversation_id": "topic_369", "turn_id": 3, "query": "Given these findings from the crystal bridge growth model, how could they be used to create predictive algorithms for simulating the long-term storage stability of sugar alcohols under different conditions? What advantages might such algorithms offer for food industry formulation and quality control processes?", "history": ["What is known about the crystal bridge growth model and its applications in materials science?", "Can this technique be used to study the stability of compounds like sugar alcohols under varying conditions?"], "ground_truth": ["permed-80898", "permed-87790", "permed-80904", "permed-78134", "permed-80899", "permed-86308", "permed-66549", "permed-73033", "permed-67213", "permed-82409"]}
{"query_id": "topic_369_turn_4", "conversation_id": "topic_369", "turn_id": 4, "query": "Building on this algorithmic approach, what specific computational methods would be most effective for calibrating the simulation parameters, such as activation energies and nucleation rates, derived from the crystal bridge model? I'm particularly interested in the statistical validation strategies—would a Bayesian calibration framework or machine learning-based parameter optimization provide more robust predictive power for the long-term stability forecasts under the complex, non-isothermal conditions typical of real-world storage?", "history": ["What is known about the crystal bridge growth model and its applications in materials science?", "Can this technique be used to study the stability of compounds like sugar alcohols under varying conditions?", "Given these findings from the crystal bridge growth model, how could they be used to create predictive algorithms for simulating the long-term storage stability of sugar alcohols under different conditions? What advantages might such algorithms offer for food industry formulation and quality control processes?"], "ground_truth": ["permed-80898", "permed-63436", "permed-80055", "permed-73317", "permed-66549", "permed-89201", "permed-73337", "permed-75492", "permed-86764", "permed-74015"]}
{"query_id": "topic_370_turn_1", "conversation_id": "topic_370", "turn_id": 1, "query": "What role does therapeutic drug monitoring play in the clinical application of cardiovascular medications?", "history": [], "ground_truth": ["permed-52745", "permed-54908", "permed-50787", "permed-74548", "permed-86166", "permed-51947", "permed-4610", "permed-58880", "permed-84409", "permed-68969"]}
{"query_id": "topic_370_turn_2", "conversation_id": "topic_370", "turn_id": 2, "query": "How effective is liquid chromatography-tandem mass spectrometry (LC-MS/MS) in this area, particularly in handling complex biological samples?", "history": ["What role does therapeutic drug monitoring play in the clinical application of cardiovascular medications?"], "ground_truth": ["permed-79011", "permed-79012", "permed-4596", "permed-4598", "permed-77044", "permed-80570", "permed-4599", "permed-52752", "permed-4602", "permed-52754"]}
{"query_id": "topic_370_turn_3", "conversation_id": "topic_370", "turn_id": 3, "query": "Given that cardiovascular drugs often have narrow therapeutic windows and high pharmacokinetic variability, how can we further optimize LC-MS/MS techniques—which we've established as effective for TDM in this context—to improve their sensitivity and specificity when analyzing these drugs in complex biological samples? This would help ensure more accurate drug concentration assessments and better guide personalized treatment plans. Additionally, for special patient populations like those with hyperlipidemia, hyperproteinemia, or diabetes, what specific challenges might arise when applying these LC-MS/MS methods, and how could we address them to achieve more precise drug monitoring?", "history": ["What role does therapeutic drug monitoring play in the clinical application of cardiovascular medications?", "How effective is liquid chromatography-tandem mass spectrometry (LC-MS/MS) in this area, particularly in handling complex biological samples?"], "ground_truth": ["permed-52745", "permed-52746", "permed-4599", "permed-58880", "permed-6240", "permed-4598", "permed-87932", "permed-80570", "permed-79011", "permed-52752"]}
{"query_id": "topic_370_turn_4", "conversation_id": "topic_370", "turn_id": 4, "query": "Building on these LC-MS/MS optimization strategies for cardiovascular TDM, what specific sample preparation modifications or chromatographic separation techniques would you recommend implementing to address matrix effects from hyperlipidemic or hyperproteinemic samples? Particularly, how should we validate these methodological adaptations—would you suggest using stable isotope-labeled internal standards with matched matrix calibration curves, and what statistical approaches for assessing recovery and matrix effects would provide the most robust validation in these complex patient populations?", "history": ["What role does therapeutic drug monitoring play in the clinical application of cardiovascular medications?", "How effective is liquid chromatography-tandem mass spectrometry (LC-MS/MS) in this area, particularly in handling complex biological samples?", "Given that cardiovascular drugs often have narrow therapeutic windows and high pharmacokinetic variability, how can we further optimize LC-MS/MS techniques—which we've established as effective for TDM in this context—to improve their sensitivity and specificity when analyzing these drugs in complex biological samples? This would help ensure more accurate drug concentration assessments and better guide personalized treatment plans. Additionally, for special patient populations like those with hyperlipidemia, hyperproteinemia, or diabetes, what specific challenges might arise when applying these LC-MS/MS methods, and how could we address them to achieve more precise drug monitoring?"], "ground_truth": ["permed-52745", "permed-87932", "permed-4606", "permed-4596", "permed-79011", "permed-6070", "permed-5567", "permed-76142", "permed-6240", "permed-2721"]}
{"query_id": "topic_371_turn_1", "conversation_id": "topic_371", "turn_id": 1, "query": "Impact of therapeutic monoclonal antibodies on diagnostic assay performance in oncology", "history": [], "ground_truth": ["permed-77407", "permed-68002", "permed-72540", "permed-53718", "permed-65912", "permed-87476", "permed-72643", "permed-63460", "permed-91528", "permed-84409"]}
{"query_id": "topic_371_turn_2", "conversation_id": "topic_371", "turn_id": 2, "query": "How do these monoclonal antibody-induced diagnostic interferences affect multiple myeloma monitoring via minimal residual disease (MRD) detection?", "history": ["Impact of therapeutic monoclonal antibodies on diagnostic assay performance in oncology"], "ground_truth": ["permed-22993", "permed-5746", "permed-22998", "permed-76854", "permed-23650", "permed-22994", "permed-5629", "permed-49200", "permed-5740", "permed-80128"]}
{"query_id": "topic_371_turn_3", "conversation_id": "topic_371", "turn_id": 3, "query": "Long-term implications of tixagevimab/cilgavimab (Evusheld) pre-exposure prophylaxis for MRD monitoring sensitivity/specificity and treatment efficacy assessment in multiple myeloma, including strategies to mitigate potential assay interferences.", "history": ["Impact of therapeutic monoclonal antibodies on diagnostic assay performance in oncology", "How do these monoclonal antibody-induced diagnostic interferences affect multiple myeloma monitoring via minimal residual disease (MRD) detection?"], "ground_truth": ["permed-77407", "permed-76854", "permed-60150", "permed-72504", "permed-71994", "permed-5629", "permed-72540", "permed-72636", "permed-22998", "permed-52729"]}
{"query_id": "topic_371_turn_4", "conversation_id": "topic_371", "turn_id": 4, "query": "Regarding these mitigation strategies for tixagevimab/cilgavimab interference in MRD monitoring, could you elaborate on the specific methodological adaptations for next-generation sequencing assays? I'm particularly interested in the technical modifications to DNA extraction protocols, adjusted primer design strategies to avoid therapeutic antibody binding regions, and the validation approaches used to establish new analytical sensitivity thresholds while maintaining clinical specificity in samples containing high concentrations of these monoclonal antibodies.", "history": ["Impact of therapeutic monoclonal antibodies on diagnostic assay performance in oncology", "How do these monoclonal antibody-induced diagnostic interferences affect multiple myeloma monitoring via minimal residual disease (MRD) detection?", "Long-term implications of tixagevimab/cilgavimab (Evusheld) pre-exposure prophylaxis for MRD monitoring sensitivity/specificity and treatment efficacy assessment in multiple myeloma, including strategies to mitigate potential assay interferences."], "ground_truth": ["permed-77407", "permed-76854", "permed-66611", "permed-4683", "permed-72864", "permed-23650", "permed-56189", "permed-2280", "permed-20811", "permed-71768"]}
{"query_id": "topic_372_turn_1", "conversation_id": "topic_372", "turn_id": 1, "query": "What are the current challenges in treating wild-type transthyretin amyloid cardiomyopathy (wtATTR) and how can predictive modeling help?", "history": [], "ground_truth": ["permed-72501", "permed-72344", "permed-9086", "permed-72347", "permed-72343", "permed-77447", "permed-72503", "permed-77446", "permed-70937", "permed-9084"]}
{"query_id": "topic_372_turn_2", "conversation_id": "topic_372", "turn_id": 2, "query": "Can integrating clinical, genetic, and biomarker data into these models improve treatment outcomes for patients undergoing specific therapies like tafamidis?", "history": ["What are the current challenges in treating wild-type transthyretin amyloid cardiomyopathy (wtATTR) and how can predictive modeling help?"], "ground_truth": ["permed-77549", "permed-68463", "permed-69067", "permed-72501", "permed-84969", "permed-70753", "permed-54229", "permed-69030", "permed-72762", "permed-68044"]}
{"query_id": "topic_372_turn_3", "conversation_id": "topic_372", "turn_id": 3, "query": "Given these challenges and the potential benefits of integrating multiple data types, how can we develop and validate predictive models that identify which wtATTR patient subgroups would benefit most from tafamidis treatment? And how should we address the ethical considerations and cost-effectiveness of implementing such targeted strategies?", "history": ["What are the current challenges in treating wild-type transthyretin amyloid cardiomyopathy (wtATTR) and how can predictive modeling help?", "Can integrating clinical, genetic, and biomarker data into these models improve treatment outcomes for patients undergoing specific therapies like tafamidis?"], "ground_truth": ["permed-72501", "permed-91055", "permed-10345", "permed-51753", "permed-77546", "permed-69030", "permed-60441", "permed-67919", "permed-69067", "permed-70671"]}
{"query_id": "topic_372_turn_4", "conversation_id": "topic_372", "turn_id": 4, "query": "Regarding this subgroup identification framework, what specific statistical methodologies would be most appropriate for handling the integration of heterogeneous data types - particularly the combination of continuous biomarker measurements with categorical clinical variables? Should we employ machine learning approaches like random forests with feature importance analysis, or would traditional multivariate regression with interaction terms provide more clinically interpretable results? Additionally, what validation strategies would you recommend to ensure model robustness given the typically limited sample sizes in rare disease cohorts like wtATTR?", "history": ["What are the current challenges in treating wild-type transthyretin amyloid cardiomyopathy (wtATTR) and how can predictive modeling help?", "Can integrating clinical, genetic, and biomarker data into these models improve treatment outcomes for patients undergoing specific therapies like tafamidis?", "Given these challenges and the potential benefits of integrating multiple data types, how can we develop and validate predictive models that identify which wtATTR patient subgroups would benefit most from tafamidis treatment? And how should we address the ethical considerations and cost-effectiveness of implementing such targeted strategies?"], "ground_truth": ["permed-51753", "permed-72501", "permed-61469", "permed-70768", "permed-51749", "permed-80653", "permed-72343", "permed-73582", "permed-53428", "permed-58672"]}
{"query_id": "topic_373_turn_1", "conversation_id": "topic_373", "turn_id": 1, "query": "What is known about the genetic mechanisms underlying Acute Promyelocytic Leukemia (APL)?", "history": [], "ground_truth": ["permed-56407", "permed-49295", "permed-49278", "permed-56406", "permed-49393", "permed-6606", "permed-21311", "permed-56409", "permed-20809", "permed-49290"]}
{"query_id": "topic_373_turn_2", "conversation_id": "topic_373", "turn_id": 2, "query": "How do variations in the fusion genes associated with APL, like PRKAR1A-RARA, impact our understanding of this disease?", "history": ["What is known about the genetic mechanisms underlying Acute Promyelocytic Leukemia (APL)?"], "ground_truth": ["permed-80343", "permed-49290", "permed-49393", "permed-49295", "permed-56406", "permed-56407", "permed-21311", "permed-72553", "permed-30029", "permed-20600"]}
{"query_id": "topic_373_turn_3", "conversation_id": "topic_373", "turn_id": 3, "query": "How do the molecular mechanisms that form the PRKAR1A-RARA fusion gene differ from those creating the typical PML-RARA fusion in APL, and what do these differences mean for diagnosing and treating patients with these variant translocations?", "history": ["What is known about the genetic mechanisms underlying Acute Promyelocytic Leukemia (APL)?", "How do variations in the fusion genes associated with APL, like PRKAR1A-RARA, impact our understanding of this disease?"], "ground_truth": ["permed-80343", "permed-49290", "permed-49393", "permed-49295", "permed-56406", "permed-56407", "permed-21311", "permed-72553", "permed-72556", "permed-56409"]}
{"query_id": "topic_373_turn_4", "conversation_id": "topic_373", "turn_id": 4, "query": "Given these mechanistic differences in fusion gene formation, what specific molecular techniques - beyond standard FISH and RT-PCR - would you recommend for reliably detecting the PRKAR1A-RARA variant in clinical diagnostics? I'm particularly interested in how laboratories validate the sensitivity and specificity thresholds for these detection methods, and whether next-generation sequencing approaches require different quality control parameters compared to conventional cytogenetic techniques when identifying such rare translocation partners.", "history": ["What is known about the genetic mechanisms underlying Acute Promyelocytic Leukemia (APL)?", "How do variations in the fusion genes associated with APL, like PRKAR1A-RARA, impact our understanding of this disease?", "How do the molecular mechanisms that form the PRKAR1A-RARA fusion gene differ from those creating the typical PML-RARA fusion in APL, and what do these differences mean for diagnosing and treating patients with these variant translocations?"], "ground_truth": ["permed-80343", "permed-56404", "permed-30330", "permed-31389", "permed-68718", "permed-66692", "permed-49907", "permed-31745", "permed-2279", "permed-5728"]}
{"query_id": "topic_374_turn_1", "conversation_id": "topic_374", "turn_id": 1, "query": "What challenges do healthcare providers face when conducting medico-legal examinations of sexually assaulted victims who cannot give informed consent?", "history": [], "ground_truth": ["permed-69866", "permed-80338", "permed-63512", "permed-80339", "permed-84520", "permed-90987", "permed-69862", "permed-74801", "permed-80341", "permed-89237"]}
{"query_id": "topic_374_turn_2", "conversation_id": "topic_374", "turn_id": 2, "query": "How do legal and ethical differences across countries impact the way healthcare providers handle this sensitive issue, particularly in terms of balancing evidence collection with victim care?", "history": ["What challenges do healthcare providers face when conducting medico-legal examinations of sexually assaulted victims who cannot give informed consent?"], "ground_truth": ["permed-53046", "permed-88739", "permed-63512", "permed-53044", "permed-69866", "permed-86778", "permed-69886", "permed-78816", "permed-69864", "permed-67623"]}
{"query_id": "topic_374_turn_3", "conversation_id": "topic_374", "turn_id": 3, "query": "Given these challenges and international differences, how do healthcare providers in countries like Portugal and others navigate the tension between immediate forensic evidence collection and the victim's long-term psychological well-being during medico-legal examinations when consent isn't possible? What practical strategies could help reconcile these competing priorities while maintaining both ethical standards and legal compliance?", "history": ["What challenges do healthcare providers face when conducting medico-legal examinations of sexually assaulted victims who cannot give informed consent?", "How do legal and ethical differences across countries impact the way healthcare providers handle this sensitive issue, particularly in terms of balancing evidence collection with victim care?"], "ground_truth": ["permed-69866", "permed-86735", "permed-92318", "permed-80340", "permed-84520", "permed-69888", "permed-57513", "permed-63512", "permed-74806", "permed-86733"]}
{"query_id": "topic_374_turn_4", "conversation_id": "topic_374", "turn_id": 4, "query": "Regarding the practical strategies mentioned for balancing forensic collection with psychological care, could you elaborate on the specific protocols used to document non-consensual examinations? I'm particularly interested in the standardized assessment tools for evaluating psychological distress during these procedures, the validation methods for these instruments in vulnerable populations, and the specific quality control measures implemented to ensure both forensic integrity and trauma-informed care are consistently maintained across different practitioners and healthcare settings.", "history": ["What challenges do healthcare providers face when conducting medico-legal examinations of sexually assaulted victims who cannot give informed consent?", "How do legal and ethical differences across countries impact the way healthcare providers handle this sensitive issue, particularly in terms of balancing evidence collection with victim care?", "Given these challenges and international differences, how do healthcare providers in countries like Portugal and others navigate the tension between immediate forensic evidence collection and the victim's long-term psychological well-being during medico-legal examinations when consent isn't possible? What practical strategies could help reconcile these competing priorities while maintaining both ethical standards and legal compliance?"], "ground_truth": ["permed-57513", "permed-64779", "permed-69866", "permed-86735", "permed-86734", "permed-69898", "permed-53877", "permed-74208", "permed-57510", "permed-74801"]}
{"query_id": "topic_375_turn_1", "conversation_id": "topic_375", "turn_id": 1, "query": "What impact does winemaking technique have on the quality and characteristics of wine?", "history": [], "ground_truth": ["permed-78735", "permed-78734", "permed-65205", "permed-78733", "permed-78739", "permed-78740", "permed-78737", "permed-78736", "permed-64375", "permed-89070"]}
{"query_id": "topic_375_turn_2", "conversation_id": "topic_375", "turn_id": 2, "query": "How might variations in techniques like carbonic maceration affect specific grape varieties, such as 'Tempranillo' and 'Graciano'?", "history": ["What impact does winemaking technique have on the quality and characteristics of wine?"], "ground_truth": ["permed-78735", "permed-78736", "permed-80911", "permed-78739", "permed-78737", "permed-64377", "permed-78733", "permed-78734", "permed-81976", "permed-80912"]}
{"query_id": "topic_375_turn_3", "conversation_id": "topic_375", "turn_id": 3, "query": "Given these differences in phenolic composition and color between carbonic maceration and conventional methods, how do they affect both the sensory profile and aging potential of Tempranillo and Graciano wines? And what specific techniques could be used to enhance their positive qualities while addressing any limitations from each approach?", "history": ["What impact does winemaking technique have on the quality and characteristics of wine?", "How might variations in techniques like carbonic maceration affect specific grape varieties, such as 'Tempranillo' and 'Graciano'?"], "ground_truth": ["permed-78736", "permed-78735", "permed-78739", "permed-78740", "permed-64377", "permed-80911", "permed-78737", "permed-78734", "permed-78733", "permed-80912"]}
{"query_id": "topic_375_turn_4", "conversation_id": "topic_375", "turn_id": 4, "query": "Regarding these phenolic and aging comparisons, what specific analytical methods are most appropriate for quantifying the degradation kinetics of anthocyanins and tannins in both maceration techniques? I'm particularly interested in the statistical approaches for modeling aging trajectories - would accelerated aging tests coupled with HPLC-MS and periodic sensory analysis provide reliable predictive validity compared to traditional bottle aging studies? How should we design sampling intervals and replication schemes to ensure robust longitudinal data?", "history": ["What impact does winemaking technique have on the quality and characteristics of wine?", "How might variations in techniques like carbonic maceration affect specific grape varieties, such as 'Tempranillo' and 'Graciano'?", "Given these differences in phenolic composition and color between carbonic maceration and conventional methods, how do they affect both the sensory profile and aging potential of Tempranillo and Graciano wines? And what specific techniques could be used to enhance their positive qualities while addressing any limitations from each approach?"], "ground_truth": ["permed-78740", "permed-80912", "permed-78736", "permed-80906", "permed-81125", "permed-80907", "permed-89170", "permed-91033", "permed-89206", "permed-78737"]}
{"query_id": "topic_376_turn_1", "conversation_id": "topic_376", "turn_id": 1, "query": "What role do host-jump events play in the evolution of pathogens like Staphylococcus aureus?", "history": [], "ground_truth": ["permed-53713", "permed-55467", "permed-53687", "permed-60453", "permed-55471", "permed-55470", "permed-55474", "permed-55473", "permed-75904", "permed-58167"]}
{"query_id": "topic_376_turn_2", "conversation_id": "topic_376", "turn_id": 2, "query": "How might changes in agricultural practices impact the spread and adaptation of this particular bacterium?", "history": ["What role do host-jump events play in the evolution of pathogens like Staphylococcus aureus?"], "ground_truth": ["permed-60604", "permed-66817", "permed-53713", "permed-55475", "permed-53705", "permed-66833", "permed-90392", "permed-66867", "permed-5959", "permed-58167"]}
{"query_id": "topic_376_turn_3", "conversation_id": "topic_376", "turn_id": 3, "query": "Given how host-jump events and agricultural changes have shaped the evolution and spread of bovine-adapted *Staphylococcus aureus*, how might upcoming shifts in farming—like stricter biosecurity or reduced antibiotic use—affect its genetic diversity and host specificity? Building on this, what predictive models could help forecast emerging clones with greater zoonotic potential, and how might these models guide public health strategies to reduce interspecies transmission risks?", "history": ["What role do host-jump events play in the evolution of pathogens like Staphylococcus aureus?", "How might changes in agricultural practices impact the spread and adaptation of this particular bacterium?"], "ground_truth": ["permed-53713", "permed-55469", "permed-55467", "permed-53687", "permed-66732", "permed-57684", "permed-53689", "permed-53683", "permed-55474", "permed-67023"]}
{"query_id": "topic_376_turn_4", "conversation_id": "topic_376", "turn_id": 4, "query": "Given the predictive modeling approach you described, could you specify which genomic features—such as specific mobile genetic elements or virulence factors—should be prioritized when parameterizing these models? Additionally, what statistical validation methods, like cross-validation against historical host-jump events or sensitivity analyses of transmission parameters, would be most appropriate to assess model robustness before applying them to public health decision-making?", "history": ["What role do host-jump events play in the evolution of pathogens like Staphylococcus aureus?", "How might changes in agricultural practices impact the spread and adaptation of this particular bacterium?", "Given how host-jump events and agricultural changes have shaped the evolution and spread of bovine-adapted *Staphylococcus aureus*, how might upcoming shifts in farming—like stricter biosecurity or reduced antibiotic use—affect its genetic diversity and host specificity? Building on this, what predictive models could help forecast emerging clones with greater zoonotic potential, and how might these models guide public health strategies to reduce interspecies transmission risks?"], "ground_truth": ["permed-36118", "permed-59205", "permed-62369", "permed-57908", "permed-59204", "permed-54928", "permed-53886", "permed-59209", "permed-53876", "permed-89397"]}
{"query_id": "topic_377_turn_1", "conversation_id": "topic_377", "turn_id": 1, "query": "What role does cannabis play in managing chronic pain for cancer survivors?", "history": [], "ground_truth": ["permed-79432", "permed-63215", "permed-72483", "permed-84378", "permed-60079", "permed-78062", "permed-69146", "permed-60009", "permed-69145", "permed-72495"]}
{"query_id": "topic_377_turn_2", "conversation_id": "topic_377", "turn_id": 2, "query": "Are there any specific concerns or benefits associated with it that researchers have identified in this area?", "history": ["What role does cannabis play in managing chronic pain for cancer survivors?"], "ground_truth": ["permed-86235", "permed-55107", "permed-61463", "permed-66153", "permed-66783", "permed-42029", "permed-82651", "permed-86233", "permed-54923", "permed-6827"]}
{"query_id": "topic_377_turn_3", "conversation_id": "topic_377", "turn_id": 3, "query": "Given these potential benefits and concerns, what do we know about the long-term outcomes and side effects of cannabis use specifically for cancer survivors with high-impact chronic pain? And how might these outcomes differ across various demographic groups or cancer types?", "history": ["What role does cannabis play in managing chronic pain for cancer survivors?", "Are there any specific concerns or benefits associated with it that researchers have identified in this area?"], "ground_truth": ["permed-79432", "permed-72483", "permed-71990", "permed-51819", "permed-78062", "permed-84378", "permed-63100", "permed-72495", "permed-79433", "permed-78691"]}
{"query_id": "topic_377_turn_4", "conversation_id": "topic_377", "turn_id": 4, "query": "Given these long-term outcome investigations, what specific methodological approaches have researchers employed to control for confounding variables like concurrent opioid use or cancer treatment regimens when analyzing cannabis efficacy? I'm particularly interested in how studies address dosage standardization across different cannabis formulations and what statistical methods they use to account for the high attrition rates common in longitudinal pain studies. Are there validated instruments being consistently used to measure pain interference across these diverse demographic subgroups?", "history": ["What role does cannabis play in managing chronic pain for cancer survivors?", "Are there any specific concerns or benefits associated with it that researchers have identified in this area?", "Given these potential benefits and concerns, what do we know about the long-term outcomes and side effects of cannabis use specifically for cancer survivors with high-impact chronic pain? And how might these outcomes differ across various demographic groups or cancer types?"], "ground_truth": ["permed-72483", "permed-55819", "permed-72485", "permed-72494", "permed-79432", "permed-76013", "permed-69152", "permed-55817", "permed-70512", "permed-55684"]}
{"query_id": "topic_378_turn_1", "conversation_id": "topic_378", "turn_id": 1, "query": "Electrospinning strategies for designing 3D electrocatalytic electrodes with tunable morphology and composition", "history": [], "ground_truth": ["permed-76068", "permed-51981", "permed-58065", "permed-76345", "permed-51980", "permed-52420", "permed-51986", "permed-89117", "permed-81150", "permed-51991"]}
{"query_id": "topic_378_turn_2", "conversation_id": "topic_378", "turn_id": 2, "query": "Impact of electrospinning process variables (e.g., precursor solution properties, applied voltage) on the resulting morphology, composition, and subsequent electrocatalytic performance of these tunable 3D electrodes", "history": ["Electrospinning strategies for designing 3D electrocatalytic electrodes with tunable morphology and composition"], "ground_truth": ["permed-76068", "permed-76345", "permed-58065", "permed-76070", "permed-64641", "permed-89117", "permed-51981", "permed-73057", "permed-64619", "permed-83657"]}
{"query_id": "topic_378_turn_3", "conversation_id": "topic_378", "turn_id": 3, "query": "Fine-tuning nickel-based, nitrogen-doped 3D electrospun electrocatalysts: investigating effects of specific Ni precursors, N-sources, and calcination parameters on their nanoscale architecture, active site distribution, long-term stability, and mechanistic pathways for CO2 reduction", "history": ["Electrospinning strategies for designing 3D electrocatalytic electrodes with tunable morphology and composition", "Impact of electrospinning process variables (e.g., precursor solution properties, applied voltage) on the resulting morphology, composition, and subsequent electrocatalytic performance of these tunable 3D electrodes"], "ground_truth": ["permed-76068", "permed-73056", "permed-74853", "permed-87230", "permed-80182", "permed-51981", "permed-75996", "permed-82647", "permed-82640", "permed-51980"]}
{"query_id": "topic_378_turn_4", "conversation_id": "topic_378", "turn_id": 4, "query": "When implementing these precursor and calcination protocols, what specific characterization techniques did you employ for quantifying active site distribution across the 3D nanofibrous architecture? I'm particularly interested in how you spatially mapped Ni-Nx coordination and correlated this with electrochemical surface area measurements through techniques like XPS depth profiling or synchrotron-based microscopy, and whether you validated these distributions against CO2 reduction performance metrics across multiple catalyst batches.", "history": ["Electrospinning strategies for designing 3D electrocatalytic electrodes with tunable morphology and composition", "Impact of electrospinning process variables (e.g., precursor solution properties, applied voltage) on the resulting morphology, composition, and subsequent electrocatalytic performance of these tunable 3D electrodes", "Fine-tuning nickel-based, nitrogen-doped 3D electrospun electrocatalysts: investigating effects of specific Ni precursors, N-sources, and calcination parameters on their nanoscale architecture, active site distribution, long-term stability, and mechanistic pathways for CO2 reduction"], "ground_truth": ["permed-76068", "permed-74853", "permed-73056", "permed-77110", "permed-73055", "permed-51981", "permed-53089", "permed-51980", "permed-88189", "permed-80182"]}
{"query_id": "topic_379_turn_1", "conversation_id": "topic_379", "turn_id": 1, "query": "How does the formation of amyloid fibrils from proteins like bovine serum albumin impact the properties of hydrogels?", "history": [], "ground_truth": ["permed-76900", "permed-89836", "permed-76772", "permed-64397", "permed-65073", "permed-80235", "permed-76267", "permed-76897", "permed-84751", "permed-76773"]}
{"query_id": "topic_379_turn_2", "conversation_id": "topic_379", "turn_id": 2, "query": "What role does the solution's pH play in modifying the structure and behavior of these fibrils, particularly in biological environments?", "history": ["How does the formation of amyloid fibrils from proteins like bovine serum albumin impact the properties of hydrogels?"], "ground_truth": ["permed-57787", "permed-75882", "permed-80966", "permed-79514", "permed-80236", "permed-73083", "permed-79545", "permed-53313", "permed-84219", "permed-83857"]}
{"query_id": "topic_379_turn_3", "conversation_id": "topic_379", "turn_id": 3, "query": "Given the role of pH in modifying fibril structure and behavior, how exactly does it influence the structural and surface charge characteristics of these amyloid fibrils, and what are the resulting effects on the mechanical strength and stability of the hydrogels they form, particularly in dynamic biological environments?", "history": ["How does the formation of amyloid fibrils from proteins like bovine serum albumin impact the properties of hydrogels?", "What role does the solution's pH play in modifying the structure and behavior of these fibrils, particularly in biological environments?"], "ground_truth": ["permed-76900", "permed-76772", "permed-57787", "permed-80236", "permed-89836", "permed-75882", "permed-80078", "permed-53313", "permed-65073", "permed-74949"]}
{"query_id": "topic_379_turn_4", "conversation_id": "topic_379", "turn_id": 4, "query": "Given these structural and charge modifications, what specific experimental techniques would you recommend for quantitatively characterizing the surface charge distribution across different fibril morphologies? Additionally, how should mechanical testing protocols be adapted to account for pH-dependent hydrogel stability in simulated biological environments - particularly regarding strain rate selection, hydration control, and validation of reproducibility across multiple fabrication batches?", "history": ["How does the formation of amyloid fibrils from proteins like bovine serum albumin impact the properties of hydrogels?", "What role does the solution's pH play in modifying the structure and behavior of these fibrils, particularly in biological environments?", "Given the role of pH in modifying fibril structure and behavior, how exactly does it influence the structural and surface charge characteristics of these amyloid fibrils, and what are the resulting effects on the mechanical strength and stability of the hydrogels they form, particularly in dynamic biological environments?"], "ground_truth": ["permed-75882", "permed-89836", "permed-81055", "permed-67605", "permed-87448", "permed-83291", "permed-89835", "permed-87216", "permed-80078", "permed-73201"]}
{"query_id": "topic_380_turn_1", "conversation_id": "topic_380", "turn_id": 1, "query": "Effective sexual education programs for adolescent girls in traditional societies", "history": [], "ground_truth": ["permed-72352", "permed-90022", "permed-88814", "permed-70087", "permed-90021", "permed-52093", "permed-84670", "permed-91878", "permed-65425", "permed-65423"]}
{"query_id": "topic_380_turn_2", "conversation_id": "topic_380", "turn_id": 2, "query": "Enhancing these sexual education programs with community-based interventions: role of family and healthcare professionals", "history": ["Effective sexual education programs for adolescent girls in traditional societies"], "ground_truth": ["permed-90021", "permed-90022", "permed-52093", "permed-65259", "permed-74517", "permed-72352", "permed-80249", "permed-58532", "permed-76889", "permed-55592"]}
{"query_id": "topic_380_turn_3", "conversation_id": "topic_380", "turn_id": 3, "query": "Adapting participatory approaches to overcome challenges in such community-based sexual education: empowering families as educators, integrating healthcare providers in traditional settings", "history": ["Effective sexual education programs for adolescent girls in traditional societies", "Enhancing these sexual education programs with community-based interventions: role of family and healthcare professionals"], "ground_truth": ["permed-90021", "permed-72352", "permed-65259", "permed-90022", "permed-52093", "permed-65425", "permed-74517", "permed-91879", "permed-76889", "permed-70087"]}
{"query_id": "topic_380_turn_4", "conversation_id": "topic_380", "turn_id": 4, "query": "When implementing these participatory approaches, what specific training protocols were developed for family educators, and how did researchers validate the cultural competency of healthcare provider integration? Were standardized fidelity measures employed to ensure consistent implementation across different traditional communities, and what mixed-methods approaches proved most effective for evaluating both process outcomes and behavioral impacts?", "history": ["Effective sexual education programs for adolescent girls in traditional societies", "Enhancing these sexual education programs with community-based interventions: role of family and healthcare professionals", "Adapting participatory approaches to overcome challenges in such community-based sexual education: empowering families as educators, integrating healthcare providers in traditional settings"], "ground_truth": ["permed-84895", "permed-57450", "permed-61184", "permed-53973", "permed-57444", "permed-66109", "permed-88838", "permed-69900", "permed-61856", "permed-88831"]}
{"query_id": "topic_381_turn_1", "conversation_id": "topic_381", "turn_id": 1, "query": "Current best imaging modalities for detection and staging of prostate cancer bone metastases", "history": [], "ground_truth": ["permed-85504", "permed-77489", "permed-36617", "permed-77449", "permed-48487", "permed-77470", "permed-6862", "permed-87969", "permed-52187", "permed-61219"]}
{"query_id": "topic_381_turn_2", "conversation_id": "topic_381", "turn_id": 2, "query": "Comparative diagnostic accuracy: SPECT/CT vs PET/CT for these prostate cancer bone metastases, focusing on sensitivity and specificity", "history": ["Current best imaging modalities for detection and staging of prostate cancer bone metastases"], "ground_truth": ["permed-77449", "permed-77460", "permed-77489", "permed-29620", "permed-36265", "permed-48367", "permed-77463", "permed-36429", "permed-48487", "permed-56145"]}
{"query_id": "topic_381_turn_3", "conversation_id": "topic_381", "turn_id": 3, "query": "Explaining and resolving SUV/volume parameter discrepancies between SPECT/CT and PET/CT for those prostate cancer bone metastases: impact on clinical decisions and optimization strategies", "history": ["Current best imaging modalities for detection and staging of prostate cancer bone metastases", "Comparative diagnostic accuracy: SPECT/CT vs PET/CT for these prostate cancer bone metastases, focusing on sensitivity and specificity"], "ground_truth": ["permed-77449", "permed-29620", "permed-3633", "permed-5108", "permed-56768", "permed-23985", "permed-61845", "permed-48367", "permed-36267", "permed-28412"]}
{"query_id": "topic_381_turn_4", "conversation_id": "topic_381", "turn_id": 4, "query": "Regarding these optimization strategies for resolving SUV/volume discrepancies, what specific phantom validation protocols and harmonization procedures would you recommend implementing across SPECT/CT and PET/CT platforms? I'm particularly interested in the methodological details for cross-calibration between systems, the statistical approaches for establishing volumetric concordance thresholds, and quality control frameworks that could standardize quantitative measurements while maintaining clinical workflow efficiency across different imaging centers.", "history": ["Current best imaging modalities for detection and staging of prostate cancer bone metastases", "Comparative diagnostic accuracy: SPECT/CT vs PET/CT for these prostate cancer bone metastases, focusing on sensitivity and specificity", "Explaining and resolving SUV/volume parameter discrepancies between SPECT/CT and PET/CT for those prostate cancer bone metastases: impact on clinical decisions and optimization strategies"], "ground_truth": ["permed-77217", "permed-48764", "permed-77449", "permed-61845", "permed-42127", "permed-78055", "permed-60521", "permed-42271", "permed-56768", "permed-56762"]}
{"query_id": "topic_382_turn_1", "conversation_id": "topic_382", "turn_id": 1, "query": "What role does the gut microbiome play in childhood obesity?", "history": [], "ground_truth": ["permed-65029", "permed-72282", "permed-51268", "permed-66893", "permed-56497", "permed-65155", "permed-66653", "permed-58898", "permed-78571", "permed-75316"]}
{"query_id": "topic_382_turn_2", "conversation_id": "topic_382", "turn_id": 2, "query": "Can dietary interventions, like supplementing with specific compounds, effectively modulate it to improve health outcomes?", "history": ["What role does the gut microbiome play in childhood obesity?"], "ground_truth": ["permed-82501", "permed-66922", "permed-67828", "permed-82583", "permed-73708", "permed-71561", "permed-92169", "permed-51203", "permed-67874", "permed-69012"]}
{"query_id": "topic_382_turn_3", "conversation_id": "topic_382", "turn_id": 3, "query": "Given that dietary interventions like butyrate supplementation can modulate the gut microbiome, how exactly does this affect inflammatory markers and metabolic profiles in obese children? What are the mechanisms behind these changes? Also, are there specific microbial signatures linked to positive responses to butyrate, and could they help predict treatment outcomes in pediatric cases?", "history": ["What role does the gut microbiome play in childhood obesity?", "Can dietary interventions, like supplementing with specific compounds, effectively modulate it to improve health outcomes?"], "ground_truth": ["permed-51268", "permed-29763", "permed-62631", "permed-72389", "permed-64874", "permed-89620", "permed-65155", "permed-66824", "permed-59032", "permed-66746"]}
{"query_id": "topic_382_turn_4", "conversation_id": "topic_382", "turn_id": 4, "query": "Given these proposed mechanisms and microbial signatures, what specific experimental protocols would you recommend for validating butyrate's anti-inflammatory effects in pediatric populations? I'm particularly interested in the technical details - should we use flow cytometry for immune cell profiling or multiplex cytokine assays for inflammatory markers? What statistical approaches would best account for baseline microbiome variability when correlating microbial signatures with metabolic outcomes, and what sample size calculations would be appropriate for such a longitudinal intervention study?", "history": ["What role does the gut microbiome play in childhood obesity?", "Can dietary interventions, like supplementing with specific compounds, effectively modulate it to improve health outcomes?", "Given that dietary interventions like butyrate supplementation can modulate the gut microbiome, how exactly does this affect inflammatory markers and metabolic profiles in obese children? What are the mechanisms behind these changes? Also, are there specific microbial signatures linked to positive responses to butyrate, and could they help predict treatment outcomes in pediatric cases?"], "ground_truth": ["permed-65219", "permed-89620", "permed-69040", "permed-70492", "permed-66824", "permed-62620", "permed-73872", "permed-22515", "permed-81130", "permed-67071"]}
{"query_id": "topic_383_turn_1", "conversation_id": "topic_383", "turn_id": 1, "query": "Common non-destructive imaging techniques for porous material characterization", "history": [], "ground_truth": ["permed-74670", "permed-91958", "permed-91655", "permed-89820", "permed-88869", "permed-73345", "permed-73926", "permed-55438", "permed-53718", "permed-87784"]}
{"query_id": "topic_383_turn_2", "conversation_id": "topic_383", "turn_id": 2, "query": "Benefits of combining NMR relaxometry with other non-destructive imaging techniques for enhanced porous material microstructure and fluid interaction analysis", "history": ["Common non-destructive imaging techniques for porous material characterization"], "ground_truth": ["permed-74670", "permed-83500", "permed-53311", "permed-76158", "permed-73116", "permed-88869", "permed-91958", "permed-76161", "permed-81331", "permed-72748"]}
{"query_id": "topic_383_turn_3", "conversation_id": "topic_383", "turn_id": 3, "query": "Advanced applications of combined dynamic NMR relaxometry, high-resolution X-ray microtomography, and neutron imaging for characterizing multiphase flow and fluid-microstructure interactions in porous materials under varying environmental conditions", "history": ["Common non-destructive imaging techniques for porous material characterization", "Benefits of combining NMR relaxometry with other non-destructive imaging techniques for enhanced porous material microstructure and fluid interaction analysis"], "ground_truth": ["permed-74670", "permed-83500", "permed-91958", "permed-58094", "permed-76159", "permed-81155", "permed-80021", "permed-76158", "permed-89820", "permed-88869"]}
{"query_id": "topic_383_turn_4", "conversation_id": "topic_383", "turn_id": 4, "query": "When implementing this multimodal approach, what specific experimental protocols do researchers use to temporally synchronize dynamic NMR relaxometry data with high-resolution X-ray microtomography acquisitions? I'm particularly interested in how they handle the differing temporal resolutions between these techniques when tracking multiphase flow processes, and what statistical correlation methods are employed to validate the co-registration of fluid distribution patterns across these complementary datasets under dynamic environmental conditions.", "history": ["Common non-destructive imaging techniques for porous material characterization", "Benefits of combining NMR relaxometry with other non-destructive imaging techniques for enhanced porous material microstructure and fluid interaction analysis", "Advanced applications of combined dynamic NMR relaxometry, high-resolution X-ray microtomography, and neutron imaging for characterizing multiphase flow and fluid-microstructure interactions in porous materials under varying environmental conditions"], "ground_truth": ["permed-74670", "permed-63378", "permed-81331", "permed-63383", "permed-73116", "permed-83814", "permed-61809", "permed-73118", "permed-74986", "permed-76078"]}
{"query_id": "topic_384_turn_1", "conversation_id": "topic_384", "turn_id": 1, "query": "Comparing trust and communication outcomes in young adults across diverse relationship structures (e.g., monogamy, polyamory, consensual non-monogamy)", "history": [], "ground_truth": ["permed-77770", "permed-69463", "permed-77769", "permed-55636", "permed-80249", "permed-55708", "permed-66153", "permed-77772", "permed-55645", "permed-69664"]}
{"query_id": "topic_384_turn_2", "conversation_id": "topic_384", "turn_id": 2, "query": "How sociosexuality levels affect these trust and communication outcomes when comparing young adults in monogamous versus consensual non-monogamous (CNM) relationships", "history": ["Comparing trust and communication outcomes in young adults across diverse relationship structures (e.g., monogamy, polyamory, consensual non-monogamy)"], "ground_truth": ["permed-77770", "permed-80249", "permed-77772", "permed-71370", "permed-69463", "permed-69292", "permed-69664", "permed-77769", "permed-77762", "permed-77771"]}
{"query_id": "topic_384_turn_3", "conversation_id": "topic_384", "turn_id": 3, "query": "Interplay of sociosexuality and long-term mating preferences: impact on trust/communication in Spanish university students (CNM vs. monogamous relationships), and implications for relationship support strategies", "history": ["Comparing trust and communication outcomes in young adults across diverse relationship structures (e.g., monogamy, polyamory, consensual non-monogamy)", "How sociosexuality levels affect these trust and communication outcomes when comparing young adults in monogamous versus consensual non-monogamous (CNM) relationships"], "ground_truth": ["permed-77770", "permed-77769", "permed-80249", "permed-69463", "permed-77762", "permed-90012", "permed-51861", "permed-77771", "permed-69292", "permed-77768"]}
{"query_id": "topic_384_turn_4", "conversation_id": "topic_384", "turn_id": 4, "query": "Given your interest in sociosexuality's interplay with mating preferences, what specific methodological approach did you employ to measure trust and communication outcomes between CNM and monogamous Spanish university students? Were these constructs assessed through validated psychometric scales, and if so, which instruments were selected? Additionally, could you detail the statistical validation procedures used to ensure measurement invariance across relationship structures before conducting your comparative analyses?", "history": ["Comparing trust and communication outcomes in young adults across diverse relationship structures (e.g., monogamy, polyamory, consensual non-monogamy)", "How sociosexuality levels affect these trust and communication outcomes when comparing young adults in monogamous versus consensual non-monogamous (CNM) relationships", "Interplay of sociosexuality and long-term mating preferences: impact on trust/communication in Spanish university students (CNM vs. monogamous relationships), and implications for relationship support strategies"], "ground_truth": ["permed-77770", "permed-50587", "permed-77772", "permed-50592", "permed-77762", "permed-50438", "permed-50603", "permed-55814", "permed-50441", "permed-89365"]}
{"query_id": "topic_385_turn_1", "conversation_id": "topic_385", "turn_id": 1, "query": "What role does the P2X7 receptor play in neurological conditions, particularly mood disorders?", "history": [], "ground_truth": ["permed-69139", "permed-11452", "permed-69132", "permed-12186", "permed-53592", "permed-81500", "permed-60855", "permed-69131", "permed-11607", "permed-71677"]}
{"query_id": "topic_385_turn_2", "conversation_id": "topic_385", "turn_id": 2, "query": "How does its activation influence neuroinflammatory responses in this context?", "history": ["What role does the P2X7 receptor play in neurological conditions, particularly mood disorders?"], "ground_truth": ["permed-66783", "permed-63218", "permed-66782", "permed-53593", "permed-71458", "permed-66780", "permed-75680", "permed-53861", "permed-68061", "permed-74024"]}
{"query_id": "topic_385_turn_3", "conversation_id": "topic_385", "turn_id": 3, "query": "Given its role in neuroinflammation and mood disorders, what are the specific molecular mechanisms by which P2X7 receptor activation contributes to these conditions? And how could targeting these mechanisms lead to new treatments that address both the neurological and immunological aspects?", "history": ["What role does the P2X7 receptor play in neurological conditions, particularly mood disorders?", "How does its activation influence neuroinflammatory responses in this context?"], "ground_truth": ["permed-69139", "permed-12186", "permed-53592", "permed-60855", "permed-81500", "permed-11452", "permed-69132", "permed-78198", "permed-72489", "permed-11607"]}
{"query_id": "topic_385_turn_4", "conversation_id": "topic_385", "turn_id": 4, "query": "Given these proposed molecular mechanisms, what specific experimental techniques—such as calcium imaging, cytokine profiling, or transcriptomic analyses—would be most effective for quantitatively mapping the downstream signaling cascades following P2X7 activation in microglia? Additionally, how should in vivo models be designed to pharmacologically or genetically manipulate these pathways while simultaneously monitoring behavioral correlates of mood and neuroinflammatory markers to establish causal links?", "history": ["What role does the P2X7 receptor play in neurological conditions, particularly mood disorders?", "How does its activation influence neuroinflammatory responses in this context?", "Given its role in neuroinflammation and mood disorders, what are the specific molecular mechanisms by which P2X7 receptor activation contributes to these conditions? And how could targeting these mechanisms lead to new treatments that address both the neurological and immunological aspects?"], "ground_truth": ["permed-69139", "permed-60855", "permed-71458", "permed-85141", "permed-11452", "permed-53592", "permed-12186", "permed-75680", "permed-81500", "permed-53593"]}
{"query_id": "topic_386_turn_1", "conversation_id": "topic_386", "turn_id": 1, "query": "What is known about the risk of gastrointestinal bleeding in patients with left ventricular assist devices?", "history": [], "ground_truth": ["permed-78844", "permed-78146", "permed-78544", "permed-78845", "permed-86801", "permed-85518", "permed-88802", "permed-57363", "permed-57006", "permed-78548"]}
{"query_id": "topic_386_turn_2", "conversation_id": "topic_386", "turn_id": 2, "query": "How does medication, specifically angiotensin II antagonists, impact this risk in such patients?", "history": ["What is known about the risk of gastrointestinal bleeding in patients with left ventricular assist devices?"], "ground_truth": ["permed-78846", "permed-78844", "permed-10881", "permed-84815", "permed-58327", "permed-64797", "permed-78376", "permed-52224", "permed-16309", "permed-74882"]}
{"query_id": "topic_386_turn_3", "conversation_id": "topic_386", "turn_id": 3, "query": "How exactly do angiotensin II antagonists lower the risk of gastrointestinal bleeding in these LVAD patients through their mechanisms of action? And how do these mechanisms vary between patients who have arteriovenous malformations versus those who don't?", "history": ["What is known about the risk of gastrointestinal bleeding in patients with left ventricular assist devices?", "How does medication, specifically angiotensin II antagonists, impact this risk in such patients?"], "ground_truth": ["permed-78844", "permed-68796", "permed-70496", "permed-88802", "permed-78846", "permed-85773", "permed-57095", "permed-78146", "permed-57610", "permed-64797"]}
{"query_id": "topic_386_turn_4", "conversation_id": "topic_386", "turn_id": 4, "query": "When studying these proposed mechanisms in LVAD patients with and without AVMs, what specific experimental protocols would you recommend for quantifying changes in vascular integrity? Should researchers employ serial endoscopic imaging with standardized scoring systems, or are there more sensitive biomarkers for monitoring subtle alterations in angiodysplasia progression? How should we statistically power such studies given the heterogeneity in AVM distribution and bleeding phenotypes across this patient population?", "history": ["What is known about the risk of gastrointestinal bleeding in patients with left ventricular assist devices?", "How does medication, specifically angiotensin II antagonists, impact this risk in such patients?", "How exactly do angiotensin II antagonists lower the risk of gastrointestinal bleeding in these LVAD patients through their mechanisms of action? And how do these mechanisms vary between patients who have arteriovenous malformations versus those who don't?"], "ground_truth": ["permed-57193", "permed-24692", "permed-46789", "permed-46943", "permed-59862", "permed-76292", "permed-2775", "permed-18661", "permed-46788", "permed-18452"]}
{"query_id": "topic_387_turn_1", "conversation_id": "topic_387", "turn_id": 1, "query": "Influence of personal experience on social justice strategies of African American activists", "history": [], "ground_truth": ["permed-55645", "permed-75160", "permed-62291", "permed-90862", "permed-65740", "permed-74583", "permed-50971", "permed-66153", "permed-55107", "permed-74580"]}
{"query_id": "topic_387_turn_2", "conversation_id": "topic_387", "turn_id": 2, "query": "How these personal experiences, combined with collective narratives, shape the development of their resistance movements", "history": ["Influence of personal experience on social justice strategies of African American activists"], "ground_truth": ["permed-75160", "permed-62292", "permed-85968", "permed-62291", "permed-55107", "permed-55645", "permed-91062", "permed-62296", "permed-67621", "permed-57558"]}
{"query_id": "topic_387_turn_3", "conversation_id": "topic_387", "turn_id": 3, "query": "Specific applications: Charles Cobb Jr. and Alex Davis using lived experience and historical memory for resistance within the Black Radical Imaginary, building on such personal and collective foundations.", "history": ["Influence of personal experience on social justice strategies of African American activists", "How these personal experiences, combined with collective narratives, shape the development of their resistance movements"], "ground_truth": ["permed-74580", "permed-67617", "permed-74584", "permed-74583", "permed-69547", "permed-70222", "permed-75160", "permed-77763", "permed-59600", "permed-55107"]}
{"query_id": "topic_387_turn_4", "conversation_id": "topic_387", "turn_id": 4, "query": "Given Cobb's and Davis's reliance on lived experience as methodological foundation, what specific ethnographic protocols did they employ to document and validate these narratives? Were there standardized interview structures or participatory action research elements in their approach? How did they address potential biases when translating personal testimony into movement strategy, and what quality control measures ensured these accounts retained their transformative potential while maintaining methodological rigor for academic and activist audiences?", "history": ["Influence of personal experience on social justice strategies of African American activists", "How these personal experiences, combined with collective narratives, shape the development of their resistance movements", "Specific applications: Charles Cobb Jr. and Alex Davis using lived experience and historical memory for resistance within the Black Radical Imaginary, building on such personal and collective foundations."], "ground_truth": ["permed-72183", "permed-88838", "permed-74580", "permed-69886", "permed-51718", "permed-52380", "permed-69900", "permed-62298", "permed-52196", "permed-88839"]}
{"query_id": "topic_388_turn_1", "conversation_id": "topic_388", "turn_id": 1, "query": "What's known about the genetic factors influencing laryngeal carcinoma recurrence and survival rates?", "history": [], "ground_truth": ["permed-80391", "permed-73768", "permed-55172", "permed-68702", "permed-91146", "permed-52984", "permed-63419", "permed-92089", "permed-92091", "permed-51816"]}
{"query_id": "topic_388_turn_2", "conversation_id": "topic_388", "turn_id": 2, "query": "Does research in this area suggest that specific polymorphisms, like those related to hypoxia pathways, play a significant role in disease outcomes?", "history": ["What's known about the genetic factors influencing laryngeal carcinoma recurrence and survival rates?"], "ground_truth": ["permed-58360", "permed-77932", "permed-60721", "permed-78225", "permed-78020", "permed-64924", "permed-80848", "permed-60369", "permed-69129", "permed-53843"]}
{"query_id": "topic_388_turn_3", "conversation_id": "topic_388", "turn_id": 3, "query": "Given this association between the HIF-1α C1772T polymorphism and recurrence/survival outcomes in laryngeal carcinoma, how might it affect patient responses to specific treatments like radiation therapy or hypoxia-targeted therapies? Could these findings help tailor more personalized treatment approaches for this cancer?", "history": ["What's known about the genetic factors influencing laryngeal carcinoma recurrence and survival rates?", "Does research in this area suggest that specific polymorphisms, like those related to hypoxia pathways, play a significant role in disease outcomes?"], "ground_truth": ["permed-80391", "permed-22578", "permed-20062", "permed-51816", "permed-51776", "permed-56127", "permed-63419", "permed-62641", "permed-52581", "permed-56200"]}
{"query_id": "topic_388_turn_4", "conversation_id": "topic_388", "turn_id": 4, "query": "When evaluating how the HIF-1α C1772T polymorphism affects patient responses to radiation or hypoxia-targeted therapies, what specific methodology would you use to validate this clinically? For instance, would you employ a prospective cohort design with stratified randomization based on genotype? What statistical models—like Cox regression with interaction terms—are optimal for detecting genotype-by-treatment interactions, and what power calculations are needed to determine sample size for such an analysis? Additionally, how should treatment protocols be standardized to ensure reproducibility across different clinical sites?", "history": ["What's known about the genetic factors influencing laryngeal carcinoma recurrence and survival rates?", "Does research in this area suggest that specific polymorphisms, like those related to hypoxia pathways, play a significant role in disease outcomes?", "Given this association between the HIF-1α C1772T polymorphism and recurrence/survival outcomes in laryngeal carcinoma, how might it affect patient responses to specific treatments like radiation therapy or hypoxia-targeted therapies? Could these findings help tailor more personalized treatment approaches for this cancer?"], "ground_truth": ["permed-80391", "permed-22578", "permed-20062", "permed-13415", "permed-80395", "permed-70754", "permed-67781", "permed-43024", "permed-65373", "permed-22300"]}
{"query_id": "topic_389_turn_1", "conversation_id": "topic_389", "turn_id": 1, "query": "Herbal supplements for preventing chemotherapy-induced hepatotoxicity studies", "history": [], "ground_truth": ["permed-78120", "permed-58324", "permed-60272", "permed-78121", "permed-86234", "permed-59159", "permed-55336", "permed-57312", "permed-91820", "permed-85758"]}
{"query_id": "topic_389_turn_2", "conversation_id": "topic_389", "turn_id": 2, "query": "Pharmacological mechanisms of these herbal agents in protecting liver function during chemotherapy", "history": ["Herbal supplements for preventing chemotherapy-induced hepatotoxicity studies"], "ground_truth": ["permed-91820", "permed-78120", "permed-60747", "permed-65150", "permed-55336", "permed-86313", "permed-52125", "permed-78121", "permed-86234", "permed-69180"]}
{"query_id": "topic_389_turn_3", "conversation_id": "topic_389", "turn_id": 3, "query": "*Melissa officinalis* L. aqueous extract molecular pathways hepatoprotection methotrexate AND <sup>99m</sup>Tc-phytate liver uptake dose-response chemotherapy toxicity", "history": ["Herbal supplements for preventing chemotherapy-induced hepatotoxicity studies", "Pharmacological mechanisms of these herbal agents in protecting liver function during chemotherapy"], "ground_truth": ["permed-78120", "permed-60272", "permed-78121", "permed-78125", "permed-60275", "permed-63832", "permed-52125", "permed-60637", "permed-85758", "permed-69179"]}
{"query_id": "topic_389_turn_4", "conversation_id": "topic_389", "turn_id": 4, "query": "Since you're investigating Melissa officinalis hepatoprotection using both molecular pathways and <sup>99m</sup>Tc-phytate imaging, I'm particularly interested in your methodological validation approach. Specifically, what quality control measures did you implement for the aqueous extract standardization, and how did you optimize the timing between extract administration and <sup>99m</sup>Tc-phytate scanning to capture peak hepatoprotective effects? Also, what statistical methods were employed to correlate the imaging data with biochemical markers across your dose-response groups?", "history": ["Herbal supplements for preventing chemotherapy-induced hepatotoxicity studies", "Pharmacological mechanisms of these herbal agents in protecting liver function during chemotherapy", "*Melissa officinalis* L. aqueous extract molecular pathways hepatoprotection methotrexate AND <sup>99m</sup>Tc-phytate liver uptake dose-response chemotherapy toxicity"], "ground_truth": ["permed-78120", "permed-78121", "permed-55336", "permed-34779", "permed-73444", "permed-36981", "permed-52753", "permed-69259", "permed-88150", "permed-60272"]}
{"query_id": "topic_390_turn_1", "conversation_id": "topic_390", "turn_id": 1, "query": "Overview of metal oxide nanomaterials in pathogen detection systems", "history": [], "ground_truth": ["permed-66235", "permed-64381", "permed-77425", "permed-73364", "permed-77790", "permed-77423", "permed-70331", "permed-52542", "permed-62237", "permed-77424"]}
{"query_id": "topic_390_turn_2", "conversation_id": "topic_390", "turn_id": 2, "query": "Leveraging oxidase-like activity in such metal oxide nanomaterials for improved sensitivity and selectivity in pathogen detection", "history": ["Overview of metal oxide nanomaterials in pathogen detection systems"], "ground_truth": ["permed-77425", "permed-77423", "permed-73364", "permed-74370", "permed-60472", "permed-73213", "permed-73214", "permed-92628", "permed-73362", "permed-58029"]}
{"query_id": "topic_390_turn_3", "conversation_id": "topic_390", "turn_id": 3, "query": "Optimizing non-MnO₂ metal oxide nanozymes exhibiting this oxidase-like activity for ultrasensitive label-free Hepatitis E Virus detection in serum: exploring catalytic mechanisms and tailoring for complex matrices", "history": ["Overview of metal oxide nanomaterials in pathogen detection systems", "Leveraging oxidase-like activity in such metal oxide nanomaterials for improved sensitivity and selectivity in pathogen detection"], "ground_truth": ["permed-77423", "permed-73214", "permed-73362", "permed-60472", "permed-58026", "permed-58030", "permed-73364", "permed-77426", "permed-58028", "permed-75346"]}
{"query_id": "topic_390_turn_4", "conversation_id": "topic_390", "turn_id": 4, "query": "Given these optimization efforts for non-MnO₂ nanozymes in complex serum matrices, could you detail the specific protocols used for characterizing their oxidase-like catalytic mechanisms? I'm particularly interested in the spectroscopic techniques employed to track reactive oxygen species generation, the kinetic assays used to determine Michaelis-Menten parameters in serum-containing buffers, and how you validated that observed catalytic enhancements weren't due to simple adsorption effects rather than genuine enzymatic activity.", "history": ["Overview of metal oxide nanomaterials in pathogen detection systems", "Leveraging oxidase-like activity in such metal oxide nanomaterials for improved sensitivity and selectivity in pathogen detection", "Optimizing non-MnO₂ metal oxide nanozymes exhibiting this oxidase-like activity for ultrasensitive label-free Hepatitis E Virus detection in serum: exploring catalytic mechanisms and tailoring for complex matrices"], "ground_truth": ["permed-60472", "permed-58029", "permed-77426", "permed-58024", "permed-73362", "permed-89159", "permed-58031", "permed-57854", "permed-58028", "permed-58025"]}
{"query_id": "topic_391_turn_1", "conversation_id": "topic_391", "turn_id": 1, "query": "What is known about the impact of agricultural chemicals on honey bee colonies?", "history": [], "ground_truth": ["permed-82241", "permed-82242", "permed-82040", "permed-82244", "permed-82243", "permed-82246", "permed-53658", "permed-53762", "permed-53654", "permed-82245"]}
{"query_id": "topic_391_turn_2", "conversation_id": "topic_391", "turn_id": 2, "query": "How might interactions between different types of these chemicals affect this impact?", "history": ["What is known about the impact of agricultural chemicals on honey bee colonies?"], "ground_truth": ["permed-82651", "permed-78358", "permed-71707", "permed-65889", "permed-55338", "permed-39670", "permed-68509", "permed-68563", "permed-72010", "permed-64159"]}
{"query_id": "topic_391_turn_3", "conversation_id": "topic_391", "turn_id": 3, "query": "Given that we've seen thiamethoxam and fluconazole have synergistic effects on honey bees, how might adding other common agricultural chemicals like fungicides or herbicides influence these interactions? And what would that mean for honey bee colony health and their ecosystem services in the long run?", "history": ["What is known about the impact of agricultural chemicals on honey bee colonies?", "How might interactions between different types of these chemicals affect this impact?"], "ground_truth": ["permed-82040", "permed-82241", "permed-82242", "permed-82244", "permed-82245", "permed-82243", "permed-53658", "permed-82246", "permed-53654", "permed-84803"]}
{"query_id": "topic_391_turn_4", "conversation_id": "topic_391", "turn_id": 4, "query": "Given this complex chemical interaction scenario, what specific experimental designs would best capture the synergistic effects when additional fungicides or herbicides are introduced? I'm particularly interested in methodological details about dose-response matrix configurations, appropriate statistical models for analyzing higher-order interactions, and validation strategies to distinguish true synergism from additive effects across multiple chemical combinations. How would you recommend standardizing exposure protocols while maintaining ecological relevance for honey bee colonies?", "history": ["What is known about the impact of agricultural chemicals on honey bee colonies?", "How might interactions between different types of these chemicals affect this impact?", "Given that we've seen thiamethoxam and fluconazole have synergistic effects on honey bees, how might adding other common agricultural chemicals like fungicides or herbicides influence these interactions? And what would that mean for honey bee colony health and their ecosystem services in the long run?"], "ground_truth": ["permed-82040", "permed-82242", "permed-82241", "permed-82244", "permed-82246", "permed-84803", "permed-53654", "permed-53658", "permed-62990", "permed-64450"]}
{"query_id": "topic_392_turn_1", "conversation_id": "topic_392", "turn_id": 1, "query": "What role do parasites play in shaping the ecological dynamics of seabird communities?", "history": [], "ground_truth": ["permed-85787", "permed-78780", "permed-74479", "permed-74411", "permed-81791", "permed-77658", "permed-67812", "permed-74492", "permed-83675", "permed-68815"]}
{"query_id": "topic_392_turn_2", "conversation_id": "topic_392", "turn_id": 2, "query": "How might discoveries of new parasite species, like those found on petrels, impact our understanding of this dynamic?", "history": ["What role do parasites play in shaping the ecological dynamics of seabird communities?"], "ground_truth": ["permed-67812", "permed-81828", "permed-62080", "permed-78447", "permed-74479", "permed-85787", "permed-66973", "permed-62182", "permed-78780", "permed-83314"]}
{"query_id": "topic_392_turn_3", "conversation_id": "topic_392", "turn_id": 3, "query": "Given these findings about new parasite species on petrels, how might the discovery of previously unrecorded chewing lice on white-chinned petrels in Brazilian waters reshape our understanding of parasite-host coevolution and seabird community dynamics? What would this mean for conservation strategies and health monitoring of these marine birds?", "history": ["What role do parasites play in shaping the ecological dynamics of seabird communities?", "How might discoveries of new parasite species, like those found on petrels, impact our understanding of this dynamic?"], "ground_truth": ["permed-81828", "permed-62080", "permed-84204", "permed-62077", "permed-78630", "permed-78622", "permed-78780", "permed-81791", "permed-67812", "permed-83314"]}
{"query_id": "topic_392_turn_4", "conversation_id": "topic_392", "turn_id": 4, "query": "When documenting these newly discovered chewing lice on white-chinned petrels, what specific morphological and molecular techniques were employed for species identification and phylogenetic placement? I'm particularly interested in the protocol details for microscopic examination, specimen preservation methods, and which genetic markers were sequenced. How did researchers validate their taxonomic conclusions, and what statistical approaches were used to analyze host-parasite coevolutionary relationships from the collected specimens?", "history": ["What role do parasites play in shaping the ecological dynamics of seabird communities?", "How might discoveries of new parasite species, like those found on petrels, impact our understanding of this dynamic?", "Given these findings about new parasite species on petrels, how might the discovery of previously unrecorded chewing lice on white-chinned petrels in Brazilian waters reshape our understanding of parasite-host coevolution and seabird community dynamics? What would this mean for conservation strategies and health monitoring of these marine birds?"], "ground_truth": ["permed-81828", "permed-89605", "permed-62080", "permed-80322", "permed-89604", "permed-88448", "permed-78622", "permed-71757", "permed-80326", "permed-79888"]}
{"query_id": "topic_393_turn_1", "conversation_id": "topic_393", "turn_id": 1, "query": "What is known about the genetic factors contributing to the variation in symptom progression among Moko disease variants?", "history": [], "ground_truth": ["permed-67061", "permed-71612", "permed-49826", "permed-70696", "permed-8846", "permed-42833", "permed-66455", "permed-45146", "permed-60722", "permed-49825"]}
{"query_id": "topic_393_turn_2", "conversation_id": "topic_393", "turn_id": 2, "query": "How do these genetic factors influence the virulence and adaptation of Moko disease in different environments, particularly in the case of the Bugtok and Sergipe facies variants?", "history": ["What is known about the genetic factors contributing to the variation in symptom progression among Moko disease variants?"], "ground_truth": ["permed-67061", "permed-58160", "permed-72198", "permed-65955", "permed-62134", "permed-85023", "permed-83668", "permed-66950", "permed-22280", "permed-72205"]}
{"query_id": "topic_393_turn_3", "conversation_id": "topic_393", "turn_id": 3, "query": "Given the high genetic similarity and presence of exclusive homolog clusters among these variants, how might specific genetic elements or regulatory networks explain the distinct symptom progression in Bugtok and Sergipe facies compared to typical Moko variants? What role do these elements play in their adaptation and virulence across different environments, and how could this understanding help develop targeted control strategies for banana bacterial wilt?", "history": ["What is known about the genetic factors contributing to the variation in symptom progression among Moko disease variants?", "How do these genetic factors influence the virulence and adaptation of Moko disease in different environments, particularly in the case of the Bugtok and Sergipe facies variants?"], "ground_truth": ["permed-67061", "permed-58160", "permed-78965", "permed-63913", "permed-65955", "permed-66662", "permed-85023", "permed-64032", "permed-66664", "permed-64091"]}
{"query_id": "topic_393_turn_4", "conversation_id": "topic_393", "turn_id": 4, "query": "Given these identified genetic elements and regulatory networks, what specific experimental approaches would you recommend for functionally validating their roles in symptom progression differences? I'm particularly interested in the technical implementation - would you use targeted mutagenesis in specific homolog clusters, or employ transcriptomic profiling across different infection timepoints? Also, what statistical methods would be most appropriate for determining whether expression differences in these networks significantly correlate with the observed virulence variations between Bugtok and Sergipe facies?", "history": ["What is known about the genetic factors contributing to the variation in symptom progression among Moko disease variants?", "How do these genetic factors influence the virulence and adaptation of Moko disease in different environments, particularly in the case of the Bugtok and Sergipe facies variants?", "Given the high genetic similarity and presence of exclusive homolog clusters among these variants, how might specific genetic elements or regulatory networks explain the distinct symptom progression in Bugtok and Sergipe facies compared to typical Moko variants? What role do these elements play in their adaptation and virulence across different environments, and how could this understanding help develop targeted control strategies for banana bacterial wilt?"], "ground_truth": ["permed-67061", "permed-63911", "permed-64137", "permed-13623", "permed-63229", "permed-53730", "permed-71607", "permed-22781", "permed-84322", "permed-82376"]}
{"query_id": "topic_394_turn_1", "conversation_id": "topic_394", "turn_id": 1, "query": "Advancements in halide perovskite and 2D material heterostructures for optoelectronic devices", "history": [], "ground_truth": ["permed-53814", "permed-53816", "permed-60957", "permed-73240", "permed-73262", "permed-53817", "permed-83323", "permed-53786", "permed-53813", "permed-76396"]}
{"query_id": "topic_394_turn_2", "conversation_id": "topic_394", "turn_id": 2, "query": "Impact of interface engineering in these perovskite-2D heterostructures on their optoelectronic performance and stability", "history": ["Advancements in halide perovskite and 2D material heterostructures for optoelectronic devices"], "ground_truth": ["permed-53814", "permed-73240", "permed-75674", "permed-77392", "permed-60957", "permed-83323", "permed-53816", "permed-53786", "permed-73241", "permed-73231"]}
{"query_id": "topic_394_turn_3", "conversation_id": "topic_394", "turn_id": 3, "query": "Precise interfacial electronic property control in perovskite-2D optoelectronics for enhanced efficiency, stability, and scalability, plus advanced techniques for interface mechanism characterization", "history": ["Advancements in halide perovskite and 2D material heterostructures for optoelectronic devices", "Impact of interface engineering in these perovskite-2D heterostructures on their optoelectronic performance and stability"], "ground_truth": ["permed-53814", "permed-73241", "permed-83323", "permed-77392", "permed-79575", "permed-73240", "permed-75674", "permed-53786", "permed-73231", "permed-73232"]}
{"query_id": "topic_394_turn_4", "conversation_id": "topic_394", "turn_id": 4, "query": "Regarding these characterization techniques for interface mechanisms, what specific spectroscopic and microscopic methods were employed to validate the precise electronic property control? Could you detail the experimental protocols for cross-sectional TEM sample preparation and the operational parameters for Kelvin probe force microscopy measurements used to map interfacial band alignments? Additionally, what statistical validation approaches ensured reproducibility in quantifying defect passivation efficacy across multiple device batches?", "history": ["Advancements in halide perovskite and 2D material heterostructures for optoelectronic devices", "Impact of interface engineering in these perovskite-2D heterostructures on their optoelectronic performance and stability", "Precise interfacial electronic property control in perovskite-2D optoelectronics for enhanced efficiency, stability, and scalability, plus advanced techniques for interface mechanism characterization"], "ground_truth": ["permed-77000", "permed-60324", "permed-53789", "permed-83500", "permed-53814", "permed-77033", "permed-87645", "permed-51039", "permed-63255", "permed-72983"]}
{"query_id": "topic_395_turn_1", "conversation_id": "topic_395", "turn_id": 1, "query": "What advancements have been made in using nanomaterials for gas detection in environmental monitoring?", "history": [], "ground_truth": ["permed-76109", "permed-78460", "permed-75983", "permed-52465", "permed-64614", "permed-79105", "permed-78705", "permed-77141", "permed-79107", "permed-73014"]}
{"query_id": "topic_395_turn_2", "conversation_id": "topic_395", "turn_id": 2, "query": "How do the properties of transition metal dichalcogenides, like WSe2, make them particularly promising for this application?", "history": ["What advancements have been made in using nanomaterials for gas detection in environmental monitoring?"], "ground_truth": ["permed-76395", "permed-78822", "permed-77027", "permed-75057", "permed-76993", "permed-75053", "permed-76035", "permed-87228", "permed-76994", "permed-78525"]}
{"query_id": "topic_395_turn_3", "conversation_id": "topic_395", "turn_id": 3, "query": "Given the unique structural and chemical properties of 3D assemblies of edge-enriched WSe<sub>2</sub> nanoplatelets, how might we optimize these materials to enhance their sensitivity and selectivity for detecting other environmentally significant gases like SO<sub>2</sub> or CO, beyond just NH<sub>3</sub> and NO<sub>2</sub>? Specifically, how could tailoring the surface chemistry or defect engineering of WSe<sub>2</sub> nanoflowers improve their interaction with these target gases, and what would that mean for sensor performance under varying operational conditions like temperature and humidity? Furthermore, how could integrating these optimized structures into portable or wearable devices advance real-world environmental monitoring and industrial safety applications?", "history": ["What advancements have been made in using nanomaterials for gas detection in environmental monitoring?", "How do the properties of transition metal dichalcogenides, like WSe2, make them particularly promising for this application?"], "ground_truth": ["permed-77145", "permed-79105", "permed-78460", "permed-79106", "permed-75956", "permed-79107", "permed-77147", "permed-78705", "permed-77144", "permed-77146"]}
{"query_id": "topic_395_turn_4", "conversation_id": "topic_395", "turn_id": 4, "query": "Given these proposed optimization strategies for WSe<sub>2</sub> nanoflowers, what specific experimental protocols would you recommend for systematically evaluating the impact of surface chemistry modifications and defect engineering on sensor performance metrics? I'm particularly interested in the methodology for quantifying changes in sensitivity and selectivity towards SO<sub>2</sub> and CO—should we employ standardized gas mixing systems with controlled humidity levels, and which characterization techniques (beyond standard XPS and SEM) would best correlate structural modifications with electrochemical response data across different operational temperatures?", "history": ["What advancements have been made in using nanomaterials for gas detection in environmental monitoring?", "How do the properties of transition metal dichalcogenides, like WSe2, make them particularly promising for this application?", "Given the unique structural and chemical properties of 3D assemblies of edge-enriched WSe<sub>2</sub> nanoplatelets, how might we optimize these materials to enhance their sensitivity and selectivity for detecting other environmentally significant gases like SO<sub>2</sub> or CO, beyond just NH<sub>3</sub> and NO<sub>2</sub>? Specifically, how could tailoring the surface chemistry or defect engineering of WSe<sub>2</sub> nanoflowers improve their interaction with these target gases, and what would that mean for sensor performance under varying operational conditions like temperature and humidity? Furthermore, how could integrating these optimized structures into portable or wearable devices advance real-world environmental monitoring and industrial safety applications?"], "ground_truth": ["permed-77145", "permed-78460", "permed-79106", "permed-53485", "permed-79105", "permed-75956", "permed-77144", "permed-87228", "permed-77147", "permed-82695"]}
{"query_id": "topic_396_turn_1", "conversation_id": "topic_396", "turn_id": 1, "query": "What is known about the binding properties of climbazole with proteins like bovine serum albumin?", "history": [], "ground_truth": ["permed-80958", "permed-78031", "permed-78128", "permed-80960", "permed-84217", "permed-76537", "permed-79555", "permed-65076", "permed-66558", "permed-75976"]}
{"query_id": "topic_396_turn_2", "conversation_id": "topic_396", "turn_id": 2, "query": "How do interactions such as hydrophobic forces and hydrogen bonds contribute to this binding process?", "history": ["What is known about the binding properties of climbazole with proteins like bovine serum albumin?"], "ground_truth": ["permed-74949", "permed-53602", "permed-75486", "permed-78854", "permed-52612", "permed-79872", "permed-75070", "permed-80966", "permed-50897", "permed-57991"]}
{"query_id": "topic_396_turn_3", "conversation_id": "topic_396", "turn_id": 3, "query": "Given that CBZ shows weak binding to BSA through these interactions we've discussed—hydrophobic forces, van der Waals, and hydrogen bonds—how might changes in pH or ionic strength influence the binding stability and characteristics of this complex? And what could these environmental variations mean for CBZ's transport and therapeutic effectiveness in biological systems?", "history": ["What is known about the binding properties of climbazole with proteins like bovine serum albumin?", "How do interactions such as hydrophobic forces and hydrogen bonds contribute to this binding process?"], "ground_truth": ["permed-80958", "permed-53602", "permed-84219", "permed-80959", "permed-80966", "permed-75977", "permed-76537", "permed-75480", "permed-78031", "permed-52616"]}
{"query_id": "topic_396_turn_4", "conversation_id": "topic_396", "turn_id": 4, "query": "Given these environmental influences on CBZ-BSA binding stability, what specific spectroscopic or calorimetric techniques would be most appropriate to quantitatively characterize the binding thermodynamics under varying pH and ionic strength conditions? I'm particularly interested in the methodological considerations for distinguishing between enthalpy-entropy compensation effects and determining whether the binding mechanism shifts from hydrophobic-driven to electrostatic-driven as environmental conditions change.", "history": ["What is known about the binding properties of climbazole with proteins like bovine serum albumin?", "How do interactions such as hydrophobic forces and hydrogen bonds contribute to this binding process?", "Given that CBZ shows weak binding to BSA through these interactions we've discussed—hydrophobic forces, van der Waals, and hydrogen bonds—how might changes in pH or ionic strength influence the binding stability and characteristics of this complex? And what could these environmental variations mean for CBZ's transport and therapeutic effectiveness in biological systems?"], "ground_truth": ["permed-79259", "permed-53602", "permed-80958", "permed-80966", "permed-84219", "permed-74685", "permed-73078", "permed-75977", "permed-87726", "permed-89843"]}
{"query_id": "topic_397_turn_1", "conversation_id": "topic_397", "turn_id": 1, "query": "Common vascular manifestations and complications in juvenile idiopathic arthritis (JIA)", "history": [], "ground_truth": ["permed-49867", "permed-77606", "permed-45835", "permed-62461", "permed-23040", "permed-55907", "permed-30951", "permed-23775", "permed-45836", "permed-87855"]}
{"query_id": "topic_397_turn_2", "conversation_id": "topic_397", "turn_id": 2, "query": "Long-term cardiovascular health consequences of these JIA-related vascular problems", "history": ["Common vascular manifestations and complications in juvenile idiopathic arthritis (JIA)"], "ground_truth": ["permed-77606", "permed-49748", "permed-49867", "permed-52036", "permed-57279", "permed-57174", "permed-44599", "permed-78995", "permed-57030", "permed-77608"]}
{"query_id": "topic_397_turn_3", "conversation_id": "topic_397", "turn_id": 3, "query": "Impact of JIA-induced vascular dysfunction (e.g., increased CIMT, reduced FMD) on future cardiovascular disease: underlying mechanisms and therapeutic interventions", "history": ["Common vascular manifestations and complications in juvenile idiopathic arthritis (JIA)", "Long-term cardiovascular health consequences of these JIA-related vascular problems"], "ground_truth": ["permed-77606", "permed-49748", "permed-78995", "permed-49867", "permed-72599", "permed-91510", "permed-52036", "permed-30951", "permed-92177", "permed-57279"]}
{"query_id": "topic_397_turn_4", "conversation_id": "topic_397", "turn_id": 4, "query": "When measuring these vascular dysfunction parameters in JIA patients, what specific protocols do researchers use to standardize CIMT and FMD assessments across pediatric populations? Given the technical challenges in obtaining reliable measurements in children, what quality control measures are typically implemented during ultrasound imaging, and how are these methods validated against established pediatric reference ranges? Also, what statistical approaches are most appropriate for analyzing longitudinal changes in vascular function while accounting for growth-related variables and medication effects?", "history": ["Common vascular manifestations and complications in juvenile idiopathic arthritis (JIA)", "Long-term cardiovascular health consequences of these JIA-related vascular problems", "Impact of JIA-induced vascular dysfunction (e.g., increased CIMT, reduced FMD) on future cardiovascular disease: underlying mechanisms and therapeutic interventions"], "ground_truth": ["permed-77606", "permed-30951", "permed-57040", "permed-77607", "permed-87855", "permed-49748", "permed-91070", "permed-12834", "permed-59137", "permed-18482"]}
{"query_id": "topic_398_turn_1", "conversation_id": "topic_398", "turn_id": 1, "query": "What role does neural activity play in the development of substance use disorders?", "history": [], "ground_truth": ["permed-76547", "permed-72304", "permed-53124", "permed-72308", "permed-55740", "permed-67672", "permed-11221", "permed-79939", "permed-72307", "permed-72301"]}
{"query_id": "topic_398_turn_2", "conversation_id": "topic_398", "turn_id": 2, "query": "Are there specific brain circuits or patterns of connectivity that are particularly relevant to this process?", "history": ["What role does neural activity play in the development of substance use disorders?"], "ground_truth": ["permed-59220", "permed-61760", "permed-66489", "permed-69427", "permed-88616", "permed-66534", "permed-64694", "permed-79969", "permed-84238", "permed-77860"]}
{"query_id": "topic_398_turn_3", "conversation_id": "topic_398", "turn_id": 3, "query": "Given these findings about specific brain circuits and connectivity patterns, how might the early-stage neural activity observed in the frontal-LHb-SN circuits predict the transition to compulsive drug use? And could these early biomarkers help inform personalized prevention strategies or treatment approaches?", "history": ["What role does neural activity play in the development of substance use disorders?", "Are there specific brain circuits or patterns of connectivity that are particularly relevant to this process?"], "ground_truth": ["permed-76547", "permed-79939", "permed-55740", "permed-55574", "permed-83396", "permed-79940", "permed-78085", "permed-74932", "permed-66500", "permed-55577"]}
{"query_id": "topic_398_turn_4", "conversation_id": "topic_398", "turn_id": 4, "query": "When implementing this early biomarker approach for predicting compulsive drug use transitions, what specific experimental protocols would you recommend for longitudinal neural activity monitoring in the frontal-LHb-SN circuits? I'm particularly interested in the statistical validation methods—would you employ machine learning classifiers, and how would you address potential confounders like individual variability in baseline neural activity? Additionally, what quality control measures ensure reproducible circuit connectivity measurements across multiple imaging sessions?", "history": ["What role does neural activity play in the development of substance use disorders?", "Are there specific brain circuits or patterns of connectivity that are particularly relevant to this process?", "Given these findings about specific brain circuits and connectivity patterns, how might the early-stage neural activity observed in the frontal-LHb-SN circuits predict the transition to compulsive drug use? And could these early biomarkers help inform personalized prevention strategies or treatment approaches?"], "ground_truth": ["permed-76547", "permed-69425", "permed-55577", "permed-74932", "permed-73851", "permed-79939", "permed-40941", "permed-55740", "permed-83396", "permed-79940"]}
{"query_id": "topic_399_turn_1", "conversation_id": "topic_399", "turn_id": 1, "query": "What approaches are being explored to improve the treatment of tuberculosis, especially in patients with compromised immune systems?", "history": [], "ground_truth": ["permed-76424", "permed-22803", "permed-67868", "permed-26562", "permed-22804", "permed-22221", "permed-61589", "permed-71543", "permed-11755", "permed-26665"]}
{"query_id": "topic_399_turn_2", "conversation_id": "topic_399", "turn_id": 2, "query": "How does modulating the immune response factor into these approaches, particularly in terms of reducing inflammation and enhancing pathogen clearance?", "history": ["What approaches are being explored to improve the treatment of tuberculosis, especially in patients with compromised immune systems?"], "ground_truth": ["permed-76424", "permed-64689", "permed-55359", "permed-67855", "permed-80514", "permed-68173", "permed-60694", "permed-76647", "permed-55927", "permed-91488"]}
{"query_id": "topic_399_turn_3", "conversation_id": "topic_399", "turn_id": 3, "query": "Given these immune modulation approaches, how can we specifically optimize cytokine signaling and neutrophil function in host-directed therapies to better balance reducing inflammation and tissue damage with enhancing Mycobacterium tuberculosis clearance—particularly for patients with comorbidities like diabetes or HIV—to improve both treatment efficacy and duration?", "history": ["What approaches are being explored to improve the treatment of tuberculosis, especially in patients with compromised immune systems?", "How does modulating the immune response factor into these approaches, particularly in terms of reducing inflammation and enhancing pathogen clearance?"], "ground_truth": ["permed-76424", "permed-85845", "permed-72219", "permed-84026", "permed-67868", "permed-27194", "permed-27026", "permed-60453", "permed-71966", "permed-68290"]}
{"query_id": "topic_399_turn_4", "conversation_id": "topic_399", "turn_id": 4, "query": "Given this cytokine and neutrophil optimization framework, what specific experimental protocols would you recommend for quantitatively assessing the spatial dynamics of neutrophil extracellular trap formation in granulomatous lesions? I'm particularly interested in how advanced imaging techniques like intravital microscopy or multiplex immunohistochemistry could be integrated with transcriptomic analyses to validate that our immunomodulatory interventions are achieving the desired balance between controlled inflammation and bacterial clearance without compromising granuloma structural integrity in co-morbid models.", "history": ["What approaches are being explored to improve the treatment of tuberculosis, especially in patients with compromised immune systems?", "How does modulating the immune response factor into these approaches, particularly in terms of reducing inflammation and enhancing pathogen clearance?", "Given these immune modulation approaches, how can we specifically optimize cytokine signaling and neutrophil function in host-directed therapies to better balance reducing inflammation and tissue damage with enhancing Mycobacterium tuberculosis clearance—particularly for patients with comorbidities like diabetes or HIV—to improve both treatment efficacy and duration?"], "ground_truth": ["permed-68104", "permed-88638", "permed-68103", "permed-79505", "permed-27530", "permed-44705", "permed-64724", "permed-27040", "permed-68102", "permed-22892"]}
{"query_id": "topic_400_turn_1", "conversation_id": "topic_400", "turn_id": 1, "query": "Recent advancements and applications of molecularly imprinted materials in biomedicine review", "history": [], "ground_truth": ["permed-72499", "permed-64381", "permed-64382", "permed-78759", "permed-83795", "permed-51339", "permed-53718", "permed-77789", "permed-60645", "permed-60899"]}
{"query_id": "topic_400_turn_2", "conversation_id": "topic_400", "turn_id": 2, "query": "Evaluating the efficacy of these molecularly imprinted materials as sensors for glutathione detection in complex biological matrices", "history": ["Recent advancements and applications of molecularly imprinted materials in biomedicine review"], "ground_truth": ["permed-74508", "permed-74509", "permed-83795", "permed-74510", "permed-87791", "permed-88006", "permed-86190", "permed-83794", "permed-80835", "permed-74511"]}
{"query_id": "topic_400_turn_3", "conversation_id": "topic_400", "turn_id": 3, "query": "Adapting molecularly imprinted gold nanoparticle platforms for real-time clinical biomarker monitoring: strategies and challenges (sensitivity, selectivity, biocompatibility)", "history": ["Recent advancements and applications of molecularly imprinted materials in biomedicine review", "Evaluating the efficacy of these molecularly imprinted materials as sensors for glutathione detection in complex biological matrices"], "ground_truth": ["permed-74509", "permed-74510", "permed-74508", "permed-80353", "permed-73044", "permed-74512", "permed-80835", "permed-72989", "permed-73043", "permed-80640"]}
{"query_id": "topic_400_turn_4", "conversation_id": "topic_400", "turn_id": 4, "query": "Regarding this molecularly imprinted gold nanoparticle platform, what specific surface functionalization protocols and characterization techniques were employed to optimize both glutathione binding affinity and sensor biocompatibility? I'm particularly interested in how you balanced these competing requirements during the material synthesis phase, and what analytical methods (such as SPR, QCM, or electrochemical impedance) provided the most reliable validation of your imprinting efficiency against control experiments in complex biological fluids.", "history": ["Recent advancements and applications of molecularly imprinted materials in biomedicine review", "Evaluating the efficacy of these molecularly imprinted materials as sensors for glutathione detection in complex biological matrices", "Adapting molecularly imprinted gold nanoparticle platforms for real-time clinical biomarker monitoring: strategies and challenges (sensitivity, selectivity, biocompatibility)"], "ground_truth": ["permed-74508", "permed-74509", "permed-78726", "permed-80835", "permed-77394", "permed-73044", "permed-74511", "permed-74510", "permed-79254", "permed-64270"]}
{"query_id": "topic_401_turn_1", "conversation_id": "topic_401", "turn_id": 1, "query": "What are the most promising investigational treatments currently in research for severe hidradenitis suppurativa, including novel mechanisms of action?", "history": [], "ground_truth": ["permed-53283", "permed-53289", "permed-81494", "permed-76817", "permed-52030", "permed-57773", "permed-86891", "permed-67332", "permed-12539", "permed-68054"]}
{"query_id": "topic_401_turn_2", "conversation_id": "topic_401", "turn_id": 2, "query": "Among these investigational treatments for severe hidradenitis suppurativa, how do biologic therapies specifically perform in terms of clinical efficacy, and what are the key differentiators between various biologics available or in late-stage trials?", "history": ["What are the most promising investigational treatments currently in research for severe hidradenitis suppurativa, including novel mechanisms of action?"], "ground_truth": ["permed-53289", "permed-53283", "permed-51194", "permed-12488", "permed-76817", "permed-12640", "permed-12923", "permed-81494", "permed-53285", "permed-53191"]}
{"query_id": "topic_401_turn_3", "conversation_id": "topic_401", "turn_id": 3, "query": "For patients with refractory severe hidradenitis suppurativa, what is the long-term comparative effectiveness, safety profile, and impact on quality of life of secukinumab (IL-17A inhibitor) versus other targeted biologic pathways (e.g., TNF-alpha, IL-23p19) when used as continuous monotherapy, and how can these data inform personalized treatment selection?", "history": ["What are the most promising investigational treatments currently in research for severe hidradenitis suppurativa, including novel mechanisms of action?", "Among these investigational treatments for severe hidradenitis suppurativa, how do biologic therapies specifically perform in terms of clinical efficacy, and what are the key differentiators between various biologics available or in late-stage trials?"], "ground_truth": ["permed-53283", "permed-88026", "permed-53289", "permed-53282", "permed-76817", "permed-52030", "permed-53284", "permed-67332", "permed-12488", "permed-57773"]}
{"query_id": "topic_401_turn_4", "conversation_id": "topic_401", "turn_id": 4, "query": "When comparing long-term outcomes for these biologic pathways, what specific statistical methods were employed to handle missing data and treatment discontinuations in longitudinal studies? Given the chronic nature of HS requiring extended follow-up, how did researchers validate their time-to-event analyses for outcomes like flare recurrence or surgical intervention, and what sensitivity analyses were implemented to test the robustness of comparative effectiveness conclusions between treatment arms?", "history": ["What are the most promising investigational treatments currently in research for severe hidradenitis suppurativa, including novel mechanisms of action?", "Among these investigational treatments for severe hidradenitis suppurativa, how do biologic therapies specifically perform in terms of clinical efficacy, and what are the key differentiators between various biologics available or in late-stage trials?", "For patients with refractory severe hidradenitis suppurativa, what is the long-term comparative effectiveness, safety profile, and impact on quality of life of secukinumab (IL-17A inhibitor) versus other targeted biologic pathways (e.g., TNF-alpha, IL-23p19) when used as continuous monotherapy, and how can these data inform personalized treatment selection?"], "ground_truth": ["permed-88027", "permed-84703", "permed-71631", "permed-75528", "permed-51194", "permed-67339", "permed-51746", "permed-54914", "permed-80123", "permed-70629"]}
{"query_id": "topic_402_turn_1", "conversation_id": "topic_402", "turn_id": 1, "query": "What is known about the anticancer properties of compounds derived from plants like Lantana camara?", "history": [], "ground_truth": ["permed-59494", "permed-85753", "permed-91184", "permed-80170", "permed-79766", "permed-89229", "permed-60650", "permed-72805", "permed-58121", "permed-74178"]}
{"query_id": "topic_402_turn_2", "conversation_id": "topic_402", "turn_id": 2, "query": "How do modifications to these natural compounds affect their efficacy against specific types of cancer cells?", "history": ["What is known about the anticancer properties of compounds derived from plants like Lantana camara?"], "ground_truth": ["permed-89229", "permed-51200", "permed-67786", "permed-73072", "permed-92369", "permed-58121", "permed-69188", "permed-73127", "permed-67855", "permed-68983"]}
{"query_id": "topic_402_turn_3", "conversation_id": "topic_402", "turn_id": 3, "query": "Given these findings about modified plant compounds, could you elaborate on how structural changes to pentacyclic triterpenoids from Lantana camara specifically enhance their anticancer mechanisms? What molecular interactions drive their increased cytotoxicity against melanoma and squamous cell carcinoma cell lines?", "history": ["What is known about the anticancer properties of compounds derived from plants like Lantana camara?", "How do modifications to these natural compounds affect their efficacy against specific types of cancer cells?"], "ground_truth": ["permed-59494", "permed-58121", "permed-75042", "permed-79609", "permed-78967", "permed-59491", "permed-73072", "permed-80170", "permed-86221", "permed-86219"]}
{"query_id": "topic_402_turn_4", "conversation_id": "topic_402", "turn_id": 4, "query": "Regarding these structural modifications to pentacyclic triterpenoids, could you detail the specific experimental protocols used to validate their enhanced cytotoxicity in melanoma and squamous cell carcinoma models? I'm particularly interested in the cell viability assay parameters, incubation periods, and concentration ranges tested. Additionally, what statistical methods were employed to compare cytotoxicity between modified versus unmodified compounds, and how was reproducibility ensured across replicate experiments?", "history": ["What is known about the anticancer properties of compounds derived from plants like Lantana camara?", "How do modifications to these natural compounds affect their efficacy against specific types of cancer cells?", "Given these findings about modified plant compounds, could you elaborate on how structural changes to pentacyclic triterpenoids from Lantana camara specifically enhance their anticancer mechanisms? What molecular interactions drive their increased cytotoxicity against melanoma and squamous cell carcinoma cell lines?"], "ground_truth": ["permed-75042", "permed-59494", "permed-75039", "permed-58121", "permed-60347", "permed-79616", "permed-59491", "permed-79609", "permed-59493", "permed-60340"]}
{"query_id": "topic_403_turn_1", "conversation_id": "topic_403", "turn_id": 1, "query": "What role do bimetallic catalysts play in non-thermal plasma reactors for volatile organic compound abatement?", "history": [], "ground_truth": ["permed-79490", "permed-88473", "permed-53477", "permed-76110", "permed-73100", "permed-55248", "permed-53473", "permed-53778", "permed-75440", "permed-88472"]}
{"query_id": "topic_403_turn_2", "conversation_id": "topic_403", "turn_id": 2, "query": "How does the choice of carrier material impact the performance of these bimetallic catalysts in such reactors?", "history": ["What role do bimetallic catalysts play in non-thermal plasma reactors for volatile organic compound abatement?"], "ground_truth": ["permed-79490", "permed-53474", "permed-53473", "permed-88221", "permed-53475", "permed-51990", "permed-74923", "permed-87150", "permed-52419", "permed-77031"]}
{"query_id": "topic_403_turn_3", "conversation_id": "topic_403", "turn_id": 3, "query": "Given that carrier properties significantly influence the performance of Mn-Ce catalysts in these non-thermal plasma reactors for toluene abatement, how could we optimize the specific surface area and pore size distribution of zeolite carriers to improve the dispersion and interaction of Mn and Ce active sites? What mechanisms would explain how these structural optimizations enhance both catalytic activity and CO2 selectivity?", "history": ["What role do bimetallic catalysts play in non-thermal plasma reactors for volatile organic compound abatement?", "How does the choice of carrier material impact the performance of these bimetallic catalysts in such reactors?"], "ground_truth": ["permed-79490", "permed-78340", "permed-64912", "permed-53476", "permed-88471", "permed-73056", "permed-57925", "permed-51983", "permed-74853", "permed-53482"]}
{"query_id": "topic_403_turn_4", "conversation_id": "topic_403", "turn_id": 4, "query": "Following these structural optimizations of zeolite carriers, what specific characterization techniques and experimental protocols would you recommend to quantitatively assess Mn-Ce dispersion and metal-support interactions? I'm particularly interested in whether temperature-programmed reduction with hydrogen (H2-TPR) coupled with X-ray photoelectron spectroscopy could effectively correlate catalyst structure with the improved activity and selectivity observed. What statistical approaches would be appropriate for validating these structure-property relationships across multiple catalyst batches?", "history": ["What role do bimetallic catalysts play in non-thermal plasma reactors for volatile organic compound abatement?", "How does the choice of carrier material impact the performance of these bimetallic catalysts in such reactors?", "Given that carrier properties significantly influence the performance of Mn-Ce catalysts in these non-thermal plasma reactors for toluene abatement, how could we optimize the specific surface area and pore size distribution of zeolite carriers to improve the dispersion and interaction of Mn and Ce active sites? What mechanisms would explain how these structural optimizations enhance both catalytic activity and CO2 selectivity?"], "ground_truth": ["permed-79490", "permed-57925", "permed-57926", "permed-87150", "permed-78878", "permed-73186", "permed-78459", "permed-53474", "permed-51983", "permed-78340"]}
{"query_id": "topic_404_turn_1", "conversation_id": "topic_404", "turn_id": 1, "query": "Fundamentals and applications of imaging mass spectrometry in microbial biofilm metabolism research", "history": [], "ground_truth": ["permed-66181", "permed-66187", "permed-4669", "permed-53718", "permed-91274", "permed-53723", "permed-4670", "permed-86308", "permed-66180", "permed-66177"]}
{"query_id": "topic_404_turn_2", "conversation_id": "topic_404", "turn_id": 2, "query": "Applying these imaging mass spectrometry approaches to map inter-species metabolic interactions and chemical gradients within mixed-species biofilms", "history": ["Fundamentals and applications of imaging mass spectrometry in microbial biofilm metabolism research"], "ground_truth": ["permed-66181", "permed-91274", "permed-66187", "permed-53718", "permed-88400", "permed-53723", "permed-4669", "permed-69753", "permed-58107", "permed-77019"]}
{"query_id": "topic_404_turn_3", "conversation_id": "topic_404", "turn_id": 3, "query": "Advanced computational modeling of Clostridioides difficile-Enterococcus faecalis synergistic metabolism by integrating imaging mass spectrometry data on their specific metabolite exchanges and spatial distributions in complex biofilms", "history": ["Fundamentals and applications of imaging mass spectrometry in microbial biofilm metabolism research", "Applying these imaging mass spectrometry approaches to map inter-species metabolic interactions and chemical gradients within mixed-species biofilms"], "ground_truth": ["permed-66181", "permed-66999", "permed-91274", "permed-61376", "permed-66766", "permed-62067", "permed-74887", "permed-73867", "permed-4669", "permed-76699"]}
{"query_id": "topic_404_turn_4", "conversation_id": "topic_404", "turn_id": 4, "query": "How were the spatial metabolite distributions from imaging mass spectrometry specifically integrated into these computational models? I'm particularly interested in the mathematical frameworks used to quantify metabolic exchanges between species - did you employ flux balance analysis with spatial constraints, or develop custom algorithms to model these gradient-based interactions? What validation strategies were implemented to ensure the computational predictions accurately reflected the observed experimental metabolite patterns across different biofilm regions?", "history": ["Fundamentals and applications of imaging mass spectrometry in microbial biofilm metabolism research", "Applying these imaging mass spectrometry approaches to map inter-species metabolic interactions and chemical gradients within mixed-species biofilms", "Advanced computational modeling of Clostridioides difficile-Enterococcus faecalis synergistic metabolism by integrating imaging mass spectrometry data on their specific metabolite exchanges and spatial distributions in complex biofilms"], "ground_truth": ["permed-66181", "permed-91274", "permed-58250", "permed-53727", "permed-77753", "permed-78571", "permed-72119", "permed-58107", "permed-69753", "permed-64258"]}
{"query_id": "topic_405_turn_1", "conversation_id": "topic_405", "turn_id": 1, "query": "Comprehensive overview of challenges in managing critically ill patients undergoing multiple extracorporeal therapies", "history": [], "ground_truth": ["permed-52257", "permed-58626", "permed-74762", "permed-71248", "permed-72540", "permed-52861", "permed-52863", "permed-7006", "permed-86445", "permed-6997"]}
{"query_id": "topic_405_turn_2", "conversation_id": "topic_405", "turn_id": 2, "query": "Strategies for optimizing tandem extracorporeal therapies in these critically ill patients to minimize common adverse events", "history": ["Comprehensive overview of challenges in managing critically ill patients undergoing multiple extracorporeal therapies"], "ground_truth": ["permed-52257", "permed-58626", "permed-6997", "permed-91349", "permed-64771", "permed-54791", "permed-74761", "permed-52863", "permed-44999", "permed-74762"]}
{"query_id": "topic_405_turn_3", "conversation_id": "topic_405", "turn_id": 3, "query": "Advanced techniques for tandem extracorporeal therapy optimization in these patients, specifically targeting thrombosis prevention, infection control, and precise anticoagulation management", "history": ["Comprehensive overview of challenges in managing critically ill patients undergoing multiple extracorporeal therapies", "Strategies for optimizing tandem extracorporeal therapies in these critically ill patients to minimize common adverse events"], "ground_truth": ["permed-52257", "permed-62892", "permed-64771", "permed-52605", "permed-78947", "permed-74764", "permed-26709", "permed-27071", "permed-76310", "permed-73795"]}
{"query_id": "topic_405_turn_4", "conversation_id": "topic_405", "turn_id": 4, "query": "For these advanced tandem therapy techniques targeting thrombosis prevention and infection control, what specific anticoagulation monitoring protocols were implemented? I'm particularly interested in how you validated the optimal therapeutic ranges for different anticoagulants during concurrent extracorporeal circuits, and what statistical methods were employed to correlate real-time monitoring parameters with clinical outcomes while ensuring reproducibility across different patient cohorts.", "history": ["Comprehensive overview of challenges in managing critically ill patients undergoing multiple extracorporeal therapies", "Strategies for optimizing tandem extracorporeal therapies in these critically ill patients to minimize common adverse events", "Advanced techniques for tandem extracorporeal therapy optimization in these patients, specifically targeting thrombosis prevention, infection control, and precise anticoagulation management"], "ground_truth": ["permed-84739", "permed-9900", "permed-37630", "permed-24109", "permed-62892", "permed-4610", "permed-61350", "permed-52257", "permed-78495", "permed-27547"]}
{"query_id": "topic_406_turn_1", "conversation_id": "topic_406", "turn_id": 1, "query": "What is known about the effects of VEGFR inhibition on neurodegenerative diseases like Alzheimer's?", "history": [], "ground_truth": ["permed-82195", "permed-51168", "permed-54216", "permed-51165", "permed-60752", "permed-66468", "permed-82556", "permed-66784", "permed-91821", "permed-72404"]}
{"query_id": "topic_406_turn_2", "conversation_id": "topic_406", "turn_id": 2, "query": "How might this area of research, particularly focusing on blood-brain barrier integrity, impact our understanding of potential therapeutic targets for conditions like cerebral amyloid angiopathy?", "history": ["What is known about the effects of VEGFR inhibition on neurodegenerative diseases like Alzheimer's?"], "ground_truth": ["permed-9173", "permed-79746", "permed-82196", "permed-66460", "permed-7919", "permed-73060", "permed-92575", "permed-51523", "permed-79867", "permed-89793"]}
{"query_id": "topic_406_turn_3", "conversation_id": "topic_406", "turn_id": 3, "query": "Given that fruquintinib has shown promise in reducing Aβ deposition and improving cognition in a CAA mouse model, what would be the long-term effects of its VEGFR-1,-2,-3 inhibition on BBB structural integrity and vascular health in both CAA and Alzheimer's? Furthermore, how might these effects influence neurogenesis and synaptic plasticity, and what implications could this have for the drug's therapeutic potential or limitations in treating such neurodegenerative conditions?", "history": ["What is known about the effects of VEGFR inhibition on neurodegenerative diseases like Alzheimer's?", "How might this area of research, particularly focusing on blood-brain barrier integrity, impact our understanding of potential therapeutic targets for conditions like cerebral amyloid angiopathy?"], "ground_truth": ["permed-82195", "permed-61111", "permed-63375", "permed-73060", "permed-82196", "permed-55501", "permed-51174", "permed-51233", "permed-82556", "permed-60750"]}
{"query_id": "topic_406_turn_4", "conversation_id": "topic_406", "turn_id": 4, "query": "Given this proposed investigation of fruquintinib's long-term vascular and cognitive effects, what specific methodological approaches would you recommend for quantitatively assessing BBB structural integrity over an extended treatment period? I'm particularly interested in the technical implementation—would you combine longitudinal in vivo imaging like two-photon microscopy with post-mortem ultrastructural analysis of tight junction proteins? Also, what statistical considerations should govern the sampling timeline and group sizes to reliably detect progressive changes in both vascular permeability and neurogenesis markers?", "history": ["What is known about the effects of VEGFR inhibition on neurodegenerative diseases like Alzheimer's?", "How might this area of research, particularly focusing on blood-brain barrier integrity, impact our understanding of potential therapeutic targets for conditions like cerebral amyloid angiopathy?", "Given that fruquintinib has shown promise in reducing Aβ deposition and improving cognition in a CAA mouse model, what would be the long-term effects of its VEGFR-1,-2,-3 inhibition on BBB structural integrity and vascular health in both CAA and Alzheimer's? Furthermore, how might these effects influence neurogenesis and synaptic plasticity, and what implications could this have for the drug's therapeutic potential or limitations in treating such neurodegenerative conditions?"], "ground_truth": ["permed-79746", "permed-63375", "permed-92575", "permed-61111", "permed-8446", "permed-66460", "permed-46781", "permed-90416", "permed-42523", "permed-63032"]}
{"query_id": "topic_407_turn_1", "conversation_id": "topic_407", "turn_id": 1, "query": "Functional roles of regulatory T cells (Tregs) in neurorecovery processes following ischemic stroke", "history": [], "ground_truth": ["permed-61115", "permed-66780", "permed-63206", "permed-51187", "permed-51185", "permed-66783", "permed-69400", "permed-82085", "permed-11696", "permed-64873"]}
{"query_id": "topic_407_turn_2", "conversation_id": "topic_407", "turn_id": 2, "query": "Mechanisms of Treg cell interactions with other CNS resident cells and their influence on this post-stroke neurorecovery", "history": ["Functional roles of regulatory T cells (Tregs) in neurorecovery processes following ischemic stroke"], "ground_truth": ["permed-61115", "permed-66780", "permed-54209", "permed-66783", "permed-63206", "permed-67798", "permed-51185", "permed-51187", "permed-92534", "permed-82085"]}
{"query_id": "topic_407_turn_3", "conversation_id": "topic_407", "turn_id": 3, "query": "Specific molecular pathways and signaling mechanisms governing Treg-CNS cell crosstalk in ischemic stroke recovery, and potential therapeutic targets to enhance neural repair based on these interactions", "history": ["Functional roles of regulatory T cells (Tregs) in neurorecovery processes following ischemic stroke", "Mechanisms of Treg cell interactions with other CNS resident cells and their influence on this post-stroke neurorecovery"], "ground_truth": ["permed-61115", "permed-51187", "permed-63206", "permed-51185", "permed-66780", "permed-54174", "permed-87290", "permed-57206", "permed-64873", "permed-74489"]}
{"query_id": "topic_407_turn_4", "conversation_id": "topic_407", "turn_id": 4, "query": "Given these signaling mechanisms governing Treg-CNS cell crosstalk, what specific experimental approaches would you recommend for validating the functional significance of these molecular pathways in vivo? I'm particularly interested in the spatial-temporal resolution techniques used to track Treg migration and interaction dynamics with different neural cell types, and how researchers control for inflammatory confounding variables when assessing therapeutic interventions targeting these pathways in stroke models.", "history": ["Functional roles of regulatory T cells (Tregs) in neurorecovery processes following ischemic stroke", "Mechanisms of Treg cell interactions with other CNS resident cells and their influence on this post-stroke neurorecovery", "Specific molecular pathways and signaling mechanisms governing Treg-CNS cell crosstalk in ischemic stroke recovery, and potential therapeutic targets to enhance neural repair based on these interactions"], "ground_truth": ["permed-61115", "permed-67798", "permed-54209", "permed-51185", "permed-56586", "permed-53593", "permed-51187", "permed-53596", "permed-68112", "permed-53772"]}
{"query_id": "topic_408_turn_1", "conversation_id": "topic_408", "turn_id": 1, "query": "Challenges of multimorbidity on patient treatment outcomes in healthcare", "history": [], "ground_truth": ["permed-91926", "permed-59965", "permed-65564", "permed-65565", "permed-81588", "permed-55107", "permed-66153", "permed-65566", "permed-66148", "permed-88327"]}
{"query_id": "topic_408_turn_2", "conversation_id": "topic_408", "turn_id": 2, "query": "Applications of genomics and pharmacogenetics to mitigate these multimorbidity challenges and address polypharmacy", "history": ["Challenges of multimorbidity on patient treatment outcomes in healthcare"], "ground_truth": ["permed-61488", "permed-91926", "permed-58880", "permed-52935", "permed-88327", "permed-77549", "permed-72540", "permed-61485", "permed-53717", "permed-66148"]}
{"query_id": "topic_408_turn_3", "conversation_id": "topic_408", "turn_id": 3, "query": "Integrating pharmacogenomic data into clinical decision support systems for personalized multimorbidity management and polypharmacy optimization", "history": ["Challenges of multimorbidity on patient treatment outcomes in healthcare", "Applications of genomics and pharmacogenetics to mitigate these multimorbidity challenges and address polypharmacy"], "ground_truth": ["permed-77549", "permed-52935", "permed-50786", "permed-61488", "permed-72540", "permed-91926", "permed-61485", "permed-66153", "permed-71083", "permed-67878"]}
{"query_id": "topic_408_turn_4", "conversation_id": "topic_408", "turn_id": 4, "query": "When implementing this pharmacogenomic integration into clinical decision support systems, what specific validation frameworks were employed to assess clinical utility? I'm particularly interested in how they established thresholds for drug-gene interactions across multiple comorbidities, what statistical methods were used to handle potential confounding in polypharmacy patients, and whether they implemented any real-time monitoring protocols to track system performance and alert accuracy in diverse clinical settings.", "history": ["Challenges of multimorbidity on patient treatment outcomes in healthcare", "Applications of genomics and pharmacogenetics to mitigate these multimorbidity challenges and address polypharmacy", "Integrating pharmacogenomic data into clinical decision support systems for personalized multimorbidity management and polypharmacy optimization"], "ground_truth": ["permed-77549", "permed-52935", "permed-50786", "permed-61485", "permed-74816", "permed-69062", "permed-71083", "permed-64715", "permed-56402", "permed-61661"]}
{"query_id": "topic_409_turn_1", "conversation_id": "topic_409", "turn_id": 1, "query": "What are the most effective pain management strategies for patients undergoing total knee arthroplasty?", "history": [], "ground_truth": ["permed-81935", "permed-54828", "permed-81936", "permed-86421", "permed-72813", "permed-72817", "permed-82323", "permed-81937", "permed-81942", "permed-72816"]}
{"query_id": "topic_409_turn_2", "conversation_id": "topic_409", "turn_id": 2, "query": "How do newer techniques like nerve catheters and liposomal bupivacaine infiltration compare in terms of postoperative analgesia in this area?", "history": ["What are the most effective pain management strategies for patients undergoing total knee arthroplasty?"], "ground_truth": ["permed-81672", "permed-54828", "permed-81670", "permed-54833", "permed-66074", "permed-66077", "permed-91547", "permed-66071", "permed-55007", "permed-81673"]}
{"query_id": "topic_409_turn_3", "conversation_id": "topic_409", "turn_id": 3, "query": "Given these findings comparing FNC, ACC, and LB infiltration for postoperative pain control in knee replacements, how do patients' long-term quality of life and functional recovery differ between these techniques over a one-year period? Specifically, what do patient-reported outcomes reveal about satisfaction and daily function with each method?", "history": ["What are the most effective pain management strategies for patients undergoing total knee arthroplasty?", "How do newer techniques like nerve catheters and liposomal bupivacaine infiltration compare in terms of postoperative analgesia in this area?"], "ground_truth": ["permed-54828", "permed-91437", "permed-91928", "permed-72819", "permed-91637", "permed-72813", "permed-55888", "permed-70901", "permed-81380", "permed-54827"]}
{"query_id": "topic_409_turn_4", "conversation_id": "topic_409", "turn_id": 4, "query": "Given these comparative findings on patient-reported outcomes across the three analgesic techniques, what specific statistical methodologies were employed to analyze the longitudinal functional recovery data? I'm particularly interested in how repeated measures of patient satisfaction and daily function were handled - were mixed-effects models used to account for within-subject correlations over the one-year follow-up period, and what validation strategies ensured the reliability of these longitudinal analyses? Additionally, how was missing data in the PRO questionnaires addressed methodologically?", "history": ["What are the most effective pain management strategies for patients undergoing total knee arthroplasty?", "How do newer techniques like nerve catheters and liposomal bupivacaine infiltration compare in terms of postoperative analgesia in this area?", "Given these findings comparing FNC, ACC, and LB infiltration for postoperative pain control in knee replacements, how do patients' long-term quality of life and functional recovery differ between these techniques over a one-year period? Specifically, what do patient-reported outcomes reveal about satisfaction and daily function with each method?"], "ground_truth": ["permed-76502", "permed-91104", "permed-58495", "permed-74570", "permed-84645", "permed-55015", "permed-63561", "permed-58489", "permed-83075", "permed-44386"]}
{"query_id": "topic_410_turn_1", "conversation_id": "topic_410", "turn_id": 1, "query": "Image data for automated cellular structure segmentation: foundational concepts and applications", "history": [], "ground_truth": ["permed-62518", "permed-62517", "permed-53718", "permed-62525", "permed-62519", "permed-77234", "permed-76073", "permed-77232", "permed-71535", "permed-79742"]}
{"query_id": "topic_410_turn_2", "conversation_id": "topic_410", "turn_id": 2, "query": "Improving accuracy of *this* segmentation process: benefits of integrating multi-modal microscopy image data", "history": ["Image data for automated cellular structure segmentation: foundational concepts and applications"], "ground_truth": ["permed-63378", "permed-53718", "permed-62519", "permed-76073", "permed-62518", "permed-71535", "permed-62517", "permed-62515", "permed-60560", "permed-60556"]}
{"query_id": "topic_410_turn_3", "conversation_id": "topic_410", "turn_id": 3, "query": "Advanced deep learning techniques for enhanced precision and reliability in automated cellular structure segmentation using fused multi-scale, multi-modal microscopy images: challenges and opportunities in *such* cross-modal feature engineering and alignment", "history": ["Image data for automated cellular structure segmentation: foundational concepts and applications", "Improving accuracy of *this* segmentation process: benefits of integrating multi-modal microscopy image data"], "ground_truth": ["permed-62518", "permed-62517", "permed-63378", "permed-76073", "permed-62519", "permed-77234", "permed-62520", "permed-62515", "permed-62525", "permed-60560"]}
{"query_id": "topic_410_turn_4", "conversation_id": "topic_410", "turn_id": 4, "query": "When implementing these cross-modal alignment techniques, what specific neural network architectures have proven most effective for handling the multi-scale feature extraction from fused microscopy data? I'm particularly interested in whether hybrid CNN-Transformer models outperform traditional encoder-decoder structures, and how their training protocols differ regarding loss functions and regularization strategies to prevent overfitting on heterogeneous imaging datasets.", "history": ["Image data for automated cellular structure segmentation: foundational concepts and applications", "Improving accuracy of *this* segmentation process: benefits of integrating multi-modal microscopy image data", "Advanced deep learning techniques for enhanced precision and reliability in automated cellular structure segmentation using fused multi-scale, multi-modal microscopy images: challenges and opportunities in *such* cross-modal feature engineering and alignment"], "ground_truth": ["permed-62531", "permed-63378", "permed-60552", "permed-60556", "permed-71484", "permed-76891", "permed-60560", "permed-53159", "permed-70862", "permed-53356"]}
{"query_id": "topic_411_turn_1", "conversation_id": "topic_411", "turn_id": 1, "query": "Current clinical challenges in cutaneous sarcoidosis diagnosis and monitoring", "history": [], "ground_truth": ["permed-60252", "permed-60247", "permed-68414", "permed-60248", "permed-60253", "permed-77102", "permed-60251", "permed-61305", "permed-60536", "permed-57233"]}
{"query_id": "topic_411_turn_2", "conversation_id": "topic_411", "turn_id": 2, "query": "Evaluating limitations of current biomarkers for tracking cutaneous sarcoidosis activity and progression, considering these diagnostic and monitoring challenges.", "history": ["Current clinical challenges in cutaneous sarcoidosis diagnosis and monitoring"], "ground_truth": ["permed-60252", "permed-57233", "permed-58684", "permed-60247", "permed-60248", "permed-60253", "permed-92424", "permed-61483", "permed-60536", "permed-68832"]}
{"query_id": "topic_411_turn_3", "conversation_id": "topic_411", "turn_id": 3, "query": "Novel biomarkers and advanced diagnostic strategies for cutaneous sarcoidosis: targeting early systemic involvement, improving activity monitoring, and moving beyond ACE/calcium limitations.", "history": ["Current clinical challenges in cutaneous sarcoidosis diagnosis and monitoring", "Evaluating limitations of current biomarkers for tracking cutaneous sarcoidosis activity and progression, considering these diagnostic and monitoring challenges."], "ground_truth": ["permed-60252", "permed-60247", "permed-57233", "permed-58684", "permed-53263", "permed-92424", "permed-60253", "permed-60248", "permed-68832", "permed-61483"]}
{"query_id": "topic_411_turn_4", "conversation_id": "topic_411", "turn_id": 4, "query": "For these novel biomarker panels targeting systemic involvement, what specific validation protocols were employed to establish their sensitivity and specificity in distinguishing cutaneous sarcoidosis from other granulomatous skin diseases? Furthermore, what statistical methods, such as ROC curve analysis or cross-validation techniques, were used to quantify the diagnostic accuracy and ensure the reproducibility of this multi-analyte approach across different patient cohorts and clinical settings?", "history": ["Current clinical challenges in cutaneous sarcoidosis diagnosis and monitoring", "Evaluating limitations of current biomarkers for tracking cutaneous sarcoidosis activity and progression, considering these diagnostic and monitoring challenges.", "Novel biomarkers and advanced diagnostic strategies for cutaneous sarcoidosis: targeting early systemic involvement, improving activity monitoring, and moving beyond ACE/calcium limitations."], "ground_truth": ["permed-57233", "permed-92424", "permed-60252", "permed-60247", "permed-71187", "permed-84211", "permed-56355", "permed-61483", "permed-60253", "permed-60536"]}
{"query_id": "topic_412_turn_1", "conversation_id": "topic_412", "turn_id": 1, "query": "What role does machine learning play in optimizing NMR spectra analysis?", "history": [], "ground_truth": ["permed-73125", "permed-73116", "permed-72754", "permed-77752", "permed-73117", "permed-5363", "permed-88870", "permed-75888", "permed-52457", "permed-75883"]}
{"query_id": "topic_412_turn_2", "conversation_id": "topic_412", "turn_id": 2, "query": "Can integrating it into specific libraries like DESPERATE improve handling of complex datasets?", "history": ["What role does machine learning play in optimizing NMR spectra analysis?"], "ground_truth": ["permed-75160", "permed-55107", "permed-70065", "permed-66153", "permed-86233", "permed-78536", "permed-58851", "permed-55645", "permed-80731", "permed-91516"]}
{"query_id": "topic_412_turn_3", "conversation_id": "topic_412", "turn_id": 3, "query": "How could integrating machine learning into DESPERATE further enhance NMR spectra denoising, especially for high-dimensional datasets, and what improvements might this bring to computational efficiency and biological sample analysis accuracy?", "history": ["What role does machine learning play in optimizing NMR spectra analysis?", "Can integrating it into specific libraries like DESPERATE improve handling of complex datasets?"], "ground_truth": ["permed-72754", "permed-73125", "permed-73116", "permed-73117", "permed-60555", "permed-75785", "permed-77752", "permed-5363", "permed-75883", "permed-53332"]}
{"query_id": "topic_412_turn_4", "conversation_id": "topic_412", "turn_id": 4, "query": "Given this proposed ML-DESPERATE integration for NMR denoising, what specific algorithmic architecture would you implement—for instance, would a convolutional neural network or an autoencoder variant be more suitable? Furthermore, what statistical validation framework, such as cross-validation against ground truth spectra or bootstrapping methods, would be most appropriate to rigorously quantify the claimed improvements in both computational efficiency and denoising accuracy for high-dimensional biological data?", "history": ["What role does machine learning play in optimizing NMR spectra analysis?", "Can integrating it into specific libraries like DESPERATE improve handling of complex datasets?", "How could integrating machine learning into DESPERATE further enhance NMR spectra denoising, especially for high-dimensional datasets, and what improvements might this bring to computational efficiency and biological sample analysis accuracy?"], "ground_truth": ["permed-72754", "permed-73125", "permed-60555", "permed-75784", "permed-73116", "permed-75785", "permed-73117", "permed-53332", "permed-51672", "permed-77752"]}
{"query_id": "topic_413_turn_1", "conversation_id": "topic_413", "turn_id": 1, "query": "Key challenges and barriers affecting adherence to HIV prevention therapies among high-risk populations", "history": [], "ground_truth": ["permed-63477", "permed-70151", "permed-74470", "permed-75281", "permed-75288", "permed-75286", "permed-74469", "permed-87820", "permed-80061", "permed-75287"]}
{"query_id": "topic_413_turn_2", "conversation_id": "topic_413", "turn_id": 2, "query": "How do long-acting injectable treatments, such as cabotegravir, help overcome these previously identified adherence barriers in HIV prevention?", "history": ["Key challenges and barriers affecting adherence to HIV prevention therapies among high-risk populations"], "ground_truth": ["permed-63471", "permed-74469", "permed-74470", "permed-74468", "permed-63470", "permed-74471", "permed-70153", "permed-70151", "permed-64716", "permed-84621"]}
{"query_id": "topic_413_turn_3", "conversation_id": "topic_413", "turn_id": 3, "query": "Advanced strategies to maximize long-term persistence with cabotegravir long-acting (CAB-LA) HIV prevention, particularly for high-risk individuals with previous oral PrEP adherence difficulties, accounting for diverse global socio-cultural and healthcare system factors.", "history": ["Key challenges and barriers affecting adherence to HIV prevention therapies among high-risk populations", "How do long-acting injectable treatments, such as cabotegravir, help overcome these previously identified adherence barriers in HIV prevention?"], "ground_truth": ["permed-63471", "permed-74469", "permed-74468", "permed-74470", "permed-63470", "permed-70151", "permed-64716", "permed-65780", "permed-74471", "permed-70153"]}
{"query_id": "topic_413_turn_4", "conversation_id": "topic_413", "turn_id": 4, "query": "Given these advanced CAB-LA persistence strategies, could you elaborate on the specific methodological approaches for tracking injection adherence across different healthcare settings? I'm particularly interested in the operational protocols for documenting missed injections, statistical methods for analyzing persistence trajectories, and validation strategies for self-reported adherence data when clinic-based verification isn't feasible in resource-limited contexts. How are researchers ensuring data quality while accounting for varied healthcare infrastructure in multi-site trials?", "history": ["Key challenges and barriers affecting adherence to HIV prevention therapies among high-risk populations", "How do long-acting injectable treatments, such as cabotegravir, help overcome these previously identified adherence barriers in HIV prevention?", "Advanced strategies to maximize long-term persistence with cabotegravir long-acting (CAB-LA) HIV prevention, particularly for high-risk individuals with previous oral PrEP adherence difficulties, accounting for diverse global socio-cultural and healthcare system factors."], "ground_truth": ["permed-63471", "permed-74469", "permed-65673", "permed-86722", "permed-63470", "permed-74470", "permed-70151", "permed-84621", "permed-91787", "permed-75287"]}
{"query_id": "topic_414_turn_1", "conversation_id": "topic_414", "turn_id": 1, "query": "What role does community resilience play in post-disaster recovery efforts?", "history": [], "ground_truth": ["permed-84562", "permed-60328", "permed-72384", "permed-50971", "permed-69928", "permed-54344", "permed-55217", "permed-78836", "permed-58472", "permed-53020"]}
{"query_id": "topic_414_turn_2", "conversation_id": "topic_414", "turn_id": 2, "query": "How can understanding the social dynamics within these communities, such as dependencies and forms of capital, impact this resilience?", "history": ["What role does community resilience play in post-disaster recovery efforts?"], "ground_truth": ["permed-78836", "permed-72384", "permed-70140", "permed-54002", "permed-62886", "permed-54344", "permed-58472", "permed-53061", "permed-80079", "permed-66197"]}
{"query_id": "topic_414_turn_3", "conversation_id": "topic_414", "turn_id": 3, "query": "Given this focus on social dynamics and forms of capital, how might we operationalize 'good dependencies' through a Bourdieusian lens to strengthen community resilience and self-reliance—specifically by examining how different capital types interact with local actors' agency in post-disaster recovery?", "history": ["What role does community resilience play in post-disaster recovery efforts?", "How can understanding the social dynamics within these communities, such as dependencies and forms of capital, impact this resilience?"], "ground_truth": ["permed-78836", "permed-54002", "permed-70140", "permed-60328", "permed-72384", "permed-58475", "permed-84562", "permed-69928", "permed-54344", "permed-67077"]}
{"query_id": "topic_414_turn_4", "conversation_id": "topic_414", "turn_id": 4, "query": "Building on this Bourdieusian framework for operationalizing capital interactions, what specific mixed-methods approach would you recommend for tracking how different forms of capital convert into community agency during longitudinal recovery studies? I'm particularly interested in methodological details about validating capital conversion metrics across diverse community subgroups, and whether there are established protocols for handling temporal variations in these conversions when analyzing resilience outcomes through structural equation modeling or similar statistical pathways.", "history": ["What role does community resilience play in post-disaster recovery efforts?", "How can understanding the social dynamics within these communities, such as dependencies and forms of capital, impact this resilience?", "Given this focus on social dynamics and forms of capital, how might we operationalize 'good dependencies' through a Bourdieusian lens to strengthen community resilience and self-reliance—specifically by examining how different capital types interact with local actors' agency in post-disaster recovery?"], "ground_truth": ["permed-72384", "permed-52380", "permed-62738", "permed-71611", "permed-55979", "permed-88838", "permed-62856", "permed-78836", "permed-90782", "permed-69684"]}
{"query_id": "topic_415_turn_1", "conversation_id": "topic_415", "turn_id": 1, "query": "What role does β-catenin play in viral replication, particularly in the context of FAdV-4?", "history": [], "ground_truth": ["permed-80574", "permed-76657", "permed-89194", "permed-66856", "permed-68267", "permed-83410", "permed-89475", "permed-68231", "permed-76658", "permed-78009"]}
{"query_id": "topic_415_turn_2", "conversation_id": "topic_415", "turn_id": 2, "query": "How might manipulating components of the pathway that β-catenin is a part of impact this process, specifically regarding autophagy and viral life cycle?", "history": ["What role does β-catenin play in viral replication, particularly in the context of FAdV-4?"], "ground_truth": ["permed-80574", "permed-72295", "permed-85052", "permed-75109", "permed-85054", "permed-56503", "permed-80578", "permed-62495", "permed-85056", "permed-85053"]}
{"query_id": "topic_415_turn_3", "conversation_id": "topic_415", "turn_id": 3, "query": "Given that β-catenin enhances FAdV-4 replication by promoting virus-induced autophagy, how might targeting other components of the Wnt/β-catenin pathway—like GSK-3β or TCF/LEF transcription factors—affect the viral life cycle? Could these components serve as potential therapeutic targets against FAdV-4?", "history": ["What role does β-catenin play in viral replication, particularly in the context of FAdV-4?", "How might manipulating components of the pathway that β-catenin is a part of impact this process, specifically regarding autophagy and viral life cycle?"], "ground_truth": ["permed-80574", "permed-72295", "permed-53822", "permed-2454", "permed-56503", "permed-66856", "permed-76657", "permed-80576", "permed-86152", "permed-89475"]}
{"query_id": "topic_415_turn_4", "conversation_id": "topic_415", "turn_id": 4, "query": "For these pathway component manipulations, what specific experimental approaches would best quantify their effects on the viral life cycle? I'm particularly interested in how researchers might design assays to measure changes in viral titers and autophagic flux when pharmacologically inhibiting GSK-3β or knocking down TCF/LEF factors. Should they use plaque assays combined with western blotting for LC3-II conversion, or would live-cell imaging with viral particle tracking provide more dynamic data? What statistical validation would be necessary to confirm that observed replication changes are pathway-specific rather than off-target effects?", "history": ["What role does β-catenin play in viral replication, particularly in the context of FAdV-4?", "How might manipulating components of the pathway that β-catenin is a part of impact this process, specifically regarding autophagy and viral life cycle?", "Given that β-catenin enhances FAdV-4 replication by promoting virus-induced autophagy, how might targeting other components of the Wnt/β-catenin pathway—like GSK-3β or TCF/LEF transcription factors—affect the viral life cycle? Could these components serve as potential therapeutic targets against FAdV-4?"], "ground_truth": ["permed-85052", "permed-68231", "permed-49231", "permed-87381", "permed-80574", "permed-66755", "permed-72295", "permed-76661", "permed-89199", "permed-80578"]}
{"query_id": "topic_416_turn_1", "conversation_id": "topic_416", "turn_id": 1, "query": "What are some common methods for synthesizing β-lactams in medicinal chemistry?", "history": [], "ground_truth": ["permed-79038", "permed-79041", "permed-60688", "permed-86698", "permed-79785", "permed-67459", "permed-60645", "permed-64164", "permed-52750", "permed-76833"]}
{"query_id": "topic_416_turn_2", "conversation_id": "topic_416", "turn_id": 2, "query": "How does the carbonylation of diazo compounds contribute to this area of synthesis, particularly in terms of efficiency and product yield?", "history": ["What are some common methods for synthesizing β-lactams in medicinal chemistry?"], "ground_truth": ["permed-79038", "permed-79039", "permed-79084", "permed-92598", "permed-92599", "permed-52675", "permed-77128", "permed-76838", "permed-73354", "permed-51051"]}
{"query_id": "topic_416_turn_3", "conversation_id": "topic_416", "turn_id": 3, "query": "Given these methods, how can we further optimize both the selectivity and yield of β-lactam synthesis when combining diazo compound carbonylation with [2 + 2] cycloaddition? Specifically, what role do catalysts play in improving these parameters under varying reaction conditions?", "history": ["What are some common methods for synthesizing β-lactams in medicinal chemistry?", "How does the carbonylation of diazo compounds contribute to this area of synthesis, particularly in terms of efficiency and product yield?"], "ground_truth": ["permed-79038", "permed-79041", "permed-79084", "permed-73353", "permed-79039", "permed-52675", "permed-82818", "permed-74923", "permed-92599", "permed-53751"]}
{"query_id": "topic_416_turn_4", "conversation_id": "topic_416", "turn_id": 4, "query": "Following this catalytic optimization approach for β-lactam synthesis, what specific analytical techniques and validation protocols would you recommend for characterizing the stereochemical outcomes of these cycloaddition products? I'm particularly interested in how we might implement chiral HPLC or NMR methods to quantify diastereomeric ratios, and whether you've found certain statistical approaches more reliable for comparing catalyst performance across multiple reaction batches while maintaining reproducibility.", "history": ["What are some common methods for synthesizing β-lactams in medicinal chemistry?", "How does the carbonylation of diazo compounds contribute to this area of synthesis, particularly in terms of efficiency and product yield?", "Given these methods, how can we further optimize both the selectivity and yield of β-lactam synthesis when combining diazo compound carbonylation with [2 + 2] cycloaddition? Specifically, what role do catalysts play in improving these parameters under varying reaction conditions?"], "ground_truth": ["permed-79038", "permed-79041", "permed-51641", "permed-73353", "permed-75875", "permed-58035", "permed-53115", "permed-82818", "permed-79785", "permed-76831"]}
{"query_id": "topic_417_turn_1", "conversation_id": "topic_417", "turn_id": 1, "query": "Severe dyslipidemia treatment options and cardiovascular risk reduction efficacy", "history": [], "ground_truth": ["permed-58889", "permed-58879", "permed-74673", "permed-58878", "permed-58880", "permed-92207", "permed-4916", "permed-74606", "permed-43032", "permed-58882"]}
{"query_id": "topic_417_turn_2", "conversation_id": "topic_417", "turn_id": 2, "query": "Beyond these treatment options, can lipoprotein apheresis provide additional cardiovascular benefits for patients with refractory severe dyslipidemia?", "history": ["Severe dyslipidemia treatment options and cardiovascular risk reduction efficacy"], "ground_truth": ["permed-74705", "permed-74736", "permed-68272", "permed-4862", "permed-4871", "permed-4863", "permed-74606", "permed-58889", "permed-58858", "permed-4864"]}
{"query_id": "topic_417_turn_3", "conversation_id": "topic_417", "turn_id": 3, "query": "Immune modulation (T cells, NK cells, monocytes) by repeated lipoprotein apheresis in refractory dyslipidemia: mechanisms, clinical correlation, and impact on atherosclerosis.", "history": ["Severe dyslipidemia treatment options and cardiovascular risk reduction efficacy", "Beyond these treatment options, can lipoprotein apheresis provide additional cardiovascular benefits for patients with refractory severe dyslipidemia?"], "ground_truth": ["permed-68272", "permed-74705", "permed-53181", "permed-74736", "permed-90443", "permed-70506", "permed-4863", "permed-4864", "permed-4862", "permed-86162"]}
{"query_id": "topic_417_turn_4", "conversation_id": "topic_417", "turn_id": 4, "query": "Given these immune modulatory effects, what specific experimental protocols were used to characterize the functional changes in T cells and monocytes after repeated apheresis sessions? I'm particularly interested in the flow cytometry panels for immune phenotyping, the statistical methods for longitudinal analysis of immune parameter changes, and how researchers controlled for concurrent medications that might independently affect immune function during these serial measurements.", "history": ["Severe dyslipidemia treatment options and cardiovascular risk reduction efficacy", "Beyond these treatment options, can lipoprotein apheresis provide additional cardiovascular benefits for patients with refractory severe dyslipidemia?", "Immune modulation (T cells, NK cells, monocytes) by repeated lipoprotein apheresis in refractory dyslipidemia: mechanisms, clinical correlation, and impact on atherosclerosis."], "ground_truth": ["permed-68272", "permed-67915", "permed-58678", "permed-73636", "permed-77407", "permed-53183", "permed-65331", "permed-42864", "permed-5952", "permed-42784"]}
{"query_id": "topic_418_turn_1", "conversation_id": "topic_418", "turn_id": 1, "query": "Comprehensive overview of pituitary carcinoma metastasis: patterns, frequency, and common sites", "history": [], "ground_truth": ["permed-58908", "permed-56708", "permed-74660", "permed-59570", "permed-47037", "permed-77470", "permed-77467", "permed-85504", "permed-89594", "permed-72720"]}
{"query_id": "topic_418_turn_2", "conversation_id": "topic_418", "turn_id": 2, "query": "Regarding these pituitary carcinoma metastases, what are the typical routes of dissemination beyond the sella turcica, and which distant organs are most commonly affected as secondary sites?", "history": ["Comprehensive overview of pituitary carcinoma metastasis: patterns, frequency, and common sites"], "ground_truth": ["permed-58908", "permed-47037", "permed-74660", "permed-36480", "permed-77467", "permed-72720", "permed-2822", "permed-87311", "permed-54110", "permed-14096"]}
{"query_id": "topic_418_turn_3", "conversation_id": "topic_418", "turn_id": 3, "query": "For pituitary carcinoma that has metastasized to distant sites beyond the cervical lymph nodes, what are the specific cytomorphologic variations observed, and how do these changes complicate its differential diagnosis from primary tumors in those metastatic locations?", "history": ["Comprehensive overview of pituitary carcinoma metastasis: patterns, frequency, and common sites", "Regarding these pituitary carcinoma metastases, what are the typical routes of dissemination beyond the sella turcica, and which distant organs are most commonly affected as secondary sites?"], "ground_truth": ["permed-58908", "permed-77467", "permed-56708", "permed-74660", "permed-2822", "permed-77492", "permed-47037", "permed-74662", "permed-77464", "permed-92201"]}
{"query_id": "topic_418_turn_4", "conversation_id": "topic_418", "turn_id": 4, "query": "Given these cytomorphologic variations complicating differential diagnosis, what specific immunohistochemical panels and molecular validation protocols would you recommend implementing to reliably distinguish metastatic pituitary carcinoma from primary tumors at distant sites? I'm particularly interested in how the technical implementation of transcription factor staining protocols should be optimized for decalcified bone specimens, and which statistical approaches for diagnostic accuracy validation would be most appropriate when dealing with such rare metastatic cases.", "history": ["Comprehensive overview of pituitary carcinoma metastasis: patterns, frequency, and common sites", "Regarding these pituitary carcinoma metastases, what are the typical routes of dissemination beyond the sella turcica, and which distant organs are most commonly affected as secondary sites?", "For pituitary carcinoma that has metastasized to distant sites beyond the cervical lymph nodes, what are the specific cytomorphologic variations observed, and how do these changes complicate its differential diagnosis from primary tumors in those metastatic locations?"], "ground_truth": ["permed-58908", "permed-76576", "permed-77467", "permed-2172", "permed-56708", "permed-77450", "permed-47858", "permed-77465", "permed-28202", "permed-61138"]}
{"query_id": "topic_419_turn_1", "conversation_id": "topic_419", "turn_id": 1, "query": "Overview of surgical treatments for pediatric ulcerative colitis and Crohn's disease", "history": [], "ground_truth": ["permed-4216", "permed-18610", "permed-62095", "permed-75297", "permed-52026", "permed-84595", "permed-52025", "permed-24705", "permed-62093", "permed-1099"]}
{"query_id": "topic_419_turn_2", "conversation_id": "topic_419", "turn_id": 2, "query": "Long-term outcomes of ileal pouch-anal anastomosis (IPAA) vs other common surgeries for these pediatric inflammatory bowel disease patients", "history": ["Overview of surgical treatments for pediatric ulcerative colitis and Crohn's disease"], "ground_truth": ["permed-75296", "permed-75297", "permed-71643", "permed-4216", "permed-24922", "permed-71328", "permed-79507", "permed-32853", "permed-2434", "permed-90910"]}
{"query_id": "topic_419_turn_3", "conversation_id": "topic_419", "turn_id": 3, "query": "Psychological impact and social adjustment in pediatric IBD patients post-IPAA versus alternative surgeries: role of family support", "history": ["Overview of surgical treatments for pediatric ulcerative colitis and Crohn's disease", "Long-term outcomes of ileal pouch-anal anastomosis (IPAA) vs other common surgeries for these pediatric inflammatory bowel disease patients"], "ground_truth": ["permed-75296", "permed-75297", "permed-4216", "permed-91537", "permed-91179", "permed-71643", "permed-71633", "permed-91714", "permed-2434", "permed-71629"]}
{"query_id": "topic_419_turn_4", "conversation_id": "topic_419", "turn_id": 4, "query": "Given these psychological assessments, what specific statistical approaches were used to control for family support as a confounding variable when comparing post-surgical adjustment between IPAA and alternative procedures? I'm particularly interested in whether researchers employed multivariate regression models, propensity score matching, or mediation analysis to isolate the surgery's independent effect from psychosocial support systems, and how they validated these methodological choices for such complex pediatric outcomes data.", "history": ["Overview of surgical treatments for pediatric ulcerative colitis and Crohn's disease", "Long-term outcomes of ileal pouch-anal anastomosis (IPAA) vs other common surgeries for these pediatric inflammatory bowel disease patients", "Psychological impact and social adjustment in pediatric IBD patients post-IPAA versus alternative surgeries: role of family support"], "ground_truth": ["permed-83075", "permed-75296", "permed-91179", "permed-88520", "permed-75297", "permed-83538", "permed-62316", "permed-91537", "permed-72694", "permed-91178"]}
{"query_id": "topic_420_turn_1", "conversation_id": "topic_420", "turn_id": 1, "query": "Clinical and demographic risk factors for ocular myasthenia gravis generalization in adult patients", "history": [], "ground_truth": ["permed-78012", "permed-90348", "permed-78013", "permed-78014", "permed-15345", "permed-87208", "permed-85408", "permed-52732", "permed-61103", "permed-70508"]}
{"query_id": "topic_420_turn_2", "conversation_id": "topic_420", "turn_id": 2, "query": "Beyond these initial factors, how do genetic and environmental influences contribute to predictive modeling for GMG conversion risk in adult OMG patients?", "history": ["Clinical and demographic risk factors for ocular myasthenia gravis generalization in adult patients"], "ground_truth": ["permed-78012", "permed-71547", "permed-83097", "permed-8316", "permed-58814", "permed-61901", "permed-90348", "permed-70671", "permed-78019", "permed-75635"]}
{"query_id": "topic_420_turn_3", "conversation_id": "topic_420", "turn_id": 3, "query": "Integrating specific genetic markers like HLA haplotypes and environmental triggers like viral exposures into nomograms for predicting GMG conversion in adult OMG: impact on identifying high-risk subgroups (males, non-thymoma, no co-autoimmunity) and guiding personalized preventive strategies.", "history": ["Clinical and demographic risk factors for ocular myasthenia gravis generalization in adult patients", "Beyond these initial factors, how do genetic and environmental influences contribute to predictive modeling for GMG conversion risk in adult OMG patients?"], "ground_truth": ["permed-78012", "permed-83097", "permed-10252", "permed-85324", "permed-72611", "permed-68047", "permed-46086", "permed-68168", "permed-68862", "permed-49023"]}
{"query_id": "topic_420_turn_4", "conversation_id": "topic_420", "turn_id": 4, "query": "For integrating these HLA haplotypes and viral exposure triggers into predictive nomograms, what specific statistical methodologies were employed to handle the combination of continuous and categorical variables? Were machine learning algorithms like random forests or gradient boosting compared against traditional Cox proportional hazards models in terms of prediction accuracy for GMG conversion? Additionally, what internal validation procedures, such as bootstrapping or cross-validation, were implemented to ensure the nomogram's reproducibility across different clinical settings?", "history": ["Clinical and demographic risk factors for ocular myasthenia gravis generalization in adult patients", "Beyond these initial factors, how do genetic and environmental influences contribute to predictive modeling for GMG conversion risk in adult OMG patients?", "Integrating specific genetic markers like HLA haplotypes and environmental triggers like viral exposures into nomograms for predicting GMG conversion in adult OMG: impact on identifying high-risk subgroups (males, non-thymoma, no co-autoimmunity) and guiding personalized preventive strategies."], "ground_truth": ["permed-56673", "permed-60549", "permed-56671", "permed-56561", "permed-85324", "permed-35270", "permed-55429", "permed-78012", "permed-73699", "permed-73890"]}
{"query_id": "topic_421_turn_1", "conversation_id": "topic_421", "turn_id": 1, "query": "Genetic determinants and key genes implicated in Primary Familial Brain Calcification (PFBC)", "history": [], "ground_truth": ["permed-71073", "permed-8868", "permed-8305", "permed-53717", "permed-88197", "permed-71706", "permed-89594", "permed-89562", "permed-23988", "permed-80980"]}
{"query_id": "topic_421_turn_2", "conversation_id": "topic_421", "turn_id": 2, "query": "Functional consequences of mutations in these PFBC-implicated genes on cerebral calcium regulation", "history": ["Genetic determinants and key genes implicated in Primary Familial Brain Calcification (PFBC)"], "ground_truth": ["permed-71073", "permed-8868", "permed-8305", "permed-72010", "permed-53616", "permed-71387", "permed-73803", "permed-59018", "permed-89562", "permed-86171"]}
{"query_id": "topic_421_turn_3", "conversation_id": "topic_421", "turn_id": 3, "query": "Molecular mechanisms of cellular calcium dyshomeostasis resulting from such PFBC gene mutations and therapeutic approaches targeting these disruptions to prevent brain calcification", "history": ["Genetic determinants and key genes implicated in Primary Familial Brain Calcification (PFBC)", "Functional consequences of mutations in these PFBC-implicated genes on cerebral calcium regulation"], "ground_truth": ["permed-71073", "permed-8868", "permed-8305", "permed-72010", "permed-84814", "permed-59018", "permed-71387", "permed-86171", "permed-89562", "permed-23988"]}
{"query_id": "topic_421_turn_4", "conversation_id": "topic_421", "turn_id": 4, "query": "Considering the therapeutic approaches targeting calcium dyshomeostasis you mentioned, what specific experimental protocols would you recommend for validating their efficacy in preventing pathological calcification? I'm particularly interested in the technical implementation—should we use in vitro mineralization assays with neuronal cell lines expressing mutant PFBC genes, or would micro-CT quantification of calcification volume in animal models provide more clinically relevant validation? Also, what statistical methods would best assess dose-response relationships for these interventions?", "history": ["Genetic determinants and key genes implicated in Primary Familial Brain Calcification (PFBC)", "Functional consequences of mutations in these PFBC-implicated genes on cerebral calcium regulation", "Molecular mechanisms of cellular calcium dyshomeostasis resulting from such PFBC gene mutations and therapeutic approaches targeting these disruptions to prevent brain calcification"], "ground_truth": ["permed-71073", "permed-91453", "permed-5694", "permed-69174", "permed-84814", "permed-23125", "permed-37077", "permed-8816", "permed-52740", "permed-11268"]}
{"query_id": "topic_422_turn_1", "conversation_id": "topic_422", "turn_id": 1, "query": "What role does ciRS-187 play in the regulation of gene expression in bovine cumulus cells?", "history": [], "ground_truth": ["permed-81049", "permed-76421", "permed-62678", "permed-92557", "permed-82373", "permed-77713", "permed-76663", "permed-77016", "permed-51202", "permed-78226"]}
{"query_id": "topic_422_turn_2", "conversation_id": "topic_422", "turn_id": 2, "query": "How might its interaction with microRNAs, like miR-187, impact cellular processes in this area?", "history": ["What role does ciRS-187 play in the regulation of gene expression in bovine cumulus cells?"], "ground_truth": ["permed-70402", "permed-70400", "permed-82373", "permed-81049", "permed-56366", "permed-70471", "permed-54117", "permed-71613", "permed-74836", "permed-22065"]}
{"query_id": "topic_422_turn_3", "conversation_id": "topic_422", "turn_id": 3, "query": "Given that ciRS-187 regulates BMPR2 expression through its interaction with miR-187 in these cells, how might changes in their expression levels influence the cells' responsiveness to other growth factors or signaling molecules involved in follicle development? What would be the potential downstream effects on oocyte maturation and fertility?", "history": ["What role does ciRS-187 play in the regulation of gene expression in bovine cumulus cells?", "How might its interaction with microRNAs, like miR-187, impact cellular processes in this area?"], "ground_truth": ["permed-81049", "permed-62678", "permed-76169", "permed-78226", "permed-76168", "permed-58645", "permed-62670", "permed-82961", "permed-7787", "permed-31124"]}
{"query_id": "topic_422_turn_4", "conversation_id": "topic_422", "turn_id": 4, "query": "Given this proposed regulatory axis between ciRS-187, miR-187, and BMPR2, what specific methodological approaches would best validate these interactions experimentally? I'm particularly interested in how you would design the controls for such binding assays, which statistical methods would be appropriate for quantifying expression changes, and what quality control measures should be implemented to ensure reproducibility when measuring downstream effects on oocyte maturation metrics.", "history": ["What role does ciRS-187 play in the regulation of gene expression in bovine cumulus cells?", "How might its interaction with microRNAs, like miR-187, impact cellular processes in this area?", "Given that ciRS-187 regulates BMPR2 expression through its interaction with miR-187 in these cells, how might changes in their expression levels influence the cells' responsiveness to other growth factors or signaling molecules involved in follicle development? What would be the potential downstream effects on oocyte maturation and fertility?"], "ground_truth": ["permed-81049", "permed-7031", "permed-7787", "permed-88075", "permed-78226", "permed-73563", "permed-66447", "permed-81053", "permed-81050", "permed-73500"]}
{"query_id": "topic_423_turn_1", "conversation_id": "topic_423", "turn_id": 1, "query": "What challenges do low-income countries face in providing adequate surgical care?", "history": [], "ground_truth": ["permed-62335", "permed-79133", "permed-59943", "permed-74290", "permed-66107", "permed-51783", "permed-79134", "permed-79135", "permed-54683", "permed-63337"]}
{"query_id": "topic_423_turn_2", "conversation_id": "topic_423", "turn_id": 2, "query": "How can strengthening health systems in this area improve access to quality surgical services?", "history": ["What challenges do low-income countries face in providing adequate surgical care?"], "ground_truth": ["permed-91926", "permed-79134", "permed-61888", "permed-67357", "permed-70910", "permed-79133", "permed-62337", "permed-63535", "permed-52567", "permed-46240"]}
{"query_id": "topic_423_turn_3", "conversation_id": "topic_423", "turn_id": 3, "query": "What specific barriers prevent countries like Liberia from achieving full essential surgical care coverage, and how can integrated health system strengthening—focusing on surgical infrastructure, workforce training, and logistics—address these challenges to improve both access and quality in these settings?", "history": ["What challenges do low-income countries face in providing adequate surgical care?", "How can strengthening health systems in this area improve access to quality surgical services?"], "ground_truth": ["permed-79133", "permed-72628", "permed-79134", "permed-54683", "permed-62335", "permed-63337", "permed-53022", "permed-60179", "permed-62336", "permed-60772"]}
{"query_id": "topic_423_turn_4", "conversation_id": "topic_423", "turn_id": 4, "query": "Given Liberia's infrastructure and workforce constraints, what specific methodological approaches were used in previous interventions to validate the effectiveness of integrated surgical strengthening programs? I'm particularly interested in how researchers designed their pre-post implementation assessments, what statistical methods they employed to measure changes in surgical capacity and outcomes, and how they ensured data reliability when evaluating training programs in low-resource settings with limited electronic health records.", "history": ["What challenges do low-income countries face in providing adequate surgical care?", "How can strengthening health systems in this area improve access to quality surgical services?", "What specific barriers prevent countries like Liberia from achieving full essential surgical care coverage, and how can integrated health system strengthening—focusing on surgical infrastructure, workforce training, and logistics—address these challenges to improve both access and quality in these settings?"], "ground_truth": ["permed-79133", "permed-54683", "permed-62335", "permed-91222", "permed-52264", "permed-62336", "permed-20316", "permed-78372", "permed-75050", "permed-79134"]}
{"query_id": "topic_424_turn_1", "conversation_id": "topic_424", "turn_id": 1, "query": "Global determinants and regional variations in diabetes mellitus prevalence and management strategies", "history": [], "ground_truth": ["permed-75652", "permed-76350", "permed-61879", "permed-65946", "permed-79124", "permed-23143", "permed-88327", "permed-75654", "permed-54675", "permed-64859"]}
{"query_id": "topic_424_turn_2", "conversation_id": "topic_424", "turn_id": 2, "query": "Applying spatial analysis techniques to understand the impact of these aforementioned determinants on diabetes patterns in Thailand", "history": ["Global determinants and regional variations in diabetes mellitus prevalence and management strategies"], "ground_truth": ["permed-75652", "permed-65946", "permed-88327", "permed-61879", "permed-54674", "permed-66153", "permed-76352", "permed-75606", "permed-59199", "permed-54664"]}
{"query_id": "topic_424_turn_3", "conversation_id": "topic_424", "turn_id": 3, "query": "Advanced spatial modeling in Thailand: Using LISA and spatial regression to analyze how socio-economic status, healthcare access, and urbanization interact to shape diabetes mellitus distribution and management outcomes", "history": ["Global determinants and regional variations in diabetes mellitus prevalence and management strategies", "Applying spatial analysis techniques to understand the impact of these aforementioned determinants on diabetes patterns in Thailand"], "ground_truth": ["permed-75652", "permed-65946", "permed-61879", "permed-71221", "permed-65364", "permed-62244", "permed-88327", "permed-89674", "permed-75651", "permed-75606"]}
{"query_id": "topic_424_turn_4", "conversation_id": "topic_424", "turn_id": 4, "query": "When implementing this spatial regression framework with LISA clusters in Thailand, what specific validation procedures did you employ to ensure the robustness of your socio-economic and healthcare access predictors? I'm particularly interested in how you handled potential multicollinearity between urbanization metrics and other covariates, and whether you conducted sensitivity analyses using different spatial weight matrices to verify the stability of your interaction effects on diabetes distribution outcomes.", "history": ["Global determinants and regional variations in diabetes mellitus prevalence and management strategies", "Applying spatial analysis techniques to understand the impact of these aforementioned determinants on diabetes patterns in Thailand", "Advanced spatial modeling in Thailand: Using LISA and spatial regression to analyze how socio-economic status, healthcare access, and urbanization interact to shape diabetes mellitus distribution and management outcomes"], "ground_truth": ["permed-75652", "permed-65884", "permed-65946", "permed-73394", "permed-75606", "permed-58483", "permed-75651", "permed-58919", "permed-65229", "permed-75616"]}
{"query_id": "topic_425_turn_1", "conversation_id": "topic_425", "turn_id": 1, "query": "What are the common challenges in treating schizophrenia when initial therapies are ineffective?", "history": [], "ground_truth": ["permed-81134", "permed-55499", "permed-55498", "permed-35185", "permed-55821", "permed-81133", "permed-88999", "permed-70275", "permed-70672", "permed-63466"]}
{"query_id": "topic_425_turn_2", "conversation_id": "topic_425", "turn_id": 2, "query": "How effective are alternative treatments like augmentation therapies in addressing this issue, particularly for patients with clozapine-resistant symptoms?", "history": ["What are the common challenges in treating schizophrenia when initial therapies are ineffective?"], "ground_truth": ["permed-81131", "permed-81132", "permed-81133", "permed-67194", "permed-25791", "permed-35185", "permed-60081", "permed-7464", "permed-55499", "permed-72475"]}
{"query_id": "topic_425_turn_3", "conversation_id": "topic_425", "turn_id": 3, "query": "Considering that mirtazapine, ECT, and memantine show promise as augmentation therapies for CRS, what do we know about their long-term effects on cognitive function and quality of life? And how might patient characteristics like age, illness duration, and comorbidities impact both the effectiveness and safety of these treatments over extended periods?", "history": ["What are the common challenges in treating schizophrenia when initial therapies are ineffective?", "How effective are alternative treatments like augmentation therapies in addressing this issue, particularly for patients with clozapine-resistant symptoms?"], "ground_truth": ["permed-81131", "permed-68380", "permed-72788", "permed-81132", "permed-79348", "permed-90881", "permed-50312", "permed-71444", "permed-55506", "permed-78084"]}
{"query_id": "topic_425_turn_4", "conversation_id": "topic_425", "turn_id": 4, "query": "Given these promising augmentation therapies for clozapine-resistant schizophrenia, what specific study designs and statistical approaches are most appropriate for evaluating their long-term cognitive and quality-of-life outcomes? I'm particularly interested in how researchers should handle potential confounding variables like illness duration and comorbidities - would propensity score matching or mixed-effects models be more suitable for adjusting for these patient characteristics? Additionally, what methodological safeguards should be implemented to ensure consistent cognitive assessment protocols across multi-center trials spanning several years?", "history": ["What are the common challenges in treating schizophrenia when initial therapies are ineffective?", "How effective are alternative treatments like augmentation therapies in addressing this issue, particularly for patients with clozapine-resistant symptoms?", "Considering that mirtazapine, ECT, and memantine show promise as augmentation therapies for CRS, what do we know about their long-term effects on cognitive function and quality of life? And how might patient characteristics like age, illness duration, and comorbidities impact both the effectiveness and safety of these treatments over extended periods?"], "ground_truth": ["permed-81131", "permed-81132", "permed-52401", "permed-70672", "permed-55503", "permed-81133", "permed-72758", "permed-77040", "permed-66043", "permed-70274"]}
{"query_id": "topic_426_turn_1", "conversation_id": "topic_426", "turn_id": 1, "query": "Laminin's role in mammary epithelial cell regulation", "history": [], "ground_truth": ["permed-74730", "permed-82373", "permed-89441", "permed-64170", "permed-90366", "permed-76663", "permed-74733", "permed-53486", "permed-53718", "permed-53491"]}
{"query_id": "topic_426_turn_2", "conversation_id": "topic_426", "turn_id": 2, "query": "Effects of disrupted laminin-integrin interactions on the homeostasis of these mammary epithelial cells", "history": ["Laminin's role in mammary epithelial cell regulation"], "ground_truth": ["permed-74730", "permed-82373", "permed-53486", "permed-64170", "permed-62479", "permed-71686", "permed-53821", "permed-89441", "permed-76663", "permed-90264"]}
{"query_id": "topic_426_turn_3", "conversation_id": "topic_426", "turn_id": 3, "query": "Laminin α5-β4 integrin disruption: impact on basal MEC identity, progenitor activity, mammary gland regeneration, cancer, and potential therapeutic targets", "history": ["Laminin's role in mammary epithelial cell regulation", "Effects of disrupted laminin-integrin interactions on the homeostasis of these mammary epithelial cells"], "ground_truth": ["permed-74730", "permed-82373", "permed-84480", "permed-74731", "permed-53821", "permed-74732", "permed-53832", "permed-67160", "permed-53828", "permed-53486"]}
{"query_id": "topic_426_turn_4", "conversation_id": "topic_426", "turn_id": 4, "query": "Given these laminin α5-β4 integrin disruption effects, what specific experimental models and dosing regimens were used to induce this disruption in the studies you mentioned? I'm particularly interested in whether genetic knockout models, blocking antibodies, or small-molecule inhibitors were employed, and how the method of disruption was validated to ensure specificity for this particular integrin-laminin interaction without affecting other signaling pathways in the mammary epithelium.", "history": ["Laminin's role in mammary epithelial cell regulation", "Effects of disrupted laminin-integrin interactions on the homeostasis of these mammary epithelial cells", "Laminin α5-β4 integrin disruption: impact on basal MEC identity, progenitor activity, mammary gland regeneration, cancer, and potential therapeutic targets"], "ground_truth": ["permed-74730", "permed-53821", "permed-53486", "permed-31429", "permed-69112", "permed-41778", "permed-38987", "permed-54261", "permed-53828", "permed-92554"]}
{"query_id": "topic_427_turn_1", "conversation_id": "topic_427", "turn_id": 1, "query": "Role and impact of continuous glucose monitoring (CGM) systems in inpatient diabetes management", "history": [], "ground_truth": ["permed-70649", "permed-47395", "permed-47396", "permed-76946", "permed-70650", "permed-60781", "permed-71236", "permed-70662", "permed-44735", "permed-87527"]}
{"query_id": "topic_427_turn_2", "conversation_id": "topic_427", "turn_id": 2, "query": "Effective strategies for healthcare providers implementing and managing *these* CGM systems for hospitalized patients with type 1 diabetes", "history": ["Role and impact of continuous glucose monitoring (CGM) systems in inpatient diabetes management"], "ground_truth": ["permed-70649", "permed-47395", "permed-47396", "permed-87527", "permed-70662", "permed-87568", "permed-60787", "permed-60784", "permed-53507", "permed-70661"]}
{"query_id": "topic_427_turn_3", "conversation_id": "topic_427", "turn_id": 3, "query": "Advanced protocols for optimizing *this* CGM integration in hospitals for type 1 diabetes: technical specifications for data systems, clinical decision support, and specialized staff training to ensure glycemic control and patient safety.", "history": ["Role and impact of continuous glucose monitoring (CGM) systems in inpatient diabetes management", "Effective strategies for healthcare providers implementing and managing *these* CGM systems for hospitalized patients with type 1 diabetes"], "ground_truth": ["permed-70649", "permed-87527", "permed-60787", "permed-87568", "permed-71236", "permed-47395", "permed-47396", "permed-76384", "permed-70662", "permed-76944"]}
{"query_id": "topic_427_turn_4", "conversation_id": "topic_427", "turn_id": 4, "query": "When implementing these specialized protocols for CGM integration in hospital settings, what specific statistical methods and validation strategies are most appropriate for analyzing the continuous glucose data streams? I'm particularly interested in how institutions establish data quality control metrics, handle missing sensor readings, and validate alarm thresholds against clinical outcomes to ensure both reproducibility and patient safety in real-time monitoring scenarios.", "history": ["Role and impact of continuous glucose monitoring (CGM) systems in inpatient diabetes management", "Effective strategies for healthcare providers implementing and managing *these* CGM systems for hospitalized patients with type 1 diabetes", "Advanced protocols for optimizing *this* CGM integration in hospitals for type 1 diabetes: technical specifications for data systems, clinical decision support, and specialized staff training to ensure glycemic control and patient safety."], "ground_truth": ["permed-44735", "permed-5038", "permed-60784", "permed-26288", "permed-60790", "permed-47394", "permed-5044", "permed-70649", "permed-30218", "permed-60780"]}
{"query_id": "topic_428_turn_1", "conversation_id": "topic_428", "turn_id": 1, "query": "Comprehensive overview of psychological impacts of Turner syndrome on women's mental health and quality of life", "history": [], "ground_truth": ["permed-76926", "permed-76931", "permed-57701", "permed-62035", "permed-51890", "permed-70805", "permed-60971", "permed-84298", "permed-71053", "permed-56719"]}
{"query_id": "topic_428_turn_2", "conversation_id": "topic_428", "turn_id": 2, "query": "Considering these psychological impacts on women with Turner syndrome, which body image and self-esteem interventions could enhance their mental health and quality of life?", "history": ["Comprehensive overview of psychological impacts of Turner syndrome on women's mental health and quality of life"], "ground_truth": ["permed-76926", "permed-55662", "permed-76931", "permed-62035", "permed-91469", "permed-26045", "permed-62796", "permed-81278", "permed-74751", "permed-63569"]}
{"query_id": "topic_428_turn_3", "conversation_id": "topic_428", "turn_id": 3, "query": "Analyzing the specific mechanisms through which interventions targeting body image and self-esteem improve mental health and quality of life in women with Turner syndrome, and principles for developing tailored support programs that account for their unique physical characteristics and personal body image perceptions.", "history": ["Comprehensive overview of psychological impacts of Turner syndrome on women's mental health and quality of life", "Considering these psychological impacts on women with Turner syndrome, which body image and self-esteem interventions could enhance their mental health and quality of life?"], "ground_truth": ["permed-76926", "permed-55662", "permed-81278", "permed-91611", "permed-62795", "permed-85585", "permed-76931", "permed-91469", "permed-62035", "permed-62796"]}
{"query_id": "topic_428_turn_4", "conversation_id": "topic_428", "turn_id": 4, "query": "Given this proposed mechanistic analysis, what specific statistical approaches would best quantify the mediating role of body image perceptions between intervention participation and mental health outcomes? Would structural equation modeling or path analysis be more appropriate for testing these relationships, and what validated instruments should we use to measure body image dimensions specific to Turner syndrome physical characteristics? I'm particularly interested in methodological considerations for ensuring these mediation models account for developmental stage variations.", "history": ["Comprehensive overview of psychological impacts of Turner syndrome on women's mental health and quality of life", "Considering these psychological impacts on women with Turner syndrome, which body image and self-esteem interventions could enhance their mental health and quality of life?", "Analyzing the specific mechanisms through which interventions targeting body image and self-esteem improve mental health and quality of life in women with Turner syndrome, and principles for developing tailored support programs that account for their unique physical characteristics and personal body image perceptions."], "ground_truth": ["permed-76926", "permed-52645", "permed-62795", "permed-81278", "permed-55662", "permed-65500", "permed-62802", "permed-76931", "permed-76927", "permed-63237"]}
{"query_id": "topic_429_turn_1", "conversation_id": "topic_429", "turn_id": 1, "query": "What role does lignin play in the RCF process and how is it currently analyzed?", "history": [], "ground_truth": ["permed-53102", "permed-53104", "permed-63732", "permed-76020", "permed-90444", "permed-79239", "permed-63727", "permed-66260", "permed-79242", "permed-89467"]}
{"query_id": "topic_429_turn_2", "conversation_id": "topic_429", "turn_id": 2, "query": "Can advanced spectroscopic techniques provide a more detailed understanding of its structure and composition beyond current methods?", "history": ["What role does lignin play in the RCF process and how is it currently analyzed?"], "ground_truth": ["permed-73115", "permed-89857", "permed-74268", "permed-58254", "permed-65169", "permed-73926", "permed-73924", "permed-83500", "permed-76029", "permed-86051"]}
{"query_id": "topic_429_turn_3", "conversation_id": "topic_429", "turn_id": 3, "query": "Given what we've discussed about lignin's role in RCF and the potential of advanced spectroscopic techniques, how could we further elucidate the structural heterogeneity of lignin fragments and hemicellulose-derived carbohydrates in RCF lignin oil using methods beyond HSQC NMR? And what would these findings mean for optimizing solvent fractionation and catalyst selection in the process?", "history": ["What role does lignin play in the RCF process and how is it currently analyzed?", "Can advanced spectroscopic techniques provide a more detailed understanding of its structure and composition beyond current methods?"], "ground_truth": ["permed-53102", "permed-79242", "permed-63732", "permed-79239", "permed-53104", "permed-76020", "permed-64643", "permed-79216", "permed-74109", "permed-82410"]}
{"query_id": "topic_429_turn_4", "conversation_id": "topic_429", "turn_id": 4, "query": "Following your discussion of techniques beyond HSQC NMR for probing structural heterogeneity in RCF lignin oil, could you elaborate on the specific chromatographic separation protocols that should precede these advanced analyses? I'm particularly interested in how we might optimize fractionation conditions—such as solvent polarity gradients and stationary phase selection—to effectively isolate different lignin fragment classes while preserving their native structural features. What methodological considerations ensure these separated fractions remain representative for subsequent mass spectrometry and multidimensional NMR characterization?", "history": ["What role does lignin play in the RCF process and how is it currently analyzed?", "Can advanced spectroscopic techniques provide a more detailed understanding of its structure and composition beyond current methods?", "Given what we've discussed about lignin's role in RCF and the potential of advanced spectroscopic techniques, how could we further elucidate the structural heterogeneity of lignin fragments and hemicellulose-derived carbohydrates in RCF lignin oil using methods beyond HSQC NMR? And what would these findings mean for optimizing solvent fractionation and catalyst selection in the process?"], "ground_truth": ["permed-53102", "permed-79239", "permed-88148", "permed-86110", "permed-79242", "permed-53104", "permed-72990", "permed-81232", "permed-82410", "permed-63732"]}
{"query_id": "topic_430_turn_1", "conversation_id": "topic_430", "turn_id": 1, "query": "Chalcones in cancer therapy: mechanisms of action and therapeutic potential", "history": [], "ground_truth": ["permed-77621", "permed-79609", "permed-82373", "permed-68563", "permed-78771", "permed-89341", "permed-79572", "permed-60878", "permed-86234", "permed-79590"]}
{"query_id": "topic_430_turn_2", "conversation_id": "topic_430", "turn_id": 2, "query": "Effects of structural modifications in these chalcones on binding affinity and selectivity for cancer protein targets", "history": ["Chalcones in cancer therapy: mechanisms of action and therapeutic potential"], "ground_truth": ["permed-77621", "permed-80887", "permed-60878", "permed-72913", "permed-82373", "permed-60876", "permed-82512", "permed-75463", "permed-58116", "permed-79609"]}
{"query_id": "topic_430_turn_3", "conversation_id": "topic_430", "turn_id": 3, "query": "Binding affinity and selectivity of (3-(furan-2-yl)pyrazol-4-yl) chalcones for specific lung carcinoma protein targets: implications for targeted therapy design", "history": ["Chalcones in cancer therapy: mechanisms of action and therapeutic potential", "Effects of structural modifications in these chalcones on binding affinity and selectivity for cancer protein targets"], "ground_truth": ["permed-77621", "permed-60872", "permed-53718", "permed-56227", "permed-92365", "permed-60347", "permed-68994", "permed-85303", "permed-60813", "permed-79609"]}
{"query_id": "topic_430_turn_4", "conversation_id": "topic_430", "turn_id": 4, "query": "Regarding these (3-(furan-2-yl)pyrazol-4-yl) chalcones, what specific experimental protocols were employed to quantify their binding affinity and selectivity for lung carcinoma targets? I'm particularly interested in the technical implementation - whether you used surface plasmon resonance or isothermal titration calorimetry, the concentration ranges tested, how you validated the specificity against non-target proteins, and what statistical methods were applied to ensure reproducibility across multiple experimental replicates.", "history": ["Chalcones in cancer therapy: mechanisms of action and therapeutic potential", "Effects of structural modifications in these chalcones on binding affinity and selectivity for cancer protein targets", "Binding affinity and selectivity of (3-(furan-2-yl)pyrazol-4-yl) chalcones for specific lung carcinoma protein targets: implications for targeted therapy design"], "ground_truth": ["permed-77621", "permed-12352", "permed-80944", "permed-72913", "permed-80958", "permed-71553", "permed-32772", "permed-84219", "permed-85303", "permed-58177"]}
{"query_id": "topic_431_turn_1", "conversation_id": "topic_431", "turn_id": 1, "query": "Review of surgical techniques for pharyngoesophageal reconstruction following oncologic resection", "history": [], "ground_truth": ["permed-59570", "permed-76409", "permed-56525", "permed-64801", "permed-70578", "permed-71347", "permed-91514", "permed-71326", "permed-72691", "permed-54987"]}
{"query_id": "topic_431_turn_2", "conversation_id": "topic_431", "turn_id": 2, "query": "Comparing perforator-based flaps (e.g., ALT) versus other methods for these pharyngoesophageal reconstructions: efficacy and outcomes", "history": ["Review of surgical techniques for pharyngoesophageal reconstruction following oncologic resection"], "ground_truth": ["permed-76409", "permed-91786", "permed-82929", "permed-64333", "permed-76413", "permed-90464", "permed-90842", "permed-88912", "permed-82928", "permed-71146"]}
{"query_id": "topic_431_turn_3", "conversation_id": "topic_431", "turn_id": 3, "query": "Impact of patient factors (tumor site, defect size, nutritional status) on functional outcomes and complications in ALT flap pharyngoesophageal reconstruction with U-shaped insetting versus traditional techniques", "history": ["Review of surgical techniques for pharyngoesophageal reconstruction following oncologic resection", "Comparing perforator-based flaps (e.g., ALT) versus other methods for these pharyngoesophageal reconstructions: efficacy and outcomes"], "ground_truth": ["permed-76409", "permed-76175", "permed-82928", "permed-82929", "permed-76411", "permed-82925", "permed-91786", "permed-75153", "permed-64801", "permed-3847"]}
{"query_id": "topic_431_turn_4", "conversation_id": "topic_431", "turn_id": 4, "query": "Given the complex interplay between patient factors and surgical techniques you described, what specific intraoperative protocols were implemented to standardize the U-shaped insetting technique? Were there particular quality control measures for assessing flap perfusion or anastomotic integrity during these procedures, and what statistical methods were employed to validate the relationship between technical execution and postoperative functional outcomes across different defect sizes?", "history": ["Review of surgical techniques for pharyngoesophageal reconstruction following oncologic resection", "Comparing perforator-based flaps (e.g., ALT) versus other methods for these pharyngoesophageal reconstructions: efficacy and outcomes", "Impact of patient factors (tumor site, defect size, nutritional status) on functional outcomes and complications in ALT flap pharyngoesophageal reconstruction with U-shaped insetting versus traditional techniques"], "ground_truth": ["permed-84761", "permed-76409", "permed-92188", "permed-41642", "permed-78675", "permed-70519", "permed-64519", "permed-84561", "permed-56546", "permed-90463"]}
{"query_id": "topic_432_turn_1", "conversation_id": "topic_432", "turn_id": 1, "query": "What role does the gut microbiome play in protecting against arsenic-induced health issues?", "history": [], "ground_truth": ["permed-81096", "permed-81098", "permed-38277", "permed-65029", "permed-65420", "permed-38525", "permed-81097", "permed-85349", "permed-81102", "permed-89112"]}
{"query_id": "topic_432_turn_2", "conversation_id": "topic_432", "turn_id": 2, "query": "How might modifying this microbial community, through interventions like prebiotics or probiotics, enhance its protective effects?", "history": ["What role does the gut microbiome play in protecting against arsenic-induced health issues?"], "ground_truth": ["permed-90392", "permed-66699", "permed-51677", "permed-58232", "permed-74534", "permed-63197", "permed-77658", "permed-58588", "permed-64094", "permed-57762"]}
{"query_id": "topic_432_turn_3", "conversation_id": "topic_432", "turn_id": 3, "query": "Building on these findings about how the gut microbiome influences arsenic metabolism and host physiology, could specific prebiotics or probiotics be strategically used to boost its protective effects against arsenic-induced metabolic disorders? What molecular pathways might mediate these protective mechanisms?", "history": ["What role does the gut microbiome play in protecting against arsenic-induced health issues?", "How might modifying this microbial community, through interventions like prebiotics or probiotics, enhance its protective effects?"], "ground_truth": ["permed-81096", "permed-81098", "permed-81097", "permed-67944", "permed-76733", "permed-56496", "permed-62619", "permed-62616", "permed-38277", "permed-89112"]}
{"query_id": "topic_432_turn_4", "conversation_id": "topic_432", "turn_id": 4, "query": "Following up on these potential interventions, what specific experimental designs would best test the efficacy of prebiotic or probiotic formulations in modifying arsenic metabolism? I'm particularly interested in the technical implementation - how would you determine optimal dosing regimens, administration timelines, and validate changes in microbial community structure through 16S rRNA sequencing? Additionally, what statistical approaches would be most appropriate for analyzing the relationship between microbial shifts and arsenic methylation ratios in different tissue compartments?", "history": ["What role does the gut microbiome play in protecting against arsenic-induced health issues?", "How might modifying this microbial community, through interventions like prebiotics or probiotics, enhance its protective effects?", "Building on these findings about how the gut microbiome influences arsenic metabolism and host physiology, could specific prebiotics or probiotics be strategically used to boost its protective effects against arsenic-induced metabolic disorders? What molecular pathways might mediate these protective mechanisms?"], "ground_truth": ["permed-81096", "permed-38140", "permed-81098", "permed-89112", "permed-81097", "permed-80677", "permed-85349", "permed-74125", "permed-38141", "permed-37664"]}
{"query_id": "topic_433_turn_1", "conversation_id": "topic_433", "turn_id": 1, "query": "Diagnostic challenges of sarcoidosis with atypical clinical presentations", "history": [], "ground_truth": ["permed-68414", "permed-60253", "permed-60250", "permed-61076", "permed-60251", "permed-61327", "permed-60252", "permed-60536", "permed-57233", "permed-68832"]}
{"query_id": "topic_433_turn_2", "conversation_id": "topic_433", "turn_id": 2, "query": "Consequences of misdiagnosing sarcoidosis due to these atypical presentations on patient long-term outcomes and therapeutic approaches", "history": ["Diagnostic challenges of sarcoidosis with atypical clinical presentations"], "ground_truth": ["permed-60250", "permed-60253", "permed-61327", "permed-60248", "permed-60251", "permed-68832", "permed-57233", "permed-60252", "permed-61076", "permed-60247"]}
{"query_id": "topic_433_turn_3", "conversation_id": "topic_433", "turn_id": 3, "query": "Sarcoidosis mimicking diabetes insipidus: implications for long-term prognosis, disease management, and best practices for early diagnosis and multidisciplinary team interventions", "history": ["Diagnostic challenges of sarcoidosis with atypical clinical presentations", "Consequences of misdiagnosing sarcoidosis due to these atypical presentations on patient long-term outcomes and therapeutic approaches"], "ground_truth": ["permed-60250", "permed-58902", "permed-61327", "permed-23104", "permed-23106", "permed-60252", "permed-60253", "permed-58327", "permed-60251", "permed-9393"]}
{"query_id": "topic_433_turn_4", "conversation_id": "topic_433", "turn_id": 4, "query": "Given these diagnostic challenges when sarcoidosis mimics diabetes insipidus, what specific biochemical and imaging protocols were implemented in your multidisciplinary diagnostic workflow? I'm particularly interested in the technical validation of the water deprivation test versus direct MRI imaging of the pituitary, and how your team established standardized criteria for differentiating neurosarcoidosis from primary central diabetes insipidus during the initial diagnostic workup to ensure consistent results across your patient cohort.", "history": ["Diagnostic challenges of sarcoidosis with atypical clinical presentations", "Consequences of misdiagnosing sarcoidosis due to these atypical presentations on patient long-term outcomes and therapeutic approaches", "Sarcoidosis mimicking diabetes insipidus: implications for long-term prognosis, disease management, and best practices for early diagnosis and multidisciplinary team interventions"], "ground_truth": ["permed-60250", "permed-58902", "permed-70571", "permed-77457", "permed-29716", "permed-25657", "permed-60536", "permed-86974", "permed-29719", "permed-61161"]}
{"query_id": "topic_434_turn_1", "conversation_id": "topic_434", "turn_id": 1, "query": "What is known about the effects of anti-inflammatory drugs on reproductive health in mares?", "history": [], "ground_truth": ["permed-81046", "permed-67820", "permed-80754", "permed-80619", "permed-92449", "permed-92451", "permed-58602", "permed-45128", "permed-74694", "permed-84262"]}
{"query_id": "topic_434_turn_2", "conversation_id": "topic_434", "turn_id": 2, "query": "How might specific treatments like dexamethasone and flunixin-meglumine impact conditions such as endometritis in this area?", "history": ["What is known about the effects of anti-inflammatory drugs on reproductive health in mares?"], "ground_truth": ["permed-81046", "permed-67820", "permed-80619", "permed-84261", "permed-84262", "permed-67823", "permed-55026", "permed-90867", "permed-72696", "permed-67817"]}
{"query_id": "topic_434_turn_3", "conversation_id": "topic_434", "turn_id": 3, "query": "Given what we know about how dexamethasone and flunixin-meglumine affect ovulation, endometrial edema, and inter-ovulatory intervals in mares, how does the timing and dosage of these treatments influence their effectiveness in managing mating-induced endometritis—especially in mares with reproductive disorders? Also, what molecular mechanisms explain their differential effects on prostaglandin production and endometrial inflammation, and how could this understanding help develop more targeted therapies?", "history": ["What is known about the effects of anti-inflammatory drugs on reproductive health in mares?", "How might specific treatments like dexamethasone and flunixin-meglumine impact conditions such as endometritis in this area?"], "ground_truth": ["permed-81046", "permed-81047", "permed-80619", "permed-67820", "permed-67819", "permed-67817", "permed-67823", "permed-6752", "permed-76170", "permed-58600"]}
{"query_id": "topic_434_turn_4", "conversation_id": "topic_434", "turn_id": 4, "query": "When studying the timing and dosage effects of dexamethasone and flunixin-meglumine on mating-induced endometritis, what specific experimental protocols would you recommend for standardizing endometrial edema scoring and inter-ovulatory interval measurements across multiple cycles? Additionally, what statistical approaches would be most appropriate for analyzing the repeated measures data from these treatment regimens, particularly when assessing their differential impacts on prostaglandin production and inflammatory markers in mares with pre-existing reproductive disorders?", "history": ["What is known about the effects of anti-inflammatory drugs on reproductive health in mares?", "How might specific treatments like dexamethasone and flunixin-meglumine impact conditions such as endometritis in this area?", "Given what we know about how dexamethasone and flunixin-meglumine affect ovulation, endometrial edema, and inter-ovulatory intervals in mares, how does the timing and dosage of these treatments influence their effectiveness in managing mating-induced endometritis—especially in mares with reproductive disorders? Also, what molecular mechanisms explain their differential effects on prostaglandin production and endometrial inflammation, and how could this understanding help develop more targeted therapies?"], "ground_truth": ["permed-81046", "permed-81047", "permed-67817", "permed-80619", "permed-67819", "permed-67823", "permed-78206", "permed-84261", "permed-67820", "permed-87673"]}
{"query_id": "topic_435_turn_1", "conversation_id": "topic_435", "turn_id": 1, "query": "What is known about the role of autoimmune responses in Hashimoto's thyroiditis?", "history": [], "ground_truth": ["permed-81840", "permed-77179", "permed-81839", "permed-83620", "permed-22979", "permed-84551", "permed-59047", "permed-37871", "permed-38442", "permed-54733"]}
{"query_id": "topic_435_turn_2", "conversation_id": "topic_435", "turn_id": 2, "query": "How do specific autoantibodies, like those targeting thyroid proteins, contribute to this condition?", "history": ["What is known about the role of autoimmune responses in Hashimoto's thyroiditis?"], "ground_truth": ["permed-59047", "permed-83620", "permed-37871", "permed-73144", "permed-77179", "permed-88755", "permed-54733", "permed-54732", "permed-61125", "permed-68828"]}
{"query_id": "topic_435_turn_3", "conversation_id": "topic_435", "turn_id": 3, "query": "Given these autoimmune responses and the role of thyroid-targeting autoantibodies, could you explain the molecular mechanisms by which IL-36γ interacts with TPO-Ab in Hashimoto's thyroiditis, and how this interaction might affect inflammation and disease progression?", "history": ["What is known about the role of autoimmune responses in Hashimoto's thyroiditis?", "How do specific autoantibodies, like those targeting thyroid proteins, contribute to this condition?"], "ground_truth": ["permed-81839", "permed-81840", "permed-77179", "permed-37871", "permed-83620", "permed-59047", "permed-38442", "permed-48538", "permed-22979", "permed-61125"]}
{"query_id": "topic_435_turn_4", "conversation_id": "topic_435", "turn_id": 4, "query": "Following the proposed IL-36γ and TPO-Ab interaction mechanisms, what specific experimental approaches would best characterize their direct binding kinetics and downstream signaling events in thyroid cells? I'm particularly interested in the technical implementation—would surface plasmon resonance or co-immunoprecipitation followed by mass spectrometry be more appropriate for validating protein interactions, and what cellular assay designs would effectively measure resultant inflammatory cytokine production while controlling for thyroid-specific microenvironments?", "history": ["What is known about the role of autoimmune responses in Hashimoto's thyroiditis?", "How do specific autoantibodies, like those targeting thyroid proteins, contribute to this condition?", "Given these autoimmune responses and the role of thyroid-targeting autoantibodies, could you explain the molecular mechanisms by which IL-36γ interacts with TPO-Ab in Hashimoto's thyroiditis, and how this interaction might affect inflammation and disease progression?"], "ground_truth": ["permed-81839", "permed-37871", "permed-82133", "permed-77179", "permed-67929", "permed-37872", "permed-59047", "permed-58843", "permed-81840", "permed-30406"]}
{"query_id": "topic_436_turn_1", "conversation_id": "topic_436", "turn_id": 1, "query": "How did silent films portray medical professionals and their practices during the early 20th century?", "history": [], "ground_truth": ["permed-81604", "permed-81602", "permed-45043", "permed-25357", "permed-70905", "permed-15215", "permed-1454", "permed-6786", "permed-70237", "permed-90586"]}
{"query_id": "topic_436_turn_2", "conversation_id": "topic_436", "turn_id": 2, "query": "What impact did this portrayal have on the public's perception of medical authority at the time?", "history": ["How did silent films portray medical professionals and their practices during the early 20th century?"], "ground_truth": ["permed-65866", "permed-69733", "permed-81623", "permed-45043", "permed-54047", "permed-81604", "permed-51528", "permed-67621", "permed-81602", "permed-72495"]}
{"query_id": "topic_436_turn_3", "conversation_id": "topic_436", "turn_id": 3, "query": "Given these portrayals and their impact on public perception, how did silent films specifically depict internists responding to infectious diseases, and what does this reveal about the public's trust in medical authority during that period? Furthermore, how might this historical perspective inform our understanding of media's role in shaping public health responses today?", "history": ["How did silent films portray medical professionals and their practices during the early 20th century?", "What impact did this portrayal have on the public's perception of medical authority at the time?"], "ground_truth": ["permed-81604", "permed-81623", "permed-69733", "permed-54934", "permed-54939", "permed-65962", "permed-57838", "permed-65959", "permed-53008", "permed-65866"]}
{"query_id": "topic_436_turn_4", "conversation_id": "topic_436", "turn_id": 4, "query": "When analyzing these silent film portrayals of internists managing infectious diseases, what specific methodological approaches would you recommend for systematically coding visual representations of medical authority? For instance, should we develop a structured annotation protocol for cinematic techniques like lighting, framing, and character positioning? How might inter-rater reliability be established when interpreting historical medical gestures or patient-physician interactions depicted without dialogue? Additionally, what statistical methods would best correlate these visual elements with contemporary public health records to validate their societal impact?", "history": ["How did silent films portray medical professionals and their practices during the early 20th century?", "What impact did this portrayal have on the public's perception of medical authority at the time?", "Given these portrayals and their impact on public perception, how did silent films specifically depict internists responding to infectious diseases, and what does this reveal about the public's trust in medical authority during that period? Furthermore, how might this historical perspective inform our understanding of media's role in shaping public health responses today?"], "ground_truth": ["permed-81604", "permed-80215", "permed-74857", "permed-90586", "permed-51507", "permed-88283", "permed-69865", "permed-60701", "permed-69741", "permed-81623"]}
{"query_id": "topic_437_turn_1", "conversation_id": "topic_437", "turn_id": 1, "query": "What key factors affect the pharmacokinetics of gepotidacin and similar triazaacenaphthylene antibiotics in diverse human populations?", "history": [], "ground_truth": ["permed-75853", "permed-60436", "permed-60431", "permed-81103", "permed-62947", "permed-80386", "permed-83079", "permed-60438", "permed-56984", "permed-69017"]}
{"query_id": "topic_437_turn_2", "conversation_id": "topic_437", "turn_id": 2, "query": "How do variations in plasma exposure and excretion of these antibiotics influence dosing regimen adjustments for different ethnic groups?", "history": ["What key factors affect the pharmacokinetics of gepotidacin and similar triazaacenaphthylene antibiotics in diverse human populations?"], "ground_truth": ["permed-68969", "permed-68907", "permed-84291", "permed-60431", "permed-60438", "permed-60434", "permed-55094", "permed-60435", "permed-75856", "permed-56972"]}
{"query_id": "topic_437_turn_3", "conversation_id": "topic_437", "turn_id": 3, "query": "Gepotidacin dosing adjustment for Japanese vs non-Japanese populations: impact of PK variability (plasma, urine), body weight, diet, and implications for global trials and treatment of uncomplicated UTI & urogenital gonorrhea.", "history": ["What key factors affect the pharmacokinetics of gepotidacin and similar triazaacenaphthylene antibiotics in diverse human populations?", "How do variations in plasma exposure and excretion of these antibiotics influence dosing regimen adjustments for different ethnic groups?"], "ground_truth": ["permed-75853", "permed-60436", "permed-90976", "permed-67878", "permed-58385", "permed-62947", "permed-67877", "permed-56983", "permed-75856", "permed-60438"]}
{"query_id": "topic_437_turn_4", "conversation_id": "topic_437", "turn_id": 4, "query": "Given these observed PK differences between Japanese and non-Japanese populations, what specific statistical methodologies were implemented to validate the population pharmacokinetic model's predictive accuracy for renal clearance adjustments? Were Bayesian forecasting techniques or bootstrapping validation approaches employed to quantify parameter uncertainty, and how did the covariate analysis protocol specifically differentiate between body weight effects versus intrinsic ethnic factors when recommending dosage modifications for global trials?", "history": ["What key factors affect the pharmacokinetics of gepotidacin and similar triazaacenaphthylene antibiotics in diverse human populations?", "How do variations in plasma exposure and excretion of these antibiotics influence dosing regimen adjustments for different ethnic groups?", "Gepotidacin dosing adjustment for Japanese vs non-Japanese populations: impact of PK variability (plasma, urine), body weight, diet, and implications for global trials and treatment of uncomplicated UTI & urogenital gonorrhea."], "ground_truth": ["permed-77219", "permed-67877", "permed-56983", "permed-71008", "permed-55398", "permed-67878", "permed-75815", "permed-56984", "permed-60431", "permed-60432"]}
{"query_id": "topic_438_turn_1", "conversation_id": "topic_438", "turn_id": 1, "query": "What are the long-term cardiac effects of preterm birth on infants with a single right ventricle?", "history": [], "ground_truth": ["permed-78501", "permed-60499", "permed-54435", "permed-24845", "permed-54482", "permed-24724", "permed-78544", "permed-82610", "permed-76599", "permed-66540"]}
{"query_id": "topic_438_turn_2", "conversation_id": "topic_438", "turn_id": 2, "query": "Does early intervention in this area, such as neonatal care and nutritional support, show promise in improving these outcomes?", "history": ["What are the long-term cardiac effects of preterm birth on infants with a single right ventricle?"], "ground_truth": ["permed-61019", "permed-21079", "permed-34631", "permed-45012", "permed-78156", "permed-87508", "permed-91844", "permed-45883", "permed-74639", "permed-87509"]}
{"query_id": "topic_438_turn_3", "conversation_id": "topic_438", "turn_id": 3, "query": "Based on these findings about cardiac remodeling and outcomes in preterm infants with a single right ventricle, how could targeted neonatal care and early developmental support—especially nutritional interventions—potentially improve their cardiac function and long-term survival? Specifically, how might early nutritional support help counteract the effects of low birth weight in this population?", "history": ["What are the long-term cardiac effects of preterm birth on infants with a single right ventricle?", "Does early intervention in this area, such as neonatal care and nutritional support, show promise in improving these outcomes?"], "ground_truth": ["permed-78501", "permed-60499", "permed-91900", "permed-78156", "permed-78497", "permed-90229", "permed-81642", "permed-89269", "permed-24724", "permed-51767"]}
{"query_id": "topic_438_turn_4", "conversation_id": "topic_438", "turn_id": 4, "query": "Given these proposed nutritional interventions, what specific methodological approaches would best evaluate their efficacy in modulating cardiac remodeling? I'm particularly interested in how researchers might design randomized controlled trials to isolate nutritional effects, what imaging protocols (such as serial echocardiography parameters) would track functional changes, and which biomarkers could serve as objective measures of myocardial response. How would you statistically power such longitudinal studies given the rarity of this patient population while controlling for confounders like concomitant medical therapies?", "history": ["What are the long-term cardiac effects of preterm birth on infants with a single right ventricle?", "Does early intervention in this area, such as neonatal care and nutritional support, show promise in improving these outcomes?", "Based on these findings about cardiac remodeling and outcomes in preterm infants with a single right ventricle, how could targeted neonatal care and early developmental support—especially nutritional interventions—potentially improve their cardiac function and long-term survival? Specifically, how might early nutritional support help counteract the effects of low birth weight in this population?"], "ground_truth": ["permed-90531", "permed-57347", "permed-83580", "permed-90532", "permed-57345", "permed-76590", "permed-57068", "permed-84011", "permed-58718", "permed-51424"]}
{"query_id": "topic_439_turn_1", "conversation_id": "topic_439", "turn_id": 1, "query": "Psychological effects of urban noise pollution on resident well-being", "history": [], "ground_truth": ["permed-63478", "permed-75629", "permed-75160", "permed-60970", "permed-66783", "permed-63320", "permed-61782", "permed-84683", "permed-66153", "permed-59331"]}
{"query_id": "topic_439_turn_2", "conversation_id": "topic_439", "turn_id": 2, "query": "Studies on how these psychological effects of urban noise pollution on residents changed during public health crises such as the COVID-19 pandemic", "history": ["Psychological effects of urban noise pollution on resident well-being"], "ground_truth": ["permed-75629", "permed-85697", "permed-69419", "permed-66221", "permed-84929", "permed-54033", "permed-85695", "permed-75630", "permed-54765", "permed-69734"]}
{"query_id": "topic_439_turn_3", "conversation_id": "topic_439", "turn_id": 3, "query": "Tehran case study: correlation analysis of differential urban noise exposure and psychological well-being during COVID-19, informing mitigation strategies for future public health crises", "history": ["Psychological effects of urban noise pollution on resident well-being", "Studies on how these psychological effects of urban noise pollution on residents changed during public health crises such as the COVID-19 pandemic"], "ground_truth": ["permed-75629", "permed-68512", "permed-84929", "permed-85697", "permed-54765", "permed-85695", "permed-88327", "permed-66221", "permed-84526", "permed-69734"]}
{"query_id": "topic_439_turn_4", "conversation_id": "topic_439", "turn_id": 4, "query": "For the Tehran correlation analysis, what specific statistical approaches were employed to quantify the relationship between differential noise exposure and psychological well-being metrics? I'm particularly interested in how you controlled for confounding variables like socioeconomic status and pre-existing mental health conditions in the regression models, and what validation methods, such as cross-validation or bootstrap resampling, were used to ensure the robustness of these correlation findings.", "history": ["Psychological effects of urban noise pollution on resident well-being", "Studies on how these psychological effects of urban noise pollution on residents changed during public health crises such as the COVID-19 pandemic", "Tehran case study: correlation analysis of differential urban noise exposure and psychological well-being during COVID-19, informing mitigation strategies for future public health crises"], "ground_truth": ["permed-55842", "permed-92401", "permed-75629", "permed-66564", "permed-66560", "permed-84711", "permed-55756", "permed-65500", "permed-50587", "permed-84683"]}
{"query_id": "topic_440_turn_1", "conversation_id": "topic_440", "turn_id": 1, "query": "Role and methodologies of spatial analysis in epidemiological research of infectious diseases like HIV", "history": [], "ground_truth": ["permed-88327", "permed-75641", "permed-35939", "permed-75640", "permed-75607", "permed-54928", "permed-75644", "permed-73394", "permed-54940", "permed-66153"]}
{"query_id": "topic_440_turn_2", "conversation_id": "topic_440", "turn_id": 2, "query": "How does integrating these spatial analysis methodologies with social determinant of health (SDOH) data improve prediction accuracy for high-risk areas of such infectious diseases?", "history": ["Role and methodologies of spatial analysis in epidemiological research of infectious diseases like HIV"], "ground_truth": ["permed-65884", "permed-75642", "permed-59199", "permed-61935", "permed-73394", "permed-75608", "permed-75640", "permed-59208", "permed-62367", "permed-59209"]}
{"query_id": "topic_440_turn_3", "conversation_id": "topic_440", "turn_id": 3, "query": "How can advanced spatial-statistical models that integrate key social determinants of health be specifically applied to predict HIV transmission hotspots and guide effective community-based prevention strategies for adolescents in Belém, Pará?", "history": ["Role and methodologies of spatial analysis in epidemiological research of infectious diseases like HIV", "How does integrating these spatial analysis methodologies with social determinant of health (SDOH) data improve prediction accuracy for high-risk areas of such infectious diseases?"], "ground_truth": ["permed-75640", "permed-75641", "permed-75642", "permed-73764", "permed-75644", "permed-75645", "permed-75643", "permed-35939", "permed-65937", "permed-59204"]}
{"query_id": "topic_440_turn_4", "conversation_id": "topic_440", "turn_id": 4, "query": "Given this proposed application of spatial-statistical models for HIV hotspots in Belém, what specific protocols would you recommend for validating these integrated models prior to field implementation? I'm particularly interested in how one would approach cross-validation strategies given the spatial autocorrelation in the data, and what statistical metrics would be most appropriate for assessing both predictive accuracy and model calibration in this epidemiological context where false negatives could significantly impact prevention outcomes.", "history": ["Role and methodologies of spatial analysis in epidemiological research of infectious diseases like HIV", "How does integrating these spatial analysis methodologies with social determinant of health (SDOH) data improve prediction accuracy for high-risk areas of such infectious diseases?", "How can advanced spatial-statistical models that integrate key social determinants of health be specifically applied to predict HIV transmission hotspots and guide effective community-based prevention strategies for adolescents in Belém, Pará?"], "ground_truth": ["permed-75644", "permed-35939", "permed-75641", "permed-36069", "permed-35938", "permed-75607", "permed-35506", "permed-75640", "permed-90666", "permed-61935"]}
{"query_id": "topic_441_turn_1", "conversation_id": "topic_441", "turn_id": 1, "query": "Current research on valorization of underutilized agricultural by-products for applications in food science and human nutrition", "history": [], "ground_truth": ["permed-65029", "permed-59650", "permed-59652", "permed-78138", "permed-59647", "permed-90871", "permed-69940", "permed-63671", "permed-83560", "permed-57680"]}
{"query_id": "topic_441_turn_2", "conversation_id": "topic_441", "turn_id": 2, "query": "Effects of incorporating these valorized agricultural by-products into cultivation substrates on the nutritional composition and yield of Pleurotus ostreatus mushrooms", "history": ["Current research on valorization of underutilized agricultural by-products for applications in food science and human nutrition"], "ground_truth": ["permed-74228", "permed-59154", "permed-74230", "permed-91769", "permed-85049", "permed-52448", "permed-78137", "permed-65248", "permed-74229", "permed-65029"]}
{"query_id": "topic_441_turn_3", "conversation_id": "topic_441", "turn_id": 3, "query": "Optimization of Pleurotus ostreatus cultivation substrates using varied ratios of palm oil waste and other agricultural by-products: effects on nutrient bioavailability, bioactive compound profiles, and potential for functional food and nutraceutical applications", "history": ["Current research on valorization of underutilized agricultural by-products for applications in food science and human nutrition", "Effects of incorporating these valorized agricultural by-products into cultivation substrates on the nutritional composition and yield of Pleurotus ostreatus mushrooms"], "ground_truth": ["permed-74228", "permed-59154", "permed-78137", "permed-74229", "permed-74230", "permed-52448", "permed-86377", "permed-75422", "permed-64076", "permed-57739"]}
{"query_id": "topic_441_turn_4", "conversation_id": "topic_441", "turn_id": 4, "query": "When implementing this substrate optimization approach, what specific analytical methods were employed to quantify the nutrient bioavailability and bioactive compound profiles? I'm particularly interested in the protocols for assessing in vitro digestibility, the chromatographic techniques used for polyphenol identification, and any validation procedures for these analytical methods. Were there specific quality control measures implemented to ensure reproducibility across different substrate batches?", "history": ["Current research on valorization of underutilized agricultural by-products for applications in food science and human nutrition", "Effects of incorporating these valorized agricultural by-products into cultivation substrates on the nutritional composition and yield of Pleurotus ostreatus mushrooms", "Optimization of Pleurotus ostreatus cultivation substrates using varied ratios of palm oil waste and other agricultural by-products: effects on nutrient bioavailability, bioactive compound profiles, and potential for functional food and nutraceutical applications"], "ground_truth": ["permed-79388", "permed-65000", "permed-80729", "permed-89209", "permed-65010", "permed-52720", "permed-80728", "permed-65015", "permed-52764", "permed-86650"]}
{"query_id": "topic_441_turn_5", "conversation_id": "topic_441", "turn_id": 5, "query": "Given the detailed analytical validation of nutrient profiles and bioavailability from optimized substrates, what clinical evidence exists regarding the therapeutic efficacy of Pleurotus ostreatus cultivated using these valorized agricultural by-products? Specifically, have human intervention trials evaluated health outcomes such as glycemic control, lipid metabolism modulation, or inflammatory markers? Furthermore, what safety profiles and potential contraindications have been documented when consuming mushrooms from these modified substrates, particularly regarding heavy metal bioaccumulation or interactions with common medications in at-risk populations?", "history": ["Current research on valorization of underutilized agricultural by-products for applications in food science and human nutrition", "Effects of incorporating these valorized agricultural by-products into cultivation substrates on the nutritional composition and yield of Pleurotus ostreatus mushrooms", "Optimization of Pleurotus ostreatus cultivation substrates using varied ratios of palm oil waste and other agricultural by-products: effects on nutrient bioavailability, bioactive compound profiles, and potential for functional food and nutraceutical applications", "When implementing this substrate optimization approach, what specific analytical methods were employed to quantify the nutrient bioavailability and bioactive compound profiles? I'm particularly interested in the protocols for assessing in vitro digestibility, the chromatographic techniques used for polyphenol identification, and any validation procedures for these analytical methods. Were there specific quality control measures implemented to ensure reproducibility across different substrate batches?"], "ground_truth": ["permed-74228", "permed-91285", "permed-59154", "permed-69008", "permed-82415", "permed-77191", "permed-39592", "permed-67457", "permed-78137", "permed-85049"]}
{"query_id": "topic_442_turn_1", "conversation_id": "topic_442", "turn_id": 1, "query": "What factors influence the population dynamics of Phlebotomus sand flies, which are vectors of leishmaniasis?", "history": [], "ground_truth": ["permed-79177", "permed-79176", "permed-79178", "permed-79179", "permed-62082", "permed-78636", "permed-62244", "permed-89605", "permed-81823", "permed-67992"]}
{"query_id": "topic_442_turn_2", "conversation_id": "topic_442", "turn_id": 2, "query": "How do environmental conditions, such as temperature and humidity, affect the behavior and prevalence of these sand flies in different regions?", "history": ["What factors influence the population dynamics of Phlebotomus sand flies, which are vectors of leishmaniasis?"], "ground_truth": ["permed-79177", "permed-74171", "permed-62538", "permed-33856", "permed-89605", "permed-89051", "permed-74162", "permed-79176", "permed-79180", "permed-74163"]}
{"query_id": "topic_442_turn_3", "conversation_id": "topic_442", "turn_id": 3, "query": "Given these environmental influences on sand fly behavior, how do microclimatic conditions—particularly humidity and temperature variations—affect the phenology and population dynamics of Phlebotomus (Paraphlebotomus) sergenti across different regions? And what do these microclimatic effects mean for the spatial and temporal patterns of anthroponotic cutaneous leishmaniasis transmission?", "history": ["What factors influence the population dynamics of Phlebotomus sand flies, which are vectors of leishmaniasis?", "How do environmental conditions, such as temperature and humidity, affect the behavior and prevalence of these sand flies in different regions?"], "ground_truth": ["permed-79176", "permed-79177", "permed-79178", "permed-62244", "permed-89605", "permed-78636", "permed-79179", "permed-81823", "permed-33856", "permed-62082"]}
{"query_id": "topic_442_turn_4", "conversation_id": "topic_442", "turn_id": 4, "query": "Given these microclimatic associations with transmission patterns, what specific statistical modeling approaches—such as time-series analyses or spatial regression techniques—were used to quantify the relationship between humidity/temperature fluctuations and P. sergenti population dynamics? How were these models validated to ensure robustness in predicting leishmaniasis risk, and what sampling protocols were implemented for microclimatic data collection across different ecological zones to maintain methodological consistency?", "history": ["What factors influence the population dynamics of Phlebotomus sand flies, which are vectors of leishmaniasis?", "How do environmental conditions, such as temperature and humidity, affect the behavior and prevalence of these sand flies in different regions?", "Given these environmental influences on sand fly behavior, how do microclimatic conditions—particularly humidity and temperature variations—affect the phenology and population dynamics of Phlebotomus (Paraphlebotomus) sergenti across different regions? And what do these microclimatic effects mean for the spatial and temporal patterns of anthroponotic cutaneous leishmaniasis transmission?"], "ground_truth": ["permed-79176", "permed-62244", "permed-38321", "permed-38546", "permed-89397", "permed-79177", "permed-79178", "permed-62205", "permed-78636", "permed-75616"]}
{"query_id": "topic_442_turn_5", "conversation_id": "topic_442", "turn_id": 5, "query": "Given these sophisticated modeling approaches for predicting leishmaniasis risk through microclimatic associations with sand fly dynamics, how have these predictive models been translated into clinical practice for preventing anthroponotic cutaneous leishmaniasis outbreaks? Specifically, what evidence exists regarding the efficacy of model-informed interventions—such as targeted vector control or preemptive public health warnings—in reducing patient case loads or improving clinical outcomes? Additionally, what implementation challenges have healthcare systems faced when deploying these climate-driven risk predictions in real-world clinical settings, particularly in resource-limited endemic regions?", "history": ["What factors influence the population dynamics of Phlebotomus sand flies, which are vectors of leishmaniasis?", "How do environmental conditions, such as temperature and humidity, affect the behavior and prevalence of these sand flies in different regions?", "Given these environmental influences on sand fly behavior, how do microclimatic conditions—particularly humidity and temperature variations—affect the phenology and population dynamics of Phlebotomus (Paraphlebotomus) sergenti across different regions? And what do these microclimatic effects mean for the spatial and temporal patterns of anthroponotic cutaneous leishmaniasis transmission?", "Given these microclimatic associations with transmission patterns, what specific statistical modeling approaches—such as time-series analyses or spatial regression techniques—were used to quantify the relationship between humidity/temperature fluctuations and P. sergenti population dynamics? How were these models validated to ensure robustness in predicting leishmaniasis risk, and what sampling protocols were implemented for microclimatic data collection across different ecological zones to maintain methodological consistency?"], "ground_truth": ["permed-62205", "permed-62244", "permed-79176", "permed-38321", "permed-90687", "permed-54697", "permed-53886", "permed-62101", "permed-62206", "permed-62103"]}
{"query_id": "topic_443_turn_1", "conversation_id": "topic_443", "turn_id": 1, "query": "Current applications and emerging trends of robotic technology in elderly care", "history": [], "ground_truth": ["permed-56932", "permed-71747", "permed-76737", "permed-82779", "permed-61638", "permed-77846", "permed-74641", "permed-84665", "permed-55218", "permed-70061"]}
{"query_id": "topic_443_turn_2", "conversation_id": "topic_443", "turn_id": 2, "query": "Ethical implications of these robotic elderly care applications for trust and authenticity in caregiving", "history": ["Current applications and emerging trends of robotic technology in elderly care"], "ground_truth": ["permed-77846", "permed-70065", "permed-56932", "permed-54373", "permed-67268", "permed-66153", "permed-76737", "permed-76739", "permed-70061", "permed-54917"]}
{"query_id": "topic_443_turn_3", "conversation_id": "topic_443", "turn_id": 3, "query": "Technical design strategies for AI and HRI in elderly care robots to ensure transparency, veracity, and user trust", "history": ["Current applications and emerging trends of robotic technology in elderly care", "Ethical implications of these robotic elderly care applications for trust and authenticity in caregiving"], "ground_truth": ["permed-77846", "permed-71747", "permed-67268", "permed-70065", "permed-76737", "permed-70061", "permed-69586", "permed-56932", "permed-72396", "permed-76739"]}
{"query_id": "topic_443_turn_4", "conversation_id": "topic_443", "turn_id": 4, "query": "Given these technical design strategies for ensuring transparency and veracity, what specific validation protocols and metrics were employed to quantitatively assess their effectiveness in actual HRI scenarios with elderly users? I'm particularly interested in whether you used standardized trust scales, behavioral coding schemes for interaction analysis, or specific reliability testing for the AI's truthfulness claims. How did the experimental design control for variables like user cognitive status or prior technology exposure when evaluating these trust-building mechanisms?", "history": ["Current applications and emerging trends of robotic technology in elderly care", "Ethical implications of these robotic elderly care applications for trust and authenticity in caregiving", "Technical design strategies for AI and HRI in elderly care robots to ensure transparency, veracity, and user trust"], "ground_truth": ["permed-71747", "permed-70837", "permed-40654", "permed-34400", "permed-25698", "permed-50683", "permed-15709", "permed-40917", "permed-34669", "permed-61043"]}
{"query_id": "topic_443_turn_5", "conversation_id": "topic_443", "turn_id": 5, "query": "Given these validation protocols for trust-building mechanisms, what clinical outcomes were observed when these transparent elderly care robots were deployed in actual care settings? I'm particularly interested in whether the quantified trust metrics correlated with improved therapeutic adherence, reduced caregiver burden, or measurable changes in patient quality of life indicators. Were there any documented safety incidents or unexpected contraindications related to cognitive impairment levels? Additionally, how did these technical trust features translate to real-world clinical efficacy compared to standard care protocols in terms of functional independence measures or hospitalization rates?", "history": ["Current applications and emerging trends of robotic technology in elderly care", "Ethical implications of these robotic elderly care applications for trust and authenticity in caregiving", "Technical design strategies for AI and HRI in elderly care robots to ensure transparency, veracity, and user trust", "Given these technical design strategies for ensuring transparency and veracity, what specific validation protocols and metrics were employed to quantitatively assess their effectiveness in actual HRI scenarios with elderly users? I'm particularly interested in whether you used standardized trust scales, behavioral coding schemes for interaction analysis, or specific reliability testing for the AI's truthfulness claims. How did the experimental design control for variables like user cognitive status or prior technology exposure when evaluating these trust-building mechanisms?"], "ground_truth": ["permed-77846", "permed-56932", "permed-76739", "permed-74641", "permed-71747", "permed-84665", "permed-61343", "permed-40917", "permed-68460", "permed-34400"]}
{"query_id": "topic_444_turn_1", "conversation_id": "topic_444", "turn_id": 1, "query": "What role do organic amendments play in restoring ecosystems, particularly in semi-arid environments?", "history": [], "ground_truth": ["permed-75709", "permed-67030", "permed-81352", "permed-81347", "permed-85870", "permed-80528", "permed-81346", "permed-71237", "permed-66776", "permed-75706"]}
{"query_id": "topic_444_turn_2", "conversation_id": "topic_444", "turn_id": 2, "query": "How does the source of these amendments, such as those derived from recycled waste, impact their effectiveness in this area?", "history": ["What role do organic amendments play in restoring ecosystems, particularly in semi-arid environments?"], "ground_truth": ["permed-61615", "permed-55107", "permed-62783", "permed-58273", "permed-74760", "permed-80731", "permed-58267", "permed-65313", "permed-66309", "permed-82651"]}
{"query_id": "topic_444_turn_3", "conversation_id": "topic_444", "turn_id": 3, "query": "Given what we've discussed about organic amendments in semi-arid ecosystems and their waste-derived sources, how do the specific composition and application rates of these amendments influence the long-term stability and resilience of soil carbon pools in restoration efforts? And what does this mean for developing sustainable land management practices in such environments?", "history": ["What role do organic amendments play in restoring ecosystems, particularly in semi-arid environments?", "How does the source of these amendments, such as those derived from recycled waste, impact their effectiveness in this area?"], "ground_truth": ["permed-75709", "permed-81347", "permed-75707", "permed-88397", "permed-81352", "permed-75706", "permed-67030", "permed-67032", "permed-85870", "permed-80528"]}
{"query_id": "topic_444_turn_4", "conversation_id": "topic_444", "turn_id": 4, "query": "When measuring long-term soil carbon pool stability following waste-derived amendment applications, what specific analytical techniques—such as soil fractionation methods or isotopic tracing approaches—are most effective for distinguishing between transient and persistent carbon fractions? How should these methods be calibrated to account for semi-arid conditions, particularly regarding microbial respiration rates and mineral stabilization processes, to ensure reproducibility across different restoration sites?", "history": ["What role do organic amendments play in restoring ecosystems, particularly in semi-arid environments?", "How does the source of these amendments, such as those derived from recycled waste, impact their effectiveness in this area?", "Given what we've discussed about organic amendments in semi-arid ecosystems and their waste-derived sources, how do the specific composition and application rates of these amendments influence the long-term stability and resilience of soil carbon pools in restoration efforts? And what does this mean for developing sustainable land management practices in such environments?"], "ground_truth": ["permed-75709", "permed-75707", "permed-81347", "permed-75706", "permed-76194", "permed-75708", "permed-88397", "permed-80528", "permed-81350", "permed-51631"]}
{"query_id": "topic_444_turn_5", "conversation_id": "topic_444", "turn_id": 5, "query": "Given our technical discussion about measuring carbon pool stability, how have these waste-derived amendments translated to clinical applications in environmental medicine? Specifically, what human health outcomes—such as reduced particulate matter exposure or decreased soil pathogen transmission—have been documented in communities near restoration sites? Furthermore, are there any documented safety concerns or contraindications regarding residual contaminants in waste-derived amendments that could pose health risks during large-scale deployment in semi-arid regions, and what clinical evidence supports these risk assessments?", "history": ["What role do organic amendments play in restoring ecosystems, particularly in semi-arid environments?", "How does the source of these amendments, such as those derived from recycled waste, impact their effectiveness in this area?", "Given what we've discussed about organic amendments in semi-arid ecosystems and their waste-derived sources, how do the specific composition and application rates of these amendments influence the long-term stability and resilience of soil carbon pools in restoration efforts? And what does this mean for developing sustainable land management practices in such environments?", "When measuring long-term soil carbon pool stability following waste-derived amendment applications, what specific analytical techniques—such as soil fractionation methods or isotopic tracing approaches—are most effective for distinguishing between transient and persistent carbon fractions? How should these methods be calibrated to account for semi-arid conditions, particularly regarding microbial respiration rates and mineral stabilization processes, to ensure reproducibility across different restoration sites?"], "ground_truth": ["permed-81873", "permed-87261", "permed-81909", "permed-63446", "permed-79185", "permed-68511", "permed-82411", "permed-83763", "permed-90172", "permed-75709"]}
{"query_id": "topic_445_turn_1", "conversation_id": "topic_445", "turn_id": 1, "query": "Comprehensive overview of lncRNA MEG3's role and molecular mechanisms in oral squamous cell carcinoma pathogenesis and progression.", "history": [], "ground_truth": ["permed-77021", "permed-56176", "permed-51114", "permed-82373", "permed-89849", "permed-89148", "permed-54978", "permed-49700", "permed-70355", "permed-89156"]}
{"query_id": "topic_445_turn_2", "conversation_id": "topic_445", "turn_id": 2, "query": "Considering its role in OSCC, what are the key epigenetic and post-transcriptional modifications directly regulating MEG3 expression, stability, and activity in this malignancy?", "history": ["Comprehensive overview of lncRNA MEG3's role and molecular mechanisms in oral squamous cell carcinoma pathogenesis and progression."], "ground_truth": ["permed-77021", "permed-82373", "permed-67631", "permed-55342", "permed-24488", "permed-51222", "permed-73657", "permed-53179", "permed-83148", "permed-88457"]}
{"query_id": "topic_445_turn_3", "conversation_id": "topic_445", "turn_id": 3, "query": "How does H3K27me3-m6A crosstalk specifically modulate MEG3's interaction with GATA3, its RNA decay rates, and downstream oncogenic signaling in oral squamous cell carcinoma, and what novel therapeutic strategies can precisely target this MEG3 regulatory axis?", "history": ["Comprehensive overview of lncRNA MEG3's role and molecular mechanisms in oral squamous cell carcinoma pathogenesis and progression.", "Considering its role in OSCC, what are the key epigenetic and post-transcriptional modifications directly regulating MEG3 expression, stability, and activity in this malignancy?"], "ground_truth": ["permed-77021", "permed-24183", "permed-67631", "permed-67630", "permed-56212", "permed-49700", "permed-24488", "permed-89851", "permed-53179", "permed-84482"]}
{"query_id": "topic_445_turn_4", "conversation_id": "topic_445", "turn_id": 4, "query": "Given this proposed H3K27me3-m6A crosstalk mechanism, what specific experimental approaches would you employ to quantitatively measure the dynamic interplay between these epigenetic marks? I'm particularly interested in the technical details for co-immunoprecipitation protocols to capture MEG3-GATA3 interactions, the optimal statistical methods for analyzing RNA decay kinetics, and validation strategies to ensure these findings aren't cell-line artifacts. How would you design controls to distinguish direct MEG3 regulation from secondary transcriptional effects in OSCC models?", "history": ["Comprehensive overview of lncRNA MEG3's role and molecular mechanisms in oral squamous cell carcinoma pathogenesis and progression.", "Considering its role in OSCC, what are the key epigenetic and post-transcriptional modifications directly regulating MEG3 expression, stability, and activity in this malignancy?", "How does H3K27me3-m6A crosstalk specifically modulate MEG3's interaction with GATA3, its RNA decay rates, and downstream oncogenic signaling in oral squamous cell carcinoma, and what novel therapeutic strategies can precisely target this MEG3 regulatory axis?"], "ground_truth": ["permed-77021", "permed-24183", "permed-24488", "permed-49700", "permed-90096", "permed-24487", "permed-51220", "permed-68166", "permed-56215", "permed-56212"]}
{"query_id": "topic_445_turn_5", "conversation_id": "topic_445", "turn_id": 5, "query": "Given these detailed mechanistic insights into MEG3 regulation, how have recent clinical trials evaluated MEG3-based therapeutic approaches in oral cancer patients, particularly regarding safety profiles and dose-limiting toxicities? What evidence exists from human studies about MEG3 restoration's impact on tumor response rates and progression-free survival compared to standard therapies? Additionally, what practical challenges have emerged in translating these epigenetic targeting strategies to clinical practice, especially concerning patient selection criteria and managing off-target effects in normal oral mucosa?", "history": ["Comprehensive overview of lncRNA MEG3's role and molecular mechanisms in oral squamous cell carcinoma pathogenesis and progression.", "Considering its role in OSCC, what are the key epigenetic and post-transcriptional modifications directly regulating MEG3 expression, stability, and activity in this malignancy?", "How does H3K27me3-m6A crosstalk specifically modulate MEG3's interaction with GATA3, its RNA decay rates, and downstream oncogenic signaling in oral squamous cell carcinoma, and what novel therapeutic strategies can precisely target this MEG3 regulatory axis?", "Given this proposed H3K27me3-m6A crosstalk mechanism, what specific experimental approaches would you employ to quantitatively measure the dynamic interplay between these epigenetic marks? I'm particularly interested in the technical details for co-immunoprecipitation protocols to capture MEG3-GATA3 interactions, the optimal statistical methods for analyzing RNA decay kinetics, and validation strategies to ensure these findings aren't cell-line artifacts. How would you design controls to distinguish direct MEG3 regulation from secondary transcriptional effects in OSCC models?"], "ground_truth": ["permed-77021", "permed-67631", "permed-24488", "permed-53179", "permed-32841", "permed-49700", "permed-31920", "permed-86634", "permed-50221", "permed-56118"]}
{"query_id": "topic_446_turn_1", "conversation_id": "topic_446", "turn_id": 1, "query": "What role do nursing professional practice models play in improving patient care outcomes?", "history": [], "ground_truth": ["permed-70261", "permed-78662", "permed-77847", "permed-70245", "permed-60198", "permed-74556", "permed-78663", "permed-87096", "permed-78656", "permed-70260"]}
{"query_id": "topic_446_turn_2", "conversation_id": "topic_446", "turn_id": 2, "query": "Can the components of these successful models be adapted for use in specialized healthcare settings?", "history": ["What role do nursing professional practice models play in improving patient care outcomes?"], "ground_truth": ["permed-61609", "permed-72360", "permed-91926", "permed-74633", "permed-63533", "permed-54920", "permed-70261", "permed-56934", "permed-59407", "permed-59138"]}
{"query_id": "topic_446_turn_3", "conversation_id": "topic_446", "turn_id": 3, "query": "Given what we know about these models and their adaptability to specialized settings, how can evidence-based components and implementation strategies from successful nursing PPMs be strategically integrated to tackle unique challenges and enhance patient care outcomes in specific contexts like the U.S. Military Health System?", "history": ["What role do nursing professional practice models play in improving patient care outcomes?", "Can the components of these successful models be adapted for use in specialized healthcare settings?"], "ground_truth": ["permed-70261", "permed-87096", "permed-74555", "permed-52379", "permed-74570", "permed-77847", "permed-74556", "permed-83209", "permed-52110", "permed-80105"]}
{"query_id": "topic_446_turn_4", "conversation_id": "topic_446", "turn_id": 4, "query": "When implementing this strategic integration in the U.S. Military Health System, what specific mixed-methods evaluation design would you recommend to quantitatively measure changes in patient outcomes, such as readmission rates, while also qualitatively capturing the contextual factors influencing the fidelity of the implementation process among nursing staff across different military treatment facilities?", "history": ["What role do nursing professional practice models play in improving patient care outcomes?", "Can the components of these successful models be adapted for use in specialized healthcare settings?", "Given what we know about these models and their adaptability to specialized settings, how can evidence-based components and implementation strategies from successful nursing PPMs be strategically integrated to tackle unique challenges and enhance patient care outcomes in specific contexts like the U.S. Military Health System?"], "ground_truth": ["permed-70261", "permed-74556", "permed-55088", "permed-69565", "permed-69063", "permed-80773", "permed-60198", "permed-74555", "permed-74570", "permed-52022"]}
{"query_id": "topic_446_turn_5", "conversation_id": "topic_446", "turn_id": 5, "query": "Given your proposed mixed-methods evaluation design for the Military Health System, what specific adverse clinical events or unintended consequences should implementation teams proactively monitor during the integration of these nursing PPM components? Considering the high-acuity patient population and unique operational stressors in military settings, which patient safety indicators—such as medication error rates or hospital-acquired infection clusters—would provide the most clinically meaningful safety data? Furthermore, how might observed side effects in staff adaptation inform real-time protocol adjustments to maintain therapeutic efficacy while minimizing patient risk during this translational process?", "history": ["What role do nursing professional practice models play in improving patient care outcomes?", "Can the components of these successful models be adapted for use in specialized healthcare settings?", "Given what we know about these models and their adaptability to specialized settings, how can evidence-based components and implementation strategies from successful nursing PPMs be strategically integrated to tackle unique challenges and enhance patient care outcomes in specific contexts like the U.S. Military Health System?", "When implementing this strategic integration in the U.S. Military Health System, what specific mixed-methods evaluation design would you recommend to quantitatively measure changes in patient outcomes, such as readmission rates, while also qualitatively capturing the contextual factors influencing the fidelity of the implementation process among nursing staff across different military treatment facilities?"], "ground_truth": ["permed-70261", "permed-74556", "permed-52270", "permed-69064", "permed-74217", "permed-60198", "permed-74555", "permed-50964", "permed-60007", "permed-90538"]}
{"query_id": "topic_447_turn_1", "conversation_id": "topic_447", "turn_id": 1, "query": "What role does the host immune system play in determining the outcome of Cryptosporidium infections?", "history": [], "ground_truth": ["permed-68337", "permed-58155", "permed-62214", "permed-57471", "permed-80718", "permed-58164", "permed-16791", "permed-67034", "permed-67037", "permed-67812"]}
{"query_id": "topic_447_turn_2", "conversation_id": "topic_447", "turn_id": 2, "query": "Are there specific immune factors within this system that have been identified as crucial for developing effective treatments against it?", "history": ["What role does the host immune system play in determining the outcome of Cryptosporidium infections?"], "ground_truth": ["permed-68004", "permed-68415", "permed-56500", "permed-16791", "permed-67998", "permed-56501", "permed-53198", "permed-4853", "permed-1919", "permed-74547"]}
{"query_id": "topic_447_turn_3", "conversation_id": "topic_447", "turn_id": 3, "query": "Given these crucial immune factors, how could targeted therapies that modulate MHC class II expression, CD40-CD40L interactions, NF-κB signaling, and IL-21 levels shape the immune response against Cryptosporidium in both immunocompetent and immunodeficient hosts? What would this mean for developing personalized treatment approaches for cryptosporidiosis?", "history": ["What role does the host immune system play in determining the outcome of Cryptosporidium infections?", "Are there specific immune factors within this system that have been identified as crucial for developing effective treatments against it?"], "ground_truth": ["permed-68337", "permed-62214", "permed-58164", "permed-58155", "permed-57471", "permed-72658", "permed-67034", "permed-67037", "permed-66631", "permed-80718"]}
{"query_id": "topic_447_turn_4", "conversation_id": "topic_447", "turn_id": 4, "query": "Given these proposed therapeutic targets, what specific experimental models would best validate the efficacy of modulating these pathways? I'm particularly interested in the technical details - would you use in vitro intestinal organoid systems with controlled cytokine environments, or murine models with conditional knockouts of these signaling components? What readouts would most accurately measure parasite clearance versus immunopathology, and how would you statistically power these experiments to detect meaningful clinical differences between immunocompetent and deficient backgrounds?", "history": ["What role does the host immune system play in determining the outcome of Cryptosporidium infections?", "Are there specific immune factors within this system that have been identified as crucial for developing effective treatments against it?", "Given these crucial immune factors, how could targeted therapies that modulate MHC class II expression, CD40-CD40L interactions, NF-κB signaling, and IL-21 levels shape the immune response against Cryptosporidium in both immunocompetent and immunodeficient hosts? What would this mean for developing personalized treatment approaches for cryptosporidiosis?"], "ground_truth": ["permed-53728", "permed-55928", "permed-83180", "permed-67975", "permed-62139", "permed-67812", "permed-59230", "permed-66970", "permed-67994", "permed-71964"]}
{"query_id": "topic_447_turn_5", "conversation_id": "topic_447", "turn_id": 5, "query": "Given the detailed experimental validation approaches discussed, how do the therapeutic windows and safety profiles compare when targeting upstream immune regulators like NF-κB signaling versus downstream effectors like IL-21 for cryptosporidiosis treatment? Specifically, in both immunocompetent and deficient murine models, what relative trade-offs emerge between achieving rapid parasite clearance through broad-spectrum pathway modulation versus minimizing collateral immunopathology through more targeted cytokine approaches? Would this comparison suggest different risk-benefit calculations for acute versus chronic infection scenarios?", "history": ["What role does the host immune system play in determining the outcome of Cryptosporidium infections?", "Are there specific immune factors within this system that have been identified as crucial for developing effective treatments against it?", "Given these crucial immune factors, how could targeted therapies that modulate MHC class II expression, CD40-CD40L interactions, NF-κB signaling, and IL-21 levels shape the immune response against Cryptosporidium in both immunocompetent and immunodeficient hosts? What would this mean for developing personalized treatment approaches for cryptosporidiosis?", "Given these proposed therapeutic targets, what specific experimental models would best validate the efficacy of modulating these pathways? I'm particularly interested in the technical details - would you use in vitro intestinal organoid systems with controlled cytokine environments, or murine models with conditional knockouts of these signaling components? What readouts would most accurately measure parasite clearance versus immunopathology, and how would you statistically power these experiments to detect meaningful clinical differences between immunocompetent and deficient backgrounds?"], "ground_truth": ["permed-68337", "permed-62214", "permed-58164", "permed-72658", "permed-3512", "permed-68050", "permed-90850", "permed-68058", "permed-82476", "permed-22524"]}
{"query_id": "topic_448_turn_1", "conversation_id": "topic_448", "turn_id": 1, "query": "What are the latest investigational therapies for severe burn wound healing and skin regeneration?", "history": [], "ground_truth": ["permed-92390", "permed-77095", "permed-39000", "permed-39122", "permed-38999", "permed-36711", "permed-61116", "permed-77075", "permed-72254", "permed-38884"]}
{"query_id": "topic_448_turn_2", "conversation_id": "topic_448", "turn_id": 2, "query": "Building on these, what research exists on topical serums for severe burns, specifically their mechanisms and comparative advantages over standard treatments?", "history": ["What are the latest investigational therapies for severe burn wound healing and skin regeneration?"], "ground_truth": ["permed-77095", "permed-72254", "permed-39000", "permed-38661", "permed-39015", "permed-38663", "permed-39043", "permed-76565", "permed-38660", "permed-38662"]}
{"query_id": "topic_448_turn_3", "conversation_id": "topic_448", "turn_id": 3, "query": "For specific autologous protein-based topical serums (e.g., Endoret-Serum) identified, what is the clinical evidence regarding long-term effects on epidermal barrier restoration, immune response modulation, and patient quality of life compared to silver sulfadiazine in severe burn recovery?", "history": ["What are the latest investigational therapies for severe burn wound healing and skin regeneration?", "Building on these, what research exists on topical serums for severe burns, specifically their mechanisms and comparative advantages over standard treatments?"], "ground_truth": ["permed-77095", "permed-76565", "permed-67337", "permed-12543", "permed-88026", "permed-38884", "permed-38705", "permed-91808", "permed-39122", "permed-24675"]}
{"query_id": "topic_448_turn_4", "conversation_id": "topic_448", "turn_id": 4, "query": "When analyzing these clinical comparisons between autologous protein serums and silver sulfadiazine, what specific statistical approaches were employed to quantify differences in epidermal barrier restoration metrics over time? I'm particularly interested in how researchers handled repeated measures of transepidermal water loss and stratum corneum integrity, whether they used mixed-effects models to account for patient variability, and what power calculations determined sample sizes for detecting clinically meaningful differences in long-term recovery endpoints.", "history": ["What are the latest investigational therapies for severe burn wound healing and skin regeneration?", "Building on these, what research exists on topical serums for severe burns, specifically their mechanisms and comparative advantages over standard treatments?", "For specific autologous protein-based topical serums (e.g., Endoret-Serum) identified, what is the clinical evidence regarding long-term effects on epidermal barrier restoration, immune response modulation, and patient quality of life compared to silver sulfadiazine in severe burn recovery?"], "ground_truth": ["permed-77095", "permed-12543", "permed-38968", "permed-38655", "permed-67337", "permed-39018", "permed-91806", "permed-39105", "permed-85383", "permed-13473"]}
{"query_id": "topic_448_turn_5", "conversation_id": "topic_448", "turn_id": 5, "query": "Given the sophisticated statistical approaches used to compare epidermal barrier restoration, how do the cost-effectiveness profiles of autologous protein serums versus silver sulfadiazine compare when factoring in long-term outcomes? Specifically, what economic analyses exist that weigh the initial higher acquisition and preparation costs of serums against potential reductions in dressing change frequency, infection rates, and rehabilitation duration? Are there modeling studies that quantify the incremental cost per quality-adjusted life year gained when transitioning from conventional to advanced topical therapies in severe burn care?", "history": ["What are the latest investigational therapies for severe burn wound healing and skin regeneration?", "Building on these, what research exists on topical serums for severe burns, specifically their mechanisms and comparative advantages over standard treatments?", "For specific autologous protein-based topical serums (e.g., Endoret-Serum) identified, what is the clinical evidence regarding long-term effects on epidermal barrier restoration, immune response modulation, and patient quality of life compared to silver sulfadiazine in severe burn recovery?", "When analyzing these clinical comparisons between autologous protein serums and silver sulfadiazine, what specific statistical approaches were employed to quantify differences in epidermal barrier restoration metrics over time? I'm particularly interested in how researchers handled repeated measures of transepidermal water loss and stratum corneum integrity, whether they used mixed-effects models to account for patient variability, and what power calculations determined sample sizes for detecting clinically meaningful differences in long-term recovery endpoints."], "ground_truth": ["permed-77095", "permed-87131", "permed-87125", "permed-38705", "permed-39017", "permed-38968", "permed-70979", "permed-39000", "permed-39018", "permed-79894"]}
{"query_id": "topic_449_turn_1", "conversation_id": "topic_449", "turn_id": 1, "query": "What's known about the genetic differences between P. ovale curtisi and P. ovale wallikeri that could impact malaria treatment?", "history": [], "ground_truth": ["permed-79161", "permed-72201", "permed-72206", "permed-72205", "permed-72198", "permed-72203", "permed-79164", "permed-72212", "permed-79162", "permed-72208"]}
{"query_id": "topic_449_turn_2", "conversation_id": "topic_449", "turn_id": 2, "query": "How might variations in mutations, such as those in the dhfr gene, affect the efficacy of certain antimalarial drugs in this area?", "history": ["What's known about the genetic differences between P. ovale curtisi and P. ovale wallikeri that could impact malaria treatment?"], "ground_truth": ["permed-72206", "permed-79161", "permed-72212", "permed-79162", "permed-72208", "permed-72204", "permed-72198", "permed-60366", "permed-72263", "permed-68735"]}
{"query_id": "topic_449_turn_3", "conversation_id": "topic_449", "turn_id": 3, "query": "Given these differences in dhfr mutations between the two species, how might their varying frequencies and patterns across African regions affect antifolate drug efficacy, and what would that mean for developing region-specific treatment strategies?", "history": ["What's known about the genetic differences between P. ovale curtisi and P. ovale wallikeri that could impact malaria treatment?", "How might variations in mutations, such as those in the dhfr gene, affect the efficacy of certain antimalarial drugs in this area?"], "ground_truth": ["permed-79161", "permed-72206", "permed-79162", "permed-72208", "permed-75284", "permed-72212", "permed-82450", "permed-22300", "permed-60351", "permed-82460"]}
{"query_id": "topic_449_turn_4", "conversation_id": "topic_449", "turn_id": 4, "query": "Given these regional patterns of dhfr mutations, what specific molecular detection methods would you recommend for simultaneously identifying P. ovale species and characterizing their antifolate resistance profiles in field settings? I'm particularly interested in the technical implementation - would you optimize multiplex PCR protocols targeting species-specific markers alongside resistance loci, or develop nested approaches? Also, what validation strategies would ensure reliable differentiation between curtisi and wallikeri variants while maintaining sensitivity for low-parasitemia samples commonly encountered in epidemiological surveys?", "history": ["What's known about the genetic differences between P. ovale curtisi and P. ovale wallikeri that could impact malaria treatment?", "How might variations in mutations, such as those in the dhfr gene, affect the efficacy of certain antimalarial drugs in this area?", "Given these differences in dhfr mutations between the two species, how might their varying frequencies and patterns across African regions affect antifolate drug efficacy, and what would that mean for developing region-specific treatment strategies?"], "ground_truth": ["permed-79161", "permed-79162", "permed-72212", "permed-72208", "permed-66237", "permed-72206", "permed-34775", "permed-60440", "permed-72210", "permed-5899"]}
{"query_id": "topic_449_turn_5", "conversation_id": "topic_449", "turn_id": 5, "query": "Given the detailed molecular detection approaches we've discussed, how would you compare the relative advantages and disadvantages of multiplex PCR versus nested PCR for simultaneous P. ovale species identification and resistance profiling in resource-limited field settings? Specifically, considering the technical implementation challenges and validation requirements from our previous discussion, which approach offers better trade-offs between throughput, cost-effectiveness, and reliability for detecting mixed-species infections with low parasitemia? Would the choice differ between routine surveillance studies versus outbreak response scenarios where rapid turnaround is critical?", "history": ["What's known about the genetic differences between P. ovale curtisi and P. ovale wallikeri that could impact malaria treatment?", "How might variations in mutations, such as those in the dhfr gene, affect the efficacy of certain antimalarial drugs in this area?", "Given these differences in dhfr mutations between the two species, how might their varying frequencies and patterns across African regions affect antifolate drug efficacy, and what would that mean for developing region-specific treatment strategies?", "Given these regional patterns of dhfr mutations, what specific molecular detection methods would you recommend for simultaneously identifying P. ovale species and characterizing their antifolate resistance profiles in field settings? I'm particularly interested in the technical implementation - would you optimize multiplex PCR protocols targeting species-specific markers alongside resistance loci, or develop nested approaches? Also, what validation strategies would ensure reliable differentiation between curtisi and wallikeri variants while maintaining sensitivity for low-parasitemia samples commonly encountered in epidemiological surveys?"], "ground_truth": ["permed-67865", "permed-4667", "permed-68718", "permed-4683", "permed-66237", "permed-5556", "permed-6228", "permed-38456", "permed-65911", "permed-81878"]}
{"query_id": "topic_450_turn_1", "conversation_id": "topic_450", "turn_id": 1, "query": "What role does community-led action play in reducing health disparities?", "history": [], "ground_truth": ["permed-65625", "permed-53049", "permed-55794", "permed-67609", "permed-65626", "permed-67607", "permed-67617", "permed-90677", "permed-91926", "permed-84597"]}
{"query_id": "topic_450_turn_2", "conversation_id": "topic_450", "turn_id": 2, "query": "Can policy reforms effectively support this type of initiative to address systemic inequalities in healthcare?", "history": ["What role does community-led action play in reducing health disparities?"], "ground_truth": ["permed-67341", "permed-91926", "permed-61615", "permed-67344", "permed-52219", "permed-53049", "permed-53027", "permed-67608", "permed-82791", "permed-80087"]}
{"query_id": "topic_450_turn_3", "conversation_id": "topic_450", "turn_id": 3, "query": "Given these approaches—community-led action and policy reforms—how can they work together to tackle the root causes of health disparities, particularly those worsened by historical and ongoing segregation? What innovative models could combine these strategies to create sustainable, equitable health outcomes for marginalized communities?", "history": ["What role does community-led action play in reducing health disparities?", "Can policy reforms effectively support this type of initiative to address systemic inequalities in healthcare?"], "ground_truth": ["permed-52117", "permed-53049", "permed-67607", "permed-52219", "permed-53037", "permed-55794", "permed-83058", "permed-65626", "permed-67609", "permed-67608"]}
{"query_id": "topic_450_turn_4", "conversation_id": "topic_450", "turn_id": 4, "query": "When implementing these combined community-policy models, what specific methodological frameworks would you recommend for evaluating their multisite effectiveness? I'm particularly interested in how to design mixed-methods approaches that capture both quantitative health outcome metrics and qualitative community empowerment indicators across different segregated neighborhoods. How should researchers establish baseline measurements and control for confounding variables when assessing these complex interventions over time?", "history": ["What role does community-led action play in reducing health disparities?", "Can policy reforms effectively support this type of initiative to address systemic inequalities in healthcare?", "Given these approaches—community-led action and policy reforms—how can they work together to tackle the root causes of health disparities, particularly those worsened by historical and ongoing segregation? What innovative models could combine these strategies to create sustainable, equitable health outcomes for marginalized communities?"], "ground_truth": ["permed-53878", "permed-65798", "permed-90782", "permed-52380", "permed-53049", "permed-58475", "permed-65623", "permed-65947", "permed-25353", "permed-55979"]}
{"query_id": "topic_450_turn_5", "conversation_id": "topic_450", "turn_id": 5, "query": "Given the methodological frameworks for evaluating combined community-policy interventions discussed previously, how do mixed-methods approaches compare to more traditional randomized controlled trials in capturing the complex, contextual impacts of these initiatives? Specifically, what are the trade-offs in internal validity versus ecological validity when studying health equity interventions across segregated neighborhoods, and how might participatory action research designs complement or outperform conventional evaluation methods in measuring both community empowerment and health outcomes?", "history": ["What role does community-led action play in reducing health disparities?", "Can policy reforms effectively support this type of initiative to address systemic inequalities in healthcare?", "Given these approaches—community-led action and policy reforms—how can they work together to tackle the root causes of health disparities, particularly those worsened by historical and ongoing segregation? What innovative models could combine these strategies to create sustainable, equitable health outcomes for marginalized communities?", "When implementing these combined community-policy models, what specific methodological frameworks would you recommend for evaluating their multisite effectiveness? I'm particularly interested in how to design mixed-methods approaches that capture both quantitative health outcome metrics and qualitative community empowerment indicators across different segregated neighborhoods. How should researchers establish baseline measurements and control for confounding variables when assessing these complex interventions over time?"], "ground_truth": ["permed-90782", "permed-53878", "permed-55979", "permed-52380", "permed-65625", "permed-53049", "permed-52377", "permed-65798", "permed-91392", "permed-62268"]}
{"query_id": "topic_451_turn_1", "conversation_id": "topic_451", "turn_id": 1, "query": "What technologies are being explored for fluoride removal from contaminated water resources?", "history": [], "ground_truth": ["permed-79338", "permed-78293", "permed-78296", "permed-80785", "permed-84115", "permed-73277", "permed-38427", "permed-80801", "permed-38156", "permed-84159"]}
{"query_id": "topic_451_turn_2", "conversation_id": "topic_451", "turn_id": 2, "query": "How effective is capacitive deionization as a method compared to others in this area?", "history": ["What technologies are being explored for fluoride removal from contaminated water resources?"], "ground_truth": ["permed-79337", "permed-79338", "permed-78274", "permed-89876", "permed-89114", "permed-77794", "permed-79501", "permed-92077", "permed-75901", "permed-89249"]}
{"query_id": "topic_451_turn_3", "conversation_id": "topic_451", "turn_id": 3, "query": "Given the potential of capacitive deionization for fluoride removal, how can we optimize the synergistic effects between MOF/PPy composites' pseudocapacitive properties and MnO<sub>2</sub>'s electrochemical behavior to improve both selectivity and long-term stability in hybrid CDI systems? What would these optimizations mean for scaling up the technology and making it economically viable to address widespread fluoride contamination?", "history": ["What technologies are being explored for fluoride removal from contaminated water resources?", "How effective is capacitive deionization as a method compared to others in this area?"], "ground_truth": ["permed-79338", "permed-80785", "permed-89876", "permed-78274", "permed-88228", "permed-78296", "permed-79337", "permed-50917", "permed-74657", "permed-80836"]}
{"query_id": "topic_451_turn_4", "conversation_id": "topic_451", "turn_id": 4, "query": "When optimizing these composite electrodes, what specific electrochemical characterization protocols would you recommend to quantitatively distinguish between pseudocapacitive and electric double-layer contributions during fluoride removal? I'm particularly interested in how we should design the cycling voltammetry parameters and electrochemical impedance spectroscopy measurements to deconvolute these mechanisms, and what statistical validation methods would ensure reproducibility when assessing long-term stability across multiple electrode batches under continuous flow conditions.", "history": ["What technologies are being explored for fluoride removal from contaminated water resources?", "How effective is capacitive deionization as a method compared to others in this area?", "Given the potential of capacitive deionization for fluoride removal, how can we optimize the synergistic effects between MOF/PPy composites' pseudocapacitive properties and MnO<sub>2</sub>'s electrochemical behavior to improve both selectivity and long-term stability in hybrid CDI systems? What would these optimizations mean for scaling up the technology and making it economically viable to address widespread fluoride contamination?"], "ground_truth": ["permed-79338", "permed-50917", "permed-88226", "permed-84017", "permed-58063", "permed-74963", "permed-85458", "permed-80801", "permed-83733", "permed-51795"]}
{"query_id": "topic_451_turn_5", "conversation_id": "topic_451", "turn_id": 5, "query": "Given these advanced electrochemical optimization protocols, what clinical evidence exists regarding the safety and therapeutic efficacy of CDI-treated water for populations with chronic fluorosis? Specifically, have any longitudinal studies measured improvements in skeletal fluorosis symptoms, dental enamel reversal, or renal function parameters when high-fluoride communities transition to CDI-purified water? Furthermore, what clinical monitoring protocols would you recommend during initial deployment to assess potential side effects from trace electrode material leaching or mineral imbalance corrections in pediatric versus geriatric populations?", "history": ["What technologies are being explored for fluoride removal from contaminated water resources?", "How effective is capacitive deionization as a method compared to others in this area?", "Given the potential of capacitive deionization for fluoride removal, how can we optimize the synergistic effects between MOF/PPy composites' pseudocapacitive properties and MnO<sub>2</sub>'s electrochemical behavior to improve both selectivity and long-term stability in hybrid CDI systems? What would these optimizations mean for scaling up the technology and making it economically viable to address widespread fluoride contamination?", "When optimizing these composite electrodes, what specific electrochemical characterization protocols would you recommend to quantitatively distinguish between pseudocapacitive and electric double-layer contributions during fluoride removal? I'm particularly interested in how we should design the cycling voltammetry parameters and electrochemical impedance spectroscopy measurements to deconvolute these mechanisms, and what statistical validation methods would ensure reproducibility when assessing long-term stability across multiple electrode batches under continuous flow conditions."], "ground_truth": ["permed-36003", "permed-38156", "permed-79338", "permed-37395", "permed-38009", "permed-38016", "permed-38019", "permed-38097", "permed-38094", "permed-38008"]}
{"query_id": "topic_452_turn_1", "conversation_id": "topic_452", "turn_id": 1, "query": "What are the current treatment options for venous insufficiency, and how effective are they in the long term?", "history": [], "ground_truth": ["permed-51399", "permed-20979", "permed-51398", "permed-51396", "permed-56265", "permed-81724", "permed-51400", "permed-78946", "permed-71333", "permed-24878"]}
{"query_id": "topic_452_turn_2", "conversation_id": "topic_452", "turn_id": 2, "query": "How do minimally invasive techniques like Ultrasound-Guided-Foam Sclerotherapy and Endovenous Laser Ablation compare in terms of their impact on the venous wall and surrounding tissues?", "history": ["What are the current treatment options for venous insufficiency, and how effective are they in the long term?"], "ground_truth": ["permed-81724", "permed-51397", "permed-56265", "permed-90686", "permed-45880", "permed-71333", "permed-81727", "permed-12225", "permed-3413", "permed-52890"]}
{"query_id": "topic_452_turn_3", "conversation_id": "topic_452", "turn_id": 3, "query": "How do the long-term effects of these two minimally invasive techniques—UGFS and EVLA—differ in terms of their impact on venous wall integrity and surrounding microcirculation? What do these differences mean for recurrence rates and the progression of chronic venous disorders? And how should these variations guide treatment selection for patients who also have conditions like diabetes or peripheral arterial disease?", "history": ["What are the current treatment options for venous insufficiency, and how effective are they in the long term?", "How do minimally invasive techniques like Ultrasound-Guided-Foam Sclerotherapy and Endovenous Laser Ablation compare in terms of their impact on the venous wall and surrounding tissues?"], "ground_truth": ["permed-81724", "permed-3413", "permed-76292", "permed-52600", "permed-78917", "permed-0013", "permed-51401", "permed-51403", "permed-50141", "permed-85336"]}
{"query_id": "topic_452_turn_4", "conversation_id": "topic_452", "turn_id": 4, "query": "Given these mechanistic differences in venous wall effects between UGFS and EVLA, what specific histological staining protocols and microscopic evaluation criteria would you recommend for quantitatively assessing long-term changes in venous wall collagen organization and smooth muscle architecture? Additionally, what statistical approaches would best account for patient comorbidities when comparing microcirculatory outcomes between these techniques over extended follow-up periods?", "history": ["What are the current treatment options for venous insufficiency, and how effective are they in the long term?", "How do minimally invasive techniques like Ultrasound-Guided-Foam Sclerotherapy and Endovenous Laser Ablation compare in terms of their impact on the venous wall and surrounding tissues?", "How do the long-term effects of these two minimally invasive techniques—UGFS and EVLA—differ in terms of their impact on venous wall integrity and surrounding microcirculation? What do these differences mean for recurrence rates and the progression of chronic venous disorders? And how should these variations guide treatment selection for patients who also have conditions like diabetes or peripheral arterial disease?"], "ground_truth": ["permed-81724", "permed-85336", "permed-80430", "permed-75242", "permed-33155", "permed-57191", "permed-76292", "permed-57073", "permed-29261", "permed-57072"]}
{"query_id": "topic_452_turn_5", "conversation_id": "topic_452", "turn_id": 5, "query": "Given these histological evaluation frameworks for venous wall remodeling, how do these structural differences translate to clinical outcomes in real-world patient populations? Specifically, what comparative evidence exists regarding ulcer healing rates, recurrence of symptomatic varicosities, and quality of life measures between UGFS and EVLA over 5-year follow-ups? Additionally, how do comorbidities like diabetes or obesity differentially impact complication rates and therapeutic durability between these techniques in clinical practice, and what patient stratification protocols have proven most effective for optimizing procedure selection?", "history": ["What are the current treatment options for venous insufficiency, and how effective are they in the long term?", "How do minimally invasive techniques like Ultrasound-Guided-Foam Sclerotherapy and Endovenous Laser Ablation compare in terms of their impact on the venous wall and surrounding tissues?", "How do the long-term effects of these two minimally invasive techniques—UGFS and EVLA—differ in terms of their impact on venous wall integrity and surrounding microcirculation? What do these differences mean for recurrence rates and the progression of chronic venous disorders? And how should these variations guide treatment selection for patients who also have conditions like diabetes or peripheral arterial disease?", "Given these mechanistic differences in venous wall effects between UGFS and EVLA, what specific histological staining protocols and microscopic evaluation criteria would you recommend for quantitatively assessing long-term changes in venous wall collagen organization and smooth muscle architecture? Additionally, what statistical approaches would best account for patient comorbidities when comparing microcirculatory outcomes between these techniques over extended follow-up periods?"], "ground_truth": ["permed-81724", "permed-85336", "permed-45729", "permed-52600", "permed-91114", "permed-83174", "permed-90561", "permed-52598", "permed-3413", "permed-88133"]}
{"query_id": "topic_453_turn_1", "conversation_id": "topic_453", "turn_id": 1, "query": "What advancements have been made in treating B-cell malignancies with targeted therapies?", "history": [], "ground_truth": ["permed-5445", "permed-22564", "permed-72019", "permed-60150", "permed-5287", "permed-49249", "permed-60149", "permed-56589", "permed-67310", "permed-68129"]}
{"query_id": "topic_453_turn_2", "conversation_id": "topic_453", "turn_id": 2, "query": "How do newer approaches, such as modifying antibodies like BAFF-R, impact the efficacy of this type of treatment?", "history": ["What advancements have been made in treating B-cell malignancies with targeted therapies?"], "ground_truth": ["permed-79195", "permed-72504", "permed-8922", "permed-39012", "permed-22572", "permed-68822", "permed-27945", "permed-49282", "permed-49249", "permed-27380"]}
{"query_id": "topic_453_turn_3", "conversation_id": "topic_453", "turn_id": 3, "query": "Given these newer approaches involving antibody modifications like BAFF-R, could you explain the mechanisms that make afucosylated versions more effective against B-cell malignancies? How might these mechanisms inform future targeted therapy designs? Also, what do we know about their long-term safety and potential off-target effects when combined with standard treatments like chemotherapy or immunotherapy?", "history": ["What advancements have been made in treating B-cell malignancies with targeted therapies?", "How do newer approaches, such as modifying antibodies like BAFF-R, impact the efficacy of this type of treatment?"], "ground_truth": ["permed-79195", "permed-67837", "permed-79197", "permed-87475", "permed-83874", "permed-77011", "permed-79198", "permed-17230", "permed-90334", "permed-67426"]}
{"query_id": "topic_453_turn_4", "conversation_id": "topic_453", "turn_id": 4, "query": "Given these afucosylated antibody mechanisms, could you detail the specific analytical techniques used to quantify FcγRIIIa binding affinity improvements? Particularly, what experimental controls were implemented to validate that enhanced ADCC specifically correlates with afucosylation levels rather than other structural modifications? Also, how did researchers standardize cytotoxicity assays across different B-cell malignancy subtypes to ensure reproducible measurement of therapeutic efficacy?", "history": ["What advancements have been made in treating B-cell malignancies with targeted therapies?", "How do newer approaches, such as modifying antibodies like BAFF-R, impact the efficacy of this type of treatment?", "Given these newer approaches involving antibody modifications like BAFF-R, could you explain the mechanisms that make afucosylated versions more effective against B-cell malignancies? How might these mechanisms inform future targeted therapy designs? Also, what do we know about their long-term safety and potential off-target effects when combined with standard treatments like chemotherapy or immunotherapy?"], "ground_truth": ["permed-79195", "permed-81838", "permed-22850", "permed-82824", "permed-75972", "permed-89407", "permed-83714", "permed-83293", "permed-67971", "permed-77344"]}
{"query_id": "topic_453_turn_5", "conversation_id": "topic_453", "turn_id": 5, "query": "Given the methodological standardization for assessing afucosylated antibody efficacy discussed previously, how do direct comparative studies evaluate the therapeutic performance between afucosylated anti-BAFF-R antibodies and other emerging modalities like bispecific T-cell engagers (BiTEs) or CAR-T therapies in relapsed/refractory B-cell malignancies? Specifically, what do meta-analyses reveal about their relative advantages in terms of response durability, tumor penetration depth, and management of adverse effects like cytokine release syndrome across different patient subgroups?", "history": ["What advancements have been made in treating B-cell malignancies with targeted therapies?", "How do newer approaches, such as modifying antibodies like BAFF-R, impact the efficacy of this type of treatment?", "Given these newer approaches involving antibody modifications like BAFF-R, could you explain the mechanisms that make afucosylated versions more effective against B-cell malignancies? How might these mechanisms inform future targeted therapy designs? Also, what do we know about their long-term safety and potential off-target effects when combined with standard treatments like chemotherapy or immunotherapy?", "Given these afucosylated antibody mechanisms, could you detail the specific analytical techniques used to quantify FcγRIIIa binding affinity improvements? Particularly, what experimental controls were implemented to validate that enhanced ADCC specifically correlates with afucosylation levels rather than other structural modifications? Also, how did researchers standardize cytotoxicity assays across different B-cell malignancy subtypes to ensure reproducible measurement of therapeutic efficacy?"], "ground_truth": ["permed-79195", "permed-49249", "permed-52304", "permed-22737", "permed-23905", "permed-7619", "permed-7215", "permed-22565", "permed-77342", "permed-72504"]}
{"query_id": "topic_454_turn_1", "conversation_id": "topic_454", "turn_id": 1, "query": "What is known about the role of eEF2 in neurological disorders and its impact on cellular processes?", "history": [], "ground_truth": ["permed-82118", "permed-88072", "permed-83436", "permed-91830", "permed-59773", "permed-78427", "permed-53583", "permed-59774", "permed-70435", "permed-11521"]}
{"query_id": "topic_454_turn_2", "conversation_id": "topic_454", "turn_id": 2, "query": "How do mutations in eEF2 affect its function, particularly in relation to ribosomal activity and protein synthesis in neural cells?", "history": ["What is known about the role of eEF2 in neurological disorders and its impact on cellular processes?"], "ground_truth": ["permed-82118", "permed-84047", "permed-83852", "permed-85402", "permed-53583", "permed-82121", "permed-68525", "permed-73527", "permed-83892", "permed-71060"]}
{"query_id": "topic_454_turn_3", "conversation_id": "topic_454", "turn_id": 3, "query": "Given eEF2's importance in ribosomal function and its link to neurological disorders, how might specific mutations—especially those at key ribosomal contact sites—affect its dynamic conformational changes during translation elongation? Could these changes alter its binding affinity for ribosomal RNA elements, and what would that mean for the efficiency and accuracy of protein synthesis in neural cells?", "history": ["What is known about the role of eEF2 in neurological disorders and its impact on cellular processes?", "How do mutations in eEF2 affect its function, particularly in relation to ribosomal activity and protein synthesis in neural cells?"], "ground_truth": ["permed-82118", "permed-82119", "permed-62114", "permed-84047", "permed-83892", "permed-85402", "permed-74560", "permed-85399", "permed-80881", "permed-62112"]}
{"query_id": "topic_454_turn_4", "conversation_id": "topic_454", "turn_id": 4, "query": "Given this proposed mechanism of altered conformational dynamics, what specific experimental approaches would best characterize how eEF2 mutations affect its real-time structural transitions during ribosomal translocation? Would single-molecule FRET be suitable for monitoring these domain movements, and what control experiments would validate that observed changes directly impact translational fidelity rather than representing compensatory cellular adaptations? Additionally, which kinetic parameters—such as translocation rates or GTP hydrolysis efficiency—should be quantified to statistically correlate structural changes with functional deficits in neural cell models?", "history": ["What is known about the role of eEF2 in neurological disorders and its impact on cellular processes?", "How do mutations in eEF2 affect its function, particularly in relation to ribosomal activity and protein synthesis in neural cells?", "Given eEF2's importance in ribosomal function and its link to neurological disorders, how might specific mutations—especially those at key ribosomal contact sites—affect its dynamic conformational changes during translation elongation? Could these changes alter its binding affinity for ribosomal RNA elements, and what would that mean for the efficiency and accuracy of protein synthesis in neural cells?"], "ground_truth": ["permed-82118", "permed-83852", "permed-83858", "permed-71540", "permed-74957", "permed-77321", "permed-71598", "permed-85402", "permed-92520", "permed-73132"]}
{"query_id": "topic_454_turn_5", "conversation_id": "topic_454", "turn_id": 5, "query": "Given these detailed biophysical mechanisms and proposed experimental validations, how have these structural insights translated to clinical understanding of eEF2-related neurological disorders? Specifically, what are the reported clinical phenotypes and patient outcomes associated with documented eEF2 mutations, and is there any evidence from clinical cohorts regarding therapeutic efficacy of existing treatments? Furthermore, what are the primary safety considerations or potential contraindications for managing these patients, particularly in relation to medications that might affect translational machinery or GTP-dependent processes in neurons?", "history": ["What is known about the role of eEF2 in neurological disorders and its impact on cellular processes?", "How do mutations in eEF2 affect its function, particularly in relation to ribosomal activity and protein synthesis in neural cells?", "Given eEF2's importance in ribosomal function and its link to neurological disorders, how might specific mutations—especially those at key ribosomal contact sites—affect its dynamic conformational changes during translation elongation? Could these changes alter its binding affinity for ribosomal RNA elements, and what would that mean for the efficiency and accuracy of protein synthesis in neural cells?", "Given this proposed mechanism of altered conformational dynamics, what specific experimental approaches would best characterize how eEF2 mutations affect its real-time structural transitions during ribosomal translocation? Would single-molecule FRET be suitable for monitoring these domain movements, and what control experiments would validate that observed changes directly impact translational fidelity rather than representing compensatory cellular adaptations? Additionally, which kinetic parameters—such as translocation rates or GTP hydrolysis efficiency—should be quantified to statistically correlate structural changes with functional deficits in neural cell models?"], "ground_truth": ["permed-82118", "permed-71060", "permed-9319", "permed-8069", "permed-9404", "permed-8909", "permed-8966", "permed-8899", "permed-85670", "permed-8068"]}
{"query_id": "topic_455_turn_1", "conversation_id": "topic_455", "turn_id": 1, "query": "Limitations and key challenges in current clinical microbial taxonomic identification methods", "history": [], "ground_truth": ["permed-4669", "permed-67115", "permed-66175", "permed-57646", "permed-67046", "permed-77835", "permed-53718", "permed-53719", "permed-90944", "permed-4670"]}
{"query_id": "topic_455_turn_2", "conversation_id": "topic_455", "turn_id": 2, "query": "Evaluating automated systems, such as Copan Colibrí, for addressing these limitations in clinical microbial identification", "history": ["Limitations and key challenges in current clinical microbial taxonomic identification methods"], "ground_truth": ["permed-77835", "permed-66175", "permed-4669", "permed-61285", "permed-5752", "permed-53718", "permed-57646", "permed-4670", "permed-89781", "permed-66179"]}
{"query_id": "topic_455_turn_3", "conversation_id": "topic_455", "turn_id": 3, "query": "Impact of formic acid sample preparation on Copan Colibrí's performance (accuracy, intra-strain repeatability) vs. manual methods for various microbial taxa, and implications for clinical lab workflow efficiency and cost-effectiveness", "history": ["Limitations and key challenges in current clinical microbial taxonomic identification methods", "Evaluating automated systems, such as Copan Colibrí, for addressing these limitations in clinical microbial identification"], "ground_truth": ["permed-77835", "permed-66585", "permed-4669", "permed-89781", "permed-64094", "permed-78694", "permed-77842", "permed-4670", "permed-66608", "permed-66175"]}
{"query_id": "topic_455_turn_4", "conversation_id": "topic_455", "turn_id": 4, "query": "Regarding these comparative analyses between automated and manual processing, could you elaborate on the specific statistical methods used to validate the intra-strain repeatability metrics? I'm particularly interested in how variance components were partitioned between technical replicates and inter-operator variability, what normalization approaches were applied to the accuracy data across different microbial taxa, and whether any power calculations were performed to determine sample sizes adequate for detecting clinically meaningful differences in workflow efficiency parameters.", "history": ["Limitations and key challenges in current clinical microbial taxonomic identification methods", "Evaluating automated systems, such as Copan Colibrí, for addressing these limitations in clinical microbial identification", "Impact of formic acid sample preparation on Copan Colibrí's performance (accuracy, intra-strain repeatability) vs. manual methods for various microbial taxa, and implications for clinical lab workflow efficiency and cost-effectiveness"], "ground_truth": ["permed-77835", "permed-5598", "permed-4962", "permed-6003", "permed-67044", "permed-71534", "permed-22419", "permed-71535", "permed-70841", "permed-60785"]}
{"query_id": "topic_455_turn_5", "conversation_id": "topic_455", "turn_id": 5, "query": "Given these detailed statistical validations of intra-strain repeatability and workflow efficiency comparisons, how do the cost-benefit analyses between automated systems like Copan Colibrí and manual methods differ when scaling from medium-sized hospital laboratories to large reference facilities? Specifically, what are the comparative trade-offs in equipment depreciation, reagent costs, and personnel time savings across different laboratory volumes, and how do these economic considerations interact with the previously established accuracy and repeatability metrics when making institutional adoption decisions?", "history": ["Limitations and key challenges in current clinical microbial taxonomic identification methods", "Evaluating automated systems, such as Copan Colibrí, for addressing these limitations in clinical microbial identification", "Impact of formic acid sample preparation on Copan Colibrí's performance (accuracy, intra-strain repeatability) vs. manual methods for various microbial taxa, and implications for clinical lab workflow efficiency and cost-effectiveness", "Regarding these comparative analyses between automated and manual processing, could you elaborate on the specific statistical methods used to validate the intra-strain repeatability metrics? I'm particularly interested in how variance components were partitioned between technical replicates and inter-operator variability, what normalization approaches were applied to the accuracy data across different microbial taxa, and whether any power calculations were performed to determine sample sizes adequate for detecting clinically meaningful differences in workflow efficiency parameters."], "ground_truth": ["permed-77835", "permed-70841", "permed-4962", "permed-70913", "permed-65911", "permed-5598", "permed-4959", "permed-4649", "permed-5578", "permed-61842"]}
{"query_id": "topic_456_turn_1", "conversation_id": "topic_456", "turn_id": 1, "query": "Principal factors influencing thermal dehydration kinetics of hydrated salts, focusing on sodium carbonate monohydrate as a model compound.", "history": [], "ground_truth": ["permed-74666", "permed-75492", "permed-76084", "permed-74188", "permed-73147", "permed-60591", "permed-74947", "permed-76507", "permed-73195", "permed-74014"]}
{"query_id": "topic_456_turn_2", "conversation_id": "topic_456", "turn_id": 2, "query": "Exploring the specific impact of ambient humidity on these dehydration kinetics and methods for integrating this factor into predictive models for industrial efficiency.", "history": ["Principal factors influencing thermal dehydration kinetics of hydrated salts, focusing on sodium carbonate monohydrate as a model compound."], "ground_truth": ["permed-74666", "permed-69842", "permed-82651", "permed-75492", "permed-74652", "permed-72892", "permed-80898", "permed-74188", "permed-85884", "permed-54139"]}
{"query_id": "topic_456_turn_3", "conversation_id": "topic_456", "turn_id": 3, "query": "Advanced modeling techniques for thermal dehydration kinetics of sodium carbonate monohydrate considering dynamic water vapor partial pressure and implications for industrial process control and material shelf-life stability.", "history": ["Principal factors influencing thermal dehydration kinetics of hydrated salts, focusing on sodium carbonate monohydrate as a model compound.", "Exploring the specific impact of ambient humidity on these dehydration kinetics and methods for integrating this factor into predictive models for industrial efficiency."], "ground_truth": ["permed-74666", "permed-60645", "permed-73169", "permed-91516", "permed-80588", "permed-80731", "permed-86388", "permed-92666", "permed-74188", "permed-73195"]}
{"query_id": "topic_456_turn_4", "conversation_id": "topic_456", "turn_id": 4, "query": "Given these advanced modeling techniques accounting for dynamic water vapor partial pressure, what specific computational methods and validation protocols were employed to ensure model accuracy? I'm particularly interested in how you handled the numerical implementation of coupled heat and mass transfer equations, statistical approaches for parameter estimation from experimental data, and quality control measures for ensuring reproducibility across different industrial dehydration scenarios. Were there specific sensitivity analyses performed to identify critical parameters affecting predictive reliability?", "history": ["Principal factors influencing thermal dehydration kinetics of hydrated salts, focusing on sodium carbonate monohydrate as a model compound.", "Exploring the specific impact of ambient humidity on these dehydration kinetics and methods for integrating this factor into predictive models for industrial efficiency.", "Advanced modeling techniques for thermal dehydration kinetics of sodium carbonate monohydrate considering dynamic water vapor partial pressure and implications for industrial process control and material shelf-life stability."], "ground_truth": ["permed-74666", "permed-74188", "permed-74185", "permed-86388", "permed-73978", "permed-80588", "permed-87492", "permed-85983", "permed-86067", "permed-74193"]}
{"query_id": "topic_456_turn_5", "conversation_id": "topic_456", "turn_id": 5, "query": "Given these validated computational models for sodium carbonate monohydrate dehydration kinetics, what clinical applications might emerge from translating these thermal dehydration principles to pharmaceutical manufacturing? Specifically, how could predictive modeling of hydration state changes improve stability testing for hydrated drug compounds, and what clinical implications might arise from better controlling dehydration processes in terms of drug efficacy, shelf-life extension, or prevention of potency loss in moisture-sensitive medications? Have any clinical trials evaluated patient outcomes when using drugs manufactured with such optimized dehydration control systems?", "history": ["Principal factors influencing thermal dehydration kinetics of hydrated salts, focusing on sodium carbonate monohydrate as a model compound.", "Exploring the specific impact of ambient humidity on these dehydration kinetics and methods for integrating this factor into predictive models for industrial efficiency.", "Advanced modeling techniques for thermal dehydration kinetics of sodium carbonate monohydrate considering dynamic water vapor partial pressure and implications for industrial process control and material shelf-life stability.", "Given these advanced modeling techniques accounting for dynamic water vapor partial pressure, what specific computational methods and validation protocols were employed to ensure model accuracy? I'm particularly interested in how you handled the numerical implementation of coupled heat and mass transfer equations, statistical approaches for parameter estimation from experimental data, and quality control measures for ensuring reproducibility across different industrial dehydration scenarios. Were there specific sensitivity analyses performed to identify critical parameters affecting predictive reliability?"], "ground_truth": ["permed-74666", "permed-79424", "permed-78834", "permed-60735", "permed-75492", "permed-60669", "permed-86388", "permed-73169", "permed-73092", "permed-67545"]}
{"query_id": "topic_457_turn_1", "conversation_id": "topic_457", "turn_id": 1, "query": "What is known about the environmental impact of automotive paint sludge disposal?", "history": [], "ground_truth": ["permed-53098", "permed-78436", "permed-72728", "permed-80731", "permed-87814", "permed-80797", "permed-53101", "permed-79502", "permed-88732", "permed-81984"]}
{"query_id": "topic_457_turn_2", "conversation_id": "topic_457", "turn_id": 2, "query": "How does the pyrolysis process affect this environmental impact, particularly in terms of gas emissions?", "history": ["What is known about the environmental impact of automotive paint sludge disposal?"], "ground_truth": ["permed-66169", "permed-53098", "permed-74757", "permed-53106", "permed-78436", "permed-78437", "permed-73221", "permed-53097", "permed-53095", "permed-80589"]}
{"query_id": "topic_457_turn_3", "conversation_id": "topic_457", "turn_id": 3, "query": "Based on these findings about pyrolysis behaviors and gas emissions from solvent-based (OAPS) and water-based (WAPS) paint sludge, how might their environmental and health impacts differ across various industrial processing conditions? And what strategies could help reduce harmful by-product formation during this process?", "history": ["What is known about the environmental impact of automotive paint sludge disposal?", "How does the pyrolysis process affect this environmental impact, particularly in terms of gas emissions?"], "ground_truth": ["permed-53098", "permed-78436", "permed-53101", "permed-60474", "permed-66169", "permed-74757", "permed-80073", "permed-53095", "permed-53106", "permed-80589"]}
{"query_id": "topic_457_turn_4", "conversation_id": "topic_457", "turn_id": 4, "query": "Given the strategies you outlined for reducing harmful by-products, what specific experimental protocols would you recommend for quantitatively comparing pyrolysis efficiency between OAPS and WAPS? I'm particularly interested in the analytical methods for characterizing solid residues and the statistical approaches for validating differences in heavy metal leaching behavior across multiple processing temperature regimes. How would you design the sampling intervals and replication scheme to ensure reproducibility in measuring VOC formation kinetics?", "history": ["What is known about the environmental impact of automotive paint sludge disposal?", "How does the pyrolysis process affect this environmental impact, particularly in terms of gas emissions?", "Based on these findings about pyrolysis behaviors and gas emissions from solvent-based (OAPS) and water-based (WAPS) paint sludge, how might their environmental and health impacts differ across various industrial processing conditions? And what strategies could help reduce harmful by-product formation during this process?"], "ground_truth": ["permed-53098", "permed-53095", "permed-53097", "permed-74757", "permed-66169", "permed-80589", "permed-53100", "permed-80588", "permed-79305", "permed-88473"]}
{"query_id": "topic_457_turn_5", "conversation_id": "topic_457", "turn_id": 5, "query": "Given these pyrolysis optimization protocols for automotive paint sludge, how might these thermal treatment strategies translate to clinical settings where medical waste containing similar solvent residues or heavy metal components requires disposal? What specific patient safety considerations would emerge from implementing such pyrolysis systems in hospital environments, particularly regarding VOC exposure risks for immunocompromised patients? Additionally, what clinical evidence exists regarding the comparative effectiveness of thermal versus chemical treatment methods for eliminating pharmaceutical contaminants from medical waste while minimizing secondary toxic byproducts?", "history": ["What is known about the environmental impact of automotive paint sludge disposal?", "How does the pyrolysis process affect this environmental impact, particularly in terms of gas emissions?", "Based on these findings about pyrolysis behaviors and gas emissions from solvent-based (OAPS) and water-based (WAPS) paint sludge, how might their environmental and health impacts differ across various industrial processing conditions? And what strategies could help reduce harmful by-product formation during this process?", "Given the strategies you outlined for reducing harmful by-products, what specific experimental protocols would you recommend for quantitatively comparing pyrolysis efficiency between OAPS and WAPS? I'm particularly interested in the analytical methods for characterizing solid residues and the statistical approaches for validating differences in heavy metal leaching behavior across multiple processing temperature regimes. How would you design the sampling intervals and replication scheme to ensure reproducibility in measuring VOC formation kinetics?"], "ground_truth": ["permed-53098", "permed-60474", "permed-81909", "permed-78436", "permed-87929", "permed-53101", "permed-53097", "permed-74760", "permed-80589", "permed-65313"]}
{"query_id": "topic_458_turn_1", "conversation_id": "topic_458", "turn_id": 1, "query": "What impact does marijuana legalization have on its use among children and adolescents?", "history": [], "ground_truth": ["permed-53123", "permed-78484", "permed-53126", "permed-71379", "permed-53119", "permed-53117", "permed-65558", "permed-78482", "permed-78485", "permed-53121"]}
{"query_id": "topic_458_turn_2", "conversation_id": "topic_458", "turn_id": 2, "query": "Are there any regional variations in this impact that could be attributed to differences in policy regulation or enforcement of it?", "history": ["What impact does marijuana legalization have on its use among children and adolescents?"], "ground_truth": ["permed-61615", "permed-59274", "permed-74118", "permed-69281", "permed-84065", "permed-67575", "permed-82373", "permed-75613", "permed-61929", "permed-55107"]}
{"query_id": "topic_458_turn_3", "conversation_id": "topic_458", "turn_id": 3, "query": "Given these regional differences in policy and enforcement, how do specific state-level variations—such as legalization status and regulations around edibles—correlate with changes in intentional misuse and abuse rates among school-aged children and adolescents across different U.S. regions? What role might factors like accessibility, parental oversight, and education programs play in explaining these regional patterns?", "history": ["What impact does marijuana legalization have on its use among children and adolescents?", "Are there any regional variations in this impact that could be attributed to differences in policy regulation or enforcement of it?"], "ground_truth": ["permed-65558", "permed-53123", "permed-71379", "permed-78484", "permed-53126", "permed-78482", "permed-72497", "permed-80083", "permed-71372", "permed-84068"]}
{"query_id": "topic_458_turn_4", "conversation_id": "topic_458", "turn_id": 4, "query": "Given these correlation patterns, what specific statistical approaches would be most appropriate for quantifying the independent effects of policy variations while controlling for confounding variables? I'm particularly interested in whether researchers typically employ difference-in-differences models, interrupted time series analyses, or hierarchical linear modeling to account for nested data structures across states and regions. How do studies typically validate these models and address potential issues like multicollinearity between policy variables or spatial autocorrelation in regional data?", "history": ["What impact does marijuana legalization have on its use among children and adolescents?", "Are there any regional variations in this impact that could be attributed to differences in policy regulation or enforcement of it?", "Given these regional differences in policy and enforcement, how do specific state-level variations—such as legalization status and regulations around edibles—correlate with changes in intentional misuse and abuse rates among school-aged children and adolescents across different U.S. regions? What role might factors like accessibility, parental oversight, and education programs play in explaining these regional patterns?"], "ground_truth": ["permed-53878", "permed-34892", "permed-82786", "permed-55479", "permed-35363", "permed-36140", "permed-80083", "permed-35794", "permed-59377", "permed-35840"]}
{"query_id": "topic_458_turn_5", "conversation_id": "topic_458", "turn_id": 5, "query": "Given the sophisticated statistical methods discussed for isolating policy effects, how do the comparative strengths of difference-in-differences versus interrupted time series analyses manifest when evaluating specific regulatory components like potency caps or packaging restrictions? Which approach better handles nuanced policy implementations that phase in gradually across states, and how do their respective capacities for addressing temporal confounding differ in practical applications? Furthermore, when these methods yield conflicting findings about particular regulatory elements, what methodological factors typically explain the divergences?", "history": ["What impact does marijuana legalization have on its use among children and adolescents?", "Are there any regional variations in this impact that could be attributed to differences in policy regulation or enforcement of it?", "Given these regional differences in policy and enforcement, how do specific state-level variations—such as legalization status and regulations around edibles—correlate with changes in intentional misuse and abuse rates among school-aged children and adolescents across different U.S. regions? What role might factors like accessibility, parental oversight, and education programs play in explaining these regional patterns?", "Given these correlation patterns, what specific statistical approaches would be most appropriate for quantifying the independent effects of policy variations while controlling for confounding variables? I'm particularly interested in whether researchers typically employ difference-in-differences models, interrupted time series analyses, or hierarchical linear modeling to account for nested data structures across states and regions. How do studies typically validate these models and address potential issues like multicollinearity between policy variables or spatial autocorrelation in regional data?"], "ground_truth": ["permed-37281", "permed-79202", "permed-53878", "permed-55479", "permed-82498", "permed-37280", "permed-36140", "permed-59377", "permed-34892", "permed-37433"]}
{"query_id": "topic_459_turn_1", "conversation_id": "topic_459", "turn_id": 1, "query": "What are the primary challenges in parastomal hernia surgical repair and overall patient management?", "history": [], "ground_truth": ["permed-78368", "permed-78920", "permed-75325", "permed-75313", "permed-75294", "permed-75302", "permed-75311", "permed-75293", "permed-52317", "permed-68800"]}
{"query_id": "topic_459_turn_2", "conversation_id": "topic_459", "turn_id": 2, "query": "Considering these parastomal hernia treatment challenges, how are recent surgical technique advancements influencing patient outcomes and recurrence rates?", "history": ["What are the primary challenges in parastomal hernia surgical repair and overall patient management?"], "ground_truth": ["permed-78368", "permed-78920", "permed-75325", "permed-82911", "permed-75313", "permed-75307", "permed-70578", "permed-75293", "permed-2654", "permed-75312"]}
{"query_id": "topic_459_turn_3", "conversation_id": "topic_459", "turn_id": 3, "query": "Following these surgical advancements, what is the comparative effectiveness of minimally invasive techniques with biocompatible mesh versus traditional Sugarbaker or keyhole repairs for parastomal hernias, specifically regarding long-term recurrence, complications, and patient-reported quality of life?", "history": ["What are the primary challenges in parastomal hernia surgical repair and overall patient management?", "Considering these parastomal hernia treatment challenges, how are recent surgical technique advancements influencing patient outcomes and recurrence rates?"], "ground_truth": ["permed-78368", "permed-78920", "permed-75301", "permed-75300", "permed-75313", "permed-72193", "permed-1395", "permed-75302", "permed-75303", "permed-75306"]}
{"query_id": "topic_459_turn_4", "conversation_id": "topic_459", "turn_id": 4, "query": "Given these comparative effectiveness findings, could you elaborate on the specific surgical protocols used for the minimally invasive approaches? I'm particularly interested in the technical implementation details - such as the standardized laparoscopic/robotic port placements, mesh fixation techniques (suture vs tacker patterns), and whether any intraoperative quality control measures were employed to ensure consistent mesh positioning and overlap. Additionally, what statistical methods were utilized to control for confounding variables when analyzing the long-term recurrence data across these different repair approaches?", "history": ["What are the primary challenges in parastomal hernia surgical repair and overall patient management?", "Considering these parastomal hernia treatment challenges, how are recent surgical technique advancements influencing patient outcomes and recurrence rates?", "Following these surgical advancements, what is the comparative effectiveness of minimally invasive techniques with biocompatible mesh versus traditional Sugarbaker or keyhole repairs for parastomal hernias, specifically regarding long-term recurrence, complications, and patient-reported quality of life?"], "ground_truth": ["permed-78368", "permed-54678", "permed-88131", "permed-75300", "permed-61087", "permed-0692", "permed-72193", "permed-82487", "permed-75305", "permed-54679"]}
{"query_id": "topic_459_turn_5", "conversation_id": "topic_459", "turn_id": 5, "query": "Given the detailed surgical protocols and statistical methodologies you've described for minimally invasive parastomal hernia repairs, what evidence exists regarding their clinical translation into real-world practice? Specifically, how do complication profiles - particularly mesh-related infections, chronic pain, and bowel obstructions - compare between laparoscopic and robotic approaches when performed outside controlled trial settings? Furthermore, what patient selection criteria (e.g., BMI, stoma type, prior surgeries) have proven most predictive of therapeutic success versus contraindications in clinical implementation, and how do these factors influence shared decision-making regarding surgical approach selection?", "history": ["What are the primary challenges in parastomal hernia surgical repair and overall patient management?", "Considering these parastomal hernia treatment challenges, how are recent surgical technique advancements influencing patient outcomes and recurrence rates?", "Following these surgical advancements, what is the comparative effectiveness of minimally invasive techniques with biocompatible mesh versus traditional Sugarbaker or keyhole repairs for parastomal hernias, specifically regarding long-term recurrence, complications, and patient-reported quality of life?", "Given these comparative effectiveness findings, could you elaborate on the specific surgical protocols used for the minimally invasive approaches? I'm particularly interested in the technical implementation details - such as the standardized laparoscopic/robotic port placements, mesh fixation techniques (suture vs tacker patterns), and whether any intraoperative quality control measures were employed to ensure consistent mesh positioning and overlap. Additionally, what statistical methods were utilized to control for confounding variables when analyzing the long-term recurrence data across these different repair approaches?"], "ground_truth": ["permed-78368", "permed-78920", "permed-72193", "permed-75305", "permed-56549", "permed-75313", "permed-78912", "permed-75303", "permed-78372", "permed-87982"]}
{"query_id": "topic_460_turn_1", "conversation_id": "topic_460", "turn_id": 1, "query": "What role can nanotechnology play in enhancing biosensing systems for monitoring neurotransmitter release?", "history": [], "ground_truth": ["permed-80657", "permed-80658", "permed-57970", "permed-58041", "permed-51339", "permed-72665", "permed-63386", "permed-89777", "permed-51721", "permed-64381"]}
{"query_id": "topic_460_turn_2", "conversation_id": "topic_460", "turn_id": 2, "query": "How can combining different nanomaterials, like gold nanoparticles and carbon nanotubes, improve the sensitivity of this technique?", "history": ["What role can nanotechnology play in enhancing biosensing systems for monitoring neurotransmitter release?"], "ground_truth": ["permed-74446", "permed-79254", "permed-64619", "permed-75956", "permed-74445", "permed-76275", "permed-88007", "permed-75350", "permed-73041", "permed-74510"]}
{"query_id": "topic_460_turn_3", "conversation_id": "topic_460", "turn_id": 3, "query": "Given the improvements in sensitivity from combining gold nanoparticles and carbon nanotubes, how could integrating additional advanced nanomaterials like graphene oxide or quantum dots further enhance both the sensitivity and specificity of this biosensing system for real-time neurotransmitter monitoring? And what potential applications might these enhancements have in developing targeted therapies for neurodegenerative diseases?", "history": ["What role can nanotechnology play in enhancing biosensing systems for monitoring neurotransmitter release?", "How can combining different nanomaterials, like gold nanoparticles and carbon nanotubes, improve the sensitivity of this technique?"], "ground_truth": ["permed-89777", "permed-82299", "permed-57970", "permed-80657", "permed-80656", "permed-80658", "permed-64615", "permed-73051", "permed-64614", "permed-64620"]}
{"query_id": "topic_460_turn_4", "conversation_id": "topic_460", "turn_id": 4, "query": "For these complex multi-material systems, what specific fabrication protocols would optimize the hierarchical assembly of gold nanoparticles, carbon nanotubes, and graphene oxide while maintaining structural integrity? Particularly, how should we sequence the deposition steps and what cross-linking strategies would ensure stable interfacial bonding between these nanomaterials? Additionally, what characterization techniques—beyond standard electron microscopy—would you recommend for quantitatively assessing the uniformity and reproducibility of these composite nanostructures across multiple biosensor batches?", "history": ["What role can nanotechnology play in enhancing biosensing systems for monitoring neurotransmitter release?", "How can combining different nanomaterials, like gold nanoparticles and carbon nanotubes, improve the sensitivity of this technique?", "Given the improvements in sensitivity from combining gold nanoparticles and carbon nanotubes, how could integrating additional advanced nanomaterials like graphene oxide or quantum dots further enhance both the sensitivity and specificity of this biosensing system for real-time neurotransmitter monitoring? And what potential applications might these enhancements have in developing targeted therapies for neurodegenerative diseases?"], "ground_truth": ["permed-64270", "permed-75698", "permed-75261", "permed-53545", "permed-64620", "permed-51480", "permed-76287", "permed-64648", "permed-77394", "permed-78726"]}
{"query_id": "topic_460_turn_5", "conversation_id": "topic_460", "turn_id": 5, "query": "Building on these fabrication and characterization advances for multi-material biosensors, what clinical validation steps are required before deploying them for real-time neurotransmitter monitoring in patients? Given the potential for neurodegenerative disease applications, what human trials would demonstrate therapeutic utility—particularly regarding detection thresholds for pathological neurotransmitter fluctuations and correlation with clinical symptoms? How should researchers address biosafety considerations for chronic neural interface use, and what regulatory pathways exist for such multifaceted nanomaterial-based diagnostic systems?", "history": ["What role can nanotechnology play in enhancing biosensing systems for monitoring neurotransmitter release?", "How can combining different nanomaterials, like gold nanoparticles and carbon nanotubes, improve the sensitivity of this technique?", "Given the improvements in sensitivity from combining gold nanoparticles and carbon nanotubes, how could integrating additional advanced nanomaterials like graphene oxide or quantum dots further enhance both the sensitivity and specificity of this biosensing system for real-time neurotransmitter monitoring? And what potential applications might these enhancements have in developing targeted therapies for neurodegenerative diseases?", "For these complex multi-material systems, what specific fabrication protocols would optimize the hierarchical assembly of gold nanoparticles, carbon nanotubes, and graphene oxide while maintaining structural integrity? Particularly, how should we sequence the deposition steps and what cross-linking strategies would ensure stable interfacial bonding between these nanomaterials? Additionally, what characterization techniques—beyond standard electron microscopy—would you recommend for quantitatively assessing the uniformity and reproducibility of these composite nanostructures across multiple biosensor batches?"], "ground_truth": ["permed-52829", "permed-63386", "permed-51729", "permed-55435", "permed-57970", "permed-51727", "permed-80657", "permed-51339", "permed-51724", "permed-80658"]}
{"query_id": "topic_461_turn_1", "conversation_id": "topic_461", "turn_id": 1, "query": "What impact does marine traffic have on baleen whales, particularly in sensitive habitats like the Galician Coast?", "history": [], "ground_truth": ["permed-80993", "permed-80994", "permed-59353", "permed-62544", "permed-88879", "permed-74158", "permed-82732", "permed-88591", "permed-80996", "permed-80995"]}
{"query_id": "topic_461_turn_2", "conversation_id": "topic_461", "turn_id": 2, "query": "How might changes in shipping patterns over time affect the risk profiles of these whale species in this area?", "history": ["What impact does marine traffic have on baleen whales, particularly in sensitive habitats like the Galician Coast?"], "ground_truth": ["permed-80993", "permed-62544", "permed-59353", "permed-59352", "permed-59330", "permed-59349", "permed-59350", "permed-59348", "permed-59354", "permed-80996"]}
{"query_id": "topic_461_turn_3", "conversation_id": "topic_461", "turn_id": 3, "query": "Given these observed differences in how baleen whale species are exposed to marine traffic over time off the Galician Coast, how might long-term shifts in shipping patterns—driven by global economic and environmental policies—affect their risk profiles, especially during critical life stages like breeding and calving? What adaptive strategies could help mitigate these risks while still supporting maritime commerce and conservation goals in the region?", "history": ["What impact does marine traffic have on baleen whales, particularly in sensitive habitats like the Galician Coast?", "How might changes in shipping patterns over time affect the risk profiles of these whale species in this area?"], "ground_truth": ["permed-80993", "permed-62544", "permed-59353", "permed-90128", "permed-59352", "permed-80994", "permed-80996", "permed-59348", "permed-88879", "permed-59350"]}
{"query_id": "topic_461_turn_4", "conversation_id": "topic_461", "turn_id": 4, "query": "When implementing the adaptive strategies you mentioned for mitigating shipping impacts on baleen whales, what specific methodological approaches would you recommend for quantifying behavioral responses during critical life stages? I'm particularly interested in the technical implementation - would you combine passive acoustic monitoring with AIS data integration, and what statistical models (e.g., GAMs or occupancy models) would best account for both temporal autocorrelation in whale movements and spatial clustering of vessel traffic in these dynamic coastal environments?", "history": ["What impact does marine traffic have on baleen whales, particularly in sensitive habitats like the Galician Coast?", "How might changes in shipping patterns over time affect the risk profiles of these whale species in this area?", "Given these observed differences in how baleen whale species are exposed to marine traffic over time off the Galician Coast, how might long-term shifts in shipping patterns—driven by global economic and environmental policies—affect their risk profiles, especially during critical life stages like breeding and calving? What adaptive strategies could help mitigate these risks while still supporting maritime commerce and conservation goals in the region?"], "ground_truth": ["permed-80993", "permed-62544", "permed-80996", "permed-88398", "permed-83444", "permed-83441", "permed-59353", "permed-74158", "permed-59350", "permed-59348"]}
{"query_id": "topic_461_turn_5", "conversation_id": "topic_461", "turn_id": 5, "query": "Given your detailed methodological recommendations for quantifying behavioral responses, how would you compare the relative effectiveness of Generalized Additive Models versus occupancy models for analyzing these integrated acoustic and AIS datasets? Specifically, what trade-offs exist between their abilities to handle temporal autocorrelation in whale vocalizations versus spatial clustering of vessel traffic during critical life stages? Which approach might prove more robust for detecting subtle behavioral shifts in response to mitigation measures while maintaining statistical power in these dynamic coastal environments?", "history": ["What impact does marine traffic have on baleen whales, particularly in sensitive habitats like the Galician Coast?", "How might changes in shipping patterns over time affect the risk profiles of these whale species in this area?", "Given these observed differences in how baleen whale species are exposed to marine traffic over time off the Galician Coast, how might long-term shifts in shipping patterns—driven by global economic and environmental policies—affect their risk profiles, especially during critical life stages like breeding and calving? What adaptive strategies could help mitigate these risks while still supporting maritime commerce and conservation goals in the region?", "When implementing the adaptive strategies you mentioned for mitigating shipping impacts on baleen whales, what specific methodological approaches would you recommend for quantifying behavioral responses during critical life stages? I'm particularly interested in the technical implementation - would you combine passive acoustic monitoring with AIS data integration, and what statistical models (e.g., GAMs or occupancy models) would best account for both temporal autocorrelation in whale movements and spatial clustering of vessel traffic in these dynamic coastal environments?"], "ground_truth": ["permed-80993", "permed-60478", "permed-60476", "permed-80996", "permed-83646", "permed-59400", "permed-59354", "permed-59350", "permed-83444", "permed-57514"]}
{"query_id": "topic_462_turn_1", "conversation_id": "topic_462", "turn_id": 1, "query": "Recent review: design advancements in molecular probes for metal ion sensing in biological systems", "history": [], "ground_truth": ["permed-64381", "permed-64611", "permed-73346", "permed-88009", "permed-87791", "permed-75501", "permed-86682", "permed-75825", "permed-80833", "permed-86600"]}
{"query_id": "topic_462_turn_2", "conversation_id": "topic_462", "turn_id": 2, "query": "Investigating AIE and ESIPT mechanisms for enhanced sensitivity and selectivity of these metal ion probes in live cells and tissues", "history": ["Recent review: design advancements in molecular probes for metal ion sensing in biological systems"], "ground_truth": ["permed-73142", "permed-78030", "permed-82292", "permed-89120", "permed-82651", "permed-64381", "permed-75825", "permed-75823", "permed-71707", "permed-53718"]}
{"query_id": "topic_462_turn_3", "conversation_id": "topic_462", "turn_id": 3, "query": "Novel AIE-ESIPT combined molecular probes for simultaneous multi-metal ion ratiometric imaging in biological samples: clinical and environmental applications", "history": ["Recent review: design advancements in molecular probes for metal ion sensing in biological systems", "Investigating AIE and ESIPT mechanisms for enhanced sensitivity and selectivity of these metal ion probes in live cells and tissues"], "ground_truth": ["permed-78030", "permed-73142", "permed-82292", "permed-75823", "permed-58179", "permed-42057", "permed-72031", "permed-53718", "permed-72012", "permed-73145"]}
{"query_id": "topic_462_turn_4", "conversation_id": "topic_462", "turn_id": 4, "query": "For these novel AIE-ESIPT combined probes designed for simultaneous multi-metal ion detection, what specific validation protocols were implemented to confirm the absence of cross-reactivity between target metal ions in complex biological matrices? Additionally, how was the ratiometric imaging data quantitatively analyzed to establish reliable calibration curves across different cellular compartments and tissue types while maintaining signal reproducibility?", "history": ["Recent review: design advancements in molecular probes for metal ion sensing in biological systems", "Investigating AIE and ESIPT mechanisms for enhanced sensitivity and selectivity of these metal ion probes in live cells and tissues", "Novel AIE-ESIPT combined molecular probes for simultaneous multi-metal ion ratiometric imaging in biological samples: clinical and environmental applications"], "ground_truth": ["permed-78030", "permed-73142", "permed-82292", "permed-75825", "permed-58179", "permed-75810", "permed-76274", "permed-77684", "permed-18625", "permed-80836"]}
{"query_id": "topic_462_turn_5", "conversation_id": "topic_462", "turn_id": 5, "query": "Given the rigorous validation protocols for cross-reactivity and quantitative ratiometric analysis established in previous research, what clinical translation challenges remain for implementing these AIE-ESIPT multi-metal probes in human diagnostics? Specifically, what safety profiles have been established regarding probe toxicity, immunogenicity, and clearance mechanisms in preclinical models? Furthermore, how do variable physiological conditions—such as pH fluctuations or competing biomolecules in human specimens—impact probe performance reliability, and what clinical evidence exists demonstrating diagnostic accuracy for metal imbalance disorders compared to current standard assays?", "history": ["Recent review: design advancements in molecular probes for metal ion sensing in biological systems", "Investigating AIE and ESIPT mechanisms for enhanced sensitivity and selectivity of these metal ion probes in live cells and tissues", "Novel AIE-ESIPT combined molecular probes for simultaneous multi-metal ion ratiometric imaging in biological samples: clinical and environmental applications", "For these novel AIE-ESIPT combined probes designed for simultaneous multi-metal ion detection, what specific validation protocols were implemented to confirm the absence of cross-reactivity between target metal ions in complex biological matrices? Additionally, how was the ratiometric imaging data quantitatively analyzed to establish reliable calibration curves across different cellular compartments and tissue types while maintaining signal reproducibility?"], "ground_truth": ["permed-5732", "permed-82874", "permed-73142", "permed-75638", "permed-59456", "permed-75825", "permed-66379", "permed-63253", "permed-5399", "permed-58179"]}
{"query_id": "topic_463_turn_1", "conversation_id": "topic_463", "turn_id": 1, "query": "What's known about the impact of anesthesia on cognitive functions in animal models?", "history": [], "ground_truth": ["permed-79864", "permed-79868", "permed-11630", "permed-87978", "permed-91812", "permed-54287", "permed-79866", "permed-76469", "permed-8619", "permed-10838"]}
{"query_id": "topic_463_turn_2", "conversation_id": "topic_463", "turn_id": 2, "query": "Does it suggest that certain types of anesthesia, like etomidate, could have particularly significant effects on cognition, especially when combined with other factors such as inflammation?", "history": ["What's known about the impact of anesthesia on cognitive functions in animal models?"], "ground_truth": ["permed-79864", "permed-79868", "permed-54986", "permed-11630", "permed-10841", "permed-8619", "permed-10838", "permed-10840", "permed-11157", "permed-10839"]}
{"query_id": "topic_463_turn_3", "conversation_id": "topic_463", "turn_id": 3, "query": "Given that both inflammation and etomidate anesthesia can independently and together worsen cognitive function in mice, how might the timing and duration of these factors influence the development and severity of perioperative neurocognitive disorders? Also, what molecular pathways could be targeted to reduce these cognitive deficits, and would potential interventions need to be adjusted based on whether inflammation was already present?", "history": ["What's known about the impact of anesthesia on cognitive functions in animal models?", "Does it suggest that certain types of anesthesia, like etomidate, could have particularly significant effects on cognition, especially when combined with other factors such as inflammation?"], "ground_truth": ["permed-79864", "permed-79866", "permed-82557", "permed-79865", "permed-60759", "permed-10969", "permed-79868", "permed-67625", "permed-65200", "permed-54289"]}
{"query_id": "topic_463_turn_4", "conversation_id": "topic_463", "turn_id": 4, "query": "To systematically investigate these temporal dynamics and molecular mechanisms, what experimental designs would best capture the interaction between etomidate exposure timing and pre-existing inflammatory states? Specifically, what statistical approaches should be employed to analyze the dose-response relationships and time-dependent effects on cognitive outcomes? How would you validate the reproducibility of neuroinflammation markers across different experimental batches, and what quality controls are essential for ensuring consistent anesthesia depth and inflammatory challenge administration throughout such longitudinal studies?", "history": ["What's known about the impact of anesthesia on cognitive functions in animal models?", "Does it suggest that certain types of anesthesia, like etomidate, could have particularly significant effects on cognition, especially when combined with other factors such as inflammation?", "Given that both inflammation and etomidate anesthesia can independently and together worsen cognitive function in mice, how might the timing and duration of these factors influence the development and severity of perioperative neurocognitive disorders? Also, what molecular pathways could be targeted to reduce these cognitive deficits, and would potential interventions need to be adjusted based on whether inflammation was already present?"], "ground_truth": ["permed-79864", "permed-10841", "permed-79868", "permed-10857", "permed-10843", "permed-11152", "permed-10737", "permed-10859", "permed-11275", "permed-11274"]}
{"query_id": "topic_463_turn_5", "conversation_id": "topic_463", "turn_id": 5, "query": "Given these experimental design considerations for studying etomidate-inflammation interactions in animal models, what clinical evidence exists regarding etomidate's impact on postoperative cognitive function in vulnerable patient populations? Specifically, how do outcomes from human studies comparing etomidate to other induction agents align with the mechanistic findings from animal models, particularly in elderly patients or those with pre-existing inflammatory conditions? What clinical recommendations can be derived regarding etomidate use in patients at high risk for perioperative neurocognitive disorders, and are there specific patient subgroups where alternative agents demonstrate superior cognitive outcomes?", "history": ["What's known about the impact of anesthesia on cognitive functions in animal models?", "Does it suggest that certain types of anesthesia, like etomidate, could have particularly significant effects on cognition, especially when combined with other factors such as inflammation?", "Given that both inflammation and etomidate anesthesia can independently and together worsen cognitive function in mice, how might the timing and duration of these factors influence the development and severity of perioperative neurocognitive disorders? Also, what molecular pathways could be targeted to reduce these cognitive deficits, and would potential interventions need to be adjusted based on whether inflammation was already present?", "To systematically investigate these temporal dynamics and molecular mechanisms, what experimental designs would best capture the interaction between etomidate exposure timing and pre-existing inflammatory states? Specifically, what statistical approaches should be employed to analyze the dose-response relationships and time-dependent effects on cognitive outcomes? How would you validate the reproducibility of neuroinflammation markers across different experimental batches, and what quality controls are essential for ensuring consistent anesthesia depth and inflammatory challenge administration throughout such longitudinal studies?"], "ground_truth": ["permed-79864", "permed-62382", "permed-79866", "permed-10926", "permed-79865", "permed-10843", "permed-8612", "permed-54986", "permed-62383", "permed-10839"]}
{"query_id": "topic_464_turn_1", "conversation_id": "topic_464", "turn_id": 1, "query": "Bioethical frameworks guiding sustainable healthcare practices and resource allocation.", "history": [], "ground_truth": ["permed-91926", "permed-68405", "permed-53038", "permed-74860", "permed-72675", "permed-53042", "permed-74725", "permed-66148", "permed-52056", "permed-81659"]}
{"query_id": "topic_464_turn_2", "conversation_id": "topic_464", "turn_id": 2, "query": "Impact of these bioethical frameworks on collaborative efforts to improve healthcare's environmental sustainability and public health indicators.", "history": ["Bioethical frameworks guiding sustainable healthcare practices and resource allocation."], "ground_truth": ["permed-72675", "permed-68405", "permed-91926", "permed-54375", "permed-53038", "permed-66153", "permed-52056", "permed-72676", "permed-53039", "permed-59645"]}
{"query_id": "topic_464_turn_3", "conversation_id": "topic_464", "turn_id": 3, "query": "Practical models for integrating joint strategies by bioethicists, environmental scientists, and policymakers for healthcare decarbonization and public health co-benefits.", "history": ["Bioethical frameworks guiding sustainable healthcare practices and resource allocation.", "Impact of these bioethical frameworks on collaborative efforts to improve healthcare's environmental sustainability and public health indicators."], "ground_truth": ["permed-91926", "permed-68405", "permed-52056", "permed-66153", "permed-82790", "permed-53039", "permed-53038", "permed-54521", "permed-74865", "permed-54928"]}
{"query_id": "topic_464_turn_4", "conversation_id": "topic_464", "turn_id": 4, "query": "For these integrated collaborative models, what specific methodological approaches have proven effective for quantifying both healthcare decarbonization metrics and public health co-benefits simultaneously? I'm particularly interested in the statistical frameworks used to establish causal relationships between intervention protocols and dual-outcome measurements, and how researchers validate that their mixed-methods designs adequately capture complex system interactions while maintaining reproducibility across different healthcare settings.", "history": ["Bioethical frameworks guiding sustainable healthcare practices and resource allocation.", "Impact of these bioethical frameworks on collaborative efforts to improve healthcare's environmental sustainability and public health indicators.", "Practical models for integrating joint strategies by bioethicists, environmental scientists, and policymakers for healthcare decarbonization and public health co-benefits."], "ground_truth": ["permed-45259", "permed-52383", "permed-25353", "permed-63533", "permed-65797", "permed-46272", "permed-69968", "permed-34403", "permed-74572", "permed-61613"]}
{"query_id": "topic_464_turn_5", "conversation_id": "topic_464", "turn_id": 5, "query": "Given these established methodologies for quantifying decarbonization and public health co-benefits, how have these metrics translated into actual clinical outcomes when implementing specific decarbonization interventions? I'm particularly interested in clinical trial evidence examining whether environmental interventions (e.g., switching to low-carbon inhalers or reducing anesthetic gas waste) directly affect patient therapeutic efficacy, recovery times, or incidence of adverse events, and whether any trade-offs exist between environmental benefits and clinical safety in different patient populations.", "history": ["Bioethical frameworks guiding sustainable healthcare practices and resource allocation.", "Impact of these bioethical frameworks on collaborative efforts to improve healthcare's environmental sustainability and public health indicators.", "Practical models for integrating joint strategies by bioethicists, environmental scientists, and policymakers for healthcare decarbonization and public health co-benefits.", "For these integrated collaborative models, what specific methodological approaches have proven effective for quantifying both healthcare decarbonization metrics and public health co-benefits simultaneously? I'm particularly interested in the statistical frameworks used to establish causal relationships between intervention protocols and dual-outcome measurements, and how researchers validate that their mixed-methods designs adequately capture complex system interactions while maintaining reproducibility across different healthcare settings."], "ground_truth": ["permed-88699", "permed-75926", "permed-86521", "permed-58626", "permed-54365", "permed-56454", "permed-69059", "permed-51750", "permed-81195", "permed-83425"]}
{"query_id": "topic_465_turn_1", "conversation_id": "topic_465", "turn_id": 1, "query": "Recent trends and patterns in opioid consumption in Iran", "history": [], "ground_truth": ["permed-78061", "permed-78063", "permed-91466", "permed-92214", "permed-69149", "permed-80561", "permed-69148", "permed-69147", "permed-80138", "permed-55817"]}
{"query_id": "topic_465_turn_2", "conversation_id": "topic_465", "turn_id": 2, "query": "Impact of healthcare policies and public awareness campaigns on these recent opioid consumption trends in Iran", "history": ["Recent trends and patterns in opioid consumption in Iran"], "ground_truth": ["permed-78061", "permed-92214", "permed-69147", "permed-80138", "permed-88264", "permed-69149", "permed-91466", "permed-78063", "permed-69148", "permed-88263"]}
{"query_id": "topic_465_turn_3", "conversation_id": "topic_465", "turn_id": 3, "query": "Iran's morphine to tramadol transition (past two decades): Role of healthcare policy, public awareness, and future outlook for pain management and opioid stewardship.", "history": ["Recent trends and patterns in opioid consumption in Iran", "Impact of healthcare policies and public awareness campaigns on these recent opioid consumption trends in Iran"], "ground_truth": ["permed-78061", "permed-69147", "permed-68904", "permed-88266", "permed-83077", "permed-78063", "permed-55826", "permed-80137", "permed-69144", "permed-69151"]}
{"query_id": "topic_465_turn_4", "conversation_id": "topic_465", "turn_id": 4, "query": "Since you mentioned Iran's transition from morphine to tramadol over the past two decades, what specific longitudinal study designs and statistical methods, such as interrupted time series analysis or segmented regression, were predominantly used to quantify the causal impact of specific healthcare policies versus public awareness campaigns on this prescribing shift, and how were potential confounders like concurrent economic sanctions or changes in pharmaceutical regulations addressed methodologically in these analyses?", "history": ["Recent trends and patterns in opioid consumption in Iran", "Impact of healthcare policies and public awareness campaigns on these recent opioid consumption trends in Iran", "Iran's morphine to tramadol transition (past two decades): Role of healthcare policy, public awareness, and future outlook for pain management and opioid stewardship."], "ground_truth": ["permed-78061", "permed-68904", "permed-78063", "permed-69144", "permed-69152", "permed-69147", "permed-69149", "permed-78065", "permed-81574", "permed-55826"]}
{"query_id": "topic_465_turn_5", "conversation_id": "topic_465", "turn_id": 5, "query": "Given the methodological approaches used to analyze Iran's opioid transition, what clinical outcomes and patient safety profiles have been observed in real-world settings following the shift from morphine to tramadol? Specifically, how have therapeutic efficacy for pain management, incidence of adverse effects like serotonin syndrome or seizures, and rates of tramadol misuse compared to traditional opioids in Iranian clinical practice? Additionally, what clinical guidelines have been developed to mitigate these risks while maintaining adequate pain control, particularly in vulnerable populations?", "history": ["Recent trends and patterns in opioid consumption in Iran", "Impact of healthcare policies and public awareness campaigns on these recent opioid consumption trends in Iran", "Iran's morphine to tramadol transition (past two decades): Role of healthcare policy, public awareness, and future outlook for pain management and opioid stewardship.", "Since you mentioned Iran's transition from morphine to tramadol over the past two decades, what specific longitudinal study designs and statistical methods, such as interrupted time series analysis or segmented regression, were predominantly used to quantify the causal impact of specific healthcare policies versus public awareness campaigns on this prescribing shift, and how were potential confounders like concurrent economic sanctions or changes in pharmaceutical regulations addressed methodologically in these analyses?"], "ground_truth": ["permed-78061", "permed-81574", "permed-69144", "permed-69147", "permed-55820", "permed-80138", "permed-78063", "permed-55826", "permed-69151", "permed-69153"]}
{"query_id": "topic_466_turn_1", "conversation_id": "topic_466", "turn_id": 1, "query": "Yeast genetic variation: mechanisms of adaptation to diverse environmental stresses", "history": [], "ground_truth": ["permed-66918", "permed-66685", "permed-53639", "permed-63992", "permed-53717", "permed-50790", "permed-76706", "permed-90068", "permed-74322", "permed-73487"]}
{"query_id": "topic_466_turn_2", "conversation_id": "topic_466", "turn_id": 2, "query": "Impact of this yeast genetic variation on industrial fermentation: optimizing strain robustness and efficiency", "history": ["Yeast genetic variation: mechanisms of adaptation to diverse environmental stresses"], "ground_truth": ["permed-66685", "permed-66583", "permed-64376", "permed-64375", "permed-64371", "permed-64373", "permed-89815", "permed-64161", "permed-66918", "permed-74229"]}
{"query_id": "topic_466_turn_3", "conversation_id": "topic_466", "turn_id": 3, "query": "Saccharomyces eubayanus: role of HAP complex and Cin5p genetic variants in adaptation to fluctuating sugar environments and potential for industrial strain enhancement", "history": ["Yeast genetic variation: mechanisms of adaptation to diverse environmental stresses", "Impact of this yeast genetic variation on industrial fermentation: optimizing strain robustness and efficiency"], "ground_truth": ["permed-66685", "permed-89815", "permed-66583", "permed-64373", "permed-64162", "permed-64161", "permed-66579", "permed-64376", "permed-53639", "permed-75422"]}
{"query_id": "topic_466_turn_4", "conversation_id": "topic_466", "turn_id": 4, "query": "When characterizing these HAP complex and Cin5p genetic variants, what specific transcriptional profiling methods were employed to quantify their differential regulatory effects under sugar fluctuations? Were RNA-seq protocols optimized for yeast samples experiencing rapid environmental shifts, and how did you statistically validate the significance of expression changes while controlling for batch effects across replicate fermentations?", "history": ["Yeast genetic variation: mechanisms of adaptation to diverse environmental stresses", "Impact of this yeast genetic variation on industrial fermentation: optimizing strain robustness and efficiency", "Saccharomyces eubayanus: role of HAP complex and Cin5p genetic variants in adaptation to fluctuating sugar environments and potential for industrial strain enhancement"], "ground_truth": ["permed-66685", "permed-63881", "permed-63886", "permed-66682", "permed-53639", "permed-84848", "permed-73487", "permed-59536", "permed-89020", "permed-64162"]}
{"query_id": "topic_466_turn_5", "conversation_id": "topic_466", "turn_id": 5, "query": "Given the transcriptional profiling insights into HAP complex and Cin5p variants' regulatory roles during sugar fluctuations, what translational potential do these genetic findings hold for clinical applications? Specifically, how might engineered yeast strains with these optimized regulatory networks improve biopharmaceutical production—such as insulin or vaccine antigens—in terms of yield stability under industrial-scale fermentation? Furthermore, what clinical-grade safety considerations arise when implementing such genetically enhanced strains, particularly regarding allergenicity or metabolic byproduct profiles in final therapeutic products?", "history": ["Yeast genetic variation: mechanisms of adaptation to diverse environmental stresses", "Impact of this yeast genetic variation on industrial fermentation: optimizing strain robustness and efficiency", "Saccharomyces eubayanus: role of HAP complex and Cin5p genetic variants in adaptation to fluctuating sugar environments and potential for industrial strain enhancement", "When characterizing these HAP complex and Cin5p genetic variants, what specific transcriptional profiling methods were employed to quantify their differential regulatory effects under sugar fluctuations? Were RNA-seq protocols optimized for yeast samples experiencing rapid environmental shifts, and how did you statistically validate the significance of expression changes while controlling for batch effects across replicate fermentations?"], "ground_truth": ["permed-66685", "permed-64162", "permed-52210", "permed-66583", "permed-64376", "permed-64161", "permed-58188", "permed-75422", "permed-64371", "permed-84848"]}
{"query_id": "topic_467_turn_1", "conversation_id": "topic_467", "turn_id": 1, "query": "What tools are available for evaluating the effectiveness of mobile health applications in managing chronic diseases?", "history": [], "ground_truth": ["permed-81455", "permed-78708", "permed-78716", "permed-78710", "permed-26285", "permed-66153", "permed-78713", "permed-88205", "permed-78711", "permed-61167"]}
{"query_id": "topic_467_turn_2", "conversation_id": "topic_467", "turn_id": 2, "query": "How can tools like it be adapted for use in specific linguistic or cultural populations?", "history": ["What tools are available for evaluating the effectiveness of mobile health applications in managing chronic diseases?"], "ground_truth": ["permed-69900", "permed-66109", "permed-70065", "permed-85489", "permed-69892", "permed-64779", "permed-84438", "permed-69898", "permed-68570", "permed-64788"]}
{"query_id": "topic_467_turn_3", "conversation_id": "topic_467", "turn_id": 3, "query": "Given the MARS-Fa tool's existing use for smartphone addiction evaluation, how could it be further adapted to assess both effectiveness and user experience of mobile health apps for chronic disease management in Farsi-speaking populations? What specific challenges might arise during this adaptation compared to its original validation?", "history": ["What tools are available for evaluating the effectiveness of mobile health applications in managing chronic diseases?", "How can tools like it be adapted for use in specific linguistic or cultural populations?"], "ground_truth": ["permed-78708", "permed-78710", "permed-81455", "permed-78711", "permed-26285", "permed-61162", "permed-70868", "permed-66136", "permed-61167", "permed-26266"]}
{"query_id": "topic_467_turn_4", "conversation_id": "topic_467", "turn_id": 4, "query": "In adapting the MARS-Fa framework for chronic disease management, what specific methodological considerations should guide the development of new subscales for therapeutic effectiveness? Should we employ exploratory factor analysis to validate these subscales, and what statistical power calculations would be appropriate for establishing reliability metrics like Cronbach's alpha in Farsi-speaking populations? Additionally, how might we implement back-translation protocols while maintaining clinical relevance of effectiveness measures across different chronic conditions?", "history": ["What tools are available for evaluating the effectiveness of mobile health applications in managing chronic diseases?", "How can tools like it be adapted for use in specific linguistic or cultural populations?", "Given the MARS-Fa tool's existing use for smartphone addiction evaluation, how could it be further adapted to assess both effectiveness and user experience of mobile health apps for chronic disease management in Farsi-speaking populations? What specific challenges might arise during this adaptation compared to its original validation?"], "ground_truth": ["permed-78708", "permed-25698", "permed-68568", "permed-78709", "permed-55815", "permed-68569", "permed-55808", "permed-25693", "permed-34668", "permed-68566"]}
{"query_id": "topic_467_turn_5", "conversation_id": "topic_467", "turn_id": 5, "query": "Given the methodological framework we've established for adapting the MARS-Fa tool with new therapeutic effectiveness subscales, what clinical implementation challenges might arise when deploying this adapted instrument in real-world Farsi-speaking patient populations? Specifically, how might comorbidities, varying health literacy levels, and different chronic disease trajectories impact the tool's ability to accurately predict actual patient outcomes and adherence? Additionally, what safety considerations should guide the interpretation of scores to prevent misinterpretation that could lead to inappropriate clinical decisions or premature app discontinuation?", "history": ["What tools are available for evaluating the effectiveness of mobile health applications in managing chronic diseases?", "How can tools like it be adapted for use in specific linguistic or cultural populations?", "Given the MARS-Fa tool's existing use for smartphone addiction evaluation, how could it be further adapted to assess both effectiveness and user experience of mobile health apps for chronic disease management in Farsi-speaking populations? What specific challenges might arise during this adaptation compared to its original validation?", "In adapting the MARS-Fa framework for chronic disease management, what specific methodological considerations should guide the development of new subscales for therapeutic effectiveness? Should we employ exploratory factor analysis to validate these subscales, and what statistical power calculations would be appropriate for establishing reliability metrics like Cronbach's alpha in Farsi-speaking populations? Additionally, how might we implement back-translation protocols while maintaining clinical relevance of effectiveness measures across different chronic conditions?"], "ground_truth": ["permed-78708", "permed-64778", "permed-91989", "permed-78709", "permed-34402", "permed-55815", "permed-91990", "permed-86722", "permed-25698", "permed-55808"]}
{"query_id": "topic_468_turn_1", "conversation_id": "topic_468", "turn_id": 1, "query": "What is known about the structure and function of the reovirus polymerase complex in viral transcription?", "history": [], "ground_truth": ["permed-80001", "permed-80002", "permed-80003", "permed-83879", "permed-80005", "permed-90078", "permed-89696", "permed-80006", "permed-76652", "permed-89199"]}
{"query_id": "topic_468_turn_2", "conversation_id": "topic_468", "turn_id": 2, "query": "How do specific regions within this complex, like the RNA-loading region, contribute to its overall activity and potential vulnerability to antiviral strategies?", "history": ["What is known about the structure and function of the reovirus polymerase complex in viral transcription?"], "ground_truth": ["permed-80001", "permed-80002", "permed-80008", "permed-83409", "permed-83382", "permed-62750", "permed-52702", "permed-83416", "permed-83410", "permed-82161"]}
{"query_id": "topic_468_turn_3", "conversation_id": "topic_468", "turn_id": 3, "query": "How do the conformational dynamics of these regions—particularly the RNA-loading region and priming loop—affect the polymerase complex's transition between transcriptional states, and what does this mean for designing antiviral strategies that target viral transcription?", "history": ["What is known about the structure and function of the reovirus polymerase complex in viral transcription?", "How do specific regions within this complex, like the RNA-loading region, contribute to its overall activity and potential vulnerability to antiviral strategies?"], "ground_truth": ["permed-80001", "permed-80003", "permed-80005", "permed-80006", "permed-83880", "permed-80004", "permed-77248", "permed-91053", "permed-88577", "permed-83892"]}
{"query_id": "topic_468_turn_4", "conversation_id": "topic_468", "turn_id": 4, "query": "When studying these conformational transitions in the RNA-loading region and priming loop, what specific experimental techniques—such as cryo-EM with time-resolved capabilities or single-molecule FRET—are most effective for capturing transient intermediate states? Additionally, how are these dynamic structural data typically correlated with functional assays measuring transcriptional output to establish causality between observed movements and polymerase activity changes?", "history": ["What is known about the structure and function of the reovirus polymerase complex in viral transcription?", "How do specific regions within this complex, like the RNA-loading region, contribute to its overall activity and potential vulnerability to antiviral strategies?", "How do the conformational dynamics of these regions—particularly the RNA-loading region and priming loop—affect the polymerase complex's transition between transcriptional states, and what does this mean for designing antiviral strategies that target viral transcription?"], "ground_truth": ["permed-71540", "permed-80001", "permed-80003", "permed-70695", "permed-83880", "permed-65171", "permed-88577", "permed-91053", "permed-92520", "permed-86711"]}
{"query_id": "topic_468_turn_5", "conversation_id": "topic_468", "turn_id": 5, "query": "Given these detailed structural insights into polymerase conformational dynamics, how have these findings translated into clinical development of reovirus-based therapeutics? Specifically, what clinical trial data exist regarding the safety profile and therapeutic efficacy of oncolytic reovirus treatments in human patients, particularly concerning potential side effects from unintended viral transcription in non-target tissues? Are there documented contraindications for immunocompromised patients given the polymerase's transcriptional mechanisms we've discussed?", "history": ["What is known about the structure and function of the reovirus polymerase complex in viral transcription?", "How do specific regions within this complex, like the RNA-loading region, contribute to its overall activity and potential vulnerability to antiviral strategies?", "How do the conformational dynamics of these regions—particularly the RNA-loading region and priming loop—affect the polymerase complex's transition between transcriptional states, and what does this mean for designing antiviral strategies that target viral transcription?", "When studying these conformational transitions in the RNA-loading region and priming loop, what specific experimental techniques—such as cryo-EM with time-resolved capabilities or single-molecule FRET—are most effective for capturing transient intermediate states? Additionally, how are these dynamic structural data typically correlated with functional assays measuring transcriptional output to establish causality between observed movements and polymerase activity changes?"], "ground_truth": ["permed-80001", "permed-71169", "permed-68006", "permed-71167", "permed-74545", "permed-82304", "permed-31667", "permed-90815", "permed-80143", "permed-89696"]}
{"query_id": "topic_469_turn_1", "conversation_id": "topic_469", "turn_id": 1, "query": "What role do molecular biomarkers play in treating non-small cell lung cancer (NSCLC)?", "history": [], "ground_truth": ["permed-54274", "permed-21036", "permed-52527", "permed-25914", "permed-56171", "permed-56369", "permed-56349", "permed-22091", "permed-56046", "permed-70484"]}
{"query_id": "topic_469_turn_2", "conversation_id": "topic_469", "turn_id": 2, "query": "Can identifying specific biomarkers in this area lead to more personalized treatment approaches for patients with varying disease characteristics?", "history": ["What role do molecular biomarkers play in treating non-small cell lung cancer (NSCLC)?"], "ground_truth": ["permed-70749", "permed-58684", "permed-50852", "permed-62485", "permed-62468", "permed-75086", "permed-56363", "permed-63232", "permed-92582", "permed-56723"]}
{"query_id": "topic_469_turn_3", "conversation_id": "topic_469", "turn_id": 3, "query": "Given these discussions about molecular biomarkers and personalized treatment in NSCLC, how might identifying specific biomarkers in T3N0-3M0 patients—particularly those with varying T3 descriptors like T-multiple—help tailor treatments and improve survival outcomes for subgroups with poorer prognoses?", "history": ["What role do molecular biomarkers play in treating non-small cell lung cancer (NSCLC)?", "Can identifying specific biomarkers in this area lead to more personalized treatment approaches for patients with varying disease characteristics?"], "ground_truth": ["permed-56082", "permed-70448", "permed-2961", "permed-70295", "permed-68635", "permed-70749", "permed-74031", "permed-54274", "permed-68256", "permed-56014"]}
{"query_id": "topic_469_turn_4", "conversation_id": "topic_469", "turn_id": 4, "query": "Given this approach of stratifying T3N0-3M0 NSCLC patients by T3 descriptors, what specific statistical methods would you employ to validate that biomarker-driven treatment assignments actually improve survival outcomes? I'm particularly interested in how you'd handle competing risks in this population with varying nodal involvement, and what sample size calculations would be appropriate for detecting clinically meaningful differences in progression-free survival between biomarker-defined subgroups while accounting for multiple testing.", "history": ["What role do molecular biomarkers play in treating non-small cell lung cancer (NSCLC)?", "Can identifying specific biomarkers in this area lead to more personalized treatment approaches for patients with varying disease characteristics?", "Given these discussions about molecular biomarkers and personalized treatment in NSCLC, how might identifying specific biomarkers in T3N0-3M0 patients—particularly those with varying T3 descriptors like T-multiple—help tailor treatments and improve survival outcomes for subgroups with poorer prognoses?"], "ground_truth": ["permed-56082", "permed-70747", "permed-68635", "permed-52520", "permed-56124", "permed-56794", "permed-56446", "permed-56769", "permed-74031", "permed-52527"]}
{"query_id": "topic_469_turn_5", "conversation_id": "topic_469", "turn_id": 5, "query": "Given the validated statistical approaches for biomarker-driven treatment assignments in T3N0-3M0 NSCLC, what are the emergent clinical outcomes and safety profiles when these protocols are implemented in real-world practice? Specifically, focusing on patients with poorer prognoses stratified by T3 descriptors, how does the therapeutic efficacy—measured by objective response rates and median overall survival—compare between biomarker-matched versus non-matched therapies? Furthermore, what are the predominant patterns of treatment-related adverse events and acquired resistance mechanisms observed in these more intensively treated, locally advanced subgroups?", "history": ["What role do molecular biomarkers play in treating non-small cell lung cancer (NSCLC)?", "Can identifying specific biomarkers in this area lead to more personalized treatment approaches for patients with varying disease characteristics?", "Given these discussions about molecular biomarkers and personalized treatment in NSCLC, how might identifying specific biomarkers in T3N0-3M0 patients—particularly those with varying T3 descriptors like T-multiple—help tailor treatments and improve survival outcomes for subgroups with poorer prognoses?", "Given this approach of stratifying T3N0-3M0 NSCLC patients by T3 descriptors, what specific statistical methods would you employ to validate that biomarker-driven treatment assignments actually improve survival outcomes? I'm particularly interested in how you'd handle competing risks in this population with varying nodal involvement, and what sample size calculations would be appropriate for detecting clinically meaningful differences in progression-free survival between biomarker-defined subgroups while accounting for multiple testing."], "ground_truth": ["permed-56082", "permed-52520", "permed-56381", "permed-56784", "permed-52527", "permed-77227", "permed-54280", "permed-75574", "permed-68591", "permed-55074"]}
{"query_id": "topic_470_turn_1", "conversation_id": "topic_470", "turn_id": 1, "query": "What is known about the effectiveness of extracorporeal photopheresis in treating immune-related disorders?", "history": [], "ground_truth": ["permed-67383", "permed-67784", "permed-74763", "permed-27940", "permed-67783", "permed-68895", "permed-61974", "permed-53260", "permed-49467", "permed-86038"]}
{"query_id": "topic_470_turn_2", "conversation_id": "topic_470", "turn_id": 2, "query": "How does this technique specifically impact patients with rare conditions like Sézary syndrome?", "history": ["What is known about the effectiveness of extracorporeal photopheresis in treating immune-related disorders?"], "ground_truth": ["permed-46199", "permed-27517", "permed-55392", "permed-77635", "permed-61974", "permed-56456", "permed-63499", "permed-55944", "permed-45931", "permed-67383"]}
{"query_id": "topic_470_turn_3", "conversation_id": "topic_470", "turn_id": 3, "query": "Given what we know about ECP's effects in Sézary syndrome, how do its immunomodulatory mechanisms differ among patients with varying disease severities, and are there specific biomarkers that could help predict which patients are most likely to respond well to this therapy?", "history": ["What is known about the effectiveness of extracorporeal photopheresis in treating immune-related disorders?", "How does this technique specifically impact patients with rare conditions like Sézary syndrome?"], "ground_truth": ["permed-67383", "permed-73635", "permed-90159", "permed-60368", "permed-68257", "permed-67337", "permed-90881", "permed-62940", "permed-56783", "permed-56024"]}
{"query_id": "topic_470_turn_4", "conversation_id": "topic_470", "turn_id": 4, "query": "Regarding these biomarker-driven response predictions, what specific validation approaches were used to assess the predictive accuracy of candidate biomarkers? I'm particularly interested in whether researchers employed time-dependent ROC analysis or machine learning algorithms for classifier development, and how they addressed potential overfitting through cross-validation strategies. Additionally, what statistical power considerations guided their patient cohort sizing for these predictive modeling exercises?", "history": ["What is known about the effectiveness of extracorporeal photopheresis in treating immune-related disorders?", "How does this technique specifically impact patients with rare conditions like Sézary syndrome?", "Given what we know about ECP's effects in Sézary syndrome, how do its immunomodulatory mechanisms differ among patients with varying disease severities, and are there specific biomarkers that could help predict which patients are most likely to respond well to this therapy?"], "ground_truth": ["permed-59413", "permed-53344", "permed-21347", "permed-62485", "permed-66294", "permed-56687", "permed-90271", "permed-56026", "permed-70297", "permed-82931"]}
{"query_id": "topic_470_turn_5", "conversation_id": "topic_470", "turn_id": 5, "query": "Given these methodological approaches for validating predictive biomarkers, what clinical outcomes have actually been demonstrated when using biomarker-guided ECP treatment in real-world Sézary syndrome patients? Specifically, how has biomarker stratification affected objective response rates, progression-free survival, or time to next treatment compared to unselected patient populations? Additionally, what practical implementation challenges have emerged in translating these predictive models into routine clinical workflows, particularly regarding test availability, turnaround times, or reimbursement barriers that might limit patient access to personalized ECP treatment approaches?", "history": ["What is known about the effectiveness of extracorporeal photopheresis in treating immune-related disorders?", "How does this technique specifically impact patients with rare conditions like Sézary syndrome?", "Given what we know about ECP's effects in Sézary syndrome, how do its immunomodulatory mechanisms differ among patients with varying disease severities, and are there specific biomarkers that could help predict which patients are most likely to respond well to this therapy?", "Regarding these biomarker-driven response predictions, what specific validation approaches were used to assess the predictive accuracy of candidate biomarkers? I'm particularly interested in whether researchers employed time-dependent ROC analysis or machine learning algorithms for classifier development, and how they addressed potential overfitting through cross-validation strategies. Additionally, what statistical power considerations guided their patient cohort sizing for these predictive modeling exercises?"], "ground_truth": ["permed-56048", "permed-82931", "permed-66294", "permed-56184", "permed-91241", "permed-56687", "permed-59413", "permed-56110", "permed-54274", "permed-61485"]}
{"query_id": "topic_471_turn_1", "conversation_id": "topic_471", "turn_id": 1, "query": "Role and applications of geospatial data in healthcare research and public health", "history": [], "ground_truth": ["permed-66153", "permed-91926", "permed-88327", "permed-70250", "permed-73394", "permed-66148", "permed-70256", "permed-69946", "permed-61201", "permed-65884"]}
{"query_id": "topic_471_turn_2", "conversation_id": "topic_471", "turn_id": 2, "query": "Challenges of data interoperability and standardization for these geospatial healthcare applications", "history": ["Role and applications of geospatial data in healthcare research and public health"], "ground_truth": ["permed-66153", "permed-91926", "permed-89409", "permed-66148", "permed-61615", "permed-55107", "permed-91022", "permed-79518", "permed-53888", "permed-88327"]}
{"query_id": "topic_471_turn_3", "conversation_id": "topic_471", "turn_id": 3, "query": "Ontologies and semantic web solutions for geospatial health data interoperability issues, including effective maintenance frameworks for evolving GeoHealth ontologies", "history": ["Role and applications of geospatial data in healthcare research and public health", "Challenges of data interoperability and standardization for these geospatial healthcare applications"], "ground_truth": ["permed-75600", "permed-91926", "permed-66153", "permed-66148", "permed-55180", "permed-75602", "permed-70250", "permed-75601", "permed-88327", "permed-73663"]}
{"query_id": "topic_471_turn_4", "conversation_id": "topic_471", "turn_id": 4, "query": "When implementing these semantic web frameworks, what specific validation protocols do researchers employ to ensure ontological consistency across distributed health datasets? I'm particularly interested in how they technically implement SPARQL-based quality checks, handle temporal versioning of evolving ontologies, and maintain data integrity when mapping between different geographic coordinate systems. Are there standardized metrics for measuring interoperability success in these implementations, and what statistical approaches best quantify the reduction in data harmonization errors post-ontology deployment?", "history": ["Role and applications of geospatial data in healthcare research and public health", "Challenges of data interoperability and standardization for these geospatial healthcare applications", "Ontologies and semantic web solutions for geospatial health data interoperability issues, including effective maintenance frameworks for evolving GeoHealth ontologies"], "ground_truth": ["permed-75601", "permed-75600", "permed-74314", "permed-87767", "permed-88216", "permed-53800", "permed-51872", "permed-87134", "permed-79170", "permed-34429"]}
{"query_id": "topic_471_turn_5", "conversation_id": "topic_471", "turn_id": 5, "query": "Given these sophisticated validation frameworks for geospatial health ontologies, how have clinical outcomes actually improved when these systems are deployed in real-world healthcare settings? I'm particularly interested in studies measuring patient outcomes - for instance, in chronic disease management or infectious disease surveillance - where semantic interoperability directly impacted care coordination, reduced diagnostic delays, or improved therapeutic targeting. What evidence exists showing clinical efficacy, and have any trials demonstrated statistically significant improvements in morbidity/mortality metrics when compared to conventional data systems?", "history": ["Role and applications of geospatial data in healthcare research and public health", "Challenges of data interoperability and standardization for these geospatial healthcare applications", "Ontologies and semantic web solutions for geospatial health data interoperability issues, including effective maintenance frameworks for evolving GeoHealth ontologies", "When implementing these semantic web frameworks, what specific validation protocols do researchers employ to ensure ontological consistency across distributed health datasets? I'm particularly interested in how they technically implement SPARQL-based quality checks, handle temporal versioning of evolving ontologies, and maintain data integrity when mapping between different geographic coordinate systems. Are there standardized metrics for measuring interoperability success in these implementations, and what statistical approaches best quantify the reduction in data harmonization errors post-ontology deployment?"], "ground_truth": ["permed-75601", "permed-53888", "permed-75600", "permed-52428", "permed-65574", "permed-54410", "permed-91926", "permed-51872", "permed-88216", "permed-61609"]}
{"query_id": "topic_472_turn_1", "conversation_id": "topic_472", "turn_id": 1, "query": "Impact of spiritual well-being on family caregiver burden in cancer care", "history": [], "ground_truth": ["permed-78103", "permed-78105", "permed-60165", "permed-65744", "permed-75682", "permed-78108", "permed-61465", "permed-62021", "permed-78104", "permed-91469"]}
{"query_id": "topic_472_turn_2", "conversation_id": "topic_472", "turn_id": 2, "query": "Effectiveness of culturally adapted interventions in Turkey for improving spiritual well-being and reducing burden in these cancer caregivers", "history": ["Impact of spiritual well-being on family caregiver burden in cancer care"], "ground_truth": ["permed-66109", "permed-78103", "permed-78105", "permed-69900", "permed-66107", "permed-75682", "permed-65839", "permed-67553", "permed-77312", "permed-65743"]}
{"query_id": "topic_472_turn_3", "conversation_id": "topic_472", "turn_id": 3, "query": "Efficacy of specific spiritual practices OR culturally adapted interventions within Turkey in enhancing spiritual well-being AND mitigating caregiver burden among family caregivers of breast cancer patients, considering moderating roles of caregiving intensity AND socio-economic status", "history": ["Impact of spiritual well-being on family caregiver burden in cancer care", "Effectiveness of culturally adapted interventions in Turkey for improving spiritual well-being and reducing burden in these cancer caregivers"], "ground_truth": ["permed-78103", "permed-78105", "permed-65744", "permed-75682", "permed-51735", "permed-65738", "permed-91469", "permed-65743", "permed-67553", "permed-51733"]}
{"query_id": "topic_472_turn_4", "conversation_id": "topic_472", "turn_id": 4, "query": "Considering the proposed evaluation of spiritual practices and culturally adapted interventions, what specific methodological approach would you recommend for measuring the moderating effects of caregiving intensity and socio-economic status? Would hierarchical linear modeling be appropriate to account for these covariates while assessing intervention efficacy on both spiritual well-being and burden reduction outcomes? Also, what validation strategies should be implemented for the culturally adapted spiritual assessment tools to ensure their reliability within the Turkish healthcare context?", "history": ["Impact of spiritual well-being on family caregiver burden in cancer care", "Effectiveness of culturally adapted interventions in Turkey for improving spiritual well-being and reducing burden in these cancer caregivers", "Efficacy of specific spiritual practices OR culturally adapted interventions within Turkey in enhancing spiritual well-being AND mitigating caregiver burden among family caregivers of breast cancer patients, considering moderating roles of caregiving intensity AND socio-economic status"], "ground_truth": ["permed-78103", "permed-62021", "permed-51733", "permed-67167", "permed-67161", "permed-64779", "permed-69900", "permed-66109", "permed-51735", "permed-67163"]}
{"query_id": "topic_472_turn_5", "conversation_id": "topic_472", "turn_id": 5, "query": "Given the methodological considerations for evaluating spiritual interventions in Turkish cancer caregivers, how do observed clinical outcomes—such as changes in caregiver depression scores, medication adherence rates among patients, or emergency healthcare utilization—correlate with improvements in spiritual well-being? What safety considerations or unintended consequences (e.g., emotional distress from spiritual interventions) have emerged in real-world implementations, and how do caregiving intensity levels moderate these clinical effects in breast cancer care settings?", "history": ["Impact of spiritual well-being on family caregiver burden in cancer care", "Effectiveness of culturally adapted interventions in Turkey for improving spiritual well-being and reducing burden in these cancer caregivers", "Efficacy of specific spiritual practices OR culturally adapted interventions within Turkey in enhancing spiritual well-being AND mitigating caregiver burden among family caregivers of breast cancer patients, considering moderating roles of caregiving intensity AND socio-economic status", "Considering the proposed evaluation of spiritual practices and culturally adapted interventions, what specific methodological approach would you recommend for measuring the moderating effects of caregiving intensity and socio-economic status? Would hierarchical linear modeling be appropriate to account for these covariates while assessing intervention efficacy on both spiritual well-being and burden reduction outcomes? Also, what validation strategies should be implemented for the culturally adapted spiritual assessment tools to ensure their reliability within the Turkish healthcare context?"], "ground_truth": ["permed-78103", "permed-78105", "permed-65743", "permed-91469", "permed-67161", "permed-65744", "permed-65755", "permed-51735", "permed-75682", "permed-67167"]}
{"query_id": "topic_473_turn_1", "conversation_id": "topic_473", "turn_id": 1, "query": "Fundamental roles of hydrated ionomer films in PEMFC performance, focusing on proton conductivity and water management.", "history": [], "ground_truth": ["permed-77109", "permed-75893", "permed-73371", "permed-77110", "permed-77111", "permed-73290", "permed-73291", "permed-81174", "permed-77114", "permed-74672"]}
{"query_id": "topic_473_turn_2", "conversation_id": "topic_473", "turn_id": 2, "query": "Impact of molecular-scale interactions within these ionomer films on PEMFC cathode catalyst layer: effects on ORR kinetics and local oxygen transport resistance.", "history": ["Fundamental roles of hydrated ionomer films in PEMFC performance, focusing on proton conductivity and water management."], "ground_truth": ["permed-77110", "permed-77109", "permed-60891", "permed-51996", "permed-53478", "permed-60890", "permed-88706", "permed-53479", "permed-77033", "permed-73291"]}
{"query_id": "topic_473_turn_3", "conversation_id": "topic_473", "turn_id": 3, "query": "Optimizing PEMFC cathode catalyst layer design by tailoring ionomer characteristics to improve O<sub>2</sub> and N<sub>2</sub> diffusion based on molecular insights for enhanced cell efficiency across operating conditions.", "history": ["Fundamental roles of hydrated ionomer films in PEMFC performance, focusing on proton conductivity and water management.", "Impact of molecular-scale interactions within these ionomer films on PEMFC cathode catalyst layer: effects on ORR kinetics and local oxygen transport resistance."], "ground_truth": ["permed-77109", "permed-77110", "permed-60891", "permed-53479", "permed-78858", "permed-73201", "permed-55250", "permed-51996", "permed-53478", "permed-60889"]}
{"query_id": "topic_473_turn_4", "conversation_id": "topic_473", "turn_id": 4, "query": "When tailoring ionomer characteristics to optimize O<sub>2</sub>/N<sub>2</sub> diffusion, what specific experimental protocols were used to quantify diffusion coefficients across different relative humidity conditions? I'm particularly interested in how researchers controlled for membrane swelling artifacts during these measurements and what statistical validation methods ensured the correlation between molecular-scale modifications and bulk transport properties was significant rather than experimental noise.", "history": ["Fundamental roles of hydrated ionomer films in PEMFC performance, focusing on proton conductivity and water management.", "Impact of molecular-scale interactions within these ionomer films on PEMFC cathode catalyst layer: effects on ORR kinetics and local oxygen transport resistance.", "Optimizing PEMFC cathode catalyst layer design by tailoring ionomer characteristics to improve O<sub>2</sub> and N<sub>2</sub> diffusion based on molecular insights for enhanced cell efficiency across operating conditions."], "ground_truth": ["permed-77109", "permed-74669", "permed-76344", "permed-79183", "permed-88586", "permed-83291", "permed-74672", "permed-87801", "permed-73151", "permed-73147"]}
{"query_id": "topic_473_turn_5", "conversation_id": "topic_473", "turn_id": 5, "query": "Given the detailed experimental protocols for measuring gas diffusion coefficients, how do the quantitative trade-offs between proton conductivity and gas diffusivity compare when tailoring ionomer side-chain chemistry versus backbone modifications? Specifically, what relative performance differences emerge in PEMFC power density and mass transport losses when prioritizing sulfonation density adjustments against fluorination degree alterations across low-to-high humidity conditions, and which modification strategy demonstrates superior compromise for practical operating windows?", "history": ["Fundamental roles of hydrated ionomer films in PEMFC performance, focusing on proton conductivity and water management.", "Impact of molecular-scale interactions within these ionomer films on PEMFC cathode catalyst layer: effects on ORR kinetics and local oxygen transport resistance.", "Optimizing PEMFC cathode catalyst layer design by tailoring ionomer characteristics to improve O<sub>2</sub> and N<sub>2</sub> diffusion based on molecular insights for enhanced cell efficiency across operating conditions.", "When tailoring ionomer characteristics to optimize O<sub>2</sub>/N<sub>2</sub> diffusion, what specific experimental protocols were used to quantify diffusion coefficients across different relative humidity conditions? I'm particularly interested in how researchers controlled for membrane swelling artifacts during these measurements and what statistical validation methods ensured the correlation between molecular-scale modifications and bulk transport properties was significant rather than experimental noise."], "ground_truth": ["permed-75893", "permed-72943", "permed-77111", "permed-88586", "permed-73290", "permed-77109", "permed-77110", "permed-73371", "permed-72964", "permed-80784"]}
{"query_id": "topic_474_turn_1", "conversation_id": "topic_474", "turn_id": 1, "query": "What role do patient decision aids play in colorectal cancer screening for older adults?", "history": [], "ground_truth": ["permed-78471", "permed-78478", "permed-78479", "permed-67438", "permed-78472", "permed-78475", "permed-82976", "permed-26325", "permed-92025", "permed-34753"]}
{"query_id": "topic_474_turn_2", "conversation_id": "topic_474", "turn_id": 2, "query": "How effective are tailored versions of these aids in improving health outcomes for this population?", "history": ["What role do patient decision aids play in colorectal cancer screening for older adults?"], "ground_truth": ["permed-66153", "permed-74318", "permed-91926", "permed-66148", "permed-75283", "permed-54923", "permed-58496", "permed-84493", "permed-61615", "permed-90617"]}
{"query_id": "topic_474_turn_3", "conversation_id": "topic_474", "turn_id": 3, "query": "How do differences in the design and content of these tailored decision aids affect older adults' understanding and screening choices, particularly when accounting for their varying health states? And what does this mean for advancing personalized medicine and patient-centered care in this context?", "history": ["What role do patient decision aids play in colorectal cancer screening for older adults?", "How effective are tailored versions of these aids in improving health outcomes for this population?"], "ground_truth": ["permed-78471", "permed-78478", "permed-50966", "permed-84492", "permed-78645", "permed-84493", "permed-69694", "permed-67438", "permed-62504", "permed-84519"]}
{"query_id": "topic_474_turn_4", "conversation_id": "topic_474", "turn_id": 4, "query": "Given these design and content variations in tailored decision aids, what specific methodological approaches were used to assess understanding and screening choices across different health states? I'm particularly interested in the validation strategies for the cognitive assessments and the statistical methods employed to analyze how aid characteristics interact with patient variables. Were there specific protocols to ensure measurement consistency when comparing outcomes between subgroups with varying comorbidities or functional limitations?", "history": ["What role do patient decision aids play in colorectal cancer screening for older adults?", "How effective are tailored versions of these aids in improving health outcomes for this population?", "How do differences in the design and content of these tailored decision aids affect older adults' understanding and screening choices, particularly when accounting for their varying health states? And what does this mean for advancing personalized medicine and patient-centered care in this context?"], "ground_truth": ["permed-78478", "permed-67438", "permed-58490", "permed-32919", "permed-78471", "permed-25787", "permed-34377", "permed-84493", "permed-74801", "permed-84519"]}
{"query_id": "topic_474_turn_5", "conversation_id": "topic_474", "turn_id": 5, "query": "Given these methodological insights into evaluating decision aid effectiveness across diverse health states, how have these tailored tools performed in actual clinical implementation? Specifically, what evidence exists regarding their impact on real-world screening completion rates and patient-reported outcomes among older adults with varying comorbidities? Additionally, what implementation challenges have emerged regarding clinician adoption, workflow integration, or managing potential decision conflicts when personalized recommendations contradict standard screening guidelines for certain health states?", "history": ["What role do patient decision aids play in colorectal cancer screening for older adults?", "How effective are tailored versions of these aids in improving health outcomes for this population?", "How do differences in the design and content of these tailored decision aids affect older adults' understanding and screening choices, particularly when accounting for their varying health states? And what does this mean for advancing personalized medicine and patient-centered care in this context?", "Given these design and content variations in tailored decision aids, what specific methodological approaches were used to assess understanding and screening choices across different health states? I'm particularly interested in the validation strategies for the cognitive assessments and the statistical methods employed to analyze how aid characteristics interact with patient variables. Were there specific protocols to ensure measurement consistency when comparing outcomes between subgroups with varying comorbidities or functional limitations?"], "ground_truth": ["permed-78471", "permed-61894", "permed-67438", "permed-78474", "permed-34377", "permed-63414", "permed-26325", "permed-85704", "permed-82606", "permed-88759"]}
{"query_id": "topic_475_turn_1", "conversation_id": "topic_475", "turn_id": 1, "query": "What advancements have been made in using nanotechnology for cancer treatment, particularly for aggressive tumors like glioblastoma?", "history": [], "ground_truth": ["permed-92530", "permed-64580", "permed-92531", "permed-52921", "permed-56161", "permed-57857", "permed-56042", "permed-81320", "permed-80423", "permed-57540"]}
{"query_id": "topic_475_turn_2", "conversation_id": "topic_475", "turn_id": 2, "query": "How can this technology be further developed to create smart nano-carriers that respond to various stimuli within the tumor microenvironment?", "history": ["What advancements have been made in using nanotechnology for cancer treatment, particularly for aggressive tumors like glioblastoma?"], "ground_truth": ["permed-59217", "permed-67174", "permed-64580", "permed-67179", "permed-67531", "permed-75902", "permed-68481", "permed-51338", "permed-67530", "permed-74795"]}
{"query_id": "topic_475_turn_3", "conversation_id": "topic_475", "turn_id": 3, "query": "Given the complexity of the tumor microenvironment, how could we design these smart nano-carriers to simultaneously respond to multiple stimuli—like pH changes, light exposure, temperature increases, and chemical signals—for more efficient and precise treatment of aggressive tumors such as glioblastoma? What key factors—such as material selection, drug-loading capacity, release mechanisms, biocompatibility, and safety—need to be prioritized to ensure clinical effectiveness and patient safety?", "history": ["What advancements have been made in using nanotechnology for cancer treatment, particularly for aggressive tumors like glioblastoma?", "How can this technology be further developed to create smart nano-carriers that respond to various stimuli within the tumor microenvironment?"], "ground_truth": ["permed-64580", "permed-57857", "permed-57540", "permed-52921", "permed-82020", "permed-81320", "permed-59217", "permed-51435", "permed-51425", "permed-8582"]}
{"query_id": "topic_475_turn_4", "conversation_id": "topic_475", "turn_id": 4, "query": "Building on this multi-stimuli responsive design framework, what specific experimental protocols and validation methods would you recommend for quantitatively assessing the sequential and synergistic activation of these nano-carriers under combined microenvironmental triggers? I'm particularly interested in how to establish robust dose-response relationships for each stimulus while maintaining reproducibility across biological replicates, and what statistical approaches would best characterize the interaction effects between different release mechanisms in complex tumor models.", "history": ["What advancements have been made in using nanotechnology for cancer treatment, particularly for aggressive tumors like glioblastoma?", "How can this technology be further developed to create smart nano-carriers that respond to various stimuli within the tumor microenvironment?", "Given the complexity of the tumor microenvironment, how could we design these smart nano-carriers to simultaneously respond to multiple stimuli—like pH changes, light exposure, temperature increases, and chemical signals—for more efficient and precise treatment of aggressive tumors such as glioblastoma? What key factors—such as material selection, drug-loading capacity, release mechanisms, biocompatibility, and safety—need to be prioritized to ensure clinical effectiveness and patient safety?"], "ground_truth": ["permed-63013", "permed-58079", "permed-63014", "permed-75002", "permed-59217", "permed-67852", "permed-64712", "permed-74798", "permed-57540", "permed-67531"]}
{"query_id": "topic_475_turn_5", "conversation_id": "topic_475", "turn_id": 5, "query": "Given these sophisticated validation protocols for multi-stimuli responsive nano-carriers, how have these systems actually performed in clinical settings for glioblastoma patients? What patient outcomes—such as progression-free survival, overall survival, and tumor recurrence rates—have been observed in early-phase trials, and what are the predominant adverse effects limiting therapeutic efficacy? Specifically, how do the complex glioblastoma microenvironment and blood-brain barrier penetration challenges observed in preclinical models translate to real-world clinical response variability and safety profiles in human subjects?", "history": ["What advancements have been made in using nanotechnology for cancer treatment, particularly for aggressive tumors like glioblastoma?", "How can this technology be further developed to create smart nano-carriers that respond to various stimuli within the tumor microenvironment?", "Given the complexity of the tumor microenvironment, how could we design these smart nano-carriers to simultaneously respond to multiple stimuli—like pH changes, light exposure, temperature increases, and chemical signals—for more efficient and precise treatment of aggressive tumors such as glioblastoma? What key factors—such as material selection, drug-loading capacity, release mechanisms, biocompatibility, and safety—need to be prioritized to ensure clinical effectiveness and patient safety?", "Building on this multi-stimuli responsive design framework, what specific experimental protocols and validation methods would you recommend for quantitatively assessing the sequential and synergistic activation of these nano-carriers under combined microenvironmental triggers? I'm particularly interested in how to establish robust dose-response relationships for each stimulus while maintaining reproducibility across biological replicates, and what statistical approaches would best characterize the interaction effects between different release mechanisms in complex tumor models."], "ground_truth": ["permed-87970", "permed-52921", "permed-51435", "permed-81320", "permed-56042", "permed-51428", "permed-57540", "permed-52301", "permed-8581", "permed-8582"]}
{"query_id": "topic_476_turn_1", "conversation_id": "topic_476", "turn_id": 1, "query": "What factors influence the survival and quality of life in elderly patients with acute myeloid leukemia (AML)?", "history": [], "ground_truth": ["permed-76500", "permed-72541", "permed-33202", "permed-33199", "permed-33197", "permed-23209", "permed-56397", "permed-47995", "permed-33198", "permed-55386"]}
{"query_id": "topic_476_turn_2", "conversation_id": "topic_476", "turn_id": 2, "query": "How do comorbid conditions impact this prognosis, particularly when intensive chemotherapy is involved?", "history": ["What factors influence the survival and quality of life in elderly patients with acute myeloid leukemia (AML)?"], "ground_truth": ["permed-89350", "permed-55400", "permed-91653", "permed-72766", "permed-56490", "permed-50747", "permed-56372", "permed-79102", "permed-51769", "permed-84394"]}
{"query_id": "topic_476_turn_3", "conversation_id": "topic_476", "turn_id": 3, "query": "Given these factors, how do specific comorbidities like cardiovascular disease or diabetes interact with age and performance status to affect long-term survival and quality of life in elderly AML patients undergoing intensive chemotherapy? And what does this mean for tailoring their treatment strategies?", "history": ["What factors influence the survival and quality of life in elderly patients with acute myeloid leukemia (AML)?", "How do comorbid conditions impact this prognosis, particularly when intensive chemotherapy is involved?"], "ground_truth": ["permed-76500", "permed-33197", "permed-33202", "permed-72541", "permed-56397", "permed-33199", "permed-56720", "permed-23209", "permed-33201", "permed-47995"]}
{"query_id": "topic_476_turn_4", "conversation_id": "topic_476", "turn_id": 4, "query": "When studying these complex interactions between comorbidities, age, and treatment outcomes, what specific statistical modeling approaches would best account for competing risks in survival analysis? I'm particularly interested in how researchers handle the correlation between multiple comorbidities when designing multivariable models, and what validation strategies they employ to ensure the reliability of interaction effect estimates between, for instance, cardiovascular disease and performance status in predicting both survival and quality of life endpoints.", "history": ["What factors influence the survival and quality of life in elderly patients with acute myeloid leukemia (AML)?", "How do comorbid conditions impact this prognosis, particularly when intensive chemotherapy is involved?", "Given these factors, how do specific comorbidities like cardiovascular disease or diabetes interact with age and performance status to affect long-term survival and quality of life in elderly AML patients undergoing intensive chemotherapy? And what does this mean for tailoring their treatment strategies?"], "ground_truth": ["permed-37830", "permed-82585", "permed-26193", "permed-65571", "permed-51756", "permed-59413", "permed-55478", "permed-76500", "permed-25465", "permed-71006"]}
{"query_id": "topic_476_turn_5", "conversation_id": "topic_476", "turn_id": 5, "query": "Given these sophisticated statistical approaches for handling competing risks and comorbidity interactions, how have these modeling insights actually translated into improved clinical decision-making for elderly AML patients? Specifically, what evidence exists from clinical trials or real-world studies demonstrating that comorbidity-adjusted risk stratification leads to better survival outcomes or quality of life when selecting between intensive chemotherapy versus lower-intensity regimens? I'm particularly interested in how clinicians practically apply these predictive models at bedside and whether this approach reduces treatment-related mortality while maintaining efficacy.", "history": ["What factors influence the survival and quality of life in elderly patients with acute myeloid leukemia (AML)?", "How do comorbid conditions impact this prognosis, particularly when intensive chemotherapy is involved?", "Given these factors, how do specific comorbidities like cardiovascular disease or diabetes interact with age and performance status to affect long-term survival and quality of life in elderly AML patients undergoing intensive chemotherapy? And what does this mean for tailoring their treatment strategies?", "When studying these complex interactions between comorbidities, age, and treatment outcomes, what specific statistical modeling approaches would best account for competing risks in survival analysis? I'm particularly interested in how researchers handle the correlation between multiple comorbidities when designing multivariable models, and what validation strategies they employ to ensure the reliability of interaction effect estimates between, for instance, cardiovascular disease and performance status in predicting both survival and quality of life endpoints."], "ground_truth": ["permed-76500", "permed-56397", "permed-33202", "permed-33197", "permed-79103", "permed-24136", "permed-23209", "permed-73481", "permed-23175", "permed-92615"]}
{"query_id": "topic_477_turn_1", "conversation_id": "topic_477", "turn_id": 1, "query": "What advancements have been made in using carbon dot dendrimers for biosensing applications?", "history": [], "ground_truth": ["permed-76272", "permed-76275", "permed-73014", "permed-80656", "permed-91207", "permed-80652", "permed-76271", "permed-64265", "permed-64621", "permed-88011"]}
{"query_id": "topic_477_turn_2", "conversation_id": "topic_477", "turn_id": 2, "query": "How can the unique properties of these self-assembled structures be leveraged to improve the efficiency and selectivity of immunosensors, particularly for detecting specific biomarkers?", "history": ["What advancements have been made in using carbon dot dendrimers for biosensing applications?"], "ground_truth": ["permed-57968", "permed-88534", "permed-74512", "permed-76272", "permed-89260", "permed-59244", "permed-75975", "permed-77684", "permed-62241", "permed-80648"]}
{"query_id": "topic_477_turn_3", "conversation_id": "topic_477", "turn_id": 3, "query": "Given the unique properties of these coordination-induced self-assembled carbon dot dendrimers, how could their structure be further optimized to enhance ECL efficiency? Additionally, what strategies might improve the sensitivity and selectivity of immunosensors for detecting other clinically relevant biomarkers beyond bone alkaline phosphatase?", "history": ["What advancements have been made in using carbon dot dendrimers for biosensing applications?", "How can the unique properties of these self-assembled structures be leveraged to improve the efficiency and selectivity of immunosensors, particularly for detecting specific biomarkers?"], "ground_truth": ["permed-76272", "permed-76275", "permed-88011", "permed-73014", "permed-91207", "permed-80644", "permed-80656", "permed-75832", "permed-76271", "permed-80652"]}
{"query_id": "topic_477_turn_4", "conversation_id": "topic_477", "turn_id": 4, "query": "Given these optimization strategies for enhancing ECL efficiency, what specific electrochemical characterization protocols would you recommend for systematically evaluating the coordination-induced structural modifications? Particularly, how should we design controlled experiments to correlate dendrimer branching density with ECL quantum yield measurements, and what statistical validation methods would ensure reproducibility when assessing immunosensor sensitivity across multiple biomarker panels?", "history": ["What advancements have been made in using carbon dot dendrimers for biosensing applications?", "How can the unique properties of these self-assembled structures be leveraged to improve the efficiency and selectivity of immunosensors, particularly for detecting specific biomarkers?", "Given the unique properties of these coordination-induced self-assembled carbon dot dendrimers, how could their structure be further optimized to enhance ECL efficiency? Additionally, what strategies might improve the sensitivity and selectivity of immunosensors for detecting other clinically relevant biomarkers beyond bone alkaline phosphatase?"], "ground_truth": ["permed-76272", "permed-52546", "permed-80644", "permed-80843", "permed-82199", "permed-80645", "permed-79149", "permed-80647", "permed-64618", "permed-80840"]}
{"query_id": "topic_477_turn_5", "conversation_id": "topic_477", "turn_id": 5, "query": "Given these comprehensive electrochemical characterization protocols for optimized carbon dot dendrimers, what clinical validation studies have been conducted to evaluate their diagnostic performance in real patient samples? Specifically, how do the enhanced ECL immunosensors compare against current gold-standard methods for detecting bone alkaline phosphatase and other bone turnover markers in conditions like osteoporosis or metastatic bone disease? What clinical sensitivity, specificity, and predictive values have been demonstrated across diverse patient populations, and what practical implementation challenges remain for translating these biosensors into routine clinical practice?", "history": ["What advancements have been made in using carbon dot dendrimers for biosensing applications?", "How can the unique properties of these self-assembled structures be leveraged to improve the efficiency and selectivity of immunosensors, particularly for detecting specific biomarkers?", "Given the unique properties of these coordination-induced self-assembled carbon dot dendrimers, how could their structure be further optimized to enhance ECL efficiency? Additionally, what strategies might improve the sensitivity and selectivity of immunosensors for detecting other clinically relevant biomarkers beyond bone alkaline phosphatase?", "Given these optimization strategies for enhancing ECL efficiency, what specific electrochemical characterization protocols would you recommend for systematically evaluating the coordination-induced structural modifications? Particularly, how should we design controlled experiments to correlate dendrimer branching density with ECL quantum yield measurements, and what statistical validation methods would ensure reproducibility when assessing immunosensor sensitivity across multiple biomarker panels?"], "ground_truth": ["permed-76272", "permed-80656", "permed-76275", "permed-73218", "permed-60783", "permed-51726", "permed-89260", "permed-73014", "permed-88011", "permed-87330"]}
{"query_id": "topic_478_turn_1", "conversation_id": "topic_478", "turn_id": 1, "query": "What advancements have been made in minimally invasive surgical techniques for lower anterior resection?", "history": [], "ground_truth": ["permed-54678", "permed-59863", "permed-70524", "permed-56792", "permed-56525", "permed-54679", "permed-62899", "permed-73906", "permed-4339", "permed-90453"]}
{"query_id": "topic_478_turn_2", "conversation_id": "topic_478", "turn_id": 2, "query": "How is robotic-assisted surgery impacting the field of minimally invasive procedures like this?", "history": ["What advancements have been made in minimally invasive surgical techniques for lower anterior resection?"], "ground_truth": ["permed-54769", "permed-70465", "permed-54771", "permed-15099", "permed-70464", "permed-54944", "permed-54681", "permed-84146", "permed-4145", "permed-88524"]}
{"query_id": "topic_478_turn_3", "conversation_id": "topic_478", "turn_id": 3, "query": "Given these robotic-assisted advancements in minimally invasive lower anterior resection, how might their adoption in private practice settings affect long-term patient outcomes and quality of life compared to traditional laparoscopic and open approaches? What specific factors in a non-academic environment could influence these results?", "history": ["What advancements have been made in minimally invasive surgical techniques for lower anterior resection?", "How is robotic-assisted surgery impacting the field of minimally invasive procedures like this?"], "ground_truth": ["permed-54678", "permed-70914", "permed-54944", "permed-72194", "permed-83898", "permed-54771", "permed-56644", "permed-82592", "permed-75305", "permed-54681"]}
{"query_id": "topic_478_turn_4", "conversation_id": "topic_478", "turn_id": 4, "query": "Given these comparative outcome studies across surgical settings, what specific statistical methodologies would best control for confounding variables like patient selection bias and surgeon experience when analyzing long-term outcomes? How should researchers design propensity score matching or mixed-effects models to account for variations in operative protocols and postoperative care pathways across private practice institutions while maintaining sufficient statistical power for quality of life measures?", "history": ["What advancements have been made in minimally invasive surgical techniques for lower anterior resection?", "How is robotic-assisted surgery impacting the field of minimally invasive procedures like this?", "Given these robotic-assisted advancements in minimally invasive lower anterior resection, how might their adoption in private practice settings affect long-term patient outcomes and quality of life compared to traditional laparoscopic and open approaches? What specific factors in a non-academic environment could influence these results?"], "ground_truth": ["permed-64338", "permed-85105", "permed-54381", "permed-81403", "permed-52856", "permed-59409", "permed-75305", "permed-81733", "permed-54944", "permed-79199"]}
{"query_id": "topic_478_turn_5", "conversation_id": "topic_478", "turn_id": 5, "query": "Given these sophisticated statistical approaches for comparing surgical outcomes, how do the economic evaluations and cost-effectiveness analyses of robotic-assisted versus laparoscopic lower anterior resection differ when accounting for both direct hospital costs and indirect societal burdens? Specifically, what methodological considerations arise when comparing total healthcare expenditure against quality-adjusted life years gained across different practice settings, and how do these economic trade-offs influence adoption decisions in resource-constrained environments versus well-funded academic centers?", "history": ["What advancements have been made in minimally invasive surgical techniques for lower anterior resection?", "How is robotic-assisted surgery impacting the field of minimally invasive procedures like this?", "Given these robotic-assisted advancements in minimally invasive lower anterior resection, how might their adoption in private practice settings affect long-term patient outcomes and quality of life compared to traditional laparoscopic and open approaches? What specific factors in a non-academic environment could influence these results?", "Given these comparative outcome studies across surgical settings, what specific statistical methodologies would best control for confounding variables like patient selection bias and surgeon experience when analyzing long-term outcomes? How should researchers design propensity score matching or mixed-effects models to account for variations in operative protocols and postoperative care pathways across private practice institutions while maintaining sufficient statistical power for quality of life measures?"], "ground_truth": ["permed-54678", "permed-70914", "permed-70913", "permed-83898", "permed-75305", "permed-83145", "permed-60212", "permed-60025", "permed-56644", "permed-56524"]}
{"query_id": "topic_479_turn_1", "conversation_id": "topic_479", "turn_id": 1, "query": "Overview of geographical disparities in primary biliary cholangitis (PBC) patient outcomes across Western Europe", "history": [], "ground_truth": ["permed-75554", "permed-59704", "permed-88327", "permed-92132", "permed-71366", "permed-91926", "permed-74921", "permed-9671", "permed-66802", "permed-66799"]}
{"query_id": "topic_479_turn_2", "conversation_id": "topic_479", "turn_id": 2, "query": "Exploring the role of environmental factors in these documented geographical disparities in PBC patient outcomes within Western Europe", "history": ["Overview of geographical disparities in primary biliary cholangitis (PBC) patient outcomes across Western Europe"], "ground_truth": ["permed-75554", "permed-88327", "permed-59704", "permed-91926", "permed-72010", "permed-91814", "permed-68512", "permed-73392", "permed-87430", "permed-59274"]}
{"query_id": "topic_479_turn_3", "conversation_id": "topic_479", "turn_id": 3, "query": "Assessing the impact of specific environmental exposures – such as dietary patterns, pollution levels, and lifestyle factors – on regional variations in PBC biochemical progression, transplant-free survival, and decompensation rates across Western Europe", "history": ["Overview of geographical disparities in primary biliary cholangitis (PBC) patient outcomes across Western Europe", "Exploring the role of environmental factors in these documented geographical disparities in PBC patient outcomes within Western Europe"], "ground_truth": ["permed-75554", "permed-66802", "permed-66799", "permed-59704", "permed-88327", "permed-80066", "permed-75555", "permed-67390", "permed-82373", "permed-68563"]}
{"query_id": "topic_479_turn_4", "conversation_id": "topic_479", "turn_id": 4, "query": "When assessing these specific environmental exposures, what statistical methodologies are most appropriate for quantifying their individual and synergistic effects on PBC progression metrics? Specifically, how should we handle potential confounding by regional healthcare access variations, and what validation approaches would ensure the reliability of exposure-response relationships across different Western European populations?", "history": ["Overview of geographical disparities in primary biliary cholangitis (PBC) patient outcomes across Western Europe", "Exploring the role of environmental factors in these documented geographical disparities in PBC patient outcomes within Western Europe", "Assessing the impact of specific environmental exposures – such as dietary patterns, pollution levels, and lifestyle factors – on regional variations in PBC biochemical progression, transplant-free survival, and decompensation rates across Western Europe"], "ground_truth": ["permed-75554", "permed-67390", "permed-78354", "permed-86383", "permed-89716", "permed-90762", "permed-73570", "permed-78414", "permed-59127", "permed-88055"]}
{"query_id": "topic_479_turn_5", "conversation_id": "topic_479", "turn_id": 5, "query": "Given these methodological considerations for quantifying environmental exposure effects, how have clinical trials for PBC therapies accounted for geographical variations when assessing therapeutic efficacy and safety profiles? Specifically, what evidence exists regarding differential treatment responses to first-line agents like ursodeoxycholic acid and obeticholic acid across Western European regions, and how should future trial designs be modified to address potential region-specific side effect patterns or contraindications that might emerge from varying environmental co-exposures?", "history": ["Overview of geographical disparities in primary biliary cholangitis (PBC) patient outcomes across Western Europe", "Exploring the role of environmental factors in these documented geographical disparities in PBC patient outcomes within Western Europe", "Assessing the impact of specific environmental exposures – such as dietary patterns, pollution levels, and lifestyle factors – on regional variations in PBC biochemical progression, transplant-free survival, and decompensation rates across Western Europe", "When assessing these specific environmental exposures, what statistical methodologies are most appropriate for quantifying their individual and synergistic effects on PBC progression metrics? Specifically, how should we handle potential confounding by regional healthcare access variations, and what validation approaches would ensure the reliability of exposure-response relationships across different Western European populations?"], "ground_truth": ["permed-75554", "permed-59704", "permed-10516", "permed-9671", "permed-56457", "permed-70512", "permed-51787", "permed-60438", "permed-9668", "permed-75856"]}
{"query_id": "topic_480_turn_1", "conversation_id": "topic_480", "turn_id": 1, "query": "What impact does Nosema sp. infection have on the western bean cutworm population?", "history": [], "ground_truth": ["permed-78778", "permed-85201", "permed-83717", "permed-85004", "permed-63587", "permed-66864", "permed-63591", "permed-83719", "permed-78779", "permed-64414"]}
{"query_id": "topic_480_turn_2", "conversation_id": "topic_480", "turn_id": 2, "query": "How do environmental conditions in areas like the Great Lakes region affect the severity of this infection?", "history": ["What impact does Nosema sp. infection have on the western bean cutworm population?"], "ground_truth": ["permed-68512", "permed-68153", "permed-67575", "permed-68513", "permed-75615", "permed-61783", "permed-17446", "permed-74164", "permed-88327", "permed-61304"]}
{"query_id": "topic_480_turn_3", "conversation_id": "topic_480", "turn_id": 3, "query": "Given these environmental effects on Nosema sp. infection in the western bean cutworm, how specifically do temperature and humidity influence its prevalence and intensity across different parts of the Great Lakes region? And what could these biotic-abiotic interactions mean for the insect's long-term population dynamics and agricultural impact in the area?", "history": ["What impact does Nosema sp. infection have on the western bean cutworm population?", "How do environmental conditions in areas like the Great Lakes region affect the severity of this infection?"], "ground_truth": ["permed-78778", "permed-78636", "permed-78617", "permed-61294", "permed-79180", "permed-84989", "permed-78779", "permed-33856", "permed-58160", "permed-85201"]}
{"query_id": "topic_480_turn_4", "conversation_id": "topic_480", "turn_id": 4, "query": "Given these biotic-abiotic interactions you've described, what specific sampling protocols and statistical models would be most appropriate for quantifying Nosema sp. prevalence and infection intensity across the Great Lakes region's microclimates? How should temperature and humidity data be integrated with insect population sampling - through regression approaches or more complex mixed-effects modeling? Additionally, what validation methods would ensure accurate spore quantification and account for potential spatial autocorrelation in your field data?", "history": ["What impact does Nosema sp. infection have on the western bean cutworm population?", "How do environmental conditions in areas like the Great Lakes region affect the severity of this infection?", "Given these environmental effects on Nosema sp. infection in the western bean cutworm, how specifically do temperature and humidity influence its prevalence and intensity across different parts of the Great Lakes region? And what could these biotic-abiotic interactions mean for the insect's long-term population dynamics and agricultural impact in the area?"], "ground_truth": ["permed-78778", "permed-78636", "permed-71980", "permed-89397", "permed-71964", "permed-84800", "permed-61294", "permed-86503", "permed-83761", "permed-62243"]}
{"query_id": "topic_480_turn_5", "conversation_id": "topic_480", "turn_id": 5, "query": "Given these detailed field sampling and modeling approaches for quantifying Nosema sp. dynamics, how might this pathogen be leveraged in clinical agricultural applications? Specifically, what evidence exists regarding Nosema sp.'s efficacy as a biological control agent against western bean cutworm in real-world settings, and what are the documented safety profiles and potential non-target effects on beneficial insects or surrounding ecosystems when considering its deployment? Additionally, have any field trials evaluated optimal application methods and timing to maximize crop protection while minimizing ecological risks?", "history": ["What impact does Nosema sp. infection have on the western bean cutworm population?", "How do environmental conditions in areas like the Great Lakes region affect the severity of this infection?", "Given these environmental effects on Nosema sp. infection in the western bean cutworm, how specifically do temperature and humidity influence its prevalence and intensity across different parts of the Great Lakes region? And what could these biotic-abiotic interactions mean for the insect's long-term population dynamics and agricultural impact in the area?", "Given these biotic-abiotic interactions you've described, what specific sampling protocols and statistical models would be most appropriate for quantifying Nosema sp. prevalence and infection intensity across the Great Lakes region's microclimates? How should temperature and humidity data be integrated with insect population sampling - through regression approaches or more complex mixed-effects modeling? Additionally, what validation methods would ensure accurate spore quantification and account for potential spatial autocorrelation in your field data?"], "ground_truth": ["permed-78778", "permed-85004", "permed-68091", "permed-83716", "permed-85201", "permed-83717", "permed-63587", "permed-84985", "permed-66591", "permed-64412"]}
{"query_id": "topic_481_turn_1", "conversation_id": "topic_481", "turn_id": 1, "query": "What is known about the medicinal properties of Aristolochia triangularis Cham. leaves, particularly in relation to diabetes management?", "history": [], "ground_truth": ["permed-81710", "permed-81711", "permed-84629", "permed-86324", "permed-51197", "permed-69101", "permed-86365", "permed-51129", "permed-81712", "permed-78785"]}
{"query_id": "topic_481_turn_2", "conversation_id": "topic_481", "turn_id": 2, "query": "How do the specific compounds found in this plant, such as lignoids and flavonoids, contribute to its potential anti-diabetic effects?", "history": ["What is known about the medicinal properties of Aristolochia triangularis Cham. leaves, particularly in relation to diabetes management?"], "ground_truth": ["permed-73081", "permed-69101", "permed-81712", "permed-81713", "permed-51129", "permed-78786", "permed-86228", "permed-78785", "permed-86365", "permed-51197"]}
{"query_id": "topic_481_turn_3", "conversation_id": "topic_481", "turn_id": 3, "query": "Given the compounds identified in this plant's leaves, how do its specific lignoids, alkaloids, and glycosylated flavonoids interact with key carbohydrate metabolism enzymes, and what molecular mechanisms explain their anti-hyperglycemic effects in diabetic models?", "history": ["What is known about the medicinal properties of Aristolochia triangularis Cham. leaves, particularly in relation to diabetes management?", "How do the specific compounds found in this plant, such as lignoids and flavonoids, contribute to its potential anti-diabetic effects?"], "ground_truth": ["permed-73081", "permed-81713", "permed-69101", "permed-81710", "permed-81712", "permed-51133", "permed-78786", "permed-78785", "permed-58207", "permed-65153"]}
{"query_id": "topic_481_turn_4", "conversation_id": "topic_481", "turn_id": 4, "query": "Given these proposed molecular interactions, what specific in vitro enzyme inhibition assays would best characterize the kinetic parameters of these lignoids and glycosylated flavonoids against α-glucosidase and α-amylase? Additionally, what positive controls and validation strategies would ensure the reliability of these enzymatic measurements, particularly regarding substrate concentrations and incubation conditions in diabetic model systems?", "history": ["What is known about the medicinal properties of Aristolochia triangularis Cham. leaves, particularly in relation to diabetes management?", "How do the specific compounds found in this plant, such as lignoids and flavonoids, contribute to its potential anti-diabetic effects?", "Given the compounds identified in this plant's leaves, how do its specific lignoids, alkaloids, and glycosylated flavonoids interact with key carbohydrate metabolism enzymes, and what molecular mechanisms explain their anti-hyperglycemic effects in diabetic models?"], "ground_truth": ["permed-65153", "permed-66805", "permed-78786", "permed-82512", "permed-66806", "permed-52959", "permed-79816", "permed-89053", "permed-59499", "permed-51133"]}
{"query_id": "topic_481_turn_5", "conversation_id": "topic_481", "turn_id": 5, "query": "Given your detailed assay framework for characterizing individual compound-enzyme interactions, how do the inhibitory kinetics and synergistic effects of Aristolochia triangularis's combined lignoid-glycosylated flavonoid extracts compare against isolated single compounds when tested against both α-glucosidase and α-amylase? Specifically, what comparative advantages in terms of inhibition potency, binding site complementarity, and reduced off-target effects might these complex natural mixtures offer over synthetic monotherapeutic inhibitors like acarbose in physiologically relevant diabetic conditions?", "history": ["What is known about the medicinal properties of Aristolochia triangularis Cham. leaves, particularly in relation to diabetes management?", "How do the specific compounds found in this plant, such as lignoids and flavonoids, contribute to its potential anti-diabetic effects?", "Given the compounds identified in this plant's leaves, how do its specific lignoids, alkaloids, and glycosylated flavonoids interact with key carbohydrate metabolism enzymes, and what molecular mechanisms explain their anti-hyperglycemic effects in diabetic models?", "Given these proposed molecular interactions, what specific in vitro enzyme inhibition assays would best characterize the kinetic parameters of these lignoids and glycosylated flavonoids against α-glucosidase and α-amylase? Additionally, what positive controls and validation strategies would ensure the reliability of these enzymatic measurements, particularly regarding substrate concentrations and incubation conditions in diabetic model systems?"], "ground_truth": ["permed-81710", "permed-65153", "permed-81711", "permed-66805", "permed-78786", "permed-69101", "permed-74177", "permed-52959", "permed-51129", "permed-59499"]}
{"query_id": "topic_482_turn_1", "conversation_id": "topic_482", "turn_id": 1, "query": "Key challenges healthcare systems face in maintaining workforce well-being and preventing burnout", "history": [], "ground_truth": ["permed-91926", "permed-66148", "permed-91347", "permed-66153", "permed-90720", "permed-75160", "permed-65873", "permed-91345", "permed-55107", "permed-65872"]}
{"query_id": "topic_482_turn_2", "conversation_id": "topic_482", "turn_id": 2, "query": "Strategies for using frontline healthcare worker feedback to address these well-being and burnout challenges", "history": ["Key challenges healthcare systems face in maintaining workforce well-being and preventing burnout"], "ground_truth": ["permed-65873", "permed-91347", "permed-90720", "permed-75160", "permed-69975", "permed-66153", "permed-91926", "permed-60989", "permed-63538", "permed-91345"]}
{"query_id": "topic_482_turn_3", "conversation_id": "topic_482", "turn_id": 3, "query": "Translating empirical data from frontline healthcare worker feedback studies (e.g., STEPPS) into actionable policies for mitigating burnout and improving long-term workforce well-being, considering ethical and practical implementation factors.", "history": ["Key challenges healthcare systems face in maintaining workforce well-being and preventing burnout", "Strategies for using frontline healthcare worker feedback to address these well-being and burnout challenges"], "ground_truth": ["permed-53035", "permed-65873", "permed-91347", "permed-91345", "permed-69924", "permed-82433", "permed-65869", "permed-65752", "permed-65872", "permed-69975"]}
{"query_id": "topic_482_turn_4", "conversation_id": "topic_482", "turn_id": 4, "query": "When implementing these feedback-to-policy translation frameworks, what specific statistical approaches are most effective for analyzing longitudinal burnout metrics while accounting for confounding variables like shift rotations and departmental variations? How should researchers validate the policy impact assessments—are there particular quasi-experimental designs or interrupted time series analyses that have proven robust for measuring real-world intervention effects in complex healthcare settings?", "history": ["Key challenges healthcare systems face in maintaining workforce well-being and preventing burnout", "Strategies for using frontline healthcare worker feedback to address these well-being and burnout challenges", "Translating empirical data from frontline healthcare worker feedback studies (e.g., STEPPS) into actionable policies for mitigating burnout and improving long-term workforce well-being, considering ethical and practical implementation factors."], "ground_truth": ["permed-53878", "permed-69924", "permed-65873", "permed-69825", "permed-34401", "permed-60992", "permed-65576", "permed-82433", "permed-65752", "permed-87153"]}
{"query_id": "topic_482_turn_5", "conversation_id": "topic_482", "turn_id": 5, "query": "Given these methodological considerations for analyzing longitudinal burnout data and validating policy impacts, what clinical outcomes have been demonstrated when such feedback-informed interventions are deployed? Specifically, how do improvements in workforce well-being metrics translate to measurable patient safety indicators—such as reduced medication errors or hospital-acquired infections—and are there documented correlations with enhanced therapeutic efficacy or patient satisfaction scores in real-world clinical settings? What evidence exists regarding the durability of these clinical benefits across different healthcare environments?", "history": ["Key challenges healthcare systems face in maintaining workforce well-being and preventing burnout", "Strategies for using frontline healthcare worker feedback to address these well-being and burnout challenges", "Translating empirical data from frontline healthcare worker feedback studies (e.g., STEPPS) into actionable policies for mitigating burnout and improving long-term workforce well-being, considering ethical and practical implementation factors.", "When implementing these feedback-to-policy translation frameworks, what specific statistical approaches are most effective for analyzing longitudinal burnout metrics while accounting for confounding variables like shift rotations and departmental variations? How should researchers validate the policy impact assessments—are there particular quasi-experimental designs or interrupted time series analyses that have proven robust for measuring real-world intervention effects in complex healthcare settings?"], "ground_truth": ["permed-65873", "permed-50964", "permed-69924", "permed-69059", "permed-65755", "permed-82433", "permed-69975", "permed-39889", "permed-69825", "permed-46409"]}
{"query_id": "topic_483_turn_1", "conversation_id": "topic_483", "turn_id": 1, "query": "What role does integrin β1 play in the development of cardiovascular diseases under hyperlipidemic conditions?", "history": [], "ground_truth": ["permed-82117", "permed-74732", "permed-69112", "permed-70414", "permed-57015", "permed-83388", "permed-78996", "permed-69248", "permed-70499", "permed-80033"]}
{"query_id": "topic_483_turn_2", "conversation_id": "topic_483", "turn_id": 2, "query": "How might modifications to it, such as S-nitrosylation, affect its function and interaction with other signaling pathways in this context?", "history": ["What role does integrin β1 play in the development of cardiovascular diseases under hyperlipidemic conditions?"], "ground_truth": ["permed-63151", "permed-71707", "permed-72041", "permed-75808", "permed-72042", "permed-72039", "permed-85479", "permed-71584", "permed-82117", "permed-82373"]}
{"query_id": "topic_483_turn_3", "conversation_id": "topic_483", "turn_id": 3, "query": "Given that S-nitrosylation can modify integrin β1's function in hyperlipidemic conditions, how might this stabilization affect the activation of other inflammatory signaling pathways, and what therapeutic targets could be leveraged to modulate these interactions for preventing cardiovascular disease progression?", "history": ["What role does integrin β1 play in the development of cardiovascular diseases under hyperlipidemic conditions?", "How might modifications to it, such as S-nitrosylation, affect its function and interaction with other signaling pathways in this context?"], "ground_truth": ["permed-82117", "permed-79152", "permed-52509", "permed-86244", "permed-50999", "permed-71432", "permed-59061", "permed-74732", "permed-78998", "permed-22845"]}
{"query_id": "topic_483_turn_4", "conversation_id": "topic_483", "turn_id": 4, "query": "Given this potential stabilization effect through S-nitrosylation, what specific experimental techniques would you employ to quantitatively assess the downstream inflammatory pathway activation? I'm particularly interested in the methodological considerations for measuring NF-κB and MAPK signaling dynamics - would you recommend Western blot quantification with phospho-specific antibodies, FRET-based biosensors for real-time monitoring in live cells, or perhaps RNA sequencing to capture comprehensive transcriptional changes? Also, what statistical approaches would best validate the causal relationship between integrin β1 modification and these pathway activations?", "history": ["What role does integrin β1 play in the development of cardiovascular diseases under hyperlipidemic conditions?", "How might modifications to it, such as S-nitrosylation, affect its function and interaction with other signaling pathways in this context?", "Given that S-nitrosylation can modify integrin β1's function in hyperlipidemic conditions, how might this stabilization affect the activation of other inflammatory signaling pathways, and what therapeutic targets could be leveraged to modulate these interactions for preventing cardiovascular disease progression?"], "ground_truth": ["permed-82117", "permed-76558", "permed-74732", "permed-90263", "permed-71458", "permed-71432", "permed-89985", "permed-10982", "permed-29823", "permed-53486"]}
{"query_id": "topic_483_turn_5", "conversation_id": "topic_483", "turn_id": 5, "query": "Given these methodological approaches for quantifying inflammatory pathway activation, how might therapeutically targeting S-nitrosylation of integrin β1 translate to clinical applications for cardiovascular disease patients? Specifically, what clinical trial evidence exists regarding pharmacological modulation of protein S-nitrosylation in hyperlipidemic patients, and what have been the observed effects on cardiovascular outcomes, inflammatory biomarkers, and safety profiles? Additionally, what practical challenges might arise in developing clinical-grade compounds that selectively modulate this specific post-translational modification without disrupting other redox signaling pathways?", "history": ["What role does integrin β1 play in the development of cardiovascular diseases under hyperlipidemic conditions?", "How might modifications to it, such as S-nitrosylation, affect its function and interaction with other signaling pathways in this context?", "Given that S-nitrosylation can modify integrin β1's function in hyperlipidemic conditions, how might this stabilization affect the activation of other inflammatory signaling pathways, and what therapeutic targets could be leveraged to modulate these interactions for preventing cardiovascular disease progression?", "Given this potential stabilization effect through S-nitrosylation, what specific experimental techniques would you employ to quantitatively assess the downstream inflammatory pathway activation? I'm particularly interested in the methodological considerations for measuring NF-κB and MAPK signaling dynamics - would you recommend Western blot quantification with phospho-specific antibodies, FRET-based biosensors for real-time monitoring in live cells, or perhaps RNA sequencing to capture comprehensive transcriptional changes? Also, what statistical approaches would best validate the causal relationship between integrin β1 modification and these pathway activations?"], "ground_truth": ["permed-82117", "permed-81297", "permed-22845", "permed-64689", "permed-59061", "permed-64932", "permed-60087", "permed-86272", "permed-78998", "permed-23605"]}
{"query_id": "topic_484_turn_1", "conversation_id": "topic_484", "turn_id": 1, "query": "What role does diet play in preventing sarcopenia among elderly populations?", "history": [], "ground_truth": ["permed-81074", "permed-77182", "permed-73390", "permed-65681", "permed-52360", "permed-68545", "permed-83237", "permed-84470", "permed-68841", "permed-61340"]}
{"query_id": "topic_484_turn_2", "conversation_id": "topic_484", "turn_id": 2, "query": "Are there specific dietary patterns, such as high or low protein intake, that have been found to significantly impact this condition?", "history": ["What role does diet play in preventing sarcopenia among elderly populations?"], "ground_truth": ["permed-65029", "permed-91759", "permed-81477", "permed-72393", "permed-66148", "permed-60012", "permed-73618", "permed-72390", "permed-82795", "permed-65185"]}
{"query_id": "topic_484_turn_3", "conversation_id": "topic_484", "turn_id": 3, "query": "Considering the connection between dietary diversity and sarcopenia, what are the specific mechanisms or key nutrients in both high- and low-protein foods that contribute to maintaining muscle health in older adults? And how could this understanding help tailor personalized nutrition strategies to prevent this condition?", "history": ["What role does diet play in preventing sarcopenia among elderly populations?", "Are there specific dietary patterns, such as high or low protein intake, that have been found to significantly impact this condition?"], "ground_truth": ["permed-81074", "permed-77182", "permed-73390", "permed-33143", "permed-65323", "permed-33278", "permed-54236", "permed-85341", "permed-52360", "permed-88392"]}
{"query_id": "topic_484_turn_4", "conversation_id": "topic_484", "turn_id": 4, "query": "Given these proposed mechanisms and nutrients, what specific experimental designs would best validate their individual contributions to muscle health? For instance, would you recommend randomized controlled trials with targeted nutrient supplementation, or perhaps multi-omics approaches to track molecular pathways? Additionally, what statistical models would effectively account for confounding factors like physical activity levels and comorbidities when analyzing the efficacy of personalized nutrition strategies in elderly populations?", "history": ["What role does diet play in preventing sarcopenia among elderly populations?", "Are there specific dietary patterns, such as high or low protein intake, that have been found to significantly impact this condition?", "Considering the connection between dietary diversity and sarcopenia, what are the specific mechanisms or key nutrients in both high- and low-protein foods that contribute to maintaining muscle health in older adults? And how could this understanding help tailor personalized nutrition strategies to prevent this condition?"], "ground_truth": ["permed-33143", "permed-33144", "permed-33489", "permed-9985", "permed-33278", "permed-64891", "permed-33258", "permed-33277", "permed-23368", "permed-9987"]}
{"query_id": "topic_484_turn_5", "conversation_id": "topic_484", "turn_id": 5, "query": "Given these proposed experimental validation approaches, what clinical translation challenges emerge when implementing personalized nutrition strategies for sarcopenia prevention in elderly patients? Specifically, how do real-world factors like medication interactions, polypharmacy, and comorbidities affect the safety and efficacy of targeted nutrient interventions? What evidence exists regarding adverse effects or contraindications for high-protein or specific micronutrient supplementation in frail elderly populations, and how should clinical protocols be adapted to monitor these risks while maintaining therapeutic benefits for muscle health?", "history": ["What role does diet play in preventing sarcopenia among elderly populations?", "Are there specific dietary patterns, such as high or low protein intake, that have been found to significantly impact this condition?", "Considering the connection between dietary diversity and sarcopenia, what are the specific mechanisms or key nutrients in both high- and low-protein foods that contribute to maintaining muscle health in older adults? And how could this understanding help tailor personalized nutrition strategies to prevent this condition?", "Given these proposed mechanisms and nutrients, what specific experimental designs would best validate their individual contributions to muscle health? For instance, would you recommend randomized controlled trials with targeted nutrient supplementation, or perhaps multi-omics approaches to track molecular pathways? Additionally, what statistical models would effectively account for confounding factors like physical activity levels and comorbidities when analyzing the efficacy of personalized nutrition strategies in elderly populations?"], "ground_truth": ["permed-73390", "permed-77182", "permed-85341", "permed-74629", "permed-81074", "permed-33258", "permed-89256", "permed-5321", "permed-58376", "permed-68546"]}
{"query_id": "topic_485_turn_1", "conversation_id": "topic_485", "turn_id": 1, "query": "What role can mobile health interventions play in improving adherence to antiretroviral therapy among people living with HIV?", "history": [], "ground_truth": ["permed-75283", "permed-75281", "permed-80061", "permed-80060", "permed-75280", "permed-72793", "permed-72798", "permed-75288", "permed-63477", "permed-59686"]}
{"query_id": "topic_485_turn_2", "conversation_id": "topic_485", "turn_id": 2, "query": "How effective are apps like WiseApp in this area, particularly in terms of initial outcomes?", "history": ["What role can mobile health interventions play in improving adherence to antiretroviral therapy among people living with HIV?"], "ground_truth": ["permed-75283", "permed-66153", "permed-66148", "permed-78712", "permed-78711", "permed-78716", "permed-78689", "permed-88433", "permed-81455", "permed-50971"]}
{"query_id": "topic_485_turn_3", "conversation_id": "topic_485", "turn_id": 3, "query": "Given that apps like WiseApp show initial promise in improving ART adherence for PLWH, how can we sustain these positive effects over time? What additional features or strategies could be built into such mHealth interventions to boost long-term engagement and treatment outcomes?", "history": ["What role can mobile health interventions play in improving adherence to antiretroviral therapy among people living with HIV?", "How effective are apps like WiseApp in this area, particularly in terms of initial outcomes?"], "ground_truth": ["permed-75283", "permed-74469", "permed-61168", "permed-54924", "permed-74468", "permed-75281", "permed-75287", "permed-78716", "permed-61162", "permed-65673"]}
{"query_id": "topic_485_turn_4", "conversation_id": "topic_485", "turn_id": 4, "query": "Given the proposed feature enhancements for long-term engagement, what specific experimental designs would best test their sustained efficacy? Would a stepped-wedge cluster randomized trial comparing basic versus enhanced feature sets over 12-18 months provide sufficient power to detect meaningful differences in adherence trajectories? Additionally, what statistical approaches - such as mixed-effects models with time-interaction terms or survival analysis for engagement drop-off - would most appropriately capture longitudinal adherence patterns while accounting for within-subject correlations?", "history": ["What role can mobile health interventions play in improving adherence to antiretroviral therapy among people living with HIV?", "How effective are apps like WiseApp in this area, particularly in terms of initial outcomes?", "Given that apps like WiseApp show initial promise in improving ART adherence for PLWH, how can we sustain these positive effects over time? What additional features or strategies could be built into such mHealth interventions to boost long-term engagement and treatment outcomes?"], "ground_truth": ["permed-65673", "permed-65668", "permed-53346", "permed-86722", "permed-73828", "permed-85586", "permed-75381", "permed-74468", "permed-80189", "permed-82776"]}
{"query_id": "topic_485_turn_5", "conversation_id": "topic_485", "turn_id": 5, "query": "Given the proposed longitudinal study designs and analytical approaches for evaluating sustained mHealth efficacy, how would the comparative effectiveness of these enhanced mobile interventions differ when implemented across diverse healthcare systems? Specifically, what trade-offs emerge when comparing resource-intensive implementations in high-income settings with simplified adaptations for low-resource environments, and how might cost-effectiveness analyses inform decisions about which feature combinations deliver optimal adherence outcomes relative to local infrastructure constraints and patient population characteristics?", "history": ["What role can mobile health interventions play in improving adherence to antiretroviral therapy among people living with HIV?", "How effective are apps like WiseApp in this area, particularly in terms of initial outcomes?", "Given that apps like WiseApp show initial promise in improving ART adherence for PLWH, how can we sustain these positive effects over time? What additional features or strategies could be built into such mHealth interventions to boost long-term engagement and treatment outcomes?", "Given the proposed feature enhancements for long-term engagement, what specific experimental designs would best test their sustained efficacy? Would a stepped-wedge cluster randomized trial comparing basic versus enhanced feature sets over 12-18 months provide sufficient power to detect meaningful differences in adherence trajectories? Additionally, what statistical approaches - such as mixed-effects models with time-interaction terms or survival analysis for engagement drop-off - would most appropriately capture longitudinal adherence patterns while accounting for within-subject correlations?"], "ground_truth": ["permed-65428", "permed-70305", "permed-61162", "permed-74318", "permed-75283", "permed-89786", "permed-65946", "permed-54924", "permed-53401", "permed-65831"]}
{"query_id": "topic_486_turn_1", "conversation_id": "topic_486", "turn_id": 1, "query": "What is known about the presence of perfluoroalkyl substances (PFASs) in infant formulas and baby foods?", "history": [], "ground_truth": ["permed-82234", "permed-77148", "permed-77151", "permed-51962", "permed-82235", "permed-77150", "permed-75628", "permed-67398", "permed-76119", "permed-74965"]}
{"query_id": "topic_486_turn_2", "conversation_id": "topic_486", "turn_id": 2, "query": "How might variations in the composition of these products affect the levels and types of PFASs detected in them?", "history": ["What is known about the presence of perfluoroalkyl substances (PFASs) in infant formulas and baby foods?"], "ground_truth": ["permed-77148", "permed-77151", "permed-82234", "permed-82235", "permed-74965", "permed-77153", "permed-77150", "permed-59127", "permed-77152", "permed-76119"]}
{"query_id": "topic_486_turn_3", "conversation_id": "topic_486", "turn_id": 3, "query": "Given these variations in composition, how do specific ingredients like different proteins or additives affect the PFAS levels and types found in these products? And what could this mean for infants' long-term health and immune system development?", "history": ["What is known about the presence of perfluoroalkyl substances (PFASs) in infant formulas and baby foods?", "How might variations in the composition of these products affect the levels and types of PFASs detected in them?"], "ground_truth": ["permed-82234", "permed-51962", "permed-78358", "permed-82235", "permed-77150", "permed-77148", "permed-75628", "permed-78242", "permed-82262", "permed-82238"]}
{"query_id": "topic_486_turn_4", "conversation_id": "topic_486", "turn_id": 4, "query": "Given these ingredient-specific PFAS profiles identified, what analytical techniques were employed to quantify PFAS concentrations across different protein matrices in infant formula? Specifically, how did the sample preparation protocols differ when handling dairy versus plant-based protein isolates, and what validation parameters (e.g., recovery rates, LOQs) were established for these complex matrices? Were any chromatographic separation challenges encountered when analyzing diverse PFAS congeners in such variable nutritional compositions?", "history": ["What is known about the presence of perfluoroalkyl substances (PFASs) in infant formulas and baby foods?", "How might variations in the composition of these products affect the levels and types of PFASs detected in them?", "Given these variations in composition, how do specific ingredients like different proteins or additives affect the PFAS levels and types found in these products? And what could this mean for infants' long-term health and immune system development?"], "ground_truth": ["permed-82234", "permed-77151", "permed-57782", "permed-77148", "permed-57672", "permed-77152", "permed-57668", "permed-77153", "permed-45126", "permed-77341"]}
{"query_id": "topic_486_turn_5", "conversation_id": "topic_486", "turn_id": 5, "query": "Given the analytical complexities revealed in quantifying PFAS across different protein matrices, how do the reported concentrations and congener profiles in dairy-based versus plant-based infant formulas systematically compare across available studies? What are the relative strengths and limitations of liquid chromatography-mass spectrometry versus emerging techniques like LC-IMS-MS for differentiating structurally similar PFAS compounds in these complex nutritional matrices, particularly regarding isomer resolution and matrix interference mitigation? Considering the variable validation parameters established, which analytical approaches demonstrate superior reliability for comparative risk assessment across formula types?", "history": ["What is known about the presence of perfluoroalkyl substances (PFASs) in infant formulas and baby foods?", "How might variations in the composition of these products affect the levels and types of PFASs detected in them?", "Given these variations in composition, how do specific ingredients like different proteins or additives affect the PFAS levels and types found in these products? And what could this mean for infants' long-term health and immune system development?", "Given these ingredient-specific PFAS profiles identified, what analytical techniques were employed to quantify PFAS concentrations across different protein matrices in infant formula? Specifically, how did the sample preparation protocols differ when handling dairy versus plant-based protein isolates, and what validation parameters (e.g., recovery rates, LOQs) were established for these complex matrices? Were any chromatographic separation challenges encountered when analyzing diverse PFAS congeners in such variable nutritional compositions?"], "ground_truth": ["permed-82234", "permed-77151", "permed-57782", "permed-77148", "permed-45110", "permed-83610", "permed-77153", "permed-57672", "permed-45126", "permed-76141"]}
{"query_id": "topic_487_turn_1", "conversation_id": "topic_487", "turn_id": 1, "query": "What is known about the genetic factors contributing to clear cell odontogenic carcinoma?", "history": [], "ground_truth": ["permed-80778", "permed-85875", "permed-40238", "permed-56252", "permed-91890", "permed-40394", "permed-53503", "permed-91831", "permed-68563", "permed-59570"]}
{"query_id": "topic_487_turn_2", "conversation_id": "topic_487", "turn_id": 2, "query": "How does the presence of specific fusion genes, like EWSR1-ATF1, impact our understanding of this area of research?", "history": ["What is known about the genetic factors contributing to clear cell odontogenic carcinoma?"], "ground_truth": ["permed-47897", "permed-45915", "permed-45578", "permed-50926", "permed-53717", "permed-64137", "permed-48030", "permed-58530", "permed-64140", "permed-80780"]}
{"query_id": "topic_487_turn_3", "conversation_id": "topic_487", "turn_id": 3, "query": "Given what we know about the EWSR1-ATF1 fusion gene's role in clear cell odontogenic carcinoma, could you explain the molecular mechanisms through which it contributes to maxillary tumor development? Specifically, how might these mechanisms affect the tumor's invasiveness and treatment response compared to other odontogenic carcinomas lacking this fusion?", "history": ["What is known about the genetic factors contributing to clear cell odontogenic carcinoma?", "How does the presence of specific fusion genes, like EWSR1-ATF1, impact our understanding of this area of research?"], "ground_truth": ["permed-80778", "permed-47897", "permed-45578", "permed-31748", "permed-50937", "permed-50926", "permed-47999", "permed-45915", "permed-76568", "permed-35060"]}
{"query_id": "topic_487_turn_4", "conversation_id": "topic_487", "turn_id": 4, "query": "Given this mechanistic understanding of EWSR1-ATF1 in tumor invasiveness, what specific experimental approaches are most validated for characterizing the downstream transcriptional targets of this fusion gene in primary odontogenic tumor cells? I'm particularly interested in how researchers establish appropriate controls—such as using fusion-negative carcinoma lines—and what statistical methods are employed to distinguish direct transcriptional regulation from secondary effects in chromatin immunoprecipitation sequencing workflows.", "history": ["What is known about the genetic factors contributing to clear cell odontogenic carcinoma?", "How does the presence of specific fusion genes, like EWSR1-ATF1, impact our understanding of this area of research?", "Given what we know about the EWSR1-ATF1 fusion gene's role in clear cell odontogenic carcinoma, could you explain the molecular mechanisms through which it contributes to maxillary tumor development? Specifically, how might these mechanisms affect the tumor's invasiveness and treatment response compared to other odontogenic carcinomas lacking this fusion?"], "ground_truth": ["permed-47897", "permed-50926", "permed-31748", "permed-80778", "permed-48030", "permed-64137", "permed-45578", "permed-50756", "permed-45915", "permed-64140"]}
{"query_id": "topic_487_turn_5", "conversation_id": "topic_487", "turn_id": 5, "query": "Given these established methodologies for identifying EWSR1-ATF1 transcriptional targets, how have these molecular findings translated into clinical management differences for patients with fusion-positive clear cell odontogenic carcinoma? Specifically, what clinical evidence exists regarding differential therapeutic efficacy—such as response to radiation therapy or specific chemotherapy regimens—compared to fusion-negative cases? Furthermore, are there documented differences in long-term survival, local recurrence rates, or patterns of metastasis in clinical cohorts that inform prognostic stratification or treatment intensification decisions based on fusion status?", "history": ["What is known about the genetic factors contributing to clear cell odontogenic carcinoma?", "How does the presence of specific fusion genes, like EWSR1-ATF1, impact our understanding of this area of research?", "Given what we know about the EWSR1-ATF1 fusion gene's role in clear cell odontogenic carcinoma, could you explain the molecular mechanisms through which it contributes to maxillary tumor development? Specifically, how might these mechanisms affect the tumor's invasiveness and treatment response compared to other odontogenic carcinomas lacking this fusion?", "Given this mechanistic understanding of EWSR1-ATF1 in tumor invasiveness, what specific experimental approaches are most validated for characterizing the downstream transcriptional targets of this fusion gene in primary odontogenic tumor cells? I'm particularly interested in how researchers establish appropriate controls—such as using fusion-negative carcinoma lines—and what statistical methods are employed to distinguish direct transcriptional regulation from secondary effects in chromatin immunoprecipitation sequencing workflows."], "ground_truth": ["permed-80778", "permed-47897", "permed-31748", "permed-48031", "permed-47999", "permed-48030", "permed-50932", "permed-31835", "permed-50756", "permed-45578"]}
{"query_id": "topic_488_turn_1", "conversation_id": "topic_488", "turn_id": 1, "query": "Current surgical treatment options for osteoporotic vertebral compression fractures (OVCF)", "history": [], "ground_truth": ["permed-53912", "permed-19279", "permed-20208", "permed-19097", "permed-77935", "permed-54886", "permed-19095", "permed-19093", "permed-19094", "permed-77691"]}
{"query_id": "topic_488_turn_2", "conversation_id": "topic_488", "turn_id": 2, "query": "Balloon kyphoplasty for OVCF: comparative effectiveness on pain and function versus other such surgical treatments.", "history": ["Current surgical treatment options for osteoporotic vertebral compression fractures (OVCF)"], "ground_truth": ["permed-77690", "permed-54886", "permed-77691", "permed-37164", "permed-77693", "permed-72820", "permed-53912", "permed-20904", "permed-77935", "permed-19097"]}
{"query_id": "topic_488_turn_3", "conversation_id": "topic_488", "turn_id": 3, "query": "Long-term spinal biomechanical impact of balloon kyphoplasty in OVCF (disc health, adjacent segment disease) and patient quality of life, especially with minimal sagittal alignment alteration.", "history": ["Current surgical treatment options for osteoporotic vertebral compression fractures (OVCF)", "Balloon kyphoplasty for OVCF: comparative effectiveness on pain and function versus other such surgical treatments."], "ground_truth": ["permed-77690", "permed-77691", "permed-77693", "permed-19097", "permed-54886", "permed-36854", "permed-53912", "permed-81539", "permed-54528", "permed-77577"]}
{"query_id": "topic_488_turn_4", "conversation_id": "topic_488", "turn_id": 4, "query": "When examining these long-term biomechanical outcomes, what specific imaging protocols and finite element modeling parameters were used to quantify disc degeneration and adjacent segment stress? How were patient-specific spinal loads validated against in vivo measurements, and what statistical approaches accounted for confounding factors like baseline bone density and activity levels in the quality of life correlations?", "history": ["Current surgical treatment options for osteoporotic vertebral compression fractures (OVCF)", "Balloon kyphoplasty for OVCF: comparative effectiveness on pain and function versus other such surgical treatments.", "Long-term spinal biomechanical impact of balloon kyphoplasty in OVCF (disc health, adjacent segment disease) and patient quality of life, especially with minimal sagittal alignment alteration."], "ground_truth": ["permed-61751", "permed-64437", "permed-77256", "permed-70307", "permed-64430", "permed-64432", "permed-70306", "permed-34480", "permed-91223", "permed-20161"]}
{"query_id": "topic_488_turn_5", "conversation_id": "topic_488", "turn_id": 5, "query": "Given the detailed methodological approaches for assessing long-term biomechanical outcomes discussed previously, how do the comparative rates of adjacent vertebral fracture development differ between balloon kyphoplasty and vertebroplasty when accounting for cement viscosity and volume parameters? Specifically, what trade-offs exist between these procedures regarding fracture risk reduction at the treated level versus increased stress on adjacent segments, and how do these biomechanical differences translate to comparative clinical outcomes across different patient bone density profiles?", "history": ["Current surgical treatment options for osteoporotic vertebral compression fractures (OVCF)", "Balloon kyphoplasty for OVCF: comparative effectiveness on pain and function versus other such surgical treatments.", "Long-term spinal biomechanical impact of balloon kyphoplasty in OVCF (disc health, adjacent segment disease) and patient quality of life, especially with minimal sagittal alignment alteration.", "When examining these long-term biomechanical outcomes, what specific imaging protocols and finite element modeling parameters were used to quantify disc degeneration and adjacent segment stress? How were patient-specific spinal loads validated against in vivo measurements, and what statistical approaches accounted for confounding factors like baseline bone density and activity levels in the quality of life correlations?"], "ground_truth": ["permed-54886", "permed-77693", "permed-77577", "permed-37164", "permed-19258", "permed-77690", "permed-37174", "permed-36995", "permed-37009", "permed-72820"]}
{"query_id": "topic_489_turn_1", "conversation_id": "topic_489", "turn_id": 1, "query": "Latest advancements in imaging techniques for pulmonary embolism diagnosis", "history": [], "ground_truth": ["permed-77613", "permed-71333", "permed-56265", "permed-60574", "permed-60069", "permed-91501", "permed-60073", "permed-61544", "permed-57602", "permed-51947"]}
{"query_id": "topic_489_turn_2", "conversation_id": "topic_489", "turn_id": 2, "query": "Role of artificial intelligence and deep learning in improving diagnostic accuracy of these pulmonary embolism imaging advancements", "history": ["Latest advancements in imaging techniques for pulmonary embolism diagnosis"], "ground_truth": ["permed-77613", "permed-71333", "permed-91501", "permed-61544", "permed-56265", "permed-60574", "permed-60069", "permed-87557", "permed-55418", "permed-77721"]}
{"query_id": "topic_489_turn_3", "conversation_id": "topic_489", "turn_id": 3, "query": "Applying deep learning to Q-SPECT/CT for enhanced differential diagnosis of pulmonary embolism versus COPD/ILD in patients with complex comorbidities and its implications for personalized treatment plans", "history": ["Latest advancements in imaging techniques for pulmonary embolism diagnosis", "Role of artificial intelligence and deep learning in improving diagnostic accuracy of these pulmonary embolism imaging advancements"], "ground_truth": ["permed-61544", "permed-60561", "permed-60566", "permed-58626", "permed-21133", "permed-77721", "permed-60574", "permed-60069", "permed-71333", "permed-77613"]}
{"query_id": "topic_489_turn_4", "conversation_id": "topic_489", "turn_id": 4, "query": "Regarding this Q-SPECT/CT deep learning approach, could you elaborate on the specific preprocessing pipeline used for multi-modal image registration and normalization? I'm particularly interested in how the methodology handles intensity variations between SPECT and CT modalities, what quality control measures were implemented during dataset curation, and which validation strategy - such as k-fold cross-validation or temporal hold-out - was employed to assess model generalizability across diverse patient comorbidities.", "history": ["Latest advancements in imaging techniques for pulmonary embolism diagnosis", "Role of artificial intelligence and deep learning in improving diagnostic accuracy of these pulmonary embolism imaging advancements", "Applying deep learning to Q-SPECT/CT for enhanced differential diagnosis of pulmonary embolism versus COPD/ILD in patients with complex comorbidities and its implications for personalized treatment plans"], "ground_truth": ["permed-77217", "permed-78055", "permed-61544", "permed-42127", "permed-28624", "permed-61811", "permed-63378", "permed-61812", "permed-28720", "permed-60556"]}
{"query_id": "topic_489_turn_5", "conversation_id": "topic_489", "turn_id": 5, "query": "Given your detailed explanation of the preprocessing and validation methods for Q-SPECT/CT deep learning, how does this approach's diagnostic performance for pulmonary embolism compare quantitatively against traditional diagnostic pathways like CT pulmonary angiography or ventilation/perfusion scanning? Specifically, I'm interested in comparative metrics such as sensitivity, specificity, and area under the curve across different patient subgroups, particularly those with pre-existing cardiopulmonary conditions where differential diagnosis remains challenging. What are the key trade-offs in clinical implementation between these modalities?", "history": ["Latest advancements in imaging techniques for pulmonary embolism diagnosis", "Role of artificial intelligence and deep learning in improving diagnostic accuracy of these pulmonary embolism imaging advancements", "Applying deep learning to Q-SPECT/CT for enhanced differential diagnosis of pulmonary embolism versus COPD/ILD in patients with complex comorbidities and its implications for personalized treatment plans", "Regarding this Q-SPECT/CT deep learning approach, could you elaborate on the specific preprocessing pipeline used for multi-modal image registration and normalization? I'm particularly interested in how the methodology handles intensity variations between SPECT and CT modalities, what quality control measures were implemented during dataset curation, and which validation strategy - such as k-fold cross-validation or temporal hold-out - was employed to assess model generalizability across diverse patient comorbidities."], "ground_truth": ["permed-61544", "permed-77613", "permed-28624", "permed-91501", "permed-60566", "permed-78055", "permed-84636", "permed-59997", "permed-60071", "permed-60069"]}
{"query_id": "topic_490_turn_1", "conversation_id": "topic_490", "turn_id": 1, "query": "What is known about the role of Eif6 in human physiology and disease?", "history": [], "ground_truth": ["permed-57020", "permed-82118", "permed-84302", "permed-10242", "permed-72010", "permed-30444", "permed-30200", "permed-62114", "permed-13123", "permed-67693"]}
{"query_id": "topic_490_turn_2", "conversation_id": "topic_490", "turn_id": 2, "query": "How does its involvement in fatty acid synthesis impact cardiovascular health, particularly in conditions like atherosclerosis?", "history": ["What is known about the role of Eif6 in human physiology and disease?"], "ground_truth": ["permed-64985", "permed-58973", "permed-57020", "permed-64981", "permed-65189", "permed-65531", "permed-86164", "permed-82370", "permed-86162", "permed-80033"]}
{"query_id": "topic_490_turn_3", "conversation_id": "topic_490", "turn_id": 3, "query": "Given Eif6's role in fatty acid synthesis and its connection to atherosclerosis, how might altering its levels affect the inflammatory response and immune cell function within plaques? Could targeting this pathway offer a dual therapeutic approach to simultaneously regulate lipid metabolism and inflammation in cardiovascular diseases?", "history": ["What is known about the role of Eif6 in human physiology and disease?", "How does its involvement in fatty acid synthesis impact cardiovascular health, particularly in conditions like atherosclerosis?"], "ground_truth": ["permed-57020", "permed-92606", "permed-64985", "permed-57015", "permed-58849", "permed-64984", "permed-65134", "permed-57013", "permed-67693", "permed-65533"]}
{"query_id": "topic_490_turn_4", "conversation_id": "topic_490", "turn_id": 4, "query": "To experimentally validate this dual therapeutic approach, what specific in vitro and in vivo models would be most appropriate for quantifying how Eif6 modulation affects both lipid accumulation and inflammatory markers simultaneously? I'm particularly interested in the technical implementation—would you recommend using macrophage-specific Eif6 knockout models combined with flow cytometry analysis of plaque immune populations, and what statistical approaches would best capture the correlation between metabolic changes and inflammation parameters in these experimental setups?", "history": ["What is known about the role of Eif6 in human physiology and disease?", "How does its involvement in fatty acid synthesis impact cardiovascular health, particularly in conditions like atherosclerosis?", "Given Eif6's role in fatty acid synthesis and its connection to atherosclerosis, how might altering its levels affect the inflammatory response and immune cell function within plaques? Could targeting this pathway offer a dual therapeutic approach to simultaneously regulate lipid metabolism and inflammation in cardiovascular diseases?"], "ground_truth": ["permed-57020", "permed-53486", "permed-57206", "permed-52511", "permed-90443", "permed-11435", "permed-48289", "permed-79152", "permed-30404", "permed-68922"]}
{"query_id": "topic_490_turn_5", "conversation_id": "topic_490", "turn_id": 5, "query": "Given these experimental validation approaches for Eif6 modulation, what clinical translation challenges might arise when advancing this dual-pathway therapy toward human trials? Specifically, considering the interconnected lipid metabolism and inflammation effects, what safety monitoring would be essential for first-in-human studies—particularly regarding off-target effects in other Eif6-involved processes like ribosome biogenesis? Additionally, which patient populations with atherosclerosis might show the best risk-benefit profile for initial trials, given potential variations in baseline metabolic and inflammatory status?", "history": ["What is known about the role of Eif6 in human physiology and disease?", "How does its involvement in fatty acid synthesis impact cardiovascular health, particularly in conditions like atherosclerosis?", "Given Eif6's role in fatty acid synthesis and its connection to atherosclerosis, how might altering its levels affect the inflammatory response and immune cell function within plaques? Could targeting this pathway offer a dual therapeutic approach to simultaneously regulate lipid metabolism and inflammation in cardiovascular diseases?", "To experimentally validate this dual therapeutic approach, what specific in vitro and in vivo models would be most appropriate for quantifying how Eif6 modulation affects both lipid accumulation and inflammatory markers simultaneously? I'm particularly interested in the technical implementation—would you recommend using macrophage-specific Eif6 knockout models combined with flow cytometry analysis of plaque immune populations, and what statistical approaches would best capture the correlation between metabolic changes and inflammation parameters in these experimental setups?"], "ground_truth": ["permed-57020", "permed-84302", "permed-22845", "permed-67693", "permed-30404", "permed-70405", "permed-80217", "permed-80023", "permed-86162", "permed-65134"]}
{"query_id": "topic_491_turn_1", "conversation_id": "topic_491", "turn_id": 1, "query": "What role does technology play in enhancing ecological restoration projects?", "history": [], "ground_truth": ["permed-81346", "permed-71237", "permed-71244", "permed-66776", "permed-74414", "permed-62986", "permed-66567", "permed-81347", "permed-53389", "permed-50971"]}
{"query_id": "topic_491_turn_2", "conversation_id": "topic_491", "turn_id": 2, "query": "Can this integration of technology also improve public engagement and transparency in such projects?", "history": ["What role does technology play in enhancing ecological restoration projects?"], "ground_truth": ["permed-69829", "permed-88209", "permed-54921", "permed-68357", "permed-53389", "permed-82003", "permed-68389", "permed-52061", "permed-87942", "permed-54521"]}
{"query_id": "topic_491_turn_3", "conversation_id": "topic_491", "turn_id": 3, "query": "Given this potential for technology to enhance both ecological restoration and public engagement, how could advanced monitoring technologies and public engagement strategies specifically improve transparency and accountability in China's ecological restoration projects? What practical measures would ensure these projects effectively tackle regional ecological challenges while also supporting global environmental governance goals?", "history": ["What role does technology play in enhancing ecological restoration projects?", "Can this integration of technology also improve public engagement and transparency in such projects?"], "ground_truth": ["permed-81346", "permed-68691", "permed-53389", "permed-55225", "permed-69390", "permed-67243", "permed-66113", "permed-67092", "permed-69930", "permed-52061"]}
{"query_id": "topic_491_turn_4", "conversation_id": "topic_491", "turn_id": 4, "query": "Regarding the advanced monitoring technologies you mentioned for China's restoration projects, what specific instrumentation protocols and data validation frameworks would ensure reliable ecological metrics across different regional contexts? How should these technical systems be calibrated to account for diverse biomes while maintaining standardized reporting for global environmental governance? Could you elaborate on the statistical methods for detecting meaningful ecological changes versus natural variability within these monitoring datasets?", "history": ["What role does technology play in enhancing ecological restoration projects?", "Can this integration of technology also improve public engagement and transparency in such projects?", "Given this potential for technology to enhance both ecological restoration and public engagement, how could advanced monitoring technologies and public engagement strategies specifically improve transparency and accountability in China's ecological restoration projects? What practical measures would ensure these projects effectively tackle regional ecological challenges while also supporting global environmental governance goals?"], "ground_truth": ["permed-81346", "permed-13377", "permed-35810", "permed-71764", "permed-68462", "permed-67495", "permed-84093", "permed-74501", "permed-67030", "permed-34623"]}
{"query_id": "topic_491_turn_5", "conversation_id": "topic_491", "turn_id": 5, "query": "Given the detailed instrumentation protocols and statistical validation frameworks discussed for China's restoration monitoring, how do these technology-driven approaches compare with traditional ecological assessment methods in terms of cost-effectiveness, scalability, and accuracy across different biomes? Specifically, what trade-offs exist between deploying advanced sensor networks versus conventional field surveys for detecting ecological changes, and how do their respective strengths in spatial coverage, temporal resolution, and data reliability impact their suitability for meeting both regional management needs and global reporting requirements?", "history": ["What role does technology play in enhancing ecological restoration projects?", "Can this integration of technology also improve public engagement and transparency in such projects?", "Given this potential for technology to enhance both ecological restoration and public engagement, how could advanced monitoring technologies and public engagement strategies specifically improve transparency and accountability in China's ecological restoration projects? What practical measures would ensure these projects effectively tackle regional ecological challenges while also supporting global environmental governance goals?", "Regarding the advanced monitoring technologies you mentioned for China's restoration projects, what specific instrumentation protocols and data validation frameworks would ensure reliable ecological metrics across different regional contexts? How should these technical systems be calibrated to account for diverse biomes while maintaining standardized reporting for global environmental governance? Could you elaborate on the statistical methods for detecting meaningful ecological changes versus natural variability within these monitoring datasets?"], "ground_truth": ["permed-81346", "permed-84093", "permed-74501", "permed-67495", "permed-71243", "permed-51639", "permed-74414", "permed-88354", "permed-25785", "permed-67030"]}
{"query_id": "topic_492_turn_1", "conversation_id": "topic_492", "turn_id": 1, "query": "Comparative analysis of microbial communities in healthy dental implants versus peri-implantitis", "history": [], "ground_truth": ["permed-72274", "permed-75119", "permed-75122", "permed-67072", "permed-75113", "permed-68120", "permed-64726", "permed-51830", "permed-75164", "permed-75138"]}
{"query_id": "topic_492_turn_2", "conversation_id": "topic_492", "turn_id": 2, "query": "Pathogenic mechanisms of these microbial differences in peri-implantitis development and progression", "history": ["Comparative analysis of microbial communities in healthy dental implants versus peri-implantitis"], "ground_truth": ["permed-72274", "permed-75113", "permed-75119", "permed-67703", "permed-75116", "permed-75114", "permed-75164", "permed-75121", "permed-75122", "permed-76005"]}
{"query_id": "topic_492_turn_3", "conversation_id": "topic_492", "turn_id": 3, "query": "Impact of unique peri-implantitis microbial consortia and interactions on host immune response, chronic inflammation, and identification of therapeutic targets or diagnostic biomarkers distinct from periodontitis", "history": ["Comparative analysis of microbial communities in healthy dental implants versus peri-implantitis", "Pathogenic mechanisms of these microbial differences in peri-implantitis development and progression"], "ground_truth": ["permed-72274", "permed-75113", "permed-75119", "permed-75122", "permed-76005", "permed-75164", "permed-75116", "permed-67703", "permed-83554", "permed-67704"]}
{"query_id": "topic_492_turn_4", "conversation_id": "topic_492", "turn_id": 4, "query": "When investigating these unique peri-implantitis microbial-host interactions, what specific immunological assays—such as multiplex cytokine profiling, flow cytometry for immune cell populations, or single-cell RNA sequencing of peri-implant crevicular fluid—were utilized to quantitatively map the host response? Furthermore, how was the subsequent data integrated with the microbial sequencing data to identify statistically robust correlations, and what multivariate statistical models were employed to control for confounding factors like smoking or diabetes in these analyses?", "history": ["Comparative analysis of microbial communities in healthy dental implants versus peri-implantitis", "Pathogenic mechanisms of these microbial differences in peri-implantitis development and progression", "Impact of unique peri-implantitis microbial consortia and interactions on host immune response, chronic inflammation, and identification of therapeutic targets or diagnostic biomarkers distinct from periodontitis"], "ground_truth": ["permed-72274", "permed-75119", "permed-58249", "permed-75116", "permed-75113", "permed-75122", "permed-64723", "permed-75183", "permed-75164", "permed-39937"]}
{"query_id": "topic_492_turn_5", "conversation_id": "topic_492", "turn_id": 5, "query": "Given the sophisticated immunological and microbial integration methodologies previously discussed, what clinical translation has occurred regarding peri-implantitis therapeutic targets? Specifically, based on these host-microbe interaction findings, have any targeted antimicrobial protocols or immunomodulatory approaches (such as cytokine inhibitors or biofilm-disrupting agents) progressed to human trials? What were the primary clinical endpoints—including implant survival rates, probing depth reduction, and inflammatory marker normalization—and were there significant safety considerations, such as unintended microbiome disruption or adverse immune reactions, observed in these intervention studies?", "history": ["Comparative analysis of microbial communities in healthy dental implants versus peri-implantitis", "Pathogenic mechanisms of these microbial differences in peri-implantitis development and progression", "Impact of unique peri-implantitis microbial consortia and interactions on host immune response, chronic inflammation, and identification of therapeutic targets or diagnostic biomarkers distinct from periodontitis", "When investigating these unique peri-implantitis microbial-host interactions, what specific immunological assays—such as multiplex cytokine profiling, flow cytometry for immune cell populations, or single-cell RNA sequencing of peri-implant crevicular fluid—were utilized to quantitatively map the host response? Furthermore, how was the subsequent data integrated with the microbial sequencing data to identify statistically robust correlations, and what multivariate statistical models were employed to control for confounding factors like smoking or diabetes in these analyses?"], "ground_truth": ["permed-75122", "permed-76005", "permed-75119", "permed-75121", "permed-72274", "permed-61086", "permed-75213", "permed-19623", "permed-75134", "permed-54882"]}
{"query_id": "topic_493_turn_1", "conversation_id": "topic_493", "turn_id": 1, "query": "Overview of DNA-peptide hybrid materials in drug delivery systems: current roles and future potential", "history": [], "ground_truth": ["permed-57953", "permed-60898", "permed-60645", "permed-53294", "permed-58042", "permed-64382", "permed-79827", "permed-72499", "permed-85305", "permed-57950"]}
{"query_id": "topic_493_turn_2", "conversation_id": "topic_493", "turn_id": 2, "query": "Machine learning techniques for improving the therapeutic efficacy of these DNA-peptide hybrid materials in such drug delivery systems", "history": ["Overview of DNA-peptide hybrid materials in drug delivery systems: current roles and future potential"], "ground_truth": ["permed-57953", "permed-60645", "permed-60898", "permed-57950", "permed-89422", "permed-53315", "permed-53294", "permed-53718", "permed-72499", "permed-85305"]}
{"query_id": "topic_493_turn_3", "conversation_id": "topic_493", "turn_id": 3, "query": "Applying machine learning models to optimize DNA-peptide hybrid design for enhanced drug targeting specificity and efficacy, AND strategies for clinical translation of these optimized materials", "history": ["Overview of DNA-peptide hybrid materials in drug delivery systems: current roles and future potential", "Machine learning techniques for improving the therapeutic efficacy of these DNA-peptide hybrid materials in such drug delivery systems"], "ground_truth": ["permed-57953", "permed-53315", "permed-60645", "permed-57950", "permed-60898", "permed-53294", "permed-89422", "permed-90361", "permed-53719", "permed-53317"]}
{"query_id": "topic_493_turn_4", "conversation_id": "topic_493", "turn_id": 4, "query": "When implementing these machine learning-optimized DNA-peptide hybrids in clinical translation studies, what specific in vitro and in vivo validation protocols should be prioritized? I'm particularly interested in methodological details regarding binding affinity quantification, cellular uptake efficiency measurements across different tissue types, and the statistical approaches for correlating structural modifications predicted by ML models with observed therapeutic outcomes in preclinical models. Should we employ standardized assays or develop customized protocols for these hybrid materials?", "history": ["Overview of DNA-peptide hybrid materials in drug delivery systems: current roles and future potential", "Machine learning techniques for improving the therapeutic efficacy of these DNA-peptide hybrid materials in such drug delivery systems", "Applying machine learning models to optimize DNA-peptide hybrid design for enhanced drug targeting specificity and efficacy, AND strategies for clinical translation of these optimized materials"], "ground_truth": ["permed-57953", "permed-53315", "permed-60898", "permed-83324", "permed-53317", "permed-67984", "permed-82823", "permed-51301", "permed-57950", "permed-57505"]}
{"query_id": "topic_493_turn_5", "conversation_id": "topic_493", "turn_id": 5, "query": "Given the comprehensive validation protocols discussed, what clinical safety profiles and adverse effect management strategies should be prioritized when advancing these ML-optimized DNA-peptide hybrids into early-phase human trials? Specifically, how should we design dose-escalation studies to monitor for immunogenicity risks unique to these hybrid materials, and what biomarkers would best predict patient-specific toxicities while maintaining therapeutic efficacy across diverse populations? Considering potential translation from preclinical models, what clinical monitoring frameworks have proven most effective for similar nanoscale delivery systems?", "history": ["Overview of DNA-peptide hybrid materials in drug delivery systems: current roles and future potential", "Machine learning techniques for improving the therapeutic efficacy of these DNA-peptide hybrid materials in such drug delivery systems", "Applying machine learning models to optimize DNA-peptide hybrid design for enhanced drug targeting specificity and efficacy, AND strategies for clinical translation of these optimized materials", "When implementing these machine learning-optimized DNA-peptide hybrids in clinical translation studies, what specific in vitro and in vivo validation protocols should be prioritized? I'm particularly interested in methodological details regarding binding affinity quantification, cellular uptake efficiency measurements across different tissue types, and the statistical approaches for correlating structural modifications predicted by ML models with observed therapeutic outcomes in preclinical models. Should we employ standardized assays or develop customized protocols for these hybrid materials?"], "ground_truth": ["permed-57953", "permed-51301", "permed-91668", "permed-60898", "permed-51332", "permed-63013", "permed-60918", "permed-60896", "permed-79827", "permed-75000"]}
{"query_id": "topic_494_turn_1", "conversation_id": "topic_494", "turn_id": 1, "query": "Overview of testosterone therapy effects on breast tissue in FTM transgender men", "history": [], "ground_truth": ["permed-77439", "permed-77441", "permed-58337", "permed-61239", "permed-92106", "permed-69337", "permed-90016", "permed-69331", "permed-76431", "permed-64929"]}
{"query_id": "topic_494_turn_2", "conversation_id": "topic_494", "turn_id": 2, "query": "Impact of these testosterone-induced breast tissue changes on breast cancer risk in transgender men versus cisgender women", "history": ["Overview of testosterone therapy effects on breast tissue in FTM transgender men"], "ground_truth": ["permed-77439", "permed-77441", "permed-82373", "permed-85504", "permed-69340", "permed-76431", "permed-61987", "permed-69334", "permed-61239", "permed-68563"]}
{"query_id": "topic_494_turn_3", "conversation_id": "topic_494", "turn_id": 3, "query": "Long-term molecular and cellular mechanisms underlying testosterone's effects on FTM breast tissue and their contribution to breast cancer development compared to cisgender women", "history": ["Overview of testosterone therapy effects on breast tissue in FTM transgender men", "Impact of these testosterone-induced breast tissue changes on breast cancer risk in transgender men versus cisgender women"], "ground_truth": ["permed-77439", "permed-70708", "permed-64929", "permed-36402", "permed-62683", "permed-92106", "permed-69331", "permed-61987", "permed-82373", "permed-77440"]}
{"query_id": "topic_494_turn_4", "conversation_id": "topic_494", "turn_id": 4, "query": "Regarding these long-term molecular mechanisms, what specific immunohistochemical markers and quantification methods were used to characterize epithelial cell proliferation and apoptosis in breast tissue samples? Were there standardized protocols for tissue processing across different study sites, and how did researchers validate the specificity of these markers given the potential for altered protein expression patterns in testosterone-treated tissue?", "history": ["Overview of testosterone therapy effects on breast tissue in FTM transgender men", "Impact of these testosterone-induced breast tissue changes on breast cancer risk in transgender men versus cisgender women", "Long-term molecular and cellular mechanisms underlying testosterone's effects on FTM breast tissue and their contribution to breast cancer development compared to cisgender women"], "ground_truth": ["permed-50852", "permed-18418", "permed-56081", "permed-68632", "permed-84728", "permed-91872", "permed-59102", "permed-56283", "permed-5710", "permed-77439"]}
{"query_id": "topic_494_turn_5", "conversation_id": "topic_494", "turn_id": 5, "query": "Given these detailed immunohistochemical methodologies, how do the quantitative differences in epithelial cell proliferation and apoptosis markers (such as Ki-67 and caspase-3 expression levels) between testosterone-treated FTM breast tissue and untreated cisgender female breast tissue compare to the differential expression patterns observed between high-risk benign breast lesions and normal breast tissue in cisgender populations? What do these comparative biomarker profiles reveal about the relative magnitude of testosterone's tissue-modifying effects versus established precancerous changes?", "history": ["Overview of testosterone therapy effects on breast tissue in FTM transgender men", "Impact of these testosterone-induced breast tissue changes on breast cancer risk in transgender men versus cisgender women", "Long-term molecular and cellular mechanisms underlying testosterone's effects on FTM breast tissue and their contribution to breast cancer development compared to cisgender women", "Regarding these long-term molecular mechanisms, what specific immunohistochemical markers and quantification methods were used to characterize epithelial cell proliferation and apoptosis in breast tissue samples? Were there standardized protocols for tissue processing across different study sites, and how did researchers validate the specificity of these markers given the potential for altered protein expression patterns in testosterone-treated tissue?"], "ground_truth": ["permed-77439", "permed-68575", "permed-2964", "permed-31746", "permed-87918", "permed-52579", "permed-56081", "permed-91872", "permed-30408", "permed-28326"]}
{"query_id": "topic_495_turn_1", "conversation_id": "topic_495", "turn_id": 1, "query": "Recent advancements in realistic brain organoid development for medical research", "history": [], "ground_truth": ["permed-64505", "permed-75367", "permed-77302", "permed-75366", "permed-75368", "permed-63248", "permed-64503", "permed-40398", "permed-63205", "permed-66780"]}
{"query_id": "topic_495_turn_2", "conversation_id": "topic_495", "turn_id": 2, "query": "Bioengineering techniques for enhancing complexity and longevity in these realistic brain organoids", "history": ["Recent advancements in realistic brain organoid development for medical research"], "ground_truth": ["permed-64505", "permed-77302", "permed-75367", "permed-75366", "permed-75368", "permed-63248", "permed-59113", "permed-64503", "permed-63207", "permed-67923"]}
{"query_id": "topic_495_turn_3", "conversation_id": "topic_495", "turn_id": 3, "query": "Microfluidics and 3D bioprinting to advance bioengineered brain organoids: enhancing physiological relevance, vascularization, non-neural cell diversity, and stability for neurological disease modeling and drug screening applications", "history": ["Recent advancements in realistic brain organoid development for medical research", "Bioengineering techniques for enhancing complexity and longevity in these realistic brain organoids"], "ground_truth": ["permed-64505", "permed-75368", "permed-75366", "permed-75367", "permed-59113", "permed-57922", "permed-75737", "permed-63248", "permed-81319", "permed-60836"]}
{"query_id": "topic_495_turn_4", "conversation_id": "topic_495", "turn_id": 4, "query": "Given this integrated microfluidics and 3D bioprinting approach, what specific protocols are used to validate the functional vascular network formation within these organoids? I'm particularly interested in the perfusion assessment methods - do researchers primarily use fluorescent bead tracking, contrast-enhanced imaging, or direct measurements of barrier integrity? Additionally, what statistical metrics are employed to quantify network maturity and reproducibility across different batches of bioengineered organoids?", "history": ["Recent advancements in realistic brain organoid development for medical research", "Bioengineering techniques for enhancing complexity and longevity in these realistic brain organoids", "Microfluidics and 3D bioprinting to advance bioengineered brain organoids: enhancing physiological relevance, vascularization, non-neural cell diversity, and stability for neurological disease modeling and drug screening applications"], "ground_truth": ["permed-64505", "permed-57407", "permed-75368", "permed-64503", "permed-12441", "permed-63028", "permed-64390", "permed-80935", "permed-59113", "permed-31201"]}
{"query_id": "topic_495_turn_5", "conversation_id": "topic_495", "turn_id": 5, "query": "Given these validation protocols for vascular network functionality, what clinical translation challenges remain for implementing these advanced brain organoids in neurological drug development pipelines? Specifically, how do current perfusion metrics correlate with actual blood-brain barrier penetration in preclinical models, and what evidence exists regarding predictive validity for human neuropharmacokinetics? Have any recent studies demonstrated successful use of vascularized organoids to identify neurotherapeutic candidates that later showed efficacy in clinical trials, addressing the persistent translational gap in CNS drug development?", "history": ["Recent advancements in realistic brain organoid development for medical research", "Bioengineering techniques for enhancing complexity and longevity in these realistic brain organoids", "Microfluidics and 3D bioprinting to advance bioengineered brain organoids: enhancing physiological relevance, vascularization, non-neural cell diversity, and stability for neurological disease modeling and drug screening applications", "Given this integrated microfluidics and 3D bioprinting approach, what specific protocols are used to validate the functional vascular network formation within these organoids? I'm particularly interested in the perfusion assessment methods - do researchers primarily use fluorescent bead tracking, contrast-enhanced imaging, or direct measurements of barrier integrity? Additionally, what statistical metrics are employed to quantify network maturity and reproducibility across different batches of bioengineered organoids?"], "ground_truth": ["permed-75368", "permed-63248", "permed-75366", "permed-75367", "permed-64505", "permed-77302", "permed-12441", "permed-86043", "permed-56692", "permed-60181"]}
{"query_id": "topic_496_turn_1", "conversation_id": "topic_496", "turn_id": 1, "query": "Fundamentals of CVD for high-quality MoS2 growth: principles and impact on optoelectronic properties", "history": [], "ground_truth": ["permed-76995", "permed-77027", "permed-51035", "permed-75053", "permed-75051", "permed-77026", "permed-92691", "permed-60963", "permed-88190", "permed-76396"]}
{"query_id": "topic_496_turn_2", "conversation_id": "topic_496", "turn_id": 2, "query": "Effect of specific CVD growth parameters, such as carrier gas flow, on these MoS2 optoelectronic properties and material characteristics", "history": ["Fundamentals of CVD for high-quality MoS2 growth: principles and impact on optoelectronic properties"], "ground_truth": ["permed-76995", "permed-75053", "permed-75051", "permed-77026", "permed-51035", "permed-77027", "permed-88190", "permed-56264", "permed-55234", "permed-60963"]}
{"query_id": "topic_496_turn_3", "conversation_id": "topic_496", "turn_id": 3, "query": "Optimizing CVD carrier gas flow for 3R-phase MoS2: strategies to enhance layer-dependent SHG, valley polarization, and quantum information processing capabilities", "history": ["Fundamentals of CVD for high-quality MoS2 growth: principles and impact on optoelectronic properties", "Effect of specific CVD growth parameters, such as carrier gas flow, on these MoS2 optoelectronic properties and material characteristics"], "ground_truth": ["permed-76995", "permed-75053", "permed-56264", "permed-77026", "permed-92691", "permed-75051", "permed-74014", "permed-77028", "permed-51035", "permed-62932"]}
{"query_id": "topic_496_turn_4", "conversation_id": "topic_496", "turn_id": 4, "query": "Regarding this carrier gas optimization protocol for 3R-phase MoS2, what specific statistical validation methods were employed to correlate flow parameters with SHG enhancement metrics? How did you establish reproducibility across multiple growth runs while maintaining consistent valley polarization measurements? Particularly, what quality control procedures ensured uniform layer thickness during these CVD processes, and were there any technical modifications to the standard CVD setup to accommodate real-time monitoring of phase purity during growth?", "history": ["Fundamentals of CVD for high-quality MoS2 growth: principles and impact on optoelectronic properties", "Effect of specific CVD growth parameters, such as carrier gas flow, on these MoS2 optoelectronic properties and material characteristics", "Optimizing CVD carrier gas flow for 3R-phase MoS2: strategies to enhance layer-dependent SHG, valley polarization, and quantum information processing capabilities"], "ground_truth": ["permed-76995", "permed-77026", "permed-77027", "permed-49231", "permed-92681", "permed-77030", "permed-51035", "permed-75052", "permed-42238", "permed-92691"]}
{"query_id": "topic_496_turn_5", "conversation_id": "topic_496", "turn_id": 5, "query": "Given these statistically validated CVD protocols for 3R-phase MoS2 with enhanced SHG properties, what translational pathways exist for implementing this material in clinical optoelectronic devices? Specifically, what biocompatibility assessments and in vivo safety profiles have been established for MoS2-based neural interfaces or biosensors? Considering the reproducible layer thickness and phase purity achieved, how do these material characteristics correlate with reduced inflammatory responses or long-term device stability in biological environments? Additionally, what clinical trial evidence exists regarding the therapeutic efficacy of such 2D material-based systems for neurological monitoring or modulation applications?", "history": ["Fundamentals of CVD for high-quality MoS2 growth: principles and impact on optoelectronic properties", "Effect of specific CVD growth parameters, such as carrier gas flow, on these MoS2 optoelectronic properties and material characteristics", "Optimizing CVD carrier gas flow for 3R-phase MoS2: strategies to enhance layer-dependent SHG, valley polarization, and quantum information processing capabilities", "Regarding this carrier gas optimization protocol for 3R-phase MoS2, what specific statistical validation methods were employed to correlate flow parameters with SHG enhancement metrics? How did you establish reproducibility across multiple growth runs while maintaining consistent valley polarization measurements? Particularly, what quality control procedures ensured uniform layer thickness during these CVD processes, and were there any technical modifications to the standard CVD setup to accommodate real-time monitoring of phase purity during growth?"], "ground_truth": ["permed-76995", "permed-75053", "permed-60963", "permed-85977", "permed-75587", "permed-68494", "permed-75051", "permed-60848", "permed-77030", "permed-63386"]}
{"query_id": "topic_497_turn_1", "conversation_id": "topic_497", "turn_id": 1, "query": "What advancements have been made in mass spectrometry techniques for proteomics research, particularly in detecting post-translational modifications?", "history": [], "ground_truth": ["permed-66190", "permed-4612", "permed-4827", "permed-77044", "permed-88526", "permed-76028", "permed-76138", "permed-71701", "permed-4601", "permed-72041"]}
{"query_id": "topic_497_turn_2", "conversation_id": "topic_497", "turn_id": 2, "query": "How can these advancements, such as improved gating techniques, be optimized to better analyze complex protein mixtures?", "history": ["What advancements have been made in mass spectrometry techniques for proteomics research, particularly in detecting post-translational modifications?"], "ground_truth": ["permed-77048", "permed-76031", "permed-73116", "permed-77044", "permed-73117", "permed-65166", "permed-77047", "permed-85983", "permed-85984", "permed-61290"]}
{"query_id": "topic_497_turn_3", "conversation_id": "topic_497", "turn_id": 3, "query": "Given these improvements in gating techniques and multiplexing for IM-FT-MS systems, how could their integration—particularly with methods like tristate gating—be further refined to better detect and characterize PTMs in complex protein mixtures? What would this mean for enhancing both sensitivity and throughput in proteomics research?", "history": ["What advancements have been made in mass spectrometry techniques for proteomics research, particularly in detecting post-translational modifications?", "How can these advancements, such as improved gating techniques, be optimized to better analyze complex protein mixtures?"], "ground_truth": ["permed-77048", "permed-66190", "permed-78978", "permed-77045", "permed-77755", "permed-79011", "permed-76031", "permed-66191", "permed-77044", "permed-78975"]}
{"query_id": "topic_497_turn_4", "conversation_id": "topic_497", "turn_id": 4, "query": "When implementing tristate gating with multiplexed IM-FT-MS systems, what specific methodological adaptations are required for PTM analysis in complex mixtures? I'm particularly interested in how the gating parameters should be optimized—such as timing windows and ion mobility thresholds—to minimize interference from co-eluting species while maintaining PTM detection sensitivity. Additionally, what statistical validation approaches would you recommend to ensure reproducibility when analyzing these modified peptide subsets across multiple experimental runs?", "history": ["What advancements have been made in mass spectrometry techniques for proteomics research, particularly in detecting post-translational modifications?", "How can these advancements, such as improved gating techniques, be optimized to better analyze complex protein mixtures?", "Given these improvements in gating techniques and multiplexing for IM-FT-MS systems, how could their integration—particularly with methods like tristate gating—be further refined to better detect and characterize PTMs in complex protein mixtures? What would this mean for enhancing both sensitivity and throughput in proteomics research?"], "ground_truth": ["permed-77048", "permed-78978", "permed-66190", "permed-77755", "permed-78976", "permed-52760", "permed-72986", "permed-52746", "permed-76142", "permed-66191"]}
{"query_id": "topic_497_turn_5", "conversation_id": "topic_497", "turn_id": 5, "query": "Given these methodological refinements for PTM detection using tristate gating in multiplexed IM-FT-MS systems, how have these technical advancements translated into clinical proteomics applications? Specifically, what evidence exists regarding the diagnostic or prognostic utility of PTM-based biomarkers discovered through these platforms in patient samples? Furthermore, what are the primary clinical validation challenges—such as batch effects in multicenter studies or pre-analytical variability—that arise when implementing these sensitive PTM detection workflows for real-world clinical biomarker verification and therapeutic monitoring?", "history": ["What advancements have been made in mass spectrometry techniques for proteomics research, particularly in detecting post-translational modifications?", "How can these advancements, such as improved gating techniques, be optimized to better analyze complex protein mixtures?", "Given these improvements in gating techniques and multiplexing for IM-FT-MS systems, how could their integration—particularly with methods like tristate gating—be further refined to better detect and characterize PTMs in complex protein mixtures? What would this mean for enhancing both sensitivity and throughput in proteomics research?", "When implementing tristate gating with multiplexed IM-FT-MS systems, what specific methodological adaptations are required for PTM analysis in complex mixtures? I'm particularly interested in how the gating parameters should be optimized—such as timing windows and ion mobility thresholds—to minimize interference from co-eluting species while maintaining PTM detection sensitivity. Additionally, what statistical validation approaches would you recommend to ensure reproducibility when analyzing these modified peptide subsets across multiple experimental runs?"], "ground_truth": ["permed-74206", "permed-4827", "permed-77048", "permed-66190", "permed-74028", "permed-4612", "permed-79011", "permed-4597", "permed-5017", "permed-76032"]}
{"query_id": "topic_498_turn_1", "conversation_id": "topic_498", "turn_id": 1, "query": "Role of diet in managing inflammatory bowel disease (IBD) and colitis symptoms", "history": [], "ground_truth": ["permed-82514", "permed-55929", "permed-82513", "permed-69039", "permed-55932", "permed-59100", "permed-55928", "permed-76632", "permed-72390", "permed-55926"]}
{"query_id": "topic_498_turn_2", "conversation_id": "topic_498", "turn_id": 2, "query": "Effectiveness of elemental diets for gut microbiome modulation in these IBD conditions", "history": ["Role of diet in managing inflammatory bowel disease (IBD) and colitis symptoms"], "ground_truth": ["permed-72391", "permed-55929", "permed-65029", "permed-82513", "permed-64094", "permed-59032", "permed-76632", "permed-51267", "permed-86436", "permed-55932"]}
{"query_id": "topic_498_turn_3", "conversation_id": "topic_498", "turn_id": 3, "query": "Modulating gut microbiota in IBD via specific amino acid profiles in elemental diets: impact on mucus layer integrity and therapeutic outcomes", "history": ["Role of diet in managing inflammatory bowel disease (IBD) and colitis symptoms", "Effectiveness of elemental diets for gut microbiome modulation in these IBD conditions"], "ground_truth": ["permed-72391", "permed-55929", "permed-76632", "permed-64094", "permed-58168", "permed-62068", "permed-59032", "permed-65029", "permed-51271", "permed-3066"]}
{"query_id": "topic_498_turn_4", "conversation_id": "topic_498", "turn_id": 4, "query": "For these amino acid-modified elemental diet protocols, what specific analytical techniques were employed to quantitatively assess changes in mucus layer thickness and composition? I'm particularly interested in the histological staining protocols, whether confocal microscopy measurements followed standardized quantification methods, and how molecular analyses of mucin glycosylation patterns were validated. Were there specific quality control measures implemented to ensure reproducibility across different tissue sampling sites given the patchy nature of IBD inflammation?", "history": ["Role of diet in managing inflammatory bowel disease (IBD) and colitis symptoms", "Effectiveness of elemental diets for gut microbiome modulation in these IBD conditions", "Modulating gut microbiota in IBD via specific amino acid profiles in elemental diets: impact on mucus layer integrity and therapeutic outcomes"], "ground_truth": ["permed-72391", "permed-77656", "permed-77164", "permed-76814", "permed-76632", "permed-50540", "permed-66181", "permed-5111", "permed-39858", "permed-86833"]}
{"query_id": "topic_498_turn_5", "conversation_id": "topic_498", "turn_id": 5, "query": "Given these detailed analytical methodologies for assessing mucus layer changes, how do the therapeutic outcomes of amino acid-modified elemental diets compare to conventional polymeric diets when considering both mucosal healing parameters and microbiome restoration metrics across different IBD subtypes? Specifically, what comparative evidence exists regarding their respective impacts on clinical remission rates, endoscopic improvement scores, and sustained microbial diversity recovery - and do the trade-offs between superior mucus enhancement versus practical implementation challenges favor one approach in particular clinical contexts?", "history": ["Role of diet in managing inflammatory bowel disease (IBD) and colitis symptoms", "Effectiveness of elemental diets for gut microbiome modulation in these IBD conditions", "Modulating gut microbiota in IBD via specific amino acid profiles in elemental diets: impact on mucus layer integrity and therapeutic outcomes", "For these amino acid-modified elemental diet protocols, what specific analytical techniques were employed to quantitatively assess changes in mucus layer thickness and composition? I'm particularly interested in the histological staining protocols, whether confocal microscopy measurements followed standardized quantification methods, and how molecular analyses of mucin glycosylation patterns were validated. Were there specific quality control measures implemented to ensure reproducibility across different tissue sampling sites given the patchy nature of IBD inflammation?"], "ground_truth": ["permed-72391", "permed-82513", "permed-82514", "permed-77164", "permed-86436", "permed-55929", "permed-86135", "permed-65163", "permed-61771", "permed-3066"]}
{"query_id": "topic_499_turn_1", "conversation_id": "topic_499", "turn_id": 1, "query": "Impact of obesity on adipose-derived mesenchymal stem cell (ADMSC) functionality and phenotypic changes", "history": [], "ground_truth": ["permed-64903", "permed-77176", "permed-70685", "permed-53559", "permed-68273", "permed-59030", "permed-77177", "permed-52737", "permed-72068", "permed-82505"]}
{"query_id": "topic_499_turn_2", "conversation_id": "topic_499", "turn_id": 2, "query": "Role of these obesity-induced ADMSC alterations, specifically in proliferation and differentiation, in type 2 diabetes pathogenesis", "history": ["Impact of obesity on adipose-derived mesenchymal stem cell (ADMSC) functionality and phenotypic changes"], "ground_truth": ["permed-64903", "permed-53559", "permed-77176", "permed-57232", "permed-59531", "permed-59532", "permed-70474", "permed-70685", "permed-58574", "permed-84426"]}
{"query_id": "topic_499_turn_3", "conversation_id": "topic_499", "turn_id": 3, "query": "Molecular mechanisms driving impaired ADMSC proliferation and differentiation in obesity-associated type 2 diabetes, and therapeutic strategies for T2D prevention or reversal", "history": ["Impact of obesity on adipose-derived mesenchymal stem cell (ADMSC) functionality and phenotypic changes", "Role of these obesity-induced ADMSC alterations, specifically in proliferation and differentiation, in type 2 diabetes pathogenesis"], "ground_truth": ["permed-64903", "permed-53559", "permed-51127", "permed-58574", "permed-59531", "permed-59532", "permed-68183", "permed-79341", "permed-59037", "permed-84426"]}
{"query_id": "topic_499_turn_4", "conversation_id": "topic_499", "turn_id": 4, "query": "For investigating these molecular mechanisms driving impaired ADMSC functionality, what specific in vitro assays and protocols would you recommend for quantifying proliferation rates and differentiation efficiency into adipogenic lineages? Furthermore, which statistical methods are most appropriate for validating the significance of observed differences between ADMSCs isolated from obese versus lean donors, particularly when dealing with potential donor-to-donor variability in primary cell cultures?", "history": ["Impact of obesity on adipose-derived mesenchymal stem cell (ADMSC) functionality and phenotypic changes", "Role of these obesity-induced ADMSC alterations, specifically in proliferation and differentiation, in type 2 diabetes pathogenesis", "Molecular mechanisms driving impaired ADMSC proliferation and differentiation in obesity-associated type 2 diabetes, and therapeutic strategies for T2D prevention or reversal"], "ground_truth": ["permed-45825", "permed-91859", "permed-45703", "permed-70685", "permed-91402", "permed-86617", "permed-52737", "permed-10616", "permed-54898", "permed-91861"]}
{"query_id": "topic_499_turn_5", "conversation_id": "topic_499", "turn_id": 5, "query": "Given these validated in vitro assays and statistical approaches for quantifying ADMSC dysfunction, what clinical evidence exists regarding the therapeutic efficacy of autologous versus allogeneic ADMSC transplantation from lean donors in patients with obesity-associated type 2 diabetes? Specifically, how do human clinical trials compare these approaches in terms of glycemic control restoration, insulin sensitivity improvements, and safety profiles—particularly regarding potential immunogenic reactions or metabolic confounding when transplanting cells into an obese inflammatory microenvironment?", "history": ["Impact of obesity on adipose-derived mesenchymal stem cell (ADMSC) functionality and phenotypic changes", "Role of these obesity-induced ADMSC alterations, specifically in proliferation and differentiation, in type 2 diabetes pathogenesis", "Molecular mechanisms driving impaired ADMSC proliferation and differentiation in obesity-associated type 2 diabetes, and therapeutic strategies for T2D prevention or reversal", "For investigating these molecular mechanisms driving impaired ADMSC functionality, what specific in vitro assays and protocols would you recommend for quantifying proliferation rates and differentiation efficiency into adipogenic lineages? Furthermore, which statistical methods are most appropriate for validating the significance of observed differences between ADMSCs isolated from obese versus lean donors, particularly when dealing with potential donor-to-donor variability in primary cell cultures?"], "ground_truth": ["permed-64903", "permed-53559", "permed-76179", "permed-68183", "permed-54428", "permed-10619", "permed-48262", "permed-58391", "permed-23189", "permed-11445"]}
{"query_id": "topic_500_turn_1", "conversation_id": "topic_500", "turn_id": 1, "query": "Influence of microbial communities on broiler chicken health and productivity", "history": [], "ground_truth": ["permed-66651", "permed-66655", "permed-66648", "permed-65029", "permed-80716", "permed-76735", "permed-66652", "permed-66976", "permed-89788", "permed-67002"]}
{"query_id": "topic_500_turn_2", "conversation_id": "topic_500", "turn_id": 2, "query": "Considering their influence, which specific broiler farm environments (e.g., litter, ceca) offer key opportunities for modifying these microbial communities to improve health and productivity?", "history": ["Influence of microbial communities on broiler chicken health and productivity"], "ground_truth": ["permed-66651", "permed-66655", "permed-66652", "permed-66648", "permed-76735", "permed-64997", "permed-80716", "permed-90392", "permed-66657", "permed-66702"]}
{"query_id": "topic_500_turn_3", "conversation_id": "topic_500", "turn_id": 3, "query": "Long-term effects of targeted litter microbial interventions on broiler health, productivity, pathogen load, and antimicrobial resistance dynamics during production.", "history": ["Influence of microbial communities on broiler chicken health and productivity", "Considering their influence, which specific broiler farm environments (e.g., litter, ceca) offer key opportunities for modifying these microbial communities to improve health and productivity?"], "ground_truth": ["permed-66651", "permed-66655", "permed-76735", "permed-66648", "permed-66650", "permed-82999", "permed-71817", "permed-66654", "permed-66976", "permed-66657"]}
{"query_id": "topic_500_turn_4", "conversation_id": "topic_500", "turn_id": 4, "query": "Given this longitudinal study design examining litter interventions, what specific sampling protocols and sequencing approaches would you recommend for tracking microbial community dynamics? I'm particularly interested in the optimal frequency for collecting litter samples, DNA extraction methods suitable for this complex matrix, and whether 16S rRNA amplicon sequencing provides sufficient resolution compared to shotgun metagenomics for monitoring both taxonomic shifts and antimicrobial resistance gene carriage throughout the production cycle.", "history": ["Influence of microbial communities on broiler chicken health and productivity", "Considering their influence, which specific broiler farm environments (e.g., litter, ceca) offer key opportunities for modifying these microbial communities to improve health and productivity?", "Long-term effects of targeted litter microbial interventions on broiler health, productivity, pathogen load, and antimicrobial resistance dynamics during production."], "ground_truth": ["permed-66651", "permed-82012", "permed-67044", "permed-67048", "permed-67045", "permed-81892", "permed-77677", "permed-67050", "permed-76743", "permed-83543"]}
{"query_id": "topic_500_turn_5", "conversation_id": "topic_500", "turn_id": 5, "query": "Given these proposed methodologies for tracking microbial dynamics, what clinical outcomes have been demonstrated when applying such targeted litter interventions in commercial broiler operations? Specifically, how do these microbial modifications translate to measurable improvements in bird mortality rates, condemnations at processing, or reductions in clinical disease presentations requiring antimicrobial interventions? Furthermore, what safety considerations or unintended consequences have been observed regarding microbiome stability or opportunistic pathogen emergence when manipulating litter microbiota at commercial scale, and how do these findings inform best practices for implementation?", "history": ["Influence of microbial communities on broiler chicken health and productivity", "Considering their influence, which specific broiler farm environments (e.g., litter, ceca) offer key opportunities for modifying these microbial communities to improve health and productivity?", "Long-term effects of targeted litter microbial interventions on broiler health, productivity, pathogen load, and antimicrobial resistance dynamics during production.", "Given this longitudinal study design examining litter interventions, what specific sampling protocols and sequencing approaches would you recommend for tracking microbial community dynamics? I'm particularly interested in the optimal frequency for collecting litter samples, DNA extraction methods suitable for this complex matrix, and whether 16S rRNA amplicon sequencing provides sufficient resolution compared to shotgun metagenomics for monitoring both taxonomic shifts and antimicrobial resistance gene carriage throughout the production cycle."], "ground_truth": ["permed-66651", "permed-66655", "permed-66648", "permed-67816", "permed-66650", "permed-66657", "permed-82999", "permed-64997", "permed-90559", "permed-66654"]}
{"query_id": "topic_501_turn_1", "conversation_id": "topic_501", "turn_id": 1, "query": "What challenges do new graduate nurses typically face in adapting to healthcare environments?", "history": [], "ground_truth": ["permed-53033", "permed-78660", "permed-78647", "permed-65756", "permed-65758", "permed-78659", "permed-54910", "permed-90489", "permed-80772", "permed-78648"]}
{"query_id": "topic_501_turn_2", "conversation_id": "topic_501", "turn_id": 2, "query": "How can organizations better support them in developing resilience, especially during times of significant change like mergers or public health crises?", "history": ["What challenges do new graduate nurses typically face in adapting to healthcare environments?"], "ground_truth": ["permed-69682", "permed-59644", "permed-58281", "permed-54344", "permed-53018", "permed-58276", "permed-65750", "permed-69684", "permed-55969", "permed-54001"]}
{"query_id": "topic_501_turn_3", "conversation_id": "topic_501", "turn_id": 3, "query": "Given these challenges and the need for better support, what evidence-based strategies or innovative practices could healthcare organizations implement to specifically enhance new graduate nurses' adaptability and resilience in rapidly changing environments—especially following major organizational shifts like mergers or during public health crises?", "history": ["What challenges do new graduate nurses typically face in adapting to healthcare environments?", "How can organizations better support them in developing resilience, especially during times of significant change like mergers or public health crises?"], "ground_truth": ["permed-53033", "permed-78647", "permed-65756", "permed-54910", "permed-78659", "permed-78660", "permed-78648", "permed-65750", "permed-65758", "permed-90489"]}
{"query_id": "topic_501_turn_4", "conversation_id": "topic_501", "turn_id": 4, "query": "In implementing these resilience-building strategies for new graduate nurses, what specific methodological approaches would you recommend for evaluating their effectiveness? I'm particularly interested in how to design longitudinal studies that track adaptability metrics across different organizational contexts, what validated instruments exist for measuring resilience in nursing populations, and what statistical methods would be appropriate for controlling confounding variables like prior clinical experience during major organizational transitions.", "history": ["What challenges do new graduate nurses typically face in adapting to healthcare environments?", "How can organizations better support them in developing resilience, especially during times of significant change like mergers or public health crises?", "Given these challenges and the need for better support, what evidence-based strategies or innovative practices could healthcare organizations implement to specifically enhance new graduate nurses' adaptability and resilience in rapidly changing environments—especially following major organizational shifts like mergers or during public health crises?"], "ground_truth": ["permed-65756", "permed-78647", "permed-78659", "permed-51973", "permed-53033", "permed-80772", "permed-90623", "permed-78648", "permed-54910", "permed-62859"]}
{"query_id": "topic_501_turn_5", "conversation_id": "topic_501", "turn_id": 5, "query": "Given these methodological approaches for evaluating resilience interventions, what clinical outcomes have been demonstrated when new graduate nurses receive structured resilience training during organizational transitions? Specifically, what evidence exists regarding reduced medication errors, decreased patient fall rates, or improved HCAHPS scores—and how do these clinical metrics correlate with the psychological resilience measures previously discussed? I'm particularly interested in studies that track both nurse wellbeing and patient safety outcomes concurrently during healthcare system mergers or pandemic responses.", "history": ["What challenges do new graduate nurses typically face in adapting to healthcare environments?", "How can organizations better support them in developing resilience, especially during times of significant change like mergers or public health crises?", "Given these challenges and the need for better support, what evidence-based strategies or innovative practices could healthcare organizations implement to specifically enhance new graduate nurses' adaptability and resilience in rapidly changing environments—especially following major organizational shifts like mergers or during public health crises?", "In implementing these resilience-building strategies for new graduate nurses, what specific methodological approaches would you recommend for evaluating their effectiveness? I'm particularly interested in how to design longitudinal studies that track adaptability metrics across different organizational contexts, what validated instruments exist for measuring resilience in nursing populations, and what statistical methods would be appropriate for controlling confounding variables like prior clinical experience during major organizational transitions."], "ground_truth": ["permed-65756", "permed-78659", "permed-54910", "permed-65750", "permed-51973", "permed-62859", "permed-55085", "permed-55526", "permed-55088", "permed-90623"]}
{"query_id": "topic_502_turn_1", "conversation_id": "topic_502", "turn_id": 1, "query": "What is known about the therapeutic potential of taraxasterol in treating liver fibrosis?", "history": [], "ground_truth": ["permed-50797", "permed-89497", "permed-60748", "permed-50795", "permed-64906", "permed-50793", "permed-79344", "permed-79140", "permed-86125", "permed-60268"]}
{"query_id": "topic_502_turn_2", "conversation_id": "topic_502", "turn_id": 2, "query": "How does it interact with major signaling pathways in this context, particularly those involved in fibrogenesis?", "history": ["What is known about the therapeutic potential of taraxasterol in treating liver fibrosis?"], "ground_truth": ["permed-71707", "permed-51215", "permed-53075", "permed-64092", "permed-51209", "permed-82053", "permed-51216", "permed-53253", "permed-50796", "permed-50802"]}
{"query_id": "topic_502_turn_3", "conversation_id": "topic_502", "turn_id": 3, "query": "Given that taraxasterol modulates multiple signaling pathways in liver fibrosis, how might the interplay between the Hippo pathway and others like HIF-1α, TGF-β/Smad, and Wnt influence its therapeutic potential? Specifically, what downstream effector molecules are commonly regulated by these pathways and could serve as biomarkers or targets for more effective interventions?", "history": ["What is known about the therapeutic potential of taraxasterol in treating liver fibrosis?", "How does it interact with major signaling pathways in this context, particularly those involved in fibrogenesis?"], "ground_truth": ["permed-50797", "permed-50801", "permed-68930", "permed-89497", "permed-78073", "permed-68299", "permed-64906", "permed-86125", "permed-50795", "permed-69023"]}
{"query_id": "topic_502_turn_4", "conversation_id": "topic_502", "turn_id": 4, "query": "When investigating these pathway interactions, what experimental approaches would best characterize the crosstalk between Hippo and TGF-β/Smad signaling in hepatic stellate cells? Specifically, what co-immunoprecipitation protocols and phosphoprotein analysis methods would validate simultaneous pathway modulation? Also, which statistical models (like multivariate regression or pathway enrichment analysis) could quantify the relative contributions of each pathway to the observed anti-fibrotic effects, particularly when assessing combinatorial inhibition versus single-pathway targeting?", "history": ["What is known about the therapeutic potential of taraxasterol in treating liver fibrosis?", "How does it interact with major signaling pathways in this context, particularly those involved in fibrogenesis?", "Given that taraxasterol modulates multiple signaling pathways in liver fibrosis, how might the interplay between the Hippo pathway and others like HIF-1α, TGF-β/Smad, and Wnt influence its therapeutic potential? Specifically, what downstream effector molecules are commonly regulated by these pathways and could serve as biomarkers or targets for more effective interventions?"], "ground_truth": ["permed-68930", "permed-86129", "permed-50797", "permed-53826", "permed-53853", "permed-9905", "permed-88073", "permed-68927", "permed-50801", "permed-50793"]}
{"query_id": "topic_502_turn_5", "conversation_id": "topic_502", "turn_id": 5, "query": "Given the experimental approaches discussed for analyzing Hippo and TGF-β/Smad crosstalk, how would the therapeutic efficacy of taraxasterol compare to direct combinatorial pathway inhibitors targeting both YAP/TAZ and Smad proteins simultaneously in hepatic stellate cells? Specifically, what relative advantages might taraxasterol's multi-pathway modulation offer compared to targeted dual-inhibition strategies in terms of off-target effects, resistance development, and long-term fibrotic regression across different liver fibrosis etiologies?", "history": ["What is known about the therapeutic potential of taraxasterol in treating liver fibrosis?", "How does it interact with major signaling pathways in this context, particularly those involved in fibrogenesis?", "Given that taraxasterol modulates multiple signaling pathways in liver fibrosis, how might the interplay between the Hippo pathway and others like HIF-1α, TGF-β/Smad, and Wnt influence its therapeutic potential? Specifically, what downstream effector molecules are commonly regulated by these pathways and could serve as biomarkers or targets for more effective interventions?", "When investigating these pathway interactions, what experimental approaches would best characterize the crosstalk between Hippo and TGF-β/Smad signaling in hepatic stellate cells? Specifically, what co-immunoprecipitation protocols and phosphoprotein analysis methods would validate simultaneous pathway modulation? Also, which statistical models (like multivariate regression or pathway enrichment analysis) could quantify the relative contributions of each pathway to the observed anti-fibrotic effects, particularly when assessing combinatorial inhibition versus single-pathway targeting?"], "ground_truth": ["permed-50797", "permed-68930", "permed-89497", "permed-50795", "permed-50793", "permed-79344", "permed-86129", "permed-86125", "permed-68299", "permed-88073"]}
{"query_id": "topic_503_turn_1", "conversation_id": "topic_503", "turn_id": 1, "query": "Is there a link between influenza vaccination and reduced incidence of other infections in high-risk populations?", "history": [], "ground_truth": ["permed-62146", "permed-82968", "permed-78579", "permed-90575", "permed-68519", "permed-21263", "permed-90577", "permed-65782", "permed-33486", "permed-78581"]}
{"query_id": "topic_503_turn_2", "conversation_id": "topic_503", "turn_id": 2, "query": "Does this observed effect extend to fungal infections like invasive aspergillosis, and if so, what role might immunological responses play?", "history": ["Is there a link between influenza vaccination and reduced incidence of other infections in high-risk populations?"], "ground_truth": ["permed-86818", "permed-86817", "permed-66619", "permed-51000", "permed-54075", "permed-60096", "permed-54076", "permed-8320", "permed-66626", "permed-20836"]}
{"query_id": "topic_503_turn_3", "conversation_id": "topic_503", "turn_id": 3, "query": "Given that the flu vaccine seems to reduce invasive aspergillosis in high-risk groups, what specific immune responses triggered by the vaccination might be responsible for this protection, and how do these mechanisms work?", "history": ["Is there a link between influenza vaccination and reduced incidence of other infections in high-risk populations?", "Does this observed effect extend to fungal infections like invasive aspergillosis, and if so, what role might immunological responses play?"], "ground_truth": ["permed-62146", "permed-85569", "permed-90831", "permed-86817", "permed-85568", "permed-42920", "permed-82968", "permed-76755", "permed-33254", "permed-13682"]}
{"query_id": "topic_503_turn_4", "conversation_id": "topic_503", "turn_id": 4, "query": "To investigate these immune mechanisms systematically, what would be the optimal experimental design for comparing immune cell populations and cytokine profiles between vaccinated and unvaccinated high-risk patients? Specifically, which flow cytometry panels and multiplex cytokine assays would be most appropriate for detecting trained immunity markers, and what statistical power calculations should inform the sample size needed to detect meaningful differences in aspergillosis incidence?", "history": ["Is there a link between influenza vaccination and reduced incidence of other infections in high-risk populations?", "Does this observed effect extend to fungal infections like invasive aspergillosis, and if so, what role might immunological responses play?", "Given that the flu vaccine seems to reduce invasive aspergillosis in high-risk groups, what specific immune responses triggered by the vaccination might be responsible for this protection, and how do these mechanisms work?"], "ground_truth": ["permed-62146", "permed-86817", "permed-86818", "permed-66293", "permed-54075", "permed-62158", "permed-67999", "permed-62356", "permed-68002", "permed-22438"]}
{"query_id": "topic_503_turn_5", "conversation_id": "topic_503", "turn_id": 5, "query": "Given these proposed experimental designs to uncover trained immunity mechanisms, what clinical evidence exists regarding influenza vaccination's real-world efficacy in reducing invasive aspergillosis among immunocompromised patients? Specifically, what do retrospective cohort studies or post-hoc analyses of clinical trials reveal about the magnitude of protection, and are there particular patient subgroups—such as those with specific immunosuppressive regimens or underlying hematological malignancies—that demonstrate differential benefit in terms of aspergillosis incidence and associated mortality rates?", "history": ["Is there a link between influenza vaccination and reduced incidence of other infections in high-risk populations?", "Does this observed effect extend to fungal infections like invasive aspergillosis, and if so, what role might immunological responses play?", "Given that the flu vaccine seems to reduce invasive aspergillosis in high-risk groups, what specific immune responses triggered by the vaccination might be responsible for this protection, and how do these mechanisms work?", "To investigate these immune mechanisms systematically, what would be the optimal experimental design for comparing immune cell populations and cytokine profiles between vaccinated and unvaccinated high-risk patients? Specifically, which flow cytometry panels and multiplex cytokine assays would be most appropriate for detecting trained immunity markers, and what statistical power calculations should inform the sample size needed to detect meaningful differences in aspergillosis incidence?"], "ground_truth": ["permed-62146", "permed-33254", "permed-49606", "permed-23428", "permed-85569", "permed-61557", "permed-54075", "permed-54081", "permed-82968", "permed-86817"]}
{"query_id": "topic_504_turn_1", "conversation_id": "topic_504", "turn_id": 1, "query": "What advancements have been made in creating artificial muscle tissues through 3D bioprinting?", "history": [], "ground_truth": ["permed-79768", "permed-75738", "permed-57921", "permed-64659", "permed-64388", "permed-31270", "permed-57917", "permed-31201", "permed-20009", "permed-57922"]}
{"query_id": "topic_504_turn_2", "conversation_id": "topic_504", "turn_id": 2, "query": "How does this technique impact the development of functional outcomes that mimic native skeletal muscle?", "history": ["What advancements have been made in creating artificial muscle tissues through 3D bioprinting?"], "ground_truth": ["permed-79768", "permed-77509", "permed-79771", "permed-82326", "permed-58377", "permed-44167", "permed-17623", "permed-72160", "permed-91223", "permed-82319"]}
{"query_id": "topic_504_turn_3", "conversation_id": "topic_504", "turn_id": 3, "query": "Given these advancements in 3D bioprinting artificial muscle tissues and their functional outcomes, how can we optimize the mechanical properties and long-term performance of those fabricated using microvalve-assisted coaxial bioprinting to better match native skeletal muscle? What are the key challenges and potential solutions in moving this technology from preclinical models to treating human patients with severe muscle injuries?", "history": ["What advancements have been made in creating artificial muscle tissues through 3D bioprinting?", "How does this technique impact the development of functional outcomes that mimic native skeletal muscle?"], "ground_truth": ["permed-79768", "permed-31270", "permed-57917", "permed-75738", "permed-57921", "permed-64388", "permed-57922", "permed-79770", "permed-64510", "permed-20009"]}
{"query_id": "topic_504_turn_4", "conversation_id": "topic_504", "turn_id": 4, "query": "Focusing specifically on the microvalve-assisted coaxial bioprinting approach mentioned, what specific crosslinking protocols and dynamic culture conditions have shown optimal results for maintaining structural integrity during mechanical maturation? Additionally, what quantitative metrics—such as Young's modulus measurements or fatigue testing protocols—are most appropriate for validating that these bioprinted constructs achieve mechanical properties comparable to native muscle tissue across multiple batches?", "history": ["What advancements have been made in creating artificial muscle tissues through 3D bioprinting?", "How does this technique impact the development of functional outcomes that mimic native skeletal muscle?", "Given these advancements in 3D bioprinting artificial muscle tissues and their functional outcomes, how can we optimize the mechanical properties and long-term performance of those fabricated using microvalve-assisted coaxial bioprinting to better match native skeletal muscle? What are the key challenges and potential solutions in moving this technology from preclinical models to treating human patients with severe muscle injuries?"], "ground_truth": ["permed-79768", "permed-64573", "permed-87447", "permed-80565", "permed-64510", "permed-57917", "permed-39120", "permed-87045", "permed-67603", "permed-64570"]}
{"query_id": "topic_504_turn_5", "conversation_id": "topic_504", "turn_id": 5, "query": "Given the established protocols for structural maturation and mechanical validation of bioprinted constructs, what clinical safety data exists regarding the inflammatory response and long-term biocompatibility of these artificial muscles in human-relevant models? Specifically, what evidence from preclinical studies informs the risk of adverse events like ectopic mineralization or immunogenic reactions to bioinks when considering human implantation for volumetric muscle loss, and how do these findings impact the design of initial clinical trials?", "history": ["What advancements have been made in creating artificial muscle tissues through 3D bioprinting?", "How does this technique impact the development of functional outcomes that mimic native skeletal muscle?", "Given these advancements in 3D bioprinting artificial muscle tissues and their functional outcomes, how can we optimize the mechanical properties and long-term performance of those fabricated using microvalve-assisted coaxial bioprinting to better match native skeletal muscle? What are the key challenges and potential solutions in moving this technology from preclinical models to treating human patients with severe muscle injuries?", "Focusing specifically on the microvalve-assisted coaxial bioprinting approach mentioned, what specific crosslinking protocols and dynamic culture conditions have shown optimal results for maintaining structural integrity during mechanical maturation? Additionally, what quantitative metrics—such as Young's modulus measurements or fatigue testing protocols—are most appropriate for validating that these bioprinted constructs achieve mechanical properties comparable to native muscle tissue across multiple batches?"], "ground_truth": ["permed-75737", "permed-79768", "permed-57917", "permed-76868", "permed-55439", "permed-85977", "permed-54072", "permed-89231", "permed-75202", "permed-51457"]}
{"query_id": "topic_505_turn_1", "conversation_id": "topic_505", "turn_id": 1, "query": "Broad mechanisms of Netrin-1 action in traumatic brain injury and its contribution to neuronal recovery.", "history": [], "ground_truth": ["permed-62645", "permed-92536", "permed-53772", "permed-34294", "permed-68951", "permed-66783", "permed-61105", "permed-66780", "permed-82322", "permed-62651"]}
{"query_id": "topic_505_turn_2", "conversation_id": "topic_505", "turn_id": 2, "query": "Given its role established in traumatic brain injury, how does targeted modulation of this protein affect specific signaling pathways crucial for neuronal survival after such an injury?", "history": ["Broad mechanisms of Netrin-1 action in traumatic brain injury and its contribution to neuronal recovery."], "ground_truth": ["permed-53772", "permed-62646", "permed-42046", "permed-92536", "permed-62651", "permed-61105", "permed-75680", "permed-56586", "permed-68968", "permed-62645"]}
{"query_id": "topic_505_turn_3", "conversation_id": "topic_505", "turn_id": 3, "query": "Deep dive into Netrin-1's impact post-TBI: Beyond initially identified pathways like UNC5B/Nrf2, what alternative or complementary signaling networks are engaged by Netrin-1 modulation, and what are the therapeutic prospects of combinatorial strategies targeting these networks for enhanced long-term neurological functional recovery?", "history": ["Broad mechanisms of Netrin-1 action in traumatic brain injury and its contribution to neuronal recovery.", "Given its role established in traumatic brain injury, how does targeted modulation of this protein affect specific signaling pathways crucial for neuronal survival after such an injury?"], "ground_truth": ["permed-62645", "permed-55038", "permed-92536", "permed-62651", "permed-34294", "permed-53772", "permed-11706", "permed-62646", "permed-75680", "permed-61120"]}
{"query_id": "topic_505_turn_4", "conversation_id": "topic_505", "turn_id": 4, "query": "Given these investigations into Netrin-1's broader signaling networks, what specific in vivo experimental design—detailing the TBI model, timing of Netrin-1 modulation, and combinatorial therapeutic administration—would you employ to dissect the functional contributions of these alternative pathways? Furthermore, what validation strategies and quantitative metrics for neurological function would be most appropriate to statistically confirm synergistic effects and ensure reproducibility across preclinical studies?", "history": ["Broad mechanisms of Netrin-1 action in traumatic brain injury and its contribution to neuronal recovery.", "Given its role established in traumatic brain injury, how does targeted modulation of this protein affect specific signaling pathways crucial for neuronal survival after such an injury?", "Deep dive into Netrin-1's impact post-TBI: Beyond initially identified pathways like UNC5B/Nrf2, what alternative or complementary signaling networks are engaged by Netrin-1 modulation, and what are the therapeutic prospects of combinatorial strategies targeting these networks for enhanced long-term neurological functional recovery?"], "ground_truth": ["permed-62645", "permed-75680", "permed-62651", "permed-34294", "permed-53772", "permed-10977", "permed-36997", "permed-61120", "permed-12195", "permed-55038"]}
{"query_id": "topic_505_turn_5", "conversation_id": "topic_505", "turn_id": 5, "query": "Given the comprehensive experimental design for testing Netrin-1's combinatorial therapeutic potential, how would the efficacy of Netrin-1-based combinatorial approaches versus single-pathway modulation compare across different TBI severities and time windows post-injury? Specifically, what are the trade-offs in functional recovery, neuroinflammatory resolution, and axonal regeneration when comparing targeted single-pathway interventions (e.g., UNC5B/Nrf2 only) against multi-network strategies, and does the relative performance advantage of combinatorial approaches hold consistently across mild, moderate, and severe TBI models in preclinical settings?", "history": ["Broad mechanisms of Netrin-1 action in traumatic brain injury and its contribution to neuronal recovery.", "Given its role established in traumatic brain injury, how does targeted modulation of this protein affect specific signaling pathways crucial for neuronal survival after such an injury?", "Deep dive into Netrin-1's impact post-TBI: Beyond initially identified pathways like UNC5B/Nrf2, what alternative or complementary signaling networks are engaged by Netrin-1 modulation, and what are the therapeutic prospects of combinatorial strategies targeting these networks for enhanced long-term neurological functional recovery?", "Given these investigations into Netrin-1's broader signaling networks, what specific in vivo experimental design—detailing the TBI model, timing of Netrin-1 modulation, and combinatorial therapeutic administration—would you employ to dissect the functional contributions of these alternative pathways? Furthermore, what validation strategies and quantitative metrics for neurological function would be most appropriate to statistically confirm synergistic effects and ensure reproducibility across preclinical studies?"], "ground_truth": ["permed-62645", "permed-62651", "permed-55038", "permed-34294", "permed-75680", "permed-60040", "permed-53772", "permed-48289", "permed-36770", "permed-12056"]}
{"query_id": "topic_506_turn_1", "conversation_id": "topic_506", "turn_id": 1, "query": "Molecular mechanisms of KIF4A's involvement in endometrial cancer pathogenesis and progression.", "history": [], "ground_truth": ["permed-76567", "permed-89646", "permed-82373", "permed-76378", "permed-84224", "permed-70469", "permed-55307", "permed-91831", "permed-82961", "permed-90457"]}
{"query_id": "topic_506_turn_2", "conversation_id": "topic_506", "turn_id": 2, "query": "Investigating KIF4A's interactions in endometrial cancer, how does its specific binding with TPX2 influence downstream signaling pathways critical for disease progression?", "history": ["Molecular mechanisms of KIF4A's involvement in endometrial cancer pathogenesis and progression."], "ground_truth": ["permed-76567", "permed-89646", "permed-84224", "permed-70469", "permed-90457", "permed-76378", "permed-62683", "permed-83534", "permed-55307", "permed-53828"]}
{"query_id": "topic_506_turn_3", "conversation_id": "topic_506", "turn_id": 3, "query": "Focusing on the KIF4A-TPX2 complex in endometrial cancer, how does its established role in regulating TPX2 degradation and maintaining genomic stability translate into specific alterations of the tumor microenvironment (e.g., immune cell infiltration, neoangiogenesis) and what are the direct implications for targeted therapy efficacy and patient survival biomarkers?", "history": ["Molecular mechanisms of KIF4A's involvement in endometrial cancer pathogenesis and progression.", "Investigating KIF4A's interactions in endometrial cancer, how does its specific binding with TPX2 influence downstream signaling pathways critical for disease progression?"], "ground_truth": ["permed-76567", "permed-84224", "permed-53177", "permed-83534", "permed-70471", "permed-67947", "permed-56430", "permed-70702", "permed-73636", "permed-70531"]}
{"query_id": "topic_506_turn_4", "conversation_id": "topic_506", "turn_id": 4, "query": "Given the established role of KIF4A-TPX2 in genomic stability and tumor microenvironment alterations, what specific experimental approaches were used to quantify TPX2 degradation kinetics and validate the downstream effects on immune cell infiltration markers? I'm particularly interested in the technical details of how you measured degradation rates—whether through cycloheximide chase assays coupled with quantitative Western blotting or live-cell imaging—and how you correlated these molecular changes with spatial analysis of tumor-infiltrating lymphocytes using multiplex immunohistochemistry.", "history": ["Molecular mechanisms of KIF4A's involvement in endometrial cancer pathogenesis and progression.", "Investigating KIF4A's interactions in endometrial cancer, how does its specific binding with TPX2 influence downstream signaling pathways critical for disease progression?", "Focusing on the KIF4A-TPX2 complex in endometrial cancer, how does its established role in regulating TPX2 degradation and maintaining genomic stability translate into specific alterations of the tumor microenvironment (e.g., immune cell infiltration, neoangiogenesis) and what are the direct implications for targeted therapy efficacy and patient survival biomarkers?"], "ground_truth": ["permed-76567", "permed-3170", "permed-67947", "permed-10575", "permed-35283", "permed-69116", "permed-53177", "permed-68286", "permed-70983", "permed-56430"]}
{"query_id": "topic_506_turn_5", "conversation_id": "topic_506", "turn_id": 5, "query": "Building on these detailed molecular quantification methods, how have these validated KIF4A-TPX2 degradation kinetics and tumor microenvironment alterations translated into clinical trial outcomes for endometrial cancer patients? I'm particularly interested in whether targeted therapies disrupting this complex have demonstrated improved progression-free survival in phase II/III trials, what the predominant treatment-related adverse events profiles look like, and if specific immune cell infiltration patterns (e.g., CD8+ T-cell densities) have emerged as predictive biomarkers for therapeutic response in these clinical settings.", "history": ["Molecular mechanisms of KIF4A's involvement in endometrial cancer pathogenesis and progression.", "Investigating KIF4A's interactions in endometrial cancer, how does its specific binding with TPX2 influence downstream signaling pathways critical for disease progression?", "Focusing on the KIF4A-TPX2 complex in endometrial cancer, how does its established role in regulating TPX2 degradation and maintaining genomic stability translate into specific alterations of the tumor microenvironment (e.g., immune cell infiltration, neoangiogenesis) and what are the direct implications for targeted therapy efficacy and patient survival biomarkers?", "Given the established role of KIF4A-TPX2 in genomic stability and tumor microenvironment alterations, what specific experimental approaches were used to quantify TPX2 degradation kinetics and validate the downstream effects on immune cell infiltration markers? I'm particularly interested in the technical details of how you measured degradation rates—whether through cycloheximide chase assays coupled with quantitative Western blotting or live-cell imaging—and how you correlated these molecular changes with spatial analysis of tumor-infiltrating lymphocytes using multiplex immunohistochemistry."], "ground_truth": ["permed-76567", "permed-84224", "permed-73636", "permed-68629", "permed-70983", "permed-56430", "permed-89646", "permed-56751", "permed-67725", "permed-80397"]}
{"query_id": "topic_507_turn_1", "conversation_id": "topic_507", "turn_id": 1, "query": "Influence of mechanical strain and magnetic fields on topological properties in 2D monolayer materials", "history": [], "ground_truth": ["permed-73286", "permed-75584", "permed-90090", "permed-75948", "permed-75950", "permed-75587", "permed-73288", "permed-62261", "permed-73287", "permed-60595"]}
{"query_id": "topic_507_turn_2", "conversation_id": "topic_507", "turn_id": 2, "query": "Methods for skyrmion engineering using these factors in such 2D materials: enhancing stability and control", "history": ["Influence of mechanical strain and magnetic fields on topological properties in 2D monolayer materials"], "ground_truth": ["permed-84127", "permed-73258", "permed-73286", "permed-75582", "permed-82695", "permed-51035", "permed-75053", "permed-60645", "permed-75054", "permed-75059"]}
{"query_id": "topic_507_turn_3", "conversation_id": "topic_507", "turn_id": 3, "query": "Optimizing biaxial strain and magnetic field parameters for skyrmion control in Janus MnSbBiSe<sub>2</sub>Te<sub>2</sub> (MSBST) monolayers: implications for spintronic device performance", "history": ["Influence of mechanical strain and magnetic fields on topological properties in 2D monolayer materials", "Methods for skyrmion engineering using these factors in such 2D materials: enhancing stability and control"], "ground_truth": ["permed-73286", "permed-73288", "permed-84127", "permed-73263", "permed-79017", "permed-75582", "permed-73024", "permed-76992", "permed-75513", "permed-75583"]}
{"query_id": "topic_507_turn_4", "conversation_id": "topic_507", "turn_id": 4, "query": "Given this optimization approach for MSBST monolayers, what specific computational and experimental validation protocols were employed to verify skyrmion stability under the identified strain-field combinations? I'm particularly interested in how the hysteresis loop measurements were calibrated against micromagnetic simulations, and what statistical criteria determined the threshold for stable skyrmion formation versus annihilation during parameter sweeps.", "history": ["Influence of mechanical strain and magnetic fields on topological properties in 2D monolayer materials", "Methods for skyrmion engineering using these factors in such 2D materials: enhancing stability and control", "Optimizing biaxial strain and magnetic field parameters for skyrmion control in Janus MnSbBiSe<sub>2</sub>Te<sub>2</sub> (MSBST) monolayers: implications for spintronic device performance"], "ground_truth": ["permed-73286", "permed-75582", "permed-73258", "permed-84127", "permed-67589", "permed-79017", "permed-16672", "permed-28446", "permed-65023", "permed-73263"]}
{"query_id": "topic_507_turn_5", "conversation_id": "topic_507", "turn_id": 5, "query": "Given these validated protocols for skyrmion stability in MSBST monolayers, what translational challenges exist for implementing these material systems in clinical neuromodulation devices? Specifically, how do skyrmion-mediated spin torque effects influence neural stimulation precision compared to conventional magnetic materials, and what biocompatibility considerations arise when interfacing 2D topological materials with neural tissue? Furthermore, what safety thresholds must be established regarding magnetic field exposure during potential therapeutic applications for neurological disorders?", "history": ["Influence of mechanical strain and magnetic fields on topological properties in 2D monolayer materials", "Methods for skyrmion engineering using these factors in such 2D materials: enhancing stability and control", "Optimizing biaxial strain and magnetic field parameters for skyrmion control in Janus MnSbBiSe<sub>2</sub>Te<sub>2</sub> (MSBST) monolayers: implications for spintronic device performance", "Given this optimization approach for MSBST monolayers, what specific computational and experimental validation protocols were employed to verify skyrmion stability under the identified strain-field combinations? I'm particularly interested in how the hysteresis loop measurements were calibrated against micromagnetic simulations, and what statistical criteria determined the threshold for stable skyrmion formation versus annihilation during parameter sweeps."], "ground_truth": ["permed-73286", "permed-84127", "permed-75582", "permed-79017", "permed-8608", "permed-75736", "permed-89162", "permed-66472", "permed-68376", "permed-91954"]}
{"query_id": "topic_508_turn_1", "conversation_id": "topic_508", "turn_id": 1, "query": "Recent advancements in hybrid microgels for biomedical applications", "history": [], "ground_truth": ["permed-70212", "permed-75001", "permed-75385", "permed-64392", "permed-75386", "permed-64382", "permed-66780", "permed-60645", "permed-53718", "permed-64386"]}
{"query_id": "topic_508_turn_2", "conversation_id": "topic_508", "turn_id": 2, "query": "Enhancing stimuli-responsiveness of these hybrid microgels for targeted drug delivery", "history": ["Recent advancements in hybrid microgels for biomedical applications"], "ground_truth": ["permed-75001", "permed-70212", "permed-75385", "permed-78832", "permed-58079", "permed-72909", "permed-67174", "permed-58042", "permed-75002", "permed-72972"]}
{"query_id": "topic_508_turn_3", "conversation_id": "topic_508", "turn_id": 3, "query": "Optimizing synthesis and functionalization of hybrid microgels incorporating organic dyes and inorganic nanoparticles for dual pH/temperature responsive targeted drug delivery in personalized medicine", "history": ["Recent advancements in hybrid microgels for biomedical applications", "Enhancing stimuli-responsiveness of these hybrid microgels for targeted drug delivery"], "ground_truth": ["permed-75001", "permed-75385", "permed-70212", "permed-80640", "permed-73082", "permed-60645", "permed-88792", "permed-67182", "permed-50878", "permed-72909"]}
{"query_id": "topic_508_turn_4", "conversation_id": "topic_508", "turn_id": 4, "query": "Given this dual-responsive optimization approach, what specific statistical methods and experimental design parameters were employed to validate the reproducibility of microgel synthesis across multiple batches? I'm particularly interested in how you established quality control metrics for nanoparticle distribution uniformity and dye conjugation efficiency, and whether you used design of experiments methodologies to systematically evaluate the interaction effects between pH and temperature triggers during drug release kinetics testing.", "history": ["Recent advancements in hybrid microgels for biomedical applications", "Enhancing stimuli-responsiveness of these hybrid microgels for targeted drug delivery", "Optimizing synthesis and functionalization of hybrid microgels incorporating organic dyes and inorganic nanoparticles for dual pH/temperature responsive targeted drug delivery in personalized medicine"], "ground_truth": ["permed-75001", "permed-75389", "permed-75386", "permed-86118", "permed-80640", "permed-64392", "permed-70212", "permed-75385", "permed-73092", "permed-59233"]}
{"query_id": "topic_508_turn_5", "conversation_id": "topic_508", "turn_id": 5, "query": "Given these robust reproducibility metrics, what clinical translation challenges have you encountered when applying these dual-responsive microgels in vivo? Specifically, how do the established pH/temperature triggers correlate with pathological microenvironments in disease models, and what patient safety profiles have emerged regarding immune responses to persistent inorganic nanoparticles? Have any clinical trials evaluated therapeutic efficacy compared to conventional delivery systems, particularly regarding reduced side effects through targeted release in inflamed or tumor tissues?", "history": ["Recent advancements in hybrid microgels for biomedical applications", "Enhancing stimuli-responsiveness of these hybrid microgels for targeted drug delivery", "Optimizing synthesis and functionalization of hybrid microgels incorporating organic dyes and inorganic nanoparticles for dual pH/temperature responsive targeted drug delivery in personalized medicine", "Given this dual-responsive optimization approach, what specific statistical methods and experimental design parameters were employed to validate the reproducibility of microgel synthesis across multiple batches? I'm particularly interested in how you established quality control metrics for nanoparticle distribution uniformity and dye conjugation efficiency, and whether you used design of experiments methodologies to systematically evaluate the interaction effects between pH and temperature triggers during drug release kinetics testing."], "ground_truth": ["permed-75001", "permed-80640", "permed-70212", "permed-75386", "permed-64392", "permed-68112", "permed-72975", "permed-86822", "permed-78832", "permed-72499"]}
{"query_id": "topic_509_turn_1", "conversation_id": "topic_509", "turn_id": 1, "query": "How does social isolation affect the mental health of elderly populations during public health crises?", "history": [], "ground_truth": ["permed-80079", "permed-54754", "permed-80267", "permed-56012", "permed-50574", "permed-51720", "permed-54023", "permed-69487", "permed-59525", "permed-54024"]}
{"query_id": "topic_509_turn_2", "conversation_id": "topic_509", "turn_id": 2, "query": "Can social support networks play a significant role in mitigating these negative effects, and if so, what aspects of them are most beneficial?", "history": ["How does social isolation affect the mental health of elderly populations during public health crises?"], "ground_truth": ["permed-67357", "permed-55773", "permed-65950", "permed-58472", "permed-53171", "permed-53168", "permed-65744", "permed-69465", "permed-53163", "permed-64241"]}
{"query_id": "topic_509_turn_3", "conversation_id": "topic_509", "turn_id": 3, "query": "Given that social support networks can help mitigate these effects, what are the specific ways they actually work to reduce isolation and loneliness in elderly populations during prolonged crises like COVID-19? And how could understanding these mechanisms help design better interventions to boost their psychological resilience?", "history": ["How does social isolation affect the mental health of elderly populations during public health crises?", "Can social support networks play a significant role in mitigating these negative effects, and if so, what aspects of them are most beneficial?"], "ground_truth": ["permed-80079", "permed-80080", "permed-54023", "permed-70268", "permed-61923", "permed-65431", "permed-65950", "permed-70269", "permed-56012", "permed-54754"]}
{"query_id": "topic_509_turn_4", "conversation_id": "topic_509", "turn_id": 4, "query": "Given these identified mechanisms for reducing isolation, what specific methodological approaches would you recommend for quantifying their relative effectiveness in intervention studies? I'm particularly interested in how researchers might design longitudinal protocols to measure both subjective loneliness metrics and objective social interaction data, while controlling for covariates like pre-existing mental health conditions. What statistical modeling techniques would best capture the dynamic relationship between support network interventions and psychological resilience outcomes over time?", "history": ["How does social isolation affect the mental health of elderly populations during public health crises?", "Can social support networks play a significant role in mitigating these negative effects, and if so, what aspects of them are most beneficial?", "Given that social support networks can help mitigate these effects, what are the specific ways they actually work to reduce isolation and loneliness in elderly populations during prolonged crises like COVID-19? And how could understanding these mechanisms help design better interventions to boost their psychological resilience?"], "ground_truth": ["permed-80187", "permed-71403", "permed-80188", "permed-81026", "permed-63357", "permed-80080", "permed-67166", "permed-69506", "permed-71402", "permed-70269"]}
{"query_id": "topic_509_turn_5", "conversation_id": "topic_509", "turn_id": 5, "query": "Given your methodological recommendations for quantifying intervention effectiveness, how would longitudinal study designs compare when examining technology-mediated versus traditional in-person social support interventions for isolated elderly populations? Specifically, what trade-offs exist between digital platforms and face-to-face approaches in terms of scalability, accessibility, and psychological outcome durability? How might statistical models need to differ when analyzing these distinct delivery modes, particularly regarding their mechanisms of action and effect sustainability across different demographic subgroups within elderly populations?", "history": ["How does social isolation affect the mental health of elderly populations during public health crises?", "Can social support networks play a significant role in mitigating these negative effects, and if so, what aspects of them are most beneficial?", "Given that social support networks can help mitigate these effects, what are the specific ways they actually work to reduce isolation and loneliness in elderly populations during prolonged crises like COVID-19? And how could understanding these mechanisms help design better interventions to boost their psychological resilience?", "Given these identified mechanisms for reducing isolation, what specific methodological approaches would you recommend for quantifying their relative effectiveness in intervention studies? I'm particularly interested in how researchers might design longitudinal protocols to measure both subjective loneliness metrics and objective social interaction data, while controlling for covariates like pre-existing mental health conditions. What statistical modeling techniques would best capture the dynamic relationship between support network interventions and psychological resilience outcomes over time?"], "ground_truth": ["permed-85231", "permed-56011", "permed-58481", "permed-82779", "permed-53168", "permed-63357", "permed-51715", "permed-69429", "permed-53165", "permed-80187"]}
{"query_id": "topic_510_turn_1", "conversation_id": "topic_510", "turn_id": 1, "query": "Predictive value of standard clinical data for acute lung injury (ALI) in patients with severe acute pancreatitis (SAP)", "history": [], "ground_truth": ["permed-60544", "permed-75525", "permed-16969", "permed-72265", "permed-24439", "permed-3597", "permed-24448", "permed-17129", "permed-16963", "permed-57121"]}
{"query_id": "topic_510_turn_2", "conversation_id": "topic_510", "turn_id": 2, "query": "Improving these ALI-SAP predictions: assessing the added value of novel biomarkers and continuous monitoring parameters beyond standard clinical data", "history": ["Predictive value of standard clinical data for acute lung injury (ALI) in patients with severe acute pancreatitis (SAP)"], "ground_truth": ["permed-60544", "permed-66153", "permed-58927", "permed-57121", "permed-70300", "permed-61540", "permed-4714", "permed-58667", "permed-89531", "permed-87116"]}
{"query_id": "topic_510_turn_3", "conversation_id": "topic_510", "turn_id": 3, "query": "Integrating dynamic biomarker profiles and real-time physiological monitoring into enhanced ALI-SAP predictive models: strategies for improved risk stratification and guiding personalized treatment decisions", "history": ["Predictive value of standard clinical data for acute lung injury (ALI) in patients with severe acute pancreatitis (SAP)", "Improving these ALI-SAP predictions: assessing the added value of novel biomarkers and continuous monitoring parameters beyond standard clinical data"], "ground_truth": ["permed-60544", "permed-57121", "permed-58927", "permed-89530", "permed-61540", "permed-44877", "permed-66153", "permed-27542", "permed-58667", "permed-11363"]}
{"query_id": "topic_510_turn_4", "conversation_id": "topic_510", "turn_id": 4, "query": "Given this integrated approach to ALI-SAP prediction, what specific computational methods were employed to handle the longitudinal biomarker data and real-time physiological streams? I'm particularly interested in how you addressed the challenges of variable sampling frequencies and missing data across these heterogeneous data sources, and which feature engineering techniques proved most effective for capturing temporal patterns relevant to ALI development.", "history": ["Predictive value of standard clinical data for acute lung injury (ALI) in patients with severe acute pancreatitis (SAP)", "Improving these ALI-SAP predictions: assessing the added value of novel biomarkers and continuous monitoring parameters beyond standard clinical data", "Integrating dynamic biomarker profiles and real-time physiological monitoring into enhanced ALI-SAP predictive models: strategies for improved risk stratification and guiding personalized treatment decisions"], "ground_truth": ["permed-60544", "permed-57121", "permed-85904", "permed-11363", "permed-25883", "permed-34458", "permed-55141", "permed-89530", "permed-61540", "permed-44877"]}
{"query_id": "topic_510_turn_5", "conversation_id": "topic_510", "turn_id": 5, "query": "Given the computational approaches discussed for heterogeneous data integration in ALI-SAP prediction, how do traditional statistical methods like mixed-effects models compare against machine learning approaches such as recurrent neural networks in handling longitudinal biomarker data? Specifically, what are their relative advantages in capturing temporal deterioration patterns while maintaining clinical interpretability, and which approach demonstrated superior performance in your validation cohort for balancing prediction accuracy with practical implementation constraints in clinical settings?", "history": ["Predictive value of standard clinical data for acute lung injury (ALI) in patients with severe acute pancreatitis (SAP)", "Improving these ALI-SAP predictions: assessing the added value of novel biomarkers and continuous monitoring parameters beyond standard clinical data", "Integrating dynamic biomarker profiles and real-time physiological monitoring into enhanced ALI-SAP predictive models: strategies for improved risk stratification and guiding personalized treatment decisions", "Given this integrated approach to ALI-SAP prediction, what specific computational methods were employed to handle the longitudinal biomarker data and real-time physiological streams? I'm particularly interested in how you addressed the challenges of variable sampling frequencies and missing data across these heterogeneous data sources, and which feature engineering techniques proved most effective for capturing temporal patterns relevant to ALI development."], "ground_truth": ["permed-34458", "permed-53344", "permed-65800", "permed-56676", "permed-55168", "permed-55484", "permed-59408", "permed-60544", "permed-61540", "permed-56483"]}
{"query_id": "topic_511_turn_1", "conversation_id": "topic_511", "turn_id": 1, "query": "What role do microparticles play in tissue repair during endoscopic procedures?", "history": [], "ground_truth": ["permed-81483", "permed-54199", "permed-67156", "permed-4339", "permed-57302", "permed-91613", "permed-56265", "permed-0304", "permed-33366", "permed-68471"]}
{"query_id": "topic_511_turn_2", "conversation_id": "topic_511", "turn_id": 2, "query": "Can modifying the properties of these microparticles, such as making them more hydrophobic, enhance their effectiveness in this area?", "history": ["What role do microparticles play in tissue repair during endoscopic procedures?"], "ground_truth": ["permed-67174", "permed-75003", "permed-60325", "permed-55453", "permed-58083", "permed-60673", "permed-86822", "permed-75389", "permed-72469", "permed-73086"]}
{"query_id": "topic_511_turn_3", "conversation_id": "topic_511", "turn_id": 3, "query": "Given that modifying these microparticles to be more hydrophobic could enhance their effectiveness, how can we further optimize the biomechanical properties and cellular interactions of hydrophobized gelatin microparticles (hMPs) to improve their efficacy in promoting tissue repair and reducing complications like infection and scarring in gastrointestinal endoscopic procedures beyond ESD? What long-term clinical outcomes would we expect in terms of safety and effectiveness?", "history": ["What role do microparticles play in tissue repair during endoscopic procedures?", "Can modifying the properties of these microparticles, such as making them more hydrophobic, enhance their effectiveness in this area?"], "ground_truth": ["permed-81483", "permed-75386", "permed-89836", "permed-52669", "permed-67411", "permed-80078", "permed-81484", "permed-67412", "permed-76270", "permed-78958"]}
{"query_id": "topic_511_turn_4", "conversation_id": "topic_511", "turn_id": 4, "query": "When implementing these biomechanical optimizations for hMPs, what specific characterization techniques would you recommend for evaluating mechanical properties like elastic modulus and adhesion strength? Additionally, what in vitro experimental models—such as specific co-culture systems or biomechanical testing setups—would best replicate the complex gastrointestinal environment to reliably assess cellular interactions and particle retention before progressing to animal studies?", "history": ["What role do microparticles play in tissue repair during endoscopic procedures?", "Can modifying the properties of these microparticles, such as making them more hydrophobic, enhance their effectiveness in this area?", "Given that modifying these microparticles to be more hydrophobic could enhance their effectiveness, how can we further optimize the biomechanical properties and cellular interactions of hydrophobized gelatin microparticles (hMPs) to improve their efficacy in promoting tissue repair and reducing complications like infection and scarring in gastrointestinal endoscopic procedures beyond ESD? What long-term clinical outcomes would we expect in terms of safety and effectiveness?"], "ground_truth": ["permed-81483", "permed-80078", "permed-81055", "permed-75386", "permed-37076", "permed-80565", "permed-60673", "permed-64570", "permed-53699", "permed-70799"]}
{"query_id": "topic_511_turn_5", "conversation_id": "topic_511", "turn_id": 5, "query": "Given these refined characterization and in vitro modeling approaches for optimized hMPs, what clinical trial designs would most effectively evaluate their therapeutic efficacy and safety in human gastrointestinal applications? Specifically, how should we structure Phase I/II trials to assess optimal hMP delivery parameters, dosing schedules, and comparative effectiveness against current standard closures in patients undergoing advanced endoscopic procedures? What clinical endpoints—such as healing rates, stricture formation, or bleeding events—would demonstrate meaningful patient benefit while monitoring for procedure-specific adverse events like particle migration or inflammatory responses?", "history": ["What role do microparticles play in tissue repair during endoscopic procedures?", "Can modifying the properties of these microparticles, such as making them more hydrophobic, enhance their effectiveness in this area?", "Given that modifying these microparticles to be more hydrophobic could enhance their effectiveness, how can we further optimize the biomechanical properties and cellular interactions of hydrophobized gelatin microparticles (hMPs) to improve their efficacy in promoting tissue repair and reducing complications like infection and scarring in gastrointestinal endoscopic procedures beyond ESD? What long-term clinical outcomes would we expect in terms of safety and effectiveness?", "When implementing these biomechanical optimizations for hMPs, what specific characterization techniques would you recommend for evaluating mechanical properties like elastic modulus and adhesion strength? Additionally, what in vitro experimental models—such as specific co-culture systems or biomechanical testing setups—would best replicate the complex gastrointestinal environment to reliably assess cellular interactions and particle retention before progressing to animal studies?"], "ground_truth": ["permed-81483", "permed-32648", "permed-0681", "permed-3495", "permed-83032", "permed-16899", "permed-52145", "permed-56992", "permed-11457", "permed-89128"]}
{"query_id": "topic_512_turn_1", "conversation_id": "topic_512", "turn_id": 1, "query": "What role do patient-preferred information sources play in decision-making for surgical oncology patients?", "history": [], "ground_truth": ["permed-81405", "permed-78476", "permed-81406", "permed-69322", "permed-82959", "permed-69328", "permed-80176", "permed-88523", "permed-91741", "permed-68617"]}
{"query_id": "topic_512_turn_2", "conversation_id": "topic_512", "turn_id": 2, "query": "How can healthcare systems effectively integrate these sources into their care frameworks to support both informed decision-making and emotional well-being?", "history": ["What role do patient-preferred information sources play in decision-making for surgical oncology patients?"], "ground_truth": ["permed-91926", "permed-80225", "permed-70065", "permed-67357", "permed-60767", "permed-66148", "permed-68445", "permed-67343", "permed-55113", "permed-52219"]}
{"query_id": "topic_512_turn_3", "conversation_id": "topic_512", "turn_id": 3, "query": "Given these considerations, how can healthcare systems structure their frameworks to incorporate patient-preferred information sources—even those that may lack full validation—in a way that maintains evidence-based decision-making while still meeting the emotional and psychological needs of newly diagnosed surgical oncology patients?", "history": ["What role do patient-preferred information sources play in decision-making for surgical oncology patients?", "How can healthcare systems effectively integrate these sources into their care frameworks to support both informed decision-making and emotional well-being?"], "ground_truth": ["permed-81405", "permed-82959", "permed-68617", "permed-69322", "permed-81406", "permed-69327", "permed-77999", "permed-80176", "permed-85103", "permed-52218"]}
{"query_id": "topic_512_turn_4", "conversation_id": "topic_512", "turn_id": 4, "query": "Given this framework for integrating potentially unvalidated sources, what specific methodological safeguards should be implemented during clinical encounters to ensure evidence-based decision-making isn't compromised? I'm particularly interested in the operational protocols for source documentation, how clinicians might systematically assess source credibility with patients, and whether validated instruments exist to measure how these discussions impact decision quality metrics. What structured approaches have been tested for balancing informational integrity with emotional support in real-time consultations?", "history": ["What role do patient-preferred information sources play in decision-making for surgical oncology patients?", "How can healthcare systems effectively integrate these sources into their care frameworks to support both informed decision-making and emotional well-being?", "Given these considerations, how can healthcare systems structure their frameworks to incorporate patient-preferred information sources—even those that may lack full validation—in a way that maintains evidence-based decision-making while still meeting the emotional and psychological needs of newly diagnosed surgical oncology patients?"], "ground_truth": ["permed-74801", "permed-79073", "permed-53883", "permed-84520", "permed-71297", "permed-83695", "permed-58493", "permed-81405", "permed-91602", "permed-51910"]}
{"query_id": "topic_512_turn_5", "conversation_id": "topic_512", "turn_id": 5, "query": "Given these methodological safeguards for maintaining evidence-based practice during source integration, what clinical outcomes have been observed when implementing such protocols in surgical oncology settings? Specifically, how do structured approaches balancing informational integrity with emotional support impact measurable patient-centric outcomes like decision regret, treatment adherence, or quality of life metrics in controlled trials? Furthermore, what evidence exists regarding potential unintended consequences—such as consultation time increases or decision delay—when systematically addressing patient-preferred sources during clinical encounters, and how do these trade-offs affect real-world therapeutic efficacy?", "history": ["What role do patient-preferred information sources play in decision-making for surgical oncology patients?", "How can healthcare systems effectively integrate these sources into their care frameworks to support both informed decision-making and emotional well-being?", "Given these considerations, how can healthcare systems structure their frameworks to incorporate patient-preferred information sources—even those that may lack full validation—in a way that maintains evidence-based decision-making while still meeting the emotional and psychological needs of newly diagnosed surgical oncology patients?", "Given this framework for integrating potentially unvalidated sources, what specific methodological safeguards should be implemented during clinical encounters to ensure evidence-based decision-making isn't compromised? I'm particularly interested in the operational protocols for source documentation, how clinicians might systematically assess source credibility with patients, and whether validated instruments exist to measure how these discussions impact decision quality metrics. What structured approaches have been tested for balancing informational integrity with emotional support in real-time consultations?"], "ground_truth": ["permed-65743", "permed-69059", "permed-60191", "permed-87096", "permed-90643", "permed-81405", "permed-85103", "permed-69323", "permed-53981", "permed-54613"]}
{"query_id": "topic_513_turn_1", "conversation_id": "topic_513", "turn_id": 1, "query": "What role do gastrointestinal symptoms play in the early diagnosis of Parkinson's disease?", "history": [], "ground_truth": ["permed-8462", "permed-9381", "permed-73749", "permed-9382", "permed-66146", "permed-90092", "permed-63189", "permed-64829", "permed-54218", "permed-8100"]}
{"query_id": "topic_513_turn_2", "conversation_id": "topic_513", "turn_id": 2, "query": "Can managing these symptoms, like constipation, lead to better patient outcomes and more effective treatment strategies in this area?", "history": ["What role do gastrointestinal symptoms play in the early diagnosis of Parkinson's disease?"], "ground_truth": ["permed-66146", "permed-66148", "permed-81519", "permed-82912", "permed-86429", "permed-91713", "permed-4134", "permed-68537", "permed-86436", "permed-82549"]}
{"query_id": "topic_513_turn_3", "conversation_id": "topic_513", "turn_id": 3, "query": "Given these findings about gastrointestinal symptoms in Parkinson's early diagnosis and their management, how might focusing on them—particularly constipation—help develop better diagnostic tools and personalized treatments? Could such interventions potentially slow disease progression and improve outcomes?", "history": ["What role do gastrointestinal symptoms play in the early diagnosis of Parkinson's disease?", "Can managing these symptoms, like constipation, lead to better patient outcomes and more effective treatment strategies in this area?"], "ground_truth": ["permed-8462", "permed-66146", "permed-81518", "permed-9381", "permed-81519", "permed-9382", "permed-63189", "permed-73749", "permed-66781", "permed-54218"]}
{"query_id": "topic_513_turn_4", "conversation_id": "topic_513", "turn_id": 4, "query": "Given this proposed framework for developing diagnostic tools and personalized treatments through gastrointestinal monitoring, what specific biomarkers and sampling protocols would be most appropriate for longitudinal tracking? I'm particularly interested in methodological considerations for stool metabolomics versus gut microbiome sequencing - which analytical platforms and statistical validation strategies would provide the most reliable data for correlating gut parameters with disease progression metrics in early Parkinson's patients?", "history": ["What role do gastrointestinal symptoms play in the early diagnosis of Parkinson's disease?", "Can managing these symptoms, like constipation, lead to better patient outcomes and more effective treatment strategies in this area?", "Given these findings about gastrointestinal symptoms in Parkinson's early diagnosis and their management, how might focusing on them—particularly constipation—help develop better diagnostic tools and personalized treatments? Could such interventions potentially slow disease progression and improve outcomes?"], "ground_truth": ["permed-90092", "permed-63189", "permed-8462", "permed-75063", "permed-54218", "permed-64829", "permed-66146", "permed-59100", "permed-57638", "permed-63188"]}
{"query_id": "topic_513_turn_5", "conversation_id": "topic_513", "turn_id": 5, "query": "Given these methodological considerations for gut biomarker tracking, what clinical trial evidence exists regarding interventions targeting gastrointestinal dysfunction in early Parkinson's disease? Specifically, what patient-reported outcomes and motor function metrics have shown improvement with prokinetic agents, probiotics, or dietary modifications in randomized controlled trials? I'm particularly interested in how these interventions have impacted disease progression rates and whether any safety concerns have emerged regarding long-term use in this vulnerable patient population, especially given their potential interactions with standard Parkinson's medications.", "history": ["What role do gastrointestinal symptoms play in the early diagnosis of Parkinson's disease?", "Can managing these symptoms, like constipation, lead to better patient outcomes and more effective treatment strategies in this area?", "Given these findings about gastrointestinal symptoms in Parkinson's early diagnosis and their management, how might focusing on them—particularly constipation—help develop better diagnostic tools and personalized treatments? Could such interventions potentially slow disease progression and improve outcomes?", "Given this proposed framework for developing diagnostic tools and personalized treatments through gastrointestinal monitoring, what specific biomarkers and sampling protocols would be most appropriate for longitudinal tracking? I'm particularly interested in methodological considerations for stool metabolomics versus gut microbiome sequencing - which analytical platforms and statistical validation strategies would provide the most reliable data for correlating gut parameters with disease progression metrics in early Parkinson's patients?"], "ground_truth": ["permed-81519", "permed-8462", "permed-71412", "permed-63189", "permed-66146", "permed-54218", "permed-90092", "permed-64835", "permed-63200", "permed-81518"]}
{"query_id": "topic_514_turn_1", "conversation_id": "topic_514", "turn_id": 1, "query": "What is the role of the ToMExO model in cancer research?", "history": [], "ground_truth": ["permed-78605", "permed-75563", "permed-82373", "permed-72762", "permed-56824", "permed-68623", "permed-56828", "permed-78169", "permed-68563", "permed-56831"]}
{"query_id": "topic_514_turn_2", "conversation_id": "topic_514", "turn_id": 2, "query": "Can this model help in understanding the progression of different cancers by identifying key genetic alterations?", "history": ["What is the role of the ToMExO model in cancer research?"], "ground_truth": ["permed-78605", "permed-82373", "permed-68563", "permed-50750", "permed-74456", "permed-78604", "permed-54311", "permed-82160", "permed-86461", "permed-73699"]}
{"query_id": "topic_514_turn_3", "conversation_id": "topic_514", "turn_id": 3, "query": "Given these capabilities of the ToMExO model in tracking cancer progression and identifying key genetic alterations, how might its insights be used to tailor personalized treatment strategies by accounting for individual patients' specific mutation patterns and the temporal sequences of their driver gene alterations?", "history": ["What is the role of the ToMExO model in cancer research?", "Can this model help in understanding the progression of different cancers by identifying key genetic alterations?"], "ground_truth": ["permed-78605", "permed-68623", "permed-77277", "permed-56402", "permed-74456", "permed-70753", "permed-50752", "permed-56401", "permed-50755", "permed-92644"]}
{"query_id": "topic_514_turn_4", "conversation_id": "topic_514", "turn_id": 4, "query": "Building on this personalized treatment approach, could you elaborate on the specific computational methodology used to translate individual mutation patterns into treatment recommendations? I'm particularly interested in how the model handles temporal sequencing data - does it employ dynamic Bayesian networks or recurrent neural architectures? Also, what validation framework was implemented to ensure these personalized predictions maintain clinical relevance across diverse patient cohorts, and how were confounding factors like tumor heterogeneity addressed in the analytical pipeline?", "history": ["What is the role of the ToMExO model in cancer research?", "Can this model help in understanding the progression of different cancers by identifying key genetic alterations?", "Given these capabilities of the ToMExO model in tracking cancer progression and identifying key genetic alterations, how might its insights be used to tailor personalized treatment strategies by accounting for individual patients' specific mutation patterns and the temporal sequences of their driver gene alterations?"], "ground_truth": ["permed-77277", "permed-78605", "permed-56401", "permed-54317", "permed-54311", "permed-70753", "permed-56399", "permed-78517", "permed-56191", "permed-51228"]}
{"query_id": "topic_514_turn_5", "conversation_id": "topic_514", "turn_id": 5, "query": "Given the detailed computational methodology and validation frameworks discussed, how does the treatment personalization accuracy of ToMExO compare against other established precision oncology approaches like molecular tumor boards or AI-driven platforms such as Watson for Oncology? Specifically, what comparative evidence exists regarding their respective abilities to handle temporal sequencing data versus static genomic profiles, and what trade-offs emerge between computational complexity and clinical interpretability when implementing these different personalized treatment recommendation systems across diverse healthcare settings?", "history": ["What is the role of the ToMExO model in cancer research?", "Can this model help in understanding the progression of different cancers by identifying key genetic alterations?", "Given these capabilities of the ToMExO model in tracking cancer progression and identifying key genetic alterations, how might its insights be used to tailor personalized treatment strategies by accounting for individual patients' specific mutation patterns and the temporal sequences of their driver gene alterations?", "Building on this personalized treatment approach, could you elaborate on the specific computational methodology used to translate individual mutation patterns into treatment recommendations? I'm particularly interested in how the model handles temporal sequencing data - does it employ dynamic Bayesian networks or recurrent neural architectures? Also, what validation framework was implemented to ensure these personalized predictions maintain clinical relevance across diverse patient cohorts, and how were confounding factors like tumor heterogeneity addressed in the analytical pipeline?"], "ground_truth": ["permed-56401", "permed-78469", "permed-78605", "permed-56402", "permed-56825", "permed-56692", "permed-84407", "permed-84409", "permed-68623", "permed-54905"]}
{"query_id": "topic_515_turn_1", "conversation_id": "topic_515", "turn_id": 1, "query": "Review of nanoparticle effects on plant growth and immunity in agricultural systems", "history": [], "ground_truth": ["permed-81209", "permed-74110", "permed-64170", "permed-78310", "permed-64083", "permed-63012", "permed-81208", "permed-80525", "permed-74109", "permed-51320"]}
{"query_id": "topic_515_turn_2", "conversation_id": "topic_515", "turn_id": 2, "query": "Investigating chitosan-based nanoparticles: How do they specifically contribute to these observed plant enhancements?", "history": ["Review of nanoparticle effects on plant growth and immunity in agricultural systems"], "ground_truth": ["permed-74107", "permed-64151", "permed-66000", "permed-81209", "permed-62999", "permed-82083", "permed-74110", "permed-66905", "permed-60674", "permed-78310"]}
{"query_id": "topic_515_turn_3", "conversation_id": "topic_515", "turn_id": 3, "query": "Detailed mechanisms of chitosan nanoparticle (ChNP) mediated plant immunity and stress tolerance (biotic/abiotic) and optimization strategies for their use in precision agriculture to develop resilient crops", "history": ["Review of nanoparticle effects on plant growth and immunity in agricultural systems", "Investigating chitosan-based nanoparticles: How do they specifically contribute to these observed plant enhancements?"], "ground_truth": ["permed-74107", "permed-63012", "permed-66000", "permed-64151", "permed-82083", "permed-74108", "permed-89481", "permed-81209", "permed-81211", "permed-63877"]}
{"query_id": "topic_515_turn_4", "conversation_id": "topic_515", "turn_id": 4, "query": "Given these detailed mechanisms of ChNP-mediated stress tolerance, what specific experimental protocols are most effective for quantifying chitosan nanoparticle uptake and distribution in plant tissues? I'm particularly interested in methodology for tracking systemic movement and localization patterns - are there standardized techniques for confocal microscopy visualization or HPLC quantification that account for plant matrix effects? How do researchers typically validate that observed immune responses are directly attributable to nanoparticle internalization versus surface interactions?", "history": ["Review of nanoparticle effects on plant growth and immunity in agricultural systems", "Investigating chitosan-based nanoparticles: How do they specifically contribute to these observed plant enhancements?", "Detailed mechanisms of chitosan nanoparticle (ChNP) mediated plant immunity and stress tolerance (biotic/abiotic) and optimization strategies for their use in precision agriculture to develop resilient crops"], "ground_truth": ["permed-78310", "permed-74107", "permed-66905", "permed-57868", "permed-64151", "permed-81209", "permed-54880", "permed-76193", "permed-88570", "permed-82083"]}
{"query_id": "topic_515_turn_5", "conversation_id": "topic_515", "turn_id": 5, "query": "Given these sophisticated methodologies for tracking ChNP internalization and localization, how do the resulting immune response outcomes compare between plants where nanoparticles fully penetrate cellular structures versus those where interactions remain primarily extracellular? Specifically, what are the relative magnitudes and durations of systemic acquired resistance triggered by internalized ChNPs compared to pattern-triggered immunity from surface interactions? Are there trade-offs in protection breadth against biotic versus abiotic stressors depending on internalization efficiency, and how might this inform nanoparticle design for targeted immune priming?", "history": ["Review of nanoparticle effects on plant growth and immunity in agricultural systems", "Investigating chitosan-based nanoparticles: How do they specifically contribute to these observed plant enhancements?", "Detailed mechanisms of chitosan nanoparticle (ChNP) mediated plant immunity and stress tolerance (biotic/abiotic) and optimization strategies for their use in precision agriculture to develop resilient crops", "Given these detailed mechanisms of ChNP-mediated stress tolerance, what specific experimental protocols are most effective for quantifying chitosan nanoparticle uptake and distribution in plant tissues? I'm particularly interested in methodology for tracking systemic movement and localization patterns - are there standardized techniques for confocal microscopy visualization or HPLC quantification that account for plant matrix effects? How do researchers typically validate that observed immune responses are directly attributable to nanoparticle internalization versus surface interactions?"], "ground_truth": ["permed-78310", "permed-88570", "permed-54980", "permed-57868", "permed-92371", "permed-54880", "permed-81209", "permed-82152", "permed-74995", "permed-64088"]}
{"query_id": "topic_516_turn_1", "conversation_id": "topic_516", "turn_id": 1, "query": "What's known about the prevalence of multidrug-resistant Mycobacterium tuberculosis in Ethiopia?", "history": [], "ground_truth": ["permed-60440", "permed-84958", "permed-88640", "permed-60431", "permed-60446", "permed-81933", "permed-60450", "permed-60441", "permed-51279", "permed-75607"]}
{"query_id": "topic_516_turn_2", "conversation_id": "topic_516", "turn_id": 2, "query": "How does this resistance impact the effectiveness of current treatment approaches in this area?", "history": ["What's known about the prevalence of multidrug-resistant Mycobacterium tuberculosis in Ethiopia?"], "ground_truth": ["permed-56525", "permed-50971", "permed-58626", "permed-56784", "permed-63463", "permed-67789", "permed-72519", "permed-55107", "permed-88631", "permed-88639"]}
{"query_id": "topic_516_turn_3", "conversation_id": "topic_516", "turn_id": 3, "query": "Given the resistance patterns we've discussed, how do the specific genetic mutations and lineage distributions of these multidrug-resistant Mycobacterium tuberculosis isolates in Northwest Ethiopia affect current treatment regimens? And based on these findings, what alternative therapeutic strategies could be considered to overcome the resistance?", "history": ["What's known about the prevalence of multidrug-resistant Mycobacterium tuberculosis in Ethiopia?", "How does this resistance impact the effectiveness of current treatment approaches in this area?"], "ground_truth": ["permed-60440", "permed-60446", "permed-60441", "permed-60443", "permed-60447", "permed-60450", "permed-60439", "permed-60442", "permed-88641", "permed-65955"]}
{"query_id": "topic_516_turn_4", "conversation_id": "topic_516", "turn_id": 4, "query": "Given these genetic mutation profiles and lineage distributions, what specific molecular diagnostic protocols were implemented to detect resistance-conferring mutations in clinical isolates? I'm particularly interested in the technical validation of these methods - were there standardized controls used, what was the limit of detection for minority variants, and how was concordance established between phenotypic drug susceptibility testing and genotypic results in your Northwest Ethiopian study population?", "history": ["What's known about the prevalence of multidrug-resistant Mycobacterium tuberculosis in Ethiopia?", "How does this resistance impact the effectiveness of current treatment approaches in this area?", "Given the resistance patterns we've discussed, how do the specific genetic mutations and lineage distributions of these multidrug-resistant Mycobacterium tuberculosis isolates in Northwest Ethiopia affect current treatment regimens? And based on these findings, what alternative therapeutic strategies could be considered to overcome the resistance?"], "ground_truth": ["permed-60440", "permed-72212", "permed-72864", "permed-66237", "permed-72206", "permed-60446", "permed-72863", "permed-60442", "permed-72865", "permed-72208"]}
{"query_id": "topic_516_turn_5", "conversation_id": "topic_516", "turn_id": 5, "query": "Given the validated molecular diagnostic protocols for detecting resistance-conferring mutations in Northwest Ethiopia, what have been the real-world clinical outcomes when implementing these genotypic results to guide individualized MDR-TB treatment? Specifically, how did treatment success rates, time to culture conversion, and adverse event profiles compare between patients receiving mutation-informed regimens versus standardized regimens in your clinical cohort? Were there particular resistance mutation patterns where this precision approach demonstrated superior therapeutic efficacy or revealed unexpected safety concerns in this population?", "history": ["What's known about the prevalence of multidrug-resistant Mycobacterium tuberculosis in Ethiopia?", "How does this resistance impact the effectiveness of current treatment approaches in this area?", "Given the resistance patterns we've discussed, how do the specific genetic mutations and lineage distributions of these multidrug-resistant Mycobacterium tuberculosis isolates in Northwest Ethiopia affect current treatment regimens? And based on these findings, what alternative therapeutic strategies could be considered to overcome the resistance?", "Given these genetic mutation profiles and lineage distributions, what specific molecular diagnostic protocols were implemented to detect resistance-conferring mutations in clinical isolates? I'm particularly interested in the technical validation of these methods - were there standardized controls used, what was the limit of detection for minority variants, and how was concordance established between phenotypic drug susceptibility testing and genotypic results in your Northwest Ethiopian study population?"], "ground_truth": ["permed-60441", "permed-60440", "permed-61589", "permed-42886", "permed-60442", "permed-60446", "permed-86816", "permed-60447", "permed-60439", "permed-33650"]}
{"query_id": "topic_517_turn_1", "conversation_id": "topic_517", "turn_id": 1, "query": "What advancements have been made in the development of all-chalcopyrite multijunction devices?", "history": [], "ground_truth": ["permed-55244", "permed-73262", "permed-76107", "permed-53816", "permed-53817", "permed-92654", "permed-75694", "permed-86530", "permed-77385", "permed-53791"]}
{"query_id": "topic_517_turn_2", "conversation_id": "topic_517", "turn_id": 2, "query": "How does the semi-monolithic integration method improve the performance of these devices, and what challenges does it pose?", "history": ["What advancements have been made in the development of all-chalcopyrite multijunction devices?"], "ground_truth": ["permed-55244", "permed-51039", "permed-72824", "permed-76993", "permed-77028", "permed-75516", "permed-60838", "permed-80934", "permed-83337", "permed-59233"]}
{"query_id": "topic_517_turn_3", "conversation_id": "topic_517", "turn_id": 3, "query": "What challenges might arise when scaling up this semi-monolithic integration approach for all-chalcopyrite multijunction devices, especially regarding maintaining layer integrity and performance during large-scale production? Are there any promising solutions to address these scaling issues?", "history": ["What advancements have been made in the development of all-chalcopyrite multijunction devices?", "How does the semi-monolithic integration method improve the performance of these devices, and what challenges does it pose?"], "ground_truth": ["permed-55244", "permed-79573", "permed-73238", "permed-76399", "permed-73262", "permed-76993", "permed-75694", "permed-53791", "permed-83337", "permed-77385"]}
{"query_id": "topic_517_turn_4", "conversation_id": "topic_517", "turn_id": 4, "query": "Given these scaling challenges for semi-monolithic integration, what specific fabrication protocols and quality control measures are most critical for maintaining layer integrity during large-area deposition? I'm particularly interested in the statistical process control methods used to monitor interface quality and the characterization techniques employed to validate performance uniformity across full-scale production substrates. How do researchers quantify and address thickness variations and defect densities in these scaled-up manufacturing environments?", "history": ["What advancements have been made in the development of all-chalcopyrite multijunction devices?", "How does the semi-monolithic integration method improve the performance of these devices, and what challenges does it pose?", "What challenges might arise when scaling up this semi-monolithic integration approach for all-chalcopyrite multijunction devices, especially regarding maintaining layer integrity and performance during large-scale production? Are there any promising solutions to address these scaling issues?"], "ground_truth": ["permed-55244", "permed-79578", "permed-77028", "permed-79573", "permed-53212", "permed-87333", "permed-76993", "permed-51039", "permed-58089", "permed-55243"]}
{"query_id": "topic_517_turn_5", "conversation_id": "topic_517", "turn_id": 5, "query": "Given the established fabrication protocols and quality control measures for semi-monolithic integration, how do alternative monolithic and mechanically stacked integration approaches compare in terms of scalability, production yield, and long-term reliability for all-chalcopyrite multijunction devices? Specifically, what are the trade-offs between these integration methods regarding thermal expansion matching, optical losses, and manufacturing complexity when transitioning from laboratory-scale demonstrations to industrial-scale production? Which integration strategy demonstrates superior performance-to-cost ratios in current pilot production lines?", "history": ["What advancements have been made in the development of all-chalcopyrite multijunction devices?", "How does the semi-monolithic integration method improve the performance of these devices, and what challenges does it pose?", "What challenges might arise when scaling up this semi-monolithic integration approach for all-chalcopyrite multijunction devices, especially regarding maintaining layer integrity and performance during large-scale production? Are there any promising solutions to address these scaling issues?", "Given these scaling challenges for semi-monolithic integration, what specific fabrication protocols and quality control measures are most critical for maintaining layer integrity during large-area deposition? I'm particularly interested in the statistical process control methods used to monitor interface quality and the characterization techniques employed to validate performance uniformity across full-scale production substrates. How do researchers quantify and address thickness variations and defect densities in these scaled-up manufacturing environments?"], "ground_truth": ["permed-55244", "permed-60838", "permed-79573", "permed-53791", "permed-77385", "permed-73238", "permed-73262", "permed-75692", "permed-75694", "permed-83337"]}
{"query_id": "topic_518_turn_1", "conversation_id": "topic_518", "turn_id": 1, "query": "What is known about the impact of adverse childhood experiences on substance misuse among children involved with the justice system?", "history": [], "ground_truth": ["permed-79515", "permed-59900", "permed-55626", "permed-57473", "permed-65558", "permed-55810", "permed-57478", "permed-66297", "permed-59902", "permed-70632"]}
{"query_id": "topic_518_turn_2", "conversation_id": "topic_518", "turn_id": 2, "query": "How does this relationship vary across different racial and ethnic backgrounds, and what implications might it have for intervention strategies?", "history": ["What is known about the impact of adverse childhood experiences on substance misuse among children involved with the justice system?"], "ground_truth": ["permed-55096", "permed-90862", "permed-64307", "permed-72620", "permed-63339", "permed-84002", "permed-70219", "permed-75619", "permed-79515", "permed-84073"]}
{"query_id": "topic_518_turn_3", "conversation_id": "topic_518", "turn_id": 3, "query": "Given these findings about how ACEs affect substance misuse differently across racial and ethnic groups among justice-involved youth, how could this inform more targeted prevention and intervention programs? Specifically, what cultural or community-based strategies might work best to address these disparities, and how could they be effectively incorporated into existing juvenile justice systems to improve equity?", "history": ["What is known about the impact of adverse childhood experiences on substance misuse among children involved with the justice system?", "How does this relationship vary across different racial and ethnic backgrounds, and what implications might it have for intervention strategies?"], "ground_truth": ["permed-79515", "permed-59902", "permed-59900", "permed-90675", "permed-57473", "permed-59600", "permed-54393", "permed-59901", "permed-84441", "permed-57478"]}
{"query_id": "topic_518_turn_4", "conversation_id": "topic_518", "turn_id": 4, "query": "Given the proposed cultural and community-based strategies for addressing ACE-related substance misuse disparities, what specific methodological approaches would be most appropriate for evaluating their implementation within juvenile justice settings? I'm particularly interested in how researchers might design mixed-methods studies to assess fidelity, dosage, and contextual adaptations while maintaining scientific rigor. What implementation science frameworks and process evaluation metrics would be most suitable for tracking how these interventions are integrated into existing system workflows and their differential effects across racial/ethnic subgroups?", "history": ["What is known about the impact of adverse childhood experiences on substance misuse among children involved with the justice system?", "How does this relationship vary across different racial and ethnic backgrounds, and what implications might it have for intervention strategies?", "Given these findings about how ACEs affect substance misuse differently across racial and ethnic groups among justice-involved youth, how could this inform more targeted prevention and intervention programs? Specifically, what cultural or community-based strategies might work best to address these disparities, and how could they be effectively incorporated into existing juvenile justice systems to improve equity?"], "ground_truth": ["permed-79515", "permed-59900", "permed-59902", "permed-73400", "permed-57473", "permed-71421", "permed-56003", "permed-90675", "permed-79125", "permed-79373"]}
{"query_id": "topic_518_turn_5", "conversation_id": "topic_518", "turn_id": 5, "query": "Given these implementation frameworks for culturally-adapted interventions, what clinical trial evidence exists regarding their therapeutic efficacy and safety profiles when deployed within juvenile justice settings? Specifically, for justice-involved youth with high ACE exposure, what reductions in substance misuse recidivism and adverse behavioral outcomes have been demonstrated in controlled studies? Additionally, how do safety considerations—such as trauma triggers or retraumatization risks—manifest during clinical delivery, and what clinical protocols have proven effective for mitigating these concerns while maintaining intervention integrity across diverse racial and ethnic subgroups?", "history": ["What is known about the impact of adverse childhood experiences on substance misuse among children involved with the justice system?", "How does this relationship vary across different racial and ethnic backgrounds, and what implications might it have for intervention strategies?", "Given these findings about how ACEs affect substance misuse differently across racial and ethnic groups among justice-involved youth, how could this inform more targeted prevention and intervention programs? Specifically, what cultural or community-based strategies might work best to address these disparities, and how could they be effectively incorporated into existing juvenile justice systems to improve equity?", "Given the proposed cultural and community-based strategies for addressing ACE-related substance misuse disparities, what specific methodological approaches would be most appropriate for evaluating their implementation within juvenile justice settings? I'm particularly interested in how researchers might design mixed-methods studies to assess fidelity, dosage, and contextual adaptations while maintaining scientific rigor. What implementation science frameworks and process evaluation metrics would be most suitable for tracking how these interventions are integrated into existing system workflows and their differential effects across racial/ethnic subgroups?"], "ground_truth": ["permed-79515", "permed-59902", "permed-55626", "permed-59900", "permed-57473", "permed-57478", "permed-58543", "permed-71421", "permed-84441", "permed-90675"]}
{"query_id": "topic_519_turn_1", "conversation_id": "topic_519", "turn_id": 1, "query": "What role does molecular profiling play in assessing lung cancer progression?", "history": [], "ground_truth": ["permed-77629", "permed-71181", "permed-56339", "permed-56418", "permed-55053", "permed-56046", "permed-56171", "permed-73599", "permed-56349", "permed-70484"]}
{"query_id": "topic_519_turn_2", "conversation_id": "topic_519", "turn_id": 2, "query": "Can integrating this technique with surgical methods improve predictions of metastasis in patients?", "history": ["What role does molecular profiling play in assessing lung cancer progression?"], "ground_truth": ["permed-50941", "permed-55172", "permed-61534", "permed-91050", "permed-70300", "permed-73895", "permed-79184", "permed-69117", "permed-51389", "permed-70767"]}
{"query_id": "topic_519_turn_3", "conversation_id": "topic_519", "turn_id": 3, "query": "How could combining these molecular profiling techniques with standard lymph node dissection methods better predict metastatic risk in lung cancer patients, and how might this integrated approach inform more personalized adjuvant therapy decisions?", "history": ["What role does molecular profiling play in assessing lung cancer progression?", "Can integrating this technique with surgical methods improve predictions of metastasis in patients?"], "ground_truth": ["permed-51389", "permed-78595", "permed-56799", "permed-55172", "permed-56797", "permed-54278", "permed-56458", "permed-55053", "permed-69289", "permed-56188"]}
{"query_id": "topic_519_turn_4", "conversation_id": "topic_519", "turn_id": 4, "query": "Given this proposed integration of molecular profiling with lymph node dissection, what specific validation framework would you recommend for assessing its predictive accuracy? I'm particularly interested in whether a time-dependent ROC analysis would be appropriate for evaluating metastasis prediction, and what statistical power considerations should inform the cohort size needed to detect clinically meaningful improvements over current staging methods. How might we establish reproducibility across different molecular platforms while maintaining clinical utility?", "history": ["What role does molecular profiling play in assessing lung cancer progression?", "Can integrating this technique with surgical methods improve predictions of metastasis in patients?", "How could combining these molecular profiling techniques with standard lymph node dissection methods better predict metastatic risk in lung cancer patients, and how might this integrated approach inform more personalized adjuvant therapy decisions?"], "ground_truth": ["permed-51389", "permed-56799", "permed-58766", "permed-56046", "permed-55172", "permed-50941", "permed-58876", "permed-91050", "permed-55174", "permed-73699"]}
{"query_id": "topic_519_turn_5", "conversation_id": "topic_519", "turn_id": 5, "query": "Given the detailed validation framework we've established, how might this integrated molecular and surgical profiling approach translate into actual clinical decision-making for adjuvant therapy? Specifically, what patient outcomes – such as recurrence-free survival or quality of life metrics – have been demonstrated in existing studies using similar combined profiling methods? Additionally, what are the primary safety considerations or potential for overtreatment when using such sensitive molecular data to guide therapy intensification, and how do these risks weigh against the benefits in different patient subgroups, like those with early-stage NSCLC?", "history": ["What role does molecular profiling play in assessing lung cancer progression?", "Can integrating this technique with surgical methods improve predictions of metastasis in patients?", "How could combining these molecular profiling techniques with standard lymph node dissection methods better predict metastatic risk in lung cancer patients, and how might this integrated approach inform more personalized adjuvant therapy decisions?", "Given this proposed integration of molecular profiling with lymph node dissection, what specific validation framework would you recommend for assessing its predictive accuracy? I'm particularly interested in whether a time-dependent ROC analysis would be appropriate for evaluating metastasis prediction, and what statistical power considerations should inform the cohort size needed to detect clinically meaningful improvements over current staging methods. How might we establish reproducibility across different molecular platforms while maintaining clinical utility?"], "ground_truth": ["permed-52520", "permed-52527", "permed-56769", "permed-56374", "permed-56106", "permed-56120", "permed-56083", "permed-73599", "permed-58768", "permed-68257"]}
{"query_id": "topic_520_turn_1", "conversation_id": "topic_520", "turn_id": 1, "query": "Role of evolutionary developmental biology in species adaptation to environmental changes", "history": [], "ground_truth": ["permed-75989", "permed-53709", "permed-60608", "permed-59317", "permed-60604", "permed-59325", "permed-61796", "permed-53717", "permed-52055", "permed-59341"]}
{"query_id": "topic_520_turn_2", "conversation_id": "topic_520", "turn_id": 2, "query": "How are genomics and epigenetics advancements influencing this field's approach to understanding species adaptation?", "history": ["Role of evolutionary developmental biology in species adaptation to environmental changes"], "ground_truth": ["permed-60608", "permed-83668", "permed-59322", "permed-64253", "permed-58527", "permed-51218", "permed-76359", "permed-61796", "permed-59341", "permed-52055"]}
{"query_id": "topic_520_turn_3", "conversation_id": "topic_520", "turn_id": 3, "query": "Specific mechanisms of phenotypic plasticity driven by these genomic and epigenetic factors in adaptive evolution within evo-devo", "history": ["Role of evolutionary developmental biology in species adaptation to environmental changes", "How are genomics and epigenetics advancements influencing this field's approach to understanding species adaptation?"], "ground_truth": ["permed-59322", "permed-59341", "permed-75989", "permed-59343", "permed-61796", "permed-50790", "permed-53717", "permed-59340", "permed-60608", "permed-58527"]}
{"query_id": "topic_520_turn_4", "conversation_id": "topic_520", "turn_id": 4, "query": "Given these mechanisms of phenotypic plasticity, what specific experimental designs and molecular techniques are most effective for quantifying epigenetic modifications like DNA methylation or histone acetylation in non-model organisms? I'm particularly interested in how researchers validate these measurements across different developmental stages while accounting for tissue-specific effects, and what statistical approaches best capture the relationship between epigenetic variance and observed phenotypic outcomes in natural populations.", "history": ["Role of evolutionary developmental biology in species adaptation to environmental changes", "How are genomics and epigenetics advancements influencing this field's approach to understanding species adaptation?", "Specific mechanisms of phenotypic plasticity driven by these genomic and epigenetic factors in adaptive evolution within evo-devo"], "ground_truth": ["permed-58527", "permed-64141", "permed-83885", "permed-59322", "permed-76619", "permed-67506", "permed-78414", "permed-53644", "permed-58111", "permed-53734"]}
{"query_id": "topic_520_turn_5", "conversation_id": "topic_520", "turn_id": 5, "query": "Given these sophisticated epigenetic quantification methods, how are these molecular insights translating into clinical applications for human adaptive disorders? Specifically, what evidence exists regarding therapeutic interventions that target DNA methylation or histone modifications to modulate phenotypic outcomes in conditions like metabolic syndrome or developmental disorders? What are the key safety considerations and efficacy metrics from clinical trials exploring epigenetic therapies, and how do researchers address tissue-specificity challenges when applying these approaches in human patients?", "history": ["Role of evolutionary developmental biology in species adaptation to environmental changes", "How are genomics and epigenetics advancements influencing this field's approach to understanding species adaptation?", "Specific mechanisms of phenotypic plasticity driven by these genomic and epigenetic factors in adaptive evolution within evo-devo", "Given these mechanisms of phenotypic plasticity, what specific experimental designs and molecular techniques are most effective for quantifying epigenetic modifications like DNA methylation or histone acetylation in non-model organisms? I'm particularly interested in how researchers validate these measurements across different developmental stages while accounting for tissue-specific effects, and what statistical approaches best capture the relationship between epigenetic variance and observed phenotypic outcomes in natural populations."], "ground_truth": ["permed-64141", "permed-51222", "permed-53644", "permed-67503", "permed-13263", "permed-66455", "permed-31448", "permed-31449", "permed-51223", "permed-40753"]}
{"query_id": "topic_521_turn_1", "conversation_id": "topic_521", "turn_id": 1, "query": "What challenges do offender populations face in accessing effective health interventions?", "history": [], "ground_truth": ["permed-59895", "permed-69993", "permed-68484", "permed-59896", "permed-65780", "permed-87461", "permed-63524", "permed-66148", "permed-77916", "permed-85067"]}
{"query_id": "topic_521_turn_2", "conversation_id": "topic_521", "turn_id": 2, "query": "How do organizational affiliations, such as universities or government bodies, impact the development and implementation of these interventions?", "history": ["What challenges do offender populations face in accessing effective health interventions?"], "ground_truth": ["permed-67345", "permed-58555", "permed-91926", "permed-61615", "permed-75050", "permed-74114", "permed-61614", "permed-53976", "permed-61613", "permed-34502"]}
{"query_id": "topic_521_turn_3", "conversation_id": "topic_521", "turn_id": 3, "query": "Given these challenges and the role of organizational affiliations in intervention development, how can we address the disparities in research output and collaboration between different types of organizations—like universities, government bodies, and prisons—to improve the quality and accessibility of these interventions? Specifically, how might this be approached in regions with weaker rule of law to better serve both incarcerated and non-incarcerated offender populations?", "history": ["What challenges do offender populations face in accessing effective health interventions?", "How do organizational affiliations, such as universities or government bodies, impact the development and implementation of these interventions?"], "ground_truth": ["permed-78732", "permed-55846", "permed-59896", "permed-59895", "permed-69993", "permed-67243", "permed-85067", "permed-52796", "permed-88839", "permed-77916"]}
{"query_id": "topic_521_turn_4", "conversation_id": "topic_521", "turn_id": 4, "query": "Building on these collaborative approaches for regions with weaker rule of law, what specific methodological frameworks could be employed to standardize data collection and intervention fidelity across these diverse organizational settings? For instance, would a mixed-methods design combining implementation science with participatory action research be most appropriate? Furthermore, what statistical techniques—such as multi-level modeling or propensity score matching—could effectively account for the nested data structure and selection biases inherent when comparing outcomes across university-led, government-run, and prison-based programs?", "history": ["What challenges do offender populations face in accessing effective health interventions?", "How do organizational affiliations, such as universities or government bodies, impact the development and implementation of these interventions?", "Given these challenges and the role of organizational affiliations in intervention development, how can we address the disparities in research output and collaboration between different types of organizations—like universities, government bodies, and prisons—to improve the quality and accessibility of these interventions? Specifically, how might this be approached in regions with weaker rule of law to better serve both incarcerated and non-incarcerated offender populations?"], "ground_truth": ["permed-52380", "permed-78732", "permed-79518", "permed-57848", "permed-55846", "permed-79201", "permed-65797", "permed-91392", "permed-34892", "permed-67345"]}
{"query_id": "topic_521_turn_5", "conversation_id": "topic_521", "turn_id": 5, "query": "Given these proposed methodological frameworks for standardizing data collection across diverse settings, what clinical outcomes have been demonstrated when implementing standardized health interventions in offender populations within weak rule-of-law regions? Specifically, what evidence exists regarding therapeutic efficacy, recidivism reduction, and mental health improvements? Additionally, what safety profiles and adverse event rates have been documented when deploying these interventions across different organizational contexts, and how do these clinical outcomes compare between university-researched protocols versus government-implemented programs in real-world correctional settings?", "history": ["What challenges do offender populations face in accessing effective health interventions?", "How do organizational affiliations, such as universities or government bodies, impact the development and implementation of these interventions?", "Given these challenges and the role of organizational affiliations in intervention development, how can we address the disparities in research output and collaboration between different types of organizations—like universities, government bodies, and prisons—to improve the quality and accessibility of these interventions? Specifically, how might this be approached in regions with weaker rule of law to better serve both incarcerated and non-incarcerated offender populations?", "Building on these collaborative approaches for regions with weaker rule of law, what specific methodological frameworks could be employed to standardize data collection and intervention fidelity across these diverse organizational settings? For instance, would a mixed-methods design combining implementation science with participatory action research be most appropriate? Furthermore, what statistical techniques—such as multi-level modeling or propensity score matching—could effectively account for the nested data structure and selection biases inherent when comparing outcomes across university-led, government-run, and prison-based programs?"], "ground_truth": ["permed-52796", "permed-59895", "permed-70841", "permed-69898", "permed-70630", "permed-59896", "permed-78732", "permed-69993", "permed-64779", "permed-74908"]}
{"query_id": "topic_522_turn_1", "conversation_id": "topic_522", "turn_id": 1, "query": "Is there a link between neighborhood environment and childhood obesity rates?", "history": [], "ground_truth": ["permed-79193", "permed-69943", "permed-89725", "permed-75651", "permed-78826", "permed-59599", "permed-74975", "permed-35408", "permed-53054", "permed-92085"]}
{"query_id": "topic_522_turn_2", "conversation_id": "topic_522", "turn_id": 2, "query": "How might factors like stress and access to resources in these environments contribute to it?", "history": ["Is there a link between neighborhood environment and childhood obesity rates?"], "ground_truth": ["permed-55107", "permed-75160", "permed-67572", "permed-54997", "permed-91925", "permed-82651", "permed-56000", "permed-61667", "permed-66148", "permed-27251"]}
{"query_id": "topic_522_turn_3", "conversation_id": "topic_522", "turn_id": 3, "query": "Given these connections between neighborhood deprivation, stress, and resource access in childhood obesity, how might early interventions that reduce environmental stressors and improve healthy resource availability in deprived areas influence brain development and obesity rates? Specifically, what community-based approaches could help counteract the negative effects of area deprivation on brain structures linked to self-regulation and eating behaviors, and how might these interventions need to be adapted for different socioeconomic groups to maximize their effectiveness?", "history": ["Is there a link between neighborhood environment and childhood obesity rates?", "How might factors like stress and access to resources in these environments contribute to it?"], "ground_truth": ["permed-78826", "permed-69947", "permed-53054", "permed-78827", "permed-74977", "permed-69943", "permed-74975", "permed-75049", "permed-25531", "permed-58898"]}
{"query_id": "topic_522_turn_4", "conversation_id": "topic_522", "turn_id": 4, "query": "For these community-based interventions targeting environmental stressors and resource availability, what specific methodological considerations should guide their implementation and evaluation? I'm particularly interested in how researchers might design longitudinal studies to measure changes in both neurodevelopmental outcomes (like amygdala-prefrontal circuitry) and obesity metrics. What statistical approaches would best account for neighborhood-level clustering effects, and how should fidelity monitoring be structured to ensure consistent intervention delivery across diverse socioeconomic settings while maintaining ecological validity?", "history": ["Is there a link between neighborhood environment and childhood obesity rates?", "How might factors like stress and access to resources in these environments contribute to it?", "Given these connections between neighborhood deprivation, stress, and resource access in childhood obesity, how might early interventions that reduce environmental stressors and improve healthy resource availability in deprived areas influence brain development and obesity rates? Specifically, what community-based approaches could help counteract the negative effects of area deprivation on brain structures linked to self-regulation and eating behaviors, and how might these interventions need to be adapted for different socioeconomic groups to maximize their effectiveness?"], "ground_truth": ["permed-74977", "permed-78826", "permed-75049", "permed-90677", "permed-69947", "permed-74466", "permed-52380", "permed-74975", "permed-75651", "permed-69943"]}
{"query_id": "topic_522_turn_5", "conversation_id": "topic_522", "turn_id": 5, "query": "Given these methodological frameworks for evaluating community interventions, what clinical evidence exists regarding the actual therapeutic efficacy of such programs in real-world settings? Specifically, how do improvements in neighborhood resources and stress reduction translate to measurable patient outcomes like BMI reduction, metabolic health improvements, or eating behavior modifications in pediatric populations? Furthermore, what safety considerations or unintended consequences have emerged when deploying these interventions across diverse socioeconomic communities, and how do adherence rates or contraindications vary between different demographic groups in clinical practice?", "history": ["Is there a link between neighborhood environment and childhood obesity rates?", "How might factors like stress and access to resources in these environments contribute to it?", "Given these connections between neighborhood deprivation, stress, and resource access in childhood obesity, how might early interventions that reduce environmental stressors and improve healthy resource availability in deprived areas influence brain development and obesity rates? Specifically, what community-based approaches could help counteract the negative effects of area deprivation on brain structures linked to self-regulation and eating behaviors, and how might these interventions need to be adapted for different socioeconomic groups to maximize their effectiveness?", "For these community-based interventions targeting environmental stressors and resource availability, what specific methodological considerations should guide their implementation and evaluation? I'm particularly interested in how researchers might design longitudinal studies to measure changes in both neurodevelopmental outcomes (like amygdala-prefrontal circuitry) and obesity metrics. What statistical approaches would best account for neighborhood-level clustering effects, and how should fidelity monitoring be structured to ensure consistent intervention delivery across diverse socioeconomic settings while maintaining ecological validity?"], "ground_truth": ["permed-74977", "permed-74975", "permed-90677", "permed-90782", "permed-58502", "permed-75049", "permed-58496", "permed-74908", "permed-74978", "permed-89012"]}
{"query_id": "topic_523_turn_1", "conversation_id": "topic_523", "turn_id": 1, "query": "What role does probabilistic modeling play in managing eutrophic lakes?", "history": [], "ground_truth": ["permed-80595", "permed-80596", "permed-64763", "permed-80605", "permed-86503", "permed-86504", "permed-80597", "permed-89397", "permed-60476", "permed-81983"]}
{"query_id": "topic_523_turn_2", "conversation_id": "topic_523", "turn_id": 2, "query": "Can this approach help balance short-term and long-term goals in lake management, especially under pressures like climate change?", "history": ["What role does probabilistic modeling play in managing eutrophic lakes?"], "ground_truth": ["permed-86504", "permed-80595", "permed-64765", "permed-80598", "permed-80601", "permed-81014", "permed-79983", "permed-62246", "permed-73999", "permed-79986"]}
{"query_id": "topic_523_turn_3", "conversation_id": "topic_523", "turn_id": 3, "query": "Given these findings about probabilistic modeling for eutrophic lakes like Lake Dianchi, how can we use those insights to develop adaptive management strategies that effectively balance immediate water quality needs with long-term ecological resilience, especially considering ongoing human pressures and climate change impacts?", "history": ["What role does probabilistic modeling play in managing eutrophic lakes?", "Can this approach help balance short-term and long-term goals in lake management, especially under pressures like climate change?"], "ground_truth": ["permed-80595", "permed-80597", "permed-86504", "permed-80605", "permed-64763", "permed-80596", "permed-64253", "permed-83707", "permed-81978", "permed-81000"]}
{"query_id": "topic_523_turn_4", "conversation_id": "topic_523", "turn_id": 4, "query": "Given this proposed adaptive management framework for Lake Dianchi, could you detail the specific statistical validation protocols used to assess model performance? I'm particularly interested in how you calibrated the probabilistic forecasts against observed water quality parameters, what metrics were employed to quantify prediction uncertainty, and whether cross-validation techniques accounted for temporal autocorrelation in the long-term monitoring data. Additionally, how were these methodological choices tested for robustness under different climate scenarios?", "history": ["What role does probabilistic modeling play in managing eutrophic lakes?", "Can this approach help balance short-term and long-term goals in lake management, especially under pressures like climate change?", "Given these findings about probabilistic modeling for eutrophic lakes like Lake Dianchi, how can we use those insights to develop adaptive management strategies that effectively balance immediate water quality needs with long-term ecological resilience, especially considering ongoing human pressures and climate change impacts?"], "ground_truth": ["permed-80595", "permed-87492", "permed-81983", "permed-60476", "permed-65946", "permed-86504", "permed-76201", "permed-64314", "permed-86503", "permed-59412"]}
{"query_id": "topic_523_turn_5", "conversation_id": "topic_523", "turn_id": 5, "query": "Given these validated probabilistic modeling protocols for Lake Dianchi's adaptive management, how might similar computational frameworks translate to clinical settings for managing eutrophication-related public health risks? Specifically, what clinical evidence exists regarding health outcomes from cyanobacterial bloom exposures, and how could predictive models inform real-time patient risk stratification or preventative interventions for vulnerable populations? I'm particularly interested in clinical trial data evaluating early warning systems' efficacy in reducing bloom-associated morbidity.", "history": ["What role does probabilistic modeling play in managing eutrophic lakes?", "Can this approach help balance short-term and long-term goals in lake management, especially under pressures like climate change?", "Given these findings about probabilistic modeling for eutrophic lakes like Lake Dianchi, how can we use those insights to develop adaptive management strategies that effectively balance immediate water quality needs with long-term ecological resilience, especially considering ongoing human pressures and climate change impacts?", "Given this proposed adaptive management framework for Lake Dianchi, could you detail the specific statistical validation protocols used to assess model performance? I'm particularly interested in how you calibrated the probabilistic forecasts against observed water quality parameters, what metrics were employed to quantify prediction uncertainty, and whether cross-validation techniques accounted for temporal autocorrelation in the long-term monitoring data. Additionally, how were these methodological choices tested for robustness under different climate scenarios?"], "ground_truth": ["permed-80596", "permed-82702", "permed-80595", "permed-87493", "permed-76631", "permed-81983", "permed-82019", "permed-82708", "permed-64763", "permed-71766"]}
{"query_id": "topic_524_turn_1", "conversation_id": "topic_524", "turn_id": 1, "query": "What role does machine learning play in analyzing genomic data for genetic variations?", "history": [], "ground_truth": ["permed-71776", "permed-71547", "permed-53719", "permed-53718", "permed-53717", "permed-53960", "permed-55584", "permed-78536", "permed-57638", "permed-71115"]}
{"query_id": "topic_524_turn_2", "conversation_id": "topic_524", "turn_id": 2, "query": "Can it help improve the identification of specific types of variations, like CNVs, in large datasets?", "history": ["What role does machine learning play in analyzing genomic data for genetic variations?"], "ground_truth": ["permed-79298", "permed-54314", "permed-53719", "permed-73523", "permed-56211", "permed-53718", "permed-56400", "permed-71115", "permed-79297", "permed-78521"]}
{"query_id": "topic_524_turn_3", "conversation_id": "topic_524", "turn_id": 3, "query": "Given that machine learning can help identify CNVs in large datasets, how can integrating these algorithms improve both the accuracy and efficiency of detecting and validating recurrent CNVs in large-scale SNP genotype datasets—especially when dealing with the variability and complexity of genomic data across diverse populations?", "history": ["What role does machine learning play in analyzing genomic data for genetic variations?", "Can it help improve the identification of specific types of variations, like CNVs, in large datasets?"], "ground_truth": ["permed-54314", "permed-79298", "permed-67508", "permed-79297", "permed-67212", "permed-6684", "permed-55584", "permed-6686", "permed-76842", "permed-5416"]}
{"query_id": "topic_524_turn_4", "conversation_id": "topic_524", "turn_id": 4, "query": "Regarding this integrated algorithmic approach for recurrent CNV detection, what specific validation framework would you recommend for assessing both technical accuracy and population-specific performance? I'm particularly interested in the statistical methods for establishing significance thresholds across diverse cohorts, the implementation details for cross-platform reproducibility, and how you would design positive control strategies to account for varying genomic architectures while maintaining computational efficiency in large-scale SNP genotype analyses.", "history": ["What role does machine learning play in analyzing genomic data for genetic variations?", "Can it help improve the identification of specific types of variations, like CNVs, in large datasets?", "Given that machine learning can help identify CNVs in large datasets, how can integrating these algorithms improve both the accuracy and efficiency of detecting and validating recurrent CNVs in large-scale SNP genotype datasets—especially when dealing with the variability and complexity of genomic data across diverse populations?"], "ground_truth": ["permed-54314", "permed-79298", "permed-56399", "permed-79299", "permed-31286", "permed-76853", "permed-6686", "permed-54317", "permed-6684", "permed-54312"]}
{"query_id": "topic_524_turn_5", "conversation_id": "topic_524", "turn_id": 5, "query": "Given these comprehensive validation frameworks for recurrent CNV detection in diverse populations, what clinical translation pathways have demonstrated success in implementing such algorithms for patient care? I'm particularly interested in how validated CNV findings impact clinical decision-making for neurodevelopmental disorders or cancer susceptibility, including how clinicians interpret probabilistic outputs, navigate variants of uncertain significance, and incorporate population-specific CNV frequencies into diagnostic workflows while maintaining patient safety and addressing potential ethical implications of automated genomic risk assessment.", "history": ["What role does machine learning play in analyzing genomic data for genetic variations?", "Can it help improve the identification of specific types of variations, like CNVs, in large datasets?", "Given that machine learning can help identify CNVs in large datasets, how can integrating these algorithms improve both the accuracy and efficiency of detecting and validating recurrent CNVs in large-scale SNP genotype datasets—especially when dealing with the variability and complexity of genomic data across diverse populations?", "Regarding this integrated algorithmic approach for recurrent CNV detection, what specific validation framework would you recommend for assessing both technical accuracy and population-specific performance? I'm particularly interested in the statistical methods for establishing significance thresholds across diverse cohorts, the implementation details for cross-platform reproducibility, and how you would design positive control strategies to account for varying genomic architectures while maintaining computational efficiency in large-scale SNP genotype analyses."], "ground_truth": ["permed-54314", "permed-79298", "permed-6684", "permed-45299", "permed-82980", "permed-31286", "permed-79297", "permed-6686", "permed-55693", "permed-68534"]}
{"query_id": "topic_525_turn_1", "conversation_id": "topic_525", "turn_id": 1, "query": "How does obstructive sleep apnea (OSA) affect the accuracy of sleep disorder diagnoses?", "history": [], "ground_truth": ["permed-54633", "permed-26362", "permed-9013", "permed-9011", "permed-11144", "permed-89057", "permed-54625", "permed-55139", "permed-73832", "permed-89390"]}
{"query_id": "topic_525_turn_2", "conversation_id": "topic_525", "turn_id": 2, "query": "Specifically, what impact does it have on diagnosing conditions like REM sleep behavior disorder (RBD) using techniques such as video-polysomnography?", "history": ["How does obstructive sleep apnea (OSA) affect the accuracy of sleep disorder diagnoses?"], "ground_truth": ["permed-54633", "permed-82334", "permed-73825", "permed-29208", "permed-32577", "permed-55139", "permed-89949", "permed-55140", "permed-8195", "permed-75907"]}
{"query_id": "topic_525_turn_3", "conversation_id": "topic_525", "turn_id": 3, "query": "Given how severe OSA can interfere with video-PSG's ability to accurately diagnose idiopathic RBD, how might starting CPAP therapy affect the timing and duration needed to normalize REM sleep patterns and improve RBD detection in these patients? Also, what are the long-term consequences if OSA remains untreated—how does that influence RBD progression and symptoms, and how could these findings help tailor treatment approaches for patients with both conditions?", "history": ["How does obstructive sleep apnea (OSA) affect the accuracy of sleep disorder diagnoses?", "Specifically, what impact does it have on diagnosing conditions like REM sleep behavior disorder (RBD) using techniques such as video-polysomnography?"], "ground_truth": ["permed-54633", "permed-54629", "permed-43407", "permed-21056", "permed-11144", "permed-55145", "permed-25777", "permed-27063", "permed-25778", "permed-9011"]}
{"query_id": "topic_525_turn_4", "conversation_id": "topic_525", "turn_id": 4, "query": "Given this proposed approach of using CPAP therapy to normalize REM sleep patterns for RBD detection, what specific video-PSG scoring protocols and REM sleep microstructure metrics would you recommend implementing to quantitatively track these changes? How should we statistically model the temporal relationship between CPAP adherence metrics and REM sleep parameters, and what validation strategies would ensure these methods reliably distinguish true RBD normalization from OSA-related artifacts in comorbid patients?", "history": ["How does obstructive sleep apnea (OSA) affect the accuracy of sleep disorder diagnoses?", "Specifically, what impact does it have on diagnosing conditions like REM sleep behavior disorder (RBD) using techniques such as video-polysomnography?", "Given how severe OSA can interfere with video-PSG's ability to accurately diagnose idiopathic RBD, how might starting CPAP therapy affect the timing and duration needed to normalize REM sleep patterns and improve RBD detection in these patients? Also, what are the long-term consequences if OSA remains untreated—how does that influence RBD progression and symptoms, and how could these findings help tailor treatment approaches for patients with both conditions?"], "ground_truth": ["permed-54633", "permed-55140", "permed-73829", "permed-73828", "permed-55141", "permed-54629", "permed-9026", "permed-25777", "permed-55147", "permed-89983"]}
{"query_id": "topic_525_turn_5", "conversation_id": "topic_525", "turn_id": 5, "query": "Given these sophisticated video-PSG protocols for tracking CPAP-induced REM normalization, how do the diagnostic accuracies of emerging automated scoring systems using machine learning algorithms compare against traditional manual scoring by sleep technologists in distinguishing RBD from OSA artifacts? Specifically, what are the relative trade-offs in sensitivity, specificity, and computational efficiency when applied to comorbid populations, and which approach demonstrates superior performance in longitudinal monitoring of treatment response while minimizing inter-rater variability?", "history": ["How does obstructive sleep apnea (OSA) affect the accuracy of sleep disorder diagnoses?", "Specifically, what impact does it have on diagnosing conditions like REM sleep behavior disorder (RBD) using techniques such as video-polysomnography?", "Given how severe OSA can interfere with video-PSG's ability to accurately diagnose idiopathic RBD, how might starting CPAP therapy affect the timing and duration needed to normalize REM sleep patterns and improve RBD detection in these patients? Also, what are the long-term consequences if OSA remains untreated—how does that influence RBD progression and symptoms, and how could these findings help tailor treatment approaches for patients with both conditions?", "Given this proposed approach of using CPAP therapy to normalize REM sleep patterns for RBD detection, what specific video-PSG scoring protocols and REM sleep microstructure metrics would you recommend implementing to quantitatively track these changes? How should we statistically model the temporal relationship between CPAP adherence metrics and REM sleep parameters, and what validation strategies would ensure these methods reliably distinguish true RBD normalization from OSA-related artifacts in comorbid patients?"], "ground_truth": ["permed-54633", "permed-9026", "permed-89983", "permed-55140", "permed-58925", "permed-25280", "permed-25283", "permed-11150", "permed-55141", "permed-11146"]}
{"query_id": "topic_526_turn_1", "conversation_id": "topic_526", "turn_id": 1, "query": "What impact does bariatric surgery have on metabolic health in severely obese patients?", "history": [], "ground_truth": ["permed-54425", "permed-58396", "permed-70966", "permed-58711", "permed-58391", "permed-72678", "permed-65033", "permed-81928", "permed-52854", "permed-84736"]}
{"query_id": "topic_526_turn_2", "conversation_id": "topic_526", "turn_id": 2, "query": "How might changes in adipokine levels following this procedure influence long-term health outcomes?", "history": ["What impact does bariatric surgery have on metabolic health in severely obese patients?"], "ground_truth": ["permed-81928", "permed-65032", "permed-82344", "permed-54428", "permed-68273", "permed-68274", "permed-54422", "permed-59030", "permed-67829", "permed-68270"]}
{"query_id": "topic_526_turn_3", "conversation_id": "topic_526", "turn_id": 3, "query": "Given the changes in adipokine levels after bariatric surgery, how might the release of persistent organic pollutants (POPs) interact with these changes—particularly in adiponectin modulation—to influence long-term metabolic health and the risk of endocrine-related disorders in severely obese patients?", "history": ["What impact does bariatric surgery have on metabolic health in severely obese patients?", "How might changes in adipokine levels following this procedure influence long-term health outcomes?"], "ground_truth": ["permed-81928", "permed-54428", "permed-52578", "permed-68273", "permed-81903", "permed-68274", "permed-59030", "permed-65032", "permed-72678", "permed-67829"]}
{"query_id": "topic_526_turn_4", "conversation_id": "topic_526", "turn_id": 4, "query": "Given this proposed interaction between POP release and adiponectin modulation, what specific experimental methodology would you recommend to isolate and quantify these effects? I'm particularly interested in the technical implementation—would you use longitudinal sampling of adipose tissue biopsies combined with mass spectrometry for POP quantification, and how would you design the statistical models to account for confounding factors like weight loss magnitude and baseline comorbidities when analyzing adiponectin pathway alterations?", "history": ["What impact does bariatric surgery have on metabolic health in severely obese patients?", "How might changes in adipokine levels following this procedure influence long-term health outcomes?", "Given the changes in adipokine levels after bariatric surgery, how might the release of persistent organic pollutants (POPs) interact with these changes—particularly in adiponectin modulation—to influence long-term metabolic health and the risk of endocrine-related disorders in severely obese patients?"], "ground_truth": ["permed-81928", "permed-65032", "permed-78491", "permed-68260", "permed-52578", "permed-82344", "permed-81903", "permed-92490", "permed-65189", "permed-70771"]}
{"query_id": "topic_526_turn_5", "conversation_id": "topic_526", "turn_id": 5, "query": "Given your proposed methodology for isolating POP-adiponectin interactions, how would the experimental outcomes and clinical interpretations differ between using serum adiponectin levels versus adipose tissue gene expression of adiponectin receptors as primary endpoints? Specifically, what comparative advantages would each endpoint offer in detecting meaningful metabolic improvements versus simply reflecting weight loss effects, and which approach would provide more clinically actionable insights for predicting diabetes remission or cardiovascular risk reduction in this patient population?", "history": ["What impact does bariatric surgery have on metabolic health in severely obese patients?", "How might changes in adipokine levels following this procedure influence long-term health outcomes?", "Given the changes in adipokine levels after bariatric surgery, how might the release of persistent organic pollutants (POPs) interact with these changes—particularly in adiponectin modulation—to influence long-term metabolic health and the risk of endocrine-related disorders in severely obese patients?", "Given this proposed interaction between POP release and adiponectin modulation, what specific experimental methodology would you recommend to isolate and quantify these effects? I'm particularly interested in the technical implementation—would you use longitudinal sampling of adipose tissue biopsies combined with mass spectrometry for POP quantification, and how would you design the statistical models to account for confounding factors like weight loss magnitude and baseline comorbidities when analyzing adiponectin pathway alterations?"], "ground_truth": ["permed-65032", "permed-54422", "permed-68260", "permed-54428", "permed-81928", "permed-53559", "permed-54413", "permed-67829", "permed-68273", "permed-82344"]}
{"query_id": "topic_527_turn_1", "conversation_id": "topic_527", "turn_id": 1, "query": "What are the common musculoskeletal issues in children with congenital Zika syndrome?", "history": [], "ground_truth": ["permed-82273", "permed-71154", "permed-71028", "permed-89699", "permed-32427", "permed-13440", "permed-11818", "permed-76987", "permed-73802", "permed-44599"]}
{"query_id": "topic_527_turn_2", "conversation_id": "topic_527", "turn_id": 2, "query": "How do these musculoskeletal problems, particularly those affecting the hips, impact the long-term mobility and health of children with this condition?", "history": ["What are the common musculoskeletal issues in children with congenital Zika syndrome?"], "ground_truth": ["permed-60113", "permed-82273", "permed-60241", "permed-90497", "permed-60111", "permed-19839", "permed-54804", "permed-35655", "permed-19836", "permed-20735"]}
{"query_id": "topic_527_turn_3", "conversation_id": "topic_527", "turn_id": 3, "query": "Given these hip-related mobility challenges in children with congenital Zika syndrome, how could early interventions addressing both spasticity and ophthalmologic issues influence their long-term hip joint outcomes? What specific therapeutic approaches might be most effective in preventing or reducing these deformities?", "history": ["What are the common musculoskeletal issues in children with congenital Zika syndrome?", "How do these musculoskeletal problems, particularly those affecting the hips, impact the long-term mobility and health of children with this condition?"], "ground_truth": ["permed-82273", "permed-71154", "permed-60113", "permed-60111", "permed-19839", "permed-19836", "permed-59829", "permed-20735", "permed-19837", "permed-59837"]}
{"query_id": "topic_527_turn_4", "conversation_id": "topic_527", "turn_id": 4, "query": "For implementing these proposed early interventions targeting spasticity and vision, what specific outcome measures would you recommend for quantitatively assessing hip joint development over time? I'm particularly interested in the imaging protocols - would you prefer serial ultrasound in infants transitioning to radiographic measurements, or would 3D gait analysis provide more meaningful functional data? Also, what statistical approaches would best account for the multifactorial nature of these interventions when analyzing their individual contributions to preventing hip subluxation?", "history": ["What are the common musculoskeletal issues in children with congenital Zika syndrome?", "How do these musculoskeletal problems, particularly those affecting the hips, impact the long-term mobility and health of children with this condition?", "Given these hip-related mobility challenges in children with congenital Zika syndrome, how could early interventions addressing both spasticity and ophthalmologic issues influence their long-term hip joint outcomes? What specific therapeutic approaches might be most effective in preventing or reducing these deformities?"], "ground_truth": ["permed-60111", "permed-17587", "permed-17594", "permed-24833", "permed-20735", "permed-91883", "permed-82273", "permed-18435", "permed-18436", "permed-17590"]}
{"query_id": "topic_527_turn_5", "conversation_id": "topic_527", "turn_id": 5, "query": "Given the detailed discussion of quantitative assessment methods for hip development, how do the predictive capabilities of serial ultrasound measurements for early subluxation risk compare against 3D gait analysis for functional mobility outcomes in these children? Specifically, when considering the multifactorial interventions discussed, which modality demonstrates superior clinical utility for guiding treatment adjustments - imaging-based anatomical tracking or functional movement analysis? Are there particular patient subgroups (e.g., different severity levels of spasticity or visual impairment) where one assessment approach shows clear advantages over the other?", "history": ["What are the common musculoskeletal issues in children with congenital Zika syndrome?", "How do these musculoskeletal problems, particularly those affecting the hips, impact the long-term mobility and health of children with this condition?", "Given these hip-related mobility challenges in children with congenital Zika syndrome, how could early interventions addressing both spasticity and ophthalmologic issues influence their long-term hip joint outcomes? What specific therapeutic approaches might be most effective in preventing or reducing these deformities?", "For implementing these proposed early interventions targeting spasticity and vision, what specific outcome measures would you recommend for quantitatively assessing hip joint development over time? I'm particularly interested in the imaging protocols - would you prefer serial ultrasound in infants transitioning to radiographic measurements, or would 3D gait analysis provide more meaningful functional data? Also, what statistical approaches would best account for the multifactorial nature of these interventions when analyzing their individual contributions to preventing hip subluxation?"], "ground_truth": ["permed-17587", "permed-17586", "permed-17594", "permed-17590", "permed-60111", "permed-64460", "permed-17595", "permed-71140", "permed-24833", "permed-17596"]}
{"query_id": "topic_528_turn_1", "conversation_id": "topic_528", "turn_id": 1, "query": "What factors affect the quality of sperm after freezing and thawing, particularly in stallions?", "history": [], "ground_truth": ["permed-80480", "permed-80482", "permed-80483", "permed-76038", "permed-80481", "permed-80485", "permed-80488", "permed-72107", "permed-80490", "permed-80486"]}
{"query_id": "topic_528_turn_2", "conversation_id": "topic_528", "turn_id": 2, "query": "Does the composition of the freezing extender play a significant role in it, and if so, how?", "history": ["What factors affect the quality of sperm after freezing and thawing, particularly in stallions?"], "ground_truth": ["permed-80485", "permed-80480", "permed-80493", "permed-82164", "permed-75485", "permed-82162", "permed-80483", "permed-74193", "permed-80015", "permed-74014"]}
{"query_id": "topic_528_turn_3", "conversation_id": "topic_528", "turn_id": 3, "query": "Given that both the freezing extender composition and pre-freeze cooling rate affect post-thaw sperm quality, what molecular mechanisms might explain these differences? And which specific biochemical pathways could we target to improve cryosurvival and functional integrity, especially in stallions with poorer initial sperm quality?", "history": ["What factors affect the quality of sperm after freezing and thawing, particularly in stallions?", "Does the composition of the freezing extender play a significant role in it, and if so, how?"], "ground_truth": ["permed-80480", "permed-80482", "permed-80485", "permed-76038", "permed-80481", "permed-80483", "permed-80488", "permed-80490", "permed-72107", "permed-80484"]}
{"query_id": "topic_528_turn_4", "conversation_id": "topic_528", "turn_id": 4, "query": "When investigating these molecular mechanisms and targeted pathways you mentioned, what specific experimental approaches would be most appropriate for quantifying cryodamage at the subcellular level? I'm particularly interested in the technical implementation – would you recommend flow cytometry with specific fluorescent probes for membrane integrity and mitochondrial function, or more specialized techniques like CASA systems for kinematic parameters? Also, what statistical validation strategies would ensure these methodological assessments reliably capture the biochemical pathway alterations affecting cryosurvival in stallion sperm?", "history": ["What factors affect the quality of sperm after freezing and thawing, particularly in stallions?", "Does the composition of the freezing extender play a significant role in it, and if so, how?", "Given that both the freezing extender composition and pre-freeze cooling rate affect post-thaw sperm quality, what molecular mechanisms might explain these differences? And which specific biochemical pathways could we target to improve cryosurvival and functional integrity, especially in stallions with poorer initial sperm quality?"], "ground_truth": ["permed-72107", "permed-80488", "permed-80482", "permed-80481", "permed-76038", "permed-80480", "permed-80490", "permed-76037", "permed-76042", "permed-77666"]}
{"query_id": "topic_528_turn_5", "conversation_id": "topic_528", "turn_id": 5, "query": "Given these validated methodologies for quantifying subcellular cryodamage in stallion sperm, what clinical implications do these mechanistic findings have for improving actual fertility outcomes in equine breeding programs? Specifically, based on the molecular pathway alterations you've identified, what targeted cryopreservation protocols or sperm handling modifications could be translated into clinical practice to enhance conception rates? Furthermore, what safety considerations or potential side effects should be monitored when implementing these refined cryopreservation strategies in a clinical equine reproduction setting, particularly for stallions with compromised initial semen quality?", "history": ["What factors affect the quality of sperm after freezing and thawing, particularly in stallions?", "Does the composition of the freezing extender play a significant role in it, and if so, how?", "Given that both the freezing extender composition and pre-freeze cooling rate affect post-thaw sperm quality, what molecular mechanisms might explain these differences? And which specific biochemical pathways could we target to improve cryosurvival and functional integrity, especially in stallions with poorer initial sperm quality?", "When investigating these molecular mechanisms and targeted pathways you mentioned, what specific experimental approaches would be most appropriate for quantifying cryodamage at the subcellular level? I'm particularly interested in the technical implementation – would you recommend flow cytometry with specific fluorescent probes for membrane integrity and mitochondrial function, or more specialized techniques like CASA systems for kinematic parameters? Also, what statistical validation strategies would ensure these methodological assessments reliably capture the biochemical pathway alterations affecting cryosurvival in stallion sperm?"], "ground_truth": ["permed-80482", "permed-80480", "permed-76038", "permed-80488", "permed-76037", "permed-72107", "permed-80481", "permed-80483", "permed-80490", "permed-80484"]}
{"query_id": "topic_529_turn_1", "conversation_id": "topic_529", "turn_id": 1, "query": "Effective fall prevention strategies for care home residents with cognitive impairments", "history": [], "ground_truth": ["permed-77526", "permed-74641", "permed-52399", "permed-75160", "permed-77043", "permed-85778", "permed-67553", "permed-66410", "permed-65589", "permed-50970"]}
{"query_id": "topic_529_turn_2", "conversation_id": "topic_529", "turn_id": 2, "query": "Tailoring these fall prevention strategies with staff empowerment for improved outcomes in diverse care home environments", "history": ["Effective fall prevention strategies for care home residents with cognitive impairments"], "ground_truth": ["permed-77526", "permed-67553", "permed-61342", "permed-51092", "permed-55087", "permed-50970", "permed-75160", "permed-61332", "permed-61615", "permed-81454"]}
{"query_id": "topic_529_turn_3", "conversation_id": "topic_529", "turn_id": 3, "query": "Implementing personalized care plans and staff empowerment within multifactorial fall prevention programs for cognitively impaired residents: adapting to varied care home leadership structures", "history": ["Effective fall prevention strategies for care home residents with cognitive impairments", "Tailoring these fall prevention strategies with staff empowerment for improved outcomes in diverse care home environments"], "ground_truth": ["permed-77526", "permed-74641", "permed-52399", "permed-51086", "permed-67553", "permed-67322", "permed-61615", "permed-51092", "permed-61342", "permed-56935"]}
{"query_id": "topic_529_turn_4", "conversation_id": "topic_529", "turn_id": 4, "query": "When implementing these multifactorial programs across varied leadership structures, what specific methodological adaptations were required for the staff empowerment component? I'm particularly interested in how empowerment protocols were adjusted for hierarchical versus distributed leadership models, what validated instruments measured empowerment levels across different staff roles, and whether randomization or stepped-wedge designs proved more feasible for evaluating these adaptations in real-world care home settings.", "history": ["Effective fall prevention strategies for care home residents with cognitive impairments", "Tailoring these fall prevention strategies with staff empowerment for improved outcomes in diverse care home environments", "Implementing personalized care plans and staff empowerment within multifactorial fall prevention programs for cognitively impaired residents: adapting to varied care home leadership structures"], "ground_truth": ["permed-77526", "permed-86840", "permed-68361", "permed-55087", "permed-60168", "permed-51092", "permed-52217", "permed-51708", "permed-70263", "permed-90782"]}
{"query_id": "topic_529_turn_5", "conversation_id": "topic_529", "turn_id": 5, "query": "Given the methodological adaptations for staff empowerment across leadership structures, what clinical outcomes were observed for cognitively impaired residents in these multifactorial programs? I'm particularly interested in how these empowerment protocols translated to reduced fall rates, fall-related injuries, and hospitalizations compared to standard care. Were there differences in therapeutic efficacy or unexpected safety events—such as increased resident agitation or staff-initiated restraint use—between hierarchical and distributed leadership settings, and how did these clinical results correlate with the previously measured staff empowerment levels?", "history": ["Effective fall prevention strategies for care home residents with cognitive impairments", "Tailoring these fall prevention strategies with staff empowerment for improved outcomes in diverse care home environments", "Implementing personalized care plans and staff empowerment within multifactorial fall prevention programs for cognitively impaired residents: adapting to varied care home leadership structures", "When implementing these multifactorial programs across varied leadership structures, what specific methodological adaptations were required for the staff empowerment component? I'm particularly interested in how empowerment protocols were adjusted for hierarchical versus distributed leadership models, what validated instruments measured empowerment levels across different staff roles, and whether randomization or stepped-wedge designs proved more feasible for evaluating these adaptations in real-world care home settings."], "ground_truth": ["permed-77526", "permed-85778", "permed-32909", "permed-61342", "permed-55085", "permed-52399", "permed-81454", "permed-67322", "permed-51078", "permed-69511"]}
{"query_id": "topic_530_turn_1", "conversation_id": "topic_530", "turn_id": 1, "query": "Recent advancements welding technologies dissimilar material joining automotive aerospace", "history": [], "ground_truth": ["permed-51613", "permed-51040", "permed-64380", "permed-60645", "permed-60917", "permed-51482", "permed-92177", "permed-69706", "permed-74258", "permed-87249"]}
{"query_id": "topic_530_turn_2", "conversation_id": "topic_530", "turn_id": 2, "query": "Challenges joining steel to lightweight alloys (aluminum, titanium) using these advanced welding techniques solutions", "history": ["Recent advancements welding technologies dissimilar material joining automotive aerospace"], "ground_truth": ["permed-51613", "permed-64380", "permed-60917", "permed-74079", "permed-74257", "permed-91516", "permed-60645", "permed-74252", "permed-71333", "permed-51040"]}
{"query_id": "topic_530_turn_3", "conversation_id": "topic_530", "turn_id": 3, "query": "Laser welding steel to aluminum titanium magnesium: strategies to control intermetallic formation porosity microstructure for enhanced joint performance and process optimization", "history": ["Recent advancements welding technologies dissimilar material joining automotive aerospace", "Challenges joining steel to lightweight alloys (aluminum, titanium) using these advanced welding techniques solutions"], "ground_truth": ["permed-51613", "permed-74252", "permed-74079", "permed-74255", "permed-51040", "permed-74257", "permed-73922", "permed-74256", "permed-73154", "permed-60917"]}
{"query_id": "topic_530_turn_4", "conversation_id": "topic_530", "turn_id": 4, "query": "Regarding these microstructural control strategies, how exactly do researchers quantify and validate the reduction in intermetallic compound thickness? Are there standardized metallographic preparation protocols specifically for dissimilar metal weld cross-sections, and what statistical methods—beyond basic descriptive statistics—do they employ to correlate process parameters with mechanical property improvements while ensuring reproducibility across multiple weld trials?", "history": ["Recent advancements welding technologies dissimilar material joining automotive aerospace", "Challenges joining steel to lightweight alloys (aluminum, titanium) using these advanced welding techniques solutions", "Laser welding steel to aluminum titanium magnesium: strategies to control intermetallic formation porosity microstructure for enhanced joint performance and process optimization"], "ground_truth": ["permed-51613", "permed-86668", "permed-89820", "permed-74255", "permed-90101", "permed-74253", "permed-51465", "permed-64571", "permed-74079", "permed-75019"]}
{"query_id": "topic_530_turn_5", "conversation_id": "topic_530", "turn_id": 5, "query": "Given these validated microstructural control methods for dissimilar material welds, what clinical translation challenges emerge when adapting these joining techniques for biomedical implants like steel-to-titanium orthopedic devices? Specifically, how do researchers evaluate long-term in vivo performance regarding fatigue resistance under physiological loading conditions, and what clinical evidence exists about metal ion release or galvanic corrosion risks at these junctions? Additionally, are there documented cases of implant failure modes attributable to dissimilar material interfaces in current orthopedic practice?", "history": ["Recent advancements welding technologies dissimilar material joining automotive aerospace", "Challenges joining steel to lightweight alloys (aluminum, titanium) using these advanced welding techniques solutions", "Laser welding steel to aluminum titanium magnesium: strategies to control intermetallic formation porosity microstructure for enhanced joint performance and process optimization", "Regarding these microstructural control strategies, how exactly do researchers quantify and validate the reduction in intermetallic compound thickness? Are there standardized metallographic preparation protocols specifically for dissimilar metal weld cross-sections, and what statistical methods—beyond basic descriptive statistics—do they employ to correlate process parameters with mechanical property improvements while ensuring reproducibility across multiple weld trials?"], "ground_truth": ["permed-61906", "permed-60052", "permed-92656", "permed-83545", "permed-54879", "permed-87817", "permed-51613", "permed-75135", "permed-81235", "permed-83544"]}
{"query_id": "topic_531_turn_1", "conversation_id": "topic_531", "turn_id": 1, "query": "What treatments are currently being explored for Rheumatoid Arthritis-related Interstitial Lung Disease (RA-ILD) to improve pulmonary function?", "history": [], "ground_truth": ["permed-57120", "permed-61768", "permed-68830", "permed-56036", "permed-82101", "permed-57108", "permed-61095", "permed-27232", "permed-21379", "permed-26821"]}
{"query_id": "topic_531_turn_2", "conversation_id": "topic_531", "turn_id": 2, "query": "How effective is immunosuppressive therapy in this area, and what patient factors influence its success?", "history": ["What treatments are currently being explored for Rheumatoid Arthritis-related Interstitial Lung Disease (RA-ILD) to improve pulmonary function?"], "ground_truth": ["permed-88028", "permed-52027", "permed-67754", "permed-61306", "permed-75318", "permed-62397", "permed-56653", "permed-68660", "permed-56648", "permed-82612"]}
{"query_id": "topic_531_turn_3", "conversation_id": "topic_531", "turn_id": 3, "query": "Given the improvements in pulmonary function observed with immunosuppressive therapy for RA-ILD, what are its long-term effects on patients' quality of life and survival rates? How do these outcomes differ based on genetic predispositions or comorbidities, and how can such factors inform personalized treatment plans to maximize benefits while reducing risks?", "history": ["What treatments are currently being explored for Rheumatoid Arthritis-related Interstitial Lung Disease (RA-ILD) to improve pulmonary function?", "How effective is immunosuppressive therapy in this area, and what patient factors influence its success?"], "ground_truth": ["permed-57120", "permed-72215", "permed-48052", "permed-56036", "permed-82101", "permed-26821", "permed-23547", "permed-53197", "permed-57108", "permed-27232"]}
{"query_id": "topic_531_turn_4", "conversation_id": "topic_531", "turn_id": 4, "query": "Given this focus on personalized treatment plans based on genetic and comorbidity profiles, what specific statistical modeling approaches—such as propensity score matching or multivariate regression—are most effective for isolating the causal effect of immunosuppressive therapy on long-term survival from confounding variables? Furthermore, how are patient-reported quality of life metrics typically validated and incorporated into these longitudinal analyses to ensure they capture clinically meaningful changes over a multi-year follow-up period?", "history": ["What treatments are currently being explored for Rheumatoid Arthritis-related Interstitial Lung Disease (RA-ILD) to improve pulmonary function?", "How effective is immunosuppressive therapy in this area, and what patient factors influence its success?", "Given the improvements in pulmonary function observed with immunosuppressive therapy for RA-ILD, what are its long-term effects on patients' quality of life and survival rates? How do these outcomes differ based on genetic predispositions or comorbidities, and how can such factors inform personalized treatment plans to maximize benefits while reducing risks?"], "ground_truth": ["permed-52834", "permed-23663", "permed-68257", "permed-56451", "permed-72215", "permed-88028", "permed-55078", "permed-75318", "permed-84970", "permed-71181"]}
{"query_id": "topic_531_turn_5", "conversation_id": "topic_531", "turn_id": 5, "query": "Given the methodological approaches for analyzing long-term outcomes, what are the specific safety profiles and treatment discontinuation rates of common immunosuppressive regimens for RA-ILD in real-world clinical practice? Focusing on agents like rituximab or mycophenolate, how do infection risks, pulmonary toxicity, or other significant adverse events vary across different patient subgroups—particularly those with pre-existing comorbidities or genetic risk factors—and what monitoring protocols or risk mitigation strategies have proven most effective in maintaining therapeutic efficacy while minimizing these clinical complications?", "history": ["What treatments are currently being explored for Rheumatoid Arthritis-related Interstitial Lung Disease (RA-ILD) to improve pulmonary function?", "How effective is immunosuppressive therapy in this area, and what patient factors influence its success?", "Given the improvements in pulmonary function observed with immunosuppressive therapy for RA-ILD, what are its long-term effects on patients' quality of life and survival rates? How do these outcomes differ based on genetic predispositions or comorbidities, and how can such factors inform personalized treatment plans to maximize benefits while reducing risks?", "Given this focus on personalized treatment plans based on genetic and comorbidity profiles, what specific statistical modeling approaches—such as propensity score matching or multivariate regression—are most effective for isolating the causal effect of immunosuppressive therapy on long-term survival from confounding variables? Furthermore, how are patient-reported quality of life metrics typically validated and incorporated into these longitudinal analyses to ensure they capture clinically meaningful changes over a multi-year follow-up period?"], "ground_truth": ["permed-57120", "permed-53271", "permed-68820", "permed-82659", "permed-68825", "permed-52046", "permed-72901", "permed-53291", "permed-75528", "permed-61312"]}
{"query_id": "topic_532_turn_1", "conversation_id": "topic_532", "turn_id": 1, "query": "What role do phthalocyanines play in photo-sonodynamic therapy?", "history": [], "ground_truth": ["permed-80451", "permed-80452", "permed-55273", "permed-56540", "permed-75827", "permed-80455", "permed-75003", "permed-75007", "permed-55274", "permed-69255"]}
{"query_id": "topic_532_turn_2", "conversation_id": "topic_532", "turn_id": 2, "query": "How does modifying their structure impact their interaction with cancer cells in this context?", "history": ["What role do phthalocyanines play in photo-sonodynamic therapy?"], "ground_truth": ["permed-82373", "permed-63463", "permed-64384", "permed-64093", "permed-56500", "permed-71585", "permed-56645", "permed-76589", "permed-78604", "permed-71584"]}
{"query_id": "topic_532_turn_3", "conversation_id": "topic_532", "turn_id": 3, "query": "Given that structural modifications influence how phthalocyanines interact with cancer cells in photo-sonodynamic therapy, how might ionic variations specifically affect their behavior with cellular components in MCF-7 and HeLa cells? And what mechanisms could explain the improved therapeutic outcomes seen when combining these treatment approaches?", "history": ["What role do phthalocyanines play in photo-sonodynamic therapy?", "How does modifying their structure impact their interaction with cancer cells in this context?"], "ground_truth": ["permed-80451", "permed-55273", "permed-80452", "permed-56542", "permed-58080", "permed-60811", "permed-86876", "permed-89912", "permed-75829", "permed-67537"]}
{"query_id": "topic_532_turn_4", "conversation_id": "topic_532", "turn_id": 4, "query": "When investigating these ionic variations in phthalocyanines and their mechanisms in MCF-7 and HeLa cells, what specific methodological approaches would you recommend for quantitatively assessing their intracellular localization patterns? I'm particularly interested in the technical implementation - would you utilize confocal microscopy with organelle-specific probes, subcellular fractionation followed by HPLC analysis, or perhaps live-cell imaging protocols? Also, how should we validate that observed localization differences directly correlate with the improved therapeutic outcomes rather than being incidental findings?", "history": ["What role do phthalocyanines play in photo-sonodynamic therapy?", "How does modifying their structure impact their interaction with cancer cells in this context?", "Given that structural modifications influence how phthalocyanines interact with cancer cells in photo-sonodynamic therapy, how might ionic variations specifically affect their behavior with cellular components in MCF-7 and HeLa cells? And what mechanisms could explain the improved therapeutic outcomes seen when combining these treatment approaches?"], "ground_truth": ["permed-63376", "permed-80451", "permed-77232", "permed-48452", "permed-80649", "permed-76151", "permed-52754", "permed-83331", "permed-61683", "permed-52692"]}
{"query_id": "topic_532_turn_5", "conversation_id": "topic_532", "turn_id": 5, "query": "Given the methodological approaches discussed for quantifying intracellular localization, how have these phthalocyanine structural modifications translated to actual clinical outcomes in existing studies? Specifically, what evidence exists regarding their therapeutic efficacy and safety profiles in human trials or advanced preclinical models? I'm particularly interested in whether the improved intracellular targeting observed in MCF-7 and HeLa cells correlates with reduced systemic toxicity or enhanced tumor selectivity in vivo, and what clinical challenges remain for implementing these optimized compounds in cancer treatment protocols.", "history": ["What role do phthalocyanines play in photo-sonodynamic therapy?", "How does modifying their structure impact their interaction with cancer cells in this context?", "Given that structural modifications influence how phthalocyanines interact with cancer cells in photo-sonodynamic therapy, how might ionic variations specifically affect their behavior with cellular components in MCF-7 and HeLa cells? And what mechanisms could explain the improved therapeutic outcomes seen when combining these treatment approaches?", "When investigating these ionic variations in phthalocyanines and their mechanisms in MCF-7 and HeLa cells, what specific methodological approaches would you recommend for quantitatively assessing their intracellular localization patterns? I'm particularly interested in the technical implementation - would you utilize confocal microscopy with organelle-specific probes, subcellular fractionation followed by HPLC analysis, or perhaps live-cell imaging protocols? Also, how should we validate that observed localization differences directly correlate with the improved therapeutic outcomes rather than being incidental findings?"], "ground_truth": ["permed-80451", "permed-62060", "permed-51304", "permed-80452", "permed-51307", "permed-52926", "permed-56221", "permed-60811", "permed-11728", "permed-87717"]}
{"query_id": "topic_533_turn_1", "conversation_id": "topic_533", "turn_id": 1, "query": "What role do proteoglycans play in the health and function of hyaline cartilage?", "history": [], "ground_truth": ["permed-64398", "permed-64457", "permed-74949", "permed-80562", "permed-91098", "permed-90885", "permed-75512", "permed-91596", "permed-64602", "permed-75998"]}
{"query_id": "topic_533_turn_2", "conversation_id": "topic_533", "turn_id": 2, "query": "How might alterations in this component affect conditions like osteoarthritis, considering its significance in cartilage mechanics?", "history": ["What role do proteoglycans play in the health and function of hyaline cartilage?"], "ground_truth": ["permed-61498", "permed-81532", "permed-91450", "permed-86412", "permed-91259", "permed-91102", "permed-54353", "permed-64625", "permed-64587", "permed-75512"]}
{"query_id": "topic_533_turn_3", "conversation_id": "topic_533", "turn_id": 3, "query": "Given their critical role in cartilage mechanics, how could targeted modifications to proteoglycan content influence osteoarthritis progression or treatment? What would be the potential advantages and drawbacks of using advanced hyperelastic models like the Fung model to predict the long-term biomechanical effects of such interventions?", "history": ["What role do proteoglycans play in the health and function of hyaline cartilage?", "How might alterations in this component affect conditions like osteoarthritis, considering its significance in cartilage mechanics?"], "ground_truth": ["permed-64457", "permed-73639", "permed-75512", "permed-80562", "permed-91450", "permed-54899", "permed-54902", "permed-91098", "permed-90890", "permed-91456"]}
{"query_id": "topic_533_turn_4", "conversation_id": "topic_533", "turn_id": 4, "query": "When implementing these hyperelastic models to predict biomechanical outcomes, what specific experimental protocols would you recommend for validating their predictions against actual tissue behavior? I'm particularly interested in how one might design mechanical testing regimes - should we prioritize unconfined compression, indentation testing, or more complex multiaxial loading scenarios to capture the anisotropic nature of proteoglycan-depleted cartilage? Additionally, what statistical approaches would be most appropriate for comparing model predictions with experimental data across multiple time points?", "history": ["What role do proteoglycans play in the health and function of hyaline cartilage?", "How might alterations in this component affect conditions like osteoarthritis, considering its significance in cartilage mechanics?", "Given their critical role in cartilage mechanics, how could targeted modifications to proteoglycan content influence osteoarthritis progression or treatment? What would be the potential advantages and drawbacks of using advanced hyperelastic models like the Fung model to predict the long-term biomechanical effects of such interventions?"], "ground_truth": ["permed-64457", "permed-75510", "permed-80562", "permed-91596", "permed-75512", "permed-53152", "permed-64587", "permed-73639", "permed-80564", "permed-64452"]}
{"query_id": "topic_533_turn_5", "conversation_id": "topic_533", "turn_id": 5, "query": "Given these validated modeling approaches for predicting biomechanical changes in proteoglycan-depleted cartilage, how have these computational insights translated to clinical applications for osteoarthritis management? Specifically, what clinical trial evidence exists regarding therapeutic strategies targeting proteoglycan content restoration, and what patient-reported outcomes have been observed? Additionally, considering the mechanical vulnerability predicted by these models, what weight-bearing activity modifications or rehabilitation protocols have demonstrated efficacy in preserving cartilage integrity in early-stage OA patients, and are there any documented safety concerns with emerging proteoglycan-targeting interventions?", "history": ["What role do proteoglycans play in the health and function of hyaline cartilage?", "How might alterations in this component affect conditions like osteoarthritis, considering its significance in cartilage mechanics?", "Given their critical role in cartilage mechanics, how could targeted modifications to proteoglycan content influence osteoarthritis progression or treatment? What would be the potential advantages and drawbacks of using advanced hyperelastic models like the Fung model to predict the long-term biomechanical effects of such interventions?", "When implementing these hyperelastic models to predict biomechanical outcomes, what specific experimental protocols would you recommend for validating their predictions against actual tissue behavior? I'm particularly interested in how one might design mechanical testing regimes - should we prioritize unconfined compression, indentation testing, or more complex multiaxial loading scenarios to capture the anisotropic nature of proteoglycan-depleted cartilage? Additionally, what statistical approaches would be most appropriate for comparing model predictions with experimental data across multiple time points?"], "ground_truth": ["permed-54899", "permed-55128", "permed-64605", "permed-54892", "permed-68964", "permed-64587", "permed-54893", "permed-55135", "permed-64601", "permed-91098"]}
{"query_id": "topic_534_turn_1", "conversation_id": "topic_534", "turn_id": 1, "query": "What are the current challenges in maintaining the stability of graphene oxide's nanoporous structure?", "history": [], "ground_truth": ["permed-78725", "permed-74391", "permed-80566", "permed-79819", "permed-76343", "permed-76287", "permed-55247", "permed-75952", "permed-82645", "permed-77112"]}
{"query_id": "topic_534_turn_2", "conversation_id": "topic_534", "turn_id": 2, "query": "How does the manipulation of its surface properties impact this stability, particularly in applications like gas sensing?", "history": ["What are the current challenges in maintaining the stability of graphene oxide's nanoporous structure?"], "ground_truth": ["permed-82843", "permed-74450", "permed-75983", "permed-78460", "permed-53484", "permed-64619", "permed-80012", "permed-77393", "permed-75956", "permed-78760"]}
{"query_id": "topic_534_turn_3", "conversation_id": "topic_534", "turn_id": 3, "query": "Given these challenges and surface property effects, how does controlling the removal of surface-bound water and decomposing labile functional groups at specific temperatures influence the long-term stability and reproducibility of graphene oxide's nanoporous structure—especially in practical applications like gas sensing or separation technologies?", "history": ["What are the current challenges in maintaining the stability of graphene oxide's nanoporous structure?", "How does the manipulation of its surface properties impact this stability, particularly in applications like gas sensing?"], "ground_truth": ["permed-78725", "permed-74391", "permed-78726", "permed-76343", "permed-75659", "permed-78763", "permed-79819", "permed-78262", "permed-76287", "permed-77112"]}
{"query_id": "topic_534_turn_4", "conversation_id": "topic_534", "turn_id": 4, "query": "Given this thermal treatment approach for controlling surface-bound water and functional group decomposition, what specific temperature ramp rates and dwell times were most effective for maintaining nanoporous stability? Were these protocols optimized through systematic TGA-DSC studies, and how was the resulting structural reproducibility quantified—perhaps through BET surface area consistency across multiple batches or statistical process control methods?", "history": ["What are the current challenges in maintaining the stability of graphene oxide's nanoporous structure?", "How does the manipulation of its surface properties impact this stability, particularly in applications like gas sensing?", "Given these challenges and surface property effects, how does controlling the removal of surface-bound water and decomposing labile functional groups at specific temperatures influence the long-term stability and reproducibility of graphene oxide's nanoporous structure—especially in practical applications like gas sensing or separation technologies?"], "ground_truth": ["permed-78725", "permed-52626", "permed-73147", "permed-75023", "permed-78341", "permed-58262", "permed-74666", "permed-63655", "permed-73154", "permed-92703"]}
{"query_id": "topic_534_turn_5", "conversation_id": "topic_534", "turn_id": 5, "query": "Given these optimized thermal protocols for structural reproducibility, how do the resulting stabilized graphene oxide membranes compare against other common nanoporous materials like activated carbon or metal-organic frameworks in practical separation applications? Specifically, what are the comparative trade-offs in terms of selectivity-permeability balance, mechanical stability under operational pressure, and long-term performance degradation when processing complex mixtures—particularly considering graphene oxide's unique interlayer spacing versus the rigid pore structures of alternative materials?", "history": ["What are the current challenges in maintaining the stability of graphene oxide's nanoporous structure?", "How does the manipulation of its surface properties impact this stability, particularly in applications like gas sensing?", "Given these challenges and surface property effects, how does controlling the removal of surface-bound water and decomposing labile functional groups at specific temperatures influence the long-term stability and reproducibility of graphene oxide's nanoporous structure—especially in practical applications like gas sensing or separation technologies?", "Given this thermal treatment approach for controlling surface-bound water and functional group decomposition, what specific temperature ramp rates and dwell times were most effective for maintaining nanoporous stability? Were these protocols optimized through systematic TGA-DSC studies, and how was the resulting structural reproducibility quantified—perhaps through BET surface area consistency across multiple batches or statistical process control methods?"], "ground_truth": ["permed-78725", "permed-78763", "permed-75659", "permed-74391", "permed-62259", "permed-76343", "permed-67181", "permed-73990", "permed-77112", "permed-73162"]}
{"query_id": "topic_535_turn_1", "conversation_id": "topic_535", "turn_id": 1, "query": "Contribution of intrinsically disordered protein regions to mechanisms of pathological protein aggregation in disease", "history": [], "ground_truth": ["permed-80237", "permed-71541", "permed-76050", "permed-72010", "permed-75067", "permed-82373", "permed-79510", "permed-54225", "permed-71707", "permed-53306"]}
{"query_id": "topic_535_turn_2", "conversation_id": "topic_535", "turn_id": 2, "query": "Influence of specific amino acid sequence motifs and conformational ensembles within these intrinsically disordered regions on their aberrant protein-protein interactions and aggregation pathways", "history": ["Contribution of intrinsically disordered protein regions to mechanisms of pathological protein aggregation in disease"], "ground_truth": ["permed-80237", "permed-71541", "permed-89298", "permed-76050", "permed-53306", "permed-61289", "permed-71539", "permed-79510", "permed-62888", "permed-80354"]}
{"query_id": "topic_535_turn_3", "conversation_id": "topic_535", "turn_id": 3, "query": "Role of hydration dynamics and the balance between electrostatic and hydrophobic interactions, as modulated by such sequence/structural features of disordered proteins, in determining their aggregation propensity under varying cellular environments", "history": ["Contribution of intrinsically disordered protein regions to mechanisms of pathological protein aggregation in disease", "Influence of specific amino acid sequence motifs and conformational ensembles within these intrinsically disordered regions on their aberrant protein-protein interactions and aggregation pathways"], "ground_truth": ["permed-74941", "permed-76050", "permed-89298", "permed-77118", "permed-74945", "permed-76054", "permed-74947", "permed-84333", "permed-53306", "permed-80237"]}
{"query_id": "topic_535_turn_4", "conversation_id": "topic_535", "turn_id": 4, "query": "When examining these hydration and interaction dynamics, what specific experimental techniques would best capture the temporal evolution of IDP aggregation? I'm particularly interested in methodological approaches that can simultaneously monitor changes in solvent accessibility and intermolecular contacts – would time-resolved spectroscopy combined with site-specific fluorophore labeling provide sufficient resolution? Also, what statistical frameworks are most appropriate for quantifying the cooperativity of these transitions from single-molecule trajectory data?", "history": ["Contribution of intrinsically disordered protein regions to mechanisms of pathological protein aggregation in disease", "Influence of specific amino acid sequence motifs and conformational ensembles within these intrinsically disordered regions on their aberrant protein-protein interactions and aggregation pathways", "Role of hydration dynamics and the balance between electrostatic and hydrophobic interactions, as modulated by such sequence/structural features of disordered proteins, in determining their aggregation propensity under varying cellular environments"], "ground_truth": ["permed-76149", "permed-91052", "permed-52457", "permed-91053", "permed-74948", "permed-91059", "permed-82174", "permed-75067", "permed-60582", "permed-60592"]}
{"query_id": "topic_535_turn_5", "conversation_id": "topic_535", "turn_id": 5, "query": "Given these mechanistic insights into IDP aggregation dynamics, what clinical implications emerge regarding therapeutic interventions? Specifically, how could targeting these early hydration and interaction dynamics translate to disease-modifying treatments for neurodegenerative conditions? What evidence exists from clinical trials attempting to disrupt pathological aggregation through small molecules or biologics, and what have been the primary challenges in achieving clinical efficacy while managing potential side effects when interfering with these fundamental protein interaction networks?", "history": ["Contribution of intrinsically disordered protein regions to mechanisms of pathological protein aggregation in disease", "Influence of specific amino acid sequence motifs and conformational ensembles within these intrinsically disordered regions on their aberrant protein-protein interactions and aggregation pathways", "Role of hydration dynamics and the balance between electrostatic and hydrophobic interactions, as modulated by such sequence/structural features of disordered proteins, in determining their aggregation propensity under varying cellular environments", "When examining these hydration and interaction dynamics, what specific experimental techniques would best capture the temporal evolution of IDP aggregation? I'm particularly interested in methodological approaches that can simultaneously monitor changes in solvent accessibility and intermolecular contacts – would time-resolved spectroscopy combined with site-specific fluorophore labeling provide sufficient resolution? Also, what statistical frameworks are most appropriate for quantifying the cooperativity of these transitions from single-molecule trajectory data?"], "ground_truth": ["permed-51169", "permed-54225", "permed-71710", "permed-61805", "permed-54221", "permed-59141", "permed-85258", "permed-73065", "permed-66782", "permed-58076"]}
{"query_id": "topic_536_turn_1", "conversation_id": "topic_536", "turn_id": 1, "query": "Comprehensive overview of dietary supplement effects on gut microbiota and liver health in murine models", "history": [], "ground_truth": ["permed-65029", "permed-64094", "permed-65214", "permed-72282", "permed-58594", "permed-76331", "permed-62631", "permed-80713", "permed-9838", "permed-90184"]}
{"query_id": "topic_536_turn_2", "conversation_id": "topic_536", "turn_id": 2, "query": "Focusing on such interactions, what is the specific impact of rhododendrol on gut microbiota and liver health in high-fat diet-fed mice?", "history": ["Comprehensive overview of dietary supplement effects on gut microbiota and liver health in murine models"], "ground_truth": ["permed-60746", "permed-67842", "permed-65154", "permed-65160", "permed-58970", "permed-62617", "permed-59032", "permed-58594", "permed-64874", "permed-64991"]}
{"query_id": "topic_536_turn_3", "conversation_id": "topic_536", "turn_id": 3, "query": "Given rhododendrol's demonstrated effects on gut microbiota and liver metabolomics in these high-fat diet mice, which specific signaling pathways governing lipid metabolism and inflammation resolution are consequently altered, and what is the translational potential of these mechanisms for NAFLD therapy?", "history": ["Comprehensive overview of dietary supplement effects on gut microbiota and liver health in murine models", "Focusing on such interactions, what is the specific impact of rhododendrol on gut microbiota and liver health in high-fat diet-fed mice?"], "ground_truth": ["permed-60746", "permed-58970", "permed-60745", "permed-58590", "permed-58208", "permed-67842", "permed-51265", "permed-57752", "permed-67841", "permed-58593"]}
{"query_id": "topic_536_turn_4", "conversation_id": "topic_536", "turn_id": 4, "query": "Given these pathway alterations in lipid metabolism and inflammation resolution, what specific analytical techniques were employed to quantify the activation states of PPAR-α and NF-κB signaling? Were Western blot densitometry, phosphoprotein-specific assays, or transcriptomic analyses used to validate pathway modulation, and what statistical approaches ensured detection of subtle signaling changes amid biological variability in your murine model?", "history": ["Comprehensive overview of dietary supplement effects on gut microbiota and liver health in murine models", "Focusing on such interactions, what is the specific impact of rhododendrol on gut microbiota and liver health in high-fat diet-fed mice?", "Given rhododendrol's demonstrated effects on gut microbiota and liver metabolomics in these high-fat diet mice, which specific signaling pathways governing lipid metabolism and inflammation resolution are consequently altered, and what is the translational potential of these mechanisms for NAFLD therapy?"], "ground_truth": ["permed-89985", "permed-9614", "permed-71435", "permed-51145", "permed-9836", "permed-10575", "permed-58597", "permed-22103", "permed-23631", "permed-74843"]}
{"query_id": "topic_536_turn_5", "conversation_id": "topic_536", "turn_id": 5, "query": "Given the detailed methodological validation of PPAR-α and NF-κB signaling quantification, how do the observed pathway modulation patterns and their downstream metabolic outcomes compare between rhododendrol supplementation and established NAFLD interventions like pioglitazone or obeticholic acid? Specifically, in translational terms, what relative advantages does rhododendrol's dual impact on lipid metabolism and inflammation resolution offer compared to these pharmacological agents, particularly regarding side effect profiles and microbiome-mediated mechanisms versus direct receptor targeting?", "history": ["Comprehensive overview of dietary supplement effects on gut microbiota and liver health in murine models", "Focusing on such interactions, what is the specific impact of rhododendrol on gut microbiota and liver health in high-fat diet-fed mice?", "Given rhododendrol's demonstrated effects on gut microbiota and liver metabolomics in these high-fat diet mice, which specific signaling pathways governing lipid metabolism and inflammation resolution are consequently altered, and what is the translational potential of these mechanisms for NAFLD therapy?", "Given these pathway alterations in lipid metabolism and inflammation resolution, what specific analytical techniques were employed to quantify the activation states of PPAR-α and NF-κB signaling? Were Western blot densitometry, phosphoprotein-specific assays, or transcriptomic analyses used to validate pathway modulation, and what statistical approaches ensured detection of subtle signaling changes amid biological variability in your murine model?"], "ground_truth": ["permed-60746", "permed-62692", "permed-58208", "permed-75520", "permed-57752", "permed-12305", "permed-58970", "permed-71435", "permed-58639", "permed-68053"]}
{"query_id": "topic_537_turn_1", "conversation_id": "topic_537", "turn_id": 1, "query": "What advancements have been made in using thermosensitive hydrogels for drug delivery systems?", "history": [], "ground_truth": ["permed-78834", "permed-77379", "permed-60670", "permed-89636", "permed-67184", "permed-64389", "permed-88792", "permed-60669", "permed-72972", "permed-60671"]}
{"query_id": "topic_537_turn_2", "conversation_id": "topic_537", "turn_id": 2, "query": "How does this technique impact the immune system when used for repeated dosing of certain therapeutics?", "history": ["What advancements have been made in using thermosensitive hydrogels for drug delivery systems?"], "ground_truth": ["permed-74547", "permed-84970", "permed-86635", "permed-65331", "permed-26840", "permed-56717", "permed-67754", "permed-73919", "permed-67784", "permed-60148"]}
{"query_id": "topic_537_turn_3", "conversation_id": "topic_537", "turn_id": 3, "query": "Given these advancements and their immune system impacts, what are the long-term safety implications of using subcutaneously administered thermosensitive in situ hydrogels—especially for repeated dosing of protein therapeutics with short half-lives? How do these effects vary across different natural polymer formulations?", "history": ["What advancements have been made in using thermosensitive hydrogels for drug delivery systems?", "How does this technique impact the immune system when used for repeated dosing of certain therapeutics?"], "ground_truth": ["permed-78834", "permed-64389", "permed-67184", "permed-89636", "permed-81844", "permed-60670", "permed-84970", "permed-60669", "permed-75771", "permed-60671"]}
{"query_id": "topic_537_turn_4", "conversation_id": "topic_537", "turn_id": 4, "query": "Given the safety concerns with repeated dosing, what specific in vitro and in vivo methodologies were employed to characterize the degradation kinetics and protein release profiles from these natural polymer formulations? I'm particularly interested in how researchers validated the correlation between accelerated stability testing and real-time release data, and what statistical models were used to predict cumulative exposure and immune cell infiltration patterns over multiple administration cycles.", "history": ["What advancements have been made in using thermosensitive hydrogels for drug delivery systems?", "How does this technique impact the immune system when used for repeated dosing of certain therapeutics?", "Given these advancements and their immune system impacts, what are the long-term safety implications of using subcutaneously administered thermosensitive in situ hydrogels—especially for repeated dosing of protein therapeutics with short half-lives? How do these effects vary across different natural polymer formulations?"], "ground_truth": ["permed-78834", "permed-79015", "permed-60733", "permed-89638", "permed-84970", "permed-83814", "permed-86390", "permed-51251", "permed-60731", "permed-74473"]}
{"query_id": "topic_537_turn_5", "conversation_id": "topic_537", "turn_id": 5, "query": "Given these detailed methodological approaches for characterizing degradation and release kinetics, what clinical evidence exists regarding therapeutic efficacy and patient outcomes when these natural polymer hydrogels are used for repeated protein delivery? Specifically, are there comparative clinical trial data showing how different formulations affect bioavailability maintenance versus conventional delivery methods? Furthermore, what real-world clinical challenges have emerged regarding injection site reactions or immunogenicity management during extended treatment regimens, and how do these correlate with the predicted immune cell infiltration patterns from preclinical models?", "history": ["What advancements have been made in using thermosensitive hydrogels for drug delivery systems?", "How does this technique impact the immune system when used for repeated dosing of certain therapeutics?", "Given these advancements and their immune system impacts, what are the long-term safety implications of using subcutaneously administered thermosensitive in situ hydrogels—especially for repeated dosing of protein therapeutics with short half-lives? How do these effects vary across different natural polymer formulations?", "Given the safety concerns with repeated dosing, what specific in vitro and in vivo methodologies were employed to characterize the degradation kinetics and protein release profiles from these natural polymer formulations? I'm particularly interested in how researchers validated the correlation between accelerated stability testing and real-time release data, and what statistical models were used to predict cumulative exposure and immune cell infiltration patterns over multiple administration cycles."], "ground_truth": ["permed-78834", "permed-64389", "permed-89836", "permed-75386", "permed-60671", "permed-81798", "permed-89638", "permed-80179", "permed-72972", "permed-72499"]}
{"query_id": "topic_538_turn_1", "conversation_id": "topic_538", "turn_id": 1, "query": "What impact does cooking have on the nutritional profile of meat, particularly in terms of fatty acid content?", "history": [], "ground_truth": ["permed-80698", "permed-80701", "permed-65046", "permed-78137", "permed-74235", "permed-89172", "permed-72150", "permed-86182", "permed-80726", "permed-80860"]}
{"query_id": "topic_538_turn_2", "conversation_id": "topic_538", "turn_id": 2, "query": "Are there specific cooking techniques that can significantly alter it, potentially affecting human health outcomes when consumed?", "history": ["What impact does cooking have on the nutritional profile of meat, particularly in terms of fatty acid content?"], "ground_truth": ["permed-78137", "permed-71561", "permed-78135", "permed-78130", "permed-37305", "permed-80705", "permed-52470", "permed-52713", "permed-52476", "permed-83045"]}
{"query_id": "topic_538_turn_3", "conversation_id": "topic_538", "turn_id": 3, "query": "Given these effects of cooking on meat's fatty acids and their potential health implications, how do the specific changes in goose meat's lipid profiles and indices—when prepared using methods like sous-vide, microwave, or stewing—affect the bioavailability and metabolism of these lipids in humans, particularly regarding cardiovascular health and inflammation? Furthermore, how could such findings guide cooking method choices for individuals with specific dietary concerns, such as those managing cholesterol or following anti-inflammatory diets?", "history": ["What impact does cooking have on the nutritional profile of meat, particularly in terms of fatty acid content?", "Are there specific cooking techniques that can significantly alter it, potentially affecting human health outcomes when consumed?"], "ground_truth": ["permed-80698", "permed-80702", "permed-80699", "permed-80860", "permed-82503", "permed-65116", "permed-78137", "permed-80701", "permed-76142", "permed-89172"]}
{"query_id": "topic_538_turn_4", "conversation_id": "topic_538", "turn_id": 4, "query": "Given this analysis of goose meat lipid changes under different cooking methods, what specific experimental protocols would you recommend for assessing human bioavailability? I'm particularly interested in methodological details regarding the in vitro digestion models used to simulate lipid release, the analytical techniques for tracking oxidized lipid metabolites, and how you would validate these findings through human intervention studies measuring postprandial inflammatory markers and lipid absorption kinetics.", "history": ["What impact does cooking have on the nutritional profile of meat, particularly in terms of fatty acid content?", "Are there specific cooking techniques that can significantly alter it, potentially affecting human health outcomes when consumed?", "Given these effects of cooking on meat's fatty acids and their potential health implications, how do the specific changes in goose meat's lipid profiles and indices—when prepared using methods like sous-vide, microwave, or stewing—affect the bioavailability and metabolism of these lipids in humans, particularly regarding cardiovascular health and inflammation? Furthermore, how could such findings guide cooking method choices for individuals with specific dietary concerns, such as those managing cholesterol or following anti-inflammatory diets?"], "ground_truth": ["permed-80698", "permed-82503", "permed-54659", "permed-80699", "permed-76142", "permed-78137", "permed-76097", "permed-76140", "permed-80702", "permed-91765"]}
{"query_id": "topic_538_turn_5", "conversation_id": "topic_538", "turn_id": 5, "query": "Given these detailed experimental protocols for assessing lipid bioavailability and oxidation, how would the comparative performance of in vitro digestion models (e.g., INFOGEST versus TIM systems) differ in predicting actual human lipid absorption kinetics from cooked goose meat? Specifically, what are the trade-offs between model complexity and predictive accuracy for oxidized lipid metabolites, and how do these methodological differences potentially affect the translation of in vitro findings to human postprandial inflammatory responses observed in intervention studies?", "history": ["What impact does cooking have on the nutritional profile of meat, particularly in terms of fatty acid content?", "Are there specific cooking techniques that can significantly alter it, potentially affecting human health outcomes when consumed?", "Given these effects of cooking on meat's fatty acids and their potential health implications, how do the specific changes in goose meat's lipid profiles and indices—when prepared using methods like sous-vide, microwave, or stewing—affect the bioavailability and metabolism of these lipids in humans, particularly regarding cardiovascular health and inflammation? Furthermore, how could such findings guide cooking method choices for individuals with specific dietary concerns, such as those managing cholesterol or following anti-inflammatory diets?", "Given this analysis of goose meat lipid changes under different cooking methods, what specific experimental protocols would you recommend for assessing human bioavailability? I'm particularly interested in methodological details regarding the in vitro digestion models used to simulate lipid release, the analytical techniques for tracking oxidized lipid metabolites, and how you would validate these findings through human intervention studies measuring postprandial inflammatory markers and lipid absorption kinetics."], "ground_truth": ["permed-54659", "permed-82503", "permed-80699", "permed-76097", "permed-72395", "permed-78137", "permed-80698", "permed-76104", "permed-76142", "permed-80894"]}
{"query_id": "topic_539_turn_1", "conversation_id": "topic_539", "turn_id": 1, "query": "What role does enoxaparin play in preventing thromboembolic events in COVID-19 patients?", "history": [], "ground_truth": ["permed-71265", "permed-70765", "permed-57156", "permed-57160", "permed-78799", "permed-78797", "permed-78669", "permed-78670", "permed-54799", "permed-80289"]}
{"query_id": "topic_539_turn_2", "conversation_id": "topic_539", "turn_id": 2, "query": "How effective is it in critically ill patients, and are there any notable differences between prophylactic and therapeutic doses?", "history": ["What role does enoxaparin play in preventing thromboembolic events in COVID-19 patients?"], "ground_truth": ["permed-50728", "permed-78797", "permed-33337", "permed-91474", "permed-71248", "permed-61574", "permed-71265", "permed-57371", "permed-84793", "permed-60435"]}
{"query_id": "topic_539_turn_3", "conversation_id": "topic_539", "turn_id": 3, "query": "Since we're seeing similar outcomes between prophylactic and therapeutic doses for thromboembolic prevention and mortality in COVID-19 patients, how do patient-specific factors like renal function, liver status, and glycemic control affect enoxaparin's efficacy and safety? What would this mean for tailoring dosing strategies in critically ill cases?", "history": ["What role does enoxaparin play in preventing thromboembolic events in COVID-19 patients?", "How effective is it in critically ill patients, and are there any notable differences between prophylactic and therapeutic doses?"], "ground_truth": ["permed-71265", "permed-70765", "permed-78797", "permed-61384", "permed-85196", "permed-85197", "permed-57156", "permed-57614", "permed-78799", "permed-80876"]}
{"query_id": "topic_539_turn_4", "conversation_id": "topic_539", "turn_id": 4, "query": "Given these patient-specific considerations for enoxaparin dosing, what specific methodological approaches have been used to monitor anti-Xa levels in COVID-19 patients with renal impairment? I'm particularly interested in the blood sampling protocols, timing relative to dose administration, and how researchers have statistically accounted for fluctuating renal function in their analyses. Were there specific quality control measures implemented for anti-Xa assays in these critically ill populations to ensure reproducibility across different clinical settings?", "history": ["What role does enoxaparin play in preventing thromboembolic events in COVID-19 patients?", "How effective is it in critically ill patients, and are there any notable differences between prophylactic and therapeutic doses?", "Since we're seeing similar outcomes between prophylactic and therapeutic doses for thromboembolic prevention and mortality in COVID-19 patients, how do patient-specific factors like renal function, liver status, and glycemic control affect enoxaparin's efficacy and safety? What would this mean for tailoring dosing strategies in critically ill cases?"], "ground_truth": ["permed-71265", "permed-70765", "permed-43769", "permed-5244", "permed-56984", "permed-49822", "permed-78799", "permed-37629", "permed-80290", "permed-78852"]}
{"query_id": "topic_539_turn_5", "conversation_id": "topic_539", "turn_id": 5, "query": "Given these methodological complexities in anti-Xa monitoring for patients with renal impairment, what clinical outcomes have been specifically associated with anti-Xa-guided enoxaparin dosing in COVID-19 trials? I'm interested in whether targeting specific anti-Xa ranges actually translated to reduced thrombotic events without increasing major bleeding complications, particularly in critically ill patients with fluctuating renal function. How have researchers balanced the goal of thrombosis prevention against hemorrhage risk when implementing these monitoring protocols in real-world ICU settings?", "history": ["What role does enoxaparin play in preventing thromboembolic events in COVID-19 patients?", "How effective is it in critically ill patients, and are there any notable differences between prophylactic and therapeutic doses?", "Since we're seeing similar outcomes between prophylactic and therapeutic doses for thromboembolic prevention and mortality in COVID-19 patients, how do patient-specific factors like renal function, liver status, and glycemic control affect enoxaparin's efficacy and safety? What would this mean for tailoring dosing strategies in critically ill cases?", "Given these patient-specific considerations for enoxaparin dosing, what specific methodological approaches have been used to monitor anti-Xa levels in COVID-19 patients with renal impairment? I'm particularly interested in the blood sampling protocols, timing relative to dose administration, and how researchers have statistically accounted for fluctuating renal function in their analyses. Were there specific quality control measures implemented for anti-Xa assays in these critically ill populations to ensure reproducibility across different clinical settings?"], "ground_truth": ["permed-71265", "permed-70765", "permed-78797", "permed-80290", "permed-78495", "permed-5244", "permed-85196", "permed-85198", "permed-57156", "permed-78799"]}
{"query_id": "topic_540_turn_1", "conversation_id": "topic_540", "turn_id": 1, "query": "Key factors determining predator-prey dynamics in aquatic ecosystems", "history": [], "ground_truth": ["permed-62987", "permed-74479", "permed-74490", "permed-74493", "permed-85787", "permed-64762", "permed-62952", "permed-59335", "permed-74492", "permed-74491"]}
{"query_id": "topic_540_turn_2", "conversation_id": "topic_540", "turn_id": 2, "query": "Considering these dynamics, how do environmental conditions specifically alter feeding behaviors within aquatic predator-prey systems?", "history": ["Key factors determining predator-prey dynamics in aquatic ecosystems"], "ground_truth": ["permed-64762", "permed-74490", "permed-74493", "permed-62952", "permed-62987", "permed-59335", "permed-85787", "permed-74479", "permed-58233", "permed-64767"]}
{"query_id": "topic_540_turn_3", "conversation_id": "topic_540", "turn_id": 3, "query": "Effects of specific environmental factors (water chemistry, light availability, substrate type) on predator feeding rate saturation in these aquatic systems, and subsequent impacts on community structure and biodiversity.", "history": ["Key factors determining predator-prey dynamics in aquatic ecosystems", "Considering these dynamics, how do environmental conditions specifically alter feeding behaviors within aquatic predator-prey systems?"], "ground_truth": ["permed-74490", "permed-64762", "permed-64758", "permed-62958", "permed-64767", "permed-74493", "permed-64760", "permed-85787", "permed-66569", "permed-74479"]}
{"query_id": "topic_540_turn_4", "conversation_id": "topic_540", "turn_id": 4, "query": "Given these environmental factor analyses, how specifically were predator feeding rate saturation curves quantified experimentally? I'm particularly interested in the statistical methods used to model non-linear responses, the temporal resolution of feeding observations, and how you validated whether saturation points represented true physiological limits versus experimental artifacts in these aquatic systems.", "history": ["Key factors determining predator-prey dynamics in aquatic ecosystems", "Considering these dynamics, how do environmental conditions specifically alter feeding behaviors within aquatic predator-prey systems?", "Effects of specific environmental factors (water chemistry, light availability, substrate type) on predator feeding rate saturation in these aquatic systems, and subsequent impacts on community structure and biodiversity."], "ground_truth": ["permed-74490", "permed-74493", "permed-74479", "permed-59350", "permed-92468", "permed-64762", "permed-72124", "permed-58233", "permed-64258", "permed-62987"]}
{"query_id": "topic_540_turn_5", "conversation_id": "topic_540", "turn_id": 5, "query": "Given your detailed analysis of experimental quantification methods for predator feeding saturation, how do the statistical approaches for modeling non-linear responses compare across different aquatic taxa? Specifically, what are the relative advantages and limitations of generalized additive models versus functional response frameworks when applied to fish versus invertebrate predators? Considering the temporal resolution requirements you discussed, are certain modeling approaches more robust for detecting true physiological limits in rapidly-responding pelagic predators compared to more deliberate benthic feeders?", "history": ["Key factors determining predator-prey dynamics in aquatic ecosystems", "Considering these dynamics, how do environmental conditions specifically alter feeding behaviors within aquatic predator-prey systems?", "Effects of specific environmental factors (water chemistry, light availability, substrate type) on predator feeding rate saturation in these aquatic systems, and subsequent impacts on community structure and biodiversity.", "Given these environmental factor analyses, how specifically were predator feeding rate saturation curves quantified experimentally? I'm particularly interested in the statistical methods used to model non-linear responses, the temporal resolution of feeding observations, and how you validated whether saturation points represented true physiological limits versus experimental artifacts in these aquatic systems."], "ground_truth": ["permed-74490", "permed-74493", "permed-74492", "permed-59350", "permed-59335", "permed-60476", "permed-64762", "permed-72124", "permed-62958", "permed-62987"]}
{"query_id": "topic_541_turn_1", "conversation_id": "topic_541", "turn_id": 1, "query": "What role does neural activity play in the development of topographic maps in the brain?", "history": [], "ground_truth": ["permed-66529", "permed-64693", "permed-74403", "permed-82340", "permed-66477", "permed-73431", "permed-68953", "permed-59220", "permed-61740", "permed-68807"]}
{"query_id": "topic_541_turn_2", "conversation_id": "topic_541", "turn_id": 2, "query": "How do changes in this neural activity during critical developmental periods impact the formation and organization of these maps?", "history": ["What role does neural activity play in the development of topographic maps in the brain?"], "ground_truth": ["permed-66529", "permed-74403", "permed-82340", "permed-53613", "permed-61740", "permed-54291", "permed-77861", "permed-66477", "permed-64698", "permed-67657"]}
{"query_id": "topic_541_turn_3", "conversation_id": "topic_541", "turn_id": 3, "query": "Given these effects of neural activity during critical periods, how do specific spatiotemporal patterns in that activity shape the formation and refinement of topographic maps? And what molecular and cellular mechanisms underlie these activity-dependent changes in circuit organization?", "history": ["What role does neural activity play in the development of topographic maps in the brain?", "How do changes in this neural activity during critical developmental periods impact the formation and organization of these maps?"], "ground_truth": ["permed-66529", "permed-74403", "permed-53613", "permed-82340", "permed-61740", "permed-82338", "permed-54291", "permed-66477", "permed-82341", "permed-88616"]}
{"query_id": "topic_541_turn_4", "conversation_id": "topic_541", "turn_id": 4, "query": "Given these complex spatiotemporal activity patterns, what specific experimental approaches would allow precise manipulation of firing sequences during map refinement? I'm particularly interested in how one would design optogenetic stimulation protocols to mimic natural wave patterns, and what statistical methods would be appropriate for quantifying topographic precision following such targeted interventions. How would you validate that observed organizational changes specifically result from patterned activity rather than overall activity levels?", "history": ["What role does neural activity play in the development of topographic maps in the brain?", "How do changes in this neural activity during critical developmental periods impact the formation and organization of these maps?", "Given these effects of neural activity during critical periods, how do specific spatiotemporal patterns in that activity shape the formation and refinement of topographic maps? And what molecular and cellular mechanisms underlie these activity-dependent changes in circuit organization?"], "ground_truth": ["permed-66529", "permed-84776", "permed-74403", "permed-55530", "permed-88616", "permed-82340", "permed-74407", "permed-68953", "permed-66477", "permed-61741"]}
{"query_id": "topic_541_turn_5", "conversation_id": "topic_541", "turn_id": 5, "query": "Given these sophisticated experimental approaches for manipulating neural activity patterns during development, how might these insights translate to clinical applications for neurodevelopmental disorders characterized by topographic map abnormalities, such as amblyopia or cortical visual impairment? What evidence exists regarding the therapeutic window for targeted neuromodulation in human patients, and have any clinical trials demonstrated improved visual outcomes using patterned stimulation protocols? Furthermore, what safety considerations emerge when applying such precise activity manipulation techniques to the developing human brain, particularly regarding seizure risk or unintended circuit modifications?", "history": ["What role does neural activity play in the development of topographic maps in the brain?", "How do changes in this neural activity during critical developmental periods impact the formation and organization of these maps?", "Given these effects of neural activity during critical periods, how do specific spatiotemporal patterns in that activity shape the formation and refinement of topographic maps? And what molecular and cellular mechanisms underlie these activity-dependent changes in circuit organization?", "Given these complex spatiotemporal activity patterns, what specific experimental approaches would allow precise manipulation of firing sequences during map refinement? I'm particularly interested in how one would design optogenetic stimulation protocols to mimic natural wave patterns, and what statistical methods would be appropriate for quantifying topographic precision following such targeted interventions. How would you validate that observed organizational changes specifically result from patterned activity rather than overall activity levels?"], "ground_truth": ["permed-74507", "permed-8415", "permed-68378", "permed-64694", "permed-75370", "permed-54203", "permed-60792", "permed-81646", "permed-68376", "permed-68377"]}
{"query_id": "topic_542_turn_1", "conversation_id": "topic_542", "turn_id": 1, "query": "Overview of Fe-N-C catalysts in proton exchange membrane fuel cells (PEMFCs): mechanisms, applications, and challenges", "history": [], "ground_truth": ["permed-60891", "permed-77110", "permed-60890", "permed-51996", "permed-77031", "permed-51992", "permed-57980", "permed-73290", "permed-53478", "permed-53479"]}
{"query_id": "topic_542_turn_2", "conversation_id": "topic_542", "turn_id": 2, "query": "Effect of elemental composition and precursor ratios in these Fe-N-C catalysts on their oxygen reduction reaction (ORR) activity and long-term stability in PEMFCs", "history": ["Overview of Fe-N-C catalysts in proton exchange membrane fuel cells (PEMFCs): mechanisms, applications, and challenges"], "ground_truth": ["permed-77031", "permed-60890", "permed-51992", "permed-53478", "permed-51980", "permed-51996", "permed-51986", "permed-75435", "permed-55250", "permed-60891"]}
{"query_id": "topic_542_turn_3", "conversation_id": "topic_542", "turn_id": 3, "query": "Optimizing Sn/Fe ratio in Fe-N-C catalyst synthesis for enhanced PEMFC durability under start-stop cycling: advanced characterization of active site evolution and degradation pathways", "history": ["Overview of Fe-N-C catalysts in proton exchange membrane fuel cells (PEMFCs): mechanisms, applications, and challenges", "Effect of elemental composition and precursor ratios in these Fe-N-C catalysts on their oxygen reduction reaction (ORR) activity and long-term stability in PEMFCs"], "ground_truth": ["permed-77031", "permed-51992", "permed-60891", "permed-60890", "permed-57980", "permed-75435", "permed-77110", "permed-51980", "permed-51990", "permed-75437"]}
{"query_id": "topic_542_turn_4", "conversation_id": "topic_542", "turn_id": 4, "query": "When implementing this Sn/Fe ratio optimization protocol, what specific electrochemical testing procedures and cycling parameters did you employ to simulate start-stop conditions? Could you detail the statistical methods used to correlate degradation rates with active site evolution data from techniques like XPS and Mössbauer spectroscopy? Additionally, how was reproducibility ensured across multiple catalyst batches when tracking these complex degradation pathways?", "history": ["Overview of Fe-N-C catalysts in proton exchange membrane fuel cells (PEMFCs): mechanisms, applications, and challenges", "Effect of elemental composition and precursor ratios in these Fe-N-C catalysts on their oxygen reduction reaction (ORR) activity and long-term stability in PEMFCs", "Optimizing Sn/Fe ratio in Fe-N-C catalyst synthesis for enhanced PEMFC durability under start-stop cycling: advanced characterization of active site evolution and degradation pathways"], "ground_truth": ["permed-77031", "permed-87150", "permed-78459", "permed-75938", "permed-53094", "permed-60891", "permed-75437", "permed-75435", "permed-66265", "permed-85155"]}
{"query_id": "topic_542_turn_5", "conversation_id": "topic_542", "turn_id": 5, "query": "Given these detailed electrochemical protocols for simulating fuel cell degradation, what clinical translation challenges arise when implementing such Fe-N-C catalysts in medical device power sources? Specifically, for implantable applications like ventricular assist devices, what safety profiles have been established regarding potential metal ion leaching during long-term operation? Are there clinical studies assessing tissue exposure risks from catalyst degradation byproducts, and what mitigation strategies exist for ensuring biocompatibility in human applications where start-stop cycling mirrors physiological demands?", "history": ["Overview of Fe-N-C catalysts in proton exchange membrane fuel cells (PEMFCs): mechanisms, applications, and challenges", "Effect of elemental composition and precursor ratios in these Fe-N-C catalysts on their oxygen reduction reaction (ORR) activity and long-term stability in PEMFCs", "Optimizing Sn/Fe ratio in Fe-N-C catalyst synthesis for enhanced PEMFC durability under start-stop cycling: advanced characterization of active site evolution and degradation pathways", "When implementing this Sn/Fe ratio optimization protocol, what specific electrochemical testing procedures and cycling parameters did you employ to simulate start-stop conditions? Could you detail the statistical methods used to correlate degradation rates with active site evolution data from techniques like XPS and Mössbauer spectroscopy? Additionally, how was reproducibility ensured across multiple catalyst batches when tracking these complex degradation pathways?"], "ground_truth": ["permed-60891", "permed-85163", "permed-77031", "permed-86789", "permed-60890", "permed-66265", "permed-75437", "permed-87150", "permed-75938", "permed-77110"]}
{"query_id": "topic_543_turn_1", "conversation_id": "topic_543", "turn_id": 1, "query": "What challenges do doctors face in diagnosing rare primary tumors, such as angiosarcoma?", "history": [], "ground_truth": ["permed-79733", "permed-74623", "permed-74663", "permed-74624", "permed-59973", "permed-60217", "permed-52905", "permed-81587", "permed-62153", "permed-76576"]}
{"query_id": "topic_543_turn_2", "conversation_id": "topic_543", "turn_id": 2, "query": "How can collaboration among different medical specialties improve diagnosis and treatment outcomes in this area?", "history": ["What challenges do doctors face in diagnosing rare primary tumors, such as angiosarcoma?"], "ground_truth": ["permed-16078", "permed-61869", "permed-57583", "permed-25349", "permed-68360", "permed-57447", "permed-67434", "permed-52946", "permed-45259", "permed-53971"]}
{"query_id": "topic_543_turn_3", "conversation_id": "topic_543", "turn_id": 3, "query": "Given these challenges and the potential benefits of collaboration you mentioned, how could hematologists, pathologists, and oncologists working together specifically improve early detection and differential diagnosis when rare tumors like angiosarcoma involve atypical bone marrow? What diagnostic tools or protocols would be most effective in enhancing accuracy in such cases?", "history": ["What challenges do doctors face in diagnosing rare primary tumors, such as angiosarcoma?", "How can collaboration among different medical specialties improve diagnosis and treatment outcomes in this area?"], "ground_truth": ["permed-79733", "permed-60217", "permed-60155", "permed-81730", "permed-23906", "permed-2286", "permed-74663", "permed-14091", "permed-59449", "permed-74624"]}
{"query_id": "topic_543_turn_4", "conversation_id": "topic_543", "turn_id": 4, "query": "Given the proposed multi-specialty approach for atypical bone marrow involvement, could you elaborate on the specific diagnostic workflow protocol? I'm particularly interested in how sequential testing would be coordinated between specialties - for instance, what would be the optimal tissue processing protocol when bone marrow biopsy samples require both flow cytometry for hematopoietic malignancies and immunohistochemistry for vascular markers? How should pathologists and hematologists standardize their analytical methods to minimize tissue exhaustion while maintaining diagnostic accuracy?", "history": ["What challenges do doctors face in diagnosing rare primary tumors, such as angiosarcoma?", "How can collaboration among different medical specialties improve diagnosis and treatment outcomes in this area?", "Given these challenges and the potential benefits of collaboration you mentioned, how could hematologists, pathologists, and oncologists working together specifically improve early detection and differential diagnosis when rare tumors like angiosarcoma involve atypical bone marrow? What diagnostic tools or protocols would be most effective in enhancing accuracy in such cases?"], "ground_truth": ["permed-50838", "permed-76854", "permed-10551", "permed-4561", "permed-76851", "permed-77582", "permed-72623", "permed-60217", "permed-4560", "permed-84592"]}
{"query_id": "topic_543_turn_5", "conversation_id": "topic_543", "turn_id": 5, "query": "Given the detailed diagnostic workflow protocol we've established for handling bone marrow samples, how does the diagnostic accuracy and efficiency of sequential specialty-driven testing (where hematologists perform flow cytometry first, followed by pathologists' immunohistochemistry) compare versus a parallel testing approach where both analyses begin simultaneously? Specifically, what are the trade-offs in terms of tissue preservation, turnaround time, and risk of diagnostic ambiguity when coordinating between these specialties, particularly when dealing with limited biopsy material from suspected angiosarcoma cases?", "history": ["What challenges do doctors face in diagnosing rare primary tumors, such as angiosarcoma?", "How can collaboration among different medical specialties improve diagnosis and treatment outcomes in this area?", "Given these challenges and the potential benefits of collaboration you mentioned, how could hematologists, pathologists, and oncologists working together specifically improve early detection and differential diagnosis when rare tumors like angiosarcoma involve atypical bone marrow? What diagnostic tools or protocols would be most effective in enhancing accuracy in such cases?", "Given the proposed multi-specialty approach for atypical bone marrow involvement, could you elaborate on the specific diagnostic workflow protocol? I'm particularly interested in how sequential testing would be coordinated between specialties - for instance, what would be the optimal tissue processing protocol when bone marrow biopsy samples require both flow cytometry for hematopoietic malignancies and immunohistochemistry for vascular markers? How should pathologists and hematologists standardize their analytical methods to minimize tissue exhaustion while maintaining diagnostic accuracy?"], "ground_truth": ["permed-79733", "permed-50838", "permed-74663", "permed-60217", "permed-76854", "permed-60155", "permed-5063", "permed-5742", "permed-82269", "permed-5059"]}
{"query_id": "topic_544_turn_1", "conversation_id": "topic_544", "turn_id": 1, "query": "Assessing the potential and limitations of solar still systems for sustainable water desalination in remote arid regions", "history": [], "ground_truth": ["permed-78343", "permed-78342", "permed-75660", "permed-78347", "permed-90109", "permed-60645", "permed-73294", "permed-78341", "permed-73978", "permed-78346"]}
{"query_id": "topic_544_turn_2", "conversation_id": "topic_544", "turn_id": 2, "query": "Enhancing these solar desalination systems: role of advanced thermal storage in improving daily water yield and efficiency", "history": ["Assessing the potential and limitations of solar still systems for sustainable water desalination in remote arid regions"], "ground_truth": ["permed-75660", "permed-78343", "permed-78342", "permed-78347", "permed-90109", "permed-73294", "permed-83528", "permed-78345", "permed-78341", "permed-58062"]}
{"query_id": "topic_544_turn_3", "conversation_id": "topic_544", "turn_id": 3, "query": "Integrating high-conductivity phase change materials (PCMs) into modified solar stills: design considerations for maximizing thermal performance, cost-benefit analysis, and adaptability to diverse arid climates", "history": ["Assessing the potential and limitations of solar still systems for sustainable water desalination in remote arid regions", "Enhancing these solar desalination systems: role of advanced thermal storage in improving daily water yield and efficiency"], "ground_truth": ["permed-78341", "permed-78343", "permed-78342", "permed-78344", "permed-80335", "permed-75660", "permed-52104", "permed-83525", "permed-79657", "permed-74187"]}
{"query_id": "topic_544_turn_4", "conversation_id": "topic_544", "turn_id": 4, "query": "When implementing these PCM-enhanced solar still designs, what specific experimental protocols and instrumentation were used to quantify thermal performance metrics like phase transition completion rates and temperature distribution uniformity? How did researchers validate the accuracy of their efficiency calculations, and what statistical methods were employed to ensure the reported cost-benefit ratios were robust across different climate simulations?", "history": ["Assessing the potential and limitations of solar still systems for sustainable water desalination in remote arid regions", "Enhancing these solar desalination systems: role of advanced thermal storage in improving daily water yield and efficiency", "Integrating high-conductivity phase change materials (PCMs) into modified solar stills: design considerations for maximizing thermal performance, cost-benefit analysis, and adaptability to diverse arid climates"], "ground_truth": ["permed-78341", "permed-78343", "permed-78342", "permed-74187", "permed-78346", "permed-79573", "permed-83525", "permed-74186", "permed-73239", "permed-88550"]}
{"query_id": "topic_544_turn_5", "conversation_id": "topic_544", "turn_id": 5, "query": "Given the detailed thermal performance validation and cost-benefit analyses established in previous research, how have these PCM-enhanced solar still systems been evaluated in clinical settings for providing safe drinking water to vulnerable populations in remote arid regions? What patient-centered outcomes—such as reductions in waterborne diseases, improvements in pediatric hydration status, or decreased healthcare utilization—have been documented? Furthermore, what implementation barriers emerged regarding long-term system maintenance and user compliance when deploying these systems in actual clinical or community health contexts?", "history": ["Assessing the potential and limitations of solar still systems for sustainable water desalination in remote arid regions", "Enhancing these solar desalination systems: role of advanced thermal storage in improving daily water yield and efficiency", "Integrating high-conductivity phase change materials (PCMs) into modified solar stills: design considerations for maximizing thermal performance, cost-benefit analysis, and adaptability to diverse arid climates", "When implementing these PCM-enhanced solar still designs, what specific experimental protocols and instrumentation were used to quantify thermal performance metrics like phase transition completion rates and temperature distribution uniformity? How did researchers validate the accuracy of their efficiency calculations, and what statistical methods were employed to ensure the reported cost-benefit ratios were robust across different climate simulations?"], "ground_truth": ["permed-78341", "permed-78343", "permed-78342", "permed-50442", "permed-78344", "permed-85855", "permed-90437", "permed-34398", "permed-57587", "permed-57549"]}
{"query_id": "topic_545_turn_1", "conversation_id": "topic_545", "turn_id": 1, "query": "How have COVID-19 pandemic trends affected causes of death in Korea?", "history": [], "ground_truth": ["permed-65984", "permed-65991", "permed-65983", "permed-68512", "permed-65989", "permed-65990", "permed-71662", "permed-65816", "permed-65985", "permed-61384"]}
{"query_id": "topic_545_turn_2", "conversation_id": "topic_545", "turn_id": 2, "query": "What specific areas of public health concern have emerged from it that require policy adjustments?", "history": ["How have COVID-19 pandemic trends affected causes of death in Korea?"], "ground_truth": ["permed-91926", "permed-54928", "permed-66148", "permed-53023", "permed-88327", "permed-55180", "permed-53008", "permed-59895", "permed-27264", "permed-27330"]}
{"query_id": "topic_545_turn_3", "conversation_id": "topic_545", "turn_id": 3, "query": "Given these observed trends in Korea's mortality patterns during the pandemic, how should public health policies and healthcare practices be adapted to specifically address the concerning rises in sepsis and aspiration pneumonia cases? Additionally, what targeted strategies could be developed to curb the increasing suicide rates, particularly among young women, that have emerged from this crisis?", "history": ["How have COVID-19 pandemic trends affected causes of death in Korea?", "What specific areas of public health concern have emerged from it that require policy adjustments?"], "ground_truth": ["permed-65984", "permed-81600", "permed-72363", "permed-61920", "permed-65570", "permed-65986", "permed-81582", "permed-65816", "permed-52340", "permed-65990"]}
{"query_id": "topic_545_turn_4", "conversation_id": "topic_545", "turn_id": 4, "query": "Given Korea's need to develop targeted strategies for sepsis, aspiration pneumonia, and youth suicide prevention, what specific methodological approaches would you recommend for evaluating policy interventions? I'm particularly interested in study designs that could simultaneously assess multiple outcomes - for instance, how might interrupted time series analyses be structured to measure both infectious disease mortality and mental health indicators? What statistical controls would be necessary to account for confounding factors like seasonal variations and concurrent healthcare system changes during implementation?", "history": ["How have COVID-19 pandemic trends affected causes of death in Korea?", "What specific areas of public health concern have emerged from it that require policy adjustments?", "Given these observed trends in Korea's mortality patterns during the pandemic, how should public health policies and healthcare practices be adapted to specifically address the concerning rises in sepsis and aspiration pneumonia cases? Additionally, what targeted strategies could be developed to curb the increasing suicide rates, particularly among young women, that have emerged from this crisis?"], "ground_truth": ["permed-65984", "permed-53878", "permed-58290", "permed-55789", "permed-49513", "permed-44871", "permed-25414", "permed-44418", "permed-54928", "permed-69736"]}
{"query_id": "topic_545_turn_5", "conversation_id": "topic_545", "turn_id": 5, "query": "Given the methodological framework for evaluating multiple outcomes, how do interrupted time series analyses compare to stepped-wedge cluster randomized trials for simultaneously assessing policy impacts on sepsis mortality and youth suicide rates? Specifically, what are their relative advantages in detecting causal effects while accounting for seasonal confounders and healthcare system disruptions? Which design offers better trade-offs between internal validity and practical implementation constraints in Korea's public health context, particularly when measuring both infectious disease and mental health outcomes across the same population cohorts?", "history": ["How have COVID-19 pandemic trends affected causes of death in Korea?", "What specific areas of public health concern have emerged from it that require policy adjustments?", "Given these observed trends in Korea's mortality patterns during the pandemic, how should public health policies and healthcare practices be adapted to specifically address the concerning rises in sepsis and aspiration pneumonia cases? Additionally, what targeted strategies could be developed to curb the increasing suicide rates, particularly among young women, that have emerged from this crisis?", "Given Korea's need to develop targeted strategies for sepsis, aspiration pneumonia, and youth suicide prevention, what specific methodological approaches would you recommend for evaluating policy interventions? I'm particularly interested in study designs that could simultaneously assess multiple outcomes - for instance, how might interrupted time series analyses be structured to measure both infectious disease mortality and mental health indicators? What statistical controls would be necessary to account for confounding factors like seasonal variations and concurrent healthcare system changes during implementation?"], "ground_truth": ["permed-65984", "permed-58290", "permed-37281", "permed-54097", "permed-37433", "permed-86513", "permed-91463", "permed-37280", "permed-44882", "permed-44939"]}
{"query_id": "topic_546_turn_1", "conversation_id": "topic_546", "turn_id": 1, "query": "Molecular mechanisms of RhoC in pluripotency gene regulation in cancer cells, including upstream signaling and downstream effector pathways.", "history": [], "ground_truth": ["permed-77712", "permed-82373", "permed-55371", "permed-83370", "permed-56198", "permed-90607", "permed-51120", "permed-64170", "permed-53495", "permed-76609"]}
{"query_id": "topic_546_turn_2", "conversation_id": "topic_546", "turn_id": 2, "query": "Therapeutic potential of targeting specific interactions within this RhoC-driven pluripotency network, particularly involving TET2 and WDR5, for developing advanced cancer therapies.", "history": ["Molecular mechanisms of RhoC in pluripotency gene regulation in cancer cells, including upstream signaling and downstream effector pathways."], "ground_truth": ["permed-77712", "permed-72562", "permed-68990", "permed-55371", "permed-56645", "permed-51120", "permed-82373", "permed-56623", "permed-53177", "permed-75084"]}
{"query_id": "topic_546_turn_3", "conversation_id": "topic_546", "turn_id": 3, "query": "Rational design and preclinical validation of small molecule inhibitors targeting the RhoC-TET2-WDR5 epigenetic axis in cervical cancer stem cells to overcome chemoresistance, with analysis of off-target effects and therapeutic efficacy.", "history": ["Molecular mechanisms of RhoC in pluripotency gene regulation in cancer cells, including upstream signaling and downstream effector pathways.", "Therapeutic potential of targeting specific interactions within this RhoC-driven pluripotency network, particularly involving TET2 and WDR5, for developing advanced cancer therapies."], "ground_truth": ["permed-77712", "permed-68990", "permed-92350", "permed-88631", "permed-80142", "permed-55371", "permed-52127", "permed-82373", "permed-69221", "permed-56180"]}
{"query_id": "topic_546_turn_4", "conversation_id": "topic_546", "turn_id": 4, "query": "For the rationally designed small molecule inhibitors targeting this RhoC-TET2-WDR5 axis, what specific biochemical and cellular validation assays were employed to confirm target engagement and pathway modulation? I'm particularly interested in the dose-response characterization, the methodology for assessing changes in histone modifications at pluripotency gene loci, and how you established the correlation between target inhibition and chemosensitivity reversal in your cervical cancer stem cell models while controlling for compensatory pathway activation.", "history": ["Molecular mechanisms of RhoC in pluripotency gene regulation in cancer cells, including upstream signaling and downstream effector pathways.", "Therapeutic potential of targeting specific interactions within this RhoC-driven pluripotency network, particularly involving TET2 and WDR5, for developing advanced cancer therapies.", "Rational design and preclinical validation of small molecule inhibitors targeting the RhoC-TET2-WDR5 epigenetic axis in cervical cancer stem cells to overcome chemoresistance, with analysis of off-target effects and therapeutic efficacy."], "ground_truth": ["permed-77712", "permed-69221", "permed-68990", "permed-54979", "permed-54970", "permed-90458", "permed-22857", "permed-69224", "permed-69215", "permed-90481"]}
{"query_id": "topic_546_turn_5", "conversation_id": "topic_546", "turn_id": 5, "query": "Given your comprehensive biochemical validation of RhoC-TET2-WDR5 axis inhibitors, how does the therapeutic efficacy of these epigenetic-targeting compounds compare directly to conventional chemotherapy agents like cisplatin in overcoming chemoresistance? Specifically, what were the comparative advantages in terms of cancer stem cell eradication potency, durability of response, and reduction of metastatic potential versus the disadvantages such as differential toxicity profiles and development of resistance mechanisms across your cervical cancer models?", "history": ["Molecular mechanisms of RhoC in pluripotency gene regulation in cancer cells, including upstream signaling and downstream effector pathways.", "Therapeutic potential of targeting specific interactions within this RhoC-driven pluripotency network, particularly involving TET2 and WDR5, for developing advanced cancer therapies.", "Rational design and preclinical validation of small molecule inhibitors targeting the RhoC-TET2-WDR5 epigenetic axis in cervical cancer stem cells to overcome chemoresistance, with analysis of off-target effects and therapeutic efficacy.", "For the rationally designed small molecule inhibitors targeting this RhoC-TET2-WDR5 axis, what specific biochemical and cellular validation assays were employed to confirm target engagement and pathway modulation? I'm particularly interested in the dose-response characterization, the methodology for assessing changes in histone modifications at pluripotency gene loci, and how you established the correlation between target inhibition and chemosensitivity reversal in your cervical cancer stem cell models while controlling for compensatory pathway activation."], "ground_truth": ["permed-77712", "permed-59588", "permed-69221", "permed-92350", "permed-84772", "permed-80142", "permed-51217", "permed-56623", "permed-71206", "permed-54970"]}
{"query_id": "topic_547_turn_1", "conversation_id": "topic_547", "turn_id": 1, "query": "What factors contribute to illicit drug use among LGBTQA youth?", "history": [], "ground_truth": ["permed-78764", "permed-84441", "permed-65427", "permed-69664", "permed-65609", "permed-71370", "permed-69600", "permed-65780", "permed-63477", "permed-59902"]}
{"query_id": "topic_547_turn_2", "conversation_id": "topic_547", "turn_id": 2, "query": "How do social and community factors, in particular, influence this issue?", "history": ["What factors contribute to illicit drug use among LGBTQA youth?"], "ground_truth": ["permed-73929", "permed-91925", "permed-53059", "permed-70088", "permed-55107", "permed-66197", "permed-58472", "permed-74343", "permed-67357", "permed-53165"]}
{"query_id": "topic_547_turn_3", "conversation_id": "topic_547", "turn_id": 3, "query": "Given these social and community factors we've discussed, could you explore how specific determinants—like community support, family acceptance, and access to mental health services—shape both the patterns and consequences of illicit drug use among LGBTQA youth in Australia? And based on that, what tailored interventions might help mitigate these determinants' negative effects on their drug use behaviors and overall well-being?", "history": ["What factors contribute to illicit drug use among LGBTQA youth?", "How do social and community factors, in particular, influence this issue?"], "ground_truth": ["permed-78764", "permed-65260", "permed-91010", "permed-54385", "permed-65629", "permed-65254", "permed-69664", "permed-65780", "permed-59902", "permed-58536"]}
{"query_id": "topic_547_turn_4", "conversation_id": "topic_547", "turn_id": 4, "query": "When implementing these tailored interventions targeting community support and mental health access, what specific methodological approaches would be most effective for evaluating their impact? I'm particularly interested in the experimental design - would a randomized controlled trial comparing different intervention components be feasible, or would a stepped-wedge design be more practical in community settings? Additionally, what validated instruments should be used to measure changes in both drug use behaviors and psychosocial outcomes like well-being and social connectedness?", "history": ["What factors contribute to illicit drug use among LGBTQA youth?", "How do social and community factors, in particular, influence this issue?", "Given these social and community factors we've discussed, could you explore how specific determinants—like community support, family acceptance, and access to mental health services—shape both the patterns and consequences of illicit drug use among LGBTQA youth in Australia? And based on that, what tailored interventions might help mitigate these determinants' negative effects on their drug use behaviors and overall well-being?"], "ground_truth": ["permed-77916", "permed-74908", "permed-84439", "permed-90677", "permed-72237", "permed-74902", "permed-69768", "permed-55522", "permed-82573", "permed-74212"]}
{"query_id": "topic_547_turn_5", "conversation_id": "topic_547", "turn_id": 5, "query": "Given the methodological considerations for evaluating tailored interventions, what clinical evidence exists regarding the real-world efficacy and safety of such programs when deployed in Australian healthcare settings? Specifically, focusing on LGBTQA youth, have any longitudinal studies or clinical trials measured significant reductions in illicit drug use or adverse events related to the interventions themselves? Furthermore, how do contraindications, such as co-occurring mental health conditions, influence treatment outcomes, and what are the reported side effects of integrating intense community support with psychological therapies in this demographic?", "history": ["What factors contribute to illicit drug use among LGBTQA youth?", "How do social and community factors, in particular, influence this issue?", "Given these social and community factors we've discussed, could you explore how specific determinants—like community support, family acceptance, and access to mental health services—shape both the patterns and consequences of illicit drug use among LGBTQA youth in Australia? And based on that, what tailored interventions might help mitigate these determinants' negative effects on their drug use behaviors and overall well-being?", "When implementing these tailored interventions targeting community support and mental health access, what specific methodological approaches would be most effective for evaluating their impact? I'm particularly interested in the experimental design - would a randomized controlled trial comparing different intervention components be feasible, or would a stepped-wedge design be more practical in community settings? Additionally, what validated instruments should be used to measure changes in both drug use behaviors and psychosocial outcomes like well-being and social connectedness?"], "ground_truth": ["permed-78764", "permed-91010", "permed-80060", "permed-91009", "permed-60333", "permed-86910", "permed-58536", "permed-69768", "permed-35652", "permed-65780"]}
{"query_id": "topic_548_turn_1", "conversation_id": "topic_548", "turn_id": 1, "query": "Significance of somatostatin receptor expression in lung lesions and common diagnostic methods.", "history": [], "ground_truth": ["permed-56701", "permed-56703", "permed-56458", "permed-56481", "permed-87042", "permed-89594", "permed-60550", "permed-21133", "permed-59570", "permed-56461"]}
{"query_id": "topic_548_turn_2", "conversation_id": "topic_548", "turn_id": 2, "query": "How does this somatostatin receptor expression impact the diagnostic accuracy of PET/CT imaging for pulmonary nodules?", "history": ["Significance of somatostatin receptor expression in lung lesions and common diagnostic methods."], "ground_truth": ["permed-56703", "permed-56702", "permed-56701", "permed-56481", "permed-28412", "permed-56705", "permed-56461", "permed-48681", "permed-3633", "permed-5108"]}
{"query_id": "topic_548_turn_3", "conversation_id": "topic_548", "turn_id": 3, "query": "Impact of somatostatin receptor expression in non-neuroendocrine pulmonary nodules like hamartomas on DOTATATE PET/CT interpretation, differential diagnosis, and management of indeterminate nodules.", "history": ["Significance of somatostatin receptor expression in lung lesions and common diagnostic methods.", "How does this somatostatin receptor expression impact the diagnostic accuracy of PET/CT imaging for pulmonary nodules?"], "ground_truth": ["permed-56703", "permed-56702", "permed-5108", "permed-56701", "permed-3633", "permed-28412", "permed-56461", "permed-56706", "permed-77483", "permed-48623"]}
{"query_id": "topic_548_turn_4", "conversation_id": "topic_548", "turn_id": 4, "query": "Given these interpretive challenges with DOTATATE PET/CT in non-neuroendocrine lesions, what specific technical protocols and quantitative parameters—such as standardized uptake value (SUV) thresholds, lesion-to-background ratios, or dual-time-point imaging—are being validated to improve specificity? Furthermore, what statistical methods, like receiver operating characteristic (ROC) curve analysis, are being employed to establish optimal cut-off values that reliably differentiate hamartomas from true neuroendocrine tumors in clinical practice?", "history": ["Significance of somatostatin receptor expression in lung lesions and common diagnostic methods.", "How does this somatostatin receptor expression impact the diagnostic accuracy of PET/CT imaging for pulmonary nodules?", "Impact of somatostatin receptor expression in non-neuroendocrine pulmonary nodules like hamartomas on DOTATATE PET/CT interpretation, differential diagnosis, and management of indeterminate nodules."], "ground_truth": ["permed-56703", "permed-56702", "permed-77455", "permed-48593", "permed-48652", "permed-5108", "permed-77463", "permed-48379", "permed-75849", "permed-48623"]}
{"query_id": "topic_548_turn_5", "conversation_id": "topic_548", "turn_id": 5, "query": "Given the ongoing validation of quantitative parameters and ROC analysis for DOTATATE PET/CT interpretation, what clinical outcomes have been observed when applying these refined protocols to actual patient management? Specifically, how have these technical refinements impacted diagnostic specificity in practice, reduced unnecessary invasive procedures for benign lesions like hamartomas, and influenced treatment pathways? Are there prospective trial data demonstrating improved patient safety or changes in clinical decision-making thresholds when differentiating non-neuroendocrine from neuroendocrine pulmonary nodules using optimized SUV cut-offs?", "history": ["Significance of somatostatin receptor expression in lung lesions and common diagnostic methods.", "How does this somatostatin receptor expression impact the diagnostic accuracy of PET/CT imaging for pulmonary nodules?", "Impact of somatostatin receptor expression in non-neuroendocrine pulmonary nodules like hamartomas on DOTATATE PET/CT interpretation, differential diagnosis, and management of indeterminate nodules.", "Given these interpretive challenges with DOTATATE PET/CT in non-neuroendocrine lesions, what specific technical protocols and quantitative parameters—such as standardized uptake value (SUV) thresholds, lesion-to-background ratios, or dual-time-point imaging—are being validated to improve specificity? Furthermore, what statistical methods, like receiver operating characteristic (ROC) curve analysis, are being employed to establish optimal cut-off values that reliably differentiate hamartomas from true neuroendocrine tumors in clinical practice?"], "ground_truth": ["permed-56703", "permed-77455", "permed-5108", "permed-28412", "permed-29620", "permed-3633", "permed-76544", "permed-56702", "permed-77217", "permed-48489"]}
{"query_id": "topic_549_turn_1", "conversation_id": "topic_549", "turn_id": 1, "query": "Overview of primary threats to West African primate populations", "history": [], "ground_truth": ["permed-74926", "permed-67575", "permed-68153", "permed-71837", "permed-68513", "permed-66153", "permed-68512", "permed-73392", "permed-55107", "permed-86233"]}
{"query_id": "topic_549_turn_2", "conversation_id": "topic_549", "turn_id": 2, "query": "Considering these primary threats, what are the specific impacts of habitat fragmentation on West African primate populations?", "history": ["Overview of primary threats to West African primate populations"], "ground_truth": ["permed-74926", "permed-74411", "permed-74410", "permed-67575", "permed-71837", "permed-62974", "permed-67581", "permed-70108", "permed-59331", "permed-74929"]}
{"query_id": "topic_549_turn_3", "conversation_id": "topic_549", "turn_id": 3, "query": "How genetic diversity and population dynamics studies of West African colobine monkeys (fragmented vs. contiguous forests) inform resilience and conservation planning against habitat loss and bushmeat hunting.", "history": ["Overview of primary threats to West African primate populations", "Considering these primary threats, what are the specific impacts of habitat fragmentation on West African primate populations?"], "ground_truth": ["permed-74926", "permed-74411", "permed-67575", "permed-52481", "permed-62963", "permed-90389", "permed-74591", "permed-62986", "permed-70108", "permed-87222"]}
{"query_id": "topic_549_turn_4", "conversation_id": "topic_549", "turn_id": 4, "query": "Given your genetic diversity and population dynamics approach, what specific molecular markers and sampling protocols were most effective for comparing fragmented versus contiguous forest populations? How did you statistically account for potential confounding variables like uneven sampling effort or recent migration events when analyzing these genetic datasets, and what quality control metrics were implemented during laboratory analysis to ensure reproducibility across different colobine species?", "history": ["Overview of primary threats to West African primate populations", "Considering these primary threats, what are the specific impacts of habitat fragmentation on West African primate populations?", "How genetic diversity and population dynamics studies of West African colobine monkeys (fragmented vs. contiguous forests) inform resilience and conservation planning against habitat loss and bushmeat hunting."], "ground_truth": ["permed-74926", "permed-52481", "permed-90391", "permed-81742", "permed-52480", "permed-20388", "permed-87222", "permed-62963", "permed-87227", "permed-62954"]}
{"query_id": "topic_549_turn_5", "conversation_id": "topic_549", "turn_id": 5, "query": "Given your detailed methodological approach to genetic analysis, how do the conservation implications derived from genetic diversity studies compare with those from demographic monitoring approaches for West African colobines? Specifically, what are the relative advantages and limitations of genetic versus field-based population surveys in informing management decisions about corridor establishment versus translocations? Considering your findings on fragmentation effects, which approach provides more actionable insights for prioritizing conservation interventions when resources are limited?", "history": ["Overview of primary threats to West African primate populations", "Considering these primary threats, what are the specific impacts of habitat fragmentation on West African primate populations?", "How genetic diversity and population dynamics studies of West African colobine monkeys (fragmented vs. contiguous forests) inform resilience and conservation planning against habitat loss and bushmeat hunting.", "Given your genetic diversity and population dynamics approach, what specific molecular markers and sampling protocols were most effective for comparing fragmented versus contiguous forest populations? How did you statistically account for potential confounding variables like uneven sampling effort or recent migration events when analyzing these genetic datasets, and what quality control metrics were implemented during laboratory analysis to ensure reproducibility across different colobine species?"], "ground_truth": ["permed-74926", "permed-62963", "permed-74591", "permed-52481", "permed-74928", "permed-81742", "permed-76629", "permed-62956", "permed-52477", "permed-71779"]}
{"query_id": "topic_550_turn_1", "conversation_id": "topic_550", "turn_id": 1, "query": "What is known about the regeneration of intrahepatic biliary cells in liver diseases?", "history": [], "ground_truth": ["permed-79930", "permed-79753", "permed-50801", "permed-9952", "permed-75564", "permed-9909", "permed-86209", "permed-10514", "permed-9948", "permed-79931"]}
{"query_id": "topic_550_turn_2", "conversation_id": "topic_550", "turn_id": 2, "query": "Does this process involve specific signaling pathways that could be targeted for therapeutic interventions?", "history": ["What is known about the regeneration of intrahepatic biliary cells in liver diseases?"], "ground_truth": ["permed-71707", "permed-64165", "permed-64170", "permed-82373", "permed-82374", "permed-51215", "permed-87435", "permed-53724", "permed-56228", "permed-67802"]}
{"query_id": "topic_550_turn_3", "conversation_id": "topic_550", "turn_id": 3, "query": "Given the importance of Jagged/Notch/Sox9 signaling in this regeneration process, how could targeted interventions to enhance this pathway be customized to account for the varying regenerative responses seen in Alagille syndrome patients? And what might be the long-term impacts of such treatments on liver function and bile duct structure?", "history": ["What is known about the regeneration of intrahepatic biliary cells in liver diseases?", "Does this process involve specific signaling pathways that could be targeted for therapeutic interventions?"], "ground_truth": ["permed-79930", "permed-50801", "permed-87387", "permed-43088", "permed-86209", "permed-79753", "permed-82142", "permed-9782", "permed-50802", "permed-9949"]}
{"query_id": "topic_550_turn_4", "conversation_id": "topic_550", "turn_id": 4, "query": "When considering these customized interventions targeting the Jagged/Notch/Sox9 axis, what specific experimental models would best capture the spectrum of regenerative responses in Alagille syndrome? Should we establish patient-derived organoid systems with varying JAG1 mutation profiles, and what validation metrics—such as cholangiocyte marker expression, tubular structure formation, or functional secretion assays—would quantitatively demonstrate pathway enhancement while ensuring reproducibility across different genetic backgrounds?", "history": ["What is known about the regeneration of intrahepatic biliary cells in liver diseases?", "Does this process involve specific signaling pathways that could be targeted for therapeutic interventions?", "Given the importance of Jagged/Notch/Sox9 signaling in this regeneration process, how could targeted interventions to enhance this pathway be customized to account for the varying regenerative responses seen in Alagille syndrome patients? And what might be the long-term impacts of such treatments on liver function and bile duct structure?"], "ground_truth": ["permed-79930", "permed-43088", "permed-64528", "permed-57863", "permed-82142", "permed-63207", "permed-9782", "permed-64204", "permed-77302", "permed-56692"]}
{"query_id": "topic_550_turn_5", "conversation_id": "topic_550", "turn_id": 5, "query": "Given the validation metrics proposed for patient-derived organoid models, how do the regenerative outcomes in these human systems compare quantitatively with established animal models of Alagille syndrome—particularly regarding the trade-offs between physiological relevance and experimental control? Specifically, when evaluating bile duct maturation and functional integration, what are the relative advantages of organoid systems versus murine models in predicting therapeutic efficacy of Jagged/Notch/Sox9 interventions, and how might combining both approaches provide complementary insights into biliary regeneration?", "history": ["What is known about the regeneration of intrahepatic biliary cells in liver diseases?", "Does this process involve specific signaling pathways that could be targeted for therapeutic interventions?", "Given the importance of Jagged/Notch/Sox9 signaling in this regeneration process, how could targeted interventions to enhance this pathway be customized to account for the varying regenerative responses seen in Alagille syndrome patients? And what might be the long-term impacts of such treatments on liver function and bile duct structure?", "When considering these customized interventions targeting the Jagged/Notch/Sox9 axis, what specific experimental models would best capture the spectrum of regenerative responses in Alagille syndrome? Should we establish patient-derived organoid systems with varying JAG1 mutation profiles, and what validation metrics—such as cholangiocyte marker expression, tubular structure formation, or functional secretion assays—would quantitatively demonstrate pathway enhancement while ensuring reproducibility across different genetic backgrounds?"], "ground_truth": ["permed-79930", "permed-57863", "permed-75562", "permed-63248", "permed-75367", "permed-56692", "permed-70055", "permed-75371", "permed-64503", "permed-9780"]}
{"query_id": "topic_551_turn_1", "conversation_id": "topic_551", "turn_id": 1, "query": "What impact do microplastics have on soil microbial communities?", "history": [], "ground_truth": ["permed-80526", "permed-80527", "permed-88909", "permed-66775", "permed-80525", "permed-82704", "permed-72734", "permed-80535", "permed-82257", "permed-81988"]}
{"query_id": "topic_551_turn_2", "conversation_id": "topic_551", "turn_id": 2, "query": "How does this impact affect specific microbial processes like nitrogen cycling in different environments?", "history": ["What impact do microplastics have on soil microbial communities?"], "ground_truth": ["permed-66569", "permed-80529", "permed-80533", "permed-80526", "permed-66571", "permed-66775", "permed-67300", "permed-81868", "permed-63946", "permed-80525"]}
{"query_id": "topic_551_turn_3", "conversation_id": "topic_551", "turn_id": 3, "query": "Given these effects on nitrogen cycling, how do different microplastic types and shapes specifically alter the microbial community structure and functional diversity involved in this process? And how might denitrifying bacteria adapt to these changes over time across various soil types?", "history": ["What impact do microplastics have on soil microbial communities?", "How does this impact affect specific microbial processes like nitrogen cycling in different environments?"], "ground_truth": ["permed-80526", "permed-80525", "permed-80529", "permed-66915", "permed-80594", "permed-67300", "permed-66571", "permed-66775", "permed-63946", "permed-66574"]}
{"query_id": "topic_551_turn_4", "conversation_id": "topic_551", "turn_id": 4, "query": "Given this investigation of microbial adaptation to microplastics, what specific methodologies would you recommend for quantifying functional gene expression changes in denitrifying bacteria across different soil types? I'm particularly interested in how to design the RNA extraction protocols to account for soil matrix effects, what normalization strategies work best for qPCR analysis of narG and nirS genes, and how to statistically validate observed expression patterns against microbial community composition data from 16S sequencing.", "history": ["What impact do microplastics have on soil microbial communities?", "How does this impact affect specific microbial processes like nitrogen cycling in different environments?", "Given these effects on nitrogen cycling, how do different microplastic types and shapes specifically alter the microbial community structure and functional diversity involved in this process? And how might denitrifying bacteria adapt to these changes over time across various soil types?"], "ground_truth": ["permed-80526", "permed-80594", "permed-80528", "permed-63946", "permed-80525", "permed-88909", "permed-80532", "permed-66571", "permed-66775", "permed-80529"]}
{"query_id": "topic_551_turn_5", "conversation_id": "topic_551", "turn_id": 5, "query": "Given these established molecular methods for tracking microbial adaptation, how have microplastic-induced changes in soil denitrification pathways translated to observable clinical or public health risks? Specifically, what evidence exists linking altered nitrogen cycling to nitrate contamination in groundwater or agricultural products, and have any epidemiological studies correlated these changes with human health outcomes like methemoglobinemia or carcinogenic compound formation? Furthermore, how should clinical monitoring protocols be adapted for populations relying on groundwater in microplastic-affected agricultural regions?", "history": ["What impact do microplastics have on soil microbial communities?", "How does this impact affect specific microbial processes like nitrogen cycling in different environments?", "Given these effects on nitrogen cycling, how do different microplastic types and shapes specifically alter the microbial community structure and functional diversity involved in this process? And how might denitrifying bacteria adapt to these changes over time across various soil types?", "Given this investigation of microbial adaptation to microplastics, what specific methodologies would you recommend for quantifying functional gene expression changes in denitrifying bacteria across different soil types? I'm particularly interested in how to design the RNA extraction protocols to account for soil matrix effects, what normalization strategies work best for qPCR analysis of narG and nirS genes, and how to statistically validate observed expression patterns against microbial community composition data from 16S sequencing."], "ground_truth": ["permed-80526", "permed-80525", "permed-82251", "permed-72253", "permed-80533", "permed-72731", "permed-85149", "permed-88909", "permed-85150", "permed-66775"]}
{"query_id": "topic_552_turn_1", "conversation_id": "topic_552", "turn_id": 1, "query": "Overview of N-WASP-Arp2/3 signaling pathway roles in mammalian neural development", "history": [], "ground_truth": ["permed-77400", "permed-71707", "permed-66780", "permed-67923", "permed-77405", "permed-66783", "permed-64170", "permed-89441", "permed-68951", "permed-63024"]}
{"query_id": "topic_552_turn_2", "conversation_id": "topic_552", "turn_id": 2, "query": "Specific mechanisms of this N-WASP-Arp2/3 signaling in Purkinje cell dendritic arborization and synapse formation", "history": ["Overview of N-WASP-Arp2/3 signaling pathway roles in mammalian neural development"], "ground_truth": ["permed-77400", "permed-66780", "permed-63024", "permed-67923", "permed-67792", "permed-82338", "permed-77402", "permed-53612", "permed-67688", "permed-71707"]}
{"query_id": "topic_552_turn_3", "conversation_id": "topic_552", "turn_id": 3, "query": "Consequences of N-WASP-Arp2/3 gene variants or pathway dysregulation on Purkinje cell morphology, cerebellar circuit integrity, and emerging therapeutic targets for related neurodevelopmental disorders", "history": ["Overview of N-WASP-Arp2/3 signaling pathway roles in mammalian neural development", "Specific mechanisms of this N-WASP-Arp2/3 signaling in Purkinje cell dendritic arborization and synapse formation"], "ground_truth": ["permed-77400", "permed-59390", "permed-67923", "permed-53612", "permed-77401", "permed-61738", "permed-67792", "permed-68951", "permed-66463", "permed-68952"]}
{"query_id": "topic_552_turn_4", "conversation_id": "topic_552", "turn_id": 4, "query": "Given these emerging therapeutic strategies targeting N-WASP-Arp2/3 dysregulation, what specific in vivo experimental designs and validation protocols would you recommend for assessing rescue of Purkinje cell dendritic complexity? I'm particularly interested in the methodological details—such as choice of animal models, stereotaxic delivery techniques for potential therapeutics, and the quantitative imaging approaches for analyzing dendritic arborization pre- and post-intervention to ensure robust statistical power and reproducibility.", "history": ["Overview of N-WASP-Arp2/3 signaling pathway roles in mammalian neural development", "Specific mechanisms of this N-WASP-Arp2/3 signaling in Purkinje cell dendritic arborization and synapse formation", "Consequences of N-WASP-Arp2/3 gene variants or pathway dysregulation on Purkinje cell morphology, cerebellar circuit integrity, and emerging therapeutic targets for related neurodevelopmental disorders"], "ground_truth": ["permed-77400", "permed-67792", "permed-51625", "permed-58410", "permed-34294", "permed-77402", "permed-66521", "permed-60791", "permed-61738", "permed-68951"]}
{"query_id": "topic_552_turn_5", "conversation_id": "topic_552", "turn_id": 5, "query": "Given the detailed experimental validation protocols for dendritic rescue, what clinical translation challenges might arise when advancing these N-WASP-Arp2/3-targeting therapies toward human neurodevelopmental disorders? Specifically, considering the established Purkinje cell sensitivity, what patient safety profiles—such as neuroinflammation risks or off-target effects on other actin-dependent neuronal processes—should be prioritized in early-phase trials? Additionally, how can preclinical functional outcomes (like motor coordination recovery) best inform clinical trial endpoints for cerebellar-associated disorders, balancing efficacy assessment with practical patient burden?", "history": ["Overview of N-WASP-Arp2/3 signaling pathway roles in mammalian neural development", "Specific mechanisms of this N-WASP-Arp2/3 signaling in Purkinje cell dendritic arborization and synapse formation", "Consequences of N-WASP-Arp2/3 gene variants or pathway dysregulation on Purkinje cell morphology, cerebellar circuit integrity, and emerging therapeutic targets for related neurodevelopmental disorders", "Given these emerging therapeutic strategies targeting N-WASP-Arp2/3 dysregulation, what specific in vivo experimental designs and validation protocols would you recommend for assessing rescue of Purkinje cell dendritic complexity? I'm particularly interested in the methodological details—such as choice of animal models, stereotaxic delivery techniques for potential therapeutics, and the quantitative imaging approaches for analyzing dendritic arborization pre- and post-intervention to ensure robust statistical power and reproducibility."], "ground_truth": ["permed-77400", "permed-54202", "permed-83649", "permed-54205", "permed-12179", "permed-51625", "permed-68376", "permed-72491", "permed-61805", "permed-51185"]}
{"query_id": "topic_553_turn_1", "conversation_id": "topic_553", "turn_id": 1, "query": "What role does spirituality play in the therapeutic relationship between chaplains and veterans?", "history": [], "ground_truth": ["permed-67163", "permed-78812", "permed-78814", "permed-78816", "permed-67161", "permed-78105", "permed-77919", "permed-51735", "permed-65744", "permed-67167"]}
{"query_id": "topic_553_turn_2", "conversation_id": "topic_553", "turn_id": 2, "query": "Can standardized assessment tools enhance this aspect of care without making it less personal?", "history": ["What role does spirituality play in the therapeutic relationship between chaplains and veterans?"], "ground_truth": ["permed-74804", "permed-74799", "permed-60168", "permed-81456", "permed-59135", "permed-61615", "permed-54490", "permed-86911", "permed-77309", "permed-58495"]}
{"query_id": "topic_553_turn_3", "conversation_id": "topic_553", "turn_id": 3, "query": "How might integrating these standardized tools affect the therapeutic relationship between chaplains and veterans, and what kind of training would help chaplains use them effectively while still maintaining the personal connection in their spiritual conversations?", "history": ["What role does spirituality play in the therapeutic relationship between chaplains and veterans?", "Can standardized assessment tools enhance this aspect of care without making it less personal?"], "ground_truth": ["permed-67163", "permed-78812", "permed-78814", "permed-78813", "permed-78816", "permed-81773", "permed-67161", "permed-55965", "permed-88848", "permed-77919"]}
{"query_id": "topic_553_turn_4", "conversation_id": "topic_553", "turn_id": 4, "query": "Regarding the training protocols mentioned for chaplain assessment tools, what specific methodological approaches would best evaluate their implementation fidelity? I'm particularly interested in how researchers might design mixed-methods studies that quantitatively track assessment administration rates while qualitatively capturing relational dynamics through structured interviews. What statistical methods would be appropriate for analyzing potential correlations between standardized tool usage and therapeutic alliance measures, and what control variables should be incorporated to account for veteran demographic factors?", "history": ["What role does spirituality play in the therapeutic relationship between chaplains and veterans?", "Can standardized assessment tools enhance this aspect of care without making it less personal?", "How might integrating these standardized tools affect the therapeutic relationship between chaplains and veterans, and what kind of training would help chaplains use them effectively while still maintaining the personal connection in their spiritual conversations?"], "ground_truth": ["permed-67163", "permed-54490", "permed-51582", "permed-34395", "permed-74373", "permed-58548", "permed-84504", "permed-85811", "permed-34674", "permed-89364"]}
{"query_id": "topic_553_turn_5", "conversation_id": "topic_553", "turn_id": 5, "query": "Given these methodological considerations for evaluating chaplain assessment tools, what clinical outcomes have been demonstrated when implementing standardized spiritual care protocols with veterans? Specifically, what evidence exists regarding impact on PTSD symptoms, depression scores, or quality of life measures in randomized controlled trials? How do safety considerations - such as potential spiritual distress triggered by standardized assessments - factor into clinical deployment, and what contraindications might determine which veterans benefit most from structured versus purely relational chaplaincy approaches?", "history": ["What role does spirituality play in the therapeutic relationship between chaplains and veterans?", "Can standardized assessment tools enhance this aspect of care without making it less personal?", "How might integrating these standardized tools affect the therapeutic relationship between chaplains and veterans, and what kind of training would help chaplains use them effectively while still maintaining the personal connection in their spiritual conversations?", "Regarding the training protocols mentioned for chaplain assessment tools, what specific methodological approaches would best evaluate their implementation fidelity? I'm particularly interested in how researchers might design mixed-methods studies that quantitatively track assessment administration rates while qualitatively capturing relational dynamics through structured interviews. What statistical methods would be appropriate for analyzing potential correlations between standardized tool usage and therapeutic alliance measures, and what control variables should be incorporated to account for veteran demographic factors?"], "ground_truth": ["permed-67163", "permed-67161", "permed-78815", "permed-60080", "permed-78818", "permed-78812", "permed-81773", "permed-77919", "permed-83060", "permed-74465"]}
{"query_id": "topic_554_turn_1", "conversation_id": "topic_554", "turn_id": 1, "query": "Key risk factors for adolescents running away from home.", "history": [], "ground_truth": ["permed-65257", "permed-65255", "permed-57479", "permed-55599", "permed-84435", "permed-84002", "permed-74518", "permed-74343", "permed-88776", "permed-91465"]}
{"query_id": "topic_554_turn_2", "conversation_id": "topic_554", "turn_id": 2, "query": "Considering those risk factors, how significantly do changes in family dynamics and socioeconomic conditions influence adolescent runaway behavior?", "history": ["Key risk factors for adolescents running away from home."], "ground_truth": ["permed-65257", "permed-84002", "permed-70088", "permed-55599", "permed-69488", "permed-57479", "permed-70172", "permed-66295", "permed-69596", "permed-55691"]}
{"query_id": "topic_554_turn_3", "conversation_id": "topic_554", "turn_id": 3, "query": "Given the influence of these family and socioeconomic changes, what is the long-term impact of shifts in family structure and socioeconomic status on adolescent runaway likelihood, and what evidence-based interventions address these specific vulnerabilities in at-risk youth?", "history": ["Key risk factors for adolescents running away from home.", "Considering those risk factors, how significantly do changes in family dynamics and socioeconomic conditions influence adolescent runaway behavior?"], "ground_truth": ["permed-65257", "permed-69488", "permed-53132", "permed-70088", "permed-55599", "permed-57479", "permed-66297", "permed-84002", "permed-66295", "permed-55691"]}
{"query_id": "topic_554_turn_4", "conversation_id": "topic_554", "turn_id": 4, "query": "Regarding these evidence-based interventions for vulnerable youth, what specific methodological approaches were used to validate their effectiveness? I'm particularly interested in the experimental designs—were these randomized controlled trials, quasi-experimental studies, or longitudinal cohort analyses? Also, what statistical methods were employed to control for confounding variables like baseline family instability or neighborhood effects when measuring intervention outcomes? Lastly, what quality control measures ensured treatment fidelity across different implementation settings?", "history": ["Key risk factors for adolescents running away from home.", "Considering those risk factors, how significantly do changes in family dynamics and socioeconomic conditions influence adolescent runaway behavior?", "Given the influence of these family and socioeconomic changes, what is the long-term impact of shifts in family structure and socioeconomic status on adolescent runaway likelihood, and what evidence-based interventions address these specific vulnerabilities in at-risk youth?"], "ground_truth": ["permed-65834", "permed-91233", "permed-51976", "permed-69768", "permed-74976", "permed-55590", "permed-69173", "permed-58547", "permed-58543", "permed-84521"]}
{"query_id": "topic_554_turn_5", "conversation_id": "topic_554", "turn_id": 5, "query": "Given the rigorous methodological validation of these interventions, what clinical outcomes have been demonstrated when implementing these evidence-based programs in real-world settings—specifically regarding reduction in runaway incidents, improvements in family reunification rates, or mental health stabilization? Furthermore, what safety profiles and potential adverse effects have been observed during clinical deployment, particularly concerning intervention dropout rates or iatrogenic harm in this vulnerable adolescent population, and how do these findings inform risk-benefit assessments for frontline practitioners?", "history": ["Key risk factors for adolescents running away from home.", "Considering those risk factors, how significantly do changes in family dynamics and socioeconomic conditions influence adolescent runaway behavior?", "Given the influence of these family and socioeconomic changes, what is the long-term impact of shifts in family structure and socioeconomic status on adolescent runaway likelihood, and what evidence-based interventions address these specific vulnerabilities in at-risk youth?", "Regarding these evidence-based interventions for vulnerable youth, what specific methodological approaches were used to validate their effectiveness? I'm particularly interested in the experimental designs—were these randomized controlled trials, quasi-experimental studies, or longitudinal cohort analyses? Also, what statistical methods were employed to control for confounding variables like baseline family instability or neighborhood effects when measuring intervention outcomes? Lastly, what quality control measures ensured treatment fidelity across different implementation settings?"], "ground_truth": ["permed-55590", "permed-65257", "permed-55587", "permed-55626", "permed-80060", "permed-55585", "permed-58543", "permed-79125", "permed-79373", "permed-91233"]}
{"query_id": "topic_555_turn_1", "conversation_id": "topic_555", "turn_id": 1, "query": "What role do macrolactam precursors play in forming supramolecular structures?", "history": [], "ground_truth": ["permed-79785", "permed-66551", "permed-75452", "permed-50898", "permed-66553", "permed-85249", "permed-66548", "permed-50892", "permed-80355", "permed-60898"]}
{"query_id": "topic_555_turn_2", "conversation_id": "topic_555", "turn_id": 2, "query": "How does the arrangement of substituents on these precursors affect the efficiency and stability of this process?", "history": ["What role do macrolactam precursors play in forming supramolecular structures?"], "ground_truth": ["permed-82820", "permed-79785", "permed-58033", "permed-87040", "permed-52683", "permed-88707", "permed-53108", "permed-75878", "permed-57934", "permed-76873"]}
{"query_id": "topic_555_turn_3", "conversation_id": "topic_555", "turn_id": 3, "query": "Given how substituent arrangement affects cyclization efficiency and stability, how could we specifically optimize bulky substituents on these macrolactam precursors to further enhance both the cyclization process and the stability of the resulting supramolecular tube structures? And what part do intermolecular interactions play in achieving these optimizations?", "history": ["What role do macrolactam precursors play in forming supramolecular structures?", "How does the arrangement of substituents on these precursors affect the efficiency and stability of this process?"], "ground_truth": ["permed-79785", "permed-50898", "permed-66551", "permed-53751", "permed-51641", "permed-79786", "permed-86545", "permed-64531", "permed-50893", "permed-77126"]}
{"query_id": "topic_555_turn_4", "conversation_id": "topic_555", "turn_id": 4, "query": "When implementing these structural optimizations, what specific experimental protocols would you recommend for systematically evaluating how bulky substituent modifications affect cyclization kinetics? Should we employ real-time NMR monitoring or HPLC-MS tracking to quantify intermediate formation rates? Also, what statistical validation approaches would best determine whether observed stability improvements in the supramolecular tubes are significant versus random variation, particularly given the role of intermolecular interactions in these assemblies?", "history": ["What role do macrolactam precursors play in forming supramolecular structures?", "How does the arrangement of substituents on these precursors affect the efficiency and stability of this process?", "Given how substituent arrangement affects cyclization efficiency and stability, how could we specifically optimize bulky substituents on these macrolactam precursors to further enhance both the cyclization process and the stability of the resulting supramolecular tube structures? And what part do intermolecular interactions play in achieving these optimizations?"], "ground_truth": ["permed-79785", "permed-75452", "permed-53751", "permed-67590", "permed-79786", "permed-50898", "permed-60898", "permed-76766", "permed-66551", "permed-77292"]}
{"query_id": "topic_555_turn_5", "conversation_id": "topic_555", "turn_id": 5, "query": "Given the established protocols for evaluating substituent effects on cyclization kinetics and supramolecular tube stability, how would you systematically compare the trade-offs between real-time NMR versus HPLC-MS for monitoring these dynamic processes? Specifically, which method offers superior advantages in capturing transient intermediates versus quantifying reaction progression rates in complex supramolecular systems, and under what experimental conditions would each analytical approach demonstrate relative strengths or limitations for optimizing bulky substituent modifications?", "history": ["What role do macrolactam precursors play in forming supramolecular structures?", "How does the arrangement of substituents on these precursors affect the efficiency and stability of this process?", "Given how substituent arrangement affects cyclization efficiency and stability, how could we specifically optimize bulky substituents on these macrolactam precursors to further enhance both the cyclization process and the stability of the resulting supramolecular tube structures? And what part do intermolecular interactions play in achieving these optimizations?", "When implementing these structural optimizations, what specific experimental protocols would you recommend for systematically evaluating how bulky substituent modifications affect cyclization kinetics? Should we employ real-time NMR monitoring or HPLC-MS tracking to quantify intermediate formation rates? Also, what statistical validation approaches would best determine whether observed stability improvements in the supramolecular tubes are significant versus random variation, particularly given the role of intermolecular interactions in these assemblies?"], "ground_truth": ["permed-80021", "permed-73116", "permed-79785", "permed-81331", "permed-76061", "permed-57954", "permed-51022", "permed-77124", "permed-89261", "permed-66551"]}
{"query_id": "topic_556_turn_1", "conversation_id": "topic_556", "turn_id": 1, "query": "Role of inflammation in endometriosis pathophysiology and progression", "history": [], "ground_truth": ["permed-68328", "permed-67820", "permed-89645", "permed-67817", "permed-78206", "permed-59894", "permed-60288", "permed-67818", "permed-67823", "permed-80619"]}
{"query_id": "topic_556_turn_2", "conversation_id": "topic_556", "turn_id": 2, "query": "Effects of this endometriosis-associated inflammation on assisted reproductive technology (ART) outcomes and oocyte quality", "history": ["Role of inflammation in endometriosis pathophysiology and progression"], "ground_truth": ["permed-84261", "permed-76425", "permed-67819", "permed-67820", "permed-84263", "permed-78206", "permed-70714", "permed-84262", "permed-67817", "permed-7404"]}
{"query_id": "topic_556_turn_3", "conversation_id": "topic_556", "turn_id": 3, "query": "Therapeutic targeting of NLRP3 inflammasome to improve oocyte quality and ART success in endometriosis, focusing on IL-1β, IL-18, and personalized medicine strategies", "history": ["Role of inflammation in endometriosis pathophysiology and progression", "Effects of this endometriosis-associated inflammation on assisted reproductive technology (ART) outcomes and oocyte quality"], "ground_truth": ["permed-78206", "permed-67820", "permed-68328", "permed-51295", "permed-89645", "permed-58640", "permed-63118", "permed-58642", "permed-53856", "permed-53857"]}
{"query_id": "topic_556_turn_4", "conversation_id": "topic_556", "turn_id": 4, "query": "When implementing NLRP3 inflammasome inhibition in clinical protocols, what specific dosing regimens and administration timelines relative to ovarian stimulation cycles have shown optimal efficacy? How do researchers validate successful target engagement - are we relying solely on cytokine level reductions in follicular fluid, or are there more direct biomarkers for NLRP3 pathway inhibition? Additionally, what statistical approaches best account for confounding factors like endometriosis stage and previous ART failures when analyzing oocyte quality metrics in these therapeutic studies?", "history": ["Role of inflammation in endometriosis pathophysiology and progression", "Effects of this endometriosis-associated inflammation on assisted reproductive technology (ART) outcomes and oocyte quality", "Therapeutic targeting of NLRP3 inflammasome to improve oocyte quality and ART success in endometriosis, focusing on IL-1β, IL-18, and personalized medicine strategies"], "ground_truth": ["permed-78206", "permed-92274", "permed-58685", "permed-58686", "permed-7104", "permed-40812", "permed-58688", "permed-31500", "permed-31315", "permed-78207"]}
{"query_id": "topic_556_turn_5", "conversation_id": "topic_556", "turn_id": 5, "query": "Given the detailed pharmacological and methodological considerations for NLRP3 inflammasome inhibition, what clinical safety profile and patient stratification approaches have emerged from early-phase trials? Specifically, how do transient versus chronic IL-1β suppression regimens impact ovarian reserve or endometrial receptivity, and what protocol modifications are recommended for patients with concurrent autoimmune conditions? Furthermore, regarding real-world implementation, how are clinicians managing the balance between anti-inflammatory benefits and potential immunosuppressive risks during ART, particularly in relation to infection susceptibility or interference with embryo implantation?", "history": ["Role of inflammation in endometriosis pathophysiology and progression", "Effects of this endometriosis-associated inflammation on assisted reproductive technology (ART) outcomes and oocyte quality", "Therapeutic targeting of NLRP3 inflammasome to improve oocyte quality and ART success in endometriosis, focusing on IL-1β, IL-18, and personalized medicine strategies", "When implementing NLRP3 inflammasome inhibition in clinical protocols, what specific dosing regimens and administration timelines relative to ovarian stimulation cycles have shown optimal efficacy? How do researchers validate successful target engagement - are we relying solely on cytokine level reductions in follicular fluid, or are there more direct biomarkers for NLRP3 pathway inhibition? Additionally, what statistical approaches best account for confounding factors like endometriosis stage and previous ART failures when analyzing oocyte quality metrics in these therapeutic studies?"], "ground_truth": ["permed-78206", "permed-15243", "permed-72679", "permed-40812", "permed-62397", "permed-78613", "permed-57120", "permed-43355", "permed-23428", "permed-12187"]}
{"query_id": "topic_557_turn_1", "conversation_id": "topic_557", "turn_id": 1, "query": "What role does imaging play in identifying microalgae species?", "history": [], "ground_truth": ["permed-55213", "permed-82718", "permed-85493", "permed-83582", "permed-82421", "permed-85492", "permed-59119", "permed-83482", "permed-63702", "permed-80997"]}
{"query_id": "topic_557_turn_2", "conversation_id": "topic_557", "turn_id": 2, "query": "Can advances in this area, such as multi-spectral imaging, improve the identification of species with valuable bioactive compounds?", "history": ["What role does imaging play in identifying microalgae species?"], "ground_truth": ["permed-86064", "permed-69257", "permed-63844", "permed-87102", "permed-86051", "permed-63825", "permed-86054", "permed-72837", "permed-86069", "permed-58099"]}
{"query_id": "topic_557_turn_3", "conversation_id": "topic_557", "turn_id": 3, "query": "Given these advances in multi-spectral imaging for identifying bioactive compound-producing microalgae, how could integrating it with deep learning frameworks improve both the precision and speed of species identification? Additionally, what novel approaches could be developed to optimize the extraction and quantification of these compounds from the identified strains?", "history": ["What role does imaging play in identifying microalgae species?", "Can advances in this area, such as multi-spectral imaging, improve the identification of species with valuable bioactive compounds?"], "ground_truth": ["permed-55213", "permed-82718", "permed-82421", "permed-83582", "permed-86063", "permed-72837", "permed-82416", "permed-86308", "permed-85493", "permed-66873"]}
{"query_id": "topic_557_turn_4", "conversation_id": "topic_557", "turn_id": 4, "query": "Building on this deep learning framework integration, what specific neural network architectures—such as CNNs versus hybrid models—would be most suitable for processing multi-spectral data, and what validation strategies, like cross-validation with field samples or synthetic data augmentation, could ensure both high precision and generalizability across diverse microalgae species? Furthermore, how might the training pipeline be structured to computationally link spectral signatures with downstream compound quantification, addressing potential batch effects in cultivation conditions?", "history": ["What role does imaging play in identifying microalgae species?", "Can advances in this area, such as multi-spectral imaging, improve the identification of species with valuable bioactive compounds?", "Given these advances in multi-spectral imaging for identifying bioactive compound-producing microalgae, how could integrating it with deep learning frameworks improve both the precision and speed of species identification? Additionally, what novel approaches could be developed to optimize the extraction and quantification of these compounds from the identified strains?"], "ground_truth": ["permed-55213", "permed-82718", "permed-61618", "permed-83582", "permed-88870", "permed-61630", "permed-85491", "permed-86069", "permed-85493", "permed-66873"]}
{"query_id": "topic_557_turn_5", "conversation_id": "topic_557", "turn_id": 5, "query": "Given these optimized deep learning architectures for spectral signature identification, how have clinical trials evaluated the therapeutic efficacy and safety profiles of microalgae-derived bioactive compounds identified through such automated systems? What evidence exists regarding patient outcomes for conditions like inflammation or metabolic disorders, and what translational challenges—such as compound bioavailability or batch-to-batch consistency—have emerged when moving from laboratory-scale identification to clinically deployable therapeutics? Additionally, how are regulatory frameworks adapting to AI-driven discovery pipelines for ensuring safety and reproducibility in clinical applications?", "history": ["What role does imaging play in identifying microalgae species?", "Can advances in this area, such as multi-spectral imaging, improve the identification of species with valuable bioactive compounds?", "Given these advances in multi-spectral imaging for identifying bioactive compound-producing microalgae, how could integrating it with deep learning frameworks improve both the precision and speed of species identification? Additionally, what novel approaches could be developed to optimize the extraction and quantification of these compounds from the identified strains?", "Building on this deep learning framework integration, what specific neural network architectures—such as CNNs versus hybrid models—would be most suitable for processing multi-spectral data, and what validation strategies, like cross-validation with field samples or synthetic data augmentation, could ensure both high precision and generalizability across diverse microalgae species? Furthermore, how might the training pipeline be structured to computationally link spectral signatures with downstream compound quantification, addressing potential batch effects in cultivation conditions?"], "ground_truth": ["permed-55213", "permed-63054", "permed-63052", "permed-82718", "permed-71743", "permed-77754", "permed-82421", "permed-57642", "permed-63663", "permed-61144"]}
{"query_id": "topic_558_turn_1", "conversation_id": "topic_558", "turn_id": 1, "query": "Selenium mechanisms for gut health protection during hypoxia", "history": [], "ground_truth": ["permed-78362", "permed-58626", "permed-65029", "permed-58349", "permed-86263", "permed-76531", "permed-68512", "permed-58211", "permed-72010", "permed-91820"]}
{"query_id": "topic_558_turn_2", "conversation_id": "topic_558", "turn_id": 2, "query": "Efficacy of microbial-synthesized selenium nanoparticles in enhancing these gut protective mechanisms under hypoxia", "history": ["Selenium mechanisms for gut health protection during hypoxia"], "ground_truth": ["permed-78362", "permed-90801", "permed-73302", "permed-76331", "permed-86333", "permed-67125", "permed-62997", "permed-91820", "permed-65029", "permed-62615"]}
{"query_id": "topic_558_turn_3", "conversation_id": "topic_558", "turn_id": 3, "query": "Lactobacillus casei ATCC 393-derived selenium nanoparticles: impact on murine gut barrier, microbiota, immune response, and cytokine profiles under acute vs chronic hypoxia, including long-term effects", "history": ["Selenium mechanisms for gut health protection during hypoxia", "Efficacy of microbial-synthesized selenium nanoparticles in enhancing these gut protective mechanisms under hypoxia"], "ground_truth": ["permed-78362", "permed-67961", "permed-66699", "permed-64094", "permed-76331", "permed-62618", "permed-90801", "permed-90873", "permed-60756", "permed-86120"]}
{"query_id": "topic_558_turn_4", "conversation_id": "topic_558", "turn_id": 4, "query": "Given these nanoparticle interventions in murine models, what specific protocols were used to validate gut barrier integrity—particularly regarding TEER measurements, tight junction protein quantification methods, and permeability assay standardization across both acute and chronic hypoxia exposures? I'm also curious about the statistical approaches employed to account for repeated measurements in the long-term effects analysis, and how sample size was determined given the multiple experimental conditions.", "history": ["Selenium mechanisms for gut health protection during hypoxia", "Efficacy of microbial-synthesized selenium nanoparticles in enhancing these gut protective mechanisms under hypoxia", "Lactobacillus casei ATCC 393-derived selenium nanoparticles: impact on murine gut barrier, microbiota, immune response, and cytokine profiles under acute vs chronic hypoxia, including long-term effects"], "ground_truth": ["permed-76186", "permed-78362", "permed-92575", "permed-57662", "permed-57866", "permed-57865", "permed-24752", "permed-81130", "permed-57115", "permed-90801"]}
{"query_id": "topic_558_turn_5", "conversation_id": "topic_558", "turn_id": 5, "query": "Given the detailed validation protocols for gut barrier integrity in murine models, how do these selenium nanoparticle interventions translate to clinical applications for human hypoxic conditions like ischemic bowel disease or high-altitude exposure? I'm particularly interested in what human trials have been conducted regarding therapeutic efficacy, safety profiles including potential selenium toxicity thresholds, and practical challenges in nanoparticle delivery systems for gastrointestinal protection. Additionally, are there any documented contraindications for selenium supplementation in patients with compromised gut barriers or concurrent gastrointestinal conditions?", "history": ["Selenium mechanisms for gut health protection during hypoxia", "Efficacy of microbial-synthesized selenium nanoparticles in enhancing these gut protective mechanisms under hypoxia", "Lactobacillus casei ATCC 393-derived selenium nanoparticles: impact on murine gut barrier, microbiota, immune response, and cytokine profiles under acute vs chronic hypoxia, including long-term effects", "Given these nanoparticle interventions in murine models, what specific protocols were used to validate gut barrier integrity—particularly regarding TEER measurements, tight junction protein quantification methods, and permeability assay standardization across both acute and chronic hypoxia exposures? I'm also curious about the statistical approaches employed to account for repeated measurements in the long-term effects analysis, and how sample size was determined given the multiple experimental conditions."], "ground_truth": ["permed-78362", "permed-73302", "permed-73963", "permed-58917", "permed-78363", "permed-71108", "permed-60756", "permed-24752", "permed-39638", "permed-76331"]}
{"query_id": "topic_559_turn_1", "conversation_id": "topic_559", "turn_id": 1, "query": "What is known about the role of BK polyomavirus in kidney transplant complications?", "history": [], "ground_truth": ["permed-61516", "permed-92375", "permed-61514", "permed-61515", "permed-61517", "permed-61518", "permed-67879", "permed-21098", "permed-92372", "permed-60090"]}
{"query_id": "topic_559_turn_2", "conversation_id": "topic_559", "turn_id": 2, "query": "How does it affect the development of nephropathy in transplant recipients, and are there any specific molecular mechanisms being researched in this area?", "history": ["What is known about the role of BK polyomavirus in kidney transplant complications?"], "ground_truth": ["permed-61518", "permed-52260", "permed-85120", "permed-92372", "permed-65327", "permed-58835", "permed-23611", "permed-85202", "permed-67917", "permed-67881"]}
{"query_id": "topic_559_turn_3", "conversation_id": "topic_559", "turn_id": 3, "query": "Given BKPyV's role in nephropathy development, how do its microRNAs specifically interact with host cellular pathways to influence BKVAN progression in kidney transplant patients? And could understanding these mechanisms reveal new therapeutic targets or biomarkers?", "history": ["What is known about the role of BK polyomavirus in kidney transplant complications?", "How does it affect the development of nephropathy in transplant recipients, and are there any specific molecular mechanisms being researched in this area?"], "ground_truth": ["permed-61515", "permed-61514", "permed-61516", "permed-61517", "permed-92375", "permed-61518", "permed-56364", "permed-58614", "permed-62468", "permed-27997"]}
{"query_id": "topic_559_turn_4", "conversation_id": "topic_559", "turn_id": 4, "query": "Given these proposed microRNA interactions, what specific experimental approaches would best validate their functional roles in BKVAN pathogenesis? I'm particularly interested in the technical details of how you'd establish causality - would you use primary renal tubular epithelial cell cultures with BKPyV infection models combined with miRNA inhibitors, or perhaps patient-derived organoids? What controls and replication strategies would ensure robust detection of pathway alterations, and which high-throughput sequencing methods would most accurately capture both viral and host transcriptome changes during progression?", "history": ["What is known about the role of BK polyomavirus in kidney transplant complications?", "How does it affect the development of nephropathy in transplant recipients, and are there any specific molecular mechanisms being researched in this area?", "Given BKPyV's role in nephropathy development, how do its microRNAs specifically interact with host cellular pathways to influence BKVAN progression in kidney transplant patients? And could understanding these mechanisms reveal new therapeutic targets or biomarkers?"], "ground_truth": ["permed-61515", "permed-61514", "permed-56366", "permed-53732", "permed-61516", "permed-71615", "permed-3162", "permed-61523", "permed-35224", "permed-61517"]}
{"query_id": "topic_559_turn_5", "conversation_id": "topic_559", "turn_id": 5, "query": "Given these experimental approaches to validate BKPyV miRNA mechanisms, how have these findings translated into clinical applications for managing BKVAN? Specifically, what clinical trials have evaluated miRNA-based diagnostics for early detection or monitoring of viral reactivation, and are there any interventional studies targeting these pathways therapeutically? Furthermore, what are the observed clinical outcomes—such as graft survival rates or reduction in immunosuppression needs—when incorporating viral load monitoring with potential miRNA biomarkers, and what safety concerns exist regarding off-target effects of miRNA-based therapies in immunocompromised transplant recipients?", "history": ["What is known about the role of BK polyomavirus in kidney transplant complications?", "How does it affect the development of nephropathy in transplant recipients, and are there any specific molecular mechanisms being researched in this area?", "Given BKPyV's role in nephropathy development, how do its microRNAs specifically interact with host cellular pathways to influence BKVAN progression in kidney transplant patients? And could understanding these mechanisms reveal new therapeutic targets or biomarkers?", "Given these proposed microRNA interactions, what specific experimental approaches would best validate their functional roles in BKVAN pathogenesis? I'm particularly interested in the technical details of how you'd establish causality - would you use primary renal tubular epithelial cell cultures with BKPyV infection models combined with miRNA inhibitors, or perhaps patient-derived organoids? What controls and replication strategies would ensure robust detection of pathway alterations, and which high-throughput sequencing methods would most accurately capture both viral and host transcriptome changes during progression?"], "ground_truth": ["permed-61515", "permed-61514", "permed-61517", "permed-61516", "permed-92375", "permed-56366", "permed-49209", "permed-59684", "permed-71615", "permed-61523"]}
{"query_id": "topic_560_turn_1", "conversation_id": "topic_560", "turn_id": 1, "query": "What strategies are being explored to reduce healthcare costs associated with biologics and biosimilars in the US?", "history": [], "ground_truth": ["permed-80117", "permed-80118", "permed-63501", "permed-81637", "permed-60656", "permed-56717", "permed-87480", "permed-71630", "permed-68823", "permed-63506"]}
{"query_id": "topic_560_turn_2", "conversation_id": "topic_560", "turn_id": 2, "query": "How effective have reference pricing systems, like the one in Germany, been in controlling these costs and ensuring access to treatments?", "history": ["What strategies are being explored to reduce healthcare costs associated with biologics and biosimilars in the US?"], "ground_truth": ["permed-80117", "permed-80113", "permed-63507", "permed-91926", "permed-63506", "permed-80118", "permed-87058", "permed-65385", "permed-69084", "permed-56717"]}
{"query_id": "topic_560_turn_3", "conversation_id": "topic_560", "turn_id": 3, "query": "Given the potential of reference pricing systems like Germany's to control costs, how could such a system be adapted for the U.S. context to ensure it both maintains affordability and provides equitable access to biologics and biosimilars across diverse socioeconomic groups?", "history": ["What strategies are being explored to reduce healthcare costs associated with biologics and biosimilars in the US?", "How effective have reference pricing systems, like the one in Germany, been in controlling these costs and ensuring access to treatments?"], "ground_truth": ["permed-80117", "permed-80118", "permed-63501", "permed-80113", "permed-46420", "permed-63507", "permed-81637", "permed-60656", "permed-69084", "permed-68823"]}
{"query_id": "topic_560_turn_4", "conversation_id": "topic_560", "turn_id": 4, "query": "Given this proposed adaptation of reference pricing for the U.S. context, what specific statistical methods and validation strategies would you recommend for modeling its impact on biologics pricing and patient access across different socioeconomic strata? I'm particularly interested in how to design the longitudinal analysis to track formulary inclusion rates and out-of-pocket costs, and what covariates should be prioritized in regression models to ensure the analysis accurately captures equity outcomes without confounding.", "history": ["What strategies are being explored to reduce healthcare costs associated with biologics and biosimilars in the US?", "How effective have reference pricing systems, like the one in Germany, been in controlling these costs and ensuring access to treatments?", "Given the potential of reference pricing systems like Germany's to control costs, how could such a system be adapted for the U.S. context to ensure it both maintains affordability and provides equitable access to biologics and biosimilars across diverse socioeconomic groups?"], "ground_truth": ["permed-80117", "permed-80118", "permed-80113", "permed-69084", "permed-80119", "permed-63507", "permed-46420", "permed-63501", "permed-87058", "permed-52838"]}
{"query_id": "topic_560_turn_5", "conversation_id": "topic_560", "turn_id": 5, "query": "Given these proposed statistical models for predicting pricing and access equity, what clinical trial evidence exists regarding patient outcomes when reference pricing systems are implemented? Specifically, for chronic conditions like rheumatoid arthritis or inflammatory bowel disease, have longitudinal studies demonstrated any significant differences in therapeutic efficacy, disease progression, or safety profiles when patients are switched to biosimilars within reference pricing frameworks compared to those remaining on originator biologics? Additionally, how do real-world adherence rates and adverse event reporting correlate with these policy-driven medication changes?", "history": ["What strategies are being explored to reduce healthcare costs associated with biologics and biosimilars in the US?", "How effective have reference pricing systems, like the one in Germany, been in controlling these costs and ensuring access to treatments?", "Given the potential of reference pricing systems like Germany's to control costs, how could such a system be adapted for the U.S. context to ensure it both maintains affordability and provides equitable access to biologics and biosimilars across diverse socioeconomic groups?", "Given this proposed adaptation of reference pricing for the U.S. context, what specific statistical methods and validation strategies would you recommend for modeling its impact on biologics pricing and patient access across different socioeconomic strata? I'm particularly interested in how to design the longitudinal analysis to track formulary inclusion rates and out-of-pocket costs, and what covariates should be prioritized in regression models to ensure the analysis accurately captures equity outcomes without confounding."], "ground_truth": ["permed-80117", "permed-68819", "permed-80113", "permed-80118", "permed-69084", "permed-54914", "permed-68823", "permed-60656", "permed-68817", "permed-63507"]}
{"query_id": "topic_561_turn_1", "conversation_id": "topic_561", "turn_id": 1, "query": "What is known about the causes and mechanisms of Ischemia with No Obstructive Coronary Arteries (INOCA)?", "history": [], "ground_truth": ["permed-57320", "permed-17927", "permed-17737", "permed-54112", "permed-30047", "permed-87980", "permed-28499", "permed-92177", "permed-59853", "permed-6034"]}
{"query_id": "topic_561_turn_2", "conversation_id": "topic_561", "turn_id": 2, "query": "How do genetic and environmental factors interact to contribute to this condition, particularly in terms of microvascular dysfunction?", "history": ["What is known about the causes and mechanisms of Ischemia with No Obstructive Coronary Arteries (INOCA)?"], "ground_truth": ["permed-66392", "permed-38591", "permed-57053", "permed-71072", "permed-26478", "permed-91368", "permed-5471", "permed-53231", "permed-61041", "permed-55529"]}
{"query_id": "topic_561_turn_3", "conversation_id": "topic_561", "turn_id": 3, "query": "Given what we know about genetic and environmental interactions in INOCA's microvascular dysfunction, how might specific genetic factors—like variations in KATP channels—combine with cardiometabolic risk factors to drive this condition's pathogenesis? And based on these mechanisms, what therapeutic targets could be explored to address the microvascular dysfunction and improve patient outcomes?", "history": ["What is known about the causes and mechanisms of Ischemia with No Obstructive Coronary Arteries (INOCA)?", "How do genetic and environmental factors interact to contribute to this condition, particularly in terms of microvascular dysfunction?"], "ground_truth": ["permed-57320", "permed-91510", "permed-60718", "permed-79430", "permed-54112", "permed-28499", "permed-54197", "permed-85327", "permed-73677", "permed-73615"]}
{"query_id": "topic_561_turn_4", "conversation_id": "topic_561", "turn_id": 4, "query": "Given this proposed interplay between KATP channel variants and cardiometabolic factors, what specific experimental approaches would best validate these mechanistic relationships? I'm particularly interested in whether you'd recommend functional assays measuring coronary flow reserve in genotyped patient cohorts, or if controlled in vitro models using endothelial cells with specific KATP mutations under metabolic stress would provide more definitive causal evidence. What statistical methods would be appropriate for detecting gene-environment interactions in such studies, and how would you power these experiments to account for INOCA's heterogeneous presentation?", "history": ["What is known about the causes and mechanisms of Ischemia with No Obstructive Coronary Arteries (INOCA)?", "How do genetic and environmental factors interact to contribute to this condition, particularly in terms of microvascular dysfunction?", "Given what we know about genetic and environmental interactions in INOCA's microvascular dysfunction, how might specific genetic factors—like variations in KATP channels—combine with cardiometabolic risk factors to drive this condition's pathogenesis? And based on these mechanisms, what therapeutic targets could be explored to address the microvascular dysfunction and improve patient outcomes?"], "ground_truth": ["permed-55497", "permed-43018", "permed-60718", "permed-73677", "permed-30047", "permed-76957", "permed-53603", "permed-57320", "permed-28499", "permed-67739"]}
{"query_id": "topic_561_turn_5", "conversation_id": "topic_561", "turn_id": 5, "query": "Building upon these proposed experimental validation approaches for KATP channel mechanisms, what clinical translation pathways show most promise for INOCA patients? Specifically, given the heterogeneous presentation you mentioned, how should future clinical trials be designed to evaluate targeted therapies—such as KATP channel modulators—while accounting for different genetic subgroups and comorbid metabolic conditions? What patient-reported outcomes and objective measures (e.g., angina frequency versus coronary flow reserve) would provide the most clinically meaningful endpoints, and what safety considerations are paramount given the cardiovascular nature of these interventions?", "history": ["What is known about the causes and mechanisms of Ischemia with No Obstructive Coronary Arteries (INOCA)?", "How do genetic and environmental factors interact to contribute to this condition, particularly in terms of microvascular dysfunction?", "Given what we know about genetic and environmental interactions in INOCA's microvascular dysfunction, how might specific genetic factors—like variations in KATP channels—combine with cardiometabolic risk factors to drive this condition's pathogenesis? And based on these mechanisms, what therapeutic targets could be explored to address the microvascular dysfunction and improve patient outcomes?", "Given this proposed interplay between KATP channel variants and cardiometabolic factors, what specific experimental approaches would best validate these mechanistic relationships? I'm particularly interested in whether you'd recommend functional assays measuring coronary flow reserve in genotyped patient cohorts, or if controlled in vitro models using endothelial cells with specific KATP mutations under metabolic stress would provide more definitive causal evidence. What statistical methods would be appropriate for detecting gene-environment interactions in such studies, and how would you power these experiments to account for INOCA's heterogeneous presentation?"], "ground_truth": ["permed-57320", "permed-30047", "permed-53603", "permed-17737", "permed-72009", "permed-66091", "permed-54112", "permed-17927", "permed-79155", "permed-80470"]}
{"query_id": "topic_562_turn_1", "conversation_id": "topic_562", "turn_id": 1, "query": "Role of targeted nutrition in post-operative recovery for complex surgical procedures", "history": [], "ground_truth": ["permed-54962", "permed-65029", "permed-4481", "permed-54824", "permed-22286", "permed-50971", "permed-91759", "permed-42863", "permed-11344", "permed-4552"]}
{"query_id": "topic_562_turn_2", "conversation_id": "topic_562", "turn_id": 2, "query": "Effectiveness of combining such targeted nutritional support with psychological interventions on outcomes for high-risk surgery patients", "history": ["Role of targeted nutrition in post-operative recovery for complex surgical procedures"], "ground_truth": ["permed-54962", "permed-91704", "permed-65029", "permed-54826", "permed-4481", "permed-54824", "permed-54657", "permed-52434", "permed-35317", "permed-22286"]}
{"query_id": "topic_562_turn_3", "conversation_id": "topic_562", "turn_id": 3, "query": "Efficacy of interdisciplinary models using advanced nutritional assessment tools, personalized dietary plans, and tailored psychological support on recovery trajectories and long-term health in complex cancer surgery patients", "history": ["Role of targeted nutrition in post-operative recovery for complex surgical procedures", "Effectiveness of combining such targeted nutritional support with psychological interventions on outcomes for high-risk surgery patients"], "ground_truth": ["permed-55047", "permed-54657", "permed-64890", "permed-54962", "permed-91838", "permed-64888", "permed-54826", "permed-55044", "permed-71192", "permed-91236"]}
{"query_id": "topic_562_turn_4", "conversation_id": "topic_562", "turn_id": 4, "query": "Regarding this interdisciplinary approach, could you detail the specific protocols used for integrating nutritional and psychological data streams? I'm particularly interested in how the advanced assessment tools were calibrated across different patient subtypes, what statistical methods were employed to analyze recovery trajectory correlations, and what quality control measures ensured consistent implementation of personalized plans across the care team throughout the study duration.", "history": ["Role of targeted nutrition in post-operative recovery for complex surgical procedures", "Effectiveness of combining such targeted nutritional support with psychological interventions on outcomes for high-risk surgery patients", "Efficacy of interdisciplinary models using advanced nutritional assessment tools, personalized dietary plans, and tailored psychological support on recovery trajectories and long-term health in complex cancer surgery patients"], "ground_truth": ["permed-68546", "permed-3876", "permed-55037", "permed-77040", "permed-89952", "permed-38878", "permed-4537", "permed-26218", "permed-52370", "permed-72419"]}
{"query_id": "topic_562_turn_5", "conversation_id": "topic_562", "turn_id": 5, "query": "Given the detailed interdisciplinary protocols discussed, what clinical trial evidence exists regarding patient-centered outcomes when implementing these integrated nutritional-psychological models? Specifically, for complex cancer surgery populations, how do these interventions impact hard endpoints like major complication rates, unplanned readmissions, or long-term functional status compared to standard care? Additionally, have any studies reported on intervention safety—particularly concerning interactions between specific nutritional components and psychoactive medications commonly used in this patient group—or identified contraindications based on comorbidities?", "history": ["Role of targeted nutrition in post-operative recovery for complex surgical procedures", "Effectiveness of combining such targeted nutritional support with psychological interventions on outcomes for high-risk surgery patients", "Efficacy of interdisciplinary models using advanced nutritional assessment tools, personalized dietary plans, and tailored psychological support on recovery trajectories and long-term health in complex cancer surgery patients", "Regarding this interdisciplinary approach, could you detail the specific protocols used for integrating nutritional and psychological data streams? I'm particularly interested in how the advanced assessment tools were calibrated across different patient subtypes, what statistical methods were employed to analyze recovery trajectory correlations, and what quality control measures ensured consistent implementation of personalized plans across the care team throughout the study duration."], "ground_truth": ["permed-54826", "permed-64890", "permed-55044", "permed-54657", "permed-64888", "permed-54962", "permed-55045", "permed-65743", "permed-87574", "permed-54824"]}
{"query_id": "topic_563_turn_1", "conversation_id": "topic_563", "turn_id": 1, "query": "What advancements have been made in improving the performance of cathode materials in potassium ion batteries?", "history": [], "ground_truth": ["permed-81164", "permed-92696", "permed-81165", "permed-81167", "permed-81166", "permed-87725", "permed-74426", "permed-82836", "permed-50831", "permed-83733"]}
{"query_id": "topic_563_turn_2", "conversation_id": "topic_563", "turn_id": 2, "query": "How does the use of conductive polymers like PEDOT impact the stability and electrochemical performance of these materials, specifically in terms of thermal stability?", "history": ["What advancements have been made in improving the performance of cathode materials in potassium ion batteries?"], "ground_truth": ["permed-92703", "permed-72959", "permed-72958", "permed-84107", "permed-76036", "permed-92690", "permed-73057", "permed-92702", "permed-72980", "permed-75995"]}
{"query_id": "topic_563_turn_3", "conversation_id": "topic_563", "turn_id": 3, "query": "Building on these findings about PEDOT's effects, could combining it with other conductive polymers or metal oxides—along with defect engineering—further improve the structural stability and electrochemical performance of NH4V3O8-based cathodes? Specifically, how might this approach enhance their thermal stability and safety during high-rate cycling in potassium ion batteries?", "history": ["What advancements have been made in improving the performance of cathode materials in potassium ion batteries?", "How does the use of conductive polymers like PEDOT impact the stability and electrochemical performance of these materials, specifically in terms of thermal stability?"], "ground_truth": ["permed-81164", "permed-82836", "permed-92696", "permed-74426", "permed-81165", "permed-88323", "permed-60925", "permed-79759", "permed-83733", "permed-87725"]}
{"query_id": "topic_563_turn_4", "conversation_id": "topic_563", "turn_id": 4, "query": "Given this proposed composite approach combining PEDOT with other conductive polymers and metal oxides, what specific electrochemical testing protocols and characterization techniques would you recommend for systematically evaluating the structural stability enhancements? More specifically, how should we design accelerated aging tests and in-situ XRD measurements to quantify the relationship between defect engineering modifications and thermal degradation thresholds during high-rate cycling, while ensuring reproducibility across multiple electrode fabrication batches?", "history": ["What advancements have been made in improving the performance of cathode materials in potassium ion batteries?", "How does the use of conductive polymers like PEDOT impact the stability and electrochemical performance of these materials, specifically in terms of thermal stability?", "Building on these findings about PEDOT's effects, could combining it with other conductive polymers or metal oxides—along with defect engineering—further improve the structural stability and electrochemical performance of NH4V3O8-based cathodes? Specifically, how might this approach enhance their thermal stability and safety during high-rate cycling in potassium ion batteries?"], "ground_truth": ["permed-83733", "permed-60922", "permed-92703", "permed-79759", "permed-84107", "permed-72959", "permed-57956", "permed-78276", "permed-81169", "permed-74850"]}
{"query_id": "topic_563_turn_5", "conversation_id": "topic_563", "turn_id": 5, "query": "Given these comprehensive electrochemical testing protocols for NH4V3O8-based cathodes, what clinical translation challenges might arise when scaling these PEDOT-enhanced potassium ion batteries for medical device applications? Specifically, how do the thermal stability improvements demonstrated in laboratory settings translate to real-world safety profiles in implantable devices, considering prolonged cycling under physiological conditions? What evidence exists regarding biocompatibility of these composite materials, and what clinical trials would be necessary to establish therapeutic efficacy and safety margins for patients requiring long-term cardiac or neurological implants?", "history": ["What advancements have been made in improving the performance of cathode materials in potassium ion batteries?", "How does the use of conductive polymers like PEDOT impact the stability and electrochemical performance of these materials, specifically in terms of thermal stability?", "Building on these findings about PEDOT's effects, could combining it with other conductive polymers or metal oxides—along with defect engineering—further improve the structural stability and electrochemical performance of NH4V3O8-based cathodes? Specifically, how might this approach enhance their thermal stability and safety during high-rate cycling in potassium ion batteries?", "Given this proposed composite approach combining PEDOT with other conductive polymers and metal oxides, what specific electrochemical testing protocols and characterization techniques would you recommend for systematically evaluating the structural stability enhancements? More specifically, how should we design accelerated aging tests and in-situ XRD measurements to quantify the relationship between defect engineering modifications and thermal degradation thresholds during high-rate cycling, while ensuring reproducibility across multiple electrode fabrication batches?"], "ground_truth": ["permed-81164", "permed-74426", "permed-83733", "permed-92696", "permed-82836", "permed-60925", "permed-88323", "permed-87725", "permed-81166", "permed-85458"]}
{"query_id": "topic_564_turn_1", "conversation_id": "topic_564", "turn_id": 1, "query": "Survey of regional malaria transmission mapping and spatiotemporal analysis techniques", "history": [], "ground_truth": ["permed-75606", "permed-88327", "permed-57908", "permed-59199", "permed-71221", "permed-72211", "permed-78118", "permed-71210", "permed-81824", "permed-61304"]}
{"query_id": "topic_564_turn_2", "conversation_id": "topic_564", "turn_id": 2, "query": "Applicability of these regional malaria mapping and analysis techniques for tracking other infectious diseases with comparable spatial dynamics", "history": ["Survey of regional malaria transmission mapping and spatiotemporal analysis techniques"], "ground_truth": ["permed-75606", "permed-57908", "permed-88327", "permed-59199", "permed-71214", "permed-54940", "permed-71964", "permed-66153", "permed-67575", "permed-72211"]}
{"query_id": "topic_564_turn_3", "conversation_id": "topic_564", "turn_id": 3, "query": "Adapting specific data visualization methods from regional malaria atlases (e.g., China's Malaria Atlas) for other infectious diseases in similar settings: implementation strategies and public health policy impact", "history": ["Survey of regional malaria transmission mapping and spatiotemporal analysis techniques", "Applicability of these regional malaria mapping and analysis techniques for tracking other infectious diseases with comparable spatial dynamics"], "ground_truth": ["permed-88327", "permed-78112", "permed-66153", "permed-75606", "permed-59199", "permed-78118", "permed-54928", "permed-71964", "permed-91926", "permed-57908"]}
{"query_id": "topic_564_turn_4", "conversation_id": "topic_564", "turn_id": 4, "query": "When implementing these visualization methods from malaria atlases for other diseases, what specific statistical validation frameworks were employed to assess spatial model accuracy? I'm particularly interested in how researchers handled cross-validation protocols for different disease transmission scales, whether they maintained consistent geostatistical modeling parameters across diseases, and what quality control measures ensured reproducibility when adapting the visualization pipelines to new epidemiological datasets with varying spatial resolutions.", "history": ["Survey of regional malaria transmission mapping and spatiotemporal analysis techniques", "Applicability of these regional malaria mapping and analysis techniques for tracking other infectious diseases with comparable spatial dynamics", "Adapting specific data visualization methods from regional malaria atlases (e.g., China's Malaria Atlas) for other infectious diseases in similar settings: implementation strategies and public health policy impact"], "ground_truth": ["permed-78112", "permed-75606", "permed-78118", "permed-34867", "permed-57908", "permed-59199", "permed-78116", "permed-59412", "permed-75636", "permed-35939"]}
{"query_id": "topic_564_turn_5", "conversation_id": "topic_564", "turn_id": 5, "query": "Given these validated spatial modeling frameworks, how have these malaria-derived visualization systems been clinically implemented for real-time patient management decisions - specifically regarding treatment protocol adjustments or resource allocation during Nipah virus outbreaks? I'm interested in clinical outcomes when these systems guided interventions, whether any unexpected contraindications emerged when applying malaria-focused spatial algorithms to hemorrhagic fever management, and what safety protocols were needed when operationalizing these tools in active outbreak settings with different transmission dynamics than malaria.", "history": ["Survey of regional malaria transmission mapping and spatiotemporal analysis techniques", "Applicability of these regional malaria mapping and analysis techniques for tracking other infectious diseases with comparable spatial dynamics", "Adapting specific data visualization methods from regional malaria atlases (e.g., China's Malaria Atlas) for other infectious diseases in similar settings: implementation strategies and public health policy impact", "When implementing these visualization methods from malaria atlases for other diseases, what specific statistical validation frameworks were employed to assess spatial model accuracy? I'm particularly interested in how researchers handled cross-validation protocols for different disease transmission scales, whether they maintained consistent geostatistical modeling parameters across diseases, and what quality control measures ensured reproducibility when adapting the visualization pipelines to new epidemiological datasets with varying spatial resolutions."], "ground_truth": ["permed-75606", "permed-78116", "permed-35939", "permed-78118", "permed-57908", "permed-68742", "permed-71964", "permed-62135", "permed-71224", "permed-53886"]}
{"query_id": "topic_565_turn_1", "conversation_id": "topic_565", "turn_id": 1, "query": "What are the main risk factors associated with the development of gastric cancer?", "history": [], "ground_truth": ["permed-85506", "permed-81437", "permed-35863", "permed-87314", "permed-20369", "permed-80858", "permed-69056", "permed-80859", "permed-56494", "permed-81435"]}
{"query_id": "topic_565_turn_2", "conversation_id": "topic_565", "turn_id": 2, "query": "How do dietary habits and infections, such as Helicobacter pylori, contribute to this risk in different populations?", "history": ["What are the main risk factors associated with the development of gastric cancer?"], "ground_truth": ["permed-65418", "permed-67908", "permed-80859", "permed-80861", "permed-66798", "permed-23886", "permed-76801", "permed-35143", "permed-20407", "permed-80858"]}
{"query_id": "topic_565_turn_3", "conversation_id": "topic_565", "turn_id": 3, "query": "Considering these risk factors—age, H. pylori infection, and spicy food consumption—are known to influence atrophic gastritis and intestinal metaplasia, how might their interactions vary across ethnic groups? And what targeted dietary changes or interventions could be most effective for reducing gastric cancer risk in high-risk populations?", "history": ["What are the main risk factors associated with the development of gastric cancer?", "How do dietary habits and infections, such as Helicobacter pylori, contribute to this risk in different populations?"], "ground_truth": ["permed-80858", "permed-80859", "permed-1520", "permed-80864", "permed-33048", "permed-35862", "permed-56494", "permed-66797", "permed-80860", "permed-80862"]}
{"query_id": "topic_565_turn_4", "conversation_id": "topic_565", "turn_id": 4, "query": "Given these proposed investigations into ethnic variations and dietary interventions, what specific methodologies would be most appropriate for quantifying the synergistic effects between H. pylori infection and spicy food consumption on accelerating atrophic gastritis progression? I'm particularly interested in the statistical models for analyzing such interactions in longitudinal cohort studies and the tissue sampling protocols required to reliably assess metaplasia stages across diverse populations while controlling for confounding factors like age and baseline mucosal status.", "history": ["What are the main risk factors associated with the development of gastric cancer?", "How do dietary habits and infections, such as Helicobacter pylori, contribute to this risk in different populations?", "Considering these risk factors—age, H. pylori infection, and spicy food consumption—are known to influence atrophic gastritis and intestinal metaplasia, how might their interactions vary across ethnic groups? And what targeted dietary changes or interventions could be most effective for reducing gastric cancer risk in high-risk populations?"], "ground_truth": ["permed-80858", "permed-80859", "permed-80861", "permed-80865", "permed-33522", "permed-80862", "permed-66798", "permed-76800", "permed-23889", "permed-67908"]}
{"query_id": "topic_565_turn_5", "conversation_id": "topic_565", "turn_id": 5, "query": "Given these sophisticated methodologies for quantifying H. pylori and dietary interactions, what clinical outcomes have been observed when high-risk populations receive combined H. pylori eradication therapy and prescribed dietary modifications? Specifically, what is the evidence from randomized controlled trials regarding the reduction in gastric cancer incidence and all-cause mortality? Furthermore, what are the real-world challenges in adherence to such dual-intervention regimens, and have any significant safety concerns or contraindications emerged from their clinical deployment, particularly concerning antibiotic resistance or nutrient deficiencies?", "history": ["What are the main risk factors associated with the development of gastric cancer?", "How do dietary habits and infections, such as Helicobacter pylori, contribute to this risk in different populations?", "Considering these risk factors—age, H. pylori infection, and spicy food consumption—are known to influence atrophic gastritis and intestinal metaplasia, how might their interactions vary across ethnic groups? And what targeted dietary changes or interventions could be most effective for reducing gastric cancer risk in high-risk populations?", "Given these proposed investigations into ethnic variations and dietary interventions, what specific methodologies would be most appropriate for quantifying the synergistic effects between H. pylori infection and spicy food consumption on accelerating atrophic gastritis progression? I'm particularly interested in the statistical models for analyzing such interactions in longitudinal cohort studies and the tissue sampling protocols required to reliably assess metaplasia stages across diverse populations while controlling for confounding factors like age and baseline mucosal status."], "ground_truth": ["permed-33513", "permed-80863", "permed-71831", "permed-20411", "permed-20414", "permed-80862", "permed-80859", "permed-66798", "permed-34823", "permed-33523"]}
{"query_id": "topic_566_turn_1", "conversation_id": "topic_566", "turn_id": 1, "query": "Common challenges in the diagnosis and treatment of vascular anomalies like hemangiomas", "history": [], "ground_truth": ["permed-56265", "permed-71333", "permed-52036", "permed-77397", "permed-24689", "permed-64805", "permed-72010", "permed-64801", "permed-92177", "permed-92120"]}
{"query_id": "topic_566_turn_2", "conversation_id": "topic_566", "turn_id": 2, "query": "How are advanced imaging techniques addressing these diagnostic and treatment challenges for vascular anomalies, especially in complex cases?", "history": ["Common challenges in the diagnosis and treatment of vascular anomalies like hemangiomas"], "ground_truth": ["permed-77397", "permed-74596", "permed-51066", "permed-52893", "permed-60503", "permed-59722", "permed-53466", "permed-18135", "permed-28628", "permed-28085"]}
{"query_id": "topic_566_turn_3", "conversation_id": "topic_566", "turn_id": 3, "query": "Specific applications of advanced imaging and innovative surgical approaches for improving diagnosis and outcomes in anterior jugular vein hemangiomas, and their potential transfer to other vascular anomalies", "history": ["Common challenges in the diagnosis and treatment of vascular anomalies like hemangiomas", "How are advanced imaging techniques addressing these diagnostic and treatment challenges for vascular anomalies, especially in complex cases?"], "ground_truth": ["permed-74291", "permed-56265", "permed-71333", "permed-76371", "permed-59862", "permed-77726", "permed-74292", "permed-74297", "permed-57599", "permed-51072"]}
{"query_id": "topic_566_turn_4", "conversation_id": "topic_566", "turn_id": 4, "query": "Regarding these combined imaging and surgical approaches for anterior jugular vein hemangiomas, could you detail the specific imaging protocols used intraoperatively? I'm particularly interested in how surgeons integrate real-time ultrasound guidance with preoperative MRI data during resection, what parameters determine surgical margins, and whether there are standardized quality control measures to ensure consistent application of these techniques across different surgical teams.", "history": ["Common challenges in the diagnosis and treatment of vascular anomalies like hemangiomas", "How are advanced imaging techniques addressing these diagnostic and treatment challenges for vascular anomalies, especially in complex cases?", "Specific applications of advanced imaging and innovative surgical approaches for improving diagnosis and outcomes in anterior jugular vein hemangiomas, and their potential transfer to other vascular anomalies"], "ground_truth": ["permed-74291", "permed-51072", "permed-77726", "permed-59862", "permed-71871", "permed-56437", "permed-14097", "permed-7985", "permed-17020", "permed-24292"]}
{"query_id": "topic_566_turn_5", "conversation_id": "topic_566", "turn_id": 5, "query": "Given the sophisticated intraoperative integration of real-time ultrasound with preoperative MRI described for anterior jugular vein hemangioma resection, what clinical outcomes have been observed regarding postoperative complication rates, recurrence rates, and functional preservation? Specifically, how do these combined imaging approaches impact critical structures like the recurrent laryngeal nerve during resection, and are there comparative clinical trial data demonstrating superior patient outcomes versus conventional surgical techniques for similar vascular anomalies in the cervical region?", "history": ["Common challenges in the diagnosis and treatment of vascular anomalies like hemangiomas", "How are advanced imaging techniques addressing these diagnostic and treatment challenges for vascular anomalies, especially in complex cases?", "Specific applications of advanced imaging and innovative surgical approaches for improving diagnosis and outcomes in anterior jugular vein hemangiomas, and their potential transfer to other vascular anomalies", "Regarding these combined imaging and surgical approaches for anterior jugular vein hemangiomas, could you detail the specific imaging protocols used intraoperatively? I'm particularly interested in how surgeons integrate real-time ultrasound guidance with preoperative MRI data during resection, what parameters determine surgical margins, and whether there are standardized quality control measures to ensure consistent application of these techniques across different surgical teams."], "ground_truth": ["permed-76791", "permed-76790", "permed-71871", "permed-51072", "permed-45880", "permed-2917", "permed-74291", "permed-46738", "permed-46882", "permed-76788"]}
{"query_id": "topic_567_turn_1", "conversation_id": "topic_567", "turn_id": 1, "query": "Key applications and overall impact of computational drug discovery in the modern pharmaceutical development pipeline.", "history": [], "ground_truth": ["permed-78128", "permed-86233", "permed-63052", "permed-86235", "permed-52957", "permed-86660", "permed-66153", "permed-53718", "permed-60645", "permed-53314"]}
{"query_id": "topic_567_turn_2", "conversation_id": "topic_567", "turn_id": 2, "query": "Investigating how machine learning advancements are enhancing predictive accuracy for molecular target identification and validation within *this* drug discovery process.", "history": ["Key applications and overall impact of computational drug discovery in the modern pharmaceutical development pipeline."], "ground_truth": ["permed-66035", "permed-61443", "permed-90340", "permed-61288", "permed-73343", "permed-53298", "permed-73934", "permed-63041", "permed-89422", "permed-61283"]}
{"query_id": "topic_567_turn_3", "conversation_id": "topic_567", "turn_id": 3, "query": "Deep dive into *these* machine learning methods: improving binding free energy calculation accuracy and efficiency for drug candidates, and novel ML strategies for predicting interactions in allosteric or membrane-bound protein systems.", "history": ["Key applications and overall impact of computational drug discovery in the modern pharmaceutical development pipeline.", "Investigating how machine learning advancements are enhancing predictive accuracy for molecular target identification and validation within *this* drug discovery process."], "ground_truth": ["permed-78128", "permed-53315", "permed-75069", "permed-53327", "permed-61283", "permed-53317", "permed-53316", "permed-61443", "permed-61289", "permed-63044"]}
{"query_id": "topic_567_turn_4", "conversation_id": "topic_567", "turn_id": 4, "query": "Regarding these binding free energy calculations and allosteric interaction predictions, what specific computational protocols are used for training set construction and validation? I'm particularly interested in how researchers handle class imbalance for rare binding events, which statistical metrics best validate prediction robustness across diverse protein families, and what quality control measures ensure reproducibility when transitioning from benchmark datasets to novel drug targets.", "history": ["Key applications and overall impact of computational drug discovery in the modern pharmaceutical development pipeline.", "Investigating how machine learning advancements are enhancing predictive accuracy for molecular target identification and validation within *this* drug discovery process.", "Deep dive into *these* machine learning methods: improving binding free energy calculation accuracy and efficiency for drug candidates, and novel ML strategies for predicting interactions in allosteric or membrane-bound protein systems."], "ground_truth": ["permed-78128", "permed-75069", "permed-53327", "permed-53315", "permed-63044", "permed-63042", "permed-61283", "permed-73555", "permed-61288", "permed-21347"]}
{"query_id": "topic_567_turn_5", "conversation_id": "topic_567", "turn_id": 5, "query": "Given these sophisticated computational protocols for predicting molecular interactions, what clinical translation challenges have emerged when advancing these AI-identified drug candidates into trials? Specifically, how frequently do candidates with excellent computational validation metrics subsequently demonstrate poor pharmacokinetics or unexpected toxicity in Phase I studies, and what strategies are being implemented to improve the clinical predictiveness of these models—particularly for allosteric modulators where traditional ADMET prediction tools may be less reliable?", "history": ["Key applications and overall impact of computational drug discovery in the modern pharmaceutical development pipeline.", "Investigating how machine learning advancements are enhancing predictive accuracy for molecular target identification and validation within *this* drug discovery process.", "Deep dive into *these* machine learning methods: improving binding free energy calculation accuracy and efficiency for drug candidates, and novel ML strategies for predicting interactions in allosteric or membrane-bound protein systems.", "Regarding these binding free energy calculations and allosteric interaction predictions, what specific computational protocols are used for training set construction and validation? I'm particularly interested in how researchers handle class imbalance for rare binding events, which statistical metrics best validate prediction robustness across diverse protein families, and what quality control measures ensure reproducibility when transitioning from benchmark datasets to novel drug targets."], "ground_truth": ["permed-90340", "permed-86660", "permed-84970", "permed-63054", "permed-78128", "permed-77555", "permed-88527", "permed-63052", "permed-87462", "permed-78843"]}
{"query_id": "topic_568_turn_1", "conversation_id": "topic_568", "turn_id": 1, "query": "What is known about the biochemical mechanisms underlying cervical vertigo?", "history": [], "ground_truth": ["permed-89962", "permed-78566", "permed-58846", "permed-20333", "permed-73743", "permed-76977", "permed-72010", "permed-92672", "permed-33290", "permed-76973"]}
{"query_id": "topic_568_turn_2", "conversation_id": "topic_568", "turn_id": 2, "query": "How might targeting these mechanisms, particularly with compounds like quinazoline derivatives, offer therapeutic benefits for this condition?", "history": ["What is known about the biochemical mechanisms underlying cervical vertigo?"], "ground_truth": ["permed-60340", "permed-92327", "permed-73348", "permed-72452", "permed-60336", "permed-60343", "permed-58120", "permed-66734", "permed-70109", "permed-12374"]}
{"query_id": "topic_568_turn_3", "conversation_id": "topic_568", "turn_id": 3, "query": "Given these findings about QAD's effects on NE, CGRP, ET-1, NO levels, and radiographic scores in the rat model, how might these biochemical and physiological changes actually benefit human patients with cervical vertigo? And what further preclinical studies would be needed to fully assess QAD's long-term safety and efficacy as a potential treatment?", "history": ["What is known about the biochemical mechanisms underlying cervical vertigo?", "How might targeting these mechanisms, particularly with compounds like quinazoline derivatives, offer therapeutic benefits for this condition?"], "ground_truth": ["permed-78566", "permed-35291", "permed-89962", "permed-68955", "permed-78039", "permed-60792", "permed-91386", "permed-55035", "permed-59779", "permed-70209"]}
{"query_id": "topic_568_turn_4", "conversation_id": "topic_568", "turn_id": 4, "query": "When implementing these biochemical and radiographic assessments in preclinical models, what specific experimental protocols would you recommend for monitoring NE, CGRP, and ET-1 levels over extended treatment periods? I'm particularly interested in the sampling frequency, tissue processing methods for maintaining analyte stability, and the statistical approaches for analyzing longitudinal biomarker data while accounting for potential circadian variations in these mediators. Additionally, what quality control measures would ensure reproducibility across different batches of QAD administration?", "history": ["What is known about the biochemical mechanisms underlying cervical vertigo?", "How might targeting these mechanisms, particularly with compounds like quinazoline derivatives, offer therapeutic benefits for this condition?", "Given these findings about QAD's effects on NE, CGRP, ET-1, NO levels, and radiographic scores in the rat model, how might these biochemical and physiological changes actually benefit human patients with cervical vertigo? And what further preclinical studies would be needed to fully assess QAD's long-term safety and efficacy as a potential treatment?"], "ground_truth": ["permed-4610", "permed-78566", "permed-52753", "permed-80389", "permed-39642", "permed-73446", "permed-4855", "permed-4775", "permed-30024", "permed-74032"]}
{"query_id": "topic_568_turn_5", "conversation_id": "topic_568", "turn_id": 5, "query": "Given these comprehensive preclinical protocols for biomarker monitoring and quality control, how would you design an early-phase clinical trial to translate these findings to human cervical vertigo patients? Specifically, what primary endpoints (e.g., vertigo frequency reduction, neck disability index scores) and safety monitoring protocols would be most appropriate for initial human studies with QAD compounds? Considering the complex biochemical pathways involved, what patient stratification strategies would help identify subgroups most likely to respond to targeted NE/CGRP/ET-1 modulation, and how should potential cardiovascular side effects be monitored given the vascular effects observed in preclinical models?", "history": ["What is known about the biochemical mechanisms underlying cervical vertigo?", "How might targeting these mechanisms, particularly with compounds like quinazoline derivatives, offer therapeutic benefits for this condition?", "Given these findings about QAD's effects on NE, CGRP, ET-1, NO levels, and radiographic scores in the rat model, how might these biochemical and physiological changes actually benefit human patients with cervical vertigo? And what further preclinical studies would be needed to fully assess QAD's long-term safety and efficacy as a potential treatment?", "When implementing these biochemical and radiographic assessments in preclinical models, what specific experimental protocols would you recommend for monitoring NE, CGRP, and ET-1 levels over extended treatment periods? I'm particularly interested in the sampling frequency, tissue processing methods for maintaining analyte stability, and the statistical approaches for analyzing longitudinal biomarker data while accounting for potential circadian variations in these mediators. Additionally, what quality control measures would ensure reproducibility across different batches of QAD administration?"], "ground_truth": ["permed-78566", "permed-89962", "permed-90882", "permed-8526", "permed-73445", "permed-15664", "permed-30924", "permed-55035", "permed-83166", "permed-12781"]}
{"query_id": "topic_569_turn_1", "conversation_id": "topic_569", "turn_id": 1, "query": "COVID-19 pandemic effects on hospital physical accessibility and emergency department wait times", "history": [], "ground_truth": ["permed-68512", "permed-61961", "permed-87891", "permed-71663", "permed-68513", "permed-71662", "permed-88327", "permed-71659", "permed-67493", "permed-71664"]}
{"query_id": "topic_569_turn_2", "conversation_id": "topic_569", "turn_id": 2, "query": "How can insights from these pandemic-related effects on hospital physical accessibility and emergency department wait times be used to improve emergency healthcare planning for vulnerable populations?", "history": ["COVID-19 pandemic effects on hospital physical accessibility and emergency department wait times"], "ground_truth": ["permed-61961", "permed-87891", "permed-76368", "permed-90539", "permed-90743", "permed-65731", "permed-53061", "permed-63442", "permed-54758", "permed-63114"]}
{"query_id": "topic_569_turn_3", "conversation_id": "topic_569", "turn_id": 3, "query": "What specific resource allocation models and public health strategies, derived from spatial-temporal analysis of COVID-19's effects on hospital physical accessibility and emergency department wait times, can be implemented in comparable regions to reduce healthcare access disparities for elderly and low-income populations during future health crises?", "history": ["COVID-19 pandemic effects on hospital physical accessibility and emergency department wait times", "How can insights from these pandemic-related effects on hospital physical accessibility and emergency department wait times be used to improve emergency healthcare planning for vulnerable populations?"], "ground_truth": ["permed-61961", "permed-65382", "permed-67465", "permed-65383", "permed-80519", "permed-68742", "permed-64816", "permed-65884", "permed-87891", "permed-55979"]}
{"query_id": "topic_569_turn_4", "conversation_id": "topic_569", "turn_id": 4, "query": "Regarding these spatial-temporal analysis approaches, what specific statistical methods and validation protocols were most effective for quantifying the relationship between emergency department wait times and physical accessibility metrics during different pandemic phases? I'm particularly interested in how researchers controlled for confounding variables like surge capacity and transportation disruptions when implementing these models across diverse healthcare systems.", "history": ["COVID-19 pandemic effects on hospital physical accessibility and emergency department wait times", "How can insights from these pandemic-related effects on hospital physical accessibility and emergency department wait times be used to improve emergency healthcare planning for vulnerable populations?", "What specific resource allocation models and public health strategies, derived from spatial-temporal analysis of COVID-19's effects on hospital physical accessibility and emergency department wait times, can be implemented in comparable regions to reduce healthcare access disparities for elderly and low-income populations during future health crises?"], "ground_truth": ["permed-61961", "permed-62738", "permed-59265", "permed-61937", "permed-85788", "permed-54099", "permed-58450", "permed-59797", "permed-53886", "permed-65823"]}
{"query_id": "topic_569_turn_5", "conversation_id": "topic_569", "turn_id": 5, "query": "Given the methodological insights about controlling for confounders in spatial-temporal analyses, how do the performance and accuracy of Bayesian hierarchical models compare with traditional regression approaches when quantifying pandemic-driven healthcare access disparities? Specifically, what are the trade-offs in their ability to account for complex interactions between transportation disruptions, hospital surge capacity, and socioeconomic vulnerability factors across different healthcare system contexts? Which approach offers better predictive validity for informing real-time resource allocation during evolving public health emergencies?", "history": ["COVID-19 pandemic effects on hospital physical accessibility and emergency department wait times", "How can insights from these pandemic-related effects on hospital physical accessibility and emergency department wait times be used to improve emergency healthcare planning for vulnerable populations?", "What specific resource allocation models and public health strategies, derived from spatial-temporal analysis of COVID-19's effects on hospital physical accessibility and emergency department wait times, can be implemented in comparable regions to reduce healthcare access disparities for elderly and low-income populations during future health crises?", "Regarding these spatial-temporal analysis approaches, what specific statistical methods and validation protocols were most effective for quantifying the relationship between emergency department wait times and physical accessibility metrics during different pandemic phases? I'm particularly interested in how researchers controlled for confounding variables like surge capacity and transportation disruptions when implementing these models across diverse healthcare systems."], "ground_truth": ["permed-61961", "permed-61935", "permed-61937", "permed-53886", "permed-54099", "permed-53887", "permed-59201", "permed-59485", "permed-58293", "permed-59207"]}
{"query_id": "topic_570_turn_1", "conversation_id": "topic_570", "turn_id": 1, "query": "Function of AC81 protein throughout the baculovirus life cycle", "history": [], "ground_truth": ["permed-76650", "permed-80578", "permed-87381", "permed-89441", "permed-70160", "permed-53717", "permed-89502", "permed-82373", "permed-53718", "permed-53719"]}
{"query_id": "topic_570_turn_2", "conversation_id": "topic_570", "turn_id": 2, "query": "Impact of its disulfide bond formation on these viruses' assembly and subsequent infectivity", "history": ["Function of AC81 protein throughout the baculovirus life cycle"], "ground_truth": ["permed-76650", "permed-68513", "permed-68512", "permed-71578", "permed-80006", "permed-72105", "permed-82172", "permed-68267", "permed-76652", "permed-92568"]}
{"query_id": "topic_570_turn_3", "conversation_id": "topic_570", "turn_id": 3, "query": "Mechanisms behind AC81's substrate specificity in this viral context, its interactions with PIF5/P33, and influence on nucleocapsid and occlusion body biogenesis.", "history": ["Function of AC81 protein throughout the baculovirus life cycle", "Impact of its disulfide bond formation on these viruses' assembly and subsequent infectivity"], "ground_truth": ["permed-76650", "permed-83382", "permed-89200", "permed-80006", "permed-80578", "permed-53445", "permed-88958", "permed-58152", "permed-85052", "permed-83409"]}
{"query_id": "topic_570_turn_4", "conversation_id": "topic_570", "turn_id": 4, "query": "Given AC81's interactions with PIF5/P33 and its role in nucleocapsid assembly, what specific experimental approaches were used to validate these protein-protein interactions? Were techniques like co-immunoprecipitation followed by mass spectrometry or yeast two-hybrid systems employed, and what controls ensured these interactions weren't artifacts? Additionally, how did you quantitatively assess AC81's influence on occlusion body formation - through morphometric analysis of electron micrographs or biochemical quantification of occlusion-derived virus yields?", "history": ["Function of AC81 protein throughout the baculovirus life cycle", "Impact of its disulfide bond formation on these viruses' assembly and subsequent infectivity", "Mechanisms behind AC81's substrate specificity in this viral context, its interactions with PIF5/P33, and influence on nucleocapsid and occlusion body biogenesis."], "ground_truth": ["permed-76650", "permed-75743", "permed-84218", "permed-80006", "permed-22033", "permed-66750", "permed-89200", "permed-22386", "permed-53445", "permed-22471"]}
{"query_id": "topic_570_turn_5", "conversation_id": "topic_570", "turn_id": 5, "query": "Given the validated mechanisms of AC81 in nucleocapsid assembly and occlusion body formation, what translational potential do these findings hold for clinical applications? Specifically, how might AC81's role in baculovirus infectivity inform therapeutic vector design for gene therapy, and what safety considerations emerge regarding immune responses or off-target effects when adapting these viral components for human medical use? Additionally, are there documented instances where baculovirus proteins have been successfully incorporated into clinical-grade delivery systems with acceptable risk profiles?", "history": ["Function of AC81 protein throughout the baculovirus life cycle", "Impact of its disulfide bond formation on these viruses' assembly and subsequent infectivity", "Mechanisms behind AC81's substrate specificity in this viral context, its interactions with PIF5/P33, and influence on nucleocapsid and occlusion body biogenesis.", "Given AC81's interactions with PIF5/P33 and its role in nucleocapsid assembly, what specific experimental approaches were used to validate these protein-protein interactions? Were techniques like co-immunoprecipitation followed by mass spectrometry or yeast two-hybrid systems employed, and what controls ensured these interactions weren't artifacts? Additionally, how did you quantitatively assess AC81's influence on occlusion body formation - through morphometric analysis of electron micrographs or biochemical quantification of occlusion-derived virus yields?"], "ground_truth": ["permed-76650", "permed-91291", "permed-82306", "permed-64451", "permed-71842", "permed-65251", "permed-74545", "permed-92559", "permed-62111", "permed-64448"]}
{"query_id": "topic_571_turn_1", "conversation_id": "topic_571", "turn_id": 1, "query": "Key factors and mechanisms driving tuberculosis (TB) cluster formation in defined geographic regions", "history": [], "ground_truth": ["permed-75607", "permed-70253", "permed-81933", "permed-75605", "permed-75610", "permed-88327", "permed-70255", "permed-62148", "permed-59205", "permed-77834"]}
{"query_id": "topic_571_turn_2", "conversation_id": "topic_571", "turn_id": 2, "query": "Influence of specific environmental and socio-economic conditions on tuberculosis (TB) transmission dynamics and control effectiveness within these identified cluster regions", "history": ["Key factors and mechanisms driving tuberculosis (TB) cluster formation in defined geographic regions"], "ground_truth": ["permed-75607", "permed-70255", "permed-75610", "permed-81933", "permed-70253", "permed-75605", "permed-88327", "permed-62148", "permed-59205", "permed-61592"]}
{"query_id": "topic_571_turn_3", "conversation_id": "topic_571", "turn_id": 3, "query": "Methodologies for integrating environmental (e.g., air quality index) and socio-economic (e.g., poverty rates, healthcare accessibility) data to refine targeted TB control strategies in North Aceh District, Indonesia, addressing the compounding impact of the COVID-19 pandemic.", "history": ["Key factors and mechanisms driving tuberculosis (TB) cluster formation in defined geographic regions", "Influence of specific environmental and socio-economic conditions on tuberculosis (TB) transmission dynamics and control effectiveness within these identified cluster regions"], "ground_truth": ["permed-70255", "permed-55977", "permed-70253", "permed-66218", "permed-75607", "permed-75610", "permed-70254", "permed-63541", "permed-61590", "permed-55973"]}
{"query_id": "topic_571_turn_4", "conversation_id": "topic_571", "turn_id": 4, "query": "After integrating these diverse datasets, what specific statistical modeling approaches—such as hierarchical Bayesian models or machine learning algorithms—were most effective for quantifying the relative contributions of environmental versus socio-economic factors to TB transmission? Additionally, how did you validate these models' predictive accuracy for identifying high-risk zones, and what quality control measures ensured reproducibility given the heterogeneous data sources from North Aceh District during the pandemic period?", "history": ["Key factors and mechanisms driving tuberculosis (TB) cluster formation in defined geographic regions", "Influence of specific environmental and socio-economic conditions on tuberculosis (TB) transmission dynamics and control effectiveness within these identified cluster regions", "Methodologies for integrating environmental (e.g., air quality index) and socio-economic (e.g., poverty rates, healthcare accessibility) data to refine targeted TB control strategies in North Aceh District, Indonesia, addressing the compounding impact of the COVID-19 pandemic."], "ground_truth": ["permed-70253", "permed-59205", "permed-75605", "permed-53876", "permed-75610", "permed-70255", "permed-75607", "permed-62148", "permed-75642", "permed-81933"]}
{"query_id": "topic_571_turn_5", "conversation_id": "topic_571", "turn_id": 5, "query": "Given these validated models identifying high-risk TB zones in North Aceh District, what clinical outcomes were observed when implementing targeted screening and preventive therapy in these identified hotspots? Specifically, how did early case detection rates, treatment completion metrics, and TB incidence reduction compare between model-prioritized areas versus standard surveillance regions? Additionally, what clinical challenges emerged regarding isoniazid preventive therapy adherence and management of drug-resistant TB cases in these resource-constrained settings during concurrent COVID-19 healthcare disruptions?", "history": ["Key factors and mechanisms driving tuberculosis (TB) cluster formation in defined geographic regions", "Influence of specific environmental and socio-economic conditions on tuberculosis (TB) transmission dynamics and control effectiveness within these identified cluster regions", "Methodologies for integrating environmental (e.g., air quality index) and socio-economic (e.g., poverty rates, healthcare accessibility) data to refine targeted TB control strategies in North Aceh District, Indonesia, addressing the compounding impact of the COVID-19 pandemic.", "After integrating these diverse datasets, what specific statistical modeling approaches—such as hierarchical Bayesian models or machine learning algorithms—were most effective for quantifying the relative contributions of environmental versus socio-economic factors to TB transmission? Additionally, how did you validate these models' predictive accuracy for identifying high-risk zones, and what quality control measures ensured reproducibility given the heterogeneous data sources from North Aceh District during the pandemic period?"], "ground_truth": ["permed-70253", "permed-70254", "permed-66218", "permed-61588", "permed-61585", "permed-63534", "permed-55977", "permed-61590", "permed-61591", "permed-75605"]}
{"query_id": "topic_572_turn_1", "conversation_id": "topic_572", "turn_id": 1, "query": "Pancreatic cancer tumor microenvironment: Key components, functions, and impact on disease progression", "history": [], "ground_truth": ["permed-67851", "permed-85506", "permed-82373", "permed-56312", "permed-59213", "permed-85505", "permed-56314", "permed-70644", "permed-68563", "permed-55322"]}
{"query_id": "topic_572_turn_2", "conversation_id": "topic_572", "turn_id": 2, "query": "Modulating this tumor microenvironment: Innovative strategies to enhance pancreatic cancer radiation therapy efficacy", "history": ["Pancreatic cancer tumor microenvironment: Key components, functions, and impact on disease progression"], "ground_truth": ["permed-67851", "permed-85556", "permed-76115", "permed-68557", "permed-51777", "permed-57543", "permed-52313", "permed-56732", "permed-0898", "permed-4520"]}
{"query_id": "topic_572_turn_3", "conversation_id": "topic_572", "turn_id": 3, "query": "Combining novel immunomodulatory agents with radiotherapy: Impact on fibrotic and inflammatory remodeling of this tumor microenvironment and therapeutic outcomes in pancreatic cancer", "history": ["Pancreatic cancer tumor microenvironment: Key components, functions, and impact on disease progression", "Modulating this tumor microenvironment: Innovative strategies to enhance pancreatic cancer radiation therapy efficacy"], "ground_truth": ["permed-67851", "permed-57543", "permed-85556", "permed-59213", "permed-59586", "permed-68588", "permed-52313", "permed-2368", "permed-87591", "permed-51772"]}
{"query_id": "topic_572_turn_4", "conversation_id": "topic_572", "turn_id": 4, "query": "Regarding this combinatorial approach, what specific irradiation protocols and immunomodulator sequencing schedules were most effective in the preclinical models? I'm particularly interested in how the timing between radiation fractions and checkpoint inhibitor administrations was optimized, what dose constraints were established for critical stromal elements, and whether any specialized imaging techniques were employed to monitor real-time changes in the fibrotic components during this combined treatment regimen.", "history": ["Pancreatic cancer tumor microenvironment: Key components, functions, and impact on disease progression", "Modulating this tumor microenvironment: Innovative strategies to enhance pancreatic cancer radiation therapy efficacy", "Combining novel immunomodulatory agents with radiotherapy: Impact on fibrotic and inflammatory remodeling of this tumor microenvironment and therapeutic outcomes in pancreatic cancer"], "ground_truth": ["permed-59586", "permed-77564", "permed-77563", "permed-42578", "permed-31872", "permed-51772", "permed-31877", "permed-57543", "permed-42577", "permed-42531"]}
{"query_id": "topic_572_turn_5", "conversation_id": "topic_572", "turn_id": 5, "query": "Given these optimized preclinical sequencing protocols and radiation constraints, what clinical evidence exists regarding safety profiles and therapeutic efficacy when translating these combination regimens to human trials? I'm particularly interested in phase I/II trial outcomes addressing dose-limiting toxicities specific to pancreatic cancer patients, observed immune-related adverse events when combining radiotherapy with checkpoint inhibitors, and whether the promising fibrotic remodeling seen preclinically correlates with improved objective response rates or overall survival in early clinical studies.", "history": ["Pancreatic cancer tumor microenvironment: Key components, functions, and impact on disease progression", "Modulating this tumor microenvironment: Innovative strategies to enhance pancreatic cancer radiation therapy efficacy", "Combining novel immunomodulatory agents with radiotherapy: Impact on fibrotic and inflammatory remodeling of this tumor microenvironment and therapeutic outcomes in pancreatic cancer", "Regarding this combinatorial approach, what specific irradiation protocols and immunomodulator sequencing schedules were most effective in the preclinical models? I'm particularly interested in how the timing between radiation fractions and checkpoint inhibitor administrations was optimized, what dose constraints were established for critical stromal elements, and whether any specialized imaging techniques were employed to monitor real-time changes in the fibrotic components during this combined treatment regimen."], "ground_truth": ["permed-68588", "permed-67851", "permed-85556", "permed-57543", "permed-2368", "permed-68557", "permed-42577", "permed-77563", "permed-52313", "permed-2611"]}
{"query_id": "topic_573_turn_1", "conversation_id": "topic_573", "turn_id": 1, "query": "What approaches are being explored to improve emotional support for patients at the end of life?", "history": [], "ground_truth": ["permed-67369", "permed-68620", "permed-74825", "permed-71620", "permed-67380", "permed-23534", "permed-86980", "permed-74824", "permed-80227", "permed-70259"]}
{"query_id": "topic_573_turn_2", "conversation_id": "topic_573", "turn_id": 2, "query": "How effective are programs like \"No One Dies Alone\" in enhancing this aspect of care, and can they be applied broadly?", "history": ["What approaches are being explored to improve emotional support for patients at the end of life?"], "ground_truth": ["permed-80196", "permed-84897", "permed-56935", "permed-70259", "permed-55875", "permed-80080", "permed-51093", "permed-67166", "permed-75682", "permed-65733"]}
{"query_id": "topic_573_turn_3", "conversation_id": "topic_573", "turn_id": 3, "query": "Given the effectiveness of programs like \"No One Dies Alone,\" how could such compassionate presence initiatives be adapted for different cultural settings to improve end-of-life care? What specific training would volunteers need to provide culturally sensitive support to patients and families while maintaining ethical standards?", "history": ["What approaches are being explored to improve emotional support for patients at the end of life?", "How effective are programs like \"No One Dies Alone\" in enhancing this aspect of care, and can they be applied broadly?"], "ground_truth": ["permed-80196", "permed-91449", "permed-80197", "permed-70259", "permed-74826", "permed-65733", "permed-67376", "permed-67375", "permed-74825", "permed-84897"]}
{"query_id": "topic_573_turn_4", "conversation_id": "topic_573", "turn_id": 4, "query": "Given these cultural adaptation frameworks for compassionate presence initiatives, what specific methodological approaches would you recommend for validating volunteer training protocols across different healthcare settings? I'm particularly interested in how researchers establish competency benchmarks for culturally sensitive communication, what standardized assessment tools exist for measuring protocol fidelity during implementation, and whether mixed-methods approaches combining quantitative surveys with qualitative interviews have proven most effective for evaluating both volunteer performance and patient/family outcomes in these cross-cultural contexts.", "history": ["What approaches are being explored to improve emotional support for patients at the end of life?", "How effective are programs like \"No One Dies Alone\" in enhancing this aspect of care, and can they be applied broadly?", "Given the effectiveness of programs like \"No One Dies Alone,\" how could such compassionate presence initiatives be adapted for different cultural settings to improve end-of-life care? What specific training would volunteers need to provide culturally sensitive support to patients and families while maintaining ethical standards?"], "ground_truth": ["permed-52380", "permed-64779", "permed-69898", "permed-66109", "permed-64788", "permed-81456", "permed-69900", "permed-51596", "permed-69899", "permed-67356"]}
{"query_id": "topic_573_turn_5", "conversation_id": "topic_573", "turn_id": 5, "query": "Given these methodological approaches for validating cross-cultural volunteer training, what clinical outcome data exist regarding how compassionate presence initiatives actually impact patient symptom burden and quality of life metrics in palliative care settings? Specifically, what evidence from clinical trials or longitudinal studies demonstrates whether these programs lead to statistically significant reductions in pain scores, anxiety levels, or hospital readmission rates compared to standard care? I'm also interested in any documented safety considerations or unintended consequences observed when implementing these volunteer-based interventions alongside clinical care teams.", "history": ["What approaches are being explored to improve emotional support for patients at the end of life?", "How effective are programs like \"No One Dies Alone\" in enhancing this aspect of care, and can they be applied broadly?", "Given the effectiveness of programs like \"No One Dies Alone,\" how could such compassionate presence initiatives be adapted for different cultural settings to improve end-of-life care? What specific training would volunteers need to provide culturally sensitive support to patients and families while maintaining ethical standards?", "Given these cultural adaptation frameworks for compassionate presence initiatives, what specific methodological approaches would you recommend for validating volunteer training protocols across different healthcare settings? I'm particularly interested in how researchers establish competency benchmarks for culturally sensitive communication, what standardized assessment tools exist for measuring protocol fidelity during implementation, and whether mixed-methods approaches combining quantitative surveys with qualitative interviews have proven most effective for evaluating both volunteer performance and patient/family outcomes in these cross-cultural contexts."], "ground_truth": ["permed-86910", "permed-70259", "permed-60170", "permed-70263", "permed-88305", "permed-86676", "permed-86907", "permed-65755", "permed-87574", "permed-51735"]}
{"query_id": "topic_574_turn_1", "conversation_id": "topic_574", "turn_id": 1, "query": "Role of rhodopsin in retinitis pigmentosa and impact on photoreceptor cell function and survival", "history": [], "ground_truth": ["permed-71682", "permed-41488", "permed-55531", "permed-70266", "permed-74376", "permed-55536", "permed-82302", "permed-67528", "permed-67628", "permed-82444"]}
{"query_id": "topic_574_turn_2", "conversation_id": "topic_574", "turn_id": 2, "query": "How do rhodopsin gene mutations or protein overexpression in retinitis pigmentosa affect energy metabolism within these photoreceptor cells?", "history": ["Role of rhodopsin in retinitis pigmentosa and impact on photoreceptor cell function and survival"], "ground_truth": ["permed-71682", "permed-41488", "permed-71679", "permed-72076", "permed-55531", "permed-70266", "permed-62433", "permed-82302", "permed-65111", "permed-71681"]}
{"query_id": "topic_574_turn_3", "conversation_id": "topic_574", "turn_id": 3, "query": "In 661W retinitis pigmentosa cell models with mutant rhodopsin, how do mitochondrial dynamics and autophagy pathways contribute to energy failure and cell death, and what therapies can target these specific dysfunctions?", "history": ["Role of rhodopsin in retinitis pigmentosa and impact on photoreceptor cell function and survival", "How do rhodopsin gene mutations or protein overexpression in retinitis pigmentosa affect energy metabolism within these photoreceptor cells?"], "ground_truth": ["permed-71682", "permed-65111", "permed-67628", "permed-58436", "permed-62815", "permed-41488", "permed-62594", "permed-81144", "permed-71681", "permed-72076"]}
{"query_id": "topic_574_turn_4", "conversation_id": "topic_574", "turn_id": 4, "query": "In these 661W models with mutant rhodopsin, what specific methodological approaches were used to quantitatively measure mitochondrial dynamics - particularly regarding fusion/fission balance - and how were autophagy flux assays validated to distinguish between increased autophagosome formation versus impaired lysosomal degradation? Additionally, what statistical methods were employed to correlate these dynamic measurements with both ATP production rates and subsequent cell death endpoints?", "history": ["Role of rhodopsin in retinitis pigmentosa and impact on photoreceptor cell function and survival", "How do rhodopsin gene mutations or protein overexpression in retinitis pigmentosa affect energy metabolism within these photoreceptor cells?", "In 661W retinitis pigmentosa cell models with mutant rhodopsin, how do mitochondrial dynamics and autophagy pathways contribute to energy failure and cell death, and what therapies can target these specific dysfunctions?"], "ground_truth": ["permed-53810", "permed-90069", "permed-79625", "permed-57097", "permed-71681", "permed-71682", "permed-79053", "permed-33532", "permed-57213", "permed-84708"]}
{"query_id": "topic_574_turn_5", "conversation_id": "topic_574", "turn_id": 5, "query": "Given the detailed quantitative characterization of mitochondrial dynamics and autophagic flux in 661W models, what translational implications do these findings have for clinical management of retinitis pigmentosa patients with rhodopsin mutations? Specifically, based on the established correlations between fusion/fission imbalances and energy failure, what candidate therapeutics have progressed to clinical trials targeting these pathways, and what have been the reported patient outcomes regarding visual preservation, safety profiles, and limitations in therapeutic windows when modulating these fundamental cellular processes?", "history": ["Role of rhodopsin in retinitis pigmentosa and impact on photoreceptor cell function and survival", "How do rhodopsin gene mutations or protein overexpression in retinitis pigmentosa affect energy metabolism within these photoreceptor cells?", "In 661W retinitis pigmentosa cell models with mutant rhodopsin, how do mitochondrial dynamics and autophagy pathways contribute to energy failure and cell death, and what therapies can target these specific dysfunctions?", "In these 661W models with mutant rhodopsin, what specific methodological approaches were used to quantitatively measure mitochondrial dynamics - particularly regarding fusion/fission balance - and how were autophagy flux assays validated to distinguish between increased autophagosome formation versus impaired lysosomal degradation? Additionally, what statistical methods were employed to correlate these dynamic measurements with both ATP production rates and subsequent cell death endpoints?"], "ground_truth": ["permed-71682", "permed-65111", "permed-70266", "permed-55531", "permed-67628", "permed-71681", "permed-62815", "permed-62594", "permed-57213", "permed-41488"]}
{"query_id": "topic_575_turn_1", "conversation_id": "topic_575", "turn_id": 1, "query": "What role can telehealth play in reducing healthcare disparities?", "history": [], "ground_truth": ["permed-71988", "permed-61891", "permed-59688", "permed-55870", "permed-53992", "permed-61872", "permed-74633", "permed-61886", "permed-61887", "permed-55112"]}
{"query_id": "topic_575_turn_2", "conversation_id": "topic_575", "turn_id": 2, "query": "How effective has it been in reaching socioeconomically disadvantaged populations so far?", "history": ["What role can telehealth play in reducing healthcare disparities?"], "ground_truth": ["permed-77916", "permed-86027", "permed-75101", "permed-64307", "permed-55645", "permed-68653", "permed-61889", "permed-63357", "permed-65399", "permed-71649"]}
{"query_id": "topic_575_turn_3", "conversation_id": "topic_575", "turn_id": 3, "query": "Given what we've discussed about telehealth's role in reducing disparities and its effectiveness for disadvantaged populations, how can systems like Kaiser Permanente better integrate these services to further bridge the gap? What specific strategies would enhance equitable access to these technologies for those communities?", "history": ["What role can telehealth play in reducing healthcare disparities?", "How effective has it been in reaching socioeconomically disadvantaged populations so far?"], "ground_truth": ["permed-61891", "permed-71988", "permed-52219", "permed-59688", "permed-55113", "permed-53992", "permed-61885", "permed-66122", "permed-53994", "permed-68488"]}
{"query_id": "topic_575_turn_4", "conversation_id": "topic_575", "turn_id": 4, "query": "Regarding Kaiser Permanente's integration strategies to bridge the access gap, what specific methodological frameworks—such as hybrid implementation-effectiveness designs or stepped-wedge cluster randomized trials—would be most appropriate for evaluating these initiatives? Furthermore, what key implementation outcomes (e.g., reach, adoption, fidelity) and corresponding mixed-methods data collection protocols should be prioritized to rigorously assess both the process and equitable impact of these telehealth service integrations on disadvantaged subpopulations?", "history": ["What role can telehealth play in reducing healthcare disparities?", "How effective has it been in reaching socioeconomically disadvantaged populations so far?", "Given what we've discussed about telehealth's role in reducing disparities and its effectiveness for disadvantaged populations, how can systems like Kaiser Permanente better integrate these services to further bridge the gap? What specific strategies would enhance equitable access to these technologies for those communities?"], "ground_truth": ["permed-61891", "permed-91392", "permed-61888", "permed-74633", "permed-83209", "permed-80191", "permed-59688", "permed-80266", "permed-84754", "permed-52110"]}
{"query_id": "topic_575_turn_5", "conversation_id": "topic_575", "turn_id": 5, "query": "Given your detailed methodological framework for evaluating telehealth integration, how do implementation outcomes like reach and adoption compare between synchronous (video visits) versus asynchronous (store-and-forward) telehealth modalities when specifically targeting disadvantaged populations? What are the relative trade-offs in terms of technological barriers, health literacy requirements, and clinical appropriateness for chronic disease management versus acute care across these different delivery approaches within systems like Kaiser Permanente?", "history": ["What role can telehealth play in reducing healthcare disparities?", "How effective has it been in reaching socioeconomically disadvantaged populations so far?", "Given what we've discussed about telehealth's role in reducing disparities and its effectiveness for disadvantaged populations, how can systems like Kaiser Permanente better integrate these services to further bridge the gap? What specific strategies would enhance equitable access to these technologies for those communities?", "Regarding Kaiser Permanente's integration strategies to bridge the access gap, what specific methodological frameworks—such as hybrid implementation-effectiveness designs or stepped-wedge cluster randomized trials—would be most appropriate for evaluating these initiatives? Furthermore, what key implementation outcomes (e.g., reach, adoption, fidelity) and corresponding mixed-methods data collection protocols should be prioritized to rigorously assess both the process and equitable impact of these telehealth service integrations on disadvantaged subpopulations?"], "ground_truth": ["permed-61891", "permed-61871", "permed-59688", "permed-57549", "permed-61953", "permed-71988", "permed-74633", "permed-61886", "permed-61885", "permed-68488"]}
{"query_id": "topic_576_turn_1", "conversation_id": "topic_576", "turn_id": 1, "query": "Human metabolism and biotransformation of 4-Cl-PVP (4-chlorophenylisobutylone) and related synthetic cathinones: current knowledge review", "history": [], "ground_truth": ["permed-77551", "permed-64159", "permed-64164", "permed-77553", "permed-87179", "permed-88749", "permed-72474", "permed-60645", "permed-88750", "permed-89441"]}
{"query_id": "topic_576_turn_2", "conversation_id": "topic_576", "turn_id": 2, "query": "Advancing understanding of 4-Cl-PVP human metabolism: applying in silico models and in vitro experimental validation for these synthetic cathinones", "history": ["Human metabolism and biotransformation of 4-Cl-PVP (4-chlorophenylisobutylone) and related synthetic cathinones: current knowledge review"], "ground_truth": ["permed-77551", "permed-77553", "permed-64159", "permed-87179", "permed-64164", "permed-60645", "permed-88749", "permed-77554", "permed-72474", "permed-55323"]}
{"query_id": "topic_576_turn_3", "conversation_id": "topic_576", "turn_id": 3, "query": "Integration of in silico predictions and in vitro metabolic data for definitive 4-Cl-PVP biotransformation pathway elucidation and forensic biomarker identification strategies", "history": ["Human metabolism and biotransformation of 4-Cl-PVP (4-chlorophenylisobutylone) and related synthetic cathinones: current knowledge review", "Advancing understanding of 4-Cl-PVP human metabolism: applying in silico models and in vitro experimental validation for these synthetic cathinones"], "ground_truth": ["permed-77551", "permed-77553", "permed-64159", "permed-77552", "permed-60350", "permed-64164", "permed-77554", "permed-71707", "permed-53718", "permed-88997"]}
{"query_id": "topic_576_turn_4", "conversation_id": "topic_576", "turn_id": 4, "query": "When integrating these in silico and in vitro datasets, what specific computational pipeline did you employ for pathway reconciliation? I'm particularly interested in your statistical validation approach for determining which predicted metabolites qualified as definitive biomarkers - did you use ROC curve analysis with established performance thresholds, and what quality control measures ensured reproducibility across different analytical platforms? Additionally, how were conflicting predictions between docking simulations and experimental metabolite profiles systematically resolved in your final pathway mapping?", "history": ["Human metabolism and biotransformation of 4-Cl-PVP (4-chlorophenylisobutylone) and related synthetic cathinones: current knowledge review", "Advancing understanding of 4-Cl-PVP human metabolism: applying in silico models and in vitro experimental validation for these synthetic cathinones", "Integration of in silico predictions and in vitro metabolic data for definitive 4-Cl-PVP biotransformation pathway elucidation and forensic biomarker identification strategies"], "ground_truth": ["permed-77753", "permed-58107", "permed-88525", "permed-69257", "permed-69753", "permed-77752", "permed-57948", "permed-73444", "permed-58106", "permed-77757"]}
{"query_id": "topic_576_turn_5", "conversation_id": "topic_576", "turn_id": 5, "query": "Given your detailed computational pipeline for reconciling in silico and in vitro data, how do the resulting definitive biomarkers from this integrated approach quantitatively compare against those identified through traditional targeted analysis alone in terms of forensic utility? Specifically, what were the relative improvements in sensitivity, specificity, and detection windows when applied to authentic case samples? Additionally, how do the resource requirements and analytical throughput trade-offs between these comprehensive versus conventional approaches impact their practical implementation in different forensic laboratory settings with varying technical capabilities?", "history": ["Human metabolism and biotransformation of 4-Cl-PVP (4-chlorophenylisobutylone) and related synthetic cathinones: current knowledge review", "Advancing understanding of 4-Cl-PVP human metabolism: applying in silico models and in vitro experimental validation for these synthetic cathinones", "Integration of in silico predictions and in vitro metabolic data for definitive 4-Cl-PVP biotransformation pathway elucidation and forensic biomarker identification strategies", "When integrating these in silico and in vitro datasets, what specific computational pipeline did you employ for pathway reconciliation? I'm particularly interested in your statistical validation approach for determining which predicted metabolites qualified as definitive biomarkers - did you use ROC curve analysis with established performance thresholds, and what quality control measures ensured reproducibility across different analytical platforms? Additionally, how were conflicting predictions between docking simulations and experimental metabolite profiles systematically resolved in your final pathway mapping?"], "ground_truth": ["permed-67114", "permed-77753", "permed-76032", "permed-69257", "permed-74088", "permed-50852", "permed-77839", "permed-52872", "permed-56363", "permed-54317"]}
{"query_id": "topic_577_turn_1", "conversation_id": "topic_577", "turn_id": 1, "query": "Role and applications of robot-assisted therapy in chronic stroke survivor rehabilitation", "history": [], "ground_truth": ["permed-70198", "permed-54854", "permed-54871", "permed-60043", "permed-73775", "permed-44223", "permed-14754", "permed-63136", "permed-44171", "permed-79469"]}
{"query_id": "topic_577_turn_2", "conversation_id": "topic_577", "turn_id": 2, "query": "How gamification can enhance engagement and outcomes in such robot-assisted therapy for chronic stroke survivors", "history": ["Role and applications of robot-assisted therapy in chronic stroke survivor rehabilitation"], "ground_truth": ["permed-54854", "permed-54871", "permed-70198", "permed-60043", "permed-61045", "permed-63258", "permed-60125", "permed-73775", "permed-74121", "permed-79469"]}
{"query_id": "topic_577_turn_3", "conversation_id": "topic_577", "turn_id": 3, "query": "Design principles for adaptive gamified robot-assisted therapy tailored to varying impairment levels in chronic stroke survivors for long-term adherence and functional recovery", "history": ["Role and applications of robot-assisted therapy in chronic stroke survivor rehabilitation", "How gamification can enhance engagement and outcomes in such robot-assisted therapy for chronic stroke survivors"], "ground_truth": ["permed-54854", "permed-54871", "permed-70198", "permed-73778", "permed-60043", "permed-73775", "permed-61045", "permed-73777", "permed-54855", "permed-63175"]}
{"query_id": "topic_577_turn_4", "conversation_id": "topic_577", "turn_id": 4, "query": "Regarding these adaptive gamification design principles for varying impairment levels, what specific algorithms or decision rules were implemented to dynamically adjust task difficulty during robot-assisted therapy sessions? Additionally, what validation metrics were used to ensure these adaptive adjustments accurately matched patients' real-time performance capabilities while maintaining therapeutic challenge?", "history": ["Role and applications of robot-assisted therapy in chronic stroke survivor rehabilitation", "How gamification can enhance engagement and outcomes in such robot-assisted therapy for chronic stroke survivors", "Design principles for adaptive gamified robot-assisted therapy tailored to varying impairment levels in chronic stroke survivors for long-term adherence and functional recovery"], "ground_truth": ["permed-54854", "permed-70061", "permed-73778", "permed-71309", "permed-71488", "permed-44153", "permed-74121", "permed-67274", "permed-61046", "permed-54871"]}
{"query_id": "topic_577_turn_5", "conversation_id": "topic_577", "turn_id": 5, "query": "Given the validated adaptive algorithms for dynamic difficulty adjustment in gamified robot-assisted therapy, what clinical trial evidence exists regarding their impact on functional recovery outcomes compared to standard protocols? Specifically, are there studies reporting standardized measures like Fugl-Meyer Assessment or Action Research Arm Test improvements, and what were the observed effect sizes? Additionally, were there any adverse events or unintended consequences related to adaptive challenge modulation in terms of patient frustration or compensatory movements during real-world clinical deployment?", "history": ["Role and applications of robot-assisted therapy in chronic stroke survivor rehabilitation", "How gamification can enhance engagement and outcomes in such robot-assisted therapy for chronic stroke survivors", "Design principles for adaptive gamified robot-assisted therapy tailored to varying impairment levels in chronic stroke survivors for long-term adherence and functional recovery", "Regarding these adaptive gamification design principles for varying impairment levels, what specific algorithms or decision rules were implemented to dynamically adjust task difficulty during robot-assisted therapy sessions? Additionally, what validation metrics were used to ensure these adaptive adjustments accurately matched patients' real-time performance capabilities while maintaining therapeutic challenge?"], "ground_truth": ["permed-54854", "permed-39025", "permed-54871", "permed-71309", "permed-44153", "permed-44267", "permed-63261", "permed-38953", "permed-44227", "permed-44365"]}
{"query_id": "topic_578_turn_1", "conversation_id": "topic_578", "turn_id": 1, "query": "Current approaches for maintaining healthy peri-implant soft tissue", "history": [], "ground_truth": ["permed-60047", "permed-75138", "permed-75141", "permed-40030", "permed-92165", "permed-75213", "permed-75121", "permed-61059", "permed-40034", "permed-75119"]}
{"query_id": "topic_578_turn_2", "conversation_id": "topic_578", "turn_id": 2, "query": "For these peri-implant tissue maintenance approaches, how effective is xenogeneic collagen matrix, especially in patients with a history of peri-implant complications?", "history": ["Current approaches for maintaining healthy peri-implant soft tissue"], "ground_truth": ["permed-75141", "permed-75199", "permed-75208", "permed-75179", "permed-75200", "permed-75242", "permed-75138", "permed-75249", "permed-60047", "permed-75197"]}
{"query_id": "topic_578_turn_3", "conversation_id": "topic_578", "turn_id": 3, "query": "Considering xenogeneic collagen matrix's role for such patients, what are its long-term effects on keratinized mucosa width and vestibular depth, and how do these outcomes influence peri-implant mucositis and peri-implantitis recurrence rates?", "history": ["Current approaches for maintaining healthy peri-implant soft tissue", "For these peri-implant tissue maintenance approaches, how effective is xenogeneic collagen matrix, especially in patients with a history of peri-implant complications?"], "ground_truth": ["permed-75141", "permed-75200", "permed-75197", "permed-75199", "permed-75138", "permed-75179", "permed-75208", "permed-75134", "permed-75242", "permed-60047"]}
{"query_id": "topic_578_turn_4", "conversation_id": "topic_578", "turn_id": 4, "query": "For the long-term outcomes you mentioned - keratinized mucosa width and vestibular depth measurements - what standardized measurement protocols were employed in clinical studies? Specifically, how were these parameters calibrated across multiple examiners, and what statistical methods were used to account for potential measurement variability when analyzing their relationship with mucositis and peri-implantitis recurrence rates? Were any digital imaging or 3D scanning validations incorporated to ensure measurement reproducibility over extended follow-up periods?", "history": ["Current approaches for maintaining healthy peri-implant soft tissue", "For these peri-implant tissue maintenance approaches, how effective is xenogeneic collagen matrix, especially in patients with a history of peri-implant complications?", "Considering xenogeneic collagen matrix's role for such patients, what are its long-term effects on keratinized mucosa width and vestibular depth, and how do these outcomes influence peri-implant mucositis and peri-implantitis recurrence rates?"], "ground_truth": ["permed-75141", "permed-75119", "permed-75138", "permed-75123", "permed-75134", "permed-40332", "permed-40452", "permed-91320", "permed-89922", "permed-51487"]}
{"query_id": "topic_578_turn_5", "conversation_id": "topic_578", "turn_id": 5, "query": "Given the methodological rigor established for measuring tissue parameters, what clinical outcomes have been observed when comparing xenogeneic collagen matrix to autologous free gingival grafts in patients with a history of peri-implantitis? Specifically, how do patient-reported outcomes—such as post-operative pain, healing discomfort, and aesthetic satisfaction—differ between these two approaches in randomized controlled trials? Furthermore, what is the comparative incidence of procedural complications and graft failure, and how do these factors ultimately influence long-term patient adherence to recommended maintenance protocols?", "history": ["Current approaches for maintaining healthy peri-implant soft tissue", "For these peri-implant tissue maintenance approaches, how effective is xenogeneic collagen matrix, especially in patients with a history of peri-implant complications?", "Considering xenogeneic collagen matrix's role for such patients, what are its long-term effects on keratinized mucosa width and vestibular depth, and how do these outcomes influence peri-implant mucositis and peri-implantitis recurrence rates?", "For the long-term outcomes you mentioned - keratinized mucosa width and vestibular depth measurements - what standardized measurement protocols were employed in clinical studies? Specifically, how were these parameters calibrated across multiple examiners, and what statistical methods were used to account for potential measurement variability when analyzing their relationship with mucositis and peri-implantitis recurrence rates? Were any digital imaging or 3D scanning validations incorporated to ensure measurement reproducibility over extended follow-up periods?"], "ground_truth": ["permed-75141", "permed-75200", "permed-75197", "permed-75142", "permed-75179", "permed-75131", "permed-75208", "permed-75150", "permed-75199", "permed-75125"]}
{"query_id": "topic_579_turn_1", "conversation_id": "topic_579", "turn_id": 1, "query": "Overview of Pseudomonas fluorescens resistance mechanisms to common disinfectants", "history": [], "ground_truth": ["permed-77885", "permed-66886", "permed-90851", "permed-72289", "permed-63615", "permed-63610", "permed-76614", "permed-66770", "permed-83310", "permed-63617"]}
{"query_id": "topic_579_turn_2", "conversation_id": "topic_579", "turn_id": 2, "query": "Impact of these Pseudomonas fluorescens resistance mechanisms on sodium chlorite-based oxyhalogen disinfectant efficacy in food processing and industrial environments", "history": ["Overview of Pseudomonas fluorescens resistance mechanisms to common disinfectants"], "ground_truth": ["permed-77885", "permed-90848", "permed-78694", "permed-81214", "permed-90851", "permed-77887", "permed-21801", "permed-66886", "permed-89783", "permed-89801"]}
{"query_id": "topic_579_turn_3", "conversation_id": "topic_579", "turn_id": 3, "query": "Long-term efficacy challenges and mitigation strategies for sodium chlorite disinfectants against stable resistant *Pseudomonas fluorescens* mutants in food and industrial settings", "history": ["Overview of Pseudomonas fluorescens resistance mechanisms to common disinfectants", "Impact of these Pseudomonas fluorescens resistance mechanisms on sodium chlorite-based oxyhalogen disinfectant efficacy in food processing and industrial environments"], "ground_truth": ["permed-77885", "permed-90848", "permed-89801", "permed-78694", "permed-89802", "permed-90851", "permed-6201", "permed-77886", "permed-77887", "permed-21801"]}
{"query_id": "topic_579_turn_4", "conversation_id": "topic_579", "turn_id": 4, "query": "Given these mitigation strategies against resistant mutants, what specific experimental protocols were employed to quantify bacterial persistence under sub-lethal sodium chlorite concentrations? I'm particularly interested in the statistical methods used to validate the minimum inhibitory concentration shifts over serial passages, and how you ensured reproducibility when measuring biofilm disruption efficacy across different industrial surface materials. Could you detail the quality control measures implemented for the ATP-bioluminescence assays used to monitor residual contamination?", "history": ["Overview of Pseudomonas fluorescens resistance mechanisms to common disinfectants", "Impact of these Pseudomonas fluorescens resistance mechanisms on sodium chlorite-based oxyhalogen disinfectant efficacy in food processing and industrial environments", "Long-term efficacy challenges and mitigation strategies for sodium chlorite disinfectants against stable resistant *Pseudomonas fluorescens* mutants in food and industrial settings"], "ground_truth": ["permed-77885", "permed-38656", "permed-89783", "permed-72242", "permed-89801", "permed-21807", "permed-70675", "permed-59237", "permed-40190", "permed-38654"]}
{"query_id": "topic_579_turn_5", "conversation_id": "topic_579", "turn_id": 5, "query": "Given these detailed experimental protocols for quantifying bacterial persistence and biofilm disruption, how have these findings translated to clinical settings where sodium chlorite disinfectants are used for medical device reprocessing? I'm particularly interested in clinical trial outcomes assessing infection rates when reprocessing endoscopes or surgical instruments contaminated with Pseudomonas fluorescens biofilms. What evidence exists regarding patient safety outcomes, including any documented adverse events or healthcare-associated infections linked to disinfection failures despite protocol optimization? Have comparative effectiveness studies measured clinical outcomes against other high-level disinfectants?", "history": ["Overview of Pseudomonas fluorescens resistance mechanisms to common disinfectants", "Impact of these Pseudomonas fluorescens resistance mechanisms on sodium chlorite-based oxyhalogen disinfectant efficacy in food processing and industrial environments", "Long-term efficacy challenges and mitigation strategies for sodium chlorite disinfectants against stable resistant *Pseudomonas fluorescens* mutants in food and industrial settings", "Given these mitigation strategies against resistant mutants, what specific experimental protocols were employed to quantify bacterial persistence under sub-lethal sodium chlorite concentrations? I'm particularly interested in the statistical methods used to validate the minimum inhibitory concentration shifts over serial passages, and how you ensured reproducibility when measuring biofilm disruption efficacy across different industrial surface materials. Could you detail the quality control measures implemented for the ATP-bioluminescence assays used to monitor residual contamination?"], "ground_truth": ["permed-80304", "permed-77885", "permed-59418", "permed-72242", "permed-38656", "permed-6201", "permed-38652", "permed-40190", "permed-0586", "permed-38654"]}
{"query_id": "topic_580_turn_1", "conversation_id": "topic_580", "turn_id": 1, "query": "What advancements have been made in automated assessment of gastric cancer using histological images?", "history": [], "ground_truth": ["permed-56051", "permed-79741", "permed-56239", "permed-48597", "permed-70948", "permed-50712", "permed-61624", "permed-85506", "permed-51959", "permed-35253"]}
{"query_id": "topic_580_turn_2", "conversation_id": "topic_580", "turn_id": 2, "query": "How can techniques like deep learning improve the accuracy of this assessment, particularly in identifying specific tissue layers?", "history": ["What advancements have been made in automated assessment of gastric cancer using histological images?"], "ground_truth": ["permed-79741", "permed-53155", "permed-60506", "permed-78184", "permed-53146", "permed-61137", "permed-78173", "permed-62525", "permed-82667", "permed-16262"]}
{"query_id": "topic_580_turn_3", "conversation_id": "topic_580", "turn_id": 3, "query": "Given these deep learning techniques for improving accuracy in tissue layer identification, how could integrating them with existing histological image labeling and annotation methods enhance the precision and reliability of automated gastric cancer invasion depth assessment? Specifically, what modifications to the current five-class labeling system would better segment tissue layers, particularly for distinguishing between closely related structures like the submucosa and muscularis propria?", "history": ["What advancements have been made in automated assessment of gastric cancer using histological images?", "How can techniques like deep learning improve the accuracy of this assessment, particularly in identifying specific tissue layers?"], "ground_truth": ["permed-79741", "permed-56239", "permed-0261", "permed-56051", "permed-71655", "permed-68007", "permed-60506", "permed-50712", "permed-35253", "permed-35125"]}
{"query_id": "topic_580_turn_4", "conversation_id": "topic_580", "turn_id": 4, "query": "Building on these proposed modifications to the five-class labeling system, what specific data augmentation strategies and loss functions would be most effective for training a segmentation model to distinguish the subtle textural differences between submucosa and muscularis propria? I'm particularly interested in how you would validate the model's performance on ambiguous boundary regions and what statistical measures, beyond standard Dice coefficients, would best quantify its reliability for clinical-grade invasion depth assessment.", "history": ["What advancements have been made in automated assessment of gastric cancer using histological images?", "How can techniques like deep learning improve the accuracy of this assessment, particularly in identifying specific tissue layers?", "Given these deep learning techniques for improving accuracy in tissue layer identification, how could integrating them with existing histological image labeling and annotation methods enhance the precision and reliability of automated gastric cancer invasion depth assessment? Specifically, what modifications to the current five-class labeling system would better segment tissue layers, particularly for distinguishing between closely related structures like the submucosa and muscularis propria?"], "ground_truth": ["permed-79741", "permed-35256", "permed-71653", "permed-78172", "permed-88981", "permed-80758", "permed-18175", "permed-62515", "permed-78175", "permed-0097"]}
{"query_id": "topic_580_turn_5", "conversation_id": "topic_580", "turn_id": 5, "query": "Given your detailed approach to distinguishing submucosa and muscularis propria through specialized data augmentation and validation metrics, how would you comparatively evaluate the performance trade-offs between single-stage versus two-stage segmentation architectures for this specific task? Considering our previous discussions about subtle textural differences and clinical reliability, which architectural approach demonstrates superior boundary precision while maintaining computational efficiency, and what evidence exists in gastric cancer histology literature supporting one approach over the other for invasion depth assessment?", "history": ["What advancements have been made in automated assessment of gastric cancer using histological images?", "How can techniques like deep learning improve the accuracy of this assessment, particularly in identifying specific tissue layers?", "Given these deep learning techniques for improving accuracy in tissue layer identification, how could integrating them with existing histological image labeling and annotation methods enhance the precision and reliability of automated gastric cancer invasion depth assessment? Specifically, what modifications to the current five-class labeling system would better segment tissue layers, particularly for distinguishing between closely related structures like the submucosa and muscularis propria?", "Building on these proposed modifications to the five-class labeling system, what specific data augmentation strategies and loss functions would be most effective for training a segmentation model to distinguish the subtle textural differences between submucosa and muscularis propria? I'm particularly interested in how you would validate the model's performance on ambiguous boundary regions and what statistical measures, beyond standard Dice coefficients, would best quantify its reliability for clinical-grade invasion depth assessment."], "ground_truth": ["permed-79741", "permed-56239", "permed-50712", "permed-35256", "permed-56051", "permed-78172", "permed-60506", "permed-81436", "permed-35253", "permed-17986"]}
{"query_id": "topic_581_turn_1", "conversation_id": "topic_581", "turn_id": 1, "query": "Overview of common orthodontic treatment approaches for pediatric Class III malocclusion", "history": [], "ground_truth": ["permed-51493", "permed-51495", "permed-40360", "permed-39921", "permed-87734", "permed-40361", "permed-65688", "permed-51496", "permed-92440", "permed-74436"]}
{"query_id": "topic_581_turn_2", "conversation_id": "topic_581", "turn_id": 2, "query": "Effectiveness and explored variations of orthopedic facemask therapy for managing this early skeletal malocclusion", "history": ["Overview of common orthodontic treatment approaches for pediatric Class III malocclusion"], "ground_truth": ["permed-51495", "permed-92440", "permed-92165", "permed-51496", "permed-51492", "permed-88765", "permed-51491", "permed-75180", "permed-55176", "permed-40367"]}
{"query_id": "topic_581_turn_3", "conversation_id": "topic_581", "turn_id": 3, "query": "PFFS vs. Petit facemask for early Class III: long-term comparison (dentoskeletal, growth patterns, aesthetics, QoL) and clinical guideline implications", "history": ["Overview of common orthodontic treatment approaches for pediatric Class III malocclusion", "Effectiveness and explored variations of orthopedic facemask therapy for managing this early skeletal malocclusion"], "ground_truth": ["permed-51495", "permed-55176", "permed-68412", "permed-54456", "permed-64741", "permed-77071", "permed-92165", "permed-58851", "permed-62122", "permed-76223"]}
{"query_id": "topic_581_turn_4", "conversation_id": "topic_581", "turn_id": 4, "query": "Regarding this long-term comparison between PFFS and Petit facemask designs, could you detail the specific cephalometric landmarks and analysis protocols used to quantify dentoskeletal changes? I'm particularly interested in how the studies controlled for natural growth variation in their longitudinal data and what statistical methods were employed to distinguish treatment effects from normal developmental patterns across the observed age ranges.", "history": ["Overview of common orthodontic treatment approaches for pediatric Class III malocclusion", "Effectiveness and explored variations of orthopedic facemask therapy for managing this early skeletal malocclusion", "PFFS vs. Petit facemask for early Class III: long-term comparison (dentoskeletal, growth patterns, aesthetics, QoL) and clinical guideline implications"], "ground_truth": ["permed-51495", "permed-75176", "permed-40502", "permed-51491", "permed-40499", "permed-92440", "permed-64741", "permed-65688", "permed-61433", "permed-91149"]}
{"query_id": "topic_581_turn_5", "conversation_id": "topic_581", "turn_id": 5, "query": "Given the detailed cephalometric protocols discussed, how do the dentoskeletal outcomes of these facemask therapies compare when applied to different skeletal subtypes of Class III malocclusion? Specifically, what are the comparative skeletal and dental compensation patterns between PFFS and Petit designs when treating patients with maxillary retrusion versus mandibular prognathism as the primary etiology? Does one design demonstrate superior adaptability or more predictable outcomes across these divergent craniofacial growth patterns in long-term follow-ups?", "history": ["Overview of common orthodontic treatment approaches for pediatric Class III malocclusion", "Effectiveness and explored variations of orthopedic facemask therapy for managing this early skeletal malocclusion", "PFFS vs. Petit facemask for early Class III: long-term comparison (dentoskeletal, growth patterns, aesthetics, QoL) and clinical guideline implications", "Regarding this long-term comparison between PFFS and Petit facemask designs, could you detail the specific cephalometric landmarks and analysis protocols used to quantify dentoskeletal changes? I'm particularly interested in how the studies controlled for natural growth variation in their longitudinal data and what statistical methods were employed to distinguish treatment effects from normal developmental patterns across the observed age ranges."], "ground_truth": ["permed-51495", "permed-51491", "permed-64741", "permed-51493", "permed-92440", "permed-65688", "permed-87734", "permed-65689", "permed-51496", "permed-40502"]}
{"query_id": "topic_582_turn_1", "conversation_id": "topic_582", "turn_id": 1, "query": "Key determinants and metrics of technical efficiency in beef cattle farming systems", "history": [], "ground_truth": ["permed-77745", "permed-77746", "permed-80740", "permed-71921", "permed-82651", "permed-91926", "permed-83328", "permed-57736", "permed-91516", "permed-82357"]}
{"query_id": "topic_582_turn_2", "conversation_id": "topic_582", "turn_id": 2, "query": "Influence of farm specialization and associated management practices on these technical efficiency determinants in beef cattle farming", "history": ["Key determinants and metrics of technical efficiency in beef cattle farming systems"], "ground_truth": ["permed-77745", "permed-77746", "permed-80740", "permed-71921", "permed-57720", "permed-82651", "permed-83328", "permed-77747", "permed-71890", "permed-57809"]}
{"query_id": "topic_582_turn_3", "conversation_id": "topic_582", "turn_id": 3, "query": "Adapting intensive rotational grazing and data-driven health monitoring from specialized beef cattle farms for enhanced technical efficiency in resource-limited agricultural settings: case studies and critical success factors", "history": ["Key determinants and metrics of technical efficiency in beef cattle farming systems", "Influence of farm specialization and associated management practices on these technical efficiency determinants in beef cattle farming"], "ground_truth": ["permed-77746", "permed-77745", "permed-57728", "permed-80740", "permed-71806", "permed-91926", "permed-57720", "permed-71921", "permed-52479", "permed-77748"]}
{"query_id": "topic_582_turn_4", "conversation_id": "topic_582", "turn_id": 4, "query": "Regarding these adapted protocols for resource-limited settings, could you elaborate on the specific data collection methodologies employed in the health monitoring systems? I'm particularly interested in how they validated the diagnostic algorithms used for early disease detection, the statistical methods applied to correlate grazing rotation intervals with productivity metrics, and what quality control measures were implemented to ensure data reliability given potential infrastructure constraints in these agricultural environments.", "history": ["Key determinants and metrics of technical efficiency in beef cattle farming systems", "Influence of farm specialization and associated management practices on these technical efficiency determinants in beef cattle farming", "Adapting intensive rotational grazing and data-driven health monitoring from specialized beef cattle farms for enhanced technical efficiency in resource-limited agricultural settings: case studies and critical success factors"], "ground_truth": ["permed-13388", "permed-57728", "permed-84672", "permed-79518", "permed-81012", "permed-65410", "permed-57804", "permed-77746", "permed-61879", "permed-68406"]}
{"query_id": "topic_582_turn_5", "conversation_id": "topic_582", "turn_id": 5, "query": "Given these validated data collection methodologies for health monitoring in resource-limited beef farming, how have these adapted systems performed in actual clinical applications regarding animal health outcomes? Specifically, what therapeutic efficacy has been demonstrated in reducing disease incidence or severity, and what safety considerations or unintended health consequences have emerged from implementing these monitoring protocols in diverse field conditions? I'm particularly interested in evidence from clinical deployments showing how early detection actually translated to improved treatment outcomes and whether any contraindications emerged when combining data-driven health interventions with existing veterinary practices in these settings.", "history": ["Key determinants and metrics of technical efficiency in beef cattle farming systems", "Influence of farm specialization and associated management practices on these technical efficiency determinants in beef cattle farming", "Adapting intensive rotational grazing and data-driven health monitoring from specialized beef cattle farms for enhanced technical efficiency in resource-limited agricultural settings: case studies and critical success factors", "Regarding these adapted protocols for resource-limited settings, could you elaborate on the specific data collection methodologies employed in the health monitoring systems? I'm particularly interested in how they validated the diagnostic algorithms used for early disease detection, the statistical methods applied to correlate grazing rotation intervals with productivity metrics, and what quality control measures were implemented to ensure data reliability given potential infrastructure constraints in these agricultural environments."], "ground_truth": ["permed-57728", "permed-82999", "permed-71968", "permed-71806", "permed-6187", "permed-59151", "permed-57804", "permed-68406", "permed-70589", "permed-71857"]}
{"query_id": "topic_583_turn_1", "conversation_id": "topic_583", "turn_id": 1, "query": "Primary imaging techniques and their contributions to early-stage prostate cancer detection and staging.", "history": [], "ground_truth": ["permed-85504", "permed-56144", "permed-56151", "permed-56145", "permed-5017", "permed-56142", "permed-51386", "permed-56154", "permed-56146", "permed-87883"]}
{"query_id": "topic_583_turn_2", "conversation_id": "topic_583", "turn_id": 2, "query": "Beyond these primary techniques for prostate cancer, which advanced imaging approaches offer superior accuracy for its rare or atypical presentations?", "history": ["Primary imaging techniques and their contributions to early-stage prostate cancer detection and staging."], "ground_truth": ["permed-28709", "permed-5021", "permed-28152", "permed-17525", "permed-52821", "permed-5017", "permed-87883", "permed-56151", "permed-20616", "permed-56144"]}
{"query_id": "topic_583_turn_3", "conversation_id": "topic_583", "turn_id": 3, "query": "Regarding such rare presentations of prostate adenocarcinoma, like solitary scapular metastasis, what is the impact of 99mTc-MDP SPECT/CT on diagnostic accuracy and personalized treatment strategies?", "history": ["Primary imaging techniques and their contributions to early-stage prostate cancer detection and staging.", "Beyond these primary techniques for prostate cancer, which advanced imaging approaches offer superior accuracy for its rare or atypical presentations?"], "ground_truth": ["permed-77489", "permed-48487", "permed-77449", "permed-77465", "permed-77450", "permed-87883", "permed-29620", "permed-77470", "permed-86439", "permed-29086"]}
{"query_id": "topic_583_turn_4", "conversation_id": "topic_583", "turn_id": 4, "query": "In the context of 99mTc-MDP SPECT/CT for solitary metastases, what specific imaging protocols and interpretation criteria were used to validate diagnostic accuracy? I'm particularly interested in how quantitative parameters like target-to-background ratios were established and whether any standardized response criteria were applied for assessing treatment efficacy following personalized interventions. How was interobserver variability in scan interpretation addressed to ensure reproducibility across different nuclear medicine specialists?", "history": ["Primary imaging techniques and their contributions to early-stage prostate cancer detection and staging.", "Beyond these primary techniques for prostate cancer, which advanced imaging approaches offer superior accuracy for its rare or atypical presentations?", "Regarding such rare presentations of prostate adenocarcinoma, like solitary scapular metastasis, what is the impact of 99mTc-MDP SPECT/CT on diagnostic accuracy and personalized treatment strategies?"], "ground_truth": ["permed-77217", "permed-77449", "permed-48619", "permed-77450", "permed-77489", "permed-42127", "permed-56768", "permed-36976", "permed-29600", "permed-77465"]}
{"query_id": "topic_583_turn_5", "conversation_id": "topic_583", "turn_id": 5, "query": "Given the established protocols for optimizing 99mTc-MDP SPECT/CT interpretation in solitary metastases, how have these imaging findings directly influenced subsequent clinical management decisions and patient outcomes? Specifically, in cases of solitary scapular metastasis from prostate adenocarcinoma, what evidence exists regarding how SPECT/CT results altered surgical planning, radiation field delineation, or systemic therapy choices? Furthermore, were there documented changes in progression-free survival or quality of life metrics when treatment strategies were personalized based on these advanced imaging findings compared to conventional approaches?", "history": ["Primary imaging techniques and their contributions to early-stage prostate cancer detection and staging.", "Beyond these primary techniques for prostate cancer, which advanced imaging approaches offer superior accuracy for its rare or atypical presentations?", "Regarding such rare presentations of prostate adenocarcinoma, like solitary scapular metastasis, what is the impact of 99mTc-MDP SPECT/CT on diagnostic accuracy and personalized treatment strategies?", "In the context of 99mTc-MDP SPECT/CT for solitary metastases, what specific imaging protocols and interpretation criteria were used to validate diagnostic accuracy? I'm particularly interested in how quantitative parameters like target-to-background ratios were established and whether any standardized response criteria were applied for assessing treatment efficacy following personalized interventions. How was interobserver variability in scan interpretation addressed to ensure reproducibility across different nuclear medicine specialists?"], "ground_truth": ["permed-77489", "permed-77465", "permed-77449", "permed-48487", "permed-77450", "permed-48619", "permed-28260", "permed-80552", "permed-41929", "permed-77217"]}
{"query_id": "topic_584_turn_1", "conversation_id": "topic_584", "turn_id": 1, "query": "How does urban expansion affect water resource management in densely populated areas?", "history": [], "ground_truth": ["permed-83790", "permed-82018", "permed-72631", "permed-87940", "permed-89244", "permed-84170", "permed-82013", "permed-85874", "permed-81859", "permed-72682"]}
{"query_id": "topic_584_turn_2", "conversation_id": "topic_584", "turn_id": 2, "query": "What strategies can be applied to mitigate its adverse effects, particularly considering climate change uncertainties in this area?", "history": ["How does urban expansion affect water resource management in densely populated areas?"], "ground_truth": ["permed-75160", "permed-59644", "permed-52052", "permed-55107", "permed-69940", "permed-52064", "permed-62866", "permed-52051", "permed-64249", "permed-69936"]}
{"query_id": "topic_584_turn_3", "conversation_id": "topic_584", "turn_id": 3, "query": "Given these challenges of urban expansion and climate change uncertainties in densely populated areas, how can integrated water resource management (IWRM) strategies be specifically tailored to address catchment runoff impacts while enhancing urban water system resilience? What practical measures would be most effective for ensuring sustainable water supply and flood risk management in regions like Southeast Queensland under varying development and climate scenarios?", "history": ["How does urban expansion affect water resource management in densely populated areas?", "What strategies can be applied to mitigate its adverse effects, particularly considering climate change uncertainties in this area?"], "ground_truth": ["permed-82013", "permed-85524", "permed-82017", "permed-81859", "permed-69938", "permed-67091", "permed-79984", "permed-82015", "permed-82018", "permed-83790"]}
{"query_id": "topic_584_turn_4", "conversation_id": "topic_584", "turn_id": 4, "query": "Regarding these integrated water resource management strategies for catchment runoff and urban resilience, what specific hydrological modeling approaches and coupling frameworks would you recommend for simulating land use change impacts under climate uncertainty? I'm particularly interested in how to technically implement scenario analysis - for instance, should we prioritize dynamic downscaling of regional climate models coupled with distributed hydrological models, and what statistical validation methods ensure these integrated models adequately capture extreme precipitation-runoff relationships in urbanizing catchments?", "history": ["How does urban expansion affect water resource management in densely populated areas?", "What strategies can be applied to mitigate its adverse effects, particularly considering climate change uncertainties in this area?", "Given these challenges of urban expansion and climate change uncertainties in densely populated areas, how can integrated water resource management (IWRM) strategies be specifically tailored to address catchment runoff impacts while enhancing urban water system resilience? What practical measures would be most effective for ensuring sustainable water supply and flood risk management in regions like Southeast Queensland under varying development and climate scenarios?"], "ground_truth": ["permed-82013", "permed-85524", "permed-82015", "permed-82014", "permed-89746", "permed-69938", "permed-83561", "permed-82017", "permed-89748", "permed-82002"]}
{"query_id": "topic_584_turn_5", "conversation_id": "topic_584", "turn_id": 5, "query": "Given these sophisticated hydrological modeling approaches for urban catchment management, how are these technical capabilities being translated into clinical practice for managing waterborne disease risks in vulnerable populations during extreme weather events? With Southeast Queensland's development pressures, what evidence exists about the therapeutic efficacy of early warning systems integrating real-time hydrological data with public health interventions? Are there clinical trial results demonstrating reduced hospitalization rates for waterborne illnesses when these integrated models guide proactive resource allocation in flood-prone urban communities?", "history": ["How does urban expansion affect water resource management in densely populated areas?", "What strategies can be applied to mitigate its adverse effects, particularly considering climate change uncertainties in this area?", "Given these challenges of urban expansion and climate change uncertainties in densely populated areas, how can integrated water resource management (IWRM) strategies be specifically tailored to address catchment runoff impacts while enhancing urban water system resilience? What practical measures would be most effective for ensuring sustainable water supply and flood risk management in regions like Southeast Queensland under varying development and climate scenarios?", "Regarding these integrated water resource management strategies for catchment runoff and urban resilience, what specific hydrological modeling approaches and coupling frameworks would you recommend for simulating land use change impacts under climate uncertainty? I'm particularly interested in how to technically implement scenario analysis - for instance, should we prioritize dynamic downscaling of regional climate models coupled with distributed hydrological models, and what statistical validation methods ensure these integrated models adequately capture extreme precipitation-runoff relationships in urbanizing catchments?"], "ground_truth": ["permed-85524", "permed-72631", "permed-82013", "permed-81983", "permed-53886", "permed-80426", "permed-64250", "permed-67297", "permed-89746", "permed-90131"]}
{"query_id": "topic_585_turn_1", "conversation_id": "topic_585", "turn_id": 1, "query": "Is there a known connection between cellular aging and mental health disorders like bipolar disorder?", "history": [], "ground_truth": ["permed-88975", "permed-77975", "permed-77945", "permed-55843", "permed-5969", "permed-51315", "permed-54249", "permed-65527", "permed-63226", "permed-84534"]}
{"query_id": "topic_585_turn_2", "conversation_id": "topic_585", "turn_id": 2, "query": "Does this link involve specific biological markers, such as leukocyte telomere length, that could be used to understand the relationship better?", "history": ["Is there a known connection between cellular aging and mental health disorders like bipolar disorder?"], "ground_truth": ["permed-62363", "permed-54614", "permed-64972", "permed-64969", "permed-64971", "permed-53641", "permed-64967", "permed-77945", "permed-64976", "permed-72010"]}
{"query_id": "topic_585_turn_3", "conversation_id": "topic_585", "turn_id": 3, "query": "Given that shortened LTL is linked to suicidal ideation in those with familial bipolar disorder, how do genetic markers or environmental factors influence this connection, and what could this mean for developing personalized treatments to reduce suicide risk and slow cellular aging in these individuals?", "history": ["Is there a known connection between cellular aging and mental health disorders like bipolar disorder?", "Does this link involve specific biological markers, such as leukocyte telomere length, that could be used to understand the relationship better?"], "ground_truth": ["permed-77945", "permed-66566", "permed-69629", "permed-81770", "permed-77946", "permed-51315", "permed-83941", "permed-55623", "permed-67682", "permed-73819"]}
{"query_id": "topic_585_turn_4", "conversation_id": "topic_585", "turn_id": 4, "query": "When studying this LTL-suicide risk connection in bipolar disorder, what specific methodological approaches would most effectively distinguish genetic from environmental influences? For instance, would twin studies with telomere length measurements provide sufficient resolution, or would epigenetic clocks like Horvath's DNAmAge offer better mechanistic insights? Also, what statistical models – such as polygenic risk score analyses or gene-environment interaction models – have demonstrated the best predictive validity for identifying high-risk subgroups in clinical populations?", "history": ["Is there a known connection between cellular aging and mental health disorders like bipolar disorder?", "Does this link involve specific biological markers, such as leukocyte telomere length, that could be used to understand the relationship better?", "Given that shortened LTL is linked to suicidal ideation in those with familial bipolar disorder, how do genetic markers or environmental factors influence this connection, and what could this mean for developing personalized treatments to reduce suicide risk and slow cellular aging in these individuals?"], "ground_truth": ["permed-77945", "permed-83941", "permed-66566", "permed-77946", "permed-51315", "permed-81770", "permed-55623", "permed-73630", "permed-69629", "permed-73819"]}
{"query_id": "topic_585_turn_5", "conversation_id": "topic_585", "turn_id": 5, "query": "Given these methodological considerations, how do twin study designs with direct telomere length measurements compare against epigenetic clock approaches in their ability to disentangle genetic from environmental contributions to accelerated cellular aging in bipolar disorder? Specifically, which method demonstrates superior predictive validity for suicide risk stratification when integrated with clinical variables, and what are the relative advantages of each approach in terms of translational potential for developing targeted interventions versus population-level screening programs?", "history": ["Is there a known connection between cellular aging and mental health disorders like bipolar disorder?", "Does this link involve specific biological markers, such as leukocyte telomere length, that could be used to understand the relationship better?", "Given that shortened LTL is linked to suicidal ideation in those with familial bipolar disorder, how do genetic markers or environmental factors influence this connection, and what could this mean for developing personalized treatments to reduce suicide risk and slow cellular aging in these individuals?", "When studying this LTL-suicide risk connection in bipolar disorder, what specific methodological approaches would most effectively distinguish genetic from environmental influences? For instance, would twin studies with telomere length measurements provide sufficient resolution, or would epigenetic clocks like Horvath's DNAmAge offer better mechanistic insights? Also, what statistical models – such as polygenic risk score analyses or gene-environment interaction models – have demonstrated the best predictive validity for identifying high-risk subgroups in clinical populations?"], "ground_truth": ["permed-77945", "permed-73630", "permed-55623", "permed-51315", "permed-66566", "permed-64969", "permed-88975", "permed-64971", "permed-69629", "permed-73819"]}
{"query_id": "topic_586_turn_1", "conversation_id": "topic_586", "turn_id": 1, "query": "What role does hydrogen bonding play in the catalytic mechanism of enzymes like 2,5-dihydroxypyridine dioxygenase?", "history": [], "ground_truth": ["permed-51649", "permed-57991", "permed-51644", "permed-58141", "permed-53086", "permed-67584", "permed-53091", "permed-53087", "permed-87040", "permed-76063"]}
{"query_id": "topic_586_turn_2", "conversation_id": "topic_586", "turn_id": 2, "query": "How do variations in this network around the active site influence the enzyme's efficiency and specificity, particularly in processes involving electron transfer?", "history": ["What role does hydrogen bonding play in the catalytic mechanism of enzymes like 2,5-dihydroxypyridine dioxygenase?"], "ground_truth": ["permed-89824", "permed-58141", "permed-53086", "permed-83856", "permed-83854", "permed-74956", "permed-71557", "permed-74957", "permed-79296", "permed-51644"]}
{"query_id": "topic_586_turn_3", "conversation_id": "topic_586", "turn_id": 3, "query": "How do these variations in the hydrogen bonding network—particularly in NicX and its mutants—affect the enzyme's catalytic efficiency and specificity, especially regarding proton-coupled electron transfer and substrate binding stability?", "history": ["What role does hydrogen bonding play in the catalytic mechanism of enzymes like 2,5-dihydroxypyridine dioxygenase?", "How do variations in this network around the active site influence the enzyme's efficiency and specificity, particularly in processes involving electron transfer?"], "ground_truth": ["permed-51649", "permed-51644", "permed-52616", "permed-53087", "permed-86883", "permed-58145", "permed-51997", "permed-71086", "permed-57991", "permed-87252"]}
{"query_id": "topic_586_turn_4", "conversation_id": "topic_586", "turn_id": 4, "query": "Regarding the NicX mutants you mentioned, what specific experimental techniques were employed to quantify changes in proton-coupled electron transfer efficiency? Were these measurements obtained through stopped-flow spectroscopy with pH-jump methods, or did the characterization rely more on kinetic isotope effects combined with computational simulations? Additionally, how were the hydrogen bonding interactions precisely mapped - through high-resolution crystallography of enzyme-substrate complexes, or via spectroscopic methods like FTIR?", "history": ["What role does hydrogen bonding play in the catalytic mechanism of enzymes like 2,5-dihydroxypyridine dioxygenase?", "How do variations in this network around the active site influence the enzyme's efficiency and specificity, particularly in processes involving electron transfer?", "How do these variations in the hydrogen bonding network—particularly in NicX and its mutants—affect the enzyme's catalytic efficiency and specificity, especially regarding proton-coupled electron transfer and substrate binding stability?"], "ground_truth": ["permed-51649", "permed-75456", "permed-86659", "permed-89824", "permed-90374", "permed-51644", "permed-52421", "permed-75484", "permed-53087", "permed-76343"]}
{"query_id": "topic_586_turn_5", "conversation_id": "topic_586", "turn_id": 5, "query": "Given the detailed mechanistic insights into NicX's catalytic efficiency and proton-coupled electron transfer, what clinical implications arise from these findings? Specifically, how might engineered NicX mutants or related dioxygenase enzymes translate into therapeutic applications for human metabolic disorders involving similar catalytic mechanisms? Furthermore, what are the anticipated challenges in clinical deployment, such as immunogenicity or bioavailability, and are there existing clinical trial data demonstrating the therapeutic efficacy or safety profiles of such enzyme-based treatments in relevant patient populations?", "history": ["What role does hydrogen bonding play in the catalytic mechanism of enzymes like 2,5-dihydroxypyridine dioxygenase?", "How do variations in this network around the active site influence the enzyme's efficiency and specificity, particularly in processes involving electron transfer?", "How do these variations in the hydrogen bonding network—particularly in NicX and its mutants—affect the enzyme's catalytic efficiency and specificity, especially regarding proton-coupled electron transfer and substrate binding stability?", "Regarding the NicX mutants you mentioned, what specific experimental techniques were employed to quantify changes in proton-coupled electron transfer efficiency? Were these measurements obtained through stopped-flow spectroscopy with pH-jump methods, or did the characterization rely more on kinetic isotope effects combined with computational simulations? Additionally, how were the hydrogen bonding interactions precisely mapped - through high-resolution crystallography of enzyme-substrate complexes, or via spectroscopic methods like FTIR?"], "ground_truth": ["permed-51649", "permed-58145", "permed-58029", "permed-53777", "permed-74574", "permed-87252", "permed-84276", "permed-92460", "permed-57987", "permed-74790"]}
{"query_id": "topic_587_turn_1", "conversation_id": "topic_587", "turn_id": 1, "query": "What role can technology play in supporting individuals with mental health disorders?", "history": [], "ground_truth": ["permed-52220", "permed-91301", "permed-78640", "permed-78641", "permed-55780", "permed-61953", "permed-78644", "permed-84511", "permed-87457", "permed-74362"]}
{"query_id": "topic_587_turn_2", "conversation_id": "topic_587", "turn_id": 2, "query": "Can advanced natural language processing techniques enhance this support, particularly for less commonly discussed conditions?", "history": ["What role can technology play in supporting individuals with mental health disorders?"], "ground_truth": ["permed-70065", "permed-89941", "permed-65056", "permed-70952", "permed-88293", "permed-87671", "permed-40955", "permed-53348", "permed-26149", "permed-66148"]}
{"query_id": "topic_587_turn_3", "conversation_id": "topic_587", "turn_id": 3, "query": "How could these advanced NLP techniques be incorporated into current peer-to-peer online platforms to better detect and address nuanced emotional states and specific informational needs, especially for those with less commonly discussed conditions like anxiety or bipolar disorders?", "history": ["What role can technology play in supporting individuals with mental health disorders?", "Can advanced natural language processing techniques enhance this support, particularly for less commonly discussed conditions?"], "ground_truth": ["permed-78640", "permed-55707", "permed-53871", "permed-89941", "permed-69695", "permed-70952", "permed-85501", "permed-70065", "permed-60971", "permed-40955"]}
{"query_id": "topic_587_turn_4", "conversation_id": "topic_587", "turn_id": 4, "query": "Given this proposed integration of advanced NLP into peer-to-peer platforms, what specific experimental designs would best validate the detection accuracy for nuanced emotional states in conditions like bipolar disorder? I'm particularly interested in the methodological approach for establishing ground truth labels for training data and the statistical methods you'd recommend to measure improvements in addressing specific informational needs while controlling for platform variability and user engagement levels.", "history": ["What role can technology play in supporting individuals with mental health disorders?", "Can advanced natural language processing techniques enhance this support, particularly for less commonly discussed conditions?", "How could these advanced NLP techniques be incorporated into current peer-to-peer online platforms to better detect and address nuanced emotional states and specific informational needs, especially for those with less commonly discussed conditions like anxiety or bipolar disorders?"], "ground_truth": ["permed-78640", "permed-70004", "permed-80473", "permed-69653", "permed-89941", "permed-55707", "permed-85656", "permed-85501", "permed-70952", "permed-40774"]}
{"query_id": "topic_587_turn_5", "conversation_id": "topic_587", "turn_id": 5, "query": "Given the experimental validation framework for NLP-based emotional state detection, what clinical trial designs would most effectively evaluate therapeutic outcomes when implementing these systems in real-world mental health platforms? Specifically, how should researchers measure impact on bipolar disorder symptom trajectories, medication adherence, and crisis intervention rates while accounting for confounding variables like concurrent therapies? What safety protocols and ethical considerations are needed when automated systems flag acute emotional states, particularly given risks of false positives/negatives in clinical decision support?", "history": ["What role can technology play in supporting individuals with mental health disorders?", "Can advanced natural language processing techniques enhance this support, particularly for less commonly discussed conditions?", "How could these advanced NLP techniques be incorporated into current peer-to-peer online platforms to better detect and address nuanced emotional states and specific informational needs, especially for those with less commonly discussed conditions like anxiety or bipolar disorders?", "Given this proposed integration of advanced NLP into peer-to-peer platforms, what specific experimental designs would best validate the detection accuracy for nuanced emotional states in conditions like bipolar disorder? I'm particularly interested in the methodological approach for establishing ground truth labels for training data and the statistical methods you'd recommend to measure improvements in addressing specific informational needs while controlling for platform variability and user engagement levels."], "ground_truth": ["permed-80473", "permed-40774", "permed-78641", "permed-63232", "permed-53930", "permed-85713", "permed-85656", "permed-85715", "permed-69470", "permed-70004"]}
{"query_id": "topic_588_turn_1", "conversation_id": "topic_588", "turn_id": 1, "query": "What treatments are currently used to reduce cerebral edema in stroke patients?", "history": [], "ground_truth": ["permed-77398", "permed-57212", "permed-51177", "permed-60515", "permed-54174", "permed-79348", "permed-54173", "permed-61115", "permed-2772", "permed-36900"]}
{"query_id": "topic_588_turn_2", "conversation_id": "topic_588", "turn_id": 2, "query": "How effective is hyperosmolar therapy in this area, particularly for those with large hemispheric infarcts?", "history": ["What treatments are currently used to reduce cerebral edema in stroke patients?"], "ground_truth": ["permed-77398", "permed-83687", "permed-60515", "permed-57212", "permed-89223", "permed-89317", "permed-89219", "permed-63329", "permed-74632", "permed-66096"]}
{"query_id": "topic_588_turn_3", "conversation_id": "topic_588", "turn_id": 3, "query": "How do different dosages and administration protocols of this therapy affect both the reduction of cerebral edema and neurological outcomes in these large hemispheric infarct patients? And what are the long-term impacts on their recovery and quality of life?", "history": ["What treatments are currently used to reduce cerebral edema in stroke patients?", "How effective is hyperosmolar therapy in this area, particularly for those with large hemispheric infarcts?"], "ground_truth": ["permed-77398", "permed-91813", "permed-89219", "permed-60515", "permed-57212", "permed-79348", "permed-57248", "permed-66040", "permed-59769", "permed-77106"]}
{"query_id": "topic_588_turn_4", "conversation_id": "topic_588", "turn_id": 4, "query": "When implementing these dosage and administration protocols, what specific statistical approaches are used to measure their differential effects on cerebral edema reduction versus neurological outcomes? Are you employing multivariate regression to control for infarct volume and timing, and what longitudinal analysis methods best capture the therapy's long-term impact on quality of life metrics while addressing potential confounding by subsequent rehabilitation interventions?", "history": ["What treatments are currently used to reduce cerebral edema in stroke patients?", "How effective is hyperosmolar therapy in this area, particularly for those with large hemispheric infarcts?", "How do different dosages and administration protocols of this therapy affect both the reduction of cerebral edema and neurological outcomes in these large hemispheric infarct patients? And what are the long-term impacts on their recovery and quality of life?"], "ground_truth": ["permed-89219", "permed-63328", "permed-32621", "permed-77106", "permed-57212", "permed-44222", "permed-50334", "permed-77398", "permed-50398", "permed-32626"]}
{"query_id": "topic_588_turn_5", "conversation_id": "topic_588", "turn_id": 5, "query": "Given the complex statistical approaches needed to evaluate hyperosmolar therapy's differential effects, how do the comparative efficacies of mannitol versus hypertonic saline for cerebral edema reduction in large hemispheric infarcts differ when analyzed through these sophisticated models? Specifically, what do multivariate analyses controlling for infarct characteristics reveal about their relative performance on short-term edema reduction versus long-term functional outcomes, and which agent demonstrates superior risk-benefit profiles when confounding factors like renal complications and rebound edema are statistically accounted for?", "history": ["What treatments are currently used to reduce cerebral edema in stroke patients?", "How effective is hyperosmolar therapy in this area, particularly for those with large hemispheric infarcts?", "How do different dosages and administration protocols of this therapy affect both the reduction of cerebral edema and neurological outcomes in these large hemispheric infarct patients? And what are the long-term impacts on their recovery and quality of life?", "When implementing these dosage and administration protocols, what specific statistical approaches are used to measure their differential effects on cerebral edema reduction versus neurological outcomes? Are you employing multivariate regression to control for infarct volume and timing, and what longitudinal analysis methods best capture the therapy's long-term impact on quality of life metrics while addressing potential confounding by subsequent rehabilitation interventions?"], "ground_truth": ["permed-77398", "permed-51189", "permed-84567", "permed-63328", "permed-50157", "permed-83687", "permed-38940", "permed-44030", "permed-47179", "permed-79744"]}
{"query_id": "topic_589_turn_1", "conversation_id": "topic_589", "turn_id": 1, "query": "What are the common cognitive side effects observed in patients after undergoing thalamotomy for tremor disorders?", "history": [], "ground_truth": ["permed-81311", "permed-55507", "permed-68380", "permed-79280", "permed-39764", "permed-76407", "permed-79467", "permed-92154", "permed-79466", "permed-11630"]}
{"query_id": "topic_589_turn_2", "conversation_id": "topic_589", "turn_id": 2, "query": "Are declines in specific cognitive functions, such as fluency, a consistent outcome of this procedure, and if so, what might be contributing to it?", "history": ["What are the common cognitive side effects observed in patients after undergoing thalamotomy for tremor disorders?"], "ground_truth": ["permed-81311", "permed-54995", "permed-83917", "permed-76407", "permed-11630", "permed-52398", "permed-91704", "permed-54986", "permed-72788", "permed-91812"]}
{"query_id": "topic_589_turn_3", "conversation_id": "topic_589", "turn_id": 3, "query": "Given these observed declines in phonemic and semantic fluency after thalamotomy, what specific neural mechanisms or pathways might underlie these changes? And how could understanding these mechanisms help in developing more targeted approaches to minimize cognitive side effects while still effectively treating motor symptoms in tremor disorders?", "history": ["What are the common cognitive side effects observed in patients after undergoing thalamotomy for tremor disorders?", "Are declines in specific cognitive functions, such as fluency, a consistent outcome of this procedure, and if so, what might be contributing to it?"], "ground_truth": ["permed-81311", "permed-79280", "permed-83050", "permed-55507", "permed-29447", "permed-83990", "permed-44236", "permed-44294", "permed-59668", "permed-63150"]}
{"query_id": "topic_589_turn_4", "conversation_id": "topic_589", "turn_id": 4, "query": "When investigating these neural mechanisms underlying fluency declines, what specific experimental protocols would you recommend for mapping connectivity changes in thalamocortical pathways? I'm particularly interested in methodological details - for example, which tractography parameters and diffusion-weighted imaging sequences provide optimal resolution for visualizing projections to prefrontal and language regions? How should one design the statistical comparison of pre- versus post-operative connectomes to reliably detect subtle pathway alterations while controlling for multiple comparisons?", "history": ["What are the common cognitive side effects observed in patients after undergoing thalamotomy for tremor disorders?", "Are declines in specific cognitive functions, such as fluency, a consistent outcome of this procedure, and if so, what might be contributing to it?", "Given these observed declines in phonemic and semantic fluency after thalamotomy, what specific neural mechanisms or pathways might underlie these changes? And how could understanding these mechanisms help in developing more targeted approaches to minimize cognitive side effects while still effectively treating motor symptoms in tremor disorders?"], "ground_truth": ["permed-81311", "permed-29451", "permed-74932", "permed-66364", "permed-29042", "permed-28740", "permed-66369", "permed-75263", "permed-66479", "permed-72002"]}
{"query_id": "topic_589_turn_5", "conversation_id": "topic_589", "turn_id": 5, "query": "Given these methodological approaches for mapping thalamocortical connectivity changes, how have these neural pathway alterations translated to clinically meaningful outcomes in patients? Specifically, what evidence exists from clinical trials or longitudinal studies correlating specific connectivity patterns with the severity of post-thalamotomy fluency deficits? Furthermore, have any therapeutic interventions been developed based on these mechanistic insights that successfully mitigate cognitive side effects while maintaining tremor control, and what are the practical challenges in implementing such interventions in standard clinical practice for movement disorder patients?", "history": ["What are the common cognitive side effects observed in patients after undergoing thalamotomy for tremor disorders?", "Are declines in specific cognitive functions, such as fluency, a consistent outcome of this procedure, and if so, what might be contributing to it?", "Given these observed declines in phonemic and semantic fluency after thalamotomy, what specific neural mechanisms or pathways might underlie these changes? And how could understanding these mechanisms help in developing more targeted approaches to minimize cognitive side effects while still effectively treating motor symptoms in tremor disorders?", "When investigating these neural mechanisms underlying fluency declines, what specific experimental protocols would you recommend for mapping connectivity changes in thalamocortical pathways? I'm particularly interested in methodological details - for example, which tractography parameters and diffusion-weighted imaging sequences provide optimal resolution for visualizing projections to prefrontal and language regions? How should one design the statistical comparison of pre- versus post-operative connectomes to reliably detect subtle pathway alterations while controlling for multiple comparisons?"], "ground_truth": ["permed-81311", "permed-79280", "permed-74932", "permed-55507", "permed-63072", "permed-67661", "permed-72005", "permed-83050", "permed-55740", "permed-72001"]}
{"query_id": "topic_590_turn_1", "conversation_id": "topic_590", "turn_id": 1, "query": "Comprehensive overview of risk factors for retinopathy of prematurity in preterm infants", "history": [], "ground_truth": ["permed-67480", "permed-76514", "permed-53848", "permed-71036", "permed-73821", "permed-78153", "permed-76512", "permed-76513", "permed-71040", "permed-71035"]}
{"query_id": "topic_590_turn_2", "conversation_id": "topic_590", "turn_id": 2, "query": "Investigating the role of platelet dynamics and early postnatal weight gain patterns in the development of this condition", "history": ["Comprehensive overview of risk factors for retinopathy of prematurity in preterm infants"], "ground_truth": ["permed-76512", "permed-72010", "permed-71922", "permed-87828", "permed-58802", "permed-72012", "permed-86564", "permed-57153", "permed-65286", "permed-50028"]}
{"query_id": "topic_590_turn_3", "conversation_id": "topic_590", "turn_id": 3, "query": "Impact of specific postnatal variations in platelet parameters and weight gain trajectories on treatment-requiring ROP, and mechanisms underlying increased TR-ROP risk with platelet transfusions", "history": ["Comprehensive overview of risk factors for retinopathy of prematurity in preterm infants", "Investigating the role of platelet dynamics and early postnatal weight gain patterns in the development of this condition"], "ground_truth": ["permed-76512", "permed-71253", "permed-72540", "permed-6012", "permed-72603", "permed-70381", "permed-49457", "permed-70378", "permed-25172", "permed-90521"]}
{"query_id": "topic_590_turn_4", "conversation_id": "topic_590", "turn_id": 4, "query": "Given this investigation of platelet parameter variations and weight gain trajectories, what specific statistical models did you employ to quantify their joint effects on treatment-requiring ROP? I'm particularly interested in how you handled potential confounding variables like gestational age and birth weight, the validation strategy for your predictive models, and the specific criteria used to define clinically significant thresholds for these dynamic parameters in your cohort analysis.", "history": ["Comprehensive overview of risk factors for retinopathy of prematurity in preterm infants", "Investigating the role of platelet dynamics and early postnatal weight gain patterns in the development of this condition", "Impact of specific postnatal variations in platelet parameters and weight gain trajectories on treatment-requiring ROP, and mechanisms underlying increased TR-ROP risk with platelet transfusions"], "ground_truth": ["permed-76512", "permed-76514", "permed-46073", "permed-6549", "permed-58802", "permed-58812", "permed-80375", "permed-58810", "permed-48337", "permed-45317"]}
{"query_id": "topic_590_turn_5", "conversation_id": "topic_590", "turn_id": 5, "query": "Given these sophisticated statistical models quantifying platelet dynamics and growth trajectories, how have these predictive parameters translated into clinical decision-making for ROP screening? Specifically, what evidence exists regarding implementing such dynamic biomarkers to modify existing screening guidelines - particularly in reducing unnecessary examinations while maintaining sensitivity for treatment-requiring ROP? I'm interested in real-world validation studies assessing whether incorporating these parameters actually improves clinical workflow efficiency and patient outcomes compared to current gestational age-based screening protocols, including any safety considerations regarding missed cases.", "history": ["Comprehensive overview of risk factors for retinopathy of prematurity in preterm infants", "Investigating the role of platelet dynamics and early postnatal weight gain patterns in the development of this condition", "Impact of specific postnatal variations in platelet parameters and weight gain trajectories on treatment-requiring ROP, and mechanisms underlying increased TR-ROP risk with platelet transfusions", "Given this investigation of platelet parameter variations and weight gain trajectories, what specific statistical models did you employ to quantify their joint effects on treatment-requiring ROP? I'm particularly interested in how you handled potential confounding variables like gestational age and birth weight, the validation strategy for your predictive models, and the specific criteria used to define clinically significant thresholds for these dynamic parameters in your cohort analysis."], "ground_truth": ["permed-76513", "permed-76514", "permed-68613", "permed-76512", "permed-15752", "permed-71038", "permed-71253", "permed-41215", "permed-16253", "permed-48231"]}
{"query_id": "topic_591_turn_1", "conversation_id": "topic_591", "turn_id": 1, "query": "Standard treatment modalities for benign superior vena cava syndrome: An overview", "history": [], "ground_truth": ["permed-56265", "permed-57198", "permed-71333", "permed-68788", "permed-80817", "permed-54711", "permed-59910", "permed-75959", "permed-1181", "permed-57599"]}
{"query_id": "topic_591_turn_2", "conversation_id": "topic_591", "turn_id": 2, "query": "For benign superior vena cava syndrome, how does the efficacy of minimally invasive endovascular stenting compare to surgical bypass, considering these common treatment approaches?", "history": ["Standard treatment modalities for benign superior vena cava syndrome: An overview"], "ground_truth": ["permed-57198", "permed-68788", "permed-92652", "permed-81728", "permed-71333", "permed-59710", "permed-56265", "permed-60512", "permed-81724", "permed-50141"]}
{"query_id": "topic_591_turn_3", "conversation_id": "topic_591", "turn_id": 3, "query": "Comparative analysis of long-term outcomes, procedural complication rates, and patient-reported quality of life following endovascular stenting versus surgical bypass for benign superior vena cava syndrome, including decision-making algorithms.", "history": ["Standard treatment modalities for benign superior vena cava syndrome: An overview", "For benign superior vena cava syndrome, how does the efficacy of minimally invasive endovascular stenting compare to surgical bypass, considering these common treatment approaches?"], "ground_truth": ["permed-92652", "permed-56265", "permed-71333", "permed-52598", "permed-50141", "permed-68788", "permed-57198", "permed-81724", "permed-70038", "permed-85511"]}
{"query_id": "topic_591_turn_4", "conversation_id": "topic_591", "turn_id": 4, "query": "Regarding this comparative analysis approach, what specific statistical methods were employed to handle confounding variables between the stenting and surgical groups? Were propensity score matching or multivariate regression techniques used for risk adjustment, and how did the study address potential selection bias in treatment allocation? Additionally, what quality control measures ensured consistent procedural data collection across multiple centers, particularly for documenting technical success and complication grading?", "history": ["Standard treatment modalities for benign superior vena cava syndrome: An overview", "For benign superior vena cava syndrome, how does the efficacy of minimally invasive endovascular stenting compare to surgical bypass, considering these common treatment approaches?", "Comparative analysis of long-term outcomes, procedural complication rates, and patient-reported quality of life following endovascular stenting versus surgical bypass for benign superior vena cava syndrome, including decision-making algorithms."], "ground_truth": ["permed-76322", "permed-50141", "permed-52598", "permed-32963", "permed-52606", "permed-57075", "permed-44918", "permed-80244", "permed-57380", "permed-92652"]}
{"query_id": "topic_591_turn_5", "conversation_id": "topic_591", "turn_id": 5, "query": "Given the rigorous statistical methods and quality control measures described for comparing these interventions, how do these findings translate to real-world clinical decision-making? Specifically, based on the comparative outcomes, what are the current evidence-based recommendations for selecting patients who would derive the greatest benefit from endovascular stenting versus surgical bypass for benign SVC syndrome? Additionally, what contraindications or specific patient comorbidities typically guide clinicians toward one approach over the other in practice, considering both immediate procedural risks and long-term patency concerns?", "history": ["Standard treatment modalities for benign superior vena cava syndrome: An overview", "For benign superior vena cava syndrome, how does the efficacy of minimally invasive endovascular stenting compare to surgical bypass, considering these common treatment approaches?", "Comparative analysis of long-term outcomes, procedural complication rates, and patient-reported quality of life following endovascular stenting versus surgical bypass for benign superior vena cava syndrome, including decision-making algorithms.", "Regarding this comparative analysis approach, what specific statistical methods were employed to handle confounding variables between the stenting and surgical groups? Were propensity score matching or multivariate regression techniques used for risk adjustment, and how did the study address potential selection bias in treatment allocation? Additionally, what quality control measures ensured consistent procedural data collection across multiple centers, particularly for documenting technical success and complication grading?"], "ground_truth": ["permed-57198", "permed-92652", "permed-57219", "permed-57222", "permed-85511", "permed-59710", "permed-76322", "permed-30711", "permed-57217", "permed-66100"]}
{"query_id": "topic_592_turn_1", "conversation_id": "topic_592", "turn_id": 1, "query": "Recent synthetic biology advances in Bacillus subtilis gene expression regulation", "history": [], "ground_truth": ["permed-77012", "permed-77013", "permed-77014", "permed-77016", "permed-82373", "permed-53717", "permed-53719", "permed-89441", "permed-53718", "permed-53723"]}
{"query_id": "topic_592_turn_2", "conversation_id": "topic_592", "turn_id": 2, "query": "Applying these Bacillus subtilis synthetic gene regulation techniques to engineer complex cellular behaviors", "history": ["Recent synthetic biology advances in Bacillus subtilis gene expression regulation"], "ground_truth": ["permed-77013", "permed-77012", "permed-77014", "permed-82373", "permed-77016", "permed-53296", "permed-64162", "permed-60645", "permed-84321", "permed-53723"]}
{"query_id": "topic_592_turn_3", "conversation_id": "topic_592", "turn_id": 3, "query": "Design principles and scalability challenges for Bacillus subtilis synthetic circuits using autoinduction modules for metabolic engineering and biosensing in industrial applications", "history": ["Recent synthetic biology advances in Bacillus subtilis gene expression regulation", "Applying these Bacillus subtilis synthetic gene regulation techniques to engineer complex cellular behaviors"], "ground_truth": ["permed-77012", "permed-53723", "permed-77013", "permed-60645", "permed-77014", "permed-64162", "permed-55475", "permed-75423", "permed-77977", "permed-51791"]}
{"query_id": "topic_592_turn_4", "conversation_id": "topic_592", "turn_id": 4, "query": "When implementing these autoinduction modules for scalable metabolic engineering, what specific experimental approaches were used to characterize the dynamic range and response thresholds? I'm particularly interested in the validation protocols for ensuring circuit robustness across different bioreactor conditions, and whether you employed statistical methods like design of experiments to optimize induction parameters while maintaining reproducibility across industrial-scale fermentations.", "history": ["Recent synthetic biology advances in Bacillus subtilis gene expression regulation", "Applying these Bacillus subtilis synthetic gene regulation techniques to engineer complex cellular behaviors", "Design principles and scalability challenges for Bacillus subtilis synthetic circuits using autoinduction modules for metabolic engineering and biosensing in industrial applications"], "ground_truth": ["permed-77012", "permed-53723", "permed-74889", "permed-64162", "permed-82387", "permed-64261", "permed-66583", "permed-69752", "permed-81812", "permed-84321"]}
{"query_id": "topic_592_turn_5", "conversation_id": "topic_592", "turn_id": 5, "query": "Given the robust characterization of autoinduction modules for industrial applications, what clinical translation pathways exist for Bacillus subtilis synthetic circuits? Specifically, how have therapeutic protein production platforms addressed patient safety considerations like endotoxin clearance, genetic stability during long-term cultivation, and immunogenicity of engineered microbial-derived biologics? Are there documented clinical trial outcomes comparing traditional production systems with Bacillus-based platforms regarding therapeutic efficacy or adverse event profiles in human subjects?", "history": ["Recent synthetic biology advances in Bacillus subtilis gene expression regulation", "Applying these Bacillus subtilis synthetic gene regulation techniques to engineer complex cellular behaviors", "Design principles and scalability challenges for Bacillus subtilis synthetic circuits using autoinduction modules for metabolic engineering and biosensing in industrial applications", "When implementing these autoinduction modules for scalable metabolic engineering, what specific experimental approaches were used to characterize the dynamic range and response thresholds? I'm particularly interested in the validation protocols for ensuring circuit robustness across different bioreactor conditions, and whether you employed statistical methods like design of experiments to optimize induction parameters while maintaining reproducibility across industrial-scale fermentations."], "ground_truth": ["permed-72241", "permed-52210", "permed-55475", "permed-77012", "permed-77978", "permed-63592", "permed-77977", "permed-72172", "permed-64162", "permed-87411"]}
{"query_id": "topic_593_turn_1", "conversation_id": "topic_593", "turn_id": 1, "query": "What role does CCR9 play in immune responses during viral infections, particularly in the brain?", "history": [], "ground_truth": ["permed-80151", "permed-22362", "permed-11706", "permed-68336", "permed-64683", "permed-66057", "permed-92505", "permed-68109", "permed-76988", "permed-74716"]}
{"query_id": "topic_593_turn_2", "conversation_id": "topic_593", "turn_id": 2, "query": "How might manipulating this receptor impact the outcome of congenital CMV infection, especially in neonates?", "history": ["What role does CCR9 play in immune responses during viral infections, particularly in the brain?"], "ground_truth": ["permed-61014", "permed-61013", "permed-80151", "permed-43607", "permed-45990", "permed-81610", "permed-23778", "permed-61016", "permed-49356", "permed-43606"]}
{"query_id": "topic_593_turn_3", "conversation_id": "topic_593", "turn_id": 3, "query": "Given CCR9's critical role in recruiting CD8+ T cells to the brain during congenital CMV infection, how might modulating its expression or function affect the balance between viral control and immunopathology—especially when developing therapeutic strategies to prevent severe neurological complications in neonates? Furthermore, what could be the long-term consequences of altering CCR9-mediated immune responses on brain development and function in infants who survive this infection?", "history": ["What role does CCR9 play in immune responses during viral infections, particularly in the brain?", "How might manipulating this receptor impact the outcome of congenital CMV infection, especially in neonates?"], "ground_truth": ["permed-80151", "permed-61013", "permed-45990", "permed-43607", "permed-23778", "permed-11706", "permed-89761", "permed-68109", "permed-67977", "permed-61017"]}
{"query_id": "topic_593_turn_4", "conversation_id": "topic_593", "turn_id": 4, "query": "Given this proposed CCR9 modulation strategy, what specific experimental models would best recapitulate the neonatal brain environment to study both viral clearance and neurodevelopmental outcomes? Would you recommend using conditional knockout models with temporal control over CCR9 deletion, or perhaps humanized mouse models with fetal/neonatal immune systems? Additionally, what technical approaches - such as multiphoton intravital imaging of the choroid plexus or single-cell RNA sequencing of infiltrating T cells - would provide the most mechanistic insights into how CCR9 manipulation affects the spatial and temporal dynamics of immune cell trafficking?", "history": ["What role does CCR9 play in immune responses during viral infections, particularly in the brain?", "How might manipulating this receptor impact the outcome of congenital CMV infection, especially in neonates?", "Given CCR9's critical role in recruiting CD8+ T cells to the brain during congenital CMV infection, how might modulating its expression or function affect the balance between viral control and immunopathology—especially when developing therapeutic strategies to prevent severe neurological complications in neonates? Furthermore, what could be the long-term consequences of altering CCR9-mediated immune responses on brain development and function in infants who survive this infection?"], "ground_truth": ["permed-80151", "permed-22362", "permed-67764", "permed-11706", "permed-64682", "permed-81501", "permed-84836", "permed-45990", "permed-5582", "permed-90732"]}
{"query_id": "topic_593_turn_5", "conversation_id": "topic_593", "turn_id": 5, "query": "Given the proposed experimental models and technical approaches for studying CCR9 modulation in neonatal CMV infection, how would the mechanistic insights gained from conditional knockout models with temporal CCR9 deletion compare to those from humanized mouse models with fetal/neonatal immune systems in predicting clinical translatability? Specifically, what are the relative advantages and limitations of each model system for evaluating the trade-offs between viral clearance efficiency and neurodevelopmental safety endpoints, particularly when assessing potential age-dependent effects of CCR9-targeted therapies?", "history": ["What role does CCR9 play in immune responses during viral infections, particularly in the brain?", "How might manipulating this receptor impact the outcome of congenital CMV infection, especially in neonates?", "Given CCR9's critical role in recruiting CD8+ T cells to the brain during congenital CMV infection, how might modulating its expression or function affect the balance between viral control and immunopathology—especially when developing therapeutic strategies to prevent severe neurological complications in neonates? Furthermore, what could be the long-term consequences of altering CCR9-mediated immune responses on brain development and function in infants who survive this infection?", "Given this proposed CCR9 modulation strategy, what specific experimental models would best recapitulate the neonatal brain environment to study both viral clearance and neurodevelopmental outcomes? Would you recommend using conditional knockout models with temporal control over CCR9 deletion, or perhaps humanized mouse models with fetal/neonatal immune systems? Additionally, what technical approaches - such as multiphoton intravital imaging of the choroid plexus or single-cell RNA sequencing of infiltrating T cells - would provide the most mechanistic insights into how CCR9 manipulation affects the spatial and temporal dynamics of immune cell trafficking?"], "ground_truth": ["permed-80151", "permed-43607", "permed-61014", "permed-61013", "permed-45990", "permed-62510", "permed-54202", "permed-83181", "permed-61017", "permed-49611"]}
{"query_id": "topic_594_turn_1", "conversation_id": "topic_594", "turn_id": 1, "query": "What are the main challenges in central venous catheter (CVC) placement that can lead to complications?", "history": [], "ground_truth": ["permed-70545", "permed-55153", "permed-12087", "permed-70543", "permed-80816", "permed-90817", "permed-38853", "permed-55152", "permed-55151", "permed-52259"]}
{"query_id": "topic_594_turn_2", "conversation_id": "topic_594", "turn_id": 2, "query": "How can advancements in medical technology, such as imaging and monitoring systems, improve the safety and accuracy of this procedure?", "history": ["What are the main challenges in central venous catheter (CVC) placement that can lead to complications?"], "ground_truth": ["permed-2071", "permed-78724", "permed-69330", "permed-62343", "permed-62563", "permed-71868", "permed-57293", "permed-78563", "permed-56265", "permed-48478"]}
{"query_id": "topic_594_turn_3", "conversation_id": "topic_594", "turn_id": 3, "query": "Given these technological advancements, how exactly can improved imaging and real-time monitoring systems enhance CVC placement accuracy while reducing risks of serious complications like hydrothorax? And what specific training should healthcare providers receive to effectively utilize these technologies?", "history": ["What are the main challenges in central venous catheter (CVC) placement that can lead to complications?", "How can advancements in medical technology, such as imaging and monitoring systems, improve the safety and accuracy of this procedure?"], "ground_truth": ["permed-55153", "permed-55151", "permed-70543", "permed-51388", "permed-78720", "permed-90817", "permed-12087", "permed-55783", "permed-48478", "permed-15669"]}
{"query_id": "topic_594_turn_4", "conversation_id": "topic_594", "turn_id": 4, "query": "When implementing these real-time monitoring systems for CVC placement, what specific validation protocols were used to establish accuracy thresholds for needle tip detection? Additionally, how did researchers determine the optimal data sampling rate and signal processing algorithms to distinguish between vascular and pleural boundaries, and what statistical methods were employed to validate these technical parameters against clinical outcomes in the study population?", "history": ["What are the main challenges in central venous catheter (CVC) placement that can lead to complications?", "How can advancements in medical technology, such as imaging and monitoring systems, improve the safety and accuracy of this procedure?", "Given these technological advancements, how exactly can improved imaging and real-time monitoring systems enhance CVC placement accuracy while reducing risks of serious complications like hydrothorax? And what specific training should healthcare providers receive to effectively utilize these technologies?"], "ground_truth": ["permed-42446", "permed-5872", "permed-45875", "permed-76544", "permed-29321", "permed-56762", "permed-29322", "permed-42238", "permed-61542", "permed-45880"]}
{"query_id": "topic_594_turn_5", "conversation_id": "topic_594", "turn_id": 5, "query": "Given the technical validation protocols and signal processing approaches discussed, how do the complication rates and placement accuracy compare between ultrasound-guided CVC placement versus real-time electromagnetic tracking systems across different patient populations? Specifically, what trade-offs exist between these approaches regarding their sensitivity in detecting near-miss events versus practical implementation challenges in resource-limited settings, and how do their respective learning curves for proceduralists compare based on current meta-analyses?", "history": ["What are the main challenges in central venous catheter (CVC) placement that can lead to complications?", "How can advancements in medical technology, such as imaging and monitoring systems, improve the safety and accuracy of this procedure?", "Given these technological advancements, how exactly can improved imaging and real-time monitoring systems enhance CVC placement accuracy while reducing risks of serious complications like hydrothorax? And what specific training should healthcare providers receive to effectively utilize these technologies?", "When implementing these real-time monitoring systems for CVC placement, what specific validation protocols were used to establish accuracy thresholds for needle tip detection? Additionally, how did researchers determine the optimal data sampling rate and signal processing algorithms to distinguish between vascular and pleural boundaries, and what statistical methods were employed to validate these technical parameters against clinical outcomes in the study population?"], "ground_truth": ["permed-90817", "permed-45880", "permed-78720", "permed-90837", "permed-12099", "permed-57293", "permed-45877", "permed-12093", "permed-45875", "permed-45201"]}
{"query_id": "topic_595_turn_1", "conversation_id": "topic_595", "turn_id": 1, "query": "What challenges exist in achieving diverse participant representation in clinical trials for COVID-19?", "history": [], "ground_truth": ["permed-78461", "permed-52839", "permed-52216", "permed-70501", "permed-70500", "permed-64307", "permed-51909", "permed-91968", "permed-84826", "permed-53992"]}
{"query_id": "topic_595_turn_2", "conversation_id": "topic_595", "turn_id": 2, "query": "Are there specific demographic groups that are particularly underrepresented or overrepresented in these trials, and what factors contribute to this imbalance?", "history": ["What challenges exist in achieving diverse participant representation in clinical trials for COVID-19?"], "ground_truth": ["permed-78461", "permed-52839", "permed-66130", "permed-52838", "permed-53992", "permed-51909", "permed-86634", "permed-87655", "permed-51873", "permed-64307"]}
{"query_id": "topic_595_turn_3", "conversation_id": "topic_595", "turn_id": 3, "query": "Given these patterns of underrepresentation and overrepresentation, what specific barriers hinder adequate participation of female, Black, and Asian populations in COVID-19 prevention trials, and how do these differ from the factors contributing to Hispanic or Latino overrepresentation in treatment trials? Furthermore, what novel community engagement strategies could help address these disparities and promote more equitable participation across all groups in future clinical research?", "history": ["What challenges exist in achieving diverse participant representation in clinical trials for COVID-19?", "Are there specific demographic groups that are particularly underrepresented or overrepresented in these trials, and what factors contribute to this imbalance?"], "ground_truth": ["permed-78461", "permed-55978", "permed-64303", "permed-64307", "permed-52839", "permed-66120", "permed-65795", "permed-78462", "permed-71268", "permed-78392"]}
{"query_id": "topic_595_turn_4", "conversation_id": "topic_595", "turn_id": 4, "query": "Given this comprehensive analysis of barriers and engagement strategies, what specific methodological adaptations should researchers implement in trial protocols to address these disparities? I'm particularly interested in concrete sampling strategies for recruiting underrepresented groups, randomization procedures that ensure equitable allocation across demographic strata, and statistical power calculations that account for subgroup analyses. How should these methodological adjustments be validated to ensure they don't compromise trial integrity while improving representation?", "history": ["What challenges exist in achieving diverse participant representation in clinical trials for COVID-19?", "Are there specific demographic groups that are particularly underrepresented or overrepresented in these trials, and what factors contribute to this imbalance?", "Given these patterns of underrepresentation and overrepresentation, what specific barriers hinder adequate participation of female, Black, and Asian populations in COVID-19 prevention trials, and how do these differ from the factors contributing to Hispanic or Latino overrepresentation in treatment trials? Furthermore, what novel community engagement strategies could help address these disparities and promote more equitable participation across all groups in future clinical research?"], "ground_truth": ["permed-68359", "permed-52216", "permed-52839", "permed-53992", "permed-65795", "permed-78461", "permed-72496", "permed-69887", "permed-77766", "permed-64779"]}
{"query_id": "topic_595_turn_5", "conversation_id": "topic_595", "turn_id": 5, "query": "Given these methodological adaptations for equitable trial design, what clinical outcomes have been observed when implementing such inclusive protocols in actual COVID-19 therapeutic trials? Specifically, how have subgroup analyses from trials with enhanced diverse recruitment impacted our understanding of differential treatment efficacy, safety profiles across demographic groups, and real-world clinical decision-making? Additionally, what evidence exists regarding whether improved representation actually translates to more generalizable treatment guidelines and reduced health disparities in pandemic response, particularly for vulnerable populations identified in previous discussions?", "history": ["What challenges exist in achieving diverse participant representation in clinical trials for COVID-19?", "Are there specific demographic groups that are particularly underrepresented or overrepresented in these trials, and what factors contribute to this imbalance?", "Given these patterns of underrepresentation and overrepresentation, what specific barriers hinder adequate participation of female, Black, and Asian populations in COVID-19 prevention trials, and how do these differ from the factors contributing to Hispanic or Latino overrepresentation in treatment trials? Furthermore, what novel community engagement strategies could help address these disparities and promote more equitable participation across all groups in future clinical research?", "Given this comprehensive analysis of barriers and engagement strategies, what specific methodological adaptations should researchers implement in trial protocols to address these disparities? I'm particularly interested in concrete sampling strategies for recruiting underrepresented groups, randomization procedures that ensure equitable allocation across demographic strata, and statistical power calculations that account for subgroup analyses. How should these methodological adjustments be validated to ensure they don't compromise trial integrity while improving representation?"], "ground_truth": ["permed-78461", "permed-64307", "permed-52216", "permed-52839", "permed-70500", "permed-70501", "permed-55978", "permed-84826", "permed-66120", "permed-51707"]}
{"query_id": "topic_596_turn_1", "conversation_id": "topic_596", "turn_id": 1, "query": "Applications and effectiveness of simulation technology in air traffic controller (ATC) training", "history": [], "ground_truth": ["permed-78719", "permed-67063", "permed-57514", "permed-74160", "permed-56264", "permed-54925", "permed-85430", "permed-1457", "permed-53425", "permed-39774"]}
{"query_id": "topic_596_turn_2", "conversation_id": "topic_596", "turn_id": 2, "query": "Integrating real-time feedback systems into these ATC simulation training programs to enhance trainee skill acquisition and performance", "history": ["Applications and effectiveness of simulation technology in air traffic controller (ATC) training"], "ground_truth": ["permed-78719", "permed-74160", "permed-51582", "permed-57514", "permed-44788", "permed-67063", "permed-85430", "permed-54925", "permed-56264", "permed-90793"]}
{"query_id": "topic_596_turn_3", "conversation_id": "topic_596", "turn_id": 3, "query": "Best practices for optimizing real-time feedback mechanism integration in advanced ATC simulators, and evaluating instructor adaptability's impact on student long-term knowledge retention and application", "history": ["Applications and effectiveness of simulation technology in air traffic controller (ATC) training", "Integrating real-time feedback systems into these ATC simulation training programs to enhance trainee skill acquisition and performance"], "ground_truth": ["permed-78719", "permed-44788", "permed-74160", "permed-69550", "permed-51574", "permed-51582", "permed-51587", "permed-84545", "permed-51586", "permed-90793"]}
{"query_id": "topic_596_turn_4", "conversation_id": "topic_596", "turn_id": 4, "query": "When implementing this approach, what specific validation protocols were used to ensure the real-time feedback mechanisms accurately capture trainee performance metrics? How were these data streams synchronized with instructor interface systems, and what statistical methods proved most effective for analyzing the correlation between feedback timing and long-term knowledge retention? Were there particular quality control measures implemented to maintain consistency across different simulator platforms during the longitudinal evaluation period?", "history": ["Applications and effectiveness of simulation technology in air traffic controller (ATC) training", "Integrating real-time feedback systems into these ATC simulation training programs to enhance trainee skill acquisition and performance", "Best practices for optimizing real-time feedback mechanism integration in advanced ATC simulators, and evaluating instructor adaptability's impact on student long-term knowledge retention and application"], "ground_truth": ["permed-44788", "permed-69550", "permed-51582", "permed-91841", "permed-44789", "permed-1457", "permed-14310", "permed-84377", "permed-39915", "permed-84310"]}
{"query_id": "topic_596_turn_5", "conversation_id": "topic_596", "turn_id": 5, "query": "Given the rigorous validation protocols and data synchronization systems established, what clinical safety outcomes and human performance metrics were observed when deploying these real-time feedback ATC simulators in operational training environments? Specifically, how did the system's therapeutic efficacy translate to reducing trainee error rates in high-stakes scenarios, and were there any documented adverse effects like cognitive overload or skill decay? Furthermore, what evidence emerged regarding the approach's impact on critical patient safety analogs, such as incident prevention and controller resilience during extended duty periods?", "history": ["Applications and effectiveness of simulation technology in air traffic controller (ATC) training", "Integrating real-time feedback systems into these ATC simulation training programs to enhance trainee skill acquisition and performance", "Best practices for optimizing real-time feedback mechanism integration in advanced ATC simulators, and evaluating instructor adaptability's impact on student long-term knowledge retention and application", "When implementing this approach, what specific validation protocols were used to ensure the real-time feedback mechanisms accurately capture trainee performance metrics? How were these data streams synchronized with instructor interface systems, and what statistical methods proved most effective for analyzing the correlation between feedback timing and long-term knowledge retention? Were there particular quality control measures implemented to maintain consistency across different simulator platforms during the longitudinal evaluation period?"], "ground_truth": ["permed-44788", "permed-1457", "permed-51589", "permed-40783", "permed-14310", "permed-23682", "permed-44789", "permed-84547", "permed-78719", "permed-39915"]}
{"query_id": "topic_597_turn_1", "conversation_id": "topic_597", "turn_id": 1, "query": "Impact of corporate social responsibility on organizational goal achievement across diverse industry sectors", "history": [], "ground_truth": ["permed-67403", "permed-66114", "permed-65481", "permed-52065", "permed-58476", "permed-74215", "permed-69462", "permed-69524", "permed-67405", "permed-62747"]}
{"query_id": "topic_597_turn_2", "conversation_id": "topic_597", "turn_id": 2, "query": "Investigating leadership's influence on strategically aligning these CSR initiatives for organizational goal attainment", "history": ["Impact of corporate social responsibility on organizational goal achievement across diverse industry sectors"], "ground_truth": ["permed-67403", "permed-69524", "permed-62747", "permed-74215", "permed-58476", "permed-67405", "permed-69616", "permed-52065", "permed-65483", "permed-66114"]}
{"query_id": "topic_597_turn_3", "conversation_id": "topic_597", "turn_id": 3, "query": "Analyzing the moderating effects of leadership gender and industry sector variations on the strategic alignment of CSR with organizational goals, and its consequential impact on stakeholder engagement and corporate reputation in B2B versus B2C environments", "history": ["Impact of corporate social responsibility on organizational goal achievement across diverse industry sectors", "Investigating leadership's influence on strategically aligning these CSR initiatives for organizational goal attainment"], "ground_truth": ["permed-74215", "permed-67403", "permed-69524", "permed-67405", "permed-62747", "permed-52065", "permed-69616", "permed-66114", "permed-65481", "permed-65483"]}
{"query_id": "topic_597_turn_4", "conversation_id": "topic_597", "turn_id": 4, "query": "When analyzing these moderating effects across B2B and B2C environments, what specific statistical modeling approaches—such as hierarchical linear modeling or moderated mediation analysis—were employed to account for nested data structures across industry sectors? Additionally, how did the methodology ensure measurement invariance when comparing leadership gender effects, and what validation strategies were implemented for the stakeholder engagement metrics across these distinct business contexts?", "history": ["Impact of corporate social responsibility on organizational goal achievement across diverse industry sectors", "Investigating leadership's influence on strategically aligning these CSR initiatives for organizational goal attainment", "Analyzing the moderating effects of leadership gender and industry sector variations on the strategic alignment of CSR with organizational goals, and its consequential impact on stakeholder engagement and corporate reputation in B2B versus B2C environments"], "ground_truth": ["permed-74215", "permed-69658", "permed-69922", "permed-69923", "permed-82787", "permed-65479", "permed-57536", "permed-69510", "permed-65477", "permed-85595"]}
{"query_id": "topic_597_turn_5", "conversation_id": "topic_597", "turn_id": 5, "query": "Given the methodological complexities in analyzing leadership and CSR alignment across business environments, how have these statistical approaches translated into clinical settings? Specifically, when implementing corporate wellness initiatives or hospital CSR programs, what evidence exists regarding their impact on patient outcomes like recovery rates or medication adherence? Are there controlled trials demonstrating whether gender-balanced leadership in healthcare organizations improves program efficacy, and what safety considerations emerge when scaling such initiatives across diverse clinical departments with varying patient populations?", "history": ["Impact of corporate social responsibility on organizational goal achievement across diverse industry sectors", "Investigating leadership's influence on strategically aligning these CSR initiatives for organizational goal attainment", "Analyzing the moderating effects of leadership gender and industry sector variations on the strategic alignment of CSR with organizational goals, and its consequential impact on stakeholder engagement and corporate reputation in B2B versus B2C environments", "When analyzing these moderating effects across B2B and B2C environments, what specific statistical modeling approaches—such as hierarchical linear modeling or moderated mediation analysis—were employed to account for nested data structures across industry sectors? Additionally, how did the methodology ensure measurement invariance when comparing leadership gender effects, and what validation strategies were implemented for the stakeholder engagement metrics across these distinct business contexts?"], "ground_truth": ["permed-74215", "permed-38603", "permed-62747", "permed-64341", "permed-71473", "permed-65484", "permed-65873", "permed-38985", "permed-86840", "permed-65931"]}
{"query_id": "topic_598_turn_1", "conversation_id": "topic_598", "turn_id": 1, "query": "Are there efforts to update anatomical terms to improve their accuracy or sensitivity?", "history": [], "ground_truth": ["permed-81630", "permed-86235", "permed-63458", "permed-47669", "permed-81729", "permed-77615", "permed-83014", "permed-66153", "permed-87671", "permed-90505"]}
{"query_id": "topic_598_turn_2", "conversation_id": "topic_598", "turn_id": 2, "query": "How might changes in this area impact medical education and communication with the public?", "history": ["Are there efforts to update anatomical terms to improve their accuracy or sensitivity?"], "ground_truth": ["permed-90987", "permed-54939", "permed-66148", "permed-65793", "permed-60724", "permed-61465", "permed-80051", "permed-91926", "permed-66153", "permed-69059"]}
{"query_id": "topic_598_turn_3", "conversation_id": "topic_598", "turn_id": 3, "query": "How might specific examples of these terminology updates, like changing \"Schambein\" to \"Schoßbein,\" affect medical education and public health communication—especially in fostering a more positive and respectful view of female anatomy?", "history": ["Are there efforts to update anatomical terms to improve their accuracy or sensitivity?", "How might changes in this area impact medical education and communication with the public?"], "ground_truth": ["permed-81628", "permed-37129", "permed-36615", "permed-45425", "permed-6783", "permed-81630", "permed-71648", "permed-78697", "permed-81606", "permed-18671"]}
{"query_id": "topic_598_turn_4", "conversation_id": "topic_598", "turn_id": 4, "query": "When implementing these terminology updates in educational contexts, what specific methodological approaches have researchers used to assess their impact? I'm particularly interested in the experimental design - do they typically use pre-post testing with control groups, and what validated instruments are employed to measure changes in students' anatomical knowledge retention versus attitudes toward female anatomy? Additionally, how do studies ensure inter-rater reliability when coding qualitative responses about terminology perception in public health communications?", "history": ["Are there efforts to update anatomical terms to improve their accuracy or sensitivity?", "How might changes in this area impact medical education and communication with the public?", "How might specific examples of these terminology updates, like changing \"Schambein\" to \"Schoßbein,\" affect medical education and public health communication—especially in fostering a more positive and respectful view of female anatomy?"], "ground_truth": ["permed-90019", "permed-92252", "permed-84733", "permed-91009", "permed-83019", "permed-62797", "permed-85811", "permed-51561", "permed-51504", "permed-58494"]}
{"query_id": "topic_598_turn_5", "conversation_id": "topic_598", "turn_id": 5, "query": "Given the methodological rigor established in educational impact assessments, how have these terminology updates translated to clinical practice regarding patient-provider communication and health outcomes? Specifically, what evidence exists from clinical trials or observational studies demonstrating whether using updated pelvic anatomy terms (e.g., \"Schoßbein\" vs \"Schambein\") improves patient comprehension of diagnoses, reduces psychological distress during gynecological consultations, or affects adherence to treatment plans? Furthermore, have any studies documented unintended consequences or communication barriers when transitioning terminology in multidisciplinary clinical teams?", "history": ["Are there efforts to update anatomical terms to improve their accuracy or sensitivity?", "How might changes in this area impact medical education and communication with the public?", "How might specific examples of these terminology updates, like changing \"Schambein\" to \"Schoßbein,\" affect medical education and public health communication—especially in fostering a more positive and respectful view of female anatomy?", "When implementing these terminology updates in educational contexts, what specific methodological approaches have researchers used to assess their impact? I'm particularly interested in the experimental design - do they typically use pre-post testing with control groups, and what validated instruments are employed to measure changes in students' anatomical knowledge retention versus attitudes toward female anatomy? Additionally, how do studies ensure inter-rater reliability when coding qualitative responses about terminology perception in public health communications?"], "ground_truth": ["permed-78697", "permed-81784", "permed-81628", "permed-51870", "permed-52841", "permed-78696", "permed-88491", "permed-74570", "permed-48357", "permed-87154"]}
{"query_id": "topic_599_turn_1", "conversation_id": "topic_599", "turn_id": 1, "query": "What is known about the formation of trans fatty acids in edible oils during thermal processing?", "history": [], "ground_truth": ["permed-80893", "permed-80894", "permed-80896", "permed-76104", "permed-74227", "permed-64979", "permed-80897", "permed-91035", "permed-80704", "permed-89076"]}
{"query_id": "topic_599_turn_2", "conversation_id": "topic_599", "turn_id": 2, "query": "Can natural compounds like polyphenols inhibit this process, and if so, how effective are they?", "history": ["What is known about the formation of trans fatty acids in edible oils during thermal processing?"], "ground_truth": ["permed-77070", "permed-68983", "permed-69258", "permed-65070", "permed-72950", "permed-75733", "permed-89208", "permed-62636", "permed-54324", "permed-52504"]}
{"query_id": "topic_599_turn_3", "conversation_id": "topic_599", "turn_id": 3, "query": "Given that trans-resveratrol (trans-Res) inhibits TFA formation in peanut oil through proton transfer isomerism, how might modifying its structure or using other natural polyphenols influence the efficiency and specificity of this inhibition across different edible oils? Also, what synergistic effects could emerge from combining trans-Res with other antioxidants, and how would these combinations affect the kinetic barriers and reaction pathways involved in TFA formation during thermal processing?", "history": ["What is known about the formation of trans fatty acids in edible oils during thermal processing?", "Can natural compounds like polyphenols inhibit this process, and if so, how effective are they?"], "ground_truth": ["permed-80893", "permed-80896", "permed-72831", "permed-80895", "permed-91035", "permed-64533", "permed-73071", "permed-72950", "permed-86164", "permed-80897"]}
{"query_id": "topic_599_turn_4", "conversation_id": "topic_599", "turn_id": 4, "query": "Given this proposed investigation of structural modifications and synergistic combinations, what specific experimental protocols would you recommend for systematically evaluating inhibition efficiency across different oil matrices? I'm particularly interested in how to design the thermal processing simulations to maintain ecological validity while controlling variables, what analytical techniques would best capture real-time TFA formation kinetics, and which statistical models would most effectively differentiate between individual versus combined polyphenol effects on reaction pathway alterations.", "history": ["What is known about the formation of trans fatty acids in edible oils during thermal processing?", "Can natural compounds like polyphenols inhibit this process, and if so, how effective are they?", "Given that trans-resveratrol (trans-Res) inhibits TFA formation in peanut oil through proton transfer isomerism, how might modifying its structure or using other natural polyphenols influence the efficiency and specificity of this inhibition across different edible oils? Also, what synergistic effects could emerge from combining trans-Res with other antioxidants, and how would these combinations affect the kinetic barriers and reaction pathways involved in TFA formation during thermal processing?"], "ground_truth": ["permed-80893", "permed-80895", "permed-80894", "permed-74958", "permed-80896", "permed-79309", "permed-82419", "permed-88473", "permed-72950", "permed-80073"]}
{"query_id": "topic_599_turn_5", "conversation_id": "topic_599", "turn_id": 5, "query": "Given the proposed experimental protocols for evaluating polyphenol efficacy across oil matrices, how would the inhibition efficiencies of structurally modified trans-resveratrol derivatives compare against conventional synthetic antioxidants like TBHQ and BHT when subjected to identical thermal processing conditions? Specifically, what trade-offs emerge between natural polyphenol systems and synthetic alternatives regarding thermal stability, concentration requirements, and potential synergistic benefits with tocopherols, particularly when considering their differential impacts on TFA formation pathways versus overall oxidative stability across various edible oils?", "history": ["What is known about the formation of trans fatty acids in edible oils during thermal processing?", "Can natural compounds like polyphenols inhibit this process, and if so, how effective are they?", "Given that trans-resveratrol (trans-Res) inhibits TFA formation in peanut oil through proton transfer isomerism, how might modifying its structure or using other natural polyphenols influence the efficiency and specificity of this inhibition across different edible oils? Also, what synergistic effects could emerge from combining trans-Res with other antioxidants, and how would these combinations affect the kinetic barriers and reaction pathways involved in TFA formation during thermal processing?", "Given this proposed investigation of structural modifications and synergistic combinations, what specific experimental protocols would you recommend for systematically evaluating inhibition efficiency across different oil matrices? I'm particularly interested in how to design the thermal processing simulations to maintain ecological validity while controlling variables, what analytical techniques would best capture real-time TFA formation kinetics, and which statistical models would most effectively differentiate between individual versus combined polyphenol effects on reaction pathway alterations."], "ground_truth": ["permed-80893", "permed-80896", "permed-80895", "permed-91035", "permed-59493", "permed-65070", "permed-80894", "permed-74459", "permed-86884", "permed-80073"]}
{"query_id": "topic_600_turn_1", "conversation_id": "topic_600", "turn_id": 1, "query": "What role do cell lines play in studying gene editing and toxicology in marine species?", "history": [], "ground_truth": ["permed-82028", "permed-80990", "permed-73496", "permed-80663", "permed-79383", "permed-74710", "permed-82351", "permed-83724", "permed-68025", "permed-82305"]}
{"query_id": "topic_600_turn_2", "conversation_id": "topic_600", "turn_id": 2, "query": "Can established cell lines like the one from Takifugu bimaculatus be used to explore specific genetic mechanisms, such as those involved in toxin production?", "history": ["What role do cell lines play in studying gene editing and toxicology in marine species?"], "ground_truth": ["permed-82028", "permed-73496", "permed-90728", "permed-89305", "permed-82736", "permed-8763", "permed-82305", "permed-22047", "permed-84898", "permed-70736"]}
{"query_id": "topic_600_turn_3", "conversation_id": "topic_600", "turn_id": 3, "query": "Since we've established the TBO cell line's usefulness for gene editing and toxicology research, how could we leverage it to investigate the molecular mechanisms behind PSTBP2's differential expression across ovarian developmental stages? What would these findings reveal about toxin production regulation and its potential effects on reproductive health and marine ecosystem dynamics?", "history": ["What role do cell lines play in studying gene editing and toxicology in marine species?", "Can established cell lines like the one from Takifugu bimaculatus be used to explore specific genetic mechanisms, such as those involved in toxin production?"], "ground_truth": ["permed-82028", "permed-67392", "permed-69225", "permed-80546", "permed-62980", "permed-76122", "permed-80792", "permed-72052", "permed-73496", "permed-79123"]}
{"query_id": "topic_600_turn_4", "conversation_id": "topic_600", "turn_id": 4, "query": "Given this experimental framework for investigating PSTBP2 expression dynamics, what specific gene editing approach would you recommend for validating its functional role? I'm particularly interested in the technical implementation - would CRISPR/Cas9 knockout or siRNA knockdown be more appropriate for stage-specific manipulation in TBO cells, and what validation methods (e.g., qPCR, Western blot, functional toxin assays) would provide the most robust confirmation of both molecular changes and downstream toxicological effects?", "history": ["What role do cell lines play in studying gene editing and toxicology in marine species?", "Can established cell lines like the one from Takifugu bimaculatus be used to explore specific genetic mechanisms, such as those involved in toxin production?", "Since we've established the TBO cell line's usefulness for gene editing and toxicology research, how could we leverage it to investigate the molecular mechanisms behind PSTBP2's differential expression across ovarian developmental stages? What would these findings reveal about toxin production regulation and its potential effects on reproductive health and marine ecosystem dynamics?"], "ground_truth": ["permed-82028", "permed-33887", "permed-52495", "permed-32043", "permed-82347", "permed-13622", "permed-81053", "permed-92545", "permed-22140", "permed-7393"]}
{"query_id": "topic_600_turn_5", "conversation_id": "topic_600", "turn_id": 5, "query": "Given our discussion of targeted gene editing approaches for PSTBP2 validation, how would the relative advantages of CRISPR knockout versus siRNA knockdown compare when specifically addressing stage-specific functional studies in TBO cells? Beyond the immediate molecular validation methods we've discussed, what are the critical trade-offs between these techniques in terms of temporal resolution for studying rapid expression changes during ovarian development, potential off-target effects in marine cell systems, and long-term versus transient manipulation needs for linking gene function to toxin production dynamics?", "history": ["What role do cell lines play in studying gene editing and toxicology in marine species?", "Can established cell lines like the one from Takifugu bimaculatus be used to explore specific genetic mechanisms, such as those involved in toxin production?", "Since we've established the TBO cell line's usefulness for gene editing and toxicology research, how could we leverage it to investigate the molecular mechanisms behind PSTBP2's differential expression across ovarian developmental stages? What would these findings reveal about toxin production regulation and its potential effects on reproductive health and marine ecosystem dynamics?", "Given this experimental framework for investigating PSTBP2 expression dynamics, what specific gene editing approach would you recommend for validating its functional role? I'm particularly interested in the technical implementation - would CRISPR/Cas9 knockout or siRNA knockdown be more appropriate for stage-specific manipulation in TBO cells, and what validation methods (e.g., qPCR, Western blot, functional toxin assays) would provide the most robust confirmation of both molecular changes and downstream toxicological effects?"], "ground_truth": ["permed-82028", "permed-52495", "permed-83928", "permed-71697", "permed-83927", "permed-82088", "permed-89334", "permed-92545", "permed-90482", "permed-83932"]}
{"query_id": "topic_601_turn_1", "conversation_id": "topic_601", "turn_id": 1, "query": "Key strategies and recent technological advancements for enhancing bioavailability of poorly soluble drug formulations", "history": [], "ground_truth": ["permed-60735", "permed-67543", "permed-60672", "permed-60730", "permed-80173", "permed-51253", "permed-59492", "permed-62599", "permed-60711", "permed-81846"]}
{"query_id": "topic_601_turn_2", "conversation_id": "topic_601", "turn_id": 2, "query": "Impact of these bioavailability enhancement strategies on the pharmacokinetic profile and absorption mechanisms of eliapixant", "history": ["Key strategies and recent technological advancements for enhancing bioavailability of poorly soluble drug formulations"], "ground_truth": ["permed-51253", "permed-67543", "permed-55323", "permed-55324", "permed-82651", "permed-78835", "permed-91820", "permed-55330", "permed-55328", "permed-78842"]}
{"query_id": "topic_601_turn_3", "conversation_id": "topic_601", "turn_id": 3, "query": "Mechanisms of eliapixant's enhanced bioavailability, food-effect mitigation, and nonlinear pharmacokinetics: implications for its dosing strategies and future formulation design for similar drugs", "history": ["Key strategies and recent technological advancements for enhancing bioavailability of poorly soluble drug formulations", "Impact of these bioavailability enhancement strategies on the pharmacokinetic profile and absorption mechanisms of eliapixant"], "ground_truth": ["permed-51253", "permed-55323", "permed-67543", "permed-81135", "permed-82651", "permed-81846", "permed-75857", "permed-78842", "permed-52785", "permed-60435"]}
{"query_id": "topic_601_turn_4", "conversation_id": "topic_601", "turn_id": 4, "query": "Given eliapixant's nonlinear pharmacokinetics and food-effect mitigation, what specific in vitro-in vivo correlation (IVIVC) models were employed to validate these absorption mechanisms? Were physiologically-based pharmacokinetic (PBPK) modeling approaches integrated with biorelevant dissolution testing to establish predictive correlations between formulation performance and clinical outcomes, particularly regarding the saturation of absorption pathways and food interactions? Additionally, what statistical methods ensured the robustness of these correlations across different dosing scenarios?", "history": ["Key strategies and recent technological advancements for enhancing bioavailability of poorly soluble drug formulations", "Impact of these bioavailability enhancement strategies on the pharmacokinetic profile and absorption mechanisms of eliapixant", "Mechanisms of eliapixant's enhanced bioavailability, food-effect mitigation, and nonlinear pharmacokinetics: implications for its dosing strategies and future formulation design for similar drugs"], "ground_truth": ["permed-51253", "permed-78840", "permed-60733", "permed-78843", "permed-86114", "permed-75859", "permed-78841", "permed-84714", "permed-60731", "permed-77219"]}
{"query_id": "topic_601_turn_5", "conversation_id": "topic_601", "turn_id": 5, "query": "Given the sophisticated IVIVC and PBPK modeling approaches used to validate eliapixant's absorption mechanisms, how do these predictive computational methods compare to traditional empirical approaches in terms of accurately forecasting food effects and nonlinear pharmacokinetics for BCS Class II drugs? Specifically, what are the relative advantages in prediction accuracy, development timelines, and regulatory acceptance between mechanism-based PBPK models versus conventional level A IVIVC correlations when optimizing formulations for drugs with saturable absorption pathways?", "history": ["Key strategies and recent technological advancements for enhancing bioavailability of poorly soluble drug formulations", "Impact of these bioavailability enhancement strategies on the pharmacokinetic profile and absorption mechanisms of eliapixant", "Mechanisms of eliapixant's enhanced bioavailability, food-effect mitigation, and nonlinear pharmacokinetics: implications for its dosing strategies and future formulation design for similar drugs", "Given eliapixant's nonlinear pharmacokinetics and food-effect mitigation, what specific in vitro-in vivo correlation (IVIVC) models were employed to validate these absorption mechanisms? Were physiologically-based pharmacokinetic (PBPK) modeling approaches integrated with biorelevant dissolution testing to establish predictive correlations between formulation performance and clinical outcomes, particularly regarding the saturation of absorption pathways and food interactions? Additionally, what statistical methods ensured the robustness of these correlations across different dosing scenarios?"], "ground_truth": ["permed-78840", "permed-51253", "permed-78843", "permed-78842", "permed-75859", "permed-78841", "permed-77219", "permed-55334", "permed-74473", "permed-55323"]}
{"query_id": "topic_602_turn_1", "conversation_id": "topic_602", "turn_id": 1, "query": "What are the primary applications of lipidomics in elucidating disease mechanisms and identifying potential biomarkers?", "history": [], "ground_truth": ["permed-76140", "permed-61490", "permed-61982", "permed-74400", "permed-76141", "permed-66180", "permed-73697", "permed-54196", "permed-79012", "permed-67918"]}
{"query_id": "topic_602_turn_2", "conversation_id": "topic_602", "turn_id": 2, "query": "How do advanced analytical techniques, such as mass spectrometry, specifically enhance the accuracy and depth of these lipidomic studies for biomarker validation?", "history": ["What are the primary applications of lipidomics in elucidating disease mechanisms and identifying potential biomarkers?"], "ground_truth": ["permed-76140", "permed-66180", "permed-76141", "permed-80385", "permed-79011", "permed-76142", "permed-79012", "permed-20343", "permed-57935", "permed-74088"]}
{"query_id": "topic_602_turn_3", "conversation_id": "topic_602", "turn_id": 3, "query": "What are the most effective machine learning algorithms for integrating with advanced mass spectrometry data to enhance the precision of lipid profile interpretation in preclinical rodent models, specifically for identifying early-stage disease biomarkers?", "history": ["What are the primary applications of lipidomics in elucidating disease mechanisms and identifying potential biomarkers?", "How do advanced analytical techniques, such as mass spectrometry, specifically enhance the accuracy and depth of these lipidomic studies for biomarker validation?"], "ground_truth": ["permed-76140", "permed-57638", "permed-57150", "permed-28317", "permed-67918", "permed-66180", "permed-81183", "permed-74088", "permed-75954", "permed-61490"]}
{"query_id": "topic_602_turn_4", "conversation_id": "topic_602", "turn_id": 4, "query": "Given the machine learning integration you described, what specific preprocessing protocols and feature selection methods were employed to handle the high-dimensional lipidomic data from rodent models? I'm particularly interested in how these approaches addressed batch effects and technical variability while maintaining biological relevance for early biomarker discovery. Were there specific validation strategies, like cross-validation schemes or independent cohort testing, implemented to assess model robustness?", "history": ["What are the primary applications of lipidomics in elucidating disease mechanisms and identifying potential biomarkers?", "How do advanced analytical techniques, such as mass spectrometry, specifically enhance the accuracy and depth of these lipidomic studies for biomarker validation?", "What are the most effective machine learning algorithms for integrating with advanced mass spectrometry data to enhance the precision of lipid profile interpretation in preclinical rodent models, specifically for identifying early-stage disease biomarkers?"], "ground_truth": ["permed-76140", "permed-69753", "permed-42009", "permed-20343", "permed-86163", "permed-56676", "permed-57150", "permed-76142", "permed-48008", "permed-67219"]}
{"query_id": "topic_602_turn_5", "conversation_id": "topic_602", "turn_id": 5, "query": "Given these robust preprocessing and validation strategies for preclinical lipidomic biomarker discovery, what are the translational challenges and clinical trial evidence for applying these lipid-based biomarkers in human patients? Specifically, how have these biomarkers performed in early-phase clinical trials for disease diagnosis or prognostic stratification, and what are the primary safety considerations or clinical limitations, such as variability in human lipid profiles or interference from common medications, that impact their real-world therapeutic or diagnostic utility?", "history": ["What are the primary applications of lipidomics in elucidating disease mechanisms and identifying potential biomarkers?", "How do advanced analytical techniques, such as mass spectrometry, specifically enhance the accuracy and depth of these lipidomic studies for biomarker validation?", "What are the most effective machine learning algorithms for integrating with advanced mass spectrometry data to enhance the precision of lipid profile interpretation in preclinical rodent models, specifically for identifying early-stage disease biomarkers?", "Given the machine learning integration you described, what specific preprocessing protocols and feature selection methods were employed to handle the high-dimensional lipidomic data from rodent models? I'm particularly interested in how these approaches addressed batch effects and technical variability while maintaining biological relevance for early biomarker discovery. Were there specific validation strategies, like cross-validation schemes or independent cohort testing, implemented to assess model robustness?"], "ground_truth": ["permed-87932", "permed-57944", "permed-58880", "permed-91583", "permed-6240", "permed-74994", "permed-74400", "permed-80217", "permed-4597", "permed-83530"]}
{"query_id": "topic_603_turn_1", "conversation_id": "topic_603", "turn_id": 1, "query": "What is known about the prevalence of anxiety in patients with multiple sclerosis?", "history": [], "ground_truth": ["permed-81308", "permed-69999", "permed-69737", "permed-92097", "permed-92290", "permed-73685", "permed-37554", "permed-78556", "permed-51740", "permed-81505"]}
{"query_id": "topic_603_turn_2", "conversation_id": "topic_603", "turn_id": 2, "query": "How does this anxiety affect their overall quality of life and cognitive function over time?", "history": ["What is known about the prevalence of anxiety in patients with multiple sclerosis?"], "ground_truth": ["permed-60970", "permed-88200", "permed-74747", "permed-91774", "permed-90708", "permed-71706", "permed-72368", "permed-77647", "permed-62310", "permed-55842"]}
{"query_id": "topic_603_turn_3", "conversation_id": "topic_603", "turn_id": 3, "query": "Given what we know about anxiety's impact on quality of life and cognitive function in MS patients, how do clinical and demographic factors—like age, disease duration, and treatment regimens—affect the development and persistence of both state and trait anxiety in these patients? What are the long-term consequences of these anxiety types on cognitive and social functioning? And could interventions focused on depression severity also help manage their anxiety?", "history": ["What is known about the prevalence of anxiety in patients with multiple sclerosis?", "How does this anxiety affect their overall quality of life and cognitive function over time?"], "ground_truth": ["permed-81308", "permed-81310", "permed-82330", "permed-81309", "permed-92097", "permed-7468", "permed-67146", "permed-84648", "permed-90902", "permed-26412"]}
{"query_id": "topic_603_turn_4", "conversation_id": "topic_603", "turn_id": 4, "query": "When investigating how clinical and demographic factors influence anxiety development in MS patients, what specific methodological approaches have proven most effective for distinguishing between state and trait anxiety in longitudinal studies? I'm particularly interested in the psychometric validation of anxiety assessment tools in this population, and how researchers statistically control for confounding variables like depression severity when analyzing anxiety's long-term cognitive and social outcomes. What statistical modeling techniques best account for repeated measures while maintaining clinical interpretability?", "history": ["What is known about the prevalence of anxiety in patients with multiple sclerosis?", "How does this anxiety affect their overall quality of life and cognitive function over time?", "Given what we know about anxiety's impact on quality of life and cognitive function in MS patients, how do clinical and demographic factors—like age, disease duration, and treatment regimens—affect the development and persistence of both state and trait anxiety in these patients? What are the long-term consequences of these anxiety types on cognitive and social functioning? And could interventions focused on depression severity also help manage their anxiety?"], "ground_truth": ["permed-81308", "permed-81310", "permed-81309", "permed-65664", "permed-82750", "permed-65493", "permed-65645", "permed-53130", "permed-7468", "permed-37554"]}
{"query_id": "topic_603_turn_5", "conversation_id": "topic_603", "turn_id": 5, "query": "Given the methodological considerations for distinguishing state and trait anxiety in MS populations, what clinical evidence exists regarding the comparative efficacy of targeted anxiety interventions versus depression-focused treatments in improving cognitive and social outcomes? Specifically, in real-world practice, how do SSRIs, cognitive behavioral therapy, and mindfulness-based interventions compare in their ability to reduce anxiety-specific symptoms while minimizing side effects that might exacerbate MS-related fatigue or cognitive impairment? What clinical trial data inform safety profiles and contraindications for these approaches in patients with progressive versus relapsing-remitting MS?", "history": ["What is known about the prevalence of anxiety in patients with multiple sclerosis?", "How does this anxiety affect their overall quality of life and cognitive function over time?", "Given what we know about anxiety's impact on quality of life and cognitive function in MS patients, how do clinical and demographic factors—like age, disease duration, and treatment regimens—affect the development and persistence of both state and trait anxiety in these patients? What are the long-term consequences of these anxiety types on cognitive and social functioning? And could interventions focused on depression severity also help manage their anxiety?", "When investigating how clinical and demographic factors influence anxiety development in MS patients, what specific methodological approaches have proven most effective for distinguishing between state and trait anxiety in longitudinal studies? I'm particularly interested in the psychometric validation of anxiety assessment tools in this population, and how researchers statistically control for confounding variables like depression severity when analyzing anxiety's long-term cognitive and social outcomes. What statistical modeling techniques best account for repeated measures while maintaining clinical interpretability?"], "ground_truth": ["permed-81308", "permed-40911", "permed-25790", "permed-55756", "permed-81310", "permed-40966", "permed-32923", "permed-55679", "permed-82573", "permed-14751"]}
{"query_id": "topic_604_turn_1", "conversation_id": "topic_604", "turn_id": 1, "query": "Role and impact of graphic medicine in public health communication", "history": [], "ground_truth": ["permed-66153", "permed-74857", "permed-91926", "permed-88327", "permed-74867", "permed-66148", "permed-92165", "permed-70065", "permed-59516", "permed-61465"]}
{"query_id": "topic_604_turn_2", "conversation_id": "topic_604", "turn_id": 2, "query": "Effectiveness of this graphic medicine approach in communicating complex COVID-19 public health information", "history": ["Role and impact of graphic medicine in public health communication"], "ground_truth": ["permed-68512", "permed-59516", "permed-61465", "permed-68513", "permed-66153", "permed-74867", "permed-54939", "permed-65961", "permed-85777", "permed-88327"]}
{"query_id": "topic_604_turn_3", "conversation_id": "topic_604", "turn_id": 3, "query": "Leveraging specific graphic medicine techniques (e.g., visual storytelling, patient narratives) for future public health crisis communication strategy and policy development beyond COVID-19", "history": ["Role and impact of graphic medicine in public health communication", "Effectiveness of this graphic medicine approach in communicating complex COVID-19 public health information"], "ground_truth": ["permed-74867", "permed-68512", "permed-54939", "permed-59516", "permed-61465", "permed-65961", "permed-53019", "permed-67094", "permed-74857", "permed-55849"]}
{"query_id": "topic_604_turn_4", "conversation_id": "topic_604", "turn_id": 4, "query": "When implementing these graphic medicine techniques for future crisis communication, what specific validation protocols would you recommend for assessing their effectiveness across diverse populations? I'm particularly interested in methodological considerations for ensuring cross-cultural validity - would you suggest using standardized instruments like the Message Credibility Scale alongside qualitative feedback, and what statistical approaches would best measure both knowledge retention and behavioral intention changes following exposure to these visual narratives?", "history": ["Role and impact of graphic medicine in public health communication", "Effectiveness of this graphic medicine approach in communicating complex COVID-19 public health information", "Leveraging specific graphic medicine techniques (e.g., visual storytelling, patient narratives) for future public health crisis communication strategy and policy development beyond COVID-19"], "ground_truth": ["permed-65961", "permed-74867", "permed-52384", "permed-65964", "permed-83109", "permed-55849", "permed-58543", "permed-59516", "permed-82909", "permed-82794"]}
{"query_id": "topic_604_turn_5", "conversation_id": "topic_604", "turn_id": 5, "query": "Given these validation protocols for cross-cultural effectiveness, what clinical translation challenges have emerged when implementing graphic medicine interventions in actual healthcare settings? Specifically, how do patient comorbidities, health literacy levels, and socioeconomic barriers affect the therapeutic efficacy of visual narratives in improving medication adherence or chronic disease management? Are there documented cases where graphic medicine tools showed divergent safety profiles or unintended consequences in vulnerable populations, and what clinical parameters should be monitored when deploying these visual aids alongside standard care protocols?", "history": ["Role and impact of graphic medicine in public health communication", "Effectiveness of this graphic medicine approach in communicating complex COVID-19 public health information", "Leveraging specific graphic medicine techniques (e.g., visual storytelling, patient narratives) for future public health crisis communication strategy and policy development beyond COVID-19", "When implementing these graphic medicine techniques for future crisis communication, what specific validation protocols would you recommend for assessing their effectiveness across diverse populations? I'm particularly interested in methodological considerations for ensuring cross-cultural validity - would you suggest using standardized instruments like the Message Credibility Scale alongside qualitative feedback, and what statistical approaches would best measure both knowledge retention and behavioral intention changes following exposure to these visual narratives?"], "ground_truth": ["permed-74867", "permed-82791", "permed-34890", "permed-89012", "permed-34990", "permed-78716", "permed-70312", "permed-86630", "permed-55096", "permed-53976"]}
{"query_id": "topic_605_turn_1", "conversation_id": "topic_605", "turn_id": 1, "query": "What role do validity and assumptions play in the design of clinical research experiments?", "history": [], "ground_truth": ["permed-80121", "permed-23679", "permed-9192", "permed-23354", "permed-22594", "permed-12951", "permed-51745", "permed-52652", "permed-6941", "permed-70838"]}
{"query_id": "topic_605_turn_2", "conversation_id": "topic_605", "turn_id": 2, "query": "How can integrating different types of assumptions into this framework impact the interpretation of results in such studies?", "history": ["What role do validity and assumptions play in the design of clinical research experiments?"], "ground_truth": ["permed-52652", "permed-55479", "permed-77300", "permed-80121", "permed-61461", "permed-66153", "permed-71649", "permed-82651", "permed-20384", "permed-57440"]}
{"query_id": "topic_605_turn_3", "conversation_id": "topic_605", "turn_id": 3, "query": "Given these considerations about validity and different types of assumptions, how might integrating theoretical, auxiliary, statistical, and inferential assumptions into the framework of internal and external validity affect both the design and interpretation of clinical research experiments? And what methodological adjustments would be needed to accommodate this integrated perspective?", "history": ["What role do validity and assumptions play in the design of clinical research experiments?", "How can integrating different types of assumptions into this framework impact the interpretation of results in such studies?"], "ground_truth": ["permed-80121", "permed-23684", "permed-70838", "permed-73843", "permed-52375", "permed-23678", "permed-53879", "permed-9192", "permed-9188", "permed-68462"]}
{"query_id": "topic_605_turn_4", "conversation_id": "topic_605", "turn_id": 4, "query": "Given this integrated framework of validity and assumptions, what specific methodological adjustments would you implement during experimental design to systematically account for auxiliary assumptions? For instance, how might we operationally differentiate between theoretical and auxiliary assumptions in power calculations, and what statistical validation strategies would you recommend to test the robustness of inferences when these assumptions are violated in clinical trial data?", "history": ["What role do validity and assumptions play in the design of clinical research experiments?", "How can integrating different types of assumptions into this framework impact the interpretation of results in such studies?", "Given these considerations about validity and different types of assumptions, how might integrating theoretical, auxiliary, statistical, and inferential assumptions into the framework of internal and external validity affect both the design and interpretation of clinical research experiments? And what methodological adjustments would be needed to accommodate this integrated perspective?"], "ground_truth": ["permed-80121", "permed-84950", "permed-82787", "permed-23684", "permed-53879", "permed-23678", "permed-79010", "permed-37607", "permed-52656", "permed-23679"]}
{"query_id": "topic_605_turn_5", "conversation_id": "topic_605", "turn_id": 5, "query": "Given the methodological adjustments for auxiliary assumptions discussed, how would you comparatively evaluate frequentist versus Bayesian approaches in validating these assumptions during clinical trial design? Specifically, what are the relative advantages and limitations of each framework in handling assumption violations through sensitivity analyses, prior specification, and robustness checks? Considering operational differentiation between theoretical and auxiliary assumptions, which statistical paradigm offers more transparent diagnostic tools for assessing how assumption violations propagate through inferential chains in complex clinical trials?", "history": ["What role do validity and assumptions play in the design of clinical research experiments?", "How can integrating different types of assumptions into this framework impact the interpretation of results in such studies?", "Given these considerations about validity and different types of assumptions, how might integrating theoretical, auxiliary, statistical, and inferential assumptions into the framework of internal and external validity affect both the design and interpretation of clinical research experiments? And what methodological adjustments would be needed to accommodate this integrated perspective?", "Given this integrated framework of validity and assumptions, what specific methodological adjustments would you implement during experimental design to systematically account for auxiliary assumptions? For instance, how might we operationally differentiate between theoretical and auxiliary assumptions in power calculations, and what statistical validation strategies would you recommend to test the robustness of inferences when these assumptions are violated in clinical trial data?"], "ground_truth": ["permed-52656", "permed-51748", "permed-82792", "permed-84948", "permed-66024", "permed-84950", "permed-68462", "permed-79010", "permed-52646", "permed-80121"]}
{"query_id": "topic_606_turn_1", "conversation_id": "topic_606", "turn_id": 1, "query": "Temperature as a key factor shaping marine *Synechococcus* community structure in coastal ecosystems", "history": [], "ground_truth": ["permed-76622", "permed-76624", "permed-59358", "permed-51796", "permed-66955", "permed-76623", "permed-66717", "permed-83707", "permed-60605", "permed-81979"]}
{"query_id": "topic_606_turn_2", "conversation_id": "topic_606", "turn_id": 2, "query": "Impact of such thermal fluctuations on specific *Synechococcus* clade distribution and ecological roles in these coastal environments", "history": ["Temperature as a key factor shaping marine *Synechococcus* community structure in coastal ecosystems"], "ground_truth": ["permed-76622", "permed-76624", "permed-73486", "permed-76625", "permed-76623", "permed-77929", "permed-60604", "permed-81979", "permed-66955", "permed-59358"]}
{"query_id": "topic_606_turn_3", "conversation_id": "topic_606", "turn_id": 3, "query": "Projected effects of sea surface warming on *Synechococcus* clades I and IV: assessing changes in their niche partitioning and biogeochemical impact in coastal marine systems", "history": ["Temperature as a key factor shaping marine *Synechococcus* community structure in coastal ecosystems", "Impact of such thermal fluctuations on specific *Synechococcus* clade distribution and ecological roles in these coastal environments"], "ground_truth": ["permed-76622", "permed-77921", "permed-76624", "permed-76625", "permed-59351", "permed-81979", "permed-76623", "permed-77900", "permed-73486", "permed-59358"]}
{"query_id": "topic_606_turn_4", "conversation_id": "topic_606", "turn_id": 4, "query": "When implementing this niche partitioning assessment, what specific sampling design and frequency would be required to adequately capture thermal adaptation responses between clades I and IV? I'm particularly interested in the statistical approaches for differentiating transient population shifts from stable niche partitioning, and whether you'd recommend using neutral community models or null model analyses to validate these observed distribution patterns against random assembly processes.", "history": ["Temperature as a key factor shaping marine *Synechococcus* community structure in coastal ecosystems", "Impact of such thermal fluctuations on specific *Synechococcus* clade distribution and ecological roles in these coastal environments", "Projected effects of sea surface warming on *Synechococcus* clades I and IV: assessing changes in their niche partitioning and biogeochemical impact in coastal marine systems"], "ground_truth": ["permed-90106", "permed-76622", "permed-60605", "permed-83925", "permed-59350", "permed-59284", "permed-59346", "permed-62963", "permed-59278", "permed-92496"]}
{"query_id": "topic_606_turn_5", "conversation_id": "topic_606", "turn_id": 5, "query": "Given the established sampling frameworks for differentiating niche partitioning in marine Synechococcus, what translational potential exists for applying these microbial ecological principles to clinical microbiome therapeutics? Specifically, how might analogous models predicting thermal adaptation and clade competition inform probiotic consortium design for temperature-sensitive conditions like gut dysbiosis during febrile illnesses? I'm interested in whether ecological null model validation approaches could translate to assessing clinical efficacy against random microbial recolonization patterns in patient populations.", "history": ["Temperature as a key factor shaping marine *Synechococcus* community structure in coastal ecosystems", "Impact of such thermal fluctuations on specific *Synechococcus* clade distribution and ecological roles in these coastal environments", "Projected effects of sea surface warming on *Synechococcus* clades I and IV: assessing changes in their niche partitioning and biogeochemical impact in coastal marine systems", "When implementing this niche partitioning assessment, what specific sampling design and frequency would be required to adequately capture thermal adaptation responses between clades I and IV? I'm particularly interested in the statistical approaches for differentiating transient population shifts from stable niche partitioning, and whether you'd recommend using neutral community models or null model analyses to validate these observed distribution patterns against random assembly processes."], "ground_truth": ["permed-62988", "permed-11781", "permed-60605", "permed-67001", "permed-76622", "permed-58171", "permed-76743", "permed-84820", "permed-58189", "permed-58172"]}
{"query_id": "topic_607_turn_1", "conversation_id": "topic_607", "turn_id": 1, "query": "What role does the micro-nano-hierarchical structure play in enhancing the performance of photoelectrochemical biosensors?", "history": [], "ground_truth": ["permed-64270", "permed-64381", "permed-77428", "permed-78807", "permed-88534", "permed-80648", "permed-64269", "permed-89878", "permed-82861", "permed-73214"]}
{"query_id": "topic_607_turn_2", "conversation_id": "topic_607", "turn_id": 2, "query": "How can optimizing this structure, particularly in materials like Cu<sub>x</sub>O@TiO<sub>2</sub>, impact their overall efficiency and stability?", "history": ["What role does the micro-nano-hierarchical structure play in enhancing the performance of photoelectrochemical biosensors?"], "ground_truth": ["permed-75936", "permed-89877", "permed-82837", "permed-55246", "permed-83407", "permed-77132", "permed-89879", "permed-79778", "permed-74576", "permed-57926"]}
{"query_id": "topic_607_turn_3", "conversation_id": "topic_607", "turn_id": 3, "query": "How does optimizing this micro-nano-hierarchical structure in Cu<sub>x</sub>O@TiO<sub>2</sub> films affect oxygen supply stability and efficiency at the triphase interface, and what would this mean for developing more sensitive and robust photoelectrochemical biosensors in practical applications?", "history": ["What role does the micro-nano-hierarchical structure play in enhancing the performance of photoelectrochemical biosensors?", "How can optimizing this structure, particularly in materials like Cu<sub>x</sub>O@TiO<sub>2</sub>, impact their overall efficiency and stability?"], "ground_truth": ["permed-78807", "permed-55246", "permed-80833", "permed-89878", "permed-57875", "permed-78808", "permed-85159", "permed-55247", "permed-52614", "permed-75592"]}
{"query_id": "topic_607_turn_4", "conversation_id": "topic_607", "turn_id": 4, "query": "Given this focus on oxygen supply stability at the triphase interface, what specific experimental methodologies—such as electrochemical impedance spectroscopy protocols, controlled atmosphere testing chambers, or quantitative oxygen consumption assays—are most critical for quantitatively validating the enhanced oxygen diffusion kinetics you described? How should researchers design these validation experiments to distinguish interfacial mass transport effects from purely charge transfer improvements in the Cu<sub>x</sub>O@TiO<sub>2</sub> system?", "history": ["What role does the micro-nano-hierarchical structure play in enhancing the performance of photoelectrochemical biosensors?", "How can optimizing this structure, particularly in materials like Cu<sub>x</sub>O@TiO<sub>2</sub>, impact their overall efficiency and stability?", "How does optimizing this micro-nano-hierarchical structure in Cu<sub>x</sub>O@TiO<sub>2</sub> films affect oxygen supply stability and efficiency at the triphase interface, and what would this mean for developing more sensitive and robust photoelectrochemical biosensors in practical applications?"], "ground_truth": ["permed-78807", "permed-77116", "permed-53484", "permed-74428", "permed-57875", "permed-77109", "permed-53094", "permed-77033", "permed-57872", "permed-79800"]}
{"query_id": "topic_607_turn_5", "conversation_id": "topic_607", "turn_id": 5, "query": "Given these optimized oxygen diffusion kinetics and validated experimental protocols for Cu<sub>x</sub>O@TiO<sub>2</sub> biosensors, how might these structural improvements translate to clinical diagnostics? Specifically, what clinical performance metrics—such as detection limits for biomarkers like cardiac troponin or viral antigens in patient samples, interference resistance against complex biofluids, or operational stability under repeated testing cycles—demonstrate practical advantages over conventional biosensors? What safety considerations regarding material biocompatibility or potential phototoxicity emerge when considering in vivo diagnostic applications of these enhanced photoelectrochemical systems?", "history": ["What role does the micro-nano-hierarchical structure play in enhancing the performance of photoelectrochemical biosensors?", "How can optimizing this structure, particularly in materials like Cu<sub>x</sub>O@TiO<sub>2</sub>, impact their overall efficiency and stability?", "How does optimizing this micro-nano-hierarchical structure in Cu<sub>x</sub>O@TiO<sub>2</sub> films affect oxygen supply stability and efficiency at the triphase interface, and what would this mean for developing more sensitive and robust photoelectrochemical biosensors in practical applications?", "Given this focus on oxygen supply stability at the triphase interface, what specific experimental methodologies—such as electrochemical impedance spectroscopy protocols, controlled atmosphere testing chambers, or quantitative oxygen consumption assays—are most critical for quantitatively validating the enhanced oxygen diffusion kinetics you described? How should researchers design these validation experiments to distinguish interfacial mass transport effects from purely charge transfer improvements in the Cu<sub>x</sub>O@TiO<sub>2</sub> system?"], "ground_truth": ["permed-78807", "permed-78808", "permed-73211", "permed-77425", "permed-80833", "permed-85159", "permed-52614", "permed-73214", "permed-74369", "permed-77428"]}
{"query_id": "topic_608_turn_1", "conversation_id": "topic_608", "turn_id": 1, "query": "Immunoprotection strategies for stem cell-derived beta cells in type 1 diabetes", "history": [], "ground_truth": ["permed-59112", "permed-68183", "permed-76179", "permed-76180", "permed-51196", "permed-72016", "permed-23187", "permed-8923", "permed-73144", "permed-59036"]}
{"query_id": "topic_608_turn_2", "conversation_id": "topic_608", "turn_id": 2, "query": "Genetic engineering of these cells for enhanced immune evasion in type 1 diabetes mouse models", "history": ["Immunoprotection strategies for stem cell-derived beta cells in type 1 diabetes"], "ground_truth": ["permed-76179", "permed-59112", "permed-68183", "permed-61255", "permed-76180", "permed-72017", "permed-51196", "permed-57227", "permed-38788", "permed-53717"]}
{"query_id": "topic_608_turn_3", "conversation_id": "topic_608", "turn_id": 3, "query": "Specific gene edits in such genetically modified beta cells for T1D: evaluating autoimmune protection, long-term function, and viability via in vivo bioluminescent imaging", "history": ["Immunoprotection strategies for stem cell-derived beta cells in type 1 diabetes", "Genetic engineering of these cells for enhanced immune evasion in type 1 diabetes mouse models"], "ground_truth": ["permed-76179", "permed-51196", "permed-68183", "permed-59112", "permed-59036", "permed-73144", "permed-76180", "permed-80285", "permed-59041", "permed-53717"]}
{"query_id": "topic_608_turn_4", "conversation_id": "topic_608", "turn_id": 4, "query": "Regarding the bioluminescent imaging approach used to evaluate these genetically modified beta cells, could you detail the specific imaging parameters and quantification methods employed? I'm particularly interested in how you established baseline signals, accounted for potential tissue attenuation effects, and validated that the bioluminescence measurements correlated with actual cell viability and functional mass over the longitudinal study period. What statistical methods were used to analyze the temporal changes in bioluminescent signal?", "history": ["Immunoprotection strategies for stem cell-derived beta cells in type 1 diabetes", "Genetic engineering of these cells for enhanced immune evasion in type 1 diabetes mouse models", "Specific gene edits in such genetically modified beta cells for T1D: evaluating autoimmune protection, long-term function, and viability via in vivo bioluminescent imaging"], "ground_truth": ["permed-76179", "permed-59036", "permed-41860", "permed-73143", "permed-61705", "permed-53513", "permed-76148", "permed-63389", "permed-58753", "permed-88987"]}
{"query_id": "topic_608_turn_5", "conversation_id": "topic_608", "turn_id": 5, "query": "Given the longitudinal bioluminescence data demonstrating sustained viability of these genetically edited beta cells, what clinical translation challenges remain regarding their therapeutic efficacy in human type 1 diabetes patients? Specifically, based on these preclinical findings, what human safety profiles and potential off-target effects should initial clinical trials prioritize monitoring? How do these edited cells compare to existing beta cell replacement therapies in terms of projected durability and need for concurrent immunosuppression? What patient selection criteria would be most appropriate for first-in-human trials given the immune evasion properties demonstrated in mouse models?", "history": ["Immunoprotection strategies for stem cell-derived beta cells in type 1 diabetes", "Genetic engineering of these cells for enhanced immune evasion in type 1 diabetes mouse models", "Specific gene edits in such genetically modified beta cells for T1D: evaluating autoimmune protection, long-term function, and viability via in vivo bioluminescent imaging", "Regarding the bioluminescent imaging approach used to evaluate these genetically modified beta cells, could you detail the specific imaging parameters and quantification methods employed? I'm particularly interested in how you established baseline signals, accounted for potential tissue attenuation effects, and validated that the bioluminescence measurements correlated with actual cell viability and functional mass over the longitudinal study period. What statistical methods were used to analyze the temporal changes in bioluminescent signal?"], "ground_truth": ["permed-76179", "permed-51196", "permed-72016", "permed-59112", "permed-80285", "permed-8923", "permed-47255", "permed-47256", "permed-54202", "permed-68183"]}
{"query_id": "topic_609_turn_1", "conversation_id": "topic_609", "turn_id": 1, "query": "Comprehensive overview of current surgical procedures for Achilles insertional calcific tendinosis", "history": [], "ground_truth": ["permed-77598", "permed-57596", "permed-80967", "permed-75258", "permed-80377", "permed-52036", "permed-77603", "permed-88747", "permed-91629", "permed-66347"]}
{"query_id": "topic_609_turn_2", "conversation_id": "topic_609", "turn_id": 2, "query": "Assessing effectiveness of these surgical procedures for Achilles insertional calcific tendinosis: focus on patient-reported outcomes (e.g., MOXFQ) and common complications.", "history": ["Comprehensive overview of current surgical procedures for Achilles insertional calcific tendinosis"], "ground_truth": ["permed-77598", "permed-57596", "permed-75258", "permed-80377", "permed-80967", "permed-91629", "permed-77601", "permed-77604", "permed-80971", "permed-54516"]}
{"query_id": "topic_609_turn_3", "conversation_id": "topic_609", "turn_id": 3, "query": "Advanced strategies for Achilles insertional calcific tendinosis surgery: refining patient selection (calcification severity, dorsal spur, individual risks) to improve MOXFQ scores, perioperative management of delayed wound healing and sensory disturbances, and comparative long-term efficacy versus non-surgical treatments.", "history": ["Comprehensive overview of current surgical procedures for Achilles insertional calcific tendinosis", "Assessing effectiveness of these surgical procedures for Achilles insertional calcific tendinosis: focus on patient-reported outcomes (e.g., MOXFQ) and common complications."], "ground_truth": ["permed-77598", "permed-57596", "permed-75258", "permed-80377", "permed-91629", "permed-77603", "permed-80967", "permed-54516", "permed-88747", "permed-36807"]}
{"query_id": "topic_609_turn_4", "conversation_id": "topic_609", "turn_id": 4, "query": "Given these refined surgical strategies, what specific intraoperative protocols and postoperative rehabilitation parameters are being implemented to minimize complications like delayed wound healing and sensory disturbances? How are surgeons quantitatively monitoring tissue response during healing - are they using standardized wound assessment scales, serial ultrasound measurements of tendon vascularity, or patient-documented sensory mapping? Additionally, what statistical methods are being employed to correlate these objective healing metrics with long-term MOXFQ score improvements across different patient selection criteria?", "history": ["Comprehensive overview of current surgical procedures for Achilles insertional calcific tendinosis", "Assessing effectiveness of these surgical procedures for Achilles insertional calcific tendinosis: focus on patient-reported outcomes (e.g., MOXFQ) and common complications.", "Advanced strategies for Achilles insertional calcific tendinosis surgery: refining patient selection (calcification severity, dorsal spur, individual risks) to improve MOXFQ scores, perioperative management of delayed wound healing and sensory disturbances, and comparative long-term efficacy versus non-surgical treatments."], "ground_truth": ["permed-91323", "permed-86991", "permed-49741", "permed-75331", "permed-66339", "permed-79719", "permed-64562", "permed-69331", "permed-38878", "permed-86988"]}
{"query_id": "topic_609_turn_5", "conversation_id": "topic_609", "turn_id": 5, "query": "Given the established intraoperative protocols and quantitative monitoring of tissue healing, what clinical evidence exists regarding the comparative therapeutic efficacy of these optimized surgical approaches versus advanced non-surgical interventions (such as image-guided percutaneous needle tenotomy or high-volume image-guided injections) for patients with moderate to severe Achilles insertional calcific tendinosis? Specifically, what do randomized controlled trials or large cohort studies reveal about their relative impact on long-term MOXFQ scores, return-to-activity rates, and the incidence of major complications like tendon rupture or deep infection when implemented in real-world clinical practice?", "history": ["Comprehensive overview of current surgical procedures for Achilles insertional calcific tendinosis", "Assessing effectiveness of these surgical procedures for Achilles insertional calcific tendinosis: focus on patient-reported outcomes (e.g., MOXFQ) and common complications.", "Advanced strategies for Achilles insertional calcific tendinosis surgery: refining patient selection (calcification severity, dorsal spur, individual risks) to improve MOXFQ scores, perioperative management of delayed wound healing and sensory disturbances, and comparative long-term efficacy versus non-surgical treatments.", "Given these refined surgical strategies, what specific intraoperative protocols and postoperative rehabilitation parameters are being implemented to minimize complications like delayed wound healing and sensory disturbances? How are surgeons quantitatively monitoring tissue response during healing - are they using standardized wound assessment scales, serial ultrasound measurements of tendon vascularity, or patient-documented sensory mapping? Additionally, what statistical methods are being employed to correlate these objective healing metrics with long-term MOXFQ score improvements across different patient selection criteria?"], "ground_truth": ["permed-77598", "permed-80377", "permed-75258", "permed-91629", "permed-57596", "permed-77599", "permed-19179", "permed-15079", "permed-72815", "permed-54516"]}
{"query_id": "topic_610_turn_1", "conversation_id": "topic_610", "turn_id": 1, "query": "What role do bimetallic materials play in enhancing electrochemical performance in energy storage and conversion systems?", "history": [], "ground_truth": ["permed-52103", "permed-78825", "permed-51993", "permed-51017", "permed-82874", "permed-74849", "permed-64381", "permed-76071", "permed-50819", "permed-82832"]}
{"query_id": "topic_610_turn_2", "conversation_id": "topic_610", "turn_id": 2, "query": "Can modifying these materials through techniques like hydrothermal sulfur etching further improve their performance in applications such as supercapacitors?", "history": ["What role do bimetallic materials play in enhancing electrochemical performance in energy storage and conversion systems?"], "ground_truth": ["permed-51993", "permed-83732", "permed-74850", "permed-87206", "permed-83734", "permed-78277", "permed-78281", "permed-50831", "permed-74425", "permed-64640"]}
{"query_id": "topic_610_turn_3", "conversation_id": "topic_610", "turn_id": 3, "query": "Given that hydrothermal sulfur etching can modify these bimetallic materials for improved performance, how can we optimize both their structural and compositional changes to further boost their electrochemical capabilities in supercapacitors and catalytic reactions? And what would these optimizations mean for scaling up and commercializing such materials in practical energy storage and conversion systems?", "history": ["What role do bimetallic materials play in enhancing electrochemical performance in energy storage and conversion systems?", "Can modifying these materials through techniques like hydrothermal sulfur etching further improve their performance in applications such as supercapacitors?"], "ground_truth": ["permed-51993", "permed-50819", "permed-52415", "permed-50821", "permed-82834", "permed-89132", "permed-78825", "permed-74849", "permed-83732", "permed-51998"]}
{"query_id": "topic_610_turn_4", "conversation_id": "topic_610", "turn_id": 4, "query": "Building on these structural and compositional optimization strategies, could you elaborate on the specific characterization techniques and electrochemical testing protocols used to quantify the performance improvements? I'm particularly interested in how researchers establish correlations between material properties (like surface area or electronic structure changes from sulfur etching) and functional metrics (specific capacitance, charge transfer resistance). What statistical validation approaches ensure these observed enhancements are reproducible across different synthesis batches?", "history": ["What role do bimetallic materials play in enhancing electrochemical performance in energy storage and conversion systems?", "Can modifying these materials through techniques like hydrothermal sulfur etching further improve their performance in applications such as supercapacitors?", "Given that hydrothermal sulfur etching can modify these bimetallic materials for improved performance, how can we optimize both their structural and compositional changes to further boost their electrochemical capabilities in supercapacitors and catalytic reactions? And what would these optimizations mean for scaling up and commercializing such materials in practical energy storage and conversion systems?"], "ground_truth": ["permed-51993", "permed-60324", "permed-50818", "permed-50831", "permed-84018", "permed-50825", "permed-50821", "permed-50828", "permed-50830", "permed-51998"]}
{"query_id": "topic_610_turn_5", "conversation_id": "topic_610", "turn_id": 5, "query": "Given these comprehensive material characterizations and performance validations, what clinical translation pathways exist for bimetallic materials with sulfur-etched surfaces in implantable energy storage devices? Specifically, how do researchers address biostability and cytotoxicity concerns when transitioning from laboratory supercapacitors to medical applications like powering neural implants or biosensors? What preclinical safety assessments—including inflammatory response evaluations and long-term degradation studies—are required before considering human trials, and are there documented cases where similar material modifications have successfully navigated regulatory approval processes?", "history": ["What role do bimetallic materials play in enhancing electrochemical performance in energy storage and conversion systems?", "Can modifying these materials through techniques like hydrothermal sulfur etching further improve their performance in applications such as supercapacitors?", "Given that hydrothermal sulfur etching can modify these bimetallic materials for improved performance, how can we optimize both their structural and compositional changes to further boost their electrochemical capabilities in supercapacitors and catalytic reactions? And what would these optimizations mean for scaling up and commercializing such materials in practical energy storage and conversion systems?", "Building on these structural and compositional optimization strategies, could you elaborate on the specific characterization techniques and electrochemical testing protocols used to quantify the performance improvements? I'm particularly interested in how researchers establish correlations between material properties (like surface area or electronic structure changes from sulfur etching) and functional metrics (specific capacitance, charge transfer resistance). What statistical validation approaches ensure these observed enhancements are reproducible across different synthesis batches?"], "ground_truth": ["permed-51993", "permed-82834", "permed-78825", "permed-50819", "permed-50828", "permed-74849", "permed-51998", "permed-50821", "permed-82697", "permed-81236"]}
{"query_id": "topic_611_turn_1", "conversation_id": "topic_611", "turn_id": 1, "query": "What advancements are being made in microfluidic platforms for bioparticle detection?", "history": [], "ground_truth": ["permed-59232", "permed-59240", "permed-58255", "permed-59231", "permed-59234", "permed-80839", "permed-83953", "permed-64711", "permed-55183", "permed-77789"]}
{"query_id": "topic_611_turn_2", "conversation_id": "topic_611", "turn_id": 2, "query": "How are innovations in materials and fabrication techniques impacting the development of these platforms?", "history": ["What advancements are being made in microfluidic platforms for bioparticle detection?"], "ground_truth": ["permed-82651", "permed-64505", "permed-64509", "permed-64380", "permed-51727", "permed-60645", "permed-52100", "permed-52060", "permed-55107", "permed-86233"]}
{"query_id": "topic_611_turn_3", "conversation_id": "topic_611", "turn_id": 3, "query": "Given these advancements in materials and fabrication techniques, how could their integration specifically enhance the performance and portability of non-optical microfluidic platforms for bioparticle detection? What innovations would be needed to address current sensitivity and specificity limitations while ensuring these platforms remain cost-effective and practical for widespread use in resource-limited settings?", "history": ["What advancements are being made in microfluidic platforms for bioparticle detection?", "How are innovations in materials and fabrication techniques impacting the development of these platforms?"], "ground_truth": ["permed-59232", "permed-59240", "permed-59231", "permed-59244", "permed-92678", "permed-64711", "permed-83953", "permed-4787", "permed-58255", "permed-4686"]}
{"query_id": "topic_611_turn_4", "conversation_id": "topic_611", "turn_id": 4, "query": "Considering the integration you described for enhancing non-optical platforms, what specific microfluidic architectures and electrode configurations would optimize label-free impedance cytometry for bioparticle discrimination? How would you statistically validate sensitivity improvements using ROC analysis while maintaining fabrication simplicity? What quality control protocols would ensure consistent electrode-sensing surface properties across production batches, particularly when using novel conductive polymers in resource-limited manufacturing environments?", "history": ["What advancements are being made in microfluidic platforms for bioparticle detection?", "How are innovations in materials and fabrication techniques impacting the development of these platforms?", "Given these advancements in materials and fabrication techniques, how could their integration specifically enhance the performance and portability of non-optical microfluidic platforms for bioparticle detection? What innovations would be needed to address current sensitivity and specificity limitations while ensuring these platforms remain cost-effective and practical for widespread use in resource-limited settings?"], "ground_truth": ["permed-70332", "permed-59232", "permed-59239", "permed-91949", "permed-62241", "permed-59244", "permed-64613", "permed-80934", "permed-80935", "permed-91951"]}
{"query_id": "topic_611_turn_5", "conversation_id": "topic_611", "turn_id": 5, "query": "Given these optimized impedance cytometry architectures and quality control protocols, what clinical validation studies have demonstrated their efficacy for specific disease diagnostics? Focusing on sepsis or malaria detection in resource-limited settings, how do sensitivity/specificity metrics from clinical samples compare to standard methods? What are the most common operational failure modes observed during field deployment, and how do environmental factors like temperature fluctuations or particulate contamination affect diagnostic reliability? What clinical workflow integrations and operator training requirements have proven essential for maintaining consistent performance in primary care clinics?", "history": ["What advancements are being made in microfluidic platforms for bioparticle detection?", "How are innovations in materials and fabrication techniques impacting the development of these platforms?", "Given these advancements in materials and fabrication techniques, how could their integration specifically enhance the performance and portability of non-optical microfluidic platforms for bioparticle detection? What innovations would be needed to address current sensitivity and specificity limitations while ensuring these platforms remain cost-effective and practical for widespread use in resource-limited settings?", "Considering the integration you described for enhancing non-optical platforms, what specific microfluidic architectures and electrode configurations would optimize label-free impedance cytometry for bioparticle discrimination? How would you statistically validate sensitivity improvements using ROC analysis while maintaining fabrication simplicity? What quality control protocols would ensure consistent electrode-sensing surface properties across production batches, particularly when using novel conductive polymers in resource-limited manufacturing environments?"], "ground_truth": ["permed-4790", "permed-20128", "permed-4686", "permed-4597", "permed-63527", "permed-4688", "permed-4782", "permed-4750", "permed-4785", "permed-65908"]}
{"query_id": "topic_612_turn_1", "conversation_id": "topic_612", "turn_id": 1, "query": "What role does genetic testing play in managing ADPKD?", "history": [], "ground_truth": ["permed-80228", "permed-57238", "permed-24945", "permed-85353", "permed-27665", "permed-58612", "permed-27912", "permed-72625", "permed-55293", "permed-27459"]}
{"query_id": "topic_612_turn_2", "conversation_id": "topic_612", "turn_id": 2, "query": "Can integrating this type of testing into routine clinical practice really improve patient outcomes?", "history": ["What role does genetic testing play in managing ADPKD?"], "ground_truth": ["permed-6827", "permed-66020", "permed-88674", "permed-52652", "permed-91708", "permed-61615", "permed-85662", "permed-52647", "permed-58502", "permed-61471"]}
{"query_id": "topic_612_turn_3", "conversation_id": "topic_612", "turn_id": 3, "query": "Given that genetic testing can improve outcomes for ADPKD patients, how can we best optimize its integration into routine clinical practice—especially in primary care settings where initial diagnosis typically happens—to enhance early intervention, tailor treatments, and ultimately improve long-term outcomes?", "history": ["What role does genetic testing play in managing ADPKD?", "Can integrating this type of testing into routine clinical practice really improve patient outcomes?"], "ground_truth": ["permed-80228", "permed-57238", "permed-24945", "permed-27665", "permed-85353", "permed-55293", "permed-27686", "permed-52935", "permed-87678", "permed-27912"]}
{"query_id": "topic_612_turn_4", "conversation_id": "topic_612", "turn_id": 4, "query": "Given this approach to optimizing genetic testing integration, what specific implementation framework would be most effective for primary care settings? I'm particularly interested in the operational logistics - would a stepped-wedge cluster randomized trial design be appropriate to evaluate implementation strategies? Also, what specific clinician decision support tools and patient education protocols should be incorporated into this framework to ensure consistent application of genetic testing criteria and interpretation of results across diverse primary care practices?", "history": ["What role does genetic testing play in managing ADPKD?", "Can integrating this type of testing into routine clinical practice really improve patient outcomes?", "Given that genetic testing can improve outcomes for ADPKD patients, how can we best optimize its integration into routine clinical practice—especially in primary care settings where initial diagnosis typically happens—to enhance early intervention, tailor treatments, and ultimately improve long-term outcomes?"], "ground_truth": ["permed-52935", "permed-65426", "permed-74816", "permed-61876", "permed-83209", "permed-77549", "permed-54916", "permed-88310", "permed-87678", "permed-78474"]}
{"query_id": "topic_612_turn_5", "conversation_id": "topic_612", "turn_id": 5, "query": "Given this comprehensive implementation framework with trial design and decision support tools, what are the anticipated clinical safety considerations and real-world barriers when deploying genetic testing in primary care? Specifically, how should clinicians manage incidental findings or variants of uncertain significance in ADPKD testing, and what patient counseling protocols are needed to address potential psychological impacts and genetic discrimination concerns, while maintaining testing accessibility across diverse socioeconomic groups?", "history": ["What role does genetic testing play in managing ADPKD?", "Can integrating this type of testing into routine clinical practice really improve patient outcomes?", "Given that genetic testing can improve outcomes for ADPKD patients, how can we best optimize its integration into routine clinical practice—especially in primary care settings where initial diagnosis typically happens—to enhance early intervention, tailor treatments, and ultimately improve long-term outcomes?", "Given this approach to optimizing genetic testing integration, what specific implementation framework would be most effective for primary care settings? I'm particularly interested in the operational logistics - would a stepped-wedge cluster randomized trial design be appropriate to evaluate implementation strategies? Also, what specific clinician decision support tools and patient education protocols should be incorporated into this framework to ensure consistent application of genetic testing criteria and interpretation of results across diverse primary care practices?"], "ground_truth": ["permed-80228", "permed-52935", "permed-74816", "permed-61876", "permed-81409", "permed-27912", "permed-80177", "permed-27665", "permed-85353", "permed-80878"]}
{"query_id": "topic_613_turn_1", "conversation_id": "topic_613", "turn_id": 1, "query": "What role do vacancies play in the performance of phase-change memory devices?", "history": [], "ground_truth": ["permed-78824", "permed-76996", "permed-75757", "permed-78702", "permed-79017", "permed-87644", "permed-76991", "permed-76992", "permed-76989", "permed-79914"]}
{"query_id": "topic_613_turn_2", "conversation_id": "topic_613", "turn_id": 2, "query": "Can manipulating the behavior of these vacancies, especially in complex structures like superlattices, lead to significant improvements in this technology?", "history": ["What role do vacancies play in the performance of phase-change memory devices?"], "ground_truth": ["permed-78824", "permed-90864", "permed-74852", "permed-79019", "permed-88202", "permed-83352", "permed-73089", "permed-72748", "permed-75751", "permed-50895"]}
{"query_id": "topic_613_turn_3", "conversation_id": "topic_613", "turn_id": 3, "query": "Given their importance in these devices and the potential of superlattice structures, how can we specifically control the kinetic behaviors of vacancies—particularly their site-switching dynamics in 2D-3D superlattices—to improve both performance and reliability? What innovative approaches could be developed to optimize these processes for next-generation memory applications?", "history": ["What role do vacancies play in the performance of phase-change memory devices?", "Can manipulating the behavior of these vacancies, especially in complex structures like superlattices, lead to significant improvements in this technology?"], "ground_truth": ["permed-78824", "permed-73089", "permed-90864", "permed-79019", "permed-74852", "permed-76991", "permed-50895", "permed-76878", "permed-73027", "permed-79017"]}
{"query_id": "topic_613_turn_4", "conversation_id": "topic_613", "turn_id": 4, "query": "Given this focus on controlling vacancy kinetics in 2D-3D superlattices, what experimental methodology would be most effective for directly probing the site-switching dynamics in situ? Specifically, are there advanced characterization techniques—such as in-situ TEM with electrical biasing or ultrafast spectroscopy—that can quantify transition rates and energy barriers with sufficient temporal resolution? Furthermore, how should such experiments be designed to statistically validate the correlation between observed vacancy dynamics and measured device parameters like switching speed and endurance?", "history": ["What role do vacancies play in the performance of phase-change memory devices?", "Can manipulating the behavior of these vacancies, especially in complex structures like superlattices, lead to significant improvements in this technology?", "Given their importance in these devices and the potential of superlattice structures, how can we specifically control the kinetic behaviors of vacancies—particularly their site-switching dynamics in 2D-3D superlattices—to improve both performance and reliability? What innovative approaches could be developed to optimize these processes for next-generation memory applications?"], "ground_truth": ["permed-78824", "permed-79019", "permed-90863", "permed-73089", "permed-77000", "permed-53553", "permed-77026", "permed-90864", "permed-75054", "permed-60597"]}
{"query_id": "topic_613_turn_5", "conversation_id": "topic_613", "turn_id": 5, "query": "Given these proposed methodologies for probing vacancy kinetics, how do advanced characterization techniques like in-situ TEM with electrical biasing versus ultrafast spectroscopy compare in their ability to quantify site-switching dynamics in 2D-3D superlattices? Specifically, what are their relative trade-offs in temporal resolution, spatial precision, and correlation with device performance metrics? Which approach offers superior statistical validation of vacancy dynamics while maintaining experimental feasibility for optimizing phase-change memory reliability?", "history": ["What role do vacancies play in the performance of phase-change memory devices?", "Can manipulating the behavior of these vacancies, especially in complex structures like superlattices, lead to significant improvements in this technology?", "Given their importance in these devices and the potential of superlattice structures, how can we specifically control the kinetic behaviors of vacancies—particularly their site-switching dynamics in 2D-3D superlattices—to improve both performance and reliability? What innovative approaches could be developed to optimize these processes for next-generation memory applications?", "Given this focus on controlling vacancy kinetics in 2D-3D superlattices, what experimental methodology would be most effective for directly probing the site-switching dynamics in situ? Specifically, are there advanced characterization techniques—such as in-situ TEM with electrical biasing or ultrafast spectroscopy—that can quantify transition rates and energy barriers with sufficient temporal resolution? Furthermore, how should such experiments be designed to statistically validate the correlation between observed vacancy dynamics and measured device parameters like switching speed and endurance?"], "ground_truth": ["permed-78824", "permed-77000", "permed-77026", "permed-76878", "permed-75587", "permed-90863", "permed-74852", "permed-75948", "permed-79017", "permed-79800"]}
{"query_id": "topic_614_turn_1", "conversation_id": "topic_614", "turn_id": 1, "query": "What role does genetics play in lipid metabolism and fat deposition in poultry?", "history": [], "ground_truth": ["permed-82357", "permed-82365", "permed-71938", "permed-89177", "permed-63902", "permed-58206", "permed-80710", "permed-57749", "permed-80706", "permed-88053"]}
{"query_id": "topic_614_turn_2", "conversation_id": "topic_614", "turn_id": 2, "query": "How might selective breeding programs impact this genetic influence, particularly in terms of inbreeding levels and genetic variation?", "history": ["What role does genetics play in lipid metabolism and fat deposition in poultry?"], "ground_truth": ["permed-90390", "permed-80736", "permed-52487", "permed-70014", "permed-63680", "permed-74591", "permed-52653", "permed-63687", "permed-70015", "permed-87537"]}
{"query_id": "topic_614_turn_3", "conversation_id": "topic_614", "turn_id": 3, "query": "Given these observed differences in ROH patterns and inbreeding levels between the random breeding and IMF-selected Beijing-You Chicken populations, how might such genetic variations affect their lipid metabolism and fat deposition traits? What molecular mechanisms could explain these differences, and how could this understanding help optimize breeding programs to enhance both productivity and health in poultry?", "history": ["What role does genetics play in lipid metabolism and fat deposition in poultry?", "How might selective breeding programs impact this genetic influence, particularly in terms of inbreeding levels and genetic variation?"], "ground_truth": ["permed-80736", "permed-71938", "permed-80748", "permed-71915", "permed-80699", "permed-89184", "permed-80738", "permed-80737", "permed-80741", "permed-80726"]}
{"query_id": "topic_614_turn_4", "conversation_id": "topic_614", "turn_id": 4, "query": "Building on these observed ROH pattern differences, what specific genomic analysis protocols were implemented to quantify their association with fat deposition traits? Were particular statistical models like mixed linear models or genomic BLUP employed to account for population structure when analyzing the IMF-selected versus control populations? Additionally, what quality control metrics were applied to the genotype data, and how was the reproducibility of these genetic associations validated across different breeding cycles or subpopulations?", "history": ["What role does genetics play in lipid metabolism and fat deposition in poultry?", "How might selective breeding programs impact this genetic influence, particularly in terms of inbreeding levels and genetic variation?", "Given these observed differences in ROH patterns and inbreeding levels between the random breeding and IMF-selected Beijing-You Chicken populations, how might such genetic variations affect their lipid metabolism and fat deposition traits? What molecular mechanisms could explain these differences, and how could this understanding help optimize breeding programs to enhance both productivity and health in poultry?"], "ground_truth": ["permed-63902", "permed-80736", "permed-82356", "permed-80738", "permed-82362", "permed-20388", "permed-70014", "permed-70017", "permed-63684", "permed-80740"]}
{"query_id": "topic_614_turn_5", "conversation_id": "topic_614", "turn_id": 5, "query": "Given the genomic analysis protocols and validation approaches discussed, how do the predictive accuracies and practical implementation trade-offs compare between mixed linear models and genomic BLUP when quantifying ROH associations with fat deposition traits? Specifically, in the context of IMF-selected versus control poultry populations, which approach demonstrates superior balance between computational efficiency, bias correction for population structure, and breeding value estimation stability across different genetic backgrounds? Does either method show consistent advantages for specific fat deposition phenotypes like abdominal fat versus intramuscular fat?", "history": ["What role does genetics play in lipid metabolism and fat deposition in poultry?", "How might selective breeding programs impact this genetic influence, particularly in terms of inbreeding levels and genetic variation?", "Given these observed differences in ROH patterns and inbreeding levels between the random breeding and IMF-selected Beijing-You Chicken populations, how might such genetic variations affect their lipid metabolism and fat deposition traits? What molecular mechanisms could explain these differences, and how could this understanding help optimize breeding programs to enhance both productivity and health in poultry?", "Building on these observed ROH pattern differences, what specific genomic analysis protocols were implemented to quantify their association with fat deposition traits? Were particular statistical models like mixed linear models or genomic BLUP employed to account for population structure when analyzing the IMF-selected versus control populations? Additionally, what quality control metrics were applied to the genotype data, and how was the reproducibility of these genetic associations validated across different breeding cycles or subpopulations?"], "ground_truth": ["permed-70017", "permed-80736", "permed-74049", "permed-74050", "permed-63902", "permed-71921", "permed-20388", "permed-67212", "permed-82356", "permed-80740"]}
{"query_id": "topic_615_turn_1", "conversation_id": "topic_615", "turn_id": 1, "query": "What natural compounds have shown promise in treating type 2 diabetes mellitus through unique biochemical pathways?", "history": [], "ground_truth": ["permed-70428", "permed-69099", "permed-51198", "permed-58968", "permed-58833", "permed-58950", "permed-60882", "permed-51128", "permed-58586", "permed-81712"]}
{"query_id": "topic_615_turn_2", "conversation_id": "topic_615", "turn_id": 2, "query": "How does the PI3K/AKT pathway modulation by some of these compounds, like those found in *Piper longum*, impact glucose metabolism?", "history": ["What natural compounds have shown promise in treating type 2 diabetes mellitus through unique biochemical pathways?"], "ground_truth": ["permed-78785", "permed-58652", "permed-58207", "permed-78786", "permed-56509", "permed-92490", "permed-86144", "permed-76749", "permed-58833", "permed-11732"]}
{"query_id": "topic_615_turn_3", "conversation_id": "topic_615", "turn_id": 3, "query": "Building on these findings about retrofractamides A and C from *Piper longum* and their PI3K/AKT pathway modulation, how might they affect other downstream pathways like mTOR or AMPK in glucose metabolism, and what would this mean for long-term glucose homeostasis and insulin sensitivity? Also, what are the potential side effects or limitations of using these compounds therapeutically, and how could their efficacy and safety be improved for clinical use?", "history": ["What natural compounds have shown promise in treating type 2 diabetes mellitus through unique biochemical pathways?", "How does the PI3K/AKT pathway modulation by some of these compounds, like those found in *Piper longum*, impact glucose metabolism?"], "ground_truth": ["permed-78785", "permed-58652", "permed-10973", "permed-58207", "permed-69100", "permed-11054", "permed-92490", "permed-53557", "permed-10652", "permed-29739"]}
{"query_id": "topic_615_turn_4", "conversation_id": "topic_615", "turn_id": 4, "query": "When examining these downstream pathway effects on mTOR and AMPK, what specific experimental methodologies would best differentiate between direct versus indirect signaling interactions? Particularly, would you recommend using selective pathway inhibitors in combination with these compounds during glucose uptake assays, or would CRISPR-based gene editing of key regulatory nodes provide more definitive mechanistic insights? Also, what statistical approaches would be appropriate for analyzing the potential synergistic or antagonistic effects between these pathways in hepatocyte and adipocyte cell lines?", "history": ["What natural compounds have shown promise in treating type 2 diabetes mellitus through unique biochemical pathways?", "How does the PI3K/AKT pathway modulation by some of these compounds, like those found in *Piper longum*, impact glucose metabolism?", "Building on these findings about retrofractamides A and C from *Piper longum* and their PI3K/AKT pathway modulation, how might they affect other downstream pathways like mTOR or AMPK in glucose metabolism, and what would this mean for long-term glucose homeostasis and insulin sensitivity? Also, what are the potential side effects or limitations of using these compounds therapeutically, and how could their efficacy and safety be improved for clinical use?"], "ground_truth": ["permed-72293", "permed-59044", "permed-53558", "permed-13656", "permed-7570", "permed-76609", "permed-10256", "permed-82441", "permed-53557", "permed-10197"]}
{"query_id": "topic_615_turn_5", "conversation_id": "topic_615", "turn_id": 5, "query": "Given these detailed mechanistic insights into retrofractamides' pathway interactions, what clinical translation challenges are anticipated when moving from in vitro models to human trials for type 2 diabetes? Specifically, considering the complex mTOR/AMPK crosstalk you've outlined, what patient safety monitoring would be essential for first-in-human studies regarding potential metabolic disturbances or organ-specific toxicities? Additionally, based on the pathway synergies observed, what primary efficacy endpoints and patient stratification strategies would you recommend for early-phase trials to best capture therapeutic potential while ensuring participant safety?", "history": ["What natural compounds have shown promise in treating type 2 diabetes mellitus through unique biochemical pathways?", "How does the PI3K/AKT pathway modulation by some of these compounds, like those found in *Piper longum*, impact glucose metabolism?", "Building on these findings about retrofractamides A and C from *Piper longum* and their PI3K/AKT pathway modulation, how might they affect other downstream pathways like mTOR or AMPK in glucose metabolism, and what would this mean for long-term glucose homeostasis and insulin sensitivity? Also, what are the potential side effects or limitations of using these compounds therapeutically, and how could their efficacy and safety be improved for clinical use?", "When examining these downstream pathway effects on mTOR and AMPK, what specific experimental methodologies would best differentiate between direct versus indirect signaling interactions? Particularly, would you recommend using selective pathway inhibitors in combination with these compounds during glucose uptake assays, or would CRISPR-based gene editing of key regulatory nodes provide more definitive mechanistic insights? Also, what statistical approaches would be appropriate for analyzing the potential synergistic or antagonistic effects between these pathways in hepatocyte and adipocyte cell lines?"], "ground_truth": ["permed-78785", "permed-29930", "permed-69099", "permed-53558", "permed-29929", "permed-58958", "permed-11993", "permed-57775", "permed-58398", "permed-12925"]}
{"query_id": "topic_616_turn_1", "conversation_id": "topic_616", "turn_id": 1, "query": "What role does the placenta play in fetal programming and the development of adult diseases?", "history": [], "ground_truth": ["permed-53538", "permed-31513", "permed-78415", "permed-66678", "permed-7172", "permed-70710", "permed-73610", "permed-54266", "permed-89331", "permed-45112"]}
{"query_id": "topic_616_turn_2", "conversation_id": "topic_616", "turn_id": 2, "query": "How can studying it at a molecular level, particularly through techniques like omics analysis, provide new insights into this process?", "history": ["What role does the placenta play in fetal programming and the development of adult diseases?"], "ground_truth": ["permed-58217", "permed-54183", "permed-58215", "permed-58105", "permed-71085", "permed-57647", "permed-58246", "permed-53721", "permed-63825", "permed-76144"]}
{"query_id": "topic_616_turn_3", "conversation_id": "topic_616", "turn_id": 3, "query": "Given what we know about placental molecular studies through omics analysis, how might combining multi-omics data—like transcriptomics and metabolomics—with DNA methylation profiles help us better understand how early-life environmental exposures affect molecular pathways in the placenta? And what could these interactions tell us about their role in fetal programming and the developmental origins of adult diseases?", "history": ["What role does the placenta play in fetal programming and the development of adult diseases?", "How can studying it at a molecular level, particularly through techniques like omics analysis, provide new insights into this process?"], "ground_truth": ["permed-58111", "permed-58098", "permed-73610", "permed-78415", "permed-53538", "permed-78414", "permed-89337", "permed-89215", "permed-80066", "permed-70709"]}
{"query_id": "topic_616_turn_4", "conversation_id": "topic_616", "turn_id": 4, "query": "Given this integrated multi-omics approach, what specific computational strategies and statistical models would be most appropriate for harmonizing transcriptomic, metabolomic, and DNA methylation datasets? In particular, how can we effectively account for batch effects across different platforms while preserving biological signals related to environmental exposures? Additionally, what validation methods should be implemented to ensure that identified pathway interactions aren't artifacts of data integration?", "history": ["What role does the placenta play in fetal programming and the development of adult diseases?", "How can studying it at a molecular level, particularly through techniques like omics analysis, provide new insights into this process?", "Given what we know about placental molecular studies through omics analysis, how might combining multi-omics data—like transcriptomics and metabolomics—with DNA methylation profiles help us better understand how early-life environmental exposures affect molecular pathways in the placenta? And what could these interactions tell us about their role in fetal programming and the developmental origins of adult diseases?"], "ground_truth": ["permed-58107", "permed-55581", "permed-69753", "permed-55579", "permed-79170", "permed-58105", "permed-63675", "permed-58096", "permed-63825", "permed-77758"]}
{"query_id": "topic_616_turn_5", "conversation_id": "topic_616", "turn_id": 5, "query": "Given these computational frameworks for integrating placental multi-omics data, what clinical applications have emerged from such analyses? Specifically, how are researchers translating identified molecular signatures—like specific methylation patterns or metabolite profiles linked to environmental exposures—into predictive biomarkers for adverse postnatal outcomes such as metabolic syndrome or neurodevelopmental disorders? Furthermore, what are the current challenges in validating these biomarkers for clinical use, particularly regarding their specificity and reliability across diverse patient populations?", "history": ["What role does the placenta play in fetal programming and the development of adult diseases?", "How can studying it at a molecular level, particularly through techniques like omics analysis, provide new insights into this process?", "Given what we know about placental molecular studies through omics analysis, how might combining multi-omics data—like transcriptomics and metabolomics—with DNA methylation profiles help us better understand how early-life environmental exposures affect molecular pathways in the placenta? And what could these interactions tell us about their role in fetal programming and the developmental origins of adult diseases?", "Given this integrated multi-omics approach, what specific computational strategies and statistical models would be most appropriate for harmonizing transcriptomic, metabolomic, and DNA methylation datasets? In particular, how can we effectively account for batch effects across different platforms while preserving biological signals related to environmental exposures? Additionally, what validation methods should be implemented to ensure that identified pathway interactions aren't artifacts of data integration?"], "ground_truth": ["permed-73610", "permed-58111", "permed-71738", "permed-58098", "permed-63825", "permed-80375", "permed-53538", "permed-89337", "permed-61489", "permed-82511"]}
{"query_id": "topic_617_turn_1", "conversation_id": "topic_617", "turn_id": 1, "query": "`Significance of \"voice\" concept in therapeutic interventions for marginalized populations`", "history": [], "ground_truth": ["permed-55645", "permed-75160", "permed-66153", "permed-92165", "permed-70065", "permed-50971", "permed-58626", "permed-60645", "permed-58211", "permed-80730"]}
{"query_id": "topic_617_turn_2", "conversation_id": "topic_617", "turn_id": 2, "query": "`How does this understanding of \"voice\" shape contemporary counseling approaches for addressing the psychological needs of these marginalized populations?`", "history": ["`Significance of \"voice\" concept in therapeutic interventions for marginalized populations`"], "ground_truth": ["permed-66306", "permed-69900", "permed-74557", "permed-69892", "permed-66303", "permed-70065", "permed-78394", "permed-51853", "permed-57558", "permed-59368"]}
{"query_id": "topic_617_turn_3", "conversation_id": "topic_617", "turn_id": 3, "query": "`Analyzing Carol Gilligan's \"voice\" framework: what specific therapeutic methods has it generated for marginalized groups, and how do these methods contribute to more inclusive and empathetic counseling practices?`", "history": ["`Significance of \"voice\" concept in therapeutic interventions for marginalized populations`", "`How does this understanding of \"voice\" shape contemporary counseling approaches for addressing the psychological needs of these marginalized populations?`"], "ground_truth": ["permed-74557", "permed-70065", "permed-75160", "permed-57558", "permed-67553", "permed-74373", "permed-66153", "permed-69864", "permed-85811", "permed-69900"]}
{"query_id": "topic_617_turn_4", "conversation_id": "topic_617", "turn_id": 4, "query": "When implementing Gilligan-inspired therapeutic methods with marginalized populations, what specific protocol modifications have been developed to ensure cultural validity? I'm particularly interested in how researchers have adapted narrative data collection techniques and relational coding frameworks for diverse populations, and what validation strategies they employ to confirm these methodological adaptations maintain therapeutic integrity while being culturally responsive.", "history": ["`Significance of \"voice\" concept in therapeutic interventions for marginalized populations`", "`How does this understanding of \"voice\" shape contemporary counseling approaches for addressing the psychological needs of these marginalized populations?`", "`Analyzing Carol Gilligan's \"voice\" framework: what specific therapeutic methods has it generated for marginalized groups, and how do these methods contribute to more inclusive and empathetic counseling practices?`"], "ground_truth": ["permed-69900", "permed-64788", "permed-69898", "permed-66109", "permed-64779", "permed-69897", "permed-88838", "permed-65835", "permed-65839", "permed-84438"]}
{"query_id": "topic_617_turn_5", "conversation_id": "topic_617", "turn_id": 5, "query": "Given these methodological adaptations for cultural validity, what clinical outcome data exists regarding the therapeutic efficacy of Gilligan-informed voice interventions for marginalized populations? Specifically, how do measured outcomes—such as psychological distress reduction, empowerment scales, or therapeutic alliance metrics—compare between standard approaches and culturally-adapted voice protocols in clinical trials? I'm particularly interested in whether enhanced cultural responsiveness translates to improved real-world patient outcomes or reveals any unique safety considerations regarding emotional processing in these populations.", "history": ["`Significance of \"voice\" concept in therapeutic interventions for marginalized populations`", "`How does this understanding of \"voice\" shape contemporary counseling approaches for addressing the psychological needs of these marginalized populations?`", "`Analyzing Carol Gilligan's \"voice\" framework: what specific therapeutic methods has it generated for marginalized groups, and how do these methods contribute to more inclusive and empathetic counseling practices?`", "When implementing Gilligan-inspired therapeutic methods with marginalized populations, what specific protocol modifications have been developed to ensure cultural validity? I'm particularly interested in how researchers have adapted narrative data collection techniques and relational coding frameworks for diverse populations, and what validation strategies they employ to confirm these methodological adaptations maintain therapeutic integrity while being culturally responsive."], "ground_truth": ["permed-69900", "permed-64779", "permed-64788", "permed-74557", "permed-69898", "permed-66109", "permed-34402", "permed-58502", "permed-78394", "permed-85811"]}
{"query_id": "topic_618_turn_1", "conversation_id": "topic_618", "turn_id": 1, "query": "What role do senescent T cells play in autoimmune diseases?", "history": [], "ground_truth": ["permed-54302", "permed-61367", "permed-59051", "permed-71176", "permed-70702", "permed-89345", "permed-65328", "permed-33035", "permed-21769", "permed-53184"]}
{"query_id": "topic_618_turn_2", "conversation_id": "topic_618", "turn_id": 2, "query": "Can modifying the behavior of these cells, specifically through mitochondrial dynamics, impact disease progression or treatment outcomes?", "history": ["What role do senescent T cells play in autoimmune diseases?"], "ground_truth": ["permed-74333", "permed-81126", "permed-84708", "permed-80504", "permed-53805", "permed-53810", "permed-89562", "permed-76336", "permed-72066", "permed-39376"]}
{"query_id": "topic_618_turn_3", "conversation_id": "topic_618", "turn_id": 3, "query": "Given what we know about senescent T cells and their mitochondrial dynamics, how could targeting these mechanisms—particularly by reducing oxidative stress—improve immunotherapy outcomes in autoimmune diseases? What specific molecular pathways would be most promising for such therapeutic interventions?", "history": ["What role do senescent T cells play in autoimmune diseases?", "Can modifying the behavior of these cells, specifically through mitochondrial dynamics, impact disease progression or treatment outcomes?"], "ground_truth": ["permed-54302", "permed-59051", "permed-81814", "permed-21769", "permed-22413", "permed-81816", "permed-51348", "permed-67699", "permed-87271", "permed-61367"]}
{"query_id": "topic_618_turn_4", "conversation_id": "topic_618", "turn_id": 4, "query": "For these proposed therapeutic interventions targeting mitochondrial oxidative stress in senescent T cells, what specific experimental models would you prioritize for validating efficacy? I'm particularly interested in the methodological considerations for assessing mitochondrial membrane potential and ROS production in these cells ex vivo, and how you would statistically power such studies to detect meaningful changes in both molecular markers and subsequent functional T-cell assays like cytokine production and proliferation.", "history": ["What role do senescent T cells play in autoimmune diseases?", "Can modifying the behavior of these cells, specifically through mitochondrial dynamics, impact disease progression or treatment outcomes?", "Given what we know about senescent T cells and their mitochondrial dynamics, how could targeting these mechanisms—particularly by reducing oxidative stress—improve immunotherapy outcomes in autoimmune diseases? What specific molecular pathways would be most promising for such therapeutic interventions?"], "ground_truth": ["permed-62594", "permed-54302", "permed-59051", "permed-22413", "permed-39490", "permed-54253", "permed-82267", "permed-54283", "permed-75171", "permed-69053"]}
{"query_id": "topic_618_turn_5", "conversation_id": "topic_618", "turn_id": 5, "query": "Given the validated experimental models and molecular assessment methods we've discussed, what clinical evidence exists for actual therapeutic interventions targeting mitochondrial oxidative stress in senescent T cells in human autoimmune patients? Specifically, what are the reported patient outcomes regarding disease activity scores, flare reduction, and steroid-sparing effects? Additionally, what safety profiles and adverse events—particularly regarding metabolic disturbances or immune compromise—have been observed in early-phase trials with such mitochondrial-targeted approaches in conditions like rheumatoid arthritis or lupus?", "history": ["What role do senescent T cells play in autoimmune diseases?", "Can modifying the behavior of these cells, specifically through mitochondrial dynamics, impact disease progression or treatment outcomes?", "Given what we know about senescent T cells and their mitochondrial dynamics, how could targeting these mechanisms—particularly by reducing oxidative stress—improve immunotherapy outcomes in autoimmune diseases? What specific molecular pathways would be most promising for such therapeutic interventions?", "For these proposed therapeutic interventions targeting mitochondrial oxidative stress in senescent T cells, what specific experimental models would you prioritize for validating efficacy? I'm particularly interested in the methodological considerations for assessing mitochondrial membrane potential and ROS production in these cells ex vivo, and how you would statistically power such studies to detect meaningful changes in both molecular markers and subsequent functional T-cell assays like cytokine production and proliferation."], "ground_truth": ["permed-54302", "permed-81814", "permed-62594", "permed-83721", "permed-67791", "permed-69053", "permed-76184", "permed-22413", "permed-59051", "permed-82267"]}
{"query_id": "topic_619_turn_1", "conversation_id": "topic_619", "turn_id": 1, "query": "What role do androgen receptors play in breast cancer, particularly in ER+ cases?", "history": [], "ground_truth": ["permed-78606", "permed-52583", "permed-71179", "permed-89641", "permed-77444", "permed-75332", "permed-73074", "permed-78889", "permed-30248", "permed-78608"]}
{"query_id": "topic_619_turn_2", "conversation_id": "topic_619", "turn_id": 2, "query": "How might targeting this receptor impact treatment strategies for patients with varying expression levels of it?", "history": ["What role do androgen receptors play in breast cancer, particularly in ER+ cases?"], "ground_truth": ["permed-33677", "permed-79927", "permed-59003", "permed-79155", "permed-68055", "permed-72042", "permed-79929", "permed-69235", "permed-60856", "permed-84366"]}
{"query_id": "topic_619_turn_3", "conversation_id": "topic_619", "turn_id": 3, "query": "Given this complex interplay between AR and ERα in ER+ breast cancer, how could we optimize therapeutic strategies involving AR modulation—like using selective agonists or inhibitors—based on a patient's initial AR and ERα expression levels? What biomarkers or molecular signatures might predict differential responses to these AR-targeted therapies, and how could that guide personalized treatment to maximize efficacy while minimizing side effects?", "history": ["What role do androgen receptors play in breast cancer, particularly in ER+ cases?", "How might targeting this receptor impact treatment strategies for patients with varying expression levels of it?"], "ground_truth": ["permed-78606", "permed-52583", "permed-78608", "permed-35060", "permed-78607", "permed-80880", "permed-71179", "permed-78612", "permed-77444", "permed-21843"]}
{"query_id": "topic_619_turn_4", "conversation_id": "topic_619", "turn_id": 4, "query": "In implementing this biomarker-driven therapeutic strategy, what specific experimental designs would be most appropriate for validating predictive molecular signatures? Would you recommend using patient-derived organoids with systematic AR:ERα ratio manipulation, or longitudinal biopsy cohorts from clinical trials? Additionally, what statistical approaches—such as time-dependent ROC analysis or machine learning classifiers—would best handle the dynamic nature of treatment response data while accounting for potential confounders like prior endocrine therapy exposure?", "history": ["What role do androgen receptors play in breast cancer, particularly in ER+ cases?", "How might targeting this receptor impact treatment strategies for patients with varying expression levels of it?", "Given this complex interplay between AR and ERα in ER+ breast cancer, how could we optimize therapeutic strategies involving AR modulation—like using selective agonists or inhibitors—based on a patient's initial AR and ERα expression levels? What biomarkers or molecular signatures might predict differential responses to these AR-targeted therapies, and how could that guide personalized treatment to maximize efficacy while minimizing side effects?"], "ground_truth": ["permed-62485", "permed-56352", "permed-56825", "permed-56687", "permed-56190", "permed-56048", "permed-57233", "permed-86462", "permed-50852", "permed-68019"]}
{"query_id": "topic_619_turn_5", "conversation_id": "topic_619", "turn_id": 5, "query": "Given these proposed biomarker validation frameworks, what clinical trial designs would most effectively evaluate the real-world efficacy and safety of AR-targeted therapies in ER+ breast cancer patients stratified by AR:ERα ratios? Considering the need for clinically actionable endpoints, should trials prioritize neoadjuvant settings with pathological response as primary outcome, or metastatic settings with progression-free survival? How should investigators balance assessing therapeutic benefits against monitoring potential adverse effects—particularly endocrine disruptions or paradoxical tumor progression in AR-low subgroups—within these stratified cohorts?", "history": ["What role do androgen receptors play in breast cancer, particularly in ER+ cases?", "How might targeting this receptor impact treatment strategies for patients with varying expression levels of it?", "Given this complex interplay between AR and ERα in ER+ breast cancer, how could we optimize therapeutic strategies involving AR modulation—like using selective agonists or inhibitors—based on a patient's initial AR and ERα expression levels? What biomarkers or molecular signatures might predict differential responses to these AR-targeted therapies, and how could that guide personalized treatment to maximize efficacy while minimizing side effects?", "In implementing this biomarker-driven therapeutic strategy, what specific experimental designs would be most appropriate for validating predictive molecular signatures? Would you recommend using patient-derived organoids with systematic AR:ERα ratio manipulation, or longitudinal biopsy cohorts from clinical trials? Additionally, what statistical approaches—such as time-dependent ROC analysis or machine learning classifiers—would best handle the dynamic nature of treatment response data while accounting for potential confounders like prior endocrine therapy exposure?"], "ground_truth": ["permed-78606", "permed-56578", "permed-78608", "permed-77803", "permed-77444", "permed-52583", "permed-77805", "permed-67426", "permed-51811", "permed-67424"]}
{"query_id": "topic_620_turn_1", "conversation_id": "topic_620", "turn_id": 1, "query": "What impact does ocean acidification have on marine species like oysters, particularly in terms of stress response and infection susceptibility?", "history": [], "ground_truth": ["permed-73491", "permed-77920", "permed-73488", "permed-77925", "permed-82254", "permed-58226", "permed-80546", "permed-82253", "permed-73485", "permed-73490"]}
{"query_id": "topic_620_turn_2", "conversation_id": "topic_620", "turn_id": 2, "query": "How might this stress response be complicated by additional factors, such as bacterial infections, in species like the Crassostrea hongkongensis?", "history": ["What impact does ocean acidification have on marine species like oysters, particularly in terms of stress response and infection susceptibility?"], "ground_truth": ["permed-73491", "permed-58229", "permed-58226", "permed-58233", "permed-54997", "permed-77020", "permed-76711", "permed-73960", "permed-73490", "permed-88363"]}
{"query_id": "topic_620_turn_3", "conversation_id": "topic_620", "turn_id": 3, "query": "Given these combined stressors—ocean acidification and Vibrio parahaemolyticus infection—how do the molecular pathways and gene expressions in Crassostrea hongkongensis specifically shift in response? What long-term evolutionary adaptations might emerge from these changes, and how could we use this understanding to build predictive models for wild oyster population resilience and zoonotic pathogen spread in increasingly acidic marine environments?", "history": ["What impact does ocean acidification have on marine species like oysters, particularly in terms of stress response and infection susceptibility?", "How might this stress response be complicated by additional factors, such as bacterial infections, in species like the Crassostrea hongkongensis?"], "ground_truth": ["permed-73491", "permed-82253", "permed-73490", "permed-73488", "permed-85982", "permed-77920", "permed-77925", "permed-73485", "permed-76711", "permed-76706"]}
{"query_id": "topic_620_turn_4", "conversation_id": "topic_620", "turn_id": 4, "query": "Following these gene expression analyses under combined stressors, what specific statistical approaches would you recommend for distinguishing interaction effects between acidification and infection from their individual impacts? Particularly, how should we handle potential multicollinearity when modeling these molecular pathway shifts, and what validation strategies would ensure the predictive models for population resilience maintain biological relevance while accounting for temporal dynamics in long-term adaptation studies?", "history": ["What impact does ocean acidification have on marine species like oysters, particularly in terms of stress response and infection susceptibility?", "How might this stress response be complicated by additional factors, such as bacterial infections, in species like the Crassostrea hongkongensis?", "Given these combined stressors—ocean acidification and Vibrio parahaemolyticus infection—how do the molecular pathways and gene expressions in Crassostrea hongkongensis specifically shift in response? What long-term evolutionary adaptations might emerge from these changes, and how could we use this understanding to build predictive models for wild oyster population resilience and zoonotic pathogen spread in increasingly acidic marine environments?"], "ground_truth": ["permed-76706", "permed-73490", "permed-66585", "permed-84325", "permed-73491", "permed-60608", "permed-71912", "permed-57644", "permed-73488", "permed-84723"]}
{"query_id": "topic_620_turn_5", "conversation_id": "topic_620", "turn_id": 5, "query": "Given the sophisticated statistical approaches for analyzing interaction effects between acidification and infection, how would you compare the relative advantages of linear mixed-effects models versus machine learning ensembles (like random forests or gradient boosting) for predicting population resilience outcomes? Specifically, which approach offers better trade-offs between interpretability of stressor interactions and predictive accuracy for long-term adaptation scenarios, particularly when dealing with the high-dimensional gene expression data and temporal autocorrelation inherent in these multi-stressor studies?", "history": ["What impact does ocean acidification have on marine species like oysters, particularly in terms of stress response and infection susceptibility?", "How might this stress response be complicated by additional factors, such as bacterial infections, in species like the Crassostrea hongkongensis?", "Given these combined stressors—ocean acidification and Vibrio parahaemolyticus infection—how do the molecular pathways and gene expressions in Crassostrea hongkongensis specifically shift in response? What long-term evolutionary adaptations might emerge from these changes, and how could we use this understanding to build predictive models for wild oyster population resilience and zoonotic pathogen spread in increasingly acidic marine environments?", "Following these gene expression analyses under combined stressors, what specific statistical approaches would you recommend for distinguishing interaction effects between acidification and infection from their individual impacts? Particularly, how should we handle potential multicollinearity when modeling these molecular pathway shifts, and what validation strategies would ensure the predictive models for population resilience maintain biological relevance while accounting for temporal dynamics in long-term adaptation studies?"], "ground_truth": ["permed-34458", "permed-85717", "permed-72744", "permed-60476", "permed-89397", "permed-71547", "permed-74049", "permed-26794", "permed-58921", "permed-85881"]}
{"query_id": "topic_621_turn_1", "conversation_id": "topic_621", "turn_id": 1, "query": "Mechanisms and therapeutic potential of ferroptosis in treating refractory tumors", "history": [], "ground_truth": ["permed-62668", "permed-71208", "permed-56277", "permed-57856", "permed-62657", "permed-56282", "permed-68892", "permed-55416", "permed-62638", "permed-68884"]}
{"query_id": "topic_621_turn_2", "conversation_id": "topic_621", "turn_id": 2, "query": "Enhancing these ferroptosis-based therapies with photothermal effects for improved efficacy against such refractory tumors", "history": ["Mechanisms and therapeutic potential of ferroptosis in treating refractory tumors"], "ground_truth": ["permed-62668", "permed-86712", "permed-57856", "permed-71208", "permed-86714", "permed-68892", "permed-56277", "permed-68741", "permed-75764", "permed-68884"]}
{"query_id": "topic_621_turn_3", "conversation_id": "topic_621", "turn_id": 3, "query": "Biomineralized nanovaccines combining ferroptosis and photothermal therapy for refractory tumors: optimization of immune response and long-term effects with CTLA-4 inhibition in advanced melanoma", "history": ["Mechanisms and therapeutic potential of ferroptosis in treating refractory tumors", "Enhancing these ferroptosis-based therapies with photothermal effects for improved efficacy against such refractory tumors"], "ground_truth": ["permed-75764", "permed-74797", "permed-79250", "permed-67783", "permed-68891", "permed-87654", "permed-67533", "permed-89635", "permed-67535", "permed-57526"]}
{"query_id": "topic_621_turn_4", "conversation_id": "topic_621", "turn_id": 4, "query": "Regarding the biomineralized nanovaccine platform combining ferroptosis and photothermal therapy, what specific characterization techniques were employed to validate nanoparticle morphology, iron content quantification, and photothermal conversion efficiency? Additionally, could you detail the experimental timeline for assessing immune cell infiltration in tumors following this combinatorial approach, particularly regarding the sequencing of CTLA-4 inhibitor administration relative to nanovaccine treatment and subsequent immunological assays?", "history": ["Mechanisms and therapeutic potential of ferroptosis in treating refractory tumors", "Enhancing these ferroptosis-based therapies with photothermal effects for improved efficacy against such refractory tumors", "Biomineralized nanovaccines combining ferroptosis and photothermal therapy for refractory tumors: optimization of immune response and long-term effects with CTLA-4 inhibition in advanced melanoma"], "ground_truth": ["permed-75764", "permed-86714", "permed-51345", "permed-89635", "permed-75772", "permed-63006", "permed-74798", "permed-51306", "permed-75768", "permed-67787"]}
{"query_id": "topic_621_turn_5", "conversation_id": "topic_621", "turn_id": 5, "query": "Given the robust characterization of this biomineralized nanovaccine platform, what clinical safety profile and immune-related adverse events were observed when combining ferroptosis-photothermal therapy with CTLA-4 inhibition in advanced melanoma models? Specifically, how did the timing of checkpoint inhibitor administration affect the incidence and severity of adverse effects like cytokine release syndrome or autoimmune reactions, and were there any dose-limiting toxicities that might inform clinical translation strategies for this combinatorial approach in treatment-resistant patients?", "history": ["Mechanisms and therapeutic potential of ferroptosis in treating refractory tumors", "Enhancing these ferroptosis-based therapies with photothermal effects for improved efficacy against such refractory tumors", "Biomineralized nanovaccines combining ferroptosis and photothermal therapy for refractory tumors: optimization of immune response and long-term effects with CTLA-4 inhibition in advanced melanoma", "Regarding the biomineralized nanovaccine platform combining ferroptosis and photothermal therapy, what specific characterization techniques were employed to validate nanoparticle morphology, iron content quantification, and photothermal conversion efficiency? Additionally, could you detail the experimental timeline for assessing immune cell infiltration in tumors following this combinatorial approach, particularly regarding the sequencing of CTLA-4 inhibitor administration relative to nanovaccine treatment and subsequent immunological assays?"], "ground_truth": ["permed-75764", "permed-75772", "permed-79250", "permed-68891", "permed-87654", "permed-51306", "permed-69211", "permed-79276", "permed-75768", "permed-67311"]}
{"query_id": "topic_622_turn_1", "conversation_id": "topic_622", "turn_id": 1, "query": "Overview of metal oxide applications in photocatalysis and photoelectrochemistry", "history": [], "ground_truth": ["permed-74577", "permed-60900", "permed-74368", "permed-55272", "permed-51006", "permed-53777", "permed-55231", "permed-55249", "permed-64381", "permed-60907"]}
{"query_id": "topic_622_turn_2", "conversation_id": "topic_622", "turn_id": 2, "query": "Enhancing performance of these metal oxides in harsh environments via surface modification techniques", "history": ["Overview of metal oxide applications in photocatalysis and photoelectrochemistry"], "ground_truth": ["permed-53484", "permed-57957", "permed-87439", "permed-78335", "permed-77116", "permed-64381", "permed-55272", "permed-60907", "permed-73201", "permed-90287"]}
{"query_id": "topic_622_turn_3", "conversation_id": "topic_622", "turn_id": 3, "query": "Trivalent nickel in metal oxide amorphous surface layers: mechanisms for enhanced photocatalytic and photoelectrochemical activity and stability in acidic environments", "history": ["Overview of metal oxide applications in photocatalysis and photoelectrochemistry", "Enhancing performance of these metal oxides in harsh environments via surface modification techniques"], "ground_truth": ["permed-55231", "permed-53777", "permed-51997", "permed-59179", "permed-52417", "permed-53484", "permed-74576", "permed-60900", "permed-78807", "permed-51987"]}
{"query_id": "topic_622_turn_4", "conversation_id": "topic_622", "turn_id": 4, "query": "Given the proposed role of trivalent nickel in amorphous surface layers, what specific electrochemical or spectroscopic techniques were employed to quantitatively distinguish between bulk and surface nickel oxidation states during accelerated stability testing? I'm particularly interested in how this methodology accounts for potential redox state fluctuations under operational photocorrosion conditions, and whether X-ray absorption or in situ Raman spectroscopy provided sufficient spatial resolution to correlate localized Ni³⁺ concentrations with degradation resistance metrics.", "history": ["Overview of metal oxide applications in photocatalysis and photoelectrochemistry", "Enhancing performance of these metal oxides in harsh environments via surface modification techniques", "Trivalent nickel in metal oxide amorphous surface layers: mechanisms for enhanced photocatalytic and photoelectrochemical activity and stability in acidic environments"], "ground_truth": ["permed-55231", "permed-73201", "permed-57874", "permed-87252", "permed-51997", "permed-77116", "permed-79777", "permed-51987", "permed-78459", "permed-60922"]}
{"query_id": "topic_622_turn_5", "conversation_id": "topic_622", "turn_id": 5, "query": "Given the methodological approaches for characterizing nickel oxidation states under corrosive conditions, what translational steps have been taken to evaluate the biocompatibility and potential cytotoxicity of these stabilized nickel-containing metal oxides in biomedical applications, such as antimicrobial photocatalytic coatings for medical devices? Specifically, have any clinical or pre-clinical studies assessed systemic safety risks, like nickel ion leaching, and how do these findings inform the risk-benefit analysis for their real-world deployment in patient-facing environments compared to existing materials?", "history": ["Overview of metal oxide applications in photocatalysis and photoelectrochemistry", "Enhancing performance of these metal oxides in harsh environments via surface modification techniques", "Trivalent nickel in metal oxide amorphous surface layers: mechanisms for enhanced photocatalytic and photoelectrochemical activity and stability in acidic environments", "Given the proposed role of trivalent nickel in amorphous surface layers, what specific electrochemical or spectroscopic techniques were employed to quantitatively distinguish between bulk and surface nickel oxidation states during accelerated stability testing? I'm particularly interested in how this methodology accounts for potential redox state fluctuations under operational photocorrosion conditions, and whether X-ray absorption or in situ Raman spectroscopy provided sufficient spatial resolution to correlate localized Ni³⁺ concentrations with degradation resistance metrics."], "ground_truth": ["permed-54879", "permed-91202", "permed-54877", "permed-92656", "permed-40486", "permed-54876", "permed-88069", "permed-87252", "permed-79777", "permed-90323"]}
{"query_id": "topic_623_turn_1", "conversation_id": "topic_623", "turn_id": 1, "query": "What are the main risks associated with cardiovascular surgery in very low birth weight neonates?", "history": [], "ground_truth": ["permed-78497", "permed-81451", "permed-76515", "permed-78499", "permed-58511", "permed-91376", "permed-75429", "permed-45093", "permed-24845", "permed-78501"]}
{"query_id": "topic_623_turn_2", "conversation_id": "topic_623", "turn_id": 2, "query": "How does the timing and complexity of this surgery impact neurological outcomes in these vulnerable patients?", "history": ["What are the main risks associated with cardiovascular surgery in very low birth weight neonates?"], "ground_truth": ["permed-77519", "permed-81646", "permed-54955", "permed-54952", "permed-90040", "permed-66044", "permed-76790", "permed-54995", "permed-54962", "permed-73902"]}
{"query_id": "topic_623_turn_3", "conversation_id": "topic_623", "turn_id": 3, "query": "Beyond birth weight and surgical timing, what other factors contribute to postoperative intracerebral hemorrhage in these neonates undergoing cardiovascular surgery, and how can we address them to better protect their neurological outcomes?", "history": ["What are the main risks associated with cardiovascular surgery in very low birth weight neonates?", "How does the timing and complexity of this surgery impact neurological outcomes in these vulnerable patients?"], "ground_truth": ["permed-78497", "permed-66044", "permed-60482", "permed-51767", "permed-11130", "permed-81646", "permed-60383", "permed-46825", "permed-57352", "permed-70422"]}
{"query_id": "topic_623_turn_4", "conversation_id": "topic_623", "turn_id": 4, "query": "Given these identified risk factors for postoperative intracerebral hemorrhage, what specific intraoperative monitoring protocols and anesthetic management strategies would you recommend implementing during cardiovascular surgery in VLBW neonates? I'm particularly interested in how to optimize cerebral oximetry thresholds, blood pressure management parameters, and coagulation monitoring techniques to detect and prevent neurological injury in real-time. What evidence supports these methodological approaches for neuroprotection?", "history": ["What are the main risks associated with cardiovascular surgery in very low birth weight neonates?", "How does the timing and complexity of this surgery impact neurological outcomes in these vulnerable patients?", "Beyond birth weight and surgical timing, what other factors contribute to postoperative intracerebral hemorrhage in these neonates undergoing cardiovascular surgery, and how can we address them to better protect their neurological outcomes?"], "ground_truth": ["permed-66044", "permed-78497", "permed-76515", "permed-11537", "permed-76792", "permed-51766", "permed-45095", "permed-10659", "permed-71127", "permed-62563"]}
{"query_id": "topic_623_turn_5", "conversation_id": "topic_623", "turn_id": 5, "query": "Given these intraoperative neuroprotective strategies, what postoperative pharmacologic interventions and neurodevelopmental surveillance protocols have demonstrated efficacy in improving long-term cognitive outcomes for VLBW neonates following cardiovascular surgery? Specifically, what clinical evidence supports the use of erythropoietin, therapeutic hypothermia, or anticonvulsant prophylaxis during the critical recovery period, and how should we structure multidisciplinary follow-up programs to optimize neurological development while managing potential medication side effects and parent-reported outcomes?", "history": ["What are the main risks associated with cardiovascular surgery in very low birth weight neonates?", "How does the timing and complexity of this surgery impact neurological outcomes in these vulnerable patients?", "Beyond birth weight and surgical timing, what other factors contribute to postoperative intracerebral hemorrhage in these neonates undergoing cardiovascular surgery, and how can we address them to better protect their neurological outcomes?", "Given these identified risk factors for postoperative intracerebral hemorrhage, what specific intraoperative monitoring protocols and anesthetic management strategies would you recommend implementing during cardiovascular surgery in VLBW neonates? I'm particularly interested in how to optimize cerebral oximetry thresholds, blood pressure management parameters, and coagulation monitoring techniques to detect and prevent neurological injury in real-time. What evidence supports these methodological approaches for neuroprotection?"], "ground_truth": ["permed-66044", "permed-45081", "permed-78497", "permed-81646", "permed-51767", "permed-89544", "permed-71127", "permed-59780", "permed-83684", "permed-90228"]}
{"query_id": "topic_624_turn_1", "conversation_id": "topic_624", "turn_id": 1, "query": "What advancements have been made in gene therapy for severe haemophilia A?", "history": [], "ground_truth": ["permed-71256", "permed-74546", "permed-71255", "permed-18483", "permed-76850", "permed-78804", "permed-71254", "permed-74549", "permed-78805", "permed-71257"]}
{"query_id": "topic_624_turn_2", "conversation_id": "topic_624", "turn_id": 2, "query": "How might this technique be implemented in healthcare systems with limited resources?", "history": ["What advancements have been made in gene therapy for severe haemophilia A?"], "ground_truth": ["permed-91926", "permed-67357", "permed-67465", "permed-60179", "permed-65660", "permed-61882", "permed-61888", "permed-56934", "permed-66148", "permed-65380"]}
{"query_id": "topic_624_turn_3", "conversation_id": "topic_624", "turn_id": 3, "query": "Given the potential of AAV-based gene therapy for severe haemophilia A and the challenges of implementing it in resource-limited settings, how can the Delphi consensus study's principles and practices be adapted to ensure equitable access to this treatment globally, particularly in regions with constrained healthcare infrastructure for haemophilia care?", "history": ["What advancements have been made in gene therapy for severe haemophilia A?", "How might this technique be implemented in healthcare systems with limited resources?"], "ground_truth": ["permed-74546", "permed-71256", "permed-72628", "permed-72629", "permed-80174", "permed-78804", "permed-71254", "permed-76850", "permed-71255", "permed-5141"]}
{"query_id": "topic_624_turn_4", "conversation_id": "topic_624", "turn_id": 4, "query": "Given the Delphi consensus approach for equitable implementation, what specific methodological adaptations would be required to validate this framework in low-resource settings? Could you elaborate on the statistical power calculations for such multi-center validation studies, the standardization protocols for AAV vector potency testing across diverse laboratory infrastructures, and the methodological considerations for establishing longitudinal monitoring systems for treatment efficacy and safety in settings with limited follow-up capacity?", "history": ["What advancements have been made in gene therapy for severe haemophilia A?", "How might this technique be implemented in healthcare systems with limited resources?", "Given the potential of AAV-based gene therapy for severe haemophilia A and the challenges of implementing it in resource-limited settings, how can the Delphi consensus study's principles and practices be adapted to ensure equitable access to this treatment globally, particularly in regions with constrained healthcare infrastructure for haemophilia care?"], "ground_truth": ["permed-74546", "permed-86011", "permed-63533", "permed-70841", "permed-63472", "permed-82306", "permed-72863", "permed-5872", "permed-70629", "permed-22020"]}
{"query_id": "topic_624_turn_5", "conversation_id": "topic_624", "turn_id": 5, "query": "Given these methodological validation frameworks, what clinical outcomes data from existing AAV-based haemophilia A therapies demonstrate real-world therapeutic efficacy and safety profiles? Specifically, what longitudinal evidence exists regarding sustained factor VIII expression levels, reduction in annualized bleeding rates, and incidence of serious adverse events like hepatotoxicity or inhibitor development across diverse patient populations? How do these clinical results inform risk-benefit assessments and treatment protocols for implementing these therapies in varied healthcare settings?", "history": ["What advancements have been made in gene therapy for severe haemophilia A?", "How might this technique be implemented in healthcare systems with limited resources?", "Given the potential of AAV-based gene therapy for severe haemophilia A and the challenges of implementing it in resource-limited settings, how can the Delphi consensus study's principles and practices be adapted to ensure equitable access to this treatment globally, particularly in regions with constrained healthcare infrastructure for haemophilia care?", "Given the Delphi consensus approach for equitable implementation, what specific methodological adaptations would be required to validate this framework in low-resource settings? Could you elaborate on the statistical power calculations for such multi-center validation studies, the standardization protocols for AAV vector potency testing across diverse laboratory infrastructures, and the methodological considerations for establishing longitudinal monitoring systems for treatment efficacy and safety in settings with limited follow-up capacity?"], "ground_truth": ["permed-71256", "permed-74546", "permed-71257", "permed-71255", "permed-71254", "permed-78804", "permed-18484", "permed-89385", "permed-71259", "permed-74545"]}
{"query_id": "topic_625_turn_1", "conversation_id": "topic_625", "turn_id": 1, "query": "What role do income support policies play in reducing health disparities among low-income populations?", "history": [], "ground_truth": ["permed-60173", "permed-60175", "permed-91926", "permed-53056", "permed-67073", "permed-66025", "permed-55112", "permed-53049", "permed-53062", "permed-65927"]}
{"query_id": "topic_625_turn_2", "conversation_id": "topic_625", "turn_id": 2, "query": "Can modifications in programs like the Earned Income Tax Credit significantly impact this area, and if so, what makes them effective?", "history": ["What role do income support policies play in reducing health disparities among low-income populations?"], "ground_truth": ["permed-80093", "permed-80094", "permed-61615", "permed-60173", "permed-58496", "permed-80097", "permed-62758", "permed-82651", "permed-84730", "permed-70632"]}
{"query_id": "topic_625_turn_3", "conversation_id": "topic_625", "turn_id": 3, "query": "Given what we've discussed about income support policies and the Earned Income Tax Credit's potential impact, how could state-level programs like these be specifically optimized in their design and implementation to better reduce health disparities? And what strategies would be most effective for addressing the systemic barriers that limit equitable access to these resources?", "history": ["What role do income support policies play in reducing health disparities among low-income populations?", "Can modifications in programs like the Earned Income Tax Credit significantly impact this area, and if so, what makes them effective?"], "ground_truth": ["permed-60173", "permed-53056", "permed-60175", "permed-55979", "permed-80094", "permed-66025", "permed-80093", "permed-66122", "permed-52219", "permed-82791"]}
{"query_id": "topic_625_turn_4", "conversation_id": "topic_625", "turn_id": 4, "query": "When implementing these state-level program optimizations, what specific methodological approaches would you recommend for evaluating their causal impact on health disparities? I'm particularly interested in how quasi-experimental designs like difference-in-differences or regression discontinuity could be applied to account for confounding variables, and what statistical power calculations would be appropriate for detecting meaningful effect sizes in health outcome measures across different demographic subgroups.", "history": ["What role do income support policies play in reducing health disparities among low-income populations?", "Can modifications in programs like the Earned Income Tax Credit significantly impact this area, and if so, what makes them effective?", "Given what we've discussed about income support policies and the Earned Income Tax Credit's potential impact, how could state-level programs like these be specifically optimized in their design and implementation to better reduce health disparities? And what strategies would be most effective for addressing the systemic barriers that limit equitable access to these resources?"], "ground_truth": ["permed-62788", "permed-90617", "permed-82791", "permed-66122", "permed-52383", "permed-25371", "permed-53056", "permed-23686", "permed-52117", "permed-53878"]}
{"query_id": "topic_625_turn_5", "conversation_id": "topic_625", "turn_id": 5, "query": "Given the methodological frameworks for evaluating causal impacts on health disparities, how have these income support interventions actually translated to clinical outcomes in practice? Specifically, what evidence exists from clinical settings or health system data showing measurable improvements in conditions like hypertension control, diabetes management, or maternal health indicators among low-income patients receiving enhanced benefits? Additionally, are there documented instances where these policies reduced emergency department utilization or hospital readmission rates, and what safety considerations or unintended clinical consequences have emerged from real-world implementation?", "history": ["What role do income support policies play in reducing health disparities among low-income populations?", "Can modifications in programs like the Earned Income Tax Credit significantly impact this area, and if so, what makes them effective?", "Given what we've discussed about income support policies and the Earned Income Tax Credit's potential impact, how could state-level programs like these be specifically optimized in their design and implementation to better reduce health disparities? And what strategies would be most effective for addressing the systemic barriers that limit equitable access to these resources?", "When implementing these state-level program optimizations, what specific methodological approaches would you recommend for evaluating their causal impact on health disparities? I'm particularly interested in how quasi-experimental designs like difference-in-differences or regression discontinuity could be applied to account for confounding variables, and what statistical power calculations would be appropriate for detecting meaningful effect sizes in health outcome measures across different demographic subgroups."], "ground_truth": ["permed-60173", "permed-82583", "permed-66025", "permed-53056", "permed-78480", "permed-80103", "permed-62325", "permed-82791", "permed-87668", "permed-78584"]}
{"query_id": "topic_626_turn_1", "conversation_id": "topic_626", "turn_id": 1, "query": "Comprehensive review of therapeutic interventions for advanced or recurrent pseudomyxoma peritonei deemed surgically unresectable", "history": [], "ground_truth": ["permed-74884", "permed-51390", "permed-92093", "permed-90592", "permed-60122", "permed-54565", "permed-4346", "permed-56525", "permed-75325", "permed-59887"]}
{"query_id": "topic_626_turn_2", "conversation_id": "topic_626", "turn_id": 2, "query": "Comparative efficacy of cytoreductive surgery with multi-organ transplantation versus systemic chemotherapy for palliative intent in these cases of unresectable pseudomyxoma peritonei", "history": ["Comprehensive review of therapeutic interventions for advanced or recurrent pseudomyxoma peritonei deemed surgically unresectable"], "ground_truth": ["permed-74884", "permed-51390", "permed-4346", "permed-56525", "permed-54565", "permed-92093", "permed-75294", "permed-68553", "permed-4351", "permed-56382"]}
{"query_id": "topic_626_turn_3", "conversation_id": "topic_626", "turn_id": 3, "query": "Detailed analysis of long-term survival, post-operative morbidity, and quality of life metrics following intestinal and/or multi-visceral transplantation for such advanced/recurrent unresectable PMP, contrasted with outcomes from serial debulking surgeries or novel biologic agent therapies", "history": ["Comprehensive review of therapeutic interventions for advanced or recurrent pseudomyxoma peritonei deemed surgically unresectable", "Comparative efficacy of cytoreductive surgery with multi-organ transplantation versus systemic chemotherapy for palliative intent in these cases of unresectable pseudomyxoma peritonei"], "ground_truth": ["permed-74884", "permed-59960", "permed-49312", "permed-52131", "permed-90193", "permed-91420", "permed-31619", "permed-52132", "permed-86535", "permed-75336"]}
{"query_id": "topic_626_turn_4", "conversation_id": "topic_626", "turn_id": 4, "query": "Regarding the long-term outcomes comparison you described, what specific statistical methodologies were employed to handle competing risks and time-varying covariates when analyzing survival data across these heterogeneous treatment groups? Were propensity score matching techniques or inverse probability weighting used to address selection bias, and how did the validation of these statistical approaches account for center-specific variations in transplantation protocols versus systemic therapy administration?", "history": ["Comprehensive review of therapeutic interventions for advanced or recurrent pseudomyxoma peritonei deemed surgically unresectable", "Comparative efficacy of cytoreductive surgery with multi-organ transplantation versus systemic chemotherapy for palliative intent in these cases of unresectable pseudomyxoma peritonei", "Detailed analysis of long-term survival, post-operative morbidity, and quality of life metrics following intestinal and/or multi-visceral transplantation for such advanced/recurrent unresectable PMP, contrasted with outcomes from serial debulking surgeries or novel biologic agent therapies"], "ground_truth": ["permed-90521", "permed-80123", "permed-9588", "permed-51749", "permed-62732", "permed-81427", "permed-83155", "permed-37830", "permed-56389", "permed-51746"]}
{"query_id": "topic_626_turn_5", "conversation_id": "topic_626", "turn_id": 5, "query": "Given the sophisticated statistical approaches discussed for handling treatment heterogeneity, how do the cumulative incidence functions and cause-specific hazard ratios from competing risks analyses compare between transplantation and systemic therapy cohorts when examining disease-specific mortality versus treatment-related deaths? Specifically, what were the comparative magnitudes of the subdistribution hazard ratios for each endpoint, and did these reveal different risk-benefit profiles when contrasting transplantation's higher procedure-related mortality against systemic therapy's longer-term disease progression risks?", "history": ["Comprehensive review of therapeutic interventions for advanced or recurrent pseudomyxoma peritonei deemed surgically unresectable", "Comparative efficacy of cytoreductive surgery with multi-organ transplantation versus systemic chemotherapy for palliative intent in these cases of unresectable pseudomyxoma peritonei", "Detailed analysis of long-term survival, post-operative morbidity, and quality of life metrics following intestinal and/or multi-visceral transplantation for such advanced/recurrent unresectable PMP, contrasted with outcomes from serial debulking surgeries or novel biologic agent therapies", "Regarding the long-term outcomes comparison you described, what specific statistical methodologies were employed to handle competing risks and time-varying covariates when analyzing survival data across these heterogeneous treatment groups? Were propensity score matching techniques or inverse probability weighting used to address selection bias, and how did the validation of these statistical approaches account for center-specific variations in transplantation protocols versus systemic therapy administration?"], "ground_truth": ["permed-83155", "permed-80129", "permed-83023", "permed-60531", "permed-56389", "permed-82638", "permed-2606", "permed-71366", "permed-81427", "permed-91868"]}
{"query_id": "topic_627_turn_1", "conversation_id": "topic_627", "turn_id": 1, "query": "Latest breakthroughs and key advancements in biomaterials for dental and orthopedic applications", "history": [], "ground_truth": ["permed-74615", "permed-75202", "permed-90323", "permed-92165", "permed-64454", "permed-31461", "permed-74610", "permed-91508", "permed-64482", "permed-75208"]}
{"query_id": "topic_627_turn_2", "conversation_id": "topic_627", "turn_id": 2, "query": "Building on these biomaterial advancements, how do specific glass-ceramics like lithium disilicate fare in terms of biocompatibility and mechanical strength for dental and orthopedic uses?", "history": ["Latest breakthroughs and key advancements in biomaterials for dental and orthopedic applications"], "ground_truth": ["permed-74610", "permed-91503", "permed-83121", "permed-75699", "permed-74615", "permed-37091", "permed-64485", "permed-54879", "permed-52106", "permed-64491"]}
{"query_id": "topic_627_turn_3", "conversation_id": "topic_627", "turn_id": 3, "query": "Exploring ion-exchange process modifications in lithium disilicate using different ionic species to enhance its biocompatibility, mechanical strength, soft tissue integration, and antimicrobial activity for advanced dental and orthopedic biomaterials.", "history": ["Latest breakthroughs and key advancements in biomaterials for dental and orthopedic applications", "Building on these biomaterial advancements, how do specific glass-ceramics like lithium disilicate fare in terms of biocompatibility and mechanical strength for dental and orthopedic uses?"], "ground_truth": ["permed-74610", "permed-91503", "permed-74615", "permed-83121", "permed-74612", "permed-64491", "permed-64652", "permed-90322", "permed-90324", "permed-82543"]}
{"query_id": "topic_627_turn_4", "conversation_id": "topic_627", "turn_id": 4, "query": "When implementing these ion-exchange modifications with different ionic species, what specific experimental protocols are used to quantify the resulting changes in fracture toughness and flexural strength? How do researchers control for variables like exchange duration and temperature to ensure reproducibility across different lithium disilicate formulations? Additionally, what statistical validation methods are employed to correlate ionic substitution levels with measured improvements in antimicrobial efficacy and soft tissue integration parameters?", "history": ["Latest breakthroughs and key advancements in biomaterials for dental and orthopedic applications", "Building on these biomaterial advancements, how do specific glass-ceramics like lithium disilicate fare in terms of biocompatibility and mechanical strength for dental and orthopedic uses?", "Exploring ion-exchange process modifications in lithium disilicate using different ionic species to enhance its biocompatibility, mechanical strength, soft tissue integration, and antimicrobial activity for advanced dental and orthopedic biomaterials."], "ground_truth": ["permed-74610", "permed-83121", "permed-91503", "permed-40482", "permed-60587", "permed-74612", "permed-84021", "permed-37078", "permed-81244", "permed-82540"]}
{"query_id": "topic_627_turn_5", "conversation_id": "topic_627", "turn_id": 5, "query": "Given the detailed methodological approaches for quantifying mechanical and biological properties of ion-exchanged lithium disilicate, how do the resulting property profiles compare across different ionic substitutions—such as silver versus zinc versus strontium—in terms of their trade-offs between antimicrobial efficacy, osseointegration potential, and mechanical durability? Specifically, what comparative analyses exist regarding whether certain ions preferentially enhance biological performance at the expense of strength parameters, and are there systematic reviews ranking these ionic modifications for specific clinical applications in load-bearing versus non-load-bearing sites?", "history": ["Latest breakthroughs and key advancements in biomaterials for dental and orthopedic applications", "Building on these biomaterial advancements, how do specific glass-ceramics like lithium disilicate fare in terms of biocompatibility and mechanical strength for dental and orthopedic uses?", "Exploring ion-exchange process modifications in lithium disilicate using different ionic species to enhance its biocompatibility, mechanical strength, soft tissue integration, and antimicrobial activity for advanced dental and orthopedic biomaterials.", "When implementing these ion-exchange modifications with different ionic species, what specific experimental protocols are used to quantify the resulting changes in fracture toughness and flexural strength? How do researchers control for variables like exchange duration and temperature to ensure reproducibility across different lithium disilicate formulations? Additionally, what statistical validation methods are employed to correlate ionic substitution levels with measured improvements in antimicrobial efficacy and soft tissue integration parameters?"], "ground_truth": ["permed-74610", "permed-83121", "permed-37078", "permed-91503", "permed-74612", "permed-83546", "permed-60916", "permed-54888", "permed-55436", "permed-82543"]}
{"query_id": "topic_628_turn_1", "conversation_id": "topic_628", "turn_id": 1, "query": "Effectiveness of mindfulness-based interventions for anxiety disorders and overall mental well-being", "history": [], "ground_truth": ["permed-55519", "permed-71425", "permed-55517", "permed-71421", "permed-71420", "permed-80557", "permed-72368", "permed-83168", "permed-55525", "permed-74908"]}
{"query_id": "topic_628_turn_2", "conversation_id": "topic_628", "turn_id": 2, "query": "Comparing online vs in-person delivery of these mindfulness interventions for such mental health outcomes", "history": ["Effectiveness of mindfulness-based interventions for anxiety disorders and overall mental well-being"], "ground_truth": ["permed-55517", "permed-55519", "permed-82573", "permed-74908", "permed-81456", "permed-90601", "permed-55518", "permed-66153", "permed-80201", "permed-71423"]}
{"query_id": "topic_628_turn_3", "conversation_id": "topic_628", "turn_id": 3, "query": "Long-term effects of audio-based online mindfulness programs on resilience and emotional regulation in individuals with varying anxiety levels post-pandemic, versus in-person formats", "history": ["Effectiveness of mindfulness-based interventions for anxiety disorders and overall mental well-being", "Comparing online vs in-person delivery of these mindfulness interventions for such mental health outcomes"], "ground_truth": ["permed-55519", "permed-55520", "permed-55517", "permed-55774", "permed-55518", "permed-55521", "permed-69423", "permed-72368", "permed-74341", "permed-71425"]}
{"query_id": "topic_628_turn_4", "conversation_id": "topic_628", "turn_id": 4, "query": "Given this comparison design between audio-based online and in-person mindfulness formats, what specific statistical approaches would best account for baseline anxiety severity when analyzing longitudinal resilience outcomes? I'm particularly interested in whether you'd recommend mixed-effects models to handle repeated measures and dropout patterns, and what covariates should be included to ensure proper adjustment for pre-existing anxiety differences across delivery modalities while maintaining statistical power throughout the extended follow-up period.", "history": ["Effectiveness of mindfulness-based interventions for anxiety disorders and overall mental well-being", "Comparing online vs in-person delivery of these mindfulness interventions for such mental health outcomes", "Long-term effects of audio-based online mindfulness programs on resilience and emotional regulation in individuals with varying anxiety levels post-pandemic, versus in-person formats"], "ground_truth": ["permed-55519", "permed-71420", "permed-55518", "permed-55517", "permed-55774", "permed-71419", "permed-55520", "permed-79607", "permed-71421", "permed-69423"]}
{"query_id": "topic_628_turn_5", "conversation_id": "topic_628", "turn_id": 5, "query": "Given these sophisticated longitudinal modeling considerations for comparing intervention formats, what clinical implications emerge regarding which patient populations might benefit most from audio-based online mindfulness versus traditional in-person delivery? Specifically, based on existing trial evidence, are there particular demographic factors, anxiety severity thresholds, or comorbidities that predict differential therapeutic response—and how should clinicians weigh accessibility benefits of digital formats against potential limitations in managing complex cases? Additionally, what safety monitoring protocols have proven effective for detecting treatment-emergent adverse effects in remote mindfulness interventions?", "history": ["Effectiveness of mindfulness-based interventions for anxiety disorders and overall mental well-being", "Comparing online vs in-person delivery of these mindfulness interventions for such mental health outcomes", "Long-term effects of audio-based online mindfulness programs on resilience and emotional regulation in individuals with varying anxiety levels post-pandemic, versus in-person formats", "Given this comparison design between audio-based online and in-person mindfulness formats, what specific statistical approaches would best account for baseline anxiety severity when analyzing longitudinal resilience outcomes? I'm particularly interested in whether you'd recommend mixed-effects models to handle repeated measures and dropout patterns, and what covariates should be included to ensure proper adjustment for pre-existing anxiety differences across delivery modalities while maintaining statistical power throughout the extended follow-up period."], "ground_truth": ["permed-55519", "permed-55518", "permed-55517", "permed-58543", "permed-55523", "permed-69423", "permed-87457", "permed-71618", "permed-74908", "permed-81456"]}
{"query_id": "topic_629_turn_1", "conversation_id": "topic_629", "turn_id": 1, "query": "What role do radiomic features play in the diagnosis and treatment planning of epithelial ovarian carcinoma?", "history": [], "ground_truth": ["permed-78182", "permed-51378", "permed-56101", "permed-78171", "permed-91240", "permed-60534", "permed-56460", "permed-56157", "permed-71523", "permed-56461"]}
{"query_id": "topic_629_turn_2", "conversation_id": "topic_629", "turn_id": 2, "query": "Can integrating it with genomic and proteomic data enhance its utility in differentiating between histological subtypes of this cancer?", "history": ["What role do radiomic features play in the diagnosis and treatment planning of epithelial ovarian carcinoma?"], "ground_truth": ["permed-50940", "permed-53428", "permed-53434", "permed-70768", "permed-50751", "permed-78182", "permed-70448", "permed-51817", "permed-56195", "permed-78467"]}
{"query_id": "topic_629_turn_3", "conversation_id": "topic_629", "turn_id": 3, "query": "Building on these findings about radiomic features from contrast-enhanced CT and their integration with genomic and proteomic data, how could we develop a comprehensive multimodal model for patient stratification and personalized treatment planning in epithelial ovarian carcinoma? What would be the key challenges and ethical considerations in implementing such an approach across diverse clinical settings?", "history": ["What role do radiomic features play in the diagnosis and treatment planning of epithelial ovarian carcinoma?", "Can integrating it with genomic and proteomic data enhance its utility in differentiating between histological subtypes of this cancer?"], "ground_truth": ["permed-78182", "permed-56101", "permed-13503", "permed-29157", "permed-56831", "permed-72790", "permed-78171", "permed-91240", "permed-56460", "permed-59580"]}
{"query_id": "topic_629_turn_4", "conversation_id": "topic_629", "turn_id": 4, "query": "When implementing this comprehensive multimodal model, what specific statistical integration methods would be most appropriate for combining radiomic, genomic, and proteomic data? I'm particularly interested in whether we should use early fusion versus late fusion approaches, and what validation strategy - perhaps nested cross-validation or bootstrapping - would best address potential overfitting given the high-dimensional nature of these heterogeneous data sources. Additionally, how should we standardize feature extraction protocols across different CT scanners to ensure reproducibility?", "history": ["What role do radiomic features play in the diagnosis and treatment planning of epithelial ovarian carcinoma?", "Can integrating it with genomic and proteomic data enhance its utility in differentiating between histological subtypes of this cancer?", "Building on these findings about radiomic features from contrast-enhanced CT and their integration with genomic and proteomic data, how could we develop a comprehensive multimodal model for patient stratification and personalized treatment planning in epithelial ovarian carcinoma? What would be the key challenges and ethical considerations in implementing such an approach across diverse clinical settings?"], "ground_truth": ["permed-63378", "permed-56460", "permed-61948", "permed-3173", "permed-42513", "permed-58784", "permed-53436", "permed-60568", "permed-62531", "permed-56238"]}
{"query_id": "topic_629_turn_5", "conversation_id": "topic_629", "turn_id": 5, "query": "Given the proposed multimodal integration framework and validation strategies, what clinical trial designs would be most appropriate to evaluate the real-world therapeutic efficacy and safety of this personalized approach? Specifically, how might we structure trials to assess whether radiogenomic-guided treatment decisions actually improve progression-free survival or reduce unnecessary toxicities compared to standard chemotherapy regimens in epithelial ovarian carcinoma patients? What patient-reported outcomes and monitoring protocols should be incorporated to capture both clinical benefits and potential unforeseen side effects of this precision medicine strategy?", "history": ["What role do radiomic features play in the diagnosis and treatment planning of epithelial ovarian carcinoma?", "Can integrating it with genomic and proteomic data enhance its utility in differentiating between histological subtypes of this cancer?", "Building on these findings about radiomic features from contrast-enhanced CT and their integration with genomic and proteomic data, how could we develop a comprehensive multimodal model for patient stratification and personalized treatment planning in epithelial ovarian carcinoma? What would be the key challenges and ethical considerations in implementing such an approach across diverse clinical settings?", "When implementing this comprehensive multimodal model, what specific statistical integration methods would be most appropriate for combining radiomic, genomic, and proteomic data? I'm particularly interested in whether we should use early fusion versus late fusion approaches, and what validation strategy - perhaps nested cross-validation or bootstrapping - would best address potential overfitting given the high-dimensional nature of these heterogeneous data sources. Additionally, how should we standardize feature extraction protocols across different CT scanners to ensure reproducibility?"], "ground_truth": ["permed-92181", "permed-51692", "permed-78182", "permed-90481", "permed-56101", "permed-52522", "permed-56318", "permed-51383", "permed-67852", "permed-56781"]}
{"query_id": "topic_630_turn_1", "conversation_id": "topic_630", "turn_id": 1, "query": "What advancements have been made in neuroimaging techniques for diagnosing and monitoring brain disorders like multiple sclerosis?", "history": [], "ground_truth": ["permed-8161", "permed-84419", "permed-8435", "permed-53332", "permed-9256", "permed-72904", "permed-29647", "permed-86973", "permed-29367", "permed-9257"]}
{"query_id": "topic_630_turn_2", "conversation_id": "topic_630", "turn_id": 2, "query": "How might newer imaging technologies, such as diffusion-weighted imaging, impact the detection and management of lesions in this area?", "history": ["What advancements have been made in neuroimaging techniques for diagnosing and monitoring brain disorders like multiple sclerosis?"], "ground_truth": ["permed-56321", "permed-51379", "permed-55912", "permed-75849", "permed-56444", "permed-17028", "permed-74985", "permed-56435", "permed-51383", "permed-56433"]}
{"query_id": "topic_630_turn_3", "conversation_id": "topic_630", "turn_id": 3, "query": "How might using simultaneous multislice (SMS) diffusion-weighted imaging (DWI) improve the precision and speed of lesion detection in MS patients compared to traditional DWI methods we've discussed? And what could this mean for managing and monitoring their treatment?", "history": ["What advancements have been made in neuroimaging techniques for diagnosing and monitoring brain disorders like multiple sclerosis?", "How might newer imaging technologies, such as diffusion-weighted imaging, impact the detection and management of lesions in this area?"], "ground_truth": ["permed-79137", "permed-55912", "permed-17852", "permed-61140", "permed-28444", "permed-84419", "permed-84345", "permed-11743", "permed-29467", "permed-56321"]}
{"query_id": "topic_630_turn_4", "conversation_id": "topic_630", "turn_id": 4, "query": "When implementing SMS-DWI for MS lesion tracking, what specific acquisition parameters and reconstruction algorithms are most critical for maintaining anatomical accuracy while achieving accelerated scan times? Particularly, how do choices in acceleration factors, parallel imaging techniques, and distortion correction methods affect the quantitative reliability of derived diffusion metrics like fractional anisotropy in longitudinal studies?", "history": ["What advancements have been made in neuroimaging techniques for diagnosing and monitoring brain disorders like multiple sclerosis?", "How might newer imaging technologies, such as diffusion-weighted imaging, impact the detection and management of lesions in this area?", "How might using simultaneous multislice (SMS) diffusion-weighted imaging (DWI) improve the precision and speed of lesion detection in MS patients compared to traditional DWI methods we've discussed? And what could this mean for managing and monitoring their treatment?"], "ground_truth": ["permed-79137", "permed-17852", "permed-51662", "permed-29527", "permed-28106", "permed-29467", "permed-29519", "permed-55121", "permed-28806", "permed-29180"]}
{"query_id": "topic_630_turn_5", "conversation_id": "topic_630", "turn_id": 5, "query": "Given the technical optimization of SMS-DWI parameters for quantitative reliability in MS monitoring, what clinical evidence exists regarding its impact on patient management decisions? Specifically, how do the improved lesion detection rates and diffusion metric precision translate into earlier treatment modifications or more personalized therapy escalation in relapsing-remitting MS patients? Furthermore, have any longitudinal studies demonstrated correlations between SMS-DWI-derived biomarker changes and clinical outcomes like EDSS progression or relapse frequency, and what are the practical implementation barriers preventing wider adoption in routine neurology practice?", "history": ["What advancements have been made in neuroimaging techniques for diagnosing and monitoring brain disorders like multiple sclerosis?", "How might newer imaging technologies, such as diffusion-weighted imaging, impact the detection and management of lesions in this area?", "How might using simultaneous multislice (SMS) diffusion-weighted imaging (DWI) improve the precision and speed of lesion detection in MS patients compared to traditional DWI methods we've discussed? And what could this mean for managing and monitoring their treatment?", "When implementing SMS-DWI for MS lesion tracking, what specific acquisition parameters and reconstruction algorithms are most critical for maintaining anatomical accuracy while achieving accelerated scan times? Particularly, how do choices in acceleration factors, parallel imaging techniques, and distortion correction methods affect the quantitative reliability of derived diffusion metrics like fractional anisotropy in longitudinal studies?"], "ground_truth": ["permed-79137", "permed-17852", "permed-65055", "permed-29467", "permed-73684", "permed-84419", "permed-87859", "permed-72508", "permed-70671", "permed-55912"]}
{"query_id": "topic_631_turn_1", "conversation_id": "topic_631", "turn_id": 1, "query": "Overview of FDG PET/CT applications in diagnosing and staging hepatocellular carcinoma metastases", "history": [], "ground_truth": ["permed-16910", "permed-3633", "permed-23985", "permed-16911", "permed-75289", "permed-48461", "permed-56107", "permed-23989", "permed-21492", "permed-5108"]}
{"query_id": "topic_631_turn_2", "conversation_id": "topic_631", "turn_id": 2, "query": "Building on its diagnostic role, can specific FDG PET/CT metabolic patterns in these hepatocellular carcinoma metastases, such as hypermetabolism or hypometabolism, indicate tumor aggressiveness?", "history": ["Overview of FDG PET/CT applications in diagnosing and staging hepatocellular carcinoma metastases"], "ground_truth": ["permed-56107", "permed-16910", "permed-77481", "permed-3633", "permed-48461", "permed-48695", "permed-32086", "permed-16911", "permed-32089", "permed-48492"]}
{"query_id": "topic_631_turn_3", "conversation_id": "topic_631", "turn_id": 3, "query": "Given these observed metabolic activity patterns, what is the clinical significance of the 'hot gloved finger sign' on FDG PET/CT for predicting aggressiveness and treatment response in endobronchial metastases of hepatocellular carcinoma, and how does this inform personalized treatment strategies?", "history": ["Overview of FDG PET/CT applications in diagnosing and staging hepatocellular carcinoma metastases", "Building on its diagnostic role, can specific FDG PET/CT metabolic patterns in these hepatocellular carcinoma metastases, such as hypermetabolism or hypometabolism, indicate tumor aggressiveness?"], "ground_truth": ["permed-77481", "permed-56107", "permed-48682", "permed-20916", "permed-48606", "permed-16910", "permed-32084", "permed-3633", "permed-48695", "permed-32082"]}
{"query_id": "topic_631_turn_4", "conversation_id": "topic_631", "turn_id": 4, "query": "When quantifying the 'hot gloved finger sign' you mentioned, what specific SUVmax threshold criteria and volumetric analysis protocols are used to standardize its assessment across different PET/CT scanners? How do researchers control for respiratory motion artifacts during image acquisition, and what statistical methods—such as intraclass correlation coefficients or Cohen's kappa—are employed to validate inter-observer reproducibility when multiple radiologists characterize this sign's metabolic intensity and spatial distribution patterns?", "history": ["Overview of FDG PET/CT applications in diagnosing and staging hepatocellular carcinoma metastases", "Building on its diagnostic role, can specific FDG PET/CT metabolic patterns in these hepatocellular carcinoma metastases, such as hypermetabolism or hypometabolism, indicate tumor aggressiveness?", "Given these observed metabolic activity patterns, what is the clinical significance of the 'hot gloved finger sign' on FDG PET/CT for predicting aggressiveness and treatment response in endobronchial metastases of hepatocellular carcinoma, and how does this inform personalized treatment strategies?"], "ground_truth": ["permed-48764", "permed-77481", "permed-60573", "permed-56768", "permed-87857", "permed-77495", "permed-56660", "permed-60564", "permed-61950", "permed-61845"]}
{"query_id": "topic_631_turn_5", "conversation_id": "topic_631", "turn_id": 5, "query": "Given these quantification protocols and validation methods for the 'hot gloved finger sign,' how does the diagnostic and prognostic performance of FDG PET/CT compare with contrast-enhanced MRI when detecting endobronchial metastases from hepatocellular carcinoma? Specifically, what are the comparative advantages in spatial resolution versus metabolic activity assessment, and what evidence exists regarding their relative accuracy in predicting treatment response and survival outcomes across different patient subgroups with varying tumor differentiation grades?", "history": ["Overview of FDG PET/CT applications in diagnosing and staging hepatocellular carcinoma metastases", "Building on its diagnostic role, can specific FDG PET/CT metabolic patterns in these hepatocellular carcinoma metastases, such as hypermetabolism or hypometabolism, indicate tumor aggressiveness?", "Given these observed metabolic activity patterns, what is the clinical significance of the 'hot gloved finger sign' on FDG PET/CT for predicting aggressiveness and treatment response in endobronchial metastases of hepatocellular carcinoma, and how does this inform personalized treatment strategies?", "When quantifying the 'hot gloved finger sign' you mentioned, what specific SUVmax threshold criteria and volumetric analysis protocols are used to standardize its assessment across different PET/CT scanners? How do researchers control for respiratory motion artifacts during image acquisition, and what statistical methods—such as intraclass correlation coefficients or Cohen's kappa—are employed to validate inter-observer reproducibility when multiple radiologists characterize this sign's metabolic intensity and spatial distribution patterns?"], "ground_truth": ["permed-77481", "permed-75289", "permed-75290", "permed-16910", "permed-56107", "permed-61159", "permed-16911", "permed-77463", "permed-48429", "permed-28409"]}
{"query_id": "topic_632_turn_1", "conversation_id": "topic_632", "turn_id": 1, "query": "Key risk factors for fractures in postmenopausal women", "history": [], "ground_truth": ["permed-77933", "permed-76431", "permed-61981", "permed-90492", "permed-90491", "permed-58571", "permed-85781", "permed-72781", "permed-58958", "permed-69191"]}
{"query_id": "topic_632_turn_2", "conversation_id": "topic_632", "turn_id": 2, "query": "How does this fracture risk in postmenopausal women differ between central (e.g., hip, spine) and peripheral (e.g., wrist, ankle) skeletal sites?", "history": ["Key risk factors for fractures in postmenopausal women"], "ground_truth": ["permed-77933", "permed-77934", "permed-85781", "permed-90492", "permed-53905", "permed-58571", "permed-64352", "permed-29308", "permed-54154", "permed-19274"]}
{"query_id": "topic_632_turn_3", "conversation_id": "topic_632", "turn_id": 3, "query": "Impact of physical activity and dietary interventions on modulating site-specific (central vs. peripheral) fracture risk progression with age in postmenopausal women", "history": ["Key risk factors for fractures in postmenopausal women", "How does this fracture risk in postmenopausal women differ between central (e.g., hip, spine) and peripheral (e.g., wrist, ankle) skeletal sites?"], "ground_truth": ["permed-77933", "permed-61981", "permed-80411", "permed-72781", "permed-65029", "permed-79841", "permed-90034", "permed-77937", "permed-85781", "permed-76431"]}
{"query_id": "topic_632_turn_4", "conversation_id": "topic_632", "turn_id": 4, "query": "When implementing these combined physical activity and dietary interventions, what specific randomization procedures and stratification factors were employed to ensure balanced groups across age cohorts and baseline bone mineral density? Additionally, how were adherence metrics quantitatively tracked for both exercise protocols and nutritional compliance, and what statistical methods were used to account for potential confounding variables like medication use or comorbidities when analyzing site-specific fracture outcomes over the longitudinal follow-up period?", "history": ["Key risk factors for fractures in postmenopausal women", "How does this fracture risk in postmenopausal women differ between central (e.g., hip, spine) and peripheral (e.g., wrist, ankle) skeletal sites?", "Impact of physical activity and dietary interventions on modulating site-specific (central vs. peripheral) fracture risk progression with age in postmenopausal women"], "ground_truth": ["permed-81949", "permed-77937", "permed-81454", "permed-68395", "permed-81763", "permed-77934", "permed-69758", "permed-63213", "permed-5336", "permed-86952"]}
{"query_id": "topic_632_turn_5", "conversation_id": "topic_632", "turn_id": 5, "query": "Given the rigorous methodology for tracking intervention adherence and controlling confounders, what were the actual clinical outcomes regarding site-specific fracture risk reduction? Specifically, in postmenopausal women participating in these combined physical activity and dietary programs, how did the incidence of vertebral fractures compare to hip fractures, and were there any emergent safety concerns or differential side effect profiles between the intervention components, particularly regarding musculoskeletal injuries from exercise versus gastrointestinal issues from nutritional supplements, that might impact real-world clinical implementation?", "history": ["Key risk factors for fractures in postmenopausal women", "How does this fracture risk in postmenopausal women differ between central (e.g., hip, spine) and peripheral (e.g., wrist, ankle) skeletal sites?", "Impact of physical activity and dietary interventions on modulating site-specific (central vs. peripheral) fracture risk progression with age in postmenopausal women", "When implementing these combined physical activity and dietary interventions, what specific randomization procedures and stratification factors were employed to ensure balanced groups across age cohorts and baseline bone mineral density? Additionally, how were adherence metrics quantitatively tracked for both exercise protocols and nutritional compliance, and what statistical methods were used to account for potential confounding variables like medication use or comorbidities when analyzing site-specific fracture outcomes over the longitudinal follow-up period?"], "ground_truth": ["permed-77937", "permed-77933", "permed-81763", "permed-91706", "permed-84304", "permed-68395", "permed-90034", "permed-68401", "permed-63213", "permed-73728"]}
{"query_id": "topic_633_turn_1", "conversation_id": "topic_633", "turn_id": 1, "query": "What's known about the relationship between cardiovascular health and multiple sclerosis progression?", "history": [], "ground_truth": ["permed-81502", "permed-73686", "permed-81297", "permed-73685", "permed-86928", "permed-65452", "permed-81505", "permed-52043", "permed-52540", "permed-51059"]}
{"query_id": "topic_633_turn_2", "conversation_id": "topic_633", "turn_id": 2, "query": "Does managing cardiovascular risk factors have a significant impact on the disease course in patients with relapsing-remitting MS?", "history": ["What's known about the relationship between cardiovascular health and multiple sclerosis progression?"], "ground_truth": ["permed-81502", "permed-73686", "permed-86635", "permed-70671", "permed-81504", "permed-53269", "permed-81297", "permed-73690", "permed-86928", "permed-87859"]}
{"query_id": "topic_633_turn_3", "conversation_id": "topic_633", "turn_id": 3, "query": "Given this potential impact of cardiovascular risk management on disease course, how might long-term control of these factors influence disability progression and the transition to secondary progressive MS in patients who start with relapsing-remitting MS?", "history": ["What's known about the relationship between cardiovascular health and multiple sclerosis progression?", "Does managing cardiovascular risk factors have a significant impact on the disease course in patients with relapsing-remitting MS?"], "ground_truth": ["permed-81502", "permed-73686", "permed-81504", "permed-65055", "permed-72508", "permed-70671", "permed-81297", "permed-73742", "permed-77587", "permed-78016"]}
{"query_id": "topic_633_turn_4", "conversation_id": "topic_633", "turn_id": 4, "query": "Given this investigation of long-term cardiovascular risk management, what specific methodological approaches would you recommend for analyzing longitudinal disability data? I'm particularly interested in how to statistically model the transition to secondary progressive MS - would you use time-to-event analysis with specific covariates, or employ multi-state models? Also, what validation strategies would ensure the reliability of these progression metrics across different clinical settings, especially when dealing with potential confounding by treatments and comorbidities?", "history": ["What's known about the relationship between cardiovascular health and multiple sclerosis progression?", "Does managing cardiovascular risk factors have a significant impact on the disease course in patients with relapsing-remitting MS?", "Given this potential impact of cardiovascular risk management on disease course, how might long-term control of these factors influence disability progression and the transition to secondary progressive MS in patients who start with relapsing-remitting MS?"], "ground_truth": ["permed-70671", "permed-65055", "permed-72508", "permed-81502", "permed-73686", "permed-81504", "permed-77587", "permed-81503", "permed-77585", "permed-73690"]}
{"query_id": "topic_633_turn_5", "conversation_id": "topic_633", "turn_id": 5, "query": "Given these sophisticated statistical approaches for modeling disability progression, what clinical evidence exists regarding the real-world efficacy of specific cardiovascular interventions? For MS patients with comorbid hypertension or dyslipidemia, do particular antihypertensive or lipid-lowering therapies demonstrate superior outcomes in delaying disability progression or secondary progressive MS transition compared to others? Additionally, what safety considerations or drug-specific contraindications have emerged when combining these cardiovascular treatments with common MS disease-modifying therapies in clinical practice?", "history": ["What's known about the relationship between cardiovascular health and multiple sclerosis progression?", "Does managing cardiovascular risk factors have a significant impact on the disease course in patients with relapsing-remitting MS?", "Given this potential impact of cardiovascular risk management on disease course, how might long-term control of these factors influence disability progression and the transition to secondary progressive MS in patients who start with relapsing-remitting MS?", "Given this investigation of long-term cardiovascular risk management, what specific methodological approaches would you recommend for analyzing longitudinal disability data? I'm particularly interested in how to statistically model the transition to secondary progressive MS - would you use time-to-event analysis with specific covariates, or employ multi-state models? Also, what validation strategies would ensure the reliability of these progression metrics across different clinical settings, especially when dealing with potential confounding by treatments and comorbidities?"], "ground_truth": ["permed-81502", "permed-72508", "permed-26213", "permed-60084", "permed-86166", "permed-92290", "permed-91912", "permed-58889", "permed-8886", "permed-81297"]}
{"query_id": "topic_634_turn_1", "conversation_id": "topic_634", "turn_id": 1, "query": "Evidence of gut microbiota association with schizophrenia and bipolar disorder", "history": [], "ground_truth": ["permed-68213", "permed-75063", "permed-75064", "permed-63226", "permed-72282", "permed-63192", "permed-84661", "permed-83490", "permed-40732", "permed-90092"]}
{"query_id": "topic_634_turn_2", "conversation_id": "topic_634", "turn_id": 2, "query": "How does this gut microbiota association inform therapeutic interventions for these psychiatric disorders?", "history": ["Evidence of gut microbiota association with schizophrenia and bipolar disorder"], "ground_truth": ["permed-63197", "permed-63200", "permed-54218", "permed-63186", "permed-68213", "permed-75063", "permed-72282", "permed-69017", "permed-83490", "permed-68214"]}
{"query_id": "topic_634_turn_3", "conversation_id": "topic_634", "turn_id": 3, "query": "Targeting specific gut microbial taxa and metabolic pathways in emerging adults with schizophrenia or bipolar disorder: impact on symptoms, treatment efficacy, and long-term gut-brain axis modulation.", "history": ["Evidence of gut microbiota association with schizophrenia and bipolar disorder", "How does this gut microbiota association inform therapeutic interventions for these psychiatric disorders?"], "ground_truth": ["permed-75063", "permed-68213", "permed-75064", "permed-63186", "permed-90092", "permed-69017", "permed-63189", "permed-83490", "permed-84661", "permed-72282"]}
{"query_id": "topic_634_turn_4", "conversation_id": "topic_634", "turn_id": 4, "query": "In this targeted microbial intervention approach, what specific experimental protocols are being used to modulate gut microbial taxa and metabolic pathways? I'm particularly interested in the technical implementation details - are you using specific probiotic formulations, fecal microbiota transplantation protocols, or dietary interventions? Additionally, what statistical methods are being employed to validate the efficacy of these interventions while accounting for potential confounders like medication use and comorbidity status in these emerging adult populations?", "history": ["Evidence of gut microbiota association with schizophrenia and bipolar disorder", "How does this gut microbiota association inform therapeutic interventions for these psychiatric disorders?", "Targeting specific gut microbial taxa and metabolic pathways in emerging adults with schizophrenia or bipolar disorder: impact on symptoms, treatment efficacy, and long-term gut-brain axis modulation."], "ground_truth": ["permed-84072", "permed-58588", "permed-56496", "permed-71560", "permed-63197", "permed-3055", "permed-58594", "permed-82561", "permed-51267", "permed-66746"]}
{"query_id": "topic_634_turn_5", "conversation_id": "topic_634", "turn_id": 5, "query": "Given the detailed experimental protocols discussed, how do the efficacy profiles of these three intervention modalities—specific probiotic formulations, fecal microbiota transplantation, and dietary interventions—compare when implemented in emerging adults with schizophrenia or bipolar disorder? I'm particularly interested in a systematic comparison of their relative advantages and limitations concerning speed of symptom improvement, durability of gut-brain axis modulation, and practical implementation challenges within clinical settings, especially considering the need to control for psychiatric medication regimens.", "history": ["Evidence of gut microbiota association with schizophrenia and bipolar disorder", "How does this gut microbiota association inform therapeutic interventions for these psychiatric disorders?", "Targeting specific gut microbial taxa and metabolic pathways in emerging adults with schizophrenia or bipolar disorder: impact on symptoms, treatment efficacy, and long-term gut-brain axis modulation.", "In this targeted microbial intervention approach, what specific experimental protocols are being used to modulate gut microbial taxa and metabolic pathways? I'm particularly interested in the technical implementation details - are you using specific probiotic formulations, fecal microbiota transplantation protocols, or dietary interventions? Additionally, what statistical methods are being employed to validate the efficacy of these interventions while accounting for potential confounders like medication use and comorbidity status in these emerging adult populations?"], "ground_truth": ["permed-75063", "permed-75064", "permed-68213", "permed-55777", "permed-55745", "permed-66745", "permed-82573", "permed-63200", "permed-49939", "permed-4309"]}
{"query_id": "topic_635_turn_1", "conversation_id": "topic_635", "turn_id": 1, "query": "Exploring key considerations for colic surgery in mares, with an initial focus on anesthesia protocols and post-operative care.", "history": [], "ground_truth": ["permed-74692", "permed-70535", "permed-57794", "permed-57726", "permed-57723", "permed-92093", "permed-67315", "permed-3121", "permed-10887", "permed-76448"]}
{"query_id": "topic_635_turn_2", "conversation_id": "topic_635", "turn_id": 2, "query": "Regarding these aspects, how do varying anesthetic techniques and perioperative management influence colic surgery outcomes in mares, specifically contrasting pregnant and non-pregnant patients?", "history": ["Exploring key considerations for colic surgery in mares, with an initial focus on anesthesia protocols and post-operative care."], "ground_truth": ["permed-74692", "permed-76448", "permed-66077", "permed-10887", "permed-70535", "permed-57726", "permed-57723", "permed-3121", "permed-57794", "permed-91375"]}
{"query_id": "topic_635_turn_3", "conversation_id": "topic_635", "turn_id": 3, "query": "Given the differing impacts of anesthesia and perioperative strategies on pregnant versus non-pregnant mares, what is the subsequent effect on incisional complication rates and types post-colic surgery, and what tailored approaches can optimize recovery for each group?", "history": ["Exploring key considerations for colic surgery in mares, with an initial focus on anesthesia protocols and post-operative care.", "Regarding these aspects, how do varying anesthetic techniques and perioperative management influence colic surgery outcomes in mares, specifically contrasting pregnant and non-pregnant patients?"], "ground_truth": ["permed-74692", "permed-6782", "permed-7192", "permed-73417", "permed-53903", "permed-87771", "permed-64807", "permed-6608", "permed-66077", "permed-70535"]}
{"query_id": "topic_635_turn_4", "conversation_id": "topic_635", "turn_id": 4, "query": "Regarding these tailored approaches for minimizing incisional complications, could you elaborate on the specific surgical closure techniques and suture material selections employed for different abdominal layers in pregnant versus non-pregnant mares? I'm particularly interested in how the fascial closure protocols differ between groups, what tension-reducing strategies are implemented, and whether specific wound dressing protocols or drainage systems are systematically evaluated for their impact on infection rates in these distinct patient populations.", "history": ["Exploring key considerations for colic surgery in mares, with an initial focus on anesthesia protocols and post-operative care.", "Regarding these aspects, how do varying anesthetic techniques and perioperative management influence colic surgery outcomes in mares, specifically contrasting pregnant and non-pregnant patients?", "Given the differing impacts of anesthesia and perioperative strategies on pregnant versus non-pregnant mares, what is the subsequent effect on incisional complication rates and types post-colic surgery, and what tailored approaches can optimize recovery for each group?"], "ground_truth": ["permed-74692", "permed-85382", "permed-84561", "permed-7224", "permed-79370", "permed-75315", "permed-75302", "permed-79371", "permed-7225", "permed-7223"]}
{"query_id": "topic_635_turn_5", "conversation_id": "topic_635", "turn_id": 5, "query": "Given the detailed discussion of surgical closure techniques and tension management strategies for minimizing incisional complications, how do these technical approaches translate to actual clinical outcomes regarding long-term survival and future reproductive success in pregnant mares undergoing colic surgery? Specifically, what evidence exists from clinical trials or large case series evaluating both the safety of various fascial closure protocols during pregnancy and their subsequent impact on foaling outcomes, including any documented risks of uterine compromise or abortion rates associated with different abdominal wall reconstruction techniques?", "history": ["Exploring key considerations for colic surgery in mares, with an initial focus on anesthesia protocols and post-operative care.", "Regarding these aspects, how do varying anesthetic techniques and perioperative management influence colic surgery outcomes in mares, specifically contrasting pregnant and non-pregnant patients?", "Given the differing impacts of anesthesia and perioperative strategies on pregnant versus non-pregnant mares, what is the subsequent effect on incisional complication rates and types post-colic surgery, and what tailored approaches can optimize recovery for each group?", "Regarding these tailored approaches for minimizing incisional complications, could you elaborate on the specific surgical closure techniques and suture material selections employed for different abdominal layers in pregnant versus non-pregnant mares? I'm particularly interested in how the fascial closure protocols differ between groups, what tension-reducing strategies are implemented, and whether specific wound dressing protocols or drainage systems are systematically evaluated for their impact on infection rates in these distinct patient populations."], "ground_truth": ["permed-74692", "permed-81644", "permed-7190", "permed-74696", "permed-7223", "permed-78369", "permed-51190", "permed-31358", "permed-57716", "permed-84262"]}
{"query_id": "topic_636_turn_1", "conversation_id": "topic_636", "turn_id": 1, "query": "What role does photobiomodulation play in tissue regeneration and repair, particularly with stem cells?", "history": [], "ground_truth": ["permed-51831", "permed-48239", "permed-64755", "permed-81145", "permed-38737", "permed-52632", "permed-12931", "permed-12442", "permed-57056", "permed-34149"]}
{"query_id": "topic_636_turn_2", "conversation_id": "topic_636", "turn_id": 2, "query": "How do variations in this technique's parameters, such as wavelength and exposure duration, affect its efficacy in promoting cellular proliferation and differentiation?", "history": ["What role does photobiomodulation play in tissue regeneration and repair, particularly with stem cells?"], "ground_truth": ["permed-45520", "permed-92390", "permed-88116", "permed-75194", "permed-92562", "permed-40549", "permed-51686", "permed-51701", "permed-79184", "permed-73919"]}
{"query_id": "topic_636_turn_3", "conversation_id": "topic_636", "turn_id": 3, "query": "Given what we know about how these parameters affect cellular proliferation and differentiation, how would adjusting wavelength, power density, and exposure duration specifically impact the long-term behavior of periodontal ligament stem cells (PDLSCs) in vitro? And how might these changes relate to the intracellular signaling pathways involved in tissue regeneration and repair?", "history": ["What role does photobiomodulation play in tissue regeneration and repair, particularly with stem cells?", "How do variations in this technique's parameters, such as wavelength and exposure duration, affect its efficacy in promoting cellular proliferation and differentiation?"], "ground_truth": ["permed-64755", "permed-51834", "permed-51829", "permed-91914", "permed-75194", "permed-72082", "permed-51831", "permed-40406", "permed-51835", "permed-75246"]}
{"query_id": "topic_636_turn_4", "conversation_id": "topic_636", "turn_id": 4, "query": "When implementing these parameter adjustments with PDLSCs, what specific experimental protocols would you recommend for measuring their long-term effects on intracellular signaling pathways? More precisely, what time-points and sampling intervals would be optimal for tracking sustained pathway activation, which statistical methods would best validate the dose-response relationships between irradiation parameters and molecular outcomes, and how should we control for potential photothermal effects that might confound the signaling pathway analysis?", "history": ["What role does photobiomodulation play in tissue regeneration and repair, particularly with stem cells?", "How do variations in this technique's parameters, such as wavelength and exposure duration, affect its efficacy in promoting cellular proliferation and differentiation?", "Given what we know about how these parameters affect cellular proliferation and differentiation, how would adjusting wavelength, power density, and exposure duration specifically impact the long-term behavior of periodontal ligament stem cells (PDLSCs) in vitro? And how might these changes relate to the intracellular signaling pathways involved in tissue regeneration and repair?"], "ground_truth": ["permed-80451", "permed-67784", "permed-64755", "permed-67783", "permed-56542", "permed-39967", "permed-77498", "permed-90191", "permed-69255", "permed-22555"]}
{"query_id": "topic_636_turn_5", "conversation_id": "topic_636", "turn_id": 5, "query": "Given these detailed experimental protocols for tracking intracellular signaling in PDLSCs, how might these photobiomodulation parameter adjustments translate to clinical applications for periodontal regeneration? Specifically, what evidence exists from human trials or case studies regarding the therapeutic window for irradiation parameters that maximize tissue regeneration while minimizing adverse effects like inflammation or unintended differentiation? Furthermore, what practical challenges exist in adapting these precisely controlled in vitro parameters to clinical settings where patient variability and anatomical constraints might affect treatment efficacy?", "history": ["What role does photobiomodulation play in tissue regeneration and repair, particularly with stem cells?", "How do variations in this technique's parameters, such as wavelength and exposure duration, affect its efficacy in promoting cellular proliferation and differentiation?", "Given what we know about how these parameters affect cellular proliferation and differentiation, how would adjusting wavelength, power density, and exposure duration specifically impact the long-term behavior of periodontal ligament stem cells (PDLSCs) in vitro? And how might these changes relate to the intracellular signaling pathways involved in tissue regeneration and repair?", "When implementing these parameter adjustments with PDLSCs, what specific experimental protocols would you recommend for measuring their long-term effects on intracellular signaling pathways? More precisely, what time-points and sampling intervals would be optimal for tracking sustained pathway activation, which statistical methods would best validate the dose-response relationships between irradiation parameters and molecular outcomes, and how should we control for potential photothermal effects that might confound the signaling pathway analysis?"], "ground_truth": ["permed-64755", "permed-72082", "permed-64756", "permed-51831", "permed-52632", "permed-48239", "permed-12337", "permed-67784", "permed-34149", "permed-38737"]}
{"query_id": "topic_637_turn_1", "conversation_id": "topic_637", "turn_id": 1, "query": "Key risk factors for type 2 diabetes in older adults", "history": [], "ground_truth": ["permed-58958", "permed-76346", "permed-54664", "permed-81334", "permed-66461", "permed-54663", "permed-58745", "permed-52175", "permed-34591", "permed-54667"]}
{"query_id": "topic_637_turn_2", "conversation_id": "topic_637", "turn_id": 2, "query": "Socioeconomic determinants of these type 2 diabetes risks for older adults in nursing home environments", "history": ["Key risk factors for type 2 diabetes in older adults"], "ground_truth": ["permed-76346", "permed-54664", "permed-84684", "permed-57029", "permed-35366", "permed-75652", "permed-88175", "permed-81334", "permed-54663", "permed-35371"]}
{"query_id": "topic_637_turn_3", "conversation_id": "topic_637", "turn_id": 3, "query": "Differential impact of employment history and income on type 2 diabetes risk: Danish older adults in nursing homes versus those living independently", "history": ["Key risk factors for type 2 diabetes in older adults", "Socioeconomic determinants of these type 2 diabetes risks for older adults in nursing home environments"], "ground_truth": ["permed-76346", "permed-84684", "permed-54664", "permed-20865", "permed-79840", "permed-54663", "permed-78591", "permed-35366", "permed-34591", "permed-81334"]}
{"query_id": "topic_637_turn_4", "conversation_id": "topic_637", "turn_id": 4, "query": "When analyzing these retrospective cohort data, what specific statistical approaches did you employ to control for confounding variables like medication adherence and comorbidities? Did you use propensity score matching between nursing home and independent living groups, and how did you validate the balance achieved? Also, what sensitivity analyses were conducted to test the robustness of your employment history and income association estimates against unmeasured confounding?", "history": ["Key risk factors for type 2 diabetes in older adults", "Socioeconomic determinants of these type 2 diabetes risks for older adults in nursing home environments", "Differential impact of employment history and income on type 2 diabetes risk: Danish older adults in nursing homes versus those living independently"], "ground_truth": ["permed-75381", "permed-51746", "permed-87616", "permed-65673", "permed-90896", "permed-77043", "permed-65457", "permed-85778", "permed-92068", "permed-80187"]}
{"query_id": "topic_637_turn_5", "conversation_id": "topic_637", "turn_id": 5, "query": "Given your detailed methodological approach to addressing confounding, how do the strengths and limitations of propensity score matching for nursing home populations compare to alternative techniques like inverse probability weighting or g-computation when analyzing socioeconomic exposures? Specifically, in terms of handling time-varying confounders like evolving comorbidity status and medication adherence patterns, which method demonstrated superior balance-performance tradeoffs in your Danish cohort data, and would you recommend different approaches for retrospective versus prospective studies of this nature?", "history": ["Key risk factors for type 2 diabetes in older adults", "Socioeconomic determinants of these type 2 diabetes risks for older adults in nursing home environments", "Differential impact of employment history and income on type 2 diabetes risk: Danish older adults in nursing homes versus those living independently", "When analyzing these retrospective cohort data, what specific statistical approaches did you employ to control for confounding variables like medication adherence and comorbidities? Did you use propensity score matching between nursing home and independent living groups, and how did you validate the balance achieved? Also, what sensitivity analyses were conducted to test the robustness of your employment history and income association estimates against unmeasured confounding?"], "ground_truth": ["permed-79199", "permed-35841", "permed-25467", "permed-37282", "permed-25771", "permed-55085", "permed-35363", "permed-78652", "permed-35580", "permed-90896"]}
{"query_id": "topic_638_turn_1", "conversation_id": "topic_638", "turn_id": 1, "query": "What role do microbial communities play in wastewater treatment, particularly in removing nitrogen and phosphorus?", "history": [], "ground_truth": ["permed-63999", "permed-66990", "permed-66568", "permed-82010", "permed-83483", "permed-66569", "permed-81868", "permed-82395", "permed-82396", "permed-66571"]}
{"query_id": "topic_638_turn_2", "conversation_id": "topic_638", "turn_id": 2, "query": "How can understanding the interactions within these microbial communities, such as those in algal-bacterial aerobic granular sludge, improve this process?", "history": ["What role do microbial communities play in wastewater treatment, particularly in removing nitrogen and phosphorus?"], "ground_truth": ["permed-66568", "permed-87936", "permed-82394", "permed-89590", "permed-83483", "permed-82010", "permed-66569", "permed-89738", "permed-85267", "permed-66640"]}
{"query_id": "topic_638_turn_3", "conversation_id": "topic_638", "turn_id": 3, "query": "Given the importance of these microbial interactions in A-AGS systems, how can we further elucidate the specific metabolic relationships between Thauera and other genera to optimize simultaneous nitrogen and phosphorus removal—particularly by examining extracellular polymeric substances and the expression of key functional genes involved in nitrification, denitrification, and polyphosphate accumulation?", "history": ["What role do microbial communities play in wastewater treatment, particularly in removing nitrogen and phosphorus?", "How can understanding the interactions within these microbial communities, such as those in algal-bacterial aerobic granular sludge, improve this process?"], "ground_truth": ["permed-66568", "permed-78332", "permed-82395", "permed-82396", "permed-63999", "permed-89113", "permed-90410", "permed-89740", "permed-81868", "permed-80532"]}
{"query_id": "topic_638_turn_4", "conversation_id": "topic_638", "turn_id": 4, "query": "Considering this proposed investigation of Thauera's metabolic relationships through EPS analysis and functional gene expression, what specific methodological approach would you recommend for quantifying extracellular polymeric substance composition while simultaneously tracking functional gene expression dynamics in A-AGS systems? I'm particularly interested in how to technically coordinate these measurements—whether through correlated sampling protocols, integrated omics approaches, or specialized cultivation techniques that maintain system integrity during both EPS extraction and RNA sequencing procedures.", "history": ["What role do microbial communities play in wastewater treatment, particularly in removing nitrogen and phosphorus?", "How can understanding the interactions within these microbial communities, such as those in algal-bacterial aerobic granular sludge, improve this process?", "Given the importance of these microbial interactions in A-AGS systems, how can we further elucidate the specific metabolic relationships between Thauera and other genera to optimize simultaneous nitrogen and phosphorus removal—particularly by examining extracellular polymeric substances and the expression of key functional genes involved in nitrification, denitrification, and polyphosphate accumulation?"], "ground_truth": ["permed-84325", "permed-65248", "permed-52999", "permed-77014", "permed-66568", "permed-65241", "permed-62116", "permed-87936", "permed-76652", "permed-66181"]}
{"query_id": "topic_638_turn_5", "conversation_id": "topic_638", "turn_id": 5, "query": "Given these methodological approaches for analyzing EPS composition and functional gene expression in A-AGS systems, how might these findings translate to clinical applications? Specifically, what potential do optimized microbial consortia have for treating hospital wastewater containing pharmaceutical residues and pathogens, and what clinical evidence exists regarding their efficacy in reducing antimicrobial resistance gene transfer while maintaining system stability under real-world healthcare facility conditions?", "history": ["What role do microbial communities play in wastewater treatment, particularly in removing nitrogen and phosphorus?", "How can understanding the interactions within these microbial communities, such as those in algal-bacterial aerobic granular sludge, improve this process?", "Given the importance of these microbial interactions in A-AGS systems, how can we further elucidate the specific metabolic relationships between Thauera and other genera to optimize simultaneous nitrogen and phosphorus removal—particularly by examining extracellular polymeric substances and the expression of key functional genes involved in nitrification, denitrification, and polyphosphate accumulation?", "Considering this proposed investigation of Thauera's metabolic relationships through EPS analysis and functional gene expression, what specific methodological approach would you recommend for quantifying extracellular polymeric substance composition while simultaneously tracking functional gene expression dynamics in A-AGS systems? I'm particularly interested in how to technically coordinate these measurements—whether through correlated sampling protocols, integrated omics approaches, or specialized cultivation techniques that maintain system integrity during both EPS extraction and RNA sequencing procedures."], "ground_truth": ["permed-83483", "permed-82010", "permed-66764", "permed-66820", "permed-82233", "permed-60413", "permed-60411", "permed-74044", "permed-83310", "permed-66770"]}
{"query_id": "topic_639_turn_1", "conversation_id": "topic_639", "turn_id": 1, "query": "Current public health strategies for managing infectious disease outbreaks in urban environments", "history": [], "ground_truth": ["permed-54928", "permed-88327", "permed-91926", "permed-68153", "permed-66153", "permed-68512", "permed-85521", "permed-75608", "permed-68513", "permed-59273"]}
{"query_id": "topic_639_turn_2", "conversation_id": "topic_639", "turn_id": 2, "query": "Role of public venue utilization analysis in enhancing effectiveness of these urban infectious disease management strategies", "history": ["Current public health strategies for managing infectious disease outbreaks in urban environments"], "ground_truth": ["permed-54928", "permed-88327", "permed-59266", "permed-73393", "permed-59273", "permed-73395", "permed-59274", "permed-67297", "permed-73394", "permed-66153"]}
{"query_id": "topic_639_turn_3", "conversation_id": "topic_639", "turn_id": 3, "query": "Applications of combined temporal-spatial analysis of public venue usage and epidemiological data for targeted non-pharmaceutical interventions (NPIs) in dense urban outbreak management", "history": ["Current public health strategies for managing infectious disease outbreaks in urban environments", "Role of public venue utilization analysis in enhancing effectiveness of these urban infectious disease management strategies"], "ground_truth": ["permed-88327", "permed-73393", "permed-73395", "permed-73394", "permed-59273", "permed-61937", "permed-54928", "permed-71792", "permed-59269", "permed-61930"]}
{"query_id": "topic_639_turn_4", "conversation_id": "topic_639", "turn_id": 4, "query": "For these combined temporal-spatial analyses, what specific statistical methodologies are most appropriate for quantifying the association between venue occupancy patterns and localized transmission rates? I'm particularly interested in how researchers account for temporal lags between mobility data and case reporting, and what spatial regression techniques (like geographically weighted regression) have proven effective for handling the autocorrelation inherent in urban epidemiological data while maintaining interpretability for public health implementation.", "history": ["Current public health strategies for managing infectious disease outbreaks in urban environments", "Role of public venue utilization analysis in enhancing effectiveness of these urban infectious disease management strategies", "Applications of combined temporal-spatial analysis of public venue usage and epidemiological data for targeted non-pharmaceutical interventions (NPIs) in dense urban outbreak management"], "ground_truth": ["permed-73394", "permed-59209", "permed-61937", "permed-58483", "permed-59265", "permed-62367", "permed-57882", "permed-65884", "permed-73393", "permed-59266"]}
{"query_id": "topic_639_turn_5", "conversation_id": "topic_639", "turn_id": 5, "query": "Given the methodological considerations for temporal-spatial analyses we've discussed, how do Bayesian spatiotemporal models compare against frequentist approaches like geographically weighted regression when quantifying venue-transmission relationships? Specifically, what are the relative advantages in handling delayed case reporting and spatial autocorrelation, and how do their computational demands and interpretability trade-offs affect practical implementation for public health decision-making during rapidly evolving urban outbreaks?", "history": ["Current public health strategies for managing infectious disease outbreaks in urban environments", "Role of public venue utilization analysis in enhancing effectiveness of these urban infectious disease management strategies", "Applications of combined temporal-spatial analysis of public venue usage and epidemiological data for targeted non-pharmaceutical interventions (NPIs) in dense urban outbreak management", "For these combined temporal-spatial analyses, what specific statistical methodologies are most appropriate for quantifying the association between venue occupancy patterns and localized transmission rates? I'm particularly interested in how researchers account for temporal lags between mobility data and case reporting, and what spatial regression techniques (like geographically weighted regression) have proven effective for handling the autocorrelation inherent in urban epidemiological data while maintaining interpretability for public health implementation."], "ground_truth": ["permed-61935", "permed-62367", "permed-61937", "permed-73394", "permed-59201", "permed-59207", "permed-59199", "permed-54940", "permed-58483", "permed-65884"]}
{"query_id": "topic_640_turn_1", "conversation_id": "topic_640", "turn_id": 1, "query": "What role can physiotherapists play in supporting patient care during a pandemic?", "history": [], "ground_truth": ["permed-52536", "permed-79805", "permed-60993", "permed-71303", "permed-68370", "permed-91602", "permed-85232", "permed-71991", "permed-70904", "permed-72360"]}
{"query_id": "topic_640_turn_2", "conversation_id": "topic_640", "turn_id": 2, "query": "How might integrating them into ICU teams impact the quality and efficiency of care in this setting?", "history": ["What role can physiotherapists play in supporting patient care during a pandemic?"], "ground_truth": ["permed-65753", "permed-11813", "permed-50059", "permed-79805", "permed-80232", "permed-67145", "permed-27141", "permed-77531", "permed-44868", "permed-68403"]}
{"query_id": "topic_640_turn_3", "conversation_id": "topic_640", "turn_id": 3, "query": "Given their potential role in ICU teams during a pandemic, how would integrating specialized critical care physiotherapists into a multidisciplinary model affect care efficiency and quality during a severe surge? And what specific competencies and training would these physiotherapists need to effectively support ICU operations in such scenarios?", "history": ["What role can physiotherapists play in supporting patient care during a pandemic?", "How might integrating them into ICU teams impact the quality and efficiency of care in this setting?"], "ground_truth": ["permed-79805", "permed-80232", "permed-52536", "permed-60993", "permed-50085", "permed-65751", "permed-65753", "permed-72360", "permed-77784", "permed-62341"]}
{"query_id": "topic_640_turn_4", "conversation_id": "topic_640", "turn_id": 4, "query": "Given this multidisciplinary integration model, what specific outcome measures and data collection protocols would be most appropriate to quantitatively assess both care efficiency (like ventilator weaning time or ICU length of stay) and care quality (like functional mobility scores) in a surge context? How would you design the statistical analysis to control for confounding variables such as patient acuity and comorbidities when evaluating the impact of these specialized physiotherapists?", "history": ["What role can physiotherapists play in supporting patient care during a pandemic?", "How might integrating them into ICU teams impact the quality and efficiency of care in this setting?", "Given their potential role in ICU teams during a pandemic, how would integrating specialized critical care physiotherapists into a multidisciplinary model affect care efficiency and quality during a severe surge? And what specific competencies and training would these physiotherapists need to effectively support ICU operations in such scenarios?"], "ground_truth": ["permed-79805", "permed-68398", "permed-61424", "permed-83067", "permed-55091", "permed-44777", "permed-61542", "permed-45397", "permed-70192", "permed-89565"]}
{"query_id": "topic_640_turn_5", "conversation_id": "topic_640", "turn_id": 5, "query": "Given these proposed outcome measures and statistical controls, how would the effectiveness of specialized critical care physiotherapists compare against other ICU team expansions—such as additional respiratory therapists or advanced practice nurses—in improving both care efficiency metrics and long-term patient functional outcomes during pandemic surges? What comparative evidence exists regarding the relative cost-benefit ratios and resource utilization trade-offs between these different staffing augmentation strategies when managing critically ill patients under surge capacity constraints?", "history": ["What role can physiotherapists play in supporting patient care during a pandemic?", "How might integrating them into ICU teams impact the quality and efficiency of care in this setting?", "Given their potential role in ICU teams during a pandemic, how would integrating specialized critical care physiotherapists into a multidisciplinary model affect care efficiency and quality during a severe surge? And what specific competencies and training would these physiotherapists need to effectively support ICU operations in such scenarios?", "Given this multidisciplinary integration model, what specific outcome measures and data collection protocols would be most appropriate to quantitatively assess both care efficiency (like ventilator weaning time or ICU length of stay) and care quality (like functional mobility scores) in a surge context? How would you design the statistical analysis to control for confounding variables such as patient acuity and comorbidities when evaluating the impact of these specialized physiotherapists?"], "ground_truth": ["permed-79805", "permed-80232", "permed-50059", "permed-62324", "permed-62341", "permed-71659", "permed-61424", "permed-77784", "permed-65751", "permed-89540"]}
{"query_id": "topic_641_turn_1", "conversation_id": "topic_641", "turn_id": 1, "query": "What advancements have been made in natural gas sweetening technologies to improve efficiency and reduce environmental impact?", "history": [], "ground_truth": ["permed-73177", "permed-73173", "permed-77339", "permed-73190", "permed-66989", "permed-73181", "permed-81893", "permed-89584", "permed-82651", "permed-90410"]}
{"query_id": "topic_641_turn_2", "conversation_id": "topic_641", "turn_id": 2, "query": "How effective are hybrid solvent blends, like those using Sulfolane and MDEA, in this area compared to traditional solvents?", "history": ["What advancements have been made in natural gas sweetening technologies to improve efficiency and reduce environmental impact?"], "ground_truth": ["permed-73177", "permed-80931", "permed-80680", "permed-73152", "permed-88698", "permed-80927", "permed-65007", "permed-75686", "permed-86649", "permed-73175"]}
{"query_id": "topic_641_turn_3", "conversation_id": "topic_641", "turn_id": 3, "query": "Given these promising results with Sulfolane-MDEA blends in natural gas sweetening, how might their advantages in energy efficiency, cost, and environmental impact drive broader adoption in other industrial gas purification processes? What research gaps remain regarding their long-term stability, recyclability, and full lifecycle impacts that would need addressing before wider implementation?", "history": ["What advancements have been made in natural gas sweetening technologies to improve efficiency and reduce environmental impact?", "How effective are hybrid solvent blends, like those using Sulfolane and MDEA, in this area compared to traditional solvents?"], "ground_truth": ["permed-73177", "permed-73180", "permed-73172", "permed-81353", "permed-66872", "permed-66640", "permed-74965", "permed-79286", "permed-86678", "permed-73175"]}
{"query_id": "topic_641_turn_4", "conversation_id": "topic_641", "turn_id": 4, "query": "Given these promising advantages of Sulfolane-MDEA blends, what specific experimental protocols have been developed to quantify their solvent degradation rates under continuous operation? I'm particularly interested in the analytical techniques used to monitor thermal and oxidative degradation products, how accelerated aging tests are designed to simulate long-term industrial conditions, and what statistical models researchers employ to predict solvent lifetime based on operational parameters like temperature, oxygen exposure, and acid gas loading cycles.", "history": ["What advancements have been made in natural gas sweetening technologies to improve efficiency and reduce environmental impact?", "How effective are hybrid solvent blends, like those using Sulfolane and MDEA, in this area compared to traditional solvents?", "Given these promising results with Sulfolane-MDEA blends in natural gas sweetening, how might their advantages in energy efficiency, cost, and environmental impact drive broader adoption in other industrial gas purification processes? What research gaps remain regarding their long-term stability, recyclability, and full lifecycle impacts that would need addressing before wider implementation?"], "ground_truth": ["permed-82682", "permed-84327", "permed-73177", "permed-80680", "permed-75477", "permed-86678", "permed-74960", "permed-80931", "permed-39613", "permed-80077"]}
{"query_id": "topic_641_turn_5", "conversation_id": "topic_641", "turn_id": 5, "query": "Given the detailed degradation protocols discussed, how do the long-term stability predictions for Sulfolane-MDEA blends quantitatively compare to those for other advanced solvent systems like ionic liquids or phase-change solvents under equivalent operational conditions? Specifically, what do comparative lifecycle assessments reveal about the trade-offs between solvent degradation rates, energy consumption for regeneration, and environmental footprint across these different solvent classes when considering full-scale industrial implementation over multi-year operational horizons?", "history": ["What advancements have been made in natural gas sweetening technologies to improve efficiency and reduce environmental impact?", "How effective are hybrid solvent blends, like those using Sulfolane and MDEA, in this area compared to traditional solvents?", "Given these promising results with Sulfolane-MDEA blends in natural gas sweetening, how might their advantages in energy efficiency, cost, and environmental impact drive broader adoption in other industrial gas purification processes? What research gaps remain regarding their long-term stability, recyclability, and full lifecycle impacts that would need addressing before wider implementation?", "Given these promising advantages of Sulfolane-MDEA blends, what specific experimental protocols have been developed to quantify their solvent degradation rates under continuous operation? I'm particularly interested in the analytical techniques used to monitor thermal and oxidative degradation products, how accelerated aging tests are designed to simulate long-term industrial conditions, and what statistical models researchers employ to predict solvent lifetime based on operational parameters like temperature, oxygen exposure, and acid gas loading cycles."], "ground_truth": ["permed-73177", "permed-80931", "permed-62610", "permed-80680", "permed-73176", "permed-80927", "permed-64003", "permed-73175", "permed-78334", "permed-65007"]}
{"query_id": "topic_642_turn_1", "conversation_id": "topic_642", "turn_id": 1, "query": "What are the current treatments for deep vein thrombosis that involve stenting and anticoagulation therapy?", "history": [], "ground_truth": ["permed-51399", "permed-51398", "permed-78946", "permed-60513", "permed-6568", "permed-71333", "permed-56947", "permed-56265", "permed-3378", "permed-21409"]}
{"query_id": "topic_642_turn_2", "conversation_id": "topic_642", "turn_id": 2, "query": "How effective is this combination of stenting and anticoagulation in preventing long-term complications, such as recurrence of thrombosis?", "history": ["What are the current treatments for deep vein thrombosis that involve stenting and anticoagulation therapy?"], "ground_truth": ["permed-51398", "permed-59718", "permed-51399", "permed-56947", "permed-76313", "permed-57404", "permed-7905", "permed-56958", "permed-66103", "permed-71333"]}
{"query_id": "topic_642_turn_3", "conversation_id": "topic_642", "turn_id": 3, "query": "How does using different types of factor XA inhibitors alongside venous stenting affect long-term vein patency and DVT recurrence rates compared to standard anticoagulation alone? What mechanisms might explain any differences in outcomes between these approaches?", "history": ["What are the current treatments for deep vein thrombosis that involve stenting and anticoagulation therapy?", "How effective is this combination of stenting and anticoagulation in preventing long-term complications, such as recurrence of thrombosis?"], "ground_truth": ["permed-51398", "permed-76313", "permed-80290", "permed-6568", "permed-80291", "permed-57382", "permed-80876", "permed-51399", "permed-51400", "permed-57057"]}
{"query_id": "topic_642_turn_4", "conversation_id": "topic_642", "turn_id": 4, "query": "For the comparison between factor XA inhibitors and standard anticoagulation alongside stenting, what specific patient stratification protocols and randomization methods were employed in the trial designs to control for confounding factors like thrombus burden or anatomical location? Additionally, how was vein patency quantitatively assessed—were standardized duplex ultrasound criteria and centralized core lab readings used to ensure consistent endpoint adjudication across study sites?", "history": ["What are the current treatments for deep vein thrombosis that involve stenting and anticoagulation therapy?", "How effective is this combination of stenting and anticoagulation in preventing long-term complications, such as recurrence of thrombosis?", "How does using different types of factor XA inhibitors alongside venous stenting affect long-term vein patency and DVT recurrence rates compared to standard anticoagulation alone? What mechanisms might explain any differences in outcomes between these approaches?"], "ground_truth": ["permed-51398", "permed-80290", "permed-86690", "permed-57087", "permed-56955", "permed-6124", "permed-27423", "permed-57084", "permed-85773", "permed-24005"]}
{"query_id": "topic_642_turn_5", "conversation_id": "topic_642", "turn_id": 5, "query": "Given the rigorous trial design and standardized imaging protocols we've discussed, what clinical outcomes have been observed regarding post-thrombotic syndrome incidence and severity scores when comparing factor XA inhibitors versus standard anticoagulation in stented DVT patients? Specifically, how do these regimens impact patient-reported quality of life measures and functional disability rates over 12-24 month follow-up periods? Furthermore, what safety profiles emerged concerning major bleeding events and stent thrombosis requiring reintervention in real-world practice settings beyond controlled trial environments?", "history": ["What are the current treatments for deep vein thrombosis that involve stenting and anticoagulation therapy?", "How effective is this combination of stenting and anticoagulation in preventing long-term complications, such as recurrence of thrombosis?", "How does using different types of factor XA inhibitors alongside venous stenting affect long-term vein patency and DVT recurrence rates compared to standard anticoagulation alone? What mechanisms might explain any differences in outcomes between these approaches?", "For the comparison between factor XA inhibitors and standard anticoagulation alongside stenting, what specific patient stratification protocols and randomization methods were employed in the trial designs to control for confounding factors like thrombus burden or anatomical location? Additionally, how was vein patency quantitatively assessed—were standardized duplex ultrasound criteria and centralized core lab readings used to ensure consistent endpoint adjudication across study sites?"], "ground_truth": ["permed-51398", "permed-51399", "permed-80290", "permed-57382", "permed-57084", "permed-57090", "permed-80291", "permed-56955", "permed-20970", "permed-86690"]}
{"query_id": "topic_643_turn_1", "conversation_id": "topic_643", "turn_id": 1, "query": "Cerebellum role in Alzheimer's and related neurodegenerative conditions", "history": [], "ground_truth": ["permed-71706", "permed-77264", "permed-77417", "permed-66783", "permed-59387", "permed-67923", "permed-66780", "permed-66354", "permed-51238", "permed-63310"]}
{"query_id": "topic_643_turn_2", "conversation_id": "topic_643", "turn_id": 2, "query": "How do these cerebellar alterations influence early Alzheimer's disease detection and pathology?", "history": ["Cerebellum role in Alzheimer's and related neurodegenerative conditions"], "ground_truth": ["permed-77264", "permed-90882", "permed-51518", "permed-81318", "permed-71706", "permed-74936", "permed-74983", "permed-86879", "permed-53618", "permed-7913"]}
{"query_id": "topic_643_turn_3", "conversation_id": "topic_643", "turn_id": 3, "query": "Advanced techniques combining cerebellar electrophysiology and neuroimaging for identifying pre-symptomatic Alzheimer's biomarkers based on neural activity changes", "history": ["Cerebellum role in Alzheimer's and related neurodegenerative conditions", "How do these cerebellar alterations influence early Alzheimer's disease detection and pathology?"], "ground_truth": ["permed-77264", "permed-90882", "permed-63310", "permed-51623", "permed-51615", "permed-52877", "permed-84891", "permed-52242", "permed-81140", "permed-77265"]}
{"query_id": "topic_643_turn_4", "conversation_id": "topic_643", "turn_id": 4, "query": "When implementing these multimodal approaches, how specifically are the electrophysiological recordings temporally synchronized with neuroimaging data acquisition? What preprocessing pipelines and statistical normalization techniques are most effective for reconciling the different spatial and temporal resolutions between, say, local field potentials and fMRI BOLD signals? Additionally, what quality control metrics do you recommend to ensure the reliability of cross-modal correlations in longitudinal studies tracking pre-symptomatic progression?", "history": ["Cerebellum role in Alzheimer's and related neurodegenerative conditions", "How do these cerebellar alterations influence early Alzheimer's disease detection and pathology?", "Advanced techniques combining cerebellar electrophysiology and neuroimaging for identifying pre-symptomatic Alzheimer's biomarkers based on neural activity changes"], "ground_truth": ["permed-55578", "permed-69441", "permed-74986", "permed-63381", "permed-66481", "permed-66496", "permed-66477", "permed-9213", "permed-77859", "permed-90881"]}
{"query_id": "topic_643_turn_5", "conversation_id": "topic_643", "turn_id": 5, "query": "Given these sophisticated multimodal synchronization methods for detecting pre-symptomatic Alzheimer's pathology, what clinical outcomes have been observed when such cerebellar-based biomarkers are integrated into early intervention trials? Specifically, how do interventions like non-invasive cerebellar stimulation or pharmacological agents targeting cerebellar circuitry affect cognitive decline rates, daily functioning, or conversion timelines to mild cognitive impairment in at-risk populations? What are the primary safety considerations or adverse event profiles when applying these interventions based on emerging cerebellar pathology, and how do they compare to established hippocampal-focused approaches in terms of therapeutic efficacy and patient tolerability?", "history": ["Cerebellum role in Alzheimer's and related neurodegenerative conditions", "How do these cerebellar alterations influence early Alzheimer's disease detection and pathology?", "Advanced techniques combining cerebellar electrophysiology and neuroimaging for identifying pre-symptomatic Alzheimer's biomarkers based on neural activity changes", "When implementing these multimodal approaches, how specifically are the electrophysiological recordings temporally synchronized with neuroimaging data acquisition? What preprocessing pipelines and statistical normalization techniques are most effective for reconciling the different spatial and temporal resolutions between, say, local field potentials and fMRI BOLD signals? Additionally, what quality control metrics do you recommend to ensure the reliability of cross-modal correlations in longitudinal studies tracking pre-symptomatic progression?"], "ground_truth": ["permed-77264", "permed-8712", "permed-51518", "permed-69749", "permed-84753", "permed-71444", "permed-77265", "permed-71445", "permed-66043", "permed-8310"]}
{"query_id": "topic_644_turn_1", "conversation_id": "topic_644", "turn_id": 1, "query": "Overview of predictive tools and scoring indices for non-invasive ventilation (NIV) failure in acute respiratory failure.", "history": [], "ground_truth": ["permed-77812", "permed-61425", "permed-77814", "permed-44880", "permed-61360", "permed-61351", "permed-61359", "permed-44655", "permed-77813", "permed-65656"]}
{"query_id": "topic_644_turn_2", "conversation_id": "topic_644", "turn_id": 2, "query": "Among these identified tools for predicting NIV failure, what is the specific efficacy and documented limitations of the ROX index in patients with acute respiratory failure?", "history": ["Overview of predictive tools and scoring indices for non-invasive ventilation (NIV) failure in acute respiratory failure."], "ground_truth": ["permed-77812", "permed-61359", "permed-44657", "permed-61425", "permed-61351", "permed-44655", "permed-77813", "permed-65656", "permed-49901", "permed-44880"]}
{"query_id": "topic_644_turn_3", "conversation_id": "topic_644", "turn_id": 3, "query": "Strategies to enhance ROX index early predictive accuracy for NIV failure: incorporating novel biomarkers or dynamic parameters within the initial hours for de novo acute respiratory failure patients.", "history": ["Overview of predictive tools and scoring indices for non-invasive ventilation (NIV) failure in acute respiratory failure.", "Among these identified tools for predicting NIV failure, what is the specific efficacy and documented limitations of the ROX index in patients with acute respiratory failure?"], "ground_truth": ["permed-77812", "permed-61359", "permed-44655", "permed-61351", "permed-65656", "permed-44657", "permed-61425", "permed-77813", "permed-58927", "permed-89524"]}
{"query_id": "topic_644_turn_4", "conversation_id": "topic_644", "turn_id": 4, "query": "When implementing these biomarker-enhanced monitoring strategies, what specific statistical approaches would you recommend for validating their incremental predictive value beyond the standard ROX index? I'm particularly interested in how to design the temporal analysis of dynamic parameter changes during those critical first 6 hours, and what statistical methods would best handle the repeated measures while maintaining clinical interpretability of the composite prediction model.", "history": ["Overview of predictive tools and scoring indices for non-invasive ventilation (NIV) failure in acute respiratory failure.", "Among these identified tools for predicting NIV failure, what is the specific efficacy and documented limitations of the ROX index in patients with acute respiratory failure?", "Strategies to enhance ROX index early predictive accuracy for NIV failure: incorporating novel biomarkers or dynamic parameters within the initial hours for de novo acute respiratory failure patients."], "ground_truth": ["permed-70297", "permed-65924", "permed-44657", "permed-51751", "permed-70446", "permed-59622", "permed-61494", "permed-83970", "permed-12223", "permed-77812"]}
{"query_id": "topic_644_turn_5", "conversation_id": "topic_644", "turn_id": 5, "query": "Given these methodological considerations for validating enhanced ROX models, what clinical evidence exists regarding the actual impact of such refined prediction tools on patient management decisions and NIV outcomes? Specifically, have any trials demonstrated that implementing dynamic biomarker-guided escalation protocols reduces ICU length of stay or intubation rates compared to standard ROX monitoring in de novo respiratory failure, and what safety considerations emerged regarding premature treatment escalation based on these sensitive parameters?", "history": ["Overview of predictive tools and scoring indices for non-invasive ventilation (NIV) failure in acute respiratory failure.", "Among these identified tools for predicting NIV failure, what is the specific efficacy and documented limitations of the ROX index in patients with acute respiratory failure?", "Strategies to enhance ROX index early predictive accuracy for NIV failure: incorporating novel biomarkers or dynamic parameters within the initial hours for de novo acute respiratory failure patients.", "When implementing these biomarker-enhanced monitoring strategies, what specific statistical approaches would you recommend for validating their incremental predictive value beyond the standard ROX index? I'm particularly interested in how to design the temporal analysis of dynamic parameter changes during those critical first 6 hours, and what statistical methods would best handle the repeated measures while maintaining clinical interpretability of the composite prediction model."], "ground_truth": ["permed-77812", "permed-61539", "permed-44657", "permed-53364", "permed-44655", "permed-70297", "permed-61359", "permed-27542", "permed-12222", "permed-65656"]}
{"query_id": "topic_645_turn_1", "conversation_id": "topic_645", "turn_id": 1, "query": "What are some common pathogens found in raw cow milk that can be transmitted to humans?", "history": [], "ground_truth": ["permed-81972", "permed-65336", "permed-66817", "permed-69277", "permed-62203", "permed-53713", "permed-87373", "permed-57684", "permed-85980", "permed-71826"]}
{"query_id": "topic_645_turn_2", "conversation_id": "topic_645", "turn_id": 2, "query": "How does the presence of bacteria like Lactococcus garvieae impact public health in regions with limited access to healthcare facilities?", "history": ["What are some common pathogens found in raw cow milk that can be transmitted to humans?"], "ground_truth": ["permed-81972", "permed-66817", "permed-87432", "permed-85980", "permed-71805", "permed-66981", "permed-66820", "permed-66699", "permed-91245", "permed-70676"]}
{"query_id": "topic_645_turn_3", "conversation_id": "topic_645", "turn_id": 3, "query": "Given the presence of Lactococcus garvieae in raw cow milk and its public health implications in resource-limited settings, how could identifying specific strains like NEP21 in Nepal help develop better diagnostic tools and interventions to reduce transmission between livestock and humans?", "history": ["What are some common pathogens found in raw cow milk that can be transmitted to humans?", "How does the presence of bacteria like Lactococcus garvieae impact public health in regions with limited access to healthcare facilities?"], "ground_truth": ["permed-81972", "permed-71805", "permed-84672", "permed-71826", "permed-91245", "permed-59148", "permed-74041", "permed-71823", "permed-62107", "permed-71824"]}
{"query_id": "topic_645_turn_4", "conversation_id": "topic_645", "turn_id": 4, "query": "When identifying specific L. garvieae strains like NEP21 for diagnostic development, what molecular characterization methods would be most appropriate for strain differentiation in resource-limited settings? Specifically, how would you validate the discriminatory power of techniques like MLST or whole-genome sequencing against phenotypic profiles, and what quality control measures would ensure reproducible strain identification across different laboratory settings with varying technical capabilities?", "history": ["What are some common pathogens found in raw cow milk that can be transmitted to humans?", "How does the presence of bacteria like Lactococcus garvieae impact public health in regions with limited access to healthcare facilities?", "Given the presence of Lactococcus garvieae in raw cow milk and its public health implications in resource-limited settings, how could identifying specific strains like NEP21 in Nepal help develop better diagnostic tools and interventions to reduce transmission between livestock and humans?"], "ground_truth": ["permed-67023", "permed-81972", "permed-38272", "permed-87366", "permed-62106", "permed-71774", "permed-77835", "permed-38309", "permed-66609", "permed-38306"]}
{"query_id": "topic_645_turn_5", "conversation_id": "topic_645", "turn_id": 5, "query": "Given the molecular characterization approaches discussed for strain differentiation, what clinical trial evidence exists regarding L. garvieae infection outcomes when using strain-specific diagnostics versus conventional methods in resource-limited settings? How do detection time, antibiotic stewardship, and patient recovery rates compare, particularly for vulnerable populations like immunocompromised individuals or children? Additionally, what safety considerations or unintended consequences have emerged when deploying these specialized diagnostics in real-world clinical workflows where co-infections with other raw milk pathogens may occur?", "history": ["What are some common pathogens found in raw cow milk that can be transmitted to humans?", "How does the presence of bacteria like Lactococcus garvieae impact public health in regions with limited access to healthcare facilities?", "Given the presence of Lactococcus garvieae in raw cow milk and its public health implications in resource-limited settings, how could identifying specific strains like NEP21 in Nepal help develop better diagnostic tools and interventions to reduce transmission between livestock and humans?", "When identifying specific L. garvieae strains like NEP21 for diagnostic development, what molecular characterization methods would be most appropriate for strain differentiation in resource-limited settings? Specifically, how would you validate the discriminatory power of techniques like MLST or whole-genome sequencing against phenotypic profiles, and what quality control measures would ensure reproducible strain identification across different laboratory settings with varying technical capabilities?"], "ground_truth": ["permed-81972", "permed-66612", "permed-61276", "permed-77190", "permed-90944", "permed-65911", "permed-71805", "permed-21498", "permed-66609", "permed-81883"]}
{"query_id": "topic_646_turn_1", "conversation_id": "topic_646", "turn_id": 1, "query": "Endophytic microorganism contributions to plant abiotic stress tolerance mechanisms.", "history": [], "ground_truth": ["permed-66992", "permed-63906", "permed-51684", "permed-66993", "permed-64170", "permed-63717", "permed-63584", "permed-53000", "permed-66895", "permed-53005"]}
{"query_id": "topic_646_turn_2", "conversation_id": "topic_646", "turn_id": 2, "query": "How do these endophytic-mediated stress tolerance mechanisms specifically affect Rheum palmatum's resilience and medicinal compound production?", "history": ["Endophytic microorganism contributions to plant abiotic stress tolerance mechanisms."], "ground_truth": ["permed-77676", "permed-66992", "permed-63584", "permed-63717", "permed-85035", "permed-87335", "permed-52203", "permed-79586", "permed-66993", "permed-77678"]}
{"query_id": "topic_646_turn_3", "conversation_id": "topic_646", "turn_id": 3, "query": "Influence of endophytic metabolic pathways and nutrient cycling in Rheum palmatum on its adaptation to soil pH and temperature fluctuations and resulting alterations in its key medicinal secondary metabolites.", "history": ["Endophytic microorganism contributions to plant abiotic stress tolerance mechanisms.", "How do these endophytic-mediated stress tolerance mechanisms specifically affect Rheum palmatum's resilience and medicinal compound production?"], "ground_truth": ["permed-77676", "permed-66992", "permed-64170", "permed-87335", "permed-86379", "permed-63584", "permed-64159", "permed-77678", "permed-66997", "permed-53005"]}
{"query_id": "topic_646_turn_4", "conversation_id": "topic_646", "turn_id": 4, "query": "Given this metabolic pathway analysis, what specific quantification methods were employed to track nutrient cycling efficiency between endophytes and Rheum palmatum roots under varying pH regimes? I'm particularly interested in the technical protocols for measuring phosphorus solubilization rates and whether you used isotopic tracing (e.g., 32P) or spectrophotometric assays. Additionally, how did you statistically validate the correlation between nutrient exchange efficiency and subsequent alterations in anthraquinone concentrations across different temperature treatments?", "history": ["Endophytic microorganism contributions to plant abiotic stress tolerance mechanisms.", "How do these endophytic-mediated stress tolerance mechanisms specifically affect Rheum palmatum's resilience and medicinal compound production?", "Influence of endophytic metabolic pathways and nutrient cycling in Rheum palmatum on its adaptation to soil pH and temperature fluctuations and resulting alterations in its key medicinal secondary metabolites."], "ground_truth": ["permed-77676", "permed-66995", "permed-64102", "permed-66992", "permed-85686", "permed-83201", "permed-63920", "permed-63835", "permed-63641", "permed-63844"]}
{"query_id": "topic_646_turn_5", "conversation_id": "topic_646", "turn_id": 5, "query": "Given these detailed nutrient exchange mechanisms, what clinical implications emerge regarding batch-to-batch consistency of Rheum palmatum-derived medicines when cultivated under different soil conditions? Specifically, how do the documented fluctuations in anthraquinone concentrations—driven by endophyte-mediated nutrient cycling—translate to variations in clinical efficacy for traditional preparations used as purgatives or anti-inflammatory agents? Have any clinical trials or pharmacovigilance data demonstrated differential patient outcomes or side effect profiles correlating with these cultivation-induced phytochemical variations, particularly regarding gastrointestinal tolerability or therapeutic potency thresholds?", "history": ["Endophytic microorganism contributions to plant abiotic stress tolerance mechanisms.", "How do these endophytic-mediated stress tolerance mechanisms specifically affect Rheum palmatum's resilience and medicinal compound production?", "Influence of endophytic metabolic pathways and nutrient cycling in Rheum palmatum on its adaptation to soil pH and temperature fluctuations and resulting alterations in its key medicinal secondary metabolites.", "Given this metabolic pathway analysis, what specific quantification methods were employed to track nutrient cycling efficiency between endophytes and Rheum palmatum roots under varying pH regimes? I'm particularly interested in the technical protocols for measuring phosphorus solubilization rates and whether you used isotopic tracing (e.g., 32P) or spectrophotometric assays. Additionally, how did you statistically validate the correlation between nutrient exchange efficiency and subsequent alterations in anthraquinone concentrations across different temperature treatments?"], "ground_truth": ["permed-77676", "permed-86213", "permed-63841", "permed-86103", "permed-79557", "permed-86379", "permed-85688", "permed-81746", "permed-79556", "permed-51146"]}
{"query_id": "topic_647_turn_1", "conversation_id": "topic_647", "turn_id": 1, "query": "Standard methods for detecting microbial and chemical alterations in commercially canned foods", "history": [], "ground_truth": ["permed-77380", "permed-52722", "permed-86186", "permed-63994", "permed-62009", "permed-80923", "permed-83608", "permed-66179", "permed-66608", "permed-83602"]}
{"query_id": "topic_647_turn_2", "conversation_id": "topic_647", "turn_id": 2, "query": "Assessing the potential of advanced spectroscopic techniques to improve these standard detection methods for microbial and chemical alterations, particularly in high-acid canned foods like tomatoes", "history": ["Standard methods for detecting microbial and chemical alterations in commercially canned foods"], "ground_truth": ["permed-77380", "permed-52722", "permed-66179", "permed-66608", "permed-63994", "permed-52720", "permed-83608", "permed-73363", "permed-78694", "permed-82012"]}
{"query_id": "topic_647_turn_3", "conversation_id": "topic_647", "turn_id": 3, "query": "Optimizing machine learning models integrated with such advanced spectroscopic data for real-time monitoring of microbial and chemical integrity in canned tomatoes throughout the production-to-sterilization pipeline: critical parameters and validation strategies", "history": ["Standard methods for detecting microbial and chemical alterations in commercially canned foods", "Assessing the potential of advanced spectroscopic techniques to improve these standard detection methods for microbial and chemical alterations, particularly in high-acid canned foods like tomatoes"], "ground_truth": ["permed-77380", "permed-52722", "permed-66179", "permed-52710", "permed-63948", "permed-53718", "permed-63994", "permed-52720", "permed-83602", "permed-86308"]}
{"query_id": "topic_647_turn_4", "conversation_id": "topic_647", "turn_id": 4, "query": "Regarding these optimized machine learning models, what specific preprocessing protocols were implemented for the spectroscopic data prior to model training? I'm particularly interested in how you handled spectral normalization, baseline correction, and outlier detection for the real-time monitoring scenario. Additionally, could you detail the cross-validation strategy used to ensure model robustness given the temporal nature of production line data and potential batch-to-batch variations in tomato composition?", "history": ["Standard methods for detecting microbial and chemical alterations in commercially canned foods", "Assessing the potential of advanced spectroscopic techniques to improve these standard detection methods for microbial and chemical alterations, particularly in high-acid canned foods like tomatoes", "Optimizing machine learning models integrated with such advanced spectroscopic data for real-time monitoring of microbial and chemical integrity in canned tomatoes throughout the production-to-sterilization pipeline: critical parameters and validation strategies"], "ground_truth": ["permed-86068", "permed-88870", "permed-52710", "permed-63948", "permed-73340", "permed-52722", "permed-83577", "permed-67212", "permed-88990", "permed-83604"]}
{"query_id": "topic_647_turn_5", "conversation_id": "topic_647", "turn_id": 5, "query": "Given these optimized preprocessing and validation protocols for spectroscopic monitoring, how have these machine learning models performed in clinical nutrition studies involving patients consuming canned tomato products? Specifically, what evidence exists regarding the correlation between improved detection sensitivity for microbial/chemical alterations and measurable impacts on patient outcomes—particularly gastrointestinal safety profiles in immunocompromised populations? Additionally, have any clinical trials evaluated whether this enhanced monitoring technology translates to reduced adverse event rates compared to conventional quality control methods?", "history": ["Standard methods for detecting microbial and chemical alterations in commercially canned foods", "Assessing the potential of advanced spectroscopic techniques to improve these standard detection methods for microbial and chemical alterations, particularly in high-acid canned foods like tomatoes", "Optimizing machine learning models integrated with such advanced spectroscopic data for real-time monitoring of microbial and chemical integrity in canned tomatoes throughout the production-to-sterilization pipeline: critical parameters and validation strategies", "Regarding these optimized machine learning models, what specific preprocessing protocols were implemented for the spectroscopic data prior to model training? I'm particularly interested in how you handled spectral normalization, baseline correction, and outlier detection for the real-time monitoring scenario. Additionally, could you detail the cross-validation strategy used to ensure model robustness given the temporal nature of production line data and potential batch-to-batch variations in tomato composition?"], "ground_truth": ["permed-77380", "permed-83602", "permed-52722", "permed-66179", "permed-83606", "permed-63948", "permed-52710", "permed-88945", "permed-54824", "permed-80917"]}
{"query_id": "topic_648_turn_1", "conversation_id": "topic_648", "turn_id": 1, "query": "Review of current diagnostic and monitoring biomarkers for juvenile neuropsychiatric systemic lupus erythematosus (j-NPSLE)", "history": [], "ground_truth": ["permed-77970", "permed-92131", "permed-77972", "permed-85290", "permed-53210", "permed-53191", "permed-52229", "permed-77973", "permed-84211", "permed-89486"]}
{"query_id": "topic_648_turn_2", "conversation_id": "topic_648", "turn_id": 2, "query": "Clinical utility of these j-NPSLE biomarkers in distinguishing active versus quiescent central neuroinflammation", "history": ["Review of current diagnostic and monitoring biomarkers for juvenile neuropsychiatric systemic lupus erythematosus (j-NPSLE)"], "ground_truth": ["permed-66783", "permed-77970", "permed-66780", "permed-77974", "permed-66782", "permed-66381", "permed-53861", "permed-70938", "permed-70936", "permed-84661"]}
{"query_id": "topic_648_turn_3", "conversation_id": "topic_648", "turn_id": 3, "query": "Investigational multi-biomarker panels including CSF neopterin, IFN-α, microRNAs, and cytokine profiles for enhanced assessment of j-NPSLE central neuroinflammation activity", "history": ["Review of current diagnostic and monitoring biomarkers for juvenile neuropsychiatric systemic lupus erythematosus (j-NPSLE)", "Clinical utility of these j-NPSLE biomarkers in distinguishing active versus quiescent central neuroinflammation"], "ground_truth": ["permed-77970", "permed-66783", "permed-66782", "permed-77974", "permed-66381", "permed-70936", "permed-70938", "permed-81503", "permed-77971", "permed-73687"]}
{"query_id": "topic_648_turn_4", "conversation_id": "topic_648", "turn_id": 4, "query": "For these multi-biomarker panels, what specific statistical validation approaches were employed to establish their diagnostic accuracy for distinguishing neuroinflammatory states? I'm particularly interested in how researchers determined optimal cutoff values for CSF neopterin and cytokine profiles, whether they used ROC curve analysis with cross-validation, and what measures were implemented to control for multiple comparisons given the panel's dimensionality. Additionally, what quality control protocols ensured analytical reproducibility across different CSF sample processing batches?", "history": ["Review of current diagnostic and monitoring biomarkers for juvenile neuropsychiatric systemic lupus erythematosus (j-NPSLE)", "Clinical utility of these j-NPSLE biomarkers in distinguishing active versus quiescent central neuroinflammation", "Investigational multi-biomarker panels including CSF neopterin, IFN-α, microRNAs, and cytokine profiles for enhanced assessment of j-NPSLE central neuroinflammation activity"], "ground_truth": ["permed-77971", "permed-52872", "permed-70598", "permed-49852", "permed-8249", "permed-77970", "permed-53084", "permed-77974", "permed-89442", "permed-82622"]}
{"query_id": "topic_648_turn_5", "conversation_id": "topic_648", "turn_id": 5, "query": "Given these statistical validation approaches for multi-biomarker panels, how have these assays translated to clinical decision-making for j-NPSLE treatment escalation? Specifically, what evidence exists regarding correlation between abnormal CSF neopterin/cytokine levels and therapeutic response to intensified immunosuppression? Have any clinical trials demonstrated that biomarker-guided treatment adjustments lead to improved neurocognitive outcomes or reduced relapse rates compared to standard monitoring? Additionally, what practical challenges emerge in implementing these CSF biomarker panels in pediatric rheumatology practice, particularly regarding lumbar puncture frequency and interpretation timing relative to treatment decisions?", "history": ["Review of current diagnostic and monitoring biomarkers for juvenile neuropsychiatric systemic lupus erythematosus (j-NPSLE)", "Clinical utility of these j-NPSLE biomarkers in distinguishing active versus quiescent central neuroinflammation", "Investigational multi-biomarker panels including CSF neopterin, IFN-α, microRNAs, and cytokine profiles for enhanced assessment of j-NPSLE central neuroinflammation activity", "For these multi-biomarker panels, what specific statistical validation approaches were employed to establish their diagnostic accuracy for distinguishing neuroinflammatory states? I'm particularly interested in how researchers determined optimal cutoff values for CSF neopterin and cytokine profiles, whether they used ROC curve analysis with cross-validation, and what measures were implemented to control for multiple comparisons given the panel's dimensionality. Additionally, what quality control protocols ensured analytical reproducibility across different CSF sample processing batches?"], "ground_truth": ["permed-77970", "permed-66381", "permed-77971", "permed-77974", "permed-61492", "permed-80826", "permed-53084", "permed-81507", "permed-84969", "permed-77972"]}
{"query_id": "topic_649_turn_1", "conversation_id": "topic_649", "turn_id": 1, "query": "What are the primary challenges in predicting and controlling rabies outbreaks at the wildlife-domestic animal interface?", "history": [], "ground_truth": ["permed-54940", "permed-75612", "permed-67815", "permed-65335", "permed-70595", "permed-54928", "permed-64243", "permed-84320", "permed-68153", "permed-22442"]}
{"query_id": "topic_649_turn_2", "conversation_id": "topic_649", "turn_id": 2, "query": "How can advanced modeling techniques help overcome these challenges in rabies outbreak prediction at such interfaces?", "history": ["What are the primary challenges in predicting and controlling rabies outbreaks at the wildlife-domestic animal interface?"], "ground_truth": ["permed-54940", "permed-36118", "permed-59199", "permed-53886", "permed-70595", "permed-62369", "permed-84995", "permed-70069", "permed-61937", "permed-67815"]}
{"query_id": "topic_649_turn_3", "conversation_id": "topic_649", "turn_id": 3, "query": "For rabies prediction in these high-interaction zones, what are best practices for integrating spatiotemporal modeling with real-time surveillance, and which specific ecological and epidemiological factors should such models prioritize for improved accuracy and effective interventions?", "history": ["What are the primary challenges in predicting and controlling rabies outbreaks at the wildlife-domestic animal interface?", "How can advanced modeling techniques help overcome these challenges in rabies outbreak prediction at such interfaces?"], "ground_truth": ["permed-54940", "permed-61935", "permed-75608", "permed-61937", "permed-62248", "permed-59199", "permed-70249", "permed-36057", "permed-36118", "permed-71846"]}
{"query_id": "topic_649_turn_4", "conversation_id": "topic_649", "turn_id": 4, "query": "Given this integrated modeling approach, could you elaborate on the specific statistical methods used to weight different ecological predictors in spatiotemporal models? I'm particularly interested in how you validate the model's temporal forecasting accuracy - do you use cross-validation techniques that account for spatial autocorrelation, and what quality control measures ensure reproducibility when integrating heterogeneous surveillance data streams?", "history": ["What are the primary challenges in predicting and controlling rabies outbreaks at the wildlife-domestic animal interface?", "How can advanced modeling techniques help overcome these challenges in rabies outbreak prediction at such interfaces?", "For rabies prediction in these high-interaction zones, what are best practices for integrating spatiotemporal modeling with real-time surveillance, and which specific ecological and epidemiological factors should such models prioritize for improved accuracy and effective interventions?"], "ground_truth": ["permed-61935", "permed-34458", "permed-65714", "permed-73971", "permed-60476", "permed-61937", "permed-36091", "permed-87495", "permed-59201", "permed-81983"]}
{"query_id": "topic_649_turn_5", "conversation_id": "topic_649", "turn_id": 5, "query": "Given these validated modeling approaches for outbreak prediction, how have such spatiotemporal forecasting systems been translated into clinical decision support tools for rabies post-exposure prophylaxis (PEP) allocation? Specifically, what clinical outcomes have been demonstrated when using predictive models to guide PEP distribution in resource-limited settings - including impacts on human mortality rates, PEP utilization efficiency, and the challenges of implementing such model-driven protocols in diverse healthcare systems where rabies exposure risk must be balanced against vaccine availability and cold chain limitations?", "history": ["What are the primary challenges in predicting and controlling rabies outbreaks at the wildlife-domestic animal interface?", "How can advanced modeling techniques help overcome these challenges in rabies outbreak prediction at such interfaces?", "For rabies prediction in these high-interaction zones, what are best practices for integrating spatiotemporal modeling with real-time surveillance, and which specific ecological and epidemiological factors should such models prioritize for improved accuracy and effective interventions?", "Given this integrated modeling approach, could you elaborate on the specific statistical methods used to weight different ecological predictors in spatiotemporal models? I'm particularly interested in how you validate the model's temporal forecasting accuracy - do you use cross-validation techniques that account for spatial autocorrelation, and what quality control measures ensure reproducibility when integrating heterogeneous surveillance data streams?"], "ground_truth": ["permed-54940", "permed-53886", "permed-61935", "permed-68742", "permed-80428", "permed-65936", "permed-61540", "permed-59407", "permed-37341", "permed-68151"]}
{"query_id": "topic_650_turn_1", "conversation_id": "topic_650", "turn_id": 1, "query": "What role do midwives play in identifying mental health issues in new mothers?", "history": [], "ground_truth": ["permed-81376", "permed-81375", "permed-75161", "permed-88309", "permed-89989", "permed-52194", "permed-60131", "permed-75159", "permed-55873", "permed-66007"]}
{"query_id": "topic_650_turn_2", "conversation_id": "topic_650", "turn_id": 2, "query": "How can their competency in this area be improved, especially in diverse cultural contexts?", "history": ["What role do midwives play in identifying mental health issues in new mothers?"], "ground_truth": ["permed-51596", "permed-69896", "permed-51541", "permed-52802", "permed-66109", "permed-88831", "permed-58534", "permed-69899", "permed-69900", "permed-64779"]}
{"query_id": "topic_650_turn_3", "conversation_id": "topic_650", "turn_id": 3, "query": "What specific training programs or educational interventions could be developed to improve their skills in recognizing and addressing perinatal mental health issues, and how might these be adapted to the cultural and healthcare context of Karachi, Pakistan?", "history": ["What role do midwives play in identifying mental health issues in new mothers?", "How can their competency in this area be improved, especially in diverse cultural contexts?"], "ground_truth": ["permed-81375", "permed-81376", "permed-60131", "permed-75159", "permed-51539", "permed-59543", "permed-91027", "permed-71097", "permed-80231", "permed-51577"]}
{"query_id": "topic_650_turn_4", "conversation_id": "topic_650", "turn_id": 4, "query": "In implementing these culturally adapted training programs, what specific methodological approaches would be most appropriate for evaluating their effectiveness in improving midwives' diagnostic accuracy? I'm particularly interested in the experimental design—would a stepped-wedge cluster randomized trial be suitable across Karachi's various healthcare facilities, and what validated assessment tools should be used to measure competency changes while controlling for confounding variables like prior experience and workplace environment?", "history": ["What role do midwives play in identifying mental health issues in new mothers?", "How can their competency in this area be improved, especially in diverse cultural contexts?", "What specific training programs or educational interventions could be developed to improve their skills in recognizing and addressing perinatal mental health issues, and how might these be adapted to the cultural and healthcare context of Karachi, Pakistan?"], "ground_truth": ["permed-89991", "permed-61212", "permed-89989", "permed-61198", "permed-80770", "permed-81375", "permed-91979", "permed-57452", "permed-81376", "permed-89986"]}
{"query_id": "topic_650_turn_5", "conversation_id": "topic_650", "turn_id": 5, "query": "Given the validated assessment tools and stepped-wedge trial design previously discussed, how do the actual clinical outcomes for mothers—such as reduced postpartum depression incidence, improved treatment adherence, and maternal-infant bonding metrics—correlate with midwives' improved diagnostic accuracy in Karachi's settings? What are the observed safety considerations or unintended consequences when implementing these mental health interventions through midwifery networks, particularly regarding stigma, family dynamics, or medication side effects in this cultural context?", "history": ["What role do midwives play in identifying mental health issues in new mothers?", "How can their competency in this area be improved, especially in diverse cultural contexts?", "What specific training programs or educational interventions could be developed to improve their skills in recognizing and addressing perinatal mental health issues, and how might these be adapted to the cultural and healthcare context of Karachi, Pakistan?", "In implementing these culturally adapted training programs, what specific methodological approaches would be most appropriate for evaluating their effectiveness in improving midwives' diagnostic accuracy? I'm particularly interested in the experimental design—would a stepped-wedge cluster randomized trial be suitable across Karachi's various healthcare facilities, and what validated assessment tools should be used to measure competency changes while controlling for confounding variables like prior experience and workplace environment?"], "ground_truth": ["permed-81375", "permed-61198", "permed-89989", "permed-61212", "permed-81376", "permed-61209", "permed-60006", "permed-80770", "permed-71097", "permed-88309"]}
{"query_id": "topic_651_turn_1", "conversation_id": "topic_651", "turn_id": 1, "query": "Current research on strategies to mitigate heavy metal accumulation in rice grown in contaminated soils.", "history": [], "ground_truth": ["permed-74124", "permed-74122", "permed-74143", "permed-74141", "permed-74131", "permed-64078", "permed-74125", "permed-89112", "permed-74126", "permed-74135"]}
{"query_id": "topic_651_turn_2", "conversation_id": "topic_651", "turn_id": 2, "query": "Evaluating the effectiveness of specific soil amendments, like zero valent iron, as one of *these strategies* for rice in *such contaminated environments*.", "history": ["Current research on strategies to mitigate heavy metal accumulation in rice grown in contaminated soils."], "ground_truth": ["permed-74122", "permed-74125", "permed-74124", "permed-89112", "permed-64011", "permed-64071", "permed-74133", "permed-74141", "permed-74143", "permed-63647"]}
{"query_id": "topic_651_turn_3", "conversation_id": "topic_651", "turn_id": 3, "query": "Influence of soil properties (e.g., pH, organic matter) on *the performance of these zero valent iron applications* in reducing cobalt (Co) and lead (Pb) uptake by rice, and their long-term consequences for soil health and crop productivity in polluted agricultural areas.", "history": ["Current research on strategies to mitigate heavy metal accumulation in rice grown in contaminated soils.", "Evaluating the effectiveness of specific soil amendments, like zero valent iron, as one of *these strategies* for rice in *such contaminated environments*."], "ground_truth": ["permed-74122", "permed-74125", "permed-74143", "permed-64011", "permed-74141", "permed-84031", "permed-66962", "permed-74133", "permed-74130", "permed-87962"]}
{"query_id": "topic_651_turn_4", "conversation_id": "topic_651", "turn_id": 4, "query": "Regarding these zero valent iron amendments, what specific analytical techniques were used to quantify the cobalt and lead concentrations in the rice plant tissues (e.g., roots, shoots, grains) and the corresponding soil fractions? Furthermore, how was the method validated, and what quality control measures, such as certified reference materials or spike recovery tests, were implemented to ensure the accuracy and reproducibility of the heavy metal analysis throughout the study?", "history": ["Current research on strategies to mitigate heavy metal accumulation in rice grown in contaminated soils.", "Evaluating the effectiveness of specific soil amendments, like zero valent iron, as one of *these strategies* for rice in *such contaminated environments*.", "Influence of soil properties (e.g., pH, organic matter) on *the performance of these zero valent iron applications* in reducing cobalt (Co) and lead (Pb) uptake by rice, and their long-term consequences for soil health and crop productivity in polluted agricultural areas."], "ground_truth": ["permed-74122", "permed-74141", "permed-80041", "permed-74143", "permed-74124", "permed-86318", "permed-77778", "permed-64071", "permed-5184", "permed-74131"]}
{"query_id": "topic_651_turn_5", "conversation_id": "topic_651", "turn_id": 5, "query": "Given the validated analytical confirmation of heavy metal reductions in rice tissues using zero valent iron amendments, what clinical evidence exists regarding the resulting health outcomes in populations consuming this remediated rice? Specifically, have any longitudinal studies or randomized trials measured changes in biomarkers of cobalt and lead toxicity (e.g., neurological or renal function parameters) in vulnerable groups like children or pregnant women? Furthermore, what are the known or potential clinical contraindications or safety thresholds for residual metal levels in rice that ensure therapeutic efficacy without introducing new health risks?", "history": ["Current research on strategies to mitigate heavy metal accumulation in rice grown in contaminated soils.", "Evaluating the effectiveness of specific soil amendments, like zero valent iron, as one of *these strategies* for rice in *such contaminated environments*.", "Influence of soil properties (e.g., pH, organic matter) on *the performance of these zero valent iron applications* in reducing cobalt (Co) and lead (Pb) uptake by rice, and their long-term consequences for soil health and crop productivity in polluted agricultural areas.", "Regarding these zero valent iron amendments, what specific analytical techniques were used to quantify the cobalt and lead concentrations in the rice plant tissues (e.g., roots, shoots, grains) and the corresponding soil fractions? Furthermore, how was the method validated, and what quality control measures, such as certified reference materials or spike recovery tests, were implemented to ensure the accuracy and reproducibility of the heavy metal analysis throughout the study?"], "ground_truth": ["permed-74122", "permed-74141", "permed-74143", "permed-74124", "permed-64071", "permed-64078", "permed-74125", "permed-74127", "permed-86318", "permed-86319"]}
{"query_id": "topic_652_turn_1", "conversation_id": "topic_652", "turn_id": 1, "query": "What is known about the role of allopregnanolone in treating anxiety and depression?", "history": [], "ground_truth": ["permed-79458", "permed-66389", "permed-74903", "permed-68871", "permed-92449", "permed-88478", "permed-81310", "permed-64831", "permed-86262", "permed-70287"]}
{"query_id": "topic_652_turn_2", "conversation_id": "topic_652", "turn_id": 2, "query": "How do its interactions with steroid receptors, like progestin or glucocorticoid receptors, impact its therapeutic effects?", "history": ["What is known about the role of allopregnanolone in treating anxiety and depression?"], "ground_truth": ["permed-73074", "permed-79463", "permed-58721", "permed-79458", "permed-77555", "permed-71386", "permed-6752", "permed-69335", "permed-79929", "permed-73069"]}
{"query_id": "topic_652_turn_3", "conversation_id": "topic_652", "turn_id": 3, "query": "Given that allopregnanolone's effects involve these steroid receptors, how might selectively targeting them affect its clinical efficacy and side effects—especially in patients with conditions like chronic stress or hormonal imbalances?", "history": ["What is known about the role of allopregnanolone in treating anxiety and depression?", "How do its interactions with steroid receptors, like progestin or glucocorticoid receptors, impact its therapeutic effects?"], "ground_truth": ["permed-79458", "permed-74903", "permed-73074", "permed-79463", "permed-58721", "permed-58726", "permed-76967", "permed-6752", "permed-29933", "permed-58863"]}
{"query_id": "topic_652_turn_4", "conversation_id": "topic_652", "turn_id": 4, "query": "Given this strategy of selectively targeting steroid receptors, what specific experimental designs would best isolate receptor-specific contributions to allopregnanolone's behavioral effects? I'm particularly interested in how researchers control for systemic neurosteroid feedback loops and whether they use pharmacological antagonists, genetic knockdown models, or receptor-specific agonists in their protocols. What statistical approaches are most appropriate for distinguishing these receptor-mediated pathways from indirect genomic effects in preclinical anxiety models?", "history": ["What is known about the role of allopregnanolone in treating anxiety and depression?", "How do its interactions with steroid receptors, like progestin or glucocorticoid receptors, impact its therapeutic effects?", "Given that allopregnanolone's effects involve these steroid receptors, how might selectively targeting them affect its clinical efficacy and side effects—especially in patients with conditions like chronic stress or hormonal imbalances?"], "ground_truth": ["permed-79458", "permed-74903", "permed-82975", "permed-87904", "permed-80500", "permed-90341", "permed-58721", "permed-76967", "permed-80503", "permed-91000"]}
{"query_id": "topic_652_turn_5", "conversation_id": "topic_652", "turn_id": 5, "query": "Given these sophisticated preclinical approaches for isolating receptor-specific effects, how have these mechanistic insights translated to clinical applications? What evidence exists from human trials regarding allopregnanolone-based treatments (like brexanolone) for mood disorders, particularly concerning differential efficacy in patient subgroups with distinct hormonal profiles? Have clinical studies documented receptor-mediated side effect profiles, and how do real-world deployment challenges—such as administration protocols and monitoring requirements—impact therapeutic outcomes compared to traditional antidepressants?", "history": ["What is known about the role of allopregnanolone in treating anxiety and depression?", "How do its interactions with steroid receptors, like progestin or glucocorticoid receptors, impact its therapeutic effects?", "Given that allopregnanolone's effects involve these steroid receptors, how might selectively targeting them affect its clinical efficacy and side effects—especially in patients with conditions like chronic stress or hormonal imbalances?", "Given this strategy of selectively targeting steroid receptors, what specific experimental designs would best isolate receptor-specific contributions to allopregnanolone's behavioral effects? I'm particularly interested in how researchers control for systemic neurosteroid feedback loops and whether they use pharmacological antagonists, genetic knockdown models, or receptor-specific agonists in their protocols. What statistical approaches are most appropriate for distinguishing these receptor-mediated pathways from indirect genomic effects in preclinical anxiety models?"], "ground_truth": ["permed-79458", "permed-66389", "permed-76967", "permed-79459", "permed-79463", "permed-74903", "permed-88478", "permed-51259", "permed-68871", "permed-25790"]}
{"query_id": "topic_653_turn_1", "conversation_id": "topic_653", "turn_id": 1, "query": "What approaches are being explored to improve diabetes management in primary care settings?", "history": [], "ground_truth": ["permed-79526", "permed-55182", "permed-71236", "permed-30207", "permed-89894", "permed-25625", "permed-63364", "permed-23143", "permed-65732", "permed-80242"]}
{"query_id": "topic_653_turn_2", "conversation_id": "topic_653", "turn_id": 2, "query": "How does the Enhanced Primary Care Diabetes model fit into this area of research, and what healthcare professionals play key roles in it?", "history": ["What approaches are being explored to improve diabetes management in primary care settings?"], "ground_truth": ["permed-79526", "permed-55182", "permed-88254", "permed-63364", "permed-71231", "permed-52946", "permed-52212", "permed-74639", "permed-51104", "permed-71236"]}
{"query_id": "topic_653_turn_3", "conversation_id": "topic_653", "turn_id": 3, "query": "Given the EPCD model's framework and the key roles of different healthcare professionals you mentioned, could you elaborate specifically on how care team nurses and clinical pharmacists contribute to improving diabetes management quality within this model? How do their roles compare to other team members? Also, what strategies have proven effective for sustaining improvements in key diabetes care metrics—like glycemic, blood pressure, and lipid control—in practices implementing this model?", "history": ["What approaches are being explored to improve diabetes management in primary care settings?", "How does the Enhanced Primary Care Diabetes model fit into this area of research, and what healthcare professionals play key roles in it?"], "ground_truth": ["permed-79526", "permed-51104", "permed-80242", "permed-25667", "permed-65732", "permed-23912", "permed-30207", "permed-79524", "permed-74556", "permed-33755"]}
{"query_id": "topic_653_turn_4", "conversation_id": "topic_653", "turn_id": 4, "query": "Regarding these strategies for sustaining diabetes care metric improvements, what specific data collection protocols and statistical analysis methods are used to quantify clinical pharmacists' impact on glycemic control versus nurses' effect on blood pressure management? How do researchers validate these role-specific contributions while controlling for confounding variables like patient comorbidities or medication adherence? Are there standardized quality control measures to ensure reproducibility across different primary care settings implementing this model?", "history": ["What approaches are being explored to improve diabetes management in primary care settings?", "How does the Enhanced Primary Care Diabetes model fit into this area of research, and what healthcare professionals play key roles in it?", "Given the EPCD model's framework and the key roles of different healthcare professionals you mentioned, could you elaborate specifically on how care team nurses and clinical pharmacists contribute to improving diabetes management quality within this model? How do their roles compare to other team members? Also, what strategies have proven effective for sustaining improvements in key diabetes care metrics—like glycemic, blood pressure, and lipid control—in practices implementing this model?"], "ground_truth": ["permed-79526", "permed-60781", "permed-79525", "permed-51104", "permed-79524", "permed-70652", "permed-47351", "permed-34662", "permed-26285", "permed-25667"]}
{"query_id": "topic_653_turn_5", "conversation_id": "topic_653", "turn_id": 5, "query": "Building upon the methodological considerations for validating role-specific contributions, how do the cost-effectiveness analyses compare between clinical pharmacist interventions for glycemic control versus nursing interventions for blood pressure management in the EPCD model? Considering the complexity of data collection and statistical controls discussed, what trade-offs exist between the resource investments required for each role's interventions and their respective long-term clinical outcomes? Are there comparative studies examining whether the economic benefits of improved glycemic control through pharmacist management outweigh the cardiovascular risk reduction benefits achieved through nurse-led hypertension management?", "history": ["What approaches are being explored to improve diabetes management in primary care settings?", "How does the Enhanced Primary Care Diabetes model fit into this area of research, and what healthcare professionals play key roles in it?", "Given the EPCD model's framework and the key roles of different healthcare professionals you mentioned, could you elaborate specifically on how care team nurses and clinical pharmacists contribute to improving diabetes management quality within this model? How do their roles compare to other team members? Also, what strategies have proven effective for sustaining improvements in key diabetes care metrics—like glycemic, blood pressure, and lipid control—in practices implementing this model?", "Regarding these strategies for sustaining diabetes care metric improvements, what specific data collection protocols and statistical analysis methods are used to quantify clinical pharmacists' impact on glycemic control versus nurses' effect on blood pressure management? How do researchers validate these role-specific contributions while controlling for confounding variables like patient comorbidities or medication adherence? Are there standardized quality control measures to ensure reproducibility across different primary care settings implementing this model?"], "ground_truth": ["permed-79526", "permed-63362", "permed-55089", "permed-79524", "permed-63365", "permed-78057", "permed-57243", "permed-54913", "permed-57245", "permed-57244"]}
{"query_id": "topic_654_turn_1", "conversation_id": "topic_654", "turn_id": 1, "query": "What is known about how anomalous trichromats process color information differently from those with typical color vision?", "history": [], "ground_truth": ["permed-81220", "permed-83455", "permed-66513", "permed-61701", "permed-88692", "permed-88183", "permed-80018", "permed-88619", "permed-77296", "permed-90768"]}
{"query_id": "topic_654_turn_2", "conversation_id": "topic_654", "turn_id": 2, "query": "Does this difference in color processing affect their perception of complex visual scenes, and if so, how?", "history": ["What is known about how anomalous trichromats process color information differently from those with typical color vision?"], "ground_truth": ["permed-66547", "permed-81220", "permed-88692", "permed-90768", "permed-80018", "permed-90767", "permed-84240", "permed-66513", "permed-69670", "permed-63177"]}
{"query_id": "topic_654_turn_3", "conversation_id": "topic_654", "turn_id": 3, "query": "Given these findings on nonlinear cortical encoding and its impact on the McCollough effect in anomalous trichromats, how might such neural adaptations shape their perception of complex scenes with multiple colors and varying luminance? And what could this mean for developing visual prosthetics to assist those with color vision deficiencies?", "history": ["What is known about how anomalous trichromats process color information differently from those with typical color vision?", "Does this difference in color processing affect their perception of complex visual scenes, and if so, how?"], "ground_truth": ["permed-81220", "permed-88863", "permed-88693", "permed-71022", "permed-66547", "permed-84240", "permed-66513", "permed-85608", "permed-63144", "permed-61823"]}
{"query_id": "topic_654_turn_4", "conversation_id": "topic_654", "turn_id": 4, "query": "Given these findings on nonlinear cortical encoding, what specific experimental paradigms would best capture how anomalous trichromats process complex multi-color scenes? I'm particularly interested in the technical implementation - would you recommend using EEG frequency-tagging with chromatic stimuli, fMRI adaptation protocols with varying luminance contrasts, or perhaps eye-tracking metrics during natural scene viewing? How should we validate these methods against behavioral measures, and what statistical approaches would best account for individual differences in the degree of color deficiency?", "history": ["What is known about how anomalous trichromats process color information differently from those with typical color vision?", "Does this difference in color processing affect their perception of complex visual scenes, and if so, how?", "Given these findings on nonlinear cortical encoding and its impact on the McCollough effect in anomalous trichromats, how might such neural adaptations shape their perception of complex scenes with multiple colors and varying luminance? And what could this mean for developing visual prosthetics to assist those with color vision deficiencies?"], "ground_truth": ["permed-81220", "permed-61701", "permed-77296", "permed-88863", "permed-59225", "permed-55542", "permed-63382", "permed-61823", "permed-63177", "permed-79060"]}
{"query_id": "topic_654_turn_5", "conversation_id": "topic_654", "turn_id": 5, "query": "Given these proposed neuroimaging and behavioral paradigms for studying complex scene processing, what translational potential do such findings hold for clinical applications? Specifically, how might insights about neural adaptations in anomalous trichromats inform the development of visual aids or digital augmentation tools that could improve real-world task performance—such as interpreting medical imaging, navigating color-coded interfaces, or distinguishing safety-critical signals? What evidence exists regarding the efficacy of existing assistive technologies, and what safety considerations or individual variability factors should be addressed in clinical deployment?", "history": ["What is known about how anomalous trichromats process color information differently from those with typical color vision?", "Does this difference in color processing affect their perception of complex visual scenes, and if so, how?", "Given these findings on nonlinear cortical encoding and its impact on the McCollough effect in anomalous trichromats, how might such neural adaptations shape their perception of complex scenes with multiple colors and varying luminance? And what could this mean for developing visual prosthetics to assist those with color vision deficiencies?", "Given these findings on nonlinear cortical encoding, what specific experimental paradigms would best capture how anomalous trichromats process complex multi-color scenes? I'm particularly interested in the technical implementation - would you recommend using EEG frequency-tagging with chromatic stimuli, fMRI adaptation protocols with varying luminance contrasts, or perhaps eye-tracking metrics during natural scene viewing? How should we validate these methods against behavioral measures, and what statistical approaches would best account for individual differences in the degree of color deficiency?"], "ground_truth": ["permed-68684", "permed-52829", "permed-81220", "permed-55578", "permed-66436", "permed-44100", "permed-70839", "permed-66547", "permed-9519", "permed-63175"]}
{"query_id": "topic_655_turn_1", "conversation_id": "topic_655", "turn_id": 1, "query": "What factors contribute to the accumulation of toxic elements in dairy products like cheese?", "history": [], "ground_truth": ["permed-80038", "permed-74144", "permed-72318", "permed-81974", "permed-74139", "permed-65098", "permed-91118", "permed-74138", "permed-91762", "permed-84625"]}
{"query_id": "topic_655_turn_2", "conversation_id": "topic_655", "turn_id": 2, "query": "Does it vary significantly depending on the region and specific farming practices, such as feed and water sources?", "history": ["What factors contribute to the accumulation of toxic elements in dairy products like cheese?"], "ground_truth": ["permed-65029", "permed-63723", "permed-66148", "permed-62969", "permed-91759", "permed-86932", "permed-55107", "permed-65286", "permed-73996", "permed-58236"]}
{"query_id": "topic_655_turn_3", "conversation_id": "topic_655", "turn_id": 3, "query": "Given these regional variations in feed and water sources, how exactly do they affect the buildup of toxic elements like lead and cadmium in cheese? And what specific changes in production practices could help reduce these contaminants without compromising the cheese's quality and safety?", "history": ["What factors contribute to the accumulation of toxic elements in dairy products like cheese?", "Does it vary significantly depending on the region and specific farming practices, such as feed and water sources?"], "ground_truth": ["permed-80038", "permed-72318", "permed-81974", "permed-91762", "permed-74144", "permed-91118", "permed-81973", "permed-22256", "permed-80042", "permed-37305"]}
{"query_id": "topic_655_turn_4", "conversation_id": "topic_655", "turn_id": 4, "query": "Given the proposed production practice modifications, what specific analytical methodologies would you recommend for quantifying lead and cadmium reduction in cheese matrices? I'm particularly interested in the sample preparation protocols for dairy products, the choice between ICP-MS versus atomic absorption spectroscopy for detection limits, and how you'd validate these methods for complex lipid-rich matrices. What quality control measures would ensure reproducibility when monitoring these trace element changes across different cheese varieties?", "history": ["What factors contribute to the accumulation of toxic elements in dairy products like cheese?", "Does it vary significantly depending on the region and specific farming practices, such as feed and water sources?", "Given these regional variations in feed and water sources, how exactly do they affect the buildup of toxic elements like lead and cadmium in cheese? And what specific changes in production practices could help reduce these contaminants without compromising the cheese's quality and safety?"], "ground_truth": ["permed-80038", "permed-5184", "permed-5183", "permed-77151", "permed-4609", "permed-4696", "permed-74144", "permed-80941", "permed-91762", "permed-85223"]}
{"query_id": "topic_655_turn_5", "conversation_id": "topic_655", "turn_id": 5, "query": "Given these validated analytical methodologies for detecting trace elements, what clinical evidence exists regarding the health impacts of chronic low-level lead and cadmium exposure from dairy consumption? Have epidemiological studies established dose-response relationships between cheese contaminant levels and specific adverse outcomes in vulnerable populations like children or pregnant women? What are the clinical recommendations for consumption thresholds, and how do current regulatory limits align with emerging toxicological data on cumulative heavy metal exposure from dairy products?", "history": ["What factors contribute to the accumulation of toxic elements in dairy products like cheese?", "Does it vary significantly depending on the region and specific farming practices, such as feed and water sources?", "Given these regional variations in feed and water sources, how exactly do they affect the buildup of toxic elements like lead and cadmium in cheese? And what specific changes in production practices could help reduce these contaminants without compromising the cheese's quality and safety?", "Given the proposed production practice modifications, what specific analytical methodologies would you recommend for quantifying lead and cadmium reduction in cheese matrices? I'm particularly interested in the sample preparation protocols for dairy products, the choice between ICP-MS versus atomic absorption spectroscopy for detection limits, and how you'd validate these methods for complex lipid-rich matrices. What quality control measures would ensure reproducibility when monitoring these trace element changes across different cheese varieties?"], "ground_truth": ["permed-80038", "permed-74144", "permed-77777", "permed-23242", "permed-81915", "permed-65098", "permed-85535", "permed-80040", "permed-90750", "permed-37468"]}
{"query_id": "topic_656_turn_1", "conversation_id": "topic_656", "turn_id": 1, "query": "Potassium doping effects on polymeric carbon nitride properties for catalytic applications", "history": [], "ground_truth": ["permed-53776", "permed-81159", "permed-74574", "permed-74424", "permed-53779", "permed-72959", "permed-51992", "permed-53774", "permed-77110", "permed-64912"]}
{"query_id": "topic_656_turn_2", "conversation_id": "topic_656", "turn_id": 2, "query": "Influence of this potassium doping on polymeric carbon nitride's oxygen interaction for hydrogen peroxide (H2O2) generation", "history": ["Potassium doping effects on polymeric carbon nitride properties for catalytic applications"], "ground_truth": ["permed-74424", "permed-53776", "permed-53775", "permed-81159", "permed-81161", "permed-53779", "permed-53774", "permed-52989", "permed-72959", "permed-51985"]}
{"query_id": "topic_656_turn_3", "conversation_id": "topic_656", "turn_id": 3, "query": "Mechanisms of potassium-induced Lewis acid-base sites in polymeric carbon nitride: role in oxygen adsorption/activation for photocatalytic H2O2 production", "history": ["Potassium doping effects on polymeric carbon nitride properties for catalytic applications", "Influence of this potassium doping on polymeric carbon nitride's oxygen interaction for hydrogen peroxide (H2O2) generation"], "ground_truth": ["permed-74424", "permed-53776", "permed-81159", "permed-53779", "permed-62930", "permed-53782", "permed-81161", "permed-53777", "permed-55231", "permed-74576"]}
{"query_id": "topic_656_turn_4", "conversation_id": "topic_656", "turn_id": 4, "query": "When implementing this potassium doping approach to create Lewis acid-base sites, what specific characterization techniques did you employ to quantify the density and strength distribution of these sites? Additionally, could you detail the experimental protocol for assessing oxygen adsorption isotherms under photocatalytic conditions, including how you controlled for potential confounding factors like moisture sensitivity during your surface interaction measurements?", "history": ["Potassium doping effects on polymeric carbon nitride properties for catalytic applications", "Influence of this potassium doping on polymeric carbon nitride's oxygen interaction for hydrogen peroxide (H2O2) generation", "Mechanisms of potassium-induced Lewis acid-base sites in polymeric carbon nitride: role in oxygen adsorption/activation for photocatalytic H2O2 production"], "ground_truth": ["permed-55231", "permed-76880", "permed-74576", "permed-53484", "permed-88728", "permed-53094", "permed-74577", "permed-77116", "permed-78807", "permed-78258"]}
{"query_id": "topic_656_turn_5", "conversation_id": "topic_656", "turn_id": 5, "query": "Given your detailed characterization of potassium-doped polymeric carbon nitride's Lewis acid-base sites and oxygen adsorption capabilities, how might these photocatalytic H2O2 generation properties translate to clinical applications? Specifically, what evidence exists regarding the therapeutic efficacy and safety profile of in-situ generated hydrogen peroxide for wound disinfection or antimicrobial treatments compared to conventional H2O2 delivery methods? Have any preclinical studies evaluated cytotoxicity thresholds or tissue response to catalyst-derived reactive oxygen species in biomedical contexts?", "history": ["Potassium doping effects on polymeric carbon nitride properties for catalytic applications", "Influence of this potassium doping on polymeric carbon nitride's oxygen interaction for hydrogen peroxide (H2O2) generation", "Mechanisms of potassium-induced Lewis acid-base sites in polymeric carbon nitride: role in oxygen adsorption/activation for photocatalytic H2O2 production", "When implementing this potassium doping approach to create Lewis acid-base sites, what specific characterization techniques did you employ to quantify the density and strength distribution of these sites? Additionally, could you detail the experimental protocol for assessing oxygen adsorption isotherms under photocatalytic conditions, including how you controlled for potential confounding factors like moisture sensitivity during your surface interaction measurements?"], "ground_truth": ["permed-74424", "permed-53776", "permed-53775", "permed-53779", "permed-60907", "permed-53782", "permed-88261", "permed-53774", "permed-76839", "permed-53777"]}
{"query_id": "topic_657_turn_1", "conversation_id": "topic_657", "turn_id": 1, "query": "What role does ZmNHL1 play in maize's response to environmental stresses?", "history": [], "ground_truth": ["permed-80760", "permed-63878", "permed-64095", "permed-63990", "permed-63959", "permed-70023", "permed-64128", "permed-63926", "permed-64155", "permed-63804"]}
{"query_id": "topic_657_turn_2", "conversation_id": "topic_657", "turn_id": 2, "query": "Can this gene's function in drought tolerance be applied to enhance stress resilience in other crops or under different stress conditions?", "history": ["What role does ZmNHL1 play in maize's response to environmental stresses?"], "ground_truth": ["permed-63812", "permed-63899", "permed-63634", "permed-80760", "permed-63868", "permed-63630", "permed-63717", "permed-63809", "permed-80761", "permed-86217"]}
{"query_id": "topic_657_turn_3", "conversation_id": "topic_657", "turn_id": 3, "query": "Since ZmNHL1 improves maize's drought tolerance through ROS scavenging and cell membrane stability, how might overexpressing it in other crops or under different stresses like salinity or extreme temperatures impact their physiological responses and stress resilience? What could be the long-term effects of such modifications on crop yield and agricultural sustainability across diverse growing conditions?", "history": ["What role does ZmNHL1 play in maize's response to environmental stresses?", "Can this gene's function in drought tolerance be applied to enhance stress resilience in other crops or under different stress conditions?"], "ground_truth": ["permed-80760", "permed-64095", "permed-63990", "permed-63878", "permed-63959", "permed-70023", "permed-63794", "permed-64048", "permed-64173", "permed-63720"]}
{"query_id": "topic_657_turn_4", "conversation_id": "topic_657", "turn_id": 4, "query": "Given these proposed transgenic approaches, what specific experimental designs would best quantify the physiological impacts of ZmNHL1 overexpression across different crops? I'm particularly interested in the methodological details—how would you standardize stress application protocols (like salinity gradients or temperature regimes) while maintaining reproducibility? What specific biomarkers beyond basic ROS assays would provide robust validation of enhanced membrane stability, and which statistical models would account for genotype-by-environment interactions in long-term yield trials across diverse agricultural conditions?", "history": ["What role does ZmNHL1 play in maize's response to environmental stresses?", "Can this gene's function in drought tolerance be applied to enhance stress resilience in other crops or under different stress conditions?", "Since ZmNHL1 improves maize's drought tolerance through ROS scavenging and cell membrane stability, how might overexpressing it in other crops or under different stresses like salinity or extreme temperatures impact their physiological responses and stress resilience? What could be the long-term effects of such modifications on crop yield and agricultural sustainability across diverse growing conditions?"], "ground_truth": ["permed-80760", "permed-63959", "permed-64173", "permed-64074", "permed-63810", "permed-63878", "permed-64083", "permed-64155", "permed-63784", "permed-64075"]}
{"query_id": "topic_657_turn_5", "conversation_id": "topic_657", "turn_id": 5, "query": "Given these detailed experimental frameworks for quantifying ZmNHL1's physiological impacts, how might transgenic crops overexpressing this gene translate to clinical nutrition and public health outcomes? Specifically, what evidence would be needed to evaluate whether stress-resilient crops actually improve nutritional bioavailability or reduce mycotoxin contamination in food supplies under real-world farming conditions? Furthermore, what clinical monitoring protocols should accompany deployment to assess potential allergenicity or unintended metabolic changes in these modified crops, particularly considering variable environmental interactions?", "history": ["What role does ZmNHL1 play in maize's response to environmental stresses?", "Can this gene's function in drought tolerance be applied to enhance stress resilience in other crops or under different stress conditions?", "Since ZmNHL1 improves maize's drought tolerance through ROS scavenging and cell membrane stability, how might overexpressing it in other crops or under different stresses like salinity or extreme temperatures impact their physiological responses and stress resilience? What could be the long-term effects of such modifications on crop yield and agricultural sustainability across diverse growing conditions?", "Given these proposed transgenic approaches, what specific experimental designs would best quantify the physiological impacts of ZmNHL1 overexpression across different crops? I'm particularly interested in the methodological details—how would you standardize stress application protocols (like salinity gradients or temperature regimes) while maintaining reproducibility? What specific biomarkers beyond basic ROS assays would provide robust validation of enhanced membrane stability, and which statistical models would account for genotype-by-environment interactions in long-term yield trials across diverse agricultural conditions?"], "ground_truth": ["permed-63926", "permed-80760", "permed-64155", "permed-63959", "permed-64083", "permed-63490", "permed-63822", "permed-64074", "permed-63878", "permed-85048"]}
{"query_id": "topic_658_turn_1", "conversation_id": "topic_658", "turn_id": 1, "query": "What are PROTACs and how are they used in protein degradation research?", "history": [], "ground_truth": ["permed-79294", "permed-76066", "permed-60880", "permed-87463", "permed-60885", "permed-79295", "permed-88621", "permed-88623", "permed-90245", "permed-36403"]}
{"query_id": "topic_658_turn_2", "conversation_id": "topic_658", "turn_id": 2, "query": "Can this technique be applied to degrade intrinsically disordered proteins, which are often challenging to target with traditional methods?", "history": ["What are PROTACs and how are they used in protein degradation research?"], "ground_truth": ["permed-80237", "permed-71541", "permed-60883", "permed-79294", "permed-75067", "permed-75066", "permed-83857", "permed-60880", "permed-80354", "permed-73085"]}
{"query_id": "topic_658_turn_3", "conversation_id": "topic_658", "turn_id": 3, "query": "Given PROTACs' modular design, how could this be specifically adapted to improve the degradation of intrinsically disordered proteins—what strategies would enhance their selectivity and efficacy in complex cellular environments?", "history": ["What are PROTACs and how are they used in protein degradation research?", "Can this technique be applied to degrade intrinsically disordered proteins, which are often challenging to target with traditional methods?"], "ground_truth": ["permed-79294", "permed-60880", "permed-87463", "permed-76066", "permed-88623", "permed-60885", "permed-60883", "permed-88622", "permed-90245", "permed-36403"]}
{"query_id": "topic_658_turn_4", "conversation_id": "topic_658", "turn_id": 4, "query": "Given these proposed strategies for enhancing PROTAC-mediated degradation of intrinsically disordered proteins, could you elaborate on the specific experimental protocols used to validate ternary complex formation in live cells? I'm particularly interested in the technical implementation of proximity-based assays like BRET or FRET, and how researchers control for nonspecific interactions when quantifying complex stability using these approaches in physiologically relevant conditions.", "history": ["What are PROTACs and how are they used in protein degradation research?", "Can this technique be applied to degrade intrinsically disordered proteins, which are often challenging to target with traditional methods?", "Given PROTACs' modular design, how could this be specifically adapted to improve the degradation of intrinsically disordered proteins—what strategies would enhance their selectivity and efficacy in complex cellular environments?"], "ground_truth": ["permed-76066", "permed-79294", "permed-60880", "permed-82292", "permed-79295", "permed-82290", "permed-60883", "permed-66551", "permed-92560", "permed-87463"]}
{"query_id": "topic_658_turn_5", "conversation_id": "topic_658", "turn_id": 5, "query": "Given the technical validation of ternary complex formation in live cells, how have these experimental approaches translated to clinical evaluation of PROTACs targeting intrinsically disordered proteins? I'm particularly interested in how efficacy metrics from cellular assays correlate with patient outcomes in early-phase trials, what dose-limiting toxicities have emerged from on-target degradation of these challenging proteins, and whether the enhanced selectivity strategies discussed previously have successfully mitigated off-target effects in human subjects compared to traditional inhibitors.", "history": ["What are PROTACs and how are they used in protein degradation research?", "Can this technique be applied to degrade intrinsically disordered proteins, which are often challenging to target with traditional methods?", "Given PROTACs' modular design, how could this be specifically adapted to improve the degradation of intrinsically disordered proteins—what strategies would enhance their selectivity and efficacy in complex cellular environments?", "Given these proposed strategies for enhancing PROTAC-mediated degradation of intrinsically disordered proteins, could you elaborate on the specific experimental protocols used to validate ternary complex formation in live cells? I'm particularly interested in the technical implementation of proximity-based assays like BRET or FRET, and how researchers control for nonspecific interactions when quantifying complex stability using these approaches in physiologically relevant conditions."], "ground_truth": ["permed-36403", "permed-60885", "permed-88623", "permed-60880", "permed-79294", "permed-76066", "permed-25597", "permed-88621", "permed-56227", "permed-79295"]}
{"query_id": "topic_659_turn_1", "conversation_id": "topic_659", "turn_id": 1, "query": "What role do smectites play in carbon dioxide sequestration?", "history": [], "ground_truth": ["permed-75491", "permed-81891", "permed-75709", "permed-73149", "permed-73191", "permed-51631", "permed-83450", "permed-73197", "permed-79069", "permed-89752"]}
{"query_id": "topic_659_turn_2", "conversation_id": "topic_659", "turn_id": 2, "query": "How does the variation among different types of smectites impact their effectiveness in this process?", "history": ["What role do smectites play in carbon dioxide sequestration?"], "ground_truth": ["permed-75491", "permed-91958", "permed-82651", "permed-57934", "permed-91516", "permed-78322", "permed-85775", "permed-91962", "permed-88731", "permed-58059"]}
{"query_id": "topic_659_turn_3", "conversation_id": "topic_659", "turn_id": 3, "query": "Building on this, since cation polarizability affects smectites' interlayer properties during CO₂ adsorption, how do structural and chemical differences between types like hectorite and montmorillonite influence their long-term sequestration performance? Specifically, what mechanisms govern how the smectite framework and interlayer cations interact to determine CO₂ storage stability and capacity under varying temperature and pressure conditions?", "history": ["What role do smectites play in carbon dioxide sequestration?", "How does the variation among different types of smectites impact their effectiveness in this process?"], "ground_truth": ["permed-75491", "permed-73197", "permed-73191", "permed-79069", "permed-78322", "permed-73193", "permed-81159", "permed-81160", "permed-73149", "permed-78299"]}
{"query_id": "topic_659_turn_4", "conversation_id": "topic_659", "turn_id": 4, "query": "Given these mechanisms governing smectite-CO₂ interactions, what specific experimental protocols are used to quantify long-term storage stability across different smectite types? Specifically, how do researchers design accelerated aging experiments to simulate geological timeframes, and what analytical techniques—such as in situ XRD or TGA-MS—are employed to monitor structural changes and CO₂ retention? Additionally, what statistical models validate the extrapolation from laboratory conditions to actual reservoir environments while accounting for variables like cation exchange dynamics and pore fluid chemistry?", "history": ["What role do smectites play in carbon dioxide sequestration?", "How does the variation among different types of smectites impact their effectiveness in this process?", "Building on this, since cation polarizability affects smectites' interlayer properties during CO₂ adsorption, how do structural and chemical differences between types like hectorite and montmorillonite influence their long-term sequestration performance? Specifically, what mechanisms govern how the smectite framework and interlayer cations interact to determine CO₂ storage stability and capacity under varying temperature and pressure conditions?"], "ground_truth": ["permed-75491", "permed-73197", "permed-73149", "permed-73191", "permed-81891", "permed-87963", "permed-75489", "permed-75488", "permed-75709", "permed-51631"]}
{"query_id": "topic_659_turn_5", "conversation_id": "topic_659", "turn_id": 5, "query": "Given the sophisticated experimental protocols for quantifying smectite-CO₂ storage stability, how are these mineralogical insights being translated into clinical applications for patients? Specifically, are there ongoing clinical trials investigating smectite-based materials for therapeutic gas delivery systems, such as localized CO₂ therapy for wound healing or ischemic conditions? What patient safety profiles have been established regarding potential mineral particle dissemination, and how do clinicians balance therapeutic efficacy against risks of inflammatory responses or tissue accumulation when considering smectite-enhanced gas therapies?", "history": ["What role do smectites play in carbon dioxide sequestration?", "How does the variation among different types of smectites impact their effectiveness in this process?", "Building on this, since cation polarizability affects smectites' interlayer properties during CO₂ adsorption, how do structural and chemical differences between types like hectorite and montmorillonite influence their long-term sequestration performance? Specifically, what mechanisms govern how the smectite framework and interlayer cations interact to determine CO₂ storage stability and capacity under varying temperature and pressure conditions?", "Given these mechanisms governing smectite-CO₂ interactions, what specific experimental protocols are used to quantify long-term storage stability across different smectite types? Specifically, how do researchers design accelerated aging experiments to simulate geological timeframes, and what analytical techniques—such as in situ XRD or TGA-MS—are employed to monitor structural changes and CO₂ retention? Additionally, what statistical models validate the extrapolation from laboratory conditions to actual reservoir environments while accounting for variables like cation exchange dynamics and pore fluid chemistry?"], "ground_truth": ["permed-75491", "permed-27316", "permed-73197", "permed-72013", "permed-39183", "permed-21169", "permed-82267", "permed-79428", "permed-63011", "permed-89636"]}
{"query_id": "topic_660_turn_1", "conversation_id": "topic_660", "turn_id": 1, "query": "Is there a link between physical activity and reduced risk of atrial fibrillation in individuals with type 2 diabetes?", "history": [], "ground_truth": ["permed-79839", "permed-54808", "permed-79840", "permed-76352", "permed-23281", "permed-57024", "permed-57022", "permed-73613", "permed-83840", "permed-85230"]}
{"query_id": "topic_660_turn_2", "conversation_id": "topic_660", "turn_id": 2, "query": "How does this relationship change when considering differences in exercise habits, such as starting a new routine versus maintaining an existing one?", "history": ["Is there a link between physical activity and reduced risk of atrial fibrillation in individuals with type 2 diabetes?"], "ground_truth": ["permed-65029", "permed-58340", "permed-66409", "permed-55666", "permed-57049", "permed-86544", "permed-79839", "permed-55665", "permed-82522", "permed-66355"]}
{"query_id": "topic_660_turn_3", "conversation_id": "topic_660", "turn_id": 3, "query": "Given this relationship between physical activity and atrial fibrillation risk in type 2 diabetes patients, what are the specific physiological mechanisms behind it? How do these mechanisms differ between people who are just starting to exercise versus those maintaining long-term activity levels? And how could understanding these differences help develop more personalized exercise recommendations for AF prevention in this group?", "history": ["Is there a link between physical activity and reduced risk of atrial fibrillation in individuals with type 2 diabetes?", "How does this relationship change when considering differences in exercise habits, such as starting a new routine versus maintaining an existing one?"], "ground_truth": ["permed-79839", "permed-54808", "permed-23281", "permed-79840", "permed-76352", "permed-73613", "permed-52534", "permed-35367", "permed-57022", "permed-35601"]}
{"query_id": "topic_660_turn_4", "conversation_id": "topic_660", "turn_id": 4, "query": "When investigating these mechanisms through longitudinal cohort studies, what specific biomarkers and cardiac imaging parameters should be prioritized for serial measurement? I'm particularly interested in the methodological considerations for tracking inflammatory markers, cardiac fibrosis indicators, and autonomic nervous system changes - and how the sampling frequency and analytical techniques might differ between the exercise initiation versus maintenance phases to capture meaningful physiological transitions while ensuring statistical power in this diabetic population.", "history": ["Is there a link between physical activity and reduced risk of atrial fibrillation in individuals with type 2 diabetes?", "How does this relationship change when considering differences in exercise habits, such as starting a new routine versus maintaining an existing one?", "Given this relationship between physical activity and atrial fibrillation risk in type 2 diabetes patients, what are the specific physiological mechanisms behind it? How do these mechanisms differ between people who are just starting to exercise versus those maintaining long-term activity levels? And how could understanding these differences help develop more personalized exercise recommendations for AF prevention in this group?"], "ground_truth": ["permed-57393", "permed-52226", "permed-17701", "permed-57319", "permed-79839", "permed-18259", "permed-80430", "permed-77180", "permed-86283", "permed-58855"]}
{"query_id": "topic_660_turn_5", "conversation_id": "topic_660", "turn_id": 5, "query": "Given the methodological considerations for tracking physiological transitions during exercise initiation versus maintenance phases, how do the comparative predictive values of inflammatory biomarkers (like IL-6 and CRP) versus cardiac imaging parameters (such as LA strain and fibrosis markers) differ for AF risk stratification? Specifically, which combination provides superior clinical utility when balancing sensitivity to change against practical implementation constraints across different exercise adaptation stages in type 2 diabetes populations?", "history": ["Is there a link between physical activity and reduced risk of atrial fibrillation in individuals with type 2 diabetes?", "How does this relationship change when considering differences in exercise habits, such as starting a new routine versus maintaining an existing one?", "Given this relationship between physical activity and atrial fibrillation risk in type 2 diabetes patients, what are the specific physiological mechanisms behind it? How do these mechanisms differ between people who are just starting to exercise versus those maintaining long-term activity levels? And how could understanding these differences help develop more personalized exercise recommendations for AF prevention in this group?", "When investigating these mechanisms through longitudinal cohort studies, what specific biomarkers and cardiac imaging parameters should be prioritized for serial measurement? I'm particularly interested in the methodological considerations for tracking inflammatory markers, cardiac fibrosis indicators, and autonomic nervous system changes - and how the sampling frequency and analytical techniques might differ between the exercise initiation versus maintenance phases to capture meaningful physiological transitions while ensuring statistical power in this diabetic population."], "ground_truth": ["permed-79839", "permed-52534", "permed-57151", "permed-58734", "permed-57146", "permed-65666", "permed-56808", "permed-54670", "permed-43125", "permed-57345"]}
{"query_id": "topic_661_turn_1", "conversation_id": "topic_661", "turn_id": 1, "query": "Recent advancements and emerging strategies in photodynamic therapy for solid tumor treatment", "history": [], "ground_truth": ["permed-52833", "permed-67784", "permed-67783", "permed-56545", "permed-56539", "permed-80414", "permed-88259", "permed-55273", "permed-74788", "permed-74795"]}
{"query_id": "topic_661_turn_2", "conversation_id": "topic_661", "turn_id": 2, "query": "Following these advancements, how are nanozyme and nanoparticle-based approaches enhancing photosensitizer delivery and targeted activation in photodynamic therapy for solid tumors?", "history": ["Recent advancements and emerging strategies in photodynamic therapy for solid tumor treatment"], "ground_truth": ["permed-56539", "permed-52833", "permed-74795", "permed-60840", "permed-60846", "permed-56540", "permed-74792", "permed-88259", "permed-58080", "permed-56545"]}
{"query_id": "topic_661_turn_3", "conversation_id": "topic_661", "turn_id": 3, "query": "Considering such nano-approaches, what are the key design principles for temperature-sensitive catalase-like nanozymes in multifunctional nanoparticles to effectively modulate the tumor microenvironment (reduce solid stress, normalize vasculature) and boost therapeutic outcomes in solid tumor photodynamic therapy?", "history": ["Recent advancements and emerging strategies in photodynamic therapy for solid tumor treatment", "Following these advancements, how are nanozyme and nanoparticle-based approaches enhancing photosensitizer delivery and targeted activation in photodynamic therapy for solid tumors?"], "ground_truth": ["permed-74790", "permed-89159", "permed-58031", "permed-74788", "permed-67531", "permed-89160", "permed-64622", "permed-74795", "permed-57857", "permed-80659"]}
{"query_id": "topic_661_turn_4", "conversation_id": "topic_661", "turn_id": 4, "query": "When implementing these temperature-sensitive catalase-like nanozyme designs, what specific experimental protocols and characterization techniques are most critical for validating their catalytic activity under thermal control? I'm particularly interested in how researchers quantify the relationship between temperature fluctuations and hydrogen peroxide decomposition kinetics, and what statistical methods are used to correlate these enzymatic measurements with subsequent changes in tumor microenvironment parameters like hypoxia reduction and vascular normalization.", "history": ["Recent advancements and emerging strategies in photodynamic therapy for solid tumor treatment", "Following these advancements, how are nanozyme and nanoparticle-based approaches enhancing photosensitizer delivery and targeted activation in photodynamic therapy for solid tumors?", "Considering such nano-approaches, what are the key design principles for temperature-sensitive catalase-like nanozymes in multifunctional nanoparticles to effectively modulate the tumor microenvironment (reduce solid stress, normalize vasculature) and boost therapeutic outcomes in solid tumor photodynamic therapy?"], "ground_truth": ["permed-74790", "permed-89159", "permed-89160", "permed-58031", "permed-74788", "permed-58028", "permed-58027", "permed-58024", "permed-60472", "permed-77426"]}
{"query_id": "topic_661_turn_5", "conversation_id": "topic_661", "turn_id": 5, "query": "Given these comprehensive characterization protocols for temperature-responsive nanozymes, what clinical evidence exists regarding their therapeutic efficacy and safety profiles in human trials? Specifically, how do catalase-like nanozyme-mediated improvements in tumor microenvironment parameters (hypoxia reduction, vascular normalization) translate to measurable patient outcomes such as progression-free survival, overall response rates, or reduced adverse events compared to conventional photodynamic therapy? Additionally, what are the primary clinical challenges in managing thermal dose control during human applications to maximize therapeutic windows while minimizing off-target effects?", "history": ["Recent advancements and emerging strategies in photodynamic therapy for solid tumor treatment", "Following these advancements, how are nanozyme and nanoparticle-based approaches enhancing photosensitizer delivery and targeted activation in photodynamic therapy for solid tumors?", "Considering such nano-approaches, what are the key design principles for temperature-sensitive catalase-like nanozymes in multifunctional nanoparticles to effectively modulate the tumor microenvironment (reduce solid stress, normalize vasculature) and boost therapeutic outcomes in solid tumor photodynamic therapy?", "When implementing these temperature-sensitive catalase-like nanozyme designs, what specific experimental protocols and characterization techniques are most critical for validating their catalytic activity under thermal control? I'm particularly interested in how researchers quantify the relationship between temperature fluctuations and hydrogen peroxide decomposition kinetics, and what statistical methods are used to correlate these enzymatic measurements with subsequent changes in tumor microenvironment parameters like hypoxia reduction and vascular normalization."], "ground_truth": ["permed-74790", "permed-74788", "permed-89159", "permed-58031", "permed-57857", "permed-89160", "permed-52626", "permed-64622", "permed-67535", "permed-60846"]}
{"query_id": "topic_662_turn_1", "conversation_id": "topic_662", "turn_id": 1, "query": "Exploring the impact of van der Waals interstice radius on electronic properties and overall performance of Transition Metal Dichalcogenide (TMD) based devices", "history": [], "ground_truth": ["permed-76989", "permed-60595", "permed-75587", "permed-73029", "permed-75054", "permed-77027", "permed-76395", "permed-76994", "permed-75057", "permed-75586"]}
{"query_id": "topic_662_turn_2", "conversation_id": "topic_662", "turn_id": 2, "query": "Building on its impact, how does this van der Waals interstice radius in TMDs specifically influence conductive filament formation and characteristics within RRAM cells?", "history": ["Exploring the impact of van der Waals interstice radius on electronic properties and overall performance of Transition Metal Dichalcogenide (TMD) based devices"], "ground_truth": ["permed-76989", "permed-60595", "permed-75587", "permed-79017", "permed-76033", "permed-75953", "permed-85939", "permed-76395", "permed-82695", "permed-76992"]}
{"query_id": "topic_662_turn_3", "conversation_id": "topic_662", "turn_id": 3, "query": "Delving into these filament characteristics: what are the precise mechanisms linking TMD van der Waals interstice radius to filament dynamics, and how do they govern RRAM device long-term stability and reliability under thermal and humidity variations?", "history": ["Exploring the impact of van der Waals interstice radius on electronic properties and overall performance of Transition Metal Dichalcogenide (TMD) based devices", "Building on its impact, how does this van der Waals interstice radius in TMDs specifically influence conductive filament formation and characteristics within RRAM cells?"], "ground_truth": ["permed-76989", "permed-75587", "permed-60595", "permed-85939", "permed-75799", "permed-76991", "permed-79017", "permed-75586", "permed-74672", "permed-54056"]}
{"query_id": "topic_662_turn_4", "conversation_id": "topic_662", "turn_id": 4, "query": "When experimentally investigating these mechanisms linking interstice radius to filament dynamics, what specific characterization techniques (beyond standard electrical testing) would you recommend for quantifying structural evolution during switching cycles? Particularly, how might in-situ TEM combined with EELS address the challenge of tracking metal ion migration pathways through van der Waals gaps, and what statistical sampling approach would ensure reproducibility when correlating interfacial defects with cycling endurance under varying humidity conditions?", "history": ["Exploring the impact of van der Waals interstice radius on electronic properties and overall performance of Transition Metal Dichalcogenide (TMD) based devices", "Building on its impact, how does this van der Waals interstice radius in TMDs specifically influence conductive filament formation and characteristics within RRAM cells?", "Delving into these filament characteristics: what are the precise mechanisms linking TMD van der Waals interstice radius to filament dynamics, and how do they govern RRAM device long-term stability and reliability under thermal and humidity variations?"], "ground_truth": ["permed-81244", "permed-73202", "permed-55257", "permed-75587", "permed-60587", "permed-83500", "permed-79803", "permed-90101", "permed-74074", "permed-74073"]}
{"query_id": "topic_662_turn_5", "conversation_id": "topic_662", "turn_id": 5, "query": "Given the characterization challenges discussed, how do the trade-offs between in-situ TEM/EELS and synchrotron X-ray absorption spectroscopy compare for studying metal ion migration in TMD-based RRAM? Specifically, which technique offers superior temporal resolution versus chemical speciation capability when tracking filament evolution through van der Waals gaps, and how do their respective sampling volumes and damage potentials affect the statistical reliability of cycling endurance correlations under different environmental conditions?", "history": ["Exploring the impact of van der Waals interstice radius on electronic properties and overall performance of Transition Metal Dichalcogenide (TMD) based devices", "Building on its impact, how does this van der Waals interstice radius in TMDs specifically influence conductive filament formation and characteristics within RRAM cells?", "Delving into these filament characteristics: what are the precise mechanisms linking TMD van der Waals interstice radius to filament dynamics, and how do they govern RRAM device long-term stability and reliability under thermal and humidity variations?", "When experimentally investigating these mechanisms linking interstice radius to filament dynamics, what specific characterization techniques (beyond standard electrical testing) would you recommend for quantifying structural evolution during switching cycles? Particularly, how might in-situ TEM combined with EELS address the challenge of tracking metal ion migration pathways through van der Waals gaps, and what statistical sampling approach would ensure reproducibility when correlating interfacial defects with cycling endurance under varying humidity conditions?"], "ground_truth": ["permed-76989", "permed-76033", "permed-77026", "permed-75586", "permed-60922", "permed-60320", "permed-79017", "permed-79800", "permed-72959", "permed-83500"]}
{"query_id": "topic_663_turn_1", "conversation_id": "topic_663", "turn_id": 1, "query": "What role can telemedicine play in enhancing home-based healthcare services, especially for elderly patients?", "history": [], "ground_truth": ["permed-57548", "permed-53990", "permed-56932", "permed-52394", "permed-56930", "permed-57549", "permed-71747", "permed-75376", "permed-59688", "permed-61343"]}
{"query_id": "topic_663_turn_2", "conversation_id": "topic_663", "turn_id": 2, "query": "How might integrating this technology with other remote monitoring tools improve the overall effectiveness of these programs?", "history": ["What role can telemedicine play in enhancing home-based healthcare services, especially for elderly patients?"], "ground_truth": ["permed-55875", "permed-52116", "permed-80242", "permed-58556", "permed-87666", "permed-74052", "permed-82103", "permed-78477", "permed-61615", "permed-59467"]}
{"query_id": "topic_663_turn_3", "conversation_id": "topic_663", "turn_id": 3, "query": "Given these discussions about telemedicine and remote monitoring tools, how could their combined use specifically improve the adaptability and effectiveness of Comprehensive Geriatric Hospital at Home programs—particularly for handling complex case-mixes and enhancing long-term patient outcomes both during and after the pandemic?", "history": ["What role can telemedicine play in enhancing home-based healthcare services, especially for elderly patients?", "How might integrating this technology with other remote monitoring tools improve the overall effectiveness of these programs?"], "ground_truth": ["permed-81759", "permed-61168", "permed-55875", "permed-71306", "permed-68427", "permed-55156", "permed-53990", "permed-75376", "permed-52394", "permed-52116"]}
{"query_id": "topic_663_turn_4", "conversation_id": "topic_663", "turn_id": 4, "query": "When implementing this combined telemedicine and remote monitoring approach for geriatric Hospital at Home programs, what specific methodological frameworks would you recommend for quantifying adaptability across diverse case-mixes? I'm particularly interested in how to statistically validate intervention protocols that dynamically adjust based on real-time patient data streams, and what quality control measures ensure reproducible outcomes when scaling this integrated care model across different healthcare systems with varying resource constraints.", "history": ["What role can telemedicine play in enhancing home-based healthcare services, especially for elderly patients?", "How might integrating this technology with other remote monitoring tools improve the overall effectiveness of these programs?", "Given these discussions about telemedicine and remote monitoring tools, how could their combined use specifically improve the adaptability and effectiveness of Comprehensive Geriatric Hospital at Home programs—particularly for handling complex case-mixes and enhancing long-term patient outcomes both during and after the pandemic?"], "ground_truth": ["permed-81759", "permed-59466", "permed-52116", "permed-59135", "permed-52394", "permed-61343", "permed-74633", "permed-56932", "permed-75376", "permed-81761"]}
{"query_id": "topic_663_turn_5", "conversation_id": "topic_663", "turn_id": 5, "query": "Given these methodological frameworks for quantifying adaptability and validating dynamic protocols, what clinical outcomes have been demonstrated when implementing such integrated telemedicine and remote monitoring systems in geriatric Hospital at Home programs? Specifically, what reductions in hospital readmission rates, improvements in functional recovery metrics, and medication adherence outcomes have been observed in real-world deployments? Additionally, how do safety profiles and adverse event rates compare between technology-enhanced home hospitalizations and traditional inpatient care, particularly regarding falls detection, medication errors, and delayed escalation of care for deteriorating patients?", "history": ["What role can telemedicine play in enhancing home-based healthcare services, especially for elderly patients?", "How might integrating this technology with other remote monitoring tools improve the overall effectiveness of these programs?", "Given these discussions about telemedicine and remote monitoring tools, how could their combined use specifically improve the adaptability and effectiveness of Comprehensive Geriatric Hospital at Home programs—particularly for handling complex case-mixes and enhancing long-term patient outcomes both during and after the pandemic?", "When implementing this combined telemedicine and remote monitoring approach for geriatric Hospital at Home programs, what specific methodological frameworks would you recommend for quantifying adaptability across diverse case-mixes? I'm particularly interested in how to statistically validate intervention protocols that dynamically adjust based on real-time patient data streams, and what quality control measures ensure reproducible outcomes when scaling this integrated care model across different healthcare systems with varying resource constraints."], "ground_truth": ["permed-75376", "permed-59466", "permed-56930", "permed-81759", "permed-78714", "permed-56932", "permed-57549", "permed-61343", "permed-53990", "permed-52394"]}
{"query_id": "topic_664_turn_1", "conversation_id": "topic_664", "turn_id": 1, "query": "What makes heterotriangulene-based COFs promising materials for topological insulator applications?", "history": [], "ground_truth": ["permed-62263", "permed-73308", "permed-76992", "permed-75590", "permed-75058", "permed-86530", "permed-51012", "permed-86725", "permed-78823", "permed-75755"]}
{"query_id": "topic_664_turn_2", "conversation_id": "topic_664", "turn_id": 2, "query": "How can the electronic properties of this material be tuned or optimized to improve its performance as a higher-order topological insulator?", "history": ["What makes heterotriangulene-based COFs promising materials for topological insulator applications?"], "ground_truth": ["permed-62263", "permed-90090", "permed-73288", "permed-75513", "permed-75583", "permed-75584", "permed-76036", "permed-83337", "permed-86530", "permed-87754"]}
{"query_id": "topic_664_turn_3", "conversation_id": "topic_664", "turn_id": 3, "query": "Building on these electronic property optimizations, what specific strategies could be used to further enhance both the electronic and structural properties of these heterotriangulene-based COFs to improve their performance as 2D higher-order topological insulators? In particular, how might we modulate the core-linker interplay to achieve a larger and more stable topological insulator gap? Additionally, how would different substrates or environmental conditions influence the stability and observable properties of these materials in practical applications?", "history": ["What makes heterotriangulene-based COFs promising materials for topological insulator applications?", "How can the electronic properties of this material be tuned or optimized to improve its performance as a higher-order topological insulator?"], "ground_truth": ["permed-62263", "permed-78823", "permed-73308", "permed-62258", "permed-51012", "permed-55232", "permed-51014", "permed-89879", "permed-76105", "permed-75590"]}
{"query_id": "topic_664_turn_4", "conversation_id": "topic_664", "turn_id": 4, "query": "Following these proposed strategies for modulating core-linker interplay and substrate interactions, what specific computational and experimental methodologies would you prioritize for systematically quantifying the resulting topological gap enhancement and structural stability? I'm particularly interested in which DFT functionals and basis sets would be most appropriate for accurately predicting band structures in these complex COF systems, and what experimental characterization techniques could provide complementary validation of both the electronic band gap and mechanical integrity under varying environmental conditions.", "history": ["What makes heterotriangulene-based COFs promising materials for topological insulator applications?", "How can the electronic properties of this material be tuned or optimized to improve its performance as a higher-order topological insulator?", "Building on these electronic property optimizations, what specific strategies could be used to further enhance both the electronic and structural properties of these heterotriangulene-based COFs to improve their performance as 2D higher-order topological insulators? In particular, how might we modulate the core-linker interplay to achieve a larger and more stable topological insulator gap? Additionally, how would different substrates or environmental conditions influence the stability and observable properties of these materials in practical applications?"], "ground_truth": ["permed-62263", "permed-75447", "permed-78823", "permed-51014", "permed-51651", "permed-62258", "permed-75590", "permed-78527", "permed-58052", "permed-51012"]}
{"query_id": "topic_664_turn_5", "conversation_id": "topic_664", "turn_id": 5, "query": "Given these comprehensive methodological approaches for characterizing topological properties, what clinical translation challenges might arise when developing heterotriangulene-based COFs for biomedical applications, such as neural interfaces or biosensing? Specifically, what in vivo safety profiles—regarding potential cytotoxicity, inflammatory responses, or long-term biocompatibility—should be prioritized in preclinical studies? Furthermore, how might the material's environmental stability, now being optimized for topological properties, impact its performance and safety under physiological conditions, and what clinical evidence would be required to advance toward first-in-human trials?", "history": ["What makes heterotriangulene-based COFs promising materials for topological insulator applications?", "How can the electronic properties of this material be tuned or optimized to improve its performance as a higher-order topological insulator?", "Building on these electronic property optimizations, what specific strategies could be used to further enhance both the electronic and structural properties of these heterotriangulene-based COFs to improve their performance as 2D higher-order topological insulators? In particular, how might we modulate the core-linker interplay to achieve a larger and more stable topological insulator gap? Additionally, how would different substrates or environmental conditions influence the stability and observable properties of these materials in practical applications?", "Following these proposed strategies for modulating core-linker interplay and substrate interactions, what specific computational and experimental methodologies would you prioritize for systematically quantifying the resulting topological gap enhancement and structural stability? I'm particularly interested in which DFT functionals and basis sets would be most appropriate for accurately predicting band structures in these complex COF systems, and what experimental characterization techniques could provide complementary validation of both the electronic band gap and mechanical integrity under varying environmental conditions."], "ground_truth": ["permed-62263", "permed-86725", "permed-73308", "permed-75590", "permed-50902", "permed-86723", "permed-83332", "permed-51014", "permed-52610", "permed-86664"]}
{"query_id": "topic_665_turn_1", "conversation_id": "topic_665", "turn_id": 1, "query": "Key diagnostic challenges in pediatric type 1 von Willebrand disease", "history": [], "ground_truth": ["permed-76848", "permed-91056", "permed-49450", "permed-49363", "permed-20878", "permed-18480", "permed-49426", "permed-89406", "permed-72012", "permed-56265"]}
{"query_id": "topic_665_turn_2", "conversation_id": "topic_665", "turn_id": 2, "query": "Improving pediatric type 1 VWD diagnosis for rare variants using advanced techniques, addressing these initial challenges", "history": ["Key diagnostic challenges in pediatric type 1 von Willebrand disease"], "ground_truth": ["permed-76848", "permed-73582", "permed-30029", "permed-31392", "permed-91056", "permed-71061", "permed-75668", "permed-68533", "permed-8662", "permed-73523"]}
{"query_id": "topic_665_turn_3", "conversation_id": "topic_665", "turn_id": 3, "query": "Combined coagulation assays, NGS, and MLPA for detecting rare type 1 VWD variants in children: implications for personalized treatment and genetic counseling", "history": ["Key diagnostic challenges in pediatric type 1 von Willebrand disease", "Improving pediatric type 1 VWD diagnosis for rare variants using advanced techniques, addressing these initial challenges"], "ground_truth": ["permed-76848", "permed-91056", "permed-50790", "permed-76849", "permed-49450", "permed-73523", "permed-18480", "permed-49452", "permed-43604", "permed-46149"]}
{"query_id": "topic_665_turn_4", "conversation_id": "topic_665", "turn_id": 4, "query": "For the combined approach using coagulation assays, NGS, and MLPA, what specific quality control metrics were implemented to validate the sensitivity and reproducibility of these methods across different pediatric samples? I'm particularly interested in how you established robust diagnostic thresholds for rare variants and whether any normalization procedures were required when integrating results from these three distinct technical platforms.", "history": ["Key diagnostic challenges in pediatric type 1 von Willebrand disease", "Improving pediatric type 1 VWD diagnosis for rare variants using advanced techniques, addressing these initial challenges", "Combined coagulation assays, NGS, and MLPA for detecting rare type 1 VWD variants in children: implications for personalized treatment and genetic counseling"], "ground_truth": ["permed-56404", "permed-46022", "permed-2278", "permed-31291", "permed-83492", "permed-6049", "permed-20131", "permed-76849", "permed-54315", "permed-4667"]}
{"query_id": "topic_665_turn_5", "conversation_id": "topic_665", "turn_id": 5, "query": "Given these validated diagnostic thresholds for rare pediatric type 1 VWD variants, how have these comprehensive molecular profiles translated into clinical decision-making regarding personalized prophylaxis regimens? Specifically, for pediatric patients with confirmed pathogenic variants identified through your multi-platform approach, what evidence exists regarding the efficacy of tailored therapeutic schedules in reducing bleeding episodes and improving quality-of-life metrics compared to standard management? Additionally, have any specific variant classes shown differential clinical responses that informed targeted treatment protocols?", "history": ["Key diagnostic challenges in pediatric type 1 von Willebrand disease", "Improving pediatric type 1 VWD diagnosis for rare variants using advanced techniques, addressing these initial challenges", "Combined coagulation assays, NGS, and MLPA for detecting rare type 1 VWD variants in children: implications for personalized treatment and genetic counseling", "For the combined approach using coagulation assays, NGS, and MLPA, what specific quality control metrics were implemented to validate the sensitivity and reproducibility of these methods across different pediatric samples? I'm particularly interested in how you established robust diagnostic thresholds for rare variants and whether any normalization procedures were required when integrating results from these three distinct technical platforms."], "ground_truth": ["permed-76848", "permed-71262", "permed-50780", "permed-91665", "permed-91056", "permed-49474", "permed-41660", "permed-66455", "permed-73459", "permed-73582"]}
{"query_id": "topic_666_turn_1", "conversation_id": "topic_666", "turn_id": 1, "query": "Neurodevelopmental alterations in structural and functional brain connectivity in ADHD across childhood, adolescence, and adulthood: A systematic review", "history": [], "ground_truth": ["permed-55735", "permed-77860", "permed-55734", "permed-40693", "permed-8888", "permed-8218", "permed-66366", "permed-55733", "permed-69485", "permed-21428"]}
{"query_id": "topic_666_turn_2", "conversation_id": "topic_666", "turn_id": 2, "query": "How do these observed developmental alterations in ADHD brain connectivity, particularly within fronto-striatal and fronto-parietal circuits, evolve from childhood to adulthood and relate to long-term clinical outcomes?", "history": ["Neurodevelopmental alterations in structural and functional brain connectivity in ADHD across childhood, adolescence, and adulthood: A systematic review"], "ground_truth": ["permed-55735", "permed-77860", "permed-8218", "permed-66366", "permed-40693", "permed-55575", "permed-8888", "permed-55734", "permed-55740", "permed-76536"]}
{"query_id": "topic_666_turn_3", "conversation_id": "topic_666", "turn_id": 3, "query": "Based on these age-specific atypical maturation patterns in ADHD fronto-striatal and fronto-parietal networks, what are the mechanisms linking them to distinct cognitive (e.g., executive function, reward processing) and behavioral profiles in children versus adults, and what novel neuromodulation or pharmacological interventions could target these pathway-specific dysfunctions?", "history": ["Neurodevelopmental alterations in structural and functional brain connectivity in ADHD across childhood, adolescence, and adulthood: A systematic review", "How do these observed developmental alterations in ADHD brain connectivity, particularly within fronto-striatal and fronto-parietal circuits, evolve from childhood to adulthood and relate to long-term clinical outcomes?"], "ground_truth": ["permed-66366", "permed-77860", "permed-55735", "permed-71493", "permed-55734", "permed-55733", "permed-21428", "permed-11218", "permed-69171", "permed-82447"]}
{"query_id": "topic_666_turn_4", "conversation_id": "topic_666", "turn_id": 4, "query": "Given these proposed pathway-specific interventions, what methodological approaches are most appropriate for validating their efficacy in longitudinal studies? Specifically, how should researchers design fMRI protocols to track fronto-striatal connectivity changes during neuromodulation trials, and what statistical models (e.g., mixed-effects or growth curve modeling) would best account for individual developmental trajectories while maintaining power across different age cohorts? Additionally, what quality control measures ensure reproducibility when comparing intervention effects between pediatric and adult ADHD populations?", "history": ["Neurodevelopmental alterations in structural and functional brain connectivity in ADHD across childhood, adolescence, and adulthood: A systematic review", "How do these observed developmental alterations in ADHD brain connectivity, particularly within fronto-striatal and fronto-parietal circuits, evolve from childhood to adulthood and relate to long-term clinical outcomes?", "Based on these age-specific atypical maturation patterns in ADHD fronto-striatal and fronto-parietal networks, what are the mechanisms linking them to distinct cognitive (e.g., executive function, reward processing) and behavioral profiles in children versus adults, and what novel neuromodulation or pharmacological interventions could target these pathway-specific dysfunctions?"], "ground_truth": ["permed-71493", "permed-66366", "permed-55735", "permed-55733", "permed-77860", "permed-90637", "permed-55577", "permed-55734", "permed-8888", "permed-90638"]}
{"query_id": "topic_666_turn_5", "conversation_id": "topic_666", "turn_id": 5, "query": "Given these methodological frameworks for tracking connectivity changes during neuromodulation trials, what clinical translation challenges arise when implementing these interventions in real-world practice? Specifically, how do safety profiles and side effect patterns of pathway-specific neuromodulation differ between pediatric and adult ADHD populations, and what clinical trial evidence exists regarding their therapeutic efficacy on core ADHD symptoms and functional outcomes? Furthermore, what practical considerations emerge regarding treatment accessibility, patient adherence, and comorbidity management when deploying these interventions across diverse healthcare settings?", "history": ["Neurodevelopmental alterations in structural and functional brain connectivity in ADHD across childhood, adolescence, and adulthood: A systematic review", "How do these observed developmental alterations in ADHD brain connectivity, particularly within fronto-striatal and fronto-parietal circuits, evolve from childhood to adulthood and relate to long-term clinical outcomes?", "Based on these age-specific atypical maturation patterns in ADHD fronto-striatal and fronto-parietal networks, what are the mechanisms linking them to distinct cognitive (e.g., executive function, reward processing) and behavioral profiles in children versus adults, and what novel neuromodulation or pharmacological interventions could target these pathway-specific dysfunctions?", "Given these proposed pathway-specific interventions, what methodological approaches are most appropriate for validating their efficacy in longitudinal studies? Specifically, how should researchers design fMRI protocols to track fronto-striatal connectivity changes during neuromodulation trials, and what statistical models (e.g., mixed-effects or growth curve modeling) would best account for individual developmental trajectories while maintaining power across different age cohorts? Additionally, what quality control measures ensure reproducibility when comparing intervention effects between pediatric and adult ADHD populations?"], "ground_truth": ["permed-77860", "permed-69171", "permed-71493", "permed-90637", "permed-69170", "permed-66366", "permed-90638", "permed-69169", "permed-74814", "permed-59828"]}
{"query_id": "topic_667_turn_1", "conversation_id": "topic_667", "turn_id": 1, "query": "What is the fundamental role of collagen in guided bone regeneration (GBR)?", "history": [], "ground_truth": ["permed-75199", "permed-75885", "permed-64453", "permed-75242", "permed-75250", "permed-74613", "permed-52666", "permed-87322", "permed-75197", "permed-78954"]}
{"query_id": "topic_667_turn_2", "conversation_id": "topic_667", "turn_id": 2, "query": "Building on that, how do different collagen membrane types, specifically crosslinked versus non-crosslinked, affect this GBR process?", "history": ["What is the fundamental role of collagen in guided bone regeneration (GBR)?"], "ground_truth": ["permed-75242", "permed-80563", "permed-89206", "permed-86653", "permed-74616", "permed-76267", "permed-80562", "permed-75199", "permed-57784", "permed-70827"]}
{"query_id": "topic_667_turn_3", "conversation_id": "topic_667", "turn_id": 3, "query": "Focusing on these crosslinked versus non-crosslinked collagen membranes, how do their distinct biochemical and mechanical properties specifically influence periosteal progenitor cell differentiation and function, and what are the implications for long-term bone quality and healing outcomes in GBR?", "history": ["What is the fundamental role of collagen in guided bone regeneration (GBR)?", "Building on that, how do different collagen membrane types, specifically crosslinked versus non-crosslinked, affect this GBR process?"], "ground_truth": ["permed-75242", "permed-75199", "permed-74613", "permed-75885", "permed-51833", "permed-79717", "permed-70827", "permed-64575", "permed-80562", "permed-20255"]}
{"query_id": "topic_667_turn_4", "conversation_id": "topic_667", "turn_id": 4, "query": "Given these distinct differentiation outcomes between crosslinked and non-crosslinked membranes, what specific in vitro methodologies would you recommend for systematically evaluating their effects on periosteal progenitor cell fate? I'm particularly interested in the optimal assay combinations—perhaps comparing Alizarin Red staining quantification methods with osteogenic gene expression panels—and how to standardize the mechanical stimulation protocols to better mimic the in vivo GBR environment while maintaining reproducibility across experimental batches.", "history": ["What is the fundamental role of collagen in guided bone regeneration (GBR)?", "Building on that, how do different collagen membrane types, specifically crosslinked versus non-crosslinked, affect this GBR process?", "Focusing on these crosslinked versus non-crosslinked collagen membranes, how do their distinct biochemical and mechanical properties specifically influence periosteal progenitor cell differentiation and function, and what are the implications for long-term bone quality and healing outcomes in GBR?"], "ground_truth": ["permed-75242", "permed-75199", "permed-51833", "permed-74613", "permed-59068", "permed-43000", "permed-80078", "permed-58210", "permed-75885", "permed-64578"]}
{"query_id": "topic_667_turn_5", "conversation_id": "topic_667", "turn_id": 5, "query": "Given our detailed discussion of in vitro methodologies for evaluating periosteal progenitor cell responses, how would you systematically compare the translational reliability of these membrane evaluation approaches? Specifically, when conducting a meta-analysis of GBR studies, what concordance rates typically emerge between in vitro osteogenic differentiation markers (like those we've discussed) and actual in vivo bone regeneration metrics across different membrane types? I'm particularly interested in whether certain in vitro assays demonstrate stronger predictive value for clinical outcomes, and how researchers might weight these different evidence streams when making clinical recommendations about membrane selection.", "history": ["What is the fundamental role of collagen in guided bone regeneration (GBR)?", "Building on that, how do different collagen membrane types, specifically crosslinked versus non-crosslinked, affect this GBR process?", "Focusing on these crosslinked versus non-crosslinked collagen membranes, how do their distinct biochemical and mechanical properties specifically influence periosteal progenitor cell differentiation and function, and what are the implications for long-term bone quality and healing outcomes in GBR?", "Given these distinct differentiation outcomes between crosslinked and non-crosslinked membranes, what specific in vitro methodologies would you recommend for systematically evaluating their effects on periosteal progenitor cell fate? I'm particularly interested in the optimal assay combinations—perhaps comparing Alizarin Red staining quantification methods with osteogenic gene expression panels—and how to standardize the mechanical stimulation protocols to better mimic the in vivo GBR environment while maintaining reproducibility across experimental batches."], "ground_truth": ["permed-75242", "permed-75199", "permed-51833", "permed-75885", "permed-74613", "permed-61082", "permed-75119", "permed-63248", "permed-75201", "permed-91859"]}
{"query_id": "topic_668_turn_1", "conversation_id": "topic_668", "turn_id": 1, "query": "What role do 3D printed scaffolds play in tissue regeneration research?", "history": [], "ground_truth": ["permed-79770", "permed-64656", "permed-79768", "permed-64490", "permed-64507", "permed-64351", "permed-75209", "permed-87321", "permed-79772", "permed-64659"]}
{"query_id": "topic_668_turn_2", "conversation_id": "topic_668", "turn_id": 2, "query": "How can advancements in materials science enhance the effectiveness of this technique?", "history": ["What role do 3D printed scaffolds play in tissue regeneration research?"], "ground_truth": ["permed-82651", "permed-87251", "permed-52100", "permed-74446", "permed-91396", "permed-74014", "permed-70308", "permed-73925", "permed-89048", "permed-51727"]}
{"query_id": "topic_668_turn_3", "conversation_id": "topic_668", "turn_id": 3, "query": "Given these advancements in materials science, how could integrating advanced materials like graphene oxide or nanocellulose further optimize the mechanical properties and biological performance of 3D printed scaffolds, and what impact might these improvements have on their ability to support vascularization and bone tissue regeneration in complex defect models?", "history": ["What role do 3D printed scaffolds play in tissue regeneration research?", "How can advancements in materials science enhance the effectiveness of this technique?"], "ground_truth": ["permed-64456", "permed-64490", "permed-64656", "permed-82183", "permed-64351", "permed-12439", "permed-64510", "permed-79770", "permed-57924", "permed-64388"]}
{"query_id": "topic_668_turn_4", "conversation_id": "topic_668", "turn_id": 4, "query": "When implementing these advanced composite scaffolds, what specific fabrication parameters—such as nozzle temperature, printing speed, and layer resolution—are most critical for maintaining the structural integrity of graphene oxide or nanocellulose during the 3D printing process? Additionally, how are researchers validating the uniformity of material distribution and pore architecture to ensure consistent mechanical properties and biological performance across different scaffold batches in complex defect models?", "history": ["What role do 3D printed scaffolds play in tissue regeneration research?", "How can advancements in materials science enhance the effectiveness of this technique?", "Given these advancements in materials science, how could integrating advanced materials like graphene oxide or nanocellulose further optimize the mechanical properties and biological performance of 3D printed scaffolds, and what impact might these improvements have on their ability to support vascularization and bone tissue regeneration in complex defect models?"], "ground_truth": ["permed-64456", "permed-51033", "permed-64510", "permed-89117", "permed-82183", "permed-64656", "permed-64490", "permed-77366", "permed-70213", "permed-80566"]}
{"query_id": "topic_668_turn_5", "conversation_id": "topic_668", "turn_id": 5, "query": "Given the established fabrication parameters and quality control measures for these advanced composite scaffolds, what clinical evidence exists regarding their therapeutic efficacy in human trials for complex bone defect repair? Specifically, how do patient outcomes—such as rates of osseointegration, functional recovery timelines, and incidence of adverse events like inflammation or scaffold fragmentation—compare between graphene oxide-enhanced scaffolds and conventional alternatives when used in critical-sized defects? Additionally, what are the primary clinical translation barriers preventing wider adoption beyond investigational settings?", "history": ["What role do 3D printed scaffolds play in tissue regeneration research?", "How can advancements in materials science enhance the effectiveness of this technique?", "Given these advancements in materials science, how could integrating advanced materials like graphene oxide or nanocellulose further optimize the mechanical properties and biological performance of 3D printed scaffolds, and what impact might these improvements have on their ability to support vascularization and bone tissue regeneration in complex defect models?", "When implementing these advanced composite scaffolds, what specific fabrication parameters—such as nozzle temperature, printing speed, and layer resolution—are most critical for maintaining the structural integrity of graphene oxide or nanocellulose during the 3D printing process? Additionally, how are researchers validating the uniformity of material distribution and pore architecture to ensure consistent mechanical properties and biological performance across different scaffold batches in complex defect models?"], "ground_truth": ["permed-76865", "permed-64483", "permed-52660", "permed-80566", "permed-87687", "permed-88246", "permed-61082", "permed-72823", "permed-64487", "permed-75702"]}
{"query_id": "topic_669_turn_1", "conversation_id": "topic_669", "turn_id": 1, "query": "Experimental techniques for studying meiotic recombination in model plant Arabidopsis thaliana", "history": [], "ground_truth": ["permed-76841", "permed-64170", "permed-76842", "permed-76845", "permed-50790", "permed-77579", "permed-53718", "permed-76843", "permed-82373", "permed-86233"]}
{"query_id": "topic_669_turn_2", "conversation_id": "topic_669", "turn_id": 2, "query": "Applicability of these Arabidopsis meiotic recombination study techniques to crop species with complex genomes", "history": ["Experimental techniques for studying meiotic recombination in model plant Arabidopsis thaliana"], "ground_truth": ["permed-76841", "permed-76842", "permed-64170", "permed-76845", "permed-76843", "permed-50790", "permed-53718", "permed-63764", "permed-77579", "permed-63678"]}
{"query_id": "topic_669_turn_3", "conversation_id": "topic_669", "turn_id": 3, "query": "Adapting cytological methods for meiotic recombination analysis from Arabidopsis to polyploid crops: challenges, optimization, and impact on breeding for genetic diversity", "history": ["Experimental techniques for studying meiotic recombination in model plant Arabidopsis thaliana", "Applicability of these Arabidopsis meiotic recombination study techniques to crop species with complex genomes"], "ground_truth": ["permed-76841", "permed-76842", "permed-64170", "permed-50790", "permed-76845", "permed-76843", "permed-64115", "permed-53718", "permed-77579", "permed-82373"]}
{"query_id": "topic_669_turn_4", "conversation_id": "topic_669", "turn_id": 4, "query": "For adapting these cytological methods to polyploid crops, what specific modifications to chromosome spreading and immunolocalization protocols were most critical for achieving clear signal resolution? How did researchers validate that observed foci patterns truly reflected recombination events versus technical artifacts, particularly given the increased chromosome complexity? Were any statistical adjustments necessary for quantifying recombination frequencies across homologous versus homeologous chromosome pairs in these polyploid systems?", "history": ["Experimental techniques for studying meiotic recombination in model plant Arabidopsis thaliana", "Applicability of these Arabidopsis meiotic recombination study techniques to crop species with complex genomes", "Adapting cytological methods for meiotic recombination analysis from Arabidopsis to polyploid crops: challenges, optimization, and impact on breeding for genetic diversity"], "ground_truth": ["permed-76841", "permed-76842", "permed-76845", "permed-67504", "permed-90277", "permed-73649", "permed-76843", "permed-64115", "permed-67567", "permed-37493"]}
{"query_id": "topic_669_turn_5", "conversation_id": "topic_669", "turn_id": 5, "query": "Given these methodological validations for cytological analysis in polyploid crops, what clinical translational implications emerge for crop breeding programs? Specifically, how have these optimized recombination quantification protocols informed the development of superior crop varieties with enhanced nutritional profiles or stress resilience in field trials? Furthermore, what safety considerations regarding unintended genomic alterations or allergenicity profiles were monitored when deploying these recombination-informed breeding strategies, and how were these balanced against therapeutic agricultural benefits such as improved food security or biofortification outcomes?", "history": ["Experimental techniques for studying meiotic recombination in model plant Arabidopsis thaliana", "Applicability of these Arabidopsis meiotic recombination study techniques to crop species with complex genomes", "Adapting cytological methods for meiotic recombination analysis from Arabidopsis to polyploid crops: challenges, optimization, and impact on breeding for genetic diversity", "For adapting these cytological methods to polyploid crops, what specific modifications to chromosome spreading and immunolocalization protocols were most critical for achieving clear signal resolution? How did researchers validate that observed foci patterns truly reflected recombination events versus technical artifacts, particularly given the increased chromosome complexity? Were any statistical adjustments necessary for quantifying recombination frequencies across homologous versus homeologous chromosome pairs in these polyploid systems?"], "ground_truth": ["permed-76842", "permed-64115", "permed-63676", "permed-63675", "permed-69982", "permed-63681", "permed-58191", "permed-88390", "permed-63819", "permed-63822"]}
{"query_id": "topic_670_turn_1", "conversation_id": "topic_670", "turn_id": 1, "query": "What is known about the adaptability of *Sphingomonas glacialis* in various environments?", "history": [], "ground_truth": ["permed-66834", "permed-60604", "permed-55471", "permed-66714", "permed-66794", "permed-76700", "permed-79923", "permed-53690", "permed-66918", "permed-66920"]}
{"query_id": "topic_670_turn_2", "conversation_id": "topic_670", "turn_id": 2, "query": "How does it respond to specific changes in its ecosystem, such as temperature fluctuations?", "history": ["What is known about the adaptability of *Sphingomonas glacialis* in various environments?"], "ground_truth": ["permed-75160", "permed-60604", "permed-82651", "permed-60605", "permed-59340", "permed-65029", "permed-72010", "permed-73486", "permed-91516", "permed-71975"]}
{"query_id": "topic_670_turn_3", "conversation_id": "topic_670", "turn_id": 3, "query": "Given its adaptability to environmental changes like temperature, how do *Sphingomonas glacialis*'s metabolic pathways and gene expression patterns shift in response to other stimuli such as light intensity variations, and what do these shifts mean for its survival and ecological role in alpine lakes?", "history": ["What is known about the adaptability of *Sphingomonas glacialis* in various environments?", "How does it respond to specific changes in its ecosystem, such as temperature fluctuations?"], "ground_truth": ["permed-79923", "permed-66714", "permed-72113", "permed-76700", "permed-73487", "permed-66918", "permed-79924", "permed-81212", "permed-63961", "permed-76623"]}
{"query_id": "topic_670_turn_4", "conversation_id": "topic_670", "turn_id": 4, "query": "When analyzing these metabolic and transcriptional shifts in response to light intensity, what specific transcriptomic profiling techniques—such as RNA-Seq—and subsequent bioinformatic pipelines were used to identify differentially expressed genes? Furthermore, how were the corresponding changes in key metabolic fluxes experimentally validated, for instance through targeted metabolomics or enzymatic assays, and what statistical thresholds were applied to ensure the robustness of these identified pathway alterations?", "history": ["What is known about the adaptability of *Sphingomonas glacialis* in various environments?", "How does it respond to specific changes in its ecosystem, such as temperature fluctuations?", "Given its adaptability to environmental changes like temperature, how do *Sphingomonas glacialis*'s metabolic pathways and gene expression patterns shift in response to other stimuli such as light intensity variations, and what do these shifts mean for its survival and ecological role in alpine lakes?"], "ground_truth": ["permed-24490", "permed-63961", "permed-63837", "permed-71920", "permed-72141", "permed-49966", "permed-63829", "permed-58105", "permed-63886", "permed-22103"]}
{"query_id": "topic_670_turn_5", "conversation_id": "topic_670", "turn_id": 5, "query": "Given the comprehensive transcriptomic and metabolic validation of *Sphingomonas glacialis*' environmental adaptability, how might these mechanistic insights into stress response pathways inform clinical applications? Specifically, considering its robust molecular adaptations, could compounds derived from its unique metabolic fluxes—particularly those activated under light/temperature stress—serve as novel therapeutic agents or biomaterials? What translational challenges exist in moving from environmental strain characterization to clinical development, particularly regarding safety profiling, biocompatibility assessment, and scaling production while maintaining bioactive compound integrity?", "history": ["What is known about the adaptability of *Sphingomonas glacialis* in various environments?", "How does it respond to specific changes in its ecosystem, such as temperature fluctuations?", "Given its adaptability to environmental changes like temperature, how do *Sphingomonas glacialis*'s metabolic pathways and gene expression patterns shift in response to other stimuli such as light intensity variations, and what do these shifts mean for its survival and ecological role in alpine lakes?", "When analyzing these metabolic and transcriptional shifts in response to light intensity, what specific transcriptomic profiling techniques—such as RNA-Seq—and subsequent bioinformatic pipelines were used to identify differentially expressed genes? Furthermore, how were the corresponding changes in key metabolic fluxes experimentally validated, for instance through targeted metabolomics or enzymatic assays, and what statistical thresholds were applied to ensure the robustness of these identified pathway alterations?"], "ground_truth": ["permed-66834", "permed-66794", "permed-66920", "permed-76704", "permed-52776", "permed-76700", "permed-82378", "permed-55475", "permed-66918", "permed-66683"]}
{"query_id": "topic_671_turn_1", "conversation_id": "topic_671", "turn_id": 1, "query": "Key principles and clinical applications of speech audiometry for evaluating cochlear implant recipient performance.", "history": [], "ground_truth": ["permed-77567", "permed-73862", "permed-73854", "permed-69439", "permed-73858", "permed-73860", "permed-61761", "permed-89946", "permed-78466", "permed-88930"]}
{"query_id": "topic_671_turn_2", "conversation_id": "topic_671", "turn_id": 2, "query": "Regarding these cochlear implant evaluations, how does speech audiometry specifically mitigate the impact of background noise on assessment accuracy?", "history": ["Key principles and clinical applications of speech audiometry for evaluating cochlear implant recipient performance."], "ground_truth": ["permed-77567", "permed-73860", "permed-69439", "permed-61761", "permed-73854", "permed-73862", "permed-43676", "permed-89946", "permed-63251", "permed-73855"]}
{"query_id": "topic_671_turn_3", "conversation_id": "topic_671", "turn_id": 3, "query": "Building on methods to mitigate noise, how do adaptive level control techniques, as used in monaural speech audiometry, affect Speech Reception Threshold (SRT) measurement reliability for cochlear implant users in realistic noise scenarios, and what are the crucial implications for standardizing their clinical fitting and follow-up protocols?", "history": ["Key principles and clinical applications of speech audiometry for evaluating cochlear implant recipient performance.", "Regarding these cochlear implant evaluations, how does speech audiometry specifically mitigate the impact of background noise on assessment accuracy?"], "ground_truth": ["permed-77567", "permed-69439", "permed-63416", "permed-73860", "permed-61761", "permed-63409", "permed-73854", "permed-63418", "permed-89946", "permed-92182"]}
{"query_id": "topic_671_turn_4", "conversation_id": "topic_671", "turn_id": 4, "query": "Given these adaptive level control approaches for SRT measurement, could you elaborate on the specific signal processing algorithms and statistical validation methods employed to ensure measurement precision? I'm particularly interested in how researchers establish the minimum number of reversals needed for stable threshold estimation, what quality control metrics are used to detect outliers in cochlear implant user responses, and how test-retest reliability is quantitatively assessed across different noise types and intensities during protocol standardization.", "history": ["Key principles and clinical applications of speech audiometry for evaluating cochlear implant recipient performance.", "Regarding these cochlear implant evaluations, how does speech audiometry specifically mitigate the impact of background noise on assessment accuracy?", "Building on methods to mitigate noise, how do adaptive level control techniques, as used in monaural speech audiometry, affect Speech Reception Threshold (SRT) measurement reliability for cochlear implant users in realistic noise scenarios, and what are the crucial implications for standardizing their clinical fitting and follow-up protocols?"], "ground_truth": ["permed-77567", "permed-73854", "permed-63416", "permed-88998", "permed-77569", "permed-73858", "permed-69439", "permed-63253", "permed-92182", "permed-63251"]}
{"query_id": "topic_671_turn_5", "conversation_id": "topic_671", "turn_id": 5, "query": "Given these detailed signal processing validation methods for SRT measurement, what clinical outcomes have been demonstrated when implementing these standardized protocols in cochlear implant fitting? Specifically, how do these precision-optimized adaptive speech tests correlate with real-world patient-reported hearing improvement, and what evidence exists regarding their impact on reducing fitting session duration or post-activation adjustment needs? Additionally, are there documented differences in long-term speech recognition outcomes between patients fitted using traditional versus these advanced audiometry protocols in clinical practice?", "history": ["Key principles and clinical applications of speech audiometry for evaluating cochlear implant recipient performance.", "Regarding these cochlear implant evaluations, how does speech audiometry specifically mitigate the impact of background noise on assessment accuracy?", "Building on methods to mitigate noise, how do adaptive level control techniques, as used in monaural speech audiometry, affect Speech Reception Threshold (SRT) measurement reliability for cochlear implant users in realistic noise scenarios, and what are the crucial implications for standardizing their clinical fitting and follow-up protocols?", "Given these adaptive level control approaches for SRT measurement, could you elaborate on the specific signal processing algorithms and statistical validation methods employed to ensure measurement precision? I'm particularly interested in how researchers establish the minimum number of reversals needed for stable threshold estimation, what quality control metrics are used to detect outliers in cochlear implant user responses, and how test-retest reliability is quantitatively assessed across different noise types and intensities during protocol standardization."], "ground_truth": ["permed-77567", "permed-63416", "permed-73862", "permed-78466", "permed-73854", "permed-92182", "permed-69439", "permed-63144", "permed-89946", "permed-63418"]}
{"query_id": "topic_672_turn_1", "conversation_id": "topic_672", "turn_id": 1, "query": "Recent advancements enhancing ultrafiltration membrane properties for water treatment", "history": [], "ground_truth": ["permed-75665", "permed-73990", "permed-87802", "permed-73296", "permed-75662", "permed-81360", "permed-75666", "permed-78298", "permed-75659", "permed-81359"]}
{"query_id": "topic_672_turn_2", "conversation_id": "topic_672", "turn_id": 2, "query": "Investigating silver and graphene oxide nanocomposites: their antibacterial and antifouling effects on these ultrafiltration membranes", "history": ["Recent advancements enhancing ultrafiltration membrane properties for water treatment"], "ground_truth": ["permed-73985", "permed-73986", "permed-81114", "permed-78763", "permed-73990", "permed-51156", "permed-81119", "permed-81120", "permed-87636", "permed-62924"]}
{"query_id": "topic_672_turn_3", "conversation_id": "topic_672", "turn_id": 3, "query": "Ag@HPEI@GO nanocomposite performance in RO/NF membranes: impact on water flux, solute rejection, stability, and synergistic antimicrobial effects", "history": ["Recent advancements enhancing ultrafiltration membrane properties for water treatment", "Investigating silver and graphene oxide nanocomposites: their antibacterial and antifouling effects on these ultrafiltration membranes"], "ground_truth": ["permed-73985", "permed-73990", "permed-75665", "permed-75663", "permed-73986", "permed-73987", "permed-87802", "permed-92311", "permed-51156", "permed-75893"]}
{"query_id": "topic_672_turn_4", "conversation_id": "topic_672", "turn_id": 4, "query": "Given the promising performance metrics observed with the Ag@HPEI@GO nanocomposite, what specific characterization techniques were employed to validate the nanocomposite's successful integration into the membrane matrix? I'm particularly interested in how you confirmed the uniform distribution of nanoparticles across the membrane surface and cross-section, and which analytical methods (e.g., SEM-EDS, XPS mapping, TEM) provided the most reliable quantification of this dispersion for correlating with the observed antimicrobial and antifouling effects.", "history": ["Recent advancements enhancing ultrafiltration membrane properties for water treatment", "Investigating silver and graphene oxide nanocomposites: their antibacterial and antifouling effects on these ultrafiltration membranes", "Ag@HPEI@GO nanocomposite performance in RO/NF membranes: impact on water flux, solute rejection, stability, and synergistic antimicrobial effects"], "ground_truth": ["permed-73985", "permed-73990", "permed-73987", "permed-73986", "permed-72983", "permed-79004", "permed-92311", "permed-34058", "permed-66767", "permed-75261"]}
{"query_id": "topic_672_turn_5", "conversation_id": "topic_672", "turn_id": 5, "query": "Given the rigorous characterization confirming successful Ag@HPEI@GO nanocomposite integration and uniform distribution, how do these modified membranes translate to clinical settings? Specifically, what evidence exists regarding their biocompatibility and safety profile when used in hemodialysis water purification systems? Have any clinical studies evaluated patient outcomes—particularly infection rates and inflammatory markers—compared to conventional membranes? Additionally, what practical deployment challenges, such as membrane sterilization protocols or long-term heavy metal leaching risks, need addressing before widespread clinical adoption?", "history": ["Recent advancements enhancing ultrafiltration membrane properties for water treatment", "Investigating silver and graphene oxide nanocomposites: their antibacterial and antifouling effects on these ultrafiltration membranes", "Ag@HPEI@GO nanocomposite performance in RO/NF membranes: impact on water flux, solute rejection, stability, and synergistic antimicrobial effects", "Given the promising performance metrics observed with the Ag@HPEI@GO nanocomposite, what specific characterization techniques were employed to validate the nanocomposite's successful integration into the membrane matrix? I'm particularly interested in how you confirmed the uniform distribution of nanoparticles across the membrane surface and cross-section, and which analytical methods (e.g., SEM-EDS, XPS mapping, TEM) provided the most reliable quantification of this dispersion for correlating with the observed antimicrobial and antifouling effects."], "ground_truth": ["permed-73985", "permed-87802", "permed-63006", "permed-77620", "permed-92311", "permed-73990", "permed-88184", "permed-66767", "permed-60736", "permed-86502"]}
{"query_id": "topic_673_turn_1", "conversation_id": "topic_673", "turn_id": 1, "query": "Platelet concentrates for accelerated orthodontic tooth movement: a comprehensive review of applications and mechanisms", "history": [], "ground_truth": ["permed-61080", "permed-52414", "permed-40544", "permed-75167", "permed-52410", "permed-75124", "permed-55126", "permed-74435", "permed-47614", "permed-91508"]}
{"query_id": "topic_673_turn_2", "conversation_id": "topic_673", "turn_id": 2, "query": "Effectiveness comparison of various platelet concentrate types for this orthodontic application", "history": ["Platelet concentrates for accelerated orthodontic tooth movement: a comprehensive review of applications and mechanisms"], "ground_truth": ["permed-61080", "permed-52414", "permed-52410", "permed-55126", "permed-91508", "permed-83472", "permed-92165", "permed-75198", "permed-56265", "permed-83122"]}
{"query_id": "topic_673_turn_3", "conversation_id": "topic_673", "turn_id": 3, "query": "Comparative analysis of PRP vs L-PRF for accelerated orthodontic tooth movement in immediate post-extraction canine distalization: efficacy, safety, and long-term periodontal effects", "history": ["Platelet concentrates for accelerated orthodontic tooth movement: a comprehensive review of applications and mechanisms", "Effectiveness comparison of various platelet concentrate types for this orthodontic application"], "ground_truth": ["permed-61080", "permed-52414", "permed-75168", "permed-75198", "permed-40544", "permed-82877", "permed-83475", "permed-83478", "permed-75167", "permed-90387"]}
{"query_id": "topic_673_turn_4", "conversation_id": "topic_673", "turn_id": 4, "query": "When implementing this comparative analysis between PRP and L-PRF for canine distalization, what specific protocols were used for platelet concentrate preparation and activation? I'm particularly interested in the centrifugation parameters, activator choices, and timing between concentrate preparation and application. Additionally, how did the study design account for potential variations in surgical technique during graft placement to ensure consistent delivery of these biologics across treatment groups?", "history": ["Platelet concentrates for accelerated orthodontic tooth movement: a comprehensive review of applications and mechanisms", "Effectiveness comparison of various platelet concentrate types for this orthodontic application", "Comparative analysis of PRP vs L-PRF for accelerated orthodontic tooth movement in immediate post-extraction canine distalization: efficacy, safety, and long-term periodontal effects"], "ground_truth": ["permed-82877", "permed-82881", "permed-61080", "permed-91148", "permed-45676", "permed-75198", "permed-45681", "permed-36870", "permed-52414", "permed-75217"]}
{"query_id": "topic_673_turn_5", "conversation_id": "topic_673", "turn_id": 5, "query": "Given the detailed protocols for PRP and L-PRF preparation established in the previous analysis, what were the comparative clinical safety outcomes observed during canine distalization? Specifically, were there significant differences in post-operative pain levels, soft tissue healing complications, or inflammatory responses between the two platelet concentrate groups? Additionally, did the study document any unexpected adverse events or contraindications that might influence clinical decision-making when selecting between these biologics for orthodontic acceleration in different patient populations?", "history": ["Platelet concentrates for accelerated orthodontic tooth movement: a comprehensive review of applications and mechanisms", "Effectiveness comparison of various platelet concentrate types for this orthodontic application", "Comparative analysis of PRP vs L-PRF for accelerated orthodontic tooth movement in immediate post-extraction canine distalization: efficacy, safety, and long-term periodontal effects", "When implementing this comparative analysis between PRP and L-PRF for canine distalization, what specific protocols were used for platelet concentrate preparation and activation? I'm particularly interested in the centrifugation parameters, activator choices, and timing between concentrate preparation and application. Additionally, how did the study design account for potential variations in surgical technique during graft placement to ensure consistent delivery of these biologics across treatment groups?"], "ground_truth": ["permed-61080", "permed-91148", "permed-83475", "permed-52414", "permed-75168", "permed-82877", "permed-70525", "permed-82881", "permed-47447", "permed-75217"]}
{"query_id": "topic_674_turn_1", "conversation_id": "topic_674", "turn_id": 1, "query": "Fundamental role and mechanisms of Er<sup>3+</sup> ions in upconversion phosphors for optical sensing applications", "history": [], "ground_truth": ["permed-73156", "permed-75773", "permed-75778", "permed-75782", "permed-75774", "permed-60843", "permed-75823", "permed-75775", "permed-75780", "permed-75776"]}
{"query_id": "topic_674_turn_2", "conversation_id": "topic_674", "turn_id": 2, "query": "Strategies for improving energy transfer efficiency in these Er<sup>3+</sup>-doped upconversion phosphors via co-dopant incorporation for enhanced optical sensing", "history": ["Fundamental role and mechanisms of Er<sup>3+</sup> ions in upconversion phosphors for optical sensing applications"], "ground_truth": ["permed-75773", "permed-73156", "permed-75775", "permed-75774", "permed-75782", "permed-75778", "permed-79145", "permed-75776", "permed-86662", "permed-75672"]}
{"query_id": "topic_674_turn_3", "conversation_id": "topic_674", "turn_id": 3, "query": "Effects of Bi<sup>3+</sup> co-doping on local crystal field, spectral tuning, and energy transfer efficiency in ZnMoO<sub>4</sub>:Er<sup>3+</sup> upconversion phosphors: optimizing for advanced optical sensing", "history": ["Fundamental role and mechanisms of Er<sup>3+</sup> ions in upconversion phosphors for optical sensing applications", "Strategies for improving energy transfer efficiency in these Er<sup>3+</sup>-doped upconversion phosphors via co-dopant incorporation for enhanced optical sensing"], "ground_truth": ["permed-75773", "permed-73156", "permed-55235", "permed-75776", "permed-75775", "permed-75774", "permed-75782", "permed-83407", "permed-73022", "permed-74515"]}
{"query_id": "topic_674_turn_4", "conversation_id": "topic_674", "turn_id": 4, "query": "When implementing this Bi3+ co-doping strategy in ZnMoO4:Er3+ phosphors, what specific annealing protocols and temperature gradients were employed to optimize the local crystal field modifications? Additionally, what spectroscopic validation methods—such as lifetime decay measurements or Judd-Ofelt analysis—were utilized to quantify the energy transfer efficiency improvements, and were there particular precautions taken during sample preparation to ensure reproducibility across different doping concentrations?", "history": ["Fundamental role and mechanisms of Er<sup>3+</sup> ions in upconversion phosphors for optical sensing applications", "Strategies for improving energy transfer efficiency in these Er<sup>3+</sup>-doped upconversion phosphors via co-dopant incorporation for enhanced optical sensing", "Effects of Bi<sup>3+</sup> co-doping on local crystal field, spectral tuning, and energy transfer efficiency in ZnMoO<sub>4</sub>:Er<sup>3+</sup> upconversion phosphors: optimizing for advanced optical sensing"], "ground_truth": ["permed-75773", "permed-55235", "permed-75774", "permed-83407", "permed-73156", "permed-75776", "permed-74515", "permed-75775", "permed-73022", "permed-91723"]}
{"query_id": "topic_674_turn_5", "conversation_id": "topic_674", "turn_id": 5, "query": "Building upon the optimized synthesis protocols and spectroscopic validation methods established for Bi3+ co-doped ZnMoO4:Er3+ phosphors, what translational challenges have been encountered when implementing these upconversion materials in clinical biosensing applications? Specifically, how do factors like physiological matrix effects, potential cytotoxicity of leached ions, and long-term photostability under continuous imaging conditions impact their diagnostic reliability? Have any pilot studies evaluated these phosphors' performance in real biological samples, and what modifications were required to address biocompatibility concerns while maintaining sensing efficiency?", "history": ["Fundamental role and mechanisms of Er<sup>3+</sup> ions in upconversion phosphors for optical sensing applications", "Strategies for improving energy transfer efficiency in these Er<sup>3+</sup>-doped upconversion phosphors via co-dopant incorporation for enhanced optical sensing", "Effects of Bi<sup>3+</sup> co-doping on local crystal field, spectral tuning, and energy transfer efficiency in ZnMoO<sub>4</sub>:Er<sup>3+</sup> upconversion phosphors: optimizing for advanced optical sensing", "When implementing this Bi3+ co-doping strategy in ZnMoO4:Er3+ phosphors, what specific annealing protocols and temperature gradients were employed to optimize the local crystal field modifications? Additionally, what spectroscopic validation methods—such as lifetime decay measurements or Judd-Ofelt analysis—were utilized to quantify the energy transfer efficiency improvements, and were there particular precautions taken during sample preparation to ensure reproducibility across different doping concentrations?"], "ground_truth": ["permed-75773", "permed-73156", "permed-60843", "permed-75782", "permed-75775", "permed-75776", "permed-64381", "permed-60322", "permed-54888", "permed-77893"]}
{"query_id": "topic_675_turn_1", "conversation_id": "topic_675", "turn_id": 1, "query": "Drone-human collision: documented injury patterns and key safety hazards", "history": [], "ground_truth": ["permed-67259", "permed-55110", "permed-92177", "permed-44839", "permed-68512", "permed-86751", "permed-86233", "permed-67923", "permed-58211", "permed-55107"]}
{"query_id": "topic_675_turn_2", "conversation_id": "topic_675", "turn_id": 2, "query": "How advancements in drone airframe design and impact-absorbing materials reduce such collision severity", "history": ["Drone-human collision: documented injury patterns and key safety hazards"], "ground_truth": ["permed-67259", "permed-86751", "permed-86233", "permed-75160", "permed-85898", "permed-53921", "permed-56264", "permed-82651", "permed-44839", "permed-92177"]}
{"query_id": "topic_675_turn_3", "conversation_id": "topic_675", "turn_id": 3, "query": "Technical specifications for integrating energy-absorbing materials and frangible designs in UAS to minimize human impact trauma and inform future drone safety certification standards", "history": ["Drone-human collision: documented injury patterns and key safety hazards", "How advancements in drone airframe design and impact-absorbing materials reduce such collision severity"], "ground_truth": ["permed-67259", "permed-74194", "permed-71748", "permed-51450", "permed-86233", "permed-59295", "permed-81056", "permed-55110", "permed-74196", "permed-80731"]}
{"query_id": "topic_675_turn_4", "conversation_id": "topic_675", "turn_id": 4, "query": "When implementing these frangible designs and energy-absorbing materials, what specific mechanical testing protocols—such as impact velocity thresholds, anvil configurations, or biofidelic surrogate models—were used to quantitatively assess their energy dissipation performance and validate the reduction in blunt force trauma metrics for human collision scenarios? Furthermore, how was the statistical power determined for these experimental setups to ensure the results are robust enough to inform certification standards?", "history": ["Drone-human collision: documented injury patterns and key safety hazards", "How advancements in drone airframe design and impact-absorbing materials reduce such collision severity", "Technical specifications for integrating energy-absorbing materials and frangible designs in UAS to minimize human impact trauma and inform future drone safety certification standards"], "ground_truth": ["permed-51448", "permed-51459", "permed-64574", "permed-86759", "permed-86748", "permed-74199", "permed-90241", "permed-67259", "permed-74194", "permed-51450"]}
{"query_id": "topic_675_turn_5", "conversation_id": "topic_675", "turn_id": 5, "query": "Given the detailed mechanical testing protocols discussed for evaluating individual safety features, how do the energy dissipation performances of frangible composite designs compare against foam-based absorption materials when subjected to identical impact scenarios? Specifically, what trade-offs emerge between structural integrity preservation and trauma reduction metrics across different collision velocities, and which approach demonstrates superior consistency in meeting proposed certification thresholds across varied anatomical surrogate models?", "history": ["Drone-human collision: documented injury patterns and key safety hazards", "How advancements in drone airframe design and impact-absorbing materials reduce such collision severity", "Technical specifications for integrating energy-absorbing materials and frangible designs in UAS to minimize human impact trauma and inform future drone safety certification standards", "When implementing these frangible designs and energy-absorbing materials, what specific mechanical testing protocols—such as impact velocity thresholds, anvil configurations, or biofidelic surrogate models—were used to quantitatively assess their energy dissipation performance and validate the reduction in blunt force trauma metrics for human collision scenarios? Furthermore, how was the statistical power determined for these experimental setups to ensure the results are robust enough to inform certification standards?"], "ground_truth": ["permed-51448", "permed-51459", "permed-51450", "permed-90241", "permed-51449", "permed-91658", "permed-51481", "permed-74194", "permed-51447", "permed-90239"]}
{"query_id": "topic_676_turn_1", "conversation_id": "topic_676", "turn_id": 1, "query": "What role does mindfulness play in enhancing leadership skills among healthcare professionals?", "history": [], "ground_truth": ["permed-70244", "permed-84853", "permed-91195", "permed-88089", "permed-72368", "permed-80048", "permed-57576", "permed-72367", "permed-71473", "permed-69511"]}
{"query_id": "topic_676_turn_2", "conversation_id": "topic_676", "turn_id": 2, "query": "Can integrating this approach with emotional intelligence training lead to broader cultural shifts within healthcare institutions?", "history": ["What role does mindfulness play in enhancing leadership skills among healthcare professionals?"], "ground_truth": ["permed-85811", "permed-70065", "permed-88831", "permed-71163", "permed-66304", "permed-74161", "permed-57447", "permed-78654", "permed-66109", "permed-57444"]}
{"query_id": "topic_676_turn_3", "conversation_id": "topic_676", "turn_id": 3, "query": "Building on these approaches, how can we best combine mindfulness and emotional intelligence training in physician leadership programs to not only strengthen individual leadership abilities but also cultivate a more resilient and adaptive organizational culture in healthcare? And what specific strategies would effectively measure the long-term impact of such programs—both on individual practitioners and the broader healthcare system—given how rapidly these environments evolve?", "history": ["What role does mindfulness play in enhancing leadership skills among healthcare professionals?", "Can integrating this approach with emotional intelligence training lead to broader cultural shifts within healthcare institutions?"], "ground_truth": ["permed-57576", "permed-71163", "permed-70244", "permed-80047", "permed-88089", "permed-85811", "permed-71473", "permed-80048", "permed-51579", "permed-51594"]}
{"query_id": "topic_676_turn_4", "conversation_id": "topic_676", "turn_id": 4, "query": "Given these proposed strategies for measuring long-term impact, what specific longitudinal study design would you recommend for tracking both individual leadership development and organizational culture changes? I'm particularly interested in how you'd balance quantitative metrics like retention rates and patient satisfaction scores with qualitative assessments of cultural adaptation. What statistical approaches would best account for the rapidly evolving healthcare environment while maintaining methodological rigor across multiple institutions over a 3-5 year timeframe?", "history": ["What role does mindfulness play in enhancing leadership skills among healthcare professionals?", "Can integrating this approach with emotional intelligence training lead to broader cultural shifts within healthcare institutions?", "Building on these approaches, how can we best combine mindfulness and emotional intelligence training in physician leadership programs to not only strengthen individual leadership abilities but also cultivate a more resilient and adaptive organizational culture in healthcare? And what specific strategies would effectively measure the long-term impact of such programs—both on individual practitioners and the broader healthcare system—given how rapidly these environments evolve?"], "ground_truth": ["permed-51594", "permed-86840", "permed-58488", "permed-57576", "permed-69923", "permed-52111", "permed-70247", "permed-82776", "permed-80046", "permed-78654"]}
{"query_id": "topic_676_turn_5", "conversation_id": "topic_676", "turn_id": 5, "query": "Given the sophisticated longitudinal methodology we've outlined for tracking program outcomes, how would you comparatively evaluate the cost-effectiveness of integrated mindfulness-emotional intelligence leadership programs versus traditional leadership training in healthcare? Specifically, what trade-offs exist between the higher initial implementation costs of comprehensive programs and their potential long-term benefits in reducing physician burnout, improving staff retention, and enhancing patient care quality across different healthcare settings?", "history": ["What role does mindfulness play in enhancing leadership skills among healthcare professionals?", "Can integrating this approach with emotional intelligence training lead to broader cultural shifts within healthcare institutions?", "Building on these approaches, how can we best combine mindfulness and emotional intelligence training in physician leadership programs to not only strengthen individual leadership abilities but also cultivate a more resilient and adaptive organizational culture in healthcare? And what specific strategies would effectively measure the long-term impact of such programs—both on individual practitioners and the broader healthcare system—given how rapidly these environments evolve?", "Given these proposed strategies for measuring long-term impact, what specific longitudinal study design would you recommend for tracking both individual leadership development and organizational culture changes? I'm particularly interested in how you'd balance quantitative metrics like retention rates and patient satisfaction scores with qualitative assessments of cultural adaptation. What statistical approaches would best account for the rapidly evolving healthcare environment while maintaining methodological rigor across multiple institutions over a 3-5 year timeframe?"], "ground_truth": ["permed-57576", "permed-58488", "permed-86840", "permed-56935", "permed-52109", "permed-89786", "permed-70244", "permed-84740", "permed-84590", "permed-71425"]}
{"query_id": "topic_677_turn_1", "conversation_id": "topic_677", "turn_id": 1, "query": "What role does nitric oxide play in reducing inflammation and degeneration in intervertebral discs?", "history": [], "ground_truth": ["permed-79754", "permed-86261", "permed-69178", "permed-87271", "permed-62596", "permed-54874", "permed-87269", "permed-84389", "permed-87268", "permed-61502"]}
{"query_id": "topic_677_turn_2", "conversation_id": "topic_677", "turn_id": 2, "query": "How do the anti-inflammatory effects of it impact osteoclast activity in this context?", "history": ["What role does nitric oxide play in reducing inflammation and degeneration in intervertebral discs?"], "ground_truth": ["permed-69196", "permed-68101", "permed-69194", "permed-68099", "permed-69195", "permed-68100", "permed-74285", "permed-58791", "permed-69189", "permed-61246"]}
{"query_id": "topic_677_turn_3", "conversation_id": "topic_677", "turn_id": 3, "query": "Given these effects on inflammation and osteoclast activity, what are the specific molecular pathways through which nitric oxide inhibits osteoclast differentiation and reduces inflammatory cytokines in intervertebral disc degeneration?", "history": ["What role does nitric oxide play in reducing inflammation and degeneration in intervertebral discs?", "How do the anti-inflammatory effects of it impact osteoclast activity in this context?"], "ground_truth": ["permed-69178", "permed-79754", "permed-86261", "permed-61502", "permed-78073", "permed-81531", "permed-58791", "permed-61506", "permed-87270", "permed-69196"]}
{"query_id": "topic_677_turn_4", "conversation_id": "topic_677", "turn_id": 4, "query": "Given these molecular pathways, what specific experimental techniques would best validate the proposed mechanism of nitric oxide-mediated osteoclast inhibition? I'm particularly interested in methodological details - would you recommend TRAP staining combined with RANKL stimulation assays to quantify differentiation rates, or would Western blot analysis of NF-κB pathway components provide more direct evidence? Also, what statistical approaches would be most appropriate for comparing cytokine expression levels across different nitric oxide concentrations in disc tissue cultures?", "history": ["What role does nitric oxide play in reducing inflammation and degeneration in intervertebral discs?", "How do the anti-inflammatory effects of it impact osteoclast activity in this context?", "Given these effects on inflammation and osteoclast activity, what are the specific molecular pathways through which nitric oxide inhibits osteoclast differentiation and reduces inflammatory cytokines in intervertebral disc degeneration?"], "ground_truth": ["permed-69196", "permed-78073", "permed-61502", "permed-68869", "permed-69193", "permed-68099", "permed-76753", "permed-69192", "permed-69195", "permed-69189"]}
{"query_id": "topic_677_turn_5", "conversation_id": "topic_677", "turn_id": 5, "query": "Building upon these molecular validation techniques, what clinical evidence exists regarding nitric oxide-based therapies for intervertebral disc degeneration in human studies? Given the mechanistic insights into osteoclast inhibition and cytokine modulation, have any clinical trials evaluated the therapeutic efficacy, safety profile, or optimal delivery methods for nitric oxide donors in patients with degenerative disc disease? I'm particularly interested in patient-reported outcomes, radiographic changes in disc height, and any reported adverse effects like hypotension or methemoglobinemia that might limit clinical translation.", "history": ["What role does nitric oxide play in reducing inflammation and degeneration in intervertebral discs?", "How do the anti-inflammatory effects of it impact osteoclast activity in this context?", "Given these effects on inflammation and osteoclast activity, what are the specific molecular pathways through which nitric oxide inhibits osteoclast differentiation and reduces inflammatory cytokines in intervertebral disc degeneration?", "Given these molecular pathways, what specific experimental techniques would best validate the proposed mechanism of nitric oxide-mediated osteoclast inhibition? I'm particularly interested in methodological details - would you recommend TRAP staining combined with RANKL stimulation assays to quantify differentiation rates, or would Western blot analysis of NF-κB pathway components provide more direct evidence? Also, what statistical approaches would be most appropriate for comparing cytokine expression levels across different nitric oxide concentrations in disc tissue cultures?"], "ground_truth": ["permed-54874", "permed-79754", "permed-51343", "permed-87269", "permed-87268", "permed-69178", "permed-57056", "permed-40042", "permed-82267", "permed-40463"]}
{"query_id": "topic_678_turn_1", "conversation_id": "topic_678", "turn_id": 1, "query": "Regulation mechanisms of Type III Secretion System 2 (T3SS2) in *Vibrio parahaemolyticus* and its contribution to infection", "history": [], "ground_truth": ["permed-66848", "permed-63912", "permed-76694", "permed-87372", "permed-78424", "permed-82087", "permed-60453", "permed-85982", "permed-66793", "permed-71594"]}
{"query_id": "topic_678_turn_2", "conversation_id": "topic_678", "turn_id": 2, "query": "Impact of environmental factors such as temperature and salinity on *Vibrio parahaemolyticus* T3SS2 gene expression, and the identity of regulatory proteins mediating these environmental responses", "history": ["Regulation mechanisms of Type III Secretion System 2 (T3SS2) in *Vibrio parahaemolyticus* and its contribution to infection"], "ground_truth": ["permed-66848", "permed-70682", "permed-85982", "permed-76694", "permed-72773", "permed-71929", "permed-82376", "permed-87372", "permed-76703", "permed-76580"]}
{"query_id": "topic_678_turn_3", "conversation_id": "topic_678", "turn_id": 3, "query": "Interaction of H-NS with two-component systems in modulating *Vibrio parahaemolyticus* T3SS2 activity in response to temperature and salinity changes, and novel therapeutic strategies targeting this regulatory network", "history": ["Regulation mechanisms of Type III Secretion System 2 (T3SS2) in *Vibrio parahaemolyticus* and its contribution to infection", "Impact of environmental factors such as temperature and salinity on *Vibrio parahaemolyticus* T3SS2 gene expression, and the identity of regulatory proteins mediating these environmental responses"], "ground_truth": ["permed-66848", "permed-70682", "permed-87372", "permed-85982", "permed-76694", "permed-80608", "permed-72773", "permed-63912", "permed-71929", "permed-76580"]}
{"query_id": "topic_678_turn_4", "conversation_id": "topic_678", "turn_id": 4, "query": "When examining this H-NS and two-component system regulatory network, what specific experimental approaches were used to validate the direct physical interactions versus indirect regulatory effects? I'm particularly interested in the chromatin immunoprecipitation protocols for H-NS binding assays and the phosphotransfer profiling methods for the two-component systems. How were these techniques quantitatively compared across different temperature and salinity conditions to ensure the observed modulations weren't artifacts of growth rate variations?", "history": ["Regulation mechanisms of Type III Secretion System 2 (T3SS2) in *Vibrio parahaemolyticus* and its contribution to infection", "Impact of environmental factors such as temperature and salinity on *Vibrio parahaemolyticus* T3SS2 gene expression, and the identity of regulatory proteins mediating these environmental responses", "Interaction of H-NS with two-component systems in modulating *Vibrio parahaemolyticus* T3SS2 activity in response to temperature and salinity changes, and novel therapeutic strategies targeting this regulatory network"], "ground_truth": ["permed-58222", "permed-76707", "permed-66848", "permed-52702", "permed-64176", "permed-84323", "permed-77012", "permed-77019", "permed-76613", "permed-71702"]}
{"query_id": "topic_678_turn_5", "conversation_id": "topic_678", "turn_id": 5, "query": "Given these validated molecular interactions, how have these regulatory network insights translated into clinical applications for managing *Vibrio parahaemolyticus* infections? Specifically, what therapeutic efficacy has been demonstrated for compounds targeting this H-NS and two-component system network in animal models, and what safety profiles or resistance emergence were observed? Additionally, how do temperature and salinity variations in human infection sites affect the clinical effectiveness of such targeted therapies compared to conventional antibiotics?", "history": ["Regulation mechanisms of Type III Secretion System 2 (T3SS2) in *Vibrio parahaemolyticus* and its contribution to infection", "Impact of environmental factors such as temperature and salinity on *Vibrio parahaemolyticus* T3SS2 gene expression, and the identity of regulatory proteins mediating these environmental responses", "Interaction of H-NS with two-component systems in modulating *Vibrio parahaemolyticus* T3SS2 activity in response to temperature and salinity changes, and novel therapeutic strategies targeting this regulatory network", "When examining this H-NS and two-component system regulatory network, what specific experimental approaches were used to validate the direct physical interactions versus indirect regulatory effects? I'm particularly interested in the chromatin immunoprecipitation protocols for H-NS binding assays and the phosphotransfer profiling methods for the two-component systems. How were these techniques quantitatively compared across different temperature and salinity conditions to ensure the observed modulations weren't artifacts of growth rate variations?"], "ground_truth": ["permed-66848", "permed-80608", "permed-89721", "permed-70682", "permed-71929", "permed-72773", "permed-72774", "permed-85982", "permed-81879", "permed-68210"]}
{"query_id": "topic_679_turn_1", "conversation_id": "topic_679", "turn_id": 1, "query": "Fundamentals of PLLA-PDLA stereocomplex formation: mechanisms, influencing factors, and impact on overall polymer properties", "history": [], "ground_truth": ["permed-73033", "permed-77317", "permed-84109", "permed-73036", "permed-57622", "permed-57618", "permed-57619", "permed-73035", "permed-89025", "permed-73031"]}
{"query_id": "topic_679_turn_2", "conversation_id": "topic_679", "turn_id": 2, "query": "Role of grafted copolymers in modulating these PLLA-PDLA stereocomplexation mechanisms, focusing on their effect on crystal nucleation kinetics and improvements to material thermal stability and degradation behavior", "history": ["Fundamentals of PLLA-PDLA stereocomplex formation: mechanisms, influencing factors, and impact on overall polymer properties"], "ground_truth": ["permed-73033", "permed-73031", "permed-73035", "permed-73036", "permed-77317", "permed-57622", "permed-84109", "permed-57618", "permed-57619", "permed-73039"]}
{"query_id": "topic_679_turn_3", "conversation_id": "topic_679", "turn_id": 3, "query": "Detailed effects of architecture (e.g., graft length, density) and composition of such PLLA-grafted copolymers on the competitive kinetics between stereocomplex and homocrystal formation in PDLA blends, and the resulting impact on mechanical strength and melt processability of these composite materials.", "history": ["Fundamentals of PLLA-PDLA stereocomplex formation: mechanisms, influencing factors, and impact on overall polymer properties", "Role of grafted copolymers in modulating these PLLA-PDLA stereocomplexation mechanisms, focusing on their effect on crystal nucleation kinetics and improvements to material thermal stability and degradation behavior"], "ground_truth": ["permed-73033", "permed-77317", "permed-57618", "permed-73036", "permed-57619", "permed-84109", "permed-73031", "permed-57622", "permed-73039", "permed-81155"]}
{"query_id": "topic_679_turn_4", "conversation_id": "topic_679", "turn_id": 4, "query": "Given the architectural parameters discussed, what specific characterization techniques were employed to quantitatively distinguish between stereocomplex and homocrystal populations in these PDLA blends? I'm particularly interested in the experimental protocols for WAXD deconvolution procedures - specifically how the 2θ = 12° and 2θ = 16-17° peaks were mathematically separated - and whether any statistical validation was performed to ensure reproducibility of these crystalline phase quantification methods across multiple sample batches.", "history": ["Fundamentals of PLLA-PDLA stereocomplex formation: mechanisms, influencing factors, and impact on overall polymer properties", "Role of grafted copolymers in modulating these PLLA-PDLA stereocomplexation mechanisms, focusing on their effect on crystal nucleation kinetics and improvements to material thermal stability and degradation behavior", "Detailed effects of architecture (e.g., graft length, density) and composition of such PLLA-grafted copolymers on the competitive kinetics between stereocomplex and homocrystal formation in PDLA blends, and the resulting impact on mechanical strength and melt processability of these composite materials."], "ground_truth": ["permed-77317", "permed-73033", "permed-73926", "permed-73036", "permed-75488", "permed-57618", "permed-86601", "permed-66552", "permed-65167", "permed-77157"]}
{"query_id": "topic_679_turn_5", "conversation_id": "topic_679", "turn_id": 5, "query": "Given these robust characterization methods for quantifying crystalline phases, how have these PLLA-PDLA stereocomplex materials translated to clinical applications? Specifically, what clinical trial evidence exists regarding their performance as resorbable implants versus traditional PLLA materials in orthopedic fixation? I'm interested in comparative data on inflammatory response, degradation timelines matching bone healing rates, and any reported complications like sterile abscess formation or device fragmentation that might relate to the improved thermal stability and mechanical properties discussed in previous turns.", "history": ["Fundamentals of PLLA-PDLA stereocomplex formation: mechanisms, influencing factors, and impact on overall polymer properties", "Role of grafted copolymers in modulating these PLLA-PDLA stereocomplexation mechanisms, focusing on their effect on crystal nucleation kinetics and improvements to material thermal stability and degradation behavior", "Detailed effects of architecture (e.g., graft length, density) and composition of such PLLA-grafted copolymers on the competitive kinetics between stereocomplex and homocrystal formation in PDLA blends, and the resulting impact on mechanical strength and melt processability of these composite materials.", "Given the architectural parameters discussed, what specific characterization techniques were employed to quantitatively distinguish between stereocomplex and homocrystal populations in these PDLA blends? I'm particularly interested in the experimental protocols for WAXD deconvolution procedures - specifically how the 2θ = 12° and 2θ = 16-17° peaks were mathematically separated - and whether any statistical validation was performed to ensure reproducibility of these crystalline phase quantification methods across multiple sample batches."], "ground_truth": ["permed-64491", "permed-75210", "permed-73033", "permed-57618", "permed-73035", "permed-64484", "permed-82177", "permed-57622", "permed-77317", "permed-73031"]}
{"query_id": "topic_680_turn_1", "conversation_id": "topic_680", "turn_id": 1, "query": "Role of medical imaging in enabling precision radionuclide therapy and personalized patient outcomes", "history": [], "ground_truth": ["permed-51692", "permed-42456", "permed-51700", "permed-5108", "permed-7584", "permed-48381", "permed-42231", "permed-3633", "permed-28987", "permed-48401"]}
{"query_id": "topic_680_turn_2", "conversation_id": "topic_680", "turn_id": 2, "query": "How are these radionuclide therapy imaging techniques evolving, specifically with SPECT-CT advancements, to further enhance personalized patient outcomes?", "history": ["Role of medical imaging in enabling precision radionuclide therapy and personalized patient outcomes"], "ground_truth": ["permed-42127", "permed-77217", "permed-80552", "permed-51700", "permed-51692", "permed-28987", "permed-56319", "permed-42057", "permed-42456", "permed-5108"]}
{"query_id": "topic_680_turn_3", "conversation_id": "topic_680", "turn_id": 3, "query": "Integrating quantitative SPECT-CT for radionuclide therapy: benefits for dosimetry optimization, patient outcome assessment, and addressing clinical implementation challenges in diverse settings", "history": ["Role of medical imaging in enabling precision radionuclide therapy and personalized patient outcomes", "How are these radionuclide therapy imaging techniques evolving, specifically with SPECT-CT advancements, to further enhance personalized patient outcomes?"], "ground_truth": ["permed-77217", "permed-80552", "permed-51700", "permed-42127", "permed-51692", "permed-5108", "permed-3633", "permed-77720", "permed-29620", "permed-48401"]}
{"query_id": "topic_680_turn_4", "conversation_id": "topic_680", "turn_id": 4, "query": "How is quantitative SPECT-CT dosimetry protocol typically validated for radionuclide therapy across different imaging systems? Specifically, what phantom studies and calibration approaches are employed to ensure dose calculation accuracy, and how are partial volume effects and recovery coefficients systematically addressed in these validation frameworks? Additionally, what statistical methods are typically used to establish confidence intervals for dosimetric estimates across diverse clinical implementations of these protocols?", "history": ["Role of medical imaging in enabling precision radionuclide therapy and personalized patient outcomes", "How are these radionuclide therapy imaging techniques evolving, specifically with SPECT-CT advancements, to further enhance personalized patient outcomes?", "Integrating quantitative SPECT-CT for radionuclide therapy: benefits for dosimetry optimization, patient outcome assessment, and addressing clinical implementation challenges in diverse settings"], "ground_truth": ["permed-77217", "permed-42127", "permed-80552", "permed-51700", "permed-41985", "permed-60277", "permed-56576", "permed-56660", "permed-65852", "permed-41907"]}
{"query_id": "topic_680_turn_5", "conversation_id": "topic_680", "turn_id": 5, "query": "Given these rigorous validation frameworks for quantitative SPIN-CT dosimetry, what clinical outcomes have been observed when applying these personalized dosimetric approaches in actual patient cohorts? Specifically, for therapies like Lu-177-PSMA or PRRT, how does adhering to protocol-driven dose thresholds correlate with objective tumor response rates, progression-free survival, and the incidence of severe hematological or renal toxicities compared to empirical, fixed-dose administration in real-world clinical practice?", "history": ["Role of medical imaging in enabling precision radionuclide therapy and personalized patient outcomes", "How are these radionuclide therapy imaging techniques evolving, specifically with SPECT-CT advancements, to further enhance personalized patient outcomes?", "Integrating quantitative SPECT-CT for radionuclide therapy: benefits for dosimetry optimization, patient outcome assessment, and addressing clinical implementation challenges in diverse settings", "How is quantitative SPECT-CT dosimetry protocol typically validated for radionuclide therapy across different imaging systems? Specifically, what phantom studies and calibration approaches are employed to ensure dose calculation accuracy, and how are partial volume effects and recovery coefficients systematically addressed in these validation frameworks? Additionally, what statistical methods are typically used to establish confidence intervals for dosimetric estimates across diverse clinical implementations of these protocols?"], "ground_truth": ["permed-51692", "permed-42040", "permed-48581", "permed-51787", "permed-41992", "permed-48749", "permed-48580", "permed-61215", "permed-19372", "permed-49133"]}
{"query_id": "topic_681_turn_1", "conversation_id": "topic_681", "turn_id": 1, "query": "Immunotherapy's role in enhancing immune responses against cancer", "history": [], "ground_truth": ["permed-56699", "permed-60148", "permed-67855", "permed-67388", "permed-82373", "permed-91488", "permed-68415", "permed-56501", "permed-70704", "permed-68066"]}
{"query_id": "topic_681_turn_2", "conversation_id": "topic_681", "turn_id": 2, "query": "Impact of combining radiation therapy on the effectiveness of this immunotherapeutic approach to cancer", "history": ["Immunotherapy's role in enhancing immune responses against cancer"], "ground_truth": ["permed-59586", "permed-51772", "permed-77564", "permed-77563", "permed-67852", "permed-21843", "permed-77565", "permed-67388", "permed-51771", "permed-85556"]}
{"query_id": "topic_681_turn_3", "conversation_id": "topic_681", "turn_id": 3, "query": "Molecular mechanisms driving B cell and CD4+ T cell activation and recruitment in the tumor microenvironment following combined 4-1BB agonist immunotherapy and radiation therapy", "history": ["Immunotherapy's role in enhancing immune responses against cancer", "Impact of combining radiation therapy on the effectiveness of this immunotherapeutic approach to cancer"], "ground_truth": ["permed-77562", "permed-77565", "permed-68242", "permed-72572", "permed-78784", "permed-53177", "permed-56645", "permed-51434", "permed-51426", "permed-54275"]}
{"query_id": "topic_681_turn_4", "conversation_id": "topic_681", "turn_id": 4, "query": "Given these identified molecular mechanisms driving B cell and CD4+ T cell activation, what specific experimental protocols were used to differentiate between direct radiation-induced effects and 4-1BB agonist-mediated signaling? I'm particularly interested in the methodological details of how you isolated and separately quantified these contributions—for instance, through selective pathway inhibition, cytokine profiling, or perhaps adoptive transfer experiments with genetically modified lymphocytes to trace activation cascades within the tumor microenvironment.", "history": ["Immunotherapy's role in enhancing immune responses against cancer", "Impact of combining radiation therapy on the effectiveness of this immunotherapeutic approach to cancer", "Molecular mechanisms driving B cell and CD4+ T cell activation and recruitment in the tumor microenvironment following combined 4-1BB agonist immunotherapy and radiation therapy"], "ground_truth": ["permed-77562", "permed-77565", "permed-10867", "permed-78784", "permed-32699", "permed-65333", "permed-68242", "permed-67971", "permed-22540", "permed-22521"]}
{"query_id": "topic_681_turn_5", "conversation_id": "topic_681", "turn_id": 5, "query": "Given the methodological approaches used to differentiate radiation-induced effects from 4-1BB agonist signaling, how do the resulting immune activation profiles compare between these two pathways? Specifically, what are the relative strengths and limitations of radiation versus 4-1BB agonism in terms of their capacity to generate durable B cell memory responses versus CD4+ T cell helper functions? I'm interested in whether one modality demonstrates superior longevity in immune synapse formation or creates fundamentally different cytokine milieus that might favor humoral versus cellular immunity long-term.", "history": ["Immunotherapy's role in enhancing immune responses against cancer", "Impact of combining radiation therapy on the effectiveness of this immunotherapeutic approach to cancer", "Molecular mechanisms driving B cell and CD4+ T cell activation and recruitment in the tumor microenvironment following combined 4-1BB agonist immunotherapy and radiation therapy", "Given these identified molecular mechanisms driving B cell and CD4+ T cell activation, what specific experimental protocols were used to differentiate between direct radiation-induced effects and 4-1BB agonist-mediated signaling? I'm particularly interested in the methodological details of how you isolated and separately quantified these contributions—for instance, through selective pathway inhibition, cytokine profiling, or perhaps adoptive transfer experiments with genetically modified lymphocytes to trace activation cascades within the tumor microenvironment."], "ground_truth": ["permed-77562", "permed-78784", "permed-68311", "permed-84015", "permed-58146", "permed-67837", "permed-67952", "permed-67971", "permed-67915", "permed-77564"]}
{"query_id": "topic_682_turn_1", "conversation_id": "topic_682", "turn_id": 1, "query": "What role can virtual reality play in treating anxiety disorders like claustrophobia?", "history": [], "ground_truth": ["permed-78741", "permed-72726", "permed-32800", "permed-88920", "permed-39319", "permed-63567", "permed-55783", "permed-55776", "permed-91431", "permed-55671"]}
{"query_id": "topic_682_turn_2", "conversation_id": "topic_682", "turn_id": 2, "query": "Can this technique be made more effective by incorporating personalized learning elements into the treatment process?", "history": ["What role can virtual reality play in treating anxiety disorders like claustrophobia?"], "ground_truth": ["permed-52264", "permed-52824", "permed-82651", "permed-90601", "permed-58626", "permed-75160", "permed-57580", "permed-51582", "permed-50971", "permed-67553"]}
{"query_id": "topic_682_turn_3", "conversation_id": "topic_682", "turn_id": 3, "query": "How could personalized adaptive learning algorithms be integrated into a VRE application to enhance treatment outcomes for claustrophobia—specifically by better modulating anxiety levels and improving the sense of presence? What design features would enable this adaptation based on real-time patient feedback and therapist input?", "history": ["What role can virtual reality play in treating anxiety disorders like claustrophobia?", "Can this technique be made more effective by incorporating personalized learning elements into the treatment process?"], "ground_truth": ["permed-78741", "permed-55783", "permed-72726", "permed-39319", "permed-32800", "permed-61047", "permed-61648", "permed-51584", "permed-88920", "permed-55775"]}
{"query_id": "topic_682_turn_4", "conversation_id": "topic_682", "turn_id": 4, "query": "Given this proposed integration of adaptive algorithms, what specific physiological and behavioral metrics would be most appropriate for the real-time feedback loop to modulate anxiety levels? Furthermore, what statistical validation methods—such as power analysis or cross-validation procedures—should be employed during pilot testing to ensure the algorithm's responsiveness to individual patient trajectories is both reliable and clinically significant before wider implementation?", "history": ["What role can virtual reality play in treating anxiety disorders like claustrophobia?", "Can this technique be made more effective by incorporating personalized learning elements into the treatment process?", "How could personalized adaptive learning algorithms be integrated into a VRE application to enhance treatment outcomes for claustrophobia—specifically by better modulating anxiety levels and improving the sense of presence? What design features would enable this adaptation based on real-time patient feedback and therapist input?"], "ground_truth": ["permed-65493", "permed-70628", "permed-53360", "permed-74352", "permed-25790", "permed-50422", "permed-53365", "permed-55585", "permed-55809", "permed-82975"]}
{"query_id": "topic_682_turn_5", "conversation_id": "topic_682", "turn_id": 5, "query": "Given the validated metrics and statistical frameworks for adaptive VR systems, what clinical trial designs would be most appropriate to evaluate their therapeutic efficacy and safety in treating claustrophobia? Specifically, how should studies balance controlled exposure protocols against real-world clinical settings when measuring patient outcomes like remission rates and functional improvement? Additionally, what safety monitoring protocols are needed for these dynamically adjusted VR environments, particularly regarding potential side effects like cybersickness or anxiety escalation during unsupervised use?", "history": ["What role can virtual reality play in treating anxiety disorders like claustrophobia?", "Can this technique be made more effective by incorporating personalized learning elements into the treatment process?", "How could personalized adaptive learning algorithms be integrated into a VRE application to enhance treatment outcomes for claustrophobia—specifically by better modulating anxiety levels and improving the sense of presence? What design features would enable this adaptation based on real-time patient feedback and therapist input?", "Given this proposed integration of adaptive algorithms, what specific physiological and behavioral metrics would be most appropriate for the real-time feedback loop to modulate anxiety levels? Furthermore, what statistical validation methods—such as power analysis or cross-validation procedures—should be employed during pilot testing to ensure the algorithm's responsiveness to individual patient trajectories is both reliable and clinically significant before wider implementation?"], "ground_truth": ["permed-78741", "permed-39319", "permed-55783", "permed-72726", "permed-56838", "permed-58542", "permed-63567", "permed-55671", "permed-61048", "permed-32800"]}
{"query_id": "topic_683_turn_1", "conversation_id": "topic_683", "turn_id": 1, "query": "What role do biomimetic photo-switches play in light-induced therapeutic applications?", "history": [], "ground_truth": ["permed-53576", "permed-72957", "permed-60318", "permed-74520", "permed-78037", "permed-72954", "permed-71742", "permed-60319", "permed-51007", "permed-77742"]}
{"query_id": "topic_683_turn_2", "conversation_id": "topic_683", "turn_id": 2, "query": "How does their integration into cellular lipid membranes affect the safety and efficacy of this technique?", "history": ["What role do biomimetic photo-switches play in light-induced therapeutic applications?"], "ground_truth": ["permed-70800", "permed-83325", "permed-53569", "permed-90174", "permed-75032", "permed-43882", "permed-63376", "permed-53573", "permed-51342", "permed-83326"]}
{"query_id": "topic_683_turn_3", "conversation_id": "topic_683", "turn_id": 3, "query": "Given their integration into cellular lipid membranes and their therapeutic potential, what long-term biological effects and biocompatibility concerns might arise from repeated use of these hydrophobic-substituted biomimetic photo-switches, and how could these factors impact the safety and efficacy of such light-induced treatments?", "history": ["What role do biomimetic photo-switches play in light-induced therapeutic applications?", "How does their integration into cellular lipid membranes affect the safety and efficacy of this technique?"], "ground_truth": ["permed-53576", "permed-71742", "permed-81985", "permed-78759", "permed-78037", "permed-78758", "permed-60228", "permed-82150", "permed-53309", "permed-83291"]}
{"query_id": "topic_683_turn_4", "conversation_id": "topic_683", "turn_id": 4, "query": "Given these identified biocompatibility concerns, what specific experimental protocols would you recommend for assessing membrane integrity and cellular stress responses during repeated photo-switching cycles? I'm particularly interested in methodological details regarding time-lapse imaging parameters, quantification of lipid peroxidation markers, and appropriate control conditions for distinguishing thermal from photochemical effects. How should experimental designs account for potential cumulative membrane damage across multiple treatment sessions?", "history": ["What role do biomimetic photo-switches play in light-induced therapeutic applications?", "How does their integration into cellular lipid membranes affect the safety and efficacy of this technique?", "Given their integration into cellular lipid membranes and their therapeutic potential, what long-term biological effects and biocompatibility concerns might arise from repeated use of these hydrophobic-substituted biomimetic photo-switches, and how could these factors impact the safety and efficacy of such light-induced treatments?"], "ground_truth": ["permed-53576", "permed-81210", "permed-78758", "permed-62011", "permed-75027", "permed-58087", "permed-83291", "permed-53572", "permed-81985", "permed-80845"]}
{"query_id": "topic_683_turn_5", "conversation_id": "topic_683", "turn_id": 5, "query": "Given these methodological frameworks for assessing membrane integrity and cellular stress, what clinical translation challenges emerge when moving from in vitro models to human applications? Specifically, how might cumulative membrane damage observed during repeated photo-switching cycles impact therapeutic efficacy and patient safety in chronic conditions requiring long-term treatment? What clinical evidence exists regarding optimal dosing intervals and restoration periods between light therapy sessions to mitigate potential adverse effects while maintaining treatment effectiveness? Additionally, what patient-specific factors (e.g., membrane lipid composition variations, comorbidities) should inform clinical deployment strategies?", "history": ["What role do biomimetic photo-switches play in light-induced therapeutic applications?", "How does their integration into cellular lipid membranes affect the safety and efficacy of this technique?", "Given their integration into cellular lipid membranes and their therapeutic potential, what long-term biological effects and biocompatibility concerns might arise from repeated use of these hydrophobic-substituted biomimetic photo-switches, and how could these factors impact the safety and efficacy of such light-induced treatments?", "Given these identified biocompatibility concerns, what specific experimental protocols would you recommend for assessing membrane integrity and cellular stress responses during repeated photo-switching cycles? I'm particularly interested in methodological details regarding time-lapse imaging parameters, quantification of lipid peroxidation markers, and appropriate control conditions for distinguishing thermal from photochemical effects. How should experimental designs account for potential cumulative membrane damage across multiple treatment sessions?"], "ground_truth": ["permed-53576", "permed-59081", "permed-12331", "permed-81511", "permed-41561", "permed-41819", "permed-13751", "permed-41220", "permed-50639", "permed-37506"]}
{"query_id": "topic_684_turn_1", "conversation_id": "topic_684", "turn_id": 1, "query": "What are the key factors affecting the quality of squid skin during frozen storage?", "history": [], "ground_truth": ["permed-80920", "permed-65114", "permed-65115", "permed-65024", "permed-65023", "permed-80493", "permed-65022", "permed-65116", "permed-65025", "permed-68412"]}
{"query_id": "topic_684_turn_2", "conversation_id": "topic_684", "turn_id": 2, "query": "Does altering the pH level of the storage solution have any significant impact on it?", "history": ["What are the key factors affecting the quality of squid skin during frozen storage?"], "ground_truth": ["permed-80920", "permed-63843", "permed-53308", "permed-81837", "permed-77382", "permed-91038", "permed-80731", "permed-77925", "permed-81833", "permed-65022"]}
{"query_id": "topic_684_turn_3", "conversation_id": "topic_684", "turn_id": 3, "query": "Given that pH levels affect squid skin quality during frozen storage, how do different concentrations of alkaline solutions specifically influence the structural integrity and pigment distribution in its chromatophores over extended periods? And what would this mean for the product's long-term sensory and commercial qualities?", "history": ["What are the key factors affecting the quality of squid skin during frozen storage?", "Does altering the pH level of the storage solution have any significant impact on it?"], "ground_truth": ["permed-80920", "permed-65025", "permed-80493", "permed-65024", "permed-65114", "permed-65022", "permed-65023", "permed-65115", "permed-80923", "permed-80922"]}
{"query_id": "topic_684_turn_4", "conversation_id": "topic_684", "turn_id": 4, "query": "Given these chromatophore-focused investigations, what specific histological techniques and imaging protocols would you recommend for quantifying structural changes in squid skin samples? I'm particularly interested in how to standardize the sampling locations, handle frozen tissue sections for microscopic analysis, and which staining methods best preserve both cellular architecture and pigment distribution patterns for reliable comparative assessment across different alkaline treatment groups.", "history": ["What are the key factors affecting the quality of squid skin during frozen storage?", "Does altering the pH level of the storage solution have any significant impact on it?", "Given that pH levels affect squid skin quality during frozen storage, how do different concentrations of alkaline solutions specifically influence the structural integrity and pigment distribution in its chromatophores over extended periods? And what would this mean for the product's long-term sensory and commercial qualities?"], "ground_truth": ["permed-80920", "permed-13752", "permed-12929", "permed-12936", "permed-13350", "permed-43889", "permed-48056", "permed-70744", "permed-59119", "permed-12935"]}
{"query_id": "topic_684_turn_5", "conversation_id": "topic_684", "turn_id": 5, "query": "Given these standardized histological protocols for assessing squid skin structural changes, how might these laboratory findings translate to clinical dermatological applications? Specifically, what potential therapeutic implications could chromatophore preservation techniques have for human pigmentary disorders like vitiligo or melasma, and have any in vitro studies evaluated the biocompatibility or immunological responses to squid-derived structural proteins in human skin models? What safety considerations would need addressing before considering such translational applications?", "history": ["What are the key factors affecting the quality of squid skin during frozen storage?", "Does altering the pH level of the storage solution have any significant impact on it?", "Given that pH levels affect squid skin quality during frozen storage, how do different concentrations of alkaline solutions specifically influence the structural integrity and pigment distribution in its chromatophores over extended periods? And what would this mean for the product's long-term sensory and commercial qualities?", "Given these chromatophore-focused investigations, what specific histological techniques and imaging protocols would you recommend for quantifying structural changes in squid skin samples? I'm particularly interested in how to standardize the sampling locations, handle frozen tissue sections for microscopic analysis, and which staining methods best preserve both cellular architecture and pigment distribution patterns for reliable comparative assessment across different alkaline treatment groups."], "ground_truth": ["permed-80920", "permed-45500", "permed-86202", "permed-75399", "permed-13752", "permed-60248", "permed-14601", "permed-12440", "permed-92424", "permed-60247"]}
{"query_id": "topic_685_turn_1", "conversation_id": "topic_685", "turn_id": 1, "query": "What's known about how exercise affects the respiratory system in patients with heart failure?", "history": [], "ground_truth": ["permed-68839", "permed-76327", "permed-82099", "permed-58626", "permed-52532", "permed-91266", "permed-51439", "permed-55659", "permed-76324", "permed-65646"]}
{"query_id": "topic_685_turn_2", "conversation_id": "topic_685", "turn_id": 2, "query": "Does this impact on respiratory function during exercise vary significantly between different types of heart conditions, such as HFpEF and pulmonary hypertension?", "history": ["What's known about how exercise affects the respiratory system in patients with heart failure?"], "ground_truth": ["permed-76327", "permed-57114", "permed-82099", "permed-52533", "permed-68839", "permed-52532", "permed-82663", "permed-18287", "permed-80033", "permed-51417"]}
{"query_id": "topic_685_turn_3", "conversation_id": "topic_685", "turn_id": 3, "query": "Given these differences between HFpEF and pulmonary hypertension in how they affect respiratory function during exercise, could you explain how the altered ventricular interaction dynamics in HFpEF specifically impact lung compliance and airway resistance? How do these respiratory mechanics changes compare to what's seen in CTEPH patients during exercise? Also, what therapeutic approaches might help counteract these negative effects on breathing mechanics in both conditions?", "history": ["What's known about how exercise affects the respiratory system in patients with heart failure?", "Does this impact on respiratory function during exercise vary significantly between different types of heart conditions, such as HFpEF and pulmonary hypertension?"], "ground_truth": ["permed-76327", "permed-57114", "permed-82099", "permed-52533", "permed-18287", "permed-52532", "permed-68839", "permed-51417", "permed-57118", "permed-21371"]}
{"query_id": "topic_685_turn_4", "conversation_id": "topic_685", "turn_id": 4, "query": "When studying these altered respiratory mechanics in HFpEF versus CTEPH patients during exercise, what specific measurement protocols and instrumentation would you recommend for precisely quantifying changes in lung compliance and airway resistance? I'm particularly interested in the technical implementation—how do you differentiate between contributions from parenchymal stiffness versus airway dynamics during progressive exercise testing, and what statistical approaches best account for intra-patient variability in longitudinal assessments of therapeutic interventions?", "history": ["What's known about how exercise affects the respiratory system in patients with heart failure?", "Does this impact on respiratory function during exercise vary significantly between different types of heart conditions, such as HFpEF and pulmonary hypertension?", "Given these differences between HFpEF and pulmonary hypertension in how they affect respiratory function during exercise, could you explain how the altered ventricular interaction dynamics in HFpEF specifically impact lung compliance and airway resistance? How do these respiratory mechanics changes compare to what's seen in CTEPH patients during exercise? Also, what therapeutic approaches might help counteract these negative effects on breathing mechanics in both conditions?"], "ground_truth": ["permed-82099", "permed-52533", "permed-76327", "permed-18287", "permed-57114", "permed-51417", "permed-63056", "permed-52534", "permed-27155", "permed-57343"]}
{"query_id": "topic_685_turn_5", "conversation_id": "topic_685", "turn_id": 5, "query": "Given these advanced measurement protocols for assessing respiratory mechanics, what clinical outcomes have been demonstrated when targeting these specific pathophysiology mechanisms? For HFpEF patients showing impaired lung compliance, have interventions like pulmonary vasodilators or exercise training regimens shown meaningful improvements in functional capacity or quality of life metrics in randomized trials? Similarly, for CTEPH patients with documented airway resistance changes, how do pulmonary endarterectomy outcomes correlate with postoperative ventilatory efficiency during exercise, and what are the safety considerations when timing these interventions relative to disease severity?", "history": ["What's known about how exercise affects the respiratory system in patients with heart failure?", "Does this impact on respiratory function during exercise vary significantly between different types of heart conditions, such as HFpEF and pulmonary hypertension?", "Given these differences between HFpEF and pulmonary hypertension in how they affect respiratory function during exercise, could you explain how the altered ventricular interaction dynamics in HFpEF specifically impact lung compliance and airway resistance? How do these respiratory mechanics changes compare to what's seen in CTEPH patients during exercise? Also, what therapeutic approaches might help counteract these negative effects on breathing mechanics in both conditions?", "When studying these altered respiratory mechanics in HFpEF versus CTEPH patients during exercise, what specific measurement protocols and instrumentation would you recommend for precisely quantifying changes in lung compliance and airway resistance? I'm particularly interested in the technical implementation—how do you differentiate between contributions from parenchymal stiffness versus airway dynamics during progressive exercise testing, and what statistical approaches best account for intra-patient variability in longitudinal assessments of therapeutic interventions?"], "ground_truth": ["permed-52533", "permed-18287", "permed-52532", "permed-82099", "permed-57108", "permed-76327", "permed-57114", "permed-27215", "permed-68839", "permed-57110"]}
{"query_id": "topic_686_turn_1", "conversation_id": "topic_686", "turn_id": 1, "query": "What advancements have been made in biosensor technology for microRNA detection?", "history": [], "ground_truth": ["permed-89621", "permed-80838", "permed-89623", "permed-80834", "permed-89622", "permed-89624", "permed-51729", "permed-57966", "permed-80839", "permed-89627"]}
{"query_id": "topic_686_turn_2", "conversation_id": "topic_686", "turn_id": 2, "query": "How can signal amplification techniques improve the sensitivity of this technology?", "history": ["What advancements have been made in biosensor technology for microRNA detection?"], "ground_truth": ["permed-57972", "permed-82651", "permed-77683", "permed-74445", "permed-80838", "permed-74446", "permed-68719", "permed-64264", "permed-59244", "permed-77684"]}
{"query_id": "topic_686_turn_3", "conversation_id": "topic_686", "turn_id": 3, "query": "Given these signal amplification techniques we've discussed, how could we further optimize approaches like target-induced recycling double amplification to enhance the dynamic range and lower detection limits in self-powered biosensors for microRNA? What challenges might arise in translating these improvements into clinical diagnostics for early cancer detection, and how could they be addressed?", "history": ["What advancements have been made in biosensor technology for microRNA detection?", "How can signal amplification techniques improve the sensitivity of this technology?"], "ground_truth": ["permed-80838", "permed-57966", "permed-89623", "permed-89621", "permed-57972", "permed-80839", "permed-80840", "permed-80834", "permed-77427", "permed-89622"]}
{"query_id": "topic_686_turn_4", "conversation_id": "topic_686", "turn_id": 4, "query": "In implementing these optimized amplification approaches, what specific experimental protocols would you recommend for validating the enhanced dynamic range in self-powered biosensors? I'm particularly interested in the statistical methods used to quantify detection limit improvements - for instance, should we employ standard addition methods with spike-and-recovery experiments, or would serial dilution analyses with probit modeling be more appropriate? Additionally, what quality control measures would ensure reproducibility when testing these systems across different microRNA isoforms in clinical samples?", "history": ["What advancements have been made in biosensor technology for microRNA detection?", "How can signal amplification techniques improve the sensitivity of this technology?", "Given these signal amplification techniques we've discussed, how could we further optimize approaches like target-induced recycling double amplification to enhance the dynamic range and lower detection limits in self-powered biosensors for microRNA? What challenges might arise in translating these improvements into clinical diagnostics for early cancer detection, and how could they be addressed?"], "ground_truth": ["permed-80838", "permed-57966", "permed-89623", "permed-57972", "permed-80834", "permed-89621", "permed-89622", "permed-74514", "permed-51732", "permed-66232"]}
{"query_id": "topic_686_turn_5", "conversation_id": "topic_686", "turn_id": 5, "query": "Given our detailed discussion of validation protocols for enhanced biosensor performance, how do these optimized amplification systems actually perform in clinical settings for early cancer detection? Specifically, what real-world data exists regarding their diagnostic accuracy when analyzing heterogeneous patient samples - particularly comparing sensitivity/specificity against standard methods like RT-qPCR? Have any clinical trials evaluated potential cross-reactivity with homologous microRNA sequences or interference from common medications? Additionally, what safety considerations emerge when implementing these self-powered systems with amplification components in human diagnostic applications?", "history": ["What advancements have been made in biosensor technology for microRNA detection?", "How can signal amplification techniques improve the sensitivity of this technology?", "Given these signal amplification techniques we've discussed, how could we further optimize approaches like target-induced recycling double amplification to enhance the dynamic range and lower detection limits in self-powered biosensors for microRNA? What challenges might arise in translating these improvements into clinical diagnostics for early cancer detection, and how could they be addressed?", "In implementing these optimized amplification approaches, what specific experimental protocols would you recommend for validating the enhanced dynamic range in self-powered biosensors? I'm particularly interested in the statistical methods used to quantify detection limit improvements - for instance, should we employ standard addition methods with spike-and-recovery experiments, or would serial dilution analyses with probit modeling be more appropriate? Additionally, what quality control measures would ensure reproducibility when testing these systems across different microRNA isoforms in clinical samples?"], "ground_truth": ["permed-80838", "permed-89623", "permed-74088", "permed-66232", "permed-80840", "permed-59242", "permed-85061", "permed-57966", "permed-86821", "permed-57972"]}
{"query_id": "topic_687_turn_1", "conversation_id": "topic_687", "turn_id": 1, "query": "Role of microbiota in gastric bypass surgery outcomes for obesity", "history": [], "ground_truth": ["permed-75316", "permed-66746", "permed-65029", "permed-58392", "permed-67960", "permed-85506", "permed-72282", "permed-59032", "permed-51268", "permed-65155"]}
{"query_id": "topic_687_turn_2", "conversation_id": "topic_687", "turn_id": 2, "query": "Which specific changes in this microbiota composition predict successful weight loss after gastric bypass surgery?", "history": ["Role of microbiota in gastric bypass surgery outcomes for obesity"], "ground_truth": ["permed-75316", "permed-66746", "permed-29764", "permed-75319", "permed-59032", "permed-67960", "permed-3459", "permed-66653", "permed-75317", "permed-3461"]}
{"query_id": "topic_687_turn_3", "conversation_id": "topic_687", "turn_id": 3, "query": "For these identified predictive microbial changes, what are the specific oral and gut microbiota alterations (e.g., Akkermansia muciniphila, Faecalibacterium prausnitzii, SCFA, bile acid metabolism) and their mechanisms influencing improved metabolic health and sustained weight loss after Roux-en-Y gastric bypass in morbidly obese patients?", "history": ["Role of microbiota in gastric bypass surgery outcomes for obesity", "Which specific changes in this microbiota composition predict successful weight loss after gastric bypass surgery?"], "ground_truth": ["permed-75316", "permed-66746", "permed-29763", "permed-29764", "permed-1806", "permed-65155", "permed-59032", "permed-75319", "permed-75323", "permed-56554"]}
{"query_id": "topic_687_turn_4", "conversation_id": "topic_687", "turn_id": 4, "query": "In investigating these specific oral-gut microbiota alterations and their mechanistic pathways, what experimental methodologies were employed to validate the causal relationships between microbial shifts (like Akkermansia muciniphila enrichment) and metabolic improvements? Specifically, were germ-free animal models with fecal microbiota transplantation used, and what analytical techniques (e.g., targeted metabolomics for SCFA quantification, stable isotope tracing for bile acid kinetics) provided the most robust evidence for these mechanisms in the RYGB context?", "history": ["Role of microbiota in gastric bypass surgery outcomes for obesity", "Which specific changes in this microbiota composition predict successful weight loss after gastric bypass surgery?", "For these identified predictive microbial changes, what are the specific oral and gut microbiota alterations (e.g., Akkermansia muciniphila, Faecalibacterium prausnitzii, SCFA, bile acid metabolism) and their mechanisms influencing improved metabolic health and sustained weight loss after Roux-en-Y gastric bypass in morbidly obese patients?"], "ground_truth": ["permed-66746", "permed-75316", "permed-86163", "permed-72277", "permed-60746", "permed-58594", "permed-66656", "permed-67004", "permed-89620", "permed-58168"]}
{"query_id": "topic_687_turn_5", "conversation_id": "topic_687", "turn_id": 5, "query": "Given the validated causal mechanisms linking specific microbiota alterations to metabolic improvements, how have these findings translated into clinical applications for RYGB patients? Specifically, have any microbiota-targeted interventions (such as probiotic supplementation with Akkermansia muciniphila or prebiotics to enhance SCFA production) been evaluated in clinical trials for improving weight maintenance or resolving comorbidities like type 2 diabetes? What safety profiles and practical implementation challenges have emerged when attempting to modulate patient microbiota in perioperative or long-term management following bariatric surgery?", "history": ["Role of microbiota in gastric bypass surgery outcomes for obesity", "Which specific changes in this microbiota composition predict successful weight loss after gastric bypass surgery?", "For these identified predictive microbial changes, what are the specific oral and gut microbiota alterations (e.g., Akkermansia muciniphila, Faecalibacterium prausnitzii, SCFA, bile acid metabolism) and their mechanisms influencing improved metabolic health and sustained weight loss after Roux-en-Y gastric bypass in morbidly obese patients?", "In investigating these specific oral-gut microbiota alterations and their mechanistic pathways, what experimental methodologies were employed to validate the causal relationships between microbial shifts (like Akkermansia muciniphila enrichment) and metabolic improvements? Specifically, were germ-free animal models with fecal microbiota transplantation used, and what analytical techniques (e.g., targeted metabolomics for SCFA quantification, stable isotope tracing for bile acid kinetics) provided the most robust evidence for these mechanisms in the RYGB context?"], "ground_truth": ["permed-66746", "permed-75316", "permed-58392", "permed-29763", "permed-68274", "permed-67004", "permed-29764", "permed-51268", "permed-70965", "permed-75318"]}
{"query_id": "topic_688_turn_1", "conversation_id": "topic_688", "turn_id": 1, "query": "What is known about cognitive impairment in schizophrenia and how does it impact patient outcomes?", "history": [], "ground_truth": ["permed-72758", "permed-52401", "permed-72456", "permed-65060", "permed-55503", "permed-88373", "permed-55499", "permed-55498", "permed-55748", "permed-70274"]}
{"query_id": "topic_688_turn_2", "conversation_id": "topic_688", "turn_id": 2, "query": "Does this understanding of cognitive impairment in schizophrenia change when considering patients with comorbid substance use disorders?", "history": ["What is known about cognitive impairment in schizophrenia and how does it impact patient outcomes?"], "ground_truth": ["permed-79088", "permed-72758", "permed-55503", "permed-55498", "permed-55778", "permed-72456", "permed-55821", "permed-81271", "permed-88373", "permed-52401"]}
{"query_id": "topic_688_turn_3", "conversation_id": "topic_688", "turn_id": 3, "query": "Given these distinct neurocognitive profiles in schizophrenia patients with comorbid substance use disorders, how could they guide the development of more targeted interventions? And what might this tell us about cognitive impairment patterns across other severe mental illnesses?", "history": ["What is known about cognitive impairment in schizophrenia and how does it impact patient outcomes?", "Does this understanding of cognitive impairment in schizophrenia change when considering patients with comorbid substance use disorders?"], "ground_truth": ["permed-79088", "permed-52401", "permed-81271", "permed-72456", "permed-88373", "permed-55778", "permed-70274", "permed-65060", "permed-72758", "permed-55503"]}
{"query_id": "topic_688_turn_4", "conversation_id": "topic_688", "turn_id": 4, "query": "Given these proposed interventions targeting specific neurocognitive profiles, what specific methodological approaches would be most appropriate for validating their efficacy? I'm particularly interested in how you would design randomization protocols for such heterogeneous patient populations, what cognitive assessment batteries would serve as optimal primary endpoints, and what statistical methods would best account for baseline substance use severity when analyzing treatment effects on cognitive outcomes.", "history": ["What is known about cognitive impairment in schizophrenia and how does it impact patient outcomes?", "Does this understanding of cognitive impairment in schizophrenia change when considering patients with comorbid substance use disorders?", "Given these distinct neurocognitive profiles in schizophrenia patients with comorbid substance use disorders, how could they guide the development of more targeted interventions? And what might this tell us about cognitive impairment patterns across other severe mental illnesses?"], "ground_truth": ["permed-79088", "permed-74897", "permed-86675", "permed-72787", "permed-73843", "permed-83166", "permed-70672", "permed-74908", "permed-55777", "permed-60083"]}
{"query_id": "topic_688_turn_5", "conversation_id": "topic_688", "turn_id": 5, "query": "Given these sophisticated methodological validation frameworks for targeted neurocognitive interventions, what clinical implementation challenges emerge when translating these approaches into real-world psychiatric practice? Specifically, how do comorbid substance use patterns affect practical issues like treatment adherence, differential response trajectories, and management of psychiatric symptom exacerbation during cognitive-focused therapy? Additionally, what safety monitoring protocols are needed given potential interactions between cognitive training demands and patients' substance use histories, particularly regarding vulnerability to relapse or emotional dysregulation?", "history": ["What is known about cognitive impairment in schizophrenia and how does it impact patient outcomes?", "Does this understanding of cognitive impairment in schizophrenia change when considering patients with comorbid substance use disorders?", "Given these distinct neurocognitive profiles in schizophrenia patients with comorbid substance use disorders, how could they guide the development of more targeted interventions? And what might this tell us about cognitive impairment patterns across other severe mental illnesses?", "Given these proposed interventions targeting specific neurocognitive profiles, what specific methodological approaches would be most appropriate for validating their efficacy? I'm particularly interested in how you would design randomization protocols for such heterogeneous patient populations, what cognitive assessment batteries would serve as optimal primary endpoints, and what statistical methods would best account for baseline substance use severity when analyzing treatment effects on cognitive outcomes."], "ground_truth": ["permed-52801", "permed-79088", "permed-40609", "permed-55760", "permed-75905", "permed-55778", "permed-60078", "permed-92399", "permed-74908", "permed-74900"]}
{"query_id": "topic_689_turn_1", "conversation_id": "topic_689", "turn_id": 1, "query": "How important is frontline leader well-being to healthcare team effectiveness?", "history": [], "ground_truth": ["permed-65873", "permed-90720", "permed-54013", "permed-91926", "permed-71473", "permed-69511", "permed-69811", "permed-61611", "permed-55687", "permed-66148"]}
{"query_id": "topic_689_turn_2", "conversation_id": "topic_689", "turn_id": 2, "query": "What specific challenges does it pose in high-pressure environments like hospitals?", "history": ["How important is frontline leader well-being to healthcare team effectiveness?"], "ground_truth": ["permed-55107", "permed-58626", "permed-58349", "permed-92177", "permed-61782", "permed-11322", "permed-44694", "permed-72010", "permed-76370", "permed-91926"]}
{"query_id": "topic_689_turn_3", "conversation_id": "topic_689", "turn_id": 3, "query": "Given these challenges in high-pressure healthcare settings, what innovative models or frameworks could integrate frontline leader well-being into organizational strategies, and how might they specifically address the unique stressors these leaders face to enhance team resilience and effectiveness?", "history": ["How important is frontline leader well-being to healthcare team effectiveness?", "What specific challenges does it pose in high-pressure environments like hospitals?"], "ground_truth": ["permed-65873", "permed-71473", "permed-78110", "permed-72360", "permed-70246", "permed-69811", "permed-51737", "permed-80047", "permed-62018", "permed-65484"]}
{"query_id": "topic_689_turn_4", "conversation_id": "topic_689", "turn_id": 4, "query": "For these proposed frameworks integrating leader well-being, what specific methodological approaches would best evaluate their implementation fidelity and impact? I'm particularly interested in how researchers might design mixed-methods studies to capture both quantitative metrics (like reduced burnout scores) and qualitative insights about organizational adoption barriers. What longitudinal assessment strategies would effectively track how these interventions affect team effectiveness indicators over time, and what statistical methods would account for clustering effects within hospital units?", "history": ["How important is frontline leader well-being to healthcare team effectiveness?", "What specific challenges does it pose in high-pressure environments like hospitals?", "Given these challenges in high-pressure healthcare settings, what innovative models or frameworks could integrate frontline leader well-being into organizational strategies, and how might they specifically address the unique stressors these leaders face to enhance team resilience and effectiveness?"], "ground_truth": ["permed-58488", "permed-34403", "permed-69975", "permed-65576", "permed-86840", "permed-46409", "permed-46616", "permed-57576", "permed-69511", "permed-46364"]}
{"query_id": "topic_689_turn_5", "conversation_id": "topic_689", "turn_id": 5, "query": "Given these methodological approaches for evaluating implementation fidelity, what clinical outcomes have been demonstrated when leader well-being interventions are successfully deployed? Specifically, how do improvements in frontline leader well-being translate to measurable patient care metrics such as reduced medication errors, decreased hospital-acquired infection rates, or improved patient satisfaction scores in real-world clinical settings? Additionally, what evidence exists regarding the safety profile of these organizational interventions, particularly concerning potential unintended consequences on clinical workflows or staff burden during implementation phases?", "history": ["How important is frontline leader well-being to healthcare team effectiveness?", "What specific challenges does it pose in high-pressure environments like hospitals?", "Given these challenges in high-pressure healthcare settings, what innovative models or frameworks could integrate frontline leader well-being into organizational strategies, and how might they specifically address the unique stressors these leaders face to enhance team resilience and effectiveness?", "For these proposed frameworks integrating leader well-being, what specific methodological approaches would best evaluate their implementation fidelity and impact? I'm particularly interested in how researchers might design mixed-methods studies to capture both quantitative metrics (like reduced burnout scores) and qualitative insights about organizational adoption barriers. What longitudinal assessment strategies would effectively track how these interventions affect team effectiveness indicators over time, and what statistical methods would account for clustering effects within hospital units?"], "ground_truth": ["permed-65873", "permed-58488", "permed-54013", "permed-69511", "permed-65484", "permed-52109", "permed-46409", "permed-65477", "permed-69975", "permed-71473"]}
{"query_id": "topic_690_turn_1", "conversation_id": "topic_690", "turn_id": 1, "query": "What role does urban planning play in reducing air pollution in cities?", "history": [], "ground_truth": ["permed-65349", "permed-54852", "permed-54838", "permed-65709", "permed-54843", "permed-91425", "permed-54841", "permed-81982", "permed-65712", "permed-84156"]}
{"query_id": "topic_690_turn_2", "conversation_id": "topic_690", "turn_id": 2, "query": "Can green infrastructure be a key component of this approach, especially in rapidly urbanizing areas?", "history": ["What role does urban planning play in reducing air pollution in cities?"], "ground_truth": ["permed-67088", "permed-90131", "permed-67091", "permed-79984", "permed-75419", "permed-88353", "permed-54369", "permed-87940", "permed-79082", "permed-67498"]}
{"query_id": "topic_690_turn_3", "conversation_id": "topic_690", "turn_id": 3, "query": "Building on these approaches, how exactly does combining green infrastructure with optimized urban layouts help lower PM2.5 levels in fast-growing cities? And are there particular urban design strategies that work best for addressing seasonal fluctuations in these pollution levels?", "history": ["What role does urban planning play in reducing air pollution in cities?", "Can green infrastructure be a key component of this approach, especially in rapidly urbanizing areas?"], "ground_truth": ["permed-65709", "permed-91427", "permed-54850", "permed-79984", "permed-90131", "permed-54846", "permed-80604", "permed-75419", "permed-54841", "permed-65711"]}
{"query_id": "topic_690_turn_4", "conversation_id": "topic_690", "turn_id": 4, "query": "Building on these urban design strategies, could you elaborate on the specific monitoring protocols used to quantify PM2.5 reductions from combined green infrastructure and layout optimization? I'm particularly interested in the sensor network design – such as optimal sensor density and placement relative to green corridors – and the statistical methods used to isolate the intervention's effect from confounding variables like background pollution trends and meteorological conditions in these longitudinal studies.", "history": ["What role does urban planning play in reducing air pollution in cities?", "Can green infrastructure be a key component of this approach, especially in rapidly urbanizing areas?", "Building on these approaches, how exactly does combining green infrastructure with optimized urban layouts help lower PM2.5 levels in fast-growing cities? And are there particular urban design strategies that work best for addressing seasonal fluctuations in these pollution levels?"], "ground_truth": ["permed-65709", "permed-91427", "permed-91425", "permed-81355", "permed-54846", "permed-84158", "permed-81982", "permed-51750", "permed-79984", "permed-65711"]}
{"query_id": "topic_690_turn_5", "conversation_id": "topic_690", "turn_id": 5, "query": "Given these robust environmental monitoring protocols demonstrating PM2.5 reductions, what translational clinical research has been conducted to link these urban design improvements to tangible patient health outcomes? Specifically, for populations in these fast-growing cities, what evidence exists regarding the intervention's impact on respiratory morbidity (e.g., asthma exacerbation rates, COPD hospitalizations) and cardiovascular endpoints? Furthermore, have any longitudinal studies evaluated whether these urban planning strategies yield clinically meaningful reductions in medication use or healthcare utilization, and are there identified subpopulations that demonstrate differential therapeutic efficacy?", "history": ["What role does urban planning play in reducing air pollution in cities?", "Can green infrastructure be a key component of this approach, especially in rapidly urbanizing areas?", "Building on these approaches, how exactly does combining green infrastructure with optimized urban layouts help lower PM2.5 levels in fast-growing cities? And are there particular urban design strategies that work best for addressing seasonal fluctuations in these pollution levels?", "Building on these urban design strategies, could you elaborate on the specific monitoring protocols used to quantify PM2.5 reductions from combined green infrastructure and layout optimization? I'm particularly interested in the sensor network design – such as optimal sensor density and placement relative to green corridors – and the statistical methods used to isolate the intervention's effect from confounding variables like background pollution trends and meteorological conditions in these longitudinal studies."], "ground_truth": ["permed-54846", "permed-65709", "permed-54841", "permed-54838", "permed-54842", "permed-69419", "permed-33732", "permed-13572", "permed-35615", "permed-65355"]}
{"query_id": "topic_691_turn_1", "conversation_id": "topic_691", "turn_id": 1, "query": "What are some common skin and mucosal disorders associated with cocaine use?", "history": [], "ground_truth": ["permed-53207", "permed-51889", "permed-55683", "permed-72050", "permed-92493", "permed-13013", "permed-61454", "permed-72307", "permed-13238", "permed-83909"]}
{"query_id": "topic_691_turn_2", "conversation_id": "topic_691", "turn_id": 2, "query": "How do the histopathological features of these disorders impact their diagnosis and treatment?", "history": ["What are some common skin and mucosal disorders associated with cocaine use?"], "ground_truth": ["permed-70447", "permed-72010", "permed-86959", "permed-50709", "permed-77397", "permed-61783", "permed-50858", "permed-85376", "permed-77067", "permed-52003"]}
{"query_id": "topic_691_turn_3", "conversation_id": "topic_691", "turn_id": 3, "query": "Given these histopathological features we've discussed, how do the specific changes seen in conditions like leukocytoclastic vasculitis and necrotizing vasculitis correlate with serological markers such as ANCAs? And what do these correlations mean for diagnosing and managing these cocaine-induced disorders?", "history": ["What are some common skin and mucosal disorders associated with cocaine use?", "How do the histopathological features of these disorders impact their diagnosis and treatment?"], "ground_truth": ["permed-53207", "permed-61560", "permed-61777", "permed-54800", "permed-53208", "permed-27553", "permed-58315", "permed-58368", "permed-61775", "permed-61780"]}
{"query_id": "topic_691_turn_4", "conversation_id": "topic_691", "turn_id": 4, "query": "When investigating these correlations between histopathological findings and serological markers, what specific laboratory protocols would you recommend for ANCA testing in cocaine-associated vasculitis cases? I'm particularly interested in methodological details regarding sample processing, immunofluorescence versus ELISA validation approaches, and whether any specialized staining techniques beyond standard HE staining might enhance detection of vascular changes in biopsy specimens. How should we address potential cross-reactivity issues in these assays when dealing with cocaine-related autoimmunity?", "history": ["What are some common skin and mucosal disorders associated with cocaine use?", "How do the histopathological features of these disorders impact their diagnosis and treatment?", "Given these histopathological features we've discussed, how do the specific changes seen in conditions like leukocytoclastic vasculitis and necrotizing vasculitis correlate with serological markers such as ANCAs? And what do these correlations mean for diagnosing and managing these cocaine-induced disorders?"], "ground_truth": ["permed-53207", "permed-61560", "permed-27553", "permed-58368", "permed-58315", "permed-16658", "permed-61780", "permed-23158", "permed-67903", "permed-53228"]}
{"query_id": "topic_691_turn_5", "conversation_id": "topic_691", "turn_id": 5, "query": "Given the detailed laboratory protocols for ANCA testing we've established, how do these serological and histopathological findings translate to clinical management decisions in cocaine-induced vasculitis? Specifically, what evidence-based treatment protocols exist that integrate ANCA monitoring with immunosuppressive therapy, and how do patient outcomes differ when treatment is guided by serial ANCA titers versus clinical symptoms alone? Additionally, what are the documented relapse rates and safety profiles when using cyclophosphamide or rituximab in this patient population, particularly regarding infection risks in individuals with ongoing substance use?", "history": ["What are some common skin and mucosal disorders associated with cocaine use?", "How do the histopathological features of these disorders impact their diagnosis and treatment?", "Given these histopathological features we've discussed, how do the specific changes seen in conditions like leukocytoclastic vasculitis and necrotizing vasculitis correlate with serological markers such as ANCAs? And what do these correlations mean for diagnosing and managing these cocaine-induced disorders?", "When investigating these correlations between histopathological findings and serological markers, what specific laboratory protocols would you recommend for ANCA testing in cocaine-associated vasculitis cases? I'm particularly interested in methodological details regarding sample processing, immunofluorescence versus ELISA validation approaches, and whether any specialized staining techniques beyond standard HE staining might enhance detection of vascular changes in biopsy specimens. How should we address potential cross-reactivity issues in these assays when dealing with cocaine-related autoimmunity?"], "ground_truth": ["permed-53207", "permed-12825", "permed-69184", "permed-58368", "permed-58315", "permed-54800", "permed-92346", "permed-61560", "permed-61775", "permed-61777"]}
{"query_id": "topic_692_turn_1", "conversation_id": "topic_692", "turn_id": 1, "query": "What role does 2-hydroxybiphenyl-3-monooxygenase play in biocatalytic processes?", "history": [], "ground_truth": ["permed-51644", "permed-51649", "permed-51650", "permed-58141", "permed-64159", "permed-64164", "permed-86692", "permed-88472", "permed-58008", "permed-89263"]}
{"query_id": "topic_692_turn_2", "conversation_id": "topic_692", "turn_id": 2, "query": "How do conformational changes affect the efficiency and specificity of this enzyme in such processes?", "history": ["What role does 2-hydroxybiphenyl-3-monooxygenase play in biocatalytic processes?"], "ground_truth": ["permed-65165", "permed-91053", "permed-79296", "permed-51644", "permed-74957", "permed-80887", "permed-82820", "permed-83852", "permed-82189", "permed-89404"]}
{"query_id": "topic_692_turn_3", "conversation_id": "topic_692", "turn_id": 3, "query": "Given what we know about how conformational changes affect this enzyme's efficiency and specificity, how could we better understand the detailed mechanisms behind these changes—especially those involving NADH/FAD interactions—to further improve its performance? Specifically, what's the dynamic relationship between the active site residues and the enzyme's redox state during these processes?", "history": ["What role does 2-hydroxybiphenyl-3-monooxygenase play in biocatalytic processes?", "How do conformational changes affect the efficiency and specificity of this enzyme in such processes?"], "ground_truth": ["permed-51644", "permed-71554", "permed-79296", "permed-86883", "permed-53086", "permed-65165", "permed-81963", "permed-85479", "permed-58145", "permed-86899"]}
{"query_id": "topic_692_turn_4", "conversation_id": "topic_692", "turn_id": 4, "query": "Considering the need to elucidate these dynamic relationships between active site residues and redox states, what specific spectroscopic or crystallographic techniques would best capture transient conformational intermediates? Would time-resolved crystallography during catalytic turnover or advanced NMR relaxation methods provide superior resolution for tracking FAD/NADH positional changes? Also, what computational approaches—such as QM/MM simulations of the electron transfer chain—should be paired with experimental data to validate the observed redox-coupled structural rearrangements?", "history": ["What role does 2-hydroxybiphenyl-3-monooxygenase play in biocatalytic processes?", "How do conformational changes affect the efficiency and specificity of this enzyme in such processes?", "Given what we know about how conformational changes affect this enzyme's efficiency and specificity, how could we better understand the detailed mechanisms behind these changes—especially those involving NADH/FAD interactions—to further improve its performance? Specifically, what's the dynamic relationship between the active site residues and the enzyme's redox state during these processes?"], "ground_truth": ["permed-51644", "permed-53086", "permed-86899", "permed-51007", "permed-53094", "permed-78773", "permed-89911", "permed-76855", "permed-89824", "permed-52517"]}
{"query_id": "topic_692_turn_5", "conversation_id": "topic_692", "turn_id": 5, "query": "Given these structural and mechanistic insights into 2-hydroxybiphenyl-3-monooxygenase's conformational dynamics and redox state, how do these biophysical properties translate to its clinical applications, particularly regarding its therapeutic efficacy and safety profile when used in prodrug activation or targeted drug delivery systems? What are the primary clinical challenges—such as immunogenicity, stability in human physiological environments, or off-target catalytic activity—that must be addressed before this enzyme can be successfully deployed in real-world patient treatments, and what evidence from preclinical or early-phase clinical studies informs these risk assessments?", "history": ["What role does 2-hydroxybiphenyl-3-monooxygenase play in biocatalytic processes?", "How do conformational changes affect the efficiency and specificity of this enzyme in such processes?", "Given what we know about how conformational changes affect this enzyme's efficiency and specificity, how could we better understand the detailed mechanisms behind these changes—especially those involving NADH/FAD interactions—to further improve its performance? Specifically, what's the dynamic relationship between the active site residues and the enzyme's redox state during these processes?", "Considering the need to elucidate these dynamic relationships between active site residues and redox states, what specific spectroscopic or crystallographic techniques would best capture transient conformational intermediates? Would time-resolved crystallography during catalytic turnover or advanced NMR relaxation methods provide superior resolution for tracking FAD/NADH positional changes? Also, what computational approaches—such as QM/MM simulations of the electron transfer chain—should be paired with experimental data to validate the observed redox-coupled structural rearrangements?"], "ground_truth": ["permed-51644", "permed-73075", "permed-51649", "permed-51645", "permed-58141", "permed-72946", "permed-51650", "permed-76063", "permed-78891", "permed-89263"]}
{"query_id": "topic_693_turn_1", "conversation_id": "topic_693", "turn_id": 1, "query": "What are the challenges in assessing heavy metal pollution in marine environments like the Bohai Sea?", "history": [], "ground_truth": ["permed-80986", "permed-80987", "permed-77928", "permed-80983", "permed-80989", "permed-88881", "permed-80984", "permed-77927", "permed-88890", "permed-89734"]}
{"query_id": "topic_693_turn_2", "conversation_id": "topic_693", "turn_id": 2, "query": "How can advanced methodologies improve the accuracy of these assessments, especially in areas with multiple contamination sources like this region?", "history": ["What are the challenges in assessing heavy metal pollution in marine environments like the Bohai Sea?"], "ground_truth": ["permed-86368", "permed-81986", "permed-80986", "permed-77780", "permed-80991", "permed-66608", "permed-78243", "permed-77783", "permed-80983", "permed-77822"]}
{"query_id": "topic_693_turn_3", "conversation_id": "topic_693", "turn_id": 3, "query": "Given these challenges and advanced methods we've discussed, how could combining multi-proxy geochemical indicators with sophisticated statistical models enhance the accuracy and reliability of heavy metal pollution assessments in the Bohai Sea—especially given its complex depositional environment and multiple contamination sources?", "history": ["What are the challenges in assessing heavy metal pollution in marine environments like the Bohai Sea?", "How can advanced methodologies improve the accuracy of these assessments, especially in areas with multiple contamination sources like this region?"], "ground_truth": ["permed-80986", "permed-80987", "permed-80983", "permed-88881", "permed-78243", "permed-80984", "permed-77927", "permed-81010", "permed-88882", "permed-80041"]}
{"query_id": "topic_693_turn_4", "conversation_id": "topic_693", "turn_id": 4, "query": "Following this multi-proxy and statistical modeling approach, could you elaborate on the specific statistical validation protocols used to distinguish anthropogenic signals from natural background variability? I'm particularly interested in how principal component analysis and enrichment factor calculations were cross-validated against sediment core chronologies, and what quality control measures were implemented to ensure the reproducibility of these geochemical fingerprints across different sediment matrices in the Bohai Sea's complex depositional system.", "history": ["What are the challenges in assessing heavy metal pollution in marine environments like the Bohai Sea?", "How can advanced methodologies improve the accuracy of these assessments, especially in areas with multiple contamination sources like this region?", "Given these challenges and advanced methods we've discussed, how could combining multi-proxy geochemical indicators with sophisticated statistical models enhance the accuracy and reliability of heavy metal pollution assessments in the Bohai Sea—especially given its complex depositional environment and multiple contamination sources?"], "ground_truth": ["permed-80986", "permed-80987", "permed-77926", "permed-80984", "permed-76624", "permed-84234", "permed-88882", "permed-81986", "permed-83744", "permed-51798"]}
{"query_id": "topic_693_turn_5", "conversation_id": "topic_693", "turn_id": 5, "query": "Given these validated geochemical fingerprinting methods for identifying anthropogenic heavy metal pollution, how are these assessment protocols being translated into clinical practice for monitoring human exposure risks in Bohai Sea coastal populations? Specifically, what epidemiological evidence exists correlating sediment contamination levels with biomarkers of heavy metal exposure in vulnerable subgroups like fishermen or children, and what clinical surveillance strategies have proven effective for early detection of adverse health effects from chronic low-level exposure in these communities?", "history": ["What are the challenges in assessing heavy metal pollution in marine environments like the Bohai Sea?", "How can advanced methodologies improve the accuracy of these assessments, especially in areas with multiple contamination sources like this region?", "Given these challenges and advanced methods we've discussed, how could combining multi-proxy geochemical indicators with sophisticated statistical models enhance the accuracy and reliability of heavy metal pollution assessments in the Bohai Sea—especially given its complex depositional environment and multiple contamination sources?", "Following this multi-proxy and statistical modeling approach, could you elaborate on the specific statistical validation protocols used to distinguish anthropogenic signals from natural background variability? I'm particularly interested in how principal component analysis and enrichment factor calculations were cross-validated against sediment core chronologies, and what quality control measures were implemented to ensure the reproducibility of these geochemical fingerprints across different sediment matrices in the Bohai Sea's complex depositional system."], "ground_truth": ["permed-80986", "permed-80987", "permed-77928", "permed-80984", "permed-88882", "permed-77927", "permed-75638", "permed-80983", "permed-81010", "permed-80989"]}
{"query_id": "topic_694_turn_1", "conversation_id": "topic_694", "turn_id": 1, "query": "Influence of environmental variability on virus-immune system interactions", "history": [], "ground_truth": ["permed-68512", "permed-68513", "permed-70160", "permed-68415", "permed-64259", "permed-67573", "permed-59569", "permed-68153", "permed-83295", "permed-67812"]}
{"query_id": "topic_694_turn_2", "conversation_id": "topic_694", "turn_id": 2, "query": "Mechanisms by which this environmental variability drives new viral strain emergence within host-immune interactions", "history": ["Influence of environmental variability on virus-immune system interactions"], "ground_truth": ["permed-68513", "permed-68512", "permed-64259", "permed-70160", "permed-59569", "permed-68153", "permed-67573", "permed-91273", "permed-57909", "permed-71578"]}
{"query_id": "topic_694_turn_3", "conversation_id": "topic_694", "turn_id": 3, "query": "Impact of temporal environmental changes (e.g., resource availability, immune pressure) on emergence and stability of viral strains with complex epistatic interactions during virus-immune coevolution", "history": ["Influence of environmental variability on virus-immune system interactions", "Mechanisms by which this environmental variability drives new viral strain emergence within host-immune interactions"], "ground_truth": ["permed-64259", "permed-68513", "permed-78446", "permed-71578", "permed-68512", "permed-70160", "permed-57909", "permed-74047", "permed-61828", "permed-75904"]}
{"query_id": "topic_694_turn_4", "conversation_id": "topic_694", "turn_id": 4, "query": "Given this focus on temporal environmental changes driving viral strain emergence, what specific experimental designs would best capture epistatic interactions under fluctuating conditions? I'm particularly interested in how researchers quantify stability thresholds - do they use longitudinal deep sequencing with defined environmental oscillations, and what statistical models (like time-series Markov chains or fitness landscape mappings) effectively distinguish transient variants from stabilized strains in such dynamic coevolution systems?", "history": ["Influence of environmental variability on virus-immune system interactions", "Mechanisms by which this environmental variability drives new viral strain emergence within host-immune interactions", "Impact of temporal environmental changes (e.g., resource availability, immune pressure) on emergence and stability of viral strains with complex epistatic interactions during virus-immune coevolution"], "ground_truth": ["permed-64259", "permed-78446", "permed-57909", "permed-90185", "permed-74047", "permed-43875", "permed-60608", "permed-75903", "permed-85578", "permed-81822"]}
{"query_id": "topic_694_turn_5", "conversation_id": "topic_694", "turn_id": 5, "query": "Given these sophisticated experimental models for tracking viral strain evolution under fluctuating conditions, how have these insights translated to clinical management of chronic viral infections? Specifically, what evidence exists regarding treatment adaptation strategies that account for environmental variability-driven viral evolution in patients - for instance, how might antiretroviral therapy cycling or immune-modulating adjuvants be deployed to preempt stabilization of resistant strains, and what clinical trial data supports the efficacy and safety of such approaches in real-world patient populations with varying comorbidities?", "history": ["Influence of environmental variability on virus-immune system interactions", "Mechanisms by which this environmental variability drives new viral strain emergence within host-immune interactions", "Impact of temporal environmental changes (e.g., resource availability, immune pressure) on emergence and stability of viral strains with complex epistatic interactions during virus-immune coevolution", "Given this focus on temporal environmental changes driving viral strain emergence, what specific experimental designs would best capture epistatic interactions under fluctuating conditions? I'm particularly interested in how researchers quantify stability thresholds - do they use longitudinal deep sequencing with defined environmental oscillations, and what statistical models (like time-series Markov chains or fitness landscape mappings) effectively distinguish transient variants from stabilized strains in such dynamic coevolution systems?"], "ground_truth": ["permed-65409", "permed-22924", "permed-42901", "permed-82454", "permed-75903", "permed-77200", "permed-82457", "permed-5882", "permed-64259", "permed-57909"]}
{"query_id": "topic_695_turn_1", "conversation_id": "topic_695", "turn_id": 1, "query": "What's known about the connection between attention deficits and communication disorders?", "history": [], "ground_truth": ["permed-75017", "permed-69479", "permed-60971", "permed-69778", "permed-63273", "permed-30399", "permed-81464", "permed-58518", "permed-69485", "permed-69480"]}
{"query_id": "topic_695_turn_2", "conversation_id": "topic_695", "turn_id": 2, "query": "Does this relationship vary significantly across different age groups or individuals with distinct social interaction skills?", "history": ["What's known about the connection between attention deficits and communication disorders?"], "ground_truth": ["permed-74339", "permed-63272", "permed-69464", "permed-78385", "permed-69851", "permed-55698", "permed-55798", "permed-79267", "permed-55803", "permed-53872"]}
{"query_id": "topic_695_turn_3", "conversation_id": "topic_695", "turn_id": 3, "query": "How might the link between attention deficits and off-topic verbosity differ based on individuals' social interaction skills, and what would these variations mean for designing therapeutic approaches to communication disorders across different age groups?", "history": ["What's known about the connection between attention deficits and communication disorders?", "Does this relationship vary significantly across different age groups or individuals with distinct social interaction skills?"], "ground_truth": ["permed-69778", "permed-58515", "permed-75017", "permed-58518", "permed-55806", "permed-58558", "permed-53872", "permed-69478", "permed-75932", "permed-55798"]}
{"query_id": "topic_695_turn_4", "conversation_id": "topic_695", "turn_id": 4, "query": "Given this therapeutic design framework, what specific experimental protocols would best assess whether attention-focused interventions reduce off-topic verbosity in socially-impaired individuals? I'm particularly interested in the methodological details: how would you operationally define and measure verbosity shifts, what control conditions would validate the attention-verbosity causality, and what longitudinal measures would capture age-specific therapeutic durability across different social skill baselines?", "history": ["What's known about the connection between attention deficits and communication disorders?", "Does this relationship vary significantly across different age groups or individuals with distinct social interaction skills?", "How might the link between attention deficits and off-topic verbosity differ based on individuals' social interaction skills, and what would these variations mean for designing therapeutic approaches to communication disorders across different age groups?"], "ground_truth": ["permed-69778", "permed-58517", "permed-81464", "permed-53872", "permed-75932", "permed-55779", "permed-75017", "permed-58515", "permed-69919", "permed-69171"]}
{"query_id": "topic_695_turn_5", "conversation_id": "topic_695", "turn_id": 5, "query": "Given these methodological considerations for assessing attention-verbosity interventions, how would the therapeutic efficacy compare between attention-focused training and more traditional social skills coaching for reducing off-topic speech? Specifically, what are the relative advantages and limitations of each approach across different social skill baselines and age groups, and could a meta-analysis reveal whether one produces more durable improvements in communication coherence when controlling for initial attention deficit severity?", "history": ["What's known about the connection between attention deficits and communication disorders?", "Does this relationship vary significantly across different age groups or individuals with distinct social interaction skills?", "How might the link between attention deficits and off-topic verbosity differ based on individuals' social interaction skills, and what would these variations mean for designing therapeutic approaches to communication disorders across different age groups?", "Given this therapeutic design framework, what specific experimental protocols would best assess whether attention-focused interventions reduce off-topic verbosity in socially-impaired individuals? I'm particularly interested in the methodological details: how would you operationally define and measure verbosity shifts, what control conditions would validate the attention-verbosity causality, and what longitudinal measures would capture age-specific therapeutic durability across different social skill baselines?"], "ground_truth": ["permed-69778", "permed-69171", "permed-58515", "permed-90638", "permed-53872", "permed-62321", "permed-58518", "permed-90636", "permed-75017", "permed-81464"]}
{"query_id": "topic_696_turn_1", "conversation_id": "topic_696", "turn_id": 1, "query": "Impact of leadership styles on employee well-being and organizational performance", "history": [], "ground_truth": ["permed-65477", "permed-69922", "permed-69658", "permed-54013", "permed-65484", "permed-69510", "permed-65478", "permed-65482", "permed-70247", "permed-54010"]}
{"query_id": "topic_696_turn_2", "conversation_id": "topic_696", "turn_id": 2, "query": "How can integrating task-oriented and human-oriented leadership development programs enhance leader effectiveness in improving *these employee and organizational outcomes*?", "history": ["Impact of leadership styles on employee well-being and organizational performance"], "ground_truth": ["permed-65482", "permed-69658", "permed-58488", "permed-65484", "permed-65478", "permed-86840", "permed-51594", "permed-69510", "permed-69564", "permed-69922"]}
{"query_id": "topic_696_turn_3", "conversation_id": "topic_696", "turn_id": 3, "query": "Specific techniques for blending task-oriented and human-oriented leadership development to cultivate rational mastery, efficient coping, modesty, and good-heartedness, and methods for measuring *their combined effect* on leader effectiveness sustainability, leader and employee well-being, and overall organizational performance.", "history": ["Impact of leadership styles on employee well-being and organizational performance", "How can integrating task-oriented and human-oriented leadership development programs enhance leader effectiveness in improving *these employee and organizational outcomes*?"], "ground_truth": ["permed-65482", "permed-51969", "permed-65478", "permed-69510", "permed-65477", "permed-65484", "permed-69661", "permed-69922", "permed-69658", "permed-61865"]}
{"query_id": "topic_696_turn_4", "conversation_id": "topic_696", "turn_id": 4, "query": "Regarding these integrated leadership development techniques, what specific experimental designs would best establish causality between the intervention and sustained outcomes? Particularly, how should control groups be structured to account for organizational context variables, and what longitudinal measurement intervals would capture both immediate skill acquisition and long-term behavioral changes in leaders? Additionally, what statistical approaches would effectively model the mediation effects between leadership development, well-being metrics, and organizational performance indicators over time?", "history": ["Impact of leadership styles on employee well-being and organizational performance", "How can integrating task-oriented and human-oriented leadership development programs enhance leader effectiveness in improving *these employee and organizational outcomes*?", "Specific techniques for blending task-oriented and human-oriented leadership development to cultivate rational mastery, efficient coping, modesty, and good-heartedness, and methods for measuring *their combined effect* on leader effectiveness sustainability, leader and employee well-being, and overall organizational performance."], "ground_truth": ["permed-58488", "permed-86840", "permed-69510", "permed-69922", "permed-61865", "permed-69658", "permed-65477", "permed-58487", "permed-57576", "permed-51594"]}
{"query_id": "topic_696_turn_5", "conversation_id": "topic_696", "turn_id": 5, "query": "Given these experimental designs for establishing causality in leadership development, what clinical translation challenges might arise when implementing such interventions in healthcare settings? Specifically, how do variables like staff shift patterns, interdisciplinary team dynamics, and patient safety priorities affect the delivery and efficacy of integrated leadership training? What adaptations are needed to maintain therapeutic fidelity while addressing real-world clinical constraints, and how should we measure the subsequent impact on both healthcare worker well-being and patient care outcomes compared to organizational performance metrics in corporate environments?", "history": ["Impact of leadership styles on employee well-being and organizational performance", "How can integrating task-oriented and human-oriented leadership development programs enhance leader effectiveness in improving *these employee and organizational outcomes*?", "Specific techniques for blending task-oriented and human-oriented leadership development to cultivate rational mastery, efficient coping, modesty, and good-heartedness, and methods for measuring *their combined effect* on leader effectiveness sustainability, leader and employee well-being, and overall organizational performance.", "Regarding these integrated leadership development techniques, what specific experimental designs would best establish causality between the intervention and sustained outcomes? Particularly, how should control groups be structured to account for organizational context variables, and what longitudinal measurement intervals would capture both immediate skill acquisition and long-term behavioral changes in leaders? Additionally, what statistical approaches would effectively model the mediation effects between leadership development, well-being metrics, and organizational performance indicators over time?"], "ground_truth": ["permed-86840", "permed-71473", "permed-51594", "permed-70247", "permed-69511", "permed-51595", "permed-78656", "permed-69510", "permed-65484", "permed-85811"]}
{"query_id": "topic_697_turn_1", "conversation_id": "topic_697", "turn_id": 1, "query": "What is currently known about the causes and development of IgE-mediated food allergies in pediatric patients?", "history": [], "ground_truth": ["permed-64927", "permed-13675", "permed-13426", "permed-76246", "permed-37229", "permed-64925", "permed-53242", "permed-49693", "permed-90736", "permed-13552"]}
{"query_id": "topic_697_turn_2", "conversation_id": "topic_697", "turn_id": 2, "query": "How can understanding this complex condition inform more effective and personalized treatment approaches for children suffering from it?", "history": ["What is currently known about the causes and development of IgE-mediated food allergies in pediatric patients?"], "ground_truth": ["permed-45845", "permed-81885", "permed-66148", "permed-38782", "permed-35655", "permed-5007", "permed-40518", "permed-30067", "permed-71113", "permed-10180"]}
{"query_id": "topic_697_turn_3", "conversation_id": "topic_697", "turn_id": 3, "query": "Given what we know about the causes and clinical presentation of IgE-mediated food allergies in children, how can combining genetic, environmental, and immunological factors within these clinical phenotypes help us develop more personalized treatments and predict how these patients will fare long-term?", "history": ["What is currently known about the causes and development of IgE-mediated food allergies in pediatric patients?", "How can understanding this complex condition inform more effective and personalized treatment approaches for children suffering from it?"], "ground_truth": ["permed-64927", "permed-68034", "permed-90736", "permed-64925", "permed-76246", "permed-13675", "permed-49693", "permed-43568", "permed-13426", "permed-61041"]}
{"query_id": "topic_697_turn_4", "conversation_id": "topic_697", "turn_id": 4, "query": "Given this multi-factorial approach to predicting clinical outcomes, what specific statistical modeling techniques would be most appropriate for integrating these heterogeneous data types? I'm particularly interested in how we might validate a prediction model that combines genetic polymorphisms, environmental exposure histories, and serial immunological measurements - would a machine learning ensemble approach outperform traditional multivariate regression, and what cross-validation strategy would ensure its clinical generalizability across different pediatric populations?", "history": ["What is currently known about the causes and development of IgE-mediated food allergies in pediatric patients?", "How can understanding this complex condition inform more effective and personalized treatment approaches for children suffering from it?", "Given what we know about the causes and clinical presentation of IgE-mediated food allergies in children, how can combining genetic, environmental, and immunological factors within these clinical phenotypes help us develop more personalized treatments and predict how these patients will fare long-term?"], "ground_truth": ["permed-71547", "permed-21347", "permed-34458", "permed-59408", "permed-56983", "permed-87119", "permed-73630", "permed-77549", "permed-21346", "permed-58921"]}
{"query_id": "topic_697_turn_5", "conversation_id": "topic_697", "turn_id": 5, "query": "Given these sophisticated prediction models, what would be the practical clinical workflow for implementing such a tool in a pediatric allergy clinic? How should clinicians interpret and act upon a model's prediction of high-risk versus low-risk allergy persistence when making decisions about oral immunotherapy candidacy or dietary recommendations? What are the critical safety protocols needed when using predictive analytics to guide clinical management, and what evidence from real-world implementation studies demonstrates actual improvements in patient outcomes like reaction frequency or quality of life?", "history": ["What is currently known about the causes and development of IgE-mediated food allergies in pediatric patients?", "How can understanding this complex condition inform more effective and personalized treatment approaches for children suffering from it?", "Given what we know about the causes and clinical presentation of IgE-mediated food allergies in children, how can combining genetic, environmental, and immunological factors within these clinical phenotypes help us develop more personalized treatments and predict how these patients will fare long-term?", "Given this multi-factorial approach to predicting clinical outcomes, what specific statistical modeling techniques would be most appropriate for integrating these heterogeneous data types? I'm particularly interested in how we might validate a prediction model that combines genetic polymorphisms, environmental exposure histories, and serial immunological measurements - would a machine learning ensemble approach outperform traditional multivariate regression, and what cross-validation strategy would ensure its clinical generalizability across different pediatric populations?"], "ground_truth": ["permed-46069", "permed-68033", "permed-68030", "permed-59407", "permed-79850", "permed-76246", "permed-43568", "permed-20451", "permed-61540", "permed-88468"]}
{"query_id": "topic_698_turn_1", "conversation_id": "topic_698", "turn_id": 1, "query": "What common and emerging treatments for inflammatory acne show promise in recent medical research?", "history": [], "ground_truth": ["permed-12539", "permed-23056", "permed-76565", "permed-52624", "permed-68055", "permed-90163", "permed-77063", "permed-12640", "permed-13617", "permed-76561"]}
{"query_id": "topic_698_turn_2", "conversation_id": "topic_698", "turn_id": 2, "query": "Among these promising treatments, how do laser therapies like Nd:YAG compare in effectiveness to botulinum toxin injections for inflammatory acne?", "history": ["What common and emerging treatments for inflammatory acne show promise in recent medical research?"], "ground_truth": ["permed-52624", "permed-52623", "permed-40380", "permed-52002", "permed-76561", "permed-76564", "permed-13200", "permed-76521", "permed-52622", "permed-12879"]}
{"query_id": "topic_698_turn_3", "conversation_id": "topic_698", "turn_id": 3, "query": "Comparing long-pulsed Nd:YAG laser vs intralesional botulinum toxin type-A for inflammatory acne: what are the patient-reported outcomes (satisfaction, QoL) and factors influencing them short-term and long-term?", "history": ["What common and emerging treatments for inflammatory acne show promise in recent medical research?", "Among these promising treatments, how do laser therapies like Nd:YAG compare in effectiveness to botulinum toxin injections for inflammatory acne?"], "ground_truth": ["permed-52624", "permed-52623", "permed-76561", "permed-76517", "permed-76563", "permed-76564", "permed-76566", "permed-91307", "permed-91365", "permed-91381"]}
{"query_id": "topic_698_turn_4", "conversation_id": "topic_698", "turn_id": 4, "query": "Regarding your comparison of long-pulsed Nd:YAG laser versus intralesional botulinum toxin type-A, what specific methodological approaches were employed to collect and validate patient-reported outcomes? I'm particularly interested in the psychometric validation of satisfaction and QoL instruments used, the temporal intervals for outcome assessment in both short-term and long-term evaluations, and how potential recall bias was mitigated in these longitudinal self-report measures. Were there any standardization protocols implemented across treatment sites to ensure data comparability?", "history": ["What common and emerging treatments for inflammatory acne show promise in recent medical research?", "Among these promising treatments, how do laser therapies like Nd:YAG compare in effectiveness to botulinum toxin injections for inflammatory acne?", "Comparing long-pulsed Nd:YAG laser vs intralesional botulinum toxin type-A for inflammatory acne: what are the patient-reported outcomes (satisfaction, QoL) and factors influencing them short-term and long-term?"], "ground_truth": ["permed-52624", "permed-52623", "permed-45612", "permed-91981", "permed-91383", "permed-91387", "permed-36362", "permed-91307", "permed-45613", "permed-91388"]}
{"query_id": "topic_698_turn_5", "conversation_id": "topic_698", "turn_id": 5, "query": "Given your detailed methodological insights into patient-reported outcome validation, how do the comparative cost-effectiveness and accessibility profiles of these treatments influence clinical decision-making? Specifically, when weighing long-pulsed Nd:YAG laser against intralesional botulinum toxin for inflammatory acne management, what trade-offs emerge between treatment efficacy (based on the validated PRO data) and practical considerations like treatment duration, required sessions, operator expertise, and healthcare system resource allocation across different demographic or geographic settings?", "history": ["What common and emerging treatments for inflammatory acne show promise in recent medical research?", "Among these promising treatments, how do laser therapies like Nd:YAG compare in effectiveness to botulinum toxin injections for inflammatory acne?", "Comparing long-pulsed Nd:YAG laser vs intralesional botulinum toxin type-A for inflammatory acne: what are the patient-reported outcomes (satisfaction, QoL) and factors influencing them short-term and long-term?", "Regarding your comparison of long-pulsed Nd:YAG laser versus intralesional botulinum toxin type-A, what specific methodological approaches were employed to collect and validate patient-reported outcomes? I'm particularly interested in the psychometric validation of satisfaction and QoL instruments used, the temporal intervals for outcome assessment in both short-term and long-term evaluations, and how potential recall bias was mitigated in these longitudinal self-report measures. Were there any standardization protocols implemented across treatment sites to ensure data comparability?"], "ground_truth": ["permed-52624", "permed-52623", "permed-68823", "permed-76560", "permed-77063", "permed-91981", "permed-76566", "permed-76561", "permed-76521", "permed-68885"]}
{"query_id": "topic_699_turn_1", "conversation_id": "topic_699", "turn_id": 1, "query": "Prevalence and types of common nutritional deficiencies in children with celiac disease.", "history": [], "ground_truth": ["permed-62226", "permed-61462", "permed-81492", "permed-79437", "permed-77164", "permed-62215", "permed-61973", "permed-35321", "permed-61309", "permed-90748"]}
{"query_id": "topic_699_turn_2", "conversation_id": "topic_699", "turn_id": 2, "query": "Among these identified nutritional deficiencies in pediatric celiac disease, how does iron deficiency specifically impact their overall health and developmental outcomes?", "history": ["Prevalence and types of common nutritional deficiencies in children with celiac disease."], "ground_truth": ["permed-62226", "permed-49412", "permed-45121", "permed-61462", "permed-75621", "permed-65235", "permed-49691", "permed-35020", "permed-79437", "permed-45982"]}
{"query_id": "topic_699_turn_3", "conversation_id": "topic_699", "turn_id": 3, "query": "Considering these nutritional deficiencies and the specific impact of iron deficiency in pediatric celiac disease, what are the long-term gastroenterological and systemic health sequelae, and how does the timing of iron deficiency diagnosis (early vs. late) influence mucosal healing and resolution of gastrointestinal symptoms?", "history": ["Prevalence and types of common nutritional deficiencies in children with celiac disease.", "Among these identified nutritional deficiencies in pediatric celiac disease, how does iron deficiency specifically impact their overall health and developmental outcomes?"], "ground_truth": ["permed-62226", "permed-77164", "permed-61309", "permed-88140", "permed-61973", "permed-90748", "permed-75621", "permed-81492", "permed-61462", "permed-65235"]}
{"query_id": "topic_699_turn_4", "conversation_id": "topic_699", "turn_id": 4, "query": "When studying how the timing of iron deficiency diagnosis affects mucosal healing and symptom resolution in pediatric celiac disease, what specific biopsy protocols and histological scoring systems are researchers using to quantify intestinal recovery? Additionally, what statistical approaches—such as time-to-event analysis or longitudinal mixed models—are most appropriate for analyzing how early versus late diagnosis impacts these healing trajectories while accounting for confounding variables like dietary adherence and baseline inflammation severity?", "history": ["Prevalence and types of common nutritional deficiencies in children with celiac disease.", "Among these identified nutritional deficiencies in pediatric celiac disease, how does iron deficiency specifically impact their overall health and developmental outcomes?", "Considering these nutritional deficiencies and the specific impact of iron deficiency in pediatric celiac disease, what are the long-term gastroenterological and systemic health sequelae, and how does the timing of iron deficiency diagnosis (early vs. late) influence mucosal healing and resolution of gastrointestinal symptoms?"], "ground_truth": ["permed-77164", "permed-62226", "permed-90985", "permed-2434", "permed-24226", "permed-75621", "permed-21053", "permed-79437", "permed-81492", "permed-61309"]}
{"query_id": "topic_699_turn_5", "conversation_id": "topic_699", "turn_id": 5, "query": "Given these sophisticated methodologies for tracking mucosal healing, what clinical translation has occurred regarding iron deficiency timing's impact on actual patient outcomes? Specifically, how does early versus late iron deficiency correction in pediatric celiac disease influence real-world metrics like growth velocity normalization, reduction in fatigue-related quality of life scores, and hospitalization rates? Furthermore, what evidence exists from clinical practice regarding optimal iron supplementation protocols that balance efficacy with minimizing gastrointestinal side effects in this sensitive population, particularly when initiating a gluten-free diet concurrently?", "history": ["Prevalence and types of common nutritional deficiencies in children with celiac disease.", "Among these identified nutritional deficiencies in pediatric celiac disease, how does iron deficiency specifically impact their overall health and developmental outcomes?", "Considering these nutritional deficiencies and the specific impact of iron deficiency in pediatric celiac disease, what are the long-term gastroenterological and systemic health sequelae, and how does the timing of iron deficiency diagnosis (early vs. late) influence mucosal healing and resolution of gastrointestinal symptoms?", "When studying how the timing of iron deficiency diagnosis affects mucosal healing and symptom resolution in pediatric celiac disease, what specific biopsy protocols and histological scoring systems are researchers using to quantify intestinal recovery? Additionally, what statistical approaches—such as time-to-event analysis or longitudinal mixed models—are most appropriate for analyzing how early versus late diagnosis impacts these healing trajectories while accounting for confounding variables like dietary adherence and baseline inflammation severity?"], "ground_truth": ["permed-62226", "permed-77164", "permed-65235", "permed-88140", "permed-81492", "permed-75621", "permed-65232", "permed-86037", "permed-61309", "permed-79437"]}
{"query_id": "topic_700_turn_1", "conversation_id": "topic_700", "turn_id": 1, "query": "What is known about the anti-angiogenic effects of second-generation H1-antihistamines?", "history": [], "ground_truth": ["permed-80307", "permed-84535", "permed-78198", "permed-60863", "permed-91068", "permed-76243", "permed-81135", "permed-57307", "permed-16309", "permed-91069"]}
{"query_id": "topic_700_turn_2", "conversation_id": "topic_700", "turn_id": 2, "query": "Does rupatadine stand out in this area for its potential to inhibit angiogenesis, and if so, how does it achieve this effect?", "history": ["What is known about the anti-angiogenic effects of second-generation H1-antihistamines?"], "ground_truth": ["permed-80307", "permed-60863", "permed-69400", "permed-88435", "permed-13230", "permed-69163", "permed-56172", "permed-59553", "permed-87850", "permed-69164"]}
{"query_id": "topic_700_turn_3", "conversation_id": "topic_700", "turn_id": 3, "query": "Since rupatadine has shown anti-angiogenic effects in the CAM model, could you explain the molecular mechanisms behind this—particularly how its PAF receptor inhibition might influence downstream signaling pathways? Also, how do these mechanisms differ from other second-generation H1-antihistamines, and what might these differences mean for using rupatadine in conditions like cancer or retinal disorders where abnormal angiogenesis plays a role?", "history": ["What is known about the anti-angiogenic effects of second-generation H1-antihistamines?", "Does rupatadine stand out in this area for its potential to inhibit angiogenesis, and if so, how does it achieve this effect?"], "ground_truth": ["permed-80307", "permed-22977", "permed-60863", "permed-89342", "permed-59553", "permed-81036", "permed-74873", "permed-60879", "permed-69232", "permed-16309"]}
{"query_id": "topic_700_turn_4", "conversation_id": "topic_700", "turn_id": 4, "query": "Given rupatadine's demonstrated effects on downstream signaling pathways in the CAM model, what specific experimental protocols would you recommend for validating these molecular mechanisms in human endothelial cell cultures? I'm particularly interested in the technical implementation—should we prioritize Western blot analysis of VEGF/VEGFR2 pathways or phosphoprotein arrays for broader pathway screening? What statistical approaches would best quantify dose-dependent inhibition of tube formation, and how might we establish reproducibility across different endothelial cell types?", "history": ["What is known about the anti-angiogenic effects of second-generation H1-antihistamines?", "Does rupatadine stand out in this area for its potential to inhibit angiogenesis, and if so, how does it achieve this effect?", "Since rupatadine has shown anti-angiogenic effects in the CAM model, could you explain the molecular mechanisms behind this—particularly how its PAF receptor inhibition might influence downstream signaling pathways? Also, how do these mechanisms differ from other second-generation H1-antihistamines, and what might these differences mean for using rupatadine in conditions like cancer or retinal disorders where abnormal angiogenesis plays a role?"], "ground_truth": ["permed-80307", "permed-57387", "permed-57386", "permed-60863", "permed-48295", "permed-14859", "permed-11734", "permed-56289", "permed-57052", "permed-89342"]}
{"query_id": "topic_700_turn_5", "conversation_id": "topic_700", "turn_id": 5, "query": "Given the robust in vitro experimental framework we've established, what is the current clinical evidence for rupatadine's anti-angiogenic effects in human patients? Specifically, have any interventional studies or retrospective analyses reported on its efficacy in managing pathological angiogenesis in conditions like age-related macular degeneration or solid tumors, and what were the observed patient outcomes regarding disease progression? Furthermore, what safety profile and potential drug interactions should be carefully monitored when considering rupatadine repurposing for long-term anti-angiogenic therapy, especially given its dual receptor antagonism?", "history": ["What is known about the anti-angiogenic effects of second-generation H1-antihistamines?", "Does rupatadine stand out in this area for its potential to inhibit angiogenesis, and if so, how does it achieve this effect?", "Since rupatadine has shown anti-angiogenic effects in the CAM model, could you explain the molecular mechanisms behind this—particularly how its PAF receptor inhibition might influence downstream signaling pathways? Also, how do these mechanisms differ from other second-generation H1-antihistamines, and what might these differences mean for using rupatadine in conditions like cancer or retinal disorders where abnormal angiogenesis plays a role?", "Given rupatadine's demonstrated effects on downstream signaling pathways in the CAM model, what specific experimental protocols would you recommend for validating these molecular mechanisms in human endothelial cell cultures? I'm particularly interested in the technical implementation—should we prioritize Western blot analysis of VEGF/VEGFR2 pathways or phosphoprotein arrays for broader pathway screening? What statistical approaches would best quantify dose-dependent inhibition of tube formation, and how might we establish reproducibility across different endothelial cell types?"], "ground_truth": ["permed-80307", "permed-66760", "permed-57411", "permed-72083", "permed-56172", "permed-62416", "permed-60863", "permed-86167", "permed-16603", "permed-41695"]}
{"query_id": "topic_701_turn_1", "conversation_id": "topic_701", "turn_id": 1, "query": "What is known about the impact of microplastics on aquatic life, particularly fish?", "history": [], "ground_truth": ["permed-80543", "permed-82249", "permed-88874", "permed-80535", "permed-82252", "permed-74156", "permed-80542", "permed-64762", "permed-81776", "permed-72738"]}
{"query_id": "topic_701_turn_2", "conversation_id": "topic_701", "turn_id": 2, "query": "Does it include any information on how microplastics affect the immune system of fish over time?", "history": ["What is known about the impact of microplastics on aquatic life, particularly fish?"], "ground_truth": ["permed-82249", "permed-80543", "permed-88874", "permed-80542", "permed-82252", "permed-80535", "permed-85149", "permed-81776", "permed-82251", "permed-82048"]}
{"query_id": "topic_701_turn_3", "conversation_id": "topic_701", "turn_id": 3, "query": "Given these effects on fish immune systems, how does prolonged exposure to polyethylene microplastics specifically impact their adaptive immune response over time, and what does this mean for their ability to fight off other pathogens and environmental stressors?", "history": ["What is known about the impact of microplastics on aquatic life, particularly fish?", "Does it include any information on how microplastics affect the immune system of fish over time?"], "ground_truth": ["permed-82048", "permed-80543", "permed-82252", "permed-82249", "permed-81776", "permed-58229", "permed-82251", "permed-80542", "permed-60609", "permed-73959"]}
{"query_id": "topic_701_turn_4", "conversation_id": "topic_701", "turn_id": 4, "query": "Given this investigation into polyethylene microplastics and adaptive immunity, what specific experimental design and exposure protocols would you recommend for a long-term study? I'm particularly interested in the dosing regimen, the methods for tracking lymphocyte populations over time, and the statistical power considerations needed to detect subtle immunological changes against a background of natural variation in a fish population.", "history": ["What is known about the impact of microplastics on aquatic life, particularly fish?", "Does it include any information on how microplastics affect the immune system of fish over time?", "Given these effects on fish immune systems, how does prolonged exposure to polyethylene microplastics specifically impact their adaptive immune response over time, and what does this mean for their ability to fight off other pathogens and environmental stressors?"], "ground_truth": ["permed-82048", "permed-80543", "permed-82252", "permed-81776", "permed-82249", "permed-72738", "permed-73959", "permed-81130", "permed-72735", "permed-82049"]}
{"query_id": "topic_701_turn_5", "conversation_id": "topic_701", "turn_id": 5, "query": "Given your detailed experimental design for tracking polyethylene microplastic impacts, how would you compare its long-term immunological effects against those from other common polymer types like polypropylene or polystyrene? Specifically, in a comparative exposure study, what key immunological endpoints (beyond lymphocyte populations) would most effectively discriminate between polymer-specific toxicity profiles versus general microplastic-induced immunomodulation, and which statistical approaches are best suited for analyzing such multi-factorial, longitudinal data to reveal these comparative risks?", "history": ["What is known about the impact of microplastics on aquatic life, particularly fish?", "Does it include any information on how microplastics affect the immune system of fish over time?", "Given these effects on fish immune systems, how does prolonged exposure to polyethylene microplastics specifically impact their adaptive immune response over time, and what does this mean for their ability to fight off other pathogens and environmental stressors?", "Given this investigation into polyethylene microplastics and adaptive immunity, what specific experimental design and exposure protocols would you recommend for a long-term study? I'm particularly interested in the dosing regimen, the methods for tracking lymphocyte populations over time, and the statistical power considerations needed to detect subtle immunological changes against a background of natural variation in a fish population."], "ground_truth": ["permed-82251", "permed-82049", "permed-82048", "permed-80543", "permed-72735", "permed-81130", "permed-82252", "permed-82250", "permed-72740", "permed-85149"]}
{"query_id": "topic_702_turn_1", "conversation_id": "topic_702", "turn_id": 1, "query": "Role and effectiveness of weather index insurance for nomadic herders in Inner Mongolia", "history": [], "ground_truth": ["permed-73993", "permed-66153", "permed-55645", "permed-86097", "permed-58851", "permed-91516", "permed-75160", "permed-73392", "permed-92177", "permed-55107"]}
{"query_id": "topic_702_turn_2", "conversation_id": "topic_702", "turn_id": 2, "query": "Methods for integrating climate prediction models with pastoral traditional ecological knowledge (TEK) to improve this weather index insurance effectiveness for these herder communities", "history": ["Role and effectiveness of weather index insurance for nomadic herders in Inner Mongolia"], "ground_truth": ["permed-73993", "permed-87495", "permed-69934", "permed-62249", "permed-91814", "permed-66153", "permed-77746", "permed-63486", "permed-85929", "permed-83561"]}
{"query_id": "topic_702_turn_3", "conversation_id": "topic_702", "turn_id": 3, "query": "Assessing the impact of integrating advanced climate prediction models with pastoral TEK on weather index insurance payout accuracy and subsequent herder trust and participation in Inner Mongolia, considering technology access and climate literacy challenges", "history": ["Role and effectiveness of weather index insurance for nomadic herders in Inner Mongolia", "Methods for integrating climate prediction models with pastoral traditional ecological knowledge (TEK) to improve this weather index insurance effectiveness for these herder communities"], "ground_truth": ["permed-73993", "permed-87495", "permed-77746", "permed-73997", "permed-62249", "permed-85929", "permed-91814", "permed-63486", "permed-69934", "permed-62970"]}
{"query_id": "topic_702_turn_4", "conversation_id": "topic_702", "turn_id": 4, "query": "Given this integrated assessment approach, could you elaborate on the specific statistical methodologies used to quantify the marginal contribution of traditional ecological knowledge components versus climate model outputs to payout accuracy? I'm particularly interested in how you controlled for confounding variables like herd size differentials and pasture mobility patterns, and what validation strategies were employed to ensure these attribution models remained robust across different ecological zones within Inner Mongolia.", "history": ["Role and effectiveness of weather index insurance for nomadic herders in Inner Mongolia", "Methods for integrating climate prediction models with pastoral traditional ecological knowledge (TEK) to improve this weather index insurance effectiveness for these herder communities", "Assessing the impact of integrating advanced climate prediction models with pastoral TEK on weather index insurance payout accuracy and subsequent herder trust and participation in Inner Mongolia, considering technology access and climate literacy challenges"], "ground_truth": ["permed-89707", "permed-38321", "permed-73997", "permed-73993", "permed-87495", "permed-62249", "permed-73996", "permed-88395", "permed-69937", "permed-69934"]}
{"query_id": "topic_702_turn_5", "conversation_id": "topic_702", "turn_id": 5, "query": "Given your detailed statistical attribution of TEK versus climate model components, how have these integrated risk assessments translated into actual clinical health outcomes for nomadic herders? Specifically, what evidence exists regarding reduced stress-related morbidity, nutritional status improvements, or mental health benefits following more accurate insurance payouts? Have any studies measured changes in healthcare utilization patterns or physiological stress biomarkers before and after implementing these refined insurance schemes, particularly considering how financial stability might mediate health impacts across different age groups and socioeconomic strata within these pastoral communities?", "history": ["Role and effectiveness of weather index insurance for nomadic herders in Inner Mongolia", "Methods for integrating climate prediction models with pastoral traditional ecological knowledge (TEK) to improve this weather index insurance effectiveness for these herder communities", "Assessing the impact of integrating advanced climate prediction models with pastoral TEK on weather index insurance payout accuracy and subsequent herder trust and participation in Inner Mongolia, considering technology access and climate literacy challenges", "Given this integrated assessment approach, could you elaborate on the specific statistical methodologies used to quantify the marginal contribution of traditional ecological knowledge components versus climate model outputs to payout accuracy? I'm particularly interested in how you controlled for confounding variables like herd size differentials and pasture mobility patterns, and what validation strategies were employed to ensure these attribution models remained robust across different ecological zones within Inner Mongolia."], "ground_truth": ["permed-73993", "permed-63108", "permed-91447", "permed-80114", "permed-80266", "permed-57720", "permed-55106", "permed-80106", "permed-87456", "permed-65657"]}
{"query_id": "topic_703_turn_1", "conversation_id": "topic_703", "turn_id": 1, "query": "Role of Malassezia yeast in the pathogenesis of seborrheic dermatitis", "history": [], "ground_truth": ["permed-77100", "permed-88635", "permed-77102", "permed-68414", "permed-89441", "permed-68063", "permed-89680", "permed-12636", "permed-90165", "permed-89681"]}
{"query_id": "topic_703_turn_2", "conversation_id": "topic_703", "turn_id": 2, "query": "Mechanisms of immune response to this Malassezia colonization in seborrheic dermatitis, focusing on T-cell activation and associated cytokine signaling", "history": ["Role of Malassezia yeast in the pathogenesis of seborrheic dermatitis"], "ground_truth": ["permed-77100", "permed-77102", "permed-88635", "permed-68414", "permed-68252", "permed-68063", "permed-67110", "permed-89681", "permed-68180", "permed-12522"]}
{"query_id": "topic_703_turn_3", "conversation_id": "topic_703", "turn_id": 3, "query": "Developing novel seborrheic dermatitis treatments by targeting these specific Malassezia-induced immune pathways: T-cell activity modulation and complement system interference", "history": ["Role of Malassezia yeast in the pathogenesis of seborrheic dermatitis", "Mechanisms of immune response to this Malassezia colonization in seborrheic dermatitis, focusing on T-cell activation and associated cytokine signaling"], "ground_truth": ["permed-77100", "permed-88635", "permed-77102", "permed-68414", "permed-89681", "permed-88637", "permed-68063", "permed-53289", "permed-61481", "permed-68180"]}
{"query_id": "topic_703_turn_4", "conversation_id": "topic_703", "turn_id": 4, "query": "For these targeted therapeutic approaches, what specific in vitro assays would you recommend to quantify T-cell modulation efficiency? Particularly, how should we standardize the measurement of cytokine secretion profiles (e.g., IL-17, IL-22) from co-cultures of patient T-cells with Malassezia antigens? Furthermore, what would be an appropriate positive control for assessing complement system interference, and which key complement activation markers should be prioritized for flow cytometric analysis to ensure robust and reproducible data across different patient-derived samples?", "history": ["Role of Malassezia yeast in the pathogenesis of seborrheic dermatitis", "Mechanisms of immune response to this Malassezia colonization in seborrheic dermatitis, focusing on T-cell activation and associated cytokine signaling", "Developing novel seborrheic dermatitis treatments by targeting these specific Malassezia-induced immune pathways: T-cell activity modulation and complement system interference"], "ground_truth": ["permed-67915", "permed-65333", "permed-68154", "permed-82133", "permed-68046", "permed-49356", "permed-22339", "permed-35689", "permed-53180", "permed-70749"]}
{"query_id": "topic_703_turn_5", "conversation_id": "topic_703", "turn_id": 5, "query": "Given the detailed in vitro assay standardization for individual immune pathways discussed, how would you systematically compare the relative therapeutic potential of T-cell modulation versus complement system interference approaches for seborrheic dermatitis? Specifically, what key efficacy metrics (e.g., pathogen clearance, inflammation reduction, skin barrier repair) and practical considerations (e.g., onset of action, safety profile, suitability for different patient subtypes) should be prioritized in a head-to-head preclinical comparison to determine which strategy warrants further clinical development?", "history": ["Role of Malassezia yeast in the pathogenesis of seborrheic dermatitis", "Mechanisms of immune response to this Malassezia colonization in seborrheic dermatitis, focusing on T-cell activation and associated cytokine signaling", "Developing novel seborrheic dermatitis treatments by targeting these specific Malassezia-induced immune pathways: T-cell activity modulation and complement system interference", "For these targeted therapeutic approaches, what specific in vitro assays would you recommend to quantify T-cell modulation efficiency? Particularly, how should we standardize the measurement of cytokine secretion profiles (e.g., IL-17, IL-22) from co-cultures of patient T-cells with Malassezia antigens? Furthermore, what would be an appropriate positive control for assessing complement system interference, and which key complement activation markers should be prioritized for flow cytometric analysis to ensure robust and reproducible data across different patient-derived samples?"], "ground_truth": ["permed-77100", "permed-83419", "permed-68054", "permed-53289", "permed-67110", "permed-23056", "permed-13617", "permed-54184", "permed-82498", "permed-61561"]}
{"query_id": "topic_704_turn_1", "conversation_id": "topic_704", "turn_id": 1, "query": "What role does the angiotensin II type 1 receptor play in vascular health during aging?", "history": [], "ground_truth": ["permed-58361", "permed-54234", "permed-86810", "permed-84815", "permed-70497", "permed-81817", "permed-72166", "permed-78846", "permed-86346", "permed-58723"]}
{"query_id": "topic_704_turn_2", "conversation_id": "topic_704", "turn_id": 2, "query": "How are changes in this receptor's activity linked to age-related declines in arterial function, specifically myogenic tone?", "history": ["What role does the angiotensin II type 1 receptor play in vascular health during aging?"], "ground_truth": ["permed-58361", "permed-54234", "permed-81817", "permed-72166", "permed-86810", "permed-82114", "permed-54325", "permed-54283", "permed-81818", "permed-74558"]}
{"query_id": "topic_704_turn_3", "conversation_id": "topic_704", "turn_id": 3, "query": "Given these links between AT1R activity and declining myogenic tone with age, could you explain the specific molecular pathways altered in mechano-activated AT1Rs during aging and how they contribute to this functional decline? Also, would targeting these pathways help mitigate cardiovascular dysfunction and promote healthier vascular aging?", "history": ["What role does the angiotensin II type 1 receptor play in vascular health during aging?", "How are changes in this receptor's activity linked to age-related declines in arterial function, specifically myogenic tone?"], "ground_truth": ["permed-58361", "permed-54234", "permed-54325", "permed-54283", "permed-27377", "permed-81817", "permed-5973", "permed-57053", "permed-74558", "permed-70498"]}
{"query_id": "topic_704_turn_4", "conversation_id": "topic_704", "turn_id": 4, "query": "How would you experimentally validate these proposed molecular pathways in aged vascular tissue? Specifically, what techniques would be optimal for measuring mechano-activated AT1R signaling dynamics in aged versus young arteries, and what statistical approaches would account for inter-individual variability in aging models while ensuring reproducibility across different vascular beds?", "history": ["What role does the angiotensin II type 1 receptor play in vascular health during aging?", "How are changes in this receptor's activity linked to age-related declines in arterial function, specifically myogenic tone?", "Given these links between AT1R activity and declining myogenic tone with age, could you explain the specific molecular pathways altered in mechano-activated AT1Rs during aging and how they contribute to this functional decline? Also, would targeting these pathways help mitigate cardiovascular dysfunction and promote healthier vascular aging?"], "ground_truth": ["permed-58361", "permed-54234", "permed-81817", "permed-57053", "permed-72166", "permed-27377", "permed-54283", "permed-77356", "permed-33155", "permed-33439"]}
{"query_id": "topic_704_turn_5", "conversation_id": "topic_704", "turn_id": 5, "query": "Given these validated molecular pathways in aged vascular tissue, what clinical evidence exists regarding AT1R blocker efficacy in improving vascular outcomes in elderly populations? Specifically, how do ARBs like losartan perform in real-world settings for mitigating age-related arterial stiffness beyond hypertension control, and what safety considerations emerge regarding hypotension risks, renal function changes, or drug interactions when administered to frail elderly patients with multimorbidity? Are there clinical trial data showing differential effects across vascular beds that might inform targeted therapeutic strategies?", "history": ["What role does the angiotensin II type 1 receptor play in vascular health during aging?", "How are changes in this receptor's activity linked to age-related declines in arterial function, specifically myogenic tone?", "Given these links between AT1R activity and declining myogenic tone with age, could you explain the specific molecular pathways altered in mechano-activated AT1Rs during aging and how they contribute to this functional decline? Also, would targeting these pathways help mitigate cardiovascular dysfunction and promote healthier vascular aging?", "How would you experimentally validate these proposed molecular pathways in aged vascular tissue? Specifically, what techniques would be optimal for measuring mechano-activated AT1R signaling dynamics in aged versus young arteries, and what statistical approaches would account for inter-individual variability in aging models while ensuring reproducibility across different vascular beds?"], "ground_truth": ["permed-58361", "permed-23377", "permed-86810", "permed-57481", "permed-64797", "permed-54234", "permed-76297", "permed-11680", "permed-11958", "permed-81817"]}
{"query_id": "topic_705_turn_1", "conversation_id": "topic_705", "turn_id": 1, "query": "Recent advancements in surgical techniques for pancreatic cancer of the neck and body", "history": [], "ground_truth": ["permed-56308", "permed-2980", "permed-1665", "permed-20929", "permed-16696", "permed-0906", "permed-0898", "permed-85506", "permed-2632", "permed-56525"]}
{"query_id": "topic_705_turn_2", "conversation_id": "topic_705", "turn_id": 2, "query": "Impact of newer such surgical techniques like laparoscopic surgery with neoadjuvant therapy on patient outcomes in these pancreatic neck and body cancers", "history": ["Recent advancements in surgical techniques for pancreatic cancer of the neck and body"], "ground_truth": ["permed-56308", "permed-2980", "permed-1665", "permed-56300", "permed-56600", "permed-0906", "permed-0898", "permed-68318", "permed-2632", "permed-76111"]}
{"query_id": "topic_705_turn_3", "conversation_id": "topic_705", "turn_id": 3, "query": "For these laparoscopic approaches with neoadjuvant therapy in pancreatic neck-body cancer, what are the long-term survival, quality of life, and predictive intraoperative factors for Radical Antegrade Modular Pancreatectomy (RAMPS) with spleen removal via dorsal-caudal artery approach, and implications for surgical decision-making?", "history": ["Recent advancements in surgical techniques for pancreatic cancer of the neck and body", "Impact of newer such surgical techniques like laparoscopic surgery with neoadjuvant therapy on patient outcomes in these pancreatic neck and body cancers"], "ground_truth": ["permed-56308", "permed-56600", "permed-56296", "permed-56293", "permed-68318", "permed-76115", "permed-1666", "permed-56301", "permed-56299", "permed-91757"]}
{"query_id": "topic_705_turn_4", "conversation_id": "topic_705", "turn_id": 4, "query": "Regarding the described RAMPS procedure with spleen removal, what specific intraoperative protocols were implemented to ensure complete mesopancreas excision? How did the surgical team validate resection margins intraoperatively, and what histological techniques were used to confirm R0 status? Were there standardized criteria for identifying the dorsal-caudal artery approach, and how was vascular preservation quantified during these procedures? Additionally, what statistical methods were employed to analyze the relationship between these technical execution factors and long-term survival outcomes?", "history": ["Recent advancements in surgical techniques for pancreatic cancer of the neck and body", "Impact of newer such surgical techniques like laparoscopic surgery with neoadjuvant therapy on patient outcomes in these pancreatic neck and body cancers", "For these laparoscopic approaches with neoadjuvant therapy in pancreatic neck-body cancer, what are the long-term survival, quality of life, and predictive intraoperative factors for Radical Antegrade Modular Pancreatectomy (RAMPS) with spleen removal via dorsal-caudal artery approach, and implications for surgical decision-making?"], "ground_truth": ["permed-56308", "permed-2934", "permed-2933", "permed-76114", "permed-56296", "permed-1903", "permed-2919", "permed-30764", "permed-17252", "permed-4468"]}
{"query_id": "topic_705_turn_5", "conversation_id": "topic_705", "turn_id": 5, "query": "Given the detailed intraoperative protocols for margin validation and mesopancreas excision discussed, how do these technical execution standards translate to tangible clinical outcomes for patients? Specifically, what were the observed rates of delayed gastric emptying, pancreatic fistulas, and other postoperative complications in cohorts undergoing this RAMPS approach? Furthermore, how did these complication profiles compare with conventional pancreaticoduodenectomy patients, and what was the associated impact on hospital stay duration and readmission rates? Were specific complication patterns correlated with particular technical aspects of the dorsal-caudal artery approach?", "history": ["Recent advancements in surgical techniques for pancreatic cancer of the neck and body", "Impact of newer such surgical techniques like laparoscopic surgery with neoadjuvant therapy on patient outcomes in these pancreatic neck and body cancers", "For these laparoscopic approaches with neoadjuvant therapy in pancreatic neck-body cancer, what are the long-term survival, quality of life, and predictive intraoperative factors for Radical Antegrade Modular Pancreatectomy (RAMPS) with spleen removal via dorsal-caudal artery approach, and implications for surgical decision-making?", "Regarding the described RAMPS procedure with spleen removal, what specific intraoperative protocols were implemented to ensure complete mesopancreas excision? How did the surgical team validate resection margins intraoperatively, and what histological techniques were used to confirm R0 status? Were there standardized criteria for identifying the dorsal-caudal artery approach, and how was vascular preservation quantified during these procedures? Additionally, what statistical methods were employed to analyze the relationship between these technical execution factors and long-term survival outcomes?"], "ground_truth": ["permed-30764", "permed-56308", "permed-70525", "permed-32860", "permed-17415", "permed-1684", "permed-90698", "permed-90695", "permed-3503", "permed-56296"]}
{"query_id": "topic_706_turn_1", "conversation_id": "topic_706", "turn_id": 1, "query": "What is known about the impact of BPA exposure on gene expression and epigenetic regulation in relation to obesity and appetite control?", "history": [], "ground_truth": ["permed-53537", "permed-50777", "permed-78353", "permed-67390", "permed-81227", "permed-67392", "permed-90762", "permed-81928", "permed-70718", "permed-81903"]}
{"query_id": "topic_706_turn_2", "conversation_id": "topic_706", "turn_id": 2, "query": "How do specific genes, such as Fto, interact with other regulatory elements in this context, and what are the implications for neural circuit development?", "history": ["What is known about the impact of BPA exposure on gene expression and epigenetic regulation in relation to obesity and appetite control?"], "ground_truth": ["permed-64137", "permed-53649", "permed-85140", "permed-58530", "permed-79360", "permed-58525", "permed-76687", "permed-83935", "permed-92574", "permed-53730"]}
{"query_id": "topic_706_turn_3", "conversation_id": "topic_706", "turn_id": 3, "query": "Given the interactions between Fto and other regulatory elements we've discussed, could you explain the molecular mechanisms behind how BPA-induced epigenetic changes alter Fto's relationship with genes like Irx3 and Irx5? And how do these altered interactions ultimately affect the development and function of appetite-regulating neural circuits across generations?", "history": ["What is known about the impact of BPA exposure on gene expression and epigenetic regulation in relation to obesity and appetite control?", "How do specific genes, such as Fto, interact with other regulatory elements in this context, and what are the implications for neural circuit development?"], "ground_truth": ["permed-53537", "permed-67392", "permed-84906", "permed-58866", "permed-65374", "permed-69269", "permed-80742", "permed-81227", "permed-22761", "permed-67396"]}
{"query_id": "topic_706_turn_4", "conversation_id": "topic_706", "turn_id": 4, "query": "Given these described epigenetic mechanisms, what specific chromatin immunoprecipitation protocols and sequencing parameters would you recommend for mapping the dynamic interactions between Fto and the Irx3/Irx5 loci across different neural cell types? I'm particularly interested in the statistical thresholds for calling significant chromatin conformation changes, the normalization methods for cross-generational comparison of Hi-C data, and how you would validate these long-range interactions through CRISPR-based perturbation assays while controlling for BPA's potential off-target effects on chromatin architecture.", "history": ["What is known about the impact of BPA exposure on gene expression and epigenetic regulation in relation to obesity and appetite control?", "How do specific genes, such as Fto, interact with other regulatory elements in this context, and what are the implications for neural circuit development?", "Given the interactions between Fto and other regulatory elements we've discussed, could you explain the molecular mechanisms behind how BPA-induced epigenetic changes alter Fto's relationship with genes like Irx3 and Irx5? And how do these altered interactions ultimately affect the development and function of appetite-regulating neural circuits across generations?"], "ground_truth": ["permed-91625", "permed-53537", "permed-70012", "permed-58222", "permed-67504", "permed-91620", "permed-91624", "permed-71110", "permed-53642", "permed-90599"]}
{"query_id": "topic_706_turn_5", "conversation_id": "topic_706", "turn_id": 5, "query": "Given your detailed Hi-C and CRISPR validation framework, how would you compare the relative advantages and limitations of using targeted capture-based Hi-C versus all-by-all Hi-C for detecting these BPA-induced chromatin conformation changes involving Fto and Irx3/Irx5? Specifically, considering the trade-offs between resolution, coverage, and cost when studying rare neural cell populations across generations, which approach would provide more statistically robust detection of significant long-range interaction changes while maintaining sufficient power to control for potential BPA-induced global chromatin architecture alterations?", "history": ["What is known about the impact of BPA exposure on gene expression and epigenetic regulation in relation to obesity and appetite control?", "How do specific genes, such as Fto, interact with other regulatory elements in this context, and what are the implications for neural circuit development?", "Given the interactions between Fto and other regulatory elements we've discussed, could you explain the molecular mechanisms behind how BPA-induced epigenetic changes alter Fto's relationship with genes like Irx3 and Irx5? And how do these altered interactions ultimately affect the development and function of appetite-regulating neural circuits across generations?", "Given these described epigenetic mechanisms, what specific chromatin immunoprecipitation protocols and sequencing parameters would you recommend for mapping the dynamic interactions between Fto and the Irx3/Irx5 loci across different neural cell types? I'm particularly interested in the statistical thresholds for calling significant chromatin conformation changes, the normalization methods for cross-generational comparison of Hi-C data, and how you would validate these long-range interactions through CRISPR-based perturbation assays while controlling for BPA's potential off-target effects on chromatin architecture."], "ground_truth": ["permed-70012", "permed-91623", "permed-91620", "permed-91622", "permed-91619", "permed-91624", "permed-57633", "permed-91625", "permed-67504", "permed-58222"]}
{"query_id": "topic_707_turn_1", "conversation_id": "topic_707", "turn_id": 1, "query": "Mechanisms of viral infection altering extracellular vesicle characteristics and their immunomodulatory functions", "history": [], "ground_truth": ["permed-64475", "permed-62552", "permed-72255", "permed-77002", "permed-64473", "permed-67844", "permed-64470", "permed-64479", "permed-23352", "permed-39125"]}
{"query_id": "topic_707_turn_2", "conversation_id": "topic_707", "turn_id": 2, "query": "Comparative effects of different viral inactivation techniques on *these altered extracellular vesicles* from SARS-CoV-2: assessing changes in their composition and immunogenicity", "history": ["Mechanisms of viral infection altering extracellular vesicle characteristics and their immunomodulatory functions"], "ground_truth": ["permed-77002", "permed-62552", "permed-68513", "permed-79110", "permed-68268", "permed-68512", "permed-53440", "permed-77003", "permed-59634", "permed-77199"]}
{"query_id": "topic_707_turn_3", "conversation_id": "topic_707", "turn_id": 3, "query": "Detailed proteomic and microRNA profiling of SARS-CoV-2 extracellular vesicles following *these inactivation methods*: consequences of *such molecular shifts* for host cell signaling and immune response pathways", "history": ["Mechanisms of viral infection altering extracellular vesicle characteristics and their immunomodulatory functions", "Comparative effects of different viral inactivation techniques on *these altered extracellular vesicles* from SARS-CoV-2: assessing changes in their composition and immunogenicity"], "ground_truth": ["permed-77002", "permed-62552", "permed-59634", "permed-62513", "permed-62512", "permed-53440", "permed-85055", "permed-79110", "permed-69959", "permed-68513"]}
{"query_id": "topic_707_turn_4", "conversation_id": "topic_707", "turn_id": 4, "query": "When implementing these proteomic and miRNA profiling approaches, what specific statistical methods did you employ to validate the significance of molecular shifts between inactivation groups? I'm particularly interested in how you controlled for multiple comparisons in your pathway analysis, whether you used supervised or unsupervised clustering for pattern recognition, and what normalization strategies were applied to account for technical variability across EV preparations while maintaining biological relevance.", "history": ["Mechanisms of viral infection altering extracellular vesicle characteristics and their immunomodulatory functions", "Comparative effects of different viral inactivation techniques on *these altered extracellular vesicles* from SARS-CoV-2: assessing changes in their composition and immunogenicity", "Detailed proteomic and microRNA profiling of SARS-CoV-2 extracellular vesicles following *these inactivation methods*: consequences of *such molecular shifts* for host cell signaling and immune response pathways"], "ground_truth": ["permed-53960", "permed-71767", "permed-64494", "permed-76032", "permed-84812", "permed-68154", "permed-58244", "permed-71768", "permed-57647", "permed-89213"]}
{"query_id": "topic_707_turn_5", "conversation_id": "topic_707", "turn_id": 5, "query": "Given your detailed statistical validation of molecular shifts between inactivation methods, how do the immunomodulatory properties of these differentially processed SARS-CoV-2 extracellular vesicles compare when tested in primary human immune cell assays? Specifically, what were the relative differences in pro-inflammatory cytokine induction (e.g., IL-6, TNF-α) versus immunosuppressive effects across inactivation techniques, and did the magnitude of proteomic/miRNA changes you identified correlate with functional immune outcomes in dendritic cells versus macrophages?", "history": ["Mechanisms of viral infection altering extracellular vesicle characteristics and their immunomodulatory functions", "Comparative effects of different viral inactivation techniques on *these altered extracellular vesicles* from SARS-CoV-2: assessing changes in their composition and immunogenicity", "Detailed proteomic and microRNA profiling of SARS-CoV-2 extracellular vesicles following *these inactivation methods*: consequences of *such molecular shifts* for host cell signaling and immune response pathways", "When implementing these proteomic and miRNA profiling approaches, what specific statistical methods did you employ to validate the significance of molecular shifts between inactivation groups? I'm particularly interested in how you controlled for multiple comparisons in your pathway analysis, whether you used supervised or unsupervised clustering for pattern recognition, and what normalization strategies were applied to account for technical variability across EV preparations while maintaining biological relevance."], "ground_truth": ["permed-77002", "permed-79110", "permed-92618", "permed-62552", "permed-62513", "permed-64682", "permed-72255", "permed-68311", "permed-68268", "permed-59634"]}
{"query_id": "topic_708_turn_1", "conversation_id": "topic_708", "turn_id": 1, "query": "What role do corrole complexes play in photochemical applications and catalysis?", "history": [], "ground_truth": ["permed-79679", "permed-52513", "permed-51020", "permed-79680", "permed-57991", "permed-67590", "permed-57983", "permed-73324", "permed-52683", "permed-75823"]}
{"query_id": "topic_708_turn_2", "conversation_id": "topic_708", "turn_id": 2, "query": "How does modifying the core structure of these complexes, such as through axial ligands or substituents, impact their photophysical properties?", "history": ["What role do corrole complexes play in photochemical applications and catalysis?"], "ground_truth": ["permed-78035", "permed-78876", "permed-67592", "permed-51020", "permed-74520", "permed-75411", "permed-84013", "permed-57983", "permed-86655", "permed-86663"]}
{"query_id": "topic_708_turn_3", "conversation_id": "topic_708", "turn_id": 3, "query": "How do changes in the electronic environment of the corrole core—through different axial ligands and nitrophenyl substituent positioning—affect charge transfer interactions, and how does this subsequently influence the photophysical properties and redox behavior of cobalt corrole complexes? More specifically, how could these modifications guide the design of new materials for photochemical sensing and catalytic applications?", "history": ["What role do corrole complexes play in photochemical applications and catalysis?", "How does modifying the core structure of these complexes, such as through axial ligands or substituents, impact their photophysical properties?"], "ground_truth": ["permed-79679", "permed-79680", "permed-52513", "permed-57983", "permed-75453", "permed-73324", "permed-60323", "permed-52519", "permed-75823", "permed-82641"]}
{"query_id": "topic_708_turn_4", "conversation_id": "topic_708", "turn_id": 4, "query": "Given the complex interplay between axial ligands and nitrophenyl positioning in cobalt corroles, what specific spectroscopic or computational methods would you recommend for precisely quantifying these charge transfer interactions? I'm particularly interested in how transient absorption spectroscopy parameters should be optimized to capture the dynamics of these systems, and whether certain DFT functionals have proven more reliable than others for predicting the redox behavior correlations observed experimentally. What methodological validations would ensure these measurements accurately reflect the structure-property relationships guiding material design?", "history": ["What role do corrole complexes play in photochemical applications and catalysis?", "How does modifying the core structure of these complexes, such as through axial ligands or substituents, impact their photophysical properties?", "How do changes in the electronic environment of the corrole core—through different axial ligands and nitrophenyl substituent positioning—affect charge transfer interactions, and how does this subsequently influence the photophysical properties and redox behavior of cobalt corrole complexes? More specifically, how could these modifications guide the design of new materials for photochemical sensing and catalytic applications?"], "ground_truth": ["permed-79679", "permed-79680", "permed-52513", "permed-72931", "permed-87244", "permed-73055", "permed-78767", "permed-53089", "permed-73324", "permed-39391"]}
{"query_id": "topic_708_turn_5", "conversation_id": "topic_708", "turn_id": 5, "query": "Given these sophisticated spectroscopic and computational methods for characterizing charge transfer interactions in cobalt corroles, how have these structure-property relationships translated into clinical applications? Specifically, what evidence exists from in vivo studies or clinical trials regarding the therapeutic efficacy and safety profile of corrole-based agents in photodynamic therapy? I'm particularly interested in how the redox behavior and photophysical properties we've discussed correlate with observed tumor selectivity, normal tissue toxicity, and overall patient outcomes in oncological treatments.", "history": ["What role do corrole complexes play in photochemical applications and catalysis?", "How does modifying the core structure of these complexes, such as through axial ligands or substituents, impact their photophysical properties?", "How do changes in the electronic environment of the corrole core—through different axial ligands and nitrophenyl substituent positioning—affect charge transfer interactions, and how does this subsequently influence the photophysical properties and redox behavior of cobalt corrole complexes? More specifically, how could these modifications guide the design of new materials for photochemical sensing and catalytic applications?", "Given the complex interplay between axial ligands and nitrophenyl positioning in cobalt corroles, what specific spectroscopic or computational methods would you recommend for precisely quantifying these charge transfer interactions? I'm particularly interested in how transient absorption spectroscopy parameters should be optimized to capture the dynamics of these systems, and whether certain DFT functionals have proven more reliable than others for predicting the redox behavior correlations observed experimentally. What methodological validations would ensure these measurements accurately reflect the structure-property relationships guiding material design?"], "ground_truth": ["permed-79679", "permed-80455", "permed-75007", "permed-87637", "permed-86714", "permed-55273", "permed-80456", "permed-79680", "permed-80457", "permed-52833"]}
{"query_id": "topic_709_turn_1", "conversation_id": "topic_709", "turn_id": 1, "query": "Zinc catalysis in CO2 fixation and polymer degradation: fundamental mechanisms and scope", "history": [], "ground_truth": ["permed-74922", "permed-74923", "permed-73223", "permed-60900", "permed-57991", "permed-58015", "permed-88509", "permed-88221", "permed-75589", "permed-67585"]}
{"query_id": "topic_709_turn_2", "conversation_id": "topic_709", "turn_id": 2, "query": "Evaluating specific zinc complexes for enhanced catalytic efficiency in these CO2 fixation and polymer degradation reactions", "history": ["Zinc catalysis in CO2 fixation and polymer degradation: fundamental mechanisms and scope"], "ground_truth": ["permed-74923", "permed-60900", "permed-74922", "permed-73223", "permed-75589", "permed-88509", "permed-52518", "permed-59174", "permed-78757", "permed-60901"]}
{"query_id": "topic_709_turn_3", "conversation_id": "topic_709", "turn_id": 3, "query": "Mechanistic insights and rational design of dinuclear β-diketiminato zinc catalysts for dual CO2 fixation and polycarbonate depolymerization towards sustainable chemistry", "history": ["Zinc catalysis in CO2 fixation and polymer degradation: fundamental mechanisms and scope", "Evaluating specific zinc complexes for enhanced catalytic efficiency in these CO2 fixation and polymer degradation reactions"], "ground_truth": ["permed-74922", "permed-74923", "permed-73223", "permed-57997", "permed-88221", "permed-88509", "permed-74853", "permed-75589", "permed-53480", "permed-91777"]}
{"query_id": "topic_709_turn_4", "conversation_id": "topic_709", "turn_id": 4, "query": "Regarding these dinuclear zinc catalysts, what specific spectroscopic techniques and kinetic analysis methods were employed to elucidate the cooperative mechanism between metal centers? Additionally, how did you validate the proposed catalytic cycle through computational modeling, particularly in distinguishing between synchronous and sequential substrate activation pathways during the dual CO2 fixation and depolymerization processes?", "history": ["Zinc catalysis in CO2 fixation and polymer degradation: fundamental mechanisms and scope", "Evaluating specific zinc complexes for enhanced catalytic efficiency in these CO2 fixation and polymer degradation reactions", "Mechanistic insights and rational design of dinuclear β-diketiminato zinc catalysts for dual CO2 fixation and polycarbonate depolymerization towards sustainable chemistry"], "ground_truth": ["permed-74923", "permed-73223", "permed-74922", "permed-88509", "permed-75589", "permed-51995", "permed-51983", "permed-67585", "permed-53474", "permed-74853"]}
{"query_id": "topic_709_turn_5", "conversation_id": "topic_709", "turn_id": 5, "query": "Given the comprehensive mechanistic validation of dinuclear zinc catalysts for CO2 fixation and polymer degradation, what translational steps are being explored to adapt these systems for clinical or biomedical applications? Specifically, how might these catalysts be utilized in controlled therapeutic environments—such as localized CO2 capture in ischemic tissues or biodegradable medical polymer clearance—and what preliminary safety assessments regarding zinc ion leaching, systemic toxicity, or immunogenic responses have been conducted to evaluate their biocompatibility for potential in vivo use?", "history": ["Zinc catalysis in CO2 fixation and polymer degradation: fundamental mechanisms and scope", "Evaluating specific zinc complexes for enhanced catalytic efficiency in these CO2 fixation and polymer degradation reactions", "Mechanistic insights and rational design of dinuclear β-diketiminato zinc catalysts for dual CO2 fixation and polycarbonate depolymerization towards sustainable chemistry", "Regarding these dinuclear zinc catalysts, what specific spectroscopic techniques and kinetic analysis methods were employed to elucidate the cooperative mechanism between metal centers? Additionally, how did you validate the proposed catalytic cycle through computational modeling, particularly in distinguishing between synchronous and sequential substrate activation pathways during the dual CO2 fixation and depolymerization processes?"], "ground_truth": ["permed-74922", "permed-73223", "permed-74923", "permed-88509", "permed-51995", "permed-60901", "permed-75589", "permed-76537", "permed-51984", "permed-55267"]}
{"query_id": "topic_710_turn_1", "conversation_id": "topic_710", "turn_id": 1, "query": "What are the main environmental factors that contribute to cardiovascular health issues?", "history": [], "ground_truth": ["permed-81993", "permed-65452", "permed-64950", "permed-35639", "permed-57149", "permed-81917", "permed-39668", "permed-87109", "permed-65355", "permed-6543"]}
{"query_id": "topic_710_turn_2", "conversation_id": "topic_710", "turn_id": 2, "query": "How does air pollution, in particular, affect this area of health, considering its various components?", "history": ["What are the main environmental factors that contribute to cardiovascular health issues?"], "ground_truth": ["permed-65349", "permed-13667", "permed-65354", "permed-13238", "permed-13664", "permed-13237", "permed-54842", "permed-57032", "permed-65355", "permed-54851"]}
{"query_id": "topic_710_turn_3", "conversation_id": "topic_710", "turn_id": 3, "query": "Since we've established how air pollution affects cardiovascular health, could you elaborate on how specific components of wildland fire smoke—like fine particulate matter and toxic gases—might uniquely accelerate atherosclerosis in hypercholesterolemic models? And given this risk, what preventive or therapeutic approaches could help protect people who are chronically exposed to such environments?", "history": ["What are the main environmental factors that contribute to cardiovascular health issues?", "How does air pollution, in particular, affect this area of health, considering its various components?"], "ground_truth": ["permed-88614", "permed-57183", "permed-81993", "permed-65355", "permed-81995", "permed-58973", "permed-80217", "permed-79824", "permed-52504", "permed-51285"]}
{"query_id": "topic_710_turn_4", "conversation_id": "topic_710", "turn_id": 4, "query": "Regarding these proposed approaches for wildland fire smoke exposure, what specific experimental protocols would you recommend for testing their efficacy in hypercholesterolemic models? I'm particularly interested in the inhalation chamber setup for smoke component delivery, the temporal parameters for chronic exposure simulation, and the specific histological techniques for quantifying atherosclerotic plaque progression. How would you statistically power such a study to detect meaningful differences in lesion area between intervention and control groups while accounting for potential confounding variables?", "history": ["What are the main environmental factors that contribute to cardiovascular health issues?", "How does air pollution, in particular, affect this area of health, considering its various components?", "Since we've established how air pollution affects cardiovascular health, could you elaborate on how specific components of wildland fire smoke—like fine particulate matter and toxic gases—might uniquely accelerate atherosclerosis in hypercholesterolemic models? And given this risk, what preventive or therapeutic approaches could help protect people who are chronically exposed to such environments?"], "ground_truth": ["permed-27528", "permed-80217", "permed-90443", "permed-57014", "permed-81995", "permed-88614", "permed-61832", "permed-65358", "permed-61840", "permed-64984"]}
{"query_id": "topic_710_turn_5", "conversation_id": "topic_710", "turn_id": 5, "query": "Given the detailed experimental framework for testing interventions against wildfire smoke-induced atherosclerosis, how would the relative efficacy of pharmacological approaches (such as PCSK9 inhibitors or anti-inflammatory biologics) compare against dietary interventions (like omega-3 supplementation or Mediterranean diets) in these hypercholesterolemic models? Specifically, what comparative advantages in plaque stabilization or regression mechanisms might emerge, and would you anticipate different effect sizes or timelines for benefit between these strategic categories based on their distinct molecular pathways?", "history": ["What are the main environmental factors that contribute to cardiovascular health issues?", "How does air pollution, in particular, affect this area of health, considering its various components?", "Since we've established how air pollution affects cardiovascular health, could you elaborate on how specific components of wildland fire smoke—like fine particulate matter and toxic gases—might uniquely accelerate atherosclerosis in hypercholesterolemic models? And given this risk, what preventive or therapeutic approaches could help protect people who are chronically exposed to such environments?", "Regarding these proposed approaches for wildland fire smoke exposure, what specific experimental protocols would you recommend for testing their efficacy in hypercholesterolemic models? I'm particularly interested in the inhalation chamber setup for smoke component delivery, the temporal parameters for chronic exposure simulation, and the specific histological techniques for quantifying atherosclerotic plaque progression. How would you statistically power such a study to detect meaningful differences in lesion area between intervention and control groups while accounting for potential confounding variables?"], "ground_truth": ["permed-60087", "permed-60085", "permed-60086", "permed-60088", "permed-52504", "permed-74676", "permed-58890", "permed-92209", "permed-57014", "permed-53181"]}
{"query_id": "topic_711_turn_1", "conversation_id": "topic_711", "turn_id": 1, "query": "Robotic assistance in nursing: supporting physically demanding tasks and reducing injury risk", "history": [], "ground_truth": ["permed-76737", "permed-54871", "permed-76738", "permed-54944", "permed-56929", "permed-83899", "permed-70466", "permed-39025", "permed-84696", "permed-84694"]}
{"query_id": "topic_711_turn_2", "conversation_id": "topic_711", "turn_id": 2, "query": "User-centered design considerations for these robotic nursing aids to ensure patient and staff acceptance", "history": ["Robotic assistance in nursing: supporting physically demanding tasks and reducing injury risk"], "ground_truth": ["permed-76737", "permed-70065", "permed-78710", "permed-54871", "permed-56929", "permed-70061", "permed-56932", "permed-84786", "permed-66153", "permed-56934"]}
{"query_id": "topic_711_turn_3", "conversation_id": "topic_711", "turn_id": 3, "query": "Best practices for user-centered integration of robotic patient turning systems: addressing workflow changes, nurse training, and continuous feedback loops", "history": ["Robotic assistance in nursing: supporting physically demanding tasks and reducing injury risk", "User-centered design considerations for these robotic nursing aids to ensure patient and staff acceptance"], "ground_truth": ["permed-76737", "permed-76738", "permed-70065", "permed-91926", "permed-66153", "permed-70466", "permed-57584", "permed-54871", "permed-88524", "permed-84786"]}
{"query_id": "topic_711_turn_4", "conversation_id": "topic_711", "turn_id": 4, "query": "Regarding your mention of continuous feedback loops for robotic patient turning systems, could you elaborate on the specific data collection protocols used to assess system effectiveness in clinical settings? I'm particularly interested in whether these studies employ standardized metrics for measuring physical strain reduction in nursing staff, what statistical methods are used to analyze workflow integration data, and how researchers control for variables like patient acuity levels when evaluating these systems' impact on care quality.", "history": ["Robotic assistance in nursing: supporting physically demanding tasks and reducing injury risk", "User-centered design considerations for these robotic nursing aids to ensure patient and staff acceptance", "Best practices for user-centered integration of robotic patient turning systems: addressing workflow changes, nurse training, and continuous feedback loops"], "ground_truth": ["permed-76737", "permed-49602", "permed-74556", "permed-69059", "permed-52110", "permed-57576", "permed-70466", "permed-54910", "permed-52267", "permed-70261"]}
{"query_id": "topic_711_turn_5", "conversation_id": "topic_711", "turn_id": 5, "query": "Given these standardized metrics for physical strain reduction and workflow integration analysis in robotic patient turning systems, what clinical outcomes have been observed regarding pressure injury incidence rates compared to manual turning protocols? I'm particularly interested in whether the implementation of these robotic systems has demonstrated statistically significant reductions in hospital-acquired pressure injuries across different patient populations, and how safety protocols address potential contraindications such as unstable spinal injuries or patients with complex medical devices that might limit robotic system applicability in real-world clinical environments.", "history": ["Robotic assistance in nursing: supporting physically demanding tasks and reducing injury risk", "User-centered design considerations for these robotic nursing aids to ensure patient and staff acceptance", "Best practices for user-centered integration of robotic patient turning systems: addressing workflow changes, nurse training, and continuous feedback loops", "Regarding your mention of continuous feedback loops for robotic patient turning systems, could you elaborate on the specific data collection protocols used to assess system effectiveness in clinical settings? I'm particularly interested in whether these studies employ standardized metrics for measuring physical strain reduction in nursing staff, what statistical methods are used to analyze workflow integration data, and how researchers control for variables like patient acuity levels when evaluating these systems' impact on care quality."], "ground_truth": ["permed-54871", "permed-36679", "permed-44153", "permed-59470", "permed-88524", "permed-36681", "permed-70912", "permed-38990", "permed-54823", "permed-70466"]}
{"query_id": "topic_712_turn_1", "conversation_id": "topic_712", "turn_id": 1, "query": "What role does sonochemistry play in enhancing the formation of protein-polyphenol conjugates like β-lactoglobulin-chlorogenic acid?", "history": [], "ground_truth": ["permed-81123", "permed-65080", "permed-80607", "permed-80610", "permed-65075", "permed-65072", "permed-69006", "permed-79872", "permed-64159", "permed-63669"]}
{"query_id": "topic_712_turn_2", "conversation_id": "topic_712", "turn_id": 2, "query": "How do variations in ultrasonic conditions during this process affect the structural and functional properties of the resulting conjugates?", "history": ["What role does sonochemistry play in enhancing the formation of protein-polyphenol conjugates like β-lactoglobulin-chlorogenic acid?"], "ground_truth": ["permed-81123", "permed-76771", "permed-76137", "permed-80959", "permed-89477", "permed-75003", "permed-89171", "permed-52721", "permed-87491", "permed-64650"]}
{"query_id": "topic_712_turn_3", "conversation_id": "topic_712", "turn_id": 3, "query": "Given these effects of ultrasonic conditions on the conjugates' structure and function, how specifically do power and frequency variations influence the efficiency of LG-CA conjugate formation and their antioxidant activity when combining sonochemistry with the redox-pair method? Also, what mechanisms might explain the structural shifts from ordered to disordered protein configurations we're seeing, and how do these changes relate to the improved functional properties observed?", "history": ["What role does sonochemistry play in enhancing the formation of protein-polyphenol conjugates like β-lactoglobulin-chlorogenic acid?", "How do variations in ultrasonic conditions during this process affect the structural and functional properties of the resulting conjugates?"], "ground_truth": ["permed-81123", "permed-80607", "permed-65080", "permed-65113", "permed-65165", "permed-80451", "permed-65075", "permed-65124", "permed-76137", "permed-86373"]}
{"query_id": "topic_712_turn_4", "conversation_id": "topic_712", "turn_id": 4, "query": "Regarding the structural transitions and enhanced antioxidant activity you described, what specific analytical techniques were employed to quantify the shift from ordered to disordered protein configurations? Did you use complementary methods like circular dichroism, FTIR spectroscopy, and differential scanning calorimetry to validate these conformational changes? Furthermore, how did you statistically correlate the degree of structural disorder with the measured antioxidant activity, and what quality control measures ensured reproducibility across different ultrasonic power and frequency settings?", "history": ["What role does sonochemistry play in enhancing the formation of protein-polyphenol conjugates like β-lactoglobulin-chlorogenic acid?", "How do variations in ultrasonic conditions during this process affect the structural and functional properties of the resulting conjugates?", "Given these effects of ultrasonic conditions on the conjugates' structure and function, how specifically do power and frequency variations influence the efficiency of LG-CA conjugate formation and their antioxidant activity when combining sonochemistry with the redox-pair method? Also, what mechanisms might explain the structural shifts from ordered to disordered protein configurations we're seeing, and how do these changes relate to the improved functional properties observed?"], "ground_truth": ["permed-81123", "permed-75067", "permed-77157", "permed-74268", "permed-65168", "permed-52760", "permed-76029", "permed-65113", "permed-65014", "permed-89207"]}
{"query_id": "topic_712_turn_5", "conversation_id": "topic_712", "turn_id": 5, "query": "Given your detailed characterization using CD, FTIR, and DSC to correlate structural disorder with antioxidant activity, how does sonochemical conjugation compare to traditional methods like alkaline or enzymatic treatment for β-lactoglobulin-polyphenol conjugates? Specifically, what are the relative advantages in terms of conjugation efficiency, structural modification extent, and functional property enhancement? Additionally, could you discuss the trade-offs between these methods regarding scalability, preservation of native protein functionality, and potential for industrial application?", "history": ["What role does sonochemistry play in enhancing the formation of protein-polyphenol conjugates like β-lactoglobulin-chlorogenic acid?", "How do variations in ultrasonic conditions during this process affect the structural and functional properties of the resulting conjugates?", "Given these effects of ultrasonic conditions on the conjugates' structure and function, how specifically do power and frequency variations influence the efficiency of LG-CA conjugate formation and their antioxidant activity when combining sonochemistry with the redox-pair method? Also, what mechanisms might explain the structural shifts from ordered to disordered protein configurations we're seeing, and how do these changes relate to the improved functional properties observed?", "Regarding the structural transitions and enhanced antioxidant activity you described, what specific analytical techniques were employed to quantify the shift from ordered to disordered protein configurations? Did you use complementary methods like circular dichroism, FTIR spectroscopy, and differential scanning calorimetry to validate these conformational changes? Furthermore, how did you statistically correlate the degree of structural disorder with the measured antioxidant activity, and what quality control measures ensured reproducibility across different ultrasonic power and frequency settings?"], "ground_truth": ["permed-81123", "permed-65080", "permed-80607", "permed-65075", "permed-69006", "permed-82828", "permed-76137", "permed-80610", "permed-58177", "permed-65072"]}
{"query_id": "topic_713_turn_1", "conversation_id": "topic_713", "turn_id": 1, "query": "Comparative analysis of dye-sensitized solar cell (DSSC) efficiency and stability against other leading solar cell technologies", "history": [], "ground_truth": ["permed-55261", "permed-55260", "permed-55266", "permed-78524", "permed-53784", "permed-64282", "permed-75688", "permed-53787", "permed-89880", "permed-53794"]}
{"query_id": "topic_713_turn_2", "conversation_id": "topic_713", "turn_id": 2, "query": "Given that initial comparison, how do charge transport mechanisms in NiO-based photocathodes specifically influence DSSC efficiency and stability?", "history": ["Comparative analysis of dye-sensitized solar cell (DSSC) efficiency and stability against other leading solar cell technologies"], "ground_truth": ["permed-74971", "permed-73307", "permed-74576", "permed-55231", "permed-72970", "permed-53777", "permed-55266", "permed-53782", "permed-60913", "permed-55261"]}
{"query_id": "topic_713_turn_3", "conversation_id": "topic_713", "turn_id": 3, "query": "Delving into NiO photocathodes: how do electron hopping pathways and rapid surface state electron transfer affect their contribution to overall DSSC efficiency and stability, and what p-type dye strategies optimize these specific charge transport phenomena?", "history": ["Comparative analysis of dye-sensitized solar cell (DSSC) efficiency and stability against other leading solar cell technologies", "Given that initial comparison, how do charge transport mechanisms in NiO-based photocathodes specifically influence DSSC efficiency and stability?"], "ground_truth": ["permed-74971", "permed-73307", "permed-55266", "permed-55231", "permed-55261", "permed-72970", "permed-74576", "permed-55260", "permed-79215", "permed-78258"]}
{"query_id": "topic_713_turn_4", "conversation_id": "topic_713", "turn_id": 4, "query": "Building on these p-type dye optimization strategies for NiO photocathodes, what specific electrochemical impedance spectroscopy protocols and equivalent circuit modeling approaches would you recommend for quantitatively distinguishing between electron hopping conductivity through NiO bulk states versus surface state-mediated charge transfer? Additionally, what experimental controls and data validation metrics should be implemented to ensure these EIS measurements accurately capture the distinct contributions to overall charge transport efficiency?", "history": ["Comparative analysis of dye-sensitized solar cell (DSSC) efficiency and stability against other leading solar cell technologies", "Given that initial comparison, how do charge transport mechanisms in NiO-based photocathodes specifically influence DSSC efficiency and stability?", "Delving into NiO photocathodes: how do electron hopping pathways and rapid surface state electron transfer affect their contribution to overall DSSC efficiency and stability, and what p-type dye strategies optimize these specific charge transport phenomena?"], "ground_truth": ["permed-74971", "permed-73307", "permed-55231", "permed-74576", "permed-55266", "permed-81169", "permed-72970", "permed-75938", "permed-72959", "permed-51997"]}
{"query_id": "topic_713_turn_5", "conversation_id": "topic_713", "turn_id": 5, "query": "Given these comprehensive electrochemical characterization protocols for NiO-based DSSCs, how could these material-level insights translate to clinical biomedical applications? Specifically, what are the therapeutic efficacy and safety profiles of implantable DSSC-powered medical devices for applications like retinal prostheses or continuous drug delivery systems? Considering charge transport stability and potential cytotoxicity of NiO/dye components, what clinical evidence exists regarding long-term patient outcomes, and what regulatory challenges would such bio-integrated energy systems face during translational development?", "history": ["Comparative analysis of dye-sensitized solar cell (DSSC) efficiency and stability against other leading solar cell technologies", "Given that initial comparison, how do charge transport mechanisms in NiO-based photocathodes specifically influence DSSC efficiency and stability?", "Delving into NiO photocathodes: how do electron hopping pathways and rapid surface state electron transfer affect their contribution to overall DSSC efficiency and stability, and what p-type dye strategies optimize these specific charge transport phenomena?", "Building on these p-type dye optimization strategies for NiO photocathodes, what specific electrochemical impedance spectroscopy protocols and equivalent circuit modeling approaches would you recommend for quantitatively distinguishing between electron hopping conductivity through NiO bulk states versus surface state-mediated charge transfer? Additionally, what experimental controls and data validation metrics should be implemented to ensure these EIS measurements accurately capture the distinct contributions to overall charge transport efficiency?"], "ground_truth": ["permed-60791", "permed-74971", "permed-55266", "permed-55261", "permed-63386", "permed-81169", "permed-73307", "permed-82150", "permed-72957", "permed-82833"]}
{"query_id": "topic_714_turn_1", "conversation_id": "topic_714", "turn_id": 1, "query": "Current diagnostic methods for sarcopenia in middle-aged and older adults", "history": [], "ground_truth": ["permed-68545", "permed-73721", "permed-61340", "permed-84369", "permed-73726", "permed-84371", "permed-52360", "permed-83237", "permed-81340", "permed-91608"]}
{"query_id": "topic_714_turn_2", "conversation_id": "topic_714", "turn_id": 2, "query": "Evaluating the effectiveness of specific diagnostic tools like bioimpedance and dynamometry for sarcopenia detection in these populations", "history": ["Current diagnostic methods for sarcopenia in middle-aged and older adults"], "ground_truth": ["permed-61339", "permed-73721", "permed-68545", "permed-73726", "permed-84369", "permed-61340", "permed-91608", "permed-52362", "permed-84371", "permed-52360"]}
{"query_id": "topic_714_turn_3", "conversation_id": "topic_714", "turn_id": 3, "query": "Optimizing combined bioimpedance and dynamometry for early sarcopenia detection in middle-aged adults: identifying predictive biomarkers and thresholds for later-life muscle health", "history": ["Current diagnostic methods for sarcopenia in middle-aged and older adults", "Evaluating the effectiveness of specific diagnostic tools like bioimpedance and dynamometry for sarcopenia detection in these populations"], "ground_truth": ["permed-73721", "permed-91608", "permed-68545", "permed-61339", "permed-84369", "permed-73720", "permed-73726", "permed-61340", "permed-73718", "permed-84371"]}
{"query_id": "topic_714_turn_4", "conversation_id": "topic_714", "turn_id": 4, "query": "Regarding this combined approach, could you elaborate on the specific dynamometry protocols used for measuring grip strength and lower extremity function? I'm particularly interested in the standardization of testing positions, number of repetitions, rest intervals between trials, and how these measurements were calibrated against bioimpedance-derived skeletal muscle mass indices. Additionally, what statistical methods were employed to determine optimal cut-points for these combined metrics in predicting future muscle health decline?", "history": ["Current diagnostic methods for sarcopenia in middle-aged and older adults", "Evaluating the effectiveness of specific diagnostic tools like bioimpedance and dynamometry for sarcopenia detection in these populations", "Optimizing combined bioimpedance and dynamometry for early sarcopenia detection in middle-aged adults: identifying predictive biomarkers and thresholds for later-life muscle health"], "ground_truth": ["permed-52357", "permed-63065", "permed-90119", "permed-81341", "permed-52364", "permed-73727", "permed-52361", "permed-60127", "permed-89538", "permed-92308"]}
{"query_id": "topic_714_turn_5", "conversation_id": "topic_714", "turn_id": 5, "query": "Given the detailed dynamometry protocols and their calibration with bioimpedance metrics discussed previously, how do the predictive accuracies compare between different diagnostic frameworks for early sarcopenia? Specifically, what are the relative strengths and limitations of combining grip strength with bioimpedance versus integrating lower extremity dynamometry with bioimpedance in terms of sensitivity, specificity, and clinical feasibility for detecting future muscle health decline in middle-aged adults across diverse healthcare settings?", "history": ["Current diagnostic methods for sarcopenia in middle-aged and older adults", "Evaluating the effectiveness of specific diagnostic tools like bioimpedance and dynamometry for sarcopenia detection in these populations", "Optimizing combined bioimpedance and dynamometry for early sarcopenia detection in middle-aged adults: identifying predictive biomarkers and thresholds for later-life muscle health", "Regarding this combined approach, could you elaborate on the specific dynamometry protocols used for measuring grip strength and lower extremity function? I'm particularly interested in the standardization of testing positions, number of repetitions, rest intervals between trials, and how these measurements were calibrated against bioimpedance-derived skeletal muscle mass indices. Additionally, what statistical methods were employed to determine optimal cut-points for these combined metrics in predicting future muscle health decline?"], "ground_truth": ["permed-73721", "permed-68545", "permed-61339", "permed-84371", "permed-52362", "permed-52361", "permed-91608", "permed-84369", "permed-52364", "permed-61340"]}
{"query_id": "topic_715_turn_1", "conversation_id": "topic_715", "turn_id": 1, "query": "What is the current understanding of adolescent insulin resistance, its development, and long-term health implications?", "history": [], "ground_truth": ["permed-79804", "permed-58944", "permed-76913", "permed-76916", "permed-78489", "permed-83391", "permed-87934", "permed-31176", "permed-58946", "permed-52586"]}
{"query_id": "topic_715_turn_2", "conversation_id": "topic_715", "turn_id": 2, "query": "Regarding this insulin resistance in adolescents, how is HOMA-IR utilized for its assessment, considering variations and validity across different pubertal stages?", "history": ["What is the current understanding of adolescent insulin resistance, its development, and long-term health implications?"], "ground_truth": ["permed-76913", "permed-76916", "permed-76915", "permed-58944", "permed-30041", "permed-79804", "permed-78489", "permed-47495", "permed-23701", "permed-76914"]}
{"query_id": "topic_715_turn_3", "conversation_id": "topic_715", "turn_id": 3, "query": "Given HOMA-IR thresholds defining adolescent insulin resistance by pubertal stage, what are the specific long-term metabolic consequences, how do these differ by sex and ethnicity, and what are the implications for targeted early intervention strategies?", "history": ["What is the current understanding of adolescent insulin resistance, its development, and long-term health implications?", "Regarding this insulin resistance in adolescents, how is HOMA-IR utilized for its assessment, considering variations and validity across different pubertal stages?"], "ground_truth": ["permed-76913", "permed-76916", "permed-58944", "permed-78489", "permed-76915", "permed-79804", "permed-30041", "permed-52588", "permed-76914", "permed-90256"]}
{"query_id": "topic_715_turn_4", "conversation_id": "topic_715", "turn_id": 4, "query": "When implementing these pubertal stage-specific HOMA-IR thresholds for longitudinal risk stratification, what methodological approaches are most effective for accounting for ethnic and sex variations in growth trajectories? Specifically, should we use mixed-effects models with random slopes for individual growth patterns, or would latent class trajectory modeling better capture subgroup heterogeneity? What statistical power considerations and validation techniques (e.g., internal-external cross-validation) are recommended when establishing these stratified thresholds across diverse adolescent cohorts?", "history": ["What is the current understanding of adolescent insulin resistance, its development, and long-term health implications?", "Regarding this insulin resistance in adolescents, how is HOMA-IR utilized for its assessment, considering variations and validity across different pubertal stages?", "Given HOMA-IR thresholds defining adolescent insulin resistance by pubertal stage, what are the specific long-term metabolic consequences, how do these differ by sex and ethnicity, and what are the implications for targeted early intervention strategies?"], "ground_truth": ["permed-76913", "permed-76916", "permed-76915", "permed-88608", "permed-65494", "permed-85390", "permed-61788", "permed-30041", "permed-73472", "permed-65643"]}
{"query_id": "topic_715_turn_5", "conversation_id": "topic_715", "turn_id": 5, "query": "Given the methodological complexities in modeling ethnic and sex-specific growth trajectories for insulin resistance stratification, how do mixed-effects models with random slopes compare against latent class trajectory modeling in terms of clinical utility and predictive accuracy? Specifically, when considering implementation in diverse pediatric populations, what are the relative advantages in identifying at-risk subgroups versus capturing individual growth variations, and which approach demonstrates superior performance in balancing model complexity with actionable risk prediction for long-term metabolic outcomes?", "history": ["What is the current understanding of adolescent insulin resistance, its development, and long-term health implications?", "Regarding this insulin resistance in adolescents, how is HOMA-IR utilized for its assessment, considering variations and validity across different pubertal stages?", "Given HOMA-IR thresholds defining adolescent insulin resistance by pubertal stage, what are the specific long-term metabolic consequences, how do these differ by sex and ethnicity, and what are the implications for targeted early intervention strategies?", "When implementing these pubertal stage-specific HOMA-IR thresholds for longitudinal risk stratification, what methodological approaches are most effective for accounting for ethnic and sex variations in growth trajectories? Specifically, should we use mixed-effects models with random slopes for individual growth patterns, or would latent class trajectory modeling better capture subgroup heterogeneity? What statistical power considerations and validation techniques (e.g., internal-external cross-validation) are recommended when establishing these stratified thresholds across diverse adolescent cohorts?"], "ground_truth": ["permed-76915", "permed-37703", "permed-76913", "permed-88608", "permed-65643", "permed-76916", "permed-6808", "permed-47495", "permed-58944", "permed-55166"]}
{"query_id": "topic_716_turn_1", "conversation_id": "topic_716", "turn_id": 1, "query": "What role do immunopurification reagents play in mass spectrometry analyses?", "history": [], "ground_truth": ["permed-79011", "permed-77044", "permed-66182", "permed-77755", "permed-56783", "permed-66191", "permed-77048", "permed-66178", "permed-66187", "permed-53718"]}
{"query_id": "topic_716_turn_2", "conversation_id": "topic_716", "turn_id": 2, "query": "How can advancements in this technique improve the detection of biomarkers in complex biological samples?", "history": ["What role do immunopurification reagents play in mass spectrometry analyses?"], "ground_truth": ["permed-74088", "permed-56363", "permed-74316", "permed-68468", "permed-65912", "permed-75899", "permed-59244", "permed-86781", "permed-50852", "permed-65059"]}
{"query_id": "topic_716_turn_3", "conversation_id": "topic_716", "turn_id": 3, "query": "Given how immunopurification reagents enhance LC-MS/MS selectivity and sensitivity for biomarker detection, how can we optimize their integration with these techniques to better quantify low-abundance biomarkers in complex samples? What would this mean for advancing personalized medicine and targeted therapies in drug discovery?", "history": ["What role do immunopurification reagents play in mass spectrometry analyses?", "How can advancements in this technique improve the detection of biomarkers in complex biological samples?"], "ground_truth": ["permed-79011", "permed-79012", "permed-74088", "permed-77755", "permed-80385", "permed-4596", "permed-4598", "permed-67918", "permed-77047", "permed-56783"]}
{"query_id": "topic_716_turn_4", "conversation_id": "topic_716", "turn_id": 4, "query": "Considering this optimization approach for integrating immunopurification with LC-MS/MS, what specific experimental controls and validation strategies would you implement to ensure robust quantification of low-abundance biomarkers? I'm particularly interested in how one would establish the linear dynamic range, determine limits of quantification, and validate antibody specificity while accounting for matrix effects in complex biological samples. Additionally, what statistical approaches would be most appropriate for assessing reproducibility across multiple sample batches?", "history": ["What role do immunopurification reagents play in mass spectrometry analyses?", "How can advancements in this technique improve the detection of biomarkers in complex biological samples?", "Given how immunopurification reagents enhance LC-MS/MS selectivity and sensitivity for biomarker detection, how can we optimize their integration with these techniques to better quantify low-abundance biomarkers in complex samples? What would this mean for advancing personalized medicine and targeted therapies in drug discovery?"], "ground_truth": ["permed-79011", "permed-58991", "permed-79012", "permed-77046", "permed-80385", "permed-66188", "permed-4602", "permed-66191", "permed-4702", "permed-66189"]}
{"query_id": "topic_716_turn_5", "conversation_id": "topic_716", "turn_id": 5, "query": "Given these robust validation frameworks for quantifying low-abundance biomarkers, what clinical evidence exists regarding their utility in guiding targeted therapies? Specifically, how have such optimized immunopurification-MS workflows demonstrated clinical impact in areas like patient stratification, treatment selection, or monitoring therapeutic response in oncology or neurodegenerative diseases? I'm interested in comparative effectiveness against standard diagnostics, observed clinical decision impacts, and any documented patient outcome improvements from real-world deployments or clinical trials utilizing these precise quantification methods.", "history": ["What role do immunopurification reagents play in mass spectrometry analyses?", "How can advancements in this technique improve the detection of biomarkers in complex biological samples?", "Given how immunopurification reagents enhance LC-MS/MS selectivity and sensitivity for biomarker detection, how can we optimize their integration with these techniques to better quantify low-abundance biomarkers in complex samples? What would this mean for advancing personalized medicine and targeted therapies in drug discovery?", "Considering this optimization approach for integrating immunopurification with LC-MS/MS, what specific experimental controls and validation strategies would you implement to ensure robust quantification of low-abundance biomarkers? I'm particularly interested in how one would establish the linear dynamic range, determine limits of quantification, and validate antibody specificity while accounting for matrix effects in complex biological samples. Additionally, what statistical approaches would be most appropriate for assessing reproducibility across multiple sample batches?"], "ground_truth": ["permed-79011", "permed-79012", "permed-56783", "permed-56802", "permed-4598", "permed-4597", "permed-59309", "permed-56401", "permed-66188", "permed-61842"]}
{"query_id": "topic_717_turn_1", "conversation_id": "topic_717", "turn_id": 1, "query": "Graphene oxide applications for scaffold biocompatibility in tissue engineering", "history": [], "ground_truth": ["permed-73015", "permed-76865", "permed-76287", "permed-89038", "permed-64382", "permed-80566", "permed-76863", "permed-64487", "permed-64620", "permed-75261"]}
{"query_id": "topic_717_turn_2", "conversation_id": "topic_717", "turn_id": 2, "query": "Following its biocompatibility role, how does graphene oxide incorporation affect regenerative capabilities in electrospun PHB biopolymer scaffolds?", "history": ["Graphene oxide applications for scaffold biocompatibility in tissue engineering"], "ground_truth": ["permed-76863", "permed-87688", "permed-64620", "permed-76865", "permed-80566", "permed-64399", "permed-76867", "permed-64644", "permed-76864", "permed-72823"]}
{"query_id": "topic_717_turn_3", "conversation_id": "topic_717", "turn_id": 3, "query": "Building on graphene oxide's effects on PHB electrospun scaffolds, how do varying reduced graphene oxide (rGO) concentrations impact their long-term in vivo biocompatibility and regenerative performance, specifically tissue integration and cellular responses over extended periods?", "history": ["Graphene oxide applications for scaffold biocompatibility in tissue engineering", "Following its biocompatibility role, how does graphene oxide incorporation affect regenerative capabilities in electrospun PHB biopolymer scaffolds?"], "ground_truth": ["permed-76863", "permed-87688", "permed-76865", "permed-64620", "permed-80566", "permed-76287", "permed-51323", "permed-76867", "permed-67181", "permed-75885"]}
{"query_id": "topic_717_turn_4", "conversation_id": "topic_717", "turn_id": 4, "query": "Building on this long-term in vivo assessment, what specific histological scoring systems and quantitative metrics were employed to systematically evaluate tissue integration and cellular responses? I'm particularly interested in the immunohistochemistry protocols for analyzing macrophage polarization markers, the statistical methods used for longitudinal data analysis of inflammatory responses, and how you ensured reproducibility across multiple implantation time points in your animal model.", "history": ["Graphene oxide applications for scaffold biocompatibility in tissue engineering", "Following its biocompatibility role, how does graphene oxide incorporation affect regenerative capabilities in electrospun PHB biopolymer scaffolds?", "Building on graphene oxide's effects on PHB electrospun scaffolds, how do varying reduced graphene oxide (rGO) concentrations impact their long-term in vivo biocompatibility and regenerative performance, specifically tissue integration and cellular responses over extended periods?"], "ground_truth": ["permed-55439", "permed-52669", "permed-75119", "permed-55437", "permed-75120", "permed-68120", "permed-58678", "permed-83130", "permed-55438", "permed-67926"]}
{"query_id": "topic_717_turn_5", "conversation_id": "topic_717", "turn_id": 5, "query": "Given these detailed histological and immunohistochemistry findings from long-term implantation studies, what clinical translation challenges have emerged regarding scaffold degradation kinetics and mechanical integrity? Specifically, how do the observed macrophage polarization patterns correlate with actual functional tissue regeneration outcomes in relevant pre-clinical models? Furthermore, what safety considerations have been identified regarding potential rGO particle migration or accumulation in distal organs, and how might these findings inform first-in-human trial designs for such graphene-enhanced scaffolds?", "history": ["Graphene oxide applications for scaffold biocompatibility in tissue engineering", "Following its biocompatibility role, how does graphene oxide incorporation affect regenerative capabilities in electrospun PHB biopolymer scaffolds?", "Building on graphene oxide's effects on PHB electrospun scaffolds, how do varying reduced graphene oxide (rGO) concentrations impact their long-term in vivo biocompatibility and regenerative performance, specifically tissue integration and cellular responses over extended periods?", "Building on this long-term in vivo assessment, what specific histological scoring systems and quantitative metrics were employed to systematically evaluate tissue integration and cellular responses? I'm particularly interested in the immunohistochemistry protocols for analyzing macrophage polarization markers, the statistical methods used for longitudinal data analysis of inflammatory responses, and how you ensured reproducibility across multiple implantation time points in your animal model."], "ground_truth": ["permed-80566", "permed-76863", "permed-85976", "permed-76865", "permed-64487", "permed-55439", "permed-61082", "permed-76867", "permed-52669", "permed-64575"]}
{"query_id": "topic_718_turn_1", "conversation_id": "topic_718", "turn_id": 1, "query": "What were the primary shifts in Mexican consumer food purchasing habits and household food management practices due to the COVID-19 pandemic?", "history": [], "ground_truth": ["permed-57678", "permed-74358", "permed-74353", "permed-57675", "permed-68550", "permed-68773", "permed-81534", "permed-74355", "permed-64879", "permed-74357"]}
{"query_id": "topic_718_turn_2", "conversation_id": "topic_718", "turn_id": 2, "query": "Building on these pandemic-related shifts in Mexico, how can such changes in consumer food behavior be leveraged to encourage more sustainable food consumption patterns?", "history": ["What were the primary shifts in Mexican consumer food purchasing habits and household food management practices due to the COVID-19 pandemic?"], "ground_truth": ["permed-57678", "permed-74353", "permed-74354", "permed-57675", "permed-63351", "permed-68686", "permed-74358", "permed-68550", "permed-68773", "permed-69497"]}
{"query_id": "topic_718_turn_3", "conversation_id": "topic_718", "turn_id": 3, "query": "What specific strategies and educational program designs can be developed in Mexico, informed by these pandemic-era food behavior changes, to foster long-term circular economy principles in household food consumption, specifically targeting food waste reduction and optimized grocery spending?", "history": ["What were the primary shifts in Mexican consumer food purchasing habits and household food management practices due to the COVID-19 pandemic?", "Building on these pandemic-related shifts in Mexico, how can such changes in consumer food behavior be leveraged to encourage more sustainable food consumption patterns?"], "ground_truth": ["permed-57678", "permed-74358", "permed-57674", "permed-74355", "permed-74356", "permed-74353", "permed-68773", "permed-81534", "permed-62781", "permed-57675"]}
{"query_id": "topic_718_turn_4", "conversation_id": "topic_718", "turn_id": 4, "query": "For the educational programs targeting food waste reduction and optimized grocery spending you mentioned, what specific methodological approaches would be most effective for measuring their real-world impact? I'm particularly interested in the experimental design—would you recommend randomized controlled trials across different Mexican regions, or longitudinal cohort studies tracking specific behavioral metrics like actual food waste quantification and receipt analysis? Also, what statistical validation methods would ensure these measured behavioral changes are attributable to the intervention rather than external factors?", "history": ["What were the primary shifts in Mexican consumer food purchasing habits and household food management practices due to the COVID-19 pandemic?", "Building on these pandemic-related shifts in Mexico, how can such changes in consumer food behavior be leveraged to encourage more sustainable food consumption patterns?", "What specific strategies and educational program designs can be developed in Mexico, informed by these pandemic-era food behavior changes, to foster long-term circular economy principles in household food consumption, specifically targeting food waste reduction and optimized grocery spending?"], "ground_truth": ["permed-57678", "permed-57674", "permed-35399", "permed-57676", "permed-76904", "permed-85701", "permed-74981", "permed-74977", "permed-78584", "permed-65092"]}
{"query_id": "topic_718_turn_5", "conversation_id": "topic_718", "turn_id": 5, "query": "Given your methodological recommendations for measuring program effectiveness, how would the comparative validity differ between using direct measurement techniques (like waste audits or smart refrigerator tracking) versus self-reported behavioral data (surveys or food diaries) for quantifying food waste reduction? Specifically in the Mexican context with its regional socioeconomic variations, what are the trade-offs in accuracy, participant burden, and scalability between these measurement approaches when trying to attribute changes specifically to educational interventions versus external factors like economic fluctuations?", "history": ["What were the primary shifts in Mexican consumer food purchasing habits and household food management practices due to the COVID-19 pandemic?", "Building on these pandemic-related shifts in Mexico, how can such changes in consumer food behavior be leveraged to encourage more sustainable food consumption patterns?", "What specific strategies and educational program designs can be developed in Mexico, informed by these pandemic-era food behavior changes, to foster long-term circular economy principles in household food consumption, specifically targeting food waste reduction and optimized grocery spending?", "For the educational programs targeting food waste reduction and optimized grocery spending you mentioned, what specific methodological approaches would be most effective for measuring their real-world impact? I'm particularly interested in the experimental design—would you recommend randomized controlled trials across different Mexican regions, or longitudinal cohort studies tracking specific behavioral metrics like actual food waste quantification and receipt analysis? Also, what statistical validation methods would ensure these measured behavioral changes are attributable to the intervention rather than external factors?"], "ground_truth": ["permed-57678", "permed-64960", "permed-72422", "permed-35399", "permed-85547", "permed-57674", "permed-72419", "permed-57676", "permed-65092", "permed-76904"]}
{"query_id": "topic_719_turn_1", "conversation_id": "topic_719", "turn_id": 1, "query": "Karst tiankeng microbial ecosystems: current understanding and general characteristics", "history": [], "ground_truth": ["permed-78300", "permed-91516", "permed-66716", "permed-86233", "permed-52063", "permed-65029", "permed-88400", "permed-66710", "permed-66911", "permed-51796"]}
{"query_id": "topic_719_turn_2", "conversation_id": "topic_719", "turn_id": 2, "query": "How do specific environmental conditions in these karst tiankengs affect microbial community diversity and behavior?", "history": ["Karst tiankeng microbial ecosystems: current understanding and general characteristics"], "ground_truth": ["permed-78300", "permed-66911", "permed-66713", "permed-52063", "permed-66716", "permed-78301", "permed-66910", "permed-66711", "permed-62254", "permed-66714"]}
{"query_id": "topic_719_turn_3", "conversation_id": "topic_719", "turn_id": 3, "query": "Specific impacts of microclimate, soil chemistry, and light availability on microbial community assembly, function, resilience, and adaptability within karst tiankengs.", "history": ["Karst tiankeng microbial ecosystems: current understanding and general characteristics", "How do specific environmental conditions in these karst tiankengs affect microbial community diversity and behavior?"], "ground_truth": ["permed-78300", "permed-66912", "permed-62254", "permed-66910", "permed-63648", "permed-66911", "permed-60605", "permed-66711", "permed-88400", "permed-88419"]}
{"query_id": "topic_719_turn_4", "conversation_id": "topic_719", "turn_id": 4, "query": "When analyzing these environmental impacts on microbial communities, what specific methods were employed to characterize soil chemistry parameters - particularly regarding sampling protocols, analytical techniques for nutrient quantification, and statistical approaches for correlating chemical gradients with microbial diversity metrics? Were there standardization procedures across different tiankeng microenvironments to ensure comparability, and how was the spatial variation in soil properties accounted for in the experimental design?", "history": ["Karst tiankeng microbial ecosystems: current understanding and general characteristics", "How do specific environmental conditions in these karst tiankengs affect microbial community diversity and behavior?", "Specific impacts of microclimate, soil chemistry, and light availability on microbial community assembly, function, resilience, and adaptability within karst tiankengs."], "ground_truth": ["permed-62254", "permed-63648", "permed-66775", "permed-66774", "permed-67032", "permed-78300", "permed-88422", "permed-85962", "permed-66001", "permed-81890"]}
{"query_id": "topic_719_turn_5", "conversation_id": "topic_719", "turn_id": 5, "query": "Given these methodological approaches for characterizing soil chemistry-microbial relationships, how do findings from karst tiankeng microbial communities compare with those from other extreme subsurface environments like lava tubes or ice caves regarding their adaptive strategies? Specifically, what are the comparative advantages and limitations of nutrient acquisition mechanisms, community stability trade-offs, and metabolic flexibility when facing similar chemical gradients but different geological constraints across these subterranean ecosystems?", "history": ["Karst tiankeng microbial ecosystems: current understanding and general characteristics", "How do specific environmental conditions in these karst tiankengs affect microbial community diversity and behavior?", "Specific impacts of microclimate, soil chemistry, and light availability on microbial community assembly, function, resilience, and adaptability within karst tiankengs.", "When analyzing these environmental impacts on microbial communities, what specific methods were employed to characterize soil chemistry parameters - particularly regarding sampling protocols, analytical techniques for nutrient quantification, and statistical approaches for correlating chemical gradients with microbial diversity metrics? Were there standardization procedures across different tiankeng microenvironments to ensure comparability, and how was the spatial variation in soil properties accounted for in the experimental design?"], "ground_truth": ["permed-78300", "permed-66711", "permed-63648", "permed-66716", "permed-66713", "permed-66775", "permed-62254", "permed-66912", "permed-80594", "permed-63946"]}
{"query_id": "topic_720_turn_1", "conversation_id": "topic_720", "turn_id": 1, "query": "What role do S1PR modulators play in treating multiple sclerosis (MS) and how do they affect the immune system?", "history": [], "ground_truth": ["permed-81297", "permed-81296", "permed-64689", "permed-49509", "permed-81298", "permed-73691", "permed-50340", "permed-73684", "permed-64346", "permed-80514"]}
{"query_id": "topic_720_turn_2", "conversation_id": "topic_720", "turn_id": 2, "query": "How might targeting specific subtypes of these receptors influence the balance between disease control and immune function, particularly concerning infections?", "history": ["What role do S1PR modulators play in treating multiple sclerosis (MS) and how do they affect the immune system?"], "ground_truth": ["permed-68055", "permed-22339", "permed-33148", "permed-59011", "permed-53184", "permed-87384", "permed-68004", "permed-59010", "permed-59009", "permed-68054"]}
{"query_id": "topic_720_turn_3", "conversation_id": "topic_720", "turn_id": 3, "query": "Given that different S1PR modulators have distinct pharmacological profiles and varying effects on lymphocyte migration and immune responses, how might selectively targeting specific subtypes (like S1PR1 versus S1PR4) help strike the right balance between controlling MS disease activity and preserving immune defenses against emerging viral infections, such as influenza or future coronaviruses? Furthermore, what approaches could be taken to optimize these therapies for MS patients at higher infection risk while still maintaining their therapeutic benefits?", "history": ["What role do S1PR modulators play in treating multiple sclerosis (MS) and how do they affect the immune system?", "How might targeting specific subtypes of these receptors influence the balance between disease control and immune function, particularly concerning infections?"], "ground_truth": ["permed-81296", "permed-81297", "permed-64689", "permed-64346", "permed-81298", "permed-49509", "permed-53271", "permed-68157", "permed-71426", "permed-69397"]}
{"query_id": "topic_720_turn_4", "conversation_id": "topic_720", "turn_id": 4, "query": "Given this approach of selectively targeting S1PR subtypes to balance therapeutic efficacy and infection risk, what specific experimental designs would best characterize lymphocyte migration patterns in MS patients receiving these modulators? Would you recommend using flow cytometry with specific homing receptor markers combined with in vitro transmigration assays against viral antigens? How should we statistically power such studies to detect clinically relevant differences in lymphocyte subsets while accounting for patient heterogeneity in baseline immune function?", "history": ["What role do S1PR modulators play in treating multiple sclerosis (MS) and how do they affect the immune system?", "How might targeting specific subtypes of these receptors influence the balance between disease control and immune function, particularly concerning infections?", "Given that different S1PR modulators have distinct pharmacological profiles and varying effects on lymphocyte migration and immune responses, how might selectively targeting specific subtypes (like S1PR1 versus S1PR4) help strike the right balance between controlling MS disease activity and preserving immune defenses against emerging viral infections, such as influenza or future coronaviruses? Furthermore, what approaches could be taken to optimize these therapies for MS patients at higher infection risk while still maintaining their therapeutic benefits?"], "ground_truth": ["permed-73687", "permed-81296", "permed-81297", "permed-89273", "permed-84708", "permed-77369", "permed-64689", "permed-8278", "permed-64346", "permed-50340"]}
{"query_id": "topic_720_turn_5", "conversation_id": "topic_720", "turn_id": 5, "query": "Given these detailed experimental frameworks for analyzing lymphocyte migration, how have real-world clinical studies translated these mechanistic insights into patient outcomes? Specifically, what comparative efficacy and safety data exist for selective versus non-selective S1PR modulators in MS patients with high infection risk profiles, and how do these findings inform clinical decision-making regarding therapy escalation or de-escalation based on individual patients' disease activity and immune vulnerability? Additionally, what monitoring protocols have proven effective in clinical practice for detecting early signs of compromised antiviral immunity while maintaining disease control?", "history": ["What role do S1PR modulators play in treating multiple sclerosis (MS) and how do they affect the immune system?", "How might targeting specific subtypes of these receptors influence the balance between disease control and immune function, particularly concerning infections?", "Given that different S1PR modulators have distinct pharmacological profiles and varying effects on lymphocyte migration and immune responses, how might selectively targeting specific subtypes (like S1PR1 versus S1PR4) help strike the right balance between controlling MS disease activity and preserving immune defenses against emerging viral infections, such as influenza or future coronaviruses? Furthermore, what approaches could be taken to optimize these therapies for MS patients at higher infection risk while still maintaining their therapeutic benefits?", "Given this approach of selectively targeting S1PR subtypes to balance therapeutic efficacy and infection risk, what specific experimental designs would best characterize lymphocyte migration patterns in MS patients receiving these modulators? Would you recommend using flow cytometry with specific homing receptor markers combined with in vitro transmigration assays against viral antigens? How should we statistically power such studies to detect clinically relevant differences in lymphocyte subsets while accounting for patient heterogeneity in baseline immune function?"], "ground_truth": ["permed-81296", "permed-64689", "permed-81297", "permed-64346", "permed-72220", "permed-67953", "permed-86635", "permed-78556", "permed-53271", "permed-70936"]}
{"query_id": "topic_721_turn_1", "conversation_id": "topic_721", "turn_id": 1, "query": "Fear of cancer recurrence (FCR) in breast cancer survivors: overview of prevalence, impact, and psychological factors.", "history": [], "ground_truth": ["permed-62798", "permed-65741", "permed-84171", "permed-71642", "permed-72419", "permed-62795", "permed-91774", "permed-62807", "permed-56719", "permed-50984"]}
{"query_id": "topic_721_turn_2", "conversation_id": "topic_721", "turn_id": 2, "query": "Gender differences in the manifestation of this fear of cancer recurrence among breast cancer survivors: comparing male and female experiences and their underlying factors.", "history": ["Fear of cancer recurrence (FCR) in breast cancer survivors: overview of prevalence, impact, and psychological factors."], "ground_truth": ["permed-65741", "permed-62798", "permed-84171", "permed-62033", "permed-62795", "permed-62805", "permed-61987", "permed-88782", "permed-65345", "permed-55662"]}
{"query_id": "topic_721_turn_3", "conversation_id": "topic_721", "turn_id": 3, "query": "Adapting the Lee-Jones model for FCR in male breast cancer survivors informed by these gender differences: investigating unique individual/interpersonal factors, gender-specific resources, coping mechanisms, and implications for tailored psychosocial interventions.", "history": ["Fear of cancer recurrence (FCR) in breast cancer survivors: overview of prevalence, impact, and psychological factors.", "Gender differences in the manifestation of this fear of cancer recurrence among breast cancer survivors: comparing male and female experiences and their underlying factors."], "ground_truth": ["permed-62798", "permed-65741", "permed-62033", "permed-62800", "permed-55662", "permed-65345", "permed-62795", "permed-88782", "permed-91469", "permed-39620"]}
{"query_id": "topic_721_turn_4", "conversation_id": "topic_721", "turn_id": 4, "query": "When implementing this adaptation of the Lee-Jones model for male survivors, what specific methodological approaches were taken to validate the newly identified gender-specific factors? For instance, could you detail the statistical analyses—such as confirmatory factor analysis or structural equation modeling—used to test the model's fit, and describe the procedures for establishing the reliability and validity of any new scales developed to measure male-specific coping mechanisms and interpersonal resources within this theoretical framework?", "history": ["Fear of cancer recurrence (FCR) in breast cancer survivors: overview of prevalence, impact, and psychological factors.", "Gender differences in the manifestation of this fear of cancer recurrence among breast cancer survivors: comparing male and female experiences and their underlying factors.", "Adapting the Lee-Jones model for FCR in male breast cancer survivors informed by these gender differences: investigating unique individual/interpersonal factors, gender-specific resources, coping mechanisms, and implications for tailored psychosocial interventions."], "ground_truth": ["permed-62798", "permed-55811", "permed-62803", "permed-90012", "permed-87441", "permed-91609", "permed-50603", "permed-50684", "permed-34667", "permed-34400"]}
{"query_id": "topic_721_turn_5", "conversation_id": "topic_721", "turn_id": 5, "query": "Given this validated adaptation of the Lee-Jones model for male breast cancer survivors, what clinical outcomes have been observed when implementing these tailored psychosocial interventions in practice? Specifically, have comparative studies or pilot trials demonstrated significant improvements in FCR severity, quality of life, or psychological distress in male survivors compared to those receiving standard care? Furthermore, what are the reported challenges or unintended consequences, such as engagement barriers or potential distress from focusing on masculine norms, that clinicians should anticipate when deploying these gender-specific interventions in real-world oncology settings?", "history": ["Fear of cancer recurrence (FCR) in breast cancer survivors: overview of prevalence, impact, and psychological factors.", "Gender differences in the manifestation of this fear of cancer recurrence among breast cancer survivors: comparing male and female experiences and their underlying factors.", "Adapting the Lee-Jones model for FCR in male breast cancer survivors informed by these gender differences: investigating unique individual/interpersonal factors, gender-specific resources, coping mechanisms, and implications for tailored psychosocial interventions.", "When implementing this adaptation of the Lee-Jones model for male survivors, what specific methodological approaches were taken to validate the newly identified gender-specific factors? For instance, could you detail the statistical analyses—such as confirmatory factor analysis or structural equation modeling—used to test the model's fit, and describe the procedures for establishing the reliability and validity of any new scales developed to measure male-specific coping mechanisms and interpersonal resources within this theoretical framework?"], "ground_truth": ["permed-62798", "permed-55662", "permed-62033", "permed-60059", "permed-62795", "permed-26045", "permed-74751", "permed-51867", "permed-62034", "permed-91469"]}
{"query_id": "topic_721_turn_6", "conversation_id": "topic_721", "turn_id": 6, "query": "Given the established clinical outcomes and implementation challenges discussed, how do the long-term cost-effectiveness and scalability of these gender-tailored interventions for male breast cancer survivors compare to standardized transdiagnostic approaches like CBT or ACT? Considering the specialized training required for gender-specific adaptations versus broader evidence-based protocols, what trade-offs exist between intervention precision and healthcare system feasibility? Furthermore, as digital health platforms emerge, how might technology-enhanced delivery affect this balance between personalized care and population-level accessibility for addressing FCR in this underserved population?", "history": ["Fear of cancer recurrence (FCR) in breast cancer survivors: overview of prevalence, impact, and psychological factors.", "Gender differences in the manifestation of this fear of cancer recurrence among breast cancer survivors: comparing male and female experiences and their underlying factors.", "Adapting the Lee-Jones model for FCR in male breast cancer survivors informed by these gender differences: investigating unique individual/interpersonal factors, gender-specific resources, coping mechanisms, and implications for tailored psychosocial interventions.", "When implementing this adaptation of the Lee-Jones model for male survivors, what specific methodological approaches were taken to validate the newly identified gender-specific factors? For instance, could you detail the statistical analyses—such as confirmatory factor analysis or structural equation modeling—used to test the model's fit, and describe the procedures for establishing the reliability and validity of any new scales developed to measure male-specific coping mechanisms and interpersonal resources within this theoretical framework?", "Given this validated adaptation of the Lee-Jones model for male breast cancer survivors, what clinical outcomes have been observed when implementing these tailored psychosocial interventions in practice? Specifically, have comparative studies or pilot trials demonstrated significant improvements in FCR severity, quality of life, or psychological distress in male survivors compared to those receiving standard care? Furthermore, what are the reported challenges or unintended consequences, such as engagement barriers or potential distress from focusing on masculine norms, that clinicians should anticipate when deploying these gender-specific interventions in real-world oncology settings?"], "ground_truth": ["permed-62033", "permed-62036", "permed-77439", "permed-77440", "permed-71988", "permed-62795", "permed-60539", "permed-72421", "permed-86795", "permed-68401"]}
{"query_id": "topic_722_turn_1", "conversation_id": "topic_722", "turn_id": 1, "query": "What are the main challenges in treating pneumonia in post-CABG patients?", "history": [], "ground_truth": ["permed-57005", "permed-78799", "permed-51937", "permed-57373", "permed-81881", "permed-27054", "permed-58626", "permed-57113", "permed-24113", "permed-5782"]}
{"query_id": "topic_722_turn_2", "conversation_id": "topic_722", "turn_id": 2, "query": "Are there any specific types of pneumonia, like pseudomonas, that pose a greater risk and require specialized treatment protocols in this patient group?", "history": ["What are the main challenges in treating pneumonia in post-CABG patients?"], "ground_truth": ["permed-57005", "permed-5782", "permed-55998", "permed-26578", "permed-55865", "permed-54080", "permed-27054", "permed-81881", "permed-3603", "permed-26576"]}
{"query_id": "topic_722_turn_3", "conversation_id": "topic_722", "turn_id": 3, "query": "Given the increased risk of pseudomonas pneumonia in post-CABG patients, how can we optimize early detection and rapid response protocols specifically for fulminant cases to improve survival rates? What diagnostic markers or clinical indicators should be prioritized when developing these protocols?", "history": ["What are the main challenges in treating pneumonia in post-CABG patients?", "Are there any specific types of pneumonia, like pseudomonas, that pose a greater risk and require specialized treatment protocols in this patient group?"], "ground_truth": ["permed-57005", "permed-81881", "permed-58287", "permed-26582", "permed-67865", "permed-61555", "permed-42610", "permed-63403", "permed-27176", "permed-86536"]}
{"query_id": "topic_722_turn_4", "conversation_id": "topic_722", "turn_id": 4, "query": "For implementing these rapid detection protocols, what specific laboratory processing workflows and rapid diagnostic technologies would you prioritize for pseudomonas identification in post-CABG patients? I'm particularly interested in the comparative validation of multiplex PCR panels versus conventional culture methods - what turnaround time differences and sensitivity/specificity metrics should we expect, and how would you design a diagnostic stewardship protocol to ensure appropriate specimen collection and minimize contamination during the perioperative period?", "history": ["What are the main challenges in treating pneumonia in post-CABG patients?", "Are there any specific types of pneumonia, like pseudomonas, that pose a greater risk and require specialized treatment protocols in this patient group?", "Given the increased risk of pseudomonas pneumonia in post-CABG patients, how can we optimize early detection and rapid response protocols specifically for fulminant cases to improve survival rates? What diagnostic markers or clinical indicators should be prioritized when developing these protocols?"], "ground_truth": ["permed-57005", "permed-62582", "permed-90944", "permed-67865", "permed-67025", "permed-66176", "permed-90465", "permed-87351", "permed-56978", "permed-5556"]}
{"query_id": "topic_722_turn_5", "conversation_id": "topic_722", "turn_id": 5, "query": "Given the promising diagnostic capabilities of multiplex PCR for pseudomonas detection we've discussed, what clinical outcomes have been demonstrated when these rapid results are integrated into antimicrobial stewardship programs for post-CABG patients? Specifically, what evidence exists regarding reduction in time to appropriate antibiotic therapy, ventilator-associated pneumonia rates, or ICU length of stay? Additionally, how do safety considerations like antibiotic de-escalation opportunities and avoidance of nephrotoxicity from broad-spectrum regimens factor into the real-world implementation of these rapid diagnostic pathways in cardiac surgery ICUs?", "history": ["What are the main challenges in treating pneumonia in post-CABG patients?", "Are there any specific types of pneumonia, like pseudomonas, that pose a greater risk and require specialized treatment protocols in this patient group?", "Given the increased risk of pseudomonas pneumonia in post-CABG patients, how can we optimize early detection and rapid response protocols specifically for fulminant cases to improve survival rates? What diagnostic markers or clinical indicators should be prioritized when developing these protocols?", "For implementing these rapid detection protocols, what specific laboratory processing workflows and rapid diagnostic technologies would you prioritize for pseudomonas identification in post-CABG patients? I'm particularly interested in the comparative validation of multiplex PCR panels versus conventional culture methods - what turnaround time differences and sensitivity/specificity metrics should we expect, and how would you design a diagnostic stewardship protocol to ensure appropriate specimen collection and minimize contamination during the perioperative period?"], "ground_truth": ["permed-57005", "permed-56978", "permed-62582", "permed-60399", "permed-67865", "permed-90944", "permed-90465", "permed-49559", "permed-22325", "permed-80202"]}
{"query_id": "topic_722_turn_6", "conversation_id": "topic_722", "turn_id": 6, "query": "Given our detailed discussion about diagnostic and antimicrobial stewardship pathways, could you precisely define what constitutes \"appropriate antibiotic therapy\" in this specific context? Beyond mere pathogen identification, what clinical parameters and host factors should determine whether a treatment regimen qualifies as appropriate for post-CABG pseudomonas pneumonia? Considering the balance between rapid broad-spectrum coverage and de-escalation, how is therapeutic appropriateness fundamentally conceptualized when measuring outcomes like reduced ICU stay, and what consensus definitions exist in critical care literature to standardize this metric across future studies?", "history": ["What are the main challenges in treating pneumonia in post-CABG patients?", "Are there any specific types of pneumonia, like pseudomonas, that pose a greater risk and require specialized treatment protocols in this patient group?", "Given the increased risk of pseudomonas pneumonia in post-CABG patients, how can we optimize early detection and rapid response protocols specifically for fulminant cases to improve survival rates? What diagnostic markers or clinical indicators should be prioritized when developing these protocols?", "For implementing these rapid detection protocols, what specific laboratory processing workflows and rapid diagnostic technologies would you prioritize for pseudomonas identification in post-CABG patients? I'm particularly interested in the comparative validation of multiplex PCR panels versus conventional culture methods - what turnaround time differences and sensitivity/specificity metrics should we expect, and how would you design a diagnostic stewardship protocol to ensure appropriate specimen collection and minimize contamination during the perioperative period?", "Given the promising diagnostic capabilities of multiplex PCR for pseudomonas detection we've discussed, what clinical outcomes have been demonstrated when these rapid results are integrated into antimicrobial stewardship programs for post-CABG patients? Specifically, what evidence exists regarding reduction in time to appropriate antibiotic therapy, ventilator-associated pneumonia rates, or ICU length of stay? Additionally, how do safety considerations like antibiotic de-escalation opportunities and avoidance of nephrotoxicity from broad-spectrum regimens factor into the real-world implementation of these rapid diagnostic pathways in cardiac surgery ICUs?"], "ground_truth": ["permed-57005", "permed-60398", "permed-56974", "permed-60399", "permed-5785", "permed-68908", "permed-68430", "permed-22325", "permed-27230", "permed-87531"]}
{"query_id": "topic_723_turn_1", "conversation_id": "topic_723", "turn_id": 1, "query": "What role do catalysts play in enhancing the performance of lithium-sulfur batteries?", "history": [], "ground_truth": ["permed-50825", "permed-50818", "permed-50820", "permed-76069", "permed-50826", "permed-50827", "permed-50821", "permed-50819", "permed-50824", "permed-78457"]}
{"query_id": "topic_723_turn_2", "conversation_id": "topic_723", "turn_id": 2, "query": "How does the design of these catalysts, particularly their integration into specific materials, impact their effectiveness in this area?", "history": ["What role do catalysts play in enhancing the performance of lithium-sulfur batteries?"], "ground_truth": ["permed-53474", "permed-74950", "permed-73264", "permed-81150", "permed-88221", "permed-58141", "permed-57955", "permed-53480", "permed-73184", "permed-74956"]}
{"query_id": "topic_723_turn_3", "conversation_id": "topic_723", "turn_id": 3, "query": "Given this focus on catalyst design and material integration, how does the structural design of single-atom catalysts—particularly when incorporated into nitrogen-doped carbon materials—affect the electrochemical performance of lithium-sulfur batteries? And what strategies could optimize these catalysts to improve polysulfide conversion and enhance reaction kinetics?", "history": ["What role do catalysts play in enhancing the performance of lithium-sulfur batteries?", "How does the design of these catalysts, particularly their integration into specific materials, impact their effectiveness in this area?"], "ground_truth": ["permed-50826", "permed-50825", "permed-50821", "permed-50827", "permed-76069", "permed-50818", "permed-52426", "permed-50824", "permed-78865", "permed-51998"]}
{"query_id": "topic_723_turn_4", "conversation_id": "topic_723", "turn_id": 4, "query": "Regarding these nitrogen-doped carbon-supported single-atom catalyst designs, what specific synthetic protocols and characterization techniques are most critical for verifying successful atomic dispersion and coordination environments? Given the importance of active site uniformity for polysulfide conversion efficiency, how do researchers typically validate catalyst structural integrity before electrochemical testing, and what quality control measures ensure batch-to-batch reproducibility in these complex material systems?", "history": ["What role do catalysts play in enhancing the performance of lithium-sulfur batteries?", "How does the design of these catalysts, particularly their integration into specific materials, impact their effectiveness in this area?", "Given this focus on catalyst design and material integration, how does the structural design of single-atom catalysts—particularly when incorporated into nitrogen-doped carbon materials—affect the electrochemical performance of lithium-sulfur batteries? And what strategies could optimize these catalysts to improve polysulfide conversion and enhance reaction kinetics?"], "ground_truth": ["permed-82647", "permed-50826", "permed-74574", "permed-57955", "permed-88509", "permed-57980", "permed-74853", "permed-50825", "permed-50827", "permed-52426"]}
{"query_id": "topic_723_turn_5", "conversation_id": "topic_723", "turn_id": 5, "query": "Given these advanced synthetic and characterization protocols for nitrogen-doped carbon single-atom catalysts, how have these material systems translated to clinical-stage applications in medical device batteries? Considering their enhanced electrochemical performance in lithium-sulfur systems, what safety profiles have been established regarding catalyst leaching or nanomaterial toxicity in implantable devices? Have any clinical trials evaluated long-term biocompatibility when these catalytic materials interface with biological systems, particularly regarding inflammatory responses or tissue compatibility in sustained-energy medical implants?", "history": ["What role do catalysts play in enhancing the performance of lithium-sulfur batteries?", "How does the design of these catalysts, particularly their integration into specific materials, impact their effectiveness in this area?", "Given this focus on catalyst design and material integration, how does the structural design of single-atom catalysts—particularly when incorporated into nitrogen-doped carbon materials—affect the electrochemical performance of lithium-sulfur batteries? And what strategies could optimize these catalysts to improve polysulfide conversion and enhance reaction kinetics?", "Regarding these nitrogen-doped carbon-supported single-atom catalyst designs, what specific synthetic protocols and characterization techniques are most critical for verifying successful atomic dispersion and coordination environments? Given the importance of active site uniformity for polysulfide conversion efficiency, how do researchers typically validate catalyst structural integrity before electrochemical testing, and what quality control measures ensure batch-to-batch reproducibility in these complex material systems?"], "ground_truth": ["permed-50827", "permed-50826", "permed-82647", "permed-76069", "permed-64622", "permed-74369", "permed-50828", "permed-50825", "permed-88509", "permed-74854"]}
{"query_id": "topic_723_turn_6", "conversation_id": "topic_723", "turn_id": 6, "query": "Given our progression from fundamental catalyst mechanisms to clinical safety considerations, how do we precisely define \"biocompatibility\" in the context of nitrogen-doped carbon single-atom catalysts for implantable battery systems? Beyond conventional ISO 10993 standards for medical devices, what specific physicochemical parameters—such as surface charge distribution, degradation byproduct profiles, or atomic leaching thresholds—constitute the operational definition of biocompatibility for these advanced nanomaterials? Furthermore, how might this definition evolve as we consider long-term tissue integration versus transient inflammatory responses, particularly when catalyst materials persist in biological environments for decades?", "history": ["What role do catalysts play in enhancing the performance of lithium-sulfur batteries?", "How does the design of these catalysts, particularly their integration into specific materials, impact their effectiveness in this area?", "Given this focus on catalyst design and material integration, how does the structural design of single-atom catalysts—particularly when incorporated into nitrogen-doped carbon materials—affect the electrochemical performance of lithium-sulfur batteries? And what strategies could optimize these catalysts to improve polysulfide conversion and enhance reaction kinetics?", "Regarding these nitrogen-doped carbon-supported single-atom catalyst designs, what specific synthetic protocols and characterization techniques are most critical for verifying successful atomic dispersion and coordination environments? Given the importance of active site uniformity for polysulfide conversion efficiency, how do researchers typically validate catalyst structural integrity before electrochemical testing, and what quality control measures ensure batch-to-batch reproducibility in these complex material systems?", "Given these advanced synthetic and characterization protocols for nitrogen-doped carbon single-atom catalysts, how have these material systems translated to clinical-stage applications in medical device batteries? Considering their enhanced electrochemical performance in lithium-sulfur systems, what safety profiles have been established regarding catalyst leaching or nanomaterial toxicity in implantable devices? Have any clinical trials evaluated long-term biocompatibility when these catalytic materials interface with biological systems, particularly regarding inflammatory responses or tissue compatibility in sustained-energy medical implants?"], "ground_truth": ["permed-51339", "permed-54876", "permed-91202", "permed-50827", "permed-74369", "permed-82647", "permed-64622", "permed-51340", "permed-81235", "permed-51302"]}
{"query_id": "topic_724_turn_1", "conversation_id": "topic_724", "turn_id": 1, "query": "Mesenchymal stem cell therapy for deep venous thrombosis in pregnancy: role and potential", "history": [], "ground_truth": ["permed-78160", "permed-58758", "permed-71333", "permed-56265", "permed-91915", "permed-55939", "permed-76355", "permed-78946", "permed-74837", "permed-51399"]}
{"query_id": "topic_724_turn_2", "conversation_id": "topic_724", "turn_id": 2, "query": "Comparing angiogenic effects of bone marrow mesenchymal stem cells versus umbilical cord mesenchymal stem cells for treating pregnancy-associated deep venous thrombosis", "history": ["Mesenchymal stem cell therapy for deep venous thrombosis in pregnancy: role and potential"], "ground_truth": ["permed-78160", "permed-71333", "permed-78161", "permed-55939", "permed-56265", "permed-54898", "permed-75248", "permed-90808", "permed-68190", "permed-55192"]}
{"query_id": "topic_724_turn_3", "conversation_id": "topic_724", "turn_id": 3, "query": "Molecular mechanisms of enhanced pro-angiogenic effects of umbilical cord MSCs vs. bone marrow MSCs in pregnant rat DVT model: angiogenic factor-receptor interactions and fetal-maternal health outcomes", "history": ["Mesenchymal stem cell therapy for deep venous thrombosis in pregnancy: role and potential", "Comparing angiogenic effects of bone marrow mesenchymal stem cells versus umbilical cord mesenchymal stem cells for treating pregnancy-associated deep venous thrombosis"], "ground_truth": ["permed-78160", "permed-78161", "permed-78162", "permed-75098", "permed-78228", "permed-89331", "permed-88435", "permed-90808", "permed-78227", "permed-55192"]}
{"query_id": "topic_724_turn_4", "conversation_id": "topic_724", "turn_id": 4, "query": "For the comparative analysis of angiogenic mechanisms in your pregnant rat DVT model, what specific experimental protocols did you implement to quantify angiogenic factor-receptor interactions? I'm particularly interested in how you validated the binding affinities between UC-MSC-derived factors and maternal endothelial receptors, and which statistical approaches were used to ensure the observed differences in fetal-maternal health outcomes weren't confounded by individual maternal physiological variations.", "history": ["Mesenchymal stem cell therapy for deep venous thrombosis in pregnancy: role and potential", "Comparing angiogenic effects of bone marrow mesenchymal stem cells versus umbilical cord mesenchymal stem cells for treating pregnancy-associated deep venous thrombosis", "Molecular mechanisms of enhanced pro-angiogenic effects of umbilical cord MSCs vs. bone marrow MSCs in pregnant rat DVT model: angiogenic factor-receptor interactions and fetal-maternal health outcomes"], "ground_truth": ["permed-78160", "permed-82471", "permed-78161", "permed-78228", "permed-80307", "permed-78162", "permed-89331", "permed-75098", "permed-7391", "permed-88435"]}
{"query_id": "topic_724_turn_5", "conversation_id": "topic_724", "turn_id": 5, "query": "Given your detailed quantification of angiogenic factor-receptor interactions in the pregnant rat DVT model, how do the therapeutic outcomes of UC-MSCs versus BM-MSCs compare when administered at different gestational timepoints? Specifically, what are the comparative risks of pregnancy loss versus thrombus resolution efficacy across trimesters, and does the timing of MSC administration create different trade-offs in maternal hemodynamic stability versus fetal developmental outcomes?", "history": ["Mesenchymal stem cell therapy for deep venous thrombosis in pregnancy: role and potential", "Comparing angiogenic effects of bone marrow mesenchymal stem cells versus umbilical cord mesenchymal stem cells for treating pregnancy-associated deep venous thrombosis", "Molecular mechanisms of enhanced pro-angiogenic effects of umbilical cord MSCs vs. bone marrow MSCs in pregnant rat DVT model: angiogenic factor-receptor interactions and fetal-maternal health outcomes", "For the comparative analysis of angiogenic mechanisms in your pregnant rat DVT model, what specific experimental protocols did you implement to quantify angiogenic factor-receptor interactions? I'm particularly interested in how you validated the binding affinities between UC-MSC-derived factors and maternal endothelial receptors, and which statistical approaches were used to ensure the observed differences in fetal-maternal health outcomes weren't confounded by individual maternal physiological variations."], "ground_truth": ["permed-78160", "permed-41724", "permed-68184", "permed-86496", "permed-47575", "permed-78161", "permed-78162", "permed-51180", "permed-78228", "permed-50192"]}
{"query_id": "topic_724_turn_6", "conversation_id": "topic_724", "turn_id": 6, "query": "Considering the trimester-dependent trade-offs between thrombus resolution and pregnancy preservation established in our pregnant rat model, how do the long-term maternal vascular health outcomes following UC-MSC therapy compare to BM-MSC treatment? Specifically, when evaluating beyond immediate gestational outcomes, what are the comparative risks of chronic venous insufficiency development versus subsequent thrombotic events during future pregnancies? Does the superior angiogenic factor-receptor binding affinity of UC-MSCs translate to lasting vascular protection that outweighs BM-MSCs' potential advantages in maternal immune tolerance, particularly when considering lifetime cardiovascular health trajectories?", "history": ["Mesenchymal stem cell therapy for deep venous thrombosis in pregnancy: role and potential", "Comparing angiogenic effects of bone marrow mesenchymal stem cells versus umbilical cord mesenchymal stem cells for treating pregnancy-associated deep venous thrombosis", "Molecular mechanisms of enhanced pro-angiogenic effects of umbilical cord MSCs vs. bone marrow MSCs in pregnant rat DVT model: angiogenic factor-receptor interactions and fetal-maternal health outcomes", "For the comparative analysis of angiogenic mechanisms in your pregnant rat DVT model, what specific experimental protocols did you implement to quantify angiogenic factor-receptor interactions? I'm particularly interested in how you validated the binding affinities between UC-MSC-derived factors and maternal endothelial receptors, and which statistical approaches were used to ensure the observed differences in fetal-maternal health outcomes weren't confounded by individual maternal physiological variations.", "Given your detailed quantification of angiogenic factor-receptor interactions in the pregnant rat DVT model, how do the therapeutic outcomes of UC-MSCs versus BM-MSCs compare when administered at different gestational timepoints? Specifically, what are the comparative risks of pregnancy loss versus thrombus resolution efficacy across trimesters, and does the timing of MSC administration create different trade-offs in maternal hemodynamic stability versus fetal developmental outcomes?"], "ground_truth": ["permed-78160", "permed-47575", "permed-68184", "permed-51180", "permed-78162", "permed-78161", "permed-68181", "permed-54169", "permed-41724", "permed-86496"]}
{"query_id": "topic_725_turn_1", "conversation_id": "topic_725", "turn_id": 1, "query": "What role do community-based organizations play in supporting patient health in urban areas?", "history": [], "ground_truth": ["permed-67357", "permed-91926", "permed-66148", "permed-53049", "permed-53059", "permed-65626", "permed-74571", "permed-80120", "permed-52213", "permed-69418"]}
{"query_id": "topic_725_turn_2", "conversation_id": "topic_725", "turn_id": 2, "query": "Can integrating these organizations with healthcare providers improve outcomes in this area?", "history": ["What role do community-based organizations play in supporting patient health in urban areas?"], "ground_truth": ["permed-91926", "permed-67357", "permed-53143", "permed-61615", "permed-66148", "permed-52110", "permed-57447", "permed-66153", "permed-50966", "permed-52213"]}
{"query_id": "topic_725_turn_3", "conversation_id": "topic_725", "turn_id": 3, "query": "How might combining these community-based organizations with healthcare providers into a comprehensive support network make patient navigation programs more effective and better address health-related social determinants in urban areas?", "history": ["What role do community-based organizations play in supporting patient health in urban areas?", "Can integrating these organizations with healthcare providers improve outcomes in this area?"], "ground_truth": ["permed-67357", "permed-80120", "permed-52113", "permed-51868", "permed-74571", "permed-67356", "permed-65626", "permed-52213", "permed-67359", "permed-60175"]}
{"query_id": "topic_725_turn_4", "conversation_id": "topic_725", "turn_id": 4, "query": "Given this network integration approach, what specific methodological frameworks would be most appropriate for evaluating the coordination mechanisms between community organizations and healthcare providers? I'm particularly interested in how researchers might quantitatively measure communication protocols, resource sharing efficiency, and care coordination workflows. What mixed-methods approaches have proven effective for capturing both implementation fidelity and patient navigation outcomes in such complex urban health interventions?", "history": ["What role do community-based organizations play in supporting patient health in urban areas?", "Can integrating these organizations with healthcare providers improve outcomes in this area?", "How might combining these community-based organizations with healthcare providers into a comprehensive support network make patient navigation programs more effective and better address health-related social determinants in urban areas?"], "ground_truth": ["permed-52380", "permed-52110", "permed-61888", "permed-74572", "permed-91392", "permed-74112", "permed-45259", "permed-58475", "permed-25353", "permed-34403"]}
{"query_id": "topic_725_turn_5", "conversation_id": "topic_725", "turn_id": 5, "query": "Given these methodological frameworks for evaluating integrated networks, what clinical outcomes have been demonstrated when such community-health provider partnerships are implemented in urban settings? Specifically, how do these interventions impact patient-level metrics like medication adherence rates, hospital readmission frequencies, and chronic disease management indicators across different socioeconomic groups? What evidence exists regarding the translation of improved care coordination into measurable therapeutic efficacy, and have any clinical trials identified specific patient populations that derive disproportionate benefit or experience unique safety considerations from these integrated approaches?", "history": ["What role do community-based organizations play in supporting patient health in urban areas?", "Can integrating these organizations with healthcare providers improve outcomes in this area?", "How might combining these community-based organizations with healthcare providers into a comprehensive support network make patient navigation programs more effective and better address health-related social determinants in urban areas?", "Given this network integration approach, what specific methodological frameworks would be most appropriate for evaluating the coordination mechanisms between community organizations and healthcare providers? I'm particularly interested in how researchers might quantitatively measure communication protocols, resource sharing efficiency, and care coordination workflows. What mixed-methods approaches have proven effective for capturing both implementation fidelity and patient navigation outcomes in such complex urban health interventions?"], "ground_truth": ["permed-74572", "permed-52428", "permed-80810", "permed-88674", "permed-52110", "permed-50969", "permed-89012", "permed-81763", "permed-55096", "permed-90780"]}
{"query_id": "topic_725_turn_6", "conversation_id": "topic_725", "turn_id": 6, "query": "Given the established methodological frameworks and clinical outcomes we've discussed, how do the implementation costs and long-term sustainability of integrated community-health provider networks compare across different urban settings? Specifically, what are the trade-offs between resource-intensive coordination models showing superior clinical outcomes versus more streamlined approaches that might offer better scalability? As we consider future directions, how do these economic considerations compare against emerging digital health platforms that promise similar care coordination benefits with potentially lower operational overhead?", "history": ["What role do community-based organizations play in supporting patient health in urban areas?", "Can integrating these organizations with healthcare providers improve outcomes in this area?", "How might combining these community-based organizations with healthcare providers into a comprehensive support network make patient navigation programs more effective and better address health-related social determinants in urban areas?", "Given this network integration approach, what specific methodological frameworks would be most appropriate for evaluating the coordination mechanisms between community organizations and healthcare providers? I'm particularly interested in how researchers might quantitatively measure communication protocols, resource sharing efficiency, and care coordination workflows. What mixed-methods approaches have proven effective for capturing both implementation fidelity and patient navigation outcomes in such complex urban health interventions?", "Given these methodological frameworks for evaluating integrated networks, what clinical outcomes have been demonstrated when such community-health provider partnerships are implemented in urban settings? Specifically, how do these interventions impact patient-level metrics like medication adherence rates, hospital readmission frequencies, and chronic disease management indicators across different socioeconomic groups? What evidence exists regarding the translation of improved care coordination into measurable therapeutic efficacy, and have any clinical trials identified specific patient populations that derive disproportionate benefit or experience unique safety considerations from these integrated approaches?"], "ground_truth": ["permed-84590", "permed-61613", "permed-91392", "permed-78657", "permed-65574", "permed-46568", "permed-74572", "permed-33681", "permed-61882", "permed-74112"]}
{"query_id": "topic_726_turn_1", "conversation_id": "topic_726", "turn_id": 1, "query": "What are the latest advancements in mRNA vaccine technology focusing on improved immune responses and safety profiles?", "history": [], "ground_truth": ["permed-51926", "permed-68312", "permed-74996", "permed-74997", "permed-58998", "permed-86821", "permed-78074", "permed-74995", "permed-22342", "permed-74994"]}
{"query_id": "topic_726_turn_2", "conversation_id": "topic_726", "turn_id": 2, "query": "Building on these advancements, how do innovations like lipid-free delivery systems impact the distribution and overall efficacy of such mRNA vaccines?", "history": ["What are the latest advancements in mRNA vaccine technology focusing on improved immune responses and safety profiles?"], "ground_truth": ["permed-74994", "permed-86822", "permed-75000", "permed-74993", "permed-51301", "permed-79016", "permed-74996", "permed-74995", "permed-51924", "permed-64449"]}
{"query_id": "topic_726_turn_3", "conversation_id": "topic_726", "turn_id": 3, "query": "Focusing on PEG-lipid-free mRNA nanoassemblies, how can their unique material properties be leveraged to improve vaccine stability, ensure efficacy under varied storage conditions, and overcome distribution hurdles in low-resource areas?", "history": ["What are the latest advancements in mRNA vaccine technology focusing on improved immune responses and safety profiles?", "Building on these advancements, how do innovations like lipid-free delivery systems impact the distribution and overall efficacy of such mRNA vaccines?"], "ground_truth": ["permed-79827", "permed-74992", "permed-74999", "permed-79825", "permed-86822", "permed-74994", "permed-74995", "permed-51301", "permed-75000", "permed-74993"]}
{"query_id": "topic_726_turn_4", "conversation_id": "topic_726", "turn_id": 4, "query": "Given the unique material properties of PEG-lipid-free mRNA nanoassemblies discussed, what specific characterization techniques and stability-indicating assays were employed to quantitatively assess their structural integrity and mRNA protection efficiency under accelerated storage conditions? Particularly, how was the correlation between biophysical parameters like particle size distribution and polydispersity index with functional outcomes such as in vitro transfection efficiency validated across different temperature ranges?", "history": ["What are the latest advancements in mRNA vaccine technology focusing on improved immune responses and safety profiles?", "Building on these advancements, how do innovations like lipid-free delivery systems impact the distribution and overall efficacy of such mRNA vaccines?", "Focusing on PEG-lipid-free mRNA nanoassemblies, how can their unique material properties be leveraged to improve vaccine stability, ensure efficacy under varied storage conditions, and overcome distribution hurdles in low-resource areas?"], "ground_truth": ["permed-79827", "permed-79256", "permed-79825", "permed-74999", "permed-74992", "permed-79016", "permed-86822", "permed-51301", "permed-86821", "permed-74995"]}
{"query_id": "topic_726_turn_5", "conversation_id": "topic_726", "turn_id": 5, "query": "Given these validated correlations between biophysical stability and functional performance in PEG-lipid-free mRNA nanoassemblies, what clinical trial evidence exists regarding their comparative therapeutic efficacy and safety profiles in human populations? Specifically, how do patient outcomes—including immunogenicity, reactogenicity, and incidence of adverse events—compare between these next-generation delivery systems and conventional lipid nanoparticle platforms in prophylactic vaccine applications? Additionally, what deployment challenges have emerged when translating these temperature-stable formulations into real-world clinical settings, particularly regarding administration logistics and cold chain independence?", "history": ["What are the latest advancements in mRNA vaccine technology focusing on improved immune responses and safety profiles?", "Building on these advancements, how do innovations like lipid-free delivery systems impact the distribution and overall efficacy of such mRNA vaccines?", "Focusing on PEG-lipid-free mRNA nanoassemblies, how can their unique material properties be leveraged to improve vaccine stability, ensure efficacy under varied storage conditions, and overcome distribution hurdles in low-resource areas?", "Given the unique material properties of PEG-lipid-free mRNA nanoassemblies discussed, what specific characterization techniques and stability-indicating assays were employed to quantitatively assess their structural integrity and mRNA protection efficiency under accelerated storage conditions? Particularly, how was the correlation between biophysical parameters like particle size distribution and polydispersity index with functional outcomes such as in vitro transfection efficiency validated across different temperature ranges?"], "ground_truth": ["permed-74992", "permed-86822", "permed-74999", "permed-79825", "permed-79827", "permed-74993", "permed-75000", "permed-86821", "permed-51332", "permed-74994"]}
{"query_id": "topic_726_turn_6", "conversation_id": "topic_726", "turn_id": 6, "query": "Given our detailed discussion about biophysical correlations and clinical translation of PEG-lipid-free mRNA nanoassemblies, how do we fundamentally define \"cold chain independence\" in practical terms for these next-generation vaccines? Beyond simply withstanding higher temperatures, what specific technical parameters—such as maximum allowable excursion duration, cumulative thermal load thresholds, or degradation kinetics under cyclic temperature variations—constitute the operational definition of true cold chain independence? Furthermore, how does this definition differ conceptually from conventional cold chain optimization, and what fundamental material properties enable these systems to achieve this paradigm shift in distribution logistics?", "history": ["What are the latest advancements in mRNA vaccine technology focusing on improved immune responses and safety profiles?", "Building on these advancements, how do innovations like lipid-free delivery systems impact the distribution and overall efficacy of such mRNA vaccines?", "Focusing on PEG-lipid-free mRNA nanoassemblies, how can their unique material properties be leveraged to improve vaccine stability, ensure efficacy under varied storage conditions, and overcome distribution hurdles in low-resource areas?", "Given the unique material properties of PEG-lipid-free mRNA nanoassemblies discussed, what specific characterization techniques and stability-indicating assays were employed to quantitatively assess their structural integrity and mRNA protection efficiency under accelerated storage conditions? Particularly, how was the correlation between biophysical parameters like particle size distribution and polydispersity index with functional outcomes such as in vitro transfection efficiency validated across different temperature ranges?", "Given these validated correlations between biophysical stability and functional performance in PEG-lipid-free mRNA nanoassemblies, what clinical trial evidence exists regarding their comparative therapeutic efficacy and safety profiles in human populations? Specifically, how do patient outcomes—including immunogenicity, reactogenicity, and incidence of adverse events—compare between these next-generation delivery systems and conventional lipid nanoparticle platforms in prophylactic vaccine applications? Additionally, what deployment challenges have emerged when translating these temperature-stable formulations into real-world clinical settings, particularly regarding administration logistics and cold chain independence?"], "ground_truth": ["permed-79827", "permed-74992", "permed-74999", "permed-86821", "permed-79016", "permed-74995", "permed-79665", "permed-57789", "permed-74994", "permed-74993"]}
{"query_id": "topic_727_turn_1", "conversation_id": "topic_727", "turn_id": 1, "query": "What factors affect the measurement of soft tissue properties in medical research?", "history": [], "ground_truth": ["permed-64570", "permed-64573", "permed-91679", "permed-91636", "permed-81055", "permed-85420", "permed-71492", "permed-67605", "permed-64457", "permed-63063"]}
{"query_id": "topic_727_turn_2", "conversation_id": "topic_727", "turn_id": 2, "query": "How do environmental conditions influence the accuracy of these measurements in this area?", "history": ["What factors affect the measurement of soft tissue properties in medical research?"], "ground_truth": ["permed-80404", "permed-74095", "permed-76194", "permed-83127", "permed-60604", "permed-88358", "permed-76197", "permed-42252", "permed-80402", "permed-55107"]}
{"query_id": "topic_727_turn_3", "conversation_id": "topic_727", "turn_id": 3, "query": "Given these factors and environmental influences, how exactly do specific mechanical testing conditions—like temperature, hydration, and pre-loading states—affect the outcomes when measuring soft tissue properties? And what does this mean for the reproducibility and clinical relevance of such data in regenerative medicine and surgical training applications?", "history": ["What factors affect the measurement of soft tissue properties in medical research?", "How do environmental conditions influence the accuracy of these measurements in this area?"], "ground_truth": ["permed-64570", "permed-64573", "permed-91679", "permed-91636", "permed-80565", "permed-81055", "permed-81057", "permed-67605", "permed-63060", "permed-89550"]}
{"query_id": "topic_727_turn_4", "conversation_id": "topic_727", "turn_id": 4, "query": "Considering these mechanical testing variables, what specific protocols do researchers employ to standardize temperature and hydration conditions during soft tissue testing? I'm particularly interested in how they implement environmental chambers and hydration control systems, and what validation methods they use to ensure consistent pre-loading states across samples. How do these standardization approaches affect the statistical power when comparing results across different laboratories, and what quality control metrics are typically reported to address reproducibility concerns?", "history": ["What factors affect the measurement of soft tissue properties in medical research?", "How do environmental conditions influence the accuracy of these measurements in this area?", "Given these factors and environmental influences, how exactly do specific mechanical testing conditions—like temperature, hydration, and pre-loading states—affect the outcomes when measuring soft tissue properties? And what does this mean for the reproducibility and clinical relevance of such data in regenerative medicine and surgical training applications?"], "ground_truth": ["permed-70841", "permed-64570", "permed-64573", "permed-91936", "permed-81055", "permed-81684", "permed-81057", "permed-91679", "permed-72026", "permed-39393"]}
{"query_id": "topic_727_turn_5", "conversation_id": "topic_727", "turn_id": 5, "query": "Given these standardization protocols for mechanical testing, how have these methodological refinements translated to clinical applications? Specifically, what clinical outcomes have been observed in areas like tendon repair or ligament reconstruction when surgical techniques are informed by standardized soft tissue property data? I'm interested in whether improved measurement consistency has led to better predictability of graft performance or reduced postoperative complications in real-world surgical settings, and what evidence exists from comparative clinical studies or registry data regarding therapeutic efficacy.", "history": ["What factors affect the measurement of soft tissue properties in medical research?", "How do environmental conditions influence the accuracy of these measurements in this area?", "Given these factors and environmental influences, how exactly do specific mechanical testing conditions—like temperature, hydration, and pre-loading states—affect the outcomes when measuring soft tissue properties? And what does this mean for the reproducibility and clinical relevance of such data in regenerative medicine and surgical training applications?", "Considering these mechanical testing variables, what specific protocols do researchers employ to standardize temperature and hydration conditions during soft tissue testing? I'm particularly interested in how they implement environmental chambers and hydration control systems, and what validation methods they use to ensure consistent pre-loading states across samples. How do these standardization approaches affect the statistical power when comparing results across different laboratories, and what quality control metrics are typically reported to address reproducibility concerns?"], "ground_truth": ["permed-64570", "permed-81684", "permed-64573", "permed-83590", "permed-70841", "permed-77591", "permed-54516", "permed-91679", "permed-81056", "permed-91327"]}
{"query_id": "topic_727_turn_6", "conversation_id": "topic_727", "turn_id": 6, "query": "Given our discussion about standardization protocols and their clinical translation, I want to clarify what we fundamentally mean by \"soft tissue property\" in this specific biomechanical context. Beyond generalized definitions, how is this term operationally defined when linking laboratory measurements to clinical outcomes? Specifically, what constitutive model parameters (e.g., hyperelastic constants, viscoelastic relaxation spectra) are now considered the essential, clinically-relevant properties that standardized testing aims to quantify, and how has this definition evolved from simple stress-strain curves to its current multi-parametric understanding that supposedly predicts in vivo performance?", "history": ["What factors affect the measurement of soft tissue properties in medical research?", "How do environmental conditions influence the accuracy of these measurements in this area?", "Given these factors and environmental influences, how exactly do specific mechanical testing conditions—like temperature, hydration, and pre-loading states—affect the outcomes when measuring soft tissue properties? And what does this mean for the reproducibility and clinical relevance of such data in regenerative medicine and surgical training applications?", "Considering these mechanical testing variables, what specific protocols do researchers employ to standardize temperature and hydration conditions during soft tissue testing? I'm particularly interested in how they implement environmental chambers and hydration control systems, and what validation methods they use to ensure consistent pre-loading states across samples. How do these standardization approaches affect the statistical power when comparing results across different laboratories, and what quality control metrics are typically reported to address reproducibility concerns?", "Given these standardization protocols for mechanical testing, how have these methodological refinements translated to clinical applications? Specifically, what clinical outcomes have been observed in areas like tendon repair or ligament reconstruction when surgical techniques are informed by standardized soft tissue property data? I'm interested in whether improved measurement consistency has led to better predictability of graft performance or reduced postoperative complications in real-world surgical settings, and what evidence exists from comparative clinical studies or registry data regarding therapeutic efficacy."], "ground_truth": ["permed-64570", "permed-64573", "permed-64457", "permed-91679", "permed-75510", "permed-14207", "permed-89550", "permed-71492", "permed-91636", "permed-80565"]}
{"query_id": "topic_728_turn_1", "conversation_id": "topic_728", "turn_id": 1, "query": "Key applications and impact of molecular dynamics simulations in advancing antibody design and engineering", "history": [], "ground_truth": ["permed-84331", "permed-75971", "permed-53323", "permed-77123", "permed-53322", "permed-60645", "permed-75972", "permed-71540", "permed-53316", "permed-74957"]}
{"query_id": "topic_728_turn_2", "conversation_id": "topic_728", "turn_id": 2, "query": "Regarding its applications in antibody engineering, how can molecular dynamics specifically enhance bispecific antibody stability and target specificity?", "history": ["Key applications and impact of molecular dynamics simulations in advancing antibody design and engineering"], "ground_truth": ["permed-75971", "permed-89407", "permed-87475", "permed-79015", "permed-79296", "permed-53323", "permed-77046", "permed-53322", "permed-75975", "permed-67213"]}
{"query_id": "topic_728_turn_3", "conversation_id": "topic_728", "turn_id": 3, "query": "Given these MD-driven enhancements for bispecifics, how can analysis of CH3-CH3 interface dissociation intermediates guide rational engineering of novel antibody formats for precisely tuned stability and specificity?", "history": ["Key applications and impact of molecular dynamics simulations in advancing antibody design and engineering", "Regarding its applications in antibody engineering, how can molecular dynamics specifically enhance bispecific antibody stability and target specificity?"], "ground_truth": ["permed-75971", "permed-77046", "permed-89407", "permed-79015", "permed-84331", "permed-87475", "permed-83831", "permed-75975", "permed-85984", "permed-58154"]}
{"query_id": "topic_728_turn_4", "conversation_id": "topic_728", "turn_id": 4, "query": "When analyzing these CH3-CH3 interface dissociation intermediates through MD simulations, what specific collective variables and enhanced sampling protocols would you recommend for quantifying the free energy landscape of domain separation? I'm particularly interested in how to technically implement these methods to distinguish between different unfolding pathways and identify critical transition states that could inform mutagenesis strategies for stability engineering.", "history": ["Key applications and impact of molecular dynamics simulations in advancing antibody design and engineering", "Regarding its applications in antibody engineering, how can molecular dynamics specifically enhance bispecific antibody stability and target specificity?", "Given these MD-driven enhancements for bispecifics, how can analysis of CH3-CH3 interface dissociation intermediates guide rational engineering of novel antibody formats for precisely tuned stability and specificity?"], "ground_truth": ["permed-75971", "permed-74957", "permed-83857", "permed-88097", "permed-75068", "permed-61290", "permed-76029", "permed-75896", "permed-75976", "permed-88195"]}
{"query_id": "topic_728_turn_5", "conversation_id": "topic_728", "turn_id": 5, "query": "Given your detailed technical recommendations for analyzing CH3-CH3 interface dissociation, how would you comparatively evaluate the trade-offs between different enhanced sampling approaches like metadynamics versus umbrella sampling when specifically applied to antibody domain separation? I'm particularly interested in how their relative performance differs in terms of computational efficiency, accuracy in reconstructing complex unfolding pathways, and practical implementation challenges for identifying mutagenesis targets. Which approach might be better suited for different stages of antibody engineering workflows, and what specific contextual factors should guide this methodological choice?", "history": ["Key applications and impact of molecular dynamics simulations in advancing antibody design and engineering", "Regarding its applications in antibody engineering, how can molecular dynamics specifically enhance bispecific antibody stability and target specificity?", "Given these MD-driven enhancements for bispecifics, how can analysis of CH3-CH3 interface dissociation intermediates guide rational engineering of novel antibody formats for precisely tuned stability and specificity?", "When analyzing these CH3-CH3 interface dissociation intermediates through MD simulations, what specific collective variables and enhanced sampling protocols would you recommend for quantifying the free energy landscape of domain separation? I'm particularly interested in how to technically implement these methods to distinguish between different unfolding pathways and identify critical transition states that could inform mutagenesis strategies for stability engineering."], "ground_truth": ["permed-75971", "permed-84331", "permed-77046", "permed-85984", "permed-75068", "permed-74957", "permed-61290", "permed-53319", "permed-53316", "permed-77047"]}
{"query_id": "topic_728_turn_6", "conversation_id": "topic_728", "turn_id": 6, "query": "Given our comprehensive discussion of enhanced sampling methods for antibody domain separation, how do the computational insights gained from these molecular dynamics approaches compare with experimental techniques like hydrogen-deuterium exchange mass spectrometry or single-molecule force spectroscopy in terms of resolving transient intermediate states? Specifically, what are the complementary strengths and limitations when correlating computational transition states with experimental unfolding pathways for validating mutagenesis strategies, and how might emerging hybrid computational-experimental frameworks address current gaps in characterizing complex antibody dissociation mechanisms?", "history": ["Key applications and impact of molecular dynamics simulations in advancing antibody design and engineering", "Regarding its applications in antibody engineering, how can molecular dynamics specifically enhance bispecific antibody stability and target specificity?", "Given these MD-driven enhancements for bispecifics, how can analysis of CH3-CH3 interface dissociation intermediates guide rational engineering of novel antibody formats for precisely tuned stability and specificity?", "When analyzing these CH3-CH3 interface dissociation intermediates through MD simulations, what specific collective variables and enhanced sampling protocols would you recommend for quantifying the free energy landscape of domain separation? I'm particularly interested in how to technically implement these methods to distinguish between different unfolding pathways and identify critical transition states that could inform mutagenesis strategies for stability engineering.", "Given your detailed technical recommendations for analyzing CH3-CH3 interface dissociation, how would you comparatively evaluate the trade-offs between different enhanced sampling approaches like metadynamics versus umbrella sampling when specifically applied to antibody domain separation? I'm particularly interested in how their relative performance differs in terms of computational efficiency, accuracy in reconstructing complex unfolding pathways, and practical implementation challenges for identifying mutagenesis targets. Which approach might be better suited for different stages of antibody engineering workflows, and what specific contextual factors should guide this methodological choice?"], "ground_truth": ["permed-75971", "permed-84331", "permed-74957", "permed-61290", "permed-77046", "permed-83857", "permed-67213", "permed-85984", "permed-71540", "permed-53322"]}
{"query_id": "topic_729_turn_1", "conversation_id": "topic_729", "turn_id": 1, "query": "Current methods for estimating prevalence of hypertension and diabetes in diverse populations", "history": [], "ground_truth": ["permed-79124", "permed-75646", "permed-88327", "permed-66153", "permed-55182", "permed-65567", "permed-58661", "permed-58663", "permed-65107", "permed-76350"]}
{"query_id": "topic_729_turn_2", "conversation_id": "topic_729", "turn_id": 2, "query": "Comparing effectiveness of spatial sampling frame (SSF) for estimating prevalence of these chronic conditions against other survey methods, especially in limited-data areas", "history": ["Current methods for estimating prevalence of hypertension and diabetes in diverse populations"], "ground_truth": ["permed-75646", "permed-88327", "permed-66153", "permed-61889", "permed-75644", "permed-87739", "permed-69946", "permed-71530", "permed-69858", "permed-86009"]}
{"query_id": "topic_729_turn_3", "conversation_id": "topic_729", "turn_id": 3, "query": "Improving spatial sampling frame (SSF) accuracy for estimating prevalence of these chronic conditions with limited household data: geospatial AI integration, ethical and practical challenges", "history": ["Current methods for estimating prevalence of hypertension and diabetes in diverse populations", "Comparing effectiveness of spatial sampling frame (SSF) for estimating prevalence of these chronic conditions against other survey methods, especially in limited-data areas"], "ground_truth": ["permed-75646", "permed-66153", "permed-71527", "permed-75644", "permed-70251", "permed-88327", "permed-85946", "permed-61889", "permed-54521", "permed-91926"]}
{"query_id": "topic_729_turn_4", "conversation_id": "topic_729", "turn_id": 4, "query": "Regarding this geospatial AI integration approach, could you specify the technical validation protocols used for the spatial sampling frames? I'm particularly interested in how cross-validation strategies were implemented given sparse household data - were spatial blocking methods employed to account for autocorrelation, and what metrics were used to quantify prediction uncertainty for the prevalence estimates? Additionally, what quality control measures ensured reproducibility when integrating disparate data sources with varying spatial resolutions?", "history": ["Current methods for estimating prevalence of hypertension and diabetes in diverse populations", "Comparing effectiveness of spatial sampling frame (SSF) for estimating prevalence of these chronic conditions against other survey methods, especially in limited-data areas", "Improving spatial sampling frame (SSF) accuracy for estimating prevalence of these chronic conditions with limited household data: geospatial AI integration, ethical and practical challenges"], "ground_truth": ["permed-75646", "permed-70251", "permed-75644", "permed-71527", "permed-57850", "permed-73394", "permed-61935", "permed-35939", "permed-75651", "permed-61937"]}
{"query_id": "topic_729_turn_5", "conversation_id": "topic_729", "turn_id": 5, "query": "Given these technical validation protocols for geospatial AI integration, how do the resulting prevalence estimates from enhanced spatial sampling frames compare against traditional household survey methods in terms of both statistical accuracy and practical implementation? Specifically, what trade-offs emerge between prediction precision and resource requirements when deploying these approaches in low-data settings, and does the improved spatial resolution of AI-enhanced methods consistently translate to better public health decision-making across different administrative levels?", "history": ["Current methods for estimating prevalence of hypertension and diabetes in diverse populations", "Comparing effectiveness of spatial sampling frame (SSF) for estimating prevalence of these chronic conditions against other survey methods, especially in limited-data areas", "Improving spatial sampling frame (SSF) accuracy for estimating prevalence of these chronic conditions with limited household data: geospatial AI integration, ethical and practical challenges", "Regarding this geospatial AI integration approach, could you specify the technical validation protocols used for the spatial sampling frames? I'm particularly interested in how cross-validation strategies were implemented given sparse household data - were spatial blocking methods employed to account for autocorrelation, and what metrics were used to quantify prediction uncertainty for the prevalence estimates? Additionally, what quality control measures ensured reproducibility when integrating disparate data sources with varying spatial resolutions?"], "ground_truth": ["permed-75646", "permed-70251", "permed-75644", "permed-71527", "permed-63469", "permed-75650", "permed-35939", "permed-79173", "permed-57850", "permed-54521"]}
{"query_id": "topic_729_turn_6", "conversation_id": "topic_729", "turn_id": 6, "query": "Building on our comparison of AI-enhanced spatial sampling frames against traditional methods, could you precisely define what constitutes \"better public health decision-making\" in this context? Given the trade-offs between statistical precision and implementation resources discussed, how should we fundamentally conceptualize decision-making quality - is it primarily about improved spatial targeting accuracy, cost-efficiency in resource allocation, or equitable coverage across administrative levels? What theoretical framework would best capture the multidimensional nature of this concept, particularly when considering future applications in diverse healthcare systems with varying data infrastructure capabilities?", "history": ["Current methods for estimating prevalence of hypertension and diabetes in diverse populations", "Comparing effectiveness of spatial sampling frame (SSF) for estimating prevalence of these chronic conditions against other survey methods, especially in limited-data areas", "Improving spatial sampling frame (SSF) accuracy for estimating prevalence of these chronic conditions with limited household data: geospatial AI integration, ethical and practical challenges", "Regarding this geospatial AI integration approach, could you specify the technical validation protocols used for the spatial sampling frames? I'm particularly interested in how cross-validation strategies were implemented given sparse household data - were spatial blocking methods employed to account for autocorrelation, and what metrics were used to quantify prediction uncertainty for the prevalence estimates? Additionally, what quality control measures ensured reproducibility when integrating disparate data sources with varying spatial resolutions?", "Given these technical validation protocols for geospatial AI integration, how do the resulting prevalence estimates from enhanced spatial sampling frames compare against traditional household survey methods in terms of both statistical accuracy and practical implementation? Specifically, what trade-offs emerge between prediction precision and resource requirements when deploying these approaches in low-data settings, and does the improved spatial resolution of AI-enhanced methods consistently translate to better public health decision-making across different administrative levels?"], "ground_truth": ["permed-54521", "permed-75646", "permed-78664", "permed-69585", "permed-33681", "permed-65945", "permed-25987", "permed-78059", "permed-89242", "permed-87133"]}
{"query_id": "topic_730_turn_1", "conversation_id": "topic_730", "turn_id": 1, "query": "What are the common management strategies for acute secondary right heart failure in patients on ECMO support?", "history": [], "ground_truth": ["permed-51941", "permed-27492", "permed-52860", "permed-52861", "permed-49994", "permed-54791", "permed-7006", "permed-71157", "permed-18865", "permed-17877"]}
{"query_id": "topic_730_turn_2", "conversation_id": "topic_730", "turn_id": 2, "query": "How effective is percutaneous pulmonary artery cannulation compared to other techniques used in this area of treatment?", "history": ["What are the common management strategies for acute secondary right heart failure in patients on ECMO support?"], "ground_truth": ["permed-51936", "permed-51941", "permed-2273", "permed-64773", "permed-51942", "permed-71333", "permed-76308", "permed-68859", "permed-56265", "permed-78849"]}
{"query_id": "topic_730_turn_3", "conversation_id": "topic_730", "turn_id": 3, "query": "How do long-term outcomes and quality of life compare between patients who received percutaneous pulmonary artery cannulation for acute secondary right heart failure on veno-venous ECMO versus those managed with other ECMO approaches, and what factors might explain these differences?", "history": ["What are the common management strategies for acute secondary right heart failure in patients on ECMO support?", "How effective is percutaneous pulmonary artery cannulation compared to other techniques used in this area of treatment?"], "ground_truth": ["permed-51941", "permed-76308", "permed-52861", "permed-51942", "permed-78848", "permed-69130", "permed-78849", "permed-51944", "permed-70917", "permed-54791"]}
{"query_id": "topic_730_turn_4", "conversation_id": "topic_730", "turn_id": 4, "query": "Given these long-term outcome comparisons, could you elaborate on the specific statistical methods used to control for confounding variables when analyzing QoL differences? I'm particularly interested in how you implemented propensity score matching or inverse probability weighting to balance baseline characteristics between the percutaneous and conventional ECMO groups, and what validation strategies were employed to ensure the robustness of these causal inference approaches in the presence of competing risks from comorbidities.", "history": ["What are the common management strategies for acute secondary right heart failure in patients on ECMO support?", "How effective is percutaneous pulmonary artery cannulation compared to other techniques used in this area of treatment?", "How do long-term outcomes and quality of life compare between patients who received percutaneous pulmonary artery cannulation for acute secondary right heart failure on veno-venous ECMO versus those managed with other ECMO approaches, and what factors might explain these differences?"], "ground_truth": ["permed-49953", "permed-49999", "permed-50073", "permed-42051", "permed-89526", "permed-89528", "permed-43101", "permed-44929", "permed-43258", "permed-89527"]}
{"query_id": "topic_730_turn_5", "conversation_id": "topic_730", "turn_id": 5, "query": "Given these sophisticated statistical approaches to establish causality in QoL outcomes, what specific clinical implementation challenges have been observed when transitioning patients from percutaneous pulmonary artery cannulation on ECMO to long-term management? I'm particularly interested in real-world safety considerations like weaning protocols, anticoagulation bridging strategies, and management of access site complications that might differentially affect recovery trajectories compared to conventional ECMO approaches, and how these practical clinical factors ultimately influence patient-centered outcomes beyond the statistical models.", "history": ["What are the common management strategies for acute secondary right heart failure in patients on ECMO support?", "How effective is percutaneous pulmonary artery cannulation compared to other techniques used in this area of treatment?", "How do long-term outcomes and quality of life compare between patients who received percutaneous pulmonary artery cannulation for acute secondary right heart failure on veno-venous ECMO versus those managed with other ECMO approaches, and what factors might explain these differences?", "Given these long-term outcome comparisons, could you elaborate on the specific statistical methods used to control for confounding variables when analyzing QoL differences? I'm particularly interested in how you implemented propensity score matching or inverse probability weighting to balance baseline characteristics between the percutaneous and conventional ECMO groups, and what validation strategies were employed to ensure the robustness of these causal inference approaches in the presence of competing risks from comorbidities."], "ground_truth": ["permed-76308", "permed-51941", "permed-51942", "permed-52861", "permed-52859", "permed-52864", "permed-42051", "permed-78849", "permed-78848", "permed-3562"]}
{"query_id": "topic_730_turn_6", "conversation_id": "topic_730", "turn_id": 6, "query": "Given the documented clinical implementation challenges with percutaneous pulmonary artery cannulation, how do the resource utilization patterns and institutional learning curves compare between this advanced technique and conventional ECMO management for acute secondary right heart failure? Specifically, considering the specialized training requirements, equipment costs, and procedural volumes needed to maintain competency, what evidence exists regarding the cost-effectiveness trade-offs at lower-volume centers versus specialized ECMO facilities, and how might these systemic factors influence the scalability of percutaneous approaches compared to more established ECMO strategies in real-world healthcare systems?", "history": ["What are the common management strategies for acute secondary right heart failure in patients on ECMO support?", "How effective is percutaneous pulmonary artery cannulation compared to other techniques used in this area of treatment?", "How do long-term outcomes and quality of life compare between patients who received percutaneous pulmonary artery cannulation for acute secondary right heart failure on veno-venous ECMO versus those managed with other ECMO approaches, and what factors might explain these differences?", "Given these long-term outcome comparisons, could you elaborate on the specific statistical methods used to control for confounding variables when analyzing QoL differences? I'm particularly interested in how you implemented propensity score matching or inverse probability weighting to balance baseline characteristics between the percutaneous and conventional ECMO groups, and what validation strategies were employed to ensure the robustness of these causal inference approaches in the presence of competing risks from comorbidities.", "Given these sophisticated statistical approaches to establish causality in QoL outcomes, what specific clinical implementation challenges have been observed when transitioning patients from percutaneous pulmonary artery cannulation on ECMO to long-term management? I'm particularly interested in real-world safety considerations like weaning protocols, anticoagulation bridging strategies, and management of access site complications that might differentially affect recovery trajectories compared to conventional ECMO approaches, and how these practical clinical factors ultimately influence patient-centered outcomes beyond the statistical models."], "ground_truth": ["permed-51941", "permed-78848", "permed-44801", "permed-76308", "permed-52862", "permed-89527", "permed-69130", "permed-51942", "permed-71157", "permed-24734"]}
{"query_id": "topic_731_turn_1", "conversation_id": "topic_731", "turn_id": 1, "query": "Recent advancements and evolving techniques in transcatheter aortic valve implantation (TAVI)", "history": [], "ground_truth": ["permed-57223", "permed-57219", "permed-57220", "permed-57217", "permed-86830", "permed-57221", "permed-57010", "permed-85517", "permed-51949", "permed-85510"]}
{"query_id": "topic_731_turn_2", "conversation_id": "topic_731", "turn_id": 2, "query": "Considering these TAVI advancements, what is the impact of adjunctive devices like the ShortCut on procedural success and patient outcomes?", "history": ["Recent advancements and evolving techniques in transcatheter aortic valve implantation (TAVI)"], "ground_truth": ["permed-57221", "permed-57223", "permed-57220", "permed-85510", "permed-75268", "permed-86830", "permed-51949", "permed-70035", "permed-18373", "permed-85511"]}
{"query_id": "topic_731_turn_3", "conversation_id": "topic_731", "turn_id": 3, "query": "Long-term outcomes, complications, and comparative efficacy of the ShortCut device for preventing coronary obstruction during valve-in-valve TAVI versus traditional BASILICA or snorkel/chimney techniques", "history": ["Recent advancements and evolving techniques in transcatheter aortic valve implantation (TAVI)", "Considering these TAVI advancements, what is the impact of adjunctive devices like the ShortCut on procedural success and patient outcomes?"], "ground_truth": ["permed-75268", "permed-57223", "permed-57220", "permed-56265", "permed-85510", "permed-71333", "permed-57219", "permed-85511", "permed-86830", "permed-70038"]}
{"query_id": "topic_731_turn_4", "conversation_id": "topic_731", "turn_id": 4, "query": "Given the comparative framework for coronary obstruction prevention strategies, what specific procedural metrics were used to evaluate technical success across these techniques? I'm particularly interested in how operators quantified leaflet laceration completeness in BASILICA versus tissue displacement measurements in ShortCut procedures, and whether standardized imaging protocols like intraprocedural OCT or post-deployment CT were systematically implemented for these assessments. What statistical approaches were employed to account for center-specific variations in technical proficiency when comparing these complex interventions?", "history": ["Recent advancements and evolving techniques in transcatheter aortic valve implantation (TAVI)", "Considering these TAVI advancements, what is the impact of adjunctive devices like the ShortCut on procedural success and patient outcomes?", "Long-term outcomes, complications, and comparative efficacy of the ShortCut device for preventing coronary obstruction during valve-in-valve TAVI versus traditional BASILICA or snorkel/chimney techniques"], "ground_truth": ["permed-75268", "permed-52606", "permed-50141", "permed-17930", "permed-28085", "permed-57223", "permed-57380", "permed-66064", "permed-70519", "permed-84850"]}
{"query_id": "topic_731_turn_5", "conversation_id": "topic_731", "turn_id": 5, "query": "Given the detailed procedural metrics and imaging validation methods discussed for coronary obstruction prevention techniques, how have these technical assessments translated to actual clinical endpoints in real-world practice? Focusing specifically on ShortCut-assisted versus BASILICA procedures, what comparative data exists regarding 30-day major adverse cardiac events, coronary access preservation for future interventions, and long-term valve hemodynamics? Additionally, have any specific patient anatomical subsets (such as those with shallow sinuses or prior root replacements) demonstrated differential safety profiles that would inform technique selection in clinical guidelines?", "history": ["Recent advancements and evolving techniques in transcatheter aortic valve implantation (TAVI)", "Considering these TAVI advancements, what is the impact of adjunctive devices like the ShortCut on procedural success and patient outcomes?", "Long-term outcomes, complications, and comparative efficacy of the ShortCut device for preventing coronary obstruction during valve-in-valve TAVI versus traditional BASILICA or snorkel/chimney techniques", "Given the comparative framework for coronary obstruction prevention strategies, what specific procedural metrics were used to evaluate technical success across these techniques? I'm particularly interested in how operators quantified leaflet laceration completeness in BASILICA versus tissue displacement measurements in ShortCut procedures, and whether standardized imaging protocols like intraprocedural OCT or post-deployment CT were systematically implemented for these assessments. What statistical approaches were employed to account for center-specific variations in technical proficiency when comparing these complex interventions?"], "ground_truth": ["permed-75268", "permed-43073", "permed-50141", "permed-57223", "permed-28085", "permed-11954", "permed-52606", "permed-57060", "permed-2737", "permed-80163"]}
{"query_id": "topic_731_turn_6", "conversation_id": "topic_731", "turn_id": 6, "query": "Considering the established clinical outcomes and anatomical-specific performance discussed, how do the economic implications and healthcare resource utilization compare between ShortCut-assisted and BASILICA procedures? Given the complex imaging requirements and specialized training needed for both techniques, what evidence exists regarding procedural cost-effectiveness, including equipment expenses, operative time differences, and learning curve-associated complications? Furthermore, as newer leaflet modification technologies emerge, how might these economic considerations influence the adoption hierarchy of coronary protection strategies in different healthcare systems with varying resource constraints?", "history": ["Recent advancements and evolving techniques in transcatheter aortic valve implantation (TAVI)", "Considering these TAVI advancements, what is the impact of adjunctive devices like the ShortCut on procedural success and patient outcomes?", "Long-term outcomes, complications, and comparative efficacy of the ShortCut device for preventing coronary obstruction during valve-in-valve TAVI versus traditional BASILICA or snorkel/chimney techniques", "Given the comparative framework for coronary obstruction prevention strategies, what specific procedural metrics were used to evaluate technical success across these techniques? I'm particularly interested in how operators quantified leaflet laceration completeness in BASILICA versus tissue displacement measurements in ShortCut procedures, and whether standardized imaging protocols like intraprocedural OCT or post-deployment CT were systematically implemented for these assessments. What statistical approaches were employed to account for center-specific variations in technical proficiency when comparing these complex interventions?", "Given the detailed procedural metrics and imaging validation methods discussed for coronary obstruction prevention techniques, how have these technical assessments translated to actual clinical endpoints in real-world practice? Focusing specifically on ShortCut-assisted versus BASILICA procedures, what comparative data exists regarding 30-day major adverse cardiac events, coronary access preservation for future interventions, and long-term valve hemodynamics? Additionally, have any specific patient anatomical subsets (such as those with shallow sinuses or prior root replacements) demonstrated differential safety profiles that would inform technique selection in clinical guidelines?"], "ground_truth": ["permed-80622", "permed-52606", "permed-66100", "permed-66097", "permed-76312", "permed-50711", "permed-75268", "permed-57361", "permed-56644", "permed-86813"]}
{"query_id": "topic_732_turn_1", "conversation_id": "topic_732", "turn_id": 1, "query": "Key physical asset management challenges confronting Water Boards in developing countries.", "history": [], "ground_truth": ["permed-74275", "permed-55107", "permed-66148", "permed-74114", "permed-91926", "permed-89244", "permed-56264", "permed-72010", "permed-84168", "permed-82651"]}
{"query_id": "topic_732_turn_2", "conversation_id": "topic_732", "turn_id": 2, "query": "How can advanced Physical Asset Management (PAM) approaches mitigate these specific challenges for Water Boards in such regions?", "history": ["Key physical asset management challenges confronting Water Boards in developing countries."], "ground_truth": ["permed-74275", "permed-55107", "permed-73999", "permed-80601", "permed-89244", "permed-84168", "permed-53135", "permed-74276", "permed-5782", "permed-60179"]}
{"query_id": "topic_732_turn_3", "conversation_id": "topic_732", "turn_id": 3, "query": "Effective strategies for implementing advanced PAM technologies (e.g., digital twin, AI-driven analytics) in Malawi's Water Boards, addressing identified operational hurdles, and replicable frameworks for other developing nations.", "history": ["Key physical asset management challenges confronting Water Boards in developing countries.", "How can advanced Physical Asset Management (PAM) approaches mitigate these specific challenges for Water Boards in such regions?"], "ground_truth": ["permed-74275", "permed-63535", "permed-82005", "permed-74276", "permed-66697", "permed-62313", "permed-65946", "permed-71536", "permed-89436", "permed-84168"]}
{"query_id": "topic_732_turn_4", "conversation_id": "topic_732", "turn_id": 4, "query": "For deploying these advanced PAM technologies in Malawi, what specific experimental design and data validation protocols were most critical during the pilot phase? I'm particularly interested in the technical implementation details for sensor calibration, how you established baseline data quality metrics, and the statistical methods used to validate the AI-driven analytics against traditional operational data before full-scale rollout. What was the protocol for ensuring these methodologies were reproducible across different Water Boards with varying infrastructure levels?", "history": ["Key physical asset management challenges confronting Water Boards in developing countries.", "How can advanced Physical Asset Management (PAM) approaches mitigate these specific challenges for Water Boards in such regions?", "Effective strategies for implementing advanced PAM technologies (e.g., digital twin, AI-driven analytics) in Malawi's Water Boards, addressing identified operational hurdles, and replicable frameworks for other developing nations."], "ground_truth": ["permed-74275", "permed-61474", "permed-82886", "permed-55141", "permed-71743", "permed-63104", "permed-63535", "permed-53344", "permed-78116", "permed-69888"]}
{"query_id": "topic_732_turn_5", "conversation_id": "topic_732", "turn_id": 5, "query": "Given the detailed pilot validation protocols established for Malawi's Water Boards, how did the implementation effectiveness and cost-benefit ratios compare between AI-driven analytics and traditional SCADA systems across different infrastructure tiers? Specifically, what were the relative advantages in predictive maintenance accuracy versus operational complexity, and how did these trade-offs manifest between urban versus rural water treatment facilities with varying technical capacities and data maturity levels?", "history": ["Key physical asset management challenges confronting Water Boards in developing countries.", "How can advanced Physical Asset Management (PAM) approaches mitigate these specific challenges for Water Boards in such regions?", "Effective strategies for implementing advanced PAM technologies (e.g., digital twin, AI-driven analytics) in Malawi's Water Boards, addressing identified operational hurdles, and replicable frameworks for other developing nations.", "For deploying these advanced PAM technologies in Malawi, what specific experimental design and data validation protocols were most critical during the pilot phase? I'm particularly interested in the technical implementation details for sensor calibration, how you established baseline data quality metrics, and the statistical methods used to validate the AI-driven analytics against traditional operational data before full-scale rollout. What was the protocol for ensuring these methodologies were reproducible across different Water Boards with varying infrastructure levels?"], "ground_truth": ["permed-74276", "permed-74275", "permed-82005", "permed-65946", "permed-78349", "permed-85832", "permed-63104", "permed-84590", "permed-54683", "permed-65764"]}
{"query_id": "topic_732_turn_6", "conversation_id": "topic_732", "turn_id": 6, "query": "Building on our comparative analysis of system implementations, how do we fundamentally define \"data maturity levels\" in the context of developing water infrastructure? Beyond basic data collection, what specific technical, organizational, and skill-based dimensions constitute this framework, and how might our understanding of its core components need to evolve to better predict the success of advanced PAM technologies in resource-constrained settings, particularly given the infrastructural disparities highlighted between urban and rural facilities?", "history": ["Key physical asset management challenges confronting Water Boards in developing countries.", "How can advanced Physical Asset Management (PAM) approaches mitigate these specific challenges for Water Boards in such regions?", "Effective strategies for implementing advanced PAM technologies (e.g., digital twin, AI-driven analytics) in Malawi's Water Boards, addressing identified operational hurdles, and replicable frameworks for other developing nations.", "For deploying these advanced PAM technologies in Malawi, what specific experimental design and data validation protocols were most critical during the pilot phase? I'm particularly interested in the technical implementation details for sensor calibration, how you established baseline data quality metrics, and the statistical methods used to validate the AI-driven analytics against traditional operational data before full-scale rollout. What was the protocol for ensuring these methodologies were reproducible across different Water Boards with varying infrastructure levels?", "Given the detailed pilot validation protocols established for Malawi's Water Boards, how did the implementation effectiveness and cost-benefit ratios compare between AI-driven analytics and traditional SCADA systems across different infrastructure tiers? Specifically, what were the relative advantages in predictive maintenance accuracy versus operational complexity, and how did these trade-offs manifest between urban versus rural water treatment facilities with varying technical capacities and data maturity levels?"], "ground_truth": ["permed-74275", "permed-82005", "permed-89244", "permed-74276", "permed-53031", "permed-53135", "permed-72670", "permed-61882", "permed-79518", "permed-68445"]}
{"query_id": "topic_733_turn_1", "conversation_id": "topic_733", "turn_id": 1, "query": "What are the current treatments for acute coronary syndrome in elderly patients?", "history": [], "ground_truth": ["permed-23601", "permed-10880", "permed-26235", "permed-11620", "permed-23619", "permed-80268", "permed-11618", "permed-56959", "permed-43002", "permed-42986"]}
{"query_id": "topic_733_turn_2", "conversation_id": "topic_733", "turn_id": 2, "query": "How do antiplatelet medications like ticagrelor and clopidogrel factor into this treatment approach?", "history": ["What are the current treatments for acute coronary syndrome in elderly patients?"], "ground_truth": ["permed-91069", "permed-66103", "permed-56947", "permed-66092", "permed-61348", "permed-52596", "permed-22939", "permed-57057", "permed-56959", "permed-56951"]}
{"query_id": "topic_733_turn_3", "conversation_id": "topic_733", "turn_id": 3, "query": "Given these two antiplatelet options, what are the long-term differences between ticagrelor and clopidogrel specifically regarding recurrence of acute coronary syndrome and major bleeding risks in elderly patients? How do dosing variations and existing comorbidities affect these outcomes?", "history": ["What are the current treatments for acute coronary syndrome in elderly patients?", "How do antiplatelet medications like ticagrelor and clopidogrel factor into this treatment approach?"], "ground_truth": ["permed-56959", "permed-77209", "permed-56958", "permed-56956", "permed-66103", "permed-43206", "permed-56953", "permed-91069", "permed-23600", "permed-56947"]}
{"query_id": "topic_733_turn_4", "conversation_id": "topic_733", "turn_id": 4, "query": "When comparing long-term outcomes between ticagrelor and clopidogrel in elderly ACS patients, what specific statistical methods would you recommend for handling competing risks like non-cardiovascular death? Particularly, how should recurrent ACS events be analyzed given that traditional time-to-first-event approaches might underestimate the true burden? Also, what methodological considerations are crucial for adjusting analyses when accounting for varying comorbidity burdens across this heterogeneous elderly population?", "history": ["What are the current treatments for acute coronary syndrome in elderly patients?", "How do antiplatelet medications like ticagrelor and clopidogrel factor into this treatment approach?", "Given these two antiplatelet options, what are the long-term differences between ticagrelor and clopidogrel specifically regarding recurrence of acute coronary syndrome and major bleeding risks in elderly patients? How do dosing variations and existing comorbidities affect these outcomes?"], "ground_truth": ["permed-56959", "permed-43206", "permed-56953", "permed-77209", "permed-56958", "permed-43002", "permed-23600", "permed-66092", "permed-56960", "permed-66103"]}
{"query_id": "topic_733_turn_5", "conversation_id": "topic_733", "turn_id": 5, "query": "Given these sophisticated methodological considerations for evaluating long-term outcomes, how have recent real-world clinical studies actually translated these statistical approaches into practice when comparing ticagrelor versus clopidogrel in elderly ACS patients? Specifically, what do contemporary observational data and pragmatic trials reveal about the net clinical benefit—balancing ischemic protection against bleeding risks—when accounting for competing mortality risks in actual elderly populations with multimorbidity? Furthermore, how are these findings influencing current clinical guideline recommendations for antiplatelet duration and de-escalation strategies in this vulnerable demographic?", "history": ["What are the current treatments for acute coronary syndrome in elderly patients?", "How do antiplatelet medications like ticagrelor and clopidogrel factor into this treatment approach?", "Given these two antiplatelet options, what are the long-term differences between ticagrelor and clopidogrel specifically regarding recurrence of acute coronary syndrome and major bleeding risks in elderly patients? How do dosing variations and existing comorbidities affect these outcomes?", "When comparing long-term outcomes between ticagrelor and clopidogrel in elderly ACS patients, what specific statistical methods would you recommend for handling competing risks like non-cardiovascular death? Particularly, how should recurrent ACS events be analyzed given that traditional time-to-first-event approaches might underestimate the true burden? Also, what methodological considerations are crucial for adjusting analyses when accounting for varying comorbidity burdens across this heterogeneous elderly population?"], "ground_truth": ["permed-56959", "permed-43206", "permed-77209", "permed-56958", "permed-56953", "permed-91069", "permed-56947", "permed-23600", "permed-66103", "permed-56956"]}
{"query_id": "topic_733_turn_6", "conversation_id": "topic_733", "turn_id": 6, "query": "Given our discussion about methodological complexities and real-world outcomes in elderly ACS patients, how should we conceptually define \"net clinical benefit\" in this specific population when comparing antiplatelet therapies? Beyond the traditional composite endpoints, what theoretical framework best captures the competing nature of ischemic protection versus bleeding risk while accounting for quality-of-life implications and competing mortality? How do current definitions adequately address the fundamental tension between preventing recurrent ACS events and avoiding catastrophic bleeds in elderly patients with limited life expectancy and multimorbidity?", "history": ["What are the current treatments for acute coronary syndrome in elderly patients?", "How do antiplatelet medications like ticagrelor and clopidogrel factor into this treatment approach?", "Given these two antiplatelet options, what are the long-term differences between ticagrelor and clopidogrel specifically regarding recurrence of acute coronary syndrome and major bleeding risks in elderly patients? How do dosing variations and existing comorbidities affect these outcomes?", "When comparing long-term outcomes between ticagrelor and clopidogrel in elderly ACS patients, what specific statistical methods would you recommend for handling competing risks like non-cardiovascular death? Particularly, how should recurrent ACS events be analyzed given that traditional time-to-first-event approaches might underestimate the true burden? Also, what methodological considerations are crucial for adjusting analyses when accounting for varying comorbidity burdens across this heterogeneous elderly population?", "Given these sophisticated methodological considerations for evaluating long-term outcomes, how have recent real-world clinical studies actually translated these statistical approaches into practice when comparing ticagrelor versus clopidogrel in elderly ACS patients? Specifically, what do contemporary observational data and pragmatic trials reveal about the net clinical benefit—balancing ischemic protection against bleeding risks—when accounting for competing mortality risks in actual elderly populations with multimorbidity? Furthermore, how are these findings influencing current clinical guideline recommendations for antiplatelet duration and de-escalation strategies in this vulnerable demographic?"], "ground_truth": ["permed-43002", "permed-22938", "permed-23601", "permed-60363", "permed-56959", "permed-43206", "permed-56947", "permed-27420", "permed-61347", "permed-4910"]}
{"query_id": "topic_734_turn_1", "conversation_id": "topic_734", "turn_id": 1, "query": "Applications of psychophysiological monitoring for reducing accident risk in road transportation", "history": [], "ground_truth": ["permed-74065", "permed-72010", "permed-75160", "permed-74220", "permed-82651", "permed-55176", "permed-72012", "permed-69706", "permed-66153", "permed-89690"]}
{"query_id": "topic_734_turn_2", "conversation_id": "topic_734", "turn_id": 2, "query": "Optimizing *this type of psychophysiological monitoring* with advanced data analytics and operational analysis for improved safety in high-stress road transport scenarios", "history": ["Applications of psychophysiological monitoring for reducing accident risk in road transportation"], "ground_truth": ["permed-74065", "permed-72010", "permed-75160", "permed-55176", "permed-66153", "permed-74220", "permed-81263", "permed-82651", "permed-72012", "permed-86950"]}
{"query_id": "topic_734_turn_3", "conversation_id": "topic_734", "turn_id": 3, "query": "Integrating wearable psychophysiological sensors and real-time analytics with Functional Resonance Analysis Method (FRAM) for dynamic operational adjustments in passenger road transport to manage risks from prolonged driving and driver stress", "history": ["Applications of psychophysiological monitoring for reducing accident risk in road transportation", "Optimizing *this type of psychophysiological monitoring* with advanced data analytics and operational analysis for improved safety in high-stress road transport scenarios"], "ground_truth": ["permed-74065", "permed-55176", "permed-74220", "permed-85680", "permed-74222", "permed-69835", "permed-74216", "permed-54923", "permed-75160", "permed-75631"]}
{"query_id": "topic_734_turn_4", "conversation_id": "topic_734", "turn_id": 4, "query": "Regarding this FRAM-integrated monitoring system, what specific validation protocols were employed to ensure the reliability of real-time psychophysiological data streams? I'm particularly interested in the statistical methods used for drift correction in the wearable sensors and how the analytical pipeline handles missing data points during continuous operation. Were there any quality control thresholds established for physiological parameters that would trigger a system recalibration?", "history": ["Applications of psychophysiological monitoring for reducing accident risk in road transportation", "Optimizing *this type of psychophysiological monitoring* with advanced data analytics and operational analysis for improved safety in high-stress road transport scenarios", "Integrating wearable psychophysiological sensors and real-time analytics with Functional Resonance Analysis Method (FRAM) for dynamic operational adjustments in passenger road transport to manage risks from prolonged driving and driver stress"], "ground_truth": ["permed-26466", "permed-68467", "permed-68462", "permed-55143", "permed-80166", "permed-49155", "permed-68466", "permed-54067", "permed-69835", "permed-55655"]}
{"query_id": "topic_734_turn_5", "conversation_id": "topic_734", "turn_id": 5, "query": "Given the rigorous validation protocols for data reliability, what clinical outcomes have been demonstrated when this FRAM-integrated psychophysiological monitoring system triggers real-time interventions in commercial passenger transport? Specifically, what reduction in adverse driver health events (e.g., hypertensive crises) or preventable safety incidents was observed in operational deployments? Furthermore, were there any unintended clinical consequences—such as alarm fatigue or increased cognitive load—that emerged from these automated interventions, and how were associated risks for drivers and passengers mitigated in practice?", "history": ["Applications of psychophysiological monitoring for reducing accident risk in road transportation", "Optimizing *this type of psychophysiological monitoring* with advanced data analytics and operational analysis for improved safety in high-stress road transport scenarios", "Integrating wearable psychophysiological sensors and real-time analytics with Functional Resonance Analysis Method (FRAM) for dynamic operational adjustments in passenger road transport to manage risks from prolonged driving and driver stress", "Regarding this FRAM-integrated monitoring system, what specific validation protocols were employed to ensure the reliability of real-time psychophysiological data streams? I'm particularly interested in the statistical methods used for drift correction in the wearable sensors and how the analytical pipeline handles missing data points during continuous operation. Were there any quality control thresholds established for physiological parameters that would trigger a system recalibration?"], "ground_truth": ["permed-74065", "permed-74217", "permed-67144", "permed-81413", "permed-90538", "permed-18357", "permed-87995", "permed-82429", "permed-85680", "permed-92363"]}
{"query_id": "topic_734_turn_6", "conversation_id": "topic_734", "turn_id": 6, "query": "Given the established clinical outcomes and intervention protocols, how exactly do we define \"successful intervention\" within this FRAM-integrated psychophysiological monitoring framework? Beyond mere statistical reductions in adverse events, what conceptual parameters constitute meaningful system success—does it encompass secondary prevention of subclinical stress manifestations, preservation of long-term driver cardiovascular health, or operational resilience metrics? Considering future implementations, should the definition incorporate adaptive thresholds that account for individual baselines and cumulative exposure effects, potentially redefining intervention success as sustained physiological homeostasis rather than discrete incident prevention?", "history": ["Applications of psychophysiological monitoring for reducing accident risk in road transportation", "Optimizing *this type of psychophysiological monitoring* with advanced data analytics and operational analysis for improved safety in high-stress road transport scenarios", "Integrating wearable psychophysiological sensors and real-time analytics with Functional Resonance Analysis Method (FRAM) for dynamic operational adjustments in passenger road transport to manage risks from prolonged driving and driver stress", "Regarding this FRAM-integrated monitoring system, what specific validation protocols were employed to ensure the reliability of real-time psychophysiological data streams? I'm particularly interested in the statistical methods used for drift correction in the wearable sensors and how the analytical pipeline handles missing data points during continuous operation. Were there any quality control thresholds established for physiological parameters that would trigger a system recalibration?", "Given the rigorous validation protocols for data reliability, what clinical outcomes have been demonstrated when this FRAM-integrated psychophysiological monitoring system triggers real-time interventions in commercial passenger transport? Specifically, what reduction in adverse driver health events (e.g., hypertensive crises) or preventable safety incidents was observed in operational deployments? Furthermore, were there any unintended clinical consequences—such as alarm fatigue or increased cognitive load—that emerged from these automated interventions, and how were associated risks for drivers and passengers mitigated in practice?"], "ground_truth": ["permed-81413", "permed-69810", "permed-23271", "permed-74217", "permed-55091", "permed-59466", "permed-44758", "permed-73843", "permed-23253", "permed-62329"]}
{"query_id": "topic_735_turn_1", "conversation_id": "topic_735", "turn_id": 1, "query": "What is known about the role of inflammation in luteinized unruptured follicle syndrome (LUFS)?", "history": [], "ground_truth": ["permed-79672", "permed-63573", "permed-53258", "permed-71426", "permed-78207", "permed-78206", "permed-31093", "permed-53230", "permed-7482", "permed-82973"]}
{"query_id": "topic_735_turn_2", "conversation_id": "topic_735", "turn_id": 2, "query": "How might understanding this inflammatory component impact the effectiveness of treatments like intrauterine insemination (IUI) in patients with LUFS?", "history": ["What is known about the role of inflammation in luteinized unruptured follicle syndrome (LUFS)?"], "ground_truth": ["permed-79672", "permed-78206", "permed-7482", "permed-60266", "permed-31093", "permed-89426", "permed-70583", "permed-70503", "permed-84261", "permed-0929"]}
{"query_id": "topic_735_turn_3", "conversation_id": "topic_735", "turn_id": 3, "query": "Given the emerging role of inflammation in LUFS, how might targeting other specific inflammatory mediators—beyond G-CSF—improve the success rates of IUI and other ART procedures? Additionally, what potential biomarkers could help predict LUFS recurrence and guide personalized treatment strategies for these patients?", "history": ["What is known about the role of inflammation in luteinized unruptured follicle syndrome (LUFS)?", "How might understanding this inflammatory component impact the effectiveness of treatments like intrauterine insemination (IUI) in patients with LUFS?"], "ground_truth": ["permed-79672", "permed-7366", "permed-58698", "permed-7362", "permed-78206", "permed-61771", "permed-58697", "permed-76433", "permed-69287", "permed-31500"]}
{"query_id": "topic_735_turn_4", "conversation_id": "topic_735", "turn_id": 4, "query": "In studying these inflammatory mediators and biomarkers for LUFS, what specific experimental approaches would you recommend for validating their predictive value in clinical settings? I'm particularly interested in the statistical power calculations needed for cohort studies, the optimal sampling protocols for cytokine measurements relative to ovulation timing, and how to establish appropriate cutoff values for these biomarkers in differentiating LUFS from normal ovulatory cycles while controlling for confounding factors like age and ovarian reserve.", "history": ["What is known about the role of inflammation in luteinized unruptured follicle syndrome (LUFS)?", "How might understanding this inflammatory component impact the effectiveness of treatments like intrauterine insemination (IUI) in patients with LUFS?", "Given the emerging role of inflammation in LUFS, how might targeting other specific inflammatory mediators—beyond G-CSF—improve the success rates of IUI and other ART procedures? Additionally, what potential biomarkers could help predict LUFS recurrence and guide personalized treatment strategies for these patients?"], "ground_truth": ["permed-7104", "permed-58667", "permed-79672", "permed-69287", "permed-31233", "permed-61318", "permed-61771", "permed-89647", "permed-6126", "permed-54749"]}
{"query_id": "topic_735_turn_5", "conversation_id": "topic_735", "turn_id": 5, "query": "Given your proposed validation approaches for LUFS biomarkers, how would you compare the predictive performance of cytokine-based models versus ultrasound-based diagnostic criteria in differentiating LUFS from normal ovulatory cycles? Specifically, what are the relative trade-offs in terms of sensitivity/specificity, cost-effectiveness, and implementation feasibility in clinical practice? Considering your statistical power calculations, would combining these approaches through machine learning algorithms provide superior diagnostic accuracy compared to either method alone, particularly when controlling for confounders like ovarian reserve?", "history": ["What is known about the role of inflammation in luteinized unruptured follicle syndrome (LUFS)?", "How might understanding this inflammatory component impact the effectiveness of treatments like intrauterine insemination (IUI) in patients with LUFS?", "Given the emerging role of inflammation in LUFS, how might targeting other specific inflammatory mediators—beyond G-CSF—improve the success rates of IUI and other ART procedures? Additionally, what potential biomarkers could help predict LUFS recurrence and guide personalized treatment strategies for these patients?", "In studying these inflammatory mediators and biomarkers for LUFS, what specific experimental approaches would you recommend for validating their predictive value in clinical settings? I'm particularly interested in the statistical power calculations needed for cohort studies, the optimal sampling protocols for cytokine measurements relative to ovulation timing, and how to establish appropriate cutoff values for these biomarkers in differentiating LUFS from normal ovulatory cycles while controlling for confounding factors like age and ovarian reserve."], "ground_truth": ["permed-56153", "permed-79672", "permed-29152", "permed-6737", "permed-29151", "permed-17973", "permed-71187", "permed-18244", "permed-85496", "permed-92133"]}
{"query_id": "topic_735_turn_6", "conversation_id": "topic_735", "turn_id": 6, "query": "Building on our discussion about diagnostic approaches for LUFS, how would you fundamentally define the \"ovulatory dysfunction\" that characterizes this syndrome beyond the simple absence of oocyte release? Given our exploration of inflammatory pathways and diagnostic limitations, what specific physiological mechanisms—at molecular, cellular, and endocrine levels—constitute the core pathological definition of LUFS versus other anovulatory disorders? How might this comprehensive mechanistic definition guide future diagnostic criteria that integrate both functional (ultrasound) and causal (inflammatory) parameters, particularly in borderline cases where traditional diagnostic boundaries blur?", "history": ["What is known about the role of inflammation in luteinized unruptured follicle syndrome (LUFS)?", "How might understanding this inflammatory component impact the effectiveness of treatments like intrauterine insemination (IUI) in patients with LUFS?", "Given the emerging role of inflammation in LUFS, how might targeting other specific inflammatory mediators—beyond G-CSF—improve the success rates of IUI and other ART procedures? Additionally, what potential biomarkers could help predict LUFS recurrence and guide personalized treatment strategies for these patients?", "In studying these inflammatory mediators and biomarkers for LUFS, what specific experimental approaches would you recommend for validating their predictive value in clinical settings? I'm particularly interested in the statistical power calculations needed for cohort studies, the optimal sampling protocols for cytokine measurements relative to ovulation timing, and how to establish appropriate cutoff values for these biomarkers in differentiating LUFS from normal ovulatory cycles while controlling for confounding factors like age and ovarian reserve.", "Given your proposed validation approaches for LUFS biomarkers, how would you compare the predictive performance of cytokine-based models versus ultrasound-based diagnostic criteria in differentiating LUFS from normal ovulatory cycles? Specifically, what are the relative trade-offs in terms of sensitivity/specificity, cost-effectiveness, and implementation feasibility in clinical practice? Considering your statistical power calculations, would combining these approaches through machine learning algorithms provide superior diagnostic accuracy compared to either method alone, particularly when controlling for confounders like ovarian reserve?"], "ground_truth": ["permed-79672", "permed-7482", "permed-31149", "permed-7360", "permed-31093", "permed-7356", "permed-31195", "permed-6652", "permed-55299", "permed-82332"]}
{"query_id": "topic_736_turn_1", "conversation_id": "topic_736", "turn_id": 1, "query": "Key factors determining optimal timing for stoma closure after colorectal surgery", "history": [], "ground_truth": ["permed-52316", "permed-78681", "permed-52319", "permed-75293", "permed-3847", "permed-71328", "permed-85505", "permed-56525", "permed-79507", "permed-52322"]}
{"query_id": "topic_736_turn_2", "conversation_id": "topic_736", "turn_id": 2, "query": "Beyond these general determinants, how do patient-specific characteristics influence the decision-making for stoma closure?", "history": ["Key factors determining optimal timing for stoma closure after colorectal surgery"], "ground_truth": ["permed-52316", "permed-78681", "permed-86427", "permed-52319", "permed-78368", "permed-83903", "permed-81703", "permed-75334", "permed-75324", "permed-78675"]}
{"query_id": "topic_736_turn_3", "conversation_id": "topic_736", "turn_id": 3, "query": "Investigating specific patient factors like nutritional status, immune function, and comorbidities: impact on optimal stoma closure timing and comparison of long-term surgical outcomes and quality of life between early versus deferred reversal.", "history": ["Key factors determining optimal timing for stoma closure after colorectal surgery", "Beyond these general determinants, how do patient-specific characteristics influence the decision-making for stoma closure?"], "ground_truth": ["permed-52316", "permed-78681", "permed-52319", "permed-86427", "permed-83903", "permed-52317", "permed-24534", "permed-75293", "permed-78368", "permed-81703"]}
{"query_id": "topic_736_turn_4", "conversation_id": "topic_736", "turn_id": 4, "query": "Given this patient factor analysis, what specific statistical models would best handle the temporal relationship between preoperative nutritional markers and subsequent reversal timing? I'm particularly interested in how you'd account for time-varying covariates and competing risks when comparing long-term outcomes between early versus deferred closure groups. What sensitivity analyses would validate whether the observed QOL differences reflect true timing effects versus residual confounding?", "history": ["Key factors determining optimal timing for stoma closure after colorectal surgery", "Beyond these general determinants, how do patient-specific characteristics influence the decision-making for stoma closure?", "Investigating specific patient factors like nutritional status, immune function, and comorbidities: impact on optimal stoma closure timing and comparison of long-term surgical outcomes and quality of life between early versus deferred reversal."], "ground_truth": ["permed-24534", "permed-24507", "permed-54824", "permed-48846", "permed-26218", "permed-77519", "permed-32530", "permed-71192", "permed-92083", "permed-54239"]}
{"query_id": "topic_736_turn_5", "conversation_id": "topic_736", "turn_id": 5, "query": "Given these sophisticated statistical approaches for addressing temporal relationships and confounding, what clinical evidence exists regarding actual quality of life trajectories in the first postoperative year following early versus deferred stoma closure? Specifically, which validated patient-reported outcome measures have most reliably captured meaningful clinical differences in domains like social functioning, body image, and stoma-related distress? Additionally, how do reported complication rates and emergency readmissions between timing groups translate into practical clinical decision thresholds for surgeons managing high-risk patients with borderline nutritional status?", "history": ["Key factors determining optimal timing for stoma closure after colorectal surgery", "Beyond these general determinants, how do patient-specific characteristics influence the decision-making for stoma closure?", "Investigating specific patient factors like nutritional status, immune function, and comorbidities: impact on optimal stoma closure timing and comparison of long-term surgical outcomes and quality of life between early versus deferred reversal.", "Given this patient factor analysis, what specific statistical models would best handle the temporal relationship between preoperative nutritional markers and subsequent reversal timing? I'm particularly interested in how you'd account for time-varying covariates and competing risks when comparing long-term outcomes between early versus deferred closure groups. What sensitivity analyses would validate whether the observed QOL differences reflect true timing effects versus residual confounding?"], "ground_truth": ["permed-52319", "permed-78681", "permed-52316", "permed-75293", "permed-83903", "permed-82924", "permed-24484", "permed-75324", "permed-32579", "permed-81403"]}
{"query_id": "topic_736_turn_6", "conversation_id": "topic_736", "turn_id": 6, "query": "Given our detailed discussion of PRO measures and complication thresholds, how do the cumulative economic and healthcare utilization impacts of early versus deferred closure compare when accounting for both initial hospitalization costs and subsequent readmissions? Specifically, what evidence exists comparing total 12-month costs, productivity losses, and caregiver burdens between timing strategies in borderline nutritional status patients? How might emerging enhanced recovery protocols with accelerated closure compare economically to traditional delayed approaches, particularly when incorporating quality-adjusted life year considerations?", "history": ["Key factors determining optimal timing for stoma closure after colorectal surgery", "Beyond these general determinants, how do patient-specific characteristics influence the decision-making for stoma closure?", "Investigating specific patient factors like nutritional status, immune function, and comorbidities: impact on optimal stoma closure timing and comparison of long-term surgical outcomes and quality of life between early versus deferred reversal.", "Given this patient factor analysis, what specific statistical models would best handle the temporal relationship between preoperative nutritional markers and subsequent reversal timing? I'm particularly interested in how you'd account for time-varying covariates and competing risks when comparing long-term outcomes between early versus deferred closure groups. What sensitivity analyses would validate whether the observed QOL differences reflect true timing effects versus residual confounding?", "Given these sophisticated statistical approaches for addressing temporal relationships and confounding, what clinical evidence exists regarding actual quality of life trajectories in the first postoperative year following early versus deferred stoma closure? Specifically, which validated patient-reported outcome measures have most reliably captured meaningful clinical differences in domains like social functioning, body image, and stoma-related distress? Additionally, how do reported complication rates and emergency readmissions between timing groups translate into practical clinical decision thresholds for surgeons managing high-risk patients with borderline nutritional status?"], "ground_truth": ["permed-72336", "permed-66065", "permed-24507", "permed-90462", "permed-70979", "permed-51079", "permed-85105", "permed-57251", "permed-54089", "permed-88342"]}
{"query_id": "topic_737_turn_1", "conversation_id": "topic_737", "turn_id": 1, "query": "What role does curcumin play in enhancing the viability and function of stem cells, particularly in therapeutic applications?", "history": [], "ground_truth": ["permed-82265", "permed-51202", "permed-91400", "permed-67789", "permed-51225", "permed-90966", "permed-89127", "permed-62059", "permed-51186", "permed-51176"]}
{"query_id": "topic_737_turn_2", "conversation_id": "topic_737", "turn_id": 2, "query": "How does this technique of using curcumin impact the stability and regenerative capacity of stem cells over multiple cycles of preservation and use?", "history": ["What role does curcumin play in enhancing the viability and function of stem cells, particularly in therapeutic applications?"], "ground_truth": ["permed-82265", "permed-91400", "permed-51202", "permed-67789", "permed-65129", "permed-89127", "permed-68221", "permed-51225", "permed-90966", "permed-86314"]}
{"query_id": "topic_737_turn_3", "conversation_id": "topic_737", "turn_id": 3, "query": "Given these effects of curcumin on stem cell stability and regenerative capacity through multiple cycles, how does its long-term priming influence the genomic stability and epigenetic modifications in adipose-derived stem cells after repeated cryopreservation and thawing—and what implications do these changes have for their regenerative performance in chronic wound healing applications?", "history": ["What role does curcumin play in enhancing the viability and function of stem cells, particularly in therapeutic applications?", "How does this technique of using curcumin impact the stability and regenerative capacity of stem cells over multiple cycles of preservation and use?"], "ground_truth": ["permed-82265", "permed-59067", "permed-91859", "permed-91400", "permed-20189", "permed-51202", "permed-74892", "permed-51225", "permed-64425", "permed-14600"]}
{"query_id": "topic_737_turn_4", "conversation_id": "topic_737", "turn_id": 4, "query": "Given these genomic and epigenetic changes observed after repeated cryopreservation, what specific analytical methodologies were employed to quantify DNA methylation patterns and histone modifications in adipose-derived stem cells? I'm particularly interested in the technical protocols for bisulfite sequencing, chromatin immunoprecipitation parameters, and how validation was performed to ensure these epigenetic markers reliably correlate with functional outcomes in wound healing assays.", "history": ["What role does curcumin play in enhancing the viability and function of stem cells, particularly in therapeutic applications?", "How does this technique of using curcumin impact the stability and regenerative capacity of stem cells over multiple cycles of preservation and use?", "Given these effects of curcumin on stem cell stability and regenerative capacity through multiple cycles, how does its long-term priming influence the genomic stability and epigenetic modifications in adipose-derived stem cells after repeated cryopreservation and thawing—and what implications do these changes have for their regenerative performance in chronic wound healing applications?"], "ground_truth": ["permed-67504", "permed-82265", "permed-64426", "permed-90428", "permed-64545", "permed-87623", "permed-51222", "permed-58527", "permed-7568", "permed-78391"]}
{"query_id": "topic_737_turn_5", "conversation_id": "topic_737", "turn_id": 5, "query": "Given these established epigenetic analysis protocols and their correlation with functional outcomes, what clinical evidence exists regarding the therapeutic efficacy and safety profile of curcumin-primed adipose-derived stem cells in human chronic wound healing trials? Specifically, what patient-centered outcomes - such as wound closure rates, infection incidence, pain reduction, and recurrence rates - have been demonstrated in clinical studies? Additionally, have any adverse events or contraindications been reported when using this combined therapeutic approach in patients with comorbidities like diabetes or vascular insufficiency?", "history": ["What role does curcumin play in enhancing the viability and function of stem cells, particularly in therapeutic applications?", "How does this technique of using curcumin impact the stability and regenerative capacity of stem cells over multiple cycles of preservation and use?", "Given these effects of curcumin on stem cell stability and regenerative capacity through multiple cycles, how does its long-term priming influence the genomic stability and epigenetic modifications in adipose-derived stem cells after repeated cryopreservation and thawing—and what implications do these changes have for their regenerative performance in chronic wound healing applications?", "Given these genomic and epigenetic changes observed after repeated cryopreservation, what specific analytical methodologies were employed to quantify DNA methylation patterns and histone modifications in adipose-derived stem cells? I'm particularly interested in the technical protocols for bisulfite sequencing, chromatin immunoprecipitation parameters, and how validation was performed to ensure these epigenetic markers reliably correlate with functional outcomes in wound healing assays."], "ground_truth": ["permed-82265", "permed-20189", "permed-86955", "permed-91400", "permed-20193", "permed-38764", "permed-38886", "permed-30304", "permed-68473", "permed-13108"]}
{"query_id": "topic_737_turn_6", "conversation_id": "topic_737", "turn_id": 6, "query": "Given the comprehensive clinical and epigenetic framework established, how precisely are we defining \"therapeutic efficacy\" in this context - is it primarily measured through objective wound closure metrics, or does it incorporate multidimensional patient-reported outcomes like quality of life restoration? Furthermore, what constitutes the theoretical threshold for \"successful\" epigenetic reprogramming versus pathological instability in these primed cells, and how might this definition evolve as we consider long-term patient monitoring beyond initial wound closure?", "history": ["What role does curcumin play in enhancing the viability and function of stem cells, particularly in therapeutic applications?", "How does this technique of using curcumin impact the stability and regenerative capacity of stem cells over multiple cycles of preservation and use?", "Given these effects of curcumin on stem cell stability and regenerative capacity through multiple cycles, how does its long-term priming influence the genomic stability and epigenetic modifications in adipose-derived stem cells after repeated cryopreservation and thawing—and what implications do these changes have for their regenerative performance in chronic wound healing applications?", "Given these genomic and epigenetic changes observed after repeated cryopreservation, what specific analytical methodologies were employed to quantify DNA methylation patterns and histone modifications in adipose-derived stem cells? I'm particularly interested in the technical protocols for bisulfite sequencing, chromatin immunoprecipitation parameters, and how validation was performed to ensure these epigenetic markers reliably correlate with functional outcomes in wound healing assays.", "Given these established epigenetic analysis protocols and their correlation with functional outcomes, what clinical evidence exists regarding the therapeutic efficacy and safety profile of curcumin-primed adipose-derived stem cells in human chronic wound healing trials? Specifically, what patient-centered outcomes - such as wound closure rates, infection incidence, pain reduction, and recurrence rates - have been demonstrated in clinical studies? Additionally, have any adverse events or contraindications been reported when using this combined therapeutic approach in patients with comorbidities like diabetes or vascular insufficiency?"], "ground_truth": ["permed-86988", "permed-71206", "permed-62514", "permed-73848", "permed-58214", "permed-51221", "permed-68028", "permed-51222", "permed-22413", "permed-14600"]}
{"query_id": "topic_738_turn_1", "conversation_id": "topic_738", "turn_id": 1, "query": "Lipoprotein apheresis: comprehensive review of its impact on established cardiovascular disease markers and patient outcomes.", "history": [], "ground_truth": ["permed-74705", "permed-68272", "permed-74736", "permed-58858", "permed-4862", "permed-74737", "permed-4864", "permed-56265", "permed-4863", "permed-4735"]}
{"query_id": "topic_738_turn_2", "conversation_id": "topic_738", "turn_id": 2, "query": "Following lipoprotein apheresis and its observed cardiovascular benefits, what are the specific temporal changes in key systemic inflammatory mediators and endothelial function parameters?", "history": ["Lipoprotein apheresis: comprehensive review of its impact on established cardiovascular disease markers and patient outcomes."], "ground_truth": ["permed-68272", "permed-74705", "permed-74736", "permed-52511", "permed-58858", "permed-4862", "permed-4864", "permed-4735", "permed-90398", "permed-4863"]}
{"query_id": "topic_738_turn_3", "conversation_id": "topic_738", "turn_id": 3, "query": "In light of lipoprotein apheresis-induced improvements in inflammatory mediators and endothelial function, which specific circulating microRNA signatures are altered post-treatment, how strongly do these miRNA changes track with the magnitude of vascular and anti-inflammatory responses, and what is their validated predictive accuracy for long-term major adverse cardiovascular events (MACE) in treated patients?", "history": ["Lipoprotein apheresis: comprehensive review of its impact on established cardiovascular disease markers and patient outcomes.", "Following lipoprotein apheresis and its observed cardiovascular benefits, what are the specific temporal changes in key systemic inflammatory mediators and endothelial function parameters?"], "ground_truth": ["permed-68272", "permed-74736", "permed-74705", "permed-70405", "permed-54172", "permed-61438", "permed-74737", "permed-90398", "permed-90443", "permed-57072"]}
{"query_id": "topic_738_turn_4", "conversation_id": "topic_738", "turn_id": 4, "query": "For these circulating miRNA signatures you identified, what specific analytical pipeline was implemented for their quantification? I'm particularly interested in the RNA extraction protocols, normalization strategies against hemolysis markers, and the statistical methods used to establish correlation strength with vascular parameters. How did you validate the predictive models for MACE, and what quality control measures ensured technical reproducibility across different patient samples and processing batches?", "history": ["Lipoprotein apheresis: comprehensive review of its impact on established cardiovascular disease markers and patient outcomes.", "Following lipoprotein apheresis and its observed cardiovascular benefits, what are the specific temporal changes in key systemic inflammatory mediators and endothelial function parameters?", "In light of lipoprotein apheresis-induced improvements in inflammatory mediators and endothelial function, which specific circulating microRNA signatures are altered post-treatment, how strongly do these miRNA changes track with the magnitude of vascular and anti-inflammatory responses, and what is their validated predictive accuracy for long-term major adverse cardiovascular events (MACE) in treated patients?"], "ground_truth": ["permed-71767", "permed-84830", "permed-47166", "permed-91557", "permed-6242", "permed-71768", "permed-61438", "permed-68193", "permed-91564", "permed-31291"]}
{"query_id": "topic_738_turn_5", "conversation_id": "topic_738", "turn_id": 5, "query": "Given the detailed analytical pipeline for miRNA quantification you described, how does the predictive performance for MACE compare between the circulating miRNA signature panel and established cardiovascular biomarkers like high-sensitivity C-reactive protein or lipoprotein(a) levels? Specifically, what were the relative areas under the curve, net reclassification improvements, and integrated discrimination improvements when these different biomarker approaches were directly compared in the same patient cohort following lipoprotein apheresis treatment?", "history": ["Lipoprotein apheresis: comprehensive review of its impact on established cardiovascular disease markers and patient outcomes.", "Following lipoprotein apheresis and its observed cardiovascular benefits, what are the specific temporal changes in key systemic inflammatory mediators and endothelial function parameters?", "In light of lipoprotein apheresis-induced improvements in inflammatory mediators and endothelial function, which specific circulating microRNA signatures are altered post-treatment, how strongly do these miRNA changes track with the magnitude of vascular and anti-inflammatory responses, and what is their validated predictive accuracy for long-term major adverse cardiovascular events (MACE) in treated patients?", "For these circulating miRNA signatures you identified, what specific analytical pipeline was implemented for their quantification? I'm particularly interested in the RNA extraction protocols, normalization strategies against hemolysis markers, and the statistical methods used to establish correlation strength with vascular parameters. How did you validate the predictive models for MACE, and what quality control measures ensured technical reproducibility across different patient samples and processing batches?"], "ground_truth": ["permed-61438", "permed-70405", "permed-80165", "permed-54172", "permed-91564", "permed-74737", "permed-71278", "permed-56190", "permed-57072", "permed-57150"]}
{"query_id": "topic_738_turn_6", "conversation_id": "topic_738", "turn_id": 6, "query": "Given the comparative performance data between miRNA signatures and traditional biomarkers for MACE prediction post-apheresis, how do these different approaches compare in terms of clinical implementation feasibility? Specifically, considering the complex analytical pipeline required for miRNA quantification versus the standardized assays for hs-CRP and Lp(a), what are the practical trade-offs between predictive accuracy and clinical utility? How might emerging point-of-care miRNA detection technologies potentially bridge this gap, and what cost-effectiveness analyses support transitioning from established biomarkers to multi-modal miRNA panels in routine cardiovascular risk assessment?", "history": ["Lipoprotein apheresis: comprehensive review of its impact on established cardiovascular disease markers and patient outcomes.", "Following lipoprotein apheresis and its observed cardiovascular benefits, what are the specific temporal changes in key systemic inflammatory mediators and endothelial function parameters?", "In light of lipoprotein apheresis-induced improvements in inflammatory mediators and endothelial function, which specific circulating microRNA signatures are altered post-treatment, how strongly do these miRNA changes track with the magnitude of vascular and anti-inflammatory responses, and what is their validated predictive accuracy for long-term major adverse cardiovascular events (MACE) in treated patients?", "For these circulating miRNA signatures you identified, what specific analytical pipeline was implemented for their quantification? I'm particularly interested in the RNA extraction protocols, normalization strategies against hemolysis markers, and the statistical methods used to establish correlation strength with vascular parameters. How did you validate the predictive models for MACE, and what quality control measures ensured technical reproducibility across different patient samples and processing batches?", "Given the detailed analytical pipeline for miRNA quantification you described, how does the predictive performance for MACE compare between the circulating miRNA signature panel and established cardiovascular biomarkers like high-sensitivity C-reactive protein or lipoprotein(a) levels? Specifically, what were the relative areas under the curve, net reclassification improvements, and integrated discrimination improvements when these different biomarker approaches were directly compared in the same patient cohort following lipoprotein apheresis treatment?"], "ground_truth": ["permed-61438", "permed-80165", "permed-70405", "permed-91564", "permed-71278", "permed-54172", "permed-84830", "permed-56190", "permed-55168", "permed-90551"]}
{"query_id": "topic_739_turn_1", "conversation_id": "topic_739", "turn_id": 1, "query": "What are the primary electrochemical and spectroscopic techniques currently being explored for monitoring redox behavior in conductive polymers?", "history": [], "ground_truth": ["permed-72959", "permed-92702", "permed-73057", "permed-72980", "permed-51027", "permed-77742", "permed-52459", "permed-89911", "permed-87172", "permed-74688"]}
{"query_id": "topic_739_turn_2", "conversation_id": "topic_739", "turn_id": 2, "query": "Focusing on *these spectroscopic methods*, how is Surface-Enhanced Raman Spectroscopy (SERS) specifically applied to enhance sensitivity and resolution when monitoring conductive polymer redox transitions?", "history": ["What are the primary electrochemical and spectroscopic techniques currently being explored for monitoring redox behavior in conductive polymers?"], "ground_truth": ["permed-72959", "permed-92702", "permed-88725", "permed-74446", "permed-77683", "permed-77688", "permed-83796", "permed-71744", "permed-86052", "permed-76033"]}
{"query_id": "topic_739_turn_3", "conversation_id": "topic_739", "turn_id": 3, "query": "Given *SERS's utility in this context*, how can plasmonic nanoparticle integration further improve its spatial resolution and sensitivity for real-time, in-situ monitoring of conductive polymer redox dynamics, especially for applications in advanced wearable electronics?", "history": ["What are the primary electrochemical and spectroscopic techniques currently being explored for monitoring redox behavior in conductive polymers?", "Focusing on *these spectroscopic methods*, how is Surface-Enhanced Raman Spectroscopy (SERS) specifically applied to enhance sensitivity and resolution when monitoring conductive polymer redox transitions?"], "ground_truth": ["permed-72959", "permed-71744", "permed-75984", "permed-64284", "permed-88725", "permed-77682", "permed-86052", "permed-74446", "permed-88704", "permed-77683"]}
{"query_id": "topic_739_turn_4", "conversation_id": "topic_739", "turn_id": 4, "query": "Given this nanoparticle-enhanced SERS approach, what specific experimental protocols and control strategies are most critical for ensuring reproducible plasmonic substrate fabrication and stable nanoparticle-polymer interfaces during dynamic redox cycling? I'm particularly interested in the technical implementation details for maintaining consistent enhancement factors across multiple measurement cycles, and whether any specialized statistical validation methods are employed to quantify interface stability under operational conditions relevant to wearable electronics.", "history": ["What are the primary electrochemical and spectroscopic techniques currently being explored for monitoring redox behavior in conductive polymers?", "Focusing on *these spectroscopic methods*, how is Surface-Enhanced Raman Spectroscopy (SERS) specifically applied to enhance sensitivity and resolution when monitoring conductive polymer redox transitions?", "Given *SERS's utility in this context*, how can plasmonic nanoparticle integration further improve its spatial resolution and sensitivity for real-time, in-situ monitoring of conductive polymer redox dynamics, especially for applications in advanced wearable electronics?"], "ground_truth": ["permed-71744", "permed-72959", "permed-64284", "permed-74446", "permed-75984", "permed-77683", "permed-79254", "permed-88725", "permed-92529", "permed-88704"]}
{"query_id": "topic_739_turn_5", "conversation_id": "topic_739", "turn_id": 5, "query": "Given these refined nanoparticle-SERS protocols for monitoring conductive polymer redox states, what clinical translation challenges arise when adapting these sensing platforms for continuous physiological monitoring in wearable medical devices? Specifically, how do redox state fluctuations correlate with actionable clinical biomarkers in conditions like diabetic ketoacidosis or sepsis, and what safety considerations emerge regarding biocompatibility of plasmonic nanoparticles during prolonged skin contact? Are there clinical trial data demonstrating reliable detection thresholds for metabolic crises compared to standard blood tests?", "history": ["What are the primary electrochemical and spectroscopic techniques currently being explored for monitoring redox behavior in conductive polymers?", "Focusing on *these spectroscopic methods*, how is Surface-Enhanced Raman Spectroscopy (SERS) specifically applied to enhance sensitivity and resolution when monitoring conductive polymer redox transitions?", "Given *SERS's utility in this context*, how can plasmonic nanoparticle integration further improve its spatial resolution and sensitivity for real-time, in-situ monitoring of conductive polymer redox dynamics, especially for applications in advanced wearable electronics?", "Given this nanoparticle-enhanced SERS approach, what specific experimental protocols and control strategies are most critical for ensuring reproducible plasmonic substrate fabrication and stable nanoparticle-polymer interfaces during dynamic redox cycling? I'm particularly interested in the technical implementation details for maintaining consistent enhancement factors across multiple measurement cycles, and whether any specialized statistical validation methods are employed to quantify interface stability under operational conditions relevant to wearable electronics."], "ground_truth": ["permed-75984", "permed-72959", "permed-88704", "permed-68468", "permed-62235", "permed-70331", "permed-71744", "permed-72989", "permed-80657", "permed-59242"]}
{"query_id": "topic_739_turn_6", "conversation_id": "topic_739", "turn_id": 6, "query": "Given the technical refinements for nanoparticle-SERS platforms and their clinical biomarker correlation potential discussed, how do these emerging conductive polymer sensors compare to established electrochemical wearable systems (like continuous glucose monitors) in terms of clinical validation timelines and regulatory pathways? Specifically, what distinct advantages in multi-analyte detection or response times might justify their development despite electrochemical systems' existing FDA approvals, and what comparative infrastructure limitations (manufacturing scalability, calibration requirements) could delay clinical adoption for metabolic crisis monitoring?", "history": ["What are the primary electrochemical and spectroscopic techniques currently being explored for monitoring redox behavior in conductive polymers?", "Focusing on *these spectroscopic methods*, how is Surface-Enhanced Raman Spectroscopy (SERS) specifically applied to enhance sensitivity and resolution when monitoring conductive polymer redox transitions?", "Given *SERS's utility in this context*, how can plasmonic nanoparticle integration further improve its spatial resolution and sensitivity for real-time, in-situ monitoring of conductive polymer redox dynamics, especially for applications in advanced wearable electronics?", "Given this nanoparticle-enhanced SERS approach, what specific experimental protocols and control strategies are most critical for ensuring reproducible plasmonic substrate fabrication and stable nanoparticle-polymer interfaces during dynamic redox cycling? I'm particularly interested in the technical implementation details for maintaining consistent enhancement factors across multiple measurement cycles, and whether any specialized statistical validation methods are employed to quantify interface stability under operational conditions relevant to wearable electronics.", "Given these refined nanoparticle-SERS protocols for monitoring conductive polymer redox states, what clinical translation challenges arise when adapting these sensing platforms for continuous physiological monitoring in wearable medical devices? Specifically, how do redox state fluctuations correlate with actionable clinical biomarkers in conditions like diabetic ketoacidosis or sepsis, and what safety considerations emerge regarding biocompatibility of plasmonic nanoparticles during prolonged skin contact? Are there clinical trial data demonstrating reliable detection thresholds for metabolic crises compared to standard blood tests?"], "ground_truth": ["permed-68468", "permed-75984", "permed-51728", "permed-51724", "permed-51727", "permed-62241", "permed-64613", "permed-59242", "permed-80660", "permed-54067"]}
{"query_id": "topic_740_turn_1", "conversation_id": "topic_740", "turn_id": 1, "query": "What strategies are being explored to increase awareness of economic benefits among low-income families?", "history": [], "ground_truth": ["permed-80088", "permed-86027", "permed-60173", "permed-82651", "permed-59607", "permed-55982", "permed-60175", "permed-78584", "permed-74977", "permed-63352"]}
{"query_id": "topic_740_turn_2", "conversation_id": "topic_740", "turn_id": 2, "query": "How effective are targeted educational interventions in this area, particularly for programs like the Earned Income Tax Credit?", "history": ["What strategies are being explored to increase awareness of economic benefits among low-income families?"], "ground_truth": ["permed-80093", "permed-80094", "permed-58496", "permed-57442", "permed-63347", "permed-80097", "permed-92342", "permed-58499", "permed-84730", "permed-82430"]}
{"query_id": "topic_740_turn_3", "conversation_id": "topic_740", "turn_id": 3, "query": "For these targeted educational interventions, how could tailoring them to the linguistic and cultural contexts of low-income Californian families specifically improve awareness and understanding of the EITC and its supplemental programs? What strategies would be most effective in boosting take-up rates among younger parents and non-English speakers to advance economic stability and health equity?", "history": ["What strategies are being explored to increase awareness of economic benefits among low-income families?", "How effective are targeted educational interventions in this area, particularly for programs like the Earned Income Tax Credit?"], "ground_truth": ["permed-80093", "permed-80094", "permed-92157", "permed-88289", "permed-74977", "permed-69900", "permed-74809", "permed-59607", "permed-63578", "permed-88287"]}
{"query_id": "topic_740_turn_4", "conversation_id": "topic_740", "turn_id": 4, "query": "Given this emphasis on cultural and linguistic tailoring, what specific methodological approaches would be most appropriate for validating the effectiveness of these interventions? I'm particularly interested in how you would design the randomized controlled trial—specifically, the optimal sample size calculation for detecting significant differences in EITC take-up rates among these diverse subgroups, and what statistical models would best account for potential confounding variables like prior program awareness or digital literacy levels.", "history": ["What strategies are being explored to increase awareness of economic benefits among low-income families?", "How effective are targeted educational interventions in this area, particularly for programs like the Earned Income Tax Credit?", "For these targeted educational interventions, how could tailoring them to the linguistic and cultural contexts of low-income Californian families specifically improve awareness and understanding of the EITC and its supplemental programs? What strategies would be most effective in boosting take-up rates among younger parents and non-English speakers to advance economic stability and health equity?"], "ground_truth": ["permed-80093", "permed-69900", "permed-74318", "permed-84050", "permed-64779", "permed-61165", "permed-80094", "permed-23686", "permed-82430", "permed-90601"]}
{"query_id": "topic_740_turn_5", "conversation_id": "topic_740", "turn_id": 5, "query": "Given the methodological framework for validating culturally-tailored EITC interventions, how have these educational strategies translated into measurable clinical or public health outcomes in real-world settings? Specifically, what evidence exists from implementation studies showing impacts on health equity markers—such as reductions in maternal stress, improvements in birth outcomes, or decreased healthcare utilization—among participating low-income families? Furthermore, are there documented unintended consequences or safety considerations, like administrative burden or data privacy concerns, that affect patient engagement and program efficacy when deploying these interventions at scale?", "history": ["What strategies are being explored to increase awareness of economic benefits among low-income families?", "How effective are targeted educational interventions in this area, particularly for programs like the Earned Income Tax Credit?", "For these targeted educational interventions, how could tailoring them to the linguistic and cultural contexts of low-income Californian families specifically improve awareness and understanding of the EITC and its supplemental programs? What strategies would be most effective in boosting take-up rates among younger parents and non-English speakers to advance economic stability and health equity?", "Given this emphasis on cultural and linguistic tailoring, what specific methodological approaches would be most appropriate for validating the effectiveness of these interventions? I'm particularly interested in how you would design the randomized controlled trial—specifically, the optimal sample size calculation for detecting significant differences in EITC take-up rates among these diverse subgroups, and what statistical models would best account for potential confounding variables like prior program awareness or digital literacy levels."], "ground_truth": ["permed-80093", "permed-80094", "permed-82791", "permed-88216", "permed-91011", "permed-56876", "permed-92342", "permed-88209", "permed-58547", "permed-82573"]}
{"query_id": "topic_740_turn_6", "conversation_id": "topic_740", "turn_id": 6, "query": "Building on our discussion of EITC interventions' health impacts and implementation challenges, how would you operationally define \"health equity\" within this specific context of tax credit outreach programs? Given that maternal stress reduction and birth outcome improvements were mentioned as markers, what theoretical frameworks or conceptual models best capture the causal pathways between economic benefit awareness and these health outcomes? Specifically, does this definition incorporate psychosocial mechanisms like increased perceived financial security, or does it primarily track biomedical indicators? How might this definition evolve as we consider long-term intergenerational health effects beyond immediate clinical metrics?", "history": ["What strategies are being explored to increase awareness of economic benefits among low-income families?", "How effective are targeted educational interventions in this area, particularly for programs like the Earned Income Tax Credit?", "For these targeted educational interventions, how could tailoring them to the linguistic and cultural contexts of low-income Californian families specifically improve awareness and understanding of the EITC and its supplemental programs? What strategies would be most effective in boosting take-up rates among younger parents and non-English speakers to advance economic stability and health equity?", "Given this emphasis on cultural and linguistic tailoring, what specific methodological approaches would be most appropriate for validating the effectiveness of these interventions? I'm particularly interested in how you would design the randomized controlled trial—specifically, the optimal sample size calculation for detecting significant differences in EITC take-up rates among these diverse subgroups, and what statistical models would best account for potential confounding variables like prior program awareness or digital literacy levels.", "Given the methodological framework for validating culturally-tailored EITC interventions, how have these educational strategies translated into measurable clinical or public health outcomes in real-world settings? Specifically, what evidence exists from implementation studies showing impacts on health equity markers—such as reductions in maternal stress, improvements in birth outcomes, or decreased healthcare utilization—among participating low-income families? Furthermore, are there documented unintended consequences or safety considerations, like administrative burden or data privacy concerns, that affect patient engagement and program efficacy when deploying these interventions at scale?"], "ground_truth": ["permed-60173", "permed-61209", "permed-80093", "permed-69969", "permed-80094", "permed-53060", "permed-60329", "permed-26456", "permed-88062", "permed-65627"]}
{"query_id": "topic_741_turn_1", "conversation_id": "topic_741", "turn_id": 1, "query": "What role do Criegee intermediates play in atmospheric chemical reactions?", "history": [], "ground_truth": ["permed-79304", "permed-73207", "permed-88643", "permed-86636", "permed-89441", "permed-53752", "permed-64164", "permed-73206", "permed-58014", "permed-85308"]}
{"query_id": "topic_741_turn_2", "conversation_id": "topic_741", "turn_id": 2, "query": "How sensitive are the formation and reactivity of these intermediates to different experimental conditions?", "history": ["What role do Criegee intermediates play in atmospheric chemical reactions?"], "ground_truth": ["permed-82820", "permed-53752", "permed-74958", "permed-51646", "permed-86882", "permed-88645", "permed-87113", "permed-58014", "permed-79787", "permed-60645"]}
{"query_id": "topic_741_turn_3", "conversation_id": "topic_741", "turn_id": 3, "query": "Given what we know about their formation and reactivity, how do factors like temperature and different scavengers influence the yield and behavior of thermalized Criegee intermediates from alkene ozonolysis? And how could these effects help improve the kinetic models for atmospheric reactions?", "history": ["What role do Criegee intermediates play in atmospheric chemical reactions?", "How sensitive are the formation and reactivity of these intermediates to different experimental conditions?"], "ground_truth": ["permed-79304", "permed-57929", "permed-86636", "permed-88645", "permed-73207", "permed-74578", "permed-86638", "permed-58141", "permed-88471", "permed-88588"]}
{"query_id": "topic_741_turn_4", "conversation_id": "topic_741", "turn_id": 4, "query": "Regarding the kinetic modeling improvements you mentioned, what specific experimental protocols are used to quantify branching ratios between thermalized Criegee intermediate decomposition pathways versus bimolecular reactions with scavengers? I'm particularly interested in how researchers validate these measurements - do they employ simultaneous detection methods like photoionization mass spectrometry coupled with infrared spectroscopy, and what statistical approaches ensure reproducibility across different temperature regimes when accounting for scavenger concentration effects?", "history": ["What role do Criegee intermediates play in atmospheric chemical reactions?", "How sensitive are the formation and reactivity of these intermediates to different experimental conditions?", "Given what we know about their formation and reactivity, how do factors like temperature and different scavengers influence the yield and behavior of thermalized Criegee intermediates from alkene ozonolysis? And how could these effects help improve the kinetic models for atmospheric reactions?"], "ground_truth": ["permed-79304", "permed-59195", "permed-85309", "permed-85306", "permed-75847", "permed-80590", "permed-88989", "permed-58048", "permed-73207", "permed-80588"]}
{"query_id": "topic_741_turn_5", "conversation_id": "topic_741", "turn_id": 5, "query": "Given these refined atmospheric chemistry models and detection methodologies for Criegee intermediates, what are the emerging clinical implications for human respiratory health? Specifically, how do secondary organic aerosols formed through these ozonolysis pathways influence pulmonary inflammation or exacerbation of pre-existing conditions like asthma in real-world exposure scenarios, and what clinical evidence exists regarding differential patient susceptibility based on exposure to these chemically distinct particulate species?", "history": ["What role do Criegee intermediates play in atmospheric chemical reactions?", "How sensitive are the formation and reactivity of these intermediates to different experimental conditions?", "Given what we know about their formation and reactivity, how do factors like temperature and different scavengers influence the yield and behavior of thermalized Criegee intermediates from alkene ozonolysis? And how could these effects help improve the kinetic models for atmospheric reactions?", "Regarding the kinetic modeling improvements you mentioned, what specific experimental protocols are used to quantify branching ratios between thermalized Criegee intermediate decomposition pathways versus bimolecular reactions with scavengers? I'm particularly interested in how researchers validate these measurements - do they employ simultaneous detection methods like photoionization mass spectrometry coupled with infrared spectroscopy, and what statistical approaches ensure reproducibility across different temperature regimes when accounting for scavenger concentration effects?"], "ground_truth": ["permed-33867", "permed-86636", "permed-81996", "permed-81095", "permed-79304", "permed-13576", "permed-68876", "permed-86637", "permed-61832", "permed-86638"]}
{"query_id": "topic_741_turn_6", "conversation_id": "topic_741", "turn_id": 6, "query": "Given our discussion of atmospheric chemistry models and clinical impacts, how do the respiratory health risks from secondary organic aerosols generated through Criegee intermediate pathways compare to those from other major particulate sources like traffic emissions or industrial combustion? Specifically, what mechanistic evidence distinguishes the inflammatory potential of these chemically distinct aerosol types in pulmonary tissues, and how should future risk assessment frameworks prioritize mitigation strategies given their differential abundance in urban versus rural environments and varying patient susceptibility patterns observed in asthma epidemiology studies?", "history": ["What role do Criegee intermediates play in atmospheric chemical reactions?", "How sensitive are the formation and reactivity of these intermediates to different experimental conditions?", "Given what we know about their formation and reactivity, how do factors like temperature and different scavengers influence the yield and behavior of thermalized Criegee intermediates from alkene ozonolysis? And how could these effects help improve the kinetic models for atmospheric reactions?", "Regarding the kinetic modeling improvements you mentioned, what specific experimental protocols are used to quantify branching ratios between thermalized Criegee intermediate decomposition pathways versus bimolecular reactions with scavengers? I'm particularly interested in how researchers validate these measurements - do they employ simultaneous detection methods like photoionization mass spectrometry coupled with infrared spectroscopy, and what statistical approaches ensure reproducibility across different temperature regimes when accounting for scavenger concentration effects?", "Given these refined atmospheric chemistry models and detection methodologies for Criegee intermediates, what are the emerging clinical implications for human respiratory health? Specifically, how do secondary organic aerosols formed through these ozonolysis pathways influence pulmonary inflammation or exacerbation of pre-existing conditions like asthma in real-world exposure scenarios, and what clinical evidence exists regarding differential patient susceptibility based on exposure to these chemically distinct particulate species?"], "ground_truth": ["permed-33867", "permed-81996", "permed-87257", "permed-13576", "permed-87256", "permed-65354", "permed-61098", "permed-78241", "permed-61834", "permed-67190"]}
{"query_id": "topic_742_turn_1", "conversation_id": "topic_742", "turn_id": 1, "query": "Current treatment challenges and management strategies for dissecting vertebral artery pseudoaneurysms.", "history": [], "ground_truth": ["permed-72189", "permed-72186", "permed-56265", "permed-71333", "permed-54121", "permed-68794", "permed-72187", "permed-54125", "permed-91171", "permed-76979"]}
{"query_id": "topic_742_turn_2", "conversation_id": "topic_742", "turn_id": 2, "query": "Considering these management challenges, how does vertebral artery anatomical variability influence the selection and technical approach of endovascular treatment for such pseudoaneurysms?", "history": ["Current treatment challenges and management strategies for dissecting vertebral artery pseudoaneurysms."], "ground_truth": ["permed-72189", "permed-54121", "permed-72186", "permed-54123", "permed-54125", "permed-72191", "permed-72187", "permed-91171", "permed-68794", "permed-54122"]}
{"query_id": "topic_742_turn_3", "conversation_id": "topic_742", "turn_id": 3, "query": "Impact of specific vertebral artery anatomical variations (PICA origin, dominance, tortuosity) and patient factors (neurological status, comorbidities) on selection criteria, technical success, and long-term clinico-radiological outcomes of different endovascular strategies (e.g., flow diversion, stent-assisted coiling, parent artery occlusion) for dissecting pseudoaneurysms.", "history": ["Current treatment challenges and management strategies for dissecting vertebral artery pseudoaneurysms.", "Considering these management challenges, how does vertebral artery anatomical variability influence the selection and technical approach of endovascular treatment for such pseudoaneurysms?"], "ground_truth": ["permed-72189", "permed-76974", "permed-59718", "permed-81321", "permed-76976", "permed-72191", "permed-68796", "permed-72186", "permed-57331", "permed-59717"]}
{"query_id": "topic_742_turn_4", "conversation_id": "topic_742", "turn_id": 4, "query": "Given these patient-specific anatomical and clinical factors, what specific technical protocols do interventionalists employ to navigate high tortuosity or anomalous PICA origins during flow diverter deployment? I'm particularly interested in how they modify device sizing, delivery system selection, and intraoperative imaging protocols to ensure accurate placement while minimizing thromboembolic complications. Are there standardized metrics for assessing device-wall apposition in these challenging anatomies during the procedure?", "history": ["Current treatment challenges and management strategies for dissecting vertebral artery pseudoaneurysms.", "Considering these management challenges, how does vertebral artery anatomical variability influence the selection and technical approach of endovascular treatment for such pseudoaneurysms?", "Impact of specific vertebral artery anatomical variations (PICA origin, dominance, tortuosity) and patient factors (neurological status, comorbidities) on selection criteria, technical success, and long-term clinico-radiological outcomes of different endovascular strategies (e.g., flow diversion, stent-assisted coiling, parent artery occlusion) for dissecting pseudoaneurysms."], "ground_truth": ["permed-76974", "permed-52606", "permed-78723", "permed-84297", "permed-85147", "permed-50690", "permed-15668", "permed-57294", "permed-12042", "permed-28483"]}
{"query_id": "topic_742_turn_5", "conversation_id": "topic_742", "turn_id": 5, "query": "Given these technical adaptations for challenging anatomies, what clinical outcomes and complication profiles have been observed with flow diversion in tortuous vertebral arteries or anomalous PICA origins? Specifically, how do perioperative ischemic complications, delayed aneurysm occlusion rates, and long-term patency compare to more conventional endovascular approaches? Furthermore, what patient-specific factors - such as antiplatelet regimen adherence or underlying vascular pathology - appear to most significantly influence the safety-efficacy balance in real-world practice, particularly regarding delayed thromboembolic events or in-stent stenosis development?", "history": ["Current treatment challenges and management strategies for dissecting vertebral artery pseudoaneurysms.", "Considering these management challenges, how does vertebral artery anatomical variability influence the selection and technical approach of endovascular treatment for such pseudoaneurysms?", "Impact of specific vertebral artery anatomical variations (PICA origin, dominance, tortuosity) and patient factors (neurological status, comorbidities) on selection criteria, technical success, and long-term clinico-radiological outcomes of different endovascular strategies (e.g., flow diversion, stent-assisted coiling, parent artery occlusion) for dissecting pseudoaneurysms.", "Given these patient-specific anatomical and clinical factors, what specific technical protocols do interventionalists employ to navigate high tortuosity or anomalous PICA origins during flow diverter deployment? I'm particularly interested in how they modify device sizing, delivery system selection, and intraoperative imaging protocols to ensure accurate placement while minimizing thromboembolic complications. Are there standardized metrics for assessing device-wall apposition in these challenging anatomies during the procedure?"], "ground_truth": ["permed-59718", "permed-76974", "permed-52606", "permed-85147", "permed-90480", "permed-72189", "permed-46871", "permed-46889", "permed-15668", "permed-85146"]}
{"query_id": "topic_742_turn_6", "conversation_id": "topic_742", "turn_id": 6, "query": "Given our detailed discussion about technical adaptations and clinical outcomes in vertebral artery flow diversion, how should we fundamentally define \"satisfactory device-wall apposition\" in tortuous anatomies from both mechanical and hemodynamic perspectives? Beyond conventional angiographic assessment, what quantitative parameters (e.g., wall apposition index, endothelial shear stress alterations) constitute this standard, and how do these definitions evolve when considering delayed aneurysm occlusion versus long-term patency? Furthermore, what conceptual challenges exist in establishing universal apposition criteria across varying anatomical complexities, and how might computational modeling redefine these definitions for personalized treatment planning?", "history": ["Current treatment challenges and management strategies for dissecting vertebral artery pseudoaneurysms.", "Considering these management challenges, how does vertebral artery anatomical variability influence the selection and technical approach of endovascular treatment for such pseudoaneurysms?", "Impact of specific vertebral artery anatomical variations (PICA origin, dominance, tortuosity) and patient factors (neurological status, comorbidities) on selection criteria, technical success, and long-term clinico-radiological outcomes of different endovascular strategies (e.g., flow diversion, stent-assisted coiling, parent artery occlusion) for dissecting pseudoaneurysms.", "Given these patient-specific anatomical and clinical factors, what specific technical protocols do interventionalists employ to navigate high tortuosity or anomalous PICA origins during flow diverter deployment? I'm particularly interested in how they modify device sizing, delivery system selection, and intraoperative imaging protocols to ensure accurate placement while minimizing thromboembolic complications. Are there standardized metrics for assessing device-wall apposition in these challenging anatomies during the procedure?", "Given these technical adaptations for challenging anatomies, what clinical outcomes and complication profiles have been observed with flow diversion in tortuous vertebral arteries or anomalous PICA origins? Specifically, how do perioperative ischemic complications, delayed aneurysm occlusion rates, and long-term patency compare to more conventional endovascular approaches? Furthermore, what patient-specific factors - such as antiplatelet regimen adherence or underlying vascular pathology - appear to most significantly influence the safety-efficacy balance in real-world practice, particularly regarding delayed thromboembolic events or in-stent stenosis development?"], "ground_truth": ["permed-57335", "permed-57185", "permed-84297", "permed-76292", "permed-46954", "permed-76293", "permed-57187", "permed-28297", "permed-46889", "permed-60181"]}
{"query_id": "topic_743_turn_1", "conversation_id": "topic_743", "turn_id": 1, "query": "Influence of cultural background on aesthetic treatment preferences and outcomes", "history": [], "ground_truth": ["permed-52826", "permed-74430", "permed-74431", "permed-60057", "permed-45427", "permed-68412", "permed-55645", "permed-66153", "permed-63479", "permed-92059"]}
{"query_id": "topic_743_turn_2", "conversation_id": "topic_743", "turn_id": 2, "query": "Personalizing aesthetic treatments for Hispanic/Latin American patients using these cultural preference insights", "history": ["Influence of cultural background on aesthetic treatment preferences and outcomes"], "ground_truth": ["permed-74430", "permed-52826", "permed-91814", "permed-92165", "permed-66153", "permed-55645", "permed-63479", "permed-68412", "permed-70065", "permed-74431"]}
{"query_id": "topic_743_turn_3", "conversation_id": "topic_743", "turn_id": 3, "query": "Tailoring aesthetic treatments for Hispanic/Latin American subgroups: leveraging specific anatomical traits, cultural beauty ideals, and assessing impact on patient satisfaction and clinical outcomes", "history": ["Influence of cultural background on aesthetic treatment preferences and outcomes", "Personalizing aesthetic treatments for Hispanic/Latin American patients using these cultural preference insights"], "ground_truth": ["permed-74430", "permed-52826", "permed-74431", "permed-84763", "permed-45427", "permed-52824", "permed-68412", "permed-92165", "permed-87146", "permed-74432"]}
{"query_id": "topic_743_turn_4", "conversation_id": "topic_743", "turn_id": 4, "query": "When implementing this subgroup-specific approach, what specific anthropometric measurements and photographic standardization protocols would you recommend for documenting nasal and labiomental anatomical variations across different Hispanic/Latin American subgroups? Additionally, what statistical methods would be most appropriate for analyzing whether treatment modifications based on these measurements actually correlate with improved satisfaction scores while controlling for regional origin and demographic variables?", "history": ["Influence of cultural background on aesthetic treatment preferences and outcomes", "Personalizing aesthetic treatments for Hispanic/Latin American patients using these cultural preference insights", "Tailoring aesthetic treatments for Hispanic/Latin American subgroups: leveraging specific anatomical traits, cultural beauty ideals, and assessing impact on patient satisfaction and clinical outcomes"], "ground_truth": ["permed-74430", "permed-86887", "permed-87469", "permed-84763", "permed-43577", "permed-34383", "permed-43537", "permed-76860", "permed-34402", "permed-65412"]}
{"query_id": "topic_743_turn_5", "conversation_id": "topic_743", "turn_id": 5, "query": "Given the detailed measurement protocols and analytical methods discussed, how do patient satisfaction outcomes and complication profiles compare when using culturally-tailored rhinoplasty techniques versus standardized Western approaches specifically for Hispanic/Latin American subgroups? I'm particularly interested in whether the comparative effectiveness of anthropometrically-informed techniques differs significantly between Caribbean-origin patients emphasizing dorsal hump reduction and Central American populations seeking nasal tip refinement, especially regarding long-term satisfaction versus immediate post-operative outcomes.", "history": ["Influence of cultural background on aesthetic treatment preferences and outcomes", "Personalizing aesthetic treatments for Hispanic/Latin American patients using these cultural preference insights", "Tailoring aesthetic treatments for Hispanic/Latin American subgroups: leveraging specific anatomical traits, cultural beauty ideals, and assessing impact on patient satisfaction and clinical outcomes", "When implementing this subgroup-specific approach, what specific anthropometric measurements and photographic standardization protocols would you recommend for documenting nasal and labiomental anatomical variations across different Hispanic/Latin American subgroups? Additionally, what statistical methods would be most appropriate for analyzing whether treatment modifications based on these measurements actually correlate with improved satisfaction scores while controlling for regional origin and demographic variables?"], "ground_truth": ["permed-74430", "permed-76226", "permed-83735", "permed-87469", "permed-83736", "permed-43537", "permed-45671", "permed-84763", "permed-90699", "permed-86887"]}
{"query_id": "topic_743_turn_6", "conversation_id": "topic_743", "turn_id": 6, "query": "Building on the subgroup-specific satisfaction patterns observed in Caribbean versus Central American rhinoplasty outcomes, how do the long-term structural stability and revision rates of culturally-tailored techniques compare to standardized Western approaches when accounting for different healing characteristics and tissue thickness variations across Hispanic/Latin American populations? Specifically, do anthropometrically-informed techniques that preserve ethnic identity while modifying specific features demonstrate superior cost-effectiveness over time compared to standardized approaches, particularly regarding reduced revision surgeries and maintenance of culturally-valued aesthetic outcomes beyond the 5-year mark?", "history": ["Influence of cultural background on aesthetic treatment preferences and outcomes", "Personalizing aesthetic treatments for Hispanic/Latin American patients using these cultural preference insights", "Tailoring aesthetic treatments for Hispanic/Latin American subgroups: leveraging specific anatomical traits, cultural beauty ideals, and assessing impact on patient satisfaction and clinical outcomes", "When implementing this subgroup-specific approach, what specific anthropometric measurements and photographic standardization protocols would you recommend for documenting nasal and labiomental anatomical variations across different Hispanic/Latin American subgroups? Additionally, what statistical methods would be most appropriate for analyzing whether treatment modifications based on these measurements actually correlate with improved satisfaction scores while controlling for regional origin and demographic variables?", "Given the detailed measurement protocols and analytical methods discussed, how do patient satisfaction outcomes and complication profiles compare when using culturally-tailored rhinoplasty techniques versus standardized Western approaches specifically for Hispanic/Latin American subgroups? I'm particularly interested in whether the comparative effectiveness of anthropometrically-informed techniques differs significantly between Caribbean-origin patients emphasizing dorsal hump reduction and Central American populations seeking nasal tip refinement, especially regarding long-term satisfaction versus immediate post-operative outcomes."], "ground_truth": ["permed-74430", "permed-90699", "permed-87469", "permed-56921", "permed-84763", "permed-76226", "permed-83735", "permed-83736", "permed-78677", "permed-83737"]}
{"query_id": "topic_744_turn_1", "conversation_id": "topic_744", "turn_id": 1, "query": "Recent advancements and applications of MXene materials in wearable electronics and sensor technology.", "history": [], "ground_truth": ["permed-75981", "permed-52103", "permed-75982", "permed-72967", "permed-75983", "permed-73246", "permed-64647", "permed-86791", "permed-92685", "permed-51214"]}
{"query_id": "topic_744_turn_2", "conversation_id": "topic_744", "turn_id": 2, "query": "Given these MXene advancements, how are these materials specifically engineered for high-performance electronic skins (E-skins), focusing on their electrical conductivity, mechanical flexibility, and biocompatibility?", "history": ["Recent advancements and applications of MXene materials in wearable electronics and sensor technology."], "ground_truth": ["permed-75981", "permed-72967", "permed-75982", "permed-51043", "permed-52103", "permed-51214", "permed-76998", "permed-64647", "permed-86791", "permed-79002"]}
{"query_id": "topic_744_turn_3", "conversation_id": "topic_744", "turn_id": 3, "query": "With these developments in MXene E-skins, which machine learning models are most effective for real-time multi-modal sensory data analysis, and what are the key challenges in ensuring the accuracy and reliability of such intelligent systems in practical, dynamic environments?", "history": ["Recent advancements and applications of MXene materials in wearable electronics and sensor technology.", "Given these MXene advancements, how are these materials specifically engineered for high-performance electronic skins (E-skins), focusing on their electrical conductivity, mechanical flexibility, and biocompatibility?"], "ground_truth": ["permed-75981", "permed-55224", "permed-64647", "permed-75982", "permed-55578", "permed-63173", "permed-57440", "permed-75983", "permed-54073", "permed-80684"]}
{"query_id": "topic_744_turn_4", "conversation_id": "topic_744", "turn_id": 4, "query": "Given these ML models for MXene E-skins, what specific validation protocols are used to assess their real-time performance across varying environmental conditions? I'm particularly interested in the statistical frameworks for handling sensor drift compensation and the technical implementation of cross-validation strategies when dealing with continuous multimodal data streams. How are these models tested for robustness against common artifacts like motion-induced noise or transient signal loss in practical deployment scenarios?", "history": ["Recent advancements and applications of MXene materials in wearable electronics and sensor technology.", "Given these MXene advancements, how are these materials specifically engineered for high-performance electronic skins (E-skins), focusing on their electrical conductivity, mechanical flexibility, and biocompatibility?", "With these developments in MXene E-skins, which machine learning models are most effective for real-time multi-modal sensory data analysis, and what are the key challenges in ensuring the accuracy and reliability of such intelligent systems in practical, dynamic environments?"], "ground_truth": ["permed-75981", "permed-75982", "permed-54073", "permed-72967", "permed-55224", "permed-51214", "permed-64647", "permed-75983", "permed-73727", "permed-86791"]}
{"query_id": "topic_744_turn_5", "conversation_id": "topic_744", "turn_id": 5, "query": "Given these comprehensive validation frameworks for MXene E-skins, how do the real-world performance trade-offs compare between different sensor fusion architectures—specifically centralized versus decentralized approaches—when integrating ML models with multimodal MXene arrays? Considering the statistical frameworks previously discussed, what are the comparative advantages in handling motion artifacts and signal loss between these fusion strategies, and how do their computational efficiency and scalability differ in practical wearable applications requiring continuous data processing?", "history": ["Recent advancements and applications of MXene materials in wearable electronics and sensor technology.", "Given these MXene advancements, how are these materials specifically engineered for high-performance electronic skins (E-skins), focusing on their electrical conductivity, mechanical flexibility, and biocompatibility?", "With these developments in MXene E-skins, which machine learning models are most effective for real-time multi-modal sensory data analysis, and what are the key challenges in ensuring the accuracy and reliability of such intelligent systems in practical, dynamic environments?", "Given these ML models for MXene E-skins, what specific validation protocols are used to assess their real-time performance across varying environmental conditions? I'm particularly interested in the statistical frameworks for handling sensor drift compensation and the technical implementation of cross-validation strategies when dealing with continuous multimodal data streams. How are these models tested for robustness against common artifacts like motion-induced noise or transient signal loss in practical deployment scenarios?"], "ground_truth": ["permed-75981", "permed-72967", "permed-75982", "permed-62531", "permed-54073", "permed-64647", "permed-51214", "permed-64623", "permed-52103", "permed-88948"]}
{"query_id": "topic_744_turn_6", "conversation_id": "topic_744", "turn_id": 6, "query": "Building upon our discussion of sensor fusion architectures for MXene E-skins, how do emerging edge computing implementations compare against cloud-based processing in terms of addressing the computational efficiency and scalability challenges you highlighted? Specifically, when considering the statistical frameworks for handling motion artifacts and signal loss in continuous multimodal data streams, what are the fundamental trade-offs between these computing paradigms in practical deployment - particularly regarding latency, energy consumption, data privacy, and robustness in dynamic real-world environments where transient connectivity issues may occur?", "history": ["Recent advancements and applications of MXene materials in wearable electronics and sensor technology.", "Given these MXene advancements, how are these materials specifically engineered for high-performance electronic skins (E-skins), focusing on their electrical conductivity, mechanical flexibility, and biocompatibility?", "With these developments in MXene E-skins, which machine learning models are most effective for real-time multi-modal sensory data analysis, and what are the key challenges in ensuring the accuracy and reliability of such intelligent systems in practical, dynamic environments?", "Given these ML models for MXene E-skins, what specific validation protocols are used to assess their real-time performance across varying environmental conditions? I'm particularly interested in the statistical frameworks for handling sensor drift compensation and the technical implementation of cross-validation strategies when dealing with continuous multimodal data streams. How are these models tested for robustness against common artifacts like motion-induced noise or transient signal loss in practical deployment scenarios?", "Given these comprehensive validation frameworks for MXene E-skins, how do the real-world performance trade-offs compare between different sensor fusion architectures—specifically centralized versus decentralized approaches—when integrating ML models with multimodal MXene arrays? Considering the statistical frameworks previously discussed, what are the comparative advantages in handling motion artifacts and signal loss between these fusion strategies, and how do their computational efficiency and scalability differ in practical wearable applications requiring continuous data processing?"], "ground_truth": ["permed-75981", "permed-59592", "permed-70859", "permed-85579", "permed-55885", "permed-59596", "permed-53219", "permed-55877", "permed-55205", "permed-70857"]}
{"query_id": "topic_745_turn_1", "conversation_id": "topic_745", "turn_id": 1, "query": "HPV infection and cervical abnormalities in older women: comprehensive overview and current understanding", "history": [], "ground_truth": ["permed-59568", "permed-70160", "permed-59569", "permed-70167", "permed-70170", "permed-37482", "permed-73418", "permed-85107", "permed-73405", "permed-70574"]}
{"query_id": "topic_745_turn_2", "conversation_id": "topic_745", "turn_id": 2, "query": "Natural history of these HPV infections, particularly types 16 and 18, and their specific impact on high-grade cervical lesion development in this older female population", "history": ["HPV infection and cervical abnormalities in older women: comprehensive overview and current understanding"], "ground_truth": ["permed-70167", "permed-70170", "permed-59568", "permed-73412", "permed-31840", "permed-70168", "permed-82906", "permed-70160", "permed-31839", "permed-37482"]}
{"query_id": "topic_745_turn_3", "conversation_id": "topic_745", "turn_id": 3, "query": "Mechanisms of HPV 16/18 differential persistence and oncogenesis in older women: implications for risk stratification and advanced HPV-based cervical screening beyond age and cytology", "history": ["HPV infection and cervical abnormalities in older women: comprehensive overview and current understanding", "Natural history of these HPV infections, particularly types 16 and 18, and their specific impact on high-grade cervical lesion development in this older female population"], "ground_truth": ["permed-70167", "permed-59568", "permed-6175", "permed-70160", "permed-70574", "permed-61180", "permed-70170", "permed-59569", "permed-73405", "permed-6178"]}
{"query_id": "topic_745_turn_4", "conversation_id": "topic_745", "turn_id": 4, "query": "Given these proposed mechanisms of differential persistence, what specific molecular detection methods would you recommend for distinguishing transient HPV 16/18 infections from those undergoing oncogenic transformation in older women? I'm particularly interested in the technical validation of methylation markers like FAM19A4 and miR124-2 - specifically, what threshold values and reproducibility metrics were established in longitudinal cohorts to ensure these biomarkers can reliably inform risk stratification beyond current screening protocols?", "history": ["HPV infection and cervical abnormalities in older women: comprehensive overview and current understanding", "Natural history of these HPV infections, particularly types 16 and 18, and their specific impact on high-grade cervical lesion development in this older female population", "Mechanisms of HPV 16/18 differential persistence and oncogenesis in older women: implications for risk stratification and advanced HPV-based cervical screening beyond age and cytology"], "ground_truth": ["permed-70167", "permed-35831", "permed-43750", "permed-6850", "permed-70163", "permed-6541", "permed-6175", "permed-56363", "permed-85725", "permed-61180"]}
{"query_id": "topic_745_turn_5", "conversation_id": "topic_745", "turn_id": 5, "query": "Given these validated methylation marker thresholds for distinguishing transforming HPV infections, what clinical outcomes have been demonstrated when implementing such biomarkers in screening programs for older women? Specifically, what reduction in CIN3+ detection intervals and cancer incidence rates were observed in real-world studies, and how did these molecular approaches affect colposcopy referral rates compared to conventional cytology? I'm particularly interested in whether the improved risk stratification translated into meaningful differences in overtreatment reduction and patient compliance within this older demographic who often face competing health priorities.", "history": ["HPV infection and cervical abnormalities in older women: comprehensive overview and current understanding", "Natural history of these HPV infections, particularly types 16 and 18, and their specific impact on high-grade cervical lesion development in this older female population", "Mechanisms of HPV 16/18 differential persistence and oncogenesis in older women: implications for risk stratification and advanced HPV-based cervical screening beyond age and cytology", "Given these proposed mechanisms of differential persistence, what specific molecular detection methods would you recommend for distinguishing transient HPV 16/18 infections from those undergoing oncogenic transformation in older women? I'm particularly interested in the technical validation of methylation markers like FAM19A4 and miR124-2 - specifically, what threshold values and reproducibility metrics were established in longitudinal cohorts to ensure these biomarkers can reliably inform risk stratification beyond current screening protocols?"], "ground_truth": ["permed-70574", "permed-73407", "permed-6178", "permed-70171", "permed-70167", "permed-73411", "permed-61995", "permed-73410", "permed-73402", "permed-73409"]}
{"query_id": "topic_745_turn_6", "conversation_id": "topic_745", "turn_id": 6, "query": "Given the demonstrated clinical outcomes of methylation-based triage, how does its long-term cost-effectiveness compare to emerging alternatives like HPV genotyping or viral load quantification specifically for older women? Considering the infrastructure requirements and technical expertise needed for methylation assays versus simpler molecular methods, what trade-offs exist between upfront implementation costs and downstream savings from reduced overtreatment? Furthermore, how might these economic considerations differ between high-resource settings with established screening programs versus regions with limited healthcare access where competing health priorities may affect screening adherence?", "history": ["HPV infection and cervical abnormalities in older women: comprehensive overview and current understanding", "Natural history of these HPV infections, particularly types 16 and 18, and their specific impact on high-grade cervical lesion development in this older female population", "Mechanisms of HPV 16/18 differential persistence and oncogenesis in older women: implications for risk stratification and advanced HPV-based cervical screening beyond age and cytology", "Given these proposed mechanisms of differential persistence, what specific molecular detection methods would you recommend for distinguishing transient HPV 16/18 infections from those undergoing oncogenic transformation in older women? I'm particularly interested in the technical validation of methylation markers like FAM19A4 and miR124-2 - specifically, what threshold values and reproducibility metrics were established in longitudinal cohorts to ensure these biomarkers can reliably inform risk stratification beyond current screening protocols?", "Given these validated methylation marker thresholds for distinguishing transforming HPV infections, what clinical outcomes have been demonstrated when implementing such biomarkers in screening programs for older women? Specifically, what reduction in CIN3+ detection intervals and cancer incidence rates were observed in real-world studies, and how did these molecular approaches affect colposcopy referral rates compared to conventional cytology? I'm particularly interested in whether the improved risk stratification translated into meaningful differences in overtreatment reduction and patient compliance within this older demographic who often face competing health priorities."], "ground_truth": ["permed-5890", "permed-7690", "permed-4661", "permed-6515", "permed-70171", "permed-70574", "permed-73411", "permed-86026", "permed-2287", "permed-21174"]}
{"query_id": "topic_746_turn_1", "conversation_id": "topic_746", "turn_id": 1, "query": "Functional roles of bacterial metabolosomes in metabolic pathways and virulence mechanisms.", "history": [], "ground_truth": ["permed-74886", "permed-52997", "permed-87371", "permed-68301", "permed-76699", "permed-53723", "permed-51674", "permed-77834", "permed-72316", "permed-66739"]}
{"query_id": "topic_746_turn_2", "conversation_id": "topic_746", "turn_id": 2, "query": "Therapeutic implications of these bacterial metabolosome functions based on recent studies.", "history": ["Functional roles of bacterial metabolosomes in metabolic pathways and virulence mechanisms."], "ground_truth": ["permed-74886", "permed-53723", "permed-52997", "permed-66643", "permed-68301", "permed-69186", "permed-77834", "permed-72010", "permed-71399", "permed-71560"]}
{"query_id": "topic_746_turn_3", "conversation_id": "topic_746", "turn_id": 3, "query": "Designing inhibitors against bacterial metabolosomes: leveraging structural insights for targeting virulence and metabolic dependencies.", "history": ["Functional roles of bacterial metabolosomes in metabolic pathways and virulence mechanisms.", "Therapeutic implications of these bacterial metabolosome functions based on recent studies."], "ground_truth": ["permed-74886", "permed-60350", "permed-73135", "permed-80608", "permed-60452", "permed-57568", "permed-79815", "permed-79814", "permed-53723", "permed-90354"]}
{"query_id": "topic_746_turn_4", "conversation_id": "topic_746", "turn_id": 4, "query": "When implementing this structural-based inhibitor design approach, what specific computational screening protocols are most effective for identifying candidate compounds? I'm particularly interested in the comparative advantages of molecular docking versus molecular dynamics simulations for predicting binding affinities to metabolosome enzyme active sites, and whether you'd recommend combining these with machine learning approaches for virtual screening. Additionally, what experimental validation strategies - such as isothermal titration calorimetry or surface plasmon resonance - provide the most reliable confirmation of computational predictions before moving to cellular assays?", "history": ["Functional roles of bacterial metabolosomes in metabolic pathways and virulence mechanisms.", "Therapeutic implications of these bacterial metabolosome functions based on recent studies.", "Designing inhibitors against bacterial metabolosomes: leveraging structural insights for targeting virulence and metabolic dependencies."], "ground_truth": ["permed-53316", "permed-60335", "permed-68943", "permed-77560", "permed-77753", "permed-77558", "permed-58128", "permed-79541", "permed-52961", "permed-57948"]}
{"query_id": "topic_746_turn_5", "conversation_id": "topic_746", "turn_id": 5, "query": "Given the detailed computational and experimental validation pipeline discussed, how do the therapeutic outcomes compare when targeting metabolosomes through structural inhibition versus alternative antibacterial strategies like phage therapy or CRISPR-based approaches? Specifically, what are the relative advantages in terms of resistance development, host microbiome preservation, and clinical translation potential? Considering metabolosomes' dual metabolic and virulence roles, does structural inhibition offer superior pathogen specificity compared to broad-spectrum antibiotics while maintaining efficacy against persistent infections?", "history": ["Functional roles of bacterial metabolosomes in metabolic pathways and virulence mechanisms.", "Therapeutic implications of these bacterial metabolosome functions based on recent studies.", "Designing inhibitors against bacterial metabolosomes: leveraging structural insights for targeting virulence and metabolic dependencies.", "When implementing this structural-based inhibitor design approach, what specific computational screening protocols are most effective for identifying candidate compounds? I'm particularly interested in the comparative advantages of molecular docking versus molecular dynamics simulations for predicting binding affinities to metabolosome enzyme active sites, and whether you'd recommend combining these with machine learning approaches for virtual screening. Additionally, what experimental validation strategies - such as isothermal titration calorimetry or surface plasmon resonance - provide the most reliable confirmation of computational predictions before moving to cellular assays?"], "ground_truth": ["permed-74886", "permed-22027", "permed-66657", "permed-66647", "permed-67459", "permed-12683", "permed-60825", "permed-86997", "permed-89276", "permed-49568"]}
{"query_id": "topic_746_turn_6", "conversation_id": "topic_746", "turn_id": 6, "query": "Building on our comparative analysis of antibacterial strategies, could you precisely define what constitutes \"structural inhibition\" in the context of bacterial metabolosomes versus conventional enzyme inhibition? Given metabolosomes' compartmentalized nature and metabolic channeling, how does structural inhibition fundamentally differ mechanistically from traditional active-site targeting? Specifically, what defines successful disruption of metabolic microcompartment integrity versus simply inhibiting individual enzyme activities, and how might this distinction influence both resistance development and the therapeutic window in clinical applications?", "history": ["Functional roles of bacterial metabolosomes in metabolic pathways and virulence mechanisms.", "Therapeutic implications of these bacterial metabolosome functions based on recent studies.", "Designing inhibitors against bacterial metabolosomes: leveraging structural insights for targeting virulence and metabolic dependencies.", "When implementing this structural-based inhibitor design approach, what specific computational screening protocols are most effective for identifying candidate compounds? I'm particularly interested in the comparative advantages of molecular docking versus molecular dynamics simulations for predicting binding affinities to metabolosome enzyme active sites, and whether you'd recommend combining these with machine learning approaches for virtual screening. Additionally, what experimental validation strategies - such as isothermal titration calorimetry or surface plasmon resonance - provide the most reliable confirmation of computational predictions before moving to cellular assays?", "Given the detailed computational and experimental validation pipeline discussed, how do the therapeutic outcomes compare when targeting metabolosomes through structural inhibition versus alternative antibacterial strategies like phage therapy or CRISPR-based approaches? Specifically, what are the relative advantages in terms of resistance development, host microbiome preservation, and clinical translation potential? Considering metabolosomes' dual metabolic and virulence roles, does structural inhibition offer superior pathogen specificity compared to broad-spectrum antibiotics while maintaining efficacy against persistent infections?"], "ground_truth": ["permed-74886", "permed-66647", "permed-71592", "permed-67462", "permed-90354", "permed-67459", "permed-60688", "permed-60350", "permed-58166", "permed-91775"]}
{"query_id": "topic_747_turn_1", "conversation_id": "topic_747", "turn_id": 1, "query": "What role does Clostridium kluyveri play in electro-fermentation systems, particularly in producing valuable compounds?", "history": [], "ground_truth": ["permed-82404", "permed-77016", "permed-87780", "permed-53002", "permed-63981", "permed-87363", "permed-78968", "permed-85413", "permed-82405", "permed-91118"]}
{"query_id": "topic_747_turn_2", "conversation_id": "topic_747", "turn_id": 2, "query": "How do interactions between Clostridium kluyveri and other microbes, like acetogens, impact the efficiency of this process?", "history": ["What role does Clostridium kluyveri play in electro-fermentation systems, particularly in producing valuable compounds?"], "ground_truth": ["permed-82404", "permed-87780", "permed-85267", "permed-66582", "permed-66777", "permed-66639", "permed-90392", "permed-53002", "permed-80716", "permed-82396"]}
{"query_id": "topic_747_turn_3", "conversation_id": "topic_747", "turn_id": 3, "query": "Given their synergistic relationship in electro-fermentation, how do pH and temperature specifically affect the interactions between Clostridium kluyveri and acetogens to enhance caproate production? Which metabolic pathways are most responsive to these environmental conditions, and how are they regulated?", "history": ["What role does Clostridium kluyveri play in electro-fermentation systems, particularly in producing valuable compounds?", "How do interactions between Clostridium kluyveri and other microbes, like acetogens, impact the efficiency of this process?"], "ground_truth": ["permed-82404", "permed-77016", "permed-66581", "permed-52446", "permed-66582", "permed-66579", "permed-87780", "permed-53002", "permed-76699", "permed-52445"]}
{"query_id": "topic_747_turn_4", "conversation_id": "topic_747", "turn_id": 4, "query": "Given these metabolic interactions, what specific experimental designs have been used to quantify the relative contributions of pH versus temperature effects on pathway regulation? I'm particularly interested in the statistical approaches for differentiating their impacts - are researchers using factorial designs with ANOVA, or more sophisticated response surface methodologies? Also, what analytical techniques provide real-time monitoring of pathway activity shifts under these controlled conditions, and how is reproducibility ensured across different electro-fermentation setups when testing these environmental parameters?", "history": ["What role does Clostridium kluyveri play in electro-fermentation systems, particularly in producing valuable compounds?", "How do interactions between Clostridium kluyveri and other microbes, like acetogens, impact the efficiency of this process?", "Given their synergistic relationship in electro-fermentation, how do pH and temperature specifically affect the interactions between Clostridium kluyveri and acetogens to enhance caproate production? Which metabolic pathways are most responsive to these environmental conditions, and how are they regulated?"], "ground_truth": ["permed-66585", "permed-75714", "permed-66579", "permed-69753", "permed-72119", "permed-64377", "permed-51792", "permed-26353", "permed-25174", "permed-52445"]}
{"query_id": "topic_747_turn_5", "conversation_id": "topic_747", "turn_id": 5, "query": "Given these well-characterized environmental optimization strategies for caproate production, what clinical translation potential exists for microbially-produced medium-chain fatty acids like caproate? Specifically, what therapeutic applications have been explored in human studies - such as metabolic disease management or gut health interventions - and what safety profiles or contraindications have emerged regarding patient administration? Additionally, what formulation challenges exist for delivering these fermentation-derived compounds in clinical settings, and have any Phase I/II trials evaluated their bioavailability and efficacy in human populations?", "history": ["What role does Clostridium kluyveri play in electro-fermentation systems, particularly in producing valuable compounds?", "How do interactions between Clostridium kluyveri and other microbes, like acetogens, impact the efficiency of this process?", "Given their synergistic relationship in electro-fermentation, how do pH and temperature specifically affect the interactions between Clostridium kluyveri and acetogens to enhance caproate production? Which metabolic pathways are most responsive to these environmental conditions, and how are they regulated?", "Given these metabolic interactions, what specific experimental designs have been used to quantify the relative contributions of pH versus temperature effects on pathway regulation? I'm particularly interested in the statistical approaches for differentiating their impacts - are researchers using factorial designs with ANOVA, or more sophisticated response surface methodologies? Also, what analytical techniques provide real-time monitoring of pathway activity shifts under these controlled conditions, and how is reproducibility ensured across different electro-fermentation setups when testing these environmental parameters?"], "ground_truth": ["permed-66581", "permed-82405", "permed-82500", "permed-66733", "permed-60712", "permed-53002", "permed-82503", "permed-82388", "permed-63008", "permed-75725"]}
{"query_id": "topic_747_turn_6", "conversation_id": "topic_747", "turn_id": 6, "query": "Given our progression from microbial ecology to clinical applications, I'd like to clarify the fundamental definition of \"bioavailability\" in the specific context of microbially-produced medium-chain fatty acids like caproate. How is this parameter operationally defined and measured in clinical trials - does it encompass simple plasma concentrations, or does it include tissue distribution and metabolic fate? Furthermore, how do researchers conceptually differentiate between bioavailability from fermentation-derived compounds versus synthetic analogs, particularly regarding absorption mechanisms and first-pass metabolism? What methodological standardization challenges exist in defining bioavailability across different delivery formulations?", "history": ["What role does Clostridium kluyveri play in electro-fermentation systems, particularly in producing valuable compounds?", "How do interactions between Clostridium kluyveri and other microbes, like acetogens, impact the efficiency of this process?", "Given their synergistic relationship in electro-fermentation, how do pH and temperature specifically affect the interactions between Clostridium kluyveri and acetogens to enhance caproate production? Which metabolic pathways are most responsive to these environmental conditions, and how are they regulated?", "Given these metabolic interactions, what specific experimental designs have been used to quantify the relative contributions of pH versus temperature effects on pathway regulation? I'm particularly interested in the statistical approaches for differentiating their impacts - are researchers using factorial designs with ANOVA, or more sophisticated response surface methodologies? Also, what analytical techniques provide real-time monitoring of pathway activity shifts under these controlled conditions, and how is reproducibility ensured across different electro-fermentation setups when testing these environmental parameters?", "Given these well-characterized environmental optimization strategies for caproate production, what clinical translation potential exists for microbially-produced medium-chain fatty acids like caproate? Specifically, what therapeutic applications have been explored in human studies - such as metabolic disease management or gut health interventions - and what safety profiles or contraindications have emerged regarding patient administration? Additionally, what formulation challenges exist for delivering these fermentation-derived compounds in clinical settings, and have any Phase I/II trials evaluated their bioavailability and efficacy in human populations?"], "ground_truth": ["permed-82405", "permed-85168", "permed-82503", "permed-89209", "permed-89129", "permed-66581", "permed-62601", "permed-63008", "permed-86364", "permed-84217"]}
{"query_id": "topic_748_turn_1", "conversation_id": "topic_748", "turn_id": 1, "query": "Specific bacterial signatures and metabolic pathways in gut microbiota linked to Non-alcoholic Fatty Liver Disease (NAFLD) and Type 2 Diabetes Mellitus (T2DM) pathogenesis", "history": [], "ground_truth": ["permed-51265", "permed-58593", "permed-65176", "permed-58590", "permed-68863", "permed-58594", "permed-60745", "permed-62722", "permed-62712", "permed-62727"]}
{"query_id": "topic_748_turn_2", "conversation_id": "topic_748", "turn_id": 2, "query": "Impact of targeted dietary strategies like low FODMAP or ketogenic diets on specific gut microbial dysbiosis pathways implicated in the progression of these diseases (NAFLD and T2DM) and related gut-liver axis dysfunction.", "history": ["Specific bacterial signatures and metabolic pathways in gut microbiota linked to Non-alcoholic Fatty Liver Disease (NAFLD) and Type 2 Diabetes Mellitus (T2DM) pathogenesis"], "ground_truth": ["permed-51265", "permed-58593", "permed-58590", "permed-62712", "permed-58594", "permed-58970", "permed-65176", "permed-62667", "permed-34727", "permed-60745"]}
{"query_id": "topic_748_turn_3", "conversation_id": "topic_748", "turn_id": 3, "query": "Molecular mechanisms of synbiotic supplements in reprogramming host epigenome via DNA methylation or histone acetylation to improve hepatic insulin signaling through the gut-liver axis in NAFLD/T2DM, and effects on biliary lipid metabolism for gallstone prevention.", "history": ["Specific bacterial signatures and metabolic pathways in gut microbiota linked to Non-alcoholic Fatty Liver Disease (NAFLD) and Type 2 Diabetes Mellitus (T2DM) pathogenesis", "Impact of targeted dietary strategies like low FODMAP or ketogenic diets on specific gut microbial dysbiosis pathways implicated in the progression of these diseases (NAFLD and T2DM) and related gut-liver axis dysfunction."], "ground_truth": ["permed-58593", "permed-58590", "permed-51265", "permed-58203", "permed-62712", "permed-58970", "permed-67828", "permed-84831", "permed-58208", "permed-65176"]}
{"query_id": "topic_748_turn_4", "conversation_id": "topic_748", "turn_id": 4, "query": "When investigating these epigenetic reprogramming mechanisms, what specific experimental approaches would you recommend for quantifying DNA methylation changes in hepatic insulin signaling genes? I'm particularly interested in the technical considerations for bisulfite sequencing protocols in liver tissue samples, and how you'd statistically account for potential confounding factors like microbiome composition variations when analyzing the relationship between synbiotic intervention and epigenetic modifications in the gut-liver axis model.", "history": ["Specific bacterial signatures and metabolic pathways in gut microbiota linked to Non-alcoholic Fatty Liver Disease (NAFLD) and Type 2 Diabetes Mellitus (T2DM) pathogenesis", "Impact of targeted dietary strategies like low FODMAP or ketogenic diets on specific gut microbial dysbiosis pathways implicated in the progression of these diseases (NAFLD and T2DM) and related gut-liver axis dysfunction.", "Molecular mechanisms of synbiotic supplements in reprogramming host epigenome via DNA methylation or histone acetylation to improve hepatic insulin signaling through the gut-liver axis in NAFLD/T2DM, and effects on biliary lipid metabolism for gallstone prevention."], "ground_truth": ["permed-67507", "permed-84831", "permed-53734", "permed-77203", "permed-53821", "permed-90599", "permed-1379", "permed-3165", "permed-1378", "permed-1380"]}
{"query_id": "topic_748_turn_5", "conversation_id": "topic_748", "turn_id": 5, "query": "Given the detailed methodological considerations for quantifying epigenetic changes, how would you comparatively evaluate the therapeutic efficacy of synbiotic interventions versus dietary modifications (like ketogenic or low FODMAP diets) in modulating gut-liver axis dysfunction? Specifically, what are the relative advantages and limitations of each approach in terms of sustainability, magnitude of epigenetic reprogramming effects on hepatic insulin signaling genes, and their differential impacts on gut microbiota composition and metabolic parameters in NAFLD/T2DM patients across different clinical contexts?", "history": ["Specific bacterial signatures and metabolic pathways in gut microbiota linked to Non-alcoholic Fatty Liver Disease (NAFLD) and Type 2 Diabetes Mellitus (T2DM) pathogenesis", "Impact of targeted dietary strategies like low FODMAP or ketogenic diets on specific gut microbial dysbiosis pathways implicated in the progression of these diseases (NAFLD and T2DM) and related gut-liver axis dysfunction.", "Molecular mechanisms of synbiotic supplements in reprogramming host epigenome via DNA methylation or histone acetylation to improve hepatic insulin signaling through the gut-liver axis in NAFLD/T2DM, and effects on biliary lipid metabolism for gallstone prevention.", "When investigating these epigenetic reprogramming mechanisms, what specific experimental approaches would you recommend for quantifying DNA methylation changes in hepatic insulin signaling genes? I'm particularly interested in the technical considerations for bisulfite sequencing protocols in liver tissue samples, and how you'd statistically account for potential confounding factors like microbiome composition variations when analyzing the relationship between synbiotic intervention and epigenetic modifications in the gut-liver axis model."], "ground_truth": ["permed-84831", "permed-58590", "permed-51265", "permed-62712", "permed-58593", "permed-34727", "permed-62693", "permed-62705", "permed-58970", "permed-64902"]}
{"query_id": "topic_748_turn_6", "conversation_id": "topic_748", "turn_id": 6, "query": "Building upon our comparative analysis of therapeutic approaches, how do the implementation challenges and cost-effectiveness profiles of synbiotic interventions versus dietary modifications differ across healthcare systems? Specifically, considering the technical complexity of epigenetic monitoring discussed earlier, what are the relative trade-offs between the higher initial costs of personalized synbiotic therapies requiring frequent epigenetic assessment versus the long-term sustainability challenges of maintaining strict dietary regimens? How might these economic considerations influence their adoption as first-line interventions in both resource-limited and advanced healthcare settings, particularly given the need for ongoing monitoring of gut microbiota and metabolic parameters?", "history": ["Specific bacterial signatures and metabolic pathways in gut microbiota linked to Non-alcoholic Fatty Liver Disease (NAFLD) and Type 2 Diabetes Mellitus (T2DM) pathogenesis", "Impact of targeted dietary strategies like low FODMAP or ketogenic diets on specific gut microbial dysbiosis pathways implicated in the progression of these diseases (NAFLD and T2DM) and related gut-liver axis dysfunction.", "Molecular mechanisms of synbiotic supplements in reprogramming host epigenome via DNA methylation or histone acetylation to improve hepatic insulin signaling through the gut-liver axis in NAFLD/T2DM, and effects on biliary lipid metabolism for gallstone prevention.", "When investigating these epigenetic reprogramming mechanisms, what specific experimental approaches would you recommend for quantifying DNA methylation changes in hepatic insulin signaling genes? I'm particularly interested in the technical considerations for bisulfite sequencing protocols in liver tissue samples, and how you'd statistically account for potential confounding factors like microbiome composition variations when analyzing the relationship between synbiotic intervention and epigenetic modifications in the gut-liver axis model.", "Given the detailed methodological considerations for quantifying epigenetic changes, how would you comparatively evaluate the therapeutic efficacy of synbiotic interventions versus dietary modifications (like ketogenic or low FODMAP diets) in modulating gut-liver axis dysfunction? Specifically, what are the relative advantages and limitations of each approach in terms of sustainability, magnitude of epigenetic reprogramming effects on hepatic insulin signaling genes, and their differential impacts on gut microbiota composition and metabolic parameters in NAFLD/T2DM patients across different clinical contexts?"], "ground_truth": ["permed-84072", "permed-57639", "permed-71561", "permed-84050", "permed-86027", "permed-57253", "permed-86028", "permed-90668", "permed-63345", "permed-55929"]}
{"query_id": "topic_749_turn_1", "conversation_id": "topic_749", "turn_id": 1, "query": "What surgical techniques are commonly used for treating aortic root aneurysms?", "history": [], "ground_truth": ["permed-57327", "permed-57331", "permed-78896", "permed-82597", "permed-57328", "permed-57338", "permed-64773", "permed-56265", "permed-73901", "permed-71333"]}
{"query_id": "topic_749_turn_2", "conversation_id": "topic_749", "turn_id": 2, "query": "How does aortic root remodeling, in particular, impact the long-term health of patients undergoing this type of surgery?", "history": ["What surgical techniques are commonly used for treating aortic root aneurysms?"], "ground_truth": ["permed-78896", "permed-68505", "permed-57327", "permed-73901", "permed-75269", "permed-82593", "permed-86963", "permed-51935", "permed-57010", "permed-84010"]}
{"query_id": "topic_749_turn_3", "conversation_id": "topic_749", "turn_id": 3, "query": "How do different approaches to aortic valve annuloplasty during aortic root remodeling affect long-term outcomes—specifically reoperation rates and aortic regurgitation progression—in patients with aortic root aneurysms who don't have severe aortic valve disease?", "history": ["What surgical techniques are commonly used for treating aortic root aneurysms?", "How does aortic root remodeling, in particular, impact the long-term health of patients undergoing this type of surgery?"], "ground_truth": ["permed-78896", "permed-73901", "permed-75431", "permed-57010", "permed-57327", "permed-84010", "permed-57222", "permed-82593", "permed-62893", "permed-56965"]}
{"query_id": "topic_749_turn_4", "conversation_id": "topic_749", "turn_id": 4, "query": "When implementing these comparative annuloplasty approaches during root remodeling, what specific intraoperative measurement protocols and postoperative echocardiographic assessment intervals do researchers typically employ to quantify aortic regurgitation progression? Additionally, how do studies typically control for confounding variables like surgeon experience or annular calcification when analyzing reoperation rates, and what statistical methods—such as time-to-event analysis or propensity score matching—are most appropriate for comparing these long-term outcomes across different annuloplasty techniques?", "history": ["What surgical techniques are commonly used for treating aortic root aneurysms?", "How does aortic root remodeling, in particular, impact the long-term health of patients undergoing this type of surgery?", "How do different approaches to aortic valve annuloplasty during aortic root remodeling affect long-term outcomes—specifically reoperation rates and aortic regurgitation progression—in patients with aortic root aneurysms who don't have severe aortic valve disease?"], "ground_truth": ["permed-78896", "permed-84010", "permed-85519", "permed-88131", "permed-75431", "permed-82593", "permed-73901", "permed-70036", "permed-56965", "permed-87983"]}
{"query_id": "topic_749_turn_5", "conversation_id": "topic_749", "turn_id": 5, "query": "Given these detailed methodological approaches for evaluating annuloplasty techniques, what clinical evidence exists regarding their translation into actual practice? Specifically, how do real-world complication rates—including thromboembolic events, endocarditis incidence, and bleeding complications requiring intervention—compare between different annuloplasty approaches when implemented outside controlled trials? Furthermore, what patient-specific factors (such as connective tissue disorders or age-related annular calcification) have emerged as significant predictors of adverse clinical outcomes in multicenter registry analyses of these procedures?", "history": ["What surgical techniques are commonly used for treating aortic root aneurysms?", "How does aortic root remodeling, in particular, impact the long-term health of patients undergoing this type of surgery?", "How do different approaches to aortic valve annuloplasty during aortic root remodeling affect long-term outcomes—specifically reoperation rates and aortic regurgitation progression—in patients with aortic root aneurysms who don't have severe aortic valve disease?", "When implementing these comparative annuloplasty approaches during root remodeling, what specific intraoperative measurement protocols and postoperative echocardiographic assessment intervals do researchers typically employ to quantify aortic regurgitation progression? Additionally, how do studies typically control for confounding variables like surgeon experience or annular calcification when analyzing reoperation rates, and what statistical methods—such as time-to-event analysis or propensity score matching—are most appropriate for comparing these long-term outcomes across different annuloplasty techniques?"], "ground_truth": ["permed-78896", "permed-25051", "permed-70036", "permed-87983", "permed-75431", "permed-75960", "permed-57335", "permed-90480", "permed-79564", "permed-61908"]}
{"query_id": "topic_749_turn_6", "conversation_id": "topic_749", "turn_id": 6, "query": "Considering the detailed methodological frameworks and real-world complication profiles we've discussed, how do the emerging transcatheter aortic valve implantation (TAVI) and valve-sparing root replacement techniques compare to traditional annuloplasty-enhanced remodeling procedures in terms of long-term durability and complication rates? Specifically, what trade-offs exist between the proven long-term data for surgical annuloplasty versus the minimally invasive advantages of TAVI, particularly for younger patients with connective tissue disorders where future reintervention risk remains a critical consideration?", "history": ["What surgical techniques are commonly used for treating aortic root aneurysms?", "How does aortic root remodeling, in particular, impact the long-term health of patients undergoing this type of surgery?", "How do different approaches to aortic valve annuloplasty during aortic root remodeling affect long-term outcomes—specifically reoperation rates and aortic regurgitation progression—in patients with aortic root aneurysms who don't have severe aortic valve disease?", "When implementing these comparative annuloplasty approaches during root remodeling, what specific intraoperative measurement protocols and postoperative echocardiographic assessment intervals do researchers typically employ to quantify aortic regurgitation progression? Additionally, how do studies typically control for confounding variables like surgeon experience or annular calcification when analyzing reoperation rates, and what statistical methods—such as time-to-event analysis or propensity score matching—are most appropriate for comparing these long-term outcomes across different annuloplasty techniques?", "Given these detailed methodological approaches for evaluating annuloplasty techniques, what clinical evidence exists regarding their translation into actual practice? Specifically, how do real-world complication rates—including thromboembolic events, endocarditis incidence, and bleeding complications requiring intervention—compare between different annuloplasty approaches when implemented outside controlled trials? Furthermore, what patient-specific factors (such as connective tissue disorders or age-related annular calcification) have emerged as significant predictors of adverse clinical outcomes in multicenter registry analyses of these procedures?"], "ground_truth": ["permed-85511", "permed-57222", "permed-57223", "permed-78896", "permed-70035", "permed-57221", "permed-75431", "permed-57219", "permed-77547", "permed-51949"]}
{"query_id": "topic_750_turn_1", "conversation_id": "topic_750", "turn_id": 1, "query": "Role of gut microbiota in development of sepsis-associated encephalopathy", "history": [], "ground_truth": ["permed-70491", "permed-67964", "permed-72282", "permed-66977", "permed-74678", "permed-72266", "permed-63304", "permed-10952", "permed-66979", "permed-68512"]}
{"query_id": "topic_750_turn_2", "conversation_id": "topic_750", "turn_id": 2, "query": "Neuroprotective benefits of molecular hydrogen therapy for sepsis-associated encephalopathy targeting its gut microbiota link", "history": ["Role of gut microbiota in development of sepsis-associated encephalopathy"], "ground_truth": ["permed-70491", "permed-63304", "permed-10948", "permed-10939", "permed-10942", "permed-10940", "permed-10941", "permed-10949", "permed-83687", "permed-83685"]}
{"query_id": "topic_750_turn_3", "conversation_id": "topic_750", "turn_id": 3, "query": "Molecular hydrogen's mechanisms in sepsis-associated encephalopathy: pathways of gut microbiota modulation for neuroprotection and systemic anti-inflammatory effects", "history": ["Role of gut microbiota in development of sepsis-associated encephalopathy", "Neuroprotective benefits of molecular hydrogen therapy for sepsis-associated encephalopathy targeting its gut microbiota link"], "ground_truth": ["permed-70491", "permed-63304", "permed-10948", "permed-10940", "permed-10939", "permed-10714", "permed-10942", "permed-72266", "permed-10941", "permed-63303"]}
{"query_id": "topic_750_turn_4", "conversation_id": "topic_750", "turn_id": 4, "query": "Given this proposed gut-brain axis modulation, what specific experimental protocols would you recommend for validating microbial translocation and barrier integrity in your animal model? I'm particularly interested in the technical implementation - would you combine techniques like FITC-dextran assay with tight junction protein quantification, and what statistical approaches would best correlate these permeability measures with neuroinflammatory markers while controlling for multiple comparisons?", "history": ["Role of gut microbiota in development of sepsis-associated encephalopathy", "Neuroprotective benefits of molecular hydrogen therapy for sepsis-associated encephalopathy targeting its gut microbiota link", "Molecular hydrogen's mechanisms in sepsis-associated encephalopathy: pathways of gut microbiota modulation for neuroprotection and systemic anti-inflammatory effects"], "ground_truth": ["permed-76186", "permed-92576", "permed-92575", "permed-66745", "permed-76757", "permed-68164", "permed-64869", "permed-11663", "permed-63199", "permed-91356"]}
{"query_id": "topic_750_turn_5", "conversation_id": "topic_750", "turn_id": 5, "query": "With these methodological considerations for assessing gut barrier integrity established, how do the neuroprotective outcomes compare between targeting microbial translocation versus directly administering neuroprotective agents like molecular hydrogen in sepsis-associated encephalopathy models? Specifically, what are the relative effect sizes for cognitive preservation and blood-brain barrier protection when intervening at the gut level versus systemically, and which approach demonstrates better translational potential considering timing constraints and clinical feasibility in critically ill patients?", "history": ["Role of gut microbiota in development of sepsis-associated encephalopathy", "Neuroprotective benefits of molecular hydrogen therapy for sepsis-associated encephalopathy targeting its gut microbiota link", "Molecular hydrogen's mechanisms in sepsis-associated encephalopathy: pathways of gut microbiota modulation for neuroprotection and systemic anti-inflammatory effects", "Given this proposed gut-brain axis modulation, what specific experimental protocols would you recommend for validating microbial translocation and barrier integrity in your animal model? I'm particularly interested in the technical implementation - would you combine techniques like FITC-dextran assay with tight junction protein quantification, and what statistical approaches would best correlate these permeability measures with neuroinflammatory markers while controlling for multiple comparisons?"], "ground_truth": ["permed-70491", "permed-63304", "permed-83685", "permed-66152", "permed-92576", "permed-10948", "permed-84613", "permed-83687", "permed-55553", "permed-10939"]}
{"query_id": "topic_750_turn_6", "conversation_id": "topic_750", "turn_id": 6, "query": "Given our evolving discussion about gut-level versus systemic interventions for sepsis-associated encephalopathy, how should we precisely define \"translational potential\" in this context? Beyond clinical feasibility, what specific criteria - including temporal windows for intervention, biomarker responsiveness, or patient stratification approaches - fundamentally constitute this concept? Considering our previous methodological dialogue about barrier integrity assessment and neuroprotective outcomes, what definitional framework would best capture both mechanistic depth and clinical applicability when evaluating these competing therapeutic strategies for future research prioritization?", "history": ["Role of gut microbiota in development of sepsis-associated encephalopathy", "Neuroprotective benefits of molecular hydrogen therapy for sepsis-associated encephalopathy targeting its gut microbiota link", "Molecular hydrogen's mechanisms in sepsis-associated encephalopathy: pathways of gut microbiota modulation for neuroprotection and systemic anti-inflammatory effects", "Given this proposed gut-brain axis modulation, what specific experimental protocols would you recommend for validating microbial translocation and barrier integrity in your animal model? I'm particularly interested in the technical implementation - would you combine techniques like FITC-dextran assay with tight junction protein quantification, and what statistical approaches would best correlate these permeability measures with neuroinflammatory markers while controlling for multiple comparisons?", "With these methodological considerations for assessing gut barrier integrity established, how do the neuroprotective outcomes compare between targeting microbial translocation versus directly administering neuroprotective agents like molecular hydrogen in sepsis-associated encephalopathy models? Specifically, what are the relative effect sizes for cognitive preservation and blood-brain barrier protection when intervening at the gut level versus systemically, and which approach demonstrates better translational potential considering timing constraints and clinical feasibility in critically ill patients?"], "ground_truth": ["permed-74681", "permed-74677", "permed-63304", "permed-70491", "permed-59914", "permed-74679", "permed-67902", "permed-55043", "permed-58294", "permed-52829"]}
{"query_id": "topic_751_turn_1", "conversation_id": "topic_751", "turn_id": 1, "query": "Research on emotional intelligence, optimism, and their impact on adolescent life satisfaction during crises", "history": [], "ground_truth": ["permed-74338", "permed-74347", "permed-57477", "permed-62855", "permed-69798", "permed-69662", "permed-65746", "permed-55599", "permed-62860", "permed-74340"]}
{"query_id": "topic_751_turn_2", "conversation_id": "topic_751", "turn_id": 2, "query": "Investigating how social factors like family support or social isolation mediate or moderate the impact of these psychological attributes on adolescent life satisfaction in such crisis contexts", "history": ["Research on emotional intelligence, optimism, and their impact on adolescent life satisfaction during crises"], "ground_truth": ["permed-74338", "permed-69798", "permed-55599", "permed-74347", "permed-65490", "permed-66297", "permed-65746", "permed-69662", "permed-69488", "permed-84523"]}
{"query_id": "topic_751_turn_3", "conversation_id": "topic_751", "turn_id": 3, "query": "Analysis of trait EI, optimism, and friendship quality interplay for Chinese adolescent life satisfaction during COVID-19: effects of social isolation vs. community support and targeted intervention strategies", "history": ["Research on emotional intelligence, optimism, and their impact on adolescent life satisfaction during crises", "Investigating how social factors like family support or social isolation mediate or moderate the impact of these psychological attributes on adolescent life satisfaction in such crisis contexts"], "ground_truth": ["permed-74338", "permed-74347", "permed-65746", "permed-69798", "permed-69530", "permed-62853", "permed-65490", "permed-57477", "permed-65431", "permed-62855"]}
{"query_id": "topic_751_turn_4", "conversation_id": "topic_751", "turn_id": 4, "query": "In analyzing these trait EI and friendship quality interactions, could you detail the specific mediation/moderation analytical framework employed? I'm particularly interested in how you operationally defined the social isolation versus community support variables, what statistical controls were implemented for demographic covariates, and whether you conducted power analysis to determine sample size adequacy for detecting these complex interaction effects within your structural equation modeling approach.", "history": ["Research on emotional intelligence, optimism, and their impact on adolescent life satisfaction during crises", "Investigating how social factors like family support or social isolation mediate or moderate the impact of these psychological attributes on adolescent life satisfaction in such crisis contexts", "Analysis of trait EI, optimism, and friendship quality interplay for Chinese adolescent life satisfaction during COVID-19: effects of social isolation vs. community support and targeted intervention strategies"], "ground_truth": ["permed-65456", "permed-50573", "permed-74339", "permed-65664", "permed-58472", "permed-65460", "permed-74338", "permed-80187", "permed-82787", "permed-50587"]}
{"query_id": "topic_751_turn_5", "conversation_id": "topic_751", "turn_id": 5, "query": "Given your detailed methodological framework analyzing trait EI and friendship quality, what translational implications emerge for clinical practice? Specifically, based on your findings about social isolation's impact, what evidence-based psychosocial interventions would you recommend for clinicians working with adolescents during crises? Have any real-world implementations of these approaches demonstrated measurable improvements in life satisfaction or mental health outcomes, and what are the primary clinical barriers (e.g., engagement challenges, resource limitations) to deploying such interventions effectively in diverse adolescent populations?", "history": ["Research on emotional intelligence, optimism, and their impact on adolescent life satisfaction during crises", "Investigating how social factors like family support or social isolation mediate or moderate the impact of these psychological attributes on adolescent life satisfaction in such crisis contexts", "Analysis of trait EI, optimism, and friendship quality interplay for Chinese adolescent life satisfaction during COVID-19: effects of social isolation vs. community support and targeted intervention strategies", "In analyzing these trait EI and friendship quality interactions, could you detail the specific mediation/moderation analytical framework employed? I'm particularly interested in how you operationally defined the social isolation versus community support variables, what statistical controls were implemented for demographic covariates, and whether you conducted power analysis to determine sample size adequacy for detecting these complex interaction effects within your structural equation modeling approach."], "ground_truth": ["permed-74338", "permed-74339", "permed-80188", "permed-77917", "permed-86866", "permed-67166", "permed-86910", "permed-69173", "permed-65456", "permed-55590"]}
{"query_id": "topic_751_turn_6", "conversation_id": "topic_751", "turn_id": 6, "query": "Building on our discussion of clinical applications and methodological frameworks, how would you precisely define the construct of \"trait emotional intelligence\" in operational terms within developmental psychopathology? Given that both your mediation models and intervention recommendations hinge on this concept, what core components (e.g., emotion perception, regulation, social expression) constitute its theoretical foundation versus its measurable manifestations in adolescents? Furthermore, how do current definitions account for developmental/cultural variations – particularly in Chinese adolescents – and what conceptual challenges remain in distinguishing trait EI from related constructs like optimism or resilience in crisis contexts?", "history": ["Research on emotional intelligence, optimism, and their impact on adolescent life satisfaction during crises", "Investigating how social factors like family support or social isolation mediate or moderate the impact of these psychological attributes on adolescent life satisfaction in such crisis contexts", "Analysis of trait EI, optimism, and friendship quality interplay for Chinese adolescent life satisfaction during COVID-19: effects of social isolation vs. community support and targeted intervention strategies", "In analyzing these trait EI and friendship quality interactions, could you detail the specific mediation/moderation analytical framework employed? I'm particularly interested in how you operationally defined the social isolation versus community support variables, what statistical controls were implemented for demographic covariates, and whether you conducted power analysis to determine sample size adequacy for detecting these complex interaction effects within your structural equation modeling approach.", "Given your detailed methodological framework analyzing trait EI and friendship quality, what translational implications emerge for clinical practice? Specifically, based on your findings about social isolation's impact, what evidence-based psychosocial interventions would you recommend for clinicians working with adolescents during crises? Have any real-world implementations of these approaches demonstrated measurable improvements in life satisfaction or mental health outcomes, and what are the primary clinical barriers (e.g., engagement challenges, resource limitations) to deploying such interventions effectively in diverse adolescent populations?"], "ground_truth": ["permed-74338", "permed-55813", "permed-69666", "permed-62863", "permed-58497", "permed-55807", "permed-51550", "permed-55814", "permed-51557", "permed-85464"]}
{"query_id": "topic_752_turn_1", "conversation_id": "topic_752", "turn_id": 1, "query": "Overall impact of COVID-19 pandemic on type 1 diabetes mellitus patients", "history": [], "ground_truth": ["permed-70660", "permed-65697", "permed-68512", "permed-70656", "permed-59817", "permed-59813", "permed-54759", "permed-90995", "permed-59814", "permed-71066"]}
{"query_id": "topic_752_turn_2", "conversation_id": "topic_752", "turn_id": 2, "query": "Specific challenges encountered by these type 1 diabetes patients as a consequence of the pandemic", "history": ["Overall impact of COVID-19 pandemic on type 1 diabetes mellitus patients"], "ground_truth": ["permed-70660", "permed-71065", "permed-70656", "permed-59814", "permed-65697", "permed-68512", "permed-54759", "permed-70653", "permed-70654", "permed-59813"]}
{"query_id": "topic_752_turn_3", "conversation_id": "topic_752", "turn_id": 3, "query": "Strategies for personalized tele-rehabilitation in type 1 diabetes addressing COVID-19 impact on physical function, hypoglycemia fear, loneliness, and diabetes adherence", "history": ["Overall impact of COVID-19 pandemic on type 1 diabetes mellitus patients", "Specific challenges encountered by these type 1 diabetes patients as a consequence of the pandemic"], "ground_truth": ["permed-71065", "permed-70658", "permed-77309", "permed-54759", "permed-53358", "permed-65651", "permed-54862", "permed-70653", "permed-65697", "permed-70654"]}
{"query_id": "topic_752_turn_4", "conversation_id": "topic_752", "turn_id": 4, "query": "For implementing these personalized tele-rehabilitation strategies, what specific digital platforms and integration protocols were most effective for combining continuous glucose monitoring data with physical activity tracking? Additionally, how were the intervention adherence metrics quantified - were standardized scales like the Hypoglycemia Fear Survey or diabetes self-management questionnaires administered electronically, and what statistical approaches validated the correlation between telehealth engagement and clinical outcomes like HbA1c improvements?", "history": ["Overall impact of COVID-19 pandemic on type 1 diabetes mellitus patients", "Specific challenges encountered by these type 1 diabetes patients as a consequence of the pandemic", "Strategies for personalized tele-rehabilitation in type 1 diabetes addressing COVID-19 impact on physical function, hypoglycemia fear, loneliness, and diabetes adherence"], "ground_truth": ["permed-80191", "permed-61168", "permed-61165", "permed-77309", "permed-80190", "permed-88205", "permed-53989", "permed-53358", "permed-74633", "permed-88217"]}
{"query_id": "topic_752_turn_5", "conversation_id": "topic_752", "turn_id": 5, "query": "Given the established efficacy of integrated telehealth platforms in improving glycemic control, what were the observed safety profiles and adverse event rates when implementing these personalized tele-rehabilitation programs? Specifically, were there protocolized approaches for managing critical hypoglycemic episodes detected through remote monitoring, and how did these interventions impact pre-existing diabetes distress or fear of hypoglycemia as measured by validated scales? Furthermore, what real-world barriers—such as digital literacy disparities or insurance reimbursement limitations—emerged when scaling these programs beyond controlled trial settings, and how did they affect long-term patient retention and therapeutic sustainability?", "history": ["Overall impact of COVID-19 pandemic on type 1 diabetes mellitus patients", "Specific challenges encountered by these type 1 diabetes patients as a consequence of the pandemic", "Strategies for personalized tele-rehabilitation in type 1 diabetes addressing COVID-19 impact on physical function, hypoglycemia fear, loneliness, and diabetes adherence", "For implementing these personalized tele-rehabilitation strategies, what specific digital platforms and integration protocols were most effective for combining continuous glucose monitoring data with physical activity tracking? Additionally, how were the intervention adherence metrics quantified - were standardized scales like the Hypoglycemia Fear Survey or diabetes self-management questionnaires administered electronically, and what statistical approaches validated the correlation between telehealth engagement and clinical outcomes like HbA1c improvements?"], "ground_truth": ["permed-80191", "permed-80190", "permed-74633", "permed-88205", "permed-53989", "permed-26285", "permed-61885", "permed-71232", "permed-76948", "permed-71065"]}
{"query_id": "topic_752_turn_6", "conversation_id": "topic_752", "turn_id": 6, "query": "Given our discussion about integrated digital health platforms for type 1 diabetes management, how are we operationally defining \"therapeutic sustainability\" in this context beyond mere HbA1c maintenance? Does this definition encompass persistent engagement with digital components, long-term behavioral modification, and economic feasibility for healthcare systems, or is it primarily a clinical endurance metric? Furthermore, what theoretical frameworks—such as the Chronic Care Model or Technology Acceptance Model—underpin these definitions, and how might evolving reimbursement structures fundamentally reshape this concept in post-pandemic diabetes care?", "history": ["Overall impact of COVID-19 pandemic on type 1 diabetes mellitus patients", "Specific challenges encountered by these type 1 diabetes patients as a consequence of the pandemic", "Strategies for personalized tele-rehabilitation in type 1 diabetes addressing COVID-19 impact on physical function, hypoglycemia fear, loneliness, and diabetes adherence", "For implementing these personalized tele-rehabilitation strategies, what specific digital platforms and integration protocols were most effective for combining continuous glucose monitoring data with physical activity tracking? Additionally, how were the intervention adherence metrics quantified - were standardized scales like the Hypoglycemia Fear Survey or diabetes self-management questionnaires administered electronically, and what statistical approaches validated the correlation between telehealth engagement and clinical outcomes like HbA1c improvements?", "Given the established efficacy of integrated telehealth platforms in improving glycemic control, what were the observed safety profiles and adverse event rates when implementing these personalized tele-rehabilitation programs? Specifically, were there protocolized approaches for managing critical hypoglycemic episodes detected through remote monitoring, and how did these interventions impact pre-existing diabetes distress or fear of hypoglycemia as measured by validated scales? Furthermore, what real-world barriers—such as digital literacy disparities or insurance reimbursement limitations—emerged when scaling these programs beyond controlled trial settings, and how did they affect long-term patient retention and therapeutic sustainability?"], "ground_truth": ["permed-54365", "permed-30187", "permed-65674", "permed-70654", "permed-70653", "permed-18393", "permed-74633", "permed-58950", "permed-70660", "permed-70658"]}
{"query_id": "topic_753_turn_1", "conversation_id": "topic_753", "turn_id": 1, "query": "Key environmental and anthropogenic factors impacting fish growth and overall body condition in the Vietnamese Mekong Delta.", "history": [], "ground_truth": ["permed-74145", "permed-64766", "permed-82364", "permed-59345", "permed-80663", "permed-64767", "permed-64768", "permed-77821", "permed-66955", "permed-82046"]}
{"query_id": "topic_753_turn_2", "conversation_id": "topic_753", "turn_id": 2, "query": "How do seasonal dynamics and habitat-specific variations within the Vietnamese Mekong Delta modulate these impacts on growth performance and condition indices for *Ellochelon vaigiensis*?", "history": ["Key environmental and anthropogenic factors impacting fish growth and overall body condition in the Vietnamese Mekong Delta."], "ground_truth": ["permed-74145", "permed-89834", "permed-64766", "permed-80750", "permed-74146", "permed-82364", "permed-59340", "permed-66588", "permed-58233", "permed-59354"]}
{"query_id": "topic_753_turn_3", "conversation_id": "topic_753", "turn_id": 3, "query": "Considering these documented seasonal and habitat-driven variations in *Ellochelon vaigiensis*' growth performance and condition indices, what are the ecophysiological adaptation mechanisms contributing to its resilience against increasing salinity intrusion and temperature extremes in the Mekong Delta, and what precision aquaculture strategies can enhance its viability under such environmental change scenarios?", "history": ["Key environmental and anthropogenic factors impacting fish growth and overall body condition in the Vietnamese Mekong Delta.", "How do seasonal dynamics and habitat-specific variations within the Vietnamese Mekong Delta modulate these impacts on growth performance and condition indices for *Ellochelon vaigiensis*?"], "ground_truth": ["permed-74145", "permed-92470", "permed-73486", "permed-63992", "permed-72116", "permed-59340", "permed-77930", "permed-71787", "permed-80750", "permed-83925"]}
{"query_id": "topic_753_turn_4", "conversation_id": "topic_753", "turn_id": 4, "query": "Regarding these documented ecophysiological mechanisms and precision aquaculture strategies, could you elaborate on the specific experimental designs used to quantify osmoregulatory capacity under salinity stress? I'm particularly interested in the sampling intervals for plasma osmolality measurements, statistical methods for comparing thermal tolerance thresholds across seasons, and validation protocols for automated water quality monitoring systems proposed in precision aquaculture implementations. How were confounding variables like fish size and nutritional status controlled during these physiological assessments?", "history": ["Key environmental and anthropogenic factors impacting fish growth and overall body condition in the Vietnamese Mekong Delta.", "How do seasonal dynamics and habitat-specific variations within the Vietnamese Mekong Delta modulate these impacts on growth performance and condition indices for *Ellochelon vaigiensis*?", "Considering these documented seasonal and habitat-driven variations in *Ellochelon vaigiensis*' growth performance and condition indices, what are the ecophysiological adaptation mechanisms contributing to its resilience against increasing salinity intrusion and temperature extremes in the Mekong Delta, and what precision aquaculture strategies can enhance its viability under such environmental change scenarios?"], "ground_truth": ["permed-92470", "permed-76130", "permed-52719", "permed-85564", "permed-65114", "permed-73489", "permed-77930", "permed-73484", "permed-70020", "permed-83484"]}
{"query_id": "topic_753_turn_5", "conversation_id": "topic_753", "turn_id": 5, "query": "Given the detailed experimental methodologies for assessing physiological stress responses in *Ellochelon vaigiensis*, how do the osmoregulatory adaptation strategies and associated energy allocation trade-offs compare between this estuarine species and truly marine mugilids like *Mugil cephalus* when facing similar salinity fluctuations? Specifically, what comparative advantages in ionic regulation efficiency versus metabolic costs emerge from their different evolutionary histories, and how might these interspecies differences inform selective breeding programs for climate-resilient aquaculture in the Mekong Delta?", "history": ["Key environmental and anthropogenic factors impacting fish growth and overall body condition in the Vietnamese Mekong Delta.", "How do seasonal dynamics and habitat-specific variations within the Vietnamese Mekong Delta modulate these impacts on growth performance and condition indices for *Ellochelon vaigiensis*?", "Considering these documented seasonal and habitat-driven variations in *Ellochelon vaigiensis*' growth performance and condition indices, what are the ecophysiological adaptation mechanisms contributing to its resilience against increasing salinity intrusion and temperature extremes in the Mekong Delta, and what precision aquaculture strategies can enhance its viability under such environmental change scenarios?", "Regarding these documented ecophysiological mechanisms and precision aquaculture strategies, could you elaborate on the specific experimental designs used to quantify osmoregulatory capacity under salinity stress? I'm particularly interested in the sampling intervals for plasma osmolality measurements, statistical methods for comparing thermal tolerance thresholds across seasons, and validation protocols for automated water quality monitoring systems proposed in precision aquaculture implementations. How were confounding variables like fish size and nutritional status controlled during these physiological assessments?"], "ground_truth": ["permed-74145", "permed-92470", "permed-73486", "permed-63992", "permed-66896", "permed-77930", "permed-83925", "permed-73490", "permed-59330", "permed-73488"]}
{"query_id": "topic_753_turn_6", "conversation_id": "topic_753", "turn_id": 6, "query": "Building upon the comparative analysis of osmoregulatory strategies between estuarine and marine mugilids, could you precisely define what constitutes \"ionic regulation efficiency\" in this physiological context? Beyond simple osmoregulatory capacity measurements, what specific cellular and molecular mechanisms—such as Na+/K+-ATPase activity, chloride cell proliferation, or hormonal regulation pathways—are encompassed by this term, and how are their respective metabolic costs quantitatively integrated into a unified efficiency metric? Furthermore, how might this definition evolve when considering temporal scales, from acute stress responses to chronic acclimation, in future resilience modeling?", "history": ["Key environmental and anthropogenic factors impacting fish growth and overall body condition in the Vietnamese Mekong Delta.", "How do seasonal dynamics and habitat-specific variations within the Vietnamese Mekong Delta modulate these impacts on growth performance and condition indices for *Ellochelon vaigiensis*?", "Considering these documented seasonal and habitat-driven variations in *Ellochelon vaigiensis*' growth performance and condition indices, what are the ecophysiological adaptation mechanisms contributing to its resilience against increasing salinity intrusion and temperature extremes in the Mekong Delta, and what precision aquaculture strategies can enhance its viability under such environmental change scenarios?", "Regarding these documented ecophysiological mechanisms and precision aquaculture strategies, could you elaborate on the specific experimental designs used to quantify osmoregulatory capacity under salinity stress? I'm particularly interested in the sampling intervals for plasma osmolality measurements, statistical methods for comparing thermal tolerance thresholds across seasons, and validation protocols for automated water quality monitoring systems proposed in precision aquaculture implementations. How were confounding variables like fish size and nutritional status controlled during these physiological assessments?", "Given the detailed experimental methodologies for assessing physiological stress responses in *Ellochelon vaigiensis*, how do the osmoregulatory adaptation strategies and associated energy allocation trade-offs compare between this estuarine species and truly marine mugilids like *Mugil cephalus* when facing similar salinity fluctuations? Specifically, what comparative advantages in ionic regulation efficiency versus metabolic costs emerge from their different evolutionary histories, and how might these interspecies differences inform selective breeding programs for climate-resilient aquaculture in the Mekong Delta?"], "ground_truth": ["permed-92470", "permed-66896", "permed-77930", "permed-73292", "permed-80922", "permed-87866", "permed-91058", "permed-53601", "permed-92469", "permed-58228"]}
{"query_id": "topic_754_turn_1", "conversation_id": "topic_754", "turn_id": 1, "query": "What role do immunoassays play in detecting contaminants in aquatic ecosystems?", "history": [], "ground_truth": ["permed-87793", "permed-80664", "permed-88798", "permed-85540", "permed-80662", "permed-77823", "permed-65912", "permed-80946", "permed-77155", "permed-66608"]}
{"query_id": "topic_754_turn_2", "conversation_id": "topic_754", "turn_id": 2, "query": "How might advancements in this technique, such as using recombinant proteins, enhance its effectiveness in environmental monitoring?", "history": ["What role do immunoassays play in detecting contaminants in aquatic ecosystems?"], "ground_truth": ["permed-74316", "permed-60604", "permed-88798", "permed-74052", "permed-87793", "permed-4788", "permed-4683", "permed-57974", "permed-4783", "permed-70332"]}
{"query_id": "topic_754_turn_3", "conversation_id": "topic_754", "turn_id": 3, "query": "Given these advancements in immunoassays using recombinant proteins, how could the newly developed Japanese flounder choriogenin-based assays be incorporated into current environmental monitoring programs to better detect and assess estrogenic contaminants in both freshwater and marine ecosystems? What long-term ecological and health effects might such contaminants have on non-target species?", "history": ["What role do immunoassays play in detecting contaminants in aquatic ecosystems?", "How might advancements in this technique, such as using recombinant proteins, enhance its effectiveness in environmental monitoring?"], "ground_truth": ["permed-80662", "permed-80663", "permed-80944", "permed-80664", "permed-82046", "permed-50839", "permed-80947", "permed-80666", "permed-82509", "permed-84218"]}
{"query_id": "topic_754_turn_4", "conversation_id": "topic_754", "turn_id": 4, "query": "Regarding these choriogenin-based assays for estrogenic contaminant detection, what specific experimental validation protocols were employed to establish their sensitivity and specificity thresholds in different aquatic matrices? How did researchers address potential cross-reactivity with structurally similar compounds during assay development, and what statistical methods were used to determine the assay's limit of detection and quantification across varying salinity conditions in freshwater versus marine environments?", "history": ["What role do immunoassays play in detecting contaminants in aquatic ecosystems?", "How might advancements in this technique, such as using recombinant proteins, enhance its effectiveness in environmental monitoring?", "Given these advancements in immunoassays using recombinant proteins, how could the newly developed Japanese flounder choriogenin-based assays be incorporated into current environmental monitoring programs to better detect and assess estrogenic contaminants in both freshwater and marine ecosystems? What long-term ecological and health effects might such contaminants have on non-target species?"], "ground_truth": ["permed-80662", "permed-80663", "permed-80664", "permed-80665", "permed-80944", "permed-80669", "permed-82509", "permed-80943", "permed-80941", "permed-87793"]}
{"query_id": "topic_754_turn_5", "conversation_id": "topic_754", "turn_id": 5, "query": "Given the established validation protocols for choriogenin-based assays in different aquatic matrices, how does the comparative performance of these recombinant protein-based immunoassays stack up against traditional ELISA methods and chemical analysis techniques like LC-MS/MS for detecting estrogenic contaminants? Specifically, what are the trade-offs in terms of sensitivity, cost-effectiveness, throughput capacity, and field-deployability across freshwater versus marine monitoring scenarios, and which method demonstrates superior performance for large-scale environmental screening versus targeted contaminant identification?", "history": ["What role do immunoassays play in detecting contaminants in aquatic ecosystems?", "How might advancements in this technique, such as using recombinant proteins, enhance its effectiveness in environmental monitoring?", "Given these advancements in immunoassays using recombinant proteins, how could the newly developed Japanese flounder choriogenin-based assays be incorporated into current environmental monitoring programs to better detect and assess estrogenic contaminants in both freshwater and marine ecosystems? What long-term ecological and health effects might such contaminants have on non-target species?", "Regarding these choriogenin-based assays for estrogenic contaminant detection, what specific experimental validation protocols were employed to establish their sensitivity and specificity thresholds in different aquatic matrices? How did researchers address potential cross-reactivity with structurally similar compounds during assay development, and what statistical methods were used to determine the assay's limit of detection and quantification across varying salinity conditions in freshwater versus marine environments?"], "ground_truth": ["permed-80662", "permed-80669", "permed-80944", "permed-80664", "permed-83610", "permed-80663", "permed-87793", "permed-80665", "permed-58981", "permed-80385"]}
{"query_id": "topic_754_turn_6", "conversation_id": "topic_754", "turn_id": 6, "query": "Given our comparative analysis of detection methodologies, I'd like to fundamentally clarify the conceptual framework defining \"field-deployability\" in environmental immunoassays. Beyond mere portability, what specific operational parameters—including sample preprocessing requirements, stability under variable field conditions, and real-time data interpretation capabilities—constitute this metric? How does this definition evolve when applied to choriogenin-based assays across freshwater versus marine environments, particularly regarding their integration with emerging technologies like microfluidic platforms or smartphone-based detection systems for comprehensive environmental surveillance?", "history": ["What role do immunoassays play in detecting contaminants in aquatic ecosystems?", "How might advancements in this technique, such as using recombinant proteins, enhance its effectiveness in environmental monitoring?", "Given these advancements in immunoassays using recombinant proteins, how could the newly developed Japanese flounder choriogenin-based assays be incorporated into current environmental monitoring programs to better detect and assess estrogenic contaminants in both freshwater and marine ecosystems? What long-term ecological and health effects might such contaminants have on non-target species?", "Regarding these choriogenin-based assays for estrogenic contaminant detection, what specific experimental validation protocols were employed to establish their sensitivity and specificity thresholds in different aquatic matrices? How did researchers address potential cross-reactivity with structurally similar compounds during assay development, and what statistical methods were used to determine the assay's limit of detection and quantification across varying salinity conditions in freshwater versus marine environments?", "Given the established validation protocols for choriogenin-based assays in different aquatic matrices, how does the comparative performance of these recombinant protein-based immunoassays stack up against traditional ELISA methods and chemical analysis techniques like LC-MS/MS for detecting estrogenic contaminants? Specifically, what are the trade-offs in terms of sensitivity, cost-effectiveness, throughput capacity, and field-deployability across freshwater versus marine monitoring scenarios, and which method demonstrates superior performance for large-scale environmental screening versus targeted contaminant identification?"], "ground_truth": ["permed-80662", "permed-4686", "permed-59244", "permed-4785", "permed-66608", "permed-87793", "permed-80942", "permed-59239", "permed-65908", "permed-62239"]}
{"query_id": "topic_755_turn_1", "conversation_id": "topic_755", "turn_id": 1, "query": "What methods are used to develop quality assessment frameworks for Massive Open Online Courses (MOOCs)?", "history": [], "ground_truth": ["permed-79072", "permed-72309", "permed-83695", "permed-74551", "permed-78111", "permed-89528", "permed-85723", "permed-56867", "permed-53880", "permed-52377"]}
{"query_id": "topic_755_turn_2", "conversation_id": "topic_755", "turn_id": 2, "query": "Can techniques like the Delphi method be effective in creating global standards for MOOC quality assessment?", "history": ["What methods are used to develop quality assessment frameworks for Massive Open Online Courses (MOOCs)?"], "ground_truth": ["permed-79072", "permed-72309", "permed-83695", "permed-68567", "permed-54490", "permed-63458", "permed-44103", "permed-84372", "permed-57585", "permed-88135"]}
{"query_id": "topic_755_turn_3", "conversation_id": "topic_755", "turn_id": 3, "query": "Given that the Delphi method could be effective for establishing global MOOC quality standards, how might it be adapted to better incorporate diverse international perspectives and ensure cultural sensitivity? What specific challenges could emerge when trying to align these varied viewpoints with existing standards from organizations like ENQA?", "history": ["What methods are used to develop quality assessment frameworks for Massive Open Online Courses (MOOCs)?", "Can techniques like the Delphi method be effective in creating global standards for MOOC quality assessment?"], "ground_truth": ["permed-79072", "permed-72309", "permed-87606", "permed-44103", "permed-51510", "permed-21706", "permed-69898", "permed-51872", "permed-74556", "permed-8061"]}
{"query_id": "topic_755_turn_4", "conversation_id": "topic_755", "turn_id": 4, "query": "This approach of adapting the Delphi method to incorporate diverse perspectives raises methodological questions about implementation. Specifically, what data collection instruments and structured communication protocols would you recommend for capturing nuanced cultural viewpoints across geographically dispersed expert panels? How might we validate the statistical convergence of these diverse responses while maintaining methodological rigor, particularly when dealing with potential conflicts between established ENQA standards and region-specific educational values?", "history": ["What methods are used to develop quality assessment frameworks for Massive Open Online Courses (MOOCs)?", "Can techniques like the Delphi method be effective in creating global standards for MOOC quality assessment?", "Given that the Delphi method could be effective for establishing global MOOC quality standards, how might it be adapted to better incorporate diverse international perspectives and ensure cultural sensitivity? What specific challenges could emerge when trying to align these varied viewpoints with existing standards from organizations like ENQA?"], "ground_truth": ["permed-44103", "permed-59362", "permed-89364", "permed-69896", "permed-69900", "permed-64779", "permed-7339", "permed-66109", "permed-64788", "permed-8058"]}
{"query_id": "topic_755_turn_5", "conversation_id": "topic_755", "turn_id": 5, "query": "Given these methodological considerations for capturing diverse educational perspectives, how might validated MOOC quality frameworks be translated into clinical education settings? Specifically, what evidence exists regarding patient outcomes or healthcare provider competencies when using MOOCs for continuing medical education? Are there documented safety risks or unintended consequences when applying globally-developed digital education standards to clinical training, particularly regarding knowledge retention or protocol adherence across different healthcare systems?", "history": ["What methods are used to develop quality assessment frameworks for Massive Open Online Courses (MOOCs)?", "Can techniques like the Delphi method be effective in creating global standards for MOOC quality assessment?", "Given that the Delphi method could be effective for establishing global MOOC quality standards, how might it be adapted to better incorporate diverse international perspectives and ensure cultural sensitivity? What specific challenges could emerge when trying to align these varied viewpoints with existing standards from organizations like ENQA?", "This approach of adapting the Delphi method to incorporate diverse perspectives raises methodological questions about implementation. Specifically, what data collection instruments and structured communication protocols would you recommend for capturing nuanced cultural viewpoints across geographically dispersed expert panels? How might we validate the statistical convergence of these diverse responses while maintaining methodological rigor, particularly when dealing with potential conflicts between established ENQA standards and region-specific educational values?"], "ground_truth": ["permed-79072", "permed-72309", "permed-78111", "permed-65575", "permed-85723", "permed-87606", "permed-44968", "permed-67288", "permed-57575", "permed-57442"]}
{"query_id": "topic_755_turn_6", "conversation_id": "topic_755", "turn_id": 6, "query": "Given our previous discussion about adapting global MOOC standards to diverse educational contexts and their potential healthcare applications, how does the regulatory landscape for continuing medical education MOOCs compare between well-resourced systems (like the US or EU) and resource-limited settings? Specifically, what are the trade-offs in implementing rigorous quality frameworks that require substantial technological infrastructure versus more accessible but potentially less standardized approaches? How might these disparities affect the long-term viability of globally-developed standards when quality assurance mechanisms vary so dramatically across healthcare systems?", "history": ["What methods are used to develop quality assessment frameworks for Massive Open Online Courses (MOOCs)?", "Can techniques like the Delphi method be effective in creating global standards for MOOC quality assessment?", "Given that the Delphi method could be effective for establishing global MOOC quality standards, how might it be adapted to better incorporate diverse international perspectives and ensure cultural sensitivity? What specific challenges could emerge when trying to align these varied viewpoints with existing standards from organizations like ENQA?", "This approach of adapting the Delphi method to incorporate diverse perspectives raises methodological questions about implementation. Specifically, what data collection instruments and structured communication protocols would you recommend for capturing nuanced cultural viewpoints across geographically dispersed expert panels? How might we validate the statistical convergence of these diverse responses while maintaining methodological rigor, particularly when dealing with potential conflicts between established ENQA standards and region-specific educational values?", "Given these methodological considerations for capturing diverse educational perspectives, how might validated MOOC quality frameworks be translated into clinical education settings? Specifically, what evidence exists regarding patient outcomes or healthcare provider competencies when using MOOCs for continuing medical education? Are there documented safety risks or unintended consequences when applying globally-developed digital education standards to clinical training, particularly regarding knowledge retention or protocol adherence across different healthcare systems?"], "ground_truth": ["permed-79072", "permed-72309", "permed-87606", "permed-51872", "permed-25804", "permed-57575", "permed-25419", "permed-66310", "permed-0850", "permed-25911"]}
{"query_id": "topic_756_turn_1", "conversation_id": "topic_756", "turn_id": 1, "query": "What alternatives are being developed to replace traditional plastic straws with more sustainable options?", "history": [], "ground_truth": ["permed-80629", "permed-82181", "permed-73370", "permed-74159", "permed-64498", "permed-73009", "permed-73114", "permed-82856", "permed-80632", "permed-55107"]}
{"query_id": "topic_756_turn_2", "conversation_id": "topic_756", "turn_id": 2, "query": "How does starch-based material perform as one of these alternatives, particularly in terms of durability and usability?", "history": ["What alternatives are being developed to replace traditional plastic straws with more sustainable options?"], "ground_truth": ["permed-82168", "permed-82171", "permed-82182", "permed-82181", "permed-78138", "permed-62605", "permed-73370", "permed-82169", "permed-80629", "permed-84111"]}
{"query_id": "topic_756_turn_3", "conversation_id": "topic_756", "turn_id": 3, "query": "Given that starch-based materials show promise as plastic straw alternatives, how can we optimize their mechanical and thermal properties by adjusting extrusion process parameters like temperature and screw speed? And how do these adjustments impact their performance when used with different liquids, including acidic or alkaline solutions?", "history": ["What alternatives are being developed to replace traditional plastic straws with more sustainable options?", "How does starch-based material perform as one of these alternatives, particularly in terms of durability and usability?"], "ground_truth": ["permed-82181", "permed-82182", "permed-80334", "permed-57788", "permed-57622", "permed-73370", "permed-82168", "permed-75799", "permed-63655", "permed-75797"]}
{"query_id": "topic_756_turn_4", "conversation_id": "topic_756", "turn_id": 4, "query": "Regarding this extrusion optimization approach, what specific characterization techniques would you recommend for systematically evaluating the mechanical and thermal property improvements? Should we prioritize standardized ASTM tests for tensile strength and heat deflection temperature, or are there more specialized methods like dynamic mechanical analysis that would provide better insight into performance under different liquid exposures? How should we design the experimental matrix to statistically validate interactions between extrusion parameters and liquid compatibility?", "history": ["What alternatives are being developed to replace traditional plastic straws with more sustainable options?", "How does starch-based material perform as one of these alternatives, particularly in terms of durability and usability?", "Given that starch-based materials show promise as plastic straw alternatives, how can we optimize their mechanical and thermal properties by adjusting extrusion process parameters like temperature and screw speed? And how do these adjustments impact their performance when used with different liquids, including acidic or alkaline solutions?"], "ground_truth": ["permed-57622", "permed-82181", "permed-52715", "permed-76778", "permed-73039", "permed-75799", "permed-80334", "permed-84109", "permed-57619", "permed-81154"]}
{"query_id": "topic_756_turn_5", "conversation_id": "topic_756", "turn_id": 5, "query": "Given these comprehensive material characterization protocols, how do these optimized starch-based straws perform in clinical settings with patients who have different swallowing capabilities or oral sensitivities? What evidence exists regarding their safety profile when used with hot beverages or acidic medications, particularly for immunocompromised patients? Are there documented cases of mucosal irritation or allergic reactions to common plasticizers or additives used in these biopolymer formulations? Furthermore, what clinical trial data supports their therapeutic efficacy for patients requiring assisted drinking compared to silicone or paper alternatives?", "history": ["What alternatives are being developed to replace traditional plastic straws with more sustainable options?", "How does starch-based material perform as one of these alternatives, particularly in terms of durability and usability?", "Given that starch-based materials show promise as plastic straw alternatives, how can we optimize their mechanical and thermal properties by adjusting extrusion process parameters like temperature and screw speed? And how do these adjustments impact their performance when used with different liquids, including acidic or alkaline solutions?", "Regarding this extrusion optimization approach, what specific characterization techniques would you recommend for systematically evaluating the mechanical and thermal property improvements? Should we prioritize standardized ASTM tests for tensile strength and heat deflection temperature, or are there more specialized methods like dynamic mechanical analysis that would provide better insight into performance under different liquid exposures? How should we design the experimental matrix to statistically validate interactions between extrusion parameters and liquid compatibility?"], "ground_truth": ["permed-82181", "permed-82168", "permed-62605", "permed-21635", "permed-83120", "permed-82182", "permed-73370", "permed-82169", "permed-57788", "permed-86191"]}
{"query_id": "topic_756_turn_6", "conversation_id": "topic_756", "turn_id": 6, "query": "Considering the extensive material characterization and clinical safety data we've discussed, how do optimized starch-based straws compare to silicone and paper alternatives in terms of long-term healthcare cost-effectiveness? Specifically, what are the trade-offs between initial material costs, sterilization/reusability potential, and patient compliance rates across different care settings? Given their biodegradability advantages, do starch-based straws present superior lifecycle cost profiles despite potentially higher per-unit costs, and how might emerging regulatory frameworks for single-use medical devices influence their economic viability compared to established alternatives?", "history": ["What alternatives are being developed to replace traditional plastic straws with more sustainable options?", "How does starch-based material perform as one of these alternatives, particularly in terms of durability and usability?", "Given that starch-based materials show promise as plastic straw alternatives, how can we optimize their mechanical and thermal properties by adjusting extrusion process parameters like temperature and screw speed? And how do these adjustments impact their performance when used with different liquids, including acidic or alkaline solutions?", "Regarding this extrusion optimization approach, what specific characterization techniques would you recommend for systematically evaluating the mechanical and thermal property improvements? Should we prioritize standardized ASTM tests for tensile strength and heat deflection temperature, or are there more specialized methods like dynamic mechanical analysis that would provide better insight into performance under different liquid exposures? How should we design the experimental matrix to statistically validate interactions between extrusion parameters and liquid compatibility?", "Given these comprehensive material characterization protocols, how do these optimized starch-based straws perform in clinical settings with patients who have different swallowing capabilities or oral sensitivities? What evidence exists regarding their safety profile when used with hot beverages or acidic medications, particularly for immunocompromised patients? Are there documented cases of mucosal irritation or allergic reactions to common plasticizers or additives used in these biopolymer formulations? Furthermore, what clinical trial data supports their therapeutic efficacy for patients requiring assisted drinking compared to silicone or paper alternatives?"], "ground_truth": ["permed-82181", "permed-82171", "permed-82168", "permed-68853", "permed-86813", "permed-90715", "permed-91209", "permed-82169", "permed-47442", "permed-80107"]}
{"query_id": "topic_757_turn_1", "conversation_id": "topic_757", "turn_id": 1, "query": "Current research on emerging treatments for subacute thyroiditis", "history": [], "ground_truth": ["permed-76951", "permed-29182", "permed-17680", "permed-62459", "permed-54732", "permed-62460", "permed-58912", "permed-89441", "permed-74029", "permed-29996"]}
{"query_id": "topic_757_turn_2", "conversation_id": "topic_757", "turn_id": 2, "query": "Investigating injectable anti-inflammatory therapies mentioned in recent subacute thyroiditis research: efficacy and safety concerns, particularly for local corticosteroid injections.", "history": ["Current research on emerging treatments for subacute thyroiditis"], "ground_truth": ["permed-76951", "permed-54732", "permed-81844", "permed-85685", "permed-78665", "permed-72901", "permed-90867", "permed-17680", "permed-72902", "permed-62452"]}
{"query_id": "topic_757_turn_3", "conversation_id": "topic_757", "turn_id": 3, "query": "Long-term outcomes of intrathyroidal triamcinolone acetonide and lidocaine injections for subacute thyroiditis: impact on thyroid function, immune response, and risk of subsequent thyroid dysfunction.", "history": ["Current research on emerging treatments for subacute thyroiditis", "Investigating injectable anti-inflammatory therapies mentioned in recent subacute thyroiditis research: efficacy and safety concerns, particularly for local corticosteroid injections."], "ground_truth": ["permed-76951", "permed-54732", "permed-91815", "permed-78665", "permed-74029", "permed-17680", "permed-58848", "permed-77179", "permed-62452", "permed-62395"]}
{"query_id": "topic_757_turn_4", "conversation_id": "topic_757", "turn_id": 4, "query": "In these long-term outcome studies, what specific statistical models were employed to analyze the temporal patterns of thyroid function recovery? I'm particularly interested in how researchers accounted for potential confounding variables like baseline inflammatory markers or pretreatment thyroid status when assessing the risk of subsequent dysfunction. Were there standardized protocols for timing the follow-up laboratory assessments, and how did the methodology ensure consistent measurement of immune response parameters across different study sites?", "history": ["Current research on emerging treatments for subacute thyroiditis", "Investigating injectable anti-inflammatory therapies mentioned in recent subacute thyroiditis research: efficacy and safety concerns, particularly for local corticosteroid injections.", "Long-term outcomes of intrathyroidal triamcinolone acetonide and lidocaine injections for subacute thyroiditis: impact on thyroid function, immune response, and risk of subsequent thyroid dysfunction."], "ground_truth": ["permed-58843", "permed-34757", "permed-79466", "permed-54430", "permed-48644", "permed-82807", "permed-11016", "permed-74029", "permed-30463", "permed-23172"]}
{"query_id": "topic_757_turn_5", "conversation_id": "topic_757", "turn_id": 5, "query": "Given these methodological considerations in long-term outcome assessments, how have clinical trials translated these statistical findings into practical treatment algorithms? Specifically, what evidence exists regarding patient selection criteria for intrathyroidal injections versus conventional oral NSAIDs or corticosteroids based on predictors like baseline CRP levels or thyroid antibody status? Have any studies compared real-world clinical outcomes—such as time to symptomatic resolution, healthcare utilization, or quality of life measures—between these treatment pathways, and what safety monitoring protocols are recommended for detecting late-onset thyroid dysfunction following intervention?", "history": ["Current research on emerging treatments for subacute thyroiditis", "Investigating injectable anti-inflammatory therapies mentioned in recent subacute thyroiditis research: efficacy and safety concerns, particularly for local corticosteroid injections.", "Long-term outcomes of intrathyroidal triamcinolone acetonide and lidocaine injections for subacute thyroiditis: impact on thyroid function, immune response, and risk of subsequent thyroid dysfunction.", "In these long-term outcome studies, what specific statistical models were employed to analyze the temporal patterns of thyroid function recovery? I'm particularly interested in how researchers accounted for potential confounding variables like baseline inflammatory markers or pretreatment thyroid status when assessing the risk of subsequent dysfunction. Were there standardized protocols for timing the follow-up laboratory assessments, and how did the methodology ensure consistent measurement of immune response parameters across different study sites?"], "ground_truth": ["permed-76951", "permed-79352", "permed-74029", "permed-88922", "permed-66101", "permed-29953", "permed-82809", "permed-78666", "permed-72901", "permed-48534"]}
{"query_id": "topic_757_turn_6", "conversation_id": "topic_757", "turn_id": 6, "query": "Given the established differences in treatment pathways and monitoring protocols discussed earlier, how do the comparative cost-effectiveness analyses between intrathyroidal injections and conventional systemic therapies account for both short-term resource utilization and long-term complications? Specifically, what economic modeling approaches have captured the trade-offs between initial procedure costs versus potential savings from reduced recurrence rates and avoided chronic thyroid dysfunction management? Furthermore, how might emerging biologic therapies compare within these economic frameworks given their substantially higher acquisition costs but potentially superior immune modulation?", "history": ["Current research on emerging treatments for subacute thyroiditis", "Investigating injectable anti-inflammatory therapies mentioned in recent subacute thyroiditis research: efficacy and safety concerns, particularly for local corticosteroid injections.", "Long-term outcomes of intrathyroidal triamcinolone acetonide and lidocaine injections for subacute thyroiditis: impact on thyroid function, immune response, and risk of subsequent thyroid dysfunction.", "In these long-term outcome studies, what specific statistical models were employed to analyze the temporal patterns of thyroid function recovery? I'm particularly interested in how researchers accounted for potential confounding variables like baseline inflammatory markers or pretreatment thyroid status when assessing the risk of subsequent dysfunction. Were there standardized protocols for timing the follow-up laboratory assessments, and how did the methodology ensure consistent measurement of immune response parameters across different study sites?", "Given these methodological considerations in long-term outcome assessments, how have clinical trials translated these statistical findings into practical treatment algorithms? Specifically, what evidence exists regarding patient selection criteria for intrathyroidal injections versus conventional oral NSAIDs or corticosteroids based on predictors like baseline CRP levels or thyroid antibody status? Have any studies compared real-world clinical outcomes—such as time to symptomatic resolution, healthcare utilization, or quality of life measures—between these treatment pathways, and what safety monitoring protocols are recommended for detecting late-onset thyroid dysfunction following intervention?"], "ground_truth": ["permed-79352", "permed-88088", "permed-76951", "permed-83271", "permed-68823", "permed-74029", "permed-56737", "permed-23443", "permed-68645", "permed-52522"]}
{"query_id": "topic_758_turn_1", "conversation_id": "topic_758", "turn_id": 1, "query": "Comprehensive overview of AMP-activated protein kinase (AMPK) role and mechanisms in metabolic health and disease states", "history": [], "ground_truth": ["permed-53562", "permed-72072", "permed-53557", "permed-74323", "permed-75391", "permed-16764", "permed-72293", "permed-65077", "permed-53809", "permed-62499"]}
{"query_id": "topic_758_turn_2", "conversation_id": "topic_758", "turn_id": 2, "query": "Impact of this enzyme's (AMPK) activation: consequences for cellular energy balance, inflammatory responses, and related metabolic pathways", "history": ["Comprehensive overview of AMP-activated protein kinase (AMPK) role and mechanisms in metabolic health and disease states"], "ground_truth": ["permed-53562", "permed-72072", "permed-75391", "permed-53557", "permed-53809", "permed-74323", "permed-16764", "permed-63572", "permed-65077", "permed-62499"]}
{"query_id": "topic_758_turn_3", "conversation_id": "topic_758", "turn_id": 3, "query": "Targeting AMPK signaling: dietary and pharmacological activators, downstream effects on inflammation, oxidative stress, gut hormone secretion, adipokine profiles, microRNA regulation in obesity, and therapeutic potential", "history": ["Comprehensive overview of AMP-activated protein kinase (AMPK) role and mechanisms in metabolic health and disease states", "Impact of this enzyme's (AMPK) activation: consequences for cellular energy balance, inflammatory responses, and related metabolic pathways"], "ground_truth": ["permed-53562", "permed-70452", "permed-53557", "permed-63572", "permed-88528", "permed-75391", "permed-59030", "permed-72072", "permed-58972", "permed-71395"]}
{"query_id": "topic_758_turn_4", "conversation_id": "topic_758", "turn_id": 4, "query": "Considering these multi-modal approaches to AMPK targeting, could you detail the specific in vitro and in vivo experimental designs used to validate efficacy? I'm particularly interested in the protocols for assessing inflammatory markers and adipokine profiles—what specific assays (e.g., ELISA, multiplex immunoassays) and time-point measurements were employed, and how were potential confounding variables like diet-controlled feeding or circadian rhythm effects accounted for in these methodological validations?", "history": ["Comprehensive overview of AMP-activated protein kinase (AMPK) role and mechanisms in metabolic health and disease states", "Impact of this enzyme's (AMPK) activation: consequences for cellular energy balance, inflammatory responses, and related metabolic pathways", "Targeting AMPK signaling: dietary and pharmacological activators, downstream effects on inflammation, oxidative stress, gut hormone secretion, adipokine profiles, microRNA regulation in obesity, and therapeutic potential"], "ground_truth": ["permed-63572", "permed-53557", "permed-70452", "permed-9620", "permed-53562", "permed-72072", "permed-82345", "permed-16764", "permed-12143", "permed-75391"]}
{"query_id": "topic_758_turn_5", "conversation_id": "topic_758", "turn_id": 5, "query": "Given these validated experimental protocols for assessing AMPK-targeted interventions, what clinical evidence exists regarding their therapeutic efficacy and safety profiles in human populations? Specifically, for pharmacological AMPK activators like metformin or emerging compounds, what patient outcomes (e.g., HbA1c reduction, inflammatory marker improvements) have been demonstrated in randomized controlled trials? Additionally, how do real-world safety considerations—such as gastrointestinal side effects, contraindications in renal impairment, or drug interactions—compare between established AMPK-activating medications and novel therapeutics in clinical development for metabolic disorders?", "history": ["Comprehensive overview of AMP-activated protein kinase (AMPK) role and mechanisms in metabolic health and disease states", "Impact of this enzyme's (AMPK) activation: consequences for cellular energy balance, inflammatory responses, and related metabolic pathways", "Targeting AMPK signaling: dietary and pharmacological activators, downstream effects on inflammation, oxidative stress, gut hormone secretion, adipokine profiles, microRNA regulation in obesity, and therapeutic potential", "Considering these multi-modal approaches to AMPK targeting, could you detail the specific in vitro and in vivo experimental designs used to validate efficacy? I'm particularly interested in the protocols for assessing inflammatory markers and adipokine profiles—what specific assays (e.g., ELISA, multiplex immunoassays) and time-point measurements were employed, and how were potential confounding variables like diet-controlled feeding or circadian rhythm effects accounted for in these methodological validations?"], "ground_truth": ["permed-53557", "permed-53562", "permed-63572", "permed-59539", "permed-74323", "permed-9620", "permed-69075", "permed-72293", "permed-74872", "permed-23994"]}
{"query_id": "topic_758_turn_6", "conversation_id": "topic_758", "turn_id": 6, "query": "Given the established clinical profiles of conventional AMPK activators like metformin discussed earlier, how do newer pharmacological approaches—such as direct allosteric activators or natural product derivatives—compare in terms of mechanistic specificity and metabolic outcomes? Considering AMPK's complex isoform expression across tissues, what evidence exists regarding tissue-selective effects versus systemic actions, and how might this influence therapeutic indices for conditions like NAFLD versus diabetes? With emerging compounds in preclinical development, what comparative advantages in inflammation resolution or mitochondrial biogenesis have been demonstrated, and what translational challenges remain regarding off-target effects compared to first-line therapies?", "history": ["Comprehensive overview of AMP-activated protein kinase (AMPK) role and mechanisms in metabolic health and disease states", "Impact of this enzyme's (AMPK) activation: consequences for cellular energy balance, inflammatory responses, and related metabolic pathways", "Targeting AMPK signaling: dietary and pharmacological activators, downstream effects on inflammation, oxidative stress, gut hormone secretion, adipokine profiles, microRNA regulation in obesity, and therapeutic potential", "Considering these multi-modal approaches to AMPK targeting, could you detail the specific in vitro and in vivo experimental designs used to validate efficacy? I'm particularly interested in the protocols for assessing inflammatory markers and adipokine profiles—what specific assays (e.g., ELISA, multiplex immunoassays) and time-point measurements were employed, and how were potential confounding variables like diet-controlled feeding or circadian rhythm effects accounted for in these methodological validations?", "Given these validated experimental protocols for assessing AMPK-targeted interventions, what clinical evidence exists regarding their therapeutic efficacy and safety profiles in human populations? Specifically, for pharmacological AMPK activators like metformin or emerging compounds, what patient outcomes (e.g., HbA1c reduction, inflammatory marker improvements) have been demonstrated in randomized controlled trials? Additionally, how do real-world safety considerations—such as gastrointestinal side effects, contraindications in renal impairment, or drug interactions—compare between established AMPK-activating medications and novel therapeutics in clinical development for metabolic disorders?"], "ground_truth": ["permed-53557", "permed-9620", "permed-63572", "permed-79291", "permed-53562", "permed-72072", "permed-70452", "permed-72293", "permed-74323", "permed-62692"]}
{"query_id": "topic_759_turn_1", "conversation_id": "topic_759", "turn_id": 1, "query": "What role do longitudinal studies play in understanding autism symptom severity?", "history": [], "ground_truth": ["permed-80463", "permed-63232", "permed-55741", "permed-63267", "permed-70975", "permed-86737", "permed-91470", "permed-63372", "permed-55798", "permed-89365"]}
{"query_id": "topic_759_turn_2", "conversation_id": "topic_759", "turn_id": 2, "query": "How effectively can this type of research account for individual differences over time?", "history": ["What role do longitudinal studies play in understanding autism symptom severity?"], "ground_truth": ["permed-70273", "permed-55479", "permed-82588", "permed-80463", "permed-71350", "permed-85718", "permed-69906", "permed-58418", "permed-82776", "permed-80110"]}
{"query_id": "topic_759_turn_3", "conversation_id": "topic_759", "turn_id": 3, "query": "Given these challenges in accounting for individual differences over time, what specific methodological improvements could make longitudinal studies more effective at capturing both individual variability and developmental changes in autism symptom severity? How might such approaches enhance the reliability of identifying consistent patterns and predictors of symptom progression?", "history": ["What role do longitudinal studies play in understanding autism symptom severity?", "How effectively can this type of research account for individual differences over time?"], "ground_truth": ["permed-80463", "permed-58509", "permed-70975", "permed-55801", "permed-28632", "permed-63232", "permed-89365", "permed-63267", "permed-86737", "permed-55720"]}
{"query_id": "topic_759_turn_4", "conversation_id": "topic_759", "turn_id": 4, "query": "Regarding these methodological improvements for capturing individual variability, what specific mixed-effects modeling approaches would you recommend for analyzing repeated measures data in autism studies? I'm particularly interested in how to properly specify random intercepts and slopes to account for heterogeneous trajectories, and what statistical techniques would best handle missing data patterns common in longitudinal autism research while maintaining power to detect true developmental changes.", "history": ["What role do longitudinal studies play in understanding autism symptom severity?", "How effectively can this type of research account for individual differences over time?", "Given these challenges in accounting for individual differences over time, what specific methodological improvements could make longitudinal studies more effective at capturing both individual variability and developmental changes in autism symptom severity? How might such approaches enhance the reliability of identifying consistent patterns and predictors of symptom progression?"], "ground_truth": ["permed-80463", "permed-63232", "permed-63267", "permed-70975", "permed-88188", "permed-89365", "permed-59395", "permed-63270", "permed-68378", "permed-63372"]}
{"query_id": "topic_759_turn_5", "conversation_id": "topic_759", "turn_id": 5, "query": "Given these sophisticated statistical approaches for modeling heterogeneous autism trajectories, how have these analytical improvements translated into clinically actionable insights? Specifically, what evidence exists from longitudinal studies using mixed-effects models that has directly influenced clinical decision-making regarding treatment timing or selection? I'm interested in whether these models have successfully identified critical developmental windows where interventions yield significantly better outcomes, and how clinicians are incorporating trajectory-based predictions into personalized care plans while managing potential risks of over-interpreting individual prognostic projections.", "history": ["What role do longitudinal studies play in understanding autism symptom severity?", "How effectively can this type of research account for individual differences over time?", "Given these challenges in accounting for individual differences over time, what specific methodological improvements could make longitudinal studies more effective at capturing both individual variability and developmental changes in autism symptom severity? How might such approaches enhance the reliability of identifying consistent patterns and predictors of symptom progression?", "Regarding these methodological improvements for capturing individual variability, what specific mixed-effects modeling approaches would you recommend for analyzing repeated measures data in autism studies? I'm particularly interested in how to properly specify random intercepts and slopes to account for heterogeneous trajectories, and what statistical techniques would best handle missing data patterns common in longitudinal autism research while maintaining power to detect true developmental changes."], "ground_truth": ["permed-80463", "permed-34458", "permed-58509", "permed-55479", "permed-53129", "permed-84075", "permed-55741", "permed-63232", "permed-70671", "permed-62322"]}
{"query_id": "topic_759_turn_6", "conversation_id": "topic_759", "turn_id": 6, "query": "Given our discussion of how longitudinal models identify critical developmental windows, what exactly constitutes the theoretical definition of a \"critical window\" in neurodevelopmental contexts? Beyond statistical significance in mixed-effects models, what mechanistic or neurobiological criteria fundamentally distinguish true sensitive periods from mere periods of rapid change? Given clinical risks of over-interpreting trajectories, how should researchers operationally define these windows to account for both neural plasticity evidence and heterogeneous autism phenotypes when translating model predictions into intervention timing decisions?", "history": ["What role do longitudinal studies play in understanding autism symptom severity?", "How effectively can this type of research account for individual differences over time?", "Given these challenges in accounting for individual differences over time, what specific methodological improvements could make longitudinal studies more effective at capturing both individual variability and developmental changes in autism symptom severity? How might such approaches enhance the reliability of identifying consistent patterns and predictors of symptom progression?", "Regarding these methodological improvements for capturing individual variability, what specific mixed-effects modeling approaches would you recommend for analyzing repeated measures data in autism studies? I'm particularly interested in how to properly specify random intercepts and slopes to account for heterogeneous trajectories, and what statistical techniques would best handle missing data patterns common in longitudinal autism research while maintaining power to detect true developmental changes.", "Given these sophisticated statistical approaches for modeling heterogeneous autism trajectories, how have these analytical improvements translated into clinically actionable insights? Specifically, what evidence exists from longitudinal studies using mixed-effects models that has directly influenced clinical decision-making regarding treatment timing or selection? I'm interested in whether these models have successfully identified critical developmental windows where interventions yield significantly better outcomes, and how clinicians are incorporating trajectory-based predictions into personalized care plans while managing potential risks of over-interpreting individual prognostic projections."], "ground_truth": ["permed-55749", "permed-78045", "permed-63270", "permed-80463", "permed-63372", "permed-58509", "permed-81646", "permed-63233", "permed-54612", "permed-75370"]}
{"query_id": "topic_760_turn_1", "conversation_id": "topic_760", "turn_id": 1, "query": "What role do perinatal healthcare professionals play in educating new parents about safe sleep practices?", "history": [], "ground_truth": ["permed-52554", "permed-52555", "permed-74104", "permed-80200", "permed-80208", "permed-69474", "permed-52552", "permed-52560", "permed-84564", "permed-80229"]}
{"query_id": "topic_760_turn_2", "conversation_id": "topic_760", "turn_id": 2, "query": "How effective is this education in promoting long-term adherence to safe sleep guidelines among new parents?", "history": ["What role do perinatal healthcare professionals play in educating new parents about safe sleep practices?"], "ground_truth": ["permed-52554", "permed-52555", "permed-52560", "permed-37831", "permed-92342", "permed-74104", "permed-91845", "permed-81493", "permed-86027", "permed-51581"]}
{"query_id": "topic_760_turn_3", "conversation_id": "topic_760", "turn_id": 3, "query": "What specific strategies could improve how perinatal healthcare professionals deliver safe sleep education to new parents, and how might these improvements affect parents' long-term adherence to the guidelines after they leave the hospital?", "history": ["What role do perinatal healthcare professionals play in educating new parents about safe sleep practices?", "How effective is this education in promoting long-term adherence to safe sleep guidelines among new parents?"], "ground_truth": ["permed-52554", "permed-52555", "permed-74104", "permed-52560", "permed-80200", "permed-80231", "permed-91181", "permed-51577", "permed-37831", "permed-80208"]}
{"query_id": "topic_760_turn_4", "conversation_id": "topic_760", "turn_id": 4, "query": "Given these proposed educational strategies, what specific methodological approaches would most effectively evaluate their implementation fidelity and longitudinal impact? I'm particularly interested in how we might design a mixed-methods study that tracks both healthcare provider delivery consistency through clinical observations and parental adherence patterns via repeated measures. What statistical models would best account for covariates like socioeconomic status while measuring the sustained effect of these educational interventions on safe sleep practices over infants' first six months?", "history": ["What role do perinatal healthcare professionals play in educating new parents about safe sleep practices?", "How effective is this education in promoting long-term adherence to safe sleep guidelines among new parents?", "What specific strategies could improve how perinatal healthcare professionals deliver safe sleep education to new parents, and how might these improvements affect parents' long-term adherence to the guidelines after they leave the hospital?"], "ground_truth": ["permed-52554", "permed-37831", "permed-57450", "permed-50562", "permed-52560", "permed-92342", "permed-45071", "permed-52555", "permed-74104", "permed-65623"]}
{"query_id": "topic_760_turn_5", "conversation_id": "topic_760", "turn_id": 5, "query": "Given your proposed mixed-methods evaluation framework, how would implementation outcomes compare between standard in-person safe sleep education versus technology-enhanced approaches (like mobile health applications or virtual reality simulations) in terms of scalability, cost-effectiveness, and provider training requirements? Considering the longitudinal adherence patterns you mentioned, what comparative advantages might each modality offer for different demographic groups, particularly when accounting for socioeconomic covariates that influence both access to technology and sustained safe sleep practice maintenance?", "history": ["What role do perinatal healthcare professionals play in educating new parents about safe sleep practices?", "How effective is this education in promoting long-term adherence to safe sleep guidelines among new parents?", "What specific strategies could improve how perinatal healthcare professionals deliver safe sleep education to new parents, and how might these improvements affect parents' long-term adherence to the guidelines after they leave the hospital?", "Given these proposed educational strategies, what specific methodological approaches would most effectively evaluate their implementation fidelity and longitudinal impact? I'm particularly interested in how we might design a mixed-methods study that tracks both healthcare provider delivery consistency through clinical observations and parental adherence patterns via repeated measures. What statistical models would best account for covariates like socioeconomic status while measuring the sustained effect of these educational interventions on safe sleep practices over infants' first six months?"], "ground_truth": ["permed-61889", "permed-81456", "permed-86027", "permed-59686", "permed-73776", "permed-68401", "permed-78710", "permed-85231", "permed-84050", "permed-90601"]}
{"query_id": "topic_760_turn_6", "conversation_id": "topic_760", "turn_id": 6, "query": "Given our previous discussion comparing implementation outcomes between standard in-person education and technology-enhanced approaches, how do the comparative cost-effectiveness trajectories of these modalities evolve when considering long-term system integration beyond the initial implementation phase? Specifically, how might the higher upfront technological investments compare against ongoing personnel costs of traditional education when scaled to population level, and what hidden costs (like technical support or content updates) might alter their relative value propositions for healthcare systems serving diverse socioeconomic populations over a 5-year horizon?", "history": ["What role do perinatal healthcare professionals play in educating new parents about safe sleep practices?", "How effective is this education in promoting long-term adherence to safe sleep guidelines among new parents?", "What specific strategies could improve how perinatal healthcare professionals deliver safe sleep education to new parents, and how might these improvements affect parents' long-term adherence to the guidelines after they leave the hospital?", "Given these proposed educational strategies, what specific methodological approaches would most effectively evaluate their implementation fidelity and longitudinal impact? I'm particularly interested in how we might design a mixed-methods study that tracks both healthcare provider delivery consistency through clinical observations and parental adherence patterns via repeated measures. What statistical models would best account for covariates like socioeconomic status while measuring the sustained effect of these educational interventions on safe sleep practices over infants' first six months?", "Given your proposed mixed-methods evaluation framework, how would implementation outcomes compare between standard in-person safe sleep education versus technology-enhanced approaches (like mobile health applications or virtual reality simulations) in terms of scalability, cost-effectiveness, and provider training requirements? Considering the longitudinal adherence patterns you mentioned, what comparative advantages might each modality offer for different demographic groups, particularly when accounting for socioeconomic covariates that influence both access to technology and sustained safe sleep practice maintenance?"], "ground_truth": ["permed-87055", "permed-52109", "permed-87060", "permed-90714", "permed-69321", "permed-80518", "permed-90668", "permed-91681", "permed-86027", "permed-90715"]}
{"query_id": "topic_761_turn_1", "conversation_id": "topic_761", "turn_id": 1, "query": "What is known about the medicinal properties of Thalictrum species and their potential applications in modern medicine?", "history": [], "ground_truth": ["permed-79556", "permed-86234", "permed-79632", "permed-55360", "permed-69095", "permed-81709", "permed-86176", "permed-60985", "permed-79555", "permed-86231"]}
{"query_id": "topic_761_turn_2", "conversation_id": "topic_761", "turn_id": 2, "query": "How do the alkaloids and other bioactive compounds in it contribute to its therapeutic effects, and are there any specific conditions where this plant has shown promise?", "history": ["What is known about the medicinal properties of Thalictrum species and their potential applications in modern medicine?"], "ground_truth": ["permed-79556", "permed-79632", "permed-86313", "permed-86231", "permed-64189", "permed-63009", "permed-60985", "permed-60638", "permed-85758", "permed-79604"]}
{"query_id": "topic_761_turn_3", "conversation_id": "topic_761", "turn_id": 3, "query": "Given these findings about Thalictrum's bioactive compounds and their therapeutic potential, could you elaborate on the specific mechanisms through which its alkaloids and other phytochemicals produce their biological effects? How might understanding these mechanisms inform the development of new treatments for conditions like cancer, infections, or neurodegenerative diseases? Additionally, are there known synergistic interactions between different compounds in this plant that could be harnessed to improve traditional remedies or inspire more effective modern formulations?", "history": ["What is known about the medicinal properties of Thalictrum species and their potential applications in modern medicine?", "How do the alkaloids and other bioactive compounds in it contribute to its therapeutic effects, and are there any specific conditions where this plant has shown promise?"], "ground_truth": ["permed-79556", "permed-79632", "permed-64189", "permed-63827", "permed-79554", "permed-79557", "permed-60747", "permed-73449", "permed-68871", "permed-73081"]}
{"query_id": "topic_761_turn_4", "conversation_id": "topic_761", "turn_id": 4, "query": "Given these detailed mechanisms of action, what specific experimental approaches were used to validate the synergistic interactions between Thalictrum compounds? Could you elaborate on the assay designs for combination studies, particularly regarding concentration ratios, temporal administration sequences, and the statistical models employed to quantify synergistic versus additive effects? Additionally, what quality control measures were implemented to ensure compound stability and reproducibility across different batches of plant extracts during these interaction studies?", "history": ["What is known about the medicinal properties of Thalictrum species and their potential applications in modern medicine?", "How do the alkaloids and other bioactive compounds in it contribute to its therapeutic effects, and are there any specific conditions where this plant has shown promise?", "Given these findings about Thalictrum's bioactive compounds and their therapeutic potential, could you elaborate on the specific mechanisms through which its alkaloids and other phytochemicals produce their biological effects? How might understanding these mechanisms inform the development of new treatments for conditions like cancer, infections, or neurodegenerative diseases? Additionally, are there known synergistic interactions between different compounds in this plant that could be harnessed to improve traditional remedies or inspire more effective modern formulations?"], "ground_truth": ["permed-79556", "permed-86057", "permed-52787", "permed-73449", "permed-86102", "permed-52753", "permed-73442", "permed-60747", "permed-73445", "permed-76183"]}
{"query_id": "topic_761_turn_5", "conversation_id": "topic_761", "turn_id": 5, "query": "Given these validated synergistic interactions between Thalictrum compounds, what are the clinical implications for patient safety and therapeutic efficacy? Specifically, how do these phytochemical combinations influence pharmacokinetic profiles, including bioavailability and metabolic pathways, in human subjects? Have any clinical trials or observational studies documented adverse effect profiles or contraindications when used alongside conventional medications for conditions like cancer or inflammatory diseases? Furthermore, what practical challenges exist in standardizing combination ratios for consistent clinical outcomes, and how might this affect real-world treatment protocols?", "history": ["What is known about the medicinal properties of Thalictrum species and their potential applications in modern medicine?", "How do the alkaloids and other bioactive compounds in it contribute to its therapeutic effects, and are there any specific conditions where this plant has shown promise?", "Given these findings about Thalictrum's bioactive compounds and their therapeutic potential, could you elaborate on the specific mechanisms through which its alkaloids and other phytochemicals produce their biological effects? How might understanding these mechanisms inform the development of new treatments for conditions like cancer, infections, or neurodegenerative diseases? Additionally, are there known synergistic interactions between different compounds in this plant that could be harnessed to improve traditional remedies or inspire more effective modern formulations?", "Given these detailed mechanisms of action, what specific experimental approaches were used to validate the synergistic interactions between Thalictrum compounds? Could you elaborate on the assay designs for combination studies, particularly regarding concentration ratios, temporal administration sequences, and the statistical models employed to quantify synergistic versus additive effects? Additionally, what quality control measures were implemented to ensure compound stability and reproducibility across different batches of plant extracts during these interaction studies?"], "ground_truth": ["permed-79556", "permed-79632", "permed-50799", "permed-63009", "permed-92489", "permed-77557", "permed-86166", "permed-79155", "permed-55360", "permed-80384"]}
{"query_id": "topic_761_turn_6", "conversation_id": "topic_761", "turn_id": 6, "query": "Building upon the clinical implications and standardization challenges discussed, how do Thalictrum-based combination therapies compare with conventional single-drug therapies in terms of therapeutic windows and resistance development? Given the complex pharmacokinetic interactions we've examined, what are the comparative risks of herb-drug interactions versus multi-drug interactions in conventional combination therapies? Furthermore, from a clinical translation perspective, how do the standardization challenges for botanical drug products compare with those for synthetic drug combinations in terms of regulatory approval pathways and manufacturing consistency requirements?", "history": ["What is known about the medicinal properties of Thalictrum species and their potential applications in modern medicine?", "How do the alkaloids and other bioactive compounds in it contribute to its therapeutic effects, and are there any specific conditions where this plant has shown promise?", "Given these findings about Thalictrum's bioactive compounds and their therapeutic potential, could you elaborate on the specific mechanisms through which its alkaloids and other phytochemicals produce their biological effects? How might understanding these mechanisms inform the development of new treatments for conditions like cancer, infections, or neurodegenerative diseases? Additionally, are there known synergistic interactions between different compounds in this plant that could be harnessed to improve traditional remedies or inspire more effective modern formulations?", "Given these detailed mechanisms of action, what specific experimental approaches were used to validate the synergistic interactions between Thalictrum compounds? Could you elaborate on the assay designs for combination studies, particularly regarding concentration ratios, temporal administration sequences, and the statistical models employed to quantify synergistic versus additive effects? Additionally, what quality control measures were implemented to ensure compound stability and reproducibility across different batches of plant extracts during these interaction studies?", "Given these validated synergistic interactions between Thalictrum compounds, what are the clinical implications for patient safety and therapeutic efficacy? Specifically, how do these phytochemical combinations influence pharmacokinetic profiles, including bioavailability and metabolic pathways, in human subjects? Have any clinical trials or observational studies documented adverse effect profiles or contraindications when used alongside conventional medications for conditions like cancer or inflammatory diseases? Furthermore, what practical challenges exist in standardizing combination ratios for consistent clinical outcomes, and how might this affect real-world treatment protocols?"], "ground_truth": ["permed-79556", "permed-63009", "permed-55360", "permed-75533", "permed-79632", "permed-63825", "permed-84444", "permed-63097", "permed-86362", "permed-86166"]}
{"query_id": "topic_762_turn_1", "conversation_id": "topic_762", "turn_id": 1, "query": "Halobenzonitrile crystals: A review of fundamental properties, synthesis methods, and emerging applications", "history": [], "ground_truth": ["permed-75445", "permed-60645", "permed-64164", "permed-73350", "permed-75451", "permed-75472", "permed-76825", "permed-64159", "permed-66548", "permed-86725"]}
{"query_id": "topic_762_turn_2", "conversation_id": "topic_762", "turn_id": 2, "query": "Investigating the influence of molecular structure, particularly halogen bonding, on the physicochemical behavior and device suitability of these halobenzonitrile crystals", "history": ["Halobenzonitrile crystals: A review of fundamental properties, synthesis methods, and emerging applications"], "ground_truth": ["permed-75445", "permed-78877", "permed-75446", "permed-75451", "permed-50905", "permed-74523", "permed-75457", "permed-75472", "permed-75458", "permed-66557"]}
{"query_id": "topic_762_turn_3", "conversation_id": "topic_762", "turn_id": 3, "query": "Analysis of 4-halobenzonitrile crystals: How molecular packing and halogen bond strength variations affect their thermal stability and optical characteristics for advanced optoelectronic applications", "history": ["Halobenzonitrile crystals: A review of fundamental properties, synthesis methods, and emerging applications", "Investigating the influence of molecular structure, particularly halogen bonding, on the physicochemical behavior and device suitability of these halobenzonitrile crystals"], "ground_truth": ["permed-75445", "permed-75451", "permed-76085", "permed-75446", "permed-73262", "permed-78877", "permed-75453", "permed-75458", "permed-50905", "permed-75457"]}
{"query_id": "topic_762_turn_4", "conversation_id": "topic_762", "turn_id": 4, "query": "When analyzing how molecular packing and halogen bond strength affect thermal stability and optical characteristics in 4-halobenzonitrile crystals, what specific experimental techniques were most critical for quantifying these relationships? I'm particularly interested in the protocols for temperature-dependent X-ray diffraction to track structural changes and the validation methods for correlating spectroscopic data with computational models of halogen bonding energetics. How was reproducibility ensured across different crystal batches?", "history": ["Halobenzonitrile crystals: A review of fundamental properties, synthesis methods, and emerging applications", "Investigating the influence of molecular structure, particularly halogen bonding, on the physicochemical behavior and device suitability of these halobenzonitrile crystals", "Analysis of 4-halobenzonitrile crystals: How molecular packing and halogen bond strength variations affect their thermal stability and optical characteristics for advanced optoelectronic applications"], "ground_truth": ["permed-75445", "permed-78877", "permed-75457", "permed-75458", "permed-50905", "permed-75446", "permed-76082", "permed-75451", "permed-60321", "permed-76877"]}
{"query_id": "topic_762_turn_5", "conversation_id": "topic_762", "turn_id": 5, "query": "Given the established relationships between halogen bonding strength and thermal stability in 4-halobenzonitrile crystals, what is the current translational evidence regarding their biocompatibility and degradation profiles for potential clinical applications? Considering their promising optoelectronic properties, what specific safety considerations—such as cytotoxicity, inflammatory responses, or long-term accumulation—have been evaluated in pre-clinical models for uses like bio-imaging or targeted drug delivery systems? Furthermore, what are the primary challenges in moving these materials from controlled laboratory synthesis to scalable, pharmaceutical-grade production that meets regulatory standards for patient use?", "history": ["Halobenzonitrile crystals: A review of fundamental properties, synthesis methods, and emerging applications", "Investigating the influence of molecular structure, particularly halogen bonding, on the physicochemical behavior and device suitability of these halobenzonitrile crystals", "Analysis of 4-halobenzonitrile crystals: How molecular packing and halogen bond strength variations affect their thermal stability and optical characteristics for advanced optoelectronic applications", "When analyzing how molecular packing and halogen bond strength affect thermal stability and optical characteristics in 4-halobenzonitrile crystals, what specific experimental techniques were most critical for quantifying these relationships? I'm particularly interested in the protocols for temperature-dependent X-ray diffraction to track structural changes and the validation methods for correlating spectroscopic data with computational models of halogen bonding energetics. How was reproducibility ensured across different crystal batches?"], "ground_truth": ["permed-75445", "permed-78877", "permed-75277", "permed-75446", "permed-60336", "permed-73262", "permed-54876", "permed-75779", "permed-66558", "permed-76085"]}
{"query_id": "topic_762_turn_6", "conversation_id": "topic_762", "turn_id": 6, "query": "Building upon our discussion of translational challenges for halobenzonitrile crystals in biomedical applications, how do their degradation profiles and cytotoxicity risks compare with other emerging organic semiconductor materials like diketopyrrolopyrrole derivatives or thermally activated delayed fluorescence compounds? Considering the established halogen bonding strength's influence on stability, what are the critical trade-offs between achieving optimal optoelectronic performance versus ensuring biological safety? Furthermore, how might these comparative risk-benefit analyses inform material selection criteria for specific clinical applications like bio-imaging versus implantable sensors?", "history": ["Halobenzonitrile crystals: A review of fundamental properties, synthesis methods, and emerging applications", "Investigating the influence of molecular structure, particularly halogen bonding, on the physicochemical behavior and device suitability of these halobenzonitrile crystals", "Analysis of 4-halobenzonitrile crystals: How molecular packing and halogen bond strength variations affect their thermal stability and optical characteristics for advanced optoelectronic applications", "When analyzing how molecular packing and halogen bond strength affect thermal stability and optical characteristics in 4-halobenzonitrile crystals, what specific experimental techniques were most critical for quantifying these relationships? I'm particularly interested in the protocols for temperature-dependent X-ray diffraction to track structural changes and the validation methods for correlating spectroscopic data with computational models of halogen bonding energetics. How was reproducibility ensured across different crystal batches?", "Given the established relationships between halogen bonding strength and thermal stability in 4-halobenzonitrile crystals, what is the current translational evidence regarding their biocompatibility and degradation profiles for potential clinical applications? Considering their promising optoelectronic properties, what specific safety considerations—such as cytotoxicity, inflammatory responses, or long-term accumulation—have been evaluated in pre-clinical models for uses like bio-imaging or targeted drug delivery systems? Furthermore, what are the primary challenges in moving these materials from controlled laboratory synthesis to scalable, pharmaceutical-grade production that meets regulatory standards for patient use?"], "ground_truth": ["permed-75445", "permed-73262", "permed-78877", "permed-75277", "permed-54876", "permed-60336", "permed-89341", "permed-75414", "permed-66558", "permed-75458"]}
{"query_id": "topic_763_turn_1", "conversation_id": "topic_763", "turn_id": 1, "query": "What are the current trends in treating mitral regurgitation with minimally invasive procedures?", "history": [], "ground_truth": ["permed-57216", "permed-75430", "permed-57427", "permed-62899", "permed-57215", "permed-73906", "permed-64521", "permed-17860", "permed-75961", "permed-18196"]}
{"query_id": "topic_763_turn_2", "conversation_id": "topic_763", "turn_id": 2, "query": "How is this area of treatment evolving with advancements in technology and patient selection criteria?", "history": ["What are the current trends in treating mitral regurgitation with minimally invasive procedures?"], "ground_truth": ["permed-77218", "permed-56318", "permed-87093", "permed-51804", "permed-56575", "permed-87991", "permed-56118", "permed-4041", "permed-41941", "permed-4021"]}
{"query_id": "topic_763_turn_3", "conversation_id": "topic_763", "turn_id": 3, "query": "How are these technological advancements in imaging and predictive modeling improving the precision of patient selection for MitraClip therapy? Specifically, what new criteria are emerging to better identify elderly and high-risk patients who would benefit most from this procedure?", "history": ["What are the current trends in treating mitral regurgitation with minimally invasive procedures?", "How is this area of treatment evolving with advancements in technology and patient selection criteria?"], "ground_truth": ["permed-57216", "permed-57247", "permed-43091", "permed-85558", "permed-18369", "permed-78423", "permed-64516", "permed-59715", "permed-90553", "permed-56959"]}
{"query_id": "topic_763_turn_4", "conversation_id": "topic_763", "turn_id": 4, "query": "Given these emerging criteria for patient selection, what specific statistical validation methods are being employed to assess the predictive accuracy of these modeling approaches? Are researchers using time-dependent ROC analysis or machine learning cross-validation techniques to evaluate how well these models identify elderly patients who will achieve meaningful clinical outcomes? Additionally, what quality control protocols ensure reproducibility when integrating multimodal imaging data into these predictive algorithms across different clinical settings?", "history": ["What are the current trends in treating mitral regurgitation with minimally invasive procedures?", "How is this area of treatment evolving with advancements in technology and patient selection criteria?", "How are these technological advancements in imaging and predictive modeling improving the precision of patient selection for MitraClip therapy? Specifically, what new criteria are emerging to better identify elderly and high-risk patients who would benefit most from this procedure?"], "ground_truth": ["permed-12214", "permed-70671", "permed-21347", "permed-59412", "permed-53344", "permed-45964", "permed-2719", "permed-59410", "permed-12213", "permed-91331"]}
{"query_id": "topic_763_turn_5", "conversation_id": "topic_763", "turn_id": 5, "query": "Given the rigorous validation of predictive models for MitraClip patient selection, how do the clinical outcomes and cost-effectiveness profiles compare between traditional surgical mitral valve repair and minimally invasive edge-to-edge repair across different age strata? Specifically, what evidence exists from matched cohort studies or propensity-score analyses regarding long-term survival, rehospitalization rates, and quality-of-life metrics in elderly patients with significant comorbidities—and do these comparative advantages shift when accounting for institutional experience with transcatheter techniques?", "history": ["What are the current trends in treating mitral regurgitation with minimally invasive procedures?", "How is this area of treatment evolving with advancements in technology and patient selection criteria?", "How are these technological advancements in imaging and predictive modeling improving the precision of patient selection for MitraClip therapy? Specifically, what new criteria are emerging to better identify elderly and high-risk patients who would benefit most from this procedure?", "Given these emerging criteria for patient selection, what specific statistical validation methods are being employed to assess the predictive accuracy of these modeling approaches? Are researchers using time-dependent ROC analysis or machine learning cross-validation techniques to evaluate how well these models identify elderly patients who will achieve meaningful clinical outcomes? Additionally, what quality control protocols ensure reproducibility when integrating multimodal imaging data into these predictive algorithms across different clinical settings?"], "ground_truth": ["permed-57216", "permed-57247", "permed-75430", "permed-60500", "permed-78423", "permed-70036", "permed-17867", "permed-51764", "permed-18369", "permed-57007"]}
{"query_id": "topic_763_turn_6", "conversation_id": "topic_763", "turn_id": 6, "query": "Given our discussion about comparative outcomes between surgical and transcatheter mitral interventions, what fundamentally constitutes a \"meaningful clinical outcome\" in elderly high-risk populations beyond traditional mortality metrics? How are researchers operationally defining composite endpoints that capture functional capacity preservation, cognitive maintenance, and frailty trajectory stabilization—particularly when these multidimensional constructs may demonstrate different temporal patterns than conventional cardiovascular endpoints? What conceptual frameworks are emerging to standardize these definitions across studies while accounting for heterogeneous aging phenotypes?", "history": ["What are the current trends in treating mitral regurgitation with minimally invasive procedures?", "How is this area of treatment evolving with advancements in technology and patient selection criteria?", "How are these technological advancements in imaging and predictive modeling improving the precision of patient selection for MitraClip therapy? Specifically, what new criteria are emerging to better identify elderly and high-risk patients who would benefit most from this procedure?", "Given these emerging criteria for patient selection, what specific statistical validation methods are being employed to assess the predictive accuracy of these modeling approaches? Are researchers using time-dependent ROC analysis or machine learning cross-validation techniques to evaluate how well these models identify elderly patients who will achieve meaningful clinical outcomes? Additionally, what quality control protocols ensure reproducibility when integrating multimodal imaging data into these predictive algorithms across different clinical settings?", "Given the rigorous validation of predictive models for MitraClip patient selection, how do the clinical outcomes and cost-effectiveness profiles compare between traditional surgical mitral valve repair and minimally invasive edge-to-edge repair across different age strata? Specifically, what evidence exists from matched cohort studies or propensity-score analyses regarding long-term survival, rehospitalization rates, and quality-of-life metrics in elderly patients with significant comorbidities—and do these comparative advantages shift when accounting for institutional experience with transcatheter techniques?"], "ground_truth": ["permed-70036", "permed-57007", "permed-57216", "permed-59847", "permed-85516", "permed-85514", "permed-59842", "permed-90975", "permed-52435", "permed-61421"]}
{"query_id": "topic_764_turn_1", "conversation_id": "topic_764", "turn_id": 1, "query": "What impact has COVID-19 had on university communities in terms of infection rates and public health responses?", "history": [], "ground_truth": ["permed-62852", "permed-66195", "permed-53015", "permed-53061", "permed-84756", "permed-62850", "permed-54928", "permed-61228", "permed-59521", "permed-75611"]}
{"query_id": "topic_764_turn_2", "conversation_id": "topic_764", "turn_id": 2, "query": "How have vaccination efforts within this area influenced the spread of the virus over time?", "history": ["What impact has COVID-19 had on university communities in terms of infection rates and public health responses?"], "ground_truth": ["permed-65719", "permed-54098", "permed-61932", "permed-54092", "permed-61929", "permed-68153", "permed-59939", "permed-89517", "permed-77867", "permed-53449"]}
{"query_id": "topic_764_turn_3", "conversation_id": "topic_764", "turn_id": 3, "query": "Given these trends in infection rates, vaccination efforts, and their impact on university communities, how can the observed patterns in SARS-CoV-2 seroprevalence and antibody levels—particularly in response to different vaccine types over time—help shape adaptive public health strategies that balance risk management with maintaining educational operations? Additionally, what potential role could advanced monitoring technologies like T-cell reactivity assays or environmental surveillance play in supporting such strategies?", "history": ["What impact has COVID-19 had on university communities in terms of infection rates and public health responses?", "How have vaccination efforts within this area influenced the spread of the virus over time?"], "ground_truth": ["permed-62359", "permed-63554", "permed-63552", "permed-61274", "permed-70143", "permed-63556", "permed-89517", "permed-91526", "permed-70127", "permed-53461"]}
{"query_id": "topic_764_turn_4", "conversation_id": "topic_764", "turn_id": 4, "query": "Given this comprehensive approach integrating seroprevalence data and advanced monitoring technologies, could you elaborate on the specific laboratory protocols for quantifying SARS-CoV-2 antibody levels across different vaccine platforms? I'm particularly interested in the standardization of ELISA versus neutralization assays, the temporal sampling intervals for longitudinal studies, and how you would statistically account for confounding variables like prior infection history when analyzing antibody durability across different demographic subgroups within university populations.", "history": ["What impact has COVID-19 had on university communities in terms of infection rates and public health responses?", "How have vaccination efforts within this area influenced the spread of the virus over time?", "Given these trends in infection rates, vaccination efforts, and their impact on university communities, how can the observed patterns in SARS-CoV-2 seroprevalence and antibody levels—particularly in response to different vaccine types over time—help shape adaptive public health strategies that balance risk management with maintaining educational operations? Additionally, what potential role could advanced monitoring technologies like T-cell reactivity assays or environmental surveillance play in supporting such strategies?"], "ground_truth": ["permed-62359", "permed-70143", "permed-91526", "permed-62240", "permed-67834", "permed-79059", "permed-62361", "permed-80892", "permed-61279", "permed-70144"]}
{"query_id": "topic_764_turn_5", "conversation_id": "topic_764", "turn_id": 5, "query": "Given the detailed laboratory protocols discussed for antibody quantification, how do the relative advantages of ELISA versus neutralization assays compare when specifically applied to university populations receiving mixed vaccine regimens? Considering the need for both high-throughput screening and functional immunity assessment, what trade-offs exist between these methods' scalability, cost-effectiveness, and clinical correlation in detecting durable immune responses? Furthermore, how might these comparative findings influence the choice of assay when designing longitudinal surveillance programs that must balance precision with practical implementation across diverse campus demographics?", "history": ["What impact has COVID-19 had on university communities in terms of infection rates and public health responses?", "How have vaccination efforts within this area influenced the spread of the virus over time?", "Given these trends in infection rates, vaccination efforts, and their impact on university communities, how can the observed patterns in SARS-CoV-2 seroprevalence and antibody levels—particularly in response to different vaccine types over time—help shape adaptive public health strategies that balance risk management with maintaining educational operations? Additionally, what potential role could advanced monitoring technologies like T-cell reactivity assays or environmental surveillance play in supporting such strategies?", "Given this comprehensive approach integrating seroprevalence data and advanced monitoring technologies, could you elaborate on the specific laboratory protocols for quantifying SARS-CoV-2 antibody levels across different vaccine platforms? I'm particularly interested in the standardization of ELISA versus neutralization assays, the temporal sampling intervals for longitudinal studies, and how you would statistically account for confounding variables like prior infection history when analyzing antibody durability across different demographic subgroups within university populations."], "ground_truth": ["permed-66293", "permed-22493", "permed-67834", "permed-61279", "permed-61265", "permed-70143", "permed-21323", "permed-80670", "permed-22701", "permed-61264"]}
{"query_id": "topic_764_turn_6", "conversation_id": "topic_764", "turn_id": 6, "query": "Given our extensive discussion of serological monitoring approaches, could you precisely define what constitutes \"durable immune response\" in the context of university surveillance programs? Beyond mere antibody persistence, what specific immunological parameters (e.g., memory B-cell generation, T-cell receptor diversity) fundamentally establish durability, and how might this definition evolve as we encounter new variants? Considering the limitations of current assays we've compared, what conceptual framework should guide our understanding of durability when designing longitudinal studies that must remain relevant despite viral evolution and waning immunity patterns?", "history": ["What impact has COVID-19 had on university communities in terms of infection rates and public health responses?", "How have vaccination efforts within this area influenced the spread of the virus over time?", "Given these trends in infection rates, vaccination efforts, and their impact on university communities, how can the observed patterns in SARS-CoV-2 seroprevalence and antibody levels—particularly in response to different vaccine types over time—help shape adaptive public health strategies that balance risk management with maintaining educational operations? Additionally, what potential role could advanced monitoring technologies like T-cell reactivity assays or environmental surveillance play in supporting such strategies?", "Given this comprehensive approach integrating seroprevalence data and advanced monitoring technologies, could you elaborate on the specific laboratory protocols for quantifying SARS-CoV-2 antibody levels across different vaccine platforms? I'm particularly interested in the standardization of ELISA versus neutralization assays, the temporal sampling intervals for longitudinal studies, and how you would statistically account for confounding variables like prior infection history when analyzing antibody durability across different demographic subgroups within university populations.", "Given the detailed laboratory protocols discussed for antibody quantification, how do the relative advantages of ELISA versus neutralization assays compare when specifically applied to university populations receiving mixed vaccine regimens? Considering the need for both high-throughput screening and functional immunity assessment, what trade-offs exist between these methods' scalability, cost-effectiveness, and clinical correlation in detecting durable immune responses? Furthermore, how might these comparative findings influence the choice of assay when designing longitudinal surveillance programs that must balance precision with practical implementation across diverse campus demographics?"], "ground_truth": ["permed-70144", "permed-53371", "permed-70145", "permed-61279", "permed-62358", "permed-22398", "permed-51933", "permed-53377", "permed-65409", "permed-70143"]}
{"query_id": "topic_765_turn_1", "conversation_id": "topic_765", "turn_id": 1, "query": "What advancements have been made in using nanocomposites for water treatment, particularly for removing heavy metals like chromium?", "history": [], "ground_truth": ["permed-66249", "permed-66248", "permed-75661", "permed-79363", "permed-74657", "permed-79364", "permed-64010", "permed-73260", "permed-81862", "permed-66257"]}
{"query_id": "topic_765_turn_2", "conversation_id": "topic_765", "turn_id": 2, "query": "How effective are these nanocomposite materials, such as the Chitosan-Fe₃O₄ @ Azolla pinnata, in real-world applications with varying environmental conditions?", "history": ["What advancements have been made in using nanocomposites for water treatment, particularly for removing heavy metals like chromium?"], "ground_truth": ["permed-66248", "permed-66258", "permed-64010", "permed-74107", "permed-81862", "permed-79428", "permed-51161", "permed-92665", "permed-73253", "permed-79363"]}
{"query_id": "topic_765_turn_3", "conversation_id": "topic_765", "turn_id": 3, "query": "Given that Chitosan-Fe₃O₄ @ Azolla pinnata has shown high efficiency and reusability for chromium removal, what modifications could enhance its adsorption capacity and stability under different environmental conditions—like varying salinity or organic matter levels—and how might these improvements affect its long-term viability and cost-effectiveness as a sustainable water treatment solution?", "history": ["What advancements have been made in using nanocomposites for water treatment, particularly for removing heavy metals like chromium?", "How effective are these nanocomposite materials, such as the Chitosan-Fe₃O₄ @ Azolla pinnata, in real-world applications with varying environmental conditions?"], "ground_truth": ["permed-66248", "permed-78284", "permed-90399", "permed-74657", "permed-73253", "permed-78283", "permed-66252", "permed-66251", "permed-66255", "permed-76726"]}
{"query_id": "topic_765_turn_4", "conversation_id": "topic_765", "turn_id": 4, "query": "When implementing these surface modifications to enhance adsorption capacity, what specific characterization techniques would you prioritize for quantifying changes in surface morphology and functional group density? Additionally, for the stability assessments under varying salinity conditions, what experimental design parameters—such as ionic strength ranges, contact time variations, and regeneration cycle protocols—would provide the most comprehensive evaluation of long-term performance while maintaining methodological reproducibility across different research settings?", "history": ["What advancements have been made in using nanocomposites for water treatment, particularly for removing heavy metals like chromium?", "How effective are these nanocomposite materials, such as the Chitosan-Fe₃O₄ @ Azolla pinnata, in real-world applications with varying environmental conditions?", "Given that Chitosan-Fe₃O₄ @ Azolla pinnata has shown high efficiency and reusability for chromium removal, what modifications could enhance its adsorption capacity and stability under different environmental conditions—like varying salinity or organic matter levels—and how might these improvements affect its long-term viability and cost-effectiveness as a sustainable water treatment solution?"], "ground_truth": ["permed-79257", "permed-78284", "permed-77393", "permed-80586", "permed-60324", "permed-60046", "permed-92663", "permed-66251", "permed-73279", "permed-73273"]}
{"query_id": "topic_765_turn_5", "conversation_id": "topic_765", "turn_id": 5, "query": "Given these comprehensive characterization protocols and stability assessments, how have these optimized nanocomposites performed in clinical or preclinical toxicology studies regarding human health impacts? Specifically, what evidence exists about chromium leaching during regeneration cycles, potential inflammatory responses to nanoparticle residues in treated water, and any documented adverse effects in biological models? Furthermore, what clinical safety thresholds would need validation before considering deployment in community water systems serving vulnerable populations, and are there any pilot-scale studies examining real-world patient health outcomes following exposure to water treated with these modified nanomaterials?", "history": ["What advancements have been made in using nanocomposites for water treatment, particularly for removing heavy metals like chromium?", "How effective are these nanocomposite materials, such as the Chitosan-Fe₃O₄ @ Azolla pinnata, in real-world applications with varying environmental conditions?", "Given that Chitosan-Fe₃O₄ @ Azolla pinnata has shown high efficiency and reusability for chromium removal, what modifications could enhance its adsorption capacity and stability under different environmental conditions—like varying salinity or organic matter levels—and how might these improvements affect its long-term viability and cost-effectiveness as a sustainable water treatment solution?", "When implementing these surface modifications to enhance adsorption capacity, what specific characterization techniques would you prioritize for quantifying changes in surface morphology and functional group density? Additionally, for the stability assessments under varying salinity conditions, what experimental design parameters—such as ionic strength ranges, contact time variations, and regeneration cycle protocols—would provide the most comprehensive evaluation of long-term performance while maintaining methodological reproducibility across different research settings?"], "ground_truth": ["permed-92656", "permed-63013", "permed-80682", "permed-57867", "permed-54876", "permed-66248", "permed-66249", "permed-85350", "permed-63006", "permed-84099"]}
{"query_id": "topic_765_turn_6", "conversation_id": "topic_765", "turn_id": 6, "query": "Building upon our detailed discussion of nanocomposite safety assessments and clinical thresholds, I'd like to fundamentally clarify what constitutes \"biocompatibility\" in this specific context. Beyond cytotoxicity metrics, how is this concept operationally defined for water treatment nanocomposites regarding their complete lifecycle—from synthesis through regeneration to eventual disposal? What specific physicochemical and biological parameters establish biocompatibility thresholds, and how do these definitions reconcile with regulatory frameworks that traditionally govern medical devices versus environmental technologies? This conceptual clarification seems crucial for establishing standardized safety protocols across research domains.", "history": ["What advancements have been made in using nanocomposites for water treatment, particularly for removing heavy metals like chromium?", "How effective are these nanocomposite materials, such as the Chitosan-Fe₃O₄ @ Azolla pinnata, in real-world applications with varying environmental conditions?", "Given that Chitosan-Fe₃O₄ @ Azolla pinnata has shown high efficiency and reusability for chromium removal, what modifications could enhance its adsorption capacity and stability under different environmental conditions—like varying salinity or organic matter levels—and how might these improvements affect its long-term viability and cost-effectiveness as a sustainable water treatment solution?", "When implementing these surface modifications to enhance adsorption capacity, what specific characterization techniques would you prioritize for quantifying changes in surface morphology and functional group density? Additionally, for the stability assessments under varying salinity conditions, what experimental design parameters—such as ionic strength ranges, contact time variations, and regeneration cycle protocols—would provide the most comprehensive evaluation of long-term performance while maintaining methodological reproducibility across different research settings?", "Given these comprehensive characterization protocols and stability assessments, how have these optimized nanocomposites performed in clinical or preclinical toxicology studies regarding human health impacts? Specifically, what evidence exists about chromium leaching during regeneration cycles, potential inflammatory responses to nanoparticle residues in treated water, and any documented adverse effects in biological models? Furthermore, what clinical safety thresholds would need validation before considering deployment in community water systems serving vulnerable populations, and are there any pilot-scale studies examining real-world patient health outcomes following exposure to water treated with these modified nanomaterials?"], "ground_truth": ["permed-54876", "permed-51339", "permed-91202", "permed-53545", "permed-57867", "permed-63013", "permed-79363", "permed-65820", "permed-80632", "permed-51340"]}
{"query_id": "topic_766_turn_1", "conversation_id": "topic_766", "turn_id": 1, "query": "Technological advancements in diabetes management: overview of impacts and key innovations", "history": [], "ground_truth": ["permed-80242", "permed-87527", "permed-30003", "permed-89894", "permed-30207", "permed-25162", "permed-77201", "permed-5032", "permed-58950", "permed-55182"]}
{"query_id": "topic_766_turn_2", "conversation_id": "topic_766", "turn_id": 2, "query": "Impact of these advancements on continuous glucose monitoring (CGM) technology development and evolving diabetes patient care strategies", "history": ["Technological advancements in diabetes management: overview of impacts and key innovations"], "ground_truth": ["permed-71236", "permed-87527", "permed-80242", "permed-70662", "permed-26052", "permed-47437", "permed-70649", "permed-5038", "permed-47337", "permed-47395"]}
{"query_id": "topic_766_turn_3", "conversation_id": "topic_766", "turn_id": 3, "query": "Clinical integration of continuous glucose monitoring (CGM): effects on diabetes management guidelines, patient long-term health outcomes, and quality of life", "history": ["Technological advancements in diabetes management: overview of impacts and key innovations", "Impact of these advancements on continuous glucose monitoring (CGM) technology development and evolving diabetes patient care strategies"], "ground_truth": ["permed-71236", "permed-70659", "permed-70662", "permed-70649", "permed-26052", "permed-5038", "permed-70655", "permed-29979", "permed-60781", "permed-47437"]}
{"query_id": "topic_766_turn_4", "conversation_id": "topic_766", "turn_id": 4, "query": "Given the growing clinical integration of CGM systems, what specific statistical approaches are researchers using to validate the accuracy of these devices against laboratory reference standards? I'm particularly interested in how they're establishing acceptable MARD thresholds across different glycemic ranges, and what quality control protocols ensure consistent sensor performance in real-world settings where factors like temperature and motion artifacts might affect readings differently than in controlled trials.", "history": ["Technological advancements in diabetes management: overview of impacts and key innovations", "Impact of these advancements on continuous glucose monitoring (CGM) technology development and evolving diabetes patient care strategies", "Clinical integration of continuous glucose monitoring (CGM): effects on diabetes management guidelines, patient long-term health outcomes, and quality of life"], "ground_truth": ["permed-60784", "permed-5038", "permed-44735", "permed-60790", "permed-47394", "permed-60778", "permed-5040", "permed-60781", "permed-47550", "permed-60780"]}
{"query_id": "topic_766_turn_5", "conversation_id": "topic_766", "turn_id": 5, "query": "Given the rigorous statistical validation methods for CGM accuracy discussed previously, how do the performance characteristics and clinical reliability of factory-calibrated CGM systems compare against those requiring user-initiated blood glucose calibration? Specifically, what evidence exists regarding their comparative accuracy in hypoglycemic ranges, consistency across different patient populations (including pediatric and elderly users), and long-term sensor drift patterns? I'm interested in whether the convenience of factory calibration comes with measurable trade-offs in precision or requires different clinical interpretation protocols.", "history": ["Technological advancements in diabetes management: overview of impacts and key innovations", "Impact of these advancements on continuous glucose monitoring (CGM) technology development and evolving diabetes patient care strategies", "Clinical integration of continuous glucose monitoring (CGM): effects on diabetes management guidelines, patient long-term health outcomes, and quality of life", "Given the growing clinical integration of CGM systems, what specific statistical approaches are researchers using to validate the accuracy of these devices against laboratory reference standards? I'm particularly interested in how they're establishing acceptable MARD thresholds across different glycemic ranges, and what quality control protocols ensure consistent sensor performance in real-world settings where factors like temperature and motion artifacts might affect readings differently than in controlled trials."], "ground_truth": ["permed-60784", "permed-60778", "permed-44735", "permed-60790", "permed-60780", "permed-70655", "permed-47438", "permed-5038", "permed-33106", "permed-47394"]}
{"query_id": "topic_766_turn_6", "conversation_id": "topic_766", "turn_id": 6, "query": "Given our extended discussion about CGM validation and calibration paradigms, I'd like to explore the fundamental definition of \"sensor drift\" in continuous glucose monitoring systems beyond the surface description. What precisely constitutes this phenomenon at the molecular and electrochemical levels—is it primarily electrode surface fouling, enzyme degradation, membrane permeability changes, or a combination? How do manufacturers operationally define acceptable drift thresholds in their quality control frameworks, and what theoretical models exist to predict drift patterns across a sensor's operational lifespan? This conceptual clarification seems crucial for interpreting long-term performance data.", "history": ["Technological advancements in diabetes management: overview of impacts and key innovations", "Impact of these advancements on continuous glucose monitoring (CGM) technology development and evolving diabetes patient care strategies", "Clinical integration of continuous glucose monitoring (CGM): effects on diabetes management guidelines, patient long-term health outcomes, and quality of life", "Given the growing clinical integration of CGM systems, what specific statistical approaches are researchers using to validate the accuracy of these devices against laboratory reference standards? I'm particularly interested in how they're establishing acceptable MARD thresholds across different glycemic ranges, and what quality control protocols ensure consistent sensor performance in real-world settings where factors like temperature and motion artifacts might affect readings differently than in controlled trials.", "Given the rigorous statistical validation methods for CGM accuracy discussed previously, how do the performance characteristics and clinical reliability of factory-calibrated CGM systems compare against those requiring user-initiated blood glucose calibration? Specifically, what evidence exists regarding their comparative accuracy in hypoglycemic ranges, consistency across different patient populations (including pediatric and elderly users), and long-term sensor drift patterns? I'm interested in whether the convenience of factory calibration comes with measurable trade-offs in precision or requires different clinical interpretation protocols."], "ground_truth": ["permed-60790", "permed-5039", "permed-5038", "permed-76197", "permed-47438", "permed-26288", "permed-47394", "permed-47437", "permed-33106", "permed-44735"]}
{"query_id": "topic_767_turn_1", "conversation_id": "topic_767", "turn_id": 1, "query": "What role does quaternion-based scoring play in evaluating human movement and spatial orientation?", "history": [], "ground_truth": ["permed-77420", "permed-66495", "permed-61716", "permed-66513", "permed-66437", "permed-61737", "permed-77419", "permed-85241", "permed-83189", "permed-71946"]}
{"query_id": "topic_767_turn_2", "conversation_id": "topic_767", "turn_id": 2, "query": "Can this technique be applied beyond its current uses to analyze movements in other parts of the body?", "history": ["What role does quaternion-based scoring play in evaluating human movement and spatial orientation?"], "ground_truth": ["permed-83189", "permed-39281", "permed-54923", "permed-71748", "permed-89828", "permed-85419", "permed-70193", "permed-74120", "permed-58426", "permed-55179"]}
{"query_id": "topic_767_turn_3", "conversation_id": "topic_767", "turn_id": 3, "query": "Building on these applications, how could we extend quaternion-based scoring to assess the rotational movements of other body parts like the head or limbs? What might this reveal about the neural mechanisms behind spatial orientation and motor planning?", "history": ["What role does quaternion-based scoring play in evaluating human movement and spatial orientation?", "Can this technique be applied beyond its current uses to analyze movements in other parts of the body?"], "ground_truth": ["permed-77420", "permed-66437", "permed-66513", "permed-66495", "permed-66532", "permed-88545", "permed-74120", "permed-58417", "permed-61737", "permed-61709"]}
{"query_id": "topic_767_turn_4", "conversation_id": "topic_767", "turn_id": 4, "query": "Given the proposed extension to head and limb rotations, what experimental protocols would best capture the transition matrices between body segment orientations? Specifically, how should we design the marker placement strategy and sampling frequency to minimize gimbal lock issues during complex multi-axis rotations, and what computational pipeline would most effectively extract quaternion derivatives to quantify rotational velocity and acceleration for correlation with neural imaging data?", "history": ["What role does quaternion-based scoring play in evaluating human movement and spatial orientation?", "Can this technique be applied beyond its current uses to analyze movements in other parts of the body?", "Building on these applications, how could we extend quaternion-based scoring to assess the rotational movements of other body parts like the head or limbs? What might this reveal about the neural mechanisms behind spatial orientation and motor planning?"], "ground_truth": ["permed-77420", "permed-70310", "permed-66437", "permed-80404", "permed-58417", "permed-80402", "permed-88050", "permed-63381", "permed-80403", "permed-66513"]}
{"query_id": "topic_767_turn_5", "conversation_id": "topic_767", "turn_id": 5, "query": "Given these optimized protocols for quantifying complex rotational dynamics, how have quaternion-derived velocity and acceleration metrics translated to clinical assessments of vestibular rehabilitation efficacy in patients with spatial orientation deficits? What evidence exists correlating these kinematic measures with functional outcomes like fall reduction or dizziness handicap inventories, and are there any documented contraindications or movement patterns where quaternion-based scoring fails to capture clinically relevant impairments compared to traditional Euler angle approaches?", "history": ["What role does quaternion-based scoring play in evaluating human movement and spatial orientation?", "Can this technique be applied beyond its current uses to analyze movements in other parts of the body?", "Building on these applications, how could we extend quaternion-based scoring to assess the rotational movements of other body parts like the head or limbs? What might this reveal about the neural mechanisms behind spatial orientation and motor planning?", "Given the proposed extension to head and limb rotations, what experimental protocols would best capture the transition matrices between body segment orientations? Specifically, how should we design the marker placement strategy and sampling frequency to minimize gimbal lock issues during complex multi-axis rotations, and what computational pipeline would most effectively extract quaternion derivatives to quantify rotational velocity and acceleration for correlation with neural imaging data?"], "ground_truth": ["permed-23978", "permed-33293", "permed-33288", "permed-58414", "permed-33295", "permed-77420", "permed-51563", "permed-33291", "permed-33290", "permed-89959"]}
{"query_id": "topic_767_turn_6", "conversation_id": "topic_767", "turn_id": 6, "query": "Given the documented clinical correlations between quaternion-derived kinematics and functional outcomes discussed previously, how do these computational approaches compare against emerging inertial measurement unit (IMU) and deep learning-based movement assessment methods in terms of practical clinical utility? Specifically, when considering long-term vestibular rehabilitation monitoring in home-based settings, what are the critical trade-offs between quaternion-based scoring's mathematical precision and IMU-deep learning systems' accessibility and automated analysis capabilities for detecting subtle spatial orientation impairments that might predict fall risk before traditional clinical measures?", "history": ["What role does quaternion-based scoring play in evaluating human movement and spatial orientation?", "Can this technique be applied beyond its current uses to analyze movements in other parts of the body?", "Building on these applications, how could we extend quaternion-based scoring to assess the rotational movements of other body parts like the head or limbs? What might this reveal about the neural mechanisms behind spatial orientation and motor planning?", "Given the proposed extension to head and limb rotations, what experimental protocols would best capture the transition matrices between body segment orientations? Specifically, how should we design the marker placement strategy and sampling frequency to minimize gimbal lock issues during complex multi-axis rotations, and what computational pipeline would most effectively extract quaternion derivatives to quantify rotational velocity and acceleration for correlation with neural imaging data?", "Given these optimized protocols for quantifying complex rotational dynamics, how have quaternion-derived velocity and acceleration metrics translated to clinical assessments of vestibular rehabilitation efficacy in patients with spatial orientation deficits? What evidence exists correlating these kinematic measures with functional outcomes like fall reduction or dizziness handicap inventories, and are there any documented contraindications or movement patterns where quaternion-based scoring fails to capture clinically relevant impairments compared to traditional Euler angle approaches?"], "ground_truth": ["permed-58414", "permed-80404", "permed-80403", "permed-74120", "permed-74121", "permed-77420", "permed-66407", "permed-80402", "permed-29527", "permed-88545"]}
{"query_id": "topic_768_turn_1", "conversation_id": "topic_768", "turn_id": 1, "query": "Heart rate variability (HRV) and atrial fibrillation (AF): current understanding of their association", "history": [], "ground_truth": ["permed-75505", "permed-57035", "permed-60492", "permed-92359", "permed-75508", "permed-83836", "permed-52534", "permed-57265", "permed-75506", "permed-17555"]}
{"query_id": "topic_768_turn_2", "conversation_id": "topic_768", "turn_id": 2, "query": "Impact of the HRV-AF association on left atrial hemodynamics in atrial fibrillation patients: insights from cardiac MRI", "history": ["Heart rate variability (HRV) and atrial fibrillation (AF): current understanding of their association"], "ground_truth": ["permed-75505", "permed-92359", "permed-60492", "permed-92358", "permed-92360", "permed-83836", "permed-43125", "permed-57260", "permed-57265", "permed-17562"]}
{"query_id": "topic_768_turn_3", "conversation_id": "topic_768", "turn_id": 3, "query": "Clinical implications of MRI-assessed left atrial hemodynamic alterations linked to HRV in atrial fibrillation for anticoagulation strategies and personalized therapy", "history": ["Heart rate variability (HRV) and atrial fibrillation (AF): current understanding of their association", "Impact of the HRV-AF association on left atrial hemodynamics in atrial fibrillation patients: insights from cardiac MRI"], "ground_truth": ["permed-75505", "permed-92359", "permed-60492", "permed-57258", "permed-92358", "permed-57260", "permed-57257", "permed-57262", "permed-57035", "permed-92360"]}
{"query_id": "topic_768_turn_4", "conversation_id": "topic_768", "turn_id": 4, "query": "Given these findings linking HRV to left atrial hemodynamics, what specific MRI protocols and imaging sequences were used to quantify the flow patterns? Were there particular parameters like 4D flow MRI with retrospective ECG gating employed, and how was the temporal resolution optimized to capture both the HRV fluctuations and the resulting hemodynamic changes during the atrial fibrillation episodes for subsequent correlation analysis?", "history": ["Heart rate variability (HRV) and atrial fibrillation (AF): current understanding of their association", "Impact of the HRV-AF association on left atrial hemodynamics in atrial fibrillation patients: insights from cardiac MRI", "Clinical implications of MRI-assessed left atrial hemodynamic alterations linked to HRV in atrial fibrillation for anticoagulation strategies and personalized therapy"], "ground_truth": ["permed-75505", "permed-17562", "permed-42326", "permed-17555", "permed-18024", "permed-92359", "permed-17563", "permed-43125", "permed-18456", "permed-57394"]}
{"query_id": "topic_768_turn_5", "conversation_id": "topic_768", "turn_id": 5, "query": "Given the detailed MRI protocols used to quantify HRV-related hemodynamic alterations, how have these imaging-derived flow parameters been translated into clinical decision-making for AF patients? Specifically, are there prospective studies demonstrating that incorporating 4D flow MRI metrics improves risk stratification for thromboembolic events or guides anticoagulation therapy discontinuation in patients achieving rhythm control? Furthermore, what are the practical challenges—such as accessibility, cost, and standardization—in implementing these advanced hemodynamic assessments into routine cardiology practice for personalized stroke prevention?", "history": ["Heart rate variability (HRV) and atrial fibrillation (AF): current understanding of their association", "Impact of the HRV-AF association on left atrial hemodynamics in atrial fibrillation patients: insights from cardiac MRI", "Clinical implications of MRI-assessed left atrial hemodynamic alterations linked to HRV in atrial fibrillation for anticoagulation strategies and personalized therapy", "Given these findings linking HRV to left atrial hemodynamics, what specific MRI protocols and imaging sequences were used to quantify the flow patterns? Were there particular parameters like 4D flow MRI with retrospective ECG gating employed, and how was the temporal resolution optimized to capture both the HRV fluctuations and the resulting hemodynamic changes during the atrial fibrillation episodes for subsequent correlation analysis?"], "ground_truth": ["permed-75505", "permed-42326", "permed-51417", "permed-31865", "permed-46810", "permed-8768", "permed-18068", "permed-57084", "permed-57343", "permed-57394"]}
{"query_id": "topic_768_turn_6", "conversation_id": "topic_768", "turn_id": 6, "query": "Given the emerging evidence linking 4D flow MRI-derived hemodynamic parameters to thromboembolic risk stratification in AF patients, how do these advanced imaging biomarkers compare against established clinical scores like CHA₂DS₂-VASc in terms of predictive accuracy and clinical utility? Considering the resource-intensive nature of 4D flow MRI, what is the comparative cost-effectiveness of implementing such detailed hemodynamic assessments versus optimizing existing clinical prediction tools with simpler HRV monitoring or serum biomarkers for personalized anticoagulation decisions? What evidence exists regarding their complementary versus competitive roles in future AF management paradigms?", "history": ["Heart rate variability (HRV) and atrial fibrillation (AF): current understanding of their association", "Impact of the HRV-AF association on left atrial hemodynamics in atrial fibrillation patients: insights from cardiac MRI", "Clinical implications of MRI-assessed left atrial hemodynamic alterations linked to HRV in atrial fibrillation for anticoagulation strategies and personalized therapy", "Given these findings linking HRV to left atrial hemodynamics, what specific MRI protocols and imaging sequences were used to quantify the flow patterns? Were there particular parameters like 4D flow MRI with retrospective ECG gating employed, and how was the temporal resolution optimized to capture both the HRV fluctuations and the resulting hemodynamic changes during the atrial fibrillation episodes for subsequent correlation analysis?", "Given the detailed MRI protocols used to quantify HRV-related hemodynamic alterations, how have these imaging-derived flow parameters been translated into clinical decision-making for AF patients? Specifically, are there prospective studies demonstrating that incorporating 4D flow MRI metrics improves risk stratification for thromboembolic events or guides anticoagulation therapy discontinuation in patients achieving rhythm control? Furthermore, what are the practical challenges—such as accessibility, cost, and standardization—in implementing these advanced hemodynamic assessments into routine cardiology practice for personalized stroke prevention?"], "ground_truth": ["permed-75505", "permed-42326", "permed-23297", "permed-18676", "permed-18174", "permed-43125", "permed-23298", "permed-57084", "permed-5913", "permed-92359"]}
{"query_id": "topic_769_turn_1", "conversation_id": "topic_769", "turn_id": 1, "query": "What are some biodegradable plastics that can be produced from food waste?", "history": [], "ground_truth": ["permed-59655", "permed-52449", "permed-84079", "permed-82856", "permed-79427", "permed-80629", "permed-64501", "permed-57761", "permed-57766", "permed-82857"]}
{"query_id": "topic_769_turn_2", "conversation_id": "topic_769", "turn_id": 2, "query": "How does the production of poly(butylene succinate) from food waste compare to other bioplastics in terms of cost and environmental impact?", "history": ["What are some biodegradable plastics that can be produced from food waste?"], "ground_truth": ["permed-80626", "permed-59655", "permed-85836", "permed-64501", "permed-84079", "permed-52449", "permed-57621", "permed-82856", "permed-80629", "permed-57623"]}
{"query_id": "topic_769_turn_3", "conversation_id": "topic_769", "turn_id": 3, "query": "How can advanced biotechnological approaches like metabolic engineering or synthetic biology improve the economic viability and environmental sustainability of producing poly(butylene succinate) from food waste? Specifically, could these methods help optimize costs for key inputs like 1,4-butanediol and reduce solvent usage during purification?", "history": ["What are some biodegradable plastics that can be produced from food waste?", "How does the production of poly(butylene succinate) from food waste compare to other bioplastics in terms of cost and environmental impact?"], "ground_truth": ["permed-80626", "permed-85836", "permed-59655", "permed-74754", "permed-52449", "permed-52455", "permed-80627", "permed-64501", "permed-83556", "permed-82856"]}
{"query_id": "topic_769_turn_4", "conversation_id": "topic_769", "turn_id": 4, "query": "For these metabolic engineering approaches targeting 1,4-butanediol biosynthesis, what specific fermentation protocols and downstream processing methods are most effective? I'm particularly interested in the reactor configurations—batch versus fed-batch—and how the choice of extraction solvents impacts both yield and environmental footprint during the purification phase. Could you detail the analytical techniques, such as HPLC or GC-MS, used to quantify monomer purity and the subsequent polymerization efficiency?", "history": ["What are some biodegradable plastics that can be produced from food waste?", "How does the production of poly(butylene succinate) from food waste compare to other bioplastics in terms of cost and environmental impact?", "How can advanced biotechnological approaches like metabolic engineering or synthetic biology improve the economic viability and environmental sustainability of producing poly(butylene succinate) from food waste? Specifically, could these methods help optimize costs for key inputs like 1,4-butanediol and reduce solvent usage during purification?"], "ground_truth": ["permed-52445", "permed-74755", "permed-73209", "permed-73429", "permed-64533", "permed-82389", "permed-85836", "permed-52446", "permed-83830", "permed-64540"]}
{"query_id": "topic_769_turn_5", "conversation_id": "topic_769", "turn_id": 5, "query": "Given the detailed fermentation and purification insights discussed, how do continuous reactor systems compare to batch/fed-batch configurations in terms of process stability and overall sustainability for PBS production from food waste? Specifically, what are the trade-offs in productivity, energy consumption, and solvent requirements when scaling these advanced bioprocesses, and how might hybridization strategies combine their advantages while mitigating limitations like microbial stress or downstream integration challenges?", "history": ["What are some biodegradable plastics that can be produced from food waste?", "How does the production of poly(butylene succinate) from food waste compare to other bioplastics in terms of cost and environmental impact?", "How can advanced biotechnological approaches like metabolic engineering or synthetic biology improve the economic viability and environmental sustainability of producing poly(butylene succinate) from food waste? Specifically, could these methods help optimize costs for key inputs like 1,4-butanediol and reduce solvent usage during purification?", "For these metabolic engineering approaches targeting 1,4-butanediol biosynthesis, what specific fermentation protocols and downstream processing methods are most effective? I'm particularly interested in the reactor configurations—batch versus fed-batch—and how the choice of extraction solvents impacts both yield and environmental footprint during the purification phase. Could you detail the analytical techniques, such as HPLC or GC-MS, used to quantify monomer purity and the subsequent polymerization efficiency?"], "ground_truth": ["permed-80626", "permed-78331", "permed-66165", "permed-81911", "permed-73429", "permed-85836", "permed-66577", "permed-73427", "permed-51611", "permed-78439"]}
{"query_id": "topic_769_turn_6", "conversation_id": "topic_769", "turn_id": 6, "query": "Throughout our discussion of PBS production from food waste, we've referenced \"process stability\" as a critical factor when comparing reactor configurations. What exactly constitutes process stability in continuous bioprocessing systems, and how is this concept fundamentally defined and measured in industrial biotechnology? Beyond simple operational consistency, does it encompass specific metrics like microbial strain robustness against metabolic drift, or maintenance of yield under varying waste feedstock compositions? How might emerging definitions incorporate long-term biocatalyst performance and resilience to feedstock heterogeneity as key stability components?", "history": ["What are some biodegradable plastics that can be produced from food waste?", "How does the production of poly(butylene succinate) from food waste compare to other bioplastics in terms of cost and environmental impact?", "How can advanced biotechnological approaches like metabolic engineering or synthetic biology improve the economic viability and environmental sustainability of producing poly(butylene succinate) from food waste? Specifically, could these methods help optimize costs for key inputs like 1,4-butanediol and reduce solvent usage during purification?", "For these metabolic engineering approaches targeting 1,4-butanediol biosynthesis, what specific fermentation protocols and downstream processing methods are most effective? I'm particularly interested in the reactor configurations—batch versus fed-batch—and how the choice of extraction solvents impacts both yield and environmental footprint during the purification phase. Could you detail the analytical techniques, such as HPLC or GC-MS, used to quantify monomer purity and the subsequent polymerization efficiency?", "Given the detailed fermentation and purification insights discussed, how do continuous reactor systems compare to batch/fed-batch configurations in terms of process stability and overall sustainability for PBS production from food waste? Specifically, what are the trade-offs in productivity, energy consumption, and solvent requirements when scaling these advanced bioprocesses, and how might hybridization strategies combine their advantages while mitigating limitations like microbial stress or downstream integration challenges?"], "ground_truth": ["permed-64261", "permed-52475", "permed-80626", "permed-78331", "permed-87583", "permed-68511", "permed-87584", "permed-55475", "permed-73427", "permed-73430"]}
{"query_id": "topic_770_turn_1", "conversation_id": "topic_770", "turn_id": 1, "query": "What role does anxiety sensitivity play in the development of fear of missing out (FoMO) among young people?", "history": [], "ground_truth": ["permed-74345", "permed-74344", "permed-60970", "permed-74339", "permed-79607", "permed-55706", "permed-55809", "permed-66484", "permed-74518", "permed-55608"]}
{"query_id": "topic_770_turn_2", "conversation_id": "topic_770", "turn_id": 2, "query": "How might this relationship between anxiety sensitivity and FoMO be influenced by social media use patterns, particularly across different age groups?", "history": ["What role does anxiety sensitivity play in the development of fear of missing out (FoMO) among young people?"], "ground_truth": ["permed-74345", "permed-74344", "permed-74339", "permed-74343", "permed-55706", "permed-65663", "permed-69909", "permed-60974", "permed-88680", "permed-62866"]}
{"query_id": "topic_770_turn_3", "conversation_id": "topic_770", "turn_id": 3, "query": "Building on these findings about anxiety sensitivity and social media's role in FoMO, how might rumination—another known predictor—interact with social media use patterns to affect FoMO differently in adolescents versus young adults? And based on these interactions, what kind of interventions could be developed to address it?", "history": ["What role does anxiety sensitivity play in the development of fear of missing out (FoMO) among young people?", "How might this relationship between anxiety sensitivity and FoMO be influenced by social media use patterns, particularly across different age groups?"], "ground_truth": ["permed-74345", "permed-74344", "permed-74343", "permed-50482", "permed-60974", "permed-55706", "permed-55754", "permed-88680", "permed-62866", "permed-65663"]}
{"query_id": "topic_770_turn_4", "conversation_id": "topic_770", "turn_id": 4, "query": "Given these potential intervention approaches targeting rumination and social media patterns, what specific methodological framework would you recommend for testing their efficacy across adolescent and young adult populations? I'm particularly interested in how you'd design the randomization protocol for different age cohorts, what control conditions would be most appropriate, and which specific validated scales you'd use to measure changes in rumination patterns and FoMO severity pre- and post-intervention while ensuring statistical power for detecting age-group differences.", "history": ["What role does anxiety sensitivity play in the development of fear of missing out (FoMO) among young people?", "How might this relationship between anxiety sensitivity and FoMO be influenced by social media use patterns, particularly across different age groups?", "Building on these findings about anxiety sensitivity and social media's role in FoMO, how might rumination—another known predictor—interact with social media use patterns to affect FoMO differently in adolescents versus young adults? And based on these interactions, what kind of interventions could be developed to address it?"], "ground_truth": ["permed-55754", "permed-69768", "permed-52200", "permed-74343", "permed-74362", "permed-74345", "permed-60974", "permed-75932", "permed-84439", "permed-50482"]}
{"query_id": "topic_770_turn_5", "conversation_id": "topic_770", "turn_id": 5, "query": "Given your proposed methodological framework for testing FoMO interventions, what clinical implementation challenges might arise when translating these evidence-based approaches into real-world practice? Specifically, considering the distinct developmental needs of adolescents versus young adults, how might safety monitoring for intervention-related distress differ between age cohorts? What contraindications should clinicians consider before administering rumination-focused interventions to populations with pre-existing anxiety disorders, and how could digital delivery platforms impact therapeutic efficacy and adherence compared to traditional clinical settings?", "history": ["What role does anxiety sensitivity play in the development of fear of missing out (FoMO) among young people?", "How might this relationship between anxiety sensitivity and FoMO be influenced by social media use patterns, particularly across different age groups?", "Building on these findings about anxiety sensitivity and social media's role in FoMO, how might rumination—another known predictor—interact with social media use patterns to affect FoMO differently in adolescents versus young adults? And based on these interactions, what kind of interventions could be developed to address it?", "Given these potential intervention approaches targeting rumination and social media patterns, what specific methodological framework would you recommend for testing their efficacy across adolescent and young adult populations? I'm particularly interested in how you'd design the randomization protocol for different age cohorts, what control conditions would be most appropriate, and which specific validated scales you'd use to measure changes in rumination patterns and FoMO severity pre- and post-intervention while ensuring statistical power for detecting age-group differences."], "ground_truth": ["permed-74345", "permed-55585", "permed-82427", "permed-55793", "permed-69768", "permed-85769", "permed-55754", "permed-58543", "permed-57449", "permed-61893"]}
{"query_id": "topic_770_turn_6", "conversation_id": "topic_770", "turn_id": 6, "query": "Given our discussion about translating FoMO interventions into clinical practice, how should we precisely define \"intervention-related distress\" within this specific context? Beyond general adverse event reporting, what specific cognitive or emotional manifestations would constitute clinically meaningful distress when targeting anxiety sensitivity and rumination mechanisms? How might this definition fundamentally differ between adolescents developing identity narratives and young adults navigating established social roles, particularly when delivered through digital platforms where therapeutic alliance dynamics differ from traditional settings?", "history": ["What role does anxiety sensitivity play in the development of fear of missing out (FoMO) among young people?", "How might this relationship between anxiety sensitivity and FoMO be influenced by social media use patterns, particularly across different age groups?", "Building on these findings about anxiety sensitivity and social media's role in FoMO, how might rumination—another known predictor—interact with social media use patterns to affect FoMO differently in adolescents versus young adults? And based on these interactions, what kind of interventions could be developed to address it?", "Given these potential intervention approaches targeting rumination and social media patterns, what specific methodological framework would you recommend for testing their efficacy across adolescent and young adult populations? I'm particularly interested in how you'd design the randomization protocol for different age cohorts, what control conditions would be most appropriate, and which specific validated scales you'd use to measure changes in rumination patterns and FoMO severity pre- and post-intervention while ensuring statistical power for detecting age-group differences.", "Given your proposed methodological framework for testing FoMO interventions, what clinical implementation challenges might arise when translating these evidence-based approaches into real-world practice? Specifically, considering the distinct developmental needs of adolescents versus young adults, how might safety monitoring for intervention-related distress differ between age cohorts? What contraindications should clinicians consider before administering rumination-focused interventions to populations with pre-existing anxiety disorders, and how could digital delivery platforms impact therapeutic efficacy and adherence compared to traditional clinical settings?"], "ground_truth": ["permed-74345", "permed-82427", "permed-55522", "permed-25273", "permed-73843", "permed-58543", "permed-55519", "permed-55809", "permed-60974", "permed-69443"]}
{"query_id": "topic_771_turn_1", "conversation_id": "topic_771", "turn_id": 1, "query": "Impact of psychological need satisfaction on university student mental health and academic performance", "history": [], "ground_truth": ["permed-69556", "permed-75160", "permed-69632", "permed-74698", "permed-65490", "permed-71422", "permed-51857", "permed-51552", "permed-62847", "permed-65539"]}
{"query_id": "topic_771_turn_2", "conversation_id": "topic_771", "turn_id": 2, "query": "Evaluating teaching approaches for enhancing *this* psychological need satisfaction in university students and their specific outcomes", "history": ["Impact of psychological need satisfaction on university student mental health and academic performance"], "ground_truth": ["permed-51853", "permed-51857", "permed-69556", "permed-74698", "permed-70065", "permed-51556", "permed-69618", "permed-69720", "permed-75160", "permed-61466"]}
{"query_id": "topic_771_turn_3", "conversation_id": "topic_771", "turn_id": 3, "query": "University implementation of *these* teaching strategies for psychological need satisfaction: Longitudinal effects on student resilience, coping, long-term mental health, and academic achievement", "history": ["Impact of psychological need satisfaction on university student mental health and academic performance", "Evaluating teaching approaches for enhancing *this* psychological need satisfaction in university students and their specific outcomes"], "ground_truth": ["permed-75160", "permed-51966", "permed-69556", "permed-74698", "permed-69784", "permed-85718", "permed-51857", "permed-74349", "permed-51853", "permed-51552"]}
{"query_id": "topic_771_turn_4", "conversation_id": "topic_771", "turn_id": 4, "query": "When implementing these longitudinal teaching strategies for psychological need satisfaction, what specific methodological approaches were used to track the dynamic interplay between resilience development and academic achievement over time? I'm particularly interested in whether researchers employed time-lagged analyses, growth curve modeling, or other sophisticated statistical techniques to account for potential bidirectional relationships, and how they addressed measurement invariance when assessing these constructs across multiple time points in the academic calendar.", "history": ["Impact of psychological need satisfaction on university student mental health and academic performance", "Evaluating teaching approaches for enhancing *this* psychological need satisfaction in university students and their specific outcomes", "University implementation of *these* teaching strategies for psychological need satisfaction: Longitudinal effects on student resilience, coping, long-term mental health, and academic achievement"], "ground_truth": ["permed-82752", "permed-69923", "permed-51857", "permed-90623", "permed-69557", "permed-71419", "permed-84852", "permed-56859", "permed-51966", "permed-74349"]}
{"query_id": "topic_771_turn_5", "conversation_id": "topic_771", "turn_id": 5, "query": "Given these sophisticated methodological approaches for tracking longitudinal dynamics, how do the observed effect sizes and sustainability of psychological need satisfaction interventions compare between different pedagogical frameworks? Specifically, when contrasting autonomy-supportive teaching models versus competence-building approaches in university settings, what comparative advantages emerge for resilience development versus academic achievement, and do these trade-offs vary across disciplines with different assessment structures?", "history": ["Impact of psychological need satisfaction on university student mental health and academic performance", "Evaluating teaching approaches for enhancing *this* psychological need satisfaction in university students and their specific outcomes", "University implementation of *these* teaching strategies for psychological need satisfaction: Longitudinal effects on student resilience, coping, long-term mental health, and academic achievement", "When implementing these longitudinal teaching strategies for psychological need satisfaction, what specific methodological approaches were used to track the dynamic interplay between resilience development and academic achievement over time? I'm particularly interested in whether researchers employed time-lagged analyses, growth curve modeling, or other sophisticated statistical techniques to account for potential bidirectional relationships, and how they addressed measurement invariance when assessing these constructs across multiple time points in the academic calendar."], "ground_truth": ["permed-58501", "permed-69922", "permed-51556", "permed-51853", "permed-90623", "permed-84852", "permed-69720", "permed-74348", "permed-51857", "permed-51854"]}
{"query_id": "topic_771_turn_6", "conversation_id": "topic_771", "turn_id": 6, "query": "Building upon the comparative analysis of pedagogical frameworks and their trade-offs, how do the implementation costs and institutional barriers differ between autonomy-supportive versus competence-building interventions in university settings? Considering the sophisticated longitudinal tracking methods discussed earlier, what evidence exists regarding the cost-effectiveness of each approach when factoring in required faculty training, curricular modifications, and technological infrastructure? Furthermore, as universities face increasing pressure to demonstrate return on investment in student support services, which intervention model shows greater potential for sustainable scalability without compromising the nuanced developmental trajectories we've observed in resilience and academic achievement?", "history": ["Impact of psychological need satisfaction on university student mental health and academic performance", "Evaluating teaching approaches for enhancing *this* psychological need satisfaction in university students and their specific outcomes", "University implementation of *these* teaching strategies for psychological need satisfaction: Longitudinal effects on student resilience, coping, long-term mental health, and academic achievement", "When implementing these longitudinal teaching strategies for psychological need satisfaction, what specific methodological approaches were used to track the dynamic interplay between resilience development and academic achievement over time? I'm particularly interested in whether researchers employed time-lagged analyses, growth curve modeling, or other sophisticated statistical techniques to account for potential bidirectional relationships, and how they addressed measurement invariance when assessing these constructs across multiple time points in the academic calendar.", "Given these sophisticated methodological approaches for tracking longitudinal dynamics, how do the observed effect sizes and sustainability of psychological need satisfaction interventions compare between different pedagogical frameworks? Specifically, when contrasting autonomy-supportive teaching models versus competence-building approaches in university settings, what comparative advantages emerge for resilience development versus academic achievement, and do these trade-offs vary across disciplines with different assessment structures?"], "ground_truth": ["permed-58501", "permed-87055", "permed-90647", "permed-56867", "permed-69720", "permed-58533", "permed-74105", "permed-90715", "permed-90781", "permed-64240"]}
{"query_id": "topic_772_turn_1", "conversation_id": "topic_772", "turn_id": 1, "query": "What support strategies are currently used to help families cope with bereavement after organ donation?", "history": [], "ground_truth": ["permed-79617", "permed-74690", "permed-87345", "permed-82902", "permed-79618", "permed-87104", "permed-75160", "permed-69467", "permed-62314", "permed-74691"]}
{"query_id": "topic_772_turn_2", "conversation_id": "topic_772", "turn_id": 2, "query": "How can understanding family dynamics and hospital interactions improve the effectiveness of these support strategies?", "history": ["What support strategies are currently used to help families cope with bereavement after organ donation?"], "ground_truth": ["permed-80214", "permed-73384", "permed-67371", "permed-82902", "permed-50970", "permed-82959", "permed-52560", "permed-67357", "permed-80231", "permed-61464"]}
{"query_id": "topic_772_turn_3", "conversation_id": "topic_772", "turn_id": 3, "query": "Building on these discussions about current support strategies and the role of family dynamics and hospital interactions, how could healthcare providers combine insights from grief theory and systems theory to create more personalized approaches that adapt to families' evolving psychosocial needs throughout the bereavement process after organ donation?", "history": ["What support strategies are currently used to help families cope with bereavement after organ donation?", "How can understanding family dynamics and hospital interactions improve the effectiveness of these support strategies?"], "ground_truth": ["permed-79617", "permed-79618", "permed-87104", "permed-87345", "permed-65745", "permed-79619", "permed-74690", "permed-74691", "permed-82902", "permed-72707"]}
{"query_id": "topic_772_turn_4", "conversation_id": "topic_772", "turn_id": 4, "query": "Given this theoretical integration between grief and systems theory, what specific mixed-methods approaches would you recommend for longitudinally tracking families' psychosocial adaptation? More concretely, how should researchers design sequential quantitative assessments and qualitative interviews to capture both individual grief trajectories and evolving family system dynamics, while maintaining methodological rigor across these different data streams? What statistical modeling techniques would best analyze these nested, time-varying processes?", "history": ["What support strategies are currently used to help families cope with bereavement after organ donation?", "How can understanding family dynamics and hospital interactions improve the effectiveness of these support strategies?", "Building on these discussions about current support strategies and the role of family dynamics and hospital interactions, how could healthcare providers combine insights from grief theory and systems theory to create more personalized approaches that adapt to families' evolving psychosocial needs throughout the bereavement process after organ donation?"], "ground_truth": ["permed-79617", "permed-79619", "permed-79618", "permed-90997", "permed-64311", "permed-69470", "permed-85581", "permed-65745", "permed-69539", "permed-79830"]}
{"query_id": "topic_772_turn_5", "conversation_id": "topic_772", "turn_id": 5, "query": "Given these methodological frameworks for tracking psychosocial adaptation, what clinical outcomes have been demonstrated when implementing such personalized, theory-informed bereavement support in actual healthcare settings? Specifically, how do these integrated approaches impact families' long-term psychological adjustment, complicated grief rates, and satisfaction with the donation experience compared to standard support protocols? Additionally, what implementation barriers—such as staff training requirements or resource allocation—affect real-world deployment and sustainability of these multifaceted support programs in diverse hospital systems?", "history": ["What support strategies are currently used to help families cope with bereavement after organ donation?", "How can understanding family dynamics and hospital interactions improve the effectiveness of these support strategies?", "Building on these discussions about current support strategies and the role of family dynamics and hospital interactions, how could healthcare providers combine insights from grief theory and systems theory to create more personalized approaches that adapt to families' evolving psychosocial needs throughout the bereavement process after organ donation?", "Given this theoretical integration between grief and systems theory, what specific mixed-methods approaches would you recommend for longitudinally tracking families' psychosocial adaptation? More concretely, how should researchers design sequential quantitative assessments and qualitative interviews to capture both individual grief trajectories and evolving family system dynamics, while maintaining methodological rigor across these different data streams? What statistical modeling techniques would best analyze these nested, time-varying processes?"], "ground_truth": ["permed-79617", "permed-79619", "permed-79618", "permed-82902", "permed-65745", "permed-85581", "permed-62316", "permed-62314", "permed-60196", "permed-88305"]}
{"query_id": "topic_772_turn_6", "conversation_id": "topic_772", "turn_id": 6, "query": "Given our progression from theoretical frameworks to methodological approaches and clinical outcomes, let's revisit the foundational concept: how exactly should \"psychosocial adaptation\" be operationally defined within this specific context of post-donation bereavement? Beyond general bereavement models, what distinct dimensions—cognitive acceptance, family role reorganization, relational connection to the recipient, or meaning reconstruction—constitute its core components when families navigate both grief and the unique moral dimensions of organ donation? How might this definition evolve to address cultural variations in adaptation processes that current Western-centric models might overlook?", "history": ["What support strategies are currently used to help families cope with bereavement after organ donation?", "How can understanding family dynamics and hospital interactions improve the effectiveness of these support strategies?", "Building on these discussions about current support strategies and the role of family dynamics and hospital interactions, how could healthcare providers combine insights from grief theory and systems theory to create more personalized approaches that adapt to families' evolving psychosocial needs throughout the bereavement process after organ donation?", "Given this theoretical integration between grief and systems theory, what specific mixed-methods approaches would you recommend for longitudinally tracking families' psychosocial adaptation? More concretely, how should researchers design sequential quantitative assessments and qualitative interviews to capture both individual grief trajectories and evolving family system dynamics, while maintaining methodological rigor across these different data streams? What statistical modeling techniques would best analyze these nested, time-varying processes?", "Given these methodological frameworks for tracking psychosocial adaptation, what clinical outcomes have been demonstrated when implementing such personalized, theory-informed bereavement support in actual healthcare settings? Specifically, how do these integrated approaches impact families' long-term psychological adjustment, complicated grief rates, and satisfaction with the donation experience compared to standard support protocols? Additionally, what implementation barriers—such as staff training requirements or resource allocation—affect real-world deployment and sustainability of these multifaceted support programs in diverse hospital systems?"], "ground_truth": ["permed-79617", "permed-79618", "permed-62314", "permed-87104", "permed-74690", "permed-65745", "permed-87197", "permed-79619", "permed-69467", "permed-72707"]}
{"query_id": "topic_773_turn_1", "conversation_id": "topic_773", "turn_id": 1, "query": "What role does Methylsulfonylmethane (MSM) play in human health, particularly in relation to DNA methylation?", "history": [], "ground_truth": ["permed-79355", "permed-79356", "permed-66932", "permed-72291", "permed-79358", "permed-72477", "permed-67507", "permed-18937", "permed-51222", "permed-67692"]}
{"query_id": "topic_773_turn_2", "conversation_id": "topic_773", "turn_id": 2, "query": "How might MSM's interaction with DNA methylation impact gene expression, especially in contexts like liver cell metabolism?", "history": ["What role does Methylsulfonylmethane (MSM) play in human health, particularly in relation to DNA methylation?"], "ground_truth": ["permed-79355", "permed-67693", "permed-79358", "permed-58196", "permed-78416", "permed-63081", "permed-53825", "permed-58205", "permed-51222", "permed-67397"]}
{"query_id": "topic_773_turn_3", "conversation_id": "topic_773", "turn_id": 3, "query": "Given these findings that MSM can act as a methyl donor for DNA methylation in HepaRG cells without affecting global methylation levels or repetitive element patterns, what might be the long-term epigenetic consequences for gene expression—especially in liver metabolism and detoxification genes? And how could these effects differ across genetic backgrounds or under environmental stress conditions?", "history": ["What role does Methylsulfonylmethane (MSM) play in human health, particularly in relation to DNA methylation?", "How might MSM's interaction with DNA methylation impact gene expression, especially in contexts like liver cell metabolism?"], "ground_truth": ["permed-79355", "permed-67397", "permed-51222", "permed-89764", "permed-69237", "permed-58527", "permed-67735", "permed-63081", "permed-53805", "permed-83148"]}
{"query_id": "topic_773_turn_4", "conversation_id": "topic_773", "turn_id": 4, "query": "Given this observed specificity of MSM's epigenetic effects in HepaRG cells, what experimental methodology would best capture targeted methylation changes at specific metabolic gene promoters? Specifically, should we employ reduced representation bisulfite sequencing with enhanced coverage of liver-specific CpG islands, or would targeted bisulfite sequencing panels focusing on detoxification pathways provide better resolution? How would you statistically differentiate true methylation changes from background noise while accounting for cell passage effects in long-term culture studies?", "history": ["What role does Methylsulfonylmethane (MSM) play in human health, particularly in relation to DNA methylation?", "How might MSM's interaction with DNA methylation impact gene expression, especially in contexts like liver cell metabolism?", "Given these findings that MSM can act as a methyl donor for DNA methylation in HepaRG cells without affecting global methylation levels or repetitive element patterns, what might be the long-term epigenetic consequences for gene expression—especially in liver metabolism and detoxification genes? And how could these effects differ across genetic backgrounds or under environmental stress conditions?"], "ground_truth": ["permed-79355", "permed-67507", "permed-76852", "permed-67504", "permed-89764", "permed-1970", "permed-59096", "permed-56215", "permed-7299", "permed-84827"]}
{"query_id": "topic_773_turn_5", "conversation_id": "topic_773", "turn_id": 5, "query": "Given the methodological considerations for detecting targeted methylation changes, how would reduced representation bisulfite sequencing (RRBS) versus whole-genome bisulfite sequencing (WGBS) compare in their ability to capture MSM's epigenetic effects on liver metabolism genes? Specifically, what are the trade-offs between RRBS's cost-efficiency in CpG island coverage and WGBS's comprehensive genomic mapping when studying promoter-specific methylation in long-term culture models, and which approach offers better statistical power for distinguishing subtle, biologically relevant changes from technical artifacts across multiple cell passages?", "history": ["What role does Methylsulfonylmethane (MSM) play in human health, particularly in relation to DNA methylation?", "How might MSM's interaction with DNA methylation impact gene expression, especially in contexts like liver cell metabolism?", "Given these findings that MSM can act as a methyl donor for DNA methylation in HepaRG cells without affecting global methylation levels or repetitive element patterns, what might be the long-term epigenetic consequences for gene expression—especially in liver metabolism and detoxification genes? And how could these effects differ across genetic backgrounds or under environmental stress conditions?", "Given this observed specificity of MSM's epigenetic effects in HepaRG cells, what experimental methodology would best capture targeted methylation changes at specific metabolic gene promoters? Specifically, should we employ reduced representation bisulfite sequencing with enhanced coverage of liver-specific CpG islands, or would targeted bisulfite sequencing panels focusing on detoxification pathways provide better resolution? How would you statistically differentiate true methylation changes from background noise while accounting for cell passage effects in long-term culture studies?"], "ground_truth": ["permed-67507", "permed-79355", "permed-90527", "permed-76852", "permed-77558", "permed-63928", "permed-6068", "permed-72859", "permed-67504", "permed-89764"]}
{"query_id": "topic_773_turn_6", "conversation_id": "topic_773", "turn_id": 6, "query": "Given our detailed methodological comparisons, how do emerging third-generation sequencing technologies like PacBio's SMRT and Oxford Nanopore's long-read platforms compare to established bisulfite sequencing approaches in detecting MSM-induced methylation changes? Specifically, what are the relative advantages in mapping complex promoter regions of liver metabolism genes, resolving epigenetic heterogeneity across cell populations in long-term culture, and distinguishing true biological signals from the technical artifacts we've discussed? Which technology shows greater promise for capturing dynamic methylation patterns while maintaining cost-effectiveness for longitudinal studies?", "history": ["What role does Methylsulfonylmethane (MSM) play in human health, particularly in relation to DNA methylation?", "How might MSM's interaction with DNA methylation impact gene expression, especially in contexts like liver cell metabolism?", "Given these findings that MSM can act as a methyl donor for DNA methylation in HepaRG cells without affecting global methylation levels or repetitive element patterns, what might be the long-term epigenetic consequences for gene expression—especially in liver metabolism and detoxification genes? And how could these effects differ across genetic backgrounds or under environmental stress conditions?", "Given this observed specificity of MSM's epigenetic effects in HepaRG cells, what experimental methodology would best capture targeted methylation changes at specific metabolic gene promoters? Specifically, should we employ reduced representation bisulfite sequencing with enhanced coverage of liver-specific CpG islands, or would targeted bisulfite sequencing panels focusing on detoxification pathways provide better resolution? How would you statistically differentiate true methylation changes from background noise while accounting for cell passage effects in long-term culture studies?", "Given the methodological considerations for detecting targeted methylation changes, how would reduced representation bisulfite sequencing (RRBS) versus whole-genome bisulfite sequencing (WGBS) compare in their ability to capture MSM's epigenetic effects on liver metabolism genes? Specifically, what are the trade-offs between RRBS's cost-efficiency in CpG island coverage and WGBS's comprehensive genomic mapping when studying promoter-specific methylation in long-term culture models, and which approach offers better statistical power for distinguishing subtle, biologically relevant changes from technical artifacts across multiple cell passages?"], "ground_truth": ["permed-67507", "permed-67044", "permed-54310", "permed-67120", "permed-52491", "permed-57629", "permed-57630", "permed-79355", "permed-63928", "permed-6017"]}
{"query_id": "topic_774_turn_1", "conversation_id": "topic_774", "turn_id": 1, "query": "Fundamental roles and formation principles of polyoxometalate capsule-based supramolecular assemblies in medical applications", "history": [], "ground_truth": ["permed-50891", "permed-66553", "permed-50895", "permed-52611", "permed-91206", "permed-67183", "permed-60645", "permed-58082", "permed-63004", "permed-66551"]}
{"query_id": "topic_774_turn_2", "conversation_id": "topic_774", "turn_id": 2, "query": "Influence of molecular interactions, particularly with porphyrins, on the structural stability of these polyoxometalate supramolecular assemblies", "history": ["Fundamental roles and formation principles of polyoxometalate capsule-based supramolecular assemblies in medical applications"], "ground_truth": ["permed-50891", "permed-66553", "permed-87439", "permed-77742", "permed-74368", "permed-75452", "permed-52611", "permed-50895", "permed-50904", "permed-78860"]}
{"query_id": "topic_774_turn_3", "conversation_id": "topic_774", "turn_id": 3, "query": "Effects of pH and ionic strength on the stability and structural dynamics of supramolecular assemblies formed by noncovalent ionic interactions between Keplerate-type polyoxometalates and cationic porphyrins, and implications for their application in targeted drug delivery", "history": ["Fundamental roles and formation principles of polyoxometalate capsule-based supramolecular assemblies in medical applications", "Influence of molecular interactions, particularly with porphyrins, on the structural stability of these polyoxometalate supramolecular assemblies"], "ground_truth": ["permed-50891", "permed-51017", "permed-66554", "permed-60921", "permed-66553", "permed-50895", "permed-73371", "permed-52611", "permed-66551", "permed-89026"]}
{"query_id": "topic_774_turn_4", "conversation_id": "topic_774", "turn_id": 4, "query": "For the structural dynamics characterization under varying pH and ionic strength conditions described in Turn 3, what specific spectroscopic or scattering techniques were employed to monitor real-time assembly-disassembly kinetics? I'm particularly interested in the temporal resolution of these measurements and how you validated that observed spectral changes specifically corresponded to structural rearrangements rather than secondary chemical modifications. Were control experiments with molecular probes implemented to distinguish between different dissociation pathways?", "history": ["Fundamental roles and formation principles of polyoxometalate capsule-based supramolecular assemblies in medical applications", "Influence of molecular interactions, particularly with porphyrins, on the structural stability of these polyoxometalate supramolecular assemblies", "Effects of pH and ionic strength on the stability and structural dynamics of supramolecular assemblies formed by noncovalent ionic interactions between Keplerate-type polyoxometalates and cationic porphyrins, and implications for their application in targeted drug delivery"], "ground_truth": ["permed-91052", "permed-79545", "permed-79510", "permed-75409", "permed-76029", "permed-65169", "permed-65165", "permed-65172", "permed-74688", "permed-75973"]}
{"query_id": "topic_774_turn_5", "conversation_id": "topic_774", "turn_id": 5, "query": "Given the detailed characterization of assembly-disassembly kinetics under physiological conditions, how have these structural insights translated to clinical performance? Specifically, what in vivo studies evaluated polyoxometalate-porphyrin supramolecular assemblies for targeted drug delivery, and what were the key therapeutic outcomes regarding tumor accumulation efficiency and payload release kinetics? Furthermore, were any adverse effects observed related to premature disassembly or off-target interactions, and how do these findings inform optimal dosing regimens and potential contraindications for clinical translation?", "history": ["Fundamental roles and formation principles of polyoxometalate capsule-based supramolecular assemblies in medical applications", "Influence of molecular interactions, particularly with porphyrins, on the structural stability of these polyoxometalate supramolecular assemblies", "Effects of pH and ionic strength on the stability and structural dynamics of supramolecular assemblies formed by noncovalent ionic interactions between Keplerate-type polyoxometalates and cationic porphyrins, and implications for their application in targeted drug delivery", "For the structural dynamics characterization under varying pH and ionic strength conditions described in Turn 3, what specific spectroscopic or scattering techniques were employed to monitor real-time assembly-disassembly kinetics? I'm particularly interested in the temporal resolution of these measurements and how you validated that observed spectral changes specifically corresponded to structural rearrangements rather than secondary chemical modifications. Were control experiments with molecular probes implemented to distinguish between different dissociation pathways?"], "ground_truth": ["permed-72499", "permed-86785", "permed-67174", "permed-58082", "permed-50895", "permed-60841", "permed-56540", "permed-66553", "permed-68898", "permed-58080"]}
{"query_id": "topic_774_turn_6", "conversation_id": "topic_774", "turn_id": 6, "query": "Building upon the in vivo therapeutic outcomes and safety profile discussed previously, how do the tumor-targeting efficiency and systemic toxicity of these polyoxometalate-porphyrin supramolecular assemblies compare with other emerging nanocarrier platforms such as lipid nanoparticles or polymeric micelles? Specifically, what are the trade-offs in terms of structural stability under physiological conditions versus drug release kinetics, and how do these comparative advantages position polyoxometalate systems against clinically established alternatives for future translation into combination therapies or personalized medicine approaches?", "history": ["Fundamental roles and formation principles of polyoxometalate capsule-based supramolecular assemblies in medical applications", "Influence of molecular interactions, particularly with porphyrins, on the structural stability of these polyoxometalate supramolecular assemblies", "Effects of pH and ionic strength on the stability and structural dynamics of supramolecular assemblies formed by noncovalent ionic interactions between Keplerate-type polyoxometalates and cationic porphyrins, and implications for their application in targeted drug delivery", "For the structural dynamics characterization under varying pH and ionic strength conditions described in Turn 3, what specific spectroscopic or scattering techniques were employed to monitor real-time assembly-disassembly kinetics? I'm particularly interested in the temporal resolution of these measurements and how you validated that observed spectral changes specifically corresponded to structural rearrangements rather than secondary chemical modifications. Were control experiments with molecular probes implemented to distinguish between different dissociation pathways?", "Given the detailed characterization of assembly-disassembly kinetics under physiological conditions, how have these structural insights translated to clinical performance? Specifically, what in vivo studies evaluated polyoxometalate-porphyrin supramolecular assemblies for targeted drug delivery, and what were the key therapeutic outcomes regarding tumor accumulation efficiency and payload release kinetics? Furthermore, were any adverse effects observed related to premature disassembly or off-target interactions, and how do these findings inform optimal dosing regimens and potential contraindications for clinical translation?"], "ground_truth": ["permed-52919", "permed-75008", "permed-67174", "permed-67176", "permed-56540", "permed-68903", "permed-59217", "permed-51306", "permed-79030", "permed-81794"]}
{"query_id": "topic_775_turn_1", "conversation_id": "topic_775", "turn_id": 1, "query": "Relationship between malnutrition, frailty, and adverse perioperative outcomes in surgical patients", "history": [], "ground_truth": ["permed-54239", "permed-54824", "permed-69447", "permed-26221", "permed-59841", "permed-78945", "permed-62820", "permed-74628", "permed-59842", "permed-59846"]}
{"query_id": "topic_775_turn_2", "conversation_id": "topic_775", "turn_id": 2, "query": "Advanced methods for preoperative assessment of these risks (malnutrition and frailty) in surgical patients, exploring imaging techniques and specific diagnostic criteria.", "history": ["Relationship between malnutrition, frailty, and adverse perioperative outcomes in surgical patients"], "ground_truth": ["permed-54239", "permed-54962", "permed-69447", "permed-59846", "permed-54824", "permed-10828", "permed-59138", "permed-78945", "permed-62820", "permed-51084"]}
{"query_id": "topic_775_turn_3", "conversation_id": "topic_775", "turn_id": 3, "query": "Effectiveness of integrating advanced imaging biomarkers (e.g., muscle mass on CT) with GLIM criteria for precise preoperative malnutrition and frailty risk stratification and guiding targeted perioperative nutritional interventions.", "history": ["Relationship between malnutrition, frailty, and adverse perioperative outcomes in surgical patients", "Advanced methods for preoperative assessment of these risks (malnutrition and frailty) in surgical patients, exploring imaging techniques and specific diagnostic criteria."], "ground_truth": ["permed-54239", "permed-71192", "permed-74627", "permed-54824", "permed-55037", "permed-55041", "permed-59846", "permed-26221", "permed-64888", "permed-69447"]}
{"query_id": "topic_775_turn_4", "conversation_id": "topic_775", "turn_id": 4, "query": "For this integrated imaging-biomarker and GLIM criteria approach, what specific statistical methods were used to validate the risk stratification model's predictive performance for postoperative complications? Could you detail the model calibration techniques, discrimination metrics like AUC-ROC values, and how you addressed potential overfitting through cross-validation or bootstrapping methods during internal validation?", "history": ["Relationship between malnutrition, frailty, and adverse perioperative outcomes in surgical patients", "Advanced methods for preoperative assessment of these risks (malnutrition and frailty) in surgical patients, exploring imaging techniques and specific diagnostic criteria.", "Effectiveness of integrating advanced imaging biomarkers (e.g., muscle mass on CT) with GLIM criteria for precise preoperative malnutrition and frailty risk stratification and guiding targeted perioperative nutritional interventions."], "ground_truth": ["permed-73883", "permed-58630", "permed-65800", "permed-27355", "permed-3714", "permed-56101", "permed-78171", "permed-36873", "permed-88675", "permed-50021"]}
{"query_id": "topic_775_turn_5", "conversation_id": "topic_775", "turn_id": 5, "query": "Given the validated predictive performance of this integrated imaging-GLIM model for postoperative complications, what clinical implementation challenges have been observed when translating this risk stratification into actual perioperative nutritional intervention protocols? Specifically, how do patient adherence rates, institutional resource constraints, and timing of preoperative nutritional optimization affect the real-world therapeutic efficacy in improving patient outcomes, and what evidence exists regarding the model's impact on reducing specific complications like surgical site infections or delirium in clinical practice?", "history": ["Relationship between malnutrition, frailty, and adverse perioperative outcomes in surgical patients", "Advanced methods for preoperative assessment of these risks (malnutrition and frailty) in surgical patients, exploring imaging techniques and specific diagnostic criteria.", "Effectiveness of integrating advanced imaging biomarkers (e.g., muscle mass on CT) with GLIM criteria for precise preoperative malnutrition and frailty risk stratification and guiding targeted perioperative nutritional interventions.", "For this integrated imaging-biomarker and GLIM criteria approach, what specific statistical methods were used to validate the risk stratification model's predictive performance for postoperative complications? Could you detail the model calibration techniques, discrimination metrics like AUC-ROC values, and how you addressed potential overfitting through cross-validation or bootstrapping methods during internal validation?"], "ground_truth": ["permed-54826", "permed-71192", "permed-54239", "permed-67322", "permed-54824", "permed-54962", "permed-26218", "permed-52434", "permed-12220", "permed-68547"]}
{"query_id": "topic_775_turn_6", "conversation_id": "topic_775", "turn_id": 6, "query": "Given the documented clinical implementation challenges with the integrated imaging-GLIM model, how does its cost-effectiveness and resource utilization profile compare against simpler frailty screening tools like the Clinical Frailty Scale or Edmonton Frail Scale when deployed at scale? Considering institutional variations in imaging infrastructure and nutritional support capabilities, what evidence exists regarding their comparative predictive accuracy for specific complications versus implementation feasibility, and which settings might justify the additional resource investment for the more complex model versus standardized screening approaches?", "history": ["Relationship between malnutrition, frailty, and adverse perioperative outcomes in surgical patients", "Advanced methods for preoperative assessment of these risks (malnutrition and frailty) in surgical patients, exploring imaging techniques and specific diagnostic criteria.", "Effectiveness of integrating advanced imaging biomarkers (e.g., muscle mass on CT) with GLIM criteria for precise preoperative malnutrition and frailty risk stratification and guiding targeted perioperative nutritional interventions.", "For this integrated imaging-biomarker and GLIM criteria approach, what specific statistical methods were used to validate the risk stratification model's predictive performance for postoperative complications? Could you detail the model calibration techniques, discrimination metrics like AUC-ROC values, and how you addressed potential overfitting through cross-validation or bootstrapping methods during internal validation?", "Given the validated predictive performance of this integrated imaging-GLIM model for postoperative complications, what clinical implementation challenges have been observed when translating this risk stratification into actual perioperative nutritional intervention protocols? Specifically, how do patient adherence rates, institutional resource constraints, and timing of preoperative nutritional optimization affect the real-world therapeutic efficacy in improving patient outcomes, and what evidence exists regarding the model's impact on reducing specific complications like surgical site infections or delirium in clinical practice?"], "ground_truth": ["permed-59138", "permed-61335", "permed-54239", "permed-80429", "permed-74627", "permed-81659", "permed-59846", "permed-35533", "permed-59135", "permed-50811"]}
{"query_id": "topic_776_turn_1", "conversation_id": "topic_776", "turn_id": 1, "query": "What are the common long-term effects of ACL reconstruction on knee function?", "history": [], "ground_truth": ["permed-64561", "permed-70901", "permed-64589", "permed-70897", "permed-64442", "permed-64557", "permed-70895", "permed-83822", "permed-91612", "permed-59438"]}
{"query_id": "topic_776_turn_2", "conversation_id": "topic_776", "turn_id": 2, "query": "How might changes in gait mechanics following this procedure contribute to increased risk of osteoarthritis?", "history": ["What are the common long-term effects of ACL reconstruction on knee function?"], "ground_truth": ["permed-64587", "permed-91316", "permed-64630", "permed-91456", "permed-58212", "permed-91677", "permed-64625", "permed-91101", "permed-80567", "permed-83138"]}
{"query_id": "topic_776_turn_3", "conversation_id": "topic_776", "turn_id": 3, "query": "Given these gait changes—particularly the increased knee stiffness and reduced flexion/extension—how do they affect long-term stress distribution in the knee joint, and what therapeutic approaches could help mitigate the resulting osteoarthritis risk?", "history": ["What are the common long-term effects of ACL reconstruction on knee function?", "How might changes in gait mechanics following this procedure contribute to increased risk of osteoarthritis?"], "ground_truth": ["permed-64625", "permed-64589", "permed-64627", "permed-59439", "permed-64583", "permed-64584", "permed-55673", "permed-64630", "permed-71945", "permed-91316"]}
{"query_id": "topic_776_turn_4", "conversation_id": "topic_776", "turn_id": 4, "query": "When studying these gait-induced stress distributions mentioned in Turn 3, what specific computational modeling approaches—such as finite element analysis or musculoskeletal modeling—are most appropriate for quantifying long-term cartilage loading? Furthermore, how are these models typically validated against in-vivo data, and what are the key sensitivity analyses performed to ensure the reliability of the predicted stress patterns in relation to osteoarthritis development?", "history": ["What are the common long-term effects of ACL reconstruction on knee function?", "How might changes in gait mechanics following this procedure contribute to increased risk of osteoarthritis?", "Given these gait changes—particularly the increased knee stiffness and reduced flexion/extension—how do they affect long-term stress distribution in the knee joint, and what therapeutic approaches could help mitigate the resulting osteoarthritis risk?"], "ground_truth": ["permed-64625", "permed-64587", "permed-71944", "permed-64452", "permed-80567", "permed-75511", "permed-36923", "permed-73639", "permed-64590", "permed-88459"]}
{"query_id": "topic_776_turn_5", "conversation_id": "topic_776", "turn_id": 5, "query": "Given the computational modeling validation approaches discussed previously, how do finite element analysis and musculoskeletal modeling compare in their ability to predict long-term cartilage degeneration patterns? Specifically, what are the relative advantages of each method in terms of spatial resolution for stress localization versus dynamic functional assessment during gait cycles, and how do their respective limitations in accounting for biological factors like cartilage adaptation affect their clinical utility for personalized osteoarthritis risk prediction following ACL reconstruction?", "history": ["What are the common long-term effects of ACL reconstruction on knee function?", "How might changes in gait mechanics following this procedure contribute to increased risk of osteoarthritis?", "Given these gait changes—particularly the increased knee stiffness and reduced flexion/extension—how do they affect long-term stress distribution in the knee joint, and what therapeutic approaches could help mitigate the resulting osteoarthritis risk?", "When studying these gait-induced stress distributions mentioned in Turn 3, what specific computational modeling approaches—such as finite element analysis or musculoskeletal modeling—are most appropriate for quantifying long-term cartilage loading? Furthermore, how are these models typically validated against in-vivo data, and what are the key sensitivity analyses performed to ensure the reliability of the predicted stress patterns in relation to osteoarthritis development?"], "ground_truth": ["permed-92297", "permed-53153", "permed-80567", "permed-19598", "permed-70897", "permed-53160", "permed-64625", "permed-53152", "permed-91450", "permed-64587"]}
{"query_id": "topic_776_turn_6", "conversation_id": "topic_776", "turn_id": 6, "query": "Given our previous discussion about finite element analysis's superior spatial resolution for stress localization versus musculoskeletal modeling's dynamic functional assessment capabilities, how do emerging multi-scale modeling approaches that integrate both methodologies compare in addressing their respective limitations? Specifically, what computational and validation challenges arise when coupling these frameworks to account for both mechanical stress concentrations and biological adaptation processes, and how might such integrated models improve clinical prediction of patient-specific osteoarthritis progression compared to standalone approaches?", "history": ["What are the common long-term effects of ACL reconstruction on knee function?", "How might changes in gait mechanics following this procedure contribute to increased risk of osteoarthritis?", "Given these gait changes—particularly the increased knee stiffness and reduced flexion/extension—how do they affect long-term stress distribution in the knee joint, and what therapeutic approaches could help mitigate the resulting osteoarthritis risk?", "When studying these gait-induced stress distributions mentioned in Turn 3, what specific computational modeling approaches—such as finite element analysis or musculoskeletal modeling—are most appropriate for quantifying long-term cartilage loading? Furthermore, how are these models typically validated against in-vivo data, and what are the key sensitivity analyses performed to ensure the reliability of the predicted stress patterns in relation to osteoarthritis development?", "Given the computational modeling validation approaches discussed previously, how do finite element analysis and musculoskeletal modeling compare in their ability to predict long-term cartilage degeneration patterns? Specifically, what are the relative advantages of each method in terms of spatial resolution for stress localization versus dynamic functional assessment during gait cycles, and how do their respective limitations in accounting for biological factors like cartilage adaptation affect their clinical utility for personalized osteoarthritis risk prediction following ACL reconstruction?"], "ground_truth": ["permed-64452", "permed-61751", "permed-64595", "permed-64625", "permed-89279", "permed-86760", "permed-64624", "permed-88434", "permed-88459", "permed-58794"]}
{"query_id": "topic_777_turn_1", "conversation_id": "topic_777", "turn_id": 1, "query": "What is the overall role of RPMB in the treatment and prognosis of papillary thyroid cancer?", "history": [], "ground_truth": ["permed-74027", "permed-56730", "permed-36408", "permed-51839", "permed-74206", "permed-58762", "permed-59576", "permed-56658", "permed-74028", "permed-30428"]}
{"query_id": "topic_777_turn_2", "conversation_id": "topic_777", "turn_id": 2, "query": "Following its general role, how does RPMB's influence on disease-free survival in male papillary thyroid cancer patients guide personalization of adjuvant RAI treatment?", "history": ["What is the overall role of RPMB in the treatment and prognosis of papillary thyroid cancer?"], "ground_truth": ["permed-74027", "permed-36408", "permed-56730", "permed-17972", "permed-48520", "permed-33111", "permed-51839", "permed-56033", "permed-48532", "permed-56658"]}
{"query_id": "topic_777_turn_3", "conversation_id": "topic_777", "turn_id": 3, "query": "Building on RPMB's predictive value for RAI therapy in male N1 papillary thyroid cancer patients, how can its combination with other molecular or clinical features refine patient stratification for such personalized treatments, and what are the underlying mechanisms of its effect on RAI response for developing novel therapeutic strategies?", "history": ["What is the overall role of RPMB in the treatment and prognosis of papillary thyroid cancer?", "Following its general role, how does RPMB's influence on disease-free survival in male papillary thyroid cancer patients guide personalization of adjuvant RAI treatment?"], "ground_truth": ["permed-74027", "permed-61769", "permed-73886", "permed-36408", "permed-48520", "permed-59576", "permed-56103", "permed-17972", "permed-56730", "permed-61194"]}
{"query_id": "topic_777_turn_4", "conversation_id": "topic_777", "turn_id": 4, "query": "Given these proposed stratification approaches combining RPMB with molecular features, what specific statistical modeling techniques—such as Cox proportional hazards regression with interaction terms or machine learning algorithms like random survival forests—would be most appropriate for validating their synergistic predictive power for RAI response? Additionally, what methodological considerations should guide the determination of optimal cutoff values for continuous RPMB measurements when constructing these multi-variable risk stratification models in terms of minimizing overfitting while maintaining clinical applicability?", "history": ["What is the overall role of RPMB in the treatment and prognosis of papillary thyroid cancer?", "Following its general role, how does RPMB's influence on disease-free survival in male papillary thyroid cancer patients guide personalization of adjuvant RAI treatment?", "Building on RPMB's predictive value for RAI therapy in male N1 papillary thyroid cancer patients, how can its combination with other molecular or clinical features refine patient stratification for such personalized treatments, and what are the underlying mechanisms of its effect on RAI response for developing novel therapeutic strategies?"], "ground_truth": ["permed-56275", "permed-84130", "permed-74027", "permed-56463", "permed-65800", "permed-61788", "permed-62686", "permed-56484", "permed-50045", "permed-82936"]}
{"query_id": "topic_777_turn_5", "conversation_id": "topic_777", "turn_id": 5, "query": "Given these sophisticated statistical approaches for validating RPMB-based risk stratification, what clinical trial designs would be most appropriate to evaluate the real-world therapeutic efficacy and safety outcomes when implementing these personalized RAI treatment strategies? Specifically, how might adaptive trial designs or pragmatic clinical trials address challenges in assessing whether RPMB-guided treatment personalization actually improves disease-specific survival while minimizing unnecessary RAI exposure and its associated complications in male N1 papillary thyroid cancer patients?", "history": ["What is the overall role of RPMB in the treatment and prognosis of papillary thyroid cancer?", "Following its general role, how does RPMB's influence on disease-free survival in male papillary thyroid cancer patients guide personalization of adjuvant RAI treatment?", "Building on RPMB's predictive value for RAI therapy in male N1 papillary thyroid cancer patients, how can its combination with other molecular or clinical features refine patient stratification for such personalized treatments, and what are the underlying mechanisms of its effect on RAI response for developing novel therapeutic strategies?", "Given these proposed stratification approaches combining RPMB with molecular features, what specific statistical modeling techniques—such as Cox proportional hazards regression with interaction terms or machine learning algorithms like random survival forests—would be most appropriate for validating their synergistic predictive power for RAI response? Additionally, what methodological considerations should guide the determination of optimal cutoff values for continuous RPMB measurements when constructing these multi-variable risk stratification models in terms of minimizing overfitting while maintaining clinical applicability?"], "ground_truth": ["permed-74027", "permed-56730", "permed-51692", "permed-56058", "permed-36408", "permed-56578", "permed-91638", "permed-60201", "permed-68579", "permed-17972"]}
{"query_id": "topic_777_turn_6", "conversation_id": "topic_777", "turn_id": 6, "query": "Building on our discussion of RPMB's clinical applications and validation frameworks, could you precisely define the fundamental biological mechanisms through which RPMB influences RAI responsiveness at the molecular level? Specifically, how does RPMB's role in iodine metabolism or cellular differentiation pathways differ mechanistically from other established biomarkers like TERT promoter mutations or BRAF V600E in modulating RAI avidity? This conceptual clarification would help contextualize whether RPMB represents a distinct pathway intervention opportunity or primarily serves as a surrogate marker aggregating multiple biological processes in N1 papillary thyroid cancer.", "history": ["What is the overall role of RPMB in the treatment and prognosis of papillary thyroid cancer?", "Following its general role, how does RPMB's influence on disease-free survival in male papillary thyroid cancer patients guide personalization of adjuvant RAI treatment?", "Building on RPMB's predictive value for RAI therapy in male N1 papillary thyroid cancer patients, how can its combination with other molecular or clinical features refine patient stratification for such personalized treatments, and what are the underlying mechanisms of its effect on RAI response for developing novel therapeutic strategies?", "Given these proposed stratification approaches combining RPMB with molecular features, what specific statistical modeling techniques—such as Cox proportional hazards regression with interaction terms or machine learning algorithms like random survival forests—would be most appropriate for validating their synergistic predictive power for RAI response? Additionally, what methodological considerations should guide the determination of optimal cutoff values for continuous RPMB measurements when constructing these multi-variable risk stratification models in terms of minimizing overfitting while maintaining clinical applicability?", "Given these sophisticated statistical approaches for validating RPMB-based risk stratification, what clinical trial designs would be most appropriate to evaluate the real-world therapeutic efficacy and safety outcomes when implementing these personalized RAI treatment strategies? Specifically, how might adaptive trial designs or pragmatic clinical trials address challenges in assessing whether RPMB-guided treatment personalization actually improves disease-specific survival while minimizing unnecessary RAI exposure and its associated complications in male N1 papillary thyroid cancer patients?"], "ground_truth": ["permed-74027", "permed-30331", "permed-17972", "permed-74206", "permed-48520", "permed-74028", "permed-56275", "permed-76570", "permed-51695", "permed-56280"]}
{"query_id": "topic_778_turn_1", "conversation_id": "topic_778", "turn_id": 1, "query": "What role do nurse practitioners play in advanced care planning discussions with elderly patients?", "history": [], "ground_truth": ["permed-67372", "permed-67370", "permed-83268", "permed-74824", "permed-80178", "permed-68621", "permed-67373", "permed-80226", "permed-67369", "permed-51092"]}
{"query_id": "topic_778_turn_2", "conversation_id": "topic_778", "turn_id": 2, "query": "How can they improve their communication strategies in this area to ensure patient preferences are accurately captured?", "history": ["What role do nurse practitioners play in advanced care planning discussions with elderly patients?"], "ground_truth": ["permed-75286", "permed-90664", "permed-74528", "permed-67371", "permed-69059", "permed-84555", "permed-67370", "permed-78202", "permed-51913", "permed-46310"]}
{"query_id": "topic_778_turn_3", "conversation_id": "topic_778", "turn_id": 3, "query": "Building on these communication strategies, how can nurse practitioners further refine their approach to ensure these advanced care planning discussions with elderly patients not only capture preferences accurately but also translate into actionable, legally compliant outcomes under frameworks like the Patient Self-Determination Act? Also, what specific challenges arise when documenting these nuanced preferences in electronic health records, and how could technology or policy changes help address them?", "history": ["What role do nurse practitioners play in advanced care planning discussions with elderly patients?", "How can they improve their communication strategies in this area to ensure patient preferences are accurately captured?"], "ground_truth": ["permed-67372", "permed-67370", "permed-74824", "permed-80226", "permed-34422", "permed-60195", "permed-67369", "permed-80178", "permed-67373", "permed-67374"]}
{"query_id": "topic_778_turn_4", "conversation_id": "topic_778", "turn_id": 4, "query": "Regarding the implementation framework for translating preferences into legally compliant outcomes, what specific documentation protocols and validation workflows would you recommend for electronic health record systems? How might we design structured data fields to capture nuanced patient preferences while maintaining compliance with the Patient Self-Determination Act? Additionally, what quality assurance mechanisms - such as automated alerts for incomplete directives or standardized templates for preference documentation - have proven effective in ensuring both accuracy and legal robustness in practice?", "history": ["What role do nurse practitioners play in advanced care planning discussions with elderly patients?", "How can they improve their communication strategies in this area to ensure patient preferences are accurately captured?", "Building on these communication strategies, how can nurse practitioners further refine their approach to ensure these advanced care planning discussions with elderly patients not only capture preferences accurately but also translate into actionable, legally compliant outcomes under frameworks like the Patient Self-Determination Act? Also, what specific challenges arise when documenting these nuanced preferences in electronic health records, and how could technology or policy changes help address them?"], "ground_truth": ["permed-60195", "permed-54487", "permed-87767", "permed-74570", "permed-83978", "permed-80225", "permed-46434", "permed-75286", "permed-79073", "permed-60197"]}
{"query_id": "topic_778_turn_5", "conversation_id": "topic_778", "turn_id": 5, "query": "Given these optimized EHR documentation protocols for capturing legally compliant advanced care preferences, what clinical outcome data exists regarding their impact on patient care quality? Specifically, how do structured documentation systems affect adherence to expressed wishes during critical decision points, reduce unwanted interventions, or influence family satisfaction? Furthermore, what evidence demonstrates whether these systems decrease medico-legal conflicts or improve care coordination between nurse practitioners and other providers when implementing patient directives in acute care settings?", "history": ["What role do nurse practitioners play in advanced care planning discussions with elderly patients?", "How can they improve their communication strategies in this area to ensure patient preferences are accurately captured?", "Building on these communication strategies, how can nurse practitioners further refine their approach to ensure these advanced care planning discussions with elderly patients not only capture preferences accurately but also translate into actionable, legally compliant outcomes under frameworks like the Patient Self-Determination Act? Also, what specific challenges arise when documenting these nuanced preferences in electronic health records, and how could technology or policy changes help address them?", "Regarding the implementation framework for translating preferences into legally compliant outcomes, what specific documentation protocols and validation workflows would you recommend for electronic health record systems? How might we design structured data fields to capture nuanced patient preferences while maintaining compliance with the Patient Self-Determination Act? Additionally, what quality assurance mechanisms - such as automated alerts for incomplete directives or standardized templates for preference documentation - have proven effective in ensuring both accuracy and legal robustness in practice?"], "ground_truth": ["permed-60195", "permed-54487", "permed-67370", "permed-55157", "permed-60189", "permed-60192", "permed-60191", "permed-52110", "permed-74570", "permed-60190"]}
{"query_id": "topic_778_turn_6", "conversation_id": "topic_778", "turn_id": 6, "query": "Given the documented clinical outcomes from structured EHR systems for advanced care planning, how do these technology-driven approaches compare to traditional narrative documentation in balancing legal compliance with preserving patient narrative authenticity? Considering our previous discussion about capturing nuanced preferences, what evidence exists regarding whether structured data fields compromise the relational aspects of care that nurse practitioners cultivate through detailed conversations? Furthermore, as artificial intelligence emerges for preference documentation, how might these automated systems compare to both current EHR protocols and traditional methods in maintaining the ethical integrity of patient-clinician relationships while ensuring legal robustness?", "history": ["What role do nurse practitioners play in advanced care planning discussions with elderly patients?", "How can they improve their communication strategies in this area to ensure patient preferences are accurately captured?", "Building on these communication strategies, how can nurse practitioners further refine their approach to ensure these advanced care planning discussions with elderly patients not only capture preferences accurately but also translate into actionable, legally compliant outcomes under frameworks like the Patient Self-Determination Act? Also, what specific challenges arise when documenting these nuanced preferences in electronic health records, and how could technology or policy changes help address them?", "Regarding the implementation framework for translating preferences into legally compliant outcomes, what specific documentation protocols and validation workflows would you recommend for electronic health record systems? How might we design structured data fields to capture nuanced patient preferences while maintaining compliance with the Patient Self-Determination Act? Additionally, what quality assurance mechanisms - such as automated alerts for incomplete directives or standardized templates for preference documentation - have proven effective in ensuring both accuracy and legal robustness in practice?", "Given these optimized EHR documentation protocols for capturing legally compliant advanced care preferences, what clinical outcome data exists regarding their impact on patient care quality? Specifically, how do structured documentation systems affect adherence to expressed wishes during critical decision points, reduce unwanted interventions, or influence family satisfaction? Furthermore, what evidence demonstrates whether these systems decrease medico-legal conflicts or improve care coordination between nurse practitioners and other providers when implementing patient directives in acute care settings?"], "ground_truth": ["permed-60195", "permed-67370", "permed-67372", "permed-80225", "permed-54366", "permed-67369", "permed-89941", "permed-67374", "permed-54487", "permed-52272"]}
{"query_id": "topic_779_turn_1", "conversation_id": "topic_779", "turn_id": 1, "query": "What role do mitochondria play in cardiomyocyte function and heart failure?", "history": [], "ground_truth": ["permed-89562", "permed-58348", "permed-81808", "permed-57100", "permed-83376", "permed-72134", "permed-83378", "permed-81807", "permed-53532", "permed-90207"]}
{"query_id": "topic_779_turn_2", "conversation_id": "topic_779", "turn_id": 2, "query": "How might alterations in mitochondrial structure, like changes in cristae density, impact this function over time?", "history": ["What role do mitochondria play in cardiomyocyte function and heart failure?"], "ground_truth": ["permed-89562", "permed-80504", "permed-53806", "permed-71681", "permed-72037", "permed-81808", "permed-53805", "permed-82352", "permed-54283", "permed-74333"]}
{"query_id": "topic_779_turn_3", "conversation_id": "topic_779", "turn_id": 3, "query": "Given that elevated dATP levels can alter mitochondrial cristae density and activity, how might these changes influence cardiomyocyte survival and regenerative capacity in chronic heart failure models over the long term?", "history": ["What role do mitochondria play in cardiomyocyte function and heart failure?", "How might alterations in mitochondrial structure, like changes in cristae density, impact this function over time?"], "ground_truth": ["permed-81807", "permed-58348", "permed-72134", "permed-83376", "permed-76592", "permed-81808", "permed-57100", "permed-83378", "permed-70458", "permed-90532"]}
{"query_id": "topic_779_turn_4", "conversation_id": "topic_779", "turn_id": 4, "query": "Given these dATP-induced cristae alterations, what specific experimental protocols would you recommend for quantifying mitochondrial membrane dynamics in live cardiomyocytes over extended timeframes? I'm particularly interested in optimal imaging techniques for tracking cristae remodeling, appropriate fluorophore selection for long-term viability studies, and how to validate that observed structural changes correlate with functional outputs like calcium handling or contractile force measurements in the same cell populations.", "history": ["What role do mitochondria play in cardiomyocyte function and heart failure?", "How might alterations in mitochondrial structure, like changes in cristae density, impact this function over time?", "Given that elevated dATP levels can alter mitochondrial cristae density and activity, how might these changes influence cardiomyocyte survival and regenerative capacity in chronic heart failure models over the long term?"], "ground_truth": ["permed-81807", "permed-72134", "permed-57100", "permed-81808", "permed-58348", "permed-17580", "permed-90206", "permed-76593", "permed-57265", "permed-90532"]}
{"query_id": "topic_779_turn_5", "conversation_id": "topic_779", "turn_id": 5, "query": "Given these advanced imaging protocols for tracking cristae dynamics, how would you systematically compare the relative advantages of super-resolution techniques like STED versus expansion microscopy for long-term mitochondrial monitoring in cardiomyocytes? Specifically, what trade-offs exist between temporal resolution, photobleaching resistance, and structural preservation when tracking progressive cristae remodeling over weeks? Additionally, how do these technical comparisons inform our ability to correlate sub-mitochondrial structural changes with functional decline across different heart failure etiologies?", "history": ["What role do mitochondria play in cardiomyocyte function and heart failure?", "How might alterations in mitochondrial structure, like changes in cristae density, impact this function over time?", "Given that elevated dATP levels can alter mitochondrial cristae density and activity, how might these changes influence cardiomyocyte survival and regenerative capacity in chronic heart failure models over the long term?", "Given these dATP-induced cristae alterations, what specific experimental protocols would you recommend for quantifying mitochondrial membrane dynamics in live cardiomyocytes over extended timeframes? I'm particularly interested in optimal imaging techniques for tracking cristae remodeling, appropriate fluorophore selection for long-term viability studies, and how to validate that observed structural changes correlate with functional outputs like calcium handling or contractile force measurements in the same cell populations."], "ground_truth": ["permed-81808", "permed-58348", "permed-17577", "permed-28585", "permed-28521", "permed-90532", "permed-29317", "permed-71681", "permed-70743", "permed-18816"]}
{"query_id": "topic_779_turn_6", "conversation_id": "topic_779", "turn_id": 6, "query": "Building upon our comparison of super-resolution imaging trade-offs, how do emerging computational approaches for mitochondrial network analysis—particularly deep learning segmentation versus traditional thresholding methods—compare in their ability to quantify progressive cristae remodeling from 3D reconstructions? Considering the complex mitochondrial networks in cardiomyocytes, what are the specific trade-offs in accuracy, computational demand, and biological interpretability when these analytical methods are applied to long-term imaging datasets? How might these computational comparisons help reconcile conflicting findings about mitochondrial fragmentation patterns across different heart failure models?", "history": ["What role do mitochondria play in cardiomyocyte function and heart failure?", "How might alterations in mitochondrial structure, like changes in cristae density, impact this function over time?", "Given that elevated dATP levels can alter mitochondrial cristae density and activity, how might these changes influence cardiomyocyte survival and regenerative capacity in chronic heart failure models over the long term?", "Given these dATP-induced cristae alterations, what specific experimental protocols would you recommend for quantifying mitochondrial membrane dynamics in live cardiomyocytes over extended timeframes? I'm particularly interested in optimal imaging techniques for tracking cristae remodeling, appropriate fluorophore selection for long-term viability studies, and how to validate that observed structural changes correlate with functional outputs like calcium handling or contractile force measurements in the same cell populations.", "Given these advanced imaging protocols for tracking cristae dynamics, how would you systematically compare the relative advantages of super-resolution techniques like STED versus expansion microscopy for long-term mitochondrial monitoring in cardiomyocytes? Specifically, what trade-offs exist between temporal resolution, photobleaching resistance, and structural preservation when tracking progressive cristae remodeling over weeks? Additionally, how do these technical comparisons inform our ability to correlate sub-mitochondrial structural changes with functional decline across different heart failure etiologies?"], "ground_truth": ["permed-83420", "permed-70047", "permed-18825", "permed-70744", "permed-81808", "permed-57347", "permed-57344", "permed-2717", "permed-28656", "permed-28110"]}
{"query_id": "topic_780_turn_1", "conversation_id": "topic_780", "turn_id": 1, "query": "What role does α-synuclein play in erythrocytes and how is it linked to neurodegenerative diseases?", "history": [], "ground_truth": ["permed-63154", "permed-63152", "permed-63151", "permed-84891", "permed-63162", "permed-51245", "permed-91270", "permed-63158", "permed-63160", "permed-63163"]}
{"query_id": "topic_780_turn_2", "conversation_id": "topic_780", "turn_id": 2, "query": "How do post-translational modifications of α-synuclein, specifically in this context, affect its behavior and potential as a therapeutic target?", "history": ["What role does α-synuclein play in erythrocytes and how is it linked to neurodegenerative diseases?"], "ground_truth": ["permed-63151", "permed-63154", "permed-63152", "permed-63156", "permed-85424", "permed-63153", "permed-91270", "permed-89762", "permed-63162", "permed-63163"]}
{"query_id": "topic_780_turn_3", "conversation_id": "topic_780", "turn_id": 3, "query": "Given these diverse modifications of lysine residues in erythrocyte α-synuclein, how might they specifically affect its functional properties—like aggregation propensity, interactions with lipid membranes, and clearance mechanisms—and what would these changes mean for developing targeted therapies in synucleinopathies?", "history": ["What role does α-synuclein play in erythrocytes and how is it linked to neurodegenerative diseases?", "How do post-translational modifications of α-synuclein, specifically in this context, affect its behavior and potential as a therapeutic target?"], "ground_truth": ["permed-63154", "permed-63151", "permed-63152", "permed-63156", "permed-85424", "permed-63160", "permed-63162", "permed-91270", "permed-79510", "permed-63159"]}
{"query_id": "topic_780_turn_4", "conversation_id": "topic_780", "turn_id": 4, "query": "Given these functional implications of modified α-synuclein, what specific experimental approaches would best characterize its aggregation kinetics and membrane interactions in erythrocytes? I'm particularly interested in methodological details: what biophysical techniques (e.g., FRET, surface plasmon resonance) would quantify membrane binding affinity, and what statistical models would appropriately analyze the aggregation time-course data while accounting for erythrocyte-specific factors like oxidative environment?", "history": ["What role does α-synuclein play in erythrocytes and how is it linked to neurodegenerative diseases?", "How do post-translational modifications of α-synuclein, specifically in this context, affect its behavior and potential as a therapeutic target?", "Given these diverse modifications of lysine residues in erythrocyte α-synuclein, how might they specifically affect its functional properties—like aggregation propensity, interactions with lipid membranes, and clearance mechanisms—and what would these changes mean for developing targeted therapies in synucleinopathies?"], "ground_truth": ["permed-79510", "permed-63154", "permed-63151", "permed-85259", "permed-63152", "permed-63156", "permed-63158", "permed-63162", "permed-63160", "permed-79509"]}
{"query_id": "topic_780_turn_5", "conversation_id": "topic_780", "turn_id": 5, "query": "Given the methodological framework discussed for studying α-synuclein in erythrocytes, how would you compare the relative merits of using FRET versus surface plasmon resonance for quantifying membrane binding affinity in this specific context? Considering erythrocytes' oxidative environment and membrane composition, which technique offers superior sensitivity for detecting subtle conformational changes, and what are their respective trade-offs in terms of throughput requirements, sample preparation complexity, and ability to maintain physiological relevance during measurement?", "history": ["What role does α-synuclein play in erythrocytes and how is it linked to neurodegenerative diseases?", "How do post-translational modifications of α-synuclein, specifically in this context, affect its behavior and potential as a therapeutic target?", "Given these diverse modifications of lysine residues in erythrocyte α-synuclein, how might they specifically affect its functional properties—like aggregation propensity, interactions with lipid membranes, and clearance mechanisms—and what would these changes mean for developing targeted therapies in synucleinopathies?", "Given these functional implications of modified α-synuclein, what specific experimental approaches would best characterize its aggregation kinetics and membrane interactions in erythrocytes? I'm particularly interested in methodological details: what biophysical techniques (e.g., FRET, surface plasmon resonance) would quantify membrane binding affinity, and what statistical models would appropriately analyze the aggregation time-course data while accounting for erythrocyte-specific factors like oxidative environment?"], "ground_truth": ["permed-63154", "permed-82290", "permed-79510", "permed-4641", "permed-84891", "permed-75480", "permed-82284", "permed-89261", "permed-92528", "permed-78031"]}
{"query_id": "topic_780_turn_6", "conversation_id": "topic_780", "turn_id": 6, "query": "Building on our comparative analysis of biophysical techniques, what fundamentally constitutes \"physiological relevance\" when studying α-synuclein-membrane interactions in erythrocytes? Beyond merely using isolated erythrocyte membranes, how should this concept be operationally defined to encompass the dynamic oxidative environment, physiological lipid-to-protein ratios, and potential cytosolic factors? What are the core theoretical and practical challenges in replicating this native context in vitro, and how might current definitions of physiological relevance limit our interpretation of binding affinity data from techniques like SPR or FRET?", "history": ["What role does α-synuclein play in erythrocytes and how is it linked to neurodegenerative diseases?", "How do post-translational modifications of α-synuclein, specifically in this context, affect its behavior and potential as a therapeutic target?", "Given these diverse modifications of lysine residues in erythrocyte α-synuclein, how might they specifically affect its functional properties—like aggregation propensity, interactions with lipid membranes, and clearance mechanisms—and what would these changes mean for developing targeted therapies in synucleinopathies?", "Given these functional implications of modified α-synuclein, what specific experimental approaches would best characterize its aggregation kinetics and membrane interactions in erythrocytes? I'm particularly interested in methodological details: what biophysical techniques (e.g., FRET, surface plasmon resonance) would quantify membrane binding affinity, and what statistical models would appropriately analyze the aggregation time-course data while accounting for erythrocyte-specific factors like oxidative environment?", "Given the methodological framework discussed for studying α-synuclein in erythrocytes, how would you compare the relative merits of using FRET versus surface plasmon resonance for quantifying membrane binding affinity in this specific context? Considering erythrocytes' oxidative environment and membrane composition, which technique offers superior sensitivity for detecting subtle conformational changes, and what are their respective trade-offs in terms of throughput requirements, sample preparation complexity, and ability to maintain physiological relevance during measurement?"], "ground_truth": ["permed-63154", "permed-79510", "permed-53306", "permed-91270", "permed-72010", "permed-84891", "permed-77118", "permed-73077", "permed-63151", "permed-71708"]}
{"query_id": "topic_781_turn_1", "conversation_id": "topic_781", "turn_id": 1, "query": "Purpose and significance of cardiopulmonary monitoring during pediatric procedural sedation", "history": [], "ground_truth": ["permed-90906", "permed-76008", "permed-91475", "permed-76011", "permed-62384", "permed-54993", "permed-76009", "permed-91479", "permed-62563", "permed-54996"]}
{"query_id": "topic_781_turn_2", "conversation_id": "topic_781", "turn_id": 2, "query": "What are the specific challenges or risks associated with such monitoring during minor pediatric procedures, particularly when midazolam is the sedative?", "history": ["Purpose and significance of cardiopulmonary monitoring during pediatric procedural sedation"], "ground_truth": ["permed-76008", "permed-76009", "permed-54993", "permed-76011", "permed-62384", "permed-76467", "permed-11778", "permed-91475", "permed-90906", "permed-92196"]}
{"query_id": "topic_781_turn_3", "conversation_id": "topic_781", "turn_id": 3, "query": "Evaluating different cardiopulmonary monitoring protocols and technologies for minor pediatric procedures with midazolam: impact on patient outcomes and development of evidence-based guidelines.", "history": ["Purpose and significance of cardiopulmonary monitoring during pediatric procedural sedation", "What are the specific challenges or risks associated with such monitoring during minor pediatric procedures, particularly when midazolam is the sedative?"], "ground_truth": ["permed-76008", "permed-60487", "permed-51757", "permed-62384", "permed-68969", "permed-54993", "permed-90906", "permed-54996", "permed-52599", "permed-33342"]}
{"query_id": "topic_781_turn_4", "conversation_id": "topic_781", "turn_id": 4, "query": "Given your evaluation of monitoring protocols for midazolam sedation, could you elaborate on the specific validation approaches used for these monitoring technologies? I'm particularly interested in how researchers established accuracy thresholds for detection of respiratory depression, what statistical methods were employed to compare false-positive rates between different monitoring systems, and how they controlled for variables like patient age and procedure duration when assessing protocol effectiveness. Were there standardized quality control measures implemented across study sites in multi-center trials?", "history": ["Purpose and significance of cardiopulmonary monitoring during pediatric procedural sedation", "What are the specific challenges or risks associated with such monitoring during minor pediatric procedures, particularly when midazolam is the sedative?", "Evaluating different cardiopulmonary monitoring protocols and technologies for minor pediatric procedures with midazolam: impact on patient outcomes and development of evidence-based guidelines."], "ground_truth": ["permed-76008", "permed-54993", "permed-54996", "permed-10895", "permed-62384", "permed-76465", "permed-4610", "permed-76009", "permed-42608", "permed-76467"]}
{"query_id": "topic_781_turn_5", "conversation_id": "topic_781", "turn_id": 5, "query": "Given these validation methodologies for pediatric sedation monitoring, what clinical outcomes have been demonstrated when implementing these protocols in real-world settings? Specifically, how have the detection thresholds for respiratory depression translated to reduced adverse event rates, rescue medication administration, or procedure interruptions? Additionally, what evidence exists regarding the clinical utility of these monitoring systems in preventing serious complications like hypoxia or apnea across different pediatric age groups? Have any studies correlated specific monitoring protocol adherence with improved patient safety metrics or cost-effectiveness in routine clinical practice?", "history": ["Purpose and significance of cardiopulmonary monitoring during pediatric procedural sedation", "What are the specific challenges or risks associated with such monitoring during minor pediatric procedures, particularly when midazolam is the sedative?", "Evaluating different cardiopulmonary monitoring protocols and technologies for minor pediatric procedures with midazolam: impact on patient outcomes and development of evidence-based guidelines.", "Given your evaluation of monitoring protocols for midazolam sedation, could you elaborate on the specific validation approaches used for these monitoring technologies? I'm particularly interested in how researchers established accuracy thresholds for detection of respiratory depression, what statistical methods were employed to compare false-positive rates between different monitoring systems, and how they controlled for variables like patient age and procedure duration when assessing protocol effectiveness. Were there standardized quality control measures implemented across study sites in multi-center trials?"], "ground_truth": ["permed-76011", "permed-90906", "permed-76008", "permed-62384", "permed-45396", "permed-74208", "permed-54993", "permed-89389", "permed-91475", "permed-53366"]}
{"query_id": "topic_781_turn_6", "conversation_id": "topic_781", "turn_id": 6, "query": "Given the established clinical outcomes and validation approaches for pediatric sedation monitoring protocols, how do the cost-effectiveness and implementation barriers of continuous capnography compare to standard pulse oximetry in preventing adverse respiratory events during midazolam sedation? Considering the trade-offs, what evidence exists regarding their relative value in resource-limited versus well-equipped settings, and how might emerging technologies like integrated monitoring systems shift this balance in future pediatric sedation practice?", "history": ["Purpose and significance of cardiopulmonary monitoring during pediatric procedural sedation", "What are the specific challenges or risks associated with such monitoring during minor pediatric procedures, particularly when midazolam is the sedative?", "Evaluating different cardiopulmonary monitoring protocols and technologies for minor pediatric procedures with midazolam: impact on patient outcomes and development of evidence-based guidelines.", "Given your evaluation of monitoring protocols for midazolam sedation, could you elaborate on the specific validation approaches used for these monitoring technologies? I'm particularly interested in how researchers established accuracy thresholds for detection of respiratory depression, what statistical methods were employed to compare false-positive rates between different monitoring systems, and how they controlled for variables like patient age and procedure duration when assessing protocol effectiveness. Were there standardized quality control measures implemented across study sites in multi-center trials?", "Given these validation methodologies for pediatric sedation monitoring, what clinical outcomes have been demonstrated when implementing these protocols in real-world settings? Specifically, how have the detection thresholds for respiratory depression translated to reduced adverse event rates, rescue medication administration, or procedure interruptions? Additionally, what evidence exists regarding the clinical utility of these monitoring systems in preventing serious complications like hypoxia or apnea across different pediatric age groups? Have any studies correlated specific monitoring protocol adherence with improved patient safety metrics or cost-effectiveness in routine clinical practice?"], "ground_truth": ["permed-76008", "permed-62384", "permed-54993", "permed-90906", "permed-76011", "permed-88521", "permed-78981", "permed-89389", "permed-45417", "permed-44757"]}
{"query_id": "topic_782_turn_1", "conversation_id": "topic_782", "turn_id": 1, "query": "What are the current trends in lumbar interbody fusion techniques, especially regarding materials and bone grafting?", "history": [], "ground_truth": ["permed-64435", "permed-84557", "permed-84561", "permed-81538", "permed-57733", "permed-78564", "permed-64431", "permed-54875", "permed-54677", "permed-64324"]}
{"query_id": "topic_782_turn_2", "conversation_id": "topic_782", "turn_id": 2, "query": "How do bioactive porous titanium spacers perform in this area, particularly for patients with compromised bone density?", "history": ["What are the current trends in lumbar interbody fusion techniques, especially regarding materials and bone grafting?"], "ground_truth": ["permed-64435", "permed-81538", "permed-59462", "permed-84230", "permed-36995", "permed-83553", "permed-37079", "permed-81235", "permed-64358", "permed-37080"]}
{"query_id": "topic_782_turn_3", "conversation_id": "topic_782", "turn_id": 3, "query": "How do the long-term biomechanical stability and patient-reported outcomes compare between LLIF procedures using these bioactive porous titanium spacers without bone grafts versus traditional LLIF with bone grafts, especially in patients with different levels of osteoporosis?", "history": ["What are the current trends in lumbar interbody fusion techniques, especially regarding materials and bone grafting?", "How do bioactive porous titanium spacers perform in this area, particularly for patients with compromised bone density?"], "ground_truth": ["permed-64435", "permed-81538", "permed-78564", "permed-64430", "permed-54875", "permed-64434", "permed-90918", "permed-64431", "permed-84557", "permed-36726"]}
{"query_id": "topic_782_turn_4", "conversation_id": "topic_782", "turn_id": 4, "query": "Given this comparison of long-term outcomes, what specific statistical methods would you recommend for analyzing the repeated measures of biomechanical stability across different osteoporosis grades? I'm particularly interested in how to handle potential missing data from longitudinal follow-ups, and what validation approaches would ensure the reliability of patient-reported outcome measures when comparing these two surgical techniques without introducing measurement bias.", "history": ["What are the current trends in lumbar interbody fusion techniques, especially regarding materials and bone grafting?", "How do bioactive porous titanium spacers perform in this area, particularly for patients with compromised bone density?", "How do the long-term biomechanical stability and patient-reported outcomes compare between LLIF procedures using these bioactive porous titanium spacers without bone grafts versus traditional LLIF with bone grafts, especially in patients with different levels of osteoporosis?"], "ground_truth": ["permed-54886", "permed-86282", "permed-75144", "permed-53912", "permed-36677", "permed-91451", "permed-58569", "permed-59473", "permed-90492", "permed-64358"]}
{"query_id": "topic_782_turn_5", "conversation_id": "topic_782", "turn_id": 5, "query": "Given these methodological considerations for analyzing longitudinal outcomes, what clinical implications have emerged from real-world deployment of bioactive porous titanium spacers in osteoporotic populations? Specifically, what postoperative complication profiles (e.g., subsidence rates, revision surgery indications) and functional recovery timelines have been observed compared to traditional bone graft techniques? Considering the statistical challenges in tracking these patients, what evidence exists regarding their return-to-function milestones and management of any device-related adverse events in routine practice?", "history": ["What are the current trends in lumbar interbody fusion techniques, especially regarding materials and bone grafting?", "How do bioactive porous titanium spacers perform in this area, particularly for patients with compromised bone density?", "How do the long-term biomechanical stability and patient-reported outcomes compare between LLIF procedures using these bioactive porous titanium spacers without bone grafts versus traditional LLIF with bone grafts, especially in patients with different levels of osteoporosis?", "Given this comparison of long-term outcomes, what specific statistical methods would you recommend for analyzing the repeated measures of biomechanical stability across different osteoporosis grades? I'm particularly interested in how to handle potential missing data from longitudinal follow-ups, and what validation approaches would ensure the reliability of patient-reported outcome measures when comparing these two surgical techniques without introducing measurement bias."], "ground_truth": ["permed-64435", "permed-59462", "permed-58569", "permed-77575", "permed-81538", "permed-59459", "permed-54875", "permed-80281", "permed-91649", "permed-59419"]}
{"query_id": "topic_782_turn_6", "conversation_id": "topic_782", "turn_id": 6, "query": "Given the established complication profiles and functional recovery patterns, how do the cost-effectiveness trajectories of bioactive porous titanium spacers versus traditional bone graft techniques compare when considering the entire treatment pathway for osteoporotic patients? Specifically, what economic analyses exist that incorporate not only initial implant costs but also long-term expenses from managing subsidence events, revision surgeries, and differential rehabilitation needs? With healthcare systems increasingly emphasizing value-based care, what evidence demonstrates whether the higher upfront costs of bioactive spacers are offset by reduced long-term complications and improved functional outcomes that might decrease overall healthcare utilization?", "history": ["What are the current trends in lumbar interbody fusion techniques, especially regarding materials and bone grafting?", "How do bioactive porous titanium spacers perform in this area, particularly for patients with compromised bone density?", "How do the long-term biomechanical stability and patient-reported outcomes compare between LLIF procedures using these bioactive porous titanium spacers without bone grafts versus traditional LLIF with bone grafts, especially in patients with different levels of osteoporosis?", "Given this comparison of long-term outcomes, what specific statistical methods would you recommend for analyzing the repeated measures of biomechanical stability across different osteoporosis grades? I'm particularly interested in how to handle potential missing data from longitudinal follow-ups, and what validation approaches would ensure the reliability of patient-reported outcome measures when comparing these two surgical techniques without introducing measurement bias.", "Given these methodological considerations for analyzing longitudinal outcomes, what clinical implications have emerged from real-world deployment of bioactive porous titanium spacers in osteoporotic populations? Specifically, what postoperative complication profiles (e.g., subsidence rates, revision surgery indications) and functional recovery timelines have been observed compared to traditional bone graft techniques? Considering the statistical challenges in tracking these patients, what evidence exists regarding their return-to-function milestones and management of any device-related adverse events in routine practice?"], "ground_truth": ["permed-64435", "permed-54886", "permed-37164", "permed-81538", "permed-81929", "permed-58569", "permed-64358", "permed-36995", "permed-54875", "permed-19711"]}
{"query_id": "topic_783_turn_1", "conversation_id": "topic_783", "turn_id": 1, "query": "Fluoroquinolone crystalline state structural preferences and polymorphism", "history": [], "ground_truth": ["permed-75471", "permed-70109", "permed-75472", "permed-64159", "permed-60926", "permed-64164", "permed-76537", "permed-60645", "permed-89441", "permed-60336"]}
{"query_id": "topic_783_turn_2", "conversation_id": "topic_783", "turn_id": 2, "query": "How do molecular structure variations in these fluoroquinolones influence their crystalline solid-state stability and biological activity?", "history": ["Fluoroquinolone crystalline state structural preferences and polymorphism"], "ground_truth": ["permed-75471", "permed-75472", "permed-70109", "permed-60336", "permed-60444", "permed-76537", "permed-77282", "permed-72289", "permed-75977", "permed-60321"]}
{"query_id": "topic_783_turn_3", "conversation_id": "topic_783", "turn_id": 3, "query": "Influence of specific substituents and ring system modifications on zwitterion versus neutral form prevalence in crystalline fluoroquinolones like danofloxacin, and the resulting impact on their physicochemical stability and pharmacological profile.", "history": ["Fluoroquinolone crystalline state structural preferences and polymorphism", "How do molecular structure variations in these fluoroquinolones influence their crystalline solid-state stability and biological activity?"], "ground_truth": ["permed-75471", "permed-75472", "permed-60926", "permed-76537", "permed-86707", "permed-60336", "permed-70109", "permed-75411", "permed-73348", "permed-74656"]}
{"query_id": "topic_783_turn_4", "conversation_id": "topic_783", "turn_id": 4, "query": "In examining these structural modifications to danofloxacin and their impact on zwitterion prevalence, what specific crystallization protocols and solvent systems were employed to isolate polymorphs? How were the resulting crystalline forms validated - particularly regarding the differentiation between zwitterionic and neutral states - and which characterization techniques (beyond basic XRD) provided the most discriminatory power for quantifying form ratios in mixed crystalline systems?", "history": ["Fluoroquinolone crystalline state structural preferences and polymorphism", "How do molecular structure variations in these fluoroquinolones influence their crystalline solid-state stability and biological activity?", "Influence of specific substituents and ring system modifications on zwitterion versus neutral form prevalence in crystalline fluoroquinolones like danofloxacin, and the resulting impact on their physicochemical stability and pharmacological profile."], "ground_truth": ["permed-75471", "permed-75472", "permed-67550", "permed-78881", "permed-75447", "permed-66549", "permed-80055", "permed-82546", "permed-66548", "permed-86707"]}
{"query_id": "topic_783_turn_5", "conversation_id": "topic_783", "turn_id": 5, "query": "Given these comprehensive crystallization and characterization findings for danofloxacin polymorphs, how do the identified zwitterionic versus neutral crystalline forms translate to clinical outcomes? Specifically, what evidence exists regarding differential bioavailability, therapeutic efficacy, or toxicity profiles between these solid forms in veterinary or human applications? Have any clinical studies demonstrated altered pharmacological performance - such as reduced efficacy or increased adverse effects - attributable to polymorphic transitions during manufacturing or storage, and what monitoring strategies are recommended for ensuring consistent clinical performance of fluoroquinolone formulations?", "history": ["Fluoroquinolone crystalline state structural preferences and polymorphism", "How do molecular structure variations in these fluoroquinolones influence their crystalline solid-state stability and biological activity?", "Influence of specific substituents and ring system modifications on zwitterion versus neutral form prevalence in crystalline fluoroquinolones like danofloxacin, and the resulting impact on their physicochemical stability and pharmacological profile.", "In examining these structural modifications to danofloxacin and their impact on zwitterion prevalence, what specific crystallization protocols and solvent systems were employed to isolate polymorphs? How were the resulting crystalline forms validated - particularly regarding the differentiation between zwitterionic and neutral states - and which characterization techniques (beyond basic XRD) provided the most discriminatory power for quantifying form ratios in mixed crystalline systems?"], "ground_truth": ["permed-75471", "permed-75472", "permed-67550", "permed-60730", "permed-60731", "permed-82546", "permed-75447", "permed-77282", "permed-53313", "permed-77316"]}
{"query_id": "topic_783_turn_6", "conversation_id": "topic_783", "turn_id": 6, "query": "Given the clinical implications of danofloxacin polymorph stability discussed previously, how does the risk-benefit profile of developing stable zwitterionic formulations compare to pursuing salt forms or co-crystals as alternative strategies? Considering the characterization challenges and potential bioavailability variations between neutral and zwitterionic forms, what are the comparative advantages in terms of manufacturing complexity, regulatory hurdles, and long-term stability assurance? Would investment in novel crystal engineering approaches ultimately provide better clinical consistency than traditional formulation optimization methods for fluoroquinolones facing polymorphic instability issues?", "history": ["Fluoroquinolone crystalline state structural preferences and polymorphism", "How do molecular structure variations in these fluoroquinolones influence their crystalline solid-state stability and biological activity?", "Influence of specific substituents and ring system modifications on zwitterion versus neutral form prevalence in crystalline fluoroquinolones like danofloxacin, and the resulting impact on their physicochemical stability and pharmacological profile.", "In examining these structural modifications to danofloxacin and their impact on zwitterion prevalence, what specific crystallization protocols and solvent systems were employed to isolate polymorphs? How were the resulting crystalline forms validated - particularly regarding the differentiation between zwitterionic and neutral states - and which characterization techniques (beyond basic XRD) provided the most discriminatory power for quantifying form ratios in mixed crystalline systems?", "Given these comprehensive crystallization and characterization findings for danofloxacin polymorphs, how do the identified zwitterionic versus neutral crystalline forms translate to clinical outcomes? Specifically, what evidence exists regarding differential bioavailability, therapeutic efficacy, or toxicity profiles between these solid forms in veterinary or human applications? Have any clinical studies demonstrated altered pharmacological performance - such as reduced efficacy or increased adverse effects - attributable to polymorphic transitions during manufacturing or storage, and what monitoring strategies are recommended for ensuring consistent clinical performance of fluoroquinolone formulations?"], "ground_truth": ["permed-75471", "permed-75472", "permed-53308", "permed-62599", "permed-81362", "permed-67550", "permed-60735", "permed-76537", "permed-66549", "permed-60731"]}
{"query_id": "topic_784_turn_1", "conversation_id": "topic_784", "turn_id": 1, "query": "Overview of fungal groups involved in lignocellulose decomposition and their primary degradative mechanisms", "history": [], "ground_truth": ["permed-63973", "permed-53003", "permed-76769", "permed-76016", "permed-57658", "permed-63996", "permed-83973", "permed-66828", "permed-63916", "permed-52995"]}
{"query_id": "topic_784_turn_2", "conversation_id": "topic_784", "turn_id": 2, "query": "Genetic determinants of lignocellulolytic enzyme systems in these fungal groups and their contribution to the efficiency of this decomposition process", "history": ["Overview of fungal groups involved in lignocellulose decomposition and their primary degradative mechanisms"], "ground_truth": ["permed-53003", "permed-76016", "permed-63973", "permed-76769", "permed-63996", "permed-81738", "permed-77432", "permed-63916", "permed-75397", "permed-52995"]}
{"query_id": "topic_784_turn_3", "conversation_id": "topic_784", "turn_id": 3, "query": "Influence of environmental factors (e.g., pH, nutrient stoichiometry) on differential expression of polyketide synthase (PKS) genes in white-rot versus brown-rot fungi, and resulting consequences for fungal competitive interactions and wood carbon mobilization.", "history": ["Overview of fungal groups involved in lignocellulose decomposition and their primary degradative mechanisms", "Genetic determinants of lignocellulolytic enzyme systems in these fungal groups and their contribution to the efficiency of this decomposition process"], "ground_truth": ["permed-63973", "permed-76704", "permed-63637", "permed-66828", "permed-63645", "permed-63916", "permed-76769", "permed-64159", "permed-66836", "permed-84398"]}
{"query_id": "topic_784_turn_4", "conversation_id": "topic_784", "turn_id": 4, "query": "Given this environmental regulation of PKS gene expression, what specific transcriptomic methodologies were used to quantify differential expression patterns between white-rot and brown-rot fungi under variable nutrient conditions? I'm particularly interested in the RNA extraction protocols from wood substrates, the normalization strategies employed for cross-species comparisons, and the statistical validation of expression changes, especially how you controlled for fungal biomass variation in mixed-substrate experiments.", "history": ["Overview of fungal groups involved in lignocellulose decomposition and their primary degradative mechanisms", "Genetic determinants of lignocellulolytic enzyme systems in these fungal groups and their contribution to the efficiency of this decomposition process", "Influence of environmental factors (e.g., pH, nutrient stoichiometry) on differential expression of polyketide synthase (PKS) genes in white-rot versus brown-rot fungi, and resulting consequences for fungal competitive interactions and wood carbon mobilization."], "ground_truth": ["permed-63973", "permed-63886", "permed-13623", "permed-63793", "permed-52776", "permed-66864", "permed-72860", "permed-33887", "permed-89755", "permed-65146"]}
{"query_id": "topic_784_turn_5", "conversation_id": "topic_784", "turn_id": 5, "query": "Given these transcriptomic methodologies for quantifying PKS expression patterns, how have these fungal degradative mechanisms been translated into clinical applications? Specifically, what evidence exists regarding the therapeutic efficacy of fungal-derived lignocellulolytic enzymes in treating conditions like biofilm-based medical device infections, and what are the primary safety considerations and contraindications when considering these enzymatic approaches compared to conventional antimicrobial treatments? Have any clinical trials evaluated the real-world deployment challenges, such as host immune responses to these fungal enzymes?", "history": ["Overview of fungal groups involved in lignocellulose decomposition and their primary degradative mechanisms", "Genetic determinants of lignocellulolytic enzyme systems in these fungal groups and their contribution to the efficiency of this decomposition process", "Influence of environmental factors (e.g., pH, nutrient stoichiometry) on differential expression of polyketide synthase (PKS) genes in white-rot versus brown-rot fungi, and resulting consequences for fungal competitive interactions and wood carbon mobilization.", "Given this environmental regulation of PKS gene expression, what specific transcriptomic methodologies were used to quantify differential expression patterns between white-rot and brown-rot fungi under variable nutrient conditions? I'm particularly interested in the RNA extraction protocols from wood substrates, the normalization strategies employed for cross-species comparisons, and the statistical validation of expression changes, especially how you controlled for fungal biomass variation in mixed-substrate experiments."], "ground_truth": ["permed-77432", "permed-53003", "permed-66770", "permed-74230", "permed-6619", "permed-55446", "permed-22408", "permed-63916", "permed-64539", "permed-76636"]}
{"query_id": "topic_784_turn_6", "conversation_id": "topic_784", "turn_id": 6, "query": "Given our discussion of fungal degradative mechanisms and their clinical translation, how exactly are \"lignocellulolytic enzymes\" fundamentally defined in medical contexts versus their ecological roles? Specifically, what constitutes the operational definition when considering therapeutic efficacy - does it encompass only the canonical lignin-modifying enzymes discussed earlier, or does it extend to accessory enzymes like PKS-derived metabolites given their environmental regulation? From a long-term clinical perspective, how might expanding this definition to include secondary metabolic networks address current limitations in conventional antimicrobial treatments, particularly regarding biofilm matrix complexity?", "history": ["Overview of fungal groups involved in lignocellulose decomposition and their primary degradative mechanisms", "Genetic determinants of lignocellulolytic enzyme systems in these fungal groups and their contribution to the efficiency of this decomposition process", "Influence of environmental factors (e.g., pH, nutrient stoichiometry) on differential expression of polyketide synthase (PKS) genes in white-rot versus brown-rot fungi, and resulting consequences for fungal competitive interactions and wood carbon mobilization.", "Given this environmental regulation of PKS gene expression, what specific transcriptomic methodologies were used to quantify differential expression patterns between white-rot and brown-rot fungi under variable nutrient conditions? I'm particularly interested in the RNA extraction protocols from wood substrates, the normalization strategies employed for cross-species comparisons, and the statistical validation of expression changes, especially how you controlled for fungal biomass variation in mixed-substrate experiments.", "Given these transcriptomic methodologies for quantifying PKS expression patterns, how have these fungal degradative mechanisms been translated into clinical applications? Specifically, what evidence exists regarding the therapeutic efficacy of fungal-derived lignocellulolytic enzymes in treating conditions like biofilm-based medical device infections, and what are the primary safety considerations and contraindications when considering these enzymatic approaches compared to conventional antimicrobial treatments? Have any clinical trials evaluated the real-world deployment challenges, such as host immune responses to these fungal enzymes?"], "ground_truth": ["permed-52995", "permed-53003", "permed-76016", "permed-76769", "permed-77432", "permed-74230", "permed-67462", "permed-76021", "permed-79404", "permed-74758"]}
{"query_id": "topic_785_turn_1", "conversation_id": "topic_785", "turn_id": 1, "query": "What role do tracheobronchial stents play in managing airway stenosis in patients with unresectable tumors?", "history": [], "ground_truth": ["permed-78903", "permed-85453", "permed-54713", "permed-70578", "permed-78905", "permed-85077", "permed-54463", "permed-70809", "permed-70813", "permed-71325"]}
{"query_id": "topic_785_turn_2", "conversation_id": "topic_785", "turn_id": 2, "query": "How do differences in stent design and material impact the effectiveness of this treatment approach?", "history": ["What role do tracheobronchial stents play in managing airway stenosis in patients with unresectable tumors?"], "ground_truth": ["permed-57409", "permed-71333", "permed-56265", "permed-68855", "permed-77722", "permed-57219", "permed-68850", "permed-68851", "permed-82624", "permed-57331"]}
{"query_id": "topic_785_turn_3", "conversation_id": "topic_785", "turn_id": 3, "query": "Given these differences in stent design and material, how do they affect long-term outcomes—particularly regarding complications like granulation tissue formation and stent migration—in patients with unresectable tumors and airway stenosis? What do these factors mean for the durability of respiratory function improvement and patient-reported quality of life over time?", "history": ["What role do tracheobronchial stents play in managing airway stenosis in patients with unresectable tumors?", "How do differences in stent design and material impact the effectiveness of this treatment approach?"], "ground_truth": ["permed-78903", "permed-70814", "permed-57075", "permed-68856", "permed-57409", "permed-90187", "permed-70578", "permed-71325", "permed-90188", "permed-70809"]}
{"query_id": "topic_785_turn_4", "conversation_id": "topic_785", "turn_id": 4, "query": "Considering these long-term complication patterns, what specific statistical methods were employed to analyze temporal trends in granulation tissue formation and stent migration rates? Were time-to-event analyses like Kaplan-Meier curves or Cox proportional hazards models used to account for varying follow-up durations? Additionally, how did researchers validate their quality of life measurement instruments, and what statistical power calculations informed their sample size determinations for detecting clinically meaningful differences in respiratory function durability?", "history": ["What role do tracheobronchial stents play in managing airway stenosis in patients with unresectable tumors?", "How do differences in stent design and material impact the effectiveness of this treatment approach?", "Given these differences in stent design and material, how do they affect long-term outcomes—particularly regarding complications like granulation tissue formation and stent migration—in patients with unresectable tumors and airway stenosis? What do these factors mean for the durability of respiratory function improvement and patient-reported quality of life over time?"], "ground_truth": ["permed-70814", "permed-52319", "permed-39525", "permed-92203", "permed-78903", "permed-70629", "permed-81200", "permed-4901", "permed-54790", "permed-25687"]}
{"query_id": "topic_785_turn_5", "conversation_id": "topic_785", "turn_id": 5, "query": "Given these sophisticated statistical approaches to evaluating long-term complications, what clinical implications have emerged regarding optimal stent selection protocols for specific patient subgroups? With demonstrated differences in granulation tissue formation and migration rates between stent types, how have institutions implemented evidence-based guidelines balancing therapeutic efficacy against complication profiles? Specifically, what clinical decision pathways now exist for choosing between silicone, metallic, or hybrid stents in patients with different tumor locations or comorbidities, and how have these protocols impacted real-world rates of unplanned reinterventions and emergency department presentations for acute airway compromise?", "history": ["What role do tracheobronchial stents play in managing airway stenosis in patients with unresectable tumors?", "How do differences in stent design and material impact the effectiveness of this treatment approach?", "Given these differences in stent design and material, how do they affect long-term outcomes—particularly regarding complications like granulation tissue formation and stent migration—in patients with unresectable tumors and airway stenosis? What do these factors mean for the durability of respiratory function improvement and patient-reported quality of life over time?", "Considering these long-term complication patterns, what specific statistical methods were employed to analyze temporal trends in granulation tissue formation and stent migration rates? Were time-to-event analyses like Kaplan-Meier curves or Cox proportional hazards models used to account for varying follow-up durations? Additionally, how did researchers validate their quality of life measurement instruments, and what statistical power calculations informed their sample size determinations for detecting clinically meaningful differences in respiratory function durability?"], "ground_truth": ["permed-68856", "permed-57075", "permed-80244", "permed-52606", "permed-68850", "permed-32963", "permed-57219", "permed-66050", "permed-92648", "permed-57409"]}
{"query_id": "topic_785_turn_6", "conversation_id": "topic_785", "turn_id": 6, "query": "Considering the established clinical decision pathways for stent selection, how do current evidence-based protocols for silicone versus metallic/hybrid stents compare across different healthcare settings (academic centers vs. community hospitals) in terms of implementation fidelity and patient outcomes? Given the previously discussed trade-offs between granulation risk and migration rates, what systematic differences exist in how institutions operationalize these guidelines? Specifically, how do resource constraints, technical expertise availability, and local complication management capabilities affect real-world adherence to optimal stent selection protocols and subsequent rates of unplanned reinterventions?", "history": ["What role do tracheobronchial stents play in managing airway stenosis in patients with unresectable tumors?", "How do differences in stent design and material impact the effectiveness of this treatment approach?", "Given these differences in stent design and material, how do they affect long-term outcomes—particularly regarding complications like granulation tissue formation and stent migration—in patients with unresectable tumors and airway stenosis? What do these factors mean for the durability of respiratory function improvement and patient-reported quality of life over time?", "Considering these long-term complication patterns, what specific statistical methods were employed to analyze temporal trends in granulation tissue formation and stent migration rates? Were time-to-event analyses like Kaplan-Meier curves or Cox proportional hazards models used to account for varying follow-up durations? Additionally, how did researchers validate their quality of life measurement instruments, and what statistical power calculations informed their sample size determinations for detecting clinically meaningful differences in respiratory function durability?", "Given these sophisticated statistical approaches to evaluating long-term complications, what clinical implications have emerged regarding optimal stent selection protocols for specific patient subgroups? With demonstrated differences in granulation tissue formation and migration rates between stent types, how have institutions implemented evidence-based guidelines balancing therapeutic efficacy against complication profiles? Specifically, what clinical decision pathways now exist for choosing between silicone, metallic, or hybrid stents in patients with different tumor locations or comorbidities, and how have these protocols impacted real-world rates of unplanned reinterventions and emergency department presentations for acute airway compromise?"], "ground_truth": ["permed-80244", "permed-90924", "permed-54449", "permed-68857", "permed-57219", "permed-88098", "permed-57409", "permed-70809", "permed-57075", "permed-76322"]}
{"query_id": "topic_786_turn_1", "conversation_id": "topic_786", "turn_id": 1, "query": "Genetic determinants and landscape of common comorbidities in Trisomy 21", "history": [], "ground_truth": ["permed-53717", "permed-50790", "permed-76307", "permed-73645", "permed-74563", "permed-73648", "permed-77651", "permed-71706", "permed-92062", "permed-89562"]}
{"query_id": "topic_786_turn_2", "conversation_id": "topic_786", "turn_id": 2, "query": "Impact of these genetic determinants on aging phenotypes and comorbidity progression in adults with Trisomy 21", "history": ["Genetic determinants and landscape of common comorbidities in Trisomy 21"], "ground_truth": ["permed-53717", "permed-50790", "permed-76307", "permed-74563", "permed-74720", "permed-76306", "permed-73648", "permed-71706", "permed-89562", "permed-82373"]}
{"query_id": "topic_786_turn_3", "conversation_id": "topic_786", "turn_id": 3, "query": "Molecular pathophysiology of key chromosome 21 genes contributing to accelerated aging and specific comorbidities in Trisomy 21: implications for targeted therapeutic interventions and multidisciplinary care models", "history": ["Genetic determinants and landscape of common comorbidities in Trisomy 21", "Impact of these genetic determinants on aging phenotypes and comorbidity progression in adults with Trisomy 21"], "ground_truth": ["permed-74563", "permed-76307", "permed-72010", "permed-53717", "permed-82373", "permed-51246", "permed-89562", "permed-50790", "permed-54286", "permed-74720"]}
{"query_id": "topic_786_turn_4", "conversation_id": "topic_786", "turn_id": 4, "query": "When investigating this molecular pathophysiology, what specific experimental approaches are you using to validate the functional consequences of chromosome 21 gene dysregulation? I'm particularly interested in your methodology for establishing causal relationships between specific gene dosage effects and aging biomarkers - are you employing CRISPR-based gene editing in relevant cell models followed by functional assays, or utilizing multi-omics integration approaches to map pathway disruptions? Additionally, what statistical methods are you implementing to distinguish driver mutations from passenger effects in your comorbidity models?", "history": ["Genetic determinants and landscape of common comorbidities in Trisomy 21", "Impact of these genetic determinants on aging phenotypes and comorbidity progression in adults with Trisomy 21", "Molecular pathophysiology of key chromosome 21 genes contributing to accelerated aging and specific comorbidities in Trisomy 21: implications for targeted therapeutic interventions and multidisciplinary care models"], "ground_truth": ["permed-54246", "permed-21333", "permed-54619", "permed-83665", "permed-21337", "permed-50788", "permed-21335", "permed-85325", "permed-85736", "permed-72592"]}
{"query_id": "topic_786_turn_5", "conversation_id": "topic_786", "turn_id": 5, "query": "Given your methodological approach to validating chromosome 21 gene dysregulation, how would you systematically compare the relative merits and limitations of CRISPR-based functional validation versus multi-omics integration for establishing causality in Trisomy 21 comorbidities? Specifically, which approach provides more robust evidence for distinguishing driver pathways from secondary effects in different tissue contexts, and what are the key trade-offs between mechanistic depth and systems-level comprehensiveness when prioritizing these strategies for aging biomarker identification?", "history": ["Genetic determinants and landscape of common comorbidities in Trisomy 21", "Impact of these genetic determinants on aging phenotypes and comorbidity progression in adults with Trisomy 21", "Molecular pathophysiology of key chromosome 21 genes contributing to accelerated aging and specific comorbidities in Trisomy 21: implications for targeted therapeutic interventions and multidisciplinary care models", "When investigating this molecular pathophysiology, what specific experimental approaches are you using to validate the functional consequences of chromosome 21 gene dysregulation? I'm particularly interested in your methodology for establishing causal relationships between specific gene dosage effects and aging biomarkers - are you employing CRISPR-based gene editing in relevant cell models followed by functional assays, or utilizing multi-omics integration approaches to map pathway disruptions? Additionally, what statistical methods are you implementing to distinguish driver mutations from passenger effects in your comorbidity models?"], "ground_truth": ["permed-55581", "permed-76307", "permed-73645", "permed-56211", "permed-83927", "permed-73734", "permed-55579", "permed-51246", "permed-83932", "permed-61484"]}
{"query_id": "topic_786_turn_6", "conversation_id": "topic_786", "turn_id": 6, "query": "Given our discussion of CRISPR validation and multi-omics approaches for establishing causality in Trisomy 21 comorbidities, how would you systematically compare their respective capacities for identifying clinically actionable therapeutic targets versus elucidating fundamental aging mechanisms? Specifically, when considering long-term translational applications, which methodology demonstrates superior cost-effectiveness and scalability for mapping tissue-specific pathway disruptions across different aging stages, and what are the critical trade-offs between target discovery throughput and mechanistic depth that might influence future research prioritization in adult Trisomy 21 populations?", "history": ["Genetic determinants and landscape of common comorbidities in Trisomy 21", "Impact of these genetic determinants on aging phenotypes and comorbidity progression in adults with Trisomy 21", "Molecular pathophysiology of key chromosome 21 genes contributing to accelerated aging and specific comorbidities in Trisomy 21: implications for targeted therapeutic interventions and multidisciplinary care models", "When investigating this molecular pathophysiology, what specific experimental approaches are you using to validate the functional consequences of chromosome 21 gene dysregulation? I'm particularly interested in your methodology for establishing causal relationships between specific gene dosage effects and aging biomarkers - are you employing CRISPR-based gene editing in relevant cell models followed by functional assays, or utilizing multi-omics integration approaches to map pathway disruptions? Additionally, what statistical methods are you implementing to distinguish driver mutations from passenger effects in your comorbidity models?", "Given your methodological approach to validating chromosome 21 gene dysregulation, how would you systematically compare the relative merits and limitations of CRISPR-based functional validation versus multi-omics integration for establishing causality in Trisomy 21 comorbidities? Specifically, which approach provides more robust evidence for distinguishing driver pathways from secondary effects in different tissue contexts, and what are the key trade-offs between mechanistic depth and systems-level comprehensiveness when prioritizing these strategies for aging biomarker identification?"], "ground_truth": ["permed-74563", "permed-83932", "permed-54286", "permed-80023", "permed-76307", "permed-54246", "permed-83665", "permed-73734", "permed-61488", "permed-58215"]}
{"query_id": "topic_787_turn_1", "conversation_id": "topic_787", "turn_id": 1, "query": "Primary healthcare access challenges for rural elderly women in Bangladesh", "history": [], "ground_truth": ["permed-53169", "permed-70909", "permed-65730", "permed-61888", "permed-63356", "permed-65725", "permed-79449", "permed-60179", "permed-51711", "permed-70906"]}
{"query_id": "topic_787_turn_2", "conversation_id": "topic_787", "turn_id": 2, "query": "Community-based interventions to address *these* healthcare access challenges and improve utilization for rural elderly women in Bangladesh", "history": ["Primary healthcare access challenges for rural elderly women in Bangladesh"], "ground_truth": ["permed-53169", "permed-65730", "permed-61888", "permed-79449", "permed-90617", "permed-65725", "permed-51711", "permed-79235", "permed-70909", "permed-63356"]}
{"query_id": "topic_787_turn_3", "conversation_id": "topic_787", "turn_id": 3, "query": "Tailoring integrated community health interventions for rural elderly women in Bangladesh considering provider-identified socio-economic, cultural, and institutional barriers", "history": ["Primary healthcare access challenges for rural elderly women in Bangladesh", "Community-based interventions to address *these* healthcare access challenges and improve utilization for rural elderly women in Bangladesh"], "ground_truth": ["permed-53169", "permed-51711", "permed-65730", "permed-90617", "permed-63356", "permed-61888", "permed-53165", "permed-79449", "permed-63361", "permed-65428"]}
{"query_id": "topic_787_turn_4", "conversation_id": "topic_787", "turn_id": 4, "query": "When tailoring these integrated community health interventions, what specific methodological approaches were used to validate the cultural appropriateness of modified care protocols? I'm particularly interested in the mixed-methods framework for triangulating provider-identified barriers with actual elderly women's experiences, and how you established reliability metrics for the adaptation process while maintaining intervention fidelity across different rural implementation sites. Could you detail the iterative validation cycles between community health workers and local stakeholders?", "history": ["Primary healthcare access challenges for rural elderly women in Bangladesh", "Community-based interventions to address *these* healthcare access challenges and improve utilization for rural elderly women in Bangladesh", "Tailoring integrated community health interventions for rural elderly women in Bangladesh considering provider-identified socio-economic, cultural, and institutional barriers"], "ground_truth": ["permed-66109", "permed-69900", "permed-25698", "permed-65839", "permed-64788", "permed-53977", "permed-8718", "permed-64779", "permed-53169", "permed-91979"]}
{"query_id": "topic_787_turn_5", "conversation_id": "topic_787", "turn_id": 5, "query": "Given these methodological validation approaches for culturally appropriate interventions, how have the adapted care protocols translated into measurable clinical outcomes for elderly rural women in Bangladesh? Specifically, what comparative clinical trial data exists regarding therapeutic efficacy in managing chronic conditions like hypertension or diabetes between standard versus culturally-tailored community health worker programs? I'm interested in both biomedical markers and patient-reported outcomes, plus any documented differences in medication adherence rates or adverse event profiles that emerged during real-world deployment across these implementation sites.", "history": ["Primary healthcare access challenges for rural elderly women in Bangladesh", "Community-based interventions to address *these* healthcare access challenges and improve utilization for rural elderly women in Bangladesh", "Tailoring integrated community health interventions for rural elderly women in Bangladesh considering provider-identified socio-economic, cultural, and institutional barriers", "When tailoring these integrated community health interventions, what specific methodological approaches were used to validate the cultural appropriateness of modified care protocols? I'm particularly interested in the mixed-methods framework for triangulating provider-identified barriers with actual elderly women's experiences, and how you established reliability metrics for the adaptation process while maintaining intervention fidelity across different rural implementation sites. Could you detail the iterative validation cycles between community health workers and local stakeholders?"], "ground_truth": ["permed-53169", "permed-25253", "permed-66109", "permed-40178", "permed-91979", "permed-65839", "permed-90617", "permed-63533", "permed-34660", "permed-25399"]}
{"query_id": "topic_787_turn_6", "conversation_id": "topic_787", "turn_id": 6, "query": "Given our progression from intervention design to validation and clinical outcomes, how would you fundamentally define \"intervention fidelity\" within this Bangladeshi context where cultural adaptations occurred? Specifically, what constitutes the essential core components that must remain invariant versus adaptable elements when balancing protocol standardization with cultural responsiveness? How do researchers operationally distinguish between fidelity erosion versus legitimate contextual adaptation, particularly when evaluating the mixed-method validation cycles and comparative outcomes we discussed? What definitional boundaries ensure we're measuring implementation quality rather than rigid adherence?", "history": ["Primary healthcare access challenges for rural elderly women in Bangladesh", "Community-based interventions to address *these* healthcare access challenges and improve utilization for rural elderly women in Bangladesh", "Tailoring integrated community health interventions for rural elderly women in Bangladesh considering provider-identified socio-economic, cultural, and institutional barriers", "When tailoring these integrated community health interventions, what specific methodological approaches were used to validate the cultural appropriateness of modified care protocols? I'm particularly interested in the mixed-methods framework for triangulating provider-identified barriers with actual elderly women's experiences, and how you established reliability metrics for the adaptation process while maintaining intervention fidelity across different rural implementation sites. Could you detail the iterative validation cycles between community health workers and local stakeholders?", "Given these methodological validation approaches for culturally appropriate interventions, how have the adapted care protocols translated into measurable clinical outcomes for elderly rural women in Bangladesh? Specifically, what comparative clinical trial data exists regarding therapeutic efficacy in managing chronic conditions like hypertension or diabetes between standard versus culturally-tailored community health worker programs? I'm interested in both biomedical markers and patient-reported outcomes, plus any documented differences in medication adherence rates or adverse event profiles that emerged during real-world deployment across these implementation sites."], "ground_truth": ["permed-66109", "permed-64779", "permed-69898", "permed-69900", "permed-64788", "permed-85662", "permed-65839", "permed-73843", "permed-85811", "permed-61613"]}
{"query_id": "topic_788_turn_1", "conversation_id": "topic_788", "turn_id": 1, "query": "What are the current challenges in treating chronic NTM infections in cystic fibrosis patients?", "history": [], "ground_truth": ["permed-60461", "permed-22221", "permed-57373", "permed-11755", "permed-26664", "permed-22508", "permed-26665", "permed-9453", "permed-61556", "permed-67862"]}
{"query_id": "topic_788_turn_2", "conversation_id": "topic_788", "turn_id": 2, "query": "Are there any new or emerging therapies, like CRS0393, that show promise in addressing these challenges?", "history": ["What are the current challenges in treating chronic NTM infections in cystic fibrosis patients?"], "ground_truth": ["permed-68132", "permed-21784", "permed-72504", "permed-58149", "permed-62455", "permed-52524", "permed-21785", "permed-79374", "permed-56699", "permed-12312"]}
{"query_id": "topic_788_turn_3", "conversation_id": "topic_788", "turn_id": 3, "query": "Given that CRS0393 shows promise for treating these infections in CF patients, how could we optimize its long-term efficacy and safety—specifically by examining how different dosing regimens and formulations affect drug distribution and resistance development? Also, what approaches might improve its oral bioavailability to make treatment more effective and patient-friendly, especially for pediatric cases?", "history": ["What are the current challenges in treating chronic NTM infections in cystic fibrosis patients?", "Are there any new or emerging therapies, like CRS0393, that show promise in addressing these challenges?"], "ground_truth": ["permed-51258", "permed-72262", "permed-67863", "permed-86020", "permed-86722", "permed-57373", "permed-67862", "permed-26380", "permed-60672", "permed-90288"]}
{"query_id": "topic_788_turn_4", "conversation_id": "topic_788", "turn_id": 4, "query": "Given this focus on dosing optimization and bioavailability enhancement, what specific preclinical models would best capture the dynamic pharmacokinetic-pharmacodynamic relationships for CRS0393 in CF lung environments? I'm particularly interested in methodological considerations for simulating CF-specific factors like mucus penetration, bacterial biofilm penetration, and epithelial transport when evaluating these formulations. Would you recommend using differentiated primary human bronchial epithelial cell cultures under air-liquid interface conditions, or are there more sophisticated in vivo models that better replicate the complex pulmonary architecture in CF patients?", "history": ["What are the current challenges in treating chronic NTM infections in cystic fibrosis patients?", "Are there any new or emerging therapies, like CRS0393, that show promise in addressing these challenges?", "Given that CRS0393 shows promise for treating these infections in CF patients, how could we optimize its long-term efficacy and safety—specifically by examining how different dosing regimens and formulations affect drug distribution and resistance development? Also, what approaches might improve its oral bioavailability to make treatment more effective and patient-friendly, especially for pediatric cases?"], "ground_truth": ["permed-51258", "permed-67863", "permed-27528", "permed-75426", "permed-51252", "permed-74473", "permed-27223", "permed-71079", "permed-60733", "permed-67278"]}
{"query_id": "topic_788_turn_5", "conversation_id": "topic_788", "turn_id": 5, "query": "Given these sophisticated preclinical modeling approaches for pharmacokinetic optimization, what clinical trial designs would be most appropriate for translating CRS0393 into human studies for CF patients with NTM infections? Specifically, how should Phase I/II trials address special considerations like pediatric dose escalation, potential drug interactions with CFTR modulators, and safety monitoring for pulmonary and gastrointestinal adverse effects? Additionally, what patient-reported outcome measures would best capture real-world treatment tolerability and adherence in this chronic infection population?", "history": ["What are the current challenges in treating chronic NTM infections in cystic fibrosis patients?", "Are there any new or emerging therapies, like CRS0393, that show promise in addressing these challenges?", "Given that CRS0393 shows promise for treating these infections in CF patients, how could we optimize its long-term efficacy and safety—specifically by examining how different dosing regimens and formulations affect drug distribution and resistance development? Also, what approaches might improve its oral bioavailability to make treatment more effective and patient-friendly, especially for pediatric cases?", "Given this focus on dosing optimization and bioavailability enhancement, what specific preclinical models would best capture the dynamic pharmacokinetic-pharmacodynamic relationships for CRS0393 in CF lung environments? I'm particularly interested in methodological considerations for simulating CF-specific factors like mucus penetration, bacterial biofilm penetration, and epithelial transport when evaluating these formulations. Would you recommend using differentiated primary human bronchial epithelial cell cultures under air-liquid interface conditions, or are there more sophisticated in vivo models that better replicate the complex pulmonary architecture in CF patients?"], "ground_truth": ["permed-51258", "permed-67860", "permed-22508", "permed-67863", "permed-26665", "permed-67862", "permed-86722", "permed-72262", "permed-68917", "permed-82476"]}
{"query_id": "topic_788_turn_6", "conversation_id": "topic_788", "turn_id": 6, "query": "Given our extensive discussion of CRS0393's development pathway, what fundamentally constitutes an \"optimal\" clinical trial endpoint for NTM infections in CF patients, particularly when balancing regulatory requirements with patient-centered outcomes? Beyond traditional microbiological endpoints, how should we conceptually define \"treatment success\" to encompass both pathogen eradication and quality-of-life improvements, especially considering the chronic nature of these infections and the potential for persistent non-culturable bacterial states? What theoretical framework best captures this multidimensional therapeutic efficacy while addressing the unique challenges of CF pulmonary pathophysiology?", "history": ["What are the current challenges in treating chronic NTM infections in cystic fibrosis patients?", "Are there any new or emerging therapies, like CRS0393, that show promise in addressing these challenges?", "Given that CRS0393 shows promise for treating these infections in CF patients, how could we optimize its long-term efficacy and safety—specifically by examining how different dosing regimens and formulations affect drug distribution and resistance development? Also, what approaches might improve its oral bioavailability to make treatment more effective and patient-friendly, especially for pediatric cases?", "Given this focus on dosing optimization and bioavailability enhancement, what specific preclinical models would best capture the dynamic pharmacokinetic-pharmacodynamic relationships for CRS0393 in CF lung environments? I'm particularly interested in methodological considerations for simulating CF-specific factors like mucus penetration, bacterial biofilm penetration, and epithelial transport when evaluating these formulations. Would you recommend using differentiated primary human bronchial epithelial cell cultures under air-liquid interface conditions, or are there more sophisticated in vivo models that better replicate the complex pulmonary architecture in CF patients?", "Given these sophisticated preclinical modeling approaches for pharmacokinetic optimization, what clinical trial designs would be most appropriate for translating CRS0393 into human studies for CF patients with NTM infections? Specifically, how should Phase I/II trials address special considerations like pediatric dose escalation, potential drug interactions with CFTR modulators, and safety monitoring for pulmonary and gastrointestinal adverse effects? Additionally, what patient-reported outcome measures would best capture real-world treatment tolerability and adherence in this chronic infection population?"], "ground_truth": ["permed-60461", "permed-26665", "permed-51258", "permed-72262", "permed-11755", "permed-22508", "permed-22221", "permed-67864", "permed-67860", "permed-33675"]}
{"query_id": "topic_789_turn_1", "conversation_id": "topic_789", "turn_id": 1, "query": "What tools are currently used for metagenotyping and variant detection in microbial communities?", "history": [], "ground_truth": ["permed-67117", "permed-67118", "permed-67046", "permed-67113", "permed-67044", "permed-67045", "permed-57646", "permed-82012", "permed-67116", "permed-57632"]}
{"query_id": "topic_789_turn_2", "conversation_id": "topic_789", "turn_id": 2, "query": "How effective is MIDAS2, in particular, in enhancing the accuracy of this process, especially for low-frequency variants?", "history": ["What tools are currently used for metagenotyping and variant detection in microbial communities?"], "ground_truth": ["permed-67117", "permed-60524", "permed-67237", "permed-84243", "permed-90571", "permed-70671", "permed-88046", "permed-56264", "permed-85394", "permed-6388"]}
{"query_id": "topic_789_turn_3", "conversation_id": "topic_789", "turn_id": 3, "query": "Given MIDAS2's effectiveness in metagenotyping and improving variant detection accuracy, particularly for low-frequency variants, how could combining its variant calling process with machine learning algorithms enhance the identification of these variants in complex microbial populations? What would be the key computational and biological challenges and opportunities of such an integration?", "history": ["What tools are currently used for metagenotyping and variant detection in microbial communities?", "How effective is MIDAS2, in particular, in enhancing the accuracy of this process, especially for low-frequency variants?"], "ground_truth": ["permed-67117", "permed-57632", "permed-90571", "permed-54310", "permed-67045", "permed-6055", "permed-71115", "permed-67114", "permed-67113", "permed-67047"]}
{"query_id": "topic_789_turn_4", "conversation_id": "topic_789", "turn_id": 4, "query": "Given this proposed integration of MIDAS2 with machine learning algorithms, what specific feature engineering approaches would be most appropriate for representing variant call outputs as training data? Would you recommend using raw alignment metrics, processed variant quality scores, or some combination of phylogenetic context features? How should the training dataset be structured to account for the hierarchical nature of microbial communities, and what cross-validation strategy would best address potential overfitting given the compositional nature of metagenomic data?", "history": ["What tools are currently used for metagenotyping and variant detection in microbial communities?", "How effective is MIDAS2, in particular, in enhancing the accuracy of this process, especially for low-frequency variants?", "Given MIDAS2's effectiveness in metagenotyping and improving variant detection accuracy, particularly for low-frequency variants, how could combining its variant calling process with machine learning algorithms enhance the identification of these variants in complex microbial populations? What would be the key computational and biological challenges and opportunities of such an integration?"], "ground_truth": ["permed-67117", "permed-57638", "permed-67113", "permed-61285", "permed-71776", "permed-74889", "permed-54310", "permed-67045", "permed-55584", "permed-56400"]}
{"query_id": "topic_789_turn_5", "conversation_id": "topic_789", "turn_id": 5, "query": "Given these methodological advances in metagenotyping and machine learning integration for variant detection, how might these analytical improvements translate into tangible clinical applications? Specifically, in infectious disease management, could enhanced detection of low-frequency antimicrobial resistance variants lead to earlier intervention strategies or more personalized antibiotic regimens? What evidence exists from clinical studies about how such refined metagenomic profiling actually impacts patient outcomes like reduced treatment failure rates or shorter hospitalization durations, and what are the practical barriers to implementing these tools in diagnostic microbiology laboratories?", "history": ["What tools are currently used for metagenotyping and variant detection in microbial communities?", "How effective is MIDAS2, in particular, in enhancing the accuracy of this process, especially for low-frequency variants?", "Given MIDAS2's effectiveness in metagenotyping and improving variant detection accuracy, particularly for low-frequency variants, how could combining its variant calling process with machine learning algorithms enhance the identification of these variants in complex microbial populations? What would be the key computational and biological challenges and opportunities of such an integration?", "Given this proposed integration of MIDAS2 with machine learning algorithms, what specific feature engineering approaches would be most appropriate for representing variant call outputs as training data? Would you recommend using raw alignment metrics, processed variant quality scores, or some combination of phylogenetic context features? How should the training dataset be structured to account for the hierarchical nature of microbial communities, and what cross-validation strategy would best address potential overfitting given the compositional nature of metagenomic data?"], "ground_truth": ["permed-6050", "permed-6053", "permed-67045", "permed-6052", "permed-6046", "permed-67026", "permed-20128", "permed-83492", "permed-5898", "permed-42620"]}
{"query_id": "topic_789_turn_6", "conversation_id": "topic_789", "turn_id": 6, "query": "Given our discussion about clinical translation of metagenotyping advances, could you precisely define what constitutes a \"clinically actionable\" low-frequency antimicrobial resistance variant in the context of infectious disease management? How do researchers fundamentally distinguish between mere detection of resistance markers versus variants that genuinely warrant therapeutic intervention, considering factors like variant frequency thresholds, microbial genomic context, and host-pathogen dynamics? What conceptual frameworks exist for determining when refined metagenomic profiling transitions from analytical curiosity to clinically meaningful detection, especially regarding unresolved questions about ecological versus pathogenic significance of low-abundance resistant subpopulations?", "history": ["What tools are currently used for metagenotyping and variant detection in microbial communities?", "How effective is MIDAS2, in particular, in enhancing the accuracy of this process, especially for low-frequency variants?", "Given MIDAS2's effectiveness in metagenotyping and improving variant detection accuracy, particularly for low-frequency variants, how could combining its variant calling process with machine learning algorithms enhance the identification of these variants in complex microbial populations? What would be the key computational and biological challenges and opportunities of such an integration?", "Given this proposed integration of MIDAS2 with machine learning algorithms, what specific feature engineering approaches would be most appropriate for representing variant call outputs as training data? Would you recommend using raw alignment metrics, processed variant quality scores, or some combination of phylogenetic context features? How should the training dataset be structured to account for the hierarchical nature of microbial communities, and what cross-validation strategy would best address potential overfitting given the compositional nature of metagenomic data?", "Given these methodological advances in metagenotyping and machine learning integration for variant detection, how might these analytical improvements translate into tangible clinical applications? Specifically, in infectious disease management, could enhanced detection of low-frequency antimicrobial resistance variants lead to earlier intervention strategies or more personalized antibiotic regimens? What evidence exists from clinical studies about how such refined metagenomic profiling actually impacts patient outcomes like reduced treatment failure rates or shorter hospitalization durations, and what are the practical barriers to implementing these tools in diagnostic microbiology laboratories?"], "ground_truth": ["permed-67045", "permed-22905", "permed-62043", "permed-67027", "permed-67116", "permed-68507", "permed-6053", "permed-67117", "permed-63444", "permed-60406"]}
{"query_id": "topic_790_turn_1", "conversation_id": "topic_790", "turn_id": 1, "query": "What role does bioinformatics play in analyzing single-cell RNA sequencing data?", "history": [], "ground_truth": ["permed-53719", "permed-92674", "permed-76585", "permed-87622", "permed-79168", "permed-79171", "permed-67920", "permed-92676", "permed-53718", "permed-79172"]}
{"query_id": "topic_790_turn_2", "conversation_id": "topic_790", "turn_id": 2, "query": "Can integrating specific tools like Secuer with existing pipelines improve this analysis process?", "history": ["What role does bioinformatics play in analyzing single-cell RNA sequencing data?"], "ground_truth": ["permed-66153", "permed-86233", "permed-82651", "permed-53718", "permed-71707", "permed-53716", "permed-78517", "permed-53719", "permed-71763", "permed-75160"]}
{"query_id": "topic_790_turn_3", "conversation_id": "topic_790", "turn_id": 3, "query": "Given that Secuer can be integrated with existing pipelines, how might this integration specifically help optimize the single-cell RNA-seq workflow—particularly by addressing computational bottlenecks and improving the biological interpretation of results?", "history": ["What role does bioinformatics play in analyzing single-cell RNA sequencing data?", "Can integrating specific tools like Secuer with existing pipelines improve this analysis process?"], "ground_truth": ["permed-79168", "permed-92674", "permed-92676", "permed-67920", "permed-79170", "permed-79172", "permed-57634", "permed-53719", "permed-79171", "permed-91600"]}
{"query_id": "topic_790_turn_4", "conversation_id": "topic_790", "turn_id": 4, "query": "Given this integrated approach using Seurat, I'm particularly interested in the specific computational implementation. What statistical validation methods were employed to benchmark pipeline performance against traditional workflows? More concretely, how did you quantify improvements in processing speed and memory usage, and what metrics were used to assess whether biological interpretation was enhanced—for instance, through differential expression analysis sensitivity or cluster stability measures? Were there specific quality control thresholds adjusted during integration to maintain reproducibility across different computational environments?", "history": ["What role does bioinformatics play in analyzing single-cell RNA sequencing data?", "Can integrating specific tools like Secuer with existing pipelines improve this analysis process?", "Given that Secuer can be integrated with existing pipelines, how might this integration specifically help optimize the single-cell RNA-seq workflow—particularly by addressing computational bottlenecks and improving the biological interpretation of results?"], "ground_truth": ["permed-79168", "permed-92674", "permed-54317", "permed-53960", "permed-71535", "permed-71767", "permed-78537", "permed-87620", "permed-92676", "permed-64058"]}
{"query_id": "topic_790_turn_5", "conversation_id": "topic_790", "turn_id": 5, "query": "Given these rigorous statistical validations of pipeline performance, how have these computational improvements in single-cell RNA-seq analysis translated to clinical applications? Specifically, in studies using this optimized workflow, what patient outcome correlations have been identified through the enhanced biological interpretation—such as discovering novel cell subtypes predictive of therapeutic response or disease progression? Furthermore, what are the current barriers to implementing this integrated analytical approach in clinical diagnostic settings, particularly regarding standardization, regulatory compliance, and demonstrating direct impact on treatment decisions or patient management?", "history": ["What role does bioinformatics play in analyzing single-cell RNA sequencing data?", "Can integrating specific tools like Secuer with existing pipelines improve this analysis process?", "Given that Secuer can be integrated with existing pipelines, how might this integration specifically help optimize the single-cell RNA-seq workflow—particularly by addressing computational bottlenecks and improving the biological interpretation of results?", "Given this integrated approach using Seurat, I'm particularly interested in the specific computational implementation. What statistical validation methods were employed to benchmark pipeline performance against traditional workflows? More concretely, how did you quantify improvements in processing speed and memory usage, and what metrics were used to assess whether biological interpretation was enhanced—for instance, through differential expression analysis sensitivity or cluster stability measures? Were there specific quality control thresholds adjusted during integration to maintain reproducibility across different computational environments?"], "ground_truth": ["permed-92674", "permed-54186", "permed-67920", "permed-15196", "permed-79171", "permed-92676", "permed-79168", "permed-87622", "permed-91599", "permed-68724"]}
{"query_id": "topic_790_turn_6", "conversation_id": "topic_790", "turn_id": 6, "query": "Given our discussion progressing from computational optimizations to clinical applications, what exactly constitutes the \"enhanced biological interpretation\" that Seurat integration provides, beyond technical improvements? Specifically, how do we fundamentally define the conceptual framework distinguishing meaningful biological discovery from statistically significant but clinically irrelevant findings? As we consider future clinical translation, what theoretical constructs determine when computational enhancements in clustering resolution or differential expression sensitivity actually translate to biologically actionable insights rather than merely refining technical artifacts?", "history": ["What role does bioinformatics play in analyzing single-cell RNA sequencing data?", "Can integrating specific tools like Secuer with existing pipelines improve this analysis process?", "Given that Secuer can be integrated with existing pipelines, how might this integration specifically help optimize the single-cell RNA-seq workflow—particularly by addressing computational bottlenecks and improving the biological interpretation of results?", "Given this integrated approach using Seurat, I'm particularly interested in the specific computational implementation. What statistical validation methods were employed to benchmark pipeline performance against traditional workflows? More concretely, how did you quantify improvements in processing speed and memory usage, and what metrics were used to assess whether biological interpretation was enhanced—for instance, through differential expression analysis sensitivity or cluster stability measures? Were there specific quality control thresholds adjusted during integration to maintain reproducibility across different computational environments?", "Given these rigorous statistical validations of pipeline performance, how have these computational improvements in single-cell RNA-seq analysis translated to clinical applications? Specifically, in studies using this optimized workflow, what patient outcome correlations have been identified through the enhanced biological interpretation—such as discovering novel cell subtypes predictive of therapeutic response or disease progression? Furthermore, what are the current barriers to implementing this integrated analytical approach in clinical diagnostic settings, particularly regarding standardization, regulatory compliance, and demonstrating direct impact on treatment decisions or patient management?"], "ground_truth": ["permed-53299", "permed-79173", "permed-74679", "permed-52652", "permed-54186", "permed-53352", "permed-79168", "permed-58767", "permed-92674", "permed-63049"]}
{"query_id": "topic_791_turn_1", "conversation_id": "topic_791", "turn_id": 1, "query": "Current investigational treatments for melasma in Asian populations", "history": [], "ground_truth": ["permed-77087", "permed-52826", "permed-76565", "permed-68412", "permed-66740", "permed-68414", "permed-76262", "permed-85440", "permed-77102", "permed-45499"]}
{"query_id": "topic_791_turn_2", "conversation_id": "topic_791", "turn_id": 2, "query": "Comparative efficacy: topical silymarin vs. hydroquinone for melasma in these Asian populations", "history": ["Current investigational treatments for melasma in Asian populations"], "ground_truth": ["permed-77087", "permed-76565", "permed-68412", "permed-77058", "permed-68414", "permed-12778", "permed-77102", "permed-77063", "permed-76562", "permed-76563"]}
{"query_id": "topic_791_turn_3", "conversation_id": "topic_791", "turn_id": 3, "query": "Topical silymarin for melasma in Asian populations: mechanism of action, long-term safety, and sustained efficacy compared to hydroquinone", "history": ["Current investigational treatments for melasma in Asian populations", "Comparative efficacy: topical silymarin vs. hydroquinone for melasma in these Asian populations"], "ground_truth": ["permed-77087", "permed-76565", "permed-68412", "permed-12778", "permed-77058", "permed-68414", "permed-91820", "permed-12777", "permed-89441", "permed-80311"]}
{"query_id": "topic_791_turn_4", "conversation_id": "topic_791", "turn_id": 4, "query": "For the comparative efficacy studies mentioned, what specific clinical trial designs were implemented to evaluate long-term safety and sustained efficacy? I'm particularly interested in how researchers addressed potential confounding factors like sun exposure patterns and hormonal fluctuations in Asian populations. Were standardized photography protocols with cross-polarized imaging used consistently across study sites, and what statistical approaches ensured adequate power for detecting differences in recurrence rates between silymarin and hydroquinone groups over extended follow-up periods?", "history": ["Current investigational treatments for melasma in Asian populations", "Comparative efficacy: topical silymarin vs. hydroquinone for melasma in these Asian populations", "Topical silymarin for melasma in Asian populations: mechanism of action, long-term safety, and sustained efficacy compared to hydroquinone"], "ground_truth": ["permed-77087", "permed-13301", "permed-38691", "permed-88026", "permed-12778", "permed-12543", "permed-13039", "permed-76565", "permed-13040", "permed-92295"]}
{"query_id": "topic_791_turn_5", "conversation_id": "topic_791", "turn_id": 5, "query": "Given the rigorous clinical trial designs and statistical approaches discussed for evaluating long-term outcomes, how do the recurrence patterns and hyperpigmentation rebound effects compare between silymarin and hydroquinone specifically in Asian populations? Considering hydroquinone's known rebound hyperpigmentation risks, does silymarin demonstrate superior relapse prevention with more stable depigmentation over 12-24 month periods? What comparative evidence exists regarding post-treatment melanocyte behavior and inflammatory responses that might explain differential recurrence mechanisms between these agents in Asian skin phenotypes?", "history": ["Current investigational treatments for melasma in Asian populations", "Comparative efficacy: topical silymarin vs. hydroquinone for melasma in these Asian populations", "Topical silymarin for melasma in Asian populations: mechanism of action, long-term safety, and sustained efficacy compared to hydroquinone", "For the comparative efficacy studies mentioned, what specific clinical trial designs were implemented to evaluate long-term safety and sustained efficacy? I'm particularly interested in how researchers addressed potential confounding factors like sun exposure patterns and hormonal fluctuations in Asian populations. Were standardized photography protocols with cross-polarized imaging used consistently across study sites, and what statistical approaches ensured adequate power for detecting differences in recurrence rates between silymarin and hydroquinone groups over extended follow-up periods?"], "ground_truth": ["permed-77087", "permed-68413", "permed-76565", "permed-79251", "permed-86238", "permed-74300", "permed-52826", "permed-52030", "permed-61307", "permed-38691"]}
{"query_id": "topic_791_turn_6", "conversation_id": "topic_791", "turn_id": 6, "query": "Building on our discussion of differential recurrence mechanisms between silymarin and hydroquinone, what precisely constitutes \"inflammatory responses\" and \"melanocyte behavior\" in the context of post-treatment melasma recurrence? Specifically, for Asian skin phenotypes, how are researchers operationally defining these pathophysiological mechanisms—are we referring to specific cytokine profiles (e.g., IL-1α, TNF-α), melanocyte apoptosis versus senescence, or alterations in melanogenic signaling pathways like MITF? Furthermore, what conceptual frameworks currently explain how sustained depigmentation differs fundamentally from mere suppression of melanogenesis in long-term melasma management?", "history": ["Current investigational treatments for melasma in Asian populations", "Comparative efficacy: topical silymarin vs. hydroquinone for melasma in these Asian populations", "Topical silymarin for melasma in Asian populations: mechanism of action, long-term safety, and sustained efficacy compared to hydroquinone", "For the comparative efficacy studies mentioned, what specific clinical trial designs were implemented to evaluate long-term safety and sustained efficacy? I'm particularly interested in how researchers addressed potential confounding factors like sun exposure patterns and hormonal fluctuations in Asian populations. Were standardized photography protocols with cross-polarized imaging used consistently across study sites, and what statistical approaches ensured adequate power for detecting differences in recurrence rates between silymarin and hydroquinone groups over extended follow-up periods?", "Given the rigorous clinical trial designs and statistical approaches discussed for evaluating long-term outcomes, how do the recurrence patterns and hyperpigmentation rebound effects compare between silymarin and hydroquinone specifically in Asian populations? Considering hydroquinone's known rebound hyperpigmentation risks, does silymarin demonstrate superior relapse prevention with more stable depigmentation over 12-24 month periods? What comparative evidence exists regarding post-treatment melanocyte behavior and inflammatory responses that might explain differential recurrence mechanisms between these agents in Asian skin phenotypes?"], "ground_truth": ["permed-68413", "permed-77087", "permed-87654", "permed-86489", "permed-61369", "permed-92191", "permed-76518", "permed-45750", "permed-76519", "permed-68417"]}
{"query_id": "topic_792_turn_1", "conversation_id": "topic_792", "turn_id": 1, "query": "What role does neutron scattering play in studying complex fluid systems?", "history": [], "ground_truth": ["permed-59189", "permed-83500", "permed-73077", "permed-89821", "permed-74269", "permed-84042", "permed-76081", "permed-74672", "permed-58254", "permed-59191"]}
{"query_id": "topic_792_turn_2", "conversation_id": "topic_792", "turn_id": 2, "query": "Can advanced analytical techniques enhance the insights gained from this method, particularly regarding dynamic behavior?", "history": ["What role does neutron scattering play in studying complex fluid systems?"], "ground_truth": ["permed-82651", "permed-79296", "permed-81055", "permed-55289", "permed-48714", "permed-61725", "permed-58418", "permed-66405", "permed-67213", "permed-79184"]}
{"query_id": "topic_792_turn_3", "conversation_id": "topic_792", "turn_id": 3, "query": "Given these advanced analytical techniques for studying dynamic behavior through neutron scattering, how could applying machine learning algorithms to this data improve our understanding of interatomic interactions in complex fluids—especially in predicting phase transitions and critical phenomena?", "history": ["What role does neutron scattering play in studying complex fluid systems?", "Can advanced analytical techniques enhance the insights gained from this method, particularly regarding dynamic behavior?"], "ground_truth": ["permed-59189", "permed-59191", "permed-83500", "permed-52457", "permed-76081", "permed-73151", "permed-89821", "permed-67213", "permed-74672", "permed-80021"]}
{"query_id": "topic_792_turn_4", "conversation_id": "topic_792", "turn_id": 4, "query": "Given these machine learning approaches for analyzing neutron scattering data, what specific validation frameworks would you recommend for ensuring the physical interpretability of learned features, particularly regarding phase transition prediction? I'm curious about methodological choices—for instance, how should we design cross-validation strategies that account for temporal correlations in dynamic scattering data, and what statistical tests would best quantify prediction uncertainty for critical phenomena?", "history": ["What role does neutron scattering play in studying complex fluid systems?", "Can advanced analytical techniques enhance the insights gained from this method, particularly regarding dynamic behavior?", "Given these advanced analytical techniques for studying dynamic behavior through neutron scattering, how could applying machine learning algorithms to this data improve our understanding of interatomic interactions in complex fluids—especially in predicting phase transitions and critical phenomena?"], "ground_truth": ["permed-59189", "permed-57440", "permed-67213", "permed-73317", "permed-73337", "permed-65170", "permed-59191", "permed-73077", "permed-85937", "permed-83500"]}
{"query_id": "topic_792_turn_5", "conversation_id": "topic_792", "turn_id": 5, "query": "Given these rigorous validation frameworks for machine learning-enhanced neutron scattering analysis, how might these computational approaches translate to clinical applications involving complex biological fluids? Specifically, what evidence exists regarding their efficacy in predicting therapeutic outcomes—such as drug delivery system stability or phase behavior of lipid nanoparticles—and what are the key safety considerations when validating these predictive models for biomedical use? I'm particularly interested in clinical trial designs that could bridge computational predictions with patient response metrics for nanomedicine formulations.", "history": ["What role does neutron scattering play in studying complex fluid systems?", "Can advanced analytical techniques enhance the insights gained from this method, particularly regarding dynamic behavior?", "Given these advanced analytical techniques for studying dynamic behavior through neutron scattering, how could applying machine learning algorithms to this data improve our understanding of interatomic interactions in complex fluids—especially in predicting phase transitions and critical phenomena?", "Given these machine learning approaches for analyzing neutron scattering data, what specific validation frameworks would you recommend for ensuring the physical interpretability of learned features, particularly regarding phase transition prediction? I'm curious about methodological choices—for instance, how should we design cross-validation strategies that account for temporal correlations in dynamic scattering data, and what statistical tests would best quantify prediction uncertainty for critical phenomena?"], "ground_truth": ["permed-67213", "permed-53305", "permed-86118", "permed-51332", "permed-59189", "permed-68480", "permed-87462", "permed-92406", "permed-53344", "permed-90340"]}
{"query_id": "topic_792_turn_6", "conversation_id": "topic_792", "turn_id": 6, "query": "Given our progression from fundamental neutron scattering to clinical validation frameworks, how do we fundamentally define \"predictive validity\" in this computational-biological context? Specifically, what constitutes the theoretical boundary between statistical correlation and causal prediction when machine learning models trained on scattering data claim to forecast therapeutic outcomes? How should we conceptually distinguish between model accuracy in predicting nanoparticle phase behavior versus actual clinical efficacy, particularly when considering the multi-scale complexity of biological systems and potential confounding variables in patient responses?", "history": ["What role does neutron scattering play in studying complex fluid systems?", "Can advanced analytical techniques enhance the insights gained from this method, particularly regarding dynamic behavior?", "Given these advanced analytical techniques for studying dynamic behavior through neutron scattering, how could applying machine learning algorithms to this data improve our understanding of interatomic interactions in complex fluids—especially in predicting phase transitions and critical phenomena?", "Given these machine learning approaches for analyzing neutron scattering data, what specific validation frameworks would you recommend for ensuring the physical interpretability of learned features, particularly regarding phase transition prediction? I'm curious about methodological choices—for instance, how should we design cross-validation strategies that account for temporal correlations in dynamic scattering data, and what statistical tests would best quantify prediction uncertainty for critical phenomena?", "Given these rigorous validation frameworks for machine learning-enhanced neutron scattering analysis, how might these computational approaches translate to clinical applications involving complex biological fluids? Specifically, what evidence exists regarding their efficacy in predicting therapeutic outcomes—such as drug delivery system stability or phase behavior of lipid nanoparticles—and what are the key safety considerations when validating these predictive models for biomedical use? I'm particularly interested in clinical trial designs that could bridge computational predictions with patient response metrics for nanomedicine formulations."], "ground_truth": ["permed-67213", "permed-53344", "permed-12213", "permed-57440", "permed-21347", "permed-59412", "permed-53352", "permed-65800", "permed-33399", "permed-59189"]}
{"query_id": "topic_793_turn_1", "conversation_id": "topic_793", "turn_id": 1, "query": "Applications of machine learning in predicting progression of rare genetic diseases such as hereditary transthyretin amyloidosis", "history": [], "ground_truth": ["permed-65056", "permed-53717", "permed-53332", "permed-55584", "permed-53718", "permed-71706", "permed-71547", "permed-53731", "permed-69746", "permed-75954"]}
{"query_id": "topic_793_turn_2", "conversation_id": "topic_793", "turn_id": 2, "query": "Improving machine learning prediction accuracy for such rare genetic diseases using electronic health record data", "history": ["Applications of machine learning in predicting progression of rare genetic diseases such as hereditary transthyretin amyloidosis"], "ground_truth": ["permed-54920", "permed-77549", "permed-87119", "permed-53341", "permed-52655", "permed-71547", "permed-72062", "permed-66153", "permed-53717", "permed-61540"]}
{"query_id": "topic_793_turn_3", "conversation_id": "topic_793", "turn_id": 3, "query": "Optimizing machine learning and EHR integration for ATTRv polyneuropathy progression: identifying key EHR features for severity and treatment response prediction", "history": ["Applications of machine learning in predicting progression of rare genetic diseases such as hereditary transthyretin amyloidosis", "Improving machine learning prediction accuracy for such rare genetic diseases using electronic health record data"], "ground_truth": ["permed-66153", "permed-65056", "permed-67923", "permed-70937", "permed-55426", "permed-79453", "permed-87119", "permed-53196", "permed-72010", "permed-53332"]}
{"query_id": "topic_793_turn_4", "conversation_id": "topic_793", "turn_id": 4, "query": "Given this optimization framework for EHR integration, what specific feature engineering approaches were most effective for handling the high-dimensionality and temporal nature of EHR data? I'm particularly interested in how you addressed missing data patterns across different clinical domains and whether you compared traditional statistical imputation methods versus deep learning approaches for representing longitudinal patient trajectories in ATTRv polyneuropathy progression modeling.", "history": ["Applications of machine learning in predicting progression of rare genetic diseases such as hereditary transthyretin amyloidosis", "Improving machine learning prediction accuracy for such rare genetic diseases using electronic health record data", "Optimizing machine learning and EHR integration for ATTRv polyneuropathy progression: identifying key EHR features for severity and treatment response prediction"], "ground_truth": ["permed-55426", "permed-53345", "permed-65676", "permed-59590", "permed-73576", "permed-73401", "permed-52655", "permed-53342", "permed-59407", "permed-59615"]}
{"query_id": "topic_793_turn_5", "conversation_id": "topic_793", "turn_id": 5, "query": "Given these optimized EHR feature engineering approaches for ATTRv polyneuropathy progression modeling, what clinical validation has been performed to assess their real-world predictive performance for patient stratification and treatment decisions? Specifically, how do these machine learning models perform in prospective clinical settings compared to standard clinical assessment tools, and what evidence exists regarding their impact on actual patient outcomes, medication adherence, or quality of life measures when integrated into routine cardiology or neurology practice?", "history": ["Applications of machine learning in predicting progression of rare genetic diseases such as hereditary transthyretin amyloidosis", "Improving machine learning prediction accuracy for such rare genetic diseases using electronic health record data", "Optimizing machine learning and EHR integration for ATTRv polyneuropathy progression: identifying key EHR features for severity and treatment response prediction", "Given this optimization framework for EHR integration, what specific feature engineering approaches were most effective for handling the high-dimensionality and temporal nature of EHR data? I'm particularly interested in how you addressed missing data patterns across different clinical domains and whether you compared traditional statistical imputation methods versus deep learning approaches for representing longitudinal patient trajectories in ATTRv polyneuropathy progression modeling."], "ground_truth": ["permed-90553", "permed-57257", "permed-71004", "permed-61788", "permed-53344", "permed-65056", "permed-52655", "permed-77447", "permed-67208", "permed-59412"]}
{"query_id": "topic_793_turn_6", "conversation_id": "topic_793", "turn_id": 6, "query": "Given the progressive validation framework discussed, what precisely constitutes \"clinical utility\" for ML models in rare disease progression? Beyond statistical performance metrics, how should we fundamentally define model readiness for clinical deployment in ATTRv amyloidosis - is it primarily about outperforming existing prognostic tools, demonstrating cost-effectiveness, enabling earlier interventions, or achieving specific improvements in hard endpoints like mortality or hospitalization rates? What conceptual framework distinguishes clinically meaningful prediction from merely accurate prediction in this context, particularly given the heterogeneous progression patterns and limited therapeutic windows?", "history": ["Applications of machine learning in predicting progression of rare genetic diseases such as hereditary transthyretin amyloidosis", "Improving machine learning prediction accuracy for such rare genetic diseases using electronic health record data", "Optimizing machine learning and EHR integration for ATTRv polyneuropathy progression: identifying key EHR features for severity and treatment response prediction", "Given this optimization framework for EHR integration, what specific feature engineering approaches were most effective for handling the high-dimensionality and temporal nature of EHR data? I'm particularly interested in how you addressed missing data patterns across different clinical domains and whether you compared traditional statistical imputation methods versus deep learning approaches for representing longitudinal patient trajectories in ATTRv polyneuropathy progression modeling.", "Given these optimized EHR feature engineering approaches for ATTRv polyneuropathy progression modeling, what clinical validation has been performed to assess their real-world predictive performance for patient stratification and treatment decisions? Specifically, how do these machine learning models perform in prospective clinical settings compared to standard clinical assessment tools, and what evidence exists regarding their impact on actual patient outcomes, medication adherence, or quality of life measures when integrated into routine cardiology or neurology practice?"], "ground_truth": ["permed-70671", "permed-21347", "permed-59412", "permed-61496", "permed-82931", "permed-53344", "permed-61540", "permed-69749", "permed-12213", "permed-56678"]}
{"query_id": "topic_794_turn_1", "conversation_id": "topic_794", "turn_id": 1, "query": "What role does water play in protein-ligand interactions, especially in drug design?", "history": [], "ground_truth": ["permed-79544", "permed-79546", "permed-53321", "permed-75069", "permed-86889", "permed-75977", "permed-78128", "permed-79873", "permed-89298", "permed-53317"]}
{"query_id": "topic_794_turn_2", "conversation_id": "topic_794", "turn_id": 2, "query": "Can machine learning enhance our understanding of this interaction, particularly in predicting dynamic behaviors?", "history": ["What role does water play in protein-ligand interactions, especially in drug design?"], "ground_truth": ["permed-66495", "permed-57440", "permed-61945", "permed-52457", "permed-85551", "permed-84316", "permed-66489", "permed-71547", "permed-57441", "permed-90042"]}
{"query_id": "topic_794_turn_3", "conversation_id": "topic_794", "turn_id": 3, "query": "Given these approaches combining machine learning with protein-ligand interactions, how specifically could integrating ML algorithms with GCMC simulations improve our ability to predict dynamic water networks at these interfaces? And what implications might this have for optimizing drug efficacy and selectivity in structure-based drug design?", "history": ["What role does water play in protein-ligand interactions, especially in drug design?", "Can machine learning enhance our understanding of this interaction, particularly in predicting dynamic behaviors?"], "ground_truth": ["permed-79544", "permed-71538", "permed-79546", "permed-53317", "permed-53315", "permed-61284", "permed-52457", "permed-53316", "permed-75069", "permed-61283"]}
{"query_id": "topic_794_turn_4", "conversation_id": "topic_794", "turn_id": 4, "query": "Given this ML-GCMC integration approach for dynamic water networks, what specific algorithmic architecture would be most effective for coupling these methods? I'm particularly interested in how we might implement a feedback loop where the GCMC simulation data continuously trains the ML model, which in turn guides subsequent sampling - could you detail the technical implementation of such an iterative framework and what validation metrics would be essential to ensure statistical robustness in these predictions?", "history": ["What role does water play in protein-ligand interactions, especially in drug design?", "Can machine learning enhance our understanding of this interaction, particularly in predicting dynamic behaviors?", "Given these approaches combining machine learning with protein-ligand interactions, how specifically could integrating ML algorithms with GCMC simulations improve our ability to predict dynamic water networks at these interfaces? And what implications might this have for optimizing drug efficacy and selectivity in structure-based drug design?"], "ground_truth": ["permed-79544", "permed-72742", "permed-87492", "permed-68733", "permed-83745", "permed-89397", "permed-61722", "permed-87873", "permed-66168", "permed-29134"]}
{"query_id": "topic_794_turn_5", "conversation_id": "topic_794", "turn_id": 5, "query": "Given these sophisticated computational frameworks for predicting interfacial water networks, how have these predictions actually translated to improved clinical outcomes in structure-based drug development? Specifically, when pharmaceutical companies have utilized ML-GCMC approaches to optimize drug candidates targeting proteins like kinases or GPCRs, what measurable improvements in therapeutic efficacy, reduction of off-target effects, or enhanced clinical trial success rates have been documented? Are there case studies where accounting for dynamic water networks directly correlated with improved patient response or reduced adverse drug reactions in Phase II/III trials?", "history": ["What role does water play in protein-ligand interactions, especially in drug design?", "Can machine learning enhance our understanding of this interaction, particularly in predicting dynamic behaviors?", "Given these approaches combining machine learning with protein-ligand interactions, how specifically could integrating ML algorithms with GCMC simulations improve our ability to predict dynamic water networks at these interfaces? And what implications might this have for optimizing drug efficacy and selectivity in structure-based drug design?", "Given this ML-GCMC integration approach for dynamic water networks, what specific algorithmic architecture would be most effective for coupling these methods? I'm particularly interested in how we might implement a feedback loop where the GCMC simulation data continuously trains the ML model, which in turn guides subsequent sampling - could you detail the technical implementation of such an iterative framework and what validation metrics would be essential to ensure statistical robustness in these predictions?"], "ground_truth": ["permed-79544", "permed-79546", "permed-57952", "permed-52957", "permed-78128", "permed-84970", "permed-66841", "permed-86118", "permed-63050", "permed-73556"]}
{"query_id": "topic_794_turn_6", "conversation_id": "topic_794", "turn_id": 6, "query": "Given the documented translational challenges of ML-GCMC approaches in clinical drug development discussed earlier, how do these sophisticated water-network prediction methods compare with traditional structure-based drug design approaches in terms of cost-effectiveness and resource allocation? Specifically, when pharmaceutical companies face decisions between investing in these computationally intensive frameworks versus established methods like molecular docking with implicit solvation, what evidence exists regarding their comparative return on investment in terms of reduced late-stage attrition rates and overall development timeline acceleration?", "history": ["What role does water play in protein-ligand interactions, especially in drug design?", "Can machine learning enhance our understanding of this interaction, particularly in predicting dynamic behaviors?", "Given these approaches combining machine learning with protein-ligand interactions, how specifically could integrating ML algorithms with GCMC simulations improve our ability to predict dynamic water networks at these interfaces? And what implications might this have for optimizing drug efficacy and selectivity in structure-based drug design?", "Given this ML-GCMC integration approach for dynamic water networks, what specific algorithmic architecture would be most effective for coupling these methods? I'm particularly interested in how we might implement a feedback loop where the GCMC simulation data continuously trains the ML model, which in turn guides subsequent sampling - could you detail the technical implementation of such an iterative framework and what validation metrics would be essential to ensure statistical robustness in these predictions?", "Given these sophisticated computational frameworks for predicting interfacial water networks, how have these predictions actually translated to improved clinical outcomes in structure-based drug development? Specifically, when pharmaceutical companies have utilized ML-GCMC approaches to optimize drug candidates targeting proteins like kinases or GPCRs, what measurable improvements in therapeutic efficacy, reduction of off-target effects, or enhanced clinical trial success rates have been documented? Are there case studies where accounting for dynamic water networks directly correlated with improved patient response or reduced adverse drug reactions in Phase II/III trials?"], "ground_truth": ["permed-79544", "permed-52957", "permed-66035", "permed-92550", "permed-90340", "permed-61437", "permed-53733", "permed-66841", "permed-89422", "permed-66840"]}
{"query_id": "topic_795_turn_1", "conversation_id": "topic_795", "turn_id": 1, "query": "有没有关于 dapagliflozin 对慢性肾病患者的治疗效果的研究？", "history": [], "ground_truth": ["permed-80238", "permed-58401", "permed-58403", "permed-58407", "permed-58395", "permed-5836", "permed-23945", "permed-69051", "permed-58397", "permed-47345"]}
{"query_id": "topic_795_turn_2", "conversation_id": "topic_795", "turn_id": 2, "query": "这些研究中，dapagliflozin 是否显示出可以减少住院率或改善肾功能的潜力？", "history": ["有没有关于 dapagliflozin 对慢性肾病患者的治疗效果的研究？"], "ground_truth": ["permed-80238", "permed-58401", "permed-80239", "permed-64794", "permed-58397", "permed-68963", "permed-57372", "permed-57244", "permed-11996", "permed-69051"]}
{"query_id": "topic_795_turn_3", "conversation_id": "topic_795", "turn_id": 3, "query": "既然dapagliflozin在减少慢性肾病患者住院率方面效果显著，能否通过机制研究进一步探讨它是如何通过改善肾脏血流动力学和代谢功能来产生这些效果的？另外，考虑到患者肾功能损害程度不同，这些效应是否会随着肾功能恶化而有所差异？", "history": ["有没有关于 dapagliflozin 对慢性肾病患者的治疗效果的研究？", "这些研究中，dapagliflozin 是否显示出可以减少住院率或改善肾功能的潜力？"], "ground_truth": ["permed-80238", "permed-58401", "permed-69051", "permed-58403", "permed-11996", "permed-58322", "permed-58397", "permed-58407", "permed-57309", "permed-5836"]}
{"query_id": "topic_795_turn_4", "conversation_id": "topic_795", "turn_id": 4, "query": "Given this dual focus on hemodynamic and metabolic pathways, what specific experimental protocols would you recommend for simultaneously measuring renal plasma flow and tubular metabolic responses in human subjects? How were these parameters technically quantified in previous dapagliflozin studies - particularly regarding the timing of measurements relative to treatment initiation and the standardization procedures employed across different CKD stages to ensure comparability?", "history": ["有没有关于 dapagliflozin 对慢性肾病患者的治疗效果的研究？", "这些研究中，dapagliflozin 是否显示出可以减少住院率或改善肾功能的潜力？", "既然dapagliflozin在减少慢性肾病患者住院率方面效果显著，能否通过机制研究进一步探讨它是如何通过改善肾脏血流动力学和代谢功能来产生这些效果的？另外，考虑到患者肾功能损害程度不同，这些效应是否会随着肾功能恶化而有所差异？"], "ground_truth": ["permed-48625", "permed-80238", "permed-58401", "permed-78412", "permed-61148", "permed-69051", "permed-58397", "permed-58395", "permed-27723", "permed-47411"]}
{"query_id": "topic_795_turn_5", "conversation_id": "topic_795", "turn_id": 5, "query": "Building on these methodological insights about renal hemodynamic and metabolic monitoring, how have these physiological measurements translated to actual clinical outcomes in real-world dapagliflozin use? Specifically, what differential safety profiles and renal function preservation rates have been observed across CKD stages in post-marketing surveillance, particularly regarding electrolyte imbalances, volume depletion risks, and need for dose adjustments in advanced CKD? Additionally, how do these real-world findings compare with the DAPA-CKD trial results in terms of long-term renal replacement therapy delay and cardiovascular mortality reduction across different patient subgroups?", "history": ["有没有关于 dapagliflozin 对慢性肾病患者的治疗效果的研究？", "这些研究中，dapagliflozin 是否显示出可以减少住院率或改善肾功能的潜力？", "既然dapagliflozin在减少慢性肾病患者住院率方面效果显著，能否通过机制研究进一步探讨它是如何通过改善肾脏血流动力学和代谢功能来产生这些效果的？另外，考虑到患者肾功能损害程度不同，这些效应是否会随着肾功能恶化而有所差异？", "Given this dual focus on hemodynamic and metabolic pathways, what specific experimental protocols would you recommend for simultaneously measuring renal plasma flow and tubular metabolic responses in human subjects? How were these parameters technically quantified in previous dapagliflozin studies - particularly regarding the timing of measurements relative to treatment initiation and the standardization procedures employed across different CKD stages to ensure comparability?"], "ground_truth": ["permed-80238", "permed-58401", "permed-58397", "permed-80239", "permed-56949", "permed-58403", "permed-64838", "permed-58407", "permed-64794", "permed-5836"]}
{"query_id": "topic_795_turn_6", "conversation_id": "topic_795", "turn_id": 6, "query": "Given the established physiological mechanisms and real-world safety profiles discussed earlier, how does dapagliflozin's risk-benefit profile compare across different SGLT2 inhibitors in advanced CKD populations? Considering the DAPA-CKD findings and post-marketing data on electrolyte imbalances and volume depletion, what comparative evidence exists regarding renal protection versus adverse event rates between dapagliflozin, empagliflozin, and canagliflozin in patients with eGFR <30 mL/min/1.73m²? Specifically, how do their respective dose adjustment protocols and long-term renal replacement therapy delay compare when accounting for different baseline cardiovascular risks and concomitant medication use in real-world practice?", "history": ["有没有关于 dapagliflozin 对慢性肾病患者的治疗效果的研究？", "这些研究中，dapagliflozin 是否显示出可以减少住院率或改善肾功能的潜力？", "既然dapagliflozin在减少慢性肾病患者住院率方面效果显著，能否通过机制研究进一步探讨它是如何通过改善肾脏血流动力学和代谢功能来产生这些效果的？另外，考虑到患者肾功能损害程度不同，这些效应是否会随着肾功能恶化而有所差异？", "Given this dual focus on hemodynamic and metabolic pathways, what specific experimental protocols would you recommend for simultaneously measuring renal plasma flow and tubular metabolic responses in human subjects? How were these parameters technically quantified in previous dapagliflozin studies - particularly regarding the timing of measurements relative to treatment initiation and the standardization procedures employed across different CKD stages to ensure comparability?", "Building on these methodological insights about renal hemodynamic and metabolic monitoring, how have these physiological measurements translated to actual clinical outcomes in real-world dapagliflozin use? Specifically, what differential safety profiles and renal function preservation rates have been observed across CKD stages in post-marketing surveillance, particularly regarding electrolyte imbalances, volume depletion risks, and need for dose adjustments in advanced CKD? Additionally, how do these real-world findings compare with the DAPA-CKD trial results in terms of long-term renal replacement therapy delay and cardiovascular mortality reduction across different patient subgroups?"], "ground_truth": ["permed-58401", "permed-58403", "permed-78412", "permed-80238", "permed-89019", "permed-58395", "permed-58407", "permed-58399", "permed-23950", "permed-23954"]}
{"query_id": "topic_796_turn_1", "conversation_id": "topic_796", "turn_id": 1, "query": "Recent advances in medical imaging techniques for gastrointestinal stromal tumor (GIST) detection and diagnosis.", "history": [], "ground_truth": ["permed-80813", "permed-56337", "permed-92030", "permed-51378", "permed-77326", "permed-4013", "permed-92031", "permed-1174", "permed-81438", "permed-71656"]}
{"query_id": "topic_796_turn_2", "conversation_id": "topic_796", "turn_id": 2, "query": "Considering these GIST imaging advances, what is the comparative efficacy of emerging PET/CT tracers, like 68Ga-FAPI-04, versus traditional methods for detecting these cancers?", "history": ["Recent advances in medical imaging techniques for gastrointestinal stromal tumor (GIST) detection and diagnosis."], "ground_truth": ["permed-61159", "permed-77454", "permed-61160", "permed-29841", "permed-48495", "permed-77460", "permed-48397", "permed-77463", "permed-48494", "permed-77459"]}
{"query_id": "topic_796_turn_3", "conversation_id": "topic_796", "turn_id": 3, "query": "What are the molecular mechanisms underlying the superior sensitivity of 68Ga-FAPI-04 PET/CT compared to 18F-FDG PET/CT in malignant GISTs, and how can this inform development of improved diagnostic tools and targeted therapies?", "history": ["Recent advances in medical imaging techniques for gastrointestinal stromal tumor (GIST) detection and diagnosis.", "Considering these GIST imaging advances, what is the comparative efficacy of emerging PET/CT tracers, like 68Ga-FAPI-04, versus traditional methods for detecting these cancers?"], "ground_truth": ["permed-61159", "permed-61160", "permed-77460", "permed-77454", "permed-48494", "permed-29841", "permed-48495", "permed-48397", "permed-48592", "permed-36431"]}
{"query_id": "topic_796_turn_4", "conversation_id": "topic_796", "turn_id": 4, "query": "Given this mechanistic understanding of 68Ga-FAPI-04's enhanced sensitivity, what specific image acquisition protocols and quantitative parameters—such as optimal time-to-scan, standardized uptake value thresholds, or target-to-background ratios—were validated in the comparative clinical studies? Furthermore, what statistical methods were employed to ensure the robustness of sensitivity and specificity comparisons between these tracers, particularly in accounting for lesion heterogeneity and inter-observer variability in PET/CT interpretation?", "history": ["Recent advances in medical imaging techniques for gastrointestinal stromal tumor (GIST) detection and diagnosis.", "Considering these GIST imaging advances, what is the comparative efficacy of emerging PET/CT tracers, like 68Ga-FAPI-04, versus traditional methods for detecting these cancers?", "What are the molecular mechanisms underlying the superior sensitivity of 68Ga-FAPI-04 PET/CT compared to 18F-FDG PET/CT in malignant GISTs, and how can this inform development of improved diagnostic tools and targeted therapies?"], "ground_truth": ["permed-48498", "permed-29841", "permed-77460", "permed-61159", "permed-48494", "permed-61160", "permed-48495", "permed-77454", "permed-77459", "permed-42276"]}
{"query_id": "topic_796_turn_5", "conversation_id": "topic_796", "turn_id": 5, "query": "Given these validated imaging protocols and statistical comparisons, what clinical outcomes have been demonstrated when using 68Ga-FAPI-04 PET/CT to guide treatment decisions in GIST patients? Specifically, how does this imaging approach impact therapeutic management—such as altering surgical planning, enabling earlier treatment modifications in tyrosine kinase inhibitor therapy, or detecting non-responsive lesions—and what is the resulting effect on progression-free survival or overall response rates compared to standard 18F-FDG PET/CT-guided management in clinical practice?", "history": ["Recent advances in medical imaging techniques for gastrointestinal stromal tumor (GIST) detection and diagnosis.", "Considering these GIST imaging advances, what is the comparative efficacy of emerging PET/CT tracers, like 68Ga-FAPI-04, versus traditional methods for detecting these cancers?", "What are the molecular mechanisms underlying the superior sensitivity of 68Ga-FAPI-04 PET/CT compared to 18F-FDG PET/CT in malignant GISTs, and how can this inform development of improved diagnostic tools and targeted therapies?", "Given this mechanistic understanding of 68Ga-FAPI-04's enhanced sensitivity, what specific image acquisition protocols and quantitative parameters—such as optimal time-to-scan, standardized uptake value thresholds, or target-to-background ratios—were validated in the comparative clinical studies? Furthermore, what statistical methods were employed to ensure the robustness of sensitivity and specificity comparisons between these tracers, particularly in accounting for lesion heterogeneity and inter-observer variability in PET/CT interpretation?"], "ground_truth": ["permed-61159", "permed-48495", "permed-77454", "permed-48494", "permed-29841", "permed-61160", "permed-36431", "permed-48498", "permed-77460", "permed-48397"]}
{"query_id": "topic_796_turn_6", "conversation_id": "topic_796", "turn_id": 6, "query": "Building upon the demonstrated clinical outcomes of 68Ga-FAPI-04 PET/CT in GIST management, how does its long-term cost-effectiveness and resource utilization profile compare to standard 18F-FDG PET/CT when considering total diagnostic pathways? Specifically, what are the trade-offs between 68Ga-FAPI-04's superior sensitivity—potentially reducing unnecessary treatments through earlier response assessment—versus its current higher tracer costs and limited availability? How might emerging theranostic applications, where FAPI ligands could be leveraged for both diagnosis and targeted radiotherapy, alter this comparative value proposition in future GIST care models?", "history": ["Recent advances in medical imaging techniques for gastrointestinal stromal tumor (GIST) detection and diagnosis.", "Considering these GIST imaging advances, what is the comparative efficacy of emerging PET/CT tracers, like 68Ga-FAPI-04, versus traditional methods for detecting these cancers?", "What are the molecular mechanisms underlying the superior sensitivity of 68Ga-FAPI-04 PET/CT compared to 18F-FDG PET/CT in malignant GISTs, and how can this inform development of improved diagnostic tools and targeted therapies?", "Given this mechanistic understanding of 68Ga-FAPI-04's enhanced sensitivity, what specific image acquisition protocols and quantitative parameters—such as optimal time-to-scan, standardized uptake value thresholds, or target-to-background ratios—were validated in the comparative clinical studies? Furthermore, what statistical methods were employed to ensure the robustness of sensitivity and specificity comparisons between these tracers, particularly in accounting for lesion heterogeneity and inter-observer variability in PET/CT interpretation?", "Given these validated imaging protocols and statistical comparisons, what clinical outcomes have been demonstrated when using 68Ga-FAPI-04 PET/CT to guide treatment decisions in GIST patients? Specifically, how does this imaging approach impact therapeutic management—such as altering surgical planning, enabling earlier treatment modifications in tyrosine kinase inhibitor therapy, or detecting non-responsive lesions—and what is the resulting effect on progression-free survival or overall response rates compared to standard 18F-FDG PET/CT-guided management in clinical practice?"], "ground_truth": ["permed-61159", "permed-61160", "permed-77454", "permed-48495", "permed-77460", "permed-48494", "permed-29841", "permed-48397", "permed-48498", "permed-48512"]}
{"query_id": "topic_797_turn_1", "conversation_id": "topic_797", "turn_id": 1, "query": "What impact does oil sands extraction have on aquatic ecosystems downstream?", "history": [], "ground_truth": ["permed-81984", "permed-59331", "permed-88379", "permed-81008", "permed-88879", "permed-64762", "permed-82046", "permed-81989", "permed-64765", "permed-80535"]}
{"query_id": "topic_797_turn_2", "conversation_id": "topic_797", "turn_id": 2, "query": "How do changes in bitumen sediments from this process affect contaminant levels in these ecosystems?", "history": ["What impact does oil sands extraction have on aquatic ecosystems downstream?"], "ground_truth": ["permed-81984", "permed-81986", "permed-81989", "permed-81008", "permed-88379", "permed-80986", "permed-88887", "permed-72732", "permed-81897", "permed-81009"]}
{"query_id": "topic_797_turn_3", "conversation_id": "topic_797", "turn_id": 3, "query": "How do these variations in bitumen sediments' chemical composition and physical properties—affected by weathering and erosion stages—influence contaminant bioaccumulation and biomagnification in aquatic food webs? And what would the long-term ecological consequences be for higher trophic levels in those downstream river ecosystems?", "history": ["What impact does oil sands extraction have on aquatic ecosystems downstream?", "How do changes in bitumen sediments from this process affect contaminant levels in these ecosystems?"], "ground_truth": ["permed-81984", "permed-81006", "permed-88379", "permed-81986", "permed-80989", "permed-80585", "permed-80542", "permed-72734", "permed-81010", "permed-89734"]}
{"query_id": "topic_797_turn_4", "conversation_id": "topic_797", "turn_id": 4, "query": "Given these complex interactions between sediment properties and contaminant transfer, what specific analytical methods would you employ to quantify bioaccumulation factors across different trophic levels? I'm particularly interested in the sampling protocols for tissue analysis, the chromatography techniques for detecting trace contaminants, and how you'd statistically model biomagnification factors while accounting for sediment composition variables. Also, what quality control measures would ensure reproducibility when tracking these low-concentration compounds through entire food webs?", "history": ["What impact does oil sands extraction have on aquatic ecosystems downstream?", "How do changes in bitumen sediments from this process affect contaminant levels in these ecosystems?", "How do these variations in bitumen sediments' chemical composition and physical properties—affected by weathering and erosion stages—influence contaminant bioaccumulation and biomagnification in aquatic food webs? And what would the long-term ecological consequences be for higher trophic levels in those downstream river ecosystems?"], "ground_truth": ["permed-81986", "permed-77825", "permed-80989", "permed-85538", "permed-88882", "permed-73269", "permed-89734", "permed-88887", "permed-85883", "permed-80983"]}
{"query_id": "topic_797_turn_5", "conversation_id": "topic_797", "turn_id": 5, "query": "Given these sophisticated analytical methods for tracking contaminant transfer through aquatic food webs, how might these findings inform clinical risk assessment for human populations consuming fish from affected waterways? Specifically, what epidemiological approaches would help correlate measured bioaccumulation factors with adverse health outcomes, and how could contaminant levels detected through your chromatography techniques translate into clinical guidance about safe consumption thresholds? Considering the biomagnification patterns you described, what would be the most concerning endpoints for vulnerable subpopulations like pregnant women or children, and what clinical monitoring strategies would you recommend?", "history": ["What impact does oil sands extraction have on aquatic ecosystems downstream?", "How do changes in bitumen sediments from this process affect contaminant levels in these ecosystems?", "How do these variations in bitumen sediments' chemical composition and physical properties—affected by weathering and erosion stages—influence contaminant bioaccumulation and biomagnification in aquatic food webs? And what would the long-term ecological consequences be for higher trophic levels in those downstream river ecosystems?", "Given these complex interactions between sediment properties and contaminant transfer, what specific analytical methods would you employ to quantify bioaccumulation factors across different trophic levels? I'm particularly interested in the sampling protocols for tissue analysis, the chromatography techniques for detecting trace contaminants, and how you'd statistically model biomagnification factors while accounting for sediment composition variables. Also, what quality control measures would ensure reproducibility when tracking these low-concentration compounds through entire food webs?"], "ground_truth": ["permed-77826", "permed-80039", "permed-90437", "permed-77827", "permed-85536", "permed-85538", "permed-77825", "permed-76126", "permed-85541", "permed-77821"]}
{"query_id": "topic_797_turn_6", "conversation_id": "topic_797", "turn_id": 6, "query": "Given our progression from ecosystem impacts to human clinical risks, how would you precisely define the \"biomagnification factor\" as both an analytical chemistry measurement and epidemiological risk parameter? Considering the methodological complexities from Turn 4 and clinical translation challenges from Turn 5, what operational definitions distinguish BMF from bioaccumulation factors in regulatory contexts, and how might evolving definitions account for differential contaminant speciation across trophic levels? Fundamentally, what conceptual framework unifies these definitions across environmental chemistry and public health disciplines when establishing protective thresholds?", "history": ["What impact does oil sands extraction have on aquatic ecosystems downstream?", "How do changes in bitumen sediments from this process affect contaminant levels in these ecosystems?", "How do these variations in bitumen sediments' chemical composition and physical properties—affected by weathering and erosion stages—influence contaminant bioaccumulation and biomagnification in aquatic food webs? And what would the long-term ecological consequences be for higher trophic levels in those downstream river ecosystems?", "Given these complex interactions between sediment properties and contaminant transfer, what specific analytical methods would you employ to quantify bioaccumulation factors across different trophic levels? I'm particularly interested in the sampling protocols for tissue analysis, the chromatography techniques for detecting trace contaminants, and how you'd statistically model biomagnification factors while accounting for sediment composition variables. Also, what quality control measures would ensure reproducibility when tracking these low-concentration compounds through entire food webs?", "Given these sophisticated analytical methods for tracking contaminant transfer through aquatic food webs, how might these findings inform clinical risk assessment for human populations consuming fish from affected waterways? Specifically, what epidemiological approaches would help correlate measured bioaccumulation factors with adverse health outcomes, and how could contaminant levels detected through your chromatography techniques translate into clinical guidance about safe consumption thresholds? Considering the biomagnification patterns you described, what would be the most concerning endpoints for vulnerable subpopulations like pregnant women or children, and what clinical monitoring strategies would you recommend?"], "ground_truth": ["permed-77825", "permed-59127", "permed-59130", "permed-62957", "permed-59291", "permed-89734", "permed-74144", "permed-31417", "permed-65860", "permed-85538"]}
{"query_id": "topic_798_turn_1", "conversation_id": "topic_798", "turn_id": 1, "query": "Overview of current methods for PIK3CA mutation detection in colorectal cancer", "history": [], "ground_truth": ["permed-74203", "permed-85505", "permed-68722", "permed-82373", "permed-74204", "permed-35195", "permed-73548", "permed-64384", "permed-78605", "permed-50790"]}
{"query_id": "topic_798_turn_2", "conversation_id": "topic_798", "turn_id": 2, "query": "Assessing qPCR effectiveness for detecting these PIK3CA mutations in colorectal cancer across diverse patient populations and genetic backgrounds", "history": ["Overview of current methods for PIK3CA mutation detection in colorectal cancer"], "ground_truth": ["permed-74203", "permed-68722", "permed-35195", "permed-73548", "permed-72554", "permed-82373", "permed-74204", "permed-68718", "permed-53718", "permed-56188"]}
{"query_id": "topic_798_turn_3", "conversation_id": "topic_798", "turn_id": 3, "query": "Multiplex allele-specific qPCR for PIK3CA exon mutation profiling in colorectal cancer: implications for personalized therapy, cross-population utility, and targeting newly identified rare variants for PI3K pathway inhibitors", "history": ["Overview of current methods for PIK3CA mutation detection in colorectal cancer", "Assessing qPCR effectiveness for detecting these PIK3CA mutations in colorectal cancer across diverse patient populations and genetic backgrounds"], "ground_truth": ["permed-74203", "permed-68722", "permed-82373", "permed-74204", "permed-73548", "permed-53718", "permed-67158", "permed-78605", "permed-85505", "permed-50790"]}
{"query_id": "topic_798_turn_4", "conversation_id": "topic_798", "turn_id": 4, "query": "Regarding this multiplex allele-specific qPCR approach for PIK3CA exon mutation profiling, could you elaborate on the specific primer and probe validation protocols used to distinguish between common hotspot mutations and rare variants? I'm particularly interested in how you established analytical sensitivity thresholds for low-frequency mutations and what statistical methods were employed to validate assay specificity across different genetic backgrounds while maintaining reproducibility in clinical samples.", "history": ["Overview of current methods for PIK3CA mutation detection in colorectal cancer", "Assessing qPCR effectiveness for detecting these PIK3CA mutations in colorectal cancer across diverse patient populations and genetic backgrounds", "Multiplex allele-specific qPCR for PIK3CA exon mutation profiling in colorectal cancer: implications for personalized therapy, cross-population utility, and targeting newly identified rare variants for PI3K pathway inhibitors"], "ground_truth": ["permed-74203", "permed-68718", "permed-47854", "permed-68722", "permed-37619", "permed-4805", "permed-48119", "permed-66237", "permed-21892", "permed-82289"]}
{"query_id": "topic_798_turn_5", "conversation_id": "topic_798", "turn_id": 5, "query": "Given the detailed analytical validation protocols established for multiplex allele-specific qPCR in detecting PIK3CA mutations, how have these methodological refinements translated to clinical utility in colorectal cancer patients? Specifically, what clinical trial evidence exists regarding therapeutic outcomes when using this approach to guide PI3K pathway inhibitor selection? I'm interested in real-world data on how detection sensitivity for low-frequency mutations correlates with treatment response rates and whether any safety considerations or unexpected side effects have emerged when targeting rare variants identified through this enhanced profiling method.", "history": ["Overview of current methods for PIK3CA mutation detection in colorectal cancer", "Assessing qPCR effectiveness for detecting these PIK3CA mutations in colorectal cancer across diverse patient populations and genetic backgrounds", "Multiplex allele-specific qPCR for PIK3CA exon mutation profiling in colorectal cancer: implications for personalized therapy, cross-population utility, and targeting newly identified rare variants for PI3K pathway inhibitors", "Regarding this multiplex allele-specific qPCR approach for PIK3CA exon mutation profiling, could you elaborate on the specific primer and probe validation protocols used to distinguish between common hotspot mutations and rare variants? I'm particularly interested in how you established analytical sensitivity thresholds for low-frequency mutations and what statistical methods were employed to validate assay specificity across different genetic backgrounds while maintaining reproducibility in clinical samples."], "ground_truth": ["permed-74203", "permed-68718", "permed-35195", "permed-47854", "permed-68722", "permed-74204", "permed-3632", "permed-79706", "permed-49227", "permed-81584"]}
{"query_id": "topic_798_turn_6", "conversation_id": "topic_798", "turn_id": 6, "query": "Given the comprehensive validation and emerging clinical evidence for multiplex allele-specific qPCR in PIK3CA profiling, how does this approach compare economically and logistically with emerging alternatives like digital PCR and next-generation sequencing for routine clinical implementation? Specifically, considering our previous discussion about analytical sensitivity and clinical utility, what are the trade-offs in cost-effectiveness, turnaround time, and infrastructure requirements when implementing these different detection platforms across diverse healthcare settings, particularly for guiding PI3K inhibitor therapy in metastatic colorectal cancer?", "history": ["Overview of current methods for PIK3CA mutation detection in colorectal cancer", "Assessing qPCR effectiveness for detecting these PIK3CA mutations in colorectal cancer across diverse patient populations and genetic backgrounds", "Multiplex allele-specific qPCR for PIK3CA exon mutation profiling in colorectal cancer: implications for personalized therapy, cross-population utility, and targeting newly identified rare variants for PI3K pathway inhibitors", "Regarding this multiplex allele-specific qPCR approach for PIK3CA exon mutation profiling, could you elaborate on the specific primer and probe validation protocols used to distinguish between common hotspot mutations and rare variants? I'm particularly interested in how you established analytical sensitivity thresholds for low-frequency mutations and what statistical methods were employed to validate assay specificity across different genetic backgrounds while maintaining reproducibility in clinical samples.", "Given the detailed analytical validation protocols established for multiplex allele-specific qPCR in detecting PIK3CA mutations, how have these methodological refinements translated to clinical utility in colorectal cancer patients? Specifically, what clinical trial evidence exists regarding therapeutic outcomes when using this approach to guide PI3K pathway inhibitor selection? I'm interested in real-world data on how detection sensitivity for low-frequency mutations correlates with treatment response rates and whether any safety considerations or unexpected side effects have emerged when targeting rare variants identified through this enhanced profiling method."], "ground_truth": ["permed-74203", "permed-68722", "permed-68718", "permed-65911", "permed-6314", "permed-49229", "permed-6315", "permed-4683", "permed-65908", "permed-82289"]}
{"query_id": "topic_799_turn_1", "conversation_id": "topic_799", "turn_id": 1, "query": "Overview of recent MRI advancements for metabolic imaging using hyperpolarized [1-<sup>13</sup>C]-pyruvate and similar isotopic tracers", "history": [], "ground_truth": ["permed-51667", "permed-28390", "permed-29232", "permed-56321", "permed-60510", "permed-23985", "permed-5375", "permed-58101", "permed-23988", "permed-72746"]}
{"query_id": "topic_799_turn_2", "conversation_id": "topic_799", "turn_id": 2, "query": "Regarding these recent MRI advancements with hyperpolarized [1-<sup>13</sup>C]-pyruvate, how does the MoReFUn technique specifically enhance image quality and data acquisition speed under complex physiological conditions?", "history": ["Overview of recent MRI advancements for metabolic imaging using hyperpolarized [1-<sup>13</sup>C]-pyruvate and similar isotopic tracers"], "ground_truth": ["permed-51667", "permed-28390", "permed-29232", "permed-72746", "permed-72745", "permed-75784", "permed-28453", "permed-17797", "permed-29048", "permed-85125"]}
{"query_id": "topic_799_turn_3", "conversation_id": "topic_799", "turn_id": 3, "query": "Building on MoReFUn's established benefits for dynamic hyperpolarized [1-<sup>13</sup>C]-pyruvate imaging, what are the future research directions for its applicability across diverse physiological states (including tumor microenvironment variations, individual metabolic rate differences, and disease progression impacts on image reconstruction quality), and for optimizing its pharmacokinetic model parameters to enhance sensitivity and specificity in detecting trace metabolites under low signal-to-noise conditions?", "history": ["Overview of recent MRI advancements for metabolic imaging using hyperpolarized [1-<sup>13</sup>C]-pyruvate and similar isotopic tracers", "Regarding these recent MRI advancements with hyperpolarized [1-<sup>13</sup>C]-pyruvate, how does the MoReFUn technique specifically enhance image quality and data acquisition speed under complex physiological conditions?"], "ground_truth": ["permed-51667", "permed-28390", "permed-81251", "permed-75784", "permed-54214", "permed-85064", "permed-18626", "permed-23985", "permed-48454", "permed-17028"]}
{"query_id": "topic_799_turn_4", "conversation_id": "topic_799", "turn_id": 4, "query": "Building on these pharmacokinetic modeling optimizations for trace metabolite detection, what specific statistical validation frameworks were employed to assess parameter identifiability and model robustness across varying SNR regimes? I'm particularly interested in how researchers implemented uncertainty quantification for metabolic rate constants, whether they used Bayesian approaches or bootstrap methods, and what criteria determined the optimal trade-off between model complexity and parameter precision during fitting procedures for low-abundance metabolites like [1-13C]-lactate in heterogeneous tumor regions.", "history": ["Overview of recent MRI advancements for metabolic imaging using hyperpolarized [1-<sup>13</sup>C]-pyruvate and similar isotopic tracers", "Regarding these recent MRI advancements with hyperpolarized [1-<sup>13</sup>C]-pyruvate, how does the MoReFUn technique specifically enhance image quality and data acquisition speed under complex physiological conditions?", "Building on MoReFUn's established benefits for dynamic hyperpolarized [1-<sup>13</sup>C]-pyruvate imaging, what are the future research directions for its applicability across diverse physiological states (including tumor microenvironment variations, individual metabolic rate differences, and disease progression impacts on image reconstruction quality), and for optimizing its pharmacokinetic model parameters to enhance sensitivity and specificity in detecting trace metabolites under low signal-to-noise conditions?"], "ground_truth": ["permed-77558", "permed-73444", "permed-53350", "permed-58106", "permed-55481", "permed-79012", "permed-77757", "permed-77753", "permed-69753", "permed-51667"]}
{"query_id": "topic_799_turn_5", "conversation_id": "topic_799", "turn_id": 5, "query": "Given the statistical validation frameworks for parameter identifiability in hyperpolarized [1-<sup>13</sup>C]-pyruvate imaging, how have these pharmacokinetic modeling approaches translated to clinical oncology applications? Specifically, what clinical trial evidence exists correlating quantified metabolic rate constants—particularly lactate production—with treatment response assessment in human tumors? I'm interested in how these metabolic measurements compare to RECIST criteria for early therapy response prediction, and what practical implementation challenges arise when deploying these complex models in multicenter trials with standardized acquisition protocols.", "history": ["Overview of recent MRI advancements for metabolic imaging using hyperpolarized [1-<sup>13</sup>C]-pyruvate and similar isotopic tracers", "Regarding these recent MRI advancements with hyperpolarized [1-<sup>13</sup>C]-pyruvate, how does the MoReFUn technique specifically enhance image quality and data acquisition speed under complex physiological conditions?", "Building on MoReFUn's established benefits for dynamic hyperpolarized [1-<sup>13</sup>C]-pyruvate imaging, what are the future research directions for its applicability across diverse physiological states (including tumor microenvironment variations, individual metabolic rate differences, and disease progression impacts on image reconstruction quality), and for optimizing its pharmacokinetic model parameters to enhance sensitivity and specificity in detecting trace metabolites under low signal-to-noise conditions?", "Building on these pharmacokinetic modeling optimizations for trace metabolite detection, what specific statistical validation frameworks were employed to assess parameter identifiability and model robustness across varying SNR regimes? I'm particularly interested in how researchers implemented uncertainty quantification for metabolic rate constants, whether they used Bayesian approaches or bootstrap methods, and what criteria determined the optimal trade-off between model complexity and parameter precision during fitting procedures for low-abundance metabolites like [1-13C]-lactate in heterogeneous tumor regions."], "ground_truth": ["permed-60510", "permed-51667", "permed-56749", "permed-85064", "permed-91241", "permed-56748", "permed-56687", "permed-57944", "permed-56108", "permed-60573"]}
{"query_id": "topic_799_turn_6", "conversation_id": "topic_799", "turn_id": 6, "query": "Given the established correlation between hyperpolarized [1-<sup>13</sup>C]-pyruvate-derived metabolic measurements and treatment response in clinical trials, how do the implementation challenges and predictive performance of this metabolic imaging approach compare against emerging PET alternatives like <sup>18</sup>F-FDG PET/MRI and <sup>18</sup>F-fluorothymidine (FLT) for early therapy assessment? Specifically, what are the comparative trade-offs in terms of tracer availability, quantification complexity, spatial resolution, and clinical workflow integration that might influence their respective adoption pathways in oncology?", "history": ["Overview of recent MRI advancements for metabolic imaging using hyperpolarized [1-<sup>13</sup>C]-pyruvate and similar isotopic tracers", "Regarding these recent MRI advancements with hyperpolarized [1-<sup>13</sup>C]-pyruvate, how does the MoReFUn technique specifically enhance image quality and data acquisition speed under complex physiological conditions?", "Building on MoReFUn's established benefits for dynamic hyperpolarized [1-<sup>13</sup>C]-pyruvate imaging, what are the future research directions for its applicability across diverse physiological states (including tumor microenvironment variations, individual metabolic rate differences, and disease progression impacts on image reconstruction quality), and for optimizing its pharmacokinetic model parameters to enhance sensitivity and specificity in detecting trace metabolites under low signal-to-noise conditions?", "Building on these pharmacokinetic modeling optimizations for trace metabolite detection, what specific statistical validation frameworks were employed to assess parameter identifiability and model robustness across varying SNR regimes? I'm particularly interested in how researchers implemented uncertainty quantification for metabolic rate constants, whether they used Bayesian approaches or bootstrap methods, and what criteria determined the optimal trade-off between model complexity and parameter precision during fitting procedures for low-abundance metabolites like [1-13C]-lactate in heterogeneous tumor regions.", "Given the statistical validation frameworks for parameter identifiability in hyperpolarized [1-<sup>13</sup>C]-pyruvate imaging, how have these pharmacokinetic modeling approaches translated to clinical oncology applications? Specifically, what clinical trial evidence exists correlating quantified metabolic rate constants—particularly lactate production—with treatment response assessment in human tumors? I'm interested in how these metabolic measurements compare to RECIST criteria for early therapy response prediction, and what practical implementation challenges arise when deploying these complex models in multicenter trials with standardized acquisition protocols."], "ground_truth": ["permed-56107", "permed-51667", "permed-56108", "permed-87434", "permed-32084", "permed-68203", "permed-60510", "permed-60573", "permed-75851", "permed-85064"]}
{"query_id": "topic_800_turn_1", "conversation_id": "topic_800", "turn_id": 1, "query": "Overview of psilocybin's potential therapeutic effects in neurodevelopmental disorders", "history": [], "ground_truth": ["permed-88083", "permed-63277", "permed-69765", "permed-82264", "permed-76968", "permed-66183", "permed-66542", "permed-67682", "permed-66783", "permed-69771"]}
{"query_id": "topic_800_turn_2", "conversation_id": "topic_800", "turn_id": 2, "query": "Building on these potential neurodevelopmental benefits, how might psilocybin impact critical brain development periods to offer new therapeutic avenues specifically for autism spectrum disorder?", "history": ["Overview of psilocybin's potential therapeutic effects in neurodevelopmental disorders"], "ground_truth": ["permed-63277", "permed-80465", "permed-55749", "permed-67665", "permed-68378", "permed-90658", "permed-63270", "permed-59390", "permed-67666", "permed-69765"]}
{"query_id": "topic_800_turn_3", "conversation_id": "topic_800", "turn_id": 3, "query": "For psilocybin treatment in ASD models during critical developmental windows, how do variations in timing and duration affect long-term cognitive outcomes and neural plasticity, what are the underlying neurobiological mechanisms, and how can this inform targeted human therapies, drawing parallels from Fragile X syndrome research?", "history": ["Overview of psilocybin's potential therapeutic effects in neurodevelopmental disorders", "Building on these potential neurodevelopmental benefits, how might psilocybin impact critical brain development periods to offer new therapeutic avenues specifically for autism spectrum disorder?"], "ground_truth": ["permed-63277", "permed-63274", "permed-55503", "permed-63373", "permed-55749", "permed-88733", "permed-63270", "permed-88084", "permed-63278", "permed-63149"]}
{"query_id": "topic_800_turn_4", "conversation_id": "topic_800", "turn_id": 4, "query": "Given these investigations into timing and duration variables, could you elaborate on the specific experimental protocols used to administer psilocybin during developmental windows in ASD models? I'm particularly interested in the dosing regimens, administration routes, and temporal precision of interventions relative to developmental milestones. Additionally, what statistical approaches were employed to distinguish between transient versus lasting cognitive effects, and how did researchers control for confounding variables like stress responses during administration?", "history": ["Overview of psilocybin's potential therapeutic effects in neurodevelopmental disorders", "Building on these potential neurodevelopmental benefits, how might psilocybin impact critical brain development periods to offer new therapeutic avenues specifically for autism spectrum disorder?", "For psilocybin treatment in ASD models during critical developmental windows, how do variations in timing and duration affect long-term cognitive outcomes and neural plasticity, what are the underlying neurobiological mechanisms, and how can this inform targeted human therapies, drawing parallels from Fragile X syndrome research?"], "ground_truth": ["permed-63277", "permed-12140", "permed-69765", "permed-66183", "permed-88083", "permed-55503", "permed-25468", "permed-55726", "permed-67666", "permed-83392"]}
{"query_id": "topic_800_turn_5", "conversation_id": "topic_800", "turn_id": 5, "query": "Given the detailed experimental protocols and statistical controls for developmental psilocybin administration in ASD models, what clinical translation challenges have emerged regarding therapeutic window determination in human pediatric populations? Specifically, how do researchers address safety monitoring for potential neuropsychiatric side effects when translating these precise dosing regimens, and what preliminary clinical evidence exists regarding cognitive versus behavioral outcome measures in early-phase trials? Furthermore, how are regulatory frameworks adapting to accommodate developmental timing considerations while ensuring patient safety in this novel therapeutic domain?", "history": ["Overview of psilocybin's potential therapeutic effects in neurodevelopmental disorders", "Building on these potential neurodevelopmental benefits, how might psilocybin impact critical brain development periods to offer new therapeutic avenues specifically for autism spectrum disorder?", "For psilocybin treatment in ASD models during critical developmental windows, how do variations in timing and duration affect long-term cognitive outcomes and neural plasticity, what are the underlying neurobiological mechanisms, and how can this inform targeted human therapies, drawing parallels from Fragile X syndrome research?", "Given these investigations into timing and duration variables, could you elaborate on the specific experimental protocols used to administer psilocybin during developmental windows in ASD models? I'm particularly interested in the dosing regimens, administration routes, and temporal precision of interventions relative to developmental milestones. Additionally, what statistical approaches were employed to distinguish between transient versus lasting cognitive effects, and how did researchers control for confounding variables like stress responses during administration?"], "ground_truth": ["permed-63277", "permed-55682", "permed-69765", "permed-87458", "permed-74814", "permed-88083", "permed-66183", "permed-72491", "permed-81922", "permed-50787"]}
{"query_id": "topic_800_turn_6", "conversation_id": "topic_800", "turn_id": 6, "query": "Given the translational challenges and regulatory considerations discussed, how do the risk-benefit profiles of psilocybin therapy in pediatric ASD populations compare against emerging alternatives like oxytocin or cannabinoid-based interventions? Specifically, considering the narrow therapeutic windows and developmental timing precision required for psilocybin, what comparative advantages exist regarding neural plasticity mechanisms versus the more established safety profiles of alternative approaches? How do these trade-offs influence research prioritization and clinical trial design for neurodevelopmental interventions, particularly when balancing long-term cognitive benefits against acute neuropsychiatric risks?", "history": ["Overview of psilocybin's potential therapeutic effects in neurodevelopmental disorders", "Building on these potential neurodevelopmental benefits, how might psilocybin impact critical brain development periods to offer new therapeutic avenues specifically for autism spectrum disorder?", "For psilocybin treatment in ASD models during critical developmental windows, how do variations in timing and duration affect long-term cognitive outcomes and neural plasticity, what are the underlying neurobiological mechanisms, and how can this inform targeted human therapies, drawing parallels from Fragile X syndrome research?", "Given these investigations into timing and duration variables, could you elaborate on the specific experimental protocols used to administer psilocybin during developmental windows in ASD models? I'm particularly interested in the dosing regimens, administration routes, and temporal precision of interventions relative to developmental milestones. Additionally, what statistical approaches were employed to distinguish between transient versus lasting cognitive effects, and how did researchers control for confounding variables like stress responses during administration?", "Given the detailed experimental protocols and statistical controls for developmental psilocybin administration in ASD models, what clinical translation challenges have emerged regarding therapeutic window determination in human pediatric populations? Specifically, how do researchers address safety monitoring for potential neuropsychiatric side effects when translating these precise dosing regimens, and what preliminary clinical evidence exists regarding cognitive versus behavioral outcome measures in early-phase trials? Furthermore, how are regulatory frameworks adapting to accommodate developmental timing considerations while ensuring patient safety in this novel therapeutic domain?"], "ground_truth": ["permed-63277", "permed-69765", "permed-55681", "permed-67670", "permed-77571", "permed-87458", "permed-72491", "permed-88083", "permed-58512", "permed-68378"]}
